,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,150001,"Carbamic acid, (5-amino-3-(3,4-dichlorophenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC(=C(C=C3)Cl)Cl)N,,,,,,
1,150002,"Carbamic acid, (5-amino-1,2-dihydro-3-(3-methoxyphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC(=CC=C3)OC)N,,,,,,
2,150003,"Carbamic acid, (5-amino-1,2-dihydro-3-(4-methoxyphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)OC)N,,,,,,
3,150004,"Carbamic acid, (5-amino-1,2-dihydro-3-(3,4,5-trimethoxyphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC(=C(C(=C3)OC)OC)OC)N,,,,,,
4,150005,"Carbamic acid, (5-amino-3-(4-aminophenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)N)N,,,,,,
5,150006,"Carbamic acid, (5-amino-1,2-dihydro-3-(4-(trifluoromethyl)phenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)C(F)(F)F)N,,,,,,
6,150007,"Carbamic acid, (5-amino-3-(1,1'-biphenyl)-4-yl-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)C4=CC=CC=C4)N,,,,,,
7,150008,"5H-Indolo(2,3-c)acridine",C1=CC=C2C(=C1)C=C3C=CC4=C(C3=N2)C5=CC=CC=C5N4,,,,,,
8,150009,"Benzo(h)naphtho(2,1,8-def)quinoline",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=C4)C=CN=C25,,,,,,
9,150010,"Bis(2,3-dibromopropyl) methylphosphate",COP(=O)(OCC(CBr)Br)OCC(CBr)Br,,,,,,
10,150011,"Phosphoric acid, 2-bromoallyl 2,3-dibromopropyl methyl ester",COP(=O)(OCC(CBr)Br)OCC(=C)Br,,,,,,
11,150012,"Phosphoric acid, bis(2-bromoallyl) methyl ester",COP(=O)(OCC(=C)Br)OCC(=C)Br,,,,,,
12,150013,"Phosphoric acid, 2-bromoallyl dimethyl ester",COP(=O)(OC)OCC(=C)Br,,,,,,
13,150014,"2,3-Dibromopropyl dimethylphosphate",COP(=O)(OC)OCC(CBr)Br,,,,,,
14,150015,Ethyl 4-((4-(bis(2-hydroxyethyl)amino)phenyl)azo)-3-bromo-5-nitrobenzoate,CCOC(=O)C1=CC(=C(C(=C1)Br)N=NC2=CC=C(C=C2)N(CCO)CCO)[N+](=O)[O-],,,,,,
15,150016,"Benzoic acid, 4-[[4-[bis(2-hydroxyethyl)amino]-2-methylphenyl]azo]-3-bromo-5-nitro-, ethyl ester",CCOC(=O)C1=CC(=C(C(=C1)Br)N=NC2=C(C=C(C=C2)N(CCO)CCO)C)[N+](=O)[O-],,,,,,
16,150017,"3-Nitrobenzothiazolo(3,2-a)quinolinium chloride",C1=CC=C2C(=C1)[N+]3=C(S2)C=CC4=C3C=CC(=C4)[N+](=O)[O-].[Cl-],,,,,,
17,150018,CID 150018,CC(C)C1=CC(=N)C(=CC1=N)N(O)O,,,,,,
18,150019,"Benzo(a)pyrene, 7,8-dimethyl-",CC1=C(C2=C(C=C1)C3=C4C(=C2)C=CC5=C4C(=CC=C5)C=C3)C,,,,,,
19,150020,"Propanamide, N,N'-1,2-ethanediylbis(3-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCC(=O)NCCNC(=O)CCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
20,150021,"Propanamide, N,N'-1,3-propanediylbis(3-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCC(=O)NCCCNC(=O)CCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
21,150022,"Glycinamide, N-9-acridinyl-beta-alanyl-N-(3-((N-(N-9-acridinyl-beta-alanyl)glycyl)amino)propyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCC(=O)NCC(=O)NCCCNCC(=O)NC(=O)CCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
22,150023,"Glycine, N-9-acridinyl-, 2-((9-acridinylamino)acetyl)hydrazide, dihydrobromide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCC(=O)NNC(=O)CNC4=C5C=CC=CC5=NC6=CC=CC=C64.Br.Br,,,,,,
23,150024,2-(acridin-9-ylamino)-N'-[2-(acridin-9-ylamino)acetyl]acetohydrazide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCC(=O)NNC(=O)CNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
24,150025,"15,16-Dihydro-15-methoxy-17H-cyclopenta(a)phenanthren-17-one",COC1CC(=O)C2=C1C3=C(C=C2)C4=CC=CC=C4C=C3,,,,,,
25,150026,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11-butoxy-",CCCCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,,,,,,
26,150027,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11-(pentyloxy)-",CCCCCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,,,,,,
27,150028,"15,16-Dihydro-11-methyl-15-methoxycyclopenta(a)phenanthren-17-one",CC1=CC2=C(C(CC2=O)OC)C3=C1C4=CC=CC=C4C=C3,,,,,,
28,150029,"Phosphonic acid, (2,2-dichloro-1-methoxyethenyl)-, dimethyl ester",COC(=C(Cl)Cl)P(=O)(OC)OC,,,,,,
29,150030,CID 150030,CCCCC1=CC=C(C=C1)NC2=NC(=O)C3=C(N2)N=CN3,,,,,,
30,150031,"Carbamic acid, (5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC4=CC=CC=C4C=C3)N,,,,,,
31,150032,Menisporphine,COC1=CC2=C(C=C1)C3=NC=CC4=CC(=C(C(=C43)C2=O)OC)OC,,,,,,
32,150033,"Benzo(a)pyrene-11,12-diol, 11,12-dihydro-, trans-(+-)-",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2[C@@H]([C@H](C5=CC=C4)O)O,,,,,,
33,150034,"Acetamide, N-(5-(4-thiazolyl)-2-furanyl)-",CC(=O)NC1=CC=C(O1)C2=CSC=N2,,,,,,
34,150035,"Benzene, 1-nitroso-4-(phenylthio)-",C1=CC=C(C=C1)SC2=CC=C(C=C2)N=O,,,,,,
35,150036,"Butanoic acid, 3-(acetylamino)-2-((1-nitro-9-acridinyl)amino)-, monohydrochloride",CC(C(C(=O)O)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])NC(=O)C.Cl,,,,,,
36,150037,3-Acetamido-2-[(1-nitroacridin-9-yl)amino]butanoic acid,CC(C(C(=O)O)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])NC(=O)C,,,,,,
37,150038,"2-Propanol, 1-(dimethylamino)-3-((1-nitro-9-acridinyl)amino)-, dihydrochloride",CN(C)CC(CNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])O.Cl.Cl,,,,,,
38,150039,1-(Dimethylamino)-3-[(1-nitroacridin-9-yl)amino]propan-2-ol,CN(C)CC(CNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])O,,,,,,
39,150040,"Ethanol, 2-((3-((1-nitro-9-acridinyl)amino)propyl)amino)-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])NCCCNCCO.Cl.Cl,,,,,,
40,150041,2-[3-[(1-Nitroacridin-9-yl)amino]propylamino]ethanol,C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])NCCCNCCO,,,,,,
41,150042,"1,3-Propanediol, 2-methyl-2-((3-((1-nitro-9-acridinyl)amino)propyl)amino)-, dihydrochloride",CC(CO)(CO)NCCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl.Cl,,,,,,
42,150043,"9,10-Dihydro-1-nitro-9-[[3-[1,1-bis(hydroxymethyl)ethylamino]propyl]imino]acridine",CC(CO)(CO)NCCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
43,150044,"L-Cysteine, S-ethyl-N-(1-nitro-9-acridinyl)-, methyl ester, monohydrochloride",CCSC[C@@H](C(=O)OC)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl,,,,,,
44,150045,methyl (2R)-3-ethylsulfanyl-2-[(1-nitroacridin-9-yl)amino]propanoate,CCSC[C@@H](C(=O)OC)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
45,150046,"L-Glutamic acid, N-(1-nitro-9-acridinyl)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])N[C@@H](CCC(=O)O)C(=O)O.Cl,,,,,,
46,150047,(2S)-2-[(1-nitroacridin-9-yl)amino]pentanedioic acid,C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])N[C@@H](CCC(=O)O)C(=O)O,,,,,,
47,150048,"Phosphonic acid, (1-((1-nitro-9-acridinyl)amino)ethyl)-, monohydrochloride",CC(NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])P(=O)(O)O.Cl,,,,,,
48,150049,1-[(1-Nitroacridin-9-yl)amino]ethylphosphonic acid,CC(NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])P(=O)(O)O,,,,,,
49,150050,"Benzo(a)pyrene-7,8-diol, 7,8-dihydro-7-methyl-, (7R-trans)-",C[C@@]1([C@@H](C=CC2=C1C=C3C=CC4=C5C3=C2C=CC5=CC=C4)O)O,,,,,,
50,150051,CID 150051,CC1=C(NC(=C2C1=NC3=CC=CC=C32)C)NC(=O)C,,,,,,
51,150052,"Phosphorothioic acid, O-(2,2-dichloro-1-(2,4-dichlorophenyl)ethenyl) O,S-dimethyl ester",COP(=O)(OC(=C(Cl)Cl)C1=C(C=C(C=C1)Cl)Cl)SC,,,,,,
52,150053,"Phosphonic acid, 1,2-propadienyl-, bis(2-chloro-1-(chloromethyl)ethyl) ester",C=C=CP(=O)(OC(CCl)CCl)OC(CCl)CCl,,,,,,
53,150054,"Phosphonic acid, 1,2-propadienyl-, 2-chloro-1-(chloromethyl)ethyl 2-propynyl ester",C=C=CP(=O)(OCC#C)OC(CCl)CCl,,,,,,
54,150055,"Benzo(b)naphtho(2,3-d)thiophene, 2-methyl-",CC1=CC2=C(C=C1)SC3=CC4=CC=CC=C4C=C32,,,,,,
55,150056,"Benzo(b)naphtho(2,3-d)thiophene, 1-methyl-",CC1=C2C(=CC=C1)SC3=CC4=CC=CC=C4C=C32,,,,,,
56,150057,"Benzo(b)naphtho(2,3-d)thiophene, 3-methyl-",CC1=CC2=C(C=C1)C3=CC4=CC=CC=C4C=C3S2,,,,,,
57,150058,"Benzo(b)naphtho(2,3-d)thiophene, 10-methyl-",CC1=C2C=C3C4=CC=CC=C4SC3=CC2=CC=C1,,,,,,
58,150059,N-Acetyl-o-dianisidine,CC(=O)NC1=C(C=C(C=C1)C2=CC(=C(C=C2)N)OC)OC,,,,,,
59,150060,"Dipyrido(1,2-a:3',2'-d)imidazole, 6-methyl-2-nitro-",CC1=CC=CN2C1=NC3=C2N=C(C=C3)[N+](=O)[O-],,,,,,
60,150061,"Dibenz(a,h)anthracen-6-ol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C(=CC5=CC=CC=C54)O,,,,,,
61,150062,Protopapaverine,CN1C=CC2=CC(=O)C(=CC2=C1CC3=CC(=C(C=C3)OC)OC)O,,,,,,
62,150063,"Benzo(b)naphtho(2,1-d)thiophene, 7-methyl-",CC1=C2C3=C(C4=CC=CC=C4C=C3)SC2=CC=C1,,,,,,
63,150064,"Benzo(b)naphtho(2,1-d)thiophene, 8-methyl-",CC1=CC2=C(C=C1)SC3=C2C=CC4=CC=CC=C43,,,,,,
64,150065,"Benzo(b)naphtho(2,1-d)thiophene, 9-methyl-",CC1=CC2=C(C=C1)C3=C(S2)C4=CC=CC=C4C=C3,,,,,,
65,150066,"Benzo(b)naphtho(2,1-d)thiophene, 10-methyl-",CC1=C2C(=CC=C1)C3=C(S2)C4=CC=CC=C4C=C3,,,,,,
66,150067,Choline dihydrogen phosphate,C[N+](C)(C)CCO.OP(=O)(O)[O-],,,,,,
67,150068,"2-(1-Hydroxyethyl)naphtho(2,3-b)furan-4,9-dione",CC(C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
68,150069,"3-Pyridinecarboxamide, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-, 1-oxide, dihydrochloride",CN(C)CC1=CC=C(O1)CSCCNC(=O)C2=C[N+](=CC=C2)[O-].Cl.Cl,,,,,,
69,150070,"Acetamide, N-(5,6,7,8,9,10,11,12-octahydro-9-hydroxy-1,2,3,10-tetramethoxybenzo(a)heptalen-7-yl)-",CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1CC(C(CC3)OC)O)OC)OC)OC,,,,,,
70,150071,Dichlorobispyridoxolpalladium (II),CC1=NC=C(C(=C1O)CO)CO.CC1=NC=C(C(=C1O)CO)CO.Cl[Pd]Cl,,,,,,
71,150072,"Diazene, (3-methyl-4-nitrosophenyl)(2-methylphenyl)-",CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N=O)C,,,,,,
72,150073,"Hydroxylamine, N-(4-(o-tolylazo)-o-tolyl)-",CC1=CC=CC=C1NNC2=CC(=C(C=C2)N=O)C,,,,,['N-hydroxy-oaminoazotohiene is a known human metabolite of [2-methyl-4-(o-tolylazo)phenyl]amine.'],
73,150074,"Bis(4-(2,4-dichlorophenoxy)phenyl)diazene 1-oxide",C1=CC(=CC=C1N=[N+](C2=CC=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)[O-])OC4=C(C=C(C=C4)Cl)Cl,,,,,,
74,150075,"Benzo[b]naphtho[1,2]thiophene, 4-methyl",CC1=C2C=CC3=C(C2=CC=C1)C4=CC=CC=C4S3,,,,,,
75,150076,"Benzo(b)naphtho(1,2-d)thiophene, 10-methyl-",CC1=CC2=C(C=C1)SC3=C2C4=CC=CC=C4C=C3,,,,,,
76,150077,"Benzo(b)naphtho(1,2-d)thiophene, 9-methyl-",CC1=CC2=C(C=C1)C3=C(S2)C=CC4=CC=CC=C43,,,,,,
77,150078,"Benzo(b)naphtho(1,2-d)thiophene, 11-methyl-",CC1=C2C(=CC=C1)SC3=C2C4=CC=CC=C4C=C3,,,,,,
78,150079,1-(4-Bromo-3-chlorophenyl)-3-methoxy-3-methyl-1-nitrosourea,CN(C(=O)N(C1=CC(=C(C=C1)Br)Cl)N=O)OC,,,,,,
79,150080,"5,8-Quinolinedione, 6,7-dichloro-, 1-oxide",C1=CC2=C(C(=O)C(=C(C2=O)Cl)Cl)[N+](=C1)[O-],,,,,,
80,150081,"6,7-Dichloro-5,8-isoquinolinedione",C1=CN=CC2=C1C(=O)C(=C(C2=O)Cl)Cl,,,,,,
81,150082,1-(Hydroxy(1-methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol hydrobromide,CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)O)O.Br,,,,,,
82,150083,"Acetamide, N,N'-(5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo(a)heptalene-7,10-diyl)bis-, (S)-",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)NC(=O)C)OC)OC)OC,,,,,,
83,150084,"2-Methyl-4-(phenylazo)-1,3-benzenediamine",CC1=C(C=CC(=C1N)N=NC2=CC=CC=C2)N,,,,,,
84,150085,"2-Methyl-4-((2-methylphenyl)azo)-1,3-benzenediamine",CC1=CC=CC=C1N=NC2=C(C(=C(C=C2)N)C)N,,,,,,
85,150086,"4-Thiazolebutanenitrile, 2-amino-gamma-oxo-",C1=C(N=C(S1)N)C(=O)CCC#N,,,,,,
86,150087,6-((4-(1-Pyrrolidinyl)phenyl)azo)benzothiazole,C1CCN(C1)C2=CC=C(C=C2)N=NC3=CC4=C(C=C3)N=CS4,,,,,,
87,150088,"1,3-Diisopropyltriazene",CC(C)NN=NC(C)C,,,,,,
88,150089,2-(Ethylnitroamino)ethyl nitrate,CCN(CCO[N+](=O)[O-])[N+](=O)[O-],,,,,,
89,150090,"4-Hydroxy-3,4-dihydro-2H-1,3-benzoxazin-2-one",C1=CC=C2C(=C1)C(NC(=O)O2)O,,,,,,
90,150091,"Chrysene, 5-(bromomethyl)-",C1=CC=C2C(=C1)C=CC3=C2C(=CC4=CC=CC=C34)CBr,,,,,,
91,150092,"Propanamide, 3-(diethylamino)-N-(3-methyl-7-oxo-7H-furo(3,2-g)(1)benzopyran-6-yl)-",CCN(CC)CCC(=O)NC1=CC2=CC3=C(C=C2OC1=O)OC=C3C,,,,,,
92,150093,"1H-Purine-2,6-dione, 9-(4-bromo-3,6-dihydro-6-methyl-3-oxo-2H-pyran-2-yl)-3,9-dihydro-1,3-dimethyl-, (2S-cis)-",C[C@H]1C=C(C(=O)[C@H](O1)N2C=NC3=C2N(C(=O)N(C3=O)C)C)Br,,,,,,
93,150094,9-Allylideneaminoacridine,C=CC=NC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
94,150095,"Ethanol, 2-(9-acridinylamino)-, acetate (ester)",CC(=O)OCCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
95,150096,"3-Acridinecarboxamide, 9-((4-((methylsulfonyl)amino)phenyl)amino)-",CS(=O)(=O)NC1=CC=C(C=C1)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)C(=O)N,,,,,,
96,150097,4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol,CN(CCCC(C1=C[N+](=CC=C1)[O-])O)N=O,,,,,['NNAL-N-Oxide is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK).'],
97,150098,"Methanamine, N-((bis(dimethylamino)phosphinyl)oxy)-N-methyl-",CN(C)OP(=O)(N(C)C)N(C)C,,,,,,
98,150099,"Benzo(a)pyrene-7,8-diol, 6-fluoro-7,8-dihydro-, (7R-trans)-",C1=CC2=C3C(=C1)C=CC4=C3C(=C5C=C[C@H]([C@@H](C5=C4F)O)O)C=C2,,,,,,
99,150100,"beta-D-Glucopyranosiduronic acid, 4,4'-bis(acetylamino)(1,1'-biphenyl)-3-yl",CC(=O)NC1=CC=C(C=C1)C2=CC(=C(C=C2)NC(=O)C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
100,150101,3-Methylbenzoic acid 2-[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]hydrazide,CC1=CC(=CC=C1)C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
101,150102,4-methyl-N-[3-(5-nitrofuran-2-yl)prop-2-enylideneamino]benzamide,CC1=CC=C(C=C1)C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
102,150103,CID 150103,CC1=C(C=CC=C1[N+](=O)[O-])C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
103,150104,CID 150104,C1=CC=C(C(=C1)C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-])C(F)(F)F,,,,,,
104,150105,"Dipyrido(1,2-a:3',2'-d)imidazol-4-ol, 7-methyl-",CC1=CC2=NC3=C(N2C=C1)NC=CC3=O,,,,,,
105,150106,"Quinolinium, 6-amino-1-methyl-4-((4-(((4-(1-methylpyridinium-4-yl)-1-piperazinyl)carbonyl)amino)phenyl)amino)-, dibromide",C[N+]1=CC=C(C=C1)N2CCN(CC2)C(=O)NC3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)C)N.[Br-].[Br-],,,,,,
106,150107,"Quinolinium, 6-amino-1-methyl-4-((4-(((4-(1-methylpyridinium-4-yl)-1-piperazinyl)carbonyl)amino)phenyl)amino)-",C[N+]1=CC=C(C=C1)N2CCN(CC2)C(=O)NC3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)C)N,,,,,,
107,150108,"Naphth(1,2-b)oxiren-2,6-dione, 1a,4,5,7,7a,7b-hexahydro-1a-(2-(hydroxymethyl)oxiranyl)-7,7a-dimethyl-",CC1C(=O)CCC2=CC(=O)C3(C(C12C)O3)C4(CO4)CO,,,,,,
108,150109,"L-Cysteine, S-(2-bromoethyl)-",C(CBr)SC[C@@H](C(=O)O)N,,,,,,
109,150110,"1-Propanamine, 3-azido-",C(CN)CN=[N+]=[N-],,,,,,
110,150111,4-Azidobutan-1-amine,C(CCN=[N+]=[N-])CN,,,,,,
111,150112,CID 150112,CCCCC[C@@H]1[C@H](O1)[C@H](C=CCCCCCCCC(=O)OC)O,,,,,,
112,150113,CID 150113,CCCCC[C@@H]1[C@H](O1)[C@@H](C=CCCCCCCCC(=O)OC)O,,,,,,
113,150114,"Benz(a)anthracene, 7-(chloromethyl)-2-methoxy-12-methyl-",CC1=C2C(=C(C3=CC=CC=C13)CCl)C=CC4=C2C=C(C=C4)OC,,,,,,
114,150115,"1H-Pyrido(2,3-b)indolemethanamine",C1=CC(=C2C3=C(NC2=C1)N=CC=C3)CN,,,,,,
115,150116,4-Hydroxy-6-oxabicyclo(3.2.1)octan-7-one,C1CC(C2CC1C(=O)O2)O,,,,,,
116,150117,6-Hydroxy-2-oxabicyclo(2.2.2)octan-3-one,C1CC2C(CC1C(=O)O2)O,,,,,,
117,150118,"6-(9-Acridinylamino)hexyl 3-diazo-1,4-cyclopentadiene-1-carboxylate",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=O)C4=CC(=[N+]=[N-])C=C4,,,,,,
118,150119,CID 150119,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=C4C=CC(=C4)[N+]#N)O,,,,,,
119,150120,CID 150120,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCN=C4C=CC(=N[N+]#N)C=C4N(O)[O-],,,,,,
120,150121,6-Bromoquinoline-8-carboxylic acid,C1=CC2=CC(=CC(=C2N=C1)C(=O)O)Br,,,,,,
121,150122,"Methanesulfonamide, N-(4-(9-acridinylamino)-3-(methylamino)phenyl)-",CNC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
122,150123,"Methanesulfonamide, N-(4-(9-acridinylamino)-3-(dimethylamino)phenyl)-",CN(C)C1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
123,150124,6-Azido-6-deoxy-D-galactose,C([C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)N=[N+]=[N-],,,,,,
124,150125,"4,11-Dioxatricyclo(5.3.1.0(3,5))undeca-1,6-diene, (1alpha,3beta,5beta,7alpha)-",C1CC2=C[C@H]3C(O3)C=C(C1)O2,,,,,,
125,150126,"(+-)-Dibenz(a,j)acridine 5,6-oxide",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C6=C4O6,,,,,,
126,150127,"6-Hydroxydibenz(a,j)acridine",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C=C4O,,,,,,
127,150128,"N-(4-(2,4,6-Trichlorophenoxy)phenyl)formamide",C1=CC(=CC=C1NC=O)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
128,150129,Monocalcium di-L-glutamate tetrahydrate,C(CC(=O)[O-])[C@@H](C(=O)[O-])N.O.O.O.O.[Ca+2],,,,,,
129,150130,1-Hydroxydibenzothiophene,C1=CC=C2C(=C1)C3=C(C=CC=C3S2)O,,,,,,
130,150131,Ccris 122,CCCC(N(CCCC(=O)OC)N=O)OC(=O)C,,,,,,
131,150132,"(1alpha,2beta,3alpha,6alpha)-7-Oxabicyclo(4.1.0)hept-ene-2,3-diol",C1C[C@@H]2C(=C([C@@H]1O)O)O2,,,,,,
132,150133,2-Cyclohexylidene-1-propanol,CC(=C1CCCCC1)CO,,,,,,
133,150134,"4-Acridinecarboxamide, N-(2-((2-((2-hydroxyethyl)amino)ethyl)amino)-2-oxoethyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCC(=O)NCCNCCO,,,,,,
134,150135,N-(2-(Dimethylamino)ethyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-4-acridinecarboxamide,CN(C)CCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC,,,,,,
135,150136,"Pyridinium, 3,3'-(1,4-phenylenebis(carbonylimino-4,1-phenyleneimino))bis(1-methyl-",C[N+]1=CC=CC(=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)NC5=C[N+](=CC=C5)C,,,,,,
136,150137,"Quinolinium, 6-amino-1-methyl-4-((4-(((4-((1-methylpyridinium-4-yl)amino)phenyl)amino)carbonyl)phenyl)amino)-",C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)C)N,,,,,,
137,150138,"4-Quinolinecarboxamide, N-hydroxy-",C1=CC=C2C(=C1)C(=CC=N2)C(=O)NO,,,,,,
138,150139,"5-Quinolinecarboxamide, N-hydroxy-",C1=CC(=C2C=CC=NC2=C1)C(=O)NO,,,,,,
139,150140,"6-Quinolinecarboxamide, N-hydroxy-",C1=CC2=C(C=CC(=C2)C(=O)NO)N=C1,,,,,,
140,150141,"8-Quinolinecarboxamide, N-hydroxy-",C1=CC2=C(C(=C1)C(=O)NO)N=CC=C2,,,,,,
141,150142,"2,4-Quinolinedicarbohydroxamic acid",C1=CC=C2C(=C1)C(=CC(=N2)C(=O)NO)C(=O)NO,,,,,,
142,150143,"1,3-Propanediamine, N,N'-bis(6-chloro-2-fluoro-9-acridinyl)-, dihydrochloride",C1=CC2=NC3=C(C=CC(=C3)Cl)C(=C2C=C1F)NCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)F.Cl.Cl,,,,,,
143,150144,"N,N'-bis(6-chloro-2-fluoroacridin-9-yl)propane-1,3-diamine",C1=CC2=NC3=C(C=CC(=C3)Cl)C(=C2C=C1F)NCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)F,,,,,,
144,150145,"1,4-Butanediamine, N,N'-bis(3-((6-chloro-2-fluoro-9-acridinyl)amino)propyl)-, tetrahydrochloride",C1=CC2=NC3=C(C=CC(=C3)Cl)C(=C2C=C1F)NCCCNCCCCNCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)F.Cl.Cl.Cl.Cl,,,,,,
145,150146,"N,N'-bis[3-[(6-chloro-2-fluoroacridin-9-yl)amino]propyl]butane-1,4-diamine",C1=CC2=NC3=C(C=CC(=C3)Cl)C(=C2C=C1F)NCCCNCCCCNCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)F,,,,,,
146,150147,"7H-Dibenzo(de,h)quinolin-7-one, 5,10-dimethoxy-6-hydroxy-",COC1=CC2=C(C=C1)C(=O)C3=C4C2=NC=CC4=CC(=C3O)OC,,,,,,
147,150148,"5,6,10-Trimethoxy-7H-dibenzo(de,h)quinolin-7-one",COC1=CC2=C(C=C1)C(=O)C3=C4C2=NC=CC4=CC(=C3OC)OC,,,,,,
148,150149,"trans-1,2-Dihydrobenz(e)acephenanthrylene-1,2-diol",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=C[C@H]([C@@H](C2=C53)O)O,,,,,,
149,150150,"4-N-[4-[[2-(diaminomethylidene)hydrazinyl]methylideneamino]phenyl]-1-N-[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=CNN=C(N)N,,,,,,
150,150151,3-Hydroxydibenzothiophene,C1=CC=C2C(=C1)C3=C(S2)C=C(C=C3)O,,,,,,
151,150152,6-Nitro-8-quinolinecarboxylic acid,C1=CC2=CC(=CC(=C2N=C1)C(=O)O)[N+](=O)[O-],,,,,,
152,150153,"1,2-Diphenylethyl isothiocyanate",C1=CC=C(C=C1)CC(C2=CC=CC=C2)N=C=S,,,,,,
153,150154,"22-Azahexacyclo[12.9.0.03,12.04,9.015,20.021,23]tricosa-1(14),2,4,6,8,10,12,15,17,19,21(23)-undecaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=C(N5)C6=CC=CC=C64,,,,,,
154,150155,"18-Azahexacyclo[10.7.2.03,8.09,20.016,21.017,19]henicosa-1,3,5,7,9(20),10,12(21),13,15,17(19)-decaene",C1=CC=C2C3=C4C(=CC2=C1)C5=C(N5)C6=CC=CC(=C64)C=C3,,,,,,
155,150156,"2,7-Dinitrodibenzo-p-dioxin",C1=CC2=C(C=C1[N+](=O)[O-])OC3=C(O2)C=C(C=C3)[N+](=O)[O-],,,,,,
156,150157,"2,8-Dinitrodibenzo-p-dioxin",C1=CC2=C(C=C1[N+](=O)[O-])OC3=C(O2)C=CC(=C3)[N+](=O)[O-],,,,,,
157,150158,"Trisodium 4,4',4''-(2,4-diamino-1,3,5-phenenyl)tris(azo)-tribenzenesulfonate",C1=CC(=CC=C1N=NC2=CC(=C(C(=C2N)N=NC3=CC=C(C=C3)S(=O)(=O)[O-])N)N=NC4=CC=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
158,150159,CID 150159,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)OCCCS(=O)(=O)[O-])O.[K+],,,,,,
159,150160,"[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoxy]benzene",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC2=CC=CC=C2)C)C,,,,,,
160,150161,N-4-Butoxyphenylacetylhydroxylamine-O-sulfonate-pyridine,CCCCOC1=CC=C(C=C1)CC(=O)NOS(=O)(=O)[O-].C1=CC=[NH+]C=C1,,,,,,
161,150162,[[2-(4-Butoxyphenyl)acetyl]amino] hydrogen sulfate,CCCCOC1=CC=C(C=C1)CC(=O)NOS(=O)(=O)O,,,,,,
162,150163,N-2-Naphthoylhydroxylamine-O-sulfonate pyridine,C1=CC=[NH+]C=C1.C1=CC=C2C=C(C=CC2=C1)C(=O)NOS(=O)(=O)[O-],,,,,,
163,150164,"Hydroxylamine-O-sulfonic acid, N-(2-naphthalenylcarbonyl)-",C1=CC=C2C=C(C=CC2=C1)C(=O)NOS(=O)(=O)O,,,,,,
164,150165,"Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11,12-dimethyl-",CC1=C(C2=C(C=CC3=CC=CC=C32)C4=C1C(=O)CC4)C,,,,,,
165,150166,4-(2-Nitroprop-1-en-1-yl)phenyl thiocyanate,CC(=CC1=CC=C(C=C1)SC#N)[N+](=O)[O-],,,,,,
166,150167,Potassium arsenite solution,[O-][As]([O-])[O-].[K+].[K+].[K+],,,,,,
167,150168,Diamminetetrachloroplatinum,N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],,,,,,
168,150169,"1,3,5,11-Tridecatetraene-7,9-diyne",CC=CC#CC#CC=CC=CC=C,,,,,,
169,150170,CID 150170,C1=CC=C(C=C1)CN2C=CN=C2C=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
170,150171,CID 150171,CC1=C(N=CN1)CSCCNC(=NCC#C)NC#N.Cl,,,,,,
171,150172,CID 150172,CC1=C(N=CN1)CSCCNC(=NCC#C)NC#N,,,,,,
172,150173,Ethyl ethylene sulfate,CCOS(=O)(=O)OCCOS(=O)(=O)OCC,,,,,,
173,150174,"Oxiranemethanol, 3-methyl-, 4-nitrobenzoate, (R)-",CC1[C@H](O1)COC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
174,150175,"Oxiranemethanol, 3-methyl-, 4-nitrobenzoate, (2S-trans)-",C[C@H]1[C@@H](O1)COC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
175,150176,"4-Acridinecarboxamide, N-(6-(dimethylamino)hexyl)-",CN(C)CCCCCCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21,,,,,,
176,150177,N-Monodemethyl-1-deoxypyrromycin,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC)O,,,,,,
177,150178,"N,N-Didemethyl-1-deoxypyrromycin",CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O,,,,,,
178,150179,N-Methyldaunomycin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC)O,,,,,,
179,150180,"1,1,1,2,3-Pentachloro-2-fluoropropane",C(C(C(Cl)(Cl)Cl)(F)Cl)Cl,,,,,,
180,150181,Heptachlorofluoropropane,C(C(F)(Cl)Cl)(C(Cl)(Cl)Cl)(Cl)Cl,,,,,,
181,150182,"1,2-Dichloro-1,2,3,3-tetrafluoropropane",C(C(C(F)Cl)(F)Cl)(F)F,,,,,,
182,150183,1-Chloro-1-fluoropropane,CCC(F)Cl,,,,,,
183,150184,"9H-pyrido[3,4-b]indole hydrochloride",C1=CC=C2C(=C1)C3=C(N2)C=NC=C3.Cl,,,"['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)', 'Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)']",,,
184,150185,"1,3,3-Trichloro-1,1-difluoropropane",C(C(Cl)Cl)C(F)(F)Cl,,,,,,
185,150186,"Molybdic acid, dipotassium salt, pentahydrate",O.O.O.O.O.[O-][Mo](=O)(=O)[O-].[K+].[K+],,,,,,
186,150187,"1,1,1,3-Tetrachloro-3,3-difluoropropane",C(C(F)(F)Cl)C(Cl)(Cl)Cl,,,,,,
187,150188,"1,1,2,3-Tetrachloro-1-fluoropropane",C(C(C(F)(Cl)Cl)Cl)Cl,,,,,,
188,150189,"1,1,1,3,3-Pentachloro-2,2,3-trifluoropropane",C(C(F)(Cl)Cl)(C(Cl)(Cl)Cl)(F)F,,,,,,
189,150190,Rhodium nitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Rh+3],,,,,,
190,150191,Sodium tungstate dihydrate,O.O.[O-][W](=O)(=O)[O-].[Na+].[Na+],,,,,,
191,150192,Potassium selenite,[O-][Se](=O)[O-].[K+].[K+],,,,,,
192,150193,Molybdenum chloride,[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mo],,,,,,
193,150194,Dichlorotetrakis(dimethyl sulfoxide)ruthenium II,CS(=O)C.CS(=O)C.CS(=O)C.CS(=O)C.Cl[Ru]Cl,,,,,,
194,150195,Ruthenium dichloride,Cl[Ru]Cl,,,,,,
195,150196,"Disodium;5-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",C1=CC(=CC(=C1)S(=O)(=O)[O-])NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)[O-])N(CCO)CCO)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
196,150197,"5-[[4-[Bis(2-hydroxyethyl)amino]-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)O)N(CCO)CCO)S(=O)(=O)O)S(=O)(=O)O,,,,,,
197,150198,Platinum;hydrochloride,Cl.[Pt],,,,,,
198,150199,"Succinimide, N-(morpholinomethyl)-",C1CC(=O)N(C1=O)CN2CCOCC2,,,,,,
199,150200,N-Monodemethylaclacinomycin A,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)NC)O,,,,,,
200,150201,5-Iodovinyldeoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CI)CO)O,,,,,,
201,150202,"1H-Indeno(1,2-c)pyridine, 2,3,4,4a,5,9b-hexahydro-2-ethyl-7-methyl-5-p-tolyl-, hydrochloride, (4aRS,5RS,9bRS)-",CCN1CC[C@H]2[C@@H](C1)C3=C([C@@H]2C4=CC=C(C=C4)C)C=C(C=C3)C.Cl,,,,,,
202,150203,"2-Ethyl-2,3,4,4abeta,5,9bbeta-hexahydro-7-methyl-5beta-(p-tolyl)-1H-indeno[1,2-c]pyridine",CCN1CC[C@H]2[C@@H](C1)C3=C([C@@H]2C4=CC=C(C=C4)C)C=C(C=C3)C,,,,,,
203,150204,Merpelan,CNC(=O)NC1=NC2=CC=CC=C2S1.C1CCC(CC1)N2C(=O)C3=C(CCC3)NC2=O,,,,,,
204,150205,Ambithion,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC.CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],,,,,,
205,150206,"Methanesulfonamide, N-(3-(dimethylamino)-4-((3-fluoro-5-methyl-9-acridinyl)amino)phenyl)-",CC1=C2C(=CC=C1)C(=C3C=CC(=CC3=N2)F)NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C,,,,,,
206,150207,"Methanesulfonamide, N-(4-((3-chloro-5-methyl-9-acridinyl)amino)-3-(dimethylamino)phenyl)-",CC1=C2C(=CC=C1)C(=C3C=CC(=CC3=N2)Cl)NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C,,,,,,
207,150208,"Methanesulfonamide, N-(4-((3-chloro-5-methoxy-9-acridinyl)amino)-3-(dimethylamino)phenyl)-",CN(C)C1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=C2C=CC=C4OC)Cl,,,,,,
208,150209,"4-Acridinecarboxamide, 6-chloro-9-((2-(dimethylamino)-4-((methylsulfonyl)amino)phenyl)amino)-N-methyl-",CNC(=O)C1=CC=CC2=C1N=C3C=C(C=CC3=C2NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C)Cl,,,,,,
209,150210,"Methanesulfonamide, N-(3-(dimethylamino)-4-((3-methoxy-5-methyl-9-acridinyl)amino)phenyl)-",CC1=C2C(=CC=C1)C(=C3C=CC(=CC3=N2)OC)NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C,,,,,,
210,150211,"Methanesulfonamide, N-(4-((4,5-dimethyl-9-acridinyl)amino)-3-(dimethylamino)phenyl)-",CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C)NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C,,,,,,
211,150212,"Methanesulfonamide, N-(4-((4,5-dimethoxy-9-acridinyl)amino)-3-(dimethylamino)phenyl)-",CN(C)C1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=C2C=CC=C4OC)OC,,,,,,
212,150213,"4-Acridinecarboxamide, 9-((2-(dimethylamino)-4-((methylsulfonyl)amino)phenyl)amino)-N,5-dimethyl-",CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C(=O)NC)NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C,,,,,,
213,150214,"2,3,4,5-Tetrachloro-4'-nitro-1,1'-biphenyl",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)[N+](=O)[O-],,,,,,
214,150215,"6-Oxohexa-2,4-dienoic acid",C(=CC=O)C=CC(=O)O,,,,,,
215,150216,"6-Hydroxyhexa-2,4-dienoic acid",C(C=CC=CC(=O)O)O,,,,,,
216,150217,"1-(Acetyl(4'-(acetylamino)(1,1'-biphenyl)-4-yl)amino)-1-deoxy-beta-D-glucopyranuronic acid",CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)N([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C(=O)C,,,,,,
217,150218,Dichloroethanol methanesulfonate,CC(OS(=O)(=O)C)(Cl)Cl,,,,,,
218,150219,CID 150219,CC=C1C[C@H]2[C@H](NC3=CC(=C(C=C3C(=O)N2C1)OC)OC)OC,,,,,,
219,150220,"Chrysene, 5-nitro-",C1=CC=C2C(=C1)C=CC3=C2C(=CC4=CC=CC=C34)[N+](=O)[O-],,,,,,
220,150221,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N.Cl.Cl,,,,,,
221,150222,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-5-methyl-, dihydrochloride",CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C(=O)NCCN(C)C)N.Cl.Cl,,,,,,
222,150223,"4-Acridinecarboxamide, 9-amino-N-[2-(dimethylamino)ethyl]-5-methyl-",CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C(=O)NCCN(C)C)N,,,,,,
223,150224,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-5-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C(=CC=C3)OC)N=C21)N.Cl.Cl,,,,,,
224,150225,9-amino-N-(2-dimethylaminoethyl)-5-methoxy-acridine-4-carboxamide,CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C(=CC=C3)OC)N=C21)N,,,,,,
225,150226,"4-Acridinecarboxamide, 9-amino-5-chloro-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C(=CC=C3)Cl)N=C21)N.Cl.Cl,,,,,,
226,150227,"4-Acridinecarboxamide, 9-amino-5-chloro-N-[2-(dimethylamino)ethyl]-",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C(=CC=C3)Cl)N=C21)N,,,,,,
227,150228,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-6-methyl-, dihydrochloride",CC1=CC2=C(C=C1)C(=C3C=CC=C(C3=N2)C(=O)NCCN(C)C)N.Cl.Cl,,,,,,
228,150229,"4-Acridinecarboxamide, 9-amino-N-[2-(dimethylamino)ethyl]-6-methyl-",CC1=CC2=C(C=C1)C(=C3C=CC=C(C3=N2)C(=O)NCCN(C)C)N,,,,,,
229,150230,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-6-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=C(C=C3)OC)N=C21)N.Cl.Cl,,,,,,
230,150231,9-Amino-N-(2-(dimethylamino)ethyl)-6-methoxy-4-acridinecarboxamide,CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=C(C=C3)OC)N=C21)N,,,,,,
231,150232,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-7-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC(=C3)OC)N=C21)N.Cl.Cl,,,,,,
232,150233,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-7-methoxy-",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC(=C3)OC)N=C21)N,,,,,,
233,150234,"4-Acridinecarboxamide, 9-amino-7-chloro-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC(=C3)Cl)N=C21)N.Cl.Cl,,,,,,
234,150235,"4-Acridinecarboxamide, 9-amino-7-chloro-N-[2-(dimethylamino)ethyl]-",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC(=C3)Cl)N=C21)N,,,,,,
235,150236,"4-Acridinecarboxamide, 9-amino-N-(2-((2-hydroxyethyl)amino)ethyl)-",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)C(=O)NCCNCCO)N,,,,,,
236,150237,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-9-methyl-",CC1=C2C=CC=C(C2=NC3=CC=CC=C13)C(=O)NCCN(C)C,,,,,,
237,150238,9-Amino-N-[3-(Dimethylamino)Propyl]Acridine-4-Carboxamide,CN(C)CCCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
238,150239,"4-Acridinecarboxamide, 9-amino-N-(2-(diethylamino)ethyl)-",CCN(CC)CCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
239,150240,"Benz(a)anthracen-4-ol, 7-fluoro-",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2F)C(=CC=C4)O,,,,,,
240,150241,"7-Methyl-2-(methylsulfonyl)1,2,8,8a-tetrahydro-cyclopropa(c)pyrrolo(3,2-e)indol-4(5H)-one",CC1=CNC2=C1C34CC3CN(C4=CC2=O)S(=O)(=O)C,,,,,,
241,150242,"(5R-trans)-7-Fluoro-5,6-dihydrobenz(a)anthracene-5,6-diol",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4[C@H]([C@@H](C3=C2F)O)O,,,,,,
242,150243,"Benz(a)anthracene-8,9-diol, 7-fluoro-8,9-dihydro-, (8R-trans)-",C1=CC=C2C(=C1)C=CC3=C2C=C4C=C[C@H]([C@@H](C4=C3F)O)O,,,,,,
243,150244,"(10R-trans)-7-Fluoro-10,11-dihydrobenz(a)anthracene-10,11-diol",C1=CC=C2C(=C1)C=CC3=C(C4=C(C=C32)[C@H]([C@@H](C=C4)O)O)F,,,,,,
244,150245,"(1aR-cis)-1a,2,3,11c-Tetrahydrobenzo(6,7)phenanthro(3,4-b)oxirene",C1CC2=C([C@H]3[C@@H]1O3)C4=CC5=CC=CC=C5C=C4C=C2,,,,,,
245,150246,"Benzo(6,7)phenanthro(3,4-b)oxirene, 1a,2,3,11c-tetrahydro-, (1aS-cis)-",C1CC2=C([C@@H]3[C@H]1O3)C4=CC5=CC=CC=C5C=C4C=C2,,,,,,
246,150247,"3,4-Epoxy-1,2,3,4-tetrahydrobenz(a)anthracene",C1CC2=C(C=CC3=CC4=CC=CC=C4C=C23)[C@@H]5[C@H]1O5,,,,,,
247,150248,"1,3,5,2,4,6-Triazatriphosphorine, 2,2,4,4,6,6-hexahydro-2,4-bis(1-aziridinyl)-2,4,6,6-tetrakis(methylamino)-, trans-",CN[P@@]1(=N[P@](=NP(=N1)(NC)NC)(NC)N2CC2)N3CC3,,,,,,
248,150249,"1,1,1,2,2,3-Hexachloro-3-fluoropropane",C(C(C(Cl)(Cl)Cl)(Cl)Cl)(F)Cl,,,,,,
249,150250,"1,1,1,3,3-Pentachloro-2,2-difluoropropane",C(C(C(Cl)(Cl)Cl)(F)F)(Cl)Cl,,,,,,
250,150251,"1,1,2-Trichloro-1-fluoropropane",CC(C(F)(Cl)Cl)Cl,,,,,,
251,150252,CID 150252,CNC1=NC(=NC(=N1)Cl)NC.C1=NNC(=N1)N,,,,,,
252,150253,CID 150253,CN=C(S)[S-].[NH4+],,,,,,
253,150254,CID 150254,C1CN(CCN1CCC=S2C3=C(CC4=CC=CC=C42)C=C(C=C3)Cl)CCO,,,,,,
254,150255,Sulpiride sulfate,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC.OS(=O)(=O)O,,,,,,
255,150256,Aspirin Mixture With Caffeine,CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,,,,
256,150257,Methyl (5-((methylthio)methoxy)-1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=C(N1)C=C(C=C2)OCSC,,,,,,
257,150258,Trimethyloxonium hexachloroantimonate,C[O+](C)C.Cl[Sb-](Cl)(Cl)(Cl)(Cl)Cl,,,,,,
258,150259,CID 150259,C(CCl)OP(=O)OCCCl.C(=O)(C(=O)O)O,,,,,,
259,150260,Phosphonic acid bis(2-chloroethyl) ester,C(CCl)OP(=O)OCCCl,,,,,,
260,150261,"Ethanesulfonamide, 2-(bis(2-chloroethyl)amino)-N,N-dimethyl-, monohydrochloride",CN(C)S(=O)(=O)CCN(CCCl)CCCl.Cl,,,,,,
261,150262,"2-[bis(2-chloroethyl)amino]-N,N-dimethylethanesulfonamide",CN(C)S(=O)(=O)CCN(CCCl)CCCl,,,,,,
262,150263,CID 150263,CC1=CC=C(C=C1)S(=O)(=O)O.C=CCN1C(N(C2=NC3=C(C=CC(=C3)Cl)[NH+]=C21)CC=C)C=CC4=C(N(C5=CC=CC=C54)C6=CC=CC=C6)C7=CC=CC=C7,,,,,,
263,150264,CID 150264,C=CCN1C(N(C2=NC3=C(C=CC(=C3)Cl)N=C21)CC=C)C=CC4=C(N(C5=CC=CC=C54)C6=CC=CC=C6)C7=CC=CC=C7,,,,,,
264,150265,CID 150265,CC[N+]1=C(SC2=C1C3=CC=CC=C3C=C2)C=CC=C4NC5=C(S4CC)C=CC6=CC=CC=C65.CC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
265,150266,CID 150266,CC[N+]1=C(SC2=C1C3=CC=CC=C3C=C2)C=CC=C4NC5=C(S4CC)C=CC6=CC=CC=C65,,,,,,
266,150267,CID 150267,CCN1C2=C(C=CC(=C2)Cl)SC1=CC=CC3=[N+](C4=C(S3)C=CC(=C4)Cl)CC.CC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
267,150268,"2-[3-(2,3-Dihydro-3-ethyl-5-chlorobenzothiazole-2-ylidene)-1-propenyl]-3-ethyl-5-chlorobenzothiazole-3-ium",CCN1C2=C(C=CC(=C2)Cl)SC1=CC=CC3=[N+](C4=C(S3)C=CC(=C4)Cl)CC,,,,,,
268,150269,CID 150269,CC(=O)OCC(C(=O)N=NC1=C(C=C(C=C1)N(O)O)[N+](=O)[O-])OC(=O)C,,,,,,
269,150270,"3,4-Diphenyl-2-furoic acid",C1=CC=C(C=C1)C2=COC(=C2C3=CC=CC=C3)C(=O)O,,,,,,
270,150271,"Chol-5-ene-3,24-diol, (3beta)-",C[C@H](CCCO)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
271,150272,"3-Hydroxymethyl-s-triazolo[3,4-a]phthalazine",C1=CC=C2C(=C1)C=NN3C2=NN=C3CO,,,,,,
272,150273,CID 150273,CC(CC(=S)[CH]C=S)Cl,,,,,,
273,150274,CID 150274,C1=CC(=C2C(=C3C(=CC(=O)C=C3OC2=C1O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
274,150275,"1H-Pyrrole-2-carboxamide, N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-propyl-1H-pyrrol-3-yl)-4-(((4-(formylamino)-1-propyl-1H-pyrrol-2-yl)carbonyl)amino)-1-propyl-",CCCN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)CCC)CCC)NC=O,,,,,,
275,150276,Cyclo-cmp,C1=CN2C3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)OC2=NC1=N,,,,,,
276,150277,CID 150277,CC1=CC2=C(C(=C1)O)C(=C3C(=O)CC(C4C3=C2OC56C4C(CC(=O)C5=C(C7=C(C6=O)C=C(C=C7O)C)O)O)O)O,,,,,,
277,150278,CID 150278,CC(=NN=C(N)S)C1=CNC2=CC3=C(C=C2C1=O)OCO3,,,,,,
278,150279,(SP-4-3)-Diamminebromo(nitrito-N)platinum,N.N.N(=O)O.[Br-].[Pt+2],,,,,,
279,150280,"Methyl (S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-hexanoate",CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCCCCC(=O)OC)O,,,,,,
280,150281,N-nitroso-n-acetoxymethyl-n-2-oxopropylamine,CC(=O)CN(COC(=O)C)N=O,,,,,,
281,150282,CID 150282,C1=CC=C2C(=C1)C(=NC3=CC=C(C=C3)N[N+]#N)C4=CC=CC=C4[N-]2,,,,,,
282,150283,CID 150283,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)N[N+]#N,,,,,,
283,150284,"Benz(e)acephenanthrylene, 7-fluoro-",C1=CC=C2C3=C4C(=CC=C3)C5=C(C4=CC2=C1)C(=CC=C5)F,,,,,,
284,150285,"N-Nitroso-2,3-dihydroxypropyl-2-hydroxypropylamine",CC(CN(CC(CO)O)N=O)O,,,,,,
285,150286,2-Hydroxycarbamoyl-1-methylpyridinium iodide,C[N+]1=CC=CC=C1C(=O)NO.[I-],,,,,,
286,150287,N-hydroxy-1-methylpyridin-1-ium-2-carboxamide,C[N+]1=CC=CC=C1C(=O)NO,,,,,,
287,150288,4-Hydroxycarbamoyl-1-methylpyridinium iodide,C[N+]1=CC=C(C=C1)C(=O)NO.[I-],,,,,,
288,150289,4-(Hydroxycarbamoyl)-1-methylpyridinium,C[N+]1=CC=C(C=C1)C(=O)NO,,,,,,
289,150290,"Picolinohydroxamic acid, N-methyl-",CN(C(=O)C1=CC=CC=N1)O,,,,,,
290,150291,"Hydroxylamine, O-acetyl-N-picolinoyl-",CC(=O)ONC(=O)C1=CC=CC=N1,,,,,,
291,150292,"Hydroxylamine, O-acetyl-N-nicotinoyl-",CC(=O)ONC(=O)C1=CN=CC=C1,,,,,,
292,150293,"Hydroxylamine, O-acetyl-N-isonicotinoyl-",CC(=O)ONC(=O)C1=CC=NC=C1,,,,,,
293,150294,"4H-1-Benzopyran-4-one, 5,6,8-trihydroxy-2-phenyl-",C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=CC(=C3O2)O)O)O,,,,,,
294,150295,CID 150295,COC1=CC=CC(=C1OC)C2=CC(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
295,150296,CID 150296,COC1=CC(=C(C=C1)OC)C2=CC(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
296,150297,"4H-1-Benzopyran-4,5,8-trione, 7-methoxy-2-phenyl-",COC1=CC(=O)C2=C(C1=O)OC(=CC2=O)C3=CC=CC=C3,,,,,,
297,150298,"4H-1-Benzopyran-4-one, 8-hydroxy-5,7-dimethoxy-2-phenyl-",COC1=CC(=C(C2=C1C(=O)C=C(O2)C3=CC=CC=C3)O)OC,,,,,,
298,150299,CID 150299,COC1=C(C=C(C=C1)C2=C(C(=C3C(=O)C=C(C(=C3O2)O)OC)O)O)OC,,,,,,
299,150300,"Acetamide, N-(2-methyldipyrido(1,2-a:3',2'-d)imidazol-4-yl)-",CC1=CC(=C2C(=N1)N3C=CC=CC3=N2)NC(=O)C,,,,,,
300,150301,"Acetamide, N-(2,7-dimethyldipyrido(1,2-a:3',2'-d)imidazol-4-yl)-",CC1=CC2=NC3=C(C=C(N=C3N2C=C1)C)NC(=O)C,,,,,,
301,150302,"10(9H)-Acridinebutanoic acid, 9-oxo-",C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CCCC(=O)O,,,,,,
302,150303,Sodium silver thiosulfate,[O-]S(=O)(=S)[O-].[O-]S(=O)(=S)[O-].[Na+].[Na+].[Na+].[Ag+],,,,,,
303,150304,"Acetaminophen, aspirin and caffeine",CC(=O)NC1=CC=C(C=C1)O.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C.C1=CC=C(C(=C1)C(=O)N)O,,,,,,
304,150305,3-Norzoanthoxanthin,CC1=C2C(=NC(=N2)N(C)C)C=CC3=C1N=C(N3)N,,,,,,
305,150306,"N-Hydroxy-3,4-dichloroformanilide",C1=CC(=C(C=C1N(C=O)O)Cl)Cl,,,,,,
306,150307,"1-Azirdineethanesulfonamide, N,N-diethyl-",CCN(CC)S(=O)(=O)CCN1CC1,,,,,,
307,150308,"Nitric acid, plutonium-239Pu salt",[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pu],,,,,,
308,150309,Cyproheptadine epoxide,CN1CCC(=C2C3=CC=CC=C3C4C(O4)C5=CC=CC=C52)CC1,,,,,,
309,150310,CID 150310,C[C@]12CCC(=O)C=C1C[C@H](C3[C@]24C(O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,,,,"['Apparent plasma clearance: approximately 10 L/hr. Less than 5% is recovered as unchanged drug in the urine and feces. Renal: 67%. Fecal: 32%.', 'Mean peak plasma concentrations of eplerenone are reached approximately 1.5 hours following oral administration. The absolute bioavailability of eplerenone is unknown. Both peak plasma levels (Cmax) and area under the curve (AUC) are dose proportional for doses of 25 to 100 mg and less than proportional at doses above 100 mg. The plasma protein binding of eplerenone is about 50% and it is primarily bound to alpha 1-acid glycoproteins. The apparent volume of distribution at steady state ranged from 43 to 90 L. Eplerenone does not preferentially bind to red blood cells.', 'Eplerenone is distributed into milk in rats; ... .', '... Preclinical data show that eplerenone and/or metabolites are present in rat breast milk (0.85:1 [milk:plasma] AUC ratio) obtained after a single oral dose. Peak concentrations in plasma and milk were obtained from 0.5 to 1 hour after dosing.']",['Eplerenone metabolism is primarily mediated via CYP3A4. No active metabolites have been identified in human plasma.'],['Elimination: 4 to 6 hours.']
310,150311,Ezetimibe,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,"['Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin). It is also indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with mixed hyperlipidemia in combination with fenofibrate, and to reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatin. Ezetimibe may also be used to reduce elevated sitosterol and campesterol in patients with homozygous sitosterolemia (phytosterolemia).']","['Ezetimibe was shown to reduce the levels of total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), apoprotein B (Apo B), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides (TG), and increase high-density lipoprotein cholesterol (HDL-C) in patients with hyperlipidemia. This therapeutic effect was more profound when ezetimibe was co-administered with a statin or fenofibrate compared to either treatment alone. In clinical trials involving patients with homozygous and heterozygous familial hypercholesterolemia and in those with sitosterolemia, a recommended therapeutic dose of ezetimibe was effective in reducing the LDL levels by 15-20% while increasing HDL-C by 2.5-5%.  The effects of increased exposure to ezetimibe secondary to moderate-severe hepatic impairment have not been assessed - patients meeting these criteria should avoid the use of ezetimibe. Post-marketing reports indicate the potential for myopathy and rhabdomyolysis in patients taking ezetimibe, and this risk appears to be exacerbated in patients concurrently receiving, or having recently received, statin therapy.']",['Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)'],"['Administration of a single 10-mg dose of ezetimibe in fasted adults resulted in peak plasma concentrations (C<sub>max</sub>) of 3.4-5.5 ng/mL within 4-12 hours (T<sub>max</sub>). The C<sub>max</sub> of the major pharmacologically-active metabolite, ezetimibe-glucuronide, was 45-71 ng/mL and its T<sub>max</sub> was 1-2 hours. Food consumption has minimal effect on ezetimibe absorption, but the C<sub>max</sub> is increased by 38% when administered alongside a high-fat meal. The true bioavailability of ezetimibe cannot be determined, as it is insoluble in aqueous media suitable for intravenous injection.', 'Approximately 78% and 11% of orally administered radiolabelled ezetimibe are recovered in the feces and urine, respectively. Unchanged parent drug is the major component in feces and accounts for approximately 69% of an administered dose, while ezetimibe-glucuronide is the major component in urine and accounts for approximately 9% of an administered dose. High recovery of unchanged parent drug in feces suggests low absorption and/or hydrolysis of ezetimibe-glucuronide secreted in the bile.', 'The relative volume of distribution of ezetimibe is 107.5L.', 'There are no pharmacokinetic data available on the clearance of ezetimibe.', 'Ezetimibe is the first member of a new class of selective cholesterol absorption inhibitors. The drug and its active glucuronide metabolite impair the intestinal reabsorption of both dietary and hepatically excreted biliary cholesterol through inhibition of a membrane transporter yet to be identified. Absorption of ezetimibe is rapid and not altered by food content following oral administration. The drug is not metabolized by the cytochrome P450 system but extensive glucuronidation takes place in the intestine. Consequently, plasma concentrations of ezetimibe represent approximately 10% of total ezetimibe in plasma. Enterohepatic recirculation observed for ezetimibe and its glucuronimide significantly increases the residence time of these compounds in the intestine, at their site of action. Elimination of ezetimibe glucuronimide appears impaired in elderly patients and patients with renal insufficiency with plasma concentrations increased 1.5- to 2-fold. So far, no drug interaction study has been associated with major changes in either the pharmokinetics of ezetimibe or coadministered drugs.', 'Ezetimibe lowers plasma cholesterol levels by inhibiting the uptake of cholesterol in the intestine. Due to extensive enterohepatic circulation of ezetimibe, relative low doses are required to be effective. In blood and bile the majority of ezetimibe is present as a glucuronide-conjugate, which is formed in the enterocyte. Presently, it is not clear which mechanisms are responsible for this efficient enterohepatic circulation. Abcc2, Abcc3 and Abcg2 are ABC transporters, which are expressed in both liver and intestine and are capable of transporting glucuronidated compounds. The aim of this study was to investigate the contribution of these transporters in the enterohepatic cycling of ezetimibe-glucuronide (Ez-gluc). Transport studies were performed in plasma membrane vesicles from ABCC2, ABCC3 and ABCG2 expressing Sf21 insect cells. Furthermore, intestinal explants from wild-type and Abcc3-/- mice were used to study vectorial transport in an Ussing chamber setup. Finally, biliary excretion of Ez-gluc was measured in vivo after duodenal delivery of ezetimibe in wild-type, Abcc3-/-, Abcc2-/-, Abcg2-/- and Abcg2-/-/Abcc2-/- mice. ABCC3-, ABCC2- and ABCG2-mediated transport was dose dependently inhibited by Ez-gluc. In the Ussing chamber Ez-gluc recovered from the basolateral side was significantly reduced in duodenal (2.2%), in jejunal (23%) and in ileal (23%) tissue of Abcc3-/- compared to wild-type mice. Biliary excretion of Ez-gluc was significantly reduced in Abcc3-/- (34%), Abcc2-/- (56%) and Abcg2-/-/Abcc2-/- (2.5%) compared to wild-type mice. These data demonstrate that enterohepatic circulation of Ez-gluc strongly depends on the joint function of Abcc3, Abcc2 and Abcg2.', 'It is not known whether ezetimibe is excreted into human breast milk. In rat studies, exposure to total ezetimibe in nursing pups was up to half of that observed in maternal plasma.', 'After oral administration, ezetimibe is absorbed and extensively conjugated to a pharmacologically active phenolic glucuronide (ezetimibe-glucuronide). After a single 10-mg dose of Zetia to fasted adults, mean ezetimibe peak plasma concentrations (Cmax) of 3.4 to 5.5 ng/mL were attained within 4 to 12 hours (Tmax). Ezetimibe-glucuronide mean Cmax values of 45 to 71 ng/mL were achieved between 1 and 2 hours (Tmax). There was no substantial deviation from dose proportionality between 5 and 20 mg. The absolute bioavailability of ezetimibe cannot be determined, as the compound is virtually insoluble in aqueous media suitable for injection.']","['In humans, ezetimibe is rapidly and extensively metabolized via a phase II glucuronide conjugation reaction in the small intestine and liver to form its main phenolic metabolite, ezetimibe glucuronide. The main human liver and/or intestinal uridine 5′-diphosphate (UDP)-glucuronosyltransferase (UGT) enzymes responsible for the glucuronidation of ezetimibe were shown to be UGT1A1, 1A3, and 2B15 _in vitro_. Minimal phase I reaction involving oxidation of ezetimibe also occurs to form SCH 57871, and human jejunum microsomes also produced trace levels of a benzylic glucuronide (SCH 488128). Ezetimibe glucuronide accounts for 80-90% of the total circulating compound in plasma, and retains some pharmacological activity in inhibiting intestinal cholesterol uptake. In humans, ezetimibe and ezetimibe-glucuronide constitutes approximately 93% of the total drug in plasma. Plasma concentration-time profiles exhibit multiple peaks, suggestive of enterohepatic recycling, and about 20% of the drug distributed is reabsorbed due to enterohepatic recirculation.', 'Ezetimibe is primarily metabolized in the small intestine and liver via glucuronide conjugation (a phase II reaction) with subsequent biliary and renal excretion. Minimal oxidative metabolism (a phase I reaction) has been observed in all species evaluated.  In humans, ezetimibe is rapidly metabolized to ezetimibe-glucuronide. Ezetimibe and ezetimibe-glucuronide are the major drug-derived compounds detected in plasma, constituting approximately 10 to 20% and 80 to 90% of the total drug in plasma, respectively. Both ezetimibe and ezetimibe-glucuronide are eliminated from plasma with a half-life of approximately 22 hours for both ezetimibe and ezetimibe-glucuronide. Plasma concentration-time profiles exhibit multiple peaks, suggesting enterohepatic recycling.  Following oral administration of (14)C-ezetimibe (20 mg) to human subjects, total ezetimibe (ezetimibe + ezetimibe-glucuronide) accounted for approximately 93% of the total radioactivity in plasma. After 48 hours, there were no detectable levels of radioactivity in the plasma.  Approximately 78% and 11% of the administered radioactivity were recovered in the feces and urine, respectively, over a 10-day collection period. Ezetimibe was the major component in feces and accounted for 69% of the administered dose, while ezetimibe-glucuronide was the major component in urine and accounted for 9% of the administered dose.', 'Ezetimibe has known human metabolites that include Ezetimibe-glucuronide.']","['Both ezetimibe and ezetimibe-glucuronide display an approximate half-life of 22 hours.', 'Both ezetimibe and ezetimibe-glucuronide are eliminated from plasma with a half-life of approximately 22 hours for both ezetimibe and ezetimibe-glucuronide.']"
311,150312,"5-Amino-1-methyl-1H-1,2,4-triazole-3-methanol",CN1C(=NC(=N1)CO)N,,,,,,
312,150313,"9H-Pyrido(3,4-b)indole, 1-methyl-9-nitroso-",CC1=NC=CC2=C1N(C3=CC=CC=C23)N=O,,,,,,
313,150314,"9H-Pyrido(3,4-b)indole, 9-nitroso-",C1=CC=C2C(=C1)C3=C(N2N=O)C=NC=C3,,,,,,
314,150315,4-Borono-L-phenylalanine,B(C1=CC=C(C=C1)C[C@@H](C(=O)O)N)(O)O,,,['Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)'],,,
315,150316,"Acetamide, N-(7-methyldipyrido(1,2-a:3',2'-d)imidazol-4-yl)-",CC1=CC2=NC3=C(C=CN=C3N2C=C1)NC(=O)C,,,,,,
316,150317,"Dipyrido(1,2-a:3',2'-d)imidazole, 4-chloro-2,9-dimethyl-",CC1=CC=CC2=NC3=C(C=C(N=C3N12)C)Cl,,,,,,
317,150318,"3-Aminodipyrido(1,2-a:3',2'-d)imidazole",C1=CC2=NC3=C(N2C=C1)N=CC(=C3)N,,,,,,
318,150319,"Dipyrido(1,2-a:3',2'-d)imidazole, 3-(dihydroxyamino)-4-methyl-, diacetate",CC1=C2C(=NC=C1N(OC(=O)C)OC(=O)C)N3C=CC=CC3=N2,,,,,,
319,150320,"Dipyrido(1,2-a:3',2'-d)imidazol-3-amine, N-hydroxy-4-methyl-",CC1=C2C(=NC=C1NO)N3C=CC=CC3=N2,,,,,,
320,150321,5-Ethenyl-3-nitroso-2-oxazolidinone,C=CC1CN(C(=O)O1)N=O,,,,,,
321,150322,"1,2-Dichloroethenylsulfanylmethylbenzene",C1=CC=C(C=C1)CSC(=CCl)Cl,,,,,,
322,150323,Dinitrosoglycolurile,C12C(NC(=O)N1)(N(C(=O)N2)N=O)N=O,,,,,,
323,150324,"Methanol, (nitroso-2-propenylamino)-, acetate (ester)",CC(=O)OCN(CC=C)N=O,,,,,,
324,150325,"Acetic acid, (cyclopropylnitrosamino)methyl ester",CC(=O)OCN(C1CC1)N=O,,,,,,
325,150326,1-(Nitroso-2-propenylamino)ethanol acetate (ester),CC(N(CC=C)N=O)OC(=O)C,,,,,,
326,150327,N-Nitroso(1-acetoxyethyl)cyclopropylamine,CC(N(C1CC1)N=O)OC(=O)C,,,,,,
327,150328,"4,5-Pyrenediol, 4,5-dihydro-1-nitro-, cis-",C1=CC2=C3C(=C1)[C@H]([C@H](C4=C3C(=C(C=C4)[N+](=O)[O-])C=C2)O)O,,,,,,
328,150329,"4-Pyrenol, 1-nitro-",C1=CC2=C3C(=C1)C=C(C4=C3C(=C(C=C4)[N+](=O)[O-])C=C2)O,,,,,,
329,150330,1-Nitropyren-5-ol,C1=CC2=C3C(=C1)C(=CC4=C3C(=C(C=C4)[N+](=O)[O-])C=C2)O,,,,,,
330,150331,"L-Cysteine, S-(5-amino-1,2-dimethyl-1H-imidazol-4-yl)-",CC1=NC(=C(N1C)N)SC[C@@H](C(=O)O)N,,,,,,
331,150332,N-(2-(((Aminocarbonyl)oxy)methyl)-1-methyl-1H-imidazol-5-yl)acetamide,CC(=O)NC1=CN=C(N1C)COC(=O)N,,,,,,
332,150333,"1-Propanesulfonic acid, ethyl ester",CCCS(=O)(=O)OCC,,,,,,
333,150334,"1-Pentanesulfonic acid, ethyl ester",CCCCCS(=O)(=O)OCC,,,,,,
334,150335,"1-Propanesulfonic acid, 1-methylethyl ester",CCCS(=O)(=O)OC(C)C,,,,,,
335,150336,"1-Butanesulfonic acid, 1-methylethyl ester",CCCCS(=O)(=O)OC(C)C,,,,,,
336,150337,1-Methylethyl 1-pentanesulfonate,CCCCCS(=O)(=O)OC(C)C,,,,,,
337,150338,"Benzenesulfonic acid, 4-methoxy-, 1-methylethyl ester",CC(C)OS(=O)(=O)C1=CC=C(C=C1)OC,,,,,,
338,150339,2-((4-Methyl-1-piperazinyl)methyl)-1-phenyl-2-propen-1-one dihydrochloride,CN1CCN(CC1)CC(=C)C(=O)C2=CC=CC=C2.Cl.Cl,,,,,,
339,150340,"4-Acridinecarboxamide, N-(2-((2-hydroxyethyl)amino)ethyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCCNCCO,,,,,,
340,150341,"1a,9b-Dihydro-1-pentyl-1H-phenanthro(9,10-b)azirine",CCCCCN1C2C1C3=CC=CC=C3C4=CC=CC=C24,,,,,,
341,150342,"1-(2-Propenyl)-1a,9b-dihydro-1H-phenanthro(9,10-b)azirine",C=CCN1C2C1C3=CC=CC=C3C4=CC=CC=C24,,,,,,
342,150343,9-Amino-N-(5-(dimethylamino)pentyl)-4-acridinecarboxamide,CN(C)CCCCCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
343,150344,9-Amino-N-(6-(dimethylamino)hexyl)-4-acridinecarboxamide,CN(C)CCCCCCNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
344,150345,9-Amino-n-(2-(4-morpholinyl)ethyl)-4-acridinecarboxamide,C1COCCN1CCNC(=O)C2=CC=CC3=C(C4=CC=CC=C4N=C32)N,,,,,,
345,150346,"Acetamide, N,N'-(methylenebis(2-chloro-4,1-phenylene))bis-",CC(=O)NC1=C(C=C(C=C1)CC2=CC(=C(C=C2)NC(=O)C)Cl)Cl,,,,,,
346,150347,1-Acetamidopyren-6-ol,CC(=O)NC1=C2C=CC3=C4C2=C(C=CC4=C(C=C3)O)C=C1,,,,,,
347,150348,"Acetamide, N-(8-hydroxy-1-pyrenyl)-",CC(=O)NC1=C2C=CC3=C(C=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
348,150349,"1,3-Benzenediol, 4-((5-methyl-1,3,4-thiadiazol-2-yl)azo)-",CC1=NN=C(S1)N=NC2=C(C=C(C=C2)O)O,,,,,,
349,150350,CID 150350,C1=CC=C2C(=C1)C3=C(C=C2N(O)O)C4=C(C=C3)C(=O)C(=O)C=C4,,,,,,
350,150351,"1-(4-Hydroxy-3-methoxyphenyl)-9-(4-hydroxyphenyl)nona-2,7-diene-4,6-dione",COC1=C(C=CC(=C1)CC=CC(=O)CC(=O)C=CCC2=CC=C(C=C2)O)O,,,,,,
351,150352,"1,9-Bis(4-hydroxyphenyl)nona-2,7-diene-4,6-dione",C1=CC(=CC=C1CC=CC(=O)CC(=O)C=CCC2=CC=C(C=C2)O)O,,,,,,
352,150353,"3,9-Dinitroperylene",C1=CC2=C3C(=C1)C(=CC=C3C4=C5C2=CC=C(C5=CC=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
353,150354,"Perylene, 3,10-dinitro-",C1=CC2=C3C(=C1)C(=CC=C3C4=CC=C(C5=CC=CC2=C54)[N+](=O)[O-])[N+](=O)[O-],,,,,,
354,150355,"1-Methoxyhepta-1,3,5-triene",CC=CC=CC=COC,,,,,,
355,150356,"1-Methoxynona-1,3,5,7-tetraene",CC=CC=CC=CC=COC,,,,,,
356,150357,"1-Methoxyundeca-1,3,5,7,9-pentaene",CC=CC=CC=CC=CC=COC,,,,,,
357,150358,"3,7-Dinitroperylene",C1=CC2=C3C(=C1)C4=C5C(=C(C=C4)[N+](=O)[O-])C=CC=C5C3=C(C=C2)[N+](=O)[O-],,,,,,
358,150359,"3,6-Dinitroperylene",C1=CC2=C3C(=C1)C4=C5C(=C(C=C4)[N+](=O)[O-])C=CC(=C5C3=CC=C2)[N+](=O)[O-],,,,,,
359,150360,"2-(1,2,3,4,5-Pentahydroxypentyl)-N-nitrosothiazolidine",C1CSC(N1N=O)C(C(C(C(CO)O)O)O)O,,,,,,
360,150361,"10-(6-((2-Aminoethyl)amino)hexyl)-3,6-bis(dimethylamino)acridinium chloride, tetrahydrochloride",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=[N+]2CCCCCCNCCN)N(C)C.Cl.Cl.Cl.Cl.[Cl-],,,,,,
361,150362,"10-[6-(2-aminoethylamino)hexyl]-3-N,3-N,6-N,6-N-tetramethylacridin-10-ium-3,6-diamine",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=[N+]2CCCCCCNCCN)N(C)C,,,,,,
362,150363,CID 150363,C1CN(CCC1CC2=CC=CC=C2)CC3=C(OC4=CC=CC=C4C3=O)O,,,,,,
363,150364,"Acetamide, N,N'-(2-methyl-1,3-phenylene)bis-",CC1=C(C=CC=C1NC(=O)C)NC(=O)C,,,,,,
364,150365,"1-(2-Thiazolidinyl)1,2,3,4,5-pentanepentol",C1CSC(N1)C(C(C(C(CO)O)O)O)O,,,,,,
365,150366,"Acetamide, N-(7-acetyl-9H-fluoren-2-yl)-N-hydroxy-",CC(=O)C1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)N(C(=O)C)O,,,,,,
366,150367,"3,8-Diamino-6-(4-(((3-((4-((4-(3,8-diamino-5-methylphenanthridinium-6-yl)benzoyl)amino)butyl)amino)propyl)amino)carbonyl)phenyl)-5-methylphenanthridinium",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)C(=O)NCCCCNCCCNC(=O)C5=CC=C(C=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
367,150368,"2-Methyl-3H-imidazo[4,5-f]quinoline",CC1=NC2=C(N1)C=CC3=C2C=CC=N3,,,,,,
368,150369,"3,4-Diphenyl-5-nitro-2-bromoacetylfuran",C1=CC=C(C=C1)C2=C(OC(=C2C3=CC=CC=C3)[N+](=O)[O-])C(=O)CBr,,,,,,
369,150370,"Dibenz(a,e)aceanthrylene, 5,6,7,8-tetrahydro-",C1CCC2=C(C1)C3=CC4=CC=CC=C4C5=CC6=CC=CC=C6C2=C35,,,,,,
370,150371,"4-Chloro-1,2-dihydro-2-hydroxy-1-nitroso-3H-indol-3-one oxime",C1=CC2=C(C(=C1)Cl)C(=NO)C(N2N=O)O,,,,,,
371,150372,CID 150372,COC1=CC2=C(C3=C(C=C(C=C3)N[N+]#N)N=C2C=C1)[N-]CCSSCCN=C(C4=CC=C(C=C4)N[N+]#N)[O-],,,,,,
372,150373,CID 150373,COC1=CC2=C(C3=C(C=C(C=C3)N[N+]#N)N=C2C=C1)NCCSSCCNC(=O)C4=CC=C(C=C4)N[N+]#N,,,,,,
373,150374,CID 150374,COC1=CC2=C(C3=C(C=C(C=C3)N[N+]#N)N=C2C=C1)[N-]CCCCCCN=C(C4=CC=C(C=C4)N[N+]#N)[O-].Cl,,,,,,
374,150375,CID 150375,COC1=CC2=C(C3=C(C=C(C=C3)N[N+]#N)N=C2C=C1)NCCCCCCNC(=O)C4=CC=C(C=C4)N[N+]#N,,,,,,
375,150376,"2,3,4,9-Tetrahydro-1H-pyrido(3,4-b)indole-1-propanol",C1CNC(C2=C1C3=CC=CC=C3N2)CCCO,,,,,,
376,150377,"9-Acridinamine, N-ethyl-",CCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
377,150378,"4-Acridinecarboxamide, 9-amino-N-methyl-",CNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
378,150379,"Methanesulfonamide, N-(4-((1-formyl-9-acridinyl)amino)phenyl)-",CS(=O)(=O)NC1=CC=C(C=C1)NC2=C3C(=NC4=CC=CC=C42)C=CC=C3C=O,,,,,,
379,150380,"8-Hydroxy-7,8-dihydrobenzo(a)pyrene",C1C(C=CC2=C1C=C3C=CC4=C5C3=C2C=CC5=CC=C4)O,,,,,,
380,150381,"Propanamide, 3-(9-acridinylamino)-N-(2-(9-acridinylamino)ethyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCC(=O)NCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
381,150382,4-(9-Acridinylamino)-N-(2-(9-acridinylamino)ethyl)butanamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCC(=O)NCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
382,150383,"Propanamide, 3-(9-acridinylamino)-N-(3-(9-acridinylamino)propyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNC(=O)CCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
383,150384,"Butanamide, 4-(9-acridinylamino)-N-(3-(9-acridinylamino)propyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCC(=O)NCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
384,150385,"1H-Pyrazole-3,5-dicarboxamide, N,N'-bis(2-(9-acridinylamino)ethyl)-1-methyl-",CN1C(=CC(=N1)C(=O)NCCNC2=C3C=CC=CC3=NC4=CC=CC=C42)C(=O)NCCNC5=C6C=CC=CC6=NC7=CC=CC=C75,,,,,,
385,150386,Dimethyl ((1-methyl-5-nitro-1H-imidazol-2-yl)methylene)propanedioate,CN1C(=CN=C1C=C(C(=O)OC)C(=O)OC)[N+](=O)[O-],,,,,,
386,150387,"Imidazo(2,1-b)thiazole, 2-methyl-5-nitro-6-(p-nitrophenyl)-",CC1=CN2C(=C(N=C2S1)C3=CC=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
387,150388,"1H-Naphth(1,2-d)imidazole, 2-azido-1-methyl-",CN1C2=C(C=CC3=CC=CC=C32)N=C1N=[N+]=[N-],,,,,,
388,150389,"Ethanone, 1-(5-nitro-1-undecylnaphtho(2,1-b)furan-2-yl)-",CCCCCCCCCCCC1=C(OC2=C1C3=CC=CC=C3C(=C2)[N+](=O)[O-])C(=O)C,,,,,,
389,150390,"1,9-Nonanediamine, N,N'-di-9-acridinyl-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
390,150391,"1,11-Undecanediamine, N,N'-di-9-acridinyl-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
391,150392,S-pentachlorobutadienyl-mercaptoacetic acid,C(C(=O)O)SC(=C(C(=C(Cl)Cl)Cl)Cl)Cl,,,,,,
392,150393,CID 150393,CC1=C(C=C(C=C1)N(O)O)N=O,,,,,,
393,150394,CID 150394,C1=CC=C2C(=C1)C3=C(C(=N)C=CC3=N2)N(O)O,,,,,,
394,150395,"Imidazo(2,1-b)thiazole, 6-(chloronitrophenyl)-2,3-dihydro-",C1CSC2=NC(=CN21)C3=C(C(=CC=C3)Cl)[N+](=O)[O-],,,,,,
395,150396,"Imidazo(2,1-b)thiazole, 2,3-dihydro-5-nitro-6-(nitrophenyl)-",C1CSC2=NC(=C(N21)[N+](=O)[O-])C3=CC=CC=C3[N+](=O)[O-],,,,,,
396,150397,"Imidazo(2,1-b)thiazole, 6-(chlorophenyl)-2,3-dihydro-5-nitro-",C1CSC2=NC(=C(N21)[N+](=O)[O-])C3=CC=CC=C3Cl,,,,,,
397,150398,"Imidazo(2,1-b)thiazole, 2,3-dihydro-6-(methylphenyl)-5-nitro-",CC1=CC=CC=C1C2=C(N3CCSC3=N2)[N+](=O)[O-],,,,,,
398,150399,"Imidazo(2,1-b)thiazole, 2-methyl-6-(nitrophenyl)-5-nitroso-",CC1=CN2C(=C(N=C2S1)C3=CC=CC=C3[N+](=O)[O-])N=O,,,,,,
399,150400,"Imidazo(2,1-b)thiazole, 6-(chlorophenyl)-5-nitroso-",C1=CC=C(C(=C1)C2=C(N3C=CSC3=N2)N=O)Cl,,,,,,
400,150401,"Imidazo(2,1-b)thiazole, 6-(chlorophenyl)-5-nitro-",C1=CC=C(C(=C1)C2=C(N3C=CSC3=N2)[N+](=O)[O-])Cl,,,,,,
401,150402,"5-Nitro-6-(nitrophenyl)imidazo(2,1-b)thiazole",C1=CC=C(C(=C1)C2=C(N3C=CSC3=N2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
402,150403,3-Amino-2'-nitrobiphenyl,C1=CC=C(C(=C1)C2=CC(=CC=C2)N)[N+](=O)[O-],,,,,,
403,150404,"1,3-Propanediol, 2-((7-fluoranthenylmethyl)amino)-2-methyl-",CC(CO)(CO)NCC1=C2C(=CC=C1)C3=CC=CC4=C3C2=CC=C4,,,,,,
404,150405,"1,3-Propanediol, 2-((3-chrysenylmethyl)amino)-2-methyl-, methanesulfonate (salt)",CC(CO)(CO)NCC1=CC2=C(C=C1)C=CC3=C2C=CC4=CC=CC=C43.CS(=O)(=O)O,,,,,,
405,150406,"1,3-Propanediol, 2-((3-chrysenylmethyl)amino)-2-methyl-",CC(CO)(CO)NCC1=CC2=C(C=C1)C=CC3=C2C=CC4=CC=CC=C43,,,,,,
406,150407,"1,3-Propanediol, 2-methyl-2-((4-pyrenylmethyl)amino)-, hydrochloride",CC(CO)(CO)NCC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3.Cl,,,,,,
407,150408,"2-[(Pyren-4-yl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3,,,,,,
408,150409,"1,3-Propanediol, 2-((8-fluoranthenylmethyl)amino)-2-methyl-, hydrochloride",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=CC=CC4=C3C2=CC=C4.Cl,,,,,,
409,150410,"1,3-Propanediol, 2-((8-fluoranthenylmethyl)amino)-2-methyl-",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=CC=CC4=C3C2=CC=C4,,,,,,
410,150411,"1,3-Propanediol, 2-((2-chrysenylmethyl)amino)-2-methyl-, methanesulfonate (salt)",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=C(C=C2)C4=CC=CC=C4C=C3.CS(=O)(=O)O,,,,,,
411,150412,"1,3-Propanediol, 2-((2-chrysenylmethyl)amino)-2-methyl-",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=C(C=C2)C4=CC=CC=C4C=C3,,,,,,
412,150413,"1,3-Propanediol, 2-methyl-2-((4-phenanthrenylmethyl)amino)-, hydrochloride",CC(CO)(CO)NCC1=CC=CC2=C1C3=CC=CC=C3C=C2.Cl,,,,,,
413,150414,"2-[(Phenanthren-4-yl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC=CC2=C1C3=CC=CC=C3C=C2,,,,,,
414,150415,"1,3-Propanediol, 2-methyl-2-((3-phenanthrenylmethyl)amino)-, hydrochloride",CC(CO)(CO)NCC1=CC2=C(C=CC3=CC=CC=C32)C=C1.Cl,,,,,,
415,150416,"2-[(Phenanthren-3-yl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC2=C(C=CC3=CC=CC=C32)C=C1,,,,,,
416,150417,"1,3-Propanediol, 2-methyl-2-((9-phenanthrenylmethyl)amino)-, hydrochloride",CC(CO)(CO)NCC1=CC2=CC=CC=C2C3=CC=CC=C31.Cl,,,,,,
417,150418,"2-[(Phenanthren-9-yl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC2=CC=CC=C2C3=CC=CC=C31,,,,,,
418,150419,"1,3-Propanediol, 2-methyl-2-((2-phenanthrenylmethyl)amino)-, hydrochloride",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=CC=CC=C3C=C2.Cl,,,,,,
419,150420,"2-[(Phenanthren-2-yl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=CC=CC=C3C=C2,,,,,,
420,150421,"1,3-Propanediol, 2-((1-anthracenylmethyl)amino)-2-methyl-, hydrochloride",CC(CO)(CO)NCC1=CC=CC2=CC3=CC=CC=C3C=C21.Cl,,,,,,
421,150422,"2-[(1-Anthracenyl)methylamino]-2-methyl-1,3-propanediol",CC(CO)(CO)NCC1=CC=CC2=CC3=CC=CC=C3C=C21,,,,,,
422,150423,Doxorubicin deriv.,CC1C2C(CC(O1)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)OC)O)(C(=O)CO)O)N7C(COCC7O2)C#N,,,,,,
423,150424,"((9-Anthracenylmethyl)amino)-2-methyl-1,3-propanediol hydrochloride",CC(CO)C(NCC1=C2C=CC=CC2=CC3=CC=CC=C31)O.Cl,,,,,,
424,150425,"1-(Anthracen-9-ylmethylamino)-2-methylpropane-1,3-diol",CC(CO)C(NCC1=C2C=CC=CC2=CC3=CC=CC=C31)O,,,,,,
425,150426,"2,3,9-Trimethylfluorene",CC1C2=CC=CC=C2C3=C1C=C(C(=C3)C)C,,,,,,
426,150427,"3,9-Dimethylfluorene",CC1C2=C(C=C(C=C2)C)C3=CC=CC=C13,,,,,,
427,150428,"4,9-Dimethylfluorene",CC1C2=CC=CC=C2C3=C(C=CC=C13)C,,,,,,
428,150429,"9H-Fluorene, 2,7-difluoro-9-methyl-",CC1C2=C(C=CC(=C2)F)C3=C1C=C(C=C3)F,,,,,,
429,150430,2-Fluoro-9-methylfluorene,CC1C2=CC=CC=C2C3=C1C=C(C=C3)F,,,,,,
430,150431,"7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((dimethylamino)methyl)-9-methoxy-, hydrochloride",CN(C)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC.Cl,,,,,,
431,150432,"4-[(Dimethylamino)methyl]-9-methoxyfuro[3,2-g]chromen-7-one",CN(C)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC,,,,,,
432,150433,"((9-Methoxy-7-oxo-7H-furo(3,2-g)(1)benzopyran-4-yl)methyl)trimethylammonium chloride",C[N+](C)(C)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC.[Cl-],,,,,,
433,150434,"(9-Methoxy-7-oxofuro[3,2-g]chromen-4-yl)methyl-trimethylazanium",C[N+](C)(C)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC,,,,,,
434,150435,"N,N,N-Triethyl-9-methoxy-7-oxo-7H-furo(3,2-g)(1)benzopyran-4-methanaminium chloride",CC[N+](CC)(CC)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC.[Cl-],,,,,,
435,150436,"Triethyl[(9-methoxy-7-oxo-7H-furo[3,2-g][1]benzopyran-4-yl)methyl]aminium",CC[N+](CC)(CC)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC,,,,,,
436,150437,"7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((bis(1-methylethyl)amino)methyl)-9-methoxy-, hydrochloride",CC(C)N(CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC)C(C)C.Cl,,,,,,
437,150438,"4-[[Di(propan-2-yl)amino]methyl]-9-methoxyfuro[3,2-g]chromen-7-one",CC(C)N(CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC)C(C)C,,,,,,
438,150439,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy-4-(1-piperidinylmethyl)-, hydrochloride",COC1=C2C(=C(C3=C1OC=C3)CN4CCCCC4)C=CC(=O)O2.Cl,,,,,,
439,150440,"9-Methoxy-4-(piperidin-1-ylmethyl)furo[3,2-g]chromen-7-one",COC1=C2C(=C(C3=C1OC=C3)CN4CCCCC4)C=CC(=O)O2,,,,,,
440,150441,"7H-Furo(3,2-g)(1)benzopyran-7-one, 4-(((2-hydroxyethyl)methylamino)methyl)-9-methoxy-, hydrochloride",CN(CCO)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC.Cl,,,,,,
441,150442,"4-[[2-Hydroxyethyl(methyl)amino]methyl]-9-methoxyfuro[3,2-g]chromen-7-one",CN(CCO)CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC,,,,,,
442,150443,"7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((bis(2-hydroxyethyl)amino)methyl)-9-methoxy-, hydrochloride",COC1=C2C(=C(C3=C1OC=C3)CN(CCO)CCO)C=CC(=O)O2.Cl,,,,,,
443,150444,"4-[[Bis(2-hydroxyethyl)amino]methyl]-9-methoxyfuro[3,2-g]chromen-7-one",COC1=C2C(=C(C3=C1OC=C3)CN(CCO)CCO)C=CC(=O)O2,,,,,,
444,150445,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy-4-(4-morpholinylmethyl)-, hydrochloride",COC1=C2C(=C(C3=C1OC=C3)CN4CCOCC4)C=CC(=O)O2.Cl,,,,,,
445,150446,"9-Methoxy-4-(morpholin-4-ylmethyl)furo[3,2-g]chromen-7-one",COC1=C2C(=C(C3=C1OC=C3)CN4CCOCC4)C=CC(=O)O2,,,,,,
446,150447,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy-4-((4-methyl-1-piperazinyl)methyl)-, monohydrochloride",CN1CCN(CC1)CC2=C3C=CC(=O)OC3=C(C4=C2C=CO4)OC.Cl,,,,,,
447,150448,"9-Methoxy-4-[(4-methylpiperazin-1-yl)methyl]furo[3,2-g]chromen-7-one",CN1CCN(CC1)CC2=C3C=CC(=O)OC3=C(C4=C2C=CO4)OC,,,,,,
448,150449,"N,N,N-Trimethyl-3-((7-oxo-7H-furo(3,2-g)(1)benzopyran-9-yl)oxy)-1-propanaminium bromide",C[N+](C)(C)CCCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2.[Br-],,,,,,
449,150450,"Trimethyl-[3-(7-oxofuro[3,2-g]chromen-9-yl)oxypropyl]azanium",C[N+](C)(C)CCCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,,,,,
450,150451,"3-((9-Methoxy-7-oxo-7H-furo(3,2-g)(1)benzopyran-4-yl)methoxy)-N,N,N-trimethyl-1-propanaminium bromide",C[N+](C)(C)CCCOCC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC.[Br-],,,,,,
451,150452,"3-[(9-Methoxy-7-oxofuro[3,2-g]chromen-4-yl)methoxy]propyl-trimethylazanium",C[N+](C)(C)CCCOCC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC,,,,,,
452,150453,"7H-Furo(3,2-g)(1)benzopyran-7-one, 3-(((2-hydroxyethyl)amino)methyl)-2,5,9-trimethyl-, hydrochloride",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CNCCO)C.Cl,,,,,,
453,150454,"3-[(2-Hydroxyethylamino)methyl]-2,5,9-trimethylfuro[3,2-g]chromen-7-one",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CNCCO)C,,,,,,
454,150455,N-methyl-valyl-amiclenomycin,CC(CC1C=CC(C=C1)N)[C@](C(=O)CCCC(=O)O)(N)NC,,,,,,
455,150456,(E)-alpha-Hydroxy tamoxifen;alpha-OHTAM,CC(C(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3)O,,,,,,
456,150457,3-(5-nitrofuran-2-yl)-N-pentylprop-2-enamide,CCCCCNC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
457,150458,"1-Methyl-4-phenyl-2,3-dihydropyridinium perchlorate",C[N+]1=CC=C(CC1)C2=CC=CC=C2.[O-]Cl(=O)(=O)=O,,,,,,
458,150459,"1-Methyl-4-phenyl-2,3-dihydropyridinium",C[N+]1=CC=C(CC1)C2=CC=CC=C2,,,,,,
459,150460,"Acetamide, N-(4-(3-(diethylamino)propoxy)-9,10-dihydro-2-methoxy-6,7,8-trimethyl-9,10-dioxo-1-anthracenyl)-",CCN(CC)CCCOC1=CC(=C(C2=C1C(=O)C3=C(C2=O)C(=C(C(=C3)C)C)C)NC(=O)C)OC,,,,,,
460,150461,"Propanamide, 3-(diethylamino)-N-(9,10-dihydro-4,5-dihydroxy-6,7,8-trimethyl-9,10-dioxo-1-anthracenyl)-",CCN(CC)CCC(=O)NC1=C2C(=C(C=C1)O)C(=O)C3=C(C2=O)C(=C(C(=C3O)C)C)C,,,,,,
461,150462,"Propanamide, 3-(diethylamino)-N-(9,10-dihydro-1,8-dihydroxy-5,6,7-trimethyl-9,10-dioxo-2-anthracenyl)-",CCN(CC)CCC(=O)NC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C(=C(C(=C3C)C)C)O)O,,,,,,
462,150463,CID 150463,CC1=C(C(=N)C(=CC1=N)N(O)O)C,,,,,,
463,150464,"9-Acridinamine, N-2-propenyl-",C=CCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
464,150465,"4-Acridinecarboxamide, 9-((2-(dimethylamino)ethyl)amino)-",CN(C)CCNC1=C2C=CC=C(C2=NC3=CC=CC=C31)C(=O)N,,,,,,
465,150466,"4(1H)-Pyridinone, 2-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC(=O)C=CN4,,,,,,
466,150467,"Acridine, 9-(1H-indol-1-yl)-",C1=CC=C2C(=C1)C=CN2C3=C4C=CC=CC4=NC5=CC=CC=C53,,,,,,
467,150468,"Acridine, 9-(2-phenylhydrazino)-",C1=CC=C(C=C1)NNC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
468,150469,"Hydrazinecarboxylic acid, 2-(9-acridinyl)-, methyl ester",COC(=O)NNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
469,150470,CID 150470,CC(=NNC1=C2C=CC=CC2=NC3=CC=CC=C31)C4=CC=CC=C4,,,,,,
470,150471,"Methanesulfonamide, N-9-acridinyl-",CS(=O)(=O)NC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
471,150472,"Propanedinitrile, 9-acridinyl-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)C(C#N)C#N,,,,,,
472,150473,N-(3-Methoxy-4-((3-((methylsulfonyl)amino)-9-acridinyl)amino)phenyl)methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)NS(=O)(=O)C,,,,,,
473,150474,"Methanesulfonamide, N-(3-methoxy-4-(((3-methylsulfonyl)-9-acridinyl)amino)phenyl)-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)S(=O)(=O)C,,,,,,
474,150475,CID 150475,CN1C(=CN=C1C=C2CC3CCC2C3)[N+](=O)[O-],,,,,,
475,150476,4-Amino-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-1H-pyrrole-2-carboxamide monohydrochloride,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C)N.Cl,,,,,,
476,150477,4-amino-N-[5-[(3-amino-3-imino-propyl)carbamoyl]-1-methyl-pyrrol-3-yl]-1-methyl-pyrrole-2-carboxamide,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C)N,,,,,,
477,150478,"3-Phenanthrenol, 6-(methylamino)-",CNC1=CC2=C(C=CC3=C2C=C(C=C3)O)C=C1,,,,,,
478,150479,"2,3-Dimethyl-3H-phenanthro(3,4-d)imidazol-10-ol",CC1=NC2=C(N1C)C=CC3=C2C4=C(C=C3)C=CC(=C4)O,,,,,,
479,150480,"1,4-Butanediamine, N,N'-bis(3-(dipyrido(1,2-a:3',2'-d)imidazol-2-ylamino)propyl)-",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)NCCCNCCCCNCCCNC4=NC5=C(C=C4)N=C6N5C=CC=C6,,,,,,
480,150481,CID 150481,CCN=N[O-].[K+],,,,,,
481,150482,Ethyl(oxido)diazene,CCN=N[O-],,,,,,
482,150483,"N,N'-Bis(2-(9-acridinylamino)ethyl)pentanediamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCNC(=O)CCCC(=O)NCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
483,150484,"N,N'-Bis(3-(9-acridinylamino)propyl)pentanediamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNC(=O)CCCC(=O)NCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
484,150485,"N,N'-Bis(4-(9-acridinylamino)butyl)pentanediamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNC(=O)CCCC(=O)NCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
485,150486,"N,N'-Bis(5-(9-acridinylamino)pentyl)pentanediamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCNC(=O)CCCC(=O)NCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
486,150487,"N,N'-Bis(6-(9-acridinylamino)hexyl)pentanediamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)CCCC(=O)NCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
487,150488,"Pentanediamide, N,N'-bis(7-(9-acridinylamino)heptyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCNC(=O)CCCC(=O)NCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
488,150489,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(3-(9-acridinylamino)propyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNC(=O)CC(CC(=O)NCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
489,150490,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(4-(9-acridinylamino)butyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNC(=O)CC(CC(=O)NCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
490,150491,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(5-(9-acridinylamino)pentyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCNC(=O)CC(CC(=O)NCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
491,150492,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(6-(9-acridinylamino)hexyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)CC(CC(=O)NCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
492,150493,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(7-(9-acridinylamino)heptyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCNC(=O)CC(CC(=O)NCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
493,150494,"Pentanediamide, 3-(9-acridinylamino)-N,N'-bis(2-(9-acridinylamino)ethyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCNC(=O)CC(CC(=O)NCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)NC7=C8C=CC=CC8=NC9=CC=CC=C97,,,,,,
494,150495,"4-Acetylamino-6-diazo-2,4-cyclohexadienone",CC(=O)NC1=CC(=C(C=C1)[O-])[N+]#N,,,,,,
495,150496,5-Acetamido-2-hydroxybenzenediazonium,CC(=O)NC1=CC(=C(C=C1)O)[N+]#N,,,,,,
496,150497,"Pentanediamide, N,N'-bis(3-(9-acridinylamino)propyl)-3-amino-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNC(=O)CC(CC(=O)NCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N,,,,,,
497,150498,"Benz(a)anthracene-8,9-diol, 8,9-dihydro-6-methyl-, trans-",CC1=CC2=CC=CC=C2C3=C1C=C4[C@@H]([C@H](C=CC4=C3)O)O,,,,,,
498,150499,N-Nitroso-N-(m-cyanobenzyl)methylamine,CN(CC1=CC(=CC=C1)C#N)N=O,,,,,,
499,150500,"2,3-Dihydro-3-hydroxy-2-(5-nitro-2-furanyl)-4H-1,3-benzoxazin-4-one",C1=CC=C2C(=C1)C(=O)N(C(O2)C3=CC=C(O3)[N+](=O)[O-])O,,,,,,
500,150501,"3,3'-Diacetylbenzidine",CC(=O)C1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C(=O)C)N,,,,,,
501,150502,"(2R,3R)-3-Phenylglycidol",C1=CC=C(C=C1)[C@@H]2[C@H](O2)CO,,,,,,
502,150503,"beta-D-Glucopyranoside, 6-nitro-1-pyrenyl",C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[N+](=O)[O-],,,,,,
503,150504,"beta-D-Glucopyranoside, 8-nitro-1-pyrenyl",C1=CC2=C3C(=C(C=C2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=CC5=C(C=CC1=C53)[N+](=O)[O-],,,,,,
504,150505,"Acetamide, N-(4-(4-chlorophenoxy)phenyl)-N-hydroxy-",CC(=O)N(C1=CC=C(C=C1)OC2=CC=C(C=C2)Cl)O,,,,,,
505,150506,"Acetamide, N-(4-(2,4-dichlorophenoxy)phenyl)-N-hydroxy-",CC(=O)N(C1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O,,,,,,
506,150507,Ccris 6643,CCCN1C=C2C[C@@H]3C(C[C@H](CN3C#N)C)C4=C2C1=CC=C4,,,,,,
507,150508,1-Allyl-6-cyano-6-norfestuclavine,C[C@@H]1CC2[C@@H](CC3=CN(C4=CC=CC2=C34)CC=C)N(C1)C#N,,,,,,
508,150509,1-Nitro-3-acetoxypyrene,CC(=O)OC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C(=C1)[N+](=O)[O-],,,,,,
509,150510,"Benzenamine, N-hydroxy-4-(2,4,6-trichlorophenoxy)-",C1=CC(=CC=C1NO)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
510,150511,"Acetamide, N-ethyl-N-9H-fluoren-2-yl-",CCN(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C(=O)C,,,,,,
511,150512,"Propanal, 3-(nitrosopropylamino)-",CCCN(CCC=O)N=O,,,,,,
512,150513,"2,3-Dibromohexanal",CCCC(C(C=O)Br)Br,,,,,,
513,150514,"2,3-Dibromo-3-methylbutanal",CC(C)(C(C=O)Br)Br,,,,,,
514,150515,2-Iodo-2-propenal,C=C(C=O)I,,,,,,
515,150516,"2,3-Dichloroacrolein",C(=C(C=O)Cl)Cl,,,,,,
516,150517,2-Bromohex-2-enal,CCCC=C(C=O)Br,,,,,,
517,150518,alpha-Ethynyl-p-methoxybenzyl alcohol acetate,CC(=O)OC(C#C)C1=CC=C(C=C1)OC,,,,,,
518,150519,"6-Hydroxyindeno(1,2,3-c,d)pyrene",C1=CC=C2C(=C1)C3=C4C2=C(C5=CC=CC6=C5C4=C(C=C6)C=C3)O,,,,,,
519,150520,"Indeno(1,2,3-cd)pyren-9-ol",C1=CC2=C3C(=C1)C=C4C5=C(C=CC=C5O)C6=C4C3=C(C=C2)C=C6,,,,,,
520,150521,"Indeno(1,2,3-cd)pyrene, 1,2-dihydro-1,2-epoxy-",C1=CC=C2C(=C1)C3=CC4=CC=CC5=C4C6=C(C=C5)C7C(C2=C36)O7,,,,,,
521,150522,"Benzene, 1-(dodecyloxy)-4-nitroso-",CCCCCCCCCCCCOC1=CC=C(C=C1)N=O,,,,,,
522,150523,"1,5,2,4-Dioxadithiocane, 2,2,4,4-tetraoxide",C1COS(=O)(=O)CS(=O)(=O)OC1,,,,,,
523,150524,"4-Acridinecarboxamide, 9-amino-1-chloro-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC=C(C2=C(C3=CC=CC=C3N=C12)N)Cl.Cl.Cl,,,,,,
524,150525,9-amino-1-chloro-N-[2-(dimethylamino)ethyl]acridine-4-carboxamide,CN(C)CCNC(=O)C1=CC=C(C2=C(C3=CC=CC=C3N=C12)N)Cl,,,,,,
525,150526,9-Amino-N-(2-(dimethylamino)ethyl)-2-methyl-4-acridinecarboxamide dihydrochloride,CC1=CC2=C(C3=CC=CC=C3N=C2C(=C1)C(=O)NCCN(C)C)N.Cl.Cl,,,,,,
526,150527,9-amino-N-[2-(dimethylamino)ethyl]-2-methylacridine-4-carboxamide,CC1=CC2=C(C3=CC=CC=C3N=C2C(=C1)C(=O)NCCN(C)C)N,,,,,,
527,150528,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-2-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=CC(=CC2=C(C3=CC=CC=C3N=C12)N)OC.Cl.Cl,,,,,,
528,150529,9-amino-N-[2-(dimethylamino)ethyl]-2-methoxyacridine-4-carboxamide,CN(C)CCNC(=O)C1=CC(=CC2=C(C3=CC=CC=C3N=C12)N)OC,,,,,,
529,150530,"4-Acridinecarboxamide, 9-amino-2-chloro-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC(=CC2=C(C3=CC=CC=C3N=C12)N)Cl.Cl.Cl,,,,,,
530,150531,9-amino-2-chloro-N-[2-(dimethylamino)ethyl]acridine-4-carboxamide,CN(C)CCNC(=O)C1=CC(=CC2=C(C3=CC=CC=C3N=C12)N)Cl,,,,,,
531,150532,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-3-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=C(C=CC2=C(C3=CC=CC=C3N=C21)N)OC.Cl.Cl,,,,,,
532,150533,9-Amino-N-(2-(dimethylamino)ethyl)-3-methoxy-4-acridinecarboxamide,CN(C)CCNC(=O)C1=C(C=CC2=C(C3=CC=CC=C3N=C21)N)OC,,,,,,
533,150534,"4-Acridinecarboxamide, 9-amino-6-chloro-N-(2-(dimethylamino)ethyl)-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=C(C=C3)Cl)N=C21)N.Cl.Cl,,,,,,
534,150535,9-amino-6-chloro-N-[2-(dimethylamino)ethyl]acridine-4-carboxamide,CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=C(C=C3)Cl)N=C21)N,,,,,,
535,150536,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-7-methyl-, dihydrochloride",CC1=CC2=C(C=C1)N=C3C(=C2N)C=CC=C3C(=O)NCCN(C)C.Cl.Cl,,,,,,
536,150537,"4-Acridinecarboxamide, 9-amino-N-[2-(dimethylamino)ethyl]-7-methyl-",CC1=CC2=C(C=C1)N=C3C(=C2N)C=CC=C3C(=O)NCCN(C)C,,,,,,
537,150538,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-8-methyl-, dihydrochloride",CC1=C2C(=CC=C1)N=C3C(=C2N)C=CC=C3C(=O)NCCN(C)C.Cl.Cl,,,,,,
538,150539,9-amino-N-[2-(dimethylamino)ethyl]-8-methylacridine-4-carboxamide,CC1=C2C(=CC=C1)N=C3C(=C2N)C=CC=C3C(=O)NCCN(C)C,,,,,,
539,150540,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-8-methoxy-, dihydrochloride",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC=C3OC)N=C21)N.Cl.Cl,,,,,,
540,150541,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-8-methoxy-",CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC=C3OC)N=C21)N,,,,,,
541,150542,9-amino-8-chloro-N-[2-(dimethylamino)ethyl]acridine-4-carboxamide,CN(C)CCNC(=O)C1=CC=CC2=C(C3=C(C=CC=C3Cl)N=C21)N,,,,,,
542,150543,"4-Acridinecarboxamide, 9-amino-N-(2-(dimethylamino)ethyl)-1-methoxy-",CN(C)CCNC(=O)C1=CC=C(C2=C(C3=CC=CC=C3N=C12)N)OC,,,,,,
543,150544,2-Chloro-N-(2-chlorophenyl)-N-(2-ethoxyethyl)acetamide,CCOCCN(C1=CC=CC=C1Cl)C(=O)CCl,,,,,,
544,150545,"Acetamide, 2-chloro-N-(2-ethoxyethyl)-N-(3-(trifluoromethyl)phenyl)-",CCOCCN(C1=CC=CC(=C1)C(F)(F)F)C(=O)CCl,,,,,,
545,150546,2-Chloro-N-(2-ethoxyethyl)-N-(2-methoxyphenyl)acetamide,CCOCCN(C1=CC=CC=C1OC)C(=O)CCl,,,,,,
546,150547,2-Chloro-N-(2-ethoxyethyl)-N-(4-methoxyphenyl)acetamide,CCOCCN(C1=CC=C(C=C1)OC)C(=O)CCl,,,,,,
547,150548,"3,6-Dinitrophenanthrene",C1=CC2=C(C=C(C=C2)[N+](=O)[O-])C3=C1C=CC(=C3)[N+](=O)[O-],,,,,,
548,150549,"2-Amino-3-(1,2-dichloroethenylsulfanyl)-2-methylpropanoic acid",CC(CSC(=CCl)Cl)(C(=O)O)N,,,,,,
549,150550,"Benzo(a)pyrene, 1-(chloromethyl)-",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)CCl)C=C3,,,,,,
550,150551,4-((((Aminoiminomethyl)amino)acetyl)amino)-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-1H-imidazole-2-carboxamide dihydrochloride,CN1C=C(C=C1C(=O)NCCC(=N)N)NC(=O)C2=NC(=CN2C)NC(=O)CN=C(N)N.Cl.Cl,,,,,,
551,150552,Monoimidazole Lexitropsin,CN1C=C(C=C1C(=O)NCCC(=N)N)NC(=O)C2=NC(=CN2C)NC(=O)CN=C(N)N,,,,,,
552,150553,"Methyl 2-acetamido-4-(1,2,3,4,4-pentachlorobuta-1,3-dienylsulfanyl)butanoate",CC(=O)NC(CCSC(=C(C(=C(Cl)Cl)Cl)Cl)Cl)C(=O)OC,,,,,,
553,150554,"Benz(a)anthracene-7-ethanol, acetate",CC(=O)OCCC1=C2C=CC3=CC=CC=C3C2=CC4=CC=CC=C41,,,,,,
554,150555,"4-Acridinecarboxamide, N-(5-(dimethylamino)pentyl)-",CN(C)CCCCCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21,,,,,,
555,150556,"4-Acridinecarboxamide, N-(2-(diethylamino)ethyl)-",CCN(CC)CCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21,,,,,,
556,150557,"4-Acridinecarboxamide, N-(2-(methylamino)ethyl)-",CNCCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21,,,,,,
557,150558,"4-Acridinecarboxamide, N-(2-aminoethyl)-",C1=CC=C2C(=C1)C=C3C=CC=C(C3=N2)C(=O)NCCN,,,,,,
558,150559,"4-Acridinecarboxamide, N-(2-((2-hydroxyethyl)amino)ethyl)-",C1=CC=C2C(=C1)C=C3C=CC=C(C3=N2)C(=O)NCCNCCO,,,,,,
559,150560,Antibiotic P 4+,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NC4=CN(C(=C4)C(=O)NCCCN(C)C)C)C)C)NC=O,,,,,,
560,150561,"Acetamide, N-(3,8-dimethyl-3H-imidazo(4,5-f)quinoxalin-2-yl)-",CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)NC(=O)C,,,,,,
561,150562,"3H-Imidazo(4,5-f)quinoxaline-8-methanol, 2-amino-3-methyl-",CN1C2=C(C3=NC(=CN=C3C=C2)CO)N=C1N,,,,,,
562,150563,"Imidazo(1,2-a)pyrido(3,2-e)pyrazine, 8,9-dihydro-2-(4-methyl-1-piperazinyl)-6-phenyl-, 5-oxide",CN1CCN(CC1)C2=NC3=C(C=C2)[N+](=C(C4=NCCN34)C5=CC=CC=C5)[O-],,,,,,
563,150564,(R)-alpha-((Butylnitrosoamino)methyl)-4-hydroxybenzenemethanol,CCCCN(C[C@@H](C1=CC=C(C=C1)O)O)N=O,,,,,,
564,150565,Diethylquinoneimine,CCC1=CC(=O)C=C(C1=N)CC,,,,,,
565,150566,"Acetamide, N-(3-methyl-3H-imidazo(4,5-f)quinolin-2-yl)-",CC(=O)NC1=NC2=C(N1C)C=CC3=C2C=CC=N3,,,,,,
566,150567,"9-Fluoranthenol, 2-nitro-",C1=CC2=CC(=CC3=C2C(=C1)C4=C3C=C(C=C4)O)[N+](=O)[O-],,,,,,
567,150568,"Tris(3,4-dibromo-2-butyl)phosphate",CC(C(CBr)Br)OP(=O)(OC(C)C(CBr)Br)OC(C)C(CBr)Br,,,,,,
568,150569,N-(2-(Dimethylamino)ethyl)-9-oxo-9H-xanthene-4-carboxamide,CN(C)CCNC(=O)C1=CC=CC2=C1OC3=CC=CC=C3C2=O,,,,,,
569,150570,"N-(2-(Dimethylamino)ethyl)-11-oxo-11H-pyrido(2,1-b)quinazoline-6-carboxamide",CN(C)CCNC(=O)C1=CC=CN2C1=NC3=CC=CC=C3C2=O,,,,,,
570,150571,N-(2-(Dimethylamino)ethyl)-10H-phenoxazine-1-carboxamide,CN(C)CCNC(=O)C1=C2C(=CC=C1)OC3=CC=CC=C3N2,,,,,,
571,150572,"2H-Furo(2,3-h)-1-benzopyran-2-one, 6,8,9-trimethyl-",CC1=CC2=C(C3=C1OC(=C3C)C)OC(=O)C=C2,,,,,,
572,150573,"Benzo(k)fluoranthene-2,3-dione",C1=CC=C2C=C3C(=CC2=C1)C4=C5C3=CC(=O)C(=O)C5=CC=C4,,,,,,
573,150574,"Estra-1,3,5(10)-trien-17-amine, 3-methoxy-N-((3-(trifluoromethyl)phenyl)methyl)-, (17beta)-",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NCC4=CC(=CC=C4)C(F)(F)F)CCC5=C3C=CC(=C5)OC,,,,,,
574,150575,"2(5H)-Furanone, 4-chloro-5-(dichloromethylene)-",C1=C(C(=C(Cl)Cl)OC1=O)Cl,,,,,,
575,150576,3-Chloro-5-dichloromethylene-2-furanone,C1=C(C(=O)OC1=C(Cl)Cl)Cl,,,,,,
576,150577,"Benzamide, N-(6-(9-acridinylamino)hexyl)-3,4-dinitro-monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=CC(=C(C=C4)[N+](=O)[O-])[N+](=O)[O-].Cl,,,,,,
577,150578,"N-[6-(acridin-9-ylamino)hexyl]-3,4-dinitrobenzamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=CC(=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
578,150579,"Benzamide, N-(6-(9-acridinylamino)hexyl)-2,4-dinitro-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-].Cl,,,,,,
579,150580,"N-[6-(acridin-9-ylamino)hexyl]-2,4-dinitrobenzamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
580,150581,"Benzamide, N-(6-(9-acridinylamino)hexyl)-4-nitro-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-].Cl,,,,,,
581,150582,N-[6-(acridin-9-ylamino)hexyl]-4-nitrobenzamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
582,150583,"7,8-Dihydrobenzo(H)quinoline-7alpha,8beta-diol",C1=CC2=C(C3=C(C=C2)[C@@H]([C@H](C=C3)O)O)N=C1,,,,,,
583,150584,N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride,CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2.Cl.Cl,,,,,,
584,150585,"2,5-Bis(1-aziridinyl)-3-bromo-6-ethyl-2,5-cyclohexadiene-1,4-dione",CCC1=C(C(=O)C(=C(C1=O)N2CC2)Br)N3CC3,,,,,,
585,150586,CID 150586,CC1=C2C3=C(CCCC3)N=C2C4=C(N1)C(=O)C(=CC4=O)OC,,,,,,
586,150587,CID 150587,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C(=CC4=O)OC,,,,,,
587,150588,CID 150588,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C(=CC4=O)N5CC5,,,,,,
588,150589,CID 150589,CSC1=NN=C(N1N=CC2=CC=C(O2)[N+](=O)[O-])SC,,,,,,
589,150590,"1H-Imidazo(4,5-f)quinoline, 1-methyl-2-nitro-",CN1C2=C(C=CC3=C2C=CC=N3)N=C1[N+](=O)[O-],,,,,,
590,150591,"trans-4,5-Dihydroxy-1-nitro-4,5-dihydrobenzo(e)pyrene",C1=CC=C2C(=C1)C3=C4C(=CC=C3)[C@@H]([C@H](C5=C4C2=C(C=C5)[N+](=O)[O-])O)O,,,,,,
591,150592,"1-Methyl-1H-naphth(2,1-g)indol-10-ol",CN1C=CC2=C1C3=C(C=CC4=C3C=C(C=C4)O)C=C2,,,,,,
592,150593,"1H-Phenanthro(3,4-d)imidazol-10-ol, 1,2-dimethyl-",CC1=NC2=C(N1C)C3=C(C=CC4=C3C=C(C=C4)O)C=C2,,,,,,
593,150594,"2,5-Dimethyl-3H-phenanthro(3,4-d)imidazol-10-ol",CC1=CC2=C(C3=C1C=CC4=C3C=C(C=C4)O)N=C(N2)C,,,,,,
594,150595,"3H-Phenanthro(3,4-d)imidazol-10-ol, 2-ethyl-",CCC1=NC2=C(N1)C=CC3=C2C4=C(C=C3)C=CC(=C4)O,,,,,,
595,150596,"2-Acetylamino-3,4-dimethylimidazo(4,5-f)quinoline",CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)NC(=O)C)C,,,,,,
596,150597,CID 150597,CC(=O)OCC=CC1=C(C2=C(N1C)C(=O)C=C(C2=O)OC)COC(=O)C,,,,,,
597,150598,"3-[5-Methoxy-3-(methoxycarbonyloxymethyl)-1-methyl-4,7-dioxoindol-2-yl]prop-2-enyl methyl carbonate",CN1C(=C(C2=C1C(=O)C=C(C2=O)OC)COC(=O)OC)C=CCOC(=O)OC,,,,,,
598,150599,CID 150599,CC(=O)OCC=CC1=C(C2=C(N1C)C(=O)C=C(C2=O)N3CC3)COC(=O)C,,,,,,
599,150600,"3'-Hydroxy-7,8-dimethoxyflavone",COC1=C(C2=C(C=C1)C(=O)C=C(O2)C3=CC(=CC=C3)O)OC,,,,,,
600,150601,"3,4-Dihydro-2-(4-hydroxyphenyl)-2H-1-benzopyran-3-ol",C1C(C(OC2=CC=CC=C21)C3=CC=C(C=C3)O)O,,,,,,
601,150602,CID 150602,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C=C(C4=O)OC,,,,,,
602,150603,CID 150603,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C=C(C4=O)N5CC5,,,,,,
603,150604,CID 150604,CC=C(C=C(C)C=C(C)C=CC=C(C)C(=O)[C@@]12[C@H](O1)[C@](NC2=O)(CCO)O)C(=O)O,,,,,,
604,150605,"3H-Naphth(1,2-d)imidazole, 3-methyl-2-nitro-",CN1C2=C(C3=CC=CC=C3C=C2)N=C1[N+](=O)[O-],,,,,,
605,150606,"1H-Naphth(1,2-d)imidazole, 1-methyl-2-nitro-",CN1C2=C(C=CC3=CC=CC=C32)N=C1[N+](=O)[O-],,,,,,
606,150607,"3-(2-Cyclopentylphenoxy)-1,2-propanediol",C1CCC(C1)C2=CC=CC=C2OCC(CO)O,,,,,,
607,150608,1-Nitrosobenzo(a)pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)N=O)C=C3,,,,,,
608,150609,Cyclopent(hi)acephenanthrylene,C1=CC2=C3C(=C4C=CC5=C4C(=CC=C5)C3=C1)C=C2,,,,,,
609,150610,Ertapenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O,"['For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to <i>Escherichia coli</i>, <i>Clostridium clostridioforme</i>, <i>Eubacterium lentum</i>, <i>Peptostreptococcus</i> species, <i>Bacteroides fragilis</i>, <i>Bacteroides distasonis</i>, <i>Bacteroides ovatus</i>, <i>Bacteroides thetaiotaomicron</i>, or <i>Bacteroides uniformis</i>, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to <i>Staphylococcus aureus</i> (methicillin susceptible isolates only), <i>Streptococcus agalactiae</i>, <i>Streptococcus pyogenes</i>, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Proteus mirabilis</i>, <i>Bacteroides fragilis</i>, <i>Peptostreptococcus</i> species, <i>Porphyromonas asaccharolytica</i>, or <i>Prevotella bivia</i>, (3) community acquired pneumonia due to <i>Streptococcus pneumoniae</i> (penicillin susceptible isolates only) including cases with concurrent bacteremia, <i>Haemophilus influenzae</i> (beta-lactamase negative isolates only), or <i>Moraxella catarrhalis</i>, (4) complicated urinary tract infections including pyelonephritis due to <i>Escherichia coli</i>, including cases with concurrent bacteremia, or <i>Klebsiella pneumoniae</i>, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to <i>Streptococcus agalactiae</i>, <i>Escherichia coli</i>, <i>Bacteroides fragilis</i>, <i>Porphyromonas asaccharolytica</i>, <i>Peptostreptococcus</i> species, or <i>Prevotella bivia</i>.']",['Ertapenem has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria.'],['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],"['Ertapenem is almost completely absorbed following intramuscular administration. The bioavailability of a 1 g intramuscular dose approximated 92% in 26 healthy subjects [77% male; median (range) age, 29 (22–41) years]. Plasma concentrations of total ertapenem were similar whether given intramuscularly or intravenously.', 'Of the 80% recovered in urine, approximately 38% is excreted as unchanged drug and approximately 37% as the ring-opened metabolite.', '0.12 liter/kg [adults]', '1.8 L/h', 'Ertapenem, reconstituted with 1% lidocaine HCl injection, USP (in saline without epinephrine), is almost completely absorbed following intramuscular (IM) administration at the recommended dose of 1 g. The mean bioavailability is approximately 90%. Following 1 g daily IM administration, mean peak plasma concentrations (Cmax) are achieved in approximately 2.3 hours (Tmax).', 'Ertapenem is highly bound to human plasma proteins, primarily albumin. In healthy young adults, the protein binding of ertapenem decreases as plasma concentrations increase, from approximately 95% bound at an approximate plasma concentration of <100 micrograms (ug)/mL to approximately 85% bound at an approximate plasma concentration of 300 ug/mL.', 'The apparent volume of distribution at steady state (Vss) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.', 'The concentration of ertapenem in breast milk from 5 lactating women with pelvic infections (5 to 14 days postpartum) was measured at random time points daily for 5 consecutive days following the last 1 g dose of intravenous therapy (3-10 days of therapy). The concentration of ertapenem in breast milk within 24 hours of the last dose of therapy in all 5 women ranged from <0.13 (lower limit of quantitation) to 0.38 ug/mL; peak concentrations were not assessed. By day 5 after discontinuation of therapy, the level of ertapenem was undetectable in the breast milk of 4 women and below the lower limit of quantitation (<0.13 ug/mL) in 1 woman.', 'For more Absorption, Distribution and Excretion (Complete) data for Ertapenem (18 total), please visit the HSDB record page.']","['The major metabolite is the inactive ring-opened derivative formed by hydrolysis of the &beta;-lactam ring. Ertapenem did not inhibit metabolism mediated by cytochrome P450 (CYP) isoforms 1A2, 2C9, 2C19, 2D6, 2E1, or 3A4 when evaluated by in vitro studies in human liver microsomes. Ertapenem is neither a substrate nor an inhibitor of P-glycoprotein or cytochrome P450 enzymes; significant drug interactions between ertapenem and drugs handled by these systems are not expected [PMID: 15150180]', 'The disposition and metabolism of ertapenem, a carbapenem antibiotic, was examined in rat, monkey and man. Sprague-Dawley rats and Rhesus monkeys were given, by intravenous administration, radiolabelled doses of ertapenem (60 and 30 mg kg(-1), respectively), and healthy normal volunteers received a single fixed dose of 1000 mg. Urine and feces were collected for determination of total radioactivity.  In healthy volunteers, (14)C-ertapenem was eliminated by a combination of hydrolytic metabolism to a beta-lactam ring-opened derivative and renal excretion of unchanged drug. Approximately equal amounts were excreted as a beta-lactam ring-opened metabolite and unchanged drug (36.7 and 37.5% of dose, respectively). A secondary amide hydrolysis product accounted for about 1% of the dose in man. About 10% of the administered radioactivity was recovered in feces, which suggested that a minor fraction underwent biliary and/or intestinal excretion.  In animals, a greater fraction of the dose was eliminated via metabolism; excretion of unchanged drug accounted for 17 and 5% of dose in rats and monkeys, respectively. In monkeys, the beta-lactam ring-opened and amide hydrolysis metabolites accounted for 74.8 and 7.59% of the dose, respectively, whereas in rats, these metabolites accounted for 31.9 and 20% of dose, respectively. In vitro studies with fresh rat tissue homogenates indicated that lung and kidney were the primary organs involved in mediating formation of the beta-lactam ring-opened metabolite. The specific inhibitor of dehydropeptidase-I, cilastatin, inhibited the in vivo and in vitro metabolism of ertapenem in rats, which suggested strongly that the hydrolysis of ertapenem in lung and kidney was mediated by this enzyme.', 'Ertapenem is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Ertapenem is hydrolyzed by metallo-beta-lactamases.', 'In healthy young adults, after infusion of 1 g IV radiolabeled ertapenem, the plasma radioactivity consists predominantly (94%) of ertapenem. The major metabolite of ertapenem is the inactive ring-opened derivative formed by hydrolysis of the beta-lactam ring.']","['The mean plasma half-life is approximately 4 hours.', 'The drug has a mean plasma half-life of approximately 4 hours and may be administered once daily.', 'The mean plasma half-life in pediatric patients 13 to 17 years of age is approximately 4 hours and approximately 2.5 hours in pediatric patients 3 months to 12 years of age.', 'The mean plasma t(1/2) ranged from 3.8 to 4.4 hr.']"
610,150611,Ertapenem disodium,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)[O-])C(=O)[O-])[C@@H](C)O.[Na+].[Na+],['* Treatment:'],,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
611,150612,CID 150612,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)[O-])C(=O)O)[C@@H](C)O.[Na+],,,,,,
612,150613,"Diethyl(8-(3,4,5-trimethoxybenzoyloxy)octyl)ammonium chloride",CC[NH+](CC)CCCCCCCCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC.[Cl-],,,,,,
613,150614,Dalapon-calcium,CC(C(=O)[O-])(Cl)Cl.CC(C(=O)[O-])(Cl)Cl.[Ca+2],,,,,,
614,150615,CID 150615,CCC1=C(C(=NC(=N1)[NH3+])[NH3+])C2=CC=C(C=C2)Cl.[O-]S(=O)(=O)[O-],,,,,,
615,150616,"1-(3-Ethyl-1,3-benzothiazol-2(3H)-ylidene)-2-[(3-ethyl-1,3-benzothiazol-2(3H)-ylidene)methyl]diazen-1-ium iodide",CCN1C2=CC=CC=C2SC1=NN=CC3=[N+](C4=CC=CC=C4S3)CC.[I-],,,,,,
616,150617,"3-ethyl-N-[(3-ethyl-1,3-benzothiazol-3-ium-2-yl)methylideneamino]-1,3-benzothiazol-2-imine",CCN1C2=CC=CC=C2SC1=NN=CC3=[N+](C4=CC=CC=C4S3)CC,,,,,,
617,150618,"4-(Chloromethyl)-2-hexyl-1,3-dithiolane",CCCCCCC1SCC(S1)CCl,,,,,,
618,150619,"1-Deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-ribofuranuronamide",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(=O)N)O)O,,,,,,
619,150620,"1-Deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-ribofuranuronamide 2,3-diacetate",CC(=O)O[C@H]1[C@H]([C@@H](O[C@@H]1C(=O)N)N2C=CC(=O)NC2=O)OC(=O)C,,,,,,
620,150621,"1,2-Dideoxy-1-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-erythro-pentofuranuronamide",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)C(=O)N)O,,,,,,
621,150622,"1,2-Dideoxy-1-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-erythro-Pentofuranurononitrile",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)C#N)O,,,,,,
622,150623,"1,2-Dideoxy-1-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-erythro-pentofuranuronamide 3-acetate",CC(=O)O[C@H]1C[C@@H](O[C@@H]1C(=O)N)N2C=C(C(=O)NC2=O)F,,,,,,
623,150624,"1,2-Dideoxy-1-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-erythro-Pentofuranurononitrile 3-acetate",CC(=O)O[C@H]1C[C@@H](O[C@@H]1C#N)N2C=C(C(=O)NC2=O)F,,,,,,
624,150625,"1,2-Dideoxy-1-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-beta-D-erythro-pentofuranuronamide",C1[C@@H]([C@H](O[C@H]1N2C(=O)NC(=O)C=N2)C(=O)N)O,,,,,,
625,150626,"1,2-Dideoxy-1-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-beta-D-erythro-Pentofuranurononitrile",C1[C@@H]([C@H](O[C@H]1N2C(=O)NC(=O)C=N2)C#N)O,,,,,,
626,150627,"1,2-Dideoxy-1-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-beta-D-erythro-Pentofuranuronamide 3-acetate",CC(=O)O[C@H]1C[C@@H](O[C@@H]1C(=O)N)N2C(=O)NC(=O)C=N2,,,,,,
627,150628,"1-Deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-beta-D-ribofuranurononitrile",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C#N)O)O,,,,,,
628,150629,2-deoxy-5-O-phosphono-D-erythro-pentose,C(C=O)[C@@H]([C@@H](COP(=O)(O)O)O)O,,,,,,
629,150630,Acetylthiamine,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C.[Cl-],,,,,,
630,150631,"2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl acetate",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C,,,,,,
631,150632,"(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-1-oxohexane-1-sulfonic acid",C[C@H]([C@H]([C@@H]([C@H](C(=O)S(=O)(=O)O)O)O)O)O,,,,,,
632,150633,Apadtg,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1OC2=CC=C(C=C2)N)CO)O)O,,,,,,
633,150634,5-Ethyl-5-phenylpyrrolidinone,CCC1(CCC(=O)N1)C2=CC=CC=C2,,,,,,
634,150635,"N-butyldodeca-2,4,6,8,10-pentaen-1-imine",CCCCN=CC=CC=CC=CC=CC=CC,,,,,,
635,150636,"3-Vinyl-4H-1,2-dithiin",C=CC1CC=CSS1,,,,,,
636,150637,1-(4-Chlorophenylazo)piperidine,C1CCN(CC1)N=NC2=CC=C(C=C2)Cl,,,,,,
637,150638,Fluorohydroxyacetone,C(C(=O)CF)O,,,,,,
638,150639,"6-Chloro-4-oxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylate",CCCC1=C2C(=CC3=C1N=C(C=C3Cl)C(=O)[O-])C(=O)C=C(O2)C(=O)[O-],,,,,,
639,150640,"6-chloro-4-oxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid",CCCC1=C2C(=CC3=C1N=C(C=C3Cl)C(=O)O)C(=O)C=C(O2)C(=O)O,,,,,,
640,150641,Phenylalanyl-phenylalanyl-glycine,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)N,,,,,,
641,150642,4-Methylthiobenzamide-S-oxide,CC1=CC=C(C=C1)C(=S=O)N,,,,,,
642,150643,3-(Dansylamino)phenylboronic acid,B(C1=CC(=CC=C1)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)(O)O,,,,,,
643,150644,1-Dodecyl-4-[4-(dimethylamino)styryl]pyridinium,CCCCCCCCCCCC[N+]1=CC=C(C=C1)C=CC2=CC=C(C=C2)N(C)C,,,,,,
644,150645,"7,7-Dimethylicosa-5,8,11,14-tetraenoic acid",CCCCCC=CCC=CCC=CC(C)(C)C=CCCCC(=O)O,,,,,,
645,150646,"N-(3,5-Dinitrobenzoyl)tyrosine",C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)C2=CC(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O,,,,,,
646,150647,CID 150647,CCC1(O[C@@H]2[C@H](OC([C@@H]2O1)N3C=NC4=C(N=NN=C43)N)C#N)CC,,,,,,
647,150648,"D-Fructose, 1-amino-1-deoxy-, acetate (ester)",CC(=O)O.C([C@H]([C@H]([C@@H](C(=O)CN)O)O)O)O,,,,,,
648,150649,1-Amino-1-deoxyfructose,C([C@H]([C@H]([C@@H](C(=O)CN)O)O)O)O,,,,,,
649,150650,CID 150650,CCOC[C@@H]1[C@H]([C@@H]([C@@H](O1)[N+]2(CC=C(N=C2)N)[O-])O)O,,,,,,
650,150651,CID 150651,COC1=CC(=O)C(=C2C1=C(C3=C(C=CC=C3O2)O)O)C4=COC=C4,,,,,,
651,150652,"Benzenamine, 4,4'-methylenebis(2,3-dimethyl-",CC1=C(C=CC(=C1C)N)CC2=C(C(=C(C=C2)N)C)C,,,,,,
652,150653,"2,4(1H,3H)-Pyrimidinedione, dihydro-1-((4-ethoxyphenyl)methyl)-",CCOC1=CC=C(C=C1)CN2CCC(=O)NC2=O,,,,,,
653,150654,Desoxycarbadox,COC(=O)NN=CC1=NC2=CC=CC=C2N=C1,,,,,,
654,150655,"1-Propanol, 3-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCO,,,,,,
655,150656,3-(9-Acridinylamino)-1-propanol monohydrochloride,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCO.Cl,,,,,,
656,150657,"4-Hydroxy-2,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one",COC1C(=O)N(C2=C(O1)C=C(C=C2)OC)O,,,,,,
657,150658,"4-Hydroxy-2-methoxy-2H-1,4-benzoxazin-3(4H)-one",COC1C(=O)N(C2=CC=CC=C2O1)O,,,,,,
658,150659,"Benzenediazonium, 4-(aminocarbonyl)-",C1=CC(=CC=C1C(=O)N)[N+]#N,,,,,,
659,150660,"Pyrido(2,3,4,5-lmn)phenanthridine-5,10-dione, 2,7-diamino-4,9-dihydro-",C1=C(C=C2C3=C1C(=O)NC4=CC(=CC(=C43)C(=O)N2)N)N,,,,,,
660,150661,"15,16-Dihydro-15-hydroxy-11-methyl-17H-cyclopenta(a)phenanthren-17-one",CC1=CC2=C(C(CC2=O)O)C3=C1C4=CC=CC=C4C=C3,,,,,,
661,150662,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11-hydroxymethyl-",C1CC(=O)C2=C1C3=C(C4=CC=CC=C4C=C3)C(=C2)CO,,,,,,
662,150663,6-Methylquinoline-8-carboxylic acid,CC1=CC2=C(C(=C1)C(=O)O)N=CC=C2,,,,,,
663,150664,8-Quinolinecarboxamide,C1=CC2=C(C(=C1)C(=O)N)N=CC=C2,,,,,,
664,150665,8-Hydroxyquinoline succinate,C1=CC2=C(C(=C1)O)N=CC=C2.C(CC(=O)O)C(=O)O,,,,,,
665,150666,CID 150666,C1=CC=C(C(=C1)C(=O)O)ON(N2C=CC=C3C2C(=CC=C3)O)N4C=CC=C5C4C(=CC=C5)O,,,,,,
666,150667,"beta-D-ribofuranuronic acid, 1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, methyl ester",COC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)O)O,,,,,,
667,150668,CID 150668,[BeH2].[Co].[Cu],,,,,,
668,150669,"Adenosine, 2',3'-didehydro-",C1=NC(=C2C(=N1)N(C=N2)C3C(=C(C(O3)CO)O)O)N,,,,,,
669,150670,"N2-((4-(Diethylamino)phenyl)methylene)-4-nitro-N1-phenyl-1,2-benzenediamine",CCN(CC)C1=CC=C(C=C1)C=NC2=C(C=CC(=C2)[N+](=O)[O-])NC3=CC=CC=C3,,,,,,
670,150671,"N2-((4-(Diphenylamino)phenyl)methylene)-4-nitro-N1-phenyl-1,2-benzenediamine",C1=CC=C(C=C1)NC2=C(C=C(C=C2)[N+](=O)[O-])N=CC3=CC=C(C=C3)N(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
671,150672,"7,12-Dimethylbenz(a)anthracene 5,6-imine",CC1=C2C3=CC=CC=C3C4=C(C2=C(C5=CC=CC=C15)C)N4,,,,,,
672,150673,"N-(4-(2,4,6-Trichlorophenoxy)phenyl)acetamide",CC(=O)NC1=CC=C(C=C1)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
673,150674,"7-Methylbenz(a)anthracene-3,4-dione",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC(=O)C3=O,,,,,,
674,150675,"Dibenz(a,c)anthracene-10,11-diol",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C=C5C=CC(=C(C5=C4)O)O,,,,,,
675,150676,N-Nitroso-N-(4-carboxybenzyl)methylamine,CN(CC1=CC=C(C=C1)C(=O)O)N=O,,,,,,
676,150677,6-Azido-6-deoxy-alpha-D-galactopyranose,C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
677,150678,1-Hydroxymethyl-tetrahydro-beta-carboline-3-carboxylic acid,C1C(NC(C2=C1C3=CC=CC=C3N2)CO)C(=O)O,,,,,,
678,150679,9-(p-Nitrobenzyl)adenine,C1=CC(=CC=C1CN2C=NC3=C(N=CN=C32)N)[N+](=O)[O-],,,,,,
679,150680,Ethyl docosahexaenate,CCCCCCCCCC=CC=CC=CC=CC=CC=CC(=O)OCC,,,,,,
680,150681,N-Benzyl-2-bromo-N-methylacetamide,CN(CC1=CC=CC=C1)C(=O)CBr,,,,,,
681,150682,"2,6-Diamidino-indole",C1=CC2=C(C=C1C(=N)N)NC(=C2)C(=N)N,,,,,,
682,150683,S-Methyl-N-(2-methyl-2(methylthio)propionyl)-L-cysteine,CC(C)(C(=O)N[C@@H](CSC)C(=O)O)SC,,,,,,
683,150684,"N-(3-hydroxypropyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NCCCO)C)C,,,,,,
684,150685,"N-(2,3-dihydroxypropyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NCC(CO)O)C)C,,,,,,
685,150686,"N-(4-hydroxybutyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NCCCCO)C)C,,,,,,
686,150687,CID 150687,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)OC(=O)C(C)(C)C)C)C,,,,,,
687,150688,"3,7-dimethyl-N-(2H-tetrazol-5-yl)-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=NNN=N2)C)C,,,,,,
688,150689,"N-(2-hydroxypropyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NCC(C)O)C)C,,,,,,
689,150690,CID 150690,CCC(C)(C)C(=CC)C=CC(=CC=CC(=CC(=O)NC1=NNN=N1)C)C,,,,,,
690,150691,"[4-[[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]phenyl] propanoate",CCC(=O)OC1=CC=C(C=C1)NC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C,,,,,,
691,150692,"1,2,6-Trimethyl-4-nitrosopiperazine",CC1CN(CC(N1C)C)N=O,,,,,,
692,150693,2-Ethoxycarbonylmethyl-1-methylindole-3-carboxylic acid,CCOC(=O)CC1=C(C2=CC=CC=C2N1C)C(=O)O,,,,,,
693,150694,"3-(4-(1-(4-(2,3-Epoxypropoxy)phenyl)-1-methylethyl)phenoxy)propane-1,2-diol",CC(C)(C1=CC=C(C=C1)OCC2CO2)C3=CC=C(C=C3)OCC(CO)O,,,,,,
694,150695,Ethyl N-butyl-N-nitrososuccinamate,CCCCN(C(=O)CCC(=O)OCC)N=O,,,,,,
695,150696,N-[4-(4-chlorophenoxy)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)Cl,,,,,,
696,150697,CID 150697,C[C@H](CCC(=O)N(CCS(=O)(=O)[O-])N=O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C.[Na+],,,,,,
697,150698,"2,3-Dichloro-1,4,5,8-naphthalenetetrone",C1=CC(=O)C2=C(C1=O)C(=O)C(=C(C2=O)Cl)Cl,,,,,,
698,150699,"3-Chloro-1-propanethiol, platinum(2+) salt",C(C[S-])CCl.C(C[S-])CCl.[Pt+2],,,,,,
699,150700,4-Hydroxy-6-methylbenz(a)anthracene,CC1=CC2=C(C=CC=C2O)C3=CC4=CC=CC=C4C=C13,,,,,,
700,150701,3-[2-(4-Aminophenyl)ethenyl]aniline,C1=CC(=CC(=C1)N)C=CC2=CC=C(C=C2)N,,,,,,
701,150702,2-(4-Bromophenyl)-2-methyloxirane,CC1(CO1)C2=CC=C(C=C2)Br,,,,,,
702,150703,"Butanoic acid, 4-((4-chlorophenyl)hydroxyamino)-4-oxo-",C1=CC(=CC=C1N(C(=O)CCC(=O)O)O)Cl,,,,,,
703,150704,CID 150704,COC(=O)C1=CC2=C3C=C(C=CC3=NC2=C(N1)C4=CC=CC=C4)[N+](=O)[O-],,,,,,
704,150705,N-(5-(Diethylamino)-4-methoxy-2-((4-nitrophenyl)azo)phenyl)acetamide,CCN(CC)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=CC=C(C=C2)[N+](=O)[O-])OC,,,,,,
705,150706,CID 150706,C1CCC2(C3=NC4=CC=CC=C4C=C3C5=C(C2(C1)O)O5)O,,,,,,
706,150707,3-Hydroxy-4-aminoazobenzene,C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)N)O,,,,,,
707,150708,Silybin sodium hemisuccinate,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)OC(=O)CCC(=O)[O-])COC(=O)CCC(=O)[O-])O.[Na+].[Na+],,,,,,
708,150709,Silybin dihemisuccinate,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)OC(=O)CCC(=O)O)COC(=O)CCC(=O)O)O,,,,,,
709,150710,3-[2-[[3-(2-carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid;dihydrochloride,CC1=C(C(=CC2=C(C(=C(N2)C=C3C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)NC1=CC4=NC(=O)C(=C4C)C=C)CCC(=O)O.Cl.Cl,,,,,,
710,150711,Balanitoside,CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)O,,,,,,
711,150712,CID 150712,CCC1[C@H]([C@H]([C@@](C(=O)OCC2=CCN(CC[C@H](C2=O)OC1=O)C)(C)O)C)O,,,,,,
712,150713,CID 150713,C[C@H]1CC=C[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2(C(=O)C=CC(=O)[C@@H](C(=C1)C)OC(=O)C)C(=O)NC4CC5=CNC6=CC=CC=C65)C)C,,,,,,
713,150714,"(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-2-[(1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1,,,,,,
714,150715,CID 150715,C1CC=CCCC=C1.C1=CC=NC(=C1)C2=CC=CC=N2.[Cl-].[Rh],,,,,,
715,150716,(S)-cetirizine,C1CN(CCN1CCOCC(=O)O)[C@@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
716,150717,4-Nitroso-2-nitrotoluene,CC1=C(C=C(C=C1)N=O)[N+](=O)[O-],,,,,,
717,150718,"1-Phenyl-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid",C1C(NC(C2=C1C3=CC=CC=C3N2)C4=CC=CC=C4)C(=O)O,,,,,,
718,150719,"15,16-Dihydro-11-propoxy-17H-cyclopenta(a)phenanthren-17-one",CCCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,,,,,,
719,150720,"syn-1,2,3-Trihydrofluoranthene-1,10b-diol-2,3-epoxide",C1=CC=C2C(=C1)C3=C4C2(C(C5C(C4=CC=C3)O5)O)O,,,,,,
720,150721,"trans-1,10b-Dihydroxy-1-hydrofluoranthene",C1=CC=C2C(=C1)C3=CC=CC4=C3[C@@]2([C@H](C=C4)O)O,,,,,,
721,150722,7-Hydroxy-2-methylanthraquinone,CC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)O,,,,,,
722,150723,"Benzo(b)triphenylene, 9-nitro-",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=CC=CC=C5C3=C2[N+](=O)[O-],,,,,,
723,150724,"N6,7-Dimethylquinoline-5,6-diamine",CC1=CC2=C(C=CC=N2)C(=C1NC)N,,,,,,
724,150725,"1-[1-[2-(4-Chlorophenoxy)ethoxy]-1-(2,4-dichlorophenyl)prop-1-en-2-yl]imidazole;nitric acid",CC(=C(C1=C(C=C(C=C1)Cl)Cl)OCCOC2=CC=C(C=C2)Cl)N3C=CN=C3.[N+](=O)(O)[O-],,,,,,
725,150726,"syn-1,2,3,4-Tetrahydrochrysene-3,4-diol-1,2-epoxide",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C(C(C5C4O5)O)O,,,,,,
726,150727,"Trisodium 7-hydroxy-8-((p-sulfophenyl)azo)-1,3-naphthalenedisulfonate",C1=CC(=CC=C1N=NC2=C(C=CC3=CC(=CC(=C32)S(=O)(=O)[O-])S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
727,150728,8-Benzyloxyquinoline,C1=CC=C(C=C1)COC2=CC=CC3=C2N=CC=C3,,,,,,
728,150729,"(R)-3-Azido-2-methylpropanoic acid, methyl ester",C[C@H](CN=[N+]=[N-])C(=O)OC,,,,,,
729,150730,"N-butyl-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CCCCNC(=O)C=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
730,150731,Ccris 3067,CCCCCC1(N(C(CO1)(C)C)[O])CCCCCC(=O)OC2C(C3(C(C=C(CC4(C3C=C(C4=O)C)O)CO)C5C2(C5(C)C)OC(=O)C)O)C,,,,,,
731,150732,"2-(2-((9a-(Acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl)oxy)-2-oxoethyl)-4,4-dimethyl-2-tridecyl-3-oxazolidinyloxy",CCCCCCCCCCCCCC1(N(C(CO1)(C)C)[O])CC(=O)OC2C(C3(C(C=C(CC4(C3C=C(C4=O)C)O)CO)C5C2(C5(C)C)OC(=O)C)O)C,,,,,,
732,150733,Ccris 4082,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC=C5OC6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)C=C2,,,,,,
733,150734,4-Phenylchalcone oxide,C1=CC=C(C=C1)C2=CC=C(C=C2)C3C(O3)C(=O)C4=CC=CC=C4,,,,,,
734,150735,"trans-5,6-Dihydrobenz(c)acridine-5,6-diol",C1=CC=C2C(=C1)C=C3[C@H]([C@@H](C4=CC=CC=C4C3=N2)O)O,,,,,,
735,150736,3-O-Ethyl-L-ascorbic acid,CCOC1=C(C(=O)O[C@@H]1[C@H](CO)O)O,,,,,,
736,150737,CID 150737,C1=CC2=C3C=C(C(=N)C=C3N=C2C=C1)N(O)O,,,,,,
737,150738,1-(2-Pyrenyl)ethanol,CC(C1=CC2=C3C(=C1)C=CC4=C3C(=CC=C4)C=C2)O,,,,,,
738,150739,4-Nitrodibenzofuran,C1=CC=C2C(=C1)C3=C(O2)C(=CC=C3)[N+](=O)[O-],,,,,,
739,150740,4-Phenoxychalcone oxide,C1=CC=C(C=C1)C(=O)C2C(O2)C3=CC=C(C=C3)OC4=CC=CC=C4,,,,,,
740,150741,"5-Methylchrysene-1,2-dione",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)C(=O)C(=O)C=C4,,,,,,
741,150742,"7H-Dibenzo(c,g)fluoren-7-one",C1=CC=C2C(=C1)C=CC3=C2C4=C(C3=O)C=CC5=CC=CC=C54,,,,,,
742,150743,"13H-Dibenzo[a,i]fluoren-13-one",C1=CC=C2C(=C1)C=CC3=C2C(=O)C4=C3C=CC5=CC=CC=C54,,,,,,
743,150744,"13H-Indeno(1,2-c)phenanthren-13-one",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C5=CC=CC=C5C4=O,,,,,,
744,150745,"Methanol, (ethylnitrosoamino)-",CCN(CO)N=O,,,,,,
745,150746,(Nitrosopropylamino)methanol,CCCN(CO)N=O,,,,,,
746,150747,Uracil-1-yl,C1=CN=C(NC1=O)[O],,,,,,
747,150748,"N,N-Diglycidyl acrylamide",C=CC(=O)N(CC1CO1)CC2CO2,,,,,,
748,150749,Methyl-2-oxobutylnitrosamine,CCC(=O)CN(C)N=O,,,,,,
749,150750,Methyl-3-oxobutylnitrosamine,CC(=O)CCN(C)N=O,,,,,,
750,150751,Trimethylsilylmethyl azide,C[Si](C)(C)CN=[N+]=[N-],,,,,,
751,150752,1-Methyllysergol methyl ether,CN1C[C@@H](C=C2[C@H]1CC3=CN(C4=CC=CC2=C34)C)COC,,,,,,
752,150753,1-Nitrodibenzofuran,C1=CC=C2C(=C1)C3=C(C=CC=C3O2)[N+](=O)[O-],,,,,,
753,150754,"N'-(3,4-Dichlorophenyl)-N-(2-hydroxyethyl)-N-methylurea",CN(CCO)C(=O)NC1=CC(=C(C=C1)Cl)Cl,,,,,,
754,150755,"S-(2-Chloroethyl)-L-cysteine, methyl ester",COC(=O)[C@H](CSCCCl)N,,,,,,
755,150756,Benzo(b)triphenylen-3-ol,C1=CC=C2C=C3C4=CC=CC=C4C5=C(C3=CC2=C1)C=CC(=C5)O,,,,,,
756,150757,"2,2,4-Trichloro-1,3-cyclopentenedione",C1=C(C(=O)C(C1=O)(Cl)Cl)Cl,,,,,,
757,150758,"6-Nitro-7,8,9,10-tetrahydrobenzo(a)pyrene",C1CCC2=C(C3=C4C(=C2C1)C=CC5=C4C(=CC=C5)C=C3)[N+](=O)[O-],,,,,,
758,150759,2-Bromomethylfluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=CC(=CC2=C43)CBr,,,,,,
759,150760,Ccris 5029,C=CCC1=CC=CC=[C-]1.C=CCC1=CC=CC=[C-]1.C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC=C3.[Pt+2],,,,,,
760,150761,N-(8-Quinolinylmethylene)benzenamine,C1=CC=C(C=C1)N=CC2=CC=CC3=C2N=CC=C3,,,,,,
761,150762,Manidipine dihydrochloride,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
762,150763,CID 150763,C=CCC1=C(C=CC(=C1Cl)Cl)[NH-].[Pd],,,,,,
763,150764,CID 150764,C=CCC1=C(C=CC(=C1Cl)Cl)N,,,,,,
764,150765,"Oxalic acid, bis(2-bromoethyl) ester",C(CBr)OC(=O)C(=O)OCCBr,,,,,,
765,150766,N-(2-(Dimethylamino)ethyl)-4-acridinecarboxamide dihydrochloride,CN(C)CCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21.Cl.Cl,,,,,,
766,150767,"Benz(c)acridine 5,6-epoxide",C1=CC=C2C(=C1)C=C3C4=C(O4)C5=CC=CC=C5C3=N2,,,,,,
767,150768,5-Hydroxy-1-methyl-2-aminobenzimidazole,CN1C2=C(C=C(C=C2)O)N=C1N,,,,,,
768,150769,1-Imino-2-(methoxyphenyl)-1H-inden-3-amine monohydrochloride,COC1=CC=CC=C1C2=C(C3=CC=CC=C3C2=N)N.Cl,,,,,,
769,150770,3-Imino-2-(2-methoxyphenyl)inden-1-amine,COC1=CC=CC=C1C2=C(C3=CC=CC=C3C2=N)N,,,,,,
770,150771,"(3R-(3alpha,3aalpha,4aalpha,8abeta,9aalpha))-3a,4a,5,8a,9,9a-Hexahydro-3-hydroxy-3,8a-dimethyl-5-methylenenaphtho(2,3-b)furan-2,6(3H,4H)-dione",C[C@]12C[C@H]3[C@@H](C[C@@H]1C(=C)C(=O)C=C2)[C@@](C(=O)O3)(C)O,,,,,,
771,150772,"(2R-(2R*(4R*,8R*)))-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl 2-acetoxybenzoate",CC1=C(C(=C(C2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)C3=CC=CC=C3OC(=O)C)C,,,,,,
772,150773,"Acridinium, 3-azido-10-methyl-, methyl sulfate (9CI)",C[N+]1=C2C=C(C=CC2=CC3=CC=CC=C31)N=[N+]=[N-].COS(=O)(=O)[O-],,,,,,
773,150774,3-Diazonioimino-10-methylacridine,CN1C2=CC=CC=C2C=C3C1=CC(=N[N+]#N)C=C3,,,,,,
774,150775,"Benzenecarboximidamide, 3,3'-(1,5-pentanediylbis(oxy))bis-",C1=CC(=CC(=C1)OCCCCCOC2=CC=CC(=C2)C(=N)N)C(=N)N,,,,,,
775,150776,"1H-Imidazol-2-amine, 4,5-dihydro-N-nitro-1-nitroso-",C1CN(C(=N1)N[N+](=O)[O-])N=O,,,,,,
776,150777,"1,3,5-Triazine-2,4-diamine, 6-phenyl-N,N,N',N'-tetramethyl-",CN(C)C1=NC(=NC(=N1)C2=CC=CC=C2)N(C)C,,,,,,
777,150778,"2(1H)-Pyrimidinone, 6-amino-5-bromo-1-methyl-",CN1C(=C(C=NC1=O)Br)N,,,,,,
778,150779,3-Hydroxyproline,C1CN[C@@H](C1O)C(=O)O,,,,,,
779,150780,alpha-Methylhistidine,C[C@](CC1=CN=CN1)(C(=O)O)N,,,,,,
780,150781,2-Octadecanol,CCCCCCCCCCCCCCCCC(C)O,,,,,,
781,150782,19-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34CO)C,,,,,,
782,150783,Isopropyl isocyanide,CC(C)[N+]#[C-],,,,,,
783,150784,2-Iodopropanoic acid,CC(C(=O)O)I,,,,,,
784,150785,"(8R,9S,10R,13S,14S,17S)-17-acetyl-15-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC([C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
785,150786,"(8S,9S,10S,13R,14S,17S)-17-ethyl-2,3,3-trihydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-2H-cyclopenta[a]phenanthren-1-one",CC[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(C(=O)C(C(C4)(O)O)O)C)C,,,,,,
786,150787,"6-Hydroxypregn-4-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(C4=CC(=O)CC[C@]34C)O)C,,,,,,
787,150788,"(8S,9S,10R,13S,14S,17S)-17-acetyl-2-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)C(C[C@]34C)O)C,,,,,,
788,150789,1-Anthracenecarboxylic acid,C1=CC=C2C=C3C(=CC2=C1)C=CC=C3C(=O)O,,,,,,
789,150790,4-Nitrosobenzoic acid,C1=CC(=CC=C1C(=O)O)N=O,,,,,,
790,150791,1-(3-(Trifluoromethyl)phenyl)propan-2-ol,CC(CC1=CC(=CC=C1)C(F)(F)F)O,,,,,,
791,150792,"2-[4-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]butyl]-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione dihydrate hydrochloride",C1CC[C@H]2[C@@H](C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSCC5=CC=CC=C54.Cl,,,,,,
792,150793,CID 150793,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSCC5=CC=CC=C54,,,,,,
793,150794,S-Naphthyridinomycin A,CC1=C(C(=O)C2=C(C1=O)[C@@H]3[C@H]4[C@H]5[C@H](C[C@@H](N5C)[C@@H]6N4[C@H]2CO6)[C@@H]7N3CCO7)OC,,,,,,
794,150795,"9-((3,4,5-Trimethoxyphenyl)methylene)-9H-fluorene",COC1=CC(=CC(=C1OC)OC)C=C2C3=CC=CC=C3C4=CC=CC=C42,,,,,,
795,150796,"1a,2,3,11b-Tetrahydro-4,11-dimethylbenz(5,6)anthra(1,2-b)oxirene-2,3-diol",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1C5C(O5)C(C4O)O)C,,,,,,
796,150797,"12-(Acetyloxy)-4-ethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione",CCC1(C2=C(COC1=O)C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C)O,,,,,,
797,150798,"8-Quinolinol, 7-(4-morpholinylmethyl)-5-nitro-",C1COCCN1CC2=CC(=C3C=CC=NC3=C2O)[N+](=O)[O-],,,,,,
798,150799,"8-Quinolinol, 5-nitro-7-(1-piperidinylmethyl)-",C1CCN(CC1)CC2=CC(=C3C=CC=NC3=C2O)[N+](=O)[O-],,,,,,
799,150800,"8-Quinolinol, 5-nitro-7-(1-pyrrolidinylmethyl)-",C1CCN(C1)CC2=CC(=C3C=CC=NC3=C2O)[N+](=O)[O-],,,,,,
800,150801,7-((Diethylamino)methyl)-5-nitro-8-quinolinol,CCN(CC)CC1=CC(=C2C=CC=NC2=C1O)[N+](=O)[O-],,,,,,
801,150802,7-((Bis(1-methylethyl)amino)methyl)-5-nitro-8-quinolinol,CC(C)N(CC1=CC(=C2C=CC=NC2=C1O)[N+](=O)[O-])C(C)C,,,,,,
802,150803,"8-Quinolinol, 7-((4-methyl-1-piperazinyl)methyl)-5-nitro-",CN1CCN(CC1)CC2=CC(=C3C=CC=NC3=C2O)[N+](=O)[O-],,,,,,
803,150804,"1,2-Triphenylenediol, 1,2,3,4-tetrahydro-, trans-",C1CC2=C([C@H]([C@@H]1O)O)C3=CC=CC=C3C4=CC=CC=C24,,,,,,
804,150805,"4-Ethyl-4,12-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione",CCC1(C2=C(COC1=O)C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)O)O,,,,,,
805,150806,"4-Ethyl-1,3,4,12-tetrahydro-1,11-dimethoxy-3-((2,3,4,6-tetra-O-acetyl-beta-L-glucopyranosyl)oxy)-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-14-one",CCC1C(OC(C2=C1C=C3C4=NC5=CC=CC=C5C(=C4CN3C2=O)OC)OC)O[C@@H]6[C@H]([C@@H]([C@H]([C@@H](O6)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
806,150807,"2,2'-((4,4'-Bipiperidine)-1,1'-diyldi-2,1-ethanediyl)bis-7H-pyrido(4,3-c)carbazolium dichloride",C1CN(CCC1C2CCN(CC2)CCN3C=CC4=CC=C5C(=C6C=CC=CC6[NH2+]5)C4=C3)CCN7C=CC8=CC=C9C(=C1C=CC=CC1[NH2+]9)C8=C7.[Cl-].[Cl-],,,,,,
807,150808,"2-[2-[4-[1-[2-(7,7a-Dihydropyrido[4,3-c]carbazol-2-yl)ethyl]piperidin-4-yl]piperidin-1-yl]ethyl]-7,7a-dihydropyrido[4,3-c]carbazole",C1CN(CCC1C2CCN(CC2)CCN3C=CC4=CC=C5C(=C6C=CC=CC6N5)C4=C3)CCN7C=CC8=CC=C9C(=C1C=CC=CC1N9)C8=C7,,,,,,
808,150809,"1H-Imidazole-1-ethanol, 2-methyl-5-nitro-, hydrogen sulfate (ester), sodium salt",CC1[N-]C=C(N1CCOS(=O)(=O)O)[N+](=O)[O-].[Na+],,,,,,
809,150810,"2-(2-Methyl-4-nitro-1,2-dihydroimidazol-3-yl)ethyl hydrogen sulfate",CC1NC=C(N1CCOS(=O)(=O)O)[N+](=O)[O-],,,,,,
810,150811,"(1,1'-Biphenyl)-2,2'-dicarboxylic acid, 4,4',6,6'-tetranitro-, dimethyl ester",COC(=O)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(=O)OC,,,,,,
811,150812,"[(7R,8R)-7-(2-methylbut-2-enoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate",CC=C(C)C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@H](C)O)(C(C)C)O,,,,,,
812,150813,"Palladium(2+), (N-(2-aminoethyl)-1,2-ethanediamine-N,N',N'')aqua-, (SP-4-2)-, dinitrate",C1CN(CCNN1)O.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pd+2],,,,,,
813,150814,"5-Hydroxy-1,2,5-triazepane",C1CN(CCNN1)O,,,,,,
814,150815,"Benzo(8,9)triphenyleno(1,2-b)oxirene-9,10-diol, 9,10,10a,11a-tetrahydro-",C1=CC2=C3C(=C1)C4=C(C5C(O5)C(C4O)O)C6=CC=CC(=C63)C=C2,,,,,,
815,150816,CID 150816,COC1=CC(=O)C2=C(C3=C(C=C4C(=C3OC2=C1OC)C5CCOC5O4)OC)O,,,,,,
816,150817,"7H-Pyrido(4,3-c)carbazolium, 2,2'-(1,3-propanediylbis(4,1-piperidinediyl-2,1-ethanediyl))bis(10-methoxy-, dichloride",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCC(CC5)CCCC6CCN(CC6)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=CC(=C1)OC)C=C7.[Cl-].[Cl-],,,,,,
817,150818,"7H-Pyrido(4,3-c)carbazolium, 2,2'-(1,10-decanediyl)bis(10-methoxy-, dibromide",CC(=O)[O-].CN(CCCCCN(C)CC[N+]1=CC2=C(C=CC3=C2C4=C(N3)C=CC(=C4)OC)C=C1)CC[N+]5=CC6=C(C=CC7=C6C8=C(N7)C=CC(=C8)OC)C=C5,,,,,,
818,150819,"N,N'-bis[2-(10-methoxy-7H-pyrido[4,3-c]carbazol-2-ium-2-yl)ethyl]-N,N'-dimethylpentane-1,5-diamine",CN(CCCCCN(C)CC[N+]1=CC2=C(C=CC3=C2C4=C(N3)C=CC(=C4)OC)C=C1)CC[N+]5=CC6=C(C=CC7=C6C8=C(N7)C=CC(=C8)OC)C=C5,,,,,,
819,150820,"7H-Pyrido(4,3-c)carbazolium, 2,2'-(1,5-pentanediybis((methylimino)-2,1-ethanediyl))bis(10-methoxy-, diacetate",CC(=O)[O-].CC(=O)[O-].CN(CCCCCN(C)CC[N+]1=CC2=C(C=CC3=C2C4=C(N3)C=CC(=C4)OC)C=C1)CC[N+]5=CC6=C(C=CC7=C6C8=C(N7)C=CC(=C8)OC)C=C5,,,,,,
820,150821,"7H-Pyrido(4,3-c)carbazolium, 2,2'-((4,4'-bipiperidine)-1,1'-diylbis(2-hydroxy-3,1-propanediyl))bis(10-methoxy-, diacetate (salt)",CC(=O)[O-].CC(=O)[O-].COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CC(CN5CCC(CC5)C6CCN(CC6)CC(C[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)OC)C=C7)O)O,,,,,,
821,150822,"1-[4-[1-[2-hydroxy-3-(10-methoxy-7H-pyrido[4,3-c]carbazol-2-ium-2-yl)propyl]piperidin-4-yl]piperidin-1-yl]-3-(9-methoxy-7H-pyrido[4,3-c]carbazol-2-ium-2-yl)propan-2-ol",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CC(CN5CCC(CC5)C6CCN(CC6)CC(C[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)OC)C=C7)O)O,,,,,,
822,150823,"7H-Pyrido(3,4-c)carbazolium, 3,3'-((4,4'-bipiperidine)-1,1'-diyldi-2,1-ethanediyl)bis(10-hydroxy-, dichloride",C1CN(CCC1C2CCN(CC2)CC[N+]3=CC4=C(C=CC5=C4C6=C(N5)C=CC(=C6)O)C=C3)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)O)C=C7.[Cl-].[Cl-],,,,,,
823,150824,"2-[2-[4-[1-[2-(9-hydroxy-7H-pyrido[4,3-c]carbazol-2-ium-2-yl)ethyl]piperidin-4-yl]piperidin-1-yl]ethyl]-7H-pyrido[4,3-c]carbazol-2-ium-10-ol",C1CN(CCC1C2CCN(CC2)CC[N+]3=CC4=C(C=CC5=C4C6=C(N5)C=CC(=C6)O)C=C3)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)O)C=C7,,,,,,
824,150825,"7H-Pyrido(3,4-c)carbazolium, 3,3'-((4,4'-bipiperidine)-1,1'-diyldi-2,1-ethanediyl)bis(10-methoxy-, dichloride",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCC(CC5)C6CCN(CC6)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)OC)C=C7.[Cl-].[Cl-],,,,,,
825,150826,"9-methoxy-2-[2-[4-[1-[2-(10-methoxy-7H-pyrido[4,3-c]carbazol-2-ium-2-yl)ethyl]piperidin-4-yl]piperidin-1-yl]ethyl]-7H-pyrido[4,3-c]carbazol-2-ium",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCC(CC5)C6CCN(CC6)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9)C=C(C=C1)OC)C=C7,,,,,,
826,150827,"7H-Pyrido(3,4-c)carbazolium, 3,3'-((4,4'-bipiperidine)-1,1'-diyldi-2,1-ethanediyl)bis(10-methoxy-7-methyl-, dichloride",CN1C2=C(C=C(C=C2)OC)C3=C1C=CC4=C3C=[N+](C=C4)CCN5CCC(CC5)C6CCN(CC6)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9C)C=C(C=C1)OC)C=C7.[Cl-].[Cl-],,,,,,
827,150828,"9-Methoxy-2-[2-[4-[1-[2-(10-methoxy-7-methylpyrido[4,3-c]carbazol-2-ium-2-yl)ethyl]piperidin-4-yl]piperidin-1-yl]ethyl]-7-methylpyrido[4,3-c]carbazol-2-ium",CN1C2=C(C=C(C=C2)OC)C3=C1C=CC4=C3C=[N+](C=C4)CCN5CCC(CC5)C6CCN(CC6)CC[N+]7=CC8=C(C=CC9=C8C1=C(N9C)C=C(C=C1)OC)C=C7,,,,,,
828,150829,"7H-Pyrido(2,3-c)carbazolium, 4,4'-((4,4'-bipiperidine)-1,1'-diyldi-2,1-ethanediyl)bis(7-methyl-, dichloride",CN1C2=C(C3=C(C=C2)[N+](=CC=C3)CCN4CCC(CC4)C5CCN(CC5)CC[N+]6=CC=CC7=C6C=CC8=C7C9=CC=CC=C9N8C)C2=CC=CC=C21.[Cl-].[Cl-],,,,,,
829,150830,"7-Methyl-4-[2-[4-[1-[2-(7-methylpyrido[2,3-c]carbazol-4-ium-4-yl)ethyl]piperidin-4-yl]piperidin-1-yl]ethyl]pyrido[2,3-c]carbazol-4-ium",CN1C2=C(C3=C(C=C2)[N+](=CC=C3)CCN4CCC(CC4)C5CCN(CC5)CC[N+]6=CC=CC7=C6C=CC8=C7C9=CC=CC=C9N8C)C2=CC=CC=C21,,,,,,
830,150831,L-Alanyldaunorubicin hydrochloride,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C)N)O.Cl,,,,,,
831,150832,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-aminopropanamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C)N)O,,,,,,
832,150833,Allophanic acid,C(=O)(N)NC(=O)O,,,,,,
833,150834,9-cis-Retinyl Oleate-[d17],CCCCCCCCC=CCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
834,150835,"[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
835,150836,[4-[(Carbamoylhydrazinylidene)methyl]-5-hydroxy-6-methylpyridin-3-yl]methyl dihydrogen phosphate,CC1=NC=C(C(=C1O)C=NNC(=O)N)COP(=O)(O)O,,,,,,
836,150837,4-Aminobutanedithioic acid,C(CC(=S)S)CN,,,,,,
837,150838,"7,14-Dihydroxypregn-4-ene-3,20-dione",CC(=O)[C@H]1CCC2([C@@]1(CC[C@H]3[C@H]2C(CC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
838,150839,"1-[(8R,9S,10R,13S,14S,17R)-3,6,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(C4[C@@]3(CCC(C4)O)C)O)C)O,,,,,,
839,150840,3-O-Methyl-6-deoxy-D-talose,C[C@H]([C@@H]([C@@H]([C@@H](C=O)O)OC)O)O,,,,,,
840,150841,Imidazole-4-acetaldehyde,C1=C(NC=N1)CC=O,,,,,,
841,150842,Perfluoroperhydrofluoranthene,C12(C3(C4(C(C1(C(C(C(C2(C(C(C3(F)F)(F)F)(F)F)F)(F)F)(F)F)(F)F)F)(C(C(C(C4(F)F)(F)F)(F)F)(F)F)F)F)F)F,,,,,,
842,150843,N-[chloro(diethylaminooxy)phosphanyl]oxy-N-ethylethanamine,CCN(CC)OP(ON(CC)CC)Cl,,,,,,
843,150844,1-(2-Chloroethyl)aziridine,C1CN1CCCl,,,,,,
844,150845,"3-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid",CN1C(=CC(=O)NC1=O)C(=O)O,,,,,,
845,150846,"1-Phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione",C1C2C1(C(=O)NC2=O)C3=CC=CC=C3,,,,,,
846,150847,CID 150847,C1=C(N=C2C(=N1)NC(=NC2=O)N)C=O,,,,,,
847,150848,Ethylene glycol bisphosphate,C(COP(=O)(O)O)OP(=O)(O)O,,,,,,
848,150849,2-Bromonaphthalen-1-ol,C1=CC=C2C(=C1)C=CC(=C2O)Br,,,,,,
849,150850,[2-(4-Methoxyphenyl)ethyl]dimethylamine,CN(C)CCC1=CC=C(C=C1)OC,,,,,,
850,150851,2'-Deoxy-2'-fluorouridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)F,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
851,150852,"15,16-Dihydro-12-methylcyclopenta(a)phenanthren-17-one",CC1=CC2=C(C=CC3=CC=CC=C32)C4=C1C(=O)CC4,,,,,,
852,150853,"Bis(alpha,2-dichlorobenzylidene)hydrazine",C1=CC=C(C(=C1)C(=NN=C(C2=CC=CC=C2Cl)Cl)Cl)Cl,,,,,,
853,150854,13-Ethyl-17-hydroxy-gon-4-en-3-one,CCC12CC[C@H]3[C@H]([C@@H]1CCC2O)CCC4=CC(=O)CC[C@H]34,,,,,,
854,150855,Deoxycytidine diphosphate,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)(O)OP(=O)(O)O)O,,,,,,
855,150856,5-Fluorouridine monophosphate,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)F,,,,,,
856,150857,"3,3'-Dichlorodibenzoyl peroxide",C1=CC(=CC(=C1)Cl)C(=O)OOC(=O)C2=CC(=CC=C2)Cl,,,,,,
857,150858,15alpha-Hydroxy-11-oxoprogesterone,CC(=O)[C@H]1C[C@@H]([C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
858,150859,Gadolinium oxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Gd+3].[Gd+3],,,,,,
859,150860,"1-Methyl-3,5,7-triaza-1-azoniaadamantane chloride",C[N+]12CN3CN(C1)CN(C3)C2.[Cl-],,,,,,
860,150861,"1-Methyl-3,5,7-triaza-1-azoniatricyclo(3.3.1.13,7)decane iodide",C[N+]12CN3CN(C1)CN(C3)C2,,,,,,
861,150862,"1,4-Dihydroanthraquinone",C1C=CCC2=C1C(=O)C3=CC=CC=C3C2=O,,,,,,
862,150863,delta 5-Pregnenetriol,C[C@@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O)O,,,,,,
863,150864,3-Fluoro-N-acetylneuraminic acid,CC(=O)N[C@@H]1[C@H](C([C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)F)O,,,,,,
864,150865,Hydroxyacetone phosphate,CC(=O)COP(=O)(O)O,,,,,,
865,150866,2-(4-Methylphenyl)propanoic acid,CC1=CC=C(C=C1)C(C)C(=O)O,,,,,,
866,150867,Morpholinophosphordichloridite,C1COCCN1P(Cl)Cl,,,,,,
867,150868,"Pyrrole-2,3,5-tricarboxylic acid",C1=C(NC(=C1C(=O)O)C(=O)O)C(=O)O,,,,,,
868,150869,Benzoyl L-arginine methyl ester,COC(=O)[C@H](CCCN=C(N)N)NC(=O)C1=CC=CC=C1,,,,,,
869,150870,"[(8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(C4=CC(=O)CC[C@]34C)(C)O)C)OC(=O)C,,,,,,
870,150871,2-(2-Oxo-4-imidazolin-4-yl)ethylamine,C1=C(NC(=O)N1)CCN,,,,,,
871,150872,(R)-2-[(Thiazole-2-yl)amino]propanoic acid,C[C@H](C(=O)O)NC1=NC=CS1,,,,,,
872,150873,20-Methylpregn-5-en-3beta-ol,CC(C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
873,150874,"2,4,6-Trinitrophenylglutamic acid",C1=C(C=C(C(=C1[N+](=O)[O-])N[C@@H](CCC(=O)O)C(=O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
874,150875,Formylpyruvate,C(C=O)C(=O)C(=O)O,,,,,,
875,150876,1-Ethylaziridine,CCN1CC1,,,,,,
876,150877,2-Cyclopropylprop-2-enoic acid,C=C(C1CC1)C(=O)O,,,,,,
877,150878,CID 150878,C1=NC2=C(N1CCC(=O)O)C(=O)N=C(N2)N,,,,,,
878,150879,Cysteinyltyrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CS)N)O,,,,,,
879,150880,N-[5-(phenylhydrazinylidene)hexan-2-ylideneamino]aniline,CC(=NNC1=CC=CC=C1)CCC(=NNC2=CC=CC=C2)C,,,,,,
880,150881,Dansylleucine,CC(C)C[C@@H](C(=O)O)NS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
881,150882,"[(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen sulfate",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](COS(=O)(=O)O)O)O)O,,,,,,
882,150883,"16alpha,17-Epoxy-3beta-hydroxy-5alpha-pregnan-20-one",CC(=O)[C@]12C(O1)C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@@H]5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
883,150884,"1H-Pyrrole-2,3-dicarboxylic acid",C1=CNC(=C1C(=O)O)C(=O)O,,,,,,
884,150885,N-Methylserotonin,CNCCC1=CNC2=C1C=C(C=C2)O,,,,,,
885,150886,4-Methyltryptophan,CC1=C2C(=CC=C1)NC=C2C[C@@H](C(=O)O)N,,,,,,
886,150887,CID 150887,C1=CC2=C3C=CC(=O)C=C3OC(=C2C=C1O)O,,,,,,
887,150888,"8,9-dihydro-8-(1-hydroxy-1-methylethyl)-2H-furo[2,3-h]1-benzopyran-2-one",CC(C)(C1CC2=C(O1)C=CC3=C2OC(=O)C=C3)O,,,,,,
888,150889,Orthonitrophenyl-beta-D-fucopyranoside,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=CC=C2[N+](=O)[O-])O)O)O,,,,,,
889,150890,16-Oxoandrostenediol,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC(=O)[C@@H]4O)C)O,,,,,,
890,150891,"2-hydroxy-1-[(8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CC=C4[C@@]3(CCC(C4)O)C,,,,,,
891,150892,CID 150892,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC(=NC(=O)C3=NN2)N)O)O)OP(=O)(O)O,,,,,,
892,150893,"3,3',4',5,6,7,8-Heptamethoxyflavone",COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC)OC,,,,,,
893,150894,CID 150894,CC(CCO)(C(C(=O)O)P(=O)(O)O)O,,,,,,
894,150895,O-Aminoserine,C([C@@H](C(=O)O)N)ON,,,,,,
895,150896,"3,4-dihydroisoquinolin-1(2H)-one",C1CNC(=O)C2=CC=CC=C21,,,,,,
896,150897,"2-(2,4-Dichlorophenoxy)ethylamine",C1=CC(=C(C=C1Cl)Cl)OCCN,,,,,,
897,150898,"2,4-Dihydroxy-6-(2-oxopropyl)benzoic acid",CC(=O)CC1=C(C(=CC(=C1)O)O)C(=O)O,,,,,,
898,150899,"1,3,5(10)-Estratriene",C[C@@]12CCC[C@H]1[C@@H]3CCC4=CC=CC=C4[C@H]3CC2,,,,,,
899,150900,"5,16-Androstadien-3beta-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CC=C4[C@@]3(CC[C@@H](C4)O)C,,,,,,
900,150901,"Pregn-5-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(=O)C4)C)C,,,,,,
901,150902,Dansyl-4-aminobutyric acid,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)C(CCC(=O)O)N,,,,,,
902,150903,Phe-arg,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N,,,,,,
903,150904,"(3R,5R,8S,9S,10S,11S,13S,14S,17R)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,11,17-triol",C[C@@H]([C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C)O)O,,,,,,
904,150905,Indium oxide,[O-2].[O-2].[O-2].[In+3].[In+3],,,,,,
905,150906,Lanthanum oxide,[O-2].[O-2].[O-2].[La+3].[La+3],,,,,,
906,150907,CID 150907,C1[C@H]([C@H]([C@H]([C@@H](O1)O)O)O)O.C1=CC(=CN=C1)C(=O)N,,,,,,
907,150908,"(2R)-oxane-2,3,4,5-tetrol",C1C(C(C([C@@H](O1)O)O)O)O,,,,,,
908,150909,6-Hydroxydodec-3-enoic acid,CCCCCCC(CC=CCC(=O)O)O,,,,,,
909,150910,"Androsta-3,5-diene-7,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C(=O)C=C4[C@@]3(CCC=C4)C,,,,,,
910,150911,"1,3-Dioctanoylglycerol",CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)O,,,,,,
911,150912,1-(Carboxyethylthio)tetradecane,CCCCCCCCCCCCCCSCCC(=O)O,,,,,,
912,150913,"2-Chloroethyl 2,6-dichloroisonicotinate",C1=C(C=C(N=C1Cl)Cl)C(=O)OCCCl,,,,,,
913,150914,gamma-Glutamylglutamine,C(CC(=O)N[C@@H](CCC(=O)N)C(=O)O)[C@@H](C(=O)O)N,,,,,,
914,150915,N-Salicylidene-3-aminocoumarin,C1=CC=C2C(=C1)C=C(C(=O)O2)N=CC3=CC=CC=C3O,,,,,,
915,150916,N-Acetylnorvaline methyl ester,CCC[C@@H](C(=O)OC)NC(=O)C,,,,,,
916,150917,Phosphoseryl Phosphoserine,C([C@@H](C(=O)N([C@@](CO)(C(=O)O)P(=O)(O)O)P(=O)(O)O)N)O,,,,,,
917,150918,Androst-5-en-3-ol,C[C@@]12CCC[C@H]1[C@@H]3CC=C4CC(CC[C@@]4([C@H]3CC2)C)O,,,,,,
918,150919,"(8R,9S,13S,14S)-3,6-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(C4=C3C=CC(=C4)O)O,,,,,,
919,150920,18-Fluoro-9-octadecenoic acid,C(CCCCF)CCCC=CCCCCCCCC(=O)O,,,,,,
920,150921,2-(1-Hydroxy-2-trimethylazaniumylethyl)-3-oxododecanoate,CCCCCCCCCC(=O)C(C(C[N+](C)(C)C)O)C(=O)[O-],,,,,,
921,150922,"3-carboxy-2-hydroxy-N,N,N-trimethyl-4-oxotridecan-1-aminium",CCCCCCCCCC(=O)C(C(C[N+](C)(C)C)O)C(=O)O,,,,,,
922,150923,3-Methyloxindole,CC1C2=CC=CC=C2NC1=O,,,,,,
923,150924,3-Fluorobenzenesulfonamide,C1=CC(=CC(=C1)S(=O)(=O)N)F,,,,,,
924,150925,(4-Methylbenzyl)triphenylphosphonium chloride,CC1=CC=C(C=C1)C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Cl-],,,,,,
925,150926,4-Methylbenzyltriphenylphosphonium,CC1=CC=C(C=C1)C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
926,150927,3-Nitrophenyl azide,C1=CC(=CC(=C1)[N+](=O)[O-])N=[N+]=[N-],,,,,,
927,150928,"3,5-Di-tert-butyl-4-methoxytoluene",CC1=CC(=C(C(=C1)C(C)(C)C)OC)C(C)(C)C,,,,,,
928,150929,"3,4-Dihydroxybutanoic acid",C(C(CO)O)C(=O)O,,,,,,
929,150930,9-(Bromomethyl)acridine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)CBr,,,,,,
930,150931,2-Methylhexacosane,CCCCCCCCCCCCCCCCCCCCCCCCC(C)C,,,,,,
931,150932,"2,3-Di(tetradecoxy)propan-1-ol",CCCCCCCCCCCCCCOCC(CO)OCCCCCCCCCCCCCC,,,,,,
932,150933,Pentaerythritol mononitrate,C(C(CO)(CO)CO[N+](=O)[O-])O,,,,,,
933,150934,N-Methyl-4-toluohydroxamic acid,CC1=CC=C(C=C1)C(=O)N(C)O,,,,,,
934,150935,Decyl nitrite,CCCCCCCCCCON=O,,,,,,
935,150936,L-Alanine-4-nitroanilide,C[C@@H](C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])N,,,,,,
936,150937,1-Hydroxyanthrone,C1C2=C(C(=CC=C2)O)C(=O)C3=CC=CC=C31,,,,,,
937,150938,"1-Methoxy-1,3,5-cycloheptatriene",COC1=CC=CC=CC1,,,,,,
938,150939,CID 150939,CN1C2=CC=CC=C2SC1=CC=CC3=[N+](C4=CC=CC=C4S3)C.[I-],,,,,,
939,150940,2-[3-[3-Methylbenzothiazol-2(3H)-ylidene]-1-propenyl]-3-methylbenzothiazol-3-ium,CN1C2=CC=CC=C2SC1=CC=CC3=[N+](C4=CC=CC=C4S3)C,,,,,,
940,150941,"[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid",CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O,,,,,,
941,150942,4-(1-Hydroxy-3-methylbutyl)phenol,CC(C)CC(C1=CC=C(C=C1)O)O,,,,,,
942,150943,2-Amino-4-methyl-5-hydroxyethylthiazole,CC1=C(SC(=N1)N)CCO,,,,,,
943,150944,"[(8R,9S,10S,13S,14S)-3,3-difluoro-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] acetate",CC(=O)OC1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)(F)F)C)C,,,,,,
944,150945,Diethyl-alpha-fluoroglutarate,CCOC(=O)CCC(C(=O)OCC)F,,,,,,
945,150946,3-Methyleneoxindole,C=C1C2=CC=CC=C2NC1=O,,,,,,
946,150947,4-Fluoro-19-nortestosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C(C(=O)CC[C@H]34)F,,,,,,
947,150948,"6-Hydroxy-2,2-dimethylchroman",CC1(CCC2=C(O1)C=CC(=C2)O)C,,,,,,
948,150949,5-Chloroindole-3-acetic acid,C1=CC2=C(C=C1Cl)C(=CN2)CC(=O)O,,,,,,
949,150950,Cyclohexyl methylphosphonic acid,CP(=O)(O)OC1CCCCC1,,,,,,
950,150951,"Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-(benzoyloxy)ethyl)-4-methyl-, chloride",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C3=CC=CC=C3.[Cl-],,,,,,
951,150952,"2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl benzoate",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C3=CC=CC=C3,,,,,,
952,150953,(S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid,C1=CC=C2C(=C1)C(=CS2)C[C@@H](C(=O)O)N,,,,,,
953,150954,"17,17-Dimethyl-18-norandrosta-4,13-dien-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CCC4=C3CCC4(C)C,,,,,,
954,150955,4-(Aminomethyl)phenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)CN,,,,,,
955,150956,4-Guanidino-methylphenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
956,150957,1-(Phenylthio)-2-aminopropane,CC(CSC1=CC=CC=C1)N,,,,,,
957,150958,"1-Propanamine, 3-(phenylthio)-",C1=CC=C(C=C1)SCCCN,,,,,,
958,150959,6-Aza uridine 5'-monophosphate,C1=NN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O,,,,,,
959,150960,"(8R,9S,10R,13S,14S)-17-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2O)CCC4[C@@]3(CCC(=O)C4)CO,,,,,,
960,150961,11-Hydroxytetradecanoic acid,CCCC(CCCCCCCCCC(=O)O)O,,,,,,
961,150962,"4-(2-Aminoethyl)benzene-1,3-diol",C1=CC(=C(C=C1O)O)CCN,,,,,,
962,150963,2-Mercaptoethylpyridine,C1=CC=NC(=C1)CCS,,,,,,
963,150964,Arginylphenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
964,150965,"2,2'-Bithiophene-5-carboxylic acid",C1=CSC(=C1)C2=CC=C(S2)C(=O)O,,,,,,
965,150966,3-Isopropyl-5-[[(1-naphthyl)oxy]methyl]oxazolidine,CC(C)N1CC(OC1)COC2=CC=CC3=CC=CC=C32,,,,,,
966,150967,Glucosyl fluoride,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)F)O)O)O)O,,,,,,
967,150968,19-Hydroxytestosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34CO,,,,,,
968,150969,4-Pyridylethylmercaptan,C1=CN=CC=C1CCS,,,,,,
969,150970,"(8S,9S,13S,14S)-10-hydroperoxy-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CCC34OO,,,,,,
970,150971,2'-O-Methylcytidine,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
971,150972,"S-(1,2-Dichlorovinyl)-3-mercaptopropionic acid",C(CSC(=CCl)Cl)C(=O)O,,,,,,
972,150973,5-Bromouridine 5'-monophosphate,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)Br,,,,,,
973,150974,3-Cyano-proxyl,CC1(CC(C(N1[O])(C)C)C#N)C,,,,,,
974,150975,"2-(Bis(2-chloroethyl)amino)-1,4-benzoquinone",C1=CC(=O)C(=CC1=O)N(CCCl)CCCl,,,,,,
975,150976,"5,6-Diphenylpyridazin-3-one",C1=CC=C(C=C1)C2=CC(=O)NN=C2C3=CC=CC=C3,,,,,,
976,150977,3-(2-Furyl)acryloylimidazole,C=CC(=O)C1=NC=CN1C2=CC=CO2,,,,,,
977,150978,Phenylcyclohexyldiethylamine,CCN(C1CCCCC1)C(C)C2=CC=CC=C2,,,,,,
978,150979,CID 150979,CC(=C(O)O)N=O,,,,,,
979,150980,1-(1-Phenylcyclohexyl)-3-methylpiperidine,CC1CCCN(C1)C2(CCCCC2)C3=CC=CC=C3,,,,,,
980,150981,"4-Tert-butyl-2,6-bis(hydroxymethyl)phenol",CC(C)(C)C1=CC(=C(C(=C1)CO)O)CO,,,,,,
981,150982,"(8R,9S,10R,13S,14S,17S)-15,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C(C[C@@H]4O)O)C,,,,,,
982,150983,5'-Azacytidine 5'-monophosphate,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)NOP(=O)(O)O)O)O,,,,,,
983,150984,5'-Azacytidine 5'-triphosphate,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)NOP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
984,150985,"(6S,8S,9S,10R,11S,13S,14S,17S)-6,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@]4(C(=O)CO)O)C)O)O,,,,,,
985,150986,"Androst-4-ene-3,6,17-trione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=O)C4=CC(=O)CC[C@]34C,,,,,,
986,150987,"alpha,alpha-Diphenyl-beta-methyl-1-pyrrolidinepropanol",CC(CN1CCCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,,,,,,
987,150988,"alpha,alpha-Diphenyl-beta-methyl-1-piperidinepropanol",CC(CN1CCCCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,,,,,,
988,150989,4-Chlorophenylisobutylamine,CCC(CC1=CC=C(C=C1)Cl)N,,,,,,
989,150990,5-methyl-L-tryptophan,CC1=CC2=C(C=C1)NC=C2C[C@@H](C(=O)O)N,,,,,,
990,150991,Mandelohydroxamic acid,C1=CC=C(C=C1)C(C(=O)NO)O,,,,,,
991,150992,"(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",CC1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4([C@H]3[C@@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C,,,,,,
992,150993,"2',4',5',7'-Tetrachlorofluorescein",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)Cl)O)Cl)Cl)O)Cl,,,,,,
993,150994,N-methyl-N-(1-phenylethyl)prop-2-yn-1-amine,CC(C1=CC=CC=C1)N(C)CC#C,,,,,,
994,150995,"4,4'-Dihydroxy-3,3'-di-(hydroxymethyl)diphenylmethane",C1=CC(=C(C=C1CC2=CC(=C(C=C2)O)CO)CO)O,,,,,,
995,150996,2-Methylacetoacetic acid,CC(C(=O)C)C(=O)O,,,,,,
996,150997,tert-Butyl phosphate,CC(C)(C)OP(=O)(O)O,,,,,,
997,150998,CID 150998,CN1C(=C2C(=NC=N2)N(C1=O)C)S,,,,,,
998,150999,"O,S,S-Triethyl phosphorodithioate",CCOP(=O)(SCC)SCC,,,,,,
999,151000,"6-Methyl-9,10-didehydro-2,3-dihydroergoline-8-carboximidic acid",CN1C[C@@H](C=C2[C@H]1CC3CNC4=CC=CC2=C34)C(=O)N,,,,,,
1000,151001,4-Amino-L-Phenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N,,,,,,
1001,151002,"1,3-Di(octadec-9-enoyloxy)propan-2-yl octadecanoate",CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1002,151003,Arginylproline,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)O,,,,,,
1003,151004,Prolylarginine,C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
1004,151005,epsilon-Tert-butyloxycarbonyllysine,CC(C)(C)OC(=O)C(CCC[C@@H](C(=O)O)N)N,,,,,,
1005,151006,Galactonolactone,C1[C@H]([C@@H]([C@@H]([C@H](C(=O)O1)O)O)O)O,,,,,,
1006,151007,Dodec-5-enoic acid,CCCCCCC=CCCCC(=O)O,,,,,,
1007,151008,N-Palmitoylglycine,CCCCCCCCCCCCCCCC(=O)NCC(=O)O,,,,,,
1008,151009,6-O-Methylglucose,COC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
1009,151010,4-O-Methylglucuronic acid,CO[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](C(=O)O)O,,,,,,
1010,151011,"2-Hydroxy-1,4-benzoquinone",C1=CC(=O)C(=CC1=O)O,,,,,,
1011,151012,4-Hydroxyhippuric acid,C1=CC(=CC=C1C(=O)NCC(=O)O)O,,,,,,
1012,151013,Methyl 2-aminobutanoate,CCC(C(=O)OC)N,,,,,,
1013,151014,13-Methyltetradecanoic acid,CC(C)CCCCCCCCCCCC(=O)O,,,,,,
1014,151015,7-Hydroxyestrone,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C(CC4=C3C=CC(=C4)O)O,,,,,,
1015,151016,"(2R,4S,5R)-2,4,5,6-tetrahydroxyhexanal",C([C@H](C=O)O)[C@@H]([C@@H](CO)O)O,,,,,,
1016,151017,"2-Bromo-2',4'-dihydroxyacetophenone",C1=CC(=C(C=C1O)O)C(=O)CBr,,,,,,
1017,151018,5-Methoxytryptophan,COC1=CC2=C(C=C1)NC=C2C[C@@H](C(=O)O)N,,,,,,
1018,151019,"N-Benzyl-N,1-dimethyl-2-propynylamine",CC(C#C)N(C)CC1=CC=CC=C1,,,,,,
1019,151020,D-Xylulose 1-phosphate,C([C@H]([C@@H](C(=O)COP(=O)(O)O)O)O)O,,,,,,
1020,151021,N-Benzoyl-L-tyrosine,C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
1021,151022,"2,4-Dinitrophenol dihydrogen phosphate",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OP(=O)(O)O,,,,,,
1022,151023,gamma-Glu-leu,CC(C)C[C@@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1023,151024,9-Oxo-decenoic acid,CC(=O)CCCCCC=CC(=O)O,,,,,,
1024,151025,Z-Phe-ONp,C1=CC=C(C=C1)C[C@@H](C(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)OCC3=CC=CC=C3,,,,,,
1025,151026,Allyl galactopyranoside,C=CCOC1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,,,,,,
1026,151027,2-Methylaminotetrahydropyran,CNC1CCCCO1,,,,,,
1027,151028,[Carboxy(dodecoxy)methyl]-trimethylazanium,CCCCCCCCCCCCOC(C(=O)O)[N+](C)(C)C,,,,,,
1028,151029,"2,5-Dichloro-4-hydroxyphenoxyacetic acid",C1=C(C(=CC(=C1Cl)OCC(=O)O)Cl)O,,,,,,
1029,151030,"N,N-Dimethyl-2-phenylaziridinium",C[N+]1(CC1C2=CC=CC=C2)C,,,,,,
1030,151031,Tricholomic acid,C1C(ONC1=O)C(C(=O)O)N,,,,,,
1031,151032,CID 151032,C1=CC(=CC=C1N=C(NN)S)Br,,,,,,
1032,151033,D-sorbose 1-phosphate,C([C@H]([C@@H]([C@H](C(=O)COP(=O)(O)O)O)O)O)O,,,,,,
1033,151034,"2-(alpha-Hydroxybenzyl)imidazo(4,5-c)pyridine",C1=CC=C(C=C1)C(C2=NC3=C(N2)C=NC=C3)O,,,,,,
1034,151035,4-Azidoquinoline 1-oxide,C1=CC=C2C(=C1)C(=N[N+]#N)C=CN2[O-],,,,,,
1035,151036,Pregnenoic acid,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C(=O)O)CCC4=CC(=O)CC[C@]34C,,,,,,
1036,151037,"Androst-5-ene-3,16,17-triol-3-sulfate",C[C@]12CCC(CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC(C4O)O)C)OS(=O)(=O)O,,,,,,
1037,151038,"3-Hydroxyandrosta-5,7-dien-17-one",C[C@]12CC[C@H]3C(=CC=C4[C@@]3(CCC(C4)O)C)[C@@H]1CCC2=O,,,,,,
1038,151039,"2-Penten-1-ol, 3-methyl-, (Z)-",CCC(=CCO)C,,,,,,
1039,151040,Didodecyl disulfide,CCCCCCCCCCCCSSCCCCCCCCCCCC,,,,,,
1040,151041,4-Methoxy-2-naphthylamine,COC1=CC(=CC2=CC=CC=C21)N,,,,,,
1041,151042,2-(2-Methylphenyl)oxirane,CC1=CC=CC=C1C2CO2,,,,,,
1042,151043,3-Hydroxyandrost-4-en-17-one,C[C@]12CCC(C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,,,,,,
1043,151044,"2,2,2-Trifluoroethyl phosphate",C(C(F)(F)F)OP(=O)(O)O,,,,,,
1044,151045,(R)-2-(Dimethylamino)propanoic acid,C[C@H](C(=O)O)N(C)C,,,,,,
1045,151046,5-Aminomethylsalicylic acid,C1=CC(=C(C=C1CN)C(=O)O)O,,,,,,
1046,151047,2-Hexadecynoic acid,CCCCCCCCCCCCCC#CC(=O)O,,,,,,
1047,151048,N-Propionylcysteine,CCC(=O)N[C@@H](CS)C(=O)O,,,,,,
1048,151049,"4-Hydroxy-5-sulfanylcyclohexa-2,4-dien-1-one",C1C(=O)C=CC(=C1S)O,,,,,,
1049,151050,3-O-Methylmannose,CO[C@H]([C@@H](C=O)O)[C@@H]([C@@H](CO)O)O,,,,,,
1050,151051,2-O-(9-Octadecenyl)glycerol,CCCCCCCCC=CCCCCCCCCOC(CO)CO,,,,,,
1051,151052,3-Carboxymethylhistidine,C1=C(N(C=N1)CC(=O)O)C[C@@H](C(=O)O)N,,,,,,
1052,151053,"1,2-Diphenylaziridine",C1C(N1C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1053,151054,3-Methylaspartic acid,CC([C@@H](C(=O)O)N)C(=O)O,,,,,,
1054,151055,6-(Phenyldithio)purine,C1=CC=C(C=C1)SSC2=NC=NC3=C2NC=N3,,,,,,
1055,151056,6-(Phenyldithio)-1H-purin-2-amine,C1=CC=C(C=C1)SSC2=NC(=NC3=C2NC=N3)N,,,,,,
1056,151057,"2,6-Diethylphenylisonitrile",CCC1=C(C(=CC=C1)CC)[N+]#[C-],,,,,,
1057,151058,Lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide,CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N,,,,,,
1058,151059,CID 151059,C(=O)(C(=O)[O-])C(C(=O)[O-])(F)F,,,,,,
1059,151060,Difluorooxaloacetate,C(=O)(C(=O)O)C(C(=O)O)(F)F,,,,,,
1060,151061,7beta-D-Ribofuranosyltheophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
1061,151062,p-Benzoquinone imine,C1=CC(=O)C=CC1=N,,,,,,
1062,151063,4-Chlorophenyl-beta-D-galactopyranoside,C1=CC(=CC=C1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)Cl,,,,,,
1063,151064,"3,4-Dihydro-2H-1,4-benzothiazine",C1CSC2=CC=CC=C2N1,,,,,,
1064,151065,"Eicosa-8,11-dienoic acid",CCCCCCCCC=CCC=CCCCCCCC(=O)O,,,,,,
1065,151066,3-Hydroxy-3-methyloxindole,CC1(C2=CC=CC=C2NC1=O)O,,,,,,
1066,151067,Cab-glutamic acid,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N(CCCl)CCCl,,,,,,
1067,151068,CID 151068,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)C(NC(=O)[C@@H]3C[C@H](CN3C(=O)C(NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,,,,"['Elimination: Fecal: 35% as drug or metabolites. Renal: 41% as drug (approximately 1.4% unchanged) or metabolites. In dialysis: Not removed by hemodialysis.', 'Following administration of a single 70 mg irradiated dose, approximately 92% of the administered radioactivity was distributed into tissues within 36 to 48 hours. Distribution into red blood cells in minimal.', 'Caspofungin crosses the placenta in rats and rabbits and was detected in the plasma of fetuses of pregnant animals who were dosed with caspofungin.', 'Caspofungin is distributed into milk in rats; not known whether caspofungin is distributed into milk in humans.', 'For more Absorption, Distribution and Excretion (Complete) data for CASPOFUNGIN (13 total), please visit the HSDB record page.']","['Slowly metabolized by hydrolysis and N-acetylation; also undergoes spontaneous chemical degradation and further hydrolysis to constitutive amino acids and their degredates, including dihydroxyhomotyrosine and N-acetyl-dihydroxyhomotyrosine.', 'Caspofungin is slowly metabolized in the liver via hydrolysis and N-acetylation; 35 and 41% of the parent drug and metabolites were excreted in feces and urine, respectively, following a single IV radiolabeled dose.', 'The metabolism, excretion, and pharmacokinetics of caspofungin were investigated after administration of a single intravenous dose to mice, rats, rabbits, and monkeys. ... Excretion of radioactivity in all species studied was slow, and low levels of radioactivity were detected in daily urine and fecal samples throughout a prolonged collection period. Although urinary profiles indicated the presence of several metabolites (M0, M1, M2, M3, M4, M5, and M6), the majority of the total radioactivity was associated with the polar metabolites M1 [4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine] and M2 (N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine). Caspofungin was thus primarily eliminated by metabolic transformation; however, the rate of metabolism was slow. ...', 'Caspofungin is slowly metabolized by hydrolysis and N-acetylation. Caspofungin also undergoes spontaneous chemical degradation to an open-ring peptide compound, L-747969. At later time points (> or = 5 days postdose), there is a low level (< or = 7 picomoles/mg protein, or < or = 1.3% of administered dose) of covalent binding of radiolabel in plasma following single-dose administration of (3)H caspofungin acetate, which may be due to two reactive intermediates formed during the chemical degradation of caspofungin to L-747969. Additional metabolism involves hydrolysis into constitutive amino acids and their degradates, including dihydroxyhomotyrosine and N-acetyl-dihydroxyhomotyrosine. These two tyrosine derivatives are found only in urine, suggesting rapid clearance of these derivatives by the kidneys. /Caspofungin acetate/', '... Following a 1 hr IV infusion of 70 mg of (3)HCaspofungin acetate to healthy subjects, excretion of drug-related material was very slow, such that 41 and 35% of the dosed radioactivity was recovered in urine and feces, respectively, over 27 days. Plasma and urine samples collected around 24 hr postdose contained predominantly unchanged caspofungin acetate, together with trace amounts of a peptide hydrolysis product, M0, a linear peptide. However, at later sampling times, M0 proved to be the major circulating component, whereas corresponding urine specimens contained mainly the hydrolytic metabolites M1 and M2, together with M0 and unchanged MK-0991, whose cumulative urinary excretion over the first 16 days postdose represented 13, 71, 1, and 9%, respectively, of the urinary radioactivity. The major metabolite, M2, was highly polar and extremely unstable under acidic conditions when it was converted to a less polar product identified as N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine gamma-lactone. Derivatization of M2 in aqueous media led to its identification as the corresponding gamma-hydroxy acid, N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine. Metabolite M1, which was extremely polar, eluting from HPLC column just after the void volume, was identified by chemical derivatization as des-acetyl-M2. Thus, the major urinary and plasma metabolites of MK-0991 resulted from peptide hydrolysis and/or N-acetylation. /Caspofungin acetate/']","['Initial: 9 TO 11 hours (beta phase). Additional: 40 to 50 hours (gamma phase).', 'After administration of a single intravenous dose to mice, rats, rabbits, and monkeys, caspofungin had a ...  long terminal elimination half-life (11.7 hr to 59.7 hr) in all preclinical species.']"
1068,151069,"carbamic acid [(3R,5S,6R,7S,10S,11S)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester",C[C@H]1C[C@@H]([C@@H]([C@H](C=C([C@@H]([C@H](C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,,,,,,
1069,151070,"Acetic acid;3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26,27-pentazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6(27),7,9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium",CCC1=C(C2=NC1=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=C2)N5)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)O.CC(=O)O.[Gd],,,,,,
1070,151071,Motexafin,CCC1=C(C2=NC1=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=C2)N5)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC,,,,,,
1071,151072,"Acetic acid;3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26,27-pentazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6(27),7,9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium",CCC1=C(C2=NC1=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=C2)N5)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)O.CC(=O)O.[Lu],,,,,,
1072,151073,"3-[4,5-Diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26,27-pentazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6(27),7,9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium",CCC1=C(C2=NC1=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=C2)N5)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.[Lu],,,,,,
1073,151074,"Acetic acid;3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26,27-pentazapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6(27),7,9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium;hydrate",CCC1=C(C2=NC1=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=C2)N5)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)O.CC(=O)O.O.[Lu],,,,,,
1074,151075,Nepafenac,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,['For the treatment of pain and inflammation associated with cataract surgery.'],"['Low but quantifiable plasma concentrations of nepafenac and amfenac were observed in the majority of subjects 2 and 3 hours postdose, respectively, following bilateral topical ocular TID dosing of nepafenac ophthalmic suspension, 0.1%. The mean steady-state Cmax for nepafenac and for amfenac were 0.310 ± 0.104 ng/ml and 0.422 ± 0.121 ng/ml, respectively, following ocular administration.']","['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']","['Nepafenac rapidly cross the cornea (6 times faster than diclofenac in vitro).', 'After oral administration of 14C-nepafenac to healthy volunteers, urinary excretion was found to be the major route of radioactivity elimination, accounting for approximately 85% of the dose, while fecal excretion represented approximately 6% of the dose. Nepafenac (prodrug) and amfenac (active compound) were not quantifiable in the urine.']","['Nepafenac (prodrug) is deaminated to amfenac (active compound) in the ciliary body epithelium, retina, and choroid by intraocular hydrolases. Subsequently, amfenac undergoes extensive metabolism to more polar metabolites involving hydroxylation of the aromatic ring leading to glucuronide conjugate formation.']",
1075,151076,"(2S)-4-(1-benzofuran-2-ylmethyl)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide",CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@H](CC2=CC=CC=C2)C(=O)NC3[C@@H](CC4=CC=CC=C34)O)O)CC5=CC6=CC=CC=C6O5,,,,,,
1076,151077,CID 151077,CCCCCCCCCC=CC=CC(=O)NCC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1[C@H](CO)O)NC2=NC=NC3=C2NC=N3)O)O,,,,,,
1077,151078,"13-(1,3-dihydroxypropan-2-ylamino)-6,20-dihydroxy-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione",C1=CC2=C(C=C1O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC(CO)CO)C6=C(N4C7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C=C(C=C6)O,,,,,,
1078,151079,CID 151079,CCCCCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCCC)CC(=O)N[C@H]([C@H]([C@@H]([C@@H](CO[C@H]1[C@@H](C([C@@H]([C@H](O1)CO)P)OC(=O)C[C@@H](CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC)NC(=O)C[C@@H](CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC)O)O)O)O,,,,,,
1079,151080,1-Methylcyclopropene,CC1=CC1,,,"['Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)']",,,
1080,151081,16-Fluoropalmitic acid,C(CCCCCCCC(=O)O)CCCCCCCF,,,,,,
1081,151082,1-Palmitoyl-2-oleoyl-rac-glycerol,CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1082,151083,3-Iodophenyl isothiocyanate,C1=CC(=CC(=C1)I)N=C=S,,,,,,
1083,151084,Testosterone formate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC=O)CCC4=CC(=O)CC[C@]34C,,,,,,
1084,151085,"1,3-Pentanediol",CCC(CCO)O,,,,,,
1085,151086,"1,2-Dihydroxyaporphine",CN1CCC2=CC(=C(C3=C2C1CC4=CC=CC=C43)O)O,,,,,,
1086,151087,Serylmethionine,CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)N,,,,,,
1087,151088,4-Formylbenzenesulfonamide,C1=CC(=CC=C1C=O)S(=O)(=O)N,,,,,,
1088,151089,"2-Hydroxy-2-[(8S,9S,10R,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ylidene]acetaldehyde",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(C[C@]4([C@H]3CCC4=C(C=O)O)C)O,,,,,,
1089,151090,10-Piperazinylpropylphenothiazine,C1CN(CCN1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42,,,,,['10-Piperazinylpropylphenothiazine is a known human metabolite of perazine.'],
1090,151091,3-(2H-tetrazol-5-yl)pyridine,C1=CC(=CN=C1)C2=NNN=N2,,,,,,
1091,151092,4-Nitrophenylethyl 5-chloropentylphosphonate,C1=CC(=CC=C1CCOP(=O)(CCCCCCl)O)[N+](=O)[O-],,,,,,
1092,151093,N-Methylglucosamine,CN[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
1093,151094,3-Hydroxymethylcholanthrene,C1CC2=C3C1=C(C=CC3=CC4=C2C=CC5=CC=CC=C54)CO,,,,,,
1094,151095,6-Carboxyfluorescein diacetate,CC(=O)OC1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)OC(=O)C)C5=C(C=CC(=C5)C(=O)O)C(=O)O3,,,,,,
1095,151096,3-Methoxybenzidine,COC1=C(C=CC(=C1)C2=CC=C(C=C2)N)N,,,,,,
1096,151097,"3,4-Dihydroxybenzaldehyde oxime",C1=CC(=C(C=C1C=NO)O)O,,,,,,
1097,151098,N-Acetyl-S-(4-bromophenyl)cysteine,CC(=O)N[C@@H](CSC1=CC=C(C=C1)Br)C(=O)O,,,,,,
1098,151099,"(8R,9S,13S,14S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,7,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2O)C(CC4=C3C=CC(=C4)O)O,,,,,,
1099,151100,"(8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1-methylidene-3,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4[C@@]3(C(=C)CC(C4)O)C,,,,,,
1100,151101,1-(Fluoren-2-yl)-2-propen-1-one,C=CC(=O)C1=CC2=C(C=C1)C3=CC=CC=C3C2,,,,,,
1101,151102,5-(4-Biphenylyl)-3-methylvaleric acid,CC(CCC1=CC=C(C=C1)C2=CC=CC=C2)CC(=O)O,,,,,,
1102,151103,N-Cyclohexyl-N'-isopropylcarbodiimide,CC(C)N=C=NC1CCCCC1,,,,,,
1103,151104,D-Ribitol-5-phosphate,C([C@@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)O,,,,,,
1104,151105,N-Isopropyldopamine,CC(C)NCCC1=CC(=C(C=C1)O)O,,,,,,
1105,151106,4-Aminophenylmercury chloride,C1=CC(=CC=C1N)[Hg]Cl,,,,,,
1106,151107,Carbobenzoxy-glycyl-tyrosyl-glycine ethyl ester,CCOC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CNC(=O)OCC2=CC=CC=C2,,,,,,
1107,151108,L-Quebrachitol,COC1[C@@H]([C@H](C([C@@H]([C@H]1O)O)O)O)O,,,,,,
1108,151109,"[(3R)-1-[[(2R,3R,4S,5R)-6-[(2R,3R,5S,6R)-3-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-4-[(3R)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxy-3,4,5-trihydroxy-1-oxohexan-2-yl]amino]-1-oxotetradecan-3-yl] hexadecanoate",CCCCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO[C@H]1[C@@H](C([C@@H]([C@H](O1)CO)OP(=O)(O)O)OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)O)O)O,,,,,,
1109,151110,"[(3S,4R,5R,6S)-2-[[(2R,3R,4R,5S,6R)-3-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-4-[(3R)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxymethyl]-3,6-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]oxan-4-yl] (3R)-3-hydroxytetradecanoate",CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1OP(=O)(O)O)CO)OCC2[C@H]([C@@H]([C@H]([C@H](O2)O)NC(=O)C[C@@H](CCCCCCCCCCC)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)O)NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC,,,,,,
1110,151111,Pirtenidine hydrochloride,CCCCCCCCN=C1C=CN(C=C1)CCCCCCCC.Cl,,,,,,
1111,151112,Thyromedan hydrochloride,CCN(CC)CCOC(=O)CC1=CC(=C(C(=C1)I)OC2=CC(=C(C=C2)OC)I)I.Cl,,,,,,
1112,151113,CID 151113,CN1C=C2C=CC=CC2=C1C3=NC(=O)N=C(N3)Cl,,,,,,
1113,151114,Exatecan mesilate hydrate,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.CS(=O)(=O)O.O.O,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)'],,,
1114,151115,Exatecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)'],,,
1115,151116,Disodium;(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;tetrahydrate,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O.O.O.O.[Na+].[Na+],,,,,,
1116,151117,7-tert-Butoxyiminomethylcamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOC(C)(C)C)O,,,,,,
1117,151118,4-Acetamido-N-tert-butylbenzamide,CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C,,,,,,
1118,151119,Desipramine trifluoroacetate,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.C(=O)(C(F)(F)F)O,,,,,,
1119,151120,"3',4'-Dehydrovinblastine",CCC1=C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,,,,,,
1120,151121,"(3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",COC1=NC(=NC2=C1N=CN2C3[C@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
1121,151122,Diuranthoside B,CC1CCC2(C(C3C(O2)CC4C3(C(=O)CC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)OC2C(C(C(C(O2)CO)O)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)C)C)OC1,,,,,,
1122,151123,"2,6-Diiodosulfanilic acid",C1=C(C=C(C(=C1I)S(=O)(=O)O)I)N,,,,,,
1123,151124,CID 151124,C1COCCN1N=C(S)[S-],,,,,,
1124,151125,CID 151125,C1COCCN1N=C(S)S,,,,,,
1125,151126,"6-methoxy-1-methyl-2,9-dihydro-1H-pyrido[3,4-b]indole",CC1C2=C(C=CN1)C3=C(N2)C=CC(=C3)OC,,,,,,
1126,151127,CID 151127,C1=C(C=C(C=C1C(=O)[O-])N[N+]#N)C(=O)O,,,,,,
1127,151128,CID 151128,C1=C(C=C(C=C1C(=O)O)N[N+]#N)C(=O)O,,,,,,
1128,151129,CID 151129,C1=CC=C(C=C1)[PH+](C2=CC=CC=C2)C3=CC=CC(=C3)CCCBr,,,,,,
1129,151130,CID 151130,C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC(=C3)CCCBr,,,,,,
1130,151131,Diacetyl phosphate,CC(=O)OP(=O)(O)OC(=O)C,,,,,,
1131,151132,"(8S,9S,10R,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4([C@H](CO)O)O)C,,,,,,
1132,151133,"(3R,5R,8R,9S,10S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4([C@H](CO)O)O)C)O,,,,,,
1133,151134,Phenylalanylglutamate,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)N,,,,,,
1134,151135,5-Decynedioic acid,C(CC#CCCCC(=O)O)CC(=O)O,,,,,,
1135,151136,Benzoylglycyl phenyllactate,CC(C1=CC=CC=C1)(C(=O)OC(=O)CNC(=O)C2=CC=CC=C2)O,,,,,,
1136,151137,3-Chloro-2-oxopropanoic acid,C(C(=O)C(=O)O)Cl,,,,,,
1137,151138,trans-4-Hydroxycyclohexanecarboxylic acid,C1CC(CCC1C(=O)O)O,,,,,,
1138,151139,CID 151139,C(=CC(=O)C(=O)O)C=C(O)O,,,,,,
1139,151140,"3-[2-[(8S,9S,10R,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]carbonylbenzenesulfonic acid",C[C@]12CC([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)C4=CC(=CC=C4)S(=O)(=O)O)O)CCC5=CC(=O)C=C[C@]35C)O,,,,,,
1140,151141,"(2S,3S,4S,5R)-6-[(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)OC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=CC=CC=C4,,,,,,
1141,151142,2-Iodolysergic acid diethylamide,CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=C(NC4=CC=CC(=C34)C2=C1)I)C,,,,,,
1142,151143,5-Hydroxy-3-vinyl-2(5H)-furanone,C=CC1=CC(OC1=O)O,,,,,,
1143,151144,Ethyl 4-nitrophenyl methylphosphonate,CCOP(=O)(C)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
1144,151145,"3-Bromo-N,N,N-trimethylpropan-1-aminium bromide",C[N+](C)(C)CCCBr.[Br-],,,,,,
1145,151146,3-Bromopropyltrimethylaminium,C[N+](C)(C)CCCBr,,,,,,
1146,151147,N-(2-Mercaptoethyl)gluconamide,C(CS)NC(=O)[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
1147,151148,Asp-gly,C([C@@H](C(=O)NCC(=O)O)N)C(=O)O,,,,,,
1148,151149,Glucose 6-(hydrogen sulfate),C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)OS(=O)(=O)O,,,,,,
1149,151150,2-Methylcortisone,CC1C[C@@]2([C@@H]3[C@@H](CCC2=CC1=O)[C@@H]4CC[C@@]([C@]4(CC3=O)C)(C(=O)CO)O)C,,,,,,
1150,151151,Trimethyl-(4-phenyldiazenylphenyl)azanium,C[N+](C)(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,,,,,,
1151,151152,Threonic acid,C([C@H]([C@@H](C(=O)O)O)O)O,,,,,,
1152,151153,Phos-phohydroxypyruvic acid,C(C(=O)C(=O)O)(O)P(=O)(O)O,,,,,,
1153,151154,CID 151154,C1=CC=C2C(=C1)C(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
1154,151155,Chloromaloside B,CC1C2C(CC3C2(C(=O)CC4C3CCC5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)OC,,,,,,
1155,151156,Chloromaloside A,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(C(=O)C[C@H]5[C@H]4CC[C@@H]6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)OC9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)C)OC1,,,,,,
1156,151157,"Quinolinium, 4-((4-(4-(bis(2-chloroethyl)amino)phenoxy)phenyl)amino)-1-methyl-, salt with trifluoromethanesulfonic acid (1:1)",C[N+]1=CC=C(C2=CC=CC=C21)NC3=CC=C(C=C3)OC4=CC=C(C=C4)N(CCCl)CCCl.C(F)(F)(F)S(=O)(=O)[O-],,,,,,
1157,151158,"4-[[4-[4-[N,N-Bis(2-chloroethyl)amino]phenoxy]phenyl]amino]-1-methylquinolinium",C[N+]1=CC=C(C2=CC=CC=C21)NC3=CC=C(C=C3)OC4=CC=C(C=C4)N(CCCl)CCCl,,,,,,
1158,151159,Diuranthoside A,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)C)OC1,,,,,,
1159,151160,CID 151160,O[32P](=O)(O)[O-].[Na+],,,,,,
1160,151161,2-(Decylthio)ethanamine,CCCCCCCCCCSCCN,,,,,,
1161,151162,2-(Decylthio)ethanamine hydrochloride,CCCCCCCCCCSCCN.Cl,,,,,,
1162,151163,1-Tetradecanol mixt. with codlelure and 1-dodecanol,CCCCCCCCCCCCCCO.CCCCCCCCCCCCO.CC=CC=CCCCCCCCO,,,,,,
1163,151164,"(1S,2S,3R,4R)-3-(1-acetamido-2-ethyl-butyl)-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid",CCC(CC)C([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C,,,,,,
1164,151165,CID 151165,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2[C@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,,,,,,
1165,151166,Lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,['For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults.'],"['Lumiracoxib has a different structure from the standard COX-2 inhibitors (e.g. celecoxib). It more closely resembles the structure of diclofenac (one chlorine substituted by fluorine, the phenylacetic acid has another methyl group in meta position), making it a member of the arylalkanoic acid family of NSAIDs. It binds to a different site on the COX-2 receptor than the standard COX-2 inhibitors. It displays extremely high COX-2 selectivity.']",['A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)'],"['Rapidly absorbed following oral administration, with an absolute oral bioavailablity of 74%.']","[""Hepatic oxidation and hydroxylation via CYP2C9. Three major metabolites have been identified in plasma: 4'-hydroxy-lumiracoxib, 5-carboxy-lumiracoxib, and 4'-hydroxy-5-carboxy-lumiracoxib."", 'Lumiracoxib has known human metabolites that include 4p-Carboxylumiracoxib, Lumiracoxib O-glucuronide, and Lumiracoxib metabolite 1.']",['Terminal half-life is approximately 4 hours.']
1166,151167,"(2S,3S)-1-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine",COC1=C(C=C(C=C1)OC(F)(F)F)CN2CCC[C@@H]([C@@H]2C3=CC=CC=C3)N,,,,,,
1167,151168,CID 151168,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C=NNO,,,,,,
1168,151169,"methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-(3-iodoprop-2-enyl)-8-azabicyclo[3.2.1]octane-2-carboxylate",COC(=O)[C@@H]1[C@H]2CC[C@H](N2CC=CI)C[C@@H]1C3=CC=C(C=C3)F,,,,,,
1169,151170,Cilomilast,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,['Investigated for use/treatment in chronic obstructive pulmonary disease (COPD).'],,['Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)'],,,
1170,151171,Conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,"['For the treatment of euvolemic or hypervolemic hyponatremia (e.g. the syndrome of inappropriate secretion of antidiuretic hormone, or in the setting of hypothyroidism, adrenal insufficiency, pulmonary disorders, etc.) in hospitalized patients.']","[""Conivaptan is a nonpeptide, dual antagonist of arginine vasopressin (AVP) V<sub>1A</sub> and V<sub>2</sub> receptors. The level of AVP in circulating blood is critical for the regulation of water and electrolyte balance and is usually elevated in both euvolemic and hypervolemic hyponatremia. The AVP effect is mediated through V<sub>2</sub> receptors, which are functionally coupled to aquaporin channels in the apical membrane of the collecting ducts of the kidney. These receptors help to maintain plasma osmolality within the normal range by increasing permeability of the renal collecting ducts to water. Vasopressin also causes vasoconstriction through its actions on vascular <sub>1A</sub> receptors. The predominant pharmacodynamic effect of conivaptan in the treatment of hyponatremia is through its V<sub>2</sub> antagonism of AVP in the renal collecting ducts, an effect that results in aquaresis, or excretion of free water. Conivaptan's antagonist activity on V<sub>1A</sub> receptors may also cause splanchnic vasodilation, resulting in possible hypotension or variceal bleeding in patients with cirrhosis. The pharmacodynamic effects of conivaptan include increased free water excretion (i.e., effective water clearance [EWC]) generally accompanied by increased net fluid loss, increased urine output, and decreased urine osmolality.""]",['Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)'],,"['CYP3A4 is the sole cytochrome P450 isozyme responsible for the metabolism of conivaptan. Four metabolites have been identified. The pharmacological activity of the metabolites at V<sub>1a</sub> and V<sub>2</sub> receptors ranged from approximately 3-50% and 50-100% that of conivaptan, respectively.']",['5 hours']
1171,151172,Cariporide,CC(C)C1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C,['Investigated for use/treatment in cardiac surgery.'],,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
1172,151173,Troxacitabine,C1C(O[C@H](O1)CO)N2C=CC(=NC2=O)N,,,"['Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
1173,151174,Tezosentan,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,"['Investigated for use/treatment in congestive heart failure, liver disease, and heart disease.']",,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,"['A pronounced and rapid disposition phase (half-life 6 min), accounting for the major part of the elimination, was followed by a slower phase (half-life 3 h), probably caused by distribution from tissues.']"
1174,151175,CID 151175,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+],,,,,,
1175,151176,Advicor,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C.C1=CC(=CN=C1)C(=O)O,,,,,,
1176,151177,Mevinacor,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1C([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,,"['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)', 'Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)']",,,
1177,151178,Disufenton sodium,CC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+],,,"['Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)']",,,
1178,151179,"N-tert-butyl-1-(2,4-disulfophenyl)methanimine oxide",CC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)O)S(=O)(=O)O)[O-],,,,,,
1179,151180,H-Phe-D-Ala-OH,C[C@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N,,,,,,
1180,151181,"2-Bromo-1,4-benzoquinone",C1=CC(=O)C(=CC1=O)Br,,,,,,
1181,151182,"5-Methoxy-N,N-diisopropyltryptamine",CC(C)N(CCC1=CNC2=C1C=C(C=C2)OC)C(C)C,,"['5-methoxy-diisopropyltryptamine, also known as 5-methoxy-N,N-diisopropyltryptamine, 5-MeO-DiPT, foxy methoxy, or just foxy, is a tryptamine that is used recreationally as a psychedelic. 5-MeO-DiPT is orally active, and dosages between 6–20 mg are commonly reported. Many users note an unpleasant body load accompanies higher dosages. 5-MeO-DiPT is also taken by insufflation, or sometimes it is smoked or injected. Some users also report sound distortion, also noted with the related drug, DiPT.']",,['5-MeO-DIPT produces effects with an onset of 20 to 30 minutes and with peak effects occurring between 1 to 1.5 hours after administration.'],"['5-Methoxy-N,N-diisopropyltryptamine has known human metabolites that include 5-MeO-IPT and 5-hydroxy-DIPT.']",
1182,151183,"5-((2,4-Dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide",COC1=C(C=C(C=C1)CC2C(=O)NC(=O)S2)C(=O)NCC3=CC=C(C=C3)C(F)(F)F,,,,,,
1183,151184,Propoxysilatran,CCCO[Si]12OCCN(CCO1)CCO2,,,,,,
1184,151185,(2-Formylethyl)phenylphosphinic acid ethyl ester,CCOP(=O)(CCC=O)C1=CC=CC=C1,,,,,,
1185,151186,"6,7-Dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline",COC1=C(C=C2C(NCCC2=C1)C3=CC=CC=C3)OC,,,,,,
1186,151187,o-Phosphohomoserine,C(COP(=O)(O)O)[C@@H](C(=O)O)N,,,,,,
1187,151188,"Androst-5-ene-3,16,17-triol",C[C@]12CCC(CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC(C4O)O)C)O,,,,,,
1188,151189,Methylpentylacetamide,CCCCCN(C)C(=O)C,,,,,,
1189,151190,Methyl tetradecanesulfonate,CCCCCCCCCCCCCCS(=O)(=O)OC,,,,,,
1190,151191,"2-[(8S,9S,10R,13S,14S)-5-bromo-3,6-dihydroxy-10,13-dimethyl-17-oxo-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]acetate",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(C4([C@@]3(CCC(C4)(CC(=O)[O-])O)C)Br)O,,,,,,
1191,151192,"2-[(8S,9S,10R,13S,14S)-5-bromo-3,6-dihydroxy-10,13-dimethyl-17-oxo-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]acetic acid",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(C4([C@@]3(CCC(C4)(CC(=O)O)O)C)Br)O,,,,,,
1192,151193,Vatalanib succinate,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.C(CC(=O)O)C(=O)O,,,['Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)'],,,
1193,151194,Vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,['Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).'],"['Vatalanib is a novel oral angiogenesis inhibitor being developed by Schering (in collaboration with Novartis AG). Vatalanib selectively inhibits the tyrosine kinase domains of vascular endothelial growth factor (VEGF) receptors, platelet-derived growth factor (PDGF) receptor, and c-KIT.']",['Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)'],['Rapid onset of absorption'],"['Mainly through oxidative metabolism. Two pharmacologically inactive metabolites, CGP 84368/ZK 260120 and NVP AAW378/ZK 261557, having systemic exposure comparable to that of vatalanib, contributed mainly to the total systemic exposure.']",['Approximately 6 hours.']
1194,151195,"Ergoline-8-carboxamide, 9,10-didehydro-N-(4-hydroxybutyl)-1,6-dimethyl-, (8beta)-",CN1C[C@@H](C=C2[C@H]1CC3=CN(C4=CC=CC2=C34)C)C(=O)NCCCCO,,,,,,
1195,151196,N-Formylbenzamide,C1=CC=C(C=C1)C(=O)NC=O,,,,,,
1196,151197,D-psicose 6-phosphate,C([C@H]([C@H]([C@H](C(=O)CO)O)O)O)OP(=O)(O)O,,,,,,
1197,151198,2-Keto-4-mercaptobutyric acid,C(CS)C(=O)C(=O)O,,,,,,
1198,151199,2-(4-Methoxyphenoxy)propanoic acid,CC(C(=O)O)OC1=CC=C(C=C1)OC,,,,,,
1199,151200,glycero-manno-Heptose,C([C@@H]([C@H]([C@H]([C@@H]([C@@H](C=O)O)O)O)O)O)O,,,,,,
1200,151201,1-(1-Oxidopyridin-1-ium-3-yl)ethanol,CC(C1=C[N+](=CC=C1)[O-])O,,,,,,
1201,151202,3-O-Acetyloleanolic acid,CC(=O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)C,,,,,,
1202,151203,Diaminoguanidine,C(=N)(N)N(N)N,,,,,,
1203,151204,3-(Trimethoxysilyl)propyl acrylate,CO[Si](CCCOC(=O)C=C)(OC)OC,,,,,,
1204,151205,L-Buthionine,CCCCSCC[C@@H](C(=O)O)N,,,,,,
1205,151206,3-Hydroxybiuret,C(=O)(N)N(C(=O)N)O,,,,,,
1206,151207,"(2S,3S)-2-Amino-3-methoxybutanoic acid",C[C@@H]([C@@H](C(=O)O)N)OC,,,,,,
1207,151208,Lysine-2-naphthylamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)[C@H](CCCCN)N,,,,,,
1208,151209,2-Cyclobutaneglycine,C1CC(C1)NCC(=O)O,,,,,,
1209,151210,2-Amino-6-methylbenzoic acid,CC1=C(C(=CC=C1)N)C(=O)O,,,,,,
1210,151211,"1,1-Ethanediol",CC(O)O,,,,,,
1211,151212,"1,1,4,4-Butanetetracarboxylic acid",C(CC(C(=O)O)C(=O)O)C(C(=O)O)C(=O)O,,,,,,
1212,151213,2-Methylene-beta-alanine,C=C(CC(=O)O)N,,,,,,
1213,151214,Acetylselenocholine,CC(=O)[Se]CC[N+](C)(C)C,,,,,,
1214,151215,Trimethyl-[2-[2-(trimethylazaniumyl)ethoxydisulfanyl]oxyethyl]azanium,C[N+](C)(C)CCOSSOCC[N+](C)(C)C,,,,,,
1215,151216,CID 151216,C1=CC(=C(C=C1NS(=O)=O)Cl)OCC(=O)O,,,,,,
1216,151217,tert-Butyloxycarbonyl-glycylphenylalanine,CC(C)(C)OC(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O,,,,,,
1217,151218,alpha-(Dihydroxyphosphinylmethyl)acrylic acid,C=C(CP(=O)(O)O)C(=O)O,,,,,,
1218,151219,17-Bromoacetoxy-4-androsten-3-one,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2OC(=O)CBr)CCC4=CC(=O)CC[C@]34C,,,,,,
1219,151220,"3-Benzyl-1,3-benzothiazol-3-ium",C1=CC=C(C=C1)C[N+]2=CSC3=CC=CC=C32,,,,,,
1220,151221,"3,3-Diphenyl-N-dimethylpropylamine",CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
1221,151222,CID 151222,C1=CNC2=NC=C(C2=C1)CCN,,,,,,
1222,151223,Estriol 3-sulfate 16-glucuronide,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)CCC5=C3C=CC(=C5)OS(=O)(=O)O,,,,,,
1223,151224,"4-Nitrobuta-1,3-dienylbenzene",C1=CC=C(C=C1)C=CC=C[N+](=O)[O-],,,,,,
1224,151225,"4,5-Dihydroxyisophthalic acid",C1=C(C=C(C(=C1C(=O)O)O)O)C(=O)O,,,,,,
1225,151226,"Ethyl 1,4-benzodioxan-2-carboxylate",CCOC(=O)C1COC2=CC=CC=C2O1,,,,,,
1226,151227,"3,17-Dioxo-4-androsten-19-oic acid",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@]34C(=O)O,,,,,,
1227,151228,4-Pyridoxolactone,CC1=NC=C2COC(=O)C2=C1O,,,,,,
1228,151229,Aminohydroxyacetic acid,C(C(=O)O)(N)O,,,,,,
1229,151230,2-Phenylethylhydroperoxide,C1=CC=C(C=C1)CCOO,,,,,,
1230,151231,"2,4,6-Triethylphenyl(imino)imidazolidine",CCC1=CC(=C(C(=C1)CC)N2CCN=C2N)CC,,,,,,
1231,151232,"1-Methyl-1H-indole-5,6-diol",CN1C=CC2=CC(=C(C=C21)O)O,,,,,,
1232,151233,4-[4-(4-Hydroxy-3-prop-2-enylphenyl)hex-3-en-3-yl]-2-prop-2-enylphenol,CCC(=C(CC)C1=CC(=C(C=C1)O)CC=C)C2=CC(=C(C=C2)O)CC=C,,,,,,
1233,151234,"N-(N(alpha)-(tert-Butyloxycarbonyl)alanyl)-N,N'-dicyclohexylurea",C[C@@H](C(=O)N(C1CCCCC1)C(=O)NC2CCCCC2)NC(=O)OC(C)(C)C,,,,,,
1234,151235,"Decalin-1,4-dione",C1CCC2C(C1)C(=O)CCC2=O,,,,,,
1235,151236,"2-(8-Quinolylazo)-4,5-diphenylimidazole",C1=CC=C(C=C1)C2=C(N=C(N2)N=NC3=CC=CC4=C3N=CC=C4)C5=CC=CC=C5,,,,,,
1236,151237,"5-Hydroxy-1,3-pentadiene",C=CC=CCO,,,,,,
1237,151238,CID 151238,CN(C1=CC=CC=C1)C(=NC(=O)C2=CC=CC=C2)S,,,,,,
1238,151239,(2S)-2-[3-(furan-2-yl)prop-2-enamido]-3-phenylpropanoic acid,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)C=CC2=CC=CO2,,,,,,
1239,151240,5-Bromo-6-azauracil,C1(=O)C(=NNC(=O)N1)Br,,,,,,
1240,151241,Bicyclo[3.1.0]hexane-6-carboxylic acid,C1CC2C(C1)C2C(=O)O,,,,,,
1241,151242,4-Nitrophenylglyoxal,C1=CC(=CC=C1C(=O)C=O)[N+](=O)[O-],,,,,,
1242,151243,L-Tyrosinamide,C1=CC(=CC=C1C[C@@H](C(=O)N)N)O,,,,,,
1243,151244,alpha-Fluoro-beta-ureidopropionic acid,C(C(C(=O)O)F)NC(=O)N,,,,,,
1244,151245,"4,5-Diphenyl-4-oxazolin-2-one",C1=CC=C(C=C1)C2=C(OC(=O)N2)C3=CC=CC=C3,,,,,,
1245,151246,"4-(11H-Dibenz(b,e)azepin-6-yl)piperazine",C1CN(CCN1)C2=NC3=CC=CC=C3CC4=CC=CC=C42,,,,,,
1246,151247,l-Tyrosinol,C1=CC(=CC=C1C[C@@H](CO)N)O,,,,,,
1247,151248,N-(Aminocarbonyl)-2-chlorobenzenesulfonamide,C1=CC=C(C(=C1)S(=O)(=O)NC(=O)N)Cl,,,,,,
1248,151249,"methyl (1S,15R,18S,19R,20S)-18-hydroxy-3-methyl-11,12,14,15,16,17,18,19,20,21-decahydro-1H-yohimban-19-carboxylate",CN1C2=CC=CC=C2C3=C1[C@@H]4C[C@H]5[C@@H](CC[C@@H]([C@@H]5C(=O)OC)O)CN4CC3,,,,,,
1249,151250,alpha-Hydrazinophloretic acid,C1=CC(=CC=C1CC(C(=O)O)NN)O,,,,,,
1250,151251,6-O-Galactopyranosylgalactose,C([C@@H]1[C@@H]([C@@H]([C@H](C(O1)OC[C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)O)O)O)O,,,,,,
1251,151252,4-Hydroxybenzoylcholine,C[N+](C)(C)CCOC(=O)C1=CC=C(C=C1)O,,,,,,
1252,151253,4-Biphenylboronic acid,B(C1=CC=C(C=C1)C2=CC=CC=C2)(O)O,,,,,,
1253,151254,4-Iodophenylboronic acid,B(C1=CC=C(C=C1)I)(O)O,,,,,,
1254,151255,"1,4,5,6-Tetrahydro-6-oxonicotinic acid",C1CC(=O)NC=C1C(=O)O,,,,,,
1255,151256,"1-(3-Dimethylaminopropyl)-1H-pyrrole-2,5-dione",CN(C)CCCN1C(=O)C=CC1=O,,,,,,
1256,151257,6-Deoxy-gulose,C[C@H]([C@@H]([C@H]([C@H](C=O)O)O)O)O,,,,,,
1257,151258,Aminomalononitrile,C(#N)C(C#N)N,,,,,,
1258,151259,"17beta-Hydroxyestra-5(10),9(11)-dien-3-one",C[C@]12CC=C3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3CCC(=O)C4,,,,,,
1259,151260,"1,2-Dipalmitoyl-3-lauroylglycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1260,151261,Ribulose,C([C@H]([C@H](C(=O)CO)O)O)O,,,,,,
1261,151262,5-Methyl-5-phenylpyrrolidin-2-one,CC1(CCC(=O)N1)C2=CC=CC=C2,,,,,,
1262,151263,D-Altritol,C([C@H]([C@H]([C@H]([C@@H](CO)O)O)O)O)O,,,,,,
1263,151264,N(alpha)-Carbobenzoxylysine-4-methyl ester,CC(CCN)C[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
1264,151265,2-(Methylamino)-5-chlorobenzophenone imine,CNC1=C(C=C(C=C1)Cl)C(=N)C2=CC=CC=C2,,,,,,
1265,151266,6-Deoxyglucitol,C[C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O,,,,,,
1266,151267,N-Acetylcyanamide,CC(=O)NC#N,,,,,,
1267,151268,"4-(2-aminoethyl)-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)CCN,,,,,,
1268,151269,Heptacosanedioic acid,C(CCCCCCCCCCCCC(=O)O)CCCCCCCCCCCCC(=O)O,,,,,,
1269,151270,"2-ethyl-N,N-bis(prop-2-ynyl)aniline",CCC1=CC=CC=C1N(CC#C)CC#C,,,,,,
1270,151271,"Methyl 1-ethyl-7-methoxy-1,2,3,4-tetrahydrophenanthrene-2-carboxylate",CCC1C(CCC2=C1C=CC3=C2C=CC(=C3)OC)C(=O)OC,,,,,,
1271,151272,2-Aminocyclohexanecarboxylic acid,C1CCC(C(C1)C(=O)O)N,,,,,,
1272,151273,"2,4,6-Trimethyltetracosanoic acid",CCCCCCCCCCCCCCCCCCC(C)CC(C)CC(C)C(=O)O,,,,,,
1273,151274,"Estrane-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4[C@@H]3CCC(=O)C4,,,,,,
1274,151275,N-Hydroxy-L-argininamide,C(C[C@@H](C(=O)NO)N)CN=C(N)N,,,,,,
1275,151276,Homovanillin,COC1=C(C=CC(=C1)CC=O)O,,,,,,
1276,151277,S-Carbamylcysteine,C([C@@H](C(=O)O)N)SC(=O)N,,,,,,
1277,151278,"2-Hydroxy-6,7-dimethoxy-3-methylquinoxaline",CC1=NC2=CC(=C(C=C2NC1=O)OC)OC,,,,,,
1278,151279,(2S)-2-amino-3-[2-(hydroxycarbamoyl)-1H-indol-3-yl]propanoic acid,C1=CC=C2C(=C1)C(=C(N2)C(=O)NO)C[C@@H](C(=O)O)N,,,,,,
1279,151280,(S)-Methyl 2-((S)-2-((tert-butoxycarbonyl)amino)-4-methylpentanamido)-3-phenylpropanoate,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC)NC(=O)OC(C)(C)C,,,,,,
1280,151281,Glycylmethionine 4-toluenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)O.CSCC[C@@H](C(=O)O)NC(=O)CN,,,,,,
1281,151282,Glycylmethionine,CSCC[C@@H](C(=O)O)NC(=O)CN,,,,,,
1282,151283,"3-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]-2-phosphonopropanoic acid",CC(C)(CO)C(C(=O)NCC(C(=O)O)P(=O)(O)O)O,,,,,,
1283,151284,L-gamma-glutamyl-D-alanine,C[C@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1284,151285,tertiary-Butyloxycarbonyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalaninamide,CC(C)(C)OC(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CN,,,,,,
1285,151286,Methionyl-aspartyl-phenylalaninamide,CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)N,,,,,,
1286,151287,14-Hydroxyestrone,C[C@]12CC[C@H]3[C@H](C1(CCC2=O)O)CCC4=C3C=CC(=C4)O,,,,,,
1287,151288,"6beta-Hydroxyestr-4-ene-3,17-dione",C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@@H](C[C@H]3[C@@H]1CCC2=O)O,,,,,,
1288,151289,Isoevodiamine,CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3,,,,,,
1289,151290,CID 151290,C1=CC(=S)C(=N)C=C1N(O)[O-].[Na+],,,,,,
1290,151291,CID 151291,C1=CC(=S)C(=N)C=C1N(O)[O-],,,,,,
1291,151292,"1-Propanone, 1,1'-(1,2-dihydro-3,6-acenaphthylenediyl)bis-",CCC(=O)C1=C2CCC3=C2C(=C(C=C3)C(=O)CC)C=C1,,,,,,
1292,151293,"alpha-Ethyl-1,2-dihydro-5-acenaphthylenemethanol",CCC(C1=CC=C2CCC3=C2C1=CC=C3)O,,,,,,
1293,151294,"1-Propanone, 1-(1,2-dihydro-5-acenaphthylenyl)-",CCC(=O)C1=CC=C2CCC3=C2C1=CC=C3,,,,,,
1294,151295,2-(5-nitro-1H-indol-3-yl)ethanamine,C1=CC2=C(C=C1[N+](=O)[O-])C(=CN2)CCN,,,,,,
1295,151296,CID 151296,CC1=C(C(=NC(=C1N(O)O)COC)N=NC(=O)C)C#N,,,,,,
1296,151297,CID 151297,CC1=C(C(=NC(=C1N(O)O)COC)N=NC)C#N,,,,,,
1297,151298,"4-Quinolinecarboxylic acid, 2-(2-methylhydrazino)-",CNNC1=NC2=CC=CC=C2C(=C1)C(=O)O,,,,,,
1298,151299,"4-Quinolinecarboxylic acid, 2-(2-acetylhydrazino)-",CC(=O)NNC1=NC2=CC=CC=C2C(=C1)C(=O)O,,,,,,
1299,151300,"4-Quinolinecarboxylic acid, 2-chloro-6-nitro-",C1=CC2=C(C=C1[N+](=O)[O-])C(=CC(=N2)Cl)C(=O)O,,,,,,
1300,151301,CID 151301,C1=CC2=C(C=C1N(O)O)C(=CC(=N2)N=N)C(=O)O,,,,,,
1301,151302,CID 151302,CN=NC1=NC2=C(C=C(C=C2)N(O)O)C(=C1)C(=O)O,,,,,,
1302,151303,CID 151303,CCOC(=O)C1=CC(=NC2=C1C=C(C=C2)N(O)O)N=NC,,,,,,
1303,151304,"3-Pyridinecarboxamide, N-((2-methylhydrazino)methyl)-",CNNCNC(=O)C1=CN=CC=C1,,,,,,
1304,151305,CID 151305,CC1=C(C(=NC(=C1N(O)O)COC)N=NC2=NC(=C(C(=C2C#N)C)[N+](=O)[O-])COC)C#N,,,,,,
1305,151306,"2,3-Dichlorobutanal",CC(C(C=O)Cl)Cl,,,,,,
1306,151307,"3-Pyridinecarboxamide, N-(chloromethyl)-",C1=CC(=CN=C1)C(=O)NCCl,,,,,,
1307,151308,CID 151308,COP(=O)(C(C(Cl)(Cl)Cl)O)[O-].[Na+],,,,,,
1308,151309,Ethyl 2-chloro-6-nitroquinoline-4-carboxylate,CCOC(=O)C1=CC(=NC2=C1C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
1309,151310,"1,3-Propanediamine, N'-(6-chloro-2-methoxy-9-acridinyl)-N,N-dimethyl-",CN(C)CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,,,,,
1310,151311,CID 151311,C=C(CS(=O)(=O)[O-])Cl.[Na+],,,,,,
1311,151312,2-Chloroprop-2-ene-1-sulfonic acid,C=C(CS(=O)(=O)O)Cl,,,,,,
1312,151313,Glycoside D,C[C@H]1[C@H]2[C@H](CC3[C@@]2(CCC4C3CC=C5[C@@]4(CCC(C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O)O)C)C)O[C@@]1(CC[C@@H](C)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O,,,,,,
1313,151314,CID 151314,CC1=CC(=C2C(=CC(=O)C(=C2O1)O)O)O,,,,,,
1314,151315,"trans-4,5-Dihydro-4,5-dihydroxypyrene",C1=CC2=C3C(=C1)[C@@H]([C@H](C4=CC=CC(=C43)C=C2)O)O,,,,,,
1315,151316,N-(2-Methyl-3-nitrophenyl)acetamide,CC1=C(C=CC=C1[N+](=O)[O-])NC(=O)C,,,,,,
1316,151317,"Aziridine, 1,1'-(sulfonylbis(2-nitro-4,1-phenylene))bis-",C1CN1C2=C(C=C(C=C2)S(=O)(=O)C3=CC(=C(C=C3)N4CC4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1317,151318,"4-Bromo-2,5-Dimethoxyphenethylamine hydrochloride",COC1=CC(=C(C=C1CCN)OC)Br.Cl,,,,,,
1318,151319,"5,6,7,8-Tetramethoxycoumarin",COC1=C(C(=C(C2=C1C=CC(=O)O2)OC)OC)OC,,,,,,
1319,151320,CID 151320,COC1=C(C2=C(C=C(OC2=CC1=O)OC3=CC=C(C=C3)O)O)O,,,,,,
1320,151321,1-Nitro-9-(5-dimethylaminopentylamino)anthracene dihydrochloride,CN(C)CCCCCNC1=C2C(=CC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl.Cl,,,,,,
1321,151322,"N',N'-dimethyl-N-(1-nitroanthracen-9-yl)pentane-1,5-diamine",CN(C)CCCCCNC1=C2C(=CC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
1322,151323,"(S)-2,3-Dihydro-6-(2-hydroxyethyl)-5-(hydroxymethyl)-2,7-dimethyl-1H-inden-1-one",C[C@H]1CC2=CC(=C(C(=C2C1=O)C)CCO)CO,,,,,,
1323,151324,Pildralazine dihydrochloride,CC(CN(C)C1=NN=C(C=C1)NN)O.Cl.Cl,,,,,,
1324,151325,"N(sup 2)-((4-Chlorophenyl)methylene)-4-nitro-N(sup 1)-phenyl-1,2-benzenediamine",C1=CC=C(C=C1)NC2=C(C=C(C=C2)[N+](=O)[O-])N=CC3=CC=C(C=C3)Cl,,,,,,
1325,151326,"4-Nitro-N2-((4-nitrophenyl)methylene)-N1-phenyl-1,2-benzenediamine",C1=CC=C(C=C1)NC2=C(C=C(C=C2)[N+](=O)[O-])N=CC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
1326,151327,"2-Hydroxy-1,2,3-propanetricarboxylic acid californium-252Cf salt",C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[253Cf],,,,,,
1327,151328,Dehydronantenine,CN1CCC2=CC(=C(C3=C4C=C5C(=CC4=CC1=C23)OCO5)OC)OC,,,,,,
1328,151329,CID 151329,C[C@H]1CC=C[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2(C(=O)C=CC(=O)[C@@H](C(=C1)C)O)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)O,,,,,,
1329,151330,CID 151330,C[C@H]1CC=C[C@H]2[C@@H](C(=C([C@@H]3[C@@]2(C(=O)CC[C@@H](C(=O)C(=C1)C)O)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C)O,,,,,,
1330,151331,CID 151331,C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O.C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,,,,,,
1331,151332,"Hepta-2,5-dienoic acid;2-(2-hydroxyethylamino)ethanol;3-(4-methoxyphenyl)prop-2-enoic acid",CC=CCC=CC(=O)O.COC1=CC=C(C=C1)C=CC(=O)O.C(CO)NCCO,,,,,,
1332,151333,CID 151333,CC=CC/C=C/C(=O)O,,,,,,
1333,151334,2-(2-Hydroxyethylamino)ethanol;3-(4-methoxyphenyl)prop-2-enoic acid,COC1=CC=C(C=C1)C=CC(=O)O.C(CO)NCCO,,,,,,
1334,151335,"1',4'-Diepidaunorubicin",C[C@H]1[C@@H]([C@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
1335,151336,"1H-Imidazole-1-ethanol, 2-methyl-5-nitro-, hydrogen sulfate (ester)",CC1=NC=C(N1CCOS(=O)(=O)O)[N+](=O)[O-],,,,,,
1336,151337,"cis-3-Bromo-1,2-epoxycyclohexane",C1C[C@@H]2[C@@H](O2)[C@H](C1)Br,,,,,,
1337,151338,"3-Amino-6-chloro-3,4-dihydro-1-hydroxy-2(1H)-quinolinone",C1C(C(=O)N(C2=C1C=C(C=C2)Cl)O)N,,,,,,
1338,151339,"3-Amino-7-chloro-1-hydroxy-3,4-dihydroquinolin-2-one",C1C(C(=O)N(C2=C1C=CC(=C2)Cl)O)N,,,,,,
1339,151340,p-Methoxyphenylbutylene oxide,COC1=CC=C(C=C1)CCC2CO2,,,,,,
1340,151341,"6H-Pyrido(4,3-b)carbazol-9-ol, 5,6,11-trimethyl-",CC1=C2C=CN=CC2=C(C3=C1N(C4=C3C=C(C=C4)O)C)C,,,,,,
1341,151342,"2-Thiazolamine, 4-(1-naphthalenyl)-",C1=CC=C2C(=C1)C=CC=C2C3=CSC(=N3)N,,,,,,
1342,151343,"5-Methoxypyrido[2,3-d]pyridazine",COC1=C2C=CC=NC2=CN=N1,,,,,,
1343,151344,"8-Methoxypyrido[2,3-d]pyridazine",COC1=C2C(=CN=N1)C=CC=N2,,,,,,
1344,151345,"Phenol, 2-(((2-chloroethyl)amino)methyl)-4-nitro-",C1=CC(=C(C=C1[N+](=O)[O-])CNCCCl)O,,,,,,
1345,151346,1-Cyclohexylcarbamoyl-5-fluorouracil,C1CCC(CC1)NC(=O)N2C=C(C(=O)NC2=O)F,,,,,,
1346,151347,"Platynecine 7,9-phenylacetate diester",C1CN2CC[C@H]([C@H]2[C@H]1COC(=O)CC3=CC=CC=C3)OC(=O)CC4=CC=CC=C4,,,,,,
1347,151348,Tri(dimethylamino)benzotriazol-1-yloxyphosphonium hexafluorophosphate,CN(C)[P+](N(C)C)(N(C)C)ON1C2=CC=CC=C2N=N1.F[P-](F)(F)(F)(F)F,,,,,,
1348,151349,4-Amino-1-(3-hydroxy-1-(hydroxymethyl)propyl)-2(1H)-pyrimidinone,C1=CN(C(=O)N=C1N)C(CCO)CO,,,,,,
1349,151350,CID 151350,CCCCCC(CN(C)C)C(=O)C=CC1=CC=CC=C1.Cl,,,,,,
1350,151351,4-[(Dimethylamino)methyl]-1-phenylnon-1-en-3-one,CCCCCC(CN(C)C)C(=O)C=CC1=CC=CC=C1,,,,,,
1351,151352,4-(3-Methylphenoxy)aniline,CC1=CC(=CC=C1)OC2=CC=C(C=C2)N,,,,,,
1352,151353,Hydroxyalachlor,CCC1=C(C(=CC=C1)CC)N(COC)C(=O)CO,,,,,,
1353,151354,N-(5-(((3-Amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-4-(formylamino)-1-methyl-1H-pyrrole-2-carboxamide,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C)NC=O,,,,,,
1354,151355,"3-Hydroxy-5-methyl-2,4-imidazolidinedione",CC1C(=O)N(C(=O)N1)O,,,,,,
1355,151356,"1,3-Diacetyl-5-(4-(acetyloxy)phenyl)-5-phenyl-2,4-imidazolidinedione",CC(=O)N1C(=O)C(N(C1=O)C(=O)C)(C2=CC=CC=C2)C3=CC=C(C=C3)OC(=O)C,,,,,,
1356,151357,"(1,1'-Biphenyl)-4,4'-diamine, 3,3'-dibromo-5,5'-dichloro-",C1=C(C=C(C(=C1Cl)N)Br)C2=CC(=C(C(=C2)Br)N)Cl,,,,,,
1357,151358,"2,4(1H,3H)-Pyrimidinedione, nitro-",C1=CNC(=O)N(C1=O)[N+](=O)[O-],,,,,,
1358,151359,"3,5-Dinitro-1,1'-biphenyl",C1=CC=C(C=C1)C2=CC(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1359,151360,2-(Acetylamino)adenosine,CC(=O)NC1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
1360,151361,"2,5-Pyrrolidinedione, 1-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-",C1CC(=O)N(C1=O)OC(=O)CCCC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
1361,151362,"2-(Aminomethyl)benzene-1,4-diol",C1=CC(=C(C=C1O)CN)O,,,,,,
1362,151363,"Benzeneacetic acid, 4-((2-chloroethyl)amino)-, compd. with 2-aminoethanol (1:1)",C1=CC(=CC=C1CC(=O)O)NCCCl.C(CO)N,,,,,,
1363,151364,"Benzeneacetic acid, 4-(2-(chloroethyl)amino)-",C1=CC(=CC=C1CC(=O)O)NCCCl,,,,,,
1364,151365,"1(2H)-Acenaphthyleneone, 6-fluoro-",C1C2=C3C(=CC=C2)C(=CC=C3C1=O)F,,,,,,
1365,151366,CID 151366,C1=NC2=C(N1)C(=O)N=C(N2)NCO,,,,,,
1366,151367,"1,3-Diazido-2-propanol",C(C(CN=[N+]=[N-])O)N=[N+]=[N-],,,,,,
1367,151368,3-Acetylaminocarbazole,CC(=O)NC1=CC2=C(C=C1)NC3=CC=CC=C32,,,,,,
1368,151369,"Acetamide, N-(3-(2-(1-methylethyl)hydrazino)propyl)-, monohydrochloride",CC(C)NNCCCNC(=O)C.Cl,,,,,,
1369,151370,N-[3-(2-propan-2-ylhydrazinyl)propyl]acetamide,CC(C)NNCCCNC(=O)C,,,,,,
1370,151371,Norfluoxetine hydrochloride,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F.Cl,,,,,,
1371,151372,"Benz(a)anthracene-7,12-dimethanol, 4-hydroxy-",C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=C2CO)C=CC=C4O)CO,,,,,,
1372,151373,"3,6-Diazidoacridine",C1=CC(=CC2=NC3=C(C=CC(=C3)N=[N+]=[N-])C=C21)N=[N+]=[N-],,,,,,
1373,151374,"3,6-Diazido-10-methylacridinium chloride",CN1C2=CC(=N[N+]#N)C=CC2=CC3=C1C=C(C=C3)N=[N+]=[N-].[Cl-],,,,,,
1374,151375,3-Azido-6-diazonioimino-10-methylacridine,CN1C2=CC(=N[N+]#N)C=CC2=CC3=C1C=C(C=C3)N=[N+]=[N-],,,,,,
1375,151376,"Benzo(10,11)chryseno(1,2-b)oxirene-8,9-diol, 6b,7a,8,9-tetrahydro-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C6C(O6)C(C(C45)O)O)C=C2,,,,,,
1376,151377,"N,N'-bis[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propyl]butane-1,4-diamine",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCCNCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)OC,,,,,,
1377,151378,"1,4-Butanediamine, N-(6-chloro-2-methoxy-9-acridinyl)-N'-(3-((6-chloro-2-methoxy-9-acridinyl)amino)propyl)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCNCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)OC,,,,,,
1378,151379,"1,3-Propanediamine, N-(6-chloro-2-methoxy-9-acridinyl)-N'-(3-((6-chloro-2-methoxy-9-acridinyl)amino)propyl)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)OC,,,,,,
1379,151380,"5-((4-Butoxy-3-methoxyphenyl)methyl)-1-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",CCCCOC1=C(C=C(C=C1)CC2C(=O)NC(=O)N(C2=O)C3=CC=CC=C3)OC,,,,,,
1380,151381,CID 151381,COC1=C(C=C(C=C1)CN2C(=O)CC(=O)N=C2S)OC,,,,,,
1381,151382,2'-Fluoro-2'-deoxy-arabinofuranosyl-cytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F,,,,,,
1382,151383,CID 151383,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,['Dificlir film-coated tablets is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12. 5 kg.'],,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
1383,151384,"3-Hydroxyimidazolidine-2,4-dione",C1C(=O)N(C(=O)N1)O,,,,,,
1384,151385,"3,4-Di-beta-phenylpropionyl-1,2-5,6-dianhydro-dulcitol",C1[C@@H](O1)[C@@H]([C@@H]([C@@H]2CO2)OC(=O)CCC3=CC=CC=C3)OC(=O)CCC4=CC=CC=C4,,,,,,
1385,151386,"(SP-4-3)-Dichloro(N-ethyl-1,2-ethanediamine-N,N')platinum",CCNCCN.[Cl-].[Cl-].[Pt+2],,,,,,
1386,151387,CID 151387,CCCCOC1=C(C=C(C=C1)CN2C(=O)CC(=O)N=C2S)OC,,,,,,
1387,151388,CID 151388,CC1=CCCC(=C[C@@H](C[C@@](C=C[C@@H](CC1)C(C)C)(C)O)O)C,,,,,,
1388,151389,"Bis(2-furanmethyl) 1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylate",CC1=C(CC(=C(N1)C)C(=O)OCC2=CC=CO2)C(=O)OCC3=CC=CO3,,,,,,
1389,151390,"L-Cystine, bis(2,2-bis(2-chloroethyl)hydrazide), monohydrobromide",C(CCl)N(CCCl)NC(=O)[C@H](CSSC[C@@H](C(=O)NN(CCCl)CCCl)N)N.Br,,,,,,
1390,151391,D-Glucosylurea,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)NC(=O)N)O)O)O)O,,,,,,
1391,151392,4-((2-Pyridinylmethyl)amino)benzoic acid,C1=CC=NC(=C1)CNC2=CC=C(C=C2)C(=O)O,,,,,,
1392,151393,4-[(Pyridin-3-ylmethyl)-amino]-benzoic acid,C1=CC(=CN=C1)CNC2=CC=C(C=C2)C(=O)O,,,,,,
1393,151394,CID 151394,C[C@]12CCC(=O)CC1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4CCO)C=O)O,,,,,,
1394,151395,"2,3,6-Trichloroindophenol",C1=CC(=O)C=CC1=NC2=CC(=C(C(=C2Cl)Cl)O)Cl,,,,,,
1395,151396,L-Methionine p-nitroanilide,CSCC[C@@H](C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])N,,,,,,
1396,151397,beta-Phenylisoserine,C1=CC=C(C=C1)[C@H](C(C(=O)O)O)N,,,,,,
1397,151398,"3,4-Dihydroxystyrene",C=CC1=CC(=C(C=C1)O)O,,,,,,
1398,151399,Cyclopentyl sulfamate,C1CCC(C1)OS(=O)(=O)N,,,,,,
1399,151400,N-Acetylprocaine,CCN(CC)CCOC(=O)C1=CC=C(C=C1)NC(=O)C,,,,,,
1400,151401,(2R)-2-acetyl-6-amino-2-(methylamino)hexanoic acid,CC(=O)[C@](CCCCN)(C(=O)O)NC,,,,,,
1401,151402,Sodium carbonate decahydrate,C(=O)([O-])[O-].O.O.O.O.O.O.O.O.O.O.[Na+].[Na+],,,,,,
1402,151403,Aspartylglutamate,C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
1403,151404,3-Oxopropanenitrile,C(C=O)C#N,,,,,,
1404,151405,Lysine 4-nitroanilide,C1=CC(=CC=C1NC(=O)[C@H](CCCCN)N)[N+](=O)[O-],,,,,,
1405,151406,"Carbamimidic acid, N-butyl-N'-((4-methylphenyl)sulfonyl)-, ethyl ester",CCCCN=C(NS(=O)(=O)C1=CC=C(C=C1)C)OCC,,,,,,
1406,151407,Galactose 6-sulfate,C([C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)OS(=O)(=O)O,,,,,,
1407,151408,3-(2-Bromoacetyl)pyridine,C1=CC(=CN=C1)C(=O)CBr,,,,,,
1408,151409,alpha-Cyanoglycine,C(#N)[C@@H](C(=O)O)N,,,,,,
1409,151410,Lysylphenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)N,,,,,,
1410,151411,2-(Methylamino)acetamide,CNCC(=O)N,,,,,,
1411,151412,N-Acetyltryptophan methylamide,CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC,,,,,,
1412,151413,(4-Carbamoylphenyl) diethyl phosphate,CCOP(=O)(OCC)OC1=CC=C(C=C1)C(=O)N,,,,,,
1413,151414,"O,O-Dimethyl S-ethyl phosphorothioate",CCSP(=O)(OC)OC,,,,,,
1414,151415,Morpholine-4-sulfonic acid,C1COCCN1S(=O)(=O)O,,,,,,
1415,151416,2-(1H-pyrazol-4-yl)ethanamine,C1=C(C=NN1)CCN,,,,,,
1416,151417,tert-Butyl 2-aminoacetate,CC(C)(C)OC(=O)CN,,,,,,
1417,151418,2-(Dimethylamino)-2-methylpropanoic acid,CC(C)(C(=O)O)N(C)C,,,,,,
1418,151419,"1-(3-Carboxypropyl)-3,7-dimethylxanthine",CN1C=NC2=C1C(=O)N(C(=O)N2C)CCCC(=O)O,,,,,,
1419,151420,Tiemonium methylsulfate,C[N+]1(CCOCC1)CCC(C2=CC=CC=C2)(C3=CC=CS3)O.COS(=O)(=O)[O-],,,,,,
1420,151421,"3-(2-Fluoro-4,5-dihydroxyphenyl)-2-methylalanine",C[C@](CC1=CC(=C(C=C1F)O)O)(C(=O)O)N,,,,,,
1421,151422,Detca,CC(=O)OC1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=C(C=C34)C(=O)O)OC(=O)C)C,,,,,,
1422,151423,"1,2-Diacetyl-4-phenyl-1,2,4-triazolidine-3,5-dione",CC(=O)N1C(=O)N(C(=O)N1C(=O)C)C2=CC=CC=C2,,,,,,
1423,151424,"2,3-Dihydrothiazole",C1NC=CS1,,,,,,
1424,151425,"Estr-4-ene-3,11,17-trione",C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@H]34,,,,,,
1425,151426,Benzoyl phosphate,C1=CC=C(C=C1)C(=O)OP(=O)(O)O,,,,,,
1426,151427,1-Methyl-4-piperidyl acetate,CC(=O)OC1CCN(CC1)C,,,,,,
1427,151428,Lysyl-serine,C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)N,,,,,,
1428,151429,Naphthalen-1-yl hexadecanoate,CCCCCCCCCCCCCCCC(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
1429,151430,11-Hydroxyestrone,C[C@]12CC([C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O)O,,,,,,
1430,151431,"17alpha-Acetoxy-16-methylene-pregn-4-EN-3,20-dione",CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OC(=O)C,,,,,,
1431,151432,Androst-5-en-17-one,C[C@]12CCCCC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,,,,,,
1432,151433,S-(2-Carboxypropyl)cysteine,CC(CSC[C@@H](C(=O)O)N)C(=O)O,,,,,,
1433,151434,CID 151434,C1=C(N=C2C(=N1)NC(=NC2=O)N)COP(=O)(O)OP(=O)(O)O,,,,,,
1434,151435,"phosphono (2R,3R,4S,5R)-2-acetamido-3,4,5,6-tetrahydroxyhexanoate",CC(=O)N[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)C(=O)OP(=O)(O)O,,,,,,
1435,151436,"9-(4-Hydroxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenal",CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=O)C)C,,,,,,
1436,151437,4-Nitrophenyl-ara,C1=CC(=CC=C1[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H](O2)CO)O)O,,,,,,
1437,151438,Demanyl phosphate,CN(C)CCOP(=O)(O)O,,,,,,
1438,151439,"Androst-4-en-3-one, 17-hydroxy-, oxime, (17beta)-",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=NO)CC[C@]34C,,,,,,
1439,151440,Manganese glycinate,C(C(=O)[O-])N.C(C(=O)[O-])N.[Mn+2],,,,,,
1440,151441,Diethyl-methyl-(2-pyridin-2-ylethyl)azanium,CC[N+](C)(CC)CCC1=CC=CC=N1,,,,,,
1441,151442,N-Biotinyl-4-aminobenzoic acid,C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NC3=CC=C(C=C3)C(=O)O)NC(=O)N2,,,,,,
1442,151443,6-Deoxyhexopyranosylamine,C[C@@H]1[C@@H]([C@@H]([C@H](C(O1)N)O)O)O,,,,,,
1443,151444,3-tert-Butylsydnone,CC(C)(C)[N+]1=NOC(=C1)[O-],,,,,,
1444,151445,"Sydnone, 3-(1,1-dimethylethyl)-",CC(C)(C)[N+]1=CC(=O)ON1,,,,,,
1445,151446,N-Acetylglucopyranosylamine,CC(=O)NC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
1446,151447,Sebacinyldicholine,C[N+](C)(C)CCOC(=O)CCCCCCCCC(=O)OCC[N+](C)(C)C,,,,,,
1447,151448,"18-Hydroxy-4-androstene-3,17-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)CO,,,,,,
1448,151449,5alpha-Androst-16-en-3beta-ol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C,,,,,,
1449,151450,CID 151450,CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=NO)C)C,,,,,,
1450,151451,(4-Methylphenyl)(oxo)acetic acid,CC1=CC=C(C=C1)C(=O)C(=O)O,,,,,,
1451,151452,Arginine beta-naphthylamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
1452,151453,Estriol-17-glucuronide,C[C@]12CC[C@@H]3[C@@H]([C@H]1C[C@H]([C@@H]2OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)CCC5=C3C=CC(=C5)O,,,,,,
1453,151454,"6,7-Dehydro Estradiol",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2O)C=CC4=C3C=CC(=C4)O,,,,,,
1454,151455,"11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl hexuronate",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O)C)O,,,,,,
1455,151456,"Ethanol, 2-(octylsulfinyl)-",CCCCCCCCS(=O)CCO,,,,,,
1456,151457,ethyl (2S)-6-amino-2-[[(2S)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]hexanoate,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)OCC,,,,,,
1457,151458,Tetradecyltrimethylphosphonium,CCCCCCCCCCCCCC[P+](C)(C)C,,,,,,
1458,151459,S-Carboxymethyl-homocysteine,C(CSCC(=O)O)[C@@H](C(=O)O)N,,,,,,
1459,151460,9H-Carbazol-3-ol,C1=CC=C2C(=C1)C3=C(N2)C=CC(=C3)O,,,,,,
1460,151461,"1,5-Dimethylbarbituric acid",CC1C(=O)NC(=O)N(C1=O)C,,,,,,
1461,151462,4-(2-Pyridylazo)naphthol,C1=CC=C2C(=C1)C(=CC=C2O)N=NC3=CC=CC=N3,,,,,,
1462,151463,"1,4-Dihydroxy-2-methoxy-6-methylbenzene",CC1=CC(=CC(=C1O)OC)O,,,,,,
1463,151464,"Methyl 2,3,4-tri-O-acetylglucopyranoside",CC(=O)O[C@@H]1[C@H](OC([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC)CO,,,,,,
1464,151465,"N,N-Dimethyl-2-bromophenylethylamine",CN(C)CCC1=CC=CC=C1Br,,,,,,
1465,151466,1-Thioglucose,C([C@H]([C@H]([C@@H]([C@H](C=S)O)O)O)O)O,,,,,,
1466,151467,"4',5'-Dihydropsoralen",C1COC2=C1C=C3C=CC(=O)OC3=C2,,,,,,
1467,151468,Methyl 4-dimethylaminocinnamate,CN(C)C1=CC=C(C=C1)C=CC(=O)OC,,,,,,
1468,151469,"2-(2,4-Dimethylphenyl)indan-1,3-dione",CC1=CC(=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O)C,,,,,,
1469,151470,Diethylamino-2-butynylsuccinimide,CCN(CC)CC#CCC1CC(=O)NC1=O,,,,,,
1470,151471,CID 151471,C=CCN1C(=NN=N1)S,,,,,,
1471,151472,Diammonium cerium(4+) trisulphate,[NH4+].[NH4+].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Ce+4],,,,,,
1472,151473,2-Fluoro-L-tyrosine,C1=CC(=C(C=C1O)F)C[C@@H](C(=O)O)N,,,,,,
1473,151474,"(2S,3S,4S,5R)-2,3,4,5-tetrahydroxyhexanal",C[C@H]([C@@H]([C@@H]([C@@H](C=O)O)O)O)O,,,,,,
1474,151475,H-Arg(NO2)-Obzl,C1=CC=C(C=C1)COC(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])N,,,,,,
1475,151476,4-Aminopyridine methiodide,CI.C1=CN=CC=C1N,,,,,,
1476,151477,1-Amino-2-methylpropane-2-thiol,CC(C)(CN)S,,,,,,
1477,151478,1-Butyltrimethylammonium,CCCCC[NH+](C)C,,,,,,
1478,151479,"N,N-Dimethyl-1-pentanamine",CCCCCN(C)C,,,,,,
1479,151480,"3-(3-Oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid",C1=CC=C2C(=C1)NC(=O)C(=N2)CCC(=O)O,,,,,,
1480,151481,1-Phthalazinecarbonitrile,C1=CC=C2C(=C1)C=NN=C2C#N,,,,,,
1481,151482,4-Ethoxy-4'-nitrosodiphenylamine,CCOC1=CC=C(C=C1)NC2=CC=C(C=C2)N=O,,,,,,
1482,151483,"N-(2,3-dihydroxybenzoyl)-L-serine",C1=CC(=C(C(=C1)O)O)C(=O)N[C@@H](CO)C(=O)O,,,,,,
1483,151484,4-Fluoro-3-hydroxyanthranilic acid,C1=CC(=C(C(=C1C(=O)O)N)O)F,,,,,,
1484,151485,3-Cyanopropyl(triphenyl)phosphonium,C1=CC=C(C=C1)[P+](CCCC#N)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1485,151486,[2-(Propan-2-ylcarbamoyl)phenyl] hypobromite,CC(C)NC(=O)C1=CC=CC=C1OBr,,,,,,
1486,151487,"4,5-Dimethyl-3-pentadecylcatechol",CCCCCCCCCCCCCCCC1=C(C(=CC(=C1O)O)C)C,,,,,,
1487,151488,CID 151488,[Li+].[O-]Cl(=O)(=O)=O,,,,,,
1488,151489,Gluconate 6-sulfate,C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)OS(=O)(=O)O,,,,,,
1489,151490,"3,3,5,5-Tetramethyl-1-pyrroline N-oxide",CC1(CC([N+](=C1)[O-])(C)C)C,,,,,,
1490,151491,3-(Pyrazol-1-yl)-L-alanine,C1=CN(N=C1)C[C@@H](C(=O)O)N,,,,,,
1491,151492,3-Hydroxyhexanoic acid,CCCC(CC(=O)O)O,,,,,,
1492,151493,CID 151493,CC(=CCC1=C(C(=C(C(=C1CC=C(C)C)OC)O)C(CC=C(C)C)(CC=C(C)C)C(=C(C)C(CC=C(C)C)CC=C(C)C)CC=C(C)C)CC=C(C)C)C,,,,,,
1493,151494,"1-Phenyl-1,2,3,4-tetrahydro-quinolin-4-ylamine",C1CN(C2=CC=CC=C2C1N)C3=CC=CC=C3,,,,,,
1494,151495,Cyanoethyl dimethyldithiocarbamate,CN(C)C(=S)SCCC#N,,,,,,
1495,151496,Amidinophenylpyruvic acid,C1=CC=C(C=C1)C(C(=O)C(=O)O)C(=N)N,,,,,,
1496,151497,Pyrazolidin-3-one,C1CNNC1=O,,,,,,
1497,151498,"N1,N3-Dibenzylpropane-1,3-diamine",C1=CC=C(C=C1)CNCCCNCC2=CC=CC=C2,,,,,,
1498,151499,"1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine",CCN1C=CC(=O)C2=C1N=C(C=C2)C,,,,,,
1499,151500,Methyl n-hexylsulfonate,CCCCCCS(=O)(=O)OC,,,,,,
1500,151501,2-(4-Chlorophenoxy)butanoic acid,CCC(C(=O)O)OC1=CC=C(C=C1)Cl,,,,,,
1501,151502,Tosyl-l-lysine alpha-naphthyl ester,CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CCCCN)C(=O)OC2=CC=CC3=CC=CC=C32,,,,,,
1502,151503,"4,8,12-Trimethyltridecanoic acid",CC(C)CCCC(C)CCCC(C)CCC(=O)O,,,,,,
1503,151504,Mannono-delta-lactone,C([C@@H]1[C@H]([C@@H]([C@@H](C(=O)O1)O)O)O)O,,,,,,
1504,151505,2-(D-glucosyloxy)benzoic acid,C1=CC=C(C(=C1)C(=O)O)OC2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1505,151506,N-(quinolin-8-yl)methanesulfonamide,CS(=O)(=O)NC1=CC=CC2=C1N=CC=C2,,,,,,
1506,151507,"Tetradeca-5,8-dienoic acid",CCCCCC=CCC=CCCCC(=O)O,,,,,,
1507,151508,"Hexadeca-4,7,10-trienoic acid",CCCCCC=CCC=CCC=CCCC(=O)O,,,,,,
1508,151509,6-Methyl-6-hepten-2-one,CC(=C)CCCC(=O)C,,,,,,
1509,151510,Isopropyl-diiodothyronine,CC(C)[C@](CC1=CC=C(C=C1)OC2=CC=C(C=C2)O)(C(=O)O)N(I)I,,,,,,
1510,151511,Decanoyl fluorescein,CCCCCCCCCC(=O)C1=C2C(=CC=C1)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
1511,151512,Octadec-12-enoic acid,CCCCCC=CCCCCCCCCCCC(=O)O,,,,,,
1512,151513,4-Methyl-L-phenylalanine,CC1=CC=C(C=C1)C[C@@H](C(=O)O)N,,,,,,
1513,151514,Mercury phosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Hg+2].[Hg+2].[Hg+2],,,,,,
1514,151515,4'-Chloroflavone,C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC=C(C=C3)Cl,,,,,,
1515,151516,Laurylpropylenediamine,CCCCCCCCCCCCC(C(C)N)N,,,,,,
1516,151517,2-Chlorophenylhydroxylamine,C1=CC=C(C(=C1)NO)Cl,,,,,,
1517,151518,"4-Methoxy-2,2'-bipyrrole-5-carboxaldehyde",COC1=C(NC(=C1)C2=CC=CN2)C=O,,,,,,
1518,151519,3-(N-Nitroso-N-methylamino)propionic acid,CN(CCC(=O)O)N=O,,,,,,
1519,151520,N-tert-Butyl-5-methylisoxazolium perchlorate,CC1=CC=[N+](O1)C(C)(C)C.[O-]Cl(=O)(=O)=O,,,,,,
1520,151521,"Pregnane-3,6,17,20-tetrol",CC([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(C4[C@@]3(CCC(C4)O)C)O)C)O)O,,,,,,
1521,151522,"(2R,3R,4S,5R)-2-phenylmethoxyoxane-3,4,5-triol",C1[C@H]([C@@H]([C@H]([C@@H](O1)OCC2=CC=CC=C2)O)O)O,,,,,,
1522,151523,N-Nitroso-N-benzylacetamide,CC(=O)N(CC1=CC=CC=C1)N=O,,,,,,
1523,151524,4-Nitrocarbazole,C1=CC=C2C(=C1)C3=C(N2)C=CC=C3[N+](=O)[O-],,,,,,
1524,151525,"2-(2-Methylpropyl)-1H-pyrrolo(2,3-b)pyridine",CC(C)CC1=CC2=C(N1)N=CC=C2,,,,,,
1525,151526,CID 151526,COC1=CC(=C(C=C1)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)OC,,,,,,
1526,151527,"Benzofurazan, 4-((4-methylphenyl)thio)-7-(phenylsulfonyl)-",CC1=CC=C(C=C1)SC2=CC=C(C3=NON=C23)S(=O)(=O)C4=CC=CC=C4,,,,,,
1527,151528,"1(2H)-Pyrimidinecarboxamide, 5-fluoro-3,4-dihydro-N-(1-methylethyl)-2,4-dioxo-",CC(C)NC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
1528,151529,Schisantherin A,C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4[C@@H]([C@@]1(C)O)OC(=O)C5=CC=CC=C5)OC)OC)OC)OC)OCO3,,,,,,
1529,151530,CID 151530,C1=CC=C2C(=C1)C(=NN2CC3=CC=C(C=C3)Cl)C(=O)[O-].[Na+],,,,,,
1530,151531,1-(Diethylamino)-3-((3-nitro-9-acridinyl)amino)-2-propanol,CCN(CC)CC(CNC1=C2C=CC(=CC2=NC3=CC=CC=C31)[N+](=O)[O-])O,,,,,,
1531,151532,"Acetamide, N-(4-((acetylamino)sulfonyl)phenyl)-2-phenoxy-",CC(=O)NS(=O)(=O)C1=CC=C(C=C1)NC(=O)COC2=CC=CC=C2,,,,,,
1532,151533,2-(4-chlorophenoxy)-N-(4-sulfamoylphenyl)acetamide,C1=CC(=CC=C1NC(=O)COC2=CC=C(C=C2)Cl)S(=O)(=O)N,,,,,,
1533,151534,"Acetamide, 2-(4-chlorophenoxy)-N-(4-((2-thiazolylamino)sulfonyl)phenyl)-",C1=CC(=CC=C1NC(=O)COC2=CC=C(C=C2)Cl)S(=O)(=O)NC3=NC=CS3,,,,,,
1534,151535,"Acetamide, N-((4-(aminosulfonyl)phenyl)methyl)-2-(4-chlorophenoxy)-",C1=CC(=CC=C1CNC(=O)COC2=CC=C(C=C2)Cl)S(=O)(=O)N,,,,,,
1535,151536,4'-epi-Adriamycin,C[C@H]1[C@@H]([C@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)']",,,
1536,151537,"(7S,9S)-7-[(2S,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@@H]([C@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,,,,"[""... The plasma and tissue distribution of /anthracyline antibiotics/ doxorubicin (1), 4' epidoxorubicin (epirubicin; II) and daunorubicin (daunomycin; III) were studied in patients. Plasma levels of I and II and their 13 hydroxy metabolites were determined by LC, as were plasma levels of III. It was concluded that plasma kinetics for the 3 drugs were similar, and that tissue uptake for I and II were virtually the same. Tumor tissue concentrated the drugs to the greatest extent, while adipose tissue had the lowest concentrations."", '... The preparation and in vitro and in vivo evaluation of egg albumin microspheres containing epirubicin hydrochloride (I) are /detailed/, I pharmacokinetics were studied in rats following single intravenous doses and efficacy studies were carried out in mice with Ehrlich ascites carcinoma and in rats with Walker carcinoma. The kinetics of in vitro release of the drug complied partially with first order as well as with a diffusion model from a matrix. The pharmacokinetics in serum, heart and lungs of rats could be described by the equation of the 2 compartment open model. The pharmacokinetic parameters calculated suggest the possibility of improving the selective entrapment of I by the lungs. In the animal efficacy studies I increased the survival times in all treated groups. It was concluded that the data suggest the possibility of organ targeting of I microspheres.', '/MILK/ Epirubicin was excreted into the milk of rats treated with 0.50 mg/kg/day of epirubicin during peri- and postnatal periods. It is not known whether this drug is excreted in human milk.', 'Following intravenous administration, epirubicin is rapidly and widely distributed into the tissues. Binding of epirubicin to plasma proteins, predominantly albumin, is about 77% and is not affected by drug concentration. Epirubicin also appears to concentrate in red blood cells; whole blood concentrations are approximately twice those of plasma.', 'For more Absorption, Distribution and Excretion (Complete) data for EPIRUBICIN (11 total), please visit the HSDB record page.']","['Epirubicin is extensively and rapidly metabolized by the liver and is also metabolized by other organs and cells, including red blood cells. Four main metabolic routes have been identified:  (1) reduction of the C-13 keto-group with the formation of the 13(S)-dihydro derivative, epirubicinol; (2) conjugation of both the unchanged drug and epirubicinol with glucuronic acid; (3) loss of the amino sugar moiety through a hydrolytic process with the formation of the doxorubicin and doxorubicinol aglycones; and (4) loss of the amino sugar moiety through a redox process with the formation of the 7-deoxy-doxorubicin aglycone and 7-deoxy-doxorubicinol aglycone. Epirubicinol has in vitro cytotoxic activity one-tenth that of epirubicin. As plasma levels of epirubicinol are lower than those of the unchanged drug, they are unlikely to reach in vivo concentrations sufficient for cytotoxicity. No significant activity or toxicity has been reported for the other metabolites.', 'Secondary alcohol metabolites have been proposed to mediate chronic cardiotoxicity induced by doxorubicin (DOX) and other anticancer anthracyclines. In this study, NADPH-supplemented human cardiac cytosol was found to reduce the carbonyl group in the side chain of the tetracyclic ring of doxorubicin, producing the secondary alcohol metabolite doxorubicinol (DOXol). A decrease in the level of alcohol metabolite formation was observed by replacing doxorubicin with epirubicin (EPI), a less cardiotoxic analogue characterized by an axial-to-equatorial epimerization of the hydroxyl group at C-4 in the amino sugar bound to the tetracyclic ring (daunosamine). A similar decrease was observed by replacing doxorubicin with MEN, a novel anthracycline with preclinical evidence of reduced cardiotoxicity. MEN is characterized by the lack of a methoxy group at C-4 in the tetracyclic ring and by intercalation of 2, 6-dideoxy-L-fucose between daunosamine and the aglycone. Multiple comparisons with methoxy- or 4-demethoxyaglycones, and a number of mono- or disaccharide 4-demethoxyanthracyclines, showed that both the lack of the methoxy group and the presence of a disaccharide moiety limited alcohol metabolite formation by MEN. Studies with enzymatically generated or purified anthracycline secondary alcohols also showed that the presence of a disaccharide moiety, but not the lack of a methoxy group, made the metabolite of MEN less reactive with the [4Fe-4S] cluster of cytoplasmic aconitase, as evidenced by its limited reoxidation to the parent carbonyl anthracycline and by a reduced level of delocalization of Fe(II) from the cluster. Collectively, these studies (i) characterize the different influence of methoxy and sugar substituents on the formation and [4Fe-4S] reactivity of anthracycline secondary alcohols, (ii) lend support to the role of alcohol metabolites in anthracycline-induced cardiotoxicity, as they demonstrate that the less cardiotoxic EPI and MEN 10755 share a reduction in the level of formation of such metabolites, and (iii) suggest that the cardiotoxicity of MEN might be further decreased by the reduced [4Fe-4S] reactivity of its alcohol metabolite.', 'Many antineoplastic drugs were found to have carcinogenic, mutagenic and teratogenic potential. The aim of this study was to carry out cytogenetic and internal dose monitoring of hospital pharmacy personnel regularly involved in the preparation of cytostatic agents, in order to test possible cytostatics-induced genotoxic effects due to occupational exposure under routine working conditions, and in cases of accidental contamination. ... Platinum in whole blood and anthracyclines in plasma were measured to assess internal exposure to cytostatics. The level of cytogenetic damage was determined in peripheral blood lymphocytes with the micronucleus test and the sister chromatid exchange assay. Five series of monitoring were performed over a period of 2 years. ... No significant differences in the mean frequencies of sister chromatid exchanges (SCE) and micronuclei (MN) were found between occupationally exposed probands and controls (9.9 +/- 1.4 vs 10.1 +/- 1.2 SCEs/cell and 21.2 +/- 7.2 vs 23.3 +/- 7.5 MN/2000 binucleated (BN) cells, n = 16). Significant elevations of SCE or MN were detected in seven out of 12 cases of accidental contamination at the workplace, whereas no increase in platinum in blood and anthracyclines in plasma was observed in these probands. Two cases of non-reported contamination were identified by measurement of epirubicin in plasma. Smoking was found to increase the SCE significantly. No correlation between individual SCE scores and MN scores was observed. ... /The authors/ findings support a transient increase in SCE or MN after relevant exposure to cytostatic drugs in cases of accidental contamination. The lack of significant differences in SCE and MN between hospital pharmacy personnel and unexposed controls, points to high standards of safety at the corresponding workplaces.', 'There is compelling in-vitro evidence that the evaluation of doxorubicin or epirubicin pharmacokinetics based solely on plasma concentration may not fully elucidate the differences between the two drugs. Both compounds bind to erythrocytes and their different binding to hemoglobin may influence their disposition in the body. The purpose of the present study was to compare the pharmacokinetics and metabolism of doxorubicin and epirubicin based on the plasma concentration, amount associated with blood cells and simultaneous monitoring of biliary and urinary elimination of unchanged drug and metabolites after single- and multiple-dose injections. The level of sarcoplasmic reticulum Ca2+ATPase in the heart was also measured as a biomarker of cardiotoxicity. Male Sprague-Dawley rats were treated in a parallel design with doxorubicin or epirubicin on a multiple-dosing basis (4 mg kg(-1) per week) or as a single dose injection (20 mg kg(-1)). Blood, urine and bile samples were collected periodically after each dose in the multiple-dosing regimen and the single dose injection, and at the end of each experiment the hearts were removed. The concentrations of each drug in plasma, blood cells, bile and urine samples were determined, and by simultaneous curve-fitting of plasma and bile data according to compartmental analysis, the pharmacokinetic parameters and constants were estimated. The concentration of drug associated with blood cells was analyzed according to non-compartmental analysis. The bile and urine samples provided the in-vivo metabolic data. The level of Ca2+ATPase in the heart, determined by Western blotting, was used as the toxicodynamic parameterto correlate with the kinetic data. Multiple-dosing regimens reduced the total plasma clearance and increased the area under the plasma concentration-time curve of both drugs. Also, the area under the curve of doxorubicin associated with blood cells increased with the weekly doses, and the related mean residence time (MRT) and apparent volume of distribution (Vdss) were steadily reduced. In contrast to doxorubicin, the mean residence time and Vdss of epirubicin increased significantly. Metabolic data indicated significant differences in the level of alcohol and aglycones metabolites. Doxorubicinol and doxorubicin aglycones were significantly greater than epirubicinol and epirubicin aglycone, whereas epirubicinol aglycone was greater than doxorubicinol aglycone. The area under the blood cells concentration-time curve correlated linearly with the changes in Ca2+ATPase net intensity. The results of this study demonstrate the importance of the kinetics of epirubicin and doxorubicin associated with blood cells. Linear correlation between the reduction of net intensity of the biomarker with the area under the curve of doxorubicin associated with blood cells confirms that the differences between the two compounds are related to their interaction with blood cells. This observation together with the observed differences in metabolism may underline a significant role for blood cells in distribution and metabolism of doxorubicin and epirubicin.', 'For more Metabolism/Metabolites (Complete) data for EPIRUBICIN (6 total), please visit the HSDB record page.']","['... Epirubicin pharmacokinetics may be described by a 3-compartment model, with median half-life values of 3.2 minutes, 1.2 and 32 hours for each phase. ...']"
1537,151538,"Stannate(2-), ((N,N'-1,2-ethanediylbis(N-((carboxymethyl)glycinato))(4-)-N,N',O,O',O(N),O(N'))-, tin(2+) (1:1), (OC-6-21)-",C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Sn+2].[Sn+2],,,,,,
1538,151539,CID 151539,CC(=O)[O-].C1=CC=NC(=C1)C=NN=C(N)[S-].[Cu],,,,,,
1539,151540,4'-Epi-daunorubicin,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
1540,151541,"2,4(1H,3H)-Pyrimidnedione, dihydro-5,6-dihydroxy-5-methyl-, (5S-cis)-",C[C@@]1([C@@H](NC(=O)NC1=O)O)O,,,,,,
1541,151542,Bleomycin-A5033,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNCCCNC(=O)CCC(=O)O)O,,,,,,
1542,151543,O-Acetyldihydrosterigmatocystin,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C4C(=C3O2)C5CCOC5O4)OC,,,,,,
1543,151544,Demethyl-diacetyl-sterigmatocystin,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C4C(=C3O2)C5C=COC5O4)OC(=O)C,,,,,,
1544,151545,Sulfacombin,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N.C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,,,,,,
1545,151546,"(+/-)-Benzo(a)pyrene-9,10-diol-7,8-epoxide,syn",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@H]6[C@@H]5O6)O)O)C=C2,,,,,,
1546,151547,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-(N,N-dimethylglycyl)glycyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, monohydrochloride, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)CNC(=O)CN(C)C)O.Cl,,,,,,
1547,151548,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-(N,N-dimethylglycyl)glycyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)CNC(=O)CN(C)C)O,,,,,,
1548,151549,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(((dipropylamino)acetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, monohydrochloride, (8S-cis)-",CCCN(CCC)CC(=O)N[C@H]1C[C@@H](O[C@H]([C@H]1O)C)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O.Cl,,,,,,
1549,151550,"N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2-(dipropylamino)acetamide",CCCN(CCC)CC(=O)N[C@H]1C[C@@H](O[C@H]([C@H]1O)C)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
1550,151551,"4'-Methyl-4-N,N-di(beta-hydroxyethylamino)azobenzene",CC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(CCO)CCO,,,,,,
1551,151552,"1H-Benzimidazole, 1-(5-O-(hydroxy(phosphonooxy)phosphinyl)-beta-D-ribofuranosyl)-",C1=CC=C2C(=C1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O,,,,,,
1552,151553,"2,7,12,17-Tetraethyl-3,8,13,18-tetramethyl-10-(dimethylaminomethyl)-21H,23H-porphyrin",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)CC)CN(C)C)C)CC)C)CC)C,,,,,,
1553,151554,"Benzoic acid, 4-(((a4-chlorophenoxy)acetyl)amino)-2-hydroxy-",C1=CC(=CC=C1OCC(=O)NC2=CC(=C(C=C2)C(=O)O)O)Cl,,,,,,
1554,151555,"1H-Pyrrolizine-1-methoanol, 7-(acetyloxy)hexahydro, acetate (ester), (1S-(1alpha,7alpha,7abeta))-",CC(=O)OC[C@H]1CCN2[C@@H]1[C@H](CC2)OC(=O)C,,,,,,
1555,151556,1-Methyl-7-nitro-1H-indazole,CN1C2=C(C=CC=C2[N+](=O)[O-])C=N1,,,,,,
1556,151557,"1,9-Dinitrophenazine",C1=CC2=C(C(=C1)[N+](=O)[O-])N=C3C(=N2)C=CC=C3[N+](=O)[O-],,,,,,
1557,151558,N-[(1-oxido-2H-pyridin-6-yl)methylideneamino]benzenesulfonamide,C1C=CC=C(N1[O-])C=NNS(=O)(=O)C2=CC=CC=C2,,,,,,
1558,151559,"2-Methoxy-6-chloro-9-amino(2,2,6,6-tetramethyl-1-oxypiperidyl-4)acridine",CC1(CC(CC(N1[O])(C)C)C2=C(C=CC3=NC4=C(C=CC(=C4)Cl)C(=C32)N)OC)C,,,,,,
1559,151560,"Acetic acid, ((1,2,3,4-tetrahydro-2-oxo-5-quinolinyl)oxy)-",C1CC(=O)NC2=C1C(=CC=C2)OCC(=O)O,,,,,,
1560,151561,CID 151561,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CC(=O)[O-].[Na+],,,,,,
1561,151562,CID 151562,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)N.[Na+],,,,,,
1562,151563,"1,3-Bis(2-chloro-2,2-dideuterioethyl)-1-nitrosourea",[2H]C([2H])(CNC(=O)N(CC([2H])([2H])Cl)N=O)Cl,,,,,,
1563,151564,"2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1,3-dicarboxylic acid",C1C(NC(C2=C1C3=CC=CC=C3N2)C(=O)O)C(=O)O,,,,,,
1564,151565,"2(1H)-Quinolinone, 3,4-dihydro-5,8-dihydroxy-",C1CC(=O)NC2=C(C=CC(=C21)O)O,,,,,,
1565,151566,"N-(((5-(4-Bromophenyl)-6-methyl-2-pyrazinyl)amino)carbonyl)-2,6-dichlorobenzamide",CC1=NC(=CN=C1C2=CC=C(C=C2)Br)NC(=O)NC(=O)C3=C(C=CC=C3Cl)Cl,,,,,,
1566,151567,"5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 1,2,3,11a-tetrahydro-8-hydroxy-3,7-dimethoxy-, (3S-trans)-",CO[C@H]1CC[C@@H]2N1C(=O)C3=CC(=C(C=C3N=C2)O)OC,,,,,,
1567,151568,"5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 1,2,3,11a-tetrahydro-8-hydroxy-3,7-dimethoxy-, (3S-cis)-",CO[C@H]1CC[C@H]2N1C(=O)C3=CC(=C(C=C3N=C2)O)OC,,,,,,
1568,151569,Neothramycin A,COC1=C(C=C2C(=C1)C(=O)N3[C@@H](CC[C@@H]3O)C=N2)O,,,,,,
1569,151570,2-methyl-N-[3-(5-nitrofuran-2-yl)prop-2-enylideneamino]benzamide,CC1=CC=CC=C1C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1570,151571,CID 151571,CCC1=CC=CC=C1C(=O)N/N=C/C=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1571,151572,5-Nitro-2-[(o-butylbenzoylhydrazono)propen-1-yl]furan,CCCCC1=CC=CC=C1C(=O)NN=CC=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1572,151573,Bufuralol hydrochloride,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O.Cl,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)']",,,
1573,151574,N-((Ethylnitrosoamino)methyl)benzamide,CCN(CNC(=O)C1=CC=CC=C1)N=O,,,,,,
1574,151575,"Benzamide, N-((nitroso(phenylmethyl)amino)methyl)-",C1=CC=C(C=C1)CN(CNC(=O)C2=CC=CC=C2)N=O,,,,,,
1575,151576,CID 151576,CC1(CC(CN1[O])NCCCNC2=C3C=CC(C=C3NC4=CC=CC=C42)(C)C)C,,,,,,
1576,151577,"3-(((6-Chloro-2-methoxy-9-acridinyl)amino)methyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy",CC1(CC(C(N1[O])(C)C)CNC2=C3C=C(C=CC3=NC4=C2C=CC(=C4)Cl)OC)C,,,,,,
1577,151578,"1-Piperidinyloxy, 4-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O])(C)C)NC2=C3C(=NC4=C2C=CC(=C4)Cl)C=CC(=N3)OC)C,,,,,,
1578,151579,"Episteganol, DL",COC1=C(C(=C2C(=C1)C[C@H]3[C@@H](COC3=O)[C@H](C4=CC5=C(C=C42)OCO5)O)OC)OC,,,,,,
1579,151580,"4-(2-aminoethyl)-N,N-bis(2-chloroethyl)aniline",C1=CC(=CC=C1CCN)N(CCCl)CCCl,,,,,,
1580,151581,4'-epi-6'-Hydroxyadriamycin,COC1=CC=CC2=C1C(=O)C3=C(C4=C(CC(CC4OC5CC(C(C(O5)CO)O)N)(C(=O)CO)O)C(=C3C2=O)O)O,,,,,,
1581,151582,"(7R,9R)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2C[C@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,,,,,
1582,151583,"(7R,9R)-9-acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@H](O1)O[C@@H]2C[C@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,,,,,
1583,151584,4'-epi-6'-Hydroxydaunorubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)CO)O)N)O,,,,,,
1584,151585,"8-Acetyl-10-((3-(9-(aminoacetyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione monohydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)CN)O.Cl,,,,,,
1585,151586,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-aminoacetamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)CN)O,,,,,,
1586,151587,"[2-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] benzoate",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)C6=CC=CC=C6)O)N)O,,,,,,
1587,151588,"(7S,9R)-9-acetyl-7-[(2R,4R,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,10-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](C(C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,,,,,,
1588,151589,"2-[9-[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl]sulfonyl-3,7-dimethylnona-1,3,5,7-tetraenyl]-1,3,3-trimethylcyclohexene",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCS(=O)(=O)CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C,,,,,,
1589,151590,Tellimagrandin II,C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O1)O)O)O)O)O)O,,,,,,
1590,151591,CID 151591,CC(C=O)[C-]=O.[Na+],,,,,,
1591,151592,Ficellomycin,CC(C)C(C(=O)NC(C1CC(C2N1C2)N=C(N)N)C(=O)O)N,,,,,,
1592,151593,CID 151593,C1CC=CCCC=C1.C1=CC=C(C=C1)N.[Cl-].[Rh],,,,,,
1593,151594,CID 151594,CC=C(C)C(=O)O[C@@H]1C[C@@]2(C(=O)C=C(O2)C(=C[C@@H]3[C@@H]1C(=C)C(=O)O3)CO)C,,,,,,
1594,151595,"Benzene, didsocyanatomythyl(phenylmethyl)-",C1=CC=C(C=C1)CC2=CC=CC=C2C(N=C=O)N=C=O,,,,,,
1595,151596,"Nitric acid, plutonium-238Pu salt",[N+](=O)(O)[O-].[238Pu],,,,,,
1596,151597,"Methyl 2,4-dichloro-9-hydroxyfluorene-9-carboxylate",COC(=O)C1(C2=CC=CC=C2C3=C1C=C(C=C3Cl)Cl)O,,,,,,
1597,151598,"3-((9-(Acridinylamino)propyl)amino)-2,2,6,6-tetramethyl-1-pyrrolidinyloxy",CC1(CC(C(N1[O])(C)C)CNC2=C3C=CC=CC3=NC4=CC=CC=C42)C,,,,,,
1598,151599,"5,10,15,20-Tetrakis(1-methylpyridin-1-ium-2-yl)-21,22-dihydroporphyrin",C[N+]1=CC=CC=C1C2=C3C=CC(=C(C4=CC=C(N4)C(=C5C=CC(=N5)C(=C6C=CC2=N6)C7=CC=CC=[N+]7C)C8=CC=CC=[N+]8C)C9=CC=CC=[N+]9C)N3,,,,,,
1599,151600,"5,10,15,20-Tetra(1-methyl-3-pyridyl)-porphyrin chloride",C[N+]1=CC=CC(=C1)C2=C3C=CC(=C(C4=CC=C(N4)C(=C5C=CC(=N5)C(=C6C=CC2=N6)C7=C[N+](=CC=C7)C)C8=C[N+](=CC=C8)C)C9=C[N+](=CC=C9)C)N3,,,,,,
1600,151601,4'-(9-Acridinylamino)-3'-methoxyethanesulfonanilide methanesulfonate,CCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OC.CS(=O)(=O)O,,,,,,
1601,151602,N-[4-(acridin-9-ylamino)-3-methoxyphenyl]ethanesulfonamide,CCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OC,,,,,,
1602,151603,Oxyclothepin succinate,C1CN(CCN1CCO)C2CC3=C(C=CC(=C3)Cl)SC4=CC=CC=C24.C(CC(=O)O)C(=O)O,,,,,,
1603,151604,Docloxythepin,C1CN(CCN1CCO)C2CC3=C(C=CC(=C3)Cl)SC4=CC=CC=C24,,,,,,
1604,151605,"2,2,4,5-Tetrafluoro-1,3-dioxolane",C1(C(OC(O1)(F)F)F)F,,,,,,
1605,151606,"4,5-Dichloro-2,2-difluoro-1,3-dioxolane",C1(C(OC(O1)(F)F)Cl)Cl,,,,,,
1606,151607,Ara-utp,C1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
1607,151608,N-Benzyl-2-bromo-2-methylpropanamide,CC(C)(C(=O)NCC1=CC=CC=C1)Br,,,,,,
1608,151609,2-Amino-N(6)-methyl-N(6)-hydroxyadenine,CN(C1=NC(=NC2=C1NC=N2)N)O,,,,,,
1609,151610,N-(N-(N-Glycylglycyl)-L-phenylalanyl)-L-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CN,,,,,,
1610,151611,Ccris 4080,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)OC6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)C=C3,,,,,,
1611,151612,"(2S,3S,4S,5R)-6-benzo[b]pyren-6-yloxy-3,4,5-trihydroxyoxane-2-carboxylic acid",C1=CC=C2C(=C1)C3=C4C(=C2OC5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)C=CC6=CC=CC(=C64)C=C3,,,,,,
1612,151613,Ccris 4083,C1=CC2=C3C(=C1)C=CC4=C5C=C(C=CC5=CC(=C43)C=C2)OC6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,,,,,,
1613,151614,(4-Nitrophenyl)arsonic acid disodium salt,C1=CC(=CC=C1[N+](=O)[O-])[As](=O)([O-])[O-].[Na+].[Na+],,,,,,
1614,151615,"Arsonic acid, (4-chlorophenyl)-, disodium salt",C1=CC(=CC=C1Cl)[As](=O)([O-])[O-].[Na+].[Na+],,,,,,
1615,151616,"9,10-Anthracenedione, 2-ethyl-1-(methylamino)-",CCC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)NC,,,,,,
1616,151617,"N-(2-Ethyl-9,10-dihydro-9,10-dioxo-1-anthracenyl)-1-propanesulfonamide",CCCS(=O)(=O)NC1=C(C=CC2=C1C(=O)C3=CC=CC=C3C2=O)CC,,,,,,
1617,151618,"9,10-Anthracenedione, 2-(hydroxymethyl)-1-(methylamino)-",CNC1=C(C=CC2=C1C(=O)C3=CC=CC=C3C2=O)CO,,,,,,
1618,151619,"9,10-Anthracenedione, 1-amino-4-((4-chlorophenyl)amino)-2-methyl-",CC1=CC(=C2C(=C1N)C(=O)C3=CC=CC=C3C2=O)NC4=CC=C(C=C4)Cl,,,,,,
1619,151620,3-(Acetyloxy)-4-methoxybenzoic acid,CC(=O)OC1=C(C=CC(=C1)C(=O)O)OC,,,,,,
1620,151621,Morindin,CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H](CO5)O)O)O)O)O)O)O,,,,,,
1621,151622,2-Chloro-5-nitronicotinamide,C1=C(C=NC(=C1C(=O)N)Cl)[N+](=O)[O-],,,,,,
1622,151623,"N-9H-Fluoren-2-yl-3,3-dimethylbutanamide",CC(C)(C)CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,,,,,,
1623,151624,"(9,9'-Bianthracene)-2,2',7,7'-tetramine, N,N,N',N',N'',N'',N''',N'''-octamethyl-",CN(C)C1=CC2=C(C3=C(C=CC(=C3)N(C)C)C=C2C=C1)C4=C5C=C(C=CC5=CC6=C4C=C(C=C6)N(C)C)N(C)C,,,,,,
1624,151625,"6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine-13-methanol, 5,8,13,13a-tetrahydro-10,11-dimethoxy-, cis-",COC1=C(C=C2[C@@H]([C@H]3C4=CC5=C(C=C4CCN3CC2=C1)OCO5)CO)OC,,,,,,
1625,151626,"6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine-13-methanol, 5,8,13,13a-tetrahydro-10,11-dimethoxy-, trans-",COC1=C(C=C2[C@@H]([C@@H]3C4=CC5=C(C=C4CCN3CC2=C1)OCO5)CO)OC,,,,,,
1626,151627,"6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine, 5,8,13,13a-tetrahydro-10,11-dimethoxy-13-methyl-, cis-",C[C@@H]1[C@H]2C3=CC4=C(C=C3CCN2CC5=CC(=C(C=C15)OC)OC)OCO4,,,,,,
1627,151628,"6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine, 5,8,13,13a-tetrahydro-10,11-dimethoxy-13-methyl-, trans-",C[C@@H]1[C@@H]2C3=CC4=C(C=C3CCN2CC5=CC(=C(C=C15)OC)OC)OCO4,,,,,,
1628,151629,"Acridine, 9-(1H-pyrrol-1-yl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)N4C=CC=C4,,,,,,
1629,151630,CID 151630,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OS(=O)(=O)O)O)O,,,,,,
1630,151631,"1,2-Dihydro-1,2-phenanthrenediol diacetate, trans-",CC(=O)O[C@@H]1C=CC2=C([C@H]1OC(=O)C)C=CC3=CC=CC=C32,,,,,,
1631,151632,Aposafranine,C1C=C(C=C2C1N(C3=CC=CC=C3[NH2+]2)C4=CC=CC=C4)N.[Cl-],,,,,,
1632,151633,"5-phenyl-4a,10-dihydro-4H-phenazin-2-amine",C1C=C(C=C2C1N(C3=CC=CC=C3N2)C4=CC=CC=C4)N,,,,,,
1633,151634,CID 151634,CC1=CC2([C@H](CC3=CNC4=C(C=CC2=C34)Cl)NC)OC1=O,,,,,,
1634,151635,CID 151635,CN(CCCl)N=CC1=CC=CC=C1.Cl,,,,,,
1635,151636,N-(benzylideneamino)-2-chloro-N-methylethanamine,CN(CCCl)N=CC1=CC=CC=C1,,,,,,
1636,151637,"Arsonic acid, (4-methlphenyl)-, monosodium salt",CC1=CC=C(C=C1)[As](=O)(O)O.[Na+],,,,,,
1637,151638,Monomethylollysine,C(CCN)C[C@@H](C(=O)O)NCO,,,,,,
1638,151639,"(SP-4-2)-Dichloro(N-(1-methylethyl)-1,2-ethanediamne-N,N')platinum",CC(C)NCCN.[Cl-].[Cl-].[Pt+2],,,,,,
1639,151640,"Pyridinium, 3,3'-(bicyclo(2.2.2)octane-1,4-diylbis(carbonylimino-4,1-phenylenecarbonylimino))bis(1-methyl-, salt with 4-methylbenzenesulfonic acid (1:2)",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C34CCC(CC3)(CC4)C(=O)NC5=CC=C(C=C5)C(=O)NC6=C[N+](=CC=C6)C,,,,,,
1640,151641,"5,5a-Dihydroxy-4a-(hydroxymethyl)-7,9-dimethyl-2-(nona-1,3-dien-1-yl)-6-oxo-10a-(prop-1-en-2-yl)-3a,3c,4a,5,5a,6,8a,9,10,10a-decahydro-2H,3bH-2,8b-epoxyoxireno[6,7]azuleno[5,4-e][1,3]benzodioxol-10-yl benzoate",CCCCCC=CC=CC12O[C@@H]3[C@@H]4[C@H]5[C@](O5)([C@H]([C@]6([C@H]([C@@]4(O1)[C@@H]([C@H]([C@@]3(O2)C(=C)C)OC(=O)C7=CC=CC=C7)C)C=C(C6=O)C)O)O)CO,,,,,,
1641,151642,CID 151642,C[C@@H]1C[C@@]2([C@H](O2)C)C(=O)O[C@@H]3CCN(CC=C(C3=O)COC(=O)[C@]1(C)OC(=O)C)C,,,,,,
1642,151643,"4,4'-Hexamethylenediiminobis(6-amino-2-methylquinoline) dihydrochloride dihydrate",CC1=CC(=C2C=C(C=CC2=N1)N)NCCCCCCNC3=C4C=C(C=CC4=NC(=C3)C)N.Cl.Cl,,,,,,
1643,151644,"1,6-Bis(6-amino-2-methyl-4-quinolylamino)hexane",CC1=CC(=C2C=C(C=CC2=N1)N)NCCCCCCNC3=C4C=C(C=CC4=NC(=C3)C)N,,,,,,
1644,151645,Tetrakis(N-methyl-4-pyridinium)yl-porphine iron(III) complex,CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1.[Fe+3],,,,,,
1645,151646,"5,10,20-tris(1-methylpyridin-1-ium-4-yl)-15-(1-methylpyridin-4-ylidene)-21H-porphyrin",CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C(N5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1,,,,,,
1646,151647,"Acetic acid, (4-(bis(2-chloroethyl)amino)phenyl)-, 17-oxo-D-homo-17a-oxaandrostan-3-yl ester",C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)O4)C)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
1647,151648,"2-Hydroxyethanethiolato(2,2',2''-terpyridine)platinum(II)",C1=CC=NC(=C1)C2=NC(=CC=C2)C3=CC=CC=N3.C(C[S-])O.[N+](=O)([O-])[O-].[Pt+2],,,,,,
1648,151649,CID 151649,CC=C1C[C@H]([C@](C(=O)OCC2=CCN(CC[C@H](C2=O)OC1=O)C)(C)OC(=O)C)C,,,,,,
1649,151650,"2,1-Benzisothiazol-3-amine, 5,7-dichloro-",C1=C(C=C(C2=NSC(=C21)N)Cl)Cl,,,,,,
1650,151651,"1,2-Anthracenediol, 1,2-dihydro-, dibenzoate, trans-",C1=CC=C(C=C1)C(=O)O[C@@H]2C=CC3=CC4=CC=CC=C4C=C3[C@H]2OC(=O)C5=CC=CC=C5,,,,,,
1651,151652,"Benz(a)anthracene-1,2-diol, 1,2-dihydro-, diacetate, trans-",CC(=O)O[C@H]1C=CC2=C([C@@H]1OC(=O)C)C3=CC4=CC=CC=C4C=C3C=C2,,,,,,
1652,151653,"3,4-Dihydrobenz(a)anthracene-3,4-diol diacetate, trans-",CC(=O)O[C@H]1C=CC2=C([C@@H]1OC(=O)C)C=CC3=CC4=CC=CC=C4C=C32,,,,,,
1653,151654,"Benz(a)anthracene-8,9-diol, 8,9-dihydro-, dibenzoate, trans-",C1=CC=C(C=C1)C(=O)O[C@H]2C=CC3=C([C@@H]2OC(=O)C4=CC=CC=C4)C=C5C=CC6=CC=CC=C6C5=C3,,,,,,
1654,151655,"Benz(a)anthracene-10,11-diol, 10,11-dihydro-, dibenzoate, trans-",C1=CC=C(C=C1)C(=O)O[C@H]2C=CC3=C([C@@H]2OC(=O)C4=CC=CC=C4)C=C5C(=C3)C=CC6=CC=CC=C65,,,,,,
1655,151656,"1,2,3,4-Tetrahydro-1,2-anthracenediol dibenzoate, trans-",C1CC2=CC3=CC=CC=C3C=C2[C@H]([C@@H]1OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5,,,,,,
1656,151657,"4-Bromo-1,2,3,4-tetrahydro-1,2-anthracenediol dibenzoate, (1alpha,2beta,4alpha)-",C1[C@@H]([C@H](C2=CC3=CC=CC=C3C=C2[C@H]1Br)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5,,,,,,
1657,151658,"1,2-Phenanthrenediol, 1,2,3,4-tetrahydro-, diacetate, trans-",CC(=O)O[C@@H]1CCC2=C([C@H]1OC(=O)C)C=CC3=CC=CC=C23,,,,,,
1658,151659,"1,2-Phenanthrenediol, 4-bromo-1,2,3,4-tetrahydro-, diacetate, (1alpha,2beta,4alpha)-",CC(=O)O[C@H]1C[C@@H](C2=C([C@@H]1OC(=O)C)C=CC3=CC=CC=C32)Br,,,,,,
1659,151660,"1,2,3,4-Tetrahydro-3,4-phenanthrenediol dibenzoate, trans-",C1CC2=C([C@@H]([C@H]1OC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4)C5=CC=CC=C5C=C2,,,,,,
1660,151661,"Benz(a)anthracene-1,2-diol, 4-bromo-1,2,3,4-tetrahydro-, diacetate, (1alpha,2beta,4alpha)-",CC(=O)O[C@H]1C[C@@H](C2=C([C@@H]1OC(=O)C)C3=CC4=CC=CC=C4C=C3C=C2)Br,,,,,,
1661,151662,"Methyl 5-hydroxy-4,5-dimethyl-2-oxo-2,5-dihydrofuran-3-carboxylate",CC1=C(C(=O)OC1(C)O)C(=O)OC,,,,,,
1662,151663,"3,4-Phenanthrenediol, 3,4-dihydro-, diacetate, trans-",CC(=O)O[C@H]1C=CC2=C([C@@H]1OC(=O)C)C3=CC=CC=C3C=C2,,,,,,
1663,151664,"Acetamide, N-9H-fluoren-2-yl-N-methoxy-",CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC,,,,,,
1664,151665,"1H-Pyrrole, 2-(methylthio)-3-nitro-",CSC1=C(C=CN1)[N+](=O)[O-],,,,,,
1665,151666,"1-Propanesulfonic acid, 3-(3,5-dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)-, calcium salt (2:1)",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCS(=O)(=O)[O-])O)O.COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCS(=O)(=O)[O-])O)O.[Ca+2],,,,,,
1666,151667,"3-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]propane-1-sulfonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCS(=O)(=O)O)O)O,,,,,,
1667,151668,"1,3,5-Triazine-2,4-diamine, N,N'-bis(1-methylethyl)-6-(methylthio)-N-nitroso-",CC(C)NC1=NC(=NC(=N1)SC)N(C(C)C)N=O,,,,,,
1668,151669,"2-(Hydroxymethyl)-1,3-dimethoxyanthraquinone",COC1=C(C(=C2C(=C1)C(=O)C3=CC=CC=C3C2=O)OC)CO,,,,,,
1669,151670,Isouvaretin,COC1=C(C(=CC(=C1C(=O)CCC2=CC=CC=C2)O)O)CC3=CC=CC=C3O,,,,,,
1670,151671,"13,14-Dihydro-15-keto-20-ethyl prostaglandin F2alpha isopropyl ester",CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)OC(C)C)O)O,,,,,,
1671,151672,"5,8-Quinolinedione, 6-amino-2-(2-aminophenyl)-",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=CC3=O)N)N,,,,,,
1672,151673,CID 151673,C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C=CC3=O)N(O)O,,,,,,
1673,151674,"5,8-Quinolinedione, 6,7-dichloro-2-(2-nitrophenyl)-",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)Cl)Cl)[N+](=O)[O-],,,,,,
1674,151675,"5,8-Quinolinedione, 7-amino-2-(2-aminophenyl)-6-methoxy-",COC1=C(C(=O)C2=C(C1=O)C=CC(=N2)C3=CC=CC=C3N)N,,,,,,
1675,151676,"5,8-Quinolinedione, 2-(2-aminophenyl)-7-cloro-6-methoxy-",COC1=C(C(=O)C2=C(C1=O)C=CC(=N2)C3=CC=CC=C3N)Cl,,,,,,
1676,151677,"6-Methoxy-2-(2-nitrophenyl)-5,8-quinolinedione",COC1=CC(=O)C2=C(C1=O)C=CC(=N2)C3=CC=CC=C3[N+](=O)[O-],,,,,,
1677,151678,"5,8-Quinolinedione, 7-bromo-6-methoxy-2-(2-nitrophenyl)-",COC1=C(C(=O)C2=C(C1=O)C=CC(=N2)C3=CC=CC=C3[N+](=O)[O-])Br,,,,,,
1678,151679,"6-Amino-7-bromo-2-(2-nitrophenyl)-5,8-quinolinedione",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)Br)N)[N+](=O)[O-],,,,,,
1679,151680,"6-Amino-2-(2-nitrophenyl)-5,8-quinolinedione",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=CC3=O)N)[N+](=O)[O-],,,,,,
1680,151681,"5,8-Quinolinedione, 6-amino-2-(2-aminophenyl)-7-bromo-",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)Br)N)N,,,,,,
1681,151682,"Benzenamine, 2-(5,8-dimethoxy-2-quinolinyl)-",COC1=C2C=CC(=NC2=C(C=C1)OC)C3=CC=CC=C3N,,,,,,
1682,151683,CID 151683,C1=CC=C(C(=C1)C2=CC=C3C(=O)C=CC(=C3N2)O)N,,,,,,
1683,151684,CID 151684,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@]([C@](O3)(C(N)(N)ON)N)(N)O)O.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
1684,151685,CID 151685,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@]([C@](O3)(C(N)(N)ON)N)(N)O)O,,,,,,
1685,151686,"3,3,5,5-Tetradeutero-N-nitrosomorpholine",[2H]C1(COCC(N1N=O)([2H])[2H])[2H],,,,,,
1686,151687,CID 151687,C1=CC(=CC(=C1)[N+](=O)[O-])C2NC(N=C(N2)S)C3=CC(=CC=C3)[N+](=O)[O-],,,,,,
1687,151688,"Platinum (II), dichloro(2,3-naphthylenediammine)-",C1=CC=C2C=C(C(=CC2=C1)N)N.Cl[Pt]Cl,,,,,,
1688,151689,"Dichloro(1,2-diaminocyclohexane)platinum(II)",C1CCC(C(C1)N)N.Cl[Pt]Cl,,,"['Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
1689,151690,"2(5H)-Furanone, 3-methyl-5-methylene-",CC1=CC(=C)OC1=O,,,,,,
1690,151691,"2-Propen-1-amine, 2-chloro-N-methyl-",CNCC(=C)Cl,,,,,,
1691,151692,"Benzenediazonium, 2-methoxy-4-nitro-, 1,5-naphthalenedisulfonate (2:1)",COC1=C(C=CC(=C1)[N+](=O)[O-])[N+]#N.COC1=C(C=CC(=C1)[N+](=O)[O-])[N+]#N.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-],,,,,,
1692,151693,Fast Corinth V zinc chloride double salt,CC1=CC(=C(C=C1)N=NC2=CC(=C(C=C2C)[N+]#N)OC)[N+](=O)[O-].CC1=CC(=C(C=C1)N=NC2=CC(=C(C=C2C)[N+]#N)OC)[N+](=O)[O-].Cl[Zn-2](Cl)(Cl)Cl,,,,,,
1693,151694,2-Methoxy-5-methyl-4-[(4-methyl-2-nitrophenyl)azo]benzenediazonium,CC1=CC(=C(C=C1)N=NC2=CC(=C(C=C2C)[N+]#N)OC)[N+](=O)[O-],,,,,,
1694,151695,"7H-Pyrido(2,3-c)carbazole, 10-methoxy-",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)N=CC=C4,,,,,,
1695,151696,"7H-Pyrido(3,4-c)carbazole, 10-methoxy-",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=NC=C4,,,,,,
1696,151697,"10-Methoxy-3,7-dimethyl-7H-pyrido(3,4-c)carbazolium iodide",C[NH+]1C2C=CC3=CN(C=CC3=C2C4=C1C=CC(=C4)OC)C.[I-],,,,,,
1697,151698,"10-methoxy-3,7-dimethyl-6aH-pyrido[3,4-c]carbazole",CN1C=CC2=C3C(C=CC2=C1)N(C4=C3C=C(C=C4)OC)C,,,,,,
1698,151699,"10-Methoxy-3-methyl-7H-pyrido(3,4-c)carbazolium iodide",CN1C=CC2=C3C(C=CC2=C1)[NH2+]C4=C3C=C(C=C4)OC.[I-],,,,,,
1699,151700,"10-Methoxy-3-methyl-6a,7-dihydropyrido[3,4-c]carbazole",CN1C=CC2=C3C(C=CC2=C1)NC4=C3C=C(C=C4)OC,,,,,,
1700,151701,"7H-Pyrido(3,4-c)carbazol-10-ol",C1=CC2=C(C=C1O)C3=C(N2)C=CC4=C3C=CN=C4,,,,,,
1701,151702,CID 151702,CN1CC2=C(C=CC3C2C4C=C(C=CC4[NH2+]3)OC)C=C1,,,,,,
1702,151703,"10-Methoxy-2-methyl-1,6a,7,7a,11a,11b-hexahydropyrido[4,3-c]carbazole",CN1CC2=C(C=CC3C2C4C=C(C=CC4N3)OC)C=C1,,,,,,
1703,151704,"10-Methoxy-2,7-dimethyl-7H-pyrido(4,3-c)carbazolium iodide",C[NH+]1C2C=CC(=CC2C3C1C=CC4=C3CN(C=C4)C)OC.[I-],,,,,,
1704,151705,"10-methoxy-2,7-dimethyl-6a,7a,11a,11b-tetrahydro-1H-pyrido[4,3-c]carbazole",CN1CC2=C(C=CC3C2C4C=C(C=CC4N3C)OC)C=C1,,,,,,
1705,151706,"7H-Pyrido(4,3-c)carbazol-10-ol",C1=CC2=C(C3=C(N2)C=CC(=C3)O)C4=C1C=CN=C4,,,,,,
1706,151707,"10-Hydroxy-2-methyl-7H-pyrido(4,3-c)carbazolium iodide",CN1CC2=C(C=CC3C2C4C=C(C=CC4[NH2+]3)O)C=C1.[I-],,,,,,
1707,151708,"2-Methyl-1,6a,7,7a,11a,11b-hexahydropyrido[4,3-c]carbazol-10-ol",CN1CC2=C(C=CC3C2C4C=C(C=CC4N3)O)C=C1,,,,,,
1708,151709,"7H-Pyrido(3,4-c)carbazole, 10-methoxy-7-methyl-",CN1C2=C(C=C(C=C2)OC)C3=C1C=CC4=C3C=CN=C4,,,,,,
1709,151710,"7H-Pyrido(4,3-c)carbazole, 10-methoxy-7-methyl-",CN1C2=C(C=C(C=C2)OC)C3=C1C=CC4=C3C=NC=C4,,,,,,
1710,151711,CID 151711,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O)O.[Na+],,,,,,
1711,151712,"2-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]acetic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O)O,,,,,,
1712,151713,CID 151713,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCC(=O)[O-])O)O.[K+],,,,,,
1713,151714,"4-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]butanoic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCC(=O)O)O)O,,,,,,
1714,151715,"2,3-Dibromo-3-phenylpropanal",C1=CC=C(C=C1)C(C(C=O)Br)Br,,,,,,
1715,151716,"5,6-Dihydro-5-azacytidine hydrochloride",C1N=C(NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N.Cl,,,"['Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)']",,,
1716,151717,"6-amino-3-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,4-dihydro-1,3,5-triazin-2-one",C1N=C(NC(=O)N1[C@H]2C(C([C@H](O2)CO)O)O)N,,,,,,
1717,151718,O-Methyl nogalarol,C[C@]1(C[C@H](C2=C(C3=C(C=C2[C@@H]1C(=O)OC)C(=O)C4=C5C(=CC(=C4C3=O)OC)[C@@]6([C@H]([C@H]([C@H]([C@H](O5)O6)O)N(C)C)O)C)O)O)O,,,,,,
1718,151719,7-Deoxynogalarol,CC1(CCC2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C5C(=CC(=C4C3=O)O)C6(C(C(C(C(O5)O6)O)N(C)C)O)C)O)O,,,,,,
1719,151720,D-Apiitol,C([C@@H](C(CO)(CO)O)O)O,,,,,,
1720,151721,Bromomethylenebis(phosphonic acid),C(P(=O)(O)O)(P(=O)(O)O)Br,,,,,,
1721,151722,Copper Histidine,C1=C(NC=N1)C[C@@H](C(=O)[O-])N.C1=C(NC=N1)C[C@@H](C(=O)[O-])N.[Cu+2],,,,,,
1722,151723,Methylmercury cysteine,C[Hg+].C([C@@H](C(=O)[O-])N)S,,,,,,
1723,151724,Tyrosyltyrosine methyl ester,COC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1724,151725,"3,4-Dihydroxymandelaldehyde",C1=CC(=C(C=C1C(C=O)O)O)O,,,,,,
1725,151726,4-Aminocatechol,C1=CC(=C(C=C1N)O)O,,,,,,
1726,151727,beta-(2-Methoxyphenoxy)lactic acid,COC1=CC=CC=C1OCC(C(=O)O)O,,,,,,
1727,151728,Phenylalanylphenylalanine methyl ester,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
1728,151729,4-Mercaptobutyrate,C(CC(=O)[O-])CS,,,,,,
1729,151730,5-Hydroxypiperidine-2-carboxylic acid,C1CC(NCC1O)C(=O)O,,,,,,
1730,151731,Palmitoylcholine,CCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)C,,,,,,
1731,151732,CID 151732,C[C@H](C(=O)O)NC(=O)C[C@@H](C(=O)O)N,,,,,,
1732,151733,"1,4-Diamino-2-butanone",C(CN)C(=O)CN,,,,,,
1733,151734,Octadec-13-enoic acid,CCCCC=CCCCCCCCCCCCC(=O)O,,,,,,
1734,151735,Secocolchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C34C1=CC(=O)C3(OC=C4)OC)OC)OC)OC,,,,,,
1735,151736,Colchiciline,CC(=O)N[C@H]1[C@@H](CC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC)O,,,,,,
1736,151737,"5,8-Quinolinedione, 6,7-dibromo-2-(2-nitrohenyl)-",C1=CC=C(C(=C1)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)Br)Br)[N+](=O)[O-],,,,,,
1737,151738,"5,8-Quinolinedione, 7-chloro-6-methoxy-2-(2-nitrohenyl)-",COC1=C(C(=O)C2=C(C1=O)C=CC(=N2)C3=CC=CC=C3[N+](=O)[O-])Cl,,,,,,
1738,151739,CID 151739,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CCOC)C)C)C)C)OC,,,,,,
1739,151740,Aflatoxicol B,COC1=C2C3=C([C@@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,,,,,
1740,151741,6'-Hydroxydaunorubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)CO)O)N)O.Cl,,,,,,
1741,151742,trans-Bis(methylammine)dichloroplatinum(II),C1CCC(C(C1)N)N.[Cl-].[Cl-].[Pt+2],,,"['Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
1742,151743,"1,2-Diaminocyclohexyl platinum sulfate",C1CCC(C(C1)N)N.[O-]S(=O)(=O)[O-].[Pt+2],,,,,,
1743,151744,Bleomycin-pyp,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNCCC7=CC=CC=N7)O,,,,,,
1744,151745,"Platinum(2+), hexaamminedi-N-hydroxydi-, dinitrate",N.N.N.N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[OH-].[OH-].[Pt+2].[Pt+2],,,,,,
1745,151746,"6,8-O-Dimethylversicolorin B",COC1=CC2=C(C(=C1)OC)C(=O)C3=C(C4=C(C=C3C2=O)O[C@@H]5[C@H]4CCO5)O,,,,,,
1746,151747,"(7S-cis)-7-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-5,12-naphthacenedione",C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)N)O,,,,,,
1747,151748,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3-dideoxy-alpha-L-ribo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",CC(=O)[C@]1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5C[C@H]([C@H]([C@@H](O5)CO)O)N)O,,,,,,
1748,151749,"Palladium(2+), diaqua(1,2-ethanediamine-N,N')-, (SP-4-2)-initrate",C(CN)N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.[Pd+2],,,,,,
1749,151750,"10-((3-Amino-2,3-dideoxy-alpha-L-ribo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride, (8S-cis)-",COC1=CC=CC2=C1C(=O)C3=C(C4=C(CC(CC4OC5CC(C(C(O5)CO)O)N)(C(=O)CO)O)C(=C3C2=O)O)O.Cl,,,,,,
1750,151751,"Cyclohexanecarboxylic acid, (9,11-dihydro-7-(1-hydroxy-1-(((1-methylethyl)amino)carbonyl)propyl)-9-oxoindolizino(1,2-b)quinolin-8-yl)methyl ester, (S)-",CC[C@](C1=C(C(=O)N2CC3=CC4=CC=CC=C4N=C3C2=C1)COC(=O)C5CCCCC5)(C(=O)NC(C)C)O,,,,,,
1751,151752,"D-Glucopyranosylamine, N,N-bis(2-chloroethyl)-",C(CCl)N(CCCl)C1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
1752,151753,"Heptanedioic acid, bis(7-oxo-7H-furo(3,2-g)(1)benzopyran-9-yl) ester",C1=CC(=O)OC2=C(C3=C(C=CO3)C=C21)OC(=O)CCCCCC(=O)OC4=C5C(=CC6=C4OC=C6)C=CC(=O)O5,,,,,,
1753,151754,"Propanedioic acid, (bis(1-aziridinyl)methylene)-, dimethyl ester",COC(=O)C(=C(N1CC1)N2CC2)C(=O)OC,,,,,,
1754,151755,"Thiocyanic acid, 4-(((5-chloro-2-hydroxyphenyl)methylene)amino)phenyl ester",C1=CC(=CC=C1N=CC2=C(C=CC(=C2)Cl)O)SC#N,,,,,,
1755,151756,"Phenol, 4-bromo-2-(4-thiocyanatophenyliminomethyl)-",C1=CC(=CC=C1N=CC2=C(C=CC(=C2)Br)O)SC#N,,,,,,
1756,151757,"Carbamic acid, (2-methoxyphenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride",COC1=CC=CC=C1NC(=O)OCCN2CCCCC2.Cl,,,,,,
1757,151758,"Carbamic acid, (2-methoxyphenyl)-, 2-(1-piperidinyl)ethyl ester",COC1=CC=CC=C1NC(=O)OCCN2CCCCC2,,,,,,
1758,151759,"Carbamic acid, (4-(nonyloxy)phenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride",CCCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2.Cl,,,,,,
1759,151760,2-(1-piperidyl)ethyl N-(4-nonoxyphenyl)carbamate,CCCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2,,,,,,
1760,151761,"Carbamic acid, (4-(decyloxy)phenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride",CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2.Cl,,,,,,
1761,151762,2-(1-piperidyl)ethyl N-(4-decoxyphenyl)carbamate,CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2,,,,,,
1762,151763,"Hydroxylamine, O-((4-ethoxyphenyl)methyl)-",CCOC1=CC=C(C=C1)CON,,,,,,
1763,151764,"Hydroxylamine, O-((4-propoxyphenyl)methyl)-",CCCOC1=CC=C(C=C1)CON,,,,,,
1764,151765,"Propanoic acid, rhodium(2+) salt",CCC(=O)O.CCC(=O)O.[Rh+2],,,,,,
1765,151766,"Gold, trichloro(triethylphosphine)-, (SP-4-2)-",CCCCCCP.[Cl-].[Cl-].[Cl-].[Au+3],,,,,,
1766,151767,Hexylphosphine,CCCCCCP,,,,,,
1767,151768,"Gold, tribromo(triethylphosphine)-, (SP-4-2)-",CCCCCCP.[Br-].[Br-].[Br-].[Au+3],,,,,,
1768,151769,CID 151769,COC1=C2C(=C3C=CC=CC3=C(O2)O)C=CC1=O,,,,,,
1769,151770,Platinum propylenediamine dichloride,CC(CN)N.[Cl-].[Cl-].[Pt+2],,,,,,
1770,151771,Estradiol-3N-diethylcarbamate-17beta phosphate,CCN(CC)C(=O)OC1=CC2=C(C=C1)[C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4OP(=O)(O)O)C,,,,,,
1771,151772,"Uridine-5,6-t2",[3H]C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)[3H],,,,,,
1772,151773,"1,3-Dioxane, 2-(4-bromobutyl)-5,5-dimethyl-",CC1(COC(OC1)CCCCBr)C,,,,,,
1773,151774,"Methanesulfonamide, N-(3-methoxy-4-((3-(trifluoromethyl)-9-acridinyl)amino)phenyl)-, monomethanesulfonate",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)C(F)(F)F.CS(=O)(=O)O,,,,,,
1774,151775,"Ethanol, 2,2'-((4-aminophenyl)imino)bis-, sulfate (2:1) (salt)",C1=CC(=CC=C1N)N(CCO)CCO.C1=CC(=CC=C1N)N(CCO)CCO.OS(=O)(=O)O,,,,,,
1775,151776,"1-deoxy-D-threo-hexo-2,5-diulose",CC(=O)[C@H]([C@@H](C(=O)CO)O)O,,,,,,
1776,151777,"L-Phenylalanine, N-(2-mercapto-1-oxopropyl)-",CC(C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)S,,,,,,
1777,151778,"1,6-Hexanediamine, N,N'-di-4-quinolinyl-",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCNC3=CC=NC4=CC=CC=C43,,,,,,
1778,151779,"1,7-Heptanediamine, N,N'-di-4-quinolinyl-",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCNC3=CC=NC4=CC=CC=C43,,,,,,
1779,151780,"1,8-Octanediamine, N,N'-di-4-quinolinyl-",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCCNC3=CC=NC4=CC=CC=C43,,,,,,
1780,151781,"1,9-Nonanediamine, N,N'-di-4-quinolinyl-",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCCCNC3=CC=NC4=CC=CC=C43,,,,,,
1781,151782,"1,10-Decanediamine, N,N'-di-4-quinolinyl-",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCCCCNC3=CC=NC4=CC=CC=C43,,,,,,
1782,151783,CID 151783,CCCOC1=C(C=C(C=C1)CN=C(N)S)OC,,,,,,
1783,151784,"Ethanol, 2-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCO.Cl,,,,,,
1784,151785,"2,5-Bis(ethoxycarbonylamino)-3,6-bis(2-methyl-1-aziridinyl)-1,4-benzoquinone",CCOC(=O)NC1=C(C(=O)C(=C(C1=O)N2CC2C)NC(=O)OCC)N3CC3C,,,,,,
1785,151786,"Methanone, (2-fluorophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)-",CC1=C(C(=O)N(N1)C)C(=O)C2=CC=CC=C2F,,,,,,
1786,151787,"Phenanthro(9,10-b)oxirene, 1a,9b-bis(4-chlorophenyl)-1a,9b-dihydro-",C1=CC=C2C(=C1)C3=CC=CC=C3C4(C2(O4)C5=CC=C(C=C5)Cl)C6=CC=C(C=C6)Cl,,,,,,
1787,151788,"1,1,2,3,4,5-Hexachloropenta-1,3-diene",C(C(=C(C(=C(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1788,151789,"[(1S,2S,4S,5S,6R,10S)-5-hydroxy-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.0^{2,4]dec-7-en-2-yl]methyl (E)-3-phenylprop-2-enoate",C1=CC=C(C=C1)C=CC(=O)OCC23C4C(C=COC4OC5C(C(C(C(O5)CO)O)O)O)C(C2O3)O,,,,,,
1789,151790,"Uridine, 5-(bromo-80Br)-2'-deoxy-",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)[80Br])CO)O,,,,,,
1790,151791,CID 151791,C[C@H](CC=CC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
1791,151792,"Benzenesulfenic acid, 2-nitro-",C1=CC=C(C(=C1)[N+](=O)[O-])SO,,,,,,
1792,151793,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione,7-amino-4-ethyl-4-hydroxy-, (4S)-",CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C(=C4)C=CC=C5N)O,,,,,,
1793,151794,"Urea, N-methyl-N-nitroso-N'-(3-pyridinylmethyl)-",CN(C(=O)NCC1=CN=CC=C1)N=O,,,,,,
1794,151795,"Urea, N-ethyl-N-nitroso-N'-(3-pyridinylmethyl)-, ethanedioate (1:1)",CCN(C(=O)NCC1=CN=CC=C1)N=O.C(=O)(C(=O)O)O,,,,,,
1795,151796,1-Ethyl-1-nitroso-3-(pyridin-3-ylmethyl)urea,CCN(C(=O)NCC1=CN=CC=C1)N=O,,,,,,
1796,151797,Vofatox 50,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-].COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-].C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,,,,,,
1797,151798,"Urea, N-(4-chlorophenyl)-N-nitroso-N'-(3-pyridinylmethyl)-",C1=CC(=CN=C1)CNC(=O)N(C2=CC=C(C=C2)Cl)N=O,,,,,,
1798,151799,CID 151799,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C(=O)C.CS(=O)(=O)O,,,,,,
1799,151800,CID 151800,COC1=C(C(=C2C(=C1)C[C@@H]3C(COC3=O)[C@H](C4=CC5=C(C=C42)OCO5)O)OC)OC,,,,,,
1800,151801,1-Methyl-4-phenyl-4-piperidinol propionate N-oxide,CCC(=O)OC1(CC[N+](CC1)(C)[O-])C2=CC=CC=C2,,,,,,
1801,151802,1-(2-Pyridinyl)benzotriazole,C1=CC=C2C(=C1)N=NN2C3=CC=CC=N3,,,,,,
1802,151803,N-Octanoyl-beta-D-glucosylamine,CCCCCCCC(=O)NC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
1803,151804,"2,2'-Thiobis-(4-methyl-6-alpha-phenylethylphenol)",CC1=CC(=C(C(=C1)SC2=CC(=CC(=C2O)C(C)C3=CC=CC=C3)C)O)C(C)C4=CC=CC=C4,,,,,,
1804,151805,"(2S,3S,4S)-2,3,4,6-tetrahydroxy-5-oxohexanoic acid",C(C(=O)[C@H]([C@@H]([C@@H](C(=O)O)O)O)O)O,,,,,,
1805,151806,Acetonyltrimethylammonium,CC(=O)C[N+](C)(C)C,,,,,,
1806,151807,"N,N',2-trimethylpropanediamide",CC(C(=O)NC)C(=O)NC,,,,,,
1807,151808,Benzyl (5-phenyloxazol-2-yl)carbamate,C1=CC=C(C=C1)COC(=O)NC2=NC=C(O2)C3=CC=CC=C3,,,,,,
1808,151809,3-Hydroxypropyl dihydrogen phosphate,C(CO)COP(=O)(O)O,,,,,,
1809,151810,Thymine hydrate,CC1C(NC(=O)NC1=O)O,,,,,,
1810,151811,6-Hydroxybenzothiazole,C1=CC2=C(C=C1O)SC=N2,,,,,,
1811,151812,"N-(2,6-Dichlorophenyl)anthranilic acid",C1=CC=C(C(=C1)C(=O)O)NC2=C(C=CC=C2Cl)Cl,,,,,,
1812,151813,Pentachloronitrosobenzene,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)N=O,,,,,,
1813,151814,"1,4-Di(2-thienyl)-1,4-butanedione",C1=CSC(=C1)C(=O)CCC(=O)C2=CC=CS2,,,,,,
1814,151815,4-Propyl-4-pentenoic acid,CCCC(=C)CCC(=O)O,,,,,,
1815,151816,"3,5-Dibromo-3'-isopropylthyronine",CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Br)C[C@@H](C(=O)O)N)Br)O,,,,,,
1816,151817,CID 151817,C[N+](C)(C)CC=CCOC(=O)NC1=CC(=CC=C1)Cl,,,,,,
1817,151818,Phosphorochloridic acid,OP(=O)(O)Cl,,,,,,
1818,151819,"3-(4-Hydroxy-3,5-diiodophenyl)propanoic acid",C1=C(C=C(C(=C1I)O)I)CCC(=O)O,,,,,,
1819,151820,CID 151820,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)[O-])C3=CC=CC=C3.[K+],,,,,,
1820,151821,Cis-ruthenium Chloride,CS(=O)C.CS(=O)C.CS(=O)C.CS(=O)C.[Cl-].[Cl-].[Ru+2],,,,,,
1821,151822,"Pregna-1,4-diene-20-carboxylic acid, 12-hydroxy-3-oxo-, (12alpha)-",CC([C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)O,,,,,,
1822,151823,5-Hydroxypyrazinamide,C1=C(N=CC(=O)N1)C(=O)N,,,,,,
1823,151824,"Phosphinic acid, dimethyl-, 3-nitrophenyl ester",CP(=O)(C)OC1=CC=CC(=C1)[N+](=O)[O-],,,,,,
1824,151825,"Pyridine, 3-tetradecyl-",CCCCCCCCCCCCCCC1=CN=CC=C1,,,,,,
1825,151826,"Quinoline, 5,6,7,8-tetrahydro-2-nonyl-",CCCCCCCCCC1=NC2=C(CCCC2)C=C1,,,,,,
1826,151827,"Pyridine, 3-dodecyl-",CCCCCCCCCCCCC1=CN=CC=C1,,,,,,
1827,151828,"10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, monohydrochloride",CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C.Cl,,,,,,
1828,151829,"3-(Acetyloxy)-15-[5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-4-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylic acid",CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)O)OC(=O)C)O)CC)OC)C(=O)OC)O,,,,,,
1829,151830,"Ethanamine, 2-(bis(2-chloroethyl)phosphinyl)-N,N-bis(2-chloroethyl)-, ethanedioate (1:1)",C(CP(=O)(CCCl)CCCl)N(CCCl)CCCl.C(=O)(C(=O)O)O,,,,,,
1830,151831,"2-[bis(2-chloroethyl)phosphoryl]-N,N-bis(2-chloroethyl)ethanamine",C(CP(=O)(CCCl)CCCl)N(CCCl)CCCl,,,,,,
1831,151832,Cresophene,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C.CC1=CC(=C(C=C1)C(C)C)O.C1=CC(=CC=C1O)Cl.C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,,,,,,
1832,151833,CID 151833,C[C@@H]1CC2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,,,,,,
1833,151834,"Sulfamic acid, ethyl-, methyl ester",CCNS(=O)(=O)OC,,,,,,
1834,151835,"Sulfamic acid, (1-methylethyl)-, methyl ester",CC(C)NS(=O)(=O)OC,,,,,,
1835,151836,CID 151836,C[C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)OC2CC(C(C(CC(=O)CC(CC(C(C=CC(=O)OC(CC(C(C=CC=CC=C2)O)C3C=CC=CCC(OC(=O)C=CC(C(CC(CC(=O)CC(C(C(CC=CC=C3)O)C(=O)O)O)O)O)O)C)C)O)O)O)O)C(=O)O)O)O)N)O,,,,,,
1836,151837,"3H-Imidazo(2,1-i)purine, 3-(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CN4C3=NC=C4)COP(=O)(O)O)O,,,,,,
1837,151838,"1,2-Dilauroyl-sn-glycerol",CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCC,,,,,,
1838,151839,"Gramicidin S, 5-(N5-acetyl-L-ornithine)-10",CC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N1)CC4=CC=CC=C4)C(C)(C)C)CCCNC(=O)C)C(C)C)CC5=CC=CC=C5)C(C)(C)C)CCCN,,,,,,
1839,151840,"Uridine, 2'-deoxy-, 4-(O-methyloxime)",CONC1=NC(=O)N(C=C1)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
1840,151841,"Quinoxaline, 2,6-dimethyl-",CC1=CC2=NC=C(N=C2C=C1)C,,,,,,
1841,151842,13-Hydroxydocosanoic acid,CCCCCCCCCC(CCCCCCCCCCCC(=O)O)O,,,,,,
1842,151843,"Platinum(2+), (2,2'-bipyridine-N,N')(1,2-ethanediamine-N,N')-, (SP-4-2)-, dinitrate",C1=CC=NC(=C1)C2=CC=CC=N2.C(CN)N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pt+2],,,,,,
1843,151844,"2,10-Dioxa-5,7-dithiaundecanedial, 5,5,7,7-tetraoxide",C(CS(=O)(=O)CS(=O)(=O)CCOC=O)OC=O,,,,,,
1844,151845,CID 151845,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCS(=O)(=O)[O-])O)O.[K+],,,,,,
1845,151846,"[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]methanesulfonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCS(=O)(=O)O)O)O,,,,,,
1846,151847,CID 151847,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCS(=O)(=O)[O-])O)O.[K+],,,,,,
1847,151848,"2-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]ethanesulfonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCS(=O)(=O)O)O)O,,,,,,
1848,151849,"Phenanthro(9,10-b)oxirene, 1a,9b-dihydro-3-methoxy-",COC1=CC2=C(C=C1)C3=CC=CC=C3C4C2O4,,,,,,
1849,151850,"Phenanthro(9,10-b)oxirene, 1a,9b-dihydro-4-methoxy-",COC1=CC2=C(C=C1)C3C(O3)C4=CC=CC=C42,,,,,,
1850,151851,"Guanidine, N-dodecyl-N-nitroso-, monoacetate",CCCCCCCCCCCCN(C(=N)N)N=O.CC(=O)[O-],,,,,,
1851,151852,1-Dodecyl-1-nitrosoguanidine,CCCCCCCCCCCCN(C(=N)N)N=O,,,,,,
1852,151853,"Quinoline, 5,8-dimethoxy-2-(2-nitrophenyl)-",COC1=C2C=CC(=NC2=C(C=C1)OC)C3=CC=CC=C3[N+](=O)[O-],,,,,,
1853,151854,"Quinoline, 6,8-dimethoxy-2-(2-nitrophenyl)-",COC1=CC(=C2C(=C1)C=CC(=N2)C3=CC=CC=C3[N+](=O)[O-])OC,,,,,,
1854,151855,"Quinoline, 6,8-dimethoxy-5-nitro-2-(2-nitrophenyl)-",COC1=CC(=C(C2=C1N=C(C=C2)C3=CC=CC=C3[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
1855,151856,"1,3-Dioxane, 5-(chloromethyl)-5-(iodomethyl)-",C1C(COCO1)(CCl)CI,,,,,,
1856,151857,"Methanesulfonic acid, (methylsulfonyl)-, methyl ester",COS(=O)(=O)CS(=O)(=O)C,,,,,,
1857,151858,"Methanimidamide, N',N'''-(9,10-dihydro-9,10-dioxo-2,6-anthracenediyl)bis(N,N-dimethyl-",CN(C)C=NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3)N=CN(C)C,,,,,,
1858,151859,"Pentanedioic acid, 2-(3,5-dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)-",C(=O)([O-])[O-].C(=O)([O-])[O-].OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[K+].[K+],,,,,,
1859,151860,CID 151860,C1=CC(=CC=C1C=C(C2=CC=C(O2)[N+](=O)[O-])S(=O)(=O)C(Cl)Cl)Cl,,,,,,
1860,151861,2-Fluoroacrolein,C=C(C=O)F,,,,,,
1861,151862,"Zinc, dichloro(4,4'-((1,2-dihydro-5,6-acenaphthylene)diimino)bis(phenol)-N,N')-, (T-4)-",C1CC2=CC=C(C3=C(C=CC1=C23)NC4=CC=C(C=C4)O)NC5=CC=C(C=C5)O.[Cl-].[Cl-].[Zn+2],,,,,,
1862,151863,"4-[[6-(4-Hydroxyanilino)-1,2-dihydroacenaphthylen-5-yl]amino]phenol",C1CC2=CC=C(C3=C(C=CC1=C23)NC4=CC=C(C=C4)O)NC5=CC=C(C=C5)O,,,,,,
1863,151864,5-(2-Chloroethyl)-2'-deoxycytidine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)CCCl)CO)O,,,,,,
1864,151865,"Benzene, pentachloro(2-chloroethenyl)-, (E)-",C1=CC(=C(C(=C1C(=C(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1865,151866,"4-(9-Acridinylimino)-3-methoxy-2,5-cyclohexadien-1-one",COC1=CC(=O)C=CC1=NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
1866,151867,1-Methyl-8-nitronaphthalene,CC1=C2C(=CC=C1)C=CC=C2[N+](=O)[O-],,,,,,
1867,151868,3-(4-Phenoxyphenyl)-1-phenylprop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC=C(C=C2)OC3=CC=CC=C3,,,,,,
1868,151869,1-Nitropyren-10-ol,C1=CC2=C3C(=C1)C=C(C4=C(C=CC(=C34)C=C2)[N+](=O)[O-])O,,,,,,
1869,151870,Ccris 5155,CC(C1=CC=CC=C1)N.CC(C1=CC=CC=C1)N.Cl[Pt]Cl,,,,,,
1870,151871,cis-Chloro(dimethylsulfoxide)(ethylenediamine)platinum chloride,CS(=O)CCl.C(CN)N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],,,,,,
1871,151872,Chloromethyl methyl sulfoxide,CS(=O)CCl,,,,,,
1872,151873,9-Amino-N-(2-(dimethylamino)ethyl)-2-acridinecarboxamide,CN(C)CCNC(=O)C1=CC2=C(C3=CC=CC=C3N=C2C=C1)N,,,,,,
1873,151874,9-Amino-N-(2-(dimethylamino)ethyl)-3-acridinecarboxamide,CN(C)CCNC(=O)C1=CC2=NC3=CC=CC=C3C(=C2C=C1)N,,,,,,
1874,151875,"4-[2-(4,4-Dimethyl-2,3-dihydrothiochromen-6-yl)prop-1-enyl]benzoic acid",CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(C=C2)SCCC3(C)C,,,,,,
1875,151876,"cis-Dichlorobis(3,5-dimethylpyridine)platinum",CC1=CC(=CN=C1)C.CC1=CC(=CN=C1)C.Cl[Pt]Cl,,,,,,
1876,151877,"3,8-Dimethyl-3H-imidazo(4,5-f)quinoxaline",CC1=CN=C2C=CC3=C(C2=N1)N=CN3C,,,,,,
1877,151878,"N6,3-Dimethylquinoxaline-5,6-diamine",CC1=CN=C2C=CC(=C(C2=N1)N)NC,,,,,,
1878,151879,"3,4-Dimethyl-3H-imidazo(4,5-f)quinoline",CC1=CC2=C(C=CC=N2)C3=C1N(C=N3)C,,,,,,
1879,151880,"1-(3-Nitroso-1,3-thiazolidin-2-yl)butane-1,2,3,4-tetrol",C1CSC(N1N=O)C(C(C(CO)O)O)O,,,,,,
1880,151881,"2-(1,2,3,4-Tetrahydroxypentyl)-N-nitrosothiazolidine",CC(C(C(C(C1N(CCS1)N=O)O)O)O)O,,,,,,
1881,151882,"2-(1,2,3,4,5-Pentahydroxypentyl)-N-nitrosothiazolidine-4-carboxylic acid",C1C(N(C(S1)C(C(C(C(CO)O)O)O)O)N=O)C(=O)O,,,,,,
1882,151883,3-(2-hydroxyethylamino)-N-oxopropanamide,C(CNCCO)C(=O)N=O,,,,,,
1883,151884,Ccris 5591,CC(=O)CNCC(C(N=O)O)O,,,,,,
1884,151885,"Actinomycin D,2-deamino-2-hydroxy-",CC1C(OC(=O)C(N(C(=O)CN(C(=O)C2CCCN2C(=O)C(NC1=O)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=O)C(=C5N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
1885,151886,"2-(N,N-diethylamino)-diazenolate-2-oxide sodium",CCN(CC)N(N=O)[O-].[Na+],,,,,,
1886,151887,"2-Methyl-1,3,5-trihydroxyanthraquinone",CC1=C(C=C2C(=C1O)C(=O)C3=C(C2=O)C(=CC=C3)O)O,,,,,,
1887,151888,4-Methyl-N-(((5-nitro-2-thiazolyl)amino)carbonyl)benzenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2=NC=C(S2)[N+](=O)[O-],,,,,,
1888,151889,Acetic acid--N-ethyl-N-(1-hydroxyethyl)nitramide (1/1),CCN(C(C)O)[N+](=O)[O-].CC(=O)O,,,,,,
1889,151890,N-ethyl-N-(1-hydroxyethyl)nitramide,CCN(C(C)O)[N+](=O)[O-],,,,,,
1890,151891,"Platinum, dichloro(2,3,6,7-tetrahydro-1H,5H-benzo(i,j)quinolizine)-",C1CC2=C3C(=CC=C2)CCCN3C1.Cl[Pt]Cl,,,,,,
1891,151892,4-[2-(3-Chlorophenyl)ethenyl]benzenamine,C1=CC(=CC(=C1)Cl)C=CC2=CC=C(C=C2)N,,,,,,
1892,151893,"5,5b-Dihydrobenzo[7,8]aceanthryleno[1,2-b]oxirene",C1C2=CC=CC3=C4C(=C(C23)C5=C1C6=CC=CC=C6C=C5)O4,,,,,,
1893,151894,"Benz(e)aceanthrylene-5,6-oxide",C1C2=CC=CC=C2C3=C4C(=C5C3C1=C6C=CC=CC6=C5)O4,,,,,,
1894,151895,"19-Oxahexacyclo[11.7.1.02,11.03,8.017,21.018,20]henicosa-1(20),2(11),3,5,7,9,13,15,17-nonaene",C1C2=C(C3=CC=CC=C3C=C2)C4=C5C(=C6C4C1=CC=C6)O5,,,,,,
1895,151896,Sabarubicin hydrochloride,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@@H](O[C@H](C[C@@H]2O)O[C@H]3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O.Cl,,,,,,
1896,151897,Sabarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@@H](O[C@H](C[C@@H]2O)O[C@H]3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O,,,,,,
1897,151898,[(4-Bromophenyl)methylideneamino]urea,C1=CC(=CC=C1C=NNC(=O)N)Br,,,,,,
1898,151899,"6-Hydroxy-2,2,5,7-tetramethylchroman",CC1=CC2=C(CCC(O2)(C)C)C(=C1O)C,,,,,,
1899,151900,4-Methylthioamphetamine,CC(CC1=CC=C(C=C1)SC)N,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
1900,151901,CID 151901,CC(C)COC(=NC)S,,,,,,
1901,151902,2-Phenyl-3(2H)-pyridazinone,C1=CC=C(C=C1)N2C(=O)C=CC=N2,,,,,,
1902,151903,"2,2,7,8-Tetramethyl-6-chromanol",CC1=C(C=C2CCC(OC2=C1C)(C)C)O,,,,,,
1903,151904,"17-Hydroxy-4,6,8(14)-pregnatriene-3,20-dione",CC(=O)[C@]1(CCC2=C3C=CC4=CC(=O)CC[C@@]4([C@H]3CC[C@@]21C)C)O,,,,,,
1904,151905,"Pyridinium,1,1'-[1,4-phenylenebis(methylene)]bis-, dibromide (9CI)",C1=CC=[N+](C=C1)CC2=CC=C(C=C2)C[N+]3=CC=CC=C3,,,,,,
1905,151906,CID 151906,C1=NC2=NC=NC2=C(N1)CBr,,,,,,
1906,151907,4-Hydroxypipecolic acid,C1CNC(CC1O)C(=O)O,,,,,,
1907,151908,Triethylphosphine gold bromide,CCP(CC)CC.[Br-].[Br-].[Br-].[Au+3],,,,,,
1908,151909,Triethylphosphine gold nitrate,CCP(CC)CC.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Au+3],,,,,,
1909,151910,Zinc glycinate,C(C(=O)[O-])N.C(C(=O)[O-])N.[Zn+2],,,,,,
1910,151911,"2,4,5-Trichloromandelic acid",C1=C(C(=CC(=C1Cl)Cl)Cl)C(C(=O)O)O,,,,,,
1911,151912,"2-(2,4,5-Trichlorophenyl)ethan-1-ol",C1=C(C(=CC(=C1Cl)Cl)Cl)CCO,,,,,,
1912,151913,3-Hydroxyadipic acid,C(CC(=O)O)C(CC(=O)O)O,,,,,,
1913,151914,3-Phosphono-2-imino-1-methyl-4-oxoimidazolidine,CN1CC(=O)N(C1=N)P(=O)(O)O,,,,,,
1914,151915,"2,4,6-Tribromo-3-hydroxybenzoic acid",C1=C(C(=C(C(=C1Br)O)Br)C(=O)O)Br,,,,,,
1915,151916,5-Phenylisoxazole-3-carboxylic acid,C1=CC=C(C=C1)C2=CC(=NO2)C(=O)O,,,,,,
1916,151917,Carbobenzoxyprolyl-leucyl-glycinamide,CC(C)C[C@@H](C(=O)NCC(=O)NC(=O)OCC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2,,,,,,
1917,151918,"N,N,5-Trimethylfurfurylamine",CC1=CC=C(O1)CN(C)C,,,,,,
1918,151919,"4'-(Dimethylamino)-2,2,2-tris(4-(dimethylamino)phenyl)acetophenone",CN(C)C1=CC=C(C=C1)C(=O)C(C2=CC=C(C=C2)N(C)C)(C3=CC=C(C=C3)N(C)C)C4=CC=C(C=C4)N(C)C,,,,,,
1919,151920,"3,5-Dinitrophenyl phosphate",C1=C(C=C(C=C1[N+](=O)[O-])OP(=O)(O)O)[N+](=O)[O-],,,,,,
1920,151921,6-Hydroxyestriol,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CC(C4=C3C=CC(=C4)O)O,,,,,,
1921,151922,12-Phenyldodecanoic acid,C1=CC=C(C=C1)CCCCCCCCCCCC(=O)O,,,,,,
1922,151923,{[1-(Pyridin-2-yl)ethylidene]amino}urea,CC(=NNC(=O)N)C1=CC=CC=N1,,,,,,
1923,151924,"3-Methoxyestra-1,3,5(10)-triene",C[C@@]12CCC[C@H]1[C@@H]3CCC4=C([C@H]3CC2)C=CC(=C4)OC,,,,,,
1924,151925,Cyanotriphenylborate,[B-](C#N)(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1925,151926,Trimethyl(2-phosphonatoethyl)azanium,C[N+](C)(C)CCP(=O)([O-])[O-],,,,,,
1926,151927,2-Trimethylaminoethylphosphonic acid,C[N+](C)(C)CCP(=O)(O)O,,,,,,
1927,151928,(-)-Menthyl chloroformate,CC1CCC(C(C1)OC(=O)Cl)C(C)C,,,,,,
1928,151929,Nitrosium tetrafluoroborate,[B-](F)(F)(F)F.[NH2+]=O,,,,,,
1929,151930,Phenyl di-n-pentylphosphinate,CCCCCP(=O)(CCCCC)OC1=CC=CC=C1,,,,,,
1930,151931,Tetrakis(p-chlorophenyl) boronanion,[B-](C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl,,,,,,
1931,151932,Chromium picolinate,C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].[Cr+3],,,,,,
1932,151933,2-Chloro-2-deoxy-D-glucose,C([C@H]([C@H]([C@@H]([C@H](C=O)Cl)O)O)O)O,,,,,,
1933,151934,"D-Ribulose-1,5-diphosphate sodium salt hydrate",[C@@H]([C@@H](C(O)OP(=O)(O)O)O)([C@H](C(=O)OP(=O)(O)O)O)O,,,,,,
1934,151935,CID 151935,C1=CC(=NC(=C1)S)C(=O)O,,,,,,
1935,151936,4-(Methylsulfinyl)phenol,CS(=O)C1=CC=C(C=C1)O,,,,,,
1936,151937,Dinickel hexacyanoferrate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2].[Ni+2].[Ni+2],,,,,,
1937,151938,3-Oxo-2-phosphonooxypropanoic acid,C(=O)C(C(=O)O)OP(=O)(O)O,,,,,,
1938,151939,"3,4,5-Trihydroxy-6-(hydroxymethyl)-2-piperidone",C([C@@H]1[C@H]([C@@H]([C@H](C(=O)N1)O)O)O)O,,,['Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)'],,,
1939,151940,4-Nitrophenylglyoxylic acid,C1=CC(=CC=C1C(=O)C(=O)O)[N+](=O)[O-],,,,,,
1940,151941,"[(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-tris(pyridine-3-carbonyloxy)pentyl] pyridine-3-carboxylate",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](COC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5)OC(=O)C6=CN=CC=C6)OC(=O)C7=CN=CC=C7,,,,,,
1941,151942,Riboflavin 5'-pyrophosphate,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](COP(=O)(O)OP(=O)(O)O)O)O)O,,,,,,
1942,151943,"5-(8,11,14-Pentadecatrienyl)-1,3-benzenediol",C=CCC=CCC=CCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
1943,151944,"2,4,6-Trinitrophenyl-lysine",C1=C(C=C(C(=C1[N+](=O)[O-])N[C@@H](CCCCN)C(=O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1944,151945,3-Decynoyl-N-acetylcysteamine,CCCCCCC#CCC(=O)N(CCS)C(=O)C,,,,,,
1945,151946,"11-Hydroxypregnane-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4[C@@]3(CCC(=O)C4)C)O)C,,,,,,
1946,151947,"3,4-Dichlorophenylbiguanide",C1=CC(=C(C=C1N=C(N)N=C(N)N)Cl)Cl,,,,,,
1947,151948,Benzenesulfonyloxybenzenesulfonic acid,C1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC=C2S(=O)(=O)O,,,,,,
1948,151949,Dimethyl-di-(N-phenylaminophenoxy)silane,C[Si](C)(OC1=CC=CC=C1NC2=CC=CC=C2)OC3=CC=CC=C3NC4=CC=CC=C4,,,,,,
1949,151950,5-Iodonicotinic acid,C1=C(C=NC=C1I)C(=O)O,,,,,,
1950,151951,"3,7,11-Trimethyldodeca-2,6,10-trienyl dihydrogen phosphate",CC(=CCCC(=CCCC(=CCOP(=O)(O)O)C)C)C,,,,,,
1951,151952,Phenylalanine anilide,C1=CC=C(C=C1)C[C@@H](C(=O)NC2=CC=CC=C2)N,,,,,,
1952,151953,"3-Amino-3,6-didesoxyglucose",C[C@H]([C@H]([C@@H]([C@H](C=O)O)N)O)O,,,,,,
1953,151954,"2,4,5-Trimethoxyphenethylamine",COC1=CC(=C(C=C1CCN)OC)OC,,,,,,
1954,151955,CID 151955,CCCCCCCC(CC(=O)OSN(CCS)C(=O)C)O,,,,,,
1955,151956,Arg-arg,C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)CN=C(N)N,,,,,,
1956,151957,Arginylarginine 2-naphthylamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
1957,151958,"2,5-Cyclohexadiene-1,4-dione, 3-(acetyloxy)-2,5-bis(4-(acetyloxy)phenyl)-",CC(=O)OC1=CC=C(C=C1)C2=CC(=O)C(=C(C2=O)OC(=O)C)C3=CC=C(C=C3)OC(=O)C,,,,,,
1958,151959,CID 151959,CCCCOC1=CC=C(C=C1)CN2CC(C(=O)N=C2S)C,,,,,,
1959,151960,CID 151960,CC1CN(C(=NC1=O)S)CC2=CC=C(C=C2)OC(C)C,,,,,,
1960,151961,Nitroso-bux-ten,CCCC(C)C1=CC=CC(=C1)CN(C(=O)[O-])N=O.CCC(CC)C1=CC(=CC=C1)OC(=O)N(C)N=O,,,,,,
1961,151962,Nitroso-[(3-pentan-2-ylphenyl)methyl]carbamic acid,CCCC(C)C1=CC=CC(=C1)CN(C(=O)O)N=O,,,,,,
1962,151963,N-[4-(3-oxo-3-phenylprop-1-en-1-yl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2,,,,,,
1963,151964,CID 151964,CCC(=NN=C(N)N)C=NN=C(N)N.OS(=O)(=O)O,,,,,,
1964,151965,2-[1-(Diaminomethylidenehydrazinylidene)butan-2-ylideneamino]guanidine,CCC(=NN=C(N)N)C=NN=C(N)N,,,,,,
1965,151966,"Acetic acid, (hydroxymethoxyphosphinyl)-, monoammonium salt",COP(=O)(CC(=O)[O-])O.[NH4+],,,,,,
1966,151967,2-[Hydroxy(methoxy)phosphoryl]acetic acid,COP(=O)(CC(=O)O)O,,,,,,
1967,151968,"Acetic acid, (hydroxypropoxyphosphinyl)-, monoammonium salt",CCCOP(=O)(CC(=O)[O-])O.[NH4+],,,,,,
1968,151969,2-[Hydroxy(propoxy)phosphoryl]acetic acid,CCCOP(=O)(CC(=O)O)O,,,,,,
1969,151970,"Acetic acid, ((hexyloxy)hydroxyphosphinyl)-, monoammonium salt",CCCCCCOP(=O)(CC(=O)[O-])O.[NH4+],,,,,,
1970,151971,2-[Hexoxy(hydroxy)phosphoryl]acetic acid,CCCCCCOP(=O)(CC(=O)O)O,,,,,,
1971,151972,"Benz(k)acephenanthrylene-4,5-oxide",C1C2=CC3=CC=CC=C3C=C2C4=CC=CC5=C6C(C1=C54)O6,,,,,,
1972,151973,"3,4-Dichloro-2(5H)-furanone",C1C(=C(C(=O)O1)Cl)Cl,,,,,,
1973,151974,"Benz(j)aceanthrylene-9,10-diol, 9,10-dihydro-, trans-",C1=CC2=CC3=C(C=CC4=C3C=C[C@@H]([C@H]4O)O)C5=C2C(=C1)C=C5,,,,,,
1974,151975,Benz(j)aceanthrylen-10-ol,C1=CC2=CC3=C(C=CC4=C3C=CC=C4O)C5=C2C(=C1)C=C5,,,,,,
1975,151976,"1,2,3,9,10,10a-Hexahydrophenanthrene",C1CC=C2C(C1)CCC3=CC=CC=C32,,,,,,
1976,151977,"(1R,2S,3S,4R)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(c,h)acridine",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@H]([C@@H]([C@H]6[C@@H]5O6)O)O)N=C32,,,,,,
1977,151978,Damvar,C(CCC(=O)O)CC1=C(N=C(NC1=O)N)O,,,,,,
1978,151979,"(1S,2R,3R,4S)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(c,h)acridine",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@@H]([C@H]([C@@H]6[C@H]5O6)O)O)N=C32,,,,,,
1979,151980,CID 151980,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2)OCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
1980,151981,3-[3-Hydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]propane-1-sulfonic acid,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2)OCCCS(=O)(=O)O)O)O,,,,,,
1981,151982,"(1S,2R,3S,4R)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(c,h)acridine",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@H]([C@@H]([C@@H]6[C@H]5O6)O)O)N=C32,,,,,,
1982,151983,"2-(2,4-Dichlorophenyl)phenol",C1=CC=C(C(=C1)C2=C(C=C(C=C2)Cl)Cl)O,,,,,,
1983,151984,"(1R,2S,3R,4S)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(c,h)acridine",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@@H]([C@H]([C@H]6[C@@H]5O6)O)O)N=C32,,,,,,
1984,151985,"Benz(c)oxireno(5,6)benz(1,2-h)acridine, 1a,2,3,13c-tetrahydro-, (1aR)-",C1CC2=C([C@H]3[C@@H]1O3)C4=C(C=C2)C=C5C=CC6=CC=CC=C6C5=N4,,,,,,
1985,151986,"(+)-(1R,2S)-1,2-Epoxy-1,2,3,4-tetrahydrodibenz(c,h)acridine",C1CC2=C([C@@H]3[C@H]1O3)C4=C(C=C2)C=C5C=CC6=CC=CC=C6C5=N4,,,,,,
1986,151987,"1-(3,5-Xylylazo)-2-naphthol",CC1=CC(=CC(=C1)N=NC2=C(C=CC3=CC=CC=C32)O)C,,,,,,
1987,151988,"10-Methylacenaphtho[1,2-b]quinoline",CC1=CC2=CC3=C(C4=CC=CC5=C4C3=CC=C5)N=C2C=C1,,,,,,
1988,151989,6-Chrysenyl isothiocyanate,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)N=C=S,,,,,,
1989,151990,"Benz(a)anthracene, 7-(methoxymethyl)-",COCC1=C2C=CC3=CC=CC=C3C2=CC4=CC=CC=C41,,,,,,
1990,151991,"1,2-Dibutylhydrazine oxalate",CCCCNNCCCC.C(=O)(C(=O)O)O,,,,,,
1991,151992,"Acetamide, N-3-dibenzothienyl-, S,S-dioxide",CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3S2(=O)=O,,,,,,
1992,151993,"(1,2-Cyclohexanediamine)hydroxy platinum",C1CCC(C(C1)N)N.O.O.[Pt],,,,,,
1993,151994,"1-Methoxypenta-1,3-diene",CC=CC=COC,,,,,,
1994,151995,"2-(Acetoxymethyl)-1,3-dihydroxyanthraquinone",CC(=O)OCC1=C(C=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
1995,151996,"Ferric ethylenediamine N,N'-diacetate",C(CNCC(=O)[O-])NCC(=O)[O-].C(CNCC(=O)[O-])NCC(=O)[O-].C(CNCC(=O)[O-])NCC(=O)[O-].[Fe+3].[Fe+3],,,,,,
1996,151997,3-Nitrodibenzothiophene,C1=CC=C2C(=C1)C3=C(S2)C=C(C=C3)[N+](=O)[O-],,,,,,
1997,151998,3-Nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=C(C=C4)[N+](=O)[O-],,,,,,
1998,151999,"12-Nitroindeno(1,2,3-cd)pyrene",C1=CC2=C3C(=C1)C=C4C5=C(C6=C4C3=C(C=C2)C=C6)C(=CC=C5)[N+](=O)[O-],,,,,,
1999,152000,CID 152000,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
2000,152001,"4-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]butane-1-sulfonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCCS(=O)(=O)O)O)O,,,,,,
2001,152002,CID 152002,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OC)OCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
2002,152003,3-[3-Hydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]-5-methoxyphenoxy]propane-1-sulfonic acid,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OC)OCCCS(=O)(=O)O)O)O,,,,,,
2003,152004,CID 152004,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OCC3=CC=CC=C3)OCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
2004,152005,3-[3-Hydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]-5-phenylmethoxyphenoxy]propane-1-sulfonic acid,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OCC3=CC=CC=C3)OCCCS(=O)(=O)O)O)O,,,,,,
2005,152006,Ccris 2984,C1=C[C@@H]2[C@@H](O2)[C@@H]([C@H]1O)O,,,,,,
2006,152007,CID 152007,CC(=O)N=C1C=CC2=NC3=CC=CC=C3C2=C1N(O)O,,,,,,
2007,152008,CID 152008,CC(=O)N=C1C=C2C3=CC=CC=C3N=C2C=C1N(O)O,,,,,,
2008,152009,N-(4-Bromophenyl)-N-hydroxyformamide,C1=CC(=CC=C1N(C=O)O)Br,,,,,,
2009,152010,N-(4-Fluorophenyl)-N-hydroxyformamide,C1=CC(=CC=C1N(C=O)O)F,,,,,,
2010,152011,(Hypoxanthine)pentaammineruthenium(3+) trichloride,C12=C(N=C(N=C1ON)N)N=C([N+]2(N)N)N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
2011,152012,"O-(2,7,7,8-tetraaminopurin-7-ium-6-yl)hydroxylamine",C12=C(N=C(N=C1ON)N)N=C([N+]2(N)N)N,,,,,,
2012,152013,N-(3-Chlorophenyl)-N-hydroxyformamide,C1=CC(=CC(=C1)Cl)N(C=O)O,,,,,,
2013,152014,"Z-Methyl-O,N,N-azoxyethane",CCN=[N+](C)[O-],,,,,,
2014,152015,"2,7,9-Trimethylfluorene",CC1C2=C(C=CC(=C2)C)C3=C1C=C(C=C3)C,,,,,,
2015,152016,Ccris 3572,C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C(=O)C6=C(C5=C4N3)O6)O,,,,,,
2016,152017,4-(2-(4-Methylphenyl)ethenyl)aniline,CC1=CC=C(C=C1)C=CC2=CC=C(C=C2)N,,,,,,
2017,152018,"5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 3-butoxy-1,2,3,10,11,11a-hexahydro-8-hydroxy-7-methoxy-, (3S-trans)-",CCCCO[C@H]1CC[C@@H]2N1C(=O)C3=CC(=C(C=C3NC2)O)OC,,,,,,
2018,152019,"3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C5C(O5)C(C4O)O,,,,,,
2019,152020,5-(2-amino-1-hydroxybutyl)-8-hydroxy-1H-quinolin-2-one,CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)N,,,,,,
2020,152021,(N-Ethylcarbamoylhydroxymethyl)furan,CCNC(=O)OCC1=CC=CO1,,,,,,
2021,152022,CID 152022,CN=NC(=O)C1=C2C(=NC=C1)C=CC=C2N(O)O,,,,,,
2022,152023,"7,8-Dihydroxy-9,10-epoxy-benzo[a]pyrene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6=C(O6)C(=C5O)O)C=C2,,,,,"['4-Oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),3(5),6,9,11,13(21),14,16,18-decaene-6,7-diol is a known human metabolite of benzo[a]pyrene-7,8-diol.']",
2023,152024,4'-Deoxydaunomycin,C[C@@H]1C[C@@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N.Cl,,,,,,
2024,152025,"(7S,9S)-9-acetyl-7-[(2R,4S,6R)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@@H]1C[C@@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N,,,,,,
2025,152026,"2-(4-Nitrophenyl)-1H-imidazo(4,5-b)pyridine",C1=CC2=C(N=C1)N=C(N2)C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
2026,152027,"2-(3-Nitrophenyl)-1H-imidazo(4,5-b)pyridine",C1=CC(=CC(=C1)[N+](=O)[O-])C2=NC3=C(N2)C=CC=N3,,,,,,
2027,152028,"1-Propanesulfonic acid, 3,3'-((5-hydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)-1,3-phenylene)bis(oxy))bis-, dipotassium salt",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OCCCS(=O)(=O)[O-])OCCCS(=O)(=O)[O-])O)O.[K+].[K+],,,,,,
2028,152029,3-[3-Hydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]-5-(3-sulfopropoxy)phenoxy]propane-1-sulfonic acid,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2OCCCS(=O)(=O)O)OCCCS(=O)(=O)O)O)O,,,,,,
2029,152030,Carbetamide-dimefuron mixt.,CCNC(=O)[C@@H](C)OC(=O)NC1=CC=CC=C1.CC(C)(C)C1=NN(C(=O)O1)C2=C(C=C(C=C2)NC(=O)N(C)C)Cl,,,,,,
2030,152031,Carbetamex,CCNC(=O)[C@@H](C)OC(=O)NC1=CC=CC=C1,,,,,,
2031,152032,"4H-Pyrano(3,2-c)quinoline-2-carboxylic acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-",CC1=C(C2=C(C=C1)C3=C(C(=O)C=C(O3)C(=O)O)C(=O)N2)C,,,,,,
2032,152033,"Ethyl 9-(2,4-dimethylthiophen-3-yl)-3,7-dimethylnona-2,4,6,8-tetraenoate",CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(SC=C1C)C,,,,,,
2033,152034,1-Isoamyl-3-isobutylxanthine,CC(C)CCN1C(=O)C2=C(N=CN2)N(C1=O)CC(C)C,,,,,,
2034,152035,Esorubicin hydrochloride,C[C@H]1C[C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N.Cl,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
2035,152036,Esorubicin,C[C@H]1C[C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
2036,152037,Manganese(III) pyrophosphate,[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[Mn+3].[Mn+3].[Mn+3].[Mn+3],,,,,,
2037,152038,"1(2H)-Pyrimidinecarboxamide, 5-fluoro-3,4-dihydro-2,4-dioxo-N-pentyl-",CCCCCNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
2038,152039,"1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-heptyl-3,4-dihydro-2,4-dioxo-",CCCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
2039,152040,"1H-Indazol-4-amine, N-(4,5-dihydro-2-thiazolyl)-1-methyl-",CN1C2=CC=CC(=C2C=N1)NC3=NCCS3,,,,,,
2040,152041,S-(1-Phenyl-2-hydroxyethyl)glutathione,C1=CC=C(C=C1)C(CO)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
2041,152042,"1,2-Benzenedicarboxylic acid, decyl-, dioctyl ester",CCCCCCCCCCC1=C(C(=CC=C1)C(=O)OCCCCCCCC)C(=O)OCCCCCCCC,,,,,,
2042,152043,"2-Propynoic acid, 5-nitro-2-furanyl ester",C#CC(=O)OC1=CC=C(O1)[N+](=O)[O-],,,,,,
2043,152044,2-Chloro-N-(2-methoxyethyl)-N-(3-methylphenyl)acetamide,CC1=CC(=CC=C1)N(CCOC)C(=O)CCl,,,,,,
2044,152045,2-Chloro-N-(2-methoxyethyl)-N-(3-methoxyphenyl)acetamide,COCCN(C1=CC(=CC=C1)OC)C(=O)CCl,,,,,,
2045,152046,2-Chloro-N-(2-methoxyethyl)-N-(4-methoxyphenyl)acetamide,COCCN(C1=CC=C(C=C1)OC)C(=O)CCl,,,,,,
2046,152047,"2-Pyrimidinamine, 5-methyl-4-(3,4,5-trimethoxyphenyl)-",CC1=CN=C(N=C1C2=CC(=C(C(=C2)OC)OC)OC)N,,,,,,
2047,152048,CID 152048,CC1=NC2=CC(=CC(=O)C2=N1)N(O)O,,,,,,
2048,152049,"Benz(a)anthracene-7-methanol, 4-methoxy-12-methyl-",CC1=C2C3=C(C=CC2=C(C4=CC=CC=C14)CO)C(=CC=C3)OC,,,,,,
2049,152050,"Benz(a)anthracene-7-methanol, 5-methoxy-12-methyl-",CC1=C2C3=CC=CC=C3C(=CC2=C(C4=CC=CC=C14)CO)OC,,,,,,
2050,152051,"2-Pyrimidinamine, 5-(4-methoxyphenyl)-4,6-dimethyl-",CC1=C(C(=NC(=N1)N)C)C2=CC=C(C=C2)OC,,,,,,
2051,152052,"1,4-Cyclohexadiene-1,2-diacetic acid, 4,5-dimethyl-3,6-dioxo-, diphenyl ester",CC1=C(C(=O)C(=C(C1=O)CC(=O)OC2=CC=CC=C2)CC(=O)OC3=CC=CC=C3)C,,,,,,
2052,152053,"2-(Dimethylamino)ethyl 3,4-bis(bromomethyl)benzoate",CN(C)CCOC(=O)C1=CC(=C(C=C1)CBr)CBr,,,,,,
2053,152054,2-(Dimethylamino)ethyl 3-(bromomethyl)benzoate,CN(C)CCOC(=O)C1=CC=CC(=C1)CBr,,,,,,
2054,152055,"Benzoic acid, 4-formyl-, 2-(dimethylamino)ethyl ester",CN(C)CCOC(=O)C1=CC=C(C=C1)C=O,,,,,,
2055,152056,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(acetyloxy)-2,3-dihydro-",CC(=O)OC1=C2C(=CC3=C1OCC3)C=CC(=O)O2,,,,,,
2056,152057,"2-Pyridinamine, N-(10-methyl-9(10H)-acridinylidene)-",CN1C2=CC=CC=C2C(=NC3=CC=CC=N3)C4=CC=CC=C41,,,,,,
2057,152058,"Benzenamine, N-(10-methyl-9(10H)-acridinylidene)-",CN1C2=CC=CC=C2C(=NC3=CC=CC=C3)C4=CC=CC=C41,,,,,,
2058,152059,"2',3'-Dihydro-phytomenadione",CC1=C(C(=O)C2=CC=CC=C2C1=O)CCC(C)CCCC(C)CCCC(C)CCCC(C)C,,,,,,
2059,152060,CID 152060,C1=C(C=C(C2=NC(=O)N=C21)O)N(O)O,,,,,,
2060,152061,"N,N'-Bis(2,4-dinitrophenyl)-N,N'-dimeth yl-1,2-ethanediamine",CN(CCN(C)C1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2061,152062,CID 152062,C1=C(C=C2C(=NN=N2)C1=O)N(O)O,,,,,,
2062,152063,"3,7,8,9-Tetrahydro-8-hydroxy-1,3,7,9-tetramethyl-1H-purine-2,6-dione",CN1C(N(C2=C1C(=O)N(C(=O)N2C)C)C)O,,,,,,
2063,152064,"2,4(1H,3H)-Pyrimidinedione, 3-hexyl-",CCCCCCN1C(=O)C=CNC1=O,,,,,,
2064,152065,"2-Hexanethiol, 1-amino-",CCCCC(CN)S,,,,,,
2065,152066,1-Amino-2-pentanethiol,CCCC(CN)S,,,,,,
2066,152067,"1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxyethyl)-8-(hydroxymethyl)-1,3-dimethyl-",CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)CO)CCO,,,,,,
2067,152068,"Aziridine, 1,1'-((1-methylethyl)phosphinylidene)bis-",CC(C)P(N1CC1)N2CC2,,,,,,
2068,152069,"6-Amino-9-beta-D-glucopyranosyl-1,9-dihydro-2H-purin-2-one",C1=NC2=C(NC(=O)N=C2N1[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)N,,,,,,
2069,152070,"1H-Purine-2,6-dione, 7-(2-(diethylamino)ethyl)-3,7-dihydro-8-(hydroxymethyl)-1,3-dimethyl-",CCN(CC)CCN1C(=NC2=C1C(=O)N(C(=O)N2C)C)CO,,,,,,
2070,152071,Benz(c)acridine-10-carboxylic acid,C1=CC=C2C(=C1)C=CC3=C2N=C4C=C(C=CC4=C3)C(=O)O,,,,,,
2071,152072,"Aziridine, 1,1',1''-(1,3,5-naphthalenetriyltris(sulfonyl))tris-",C1CN1S(=O)(=O)C2=CC=CC3=C2C=C(C=C3S(=O)(=O)N4CC4)S(=O)(=O)N5CC5,,,,,,
2072,152073,"4-Quinolinethiol, 1-oxide, sodium salt",C1=CC=C2C(=C1)C(=S)C=CN2[O-].[Na+],,,,,,
2073,152074,1-Oxidoquinoline-4-thione,C1=CC=C2C(=C1)C(=S)C=CN2[O-],,,,,,
2074,152075,"Ethyl ((methoxy(2,4,5-trichlorophenoxy)phosphinyl)oxy)acetate",CCOC(=O)COP(=O)(OC)OC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
2075,152076,"1,3,5-Triazine, 2,4,6-tris(1-azetidinyl)-",C1CN(C1)C2=NC(=NC(=N2)N3CCC3)N4CCC4,,,,,,
2076,152077,"1(2H)-Pyrimidinecarboxamide, N-(1,1-dimethylethyl)-5-fluoro-3,4-dihydro-2,4-dioxo-",CC(C)(C)NC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
2077,152078,"Aziridine, 1,1'-(1,4-butanediylbis(sulfonyl))bis(2-methyl-",CC1CN1S(=O)(=O)CCCCS(=O)(=O)N2CC2C,,,,,,
2078,152079,"Aziridine, 1,1'-(1,5-pentanediylbis(sulfonyl))bis-",C1CN1S(=O)(=O)CCCCCS(=O)(=O)N2CC2,,,,,,
2079,152080,"3,6-Acridinediamine, N-propyl-",CCCNC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N,,,,,,
2080,152081,"1,6-Hexanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-].Cl.Cl,,,,,,
2081,152082,"N,N'-bis(2-methyl-7-nitroquinolin-4-yl)hexane-1,6-diamine",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-],,,,,,
2082,152083,"N,N'-Bis(2-methyl-7-nitro-4-quinolinyl)-1,8-octanediamine dihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-].Cl.Cl,,,,,,
2083,152084,"N,N'-bis(2-methyl-7-nitroquinolin-4-yl)octane-1,8-diamine",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-],,,,,,
2084,152085,"1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-].Cl.Cl,,,,,,
2085,152086,"N,N'-bis(2-methyl-7-nitro-4-quinolyl)heptane-1,7-diamine",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-],,,,,,
2086,152087,"1,3-Propanediamine, N-(2-methyl-7-nitro-4-quinolinyl)-N'-(3-((2-methyl-7-nitro-4-quinolinyl)amino)propyl)-, dihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-].Cl.Cl,,,,,,
2087,152088,"N'-(2-methyl-7-nitroquinolin-4-yl)-N-[3-[(2-methyl-7-nitroquinolin-4-yl)amino]propyl]propane-1,3-diamine",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-],,,,,,
2088,152089,"1,4-Butanediamine, N-(2-methyl-7-nitro-4-quinolinyl)-N'-(3-((2-methyl-7-nitro-4-quinolinyl)amino)propyl)-, dihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-].Cl.Cl,,,,,,
2089,152090,"N'-(2-methyl-7-nitroquinolin-4-yl)-N-[3-[(2-methyl-7-nitroquinolin-4-yl)amino]propyl]butane-1,4-diamine",CC1=CC(=C2C=CC(=CC2=N1)[N+](=O)[O-])NCCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)[N+](=O)[O-],,,,,,
2090,152091,"2,2-Dichloro-1,1-dihydroxyethanephosphonic acid methyl ester",COP(=O)(C(C(Cl)Cl)(O)O)O,,,,,,
2091,152092,"Benz(a)anthracene-7-methanol, 5-(acetyloxy)-12-methyl-",CC1=C2C3=CC=CC=C3C(=CC2=C(C4=CC=CC=C14)CO)OC(=O)C,,,,,,
2092,152093,"Acetic acid, 1,2-diethylhydrazide",CCNN(CC)C(=O)C,,,,,,
2093,152094,"Acetic acid, iodo-, 1,2-phenylene ester",C1=CC=C(C(=C1)OC(=O)CI)OC(=O)CI,,,,,,
2094,152095,"Acetamide, N,N'-1,2-phenylenebis(2-iodo-",C1=CC=C(C(=C1)NC(=O)CI)NC(=O)CI,,,,,,
2095,152096,"1,3,5-Triazine, 2-aziridino-4,6-diamino-",C1CN1C2=NC(=NC(=N2)N)N,,,,,,
2096,152097,"5,12-Naphthacenedione, 8-acetyl-10-((2-amino-2-deoxy-beta-D-glucopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-",CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)N)O.Cl,,,,,,
2097,152098,7-O-(beta-D-Glucosaminyl)daunomycinone,CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)N)O,,,,,,
2098,152099,"9-Acridinamine, N-(4-methylphenyl)-, monohydrochloride",CC1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2099,152100,"1-Propanesulfonic acid, propyl ester",CCCOS(=O)(=O)CCC,,,,,,
2100,152101,"1H-Benzimidazole-2-ethanamine, N-(2-chloroethyl)-, dihydrochloride",C1=CC=C2C(=C1)NC(=N2)CCNCCCl.Cl.Cl,,,,,,
2101,152102,2-(1H-benzimidazol-2-yl)-N-(2-chloroethyl)ethanamine,C1=CC=C2C(=C1)NC(=N2)CCNCCCl,,,,,,
2102,152103,"1H-Benzimidazole, 2-(((2-chloroethyl)thio)methyl)-, monohydrochloride",C1=CC=C2C(=C1)NC(=N2)CSCCCl.Cl,,,,,,
2103,152104,2-{[(2-Chloroethyl)sulfanyl]methyl}-1H-benzimidazole,C1=CC=C2C(=C1)NC(=N2)CSCCCl,,,,,,
2104,152105,"1H-Purine-2,6-dione, 8-(chloromethyl)-3,7-dihydro-1,3-dimethyl-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCl,,,,,,
2105,152106,CID 152106,C1=CC(=CC=C1C=CC(=O)N(CCCl)CCCl)Cl,,,,,,
2106,152107,CID 152107,CCCCCC=CCC=CCCCCC=CCCCC(=O)O.CCCCCC=CCC=CCCCCC=CCCCC(=O)O,,,,,,
2107,152108,"Eicosa-5,11,14-trienoic acid",CCCCCC=CCC=CCCCCC=CCCCC(=O)O,,,,,,
2108,152109,4-O-beta-D-Mannopyranosyl-D-mannopyranose,C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H](OC([C@H]([C@H]2O)O)O)CO)O)O)O)O,,,,,,
2109,152110,"Bis(2,2'-bipyridine)iron(II)",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Fe+2],,,,,,
2110,152111,"5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione",CC1(OC(=O)C(=COC)C(=O)O1)C,,,,,,
2111,152112,Tetrapotassium peroxydiphosphorate,[O-]OP(=O)([O-])OP(=O)([O-])[O-].[K+].[K+].[K+].[K+],,,,,,
2112,152113,CID 152113,OP(=O)(O)OP(=O)(O)O[O-],,,,,,
2113,152114,"2,6-Pyridinedicarbohydroxamic acid",C1=CC(=NC(=C1)C(=O)NO)C(=O)NO,,,,,,
2114,152115,"2,2,3,3-Tetramethylcyclopropanecarboxylic acid",CC1(C(C1(C)C)C(=O)O)C,,,,,,
2115,152116,"3,4-Dichloro-alpha-phenoxyhippuric acid",C1=CC=C(C=C1)OC(C(=O)O)NC(=O)C2=CC(=C(C=C2)Cl)Cl,,,,,,
2116,152117,Pentacyanoferrate (II),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2],,,,,,
2117,152118,"1,5-Diphenyl-1,4-pentadiyn-3-one",C1=CC=C(C=C1)C#CC(=O)C#CC2=CC=CC=C2,,,,,,
2118,152119,Dithiophosphoric acid,OP(=S)(O)S,,,,,,
2119,152120,"(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-4-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]hexanal",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)[C@@]([C@@H](CO)O)([C@@H]([C@@H](C=O)O)O)O)O)O)O)O,,,,,,
2120,152121,"phosphono (2R,3S,4R)-2,3,4,5-tetrahydroxypentanoate",C([C@H]([C@@H]([C@H](C(=O)OP(=O)(O)O)O)O)O)O,,,,,,
2121,152122,Dirhodium tetraacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Rh+2].[Rh+2],,,,,,
2122,152123,CID 152123,C1CNC(NC1)(N=O)N=O,,,,,,
2123,152124,Tetraamminepalladium(II) dichloride,N.N.N.N.Cl[Pd]Cl,,,,,,
2124,152125,"Pregn-4-ene-3,20-dione, 14-hydroxy-",CC(=O)[C@H]1CCC2([C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
2125,152126,"1-Acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione",CC(=O)N1C(=O)N(C(=O)N1)C2=CC=CC=C2,,,,,,
2126,152127,"3-Bromo-N,N,N-trimethyl-2-oxopropane-1-aminium",C[N+](C)(C)CC(=O)CBr,,,,,,
2127,152128,N-Benzyloxycarbonylphenylalanylalanine,C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
2128,152129,N-Isopropyl-4-hydroxymethylbenzamide,CC(C)NC(=O)C1=CC=C(C=C1)CO,,,,,,
2129,152130,2-Amino-3-hydroxyoctadecanoic acid,CCCCCCCCCCCCCCCC(C(C(=O)O)N)O,,,,,,
2130,152131,"1,3-Bis(2-carboxychromone-7-oxy)-2-hydroxypropane",C1=CC2=C(C=C1OCC(COC3=CC4=C(C=C3)C(=O)C=C(O4)C(=O)O)O)OC(=CC2=O)C(=O)O,,,,,,
2131,152132,"5H-Dibenzo(a,d)cycloheptene-10,11-oxide",C1C=CC=C2C1=C3C(=C4CC=CC=C4C2)O3,,,,,,
2132,152133,"2,5,7,8-Tetramethyl-2-(4,8-dimethylnonyl)-6-hydroxychroman",CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)C)C(=C1O)C)C,,,,,,
2133,152134,N-Methylolpentamethylmelamine,CN(C)C1=NC(=NC(=N1)N(C)CO)N(C)C,,,,,,
2134,152135,5-Methyl-3-n-pentadecylcatechol,CCCCCCCCCCCCCCCC1=C(C(=CC(=C1)C)O)O,,,,,,
2135,152136,4-Methyl-3-pentadecylcatechol,CCCCCCCCCCCCCCCC1=C(C=CC(=C1O)O)C,,,,,,
2136,152137,2-Benzoyl-9H-fluoren-9-one,C1=CC=C(C=C1)C(=O)C2=CC3=C(C=C2)C4=CC=CC=C4C3=O,,,,,,
2137,152138,"4-Methoxy-7,12-dimethylbenz(a)anthracene",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC=C3OC,,,,,,
2138,152139,"6,11,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione",C[C@]12CC([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CC(C4=CC(=O)C=C[C@]34C)O)O,,,,,,
2139,152140,6-Propyladenine,CCCC1(C2=NC=NC2=NC=N1)N,,,,,,
2140,152141,4-Acetamidobenzyl alcohol,CC(=O)NC1=CC=C(C=C1)CO,,,,,,
2141,152142,"Carbamic acid, methylnitroso-, 2,3,5-trimethylphenyl ester, mixt. with 3,4,5-trimethylphenyl methylnitrosocarbamate",CC1=CC(=C(C(=C1)OC(=O)N(C)N=O)C)C.CC1=CC(=CC(=C1C)C)OC(=O)N(C)N=O,,,,,,
2142,152143,"(3,4,5-trimethylphenyl) N-methyl-N-nitrosocarbamate",CC1=CC(=CC(=C1C)C)OC(=O)N(C)N=O,,,,,,
2143,152144,3-Piperidinomethyl-5-chlorobenzoxazolin-2-one,C1CCN(CC1)CN2C3=C(C=CC(=C3)Cl)OC2=O,,,,,,
2144,152145,"Hydrazinecarboximidamide, 2,2'-(2,5-cyclohexadiene-1,4-diylidene)bis-,hydrochloride",C1=CC(=CC=C1NN=C(N)N)N=NC(=N)N.Cl,,,,,,
2145,152146,1-[4-[2-(Diaminomethylidene)hydrazinyl]phenyl]iminoguanidine,C1=CC(=CC=C1NN=C(N)N)N=NC(=N)N,,,,,,
2146,152147,CID 152147,C1=CC(=CC=C1C=NN=C(N)N)C=NN=C(N)N.Cl,,,,,,
2147,152148,"2,2'-(1,4-Phenylenedimethylidyne)bis[hydrazinecarboximidamide]",C1=CC(=CC=C1C=NN=C(N)N)C=NN=C(N)N,,,,,,
2148,152149,CID 152149,CC(=NN(C)C(=N)N)C=NN(C)C(=N)N.OS(=O)(=O)O,,,,,,
2149,152150,1-[1-[Carbamimidoyl(methyl)hydrazinylidene]propan-2-ylideneamino]-1-methylguanidine,CC(=NN(C)C(=N)N)C=NN(C)C(=N)N,,,,,,
2150,152151,Serotonin O-sulfate,C1=CC2=C(C=C1OS(=O)(=O)O)C(=CN2)CCN,,,,,,
2151,152152,4-Acetylisocoumarin,CC(=O)C1=COC(=O)C2=CC=CC=C21,,,,,,
2152,152153,D-erythrulose 1-phosphate,C([C@H](C(=O)COP(=O)(O)O)O)O,,,,,,
2153,152154,2-Aminocyclohexanesulfonic acid,C1CCC(C(C1)N)S(=O)(=O)O,,,,,,
2154,152155,2-[(4-Methylphenyl)amino]benzoic acid,CC1=CC=C(C=C1)NC2=CC=CC=C2C(=O)O,,,,,,
2155,152156,{[(2E)-3-phenylprop-2-enoyl]amino}acetic acid,C1=CC=C(C=C1)C=CC(=O)NCC(=O)O,,,,,,
2156,152157,Carboxymethyl(dimethyl)selanium,C[Se+](C)CC(=O)O,,,,,,
2157,152158,CID 152158,CC1=CC(=N)C(=C(C1=N)C)N(O)O,,,,,,
2158,152159,CID 152159,C1=CC(=C2C=CC(=O)C(=C2)N(O)O)C(=O)C(=C1)[N+](=O)[O-],,,,,,
2159,152160,"Z-Ethyl-O,N,N-azoxymethane",CC[N+](=NC)[O-],,,,,,
2160,152161,"6-Nitro-7-hydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene",C1CC(C2=C(C3=C4C(=C2C1)C=CC5=C4C(=CC=C5)C=C3)[N+](=O)[O-])O,,,,,,
2161,152162,5-(3-Chloropropyl)-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CCCCl)CO)O,,,,,,
2162,152163,"2-Methylphenanthro(3,4-d)oxazol-10-ol",CC1=NC2=C(O1)C3=C(C=CC4=C3C=C(C=C4)O)C=C2,,,,,,
2163,152164,"2-Methyl-3H-phenanthro-(3,4-d)imidazol-10-ol",CC1=NC2=C(N1)C=CC3=C2C4=C(C=C3)C=CC(=C4)O,,,,,,
2164,152165,"3-Hydroxyamino-4,6-dimethyldipyrido(1,2-a:3',2'-d)imidazole",CC1=CC=CN2C1=NC3=C2NCC(=C3C)N=O,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)']",,,
2165,152166,"3-Hydroxyaminodipyrido(1,2-a:3',2'-d)imidazole",C1C(=CC2=C(N1)N3C=CC=CC3=N2)N=O,,,,,,
2166,152167,"Dipyrido(1,2-a:3',2'-d)imidazole, 4,6-dimethyl-3-nitro-",CC1=CC=CN2C1=NC3=C(C(=CN=C32)[N+](=O)[O-])C,,,,,,
2167,152168,"Dipyrido(1,2-a:3',2'-d)imidazole, 3-nitro-",C1=CC2=NC3=C(N2C=C1)N=CC(=C3)[N+](=O)[O-],,,,,,
2168,152169,1-Methyl-4H-cyclopenta(def)phenanthrene,CC1=C2C=CC3=C4C2=C(CC4=CC=C3)C=C1,,,,,,
2169,152170,1-Methyl-4H-cyclopenta(def)phenanthren-4-one,CC1=C2C=CC3=C4C2=C(C=C1)C(=O)C4=CC=C3,,,,,,
2170,152171,CID 152171,C(N=N)[O-].[K+],,,,,,
2171,152172,Hydroxymethyldiazene,C(N=N)O,,,,,,
2172,152173,CID 152173,C(CN=N)C[O-].[K+],,,,,,
2173,152174,3-Diazenylpropan-1-ol,C(CN=N)CO,,,,,,
2174,152175,"Benz(a)anthracene-3,4-diol, 3,4-dihydro-6-methyl-, trans-",CC1=CC2=C(C=C[C@@H]([C@H]2O)O)C3=CC4=CC=CC=C4C=C13,,,,,,
2175,152176,"trans-10,11-Dihydroxy-10,11-dihydro-6-methylbenz(a)anthracene",CC1=CC2=CC=CC=C2C3=C1C=C4C=C[C@@H]([C@H](C4=C3)O)O,,,,,,
2176,152177,"6-Methyl-10,11-dihydrotetraphene-4,9,11-triol",CC1=CC2=C(C=CC=C2O)C3=C1C=C4C=C(CC(C4=C3)O)O,,,,,,
2177,152178,"S-(1,1,2,2,3,3-Hexafluoropropyl)-L-cysteine",C([C@@H](C(=O)O)N)SC(C(C(F)F)(F)F)(F)F,,,,,,
2178,152179,"(2R)-2-acetamido-3-(1,2,3,3,3-pentafluoroprop-1-enylsulfanyl)propanoic acid",CC(=O)N[C@@H](CSC(=C(C(F)(F)F)F)F)C(=O)O,,,,,,
2179,152180,N-(4-Methylphenyl)-8-quinolinesulfonamide,CC1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
2180,152181,"N-Hydroxy-N-(4-(2,4,6-trichlorophenoxy)phenyl)acetamide",CC(=O)N(C1=CC=C(C=C1)OC2=C(C=C(C=C2Cl)Cl)Cl)O,,,,,,
2181,152182,"Acetohydroxamic acid, N-(p-(p-chlorophenoxy)phenyl)-O-beta-D-glucopyranosyl-, hydrate (2:1)",CC(=O)N(C1=CC=C(C=C1)OC2=CC=C(C=C2)Cl)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O.O.O,,,,,,
2182,152183,"N-[4-(4-chlorophenoxy)phenyl]-N-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyacetamide",CC(=O)N(C1=CC=C(C=C1)OC2=CC=C(C=C2)Cl)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
2183,152184,"1-Hydroxyindeno(1,2,3-cd)pyrene",C1=CC=C2C(=C1)C3=CC4=CC=CC5=C4C6=C3C2=C(C=C6C=C5)O,,,,,,
2184,152185,"2-Hydroxyindeno(1,2,3-cd)pyrene",C1=CC=C2C(=C1)C3=CC4=CC=CC5=C4C6=C3C2=CC(=C6C=C5)O,,,,,,
2185,152186,"Hexacyclo[16.3.1.02,7.08,21.011,20.014,19]docosa-1(22),2,4,6,8(21),9,11(20),12,14,16,18-undecaen-16-ol",C1=CC=C2C(=C1)C3=C4C2=CC5=C6C4=C(C=CC6=CC(=C5)O)C=C3,,,,,,
2186,152187,"cis-(2R,3R)Methylepoxycinnamate",CC1=CC=CC=C1C2=C(O2)C(=O)[O-],,,,,,
2187,152188,3-(2-Methylphenyl)oxirene-2-carboxylic acid,CC1=CC=CC=C1C2=C(O2)C(=O)O,,,,,,
2188,152189,"3-Acetyloxolane-2,4-dione",CC(=O)C1C(=O)COC1=O,,,,,,
2189,152190,2-Benzenesulfonamidopyrimidine,C1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2,,,,,,
2190,152191,3-Hydroxyasparagine,[C@H](C(C(=O)N)O)(C(=O)O)N,,,,,,
2191,152192,"3,7-Dimethylocta-1,6-dien-3-yl phosphono hydrogen phosphate",CC(=CCCC(C)(C=C)OP(=O)(O)OP(=O)(O)O)C,,,,,,
2192,152193,2-Fluoro-alpha-methyltyrosine,C[C@](CC1=C(C=C(C=C1)O)F)(C(=O)O)N,,,,,,
2193,152194,N-Methylpicolinium perchlorate,CC1=CC=CC=[N+]1C.[O-]Cl(=O)(=O)=O,,,,,,
2194,152195,2-Deoxy-D-lyxo-hexonic acid,C([C@H]([C@H]([C@@H](CO)O)O)O)C(=O)O,,,,,,
2195,152196,11-Dodecynoic acid,C#CCCCCCCCCCC(=O)O,,,,,,
2196,152197,2-Benzylmalic acid,C1=CC=C(C=C1)CC(CC(=O)O)(C(=O)O)O,,,,,,
2197,152198,Histidylphenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N,,,,,,
2198,152199,Prolyl-prolyl-glycine,C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)NCC(=O)O,,,,,,
2199,152200,"6a,7,10,10a-Tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo(b,d)pyran-9(8H)-one",CCCCCC1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,,,,,,
2200,152201,12-Methylhexadecanoic acid,CCCCC(C)CCCCCCCCCCC(=O)O,,,,,,
2201,152202,Dansylmethionine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N[C@@H](CCSC)C(=O)O,,,,,,
2202,152203,4-(Dimethylamino)phenylacetic acid,CN(C)C1=CC=C(C=C1)CC(=O)O,,,,,,
2203,152204,N-Acetylthreonine,C[C@H]([C@@H](C(=O)O)NC(=O)C)O,,,,,,
2204,152205,3-O-Sulfogalactose,C([C@H]([C@@H]([C@@H]([C@H](C=O)O)OS(=O)(=O)O)O)O)O,,,,,,
2205,152206,N-Bromoacetazolamide,CC(=O)N(C1=NN=C(S1)S(=O)(=O)N)Br,,,,,,
2206,152207,Leucyl-alanyl-glycyl-valine,C[C@@H](C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(C)C)N,,,,,,
2207,152208,"phosphono (3S,4R)-3,4,5-trihydroxypentanoate",C([C@@H]([C@@H](CO)O)O)C(=O)OP(=O)(O)O,,,,,,
2208,152209,Methyl 4-(3-pyridyl)butyrate,COC(=O)CCCC1=CN=CC=C1,,,,,,
2209,152210,Benzyloxycarbonyl-glycyl-glycyl-arginine beta-naphthylamide,C1=CC=C(C=C1)COC(=O)N([C@@H](CCCN=C(N)N)C(=O)NC2=CC3=CC=CC=C3C=C2)C(=O)CNC(=O)CN,,,,,,
2210,152211,N-Benzyloxycarbonylserylleucinamide,CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CO)NC(=O)OCC1=CC=CC=C1,,,,,,
2211,152212,Dodecylethylphosphate,CCCCCCCCCCCCC(C)OP(=O)(O)O,,,,,,
2212,152213,"2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one",COC1=CC2=C(C=C1)NC(=O)C(O2)O,,,,,,
2213,152214,1-Phenylcyclobutylamine,C1CC(C1)(C2=CC=CC=C2)N,,,,,,
2214,152215,"3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indole",CN1CCC(=CC1)C2=CNC3=CC=CC=C32,,,,,,
2215,152216,CID 152216,C1=CC(=CC(=C1)S(=O)(=O)O)[N+]#N,,,,,,
2216,152217,"2,4,6-Triamino-5-chloroquinazoline",C1=CC2=C(C(=C1N)Cl)C(=NC(=N2)N)N,,,,,,
2217,152218,Diacetylaminocyclohexenone,CC(=O)N(C1=CCCCC1=O)C(=O)C,,,,,,
2218,152219,"2,4,5-Trimethoxystyrene",COC1=CC(=C(C=C1C=C)OC)OC,,,,,,
2219,152220,"N-[(4-hydroxy-3-methoxyphenyl)methyl]-2,8-dimethylnon-6-enamide",CC(C)C=CCCCC(C)C(=O)NCC1=CC(=C(C=C1)O)OC,,,,,,
2220,152221,Butyloxycarbonyl-tryptophyl-leucyl-aspartyl-phenylalaninamide,CCCCOC(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N,,,,,,
2221,152222,"1,2-Dihexanoylglycerol",CCCCCC(=O)OCC(CO)OC(=O)CCCCC,,,,,,
2222,152223,3-(Pentylthio)lactic acid,CCCCCSCC(C(=O)O)O,,,,,,
2223,152224,4-Nitrophenyl 2-aminoacetate,C1=CC(=CC=C1[N+](=O)[O-])OC(=O)CN,,,,,,
2224,152225,Diethyl dimercaptosuccinate,CCOC(=O)CC(C(=O)OCC)(S)S,,,,,,
2225,152226,"(2S,3S,4S,5R)-6-ethoxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CCOC1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O,,,,,,
2226,152227,"Bis(2,4,6-trichlorophenyl) phosphorochloridate",C1=C(C=C(C(=C1Cl)OP(=O)(OC2=C(C=C(C=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2227,152228,1-O-Hexadecyl-2-O-palmitoylglycerol,CCCCCCCCCCCCCCCCOCC(CO)OC(=O)CCCCCCCCCCCCCCC,,,,,,
2228,152229,3-(2-methylbut-3-en-2-yl)-1H-indole,CC(C)(C=C)C1=CNC2=CC=CC=C21,,,,,,
2229,152230,alpha-Keto-gamma-guanidinooxybutyrate,C(CON=C(N)N)C(=O)C(=O)O,,,,,,
2230,152231,5-Diazo-4-oxonorvaline,C([C@@H](C(=O)O)N)C(=O)C=[N+]=[N-],,,,,,
2231,152232,CID 152232,C([C@@H](C(=O)O)N)C(=C[N+]#N)O,,,,,,
2232,152233,1-O-Hexadecyl-3-O-hexadecanoylglycerol,CCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)O,,,,,,
2233,152234,3-Methoxyamphetamine,CC(CC1=CC(=CC=C1)OC)N,,,,,,
2234,152235,CID 152235,CNC1=NC2=C(C=C(C=C2)Cl)N(C1)C(=O)C3=CC=CC=C3,,,,,,
2235,152236,1-Phenyl-2-vinylcyclopropane,C=CC1CC1C2=CC=CC=C2,,,,,,
2236,152237,CID 152237,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=O)C(=C3O)O)O2)O)O)O,,,,,,
2237,152238,Cysteinylcysteine,C([C@@H](C(=O)N[C@@H](CS)C(=O)O)N)S,,,,,,
2238,152239,2-Oxoglutaramate,C(CC(=O)N)C(=O)C(=O)[O-],,,,,,
2239,152240,"3,4-Bis(chloranyl)-1,2-thiazole-5-carboxylate",C1(=C(SN=C1Cl)C(=O)[O-])Cl,,,,,,
2240,152241,6-Deoxyaltrose,C[C@H]([C@H]([C@H]([C@@H](C=O)O)O)O)O,,,,,,
2241,152242,CID 152242,CC1=CC(=C(N=N1)N)S,,,,,,
2242,152243,"2-Hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid",C=CCC=CCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O,,,,,,
2243,152244,Bci-3 glud,C1=CC(=C(C2=C1NC=C2OC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)Cl)Br,,,,,,
2244,152245,Hexakis(trifluoroacetyl)inositol,C1(C(C(C(C(C1O)(C(=O)C(F)(F)F)OC(=O)C(F)(F)F)(C(=O)C(F)(F)F)OC(=O)C(F)(F)F)(C(=O)C(F)(F)F)OC(=O)C(F)(F)F)O)O,,,,,,
2245,152246,2-Hydroxy-5-nitro-alpha-toluenesulfonic acid,C1=CC(=C(C=C1[N+](=O)[O-])CS(=O)(=O)O)O,,,,,,
2246,152247,Methylsulfenyl bromide,CSBr,,,,,,
2247,152248,"2-Amino-4,5-hexadienoic acid",C=C=CCC(C(=O)O)N,,,,,,
2248,152249,N-tert-Butylserine,CC(C)(C)N[C@@H](CO)C(=O)O,,,,,,
2249,152250,"2-Methylthio-4H-1,3,2-benzodioxaphosphorin 2-oxide",CSP1(=O)OCC2=CC=CC=C2O1,,,,,,
2250,152251,(4-Iodophenyl)trimethylaminium,C[N+](C)(C)C1=CC=C(C=C1)I,,,,,,
2251,152252,N-Stearoylhistidine,CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O,,,,,,
2252,152253,Bis(4-chlorobenzyl)tin dichloride,C1=CC(=CC=C1C[Sn](CC2=CC=C(C=C2)Cl)(Cl)Cl)Cl,,,,,,
2253,152254,2-Deoxy-L-fucose,C[C@@H]([C@H]([C@H](CC=O)O)O)O,,,,,,
2254,152255,Beryllium trifluoride,[Be+2].[F-].[F-].[F-],,,,,,
2255,152256,"2,4,6-Triiodoresorcinol",C1=C(C(=C(C(=C1I)O)I)O)I,,,,,,
2256,152257,"2,4-diethyl-2-methyl-1H-quinoline",CCC1=CC(NC2=CC=CC=C21)(C)CC,,,,,,
2257,152258,"1-Methylimidazole-4,5-dicarboxylic acid",CN1C=NC(=C1C(=O)O)C(=O)O,,,,,,
2258,152259,"phosphono (2S,3S,4S,5S)-2,3,4,5,6-pentahydroxy-6-phosphonooxyhexanoate",[C@H]([C@@H]([C@@H](C(=O)OP(=O)(O)O)O)O)([C@@H](C(O)OP(=O)(O)O)O)O,,,,,,
2259,152260,Methyl picolinimidate,COC(=N)C1=CC=CC=N1,,,,,,
2260,152261,"5,8-Dihydro-8-oxo-2H-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid",C1OC2=C(O1)C=C3C(=C2)C(=O)C(=CN3)C(=O)O,,,,,,
2261,152262,Decylcitric acid,CCCCCCCCCCC(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
2262,152263,Benzoyl-L-histidine,C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O,,,,,,
2263,152264,Prolyl-tyrosine,C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
2264,152265,"Methyl 2,3-dihydroxy-2-methylpropanoate",CC(CO)(C(=O)OC)O,,,,,,
2265,152266,12alpha-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,,,,,,
2266,152267,"5,8,11,14-Heneicosatetraynoic acid",CCCCCCC#CCC#CCC#CCC#CCCCC(=O)O,,,,,,
2267,152268,2-Nitro-4-carboxyphenylsulfenyl chloride,C1=CC(=C(C=C1C(=O)O)[N+](=O)[O-])SCl,,,,,,
2268,152269,"Theophylline, 7-(3-(4-benzyl-1-piperazinyl)-2-hydroxypropyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(C(CC3=CC=CC=C3)N4CCNCC4)O,,,,,,
2269,152270,(2S)-2-[[(2R)-2-acetamidopropanoyl]amino]propanoic acid,C[C@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)C,,,,,,
2270,152271,CID 152271,CCOOP(=O)(N=C=O)OOCC,,,,,,
2271,152272,"4,7-Dicyanobenzofurazan",C1=C(C2=NON=C2C(=C1)C#N)C#N,,,,,,
2272,152273,3-(2-Hydroxyethoxy)phenol,C1=CC(=CC(=C1)OCCO)O,,,,,,
2273,152274,5-Hydroxy-2-nitrofluorene,C1C2=C(C3=C1C=C(C=C3)[N+](=O)[O-])C(=CC=C2)O,,,,,,
2274,152275,"3H-Imidazo(4,5-f)quinoxaline, 2-amino-3-ethyl-7-methyl-",CCN1C2=C(C3=NC=C(N=C3C=C2)C)N=C1N,,,,,,
2275,152276,"3H-Imidazo(4,5-f)quinoxaline, 2-amino-3-ethyl-8-methyl-",CCN1C2=C(C3=NC(=CN=C3C=C2)C)N=C1N,,,,,,
2276,152277,"3-Ethyl-4-methyl-3H-imidazo(4,5,f)quinolin-2-amine",CCN1C2=C(C3=C(C=C2C)N=CC=C3)N=C1N,,,,,,
2277,152278,"3-Ethyl-3H-imidazo(4,5,f)quinolin-2-amine",CCN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,,,,,,
2278,152279,"2,6-Diethylnitrosobenzene",CCC1=C(C(=CC=C1)CC)N=O,,,,,,
2279,152280,N-Benzyl-2-bromo-N-methylpropanamide,CC(C(=O)N(C)CC1=CC=CC=C1)Br,,,,,,
2280,152281,p-Nitrosophenyl pentyl ether,CCCCCOC1=CC=C(C=C1)N=O,,,,,,
2281,152282,"2,2-Dichlorocyclopentene-1,3-dione",C1=CC(=O)C(C1=O)(Cl)Cl,,,,,,
2282,152283,"Ethyl (8-ethyl-6-hydroxy-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate",CCC1=C2C(=CC(=C1)O)C3=C(N2)C(OCC3)CC(=O)OCC,,,,,,
2283,152284,"1,8-Diethyl-1,3,4,9-tetrahydro-7-hydroxypyrano(3,4-b)indole-1-acetic acid",CCC1=C(C=CC2=C1NC3=C2CCOC3CC(=O)OCC)O,,,,,,
2284,152285,"Ethyl [8-(1-hydroxyethyl)-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate",CCOC(=O)CC1C2=C(CCO1)C3=C(N2)C(=CC=C3)C(C)O,,,,,,
2285,152286,Ccris 3570,C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=C4C6C(O6)C(C5O)O)N=C32,,,,,,
2286,152287,"(1S,2S)-cyclohexa-3,5-diene-1,2-diol",C1=C[C@@H]([C@H](C=C1)O)O,,,,,,
2287,152288,2-Chloromethylfluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=CC(=CC2=C43)CCl,,,,,,
2288,152289,7-Chloromethylfluoranthene,C1=CC2=C3C(=C1)C4=CC=CC(=C4C3=CC=C2)CCl,,,,,,
2289,152290,8-Chloromethylfluoranthene,C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C(C=C4)CCl,,,,,,
2290,152291,1-Chloromethylfluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=C(C=C4)CCl,,,,,,
2291,152292,CID 152292,COC(=O)C1=CC2=C3C=CC=CC3=NC2=C(N1)C4=NC5=C(C=C4)C(=O)C=CC5=O,,,,,,
2292,152293,Diethyl S-n-propyl phosphorothiolate,CCCSP(=O)(OCC)OCC,,,,,,
2293,152294,4-Pentenoylcarnitine,C[N+](C)(C)CC(C(C(=O)CCC=C)C(=O)[O-])O,,,,,,
2294,152295,(3-Carboxy-2-hydroxy-4-oxooct-7-enyl)-trimethylazanium,C[N+](C)(C)CC(C(C(=O)CCC=C)C(=O)O)O,,,,,,
2295,152296,PZ-Plgpa,CC(C)C[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N([C@@H](CCCN=C(N)N)C(=O)O)N=NC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)OCC4=CC=CC=C4,,,,,,
2296,152297,Ethyl 2-(2-(4-chlorophenyl)thiazol-4-yl)acetate,CCOC(=O)CC1=CSC(=N1)C2=CC=C(C=C2)Cl,,,,,,
2297,152298,2-(1-Hydroxyethyl)thiamine pyrophosphate,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOCCOP(=O)(O)OP(=O)(O)O.[Cl-],,,,,,
2298,152299,"2-[2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy]ethyl phosphono hydrogen phosphate",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOCCOP(=O)(O)OP(=O)(O)O,,,,,,
2299,152300,"Indole-4,7-dione",C1=CC(=O)C2=C(C1=O)C=CN2,,,,,,
2300,152301,4-Methylene-L-proline,C=C1C[C@H](NC1)C(=O)O,,,,,,
2301,152302,4-Azido-4-deoxyglucose,C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)N=[N+]=[N-])O)O,,,,,,
2302,152303,CID 152303,COC1=CC(=O)C2=C(C(=C(OC2=C1)C3=CC=C(C=C3)O)O)O,,,,,,
2303,152304,Gulonic acid,C([C@H]([C@@H]([C@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
2304,152305,17-Hydroxyandrostan-3-one 17-sulfate,C[C@]12CCC(=O)CC1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4OS(=O)(=O)O)C,,,,,,
2305,152306,Sorbitol-6-phosphate,C([C@@H]([C@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)O)O,,,,,,
2306,152307,L-Prolyl-L-valine,CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1,,,,,,
2307,152308,Ndelta-Chloroacetyl-L-ornithine,C(C[C@@H](C(=O)O)N)CNC(=O)CCl,,,,,,
2308,152309,"3,4-Bis(4-hydroxycyclohexyl)-2-oxohexanal",CCC(C1CCC(CC1)O)C(C2CCC(CC2)O)C(=O)C=O,,,,,,
2309,152310,2-Pyridylbenzylcarbinol,C1=CC=C(C(=C1)CCO)C2=CC=CC=N2,,,,,,
2310,152311,1-(4-Bromophenyl)-3-methylurea,CNC(=O)NC1=CC=C(C=C1)Br,,,,,,
2311,152312,m-Methylstyrene oxide,CC1=CC(=CC=C1)C2CO2,,,,,,
2312,152313,Selenodicysteine,C([C@@H](C(=O)O)N[Se]N[C@@H](CS)C(=O)O)S,,,,,,
2313,152314,N-Acetylcystathionine,CC(=O)NC(CSCC[C@@H](C(=O)O)N)C(=O)O,,,,,,
2314,152315,"Ethanamine, 2-((3-chloro(1,1'-biphenyl)-2-yl)oxy)-",C1=CC=C(C=C1)C2=C(C(=CC=C2)Cl)OCCN,,,,,,
2315,152316,1-[Methoxy(methyl)phosphoryl]sulfanylhexane,CCCCCCSP(=O)(C)OC,,,,,,
2316,152317,2-Bromobutyrate,CCC(C(=O)[O-])Br,,,,,,
2317,152318,9-(1-Hydroxy-2-octyl)adenine,CCCCCCC(CO)N1C=NC2=C(N=CN=C21)N,,,['Drugs that inhibit ADENOSINE DEAMINASE activity. (See all compounds classified as Adenosine Deaminase Inhibitors.)'],,,
2318,152319,Boc-L-cysteine,CC(C)(C)OC(=O)N[C@@H](CS)C(=O)O,,,,,,
2319,152320,"N-(2,4-Dinitroanilino)maleimide",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN2C(=O)C=CC2=O,,,,,,
2320,152321,4-Methoxyandrostenedione,C[C@]12CCC(=O)C(=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)OC,,,,,,
2321,152322,Histidylproline,C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)N)C(=O)O,,,,,,
2322,152323,Phenylpropionylglycine,C1=CC=C(C=C1)CCC(=O)NCC(=O)O,,,,,,
2323,152324,5-(2-Thienyl)Pentanoic Acid,C1=CSC(=C1)CCCCC(=O)O,,,,,,
2324,152325,"4-hydroxy-3,4-dihydronaphthalen-1(2H)-one",C1CC(=O)C2=CC=CC=C2C1O,,,,,,
2325,152326,Bis(triphenylphosphonio)amine anion,C1=CC=C(C=C1)P(=N[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
2326,152327,1H-Pyrazole-4-propanamine,C1=C(C=NN1)CCCN,,,,,,
2327,152328,N-(Mercaptoacetyl)glycine,C(C(=O)O)NC(=O)CS,,,,,,
2328,152329,"3,7-Dihydroxyandrostan-17-one",C[C@]12CCC(CC1CC([C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O)O,,,,,,
2329,152330,9-N-Ribofuranosyluric acid 5'-monophosphate,C([C@@H]1[C@H]([C@H](C(O1)N2C3=C(C(=O)NC(=O)N3)NC2=O)O)O)OP(=O)(O)O,,,,,,
2330,152331,2-Chloroamphetamine,CC(CC1=CC=CC=C1Cl)N,,,,,,
2331,152332,"Methyl 9-(3-ethyl-3-methyloxiran-2-yl)-3,7-dimethylnona-2,6-dienoate",CCC1(C(O1)CCC(=CCCC(=CC(=O)OC)C)C)C,,,,,,
2332,152333,2-(Hydroxymethyl)-4-[(4-hydroxyphenyl)methyl]phenol,C1=CC(=CC=C1CC2=CC(=C(C=C2)O)CO)O,,,,,,
2333,152334,CID 152334,CC(=CN=NC(=NC)N)NNC(=NC)N.I,,,,,,
2334,152335,CID 152335,CC(=CN=NC(=NC)N)NNC(=NC)N,,,,,,
2335,152336,CID 152336,CC(=NN=C(N)N)C(=NN=C(N)N)C.CC(=O)O,,,,,,
2336,152337,CID 152337,C(C=NN=C(N)N)C=NN=C(N)N.OS(=O)(=O)O,,,,,,
2337,152338,CID 152338,C(CC=NN=C(N)N)CC=NN=C(N)N.OS(=O)(=O)O,,,,,,
2338,152339,CID 152339,C1=CC(=CC=C1C=NN=C(N)N)NC(=O)NC2=CC=C(C=C2)C=NN=C(N)N,,,,,,
2339,152340,CID 152340,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(=NN=C(N)N)C)S.Cl,,,,,,
2340,152341,CID 152341,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(=NN=C(N)N)C)S,,,,,,
2341,152342,CID 152342,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(=NN=C(N)N)C)N.Cl,,,,,,
2342,152343,CID 152343,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(=NN=C(N)N)C)N,,,,,,
2343,152344,CID 152344,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C(=NN=C(N)N)C.Cl,,,,,,
2344,152345,CID 152345,C1=CC(=CC=C1C=NN=C(N)N)C2=CC=C(C=C2)C=NN=C(N)N.Cl,,,,,,
2345,152346,CID 152346,C1=CC(=CC=C1C=NN=C(N)N)C2=CC=C(C=C2)C=NN=C(N)N,,,,,,
2346,152347,(-)-Bis(ethanediam8ine)(ethanedioato)cobalt chloride,C(CN)N.C(CN)N.C(=O)(C(=O)[O-])[O-].[Cl-].[Co+3],,,,,,
2347,152348,"Phenol, 2-cyclohexyl-4-(1-phenylethyl)-",CC(C1=CC=CC=C1)C2=CC(=C(C=C2)O)C3CCCCC3,,,,,,
2348,152349,4-Cyclohexyl-2-(1-phenylethyl)phenol,CC(C1=CC=CC=C1)C2=C(C=CC(=C2)C3CCCCC3)O,,,,,,
2349,152350,"Phenanthridinium, 3,8-diamino-5-ethyl-6-(2-naphthalenyl)-",CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC5=CC=CC=C5C=C4)N)N,,,,,,
2350,152351,"Phenanthro(9,10-b)oxirene, 1a,9b-dihydro-2-methyl-",CC1=C2C3C(O3)C4=CC=CC=C4C2=CC=C1,,,,,,
2351,152352,"Quinoline, 4,6,8-trinitro-, 1-oxide",C1=C[N+](=C2C(=CC(=CC2=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[O-],,,,,,
2352,152353,"Benzenamine, N,N-dimethyl-4-(2-phenylhydrazino)-",CN(C)C1=CC=C(C=C1)NNC2=CC=CC=C2,,,,,,
2353,152354,"Phenol, 5-(2-(3,4-dimethoxyphenyl)ethyl)-2-methoxy-",COC1=C(C=C(C=C1)CCC2=CC(=C(C=C2)OC)OC)O,,,,,,
2354,152355,Cbz-DL-Ser(1)-DL-Ala-DL-Cys(Acm)-DL-Nva-(2).Cbz-DL-Ser(2)-DL-Ala-DL-Cys(Acm)-DL-Nva-(1),CCCC1C(=O)OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)OCC(C(=O)NC(C(=O)NC(C(=O)N1)CSCNC(=O)C)C)NC(=O)OCC2=CC=CC=C2)CCC)CSCNC(=O)C)C)NC(=O)OCC3=CC=CC=C3,,,,,,
2355,152356,Bocanta,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)OCC(C(=O)N1)NC(=O)OCC3=CC=CC=C3)C(C)C)NC(=O)C(NC(=O)C(COC(=O)C(NC2=O)C(C)C)NC(=O)OCC4=CC=CC=C4)C,,,,,,
2356,152357,"Furo(2,3-b)benzofuran, 2,3,3a,8a-tetrahydro-",C1COC2C1C3=CC=CC=C3O2,,,,,,
2357,152358,N-Benzylalbuterone,CC(C)(C)N(CC1=CC=CC=C1)CC(=O)C2=CC(=C(C=C2)O)CO,,,,,,
2358,152359,"Pyrido(2,3-d)pyrimidine-2,4-diamine, 6-butyl-, hydrochloride",CCCCC1=CC2=C(N=C(N=C2N=C1)N)N.Cl,,,,,,
2359,152360,"2,4-Diamino-6-butylpyrido(2,3-d)pyrimidine",CCCCC1=CC2=C(N=C(N=C2N=C1)N)N,,,,,,
2360,152361,"Ethanethiol, 2-((2,3-diaminopropyl)amino)-, dihydrogen phosphate (ester)",C(CSP(=O)(O)O)NCC(CN)N,,,,,,
2361,152362,"Ethanethiol, 2-((3,3-diaminopropyl)amino)-, dihydrogen phosphate (ester)",C(CNCCSP(=O)(O)O)C(N)N,,,,,,
2362,152363,Quinoline N-oxide hydrate,C1=CC=C2C(=C1)C=CC=[N+]2[O-].O,,,,,,
2363,152364,"Carbamic acid, nitroso(1-oxobutyl)-, ethyl ester",CCCC(=O)N(C(=O)OCC)N=O,,,,,,
2364,152365,Hycanthone Ethansulfonate,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CCS(=O)(=O)O,,,,,,
2365,152366,"Propanoic acid, 3-chloro-2,3-dihydroxy-",C(C(O)Cl)(C(=O)O)O,,,,,,
2366,152367,"Uridine, 2'-deoxy-4'-C-5H-tetrazol-5-yl-, (R)-",C1C(C(OC1N2C=CC(=O)NC2=O)(CO)C3N=NN=N3)O,,,,,,
2367,152368,N-nitrosoethenamine,C=CNN=O,,,,,,
2368,152369,"Thymidine, 2',3'-didehydro-",CC1=CN(C(=O)NC1=O)C2C=C(C(O2)CO)O,,,,,,
2369,152370,"Uridine, 2'-deoxy-5-fluoro-4'-C-5H-tetrazol-5-yl-, (R)-",C1C(C(OC1N2C=C(C(=O)NC2=O)F)(CO)C3N=NN=N3)O,,,,,,
2370,152371,CID 152371,CCSCC[C@@H](C(=O)N[C@H](C)C(=O)O)N,,,,,,
2371,152372,"Pyrimidine, 4,6-bis(1-aziridinyl)-2-(4-methylnitrophenyl)-5-nitro-",CC1=CC(=C(C=C1)C2=NC(=C(C(=N2)N3CC3)[N+](=O)[O-])N4CC4)[N+](=O)[O-],,,,,,
2372,152373,"Carbamic acid, nitrosophenyl-, methyl ester",COC(=O)N(C1=CC=CC=C1)N=O,,,,,,
2373,152374,"Hydroxylamine-O-sulfonic acid, N-acetyl-N-2-phenanthrenyl-",CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C=C2)OS(=O)(=O)O,,,,,,
2374,152375,CID 152375,CC(=O)N(C1=CC=C(C=C1)C=CC2=CC=CC=C2)OS(=O)(=O)O,,,,,,
2375,152376,"Guanidine, ((3-chloro-4-methoxyphenyl)methoxy)-, sulfate (1:1)",COC1=C(C=C(C=C1)CON=C(N)N)Cl.OS(=O)(=O)O,,,,,,
2376,152377,2-[(3-Chloro-4-methoxyphenyl)methoxy]guanidine,COC1=C(C=C(C=C1)CON=C(N)N)Cl,,,,,,
2377,152378,"Iron chloride (FeCl3), hydrate (2:7)",O.O.O.O.O.O.O.Cl[Fe](Cl)Cl.Cl[Fe](Cl)Cl,,,,,,
2378,152379,2-[(N'-nitrocarbamimidoyl)-nitrosoamino]ethyl acetate,CC(=O)OCCN(C(=N[N+](=O)[O-])N)N=O,,,,,,
2379,152380,"Thymidine, 2',3'-didehydro-alpha,alpha,alpha-trifluoro-",C1=C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,,,,,,
2380,152381,2-Acetamidopropanamide,CC(C(=O)N)NC(=O)C,,,,,,
2381,152382,"Pyrimidine, 4-(1-aziridinyl)-2-chloro-, homopolymer",C1CN1C2=NC(=NC=C2)Cl,,,,,,
2382,152383,CID 152383,CC=COC(=O)NC1=CC(=CC=C1)F,,,,,,
2383,152384,"Phosphoric acid, 2-(bis(2-chloroethyl)amino)ethyl dibutyl ester, hydrochloride",CCCCOP(=O)(OCCCC)OCCN(CCCl)CCCl.Cl,,,,,,
2384,152385,2-[Bis(2-chloroethyl)amino]ethyl dibutyl phosphate,CCCCOP(=O)(OCCCC)OCCN(CCCl)CCCl,,,,,,
2385,152386,CID 152386,C(CN(C(=N[N+](=O)[O-])N)N=O)CCl,,,,,,
2386,152387,"Thymidine, 3-chloro-",CC1=CN(C(=O)N(C1=O)Cl)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
2387,152388,"Pyrimidine, 4-(1-aziridinyl)-6-chloro-2-(4-methoxyphenyl)-",COC1=CC=C(C=C1)C2=NC(=CC(=N2)Cl)N3CC3,,,,,,
2388,152389,"Quinoline, 4-chloro-8-nitro-, 1-oxide",C1=CC2=C(C=C[N+](=C2C(=C1)[N+](=O)[O-])[O-])Cl,,,,,,
2389,152390,"Phosphoramidic acid, diethyl-, 1-chloroethenyl methyl ester",CCN(CC)P(=O)(OC)OC(=C)Cl,,,,,,
2390,152391,"Acetic acid, phosphono-, 1-(phenylmethyl) ester, monoammonium salt",C1=CC=C(C=C1)COC(=O)CP(=O)(O)O.N,,,,,,
2391,152392,"Acetic acid, phosphono-, 1-(phenylmethyl) ester",C1=CC=C(C=C1)COC(=O)CP(=O)(O)O,,,,,,
2392,152393,"Acetic acid, phosphono-, 1-cyclohexyl ester, monoammonium salt",C1CCC(CC1)OC(=O)CP(=O)(O)O.N,,,,,,
2393,152394,"Acetic acid, phosphono-, cyclohexyl ester",C1CCC(CC1)OC(=O)CP(=O)(O)O,,,,,,
2394,152395,"Bleomycinamide, N(sup 1)-(4-((aminoiminomethyl)amino)butyl)-, (33R)-",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=C(N=CS6)C(=O)NCCCCN=C(N)N)O,,,,,,
2395,152396,CID 152396,CC1=C(N=C(N=C1N)C(CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,,,,,,
2396,152397,"Platinum, bis(2-(eta2-ethenyl)benzenethiolato-S)-",C=CC1=CC=CC=C1[S-].C=CC1=CC=CC=C1[S-].[Pt+2],,,,,,
2397,152398,"Benzenethiol, 2-ethenyl-",C=CC1=CC=CC=C1S,,,,,,
2398,152399,"L-Histidine, N-(N-glycylglycyl)-, copper complex",C1=C(NC=N1)CC(C(=O)O)N=C(CN=C(CN)[O-])[O-].[Cu+2],,,,,,
2399,152400,Spermine platinum(II) chloride,CCCC(NCCCN)NCCCN.[Cl-].[Cl-].[Pt+2],,,,,,
2400,152401,"1-N,1-N'-bis(3-aminopropyl)butane-1,1-diamine",CCCC(NCCCN)NCCCN,,,,,,
2401,152402,cis-Bis(isobutylammine)dichloroplatinum (II),CC(C)(C)N.CC(C)(C)N.[Cl-].[Cl-].[Pt+2],,,,,,
2402,152403,cis-Dichlorodiisoamylamineplatinum(II),CC(C)CCN.CC(C)CCN.[Cl-].[Cl-].[Pt+2],,,,,,
2403,152404,Carbendazim mixture with thiram,CN(C)C(=S)SSC(=S)N(C)C.COC(=O)NC1=NC2=CC=CC=C2N1,,,,,,
2404,152405,(Adenosine)pentaammineruthenium(3+) tribromide,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.N.N.N.N.N.[Br-].[Br-].[Br-].[Ru+3],,,,,,
2405,152406,"rel-(1aR,2S,3R,11cS)-1a,2,3,11c-Tetrahydrotetrapheno[1,2-b]oxirene-2,3-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]5[C@H](O5)[C@H]([C@@H]4O)O,,,,,,
2406,152407,"3,4-Isopropylydene-1,2-5,6-dianhydro-dulcitol",CC1(O[C@@H]([C@H](O1)[C@H]2CO2)[C@H]3CO3)C,,,,,,
2407,152408,(106Ru)Ruthenium chloride,Cl[106Ru](Cl)Cl,,,,,,
2408,152409,CID 152409,CC=CCC(C)C1C(C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)O1)C(C)C)C)C(C)(C)C)C)C(C)(C)C)C)C)C)C(C)(C)C)C)C(C)C)C(C)(C)C)C)C)C(C)C)NC,,,,,,
2409,152410,CID 152410,CC=CC1=CN2C(=C1)C(NC3=C(C(=C(C=C3C2=O)OC4C(C(C(C(O4)C)NC)(C)O)O)C)OC)O,,,,,,
2410,152411,CID 152411,CC=CC1=CN2C(=C1)C=NC3=C(C(=C(C=C3C2=O)O[C@H]4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O.Cl,,,,,,
2411,152412,CID 152412,CC=CC1=CN2C(=C1)C=NC3=C(C(=C(C=C3C2=O)O[C@H]4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O,,,,,,
2412,152413,Doxorubicinol hydrochloride,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)([C@H](CO)O)O)N)O.Cl,,,,,,
2413,152414,"4'-Epi-daunorubicin, beta-anomer",C[C@H]1[C@@H]([C@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl,,,,,,
2414,152415,"Platinum (II), (cyclohexane-1,2-diammine)hydroxonitrato-",C1CCC(C(C1)N)N.[N+](=O)([O-])[O-].[OH-].[Pt+2],,,,,,
2415,152416,Pyroglutamylvaline,CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCC(=O)N1,,,,,,
2416,152417,Pyroglutamylleucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCC(=O)N1,,,,,,
2417,152418,"2,3,4,5,6,6-Hexachloro-2,4-cyclohexadien-1-one",C1(=C(C(=O)C(C(=C1Cl)Cl)(Cl)Cl)Cl)Cl,,,,,,
2418,152419,1-Phenyluracil,C1=CC=C(C=C1)N2C=CC(=O)NC2=O,,,,,,
2419,152420,9-Propyl-beta-carboline,CCCN1C2=CC=CC=C2C3=C1C=NC=C3,,,,,,
2420,152421,9-Hydroxymethyl-beta-carboline,C1=CC=C2C(=C1)C3=C(N2CO)C=NC=C3,,,,,,
2421,152422,3H-cyclopropa[c]quinoline,C1=CC=C2C(=C1)C3=CC3=CN2,,,,,,
2422,152423,Glycyl-L-phenylalanine 2-naphthylamide,C1=CC=C(C=C1)C[C@@H](C(=O)NC2=CC3=CC=CC=C3C=C2)NC(=O)CN,,,,,,
2423,152424,Thyroxine glucuronide,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)OC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)I)I)C[C@@H](C(=O)O)N,,,,,['Thyroxine glucuronide is a known human metabolite of Thyroxine.'],
2424,152425,Myristoyl tryptamine,CCCCCCCCCCCCCC(=O)NCCC1=CNC2=CC=CC=C21,,,,,,
2425,152426,Methylvinylmaleimide,CC1=C(C(=O)NC1=O)C=C,,,,,,
2426,152427,"N,N-Dimethyldopamine",CN(C)CCC1=CC(=C(C=C1)O)O,,,,,,
2427,152428,"5-[(2-Methoxyphenyl)methylidene]imidazolidine-2,4-dione",COC1=CC=CC=C1C=C2C(=O)NC(=O)N2,,,,,,
2428,152429,Pentyltriethylammonium,CCCCC[N+](CC)(CC)CC,,,,,,
2429,152430,"5-Hydroxy-3',4',6,7-tetramethoxyflavone",COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC,,,,,,
2430,152431,"2-Propanaminium, 1-hydroxy-N,N,N-trimethyl-",CC(CO)[N+](C)(C)C,,,,,,
2431,152432,"5-[(3,4-Dihydroxyphenyl)methyl]oxolan-2-one",C1CC(=O)OC1CC2=CC(=C(C=C2)O)O,,,,,"[""5-(3',4'-dihydroxyphenyl)-gamma-valerolactone is a known human metabolite of Epicatechin.""]",
2432,152433,"1-(1,3-Dioxolan-2-yl)ethyl-trimethylazanium",CC(C1OCCO1)[N+](C)(C)C,,,,,,
2433,152434,"Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)OC,,,,,,
2434,152435,"3,3-Dimethylheptadecanoic acid",CCCCCCCCCCCCCCC(C)(C)CC(=O)O,,,,,,
2435,152436,"5,9,13-Trimethyltetradecanoic acid",CC(C)CCCC(C)CCCC(C)CCCC(=O)O,,,,,,
2436,152437,"3,4-Dimethoxy-2-nitrobenzaldehyde",COC1=C(C(=C(C=C1)C=O)[N+](=O)[O-])OC,,,,,,
2437,152438,N-(Hexanoyloxy)succinimide,CCCCCC(=O)ON1C(=O)CCC1=O,,,,,,
2438,152439,10-[3-(Dimethylamino)propyl]-1-nitroacridin-9(10H)-one--hydrogen chloride (1/1),CN(C)CCCN1C2=C(C(=CC=C2)[N+](=O)[O-])C(=O)C3=CC=CC=C31.Cl,,,,,,
2439,152440,5-Amino-3-methylisothiazole-4-carboxylic acid,CC1=NSC(=C1C(=O)O)N,,,,,,
2440,152441,Aspartyl phosphate,C([C@@H](C(=O)O)N)C(=O)OP(=O)(O)O,,,,,,
2441,152442,CID 152442,C12=C(NC(=NC1=O)N)N=C(S2)N,,,,,,
2442,152443,CID 152443,CC1=CC2=C3C=CC=CC3=NC2=C(N1)C,,,,,,
2443,152444,"3,3',4,5'-Tetrahydroxybibenzyl",C1=CC(=C(C=C1CCC2=CC(=CC(=C2)O)O)O)O,,,,,,
2444,152445,"N-methyl-2,3,4,9-tetrahydro-1H-carbazol-3-amine",CNC1CCC2=C(C1)C3=CC=CC=C3N2,,,,,,
2445,152446,CID 152446,CC1=CC(=O)N=C(N1)[SeH],,,,,,
2446,152447,"2-(4-Nitrophenyl)-1,3-oxathiolane",C1CSC(O1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2447,152448,1-(2-Phenylbutyryl)-3-methylurea,CCC(C1=CC=CC=C1)C(=O)NC(=O)NC,,,,,,
2448,152449,(5-Fluoropyridin-3-yl)methanol,C1=C(C=NC=C1F)CO,,,,,,
2449,152450,4-(4-Nitrophenoxy)phenol,C1=CC(=CC=C1[N+](=O)[O-])OC2=CC=C(C=C2)O,,,,,,
2450,152451,"2,2,6,6-Tetramethyl-4-capryloyl-oxypiperidine-1-oxyl",CCCCCCCC(=O)OC1CC(N(C(C1)(C)C)[O])(C)C,,,,,,
2451,152452,7-Oxa-13-prostynoic acid,CCCCCCC#C[C@H]1CCC[C@@H]1OCCCCCC(=O)O,,,,,,
2452,152453,1-(4'-Nitrophenyl)prop-2-en-1-one,C=CC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
2453,152454,4-Nitrophenyl 4-methylphenacyl methylphosphonate,CC1=CC=C(C=C1)C(=O)COP(=O)(C)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2454,152455,Asp-tyr,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)N)O,,,,,,
2455,152456,N-(2-Furyl)acryloyl-L-tryptophan methyl ester,COC(=O)[C@H](CC1=CNC2=CC=CC=C21)N(C3=CC=CO3)C(=O)C=C,,,,,,
2456,152457,Triphenyl(6-triphenylphosphaniumylhexyl)phosphanium,C1=CC=C(C=C1)[P+](CCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
2457,152458,2-Methylicosanoic acid,CCCCCCCCCCCCCCCCCCC(C)C(=O)O,,,,,,
2458,152459,2-Ethyladipic acid,CCC(CCCC(=O)O)C(=O)O,,,,,,
2459,152460,N-phenyl-2-(methylthio)benzamide,CSC1=CC=CC=C1C(=O)NC2=CC=CC=C2,,,,,,
2460,152461,gamma-Glu-cys disulfide,C(CC(=O)N[C@@H](CSSCC(C(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C(=O)O)[C@@H](C(=O)O)N,,,,,,
2461,152462,CID 152462,C1=CC=C(C=C1)C2C(=O)C(=C(O2)O)O,,,,,,
2462,152463,"2-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid",CC(C1=CC(=C(C=C1)O)O)(C(=O)O)O,,,,,,
2463,152464,"3,4-Dimethylhippuric acid",CC1=C(C=C(C=C1)C(=O)NCC(=O)O)C,,,,,,
2464,152465,"3,5-Dimethylhippuric acid",CC1=CC(=CC(=C1)C(=O)NCC(=O)O)C,,,,,,
2465,152466,1-(2-Nitroethenyl)-4-prop-2-ynoxybenzene,C#CCOC1=CC=C(C=C1)C=C[N+](=O)[O-],,,,,,
2466,152467,N-Acetyl-S-allyl-L-cysteine,CC(=O)N[C@@H](CSCC=C)C(=O)O,,,,,,
2467,152468,2-Amino-4-phenylsulfonylbenzenesulfonamide,C1=CC=C(C=C1)S(=O)(=O)C2=CC(=C(C=C2)S(=O)(=O)N)N,,,,,,
2468,152469,Glycerylcysteine,C([C@@H](C(=O)O)NCC(CO)O)S,,,,,,
2469,152470,Farnesylacetic acid,CC(=CCCC(=CCCC(=CCCC(=O)O)C)C)C,,,,,,
2470,152471,CID 152471,C1=CC=C(C(=C1)C=C(C(=CC2=CC=CC=C2O)S(=O)(=O)O)C(N)(N)S(=O)(=O)O)O,,,,,,
2471,152472,Rhodirubin A,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CC[C@@H]([C@@H](O7)C)O)O)N(C)C)O,,,,,,
2472,152473,Nogalamycinic acid,C[C@H]1[C@@H]([C@@]([C@H]([C@@H](O1)O[C@H]2C[C@]([C@@H](C3=CC4=C(C(=C23)O)C(=O)C5=C(C=C6C(=C5C4=O)O[C@H]7[C@H]([C@@H]([C@H]([C@@]6(O7)C)O)N(C)C)O)O)C(=O)O)(C)O)OC)(C)OC)OC,,,,,,
2473,152474,Disnogamycin,C[C@H]1[C@@H]([C@@]([C@H]([C@@H](O1)O[C@H]2C[C@](CC3=CC4=C(C(=C23)O)C(=O)C5=C(C=C6C(=C5C4=O)O[C@H]7[C@H]([C@@H]([C@H]([C@@]6(O7)C)O)N(C)C)O)O)(C)O)OC)(C)OC)OC,,,,,,
2474,152475,"(R)-2-(2-Deoxy-4-C-5H-tetrazol-5-yl-beta-D-erythro-pentofuranosyl)-1,2,4-triazine-3,5(2H,4H)dione",C1C(C(OC1N2C(=O)NC(=O)C=N2)(CO)C3N=NN=N3)O,,,,,,
2475,152476,"1H-Purine-2,6-dione, 8,8'-(1,2-ethanediyldiimino)bis(3,7-dihydro-1,3-dimethyl-",CN1C2=C(C(=O)N(C1=O)C)NN=C2NCCNC3=NNC4=C3N(C(=O)N(C4=O)C)C,,,,,,
2476,152477,Baumycin B2,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC(CC(C)O)OC(C)C(=O)O,,,,,,
2477,152478,"Quinoline, 4,4'-hexamethylenediiminobis(7-amino-2-methyl-, dihydrochloride, methanol, trihydrate",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N.Cl.Cl,,,,,,
2478,152479,"4-N-[6-[(7-amino-2-methylquinolin-4-yl)amino]hexyl]-2-methylquinoline-4,7-diamine",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N,,,,,,
2479,152480,"Quinoline, 4,4'-heptamethylenediiminobis(7-amino-2-methyl-, dihydrochloride, methanol, monohydrate",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N.Cl.Cl,,,,,,
2480,152481,"N(4)-(7-((7-Amino-2-methyl-4-quinolinyl)amino)heptyl)-2-methyl-4,7-quinolinediamine",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N,,,,,,
2481,152482,"Quinoline, 4,4'-octamethylenediiminobis(7-amino-2-methyl-, dihydrochloride, dimethanol, monohydrate",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N.Cl.Cl,,,,,,
2482,152483,"4,7-Quinolinediamine, N4,N4'-1,8-octanediylbis[2-methyl-, diacetate",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCCCCCNC3=C4C=CC(=CC4=NC(=C3)C)N,,,,,,
2483,152484,"4,7-Quinolinediamine, N4,N4'-(iminodi-3,1-propanediyl)bis(2-methyl-, trihydrochloride",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)N.Cl.Cl.Cl,,,,,,
2484,152485,"4-N-[4-[3-[(7-amino-2-methylquinolin-4-yl)amino]propylamino]butyl]-2-methylquinoline-4,7-diamine",CC1=CC(=C2C=CC(=CC2=N1)N)NCCCCNCCCNC3=C4C=CC(=CC4=NC(=C3)C)N,,,,,,
2485,152486,4-Demethoxyadriamycin hydrochloride,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)N)O.Cl,,,,,,
2486,152487,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-(3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl)-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC(CC(C)O)OC(C)CO,,,,,,
2487,152488,(R)-2'-Deoxy-4'-C-5H-tetrazol-5-yladenosine,C1C(C(OC1N2C=NC3=C(N=CN=C32)N)(CO)C4N=NN=N4)O,,,,,,
2488,152489,"Pyrimidine, 6-aziridino-4-chloro-2-(2-naphthyl)-",C1CN1C2=CC(=NC(=N2)C3=CC4=CC=CC=C4C=C3)Cl,,,,,,
2489,152490,"Pyrimidine, 6-aziridino-4-chloro-2-(p-chloroanilino)-",C1CN1C2=CC(=NC(=N2)NC3=CC=C(C=C3)Cl)Cl,,,,,,
2490,152491,"1,6-Dicloro-N-(2-chloroethyl)-2-heptanamine hydrochloride",CC(CCCC(CCl)NCCCl)Cl.Cl,,,,,,
2491,152492,"1,6-dichloro-N-(2-chloroethyl)heptan-2-amine",CC(CCCC(CCl)NCCCl)Cl,,,,,,
2492,152493,"s,4-Pyrimidinediamine, 6-chloro-N,N,N',N'-tetramethyl-5-phenyl-",CN(C)C1=C(C(=NC(=N1)N(C)C)Cl)C2=CC=CC=C2,,,,,,
2493,152494,"1,3,5-Triazine, 2-aziridino-4-chloro-6-(p-methoxyphenyl)-",COC1=CC=C(C=C1)C2=NC(=NC(=N2)Cl)N3CC3,,,,,,
2494,152495,"Aziridine, 1,1'-(1,5-naphthalenediylbis(sulfonyl))bis-",C1CN1S(=O)(=O)C2=CC=CC3=C2C=CC=C3S(=O)(=O)N4CC4,,,,,,
2495,152496,"Aziridine, 1,1'-(2,7-naphthalenediylbis(sulfonyl))bis-",C1CN1S(=O)(=O)C2=CC3=C(C=C2)C=CC(=C3)S(=O)(=O)N4CC4,,,,,,
2496,152497,CID 152497,C1=CC=C2C(=C1)C=CC(=C2O)N(N=C3C=CC4=CC=CC=C4C3=O)O,,,,,,
2497,152498,"Benz(a)anthracene-9,10-dimethanol",C1=CC=C2C(=C1)C=CC3=CC4=CC(=C(C=C4C=C32)CO)CO,,,,,,
2498,152499,"3,6-Acridinediamine, N,N'-diphenyl-",C1=CC=C(C=C1)NC2=CC3=C(C=C2)C=C4C=CC(=CC4=N3)NC5=CC=CC=C5,,,,,,
2499,152500,5-((Bis(2-chloroethyl)amino)methyl)-4-(methoxymethyl)-2-methyl-3-pyridinol dihydrochloride,CC1=NC=C(C(=C1O)COC)CN(CCCl)CCCl.Cl.Cl,,,,,,
2500,152501,5-[Bis(2-chloroethyl)aminomethyl]-4-(methoxymethyl)-2-methylpyridin-3-ol,CC1=NC=C(C(=C1O)COC)CN(CCCl)CCCl,,,,,,
2501,152502,"1,3,5-Triazine-2,4,6-triamine, N,N,N',N'-tetramethyl-N''-2-naphthalenyl-",CN(C)C1=NC(=NC(=N1)NC2=CC3=CC=CC=C3C=C2)N(C)C,,,,,,
2502,152503,"1,3,5-Triazine, 2,4-bis(1-aziridinyl)-6-(1-methylethoxy)-",CC(C)OC1=NC(=NC(=N1)N2CC2)N3CC3,,,,,,
2503,152504,"1,3,5-Triazine, 2,4-bis(1-aziridinyl)-6-methyl-",CC1=NC(=NC(=N1)N2CC2)N3CC3,,,,,,
2504,152505,"1,3,5-Triazine, 2,4-bis(1-aziridinyl)-6-phenyl-",C1CN1C2=NC(=NC(=N2)C3=CC=CC=C3)N4CC4,,,,,,
2505,152506,"4,6-Bis(1-aziridinyl)-2-phenyl-5-pyrimidinamine",C1CN1C2=C(C(=NC(=N2)C3=CC=CC=C3)N4CC4)N,,,,,,
2506,152507,2-Methoxy-4-((3-methoxyphenyl)azo)benzenamine,COC1=CC=CC(=C1)N=NC2=CC(=C(C=C2)N)OC,,,,,,
2507,152508,N2-Acetyl-3-hydroxyarginine,CC(=O)N[C@@H](C(CCN=C(N)N)O)C(=O)O,,,,,,
2508,152509,2-(Methylamino)ethyl 2-(bromomethyl)benzoate,CNCCOC(=O)C1=CC=CC=C1CBr,,,,,,
2509,152510,"1,2,11,12-Tetrahydro-9-methylbenz(j)aceanthrylene-11,12-diol",CC1=CC2=C(C=C1)C3=C(C(C2O)O)C4=C5C(=CC=CC5=C3)CC4,,,,,,
2510,152511,"1-Aziridinecarboxamide, N,N'-(4-chloro-1,3-phenylene)bis-",C1CN1C(=O)NC2=CC(=C(C=C2)Cl)NC(=O)N3CC3,,,,,,
2511,152512,"1,3-Propanedisulfonic acid, monoethyl ester",CCOS(=O)(=O)CCCS(=O)(=O)O,,,,,,
2512,152513,CID 152513,C1COCCN1CCC2=CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,,,,,,
2513,152514,CID 152514,C1COCCN1CCC2=CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
2514,152515,"1H-Pyrrol-1-yloxy, 3-((2-anthracenylamino)carbonyl)-2,5-dihydro-2,2,5,5-tetramethyl-",CC1(C=C(C(N1[O])(C)C)C(=O)NC2=CC3=CC4=CC=CC=C4C=C3C=C2)C,,,,,,
2515,152516,"1H-Pyrrol-1-yloxy, 3-((6-chrysenylamino)carbonyl)-2,5-dihydro-2,2,5,5-tetramethyl-",CC1(C=C(C(N1[O])(C)C)C(=O)NC2=CC3=C(C=CC4=CC=CC=C43)C5=CC=CC=C52)C,,,,,,
2516,152517,"7,14-Ethanodibenz(a,h)anthracene-15,16-dicarboxylic acid",C1=CC=C2C(=C1)C=CC3=C4C(C(C(=C32)C5=C4C6=CC=CC=C6C=C5)C(=O)O)C(=O)O,,,,,,
2517,152518,"9,10-Diethylbenz(a)anthracene-3,4-diol",CCC1=C(C=C2C=C3C(=CC2=C1)C=CC4=C3C=CC(=C4O)O)CC,,,,,,
2518,152519,"Benzo(a)pyrene-4,4,5(5H)-triol",C1=CC=C2C3=C4C(=CC2=C1)C(C(C5=CC=CC(=C54)C=C3)(O)O)O,,,,,,
2519,152520,"4,4,5(5H)-Pyrenetriol",C1=CC2=C3C(=C1)C(C(C4=CC=CC(=C43)C=C2)(O)O)O,,,,,,
2520,152521,"9-beta-D-glucopyranosyl-9H-purine-2,6-diamine",C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)N)N,,,,,,
2521,152522,"2,5-Acridinediamine",C1=CC2=CC3=C(C=CC(=C3)N)N=C2C(=C1)N,,,,,,
2522,152523,"1,6-Dichloro-N-(2-chloroethyl)-2-hexanamine hydrochloride",C(CCCl)CC(CCl)NCCCl.Cl,,,,,,
2523,152524,"1,6-dichloro-N-(2-chloroethyl)hexan-2-amine",C(CCCl)CC(CCl)NCCCl,,,,,,
2524,152525,"1-Butanol, 2,2'-(1,2-ethanediylbis(nitrosoimino))bis-, diacetate (ester)",C(CCCCCN(CCCCCC(=O)O)N=O)CCCCN(CCCCCC(=O)O)N=O,,,,,,
2525,152526,"Benzenesulfonic acid, 4-aziridino-3,5-dinitro-, potassium salt",C1CN1C2=C(C=C(C=C2[N+](=O)[O-])S(=O)(=O)[O-])[N+](=O)[O-].[K+],,,,,,
2526,152527,"4-(Aziridin-1-yl)-3,5-dinitrobenzenesulfonic acid",C1CN1C2=C(C=C(C=C2[N+](=O)[O-])S(=O)(=O)O)[N+](=O)[O-],,,,,,
2527,152528,"6-Oxabicyclo(3.1.1)heptane-2,3-dicarboxylic acid, disodium salt",C1C2CC(O2)C(C1C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
2528,152529,"Hexahydro-3,5-epoxyphthalic acid",C1C2CC(O2)C(C1C(=O)O)C(=O)O,,,,,,
2529,152530,"Benzoic acid, 4-((chlorosulfonyl)amino)-, disodium salt",C1=CC(=CC=C1C(=O)[O-])NS(=O)(=O)Cl.C1=CC(=CC=C1C(=O)[O-])NS(=O)(=O)Cl.[Na+].[Na+],,,,,,
2530,152531,4-(Chlorosulfonylamino)benzoic acid,C1=CC(=CC=C1C(=O)O)NS(=O)(=O)Cl,,,,,,
2531,152532,"N,N-Bis(1,1-dimethylethyl)-2,2-dimethyl-1-aziridinemethanamine",CC1(CN1CN(C(C)(C)C)C(C)(C)C)C,,,,,,
2532,152533,"Hydroxylamine, N-(2-phenanthryl)-",C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)NO,,,,,,
2533,152534,N-Hydroxy-9H-fluorene-4-acetamide,C1C2=C(C(=CC=C2)CC(=O)NO)C3=CC=CC=C31,,,,,,
2534,152535,"Pyrimidine, 2-amino-6-aziridino-4-methyl-5-nitro-",CC1=C(C(=NC(=N1)N)N2CC2)[N+](=O)[O-],,,,,,
2535,152536,CID 152536,C=CC=NC1C(=O)N(C(=O)N1C2=CC=C(O2)[N+](=O)[O-])C3=CC=C(O3)[N+](=O)[O-],,,,,,
2536,152537,"2-Propanone, 1,3-bis(5-nitro-2-furanyl)-",C1=C(OC(=C1)[N+](=O)[O-])CC(=O)CC2=CC=C(O2)[N+](=O)[O-],,,,,,
2537,152538,"3,6-Acridinediamine, N-butyl-",CCCCNC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N,,,,,,
2538,152539,"3,6-Pyridazinedione, 1,2-dihydro-1-(1-oxohexyl)-",CCCCCC(=O)N1C(=O)C=CC(=O)N1,,,,,,
2539,152540,"Aziridine, 1-nonadecyl-",CCCCCCCCCCCCCCCCCCCN1CC1,,,,,,
2540,152541,6-Ethoxy-4-nitro-1H-benzimidazole,CCOC1=CC2=C(C(=C1)[N+](=O)[O-])N=CN2,,,,,,
2541,152542,6-Methoxy-4-nitro-1H-benzimidazole,COC1=CC2=C(C(=C1)[N+](=O)[O-])N=CN2,,,,,,
2542,152543,"3,6-Acridinediamine, N-methyl-",CNC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N,,,,,,
2543,152544,3-Phenoxybutanoic acid,CC(CC(=O)O)OC1=CC=CC=C1,,,,,,
2544,152545,N-9H-Fluoren-2-ylbutanediamide,C1C2=CC=CC=C2C3=C1C=C(C=C3)NC(=O)CCC(=O)N,,,,,,
2545,152546,"9,10-Dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid disodium salt",C1=CC=C2C3C(C(C(C2=C1)C4=CC=CC=C34)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
2546,152547,"3,4-Dihydro-2-methyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl 2-(acetyloxy)benzoate",CC(C)CCCC(C)CCCC(C)CCCC1(CCC2=C(O1)C=CC(=C2)OC(=O)C3=CC=CC=C3OC(=O)C)C,,,,,,
2547,152548,"Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-N-hydroxy-",CCN(CC)CCN(C(=O)C1=CC=C(C=C1)N)O,,,,,,
2548,152549,4-Amino-1-(2-furanyl)-2(1H)-pyrimidinone,C1=COC(=C1)N2C=CC(=NC2=O)N,,,,,,
2549,152550,4-Amino-1-(tetrahydro-5-oxo-2-furanyl)-2(1H)-pyrimidinone,C1CC(=O)OC1N2C=CC(=NC2=O)N,,,,,,
2550,152551,"(4R,6S,7R,8S)-5-oxapentacyclo[9.8.0.03,9.04,6.012,17]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@@H]([C@H]([C@H]5[C@@H]4O5)O)O,,,,,,
2551,152552,"(+-)-trans-anti-3,4-Dihydro-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydro-7-methylbenz(a)anthracene",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)[C@H]5[C@@H](O5)C(C3O)O,,,,,,
2552,152553,"Gold, chlorobis(triethylphosphine)-",CCP(CC)CC.CCP(CC)CC.Cl[Au],,,,,,
2553,152554,"Benzenesulfonic acid, 3-nitro-, 1,3-propanediyl ester",C1=CC(=CC(=C1)S(=O)(=O)OCCCOS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2554,152555,"Benzenesulfonic acid, 2-nitro-, 1,3-propanediyl ester",C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)OCCCOS(=O)(=O)C2=CC=CC=C2[N+](=O)[O-],,,,,,
2555,152556,"Benzenesulfonic acid, 4-(acetylamino)-, 1,2-ethanediyl ester",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)OCCOS(=O)(=O)C2=CC=C(C=C2)NC(=O)C,,,,,,
2556,152557,"Benzenesulfonic acid, 4-(acetylamino)-, 1-methylethyl ester",CC(C)OS(=O)(=O)C1=CC=C(C=C1)NC(=O)C,,,,,,
2557,152558,"7H-Benzo(c)carbazole-10-carboxylic acid, 5,6-dihydro-, 2-(diethylamino)ethyl ester, hydrochloride",CCN(CC)CCOC(=O)C1=CC2=C(C=C1)NC3=C2C4=CC=CC=C4CC3.Cl,,,,,,
2558,152559,"2-(diethylamino)ethyl 6,7-dihydro-5H-benzo[c]carbazole-10-carboxylate",CCN(CC)CCOC(=O)C1=CC2=C(C=C1)NC3=C2C4=CC=CC=C4CC3,,,,,,
2559,152560,"Benz(a)anthracene-10,11-diol, 10,11-dihydro-7-methyl-, trans-",CC1=C2C=CC3=CC=CC=C3C2=CC4=C1C=C[C@@H]([C@H]4O)O,,,,,,
2560,152561,4-(9-Acridinylamino)-3-hydroxybenzoic acid monohydrochloride,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=C(C=C(C=C4)C(=O)O)O.Cl,,,,,,
2561,152562,4-(Acridin-9-ylamino)-3-hydroxybenzoic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=C(C=C(C=C4)C(=O)O)O,,,,,,
2562,152563,"Benzoic acid, 4-(9-acridinylamino)-3-methoxy-, monohydrochloride",COC1=C(C=CC(=C1)C(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2563,152564,4-(Acridin-9-ylamino)-3-methoxybenzoic acid,COC1=C(C=CC(=C1)C(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2564,152565,"Benzoic acid, 4-((3-amino-9-acridinyl)amino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)N)NC4=CC=C(C=C4)C(=O)O.Cl,,,,,,
2565,152566,4-[(3-Aminoacridin-9-yl)amino]benzoic acid,C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)N)NC4=CC=C(C=C4)C(=O)O,,,,,,
2566,152567,"Benzoic acid, 4-((3-(acetylamino)-9-acridinyl)amino)-, monohydrochloride",CC(=O)NC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=CC=C(C=C4)C(=O)O.Cl,,,,,,
2567,152568,4-[(3-Acetamidoacridin-9-yl)amino]benzoic acid,CC(=O)NC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=CC=C(C=C4)C(=O)O,,,,,,
2568,152569,"Benzoic acid, 4-((4-methyl-9-acridinyl)amino)-, monohydrochloride",CC1=CC=CC2=C(C3=CC=CC=C3N=C12)NC4=CC=C(C=C4)C(=O)O.Cl,,,,,,
2569,152570,4-[(4-Methylacridin-9-yl)amino]benzoic acid,CC1=CC=CC2=C(C3=CC=CC=C3N=C12)NC4=CC=C(C=C4)C(=O)O,,,,,,
2570,152571,"4-Acridinecarboxamide, 9-((4-((methylsulfonyl)amino)phenyl)amino)-, monohydrochloride",CS(=O)(=O)NC1=CC=C(C=C1)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N.Cl,,,,,,
2571,152572,"Methanesulfonanilide, 4'-((4-carbamoyl-9-acridinyl)amino)-",CS(=O)(=O)NC1=CC=C(C=C1)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N,,,,,,
2572,152573,"Benzoic acid, 2-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4C(=O)O.Cl,,,,,,
2573,152574,2-(9-Acridinylamino)benzoic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4C(=O)O,,,,,,
2574,152575,"Benzeneacetic acid, 3-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)CC(=O)O.Cl,,,,,,
2575,152576,2-[3-(Acridin-9-ylamino)phenyl]acetic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)CC(=O)O,,,,,,
2576,152577,"Benzenepropanoic acid, 3-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)CCC(=O)O.Cl,,,,,,
2577,152578,3-[3-(Acridin-9-ylamino)phenyl]propanoic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)CCC(=O)O,,,,,,
2578,152579,CID 152579,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)C=CC(=O)O.Cl,,,,,,
2579,152580,CID 152580,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC(=C4)C=CC(=O)O,,,,,,
2580,152581,"Benzeneacetic acid, 2-(9-acridinylamino)-, monohydrochloride",C1=CC=C(C(=C1)CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2581,152582,2-[2-(Acridin-9-ylamino)phenyl]acetic acid,C1=CC=C(C(=C1)CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2582,152583,"Benzenepropanoic acid, 2-(9-acridinylamino)-, monohydrochloride",C1=CC=C(C(=C1)CCC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2583,152584,3-[2-(Acridin-9-ylamino)phenyl]propanoic acid,C1=CC=C(C(=C1)CCC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2584,152585,CID 152585,C1=CC=C(C(=C1)C=CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2585,152586,CID 152586,C1=CC=C(C(=C1)C=CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2586,152587,"Benzeneacetic acid, 4-(9-acridinylamino)-3-methoxy-, monohydrochloride",COC1=C(C=CC(=C1)CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2587,152588,2-[4-(Acridin-9-ylamino)-3-methoxyphenyl]acetic acid,COC1=C(C=CC(=C1)CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2588,152589,"Benzeneacetic acid, 4-((3-(methylamino)-9-acridinyl)amino)-, monohydrochloride",CNC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=CC=C(C=C4)CC(=O)O.Cl,,,,,,
2589,152590,2-[4-[[3-(Methylamino)acridin-9-yl]amino]phenyl]acetic acid,CNC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=CC=C(C=C4)CC(=O)O,,,,,,
2590,152591,"4-((4-(2,3-Dihydroxypropoxy)-9-acridinyl)amino)benzeneacetic acid",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)OCC(CO)O)NC4=CC=C(C=C4)CC(=O)O,,,,,,
2591,152592,4-(9-Acridinylamino)-3-methoxybenzenepropanoic acid monohydrochloride,COC1=C(C=CC(=C1)CCC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2592,152593,3-[4-(Acridin-9-ylamino)-3-methoxyphenyl]propanoic acid,COC1=C(C=CC(=C1)CCC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2593,152594,CID 152594,COC1=C(C=CC(=C1)C=CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2594,152595,CID 152595,COC1=C(C=CC(=C1)C=CC(=O)O)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2595,152596,"5-(9-Acridinylamino)-2-hydroxy-2,4,6-cycloheptatrien-1-one monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C(=O)C=C4)O.Cl,,,,,,
2596,152597,CID 152597,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C=CC(=O)N.Cl,,,,,,
2597,152598,CID 152598,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C=CC(=O)N,,,,,,
2598,152599,"Benzenepropanamide, 4-(9-acridinylamino)-3-methoxy-, monohydrochloride",COC1=C(C=CC(=C1)CCC(=O)N)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2599,152600,3-[4-(Acridin-9-ylamino)-3-methoxyphenyl]propanamide,COC1=C(C=CC(=C1)CCC(=O)N)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
2600,152601,"Benzenemethanesulfonamide, 4-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CS(=O)(=O)N.Cl,,,,,,
2601,152602,"Methanesulfonamide, 1-(p-(9-acridinylamino)phenyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CS(=O)(=O)N,,,,,,
2602,152603,"Benzeneethanesulfonamide, 4-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CCS(=O)(=O)N.Cl,,,,,,
2603,152604,"1-Ethanesulfonamide, 2-(p-(9-acridinylamino)phenyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CCS(=O)(=O)N,,,,,,
2604,152605,4-(9-Acridinylamino)-N-2-pyridinylbenzenemethanesulfonamide monohydrochloride,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CS(=O)(=O)NC5=CC=CC=N5.Cl,,,,,,
2605,152606,"Methanesulfonamide, 1-(p-(9-acridinylamino)phenyl)-N-(2-pyridyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)CS(=O)(=O)NC5=CC=CC=N5,,,,,,
2606,152607,"Benzonitrile, 4-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C#N.Cl,,,,,,
2607,152608,"9-Acridinamine, N-(4-bromophenyl)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)Br.Cl,,,,,,
2608,152609,9-(p-Chloroanilino)acridine hydrochloride,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)Cl.Cl,,,,,,
2609,152610,"Methanesulfonanilide, 3'-methoxy-4-((benzo(b)1,7-naphthyridin-5-yl)amino)-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CN=CC3=NC4=CC=CC=C42,,,,,,
2610,152611,"N,N,N,N',N',N'-Hexamethyl-(1,1'-biphenyl)-4,4'-diaminium dichloride",C[N+](C)(C)C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](C)(C)C.[Cl-].[Cl-],,,,,,
2611,152612,[4-[2-[4-(Dimethylamino)phenyl]ethenyl]phenyl]-trimethylazanium;chloride,CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](C)(C)C.[Cl-],,,,,,
2612,152613,[4-[2-[4-(Dimethylamino)phenyl]ethenyl]phenyl]-trimethylazanium,CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](C)(C)C,,,,,,
2613,152614,"N,N,N,N',N',N',N'',N'',N'',N''',N''',N'''-Dodecamethyl-(9,9'-bianthracene)-2,2',7,7'-tetraminium tetrachloride",C[N+](C)(C)C1=CC2=C(C3=C(C=CC(=C3)[N+](C)(C)C)C=C2C=C1)C4=C5C=C(C=CC5=CC6=C4C=C(C=C6)[N+](C)(C)C)[N+](C)(C)C.[Cl-].[Cl-].[Cl-].[Cl-],,,,,,
2614,152615,"[9-[2,7-Bis(trimethylazaniumyl)anthracen-9-yl]-7-(trimethylazaniumyl)anthracen-2-yl]-trimethylazanium",C[N+](C)(C)C1=CC2=C(C3=C(C=CC(=C3)[N+](C)(C)C)C=C2C=C1)C4=C5C=C(C=CC5=CC6=C4C=C(C=C6)[N+](C)(C)C)[N+](C)(C)C,,,,,,
2615,152616,"2,7-Anthracenediaminium, N,N,N,N',N',N'-hexamethyl-, dichloride",C[N+](C)(C)C1=CC2=CC3=C(C=CC(=C3)[N+](C)(C)C)C=C2C=C1.[Cl-].[Cl-],,,,,,
2616,152617,Trimethyl-[7-(trimethylazaniumyl)anthracen-2-yl]azanium,C[N+](C)(C)C1=CC2=CC3=C(C=CC(=C3)[N+](C)(C)C)C=C2C=C1,,,,,,
2617,152618,"9,10-Dihydro-N,N,N,N',N',N'-hexamethyl-2,7-anthracenediaminium dichloride",C[N+](C)(C)C1=CC2=C(CC3=C(C2)C=C(C=C3)[N+](C)(C)C)C=C1.[Cl-].[Cl-],,,,,,
2618,152619,"Trimethyl-[7-(trimethylazaniumyl)-9,10-dihydroanthracen-2-yl]azanium",C[N+](C)(C)C1=CC2=C(CC3=C(C2)C=C(C=C3)[N+](C)(C)C)C=C1,,,,,,
2619,152620,alpha-((2-Mercapto-1-oxopropyl)amino)benzeneacetamide,CC(C(=O)NC(C1=CC=CC=C1)C(=O)N)S,,,,,,
2620,152621,"9,10-Anthracenedione, 1,4-bis((2-(1-piperidinyl)ethyl)amino)-",C1CCN(CC1)CCNC2=C3C(=C(C=C2)NCCN4CCCCC4)C(=O)C5=CC=CC=C5C3=O,,,,,,
2621,152622,"9,10-Anthracenedione, 1,4-bis((2-((2-hydroxyethyl)thio)ethyl)amino)-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCSCCO)NCCSCCO,,,,,,
2622,152623,"Acetic acid, (ethoxyhydroxyphosphinyl)-",CCOP(=O)(CC(=O)O)O,,,,,,
2623,152624,"Benzeneamine, 4-butyl-N,N-bis(2-chloroethyl)-",CCCCC1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
2624,152625,"Acetamide, N-(4-((7-nitro-4-benzofurazanyl)amino)butyl)-",CC(=O)NCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
2625,152626,"Benzofurazan, 4-nitro-7-(4-(phenylmethyl)-1-piperazinyl)-",C1CN(CCN1CC2=CC=CC=C2)C3=CC=C(C4=NON=C34)[N+](=O)[O-],,,,,,
2626,152627,"Benzofurazan, 4-(4-(4-chlorophenyl)-1-piperazinyl)-7-nitro-",C1CN(CCN1C2=CC=C(C=C2)Cl)C3=CC=C(C4=NON=C34)[N+](=O)[O-],,,,,,
2627,152628,"Benzofurazan, 4-nitro-7-(4-phenyl-1-piperazinyl)-",C1CN(CCN1C2=CC=CC=C2)C3=CC=C(C4=NON=C34)[N+](=O)[O-],,,,,,
2628,152629,"1-Anthracenesulfonic acid, 5-hydroxy-9,10-dihydro-9,10-dioxo-, disodium salt",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)[O-].C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2629,152630,1-Hydroxyanthraquinone-5-sulfonic acid,C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)O,,,,,,
2630,152631,CID 152631,COC1=C(OC2=CC(=O)C=CC2=C1O)C3=CC=CC=C3,,,,,,
2631,152632,"Benzamide, N-(2-(hydroxyamino)-2-oxoethyl)-2,3-dimethoxy-",COC1=CC=CC(=C1OC)C(=O)NCC(=O)NO,,,,,,
2632,152633,"3H-Imidazo(1,2-a)imidazol-3-one, 2,5,6,7-tetrahydro-",C1CN2C(=O)CN=C2N1,,,,,,
2633,152634,N-(3-Amino-2-methylphenyl)acetamide,CC1=C(C=CC=C1NC(=O)C)N,,,,,,
2634,152635,N-(2-Chloro-1(2H)(or 1(4H))-naphthalenylidene)-2-methoxybenzenamine,COC1=CC=CC=C1N=C2C(CCC3=CC=CC=C32)Cl,,,,,,
2635,152636,"1,3,5-Triazine, 2,4-bis(1-aziridinyl)-6-(4-methyphenyl)-",CC1=CC=C(C=C1)C2=NC(=NC(=N2)N3CC3)N4CC4,,,,,,
2636,152637,"Pyrimidine, 6-aziridino-4,5-dichloro-2-phenyl-",C1CN1C2=C(C(=NC(=N2)C3=CC=CC=C3)Cl)Cl,,,,,,
2637,152638,Antibiotic MA 144M1,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CC[C@H]([C@@H](O7)C)O)O)N(C)C)O,,,,,,
2638,152639,aclacinomycin S,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)O)N(C)C)O,,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
2639,152640,"Methyl 13-[11-acetyloxy-12-ethyl-10-hydroxy-5-methoxy-8-methyl-10-(methylcarbamoyl)-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate",CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NC)O)OC(=O)C)CC)OC)C(=O)OC)O,,,,,,
2640,152641,Antibiotic MA 144M2,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CC[C@H]([C@@H](O7)C)O)O)N(C)C)O,,,,,,
2641,152642,"(8R,9S,10S,13S,14S)-3,16-dihydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC(C2=O)O)CC=C4[C@@]3(CCC(C4)O)CO,,,,,,
2642,152643,N-(4-Aminobutyl)aziridine,C1CN1CCCCN,,,,,,
2643,152644,Phe-gly-gly,C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)NCC(=O)O)N,,,,,,
2644,152645,N-Methacryloylglycine,CC(=C)C(=O)NCC(=O)O,,,,,,
2645,152646,3-(3-(4-Nitrophenylureido)phenoxypropoxy)benzamidine,C1=CC(=CC(=C1)OCCCOC2=CC=CC(=C2)N(C3=CC=C(C=C3)[N+](=O)[O-])C(=O)N)C(=N)N,,,,,,
2646,152647,Cyanoethyl-4-phenetidine,CCOC1=CC=C(C=C1)NCCC#N,,,,,,
2647,152648,CID 152648,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O,,,,,,
2648,152649,Iminoglutarate,C(CC(=O)[O-])C(=N)C(=O)[O-],,,,,,
2649,152650,"Pentanedioic acid, 2-imino-",C(CC(=O)O)C(=N)C(=O)O,,,,,,
2650,152651,"(2R,3R,4R)-2,3,4,5-tetrahydroxyhexanethial",CC([C@H]([C@H]([C@H](C=S)O)O)O)O,,,,,,
2651,152652,Ferrous histidinate,C1=C(NC=N1)C[C@@H](C(=O)[O-])N.C1=C(NC=N1)C[C@@H](C(=O)[O-])N.[Fe+2],,,,,,
2652,152653,(4-Hydroxyphenyl)acetaldehyde oxime,C1=CC(=CC=C1CC=NO)O,,,,,,
2653,152654,Tmtcu,CC1(C2C1CC3(CCC(=O)C=C3C2)C)C,,,,,,
2654,152655,"2,3-Methylenedioxyamphetamine",CC(CC1=C2C(=CC=C1)OCO2)N,,,,,,
2655,152656,"(2,3,4,5,6-pentahydroxycyclohexyl) 2-(1H-indol-3-yl)acetate",C1=CC=C2C(=C1)C(=CN2)CC(=O)OC3C(C(C(C(C3O)O)O)O)O,,,,,,
2656,152657,Histidinal,C1=C(NC=N1)C[C@@H](C=O)N,,,,,,
2657,152658,S-(2-Acetamidoethyl) but-2-enethioate,CC=CC(=O)SCCNC(=O)C,,,,,,
2658,152659,Glycidol phosphate,C1C(O1)COP(=O)(O)O,,,,,,
2659,152660,Arginyl-prolyl-proline,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)O,,,,,,
2660,152661,2-Amino-1-(4-chlorophenyl)propan-1-ol,CC(C(C1=CC=C(C=C1)Cl)O)N,,,,,,
2661,152662,4-(2-Hydroxy-3-tert-butylaminopropoxy)-2-methylindole,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)O,,,,,,
2662,152663,"2,3-Bis(p-methoxyphenyl)imidazo(1,2-a)pyrimidine",COC1=CC=C(C=C1)C2=C(N3C=CC=NC3=N2)C4=CC=C(C=C4)OC,,,,,,
2663,152664,N-(2-Aminoethyl)acrylamide,C=CC(=O)NCCN,,,,,,
2664,152665,"(9R,10R,13S)-17-hydroxy-10,13-dimethyl-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1C=CC3=C4CCC([C@]4(CC[C@H]23)C)O,,,,,,
2665,152666,Mesgalp,C[C@@H]1[C@H]([C@H]([C@H](O[C@H]1SOP(=O)(O)O)CO)O)O,,,,,,
2666,152667,"N-(3,5-Dichlorophenyl)maleimide",C1=CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
2667,152668,2-Benzylthio-5-trifluoromethylbenzoic acid,C1=CC=C(C=C1)CSC2=C(C=C(C=C2)C(F)(F)F)C(=O)O,,,,,,
2668,152669,"1-Methyl-7-[2-(5-nitrofuran-2-yl)ethenyl]-4-oxo-1,8-naphthyridine-3-carboxylate",CN1C=C(C(=O)C2=C1N=C(C=C2)C=CC3=CC=C(O3)[N+](=O)[O-])C(=O)[O-],,,,,,
2669,152670,"(S)-2-Amino-3-(2,4-dihydroxyphenyl)propanoic acid",C1=CC(=C(C=C1O)O)C[C@@H](C(=O)O)N,,,,,,
2670,152671,2-Acetylbenzaldehyde,CC(=O)C1=CC=CC=C1C=O,,,,,,
2671,152672,1-(2-Benzimidazolyl)-3-n-butylurea,CCCCNC(=O)NC1=NC2=CC=CC=C2N1,,,,,,
2672,152673,2-Nitrophenyl chloroacetate,C1=CC=C(C(=C1)[N+](=O)[O-])OC(=O)CCl,,,,,,
2673,152674,4-(Aminomethyl)bicyclo[2.2.2]octane-1-carboxylic acid,C1CC2(CCC1(CC2)CN)C(=O)O,,,,,,
2674,152675,Bromohydroxyacetone phosphate,C(C(=O)CBr)OP(=O)(O)O,,,,,,
2675,152676,(2-Benzoylethyl)trimethylammonium,C[N+](C)(C)CCC(=O)C1=CC=CC=C1,,,,,,
2676,152677,Tempo 4-bromoacetamide,CC1(CC(CC(N1[O])(C)C)C(C(=O)N)Br)C,,,,,,
2677,152678,(Ac)2-L-Lys-D-Ala-D-Ala,C[C@H](C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CCCCNC(=O)C)NC(=O)C,,,,,,
2678,152679,"2,6-Dichloromercuri-4-nitrophenol",C1=C(C=C(C(=C1[Hg]Cl)O)[Hg]Cl)[N+](=O)[O-],,,,,,
2679,152680,CID 152680,CC1=C2C(=C3C=CC(=CC3=N2)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)C=CN1,,,,,,
2680,152681,"N,N-Bis(2-chloroethyl)-3-iodoaniline",C1=CC(=CC(=C1)I)N(CCCl)CCCl,,,,,,
2681,152682,"Androstane-3,17-diol 17-sulfate",C[C@]12CCC(CC1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4OS(=O)(=O)O)C)O,,,,,,
2682,152683,"2-Bromo-1-(2,5-dihydroxyphenyl)ethanone",C1=CC(=C(C=C1O)C(=O)CBr)O,,,,,,
2683,152684,"4-(2-Methyl-1,3-thiazol-4-yl)aniline",CC1=NC(=CS1)C2=CC=C(C=C2)N,,,,,,
2684,152685,CID 152685,CCCCCCCCC=CCCCCCCCC(=O)OC.O[O-],,,,,,
2685,152686,CID 152686,CC1CNC2=C(N1C)C(=O)N=C(N2)N,,,,,,
2686,152687,Baumycin C2,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)NC=O)O,,,,,,
2687,152688,Antibiotic MA 144G1,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C)O)N(C)C)O,,,,,,
2688,152689,7-(Benzylamino)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)NCC8=CC=CC=C8,,,,,,
2689,152690,"Benzeneaulfonic acid, 2-nitro-, 1,4-butanediyl ester",C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)OCCCCOS(=O)(=O)C2=CC=CC=C2[N+](=O)[O-],,,,,,
2690,152691,Desacetyladriamycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)O)N)O,,,,,,
2691,152692,"[2-[2-[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[5-[[1-[[2-[2-[2-[3-(4-aminobutylamino)propylcarbamoyl]-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]-1-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)oxy-2-hydroxyethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate",CC1C(C(C(C(O1)OC(C(C2=CSC(=N2)C3=CSC(=N3)C(=O)NCCCNCCCCN)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)NC(=O)C(C(C4=CN=CN4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)OC(=O)N)O)NC(=O)C7=C(C(=NC(=N7)C(CC(=O)N)NCC(C(=O)N)N)N)C)O)O)O)N,,,,,,
2692,152693,CID 152693,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)O)N)C(=O)N[C@@H]([C@@H](C2=CN=CN2)OC3[C@@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)OC(=O)N)O)C(=O)NC(C)[C@@H]([C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,,,,,,
2693,152694,"3b,4a,6,7,8,9-Hexahydrobenzo(1,2)pyreno(4,5-b)oxirene",C1CCC2=C3C=CC4=C5C3=C(C=C2C1)C6C(C5=CC=C4)O6,,,,,,
2694,152695,"Benzenaminium, 4,4'-carbonylbis(N,N,N-trimethyl-, dichloride",C[N+](C)(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)[N+](C)(C)C.[Cl-].[Cl-],,,,,,
2695,152696,Trimethyl-[4-[4-(trimethylazaniumyl)benzoyl]phenyl]azanium,C[N+](C)(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)[N+](C)(C)C,,,,,,
2696,152697,"Benzenaminium, 4,4'-methylenebis(N,N,N-trimethyl-, dichloride",C[N+](C)(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)[N+](C)(C)C.[Cl-].[Cl-],,,,,,
2697,152698,"4,4'-Methylenebis(N,N,N-trimethylanilinium)",C[N+](C)(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)[N+](C)(C)C,,,,,,
2698,152699,Antibiotic MA 144U5,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@H](O7)C)O)O)O,,,,,,
2699,152700,Antibiotic MA 144U1,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)O)O)N(C)C)O,,,,,,
2700,152701,Dihydroergosine methanesulfonate,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)C(C)(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C.CS(=O)(=O)O,,,,,,
2701,152702,"(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-tert-butyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)C(C)(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C,,,,,,
2702,152703,ZnDTPA,[H+].[H+].[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Zn+2],,,,,,
2703,152704,"(1,2-Cyclohexanediamine-N,N')bis(methanesulfanato-O-) platinum",CS(=O)(=O)[O-].CS(=O)(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],,,,,,
2704,152705,CID 152705,C1=CC2=C(C(=C1)C(=O)O)C(=O)C3=C(C=CC(=C3C2=O)O)O.[OH-],,,,,,
2705,152706,"5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1-carboxylic acid",C1=CC2=C(C(=C1)C(=O)O)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
2706,152707,"cis-Diiodo(1,2-diaminobenzene)platinum(II)",C1=CC=C(C(=C1)N)N.[I-].[I-].[Pt+2],,,,,,
2707,152708,(SP-4-2)-Dichlorobis(3-methoxy-1-propanamine-N)platinum,COCCCN.COCCCN.[Cl-].[Cl-].[Pt+2],,,,,,
2708,152709,"Benzo(e)pyrene, 12c,12d-dihydro-12c,12d-dimethyl-, trans-",C[C@@]12C3=CC=C4[C@]1(C(=CC=C4)C5=CC=CC=C5C2=CC=C3)C,,,,,,
2709,152710,Tecleaverdoornine,CC(=CCC1=C2C(=C(C3=C1OCO3)O)N=C4C(=C2OC)C=CO4)C,,,,,,
2710,152711,"L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-4-hydroxy-, trans-",CC1CC2=C(C=C(C=C2Cl)C(=O)N3C[C@@H](C[C@H]3C(=O)O)O)C(=O)O1,,,,,,
2711,152712,"L-Methionine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CCSC)C(=O)O)C(=O)O1,,,,,,
2712,152713,"L-Tryptophan, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O)C(=O)O1,,,,,,
2713,152714,"L-Valine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](C(C)C)C(=O)O)C(=O)O1,,,,,,
2714,152715,"L-Tyrosine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)C(=O)O1,,,,,,
2715,152716,CID 152716,CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@H](C)C(=O)O)C(=O)O1,,,,,,
2716,152717,"L-Leucine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)O1,,,,,,
2717,152718,"L-Asparagine, N2-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CC(=O)N)C(=O)O)C(=O)O1,,,,,,
2718,152719,"L-Cystine, N,N'-bis((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CSSCC(C(=O)O)NC(=O)C3=CC4=C(CC(OC4=O)C)C(=C3)Cl)C(=O)O)C(=O)O1,,,,,,
2719,152720,"L-Threonine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)C(=O)O1,,,,,,
2720,152721,"L-Glutamic acid, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O1,,,,,,
2721,152722,"L-Serine, N-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N[C@@H](CO)C(=O)O)C(=O)O1,,,,,,
2722,152723,"Pyrimidine, 4,6-bis(1-aziridinyl)-2-(2-naphthalenyl)-",C1CN1C2=CC(=NC(=N2)C3=CC4=CC=CC=C4C=C3)N5CC5,,,,,,
2723,152724,"Pyrimidine, 2,4-bis(1-aziridinyl)-6-(1-methylethoxy)-",CC(C)OC1=NC(=NC(=C1)N2CC2)N3CC3,,,,,,
2724,152725,"Piperazine, 2-methyl-1,4-bis(4-((methylsulfonyl)oxy)-1-oxobutyl)-",CC1CN(CCN1C(=O)CCCOS(=O)(=O)C)C(=O)CCCOS(=O)(=O)C,,,,,,
2725,152726,"Phenanthridinium, 8-amino-5-methyl-6-phenyl-",C[N+]1=C(C2=C(C=CC(=C2)N)C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
2726,152727,"Oxirane, 2-(bromomethyl)-2-phenyl-",C1C(O1)(CBr)C2=CC=CC=C2,,,,,,
2727,152728,"Phenol, 2-amino-5-arsenoso-",C1=CC(=C(C=C1[As]=O)O)N,,,,,,
2728,152729,"L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-(((4-pyridinylcarbonyl)amino)methyl)-",C1=CC(=CC=C1C[C@@H](C(=O)O)NCNC(=O)C2=CC=NC=C2)N(CCCl)CCCl,,,,,,
2729,152730,"L-Glutamic acid, N-(1-(ethoxycarbonyl)-2-propenyl)-, compd. with N-cyclohexylcyclohexanamine (1:1)",CCOC(=O)C(C=C)N[C@@H](CCC(=O)O)C(=O)O.C1CCC(CC1)NC2CCCCC2,,,,,,
2730,152731,(2S)-2-[(1-ethoxy-1-oxobut-3-en-2-yl)amino]pentanedioic acid,CCOC(=O)C(C=C)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
2731,152732,"Pyrimidine, 4-(1-aziridinyl)-2,6-dichloro-",C1CN1C2=CC(=NC(=N2)Cl)Cl,,,,,,
2732,152733,"L-Asparagine, N2-methylene-",C=N[C@@H](CC(=O)N)C(=O)O,,,,,,
2733,152734,"L-Proline, 1-((5-chloro-3,4-dihydro-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-",CC1CC2=C(C=C(C=C2Cl)C(=O)N3CCC[C@H]3C(=O)O)C(=O)O1,,,,,,
2734,152735,"Disulfuric acid, diethyl ester",CCOS(=O)(=O)OS(=O)(=O)OCC,,,,,,
2735,152736,"Phenanthridinium, 5-propyl-, bromide",CCC[N+]1=CC2=CC=CC=C2C3=CC=CC=C31.[Br-],,,,,,
2736,152737,5-Propylphenanthridinium,CCC[N+]1=CC2=CC=CC=C2C3=CC=CC=C31,,,,,,
2737,152738,CID 152738,C[C@H]1[C@H]([C@H](C[C@H](O1)O[C@@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NN=C(N)S)C)O)N)O.Cl,,,,,,
2738,152739,CID 152739,C[C@H]1[C@H]([C@H](C[C@H](O1)O[C@@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NN=C(N)S)C)O)N)O,,,,,,
2739,152740,CID 152740,C1=C(OC(=C1CCO)[N+](=O)[O-])C=NNC(=O)N,,,,,,
2740,152741,"Pyrimidine, 4,6-bis(1-aziridinyl)-2-(2-naphthalenyl)-5-nitro-",C1CN1C2=C(C(=NC(=N2)C3=CC4=CC=CC=C4C=C3)N5CC5)[N+](=O)[O-],,,,,,
2741,152742,"Pyrimidine, 4,6-bis(1-aziridinyl)-2-(4-chlorophenyl)-5-nitro-",C1CN1C2=C(C(=NC(=N2)C3=CC=C(C=C3)Cl)N4CC4)[N+](=O)[O-],,,,,,
2742,152743,"beta-D-Ribofuranuronamide, 1-deoxy-1-(3-ethyl-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-",CCN1C(=O)C=CN(C1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(=O)N)O)O,,,,,,
2743,152744,"1-Hexyl-1,2-dinitrosoguanidine",CCCCCCN(C(=NN=O)N)N=O,,,,,,
2744,152745,"beta-D-Ribofuranuronamide, 1-deoxy-1-(3,4-dihydro-2,4-dioxo-3-propyl-1(2H)-pyrimidinyl)-",CCCN1C(=O)C=CN(C1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)C(=O)N)O)O,,,,,,
2745,152746,"Quinoxaline, 7-methoxy-5-nitro-",COC1=CC2=NC=CN=C2C(=C1)[N+](=O)[O-],,,,,,
2746,152747,"Heptanedioic acid, bis(2,3-dihydro-7-oxo-7H-furo(3,2-g)(1)benzopyran-9-yl)ester",C1COC2=C1C=C3C=CC(=O)OC3=C2OC(=O)CCCCCC(=O)OC4=C5C(=CC6=C4OCC6)C=CC(=O)O5,,,,,,
2747,152748,"Urea, tris(trimethylsilyl)((trimethylsilyl)oxy)-",C[Si](C)(C)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)O[Si](C)(C)C,,,,,,
2748,152749,"Quinoline, 2-(5-pyrimidinyl)-",C1=CC=C2C(=C1)C=CC(=N2)C3=CN=CN=C3,,,,,,
2749,152750,CID 152750,COC1=CC(=CC(=C1O)OC)C(=O)O.[Cu],,,,,,
2750,152751,Syringic acid-copper(II) complex,COC1=CC(=CC(=C1O)OC)C(=O)O.[Cu+2],,,,,,
2751,152752,"Phenylalanine, 4-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C[C@@H](C(=O)O)N.Cl,,,,,,
2752,152753,(2S)-3-[4-(acridin-9-ylamino)phenyl]-2-aminopropanoic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C[C@@H](C(=O)O)N,,,,,,
2753,152754,"Phenylalanine, 4-((3-nitro-9-acridinyl)amino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)[N+](=O)[O-])NC4=CC=C(C=C4)C[C@@H](C(=O)O)N.Cl,,,,,,
2754,152755,(2S)-2-amino-3-[4-[(3-nitroacridin-9-yl)amino]phenyl]propanoic acid,C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)[N+](=O)[O-])NC4=CC=C(C=C4)C[C@@H](C(=O)O)N,,,,,,
2755,152756,"Ethanone, 1-(4-(9-acridinylamino)phenyl)-, monohydrochloride",CC(=O)C1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
2756,152757,"Chrysene, 12-methoxy-5-methyl-",CC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C(=C3)OC,,,,,,
2757,152758,Glucosyl steviol,C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@](C3)(C(=C)C4)O)(C)C(=O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
2758,152759,"Benz(f)oxireno(h)quinoline, 1a,9b-dihydro-",C1=CC=C2C3=C(C4C(C2=C1)O4)N=CC=C3,,,,,,
2759,152760,CID 152760,CC[N+]1=C(C=CC2=CC=CC=C21)C=CC3=CC(=CC=C3)N(C)C.[Cl-],,,,,,
2760,152761,CID 152761,CC[N+]1=C(C=CC2=CC=CC=C21)C=CC3=CC(=CC=C3)N(C)C,,,,,,
2761,152762,"Imidazo(1,2-a)pyrimidin-7(1H)-one, 2,3,5,6-tetrahydro-",C1CN2CCN=C2NC1=O,,,,,,
2762,152763,"Imidazo(1,2-a)pyrimidin-7(1H)-one, 2,3,5,6-tetrahydro-5-methyl-",CC1CC(=O)NC2=NCCN12,,,,,,
2763,152764,"Imidazo(1,2-a)pyrimidin-7(1H)-one, 2,3,5,6-tetrahydro-6-methyl-",CC1CN2CCN=C2NC1=O,,,,,,
2764,152765,"Imidazo(1,2-a)pyrimidin-7(1H)-one, 2,3,5,6-tetrahydro-5-phenyl-",C1CN2C(CC(=O)NC2=N1)C3=CC=CC=C3,,,,,,
2765,152766,"Imidazo(1,2-a)pyrimidin-5(1H)-one, 2,3-dihydro-7-phenyl-",C1CN2C(=O)C=C(N=C2N1)C3=CC=CC=C3,,,,,,
2766,152767,"Imidazo(1,2-a)pyrimidin-5(1H)-one, 6-ethyl-2,3-dihydro-7-methyl-",CCC1=C(N=C2NCCN2C1=O)C,,,,,,
2767,152768,"beta-Alanine, N-(4,5-dihydro-1H-imidazol-2-yl)-",C1CN=C(N1)NCCC(=O)O,,,,,,
2768,152769,"Phenanthridinium, 3,8-diamino-5-ethyl-6-pentadecyl-, bromide",CCCCCCCCCCCCCCCC1=C2C=C(C=CC2=C3C=CC(=CC3=[N+]1CC)N)N.[Br-],,,,,,
2769,152770,"5-Ethyl-6-pentadecylphenanthridin-5-ium-3,8-diamine",CCCCCCCCCCCCCCCC1=C2C=C(C=CC2=C3C=CC(=CC3=[N+]1CC)N)N,,,,,,
2770,152771,2'-Hydroxydaunorubicin,C[C@H]1[C@H](C([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)O)N)O,,,,,,
2771,152772,6-Chloro-1-((2-(diethylamino)ethyl)methylamino)-4-methyl-9H-thioxanthen-9-one N-oxide,CCN(CC)CC[N+](C)(C1=C2C(=C(C=C1)C)SC3=C(C2=O)C=CC(=C3)Cl)[O-],,,,,,
2772,152773,"3-Pyridinamine, 6-(2-pyrimidinylthio)-",C1=CN=C(N=C1)SC2=NC=C(C=C2)N,,,,,,
2773,152774,"2,5,11-Trimethyl-6H-pyrido(4,3-b)carbazolium iodide",CC1=C2C=CN(C=C2C(=C3C1[NH2+]C4=CC=CC=C43)C)C.[I-],,,,,,
2774,152775,"Benzenamine, 2-(heptyloxy)-, hydrochloride",CCCCCCCOC1=CC=CC=C1N.Cl,,,,,,
2775,152776,2-(Heptyloxy)aniline,CCCCCCCOC1=CC=CC=C1N,,,,,,
2776,152777,"7,8-Dimethyl-5H-pyrido(4,3-b)indole",CC1=CC2=C(C=C1C)NC3=C2C=NC=C3,,,,,,
2777,152778,Actinocylbis(threonyl(O-acetyl)-D-valine methyl ester,CC1=C2C(=C(C=C1)C(=O)NC(C(C)OC(=O)C)C(=O)NC(C(C)C)C(=O)OC)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)N[C@@H]([C@@H](C)OC(=O)C)C(=O)N[C@H](C(C)C)C(=O)OC,,,,,,
2778,152779,Actinocylbis(threonyl-d-valine Methylamide),CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NC(=O)[C@@H](C(C)C)NC,,,,,,
2779,152780,Actinocylbis(threonyl-d-valine Hydrazide),CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NN)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)NN,,,,,,
2780,152781,"Acetamide, N-hydroxy-N-(4-methoxyphenyl)-",CC(=O)N(C1=CC=C(C=C1)OC)O,,,,,,
2781,152782,"2,3,5-Trimethyl-1H-indene",CC1=C(C2=C(C1)C=CC(=C2)C)C,,,,,,
2782,152783,"Methanesulfonanilide, 4'-(4-quinolinylamino)-",CS(=O)(=O)NC1=CC=C(C=C1)NC2=CC=NC3=CC=CC=C32,,,,,,
2783,152784,"2-Formyl-3,4,5-trichlorothiophene",C(=O)C1=C(C(=C(S1)Cl)Cl)Cl,,,,,,
2784,152785,"7-Chloro-2-methoxy-N-(3-(1-pyrrolidinyl)propyl)benzo(b)-1,5-naphthyridin-10-amine trihydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCN4CCCC4.Cl.Cl.Cl,,,,,,
2785,152786,"7-chloro-2-methoxy-N-(3-pyrrolidin-1-ylpropyl)benzo[b][1,5]naphthyridin-10-amine",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCN4CCCC4,,,,,,
2786,152787,"N-(3-((7-Chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)phenyl)acetamide monohydrochloride",CC(=O)NC1=CC=CC(=C1)NC2=C3C(=NC4=C2C=CC(=C4)Cl)C=CC(=N3)OC.Cl,,,,,,
2787,152788,"N-[3-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]phenyl]acetamide",CC(=O)NC1=CC=CC(=C1)NC2=C3C(=NC4=C2C=CC(=C4)Cl)C=CC(=N3)OC,,,,,,
2788,152789,"Acetamide, N-(2-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)phenyl)-, monohydrochloride",CC(=O)NC1=CC=CC=C1NC2=C3C(=NC4=C2C=CC(=C4)Cl)C=CC(=N3)OC.Cl,,,,,,
2789,152790,"N-[2-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]phenyl]acetamide",CC(=O)NC1=CC=CC=C1NC2=C3C(=NC4=C2C=CC(=C4)Cl)C=CC(=N3)OC,,,,,,
2790,152791,"Benz(e)pyrene-4,5-diol, 4,5-dihydro-, trans-",C1=CC=C2C3=C4C(=CC=C3)[C@@H]([C@H](C5=CC=CC(=C54)C2=C1)O)O,,,,,,
2791,152792,"Platinum, (1,2-cyclohexanediamine-N,N')(sulfato(2-)-O,O')-, (SP-4-3-(cis))-",C1CCC(CC1)N.C1CCC(CC1)N.[NH2-].[NH2-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Pt+4].[Pt+4],,,,,,
2792,152793,"N,N-Dipropylcyclohexanecarboxamide",CCCN(CCC)C(=O)C1CCCCC1,,,,,,
2793,152794,3-(1H-imidazol-5-yl)-2-sulfanylpropanoic acid,C1=C(NC=N1)CC(C(=O)O)S,,,,,,
2794,152795,"1-Piperidinyloxy, 4-((((1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)oxy)acetyl)amino)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O])(C)C)NC(=O)COC2=CN(C(=O)NC2=O)[C@@H]3C[C@@H]([C@H](O3)CO)O)C,,,,,,
2795,152796,"15,16-Dioxa-3-thia-10-azatricyclo(10.2.1.1(5,8))hexadeca-5,7,12,14-tetraene-9,11-dione, 10-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-",C1C2=CC=C(O2)C(=O)N(C(=O)C3=CC=C(O3)CS1)N4C(=O)C5=CC=CC=C5C4=O,,,,,,
2796,152797,"Benzenamine, N-hydroxy-N-methyl-4-((3-methylphenyl)azo)-",CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)O,,,,,,
2797,152798,"Benzenamine, N-hydroxy-N-methyl-4-((4-methylphenyl)azo)-",CC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(C)O,,,,,,
2798,152799,"Benzenamine, N-(acetyloxy)-N-methyl-4-((3-methylphenyl)azo)-",CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)OC(=O)C,,,,,,
2799,152800,"S-(9-Hydroxy-9,10-dihydro-10-phenanthryl)-L-cysteine",C1=CC=C2C(=C1)C(C(C3=CC=CC=C32)SC[C@@H](C(=O)O)N)O,,,,,,
2800,152801,5-Chlorooxindole,C1C2=C(C=CC(=C2)Cl)NC1=O,,,,,,
2801,152802,Hexadec-2-enoic acid,CCCCCCCCCCCCCC=CC(=O)O,,,,,,
2802,152803,"2,2-Dichloro-1,1-difluoroethyl difluoromethyl ether",C(C(OC(F)F)(F)F)(Cl)Cl,,,,,,
2803,152804,Pentachlorophenol glucuronide,[C@@H]1([C@@H]([C@H](OC([C@@H]1O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)C(=O)O)O)O,,,,,,
2804,152805,CID 152805,C1=NC2=C(N(C=NC2=N1)CCC(C(=O)O)N)N,,,,,,
2805,152806,Homophthalaldehyde,C1=CC=C(C(=C1)CC=O)C=O,,,,,,
2806,152807,4-Hydroxy-2-pyrrolidone,C1C(CNC1=O)O,,,,,,
2807,152808,Isopropoxyacetic anhydride,CC(C)OCC(=O)OC(=O)COC(C)C,,,,,,
2808,152809,"2',4'-Dinitrophenyl-beta-galactopyranoside",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O,,,,,,
2809,152810,"2',4'-Dinitrophenylglucopyranoside",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OC2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2810,152811,21-Fluoro-16-ethyl-19-norprogesterone,CCC1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]2([C@H]1C(=O)CF)C,,,,,,
2811,152812,4-Methyl-N-phenylbenzenecarbohydrazonoyl chloride,CC1=CC=C(C=C1)C(=NNC2=CC=CC=C2)Cl,,,,,,
2812,152813,CID 152813,CCC(=O)C(=O)OP(=O)(O)OO,,,,,,
2813,152814,"4-Benzylamino-6-methyl-7-benzylpyrrolo(2,3-d)pyrimidine",CC1=CC2=C(N=CN=C2N1CC3=CC=CC=C3)NCC4=CC=CC=C4,,,,,,
2814,152815,S-(2-Hydroxy-2-carboxyethyl)homocysteine,C(CSCC(C(=O)O)O)[C@@H](C(=O)O)N,,,,,,
2815,152816,"N,N'-Bis(dichloroacetyl)-1,12-diaminododecane",C(CCCCCCNC(=O)C(Cl)Cl)CCCCCNC(=O)C(Cl)Cl,,,,,,
2816,152817,1-Hydroxy-6-nitrobenzotriazole,C1=CC2=C(C=C1[N+](=O)[O-])N(N=N2)O,,,,,,
2817,152818,2-Amino-4-iminothiazole,C1C(=NC(=N)S1)N,,,,,,
2818,152819,"3,5-Dichloro-2-hydroxybenzenesulfonic acid",C1=C(C=C(C(=C1S(=O)(=O)O)O)Cl)Cl,,,,,,
2819,152820,"9,10-Dihydro-9,10-dihydroxy-5-methylchrysene",CC1=CC2=C(C(C(C=C2)O)O)C3=C1C4=CC=CC=C4C=C3,,,,,,
2820,152821,CID 152821,CCC(=O)N([C@@H]1CCC[C@H]1N(C)C)C2=CC(=C(C=C2)Cl)Cl.C(=CC(=O)[O-])C(=O)[O-],,,,,,
2821,152822,"Benzeneacetamide, N-(4-bromo-9,10-dihydro-2-methyl-9,10-dioxo-1-anthracenyl)-",CC1=CC(=C2C(=C1NC(=O)CC3=CC=CC=C3)C(=O)C4=CC=CC=C4C2=O)Br,,,,,,
2822,152823,"3alpha,4alpha-Epoxyphenanthrene-1beta,2alpha-diol",C1=CC=C2C(=C1)C=CC3=C2C4=C(O4)C(=C3O)O,,,,,,
2823,152824,(Guanine)pentaammineruthenium(3+) trichloride,C12=C(N=C(N1N)N)N=C(N(C2=O)N)N(N)N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
2824,152825,"1,7,8-Triamino-2-(diaminoamino)purin-6-one",C12=C(N=C(N1N)N)N=C(N(C2=O)N)N(N)N,,,,,,
2825,152826,"4-Quinolinecarboxylic acid, 6-hydroxy-5-(4-morpholinylmethyl)-, methyl ester, dihydrochloride",COC(=O)C1=C2C(=NC=C1)C=CC(=C2CN3CCOCC3)O.Cl.Cl,,,,,,
2826,152827,Methyl 6-hydroxy-5-(morpholin-4-ylmethyl)quinoline-4-carboxylate,COC(=O)C1=C2C(=NC=C1)C=CC(=C2CN3CCOCC3)O,,,,,,
2827,152828,Methyl 5-bromo-6-hydroxy-8-(4-morpholinylmethyl)-4-quinolinecarboxylate,COC(=O)C1=C2C(=C(C=C(C2=NC=C1)CN3CCOCC3)O)Br,,,,,,
2828,152829,Methyl 5-bromo-6-hydroxy-8-(1-piperidinylmethyl)-4-quinolinecarboxylate,COC(=O)C1=C2C(=C(C=C(C2=NC=C1)CN3CCCCC3)O)Br,,,,,,
2829,152830,"4-Quinolinecarboxylic acid, 2-(4-morpholinyl)-6-nitro-",C1COCCN1C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)C(=O)O,,,,,,
2830,152831,"3,8-Diamino-6-(3-((ethylamino)carbonyl)phenyl)-5-methylphenanthridinium bromide",CCNC(=O)C1=CC=CC(=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=[N+]2C)N)N.[Br-],,,,,,
2831,152832,"3-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)-N-ethylbenzamide",CCNC(=O)C1=CC=CC(=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=[N+]2C)N)N,,,,,,
2832,152833,"1,2-Triphenylenediol, 1,2-dihydro-, trans-",C1=CC=C2C(=C1)C3=C([C@H]([C@@H](C=C3)O)O)C4=CC=CC=C24,,,,,,
2833,152834,"1H-Pyrrole-2-ethanol, 3-(hydroxymethyl)-1-methyl-",CN1C=CC(=C1CCO)CO,,,,,,
2834,152835,"1H-Pyrrole-2,3-dimethanol, 1,5-dimethyl-",CC1=CC(=C(N1C)CO)CO,,,,,,
2835,152836,"5-Methyl-1-phenyl-1H-pyrrole-2,3-dimethanol",CC1=CC(=C(N1C2=CC=CC=C2)CO)CO,,,,,,
2836,152837,"1H-Imidazole, 2-nitro-4-(1-pyrrolidinylmethyl)-",C1CCN(C1)CC2=CN=C(N2)[N+](=O)[O-],,,,,,
2837,152838,Mollicellin A,CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C(=C4C(=O)CC(OC4=C3)(C)C)C)C=O)O,,,,,,
2838,152839,mollicellin B,CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C=C4C(=C3C)C(=O)CC(O4)(C)C)C=O)O,,,,,,
2839,152840,Mollicellin D,CC1=C(C(=CC2=C1OC(=O)C3=C(C(=C(C(=C3O2)CO)O)Cl)C)O)CC=C(C)C,,,,,,
2840,152841,mollicellin F,CC1=C2C(=O)CC(OC2=C(C3=C1OC4=C(C(=C(C(=C4C(=O)O3)C)Cl)O)C=O)O)(C)C,,,,,,
2841,152842,Bis(2-oxo-3-oxazolidinyl)phosphinic chloride,C1COC(=O)N1P(=O)(N2CCOC2=O)Cl,,,,,,
2842,152843,"5,6-Bis(dibenzyloxy)-1-oxo-2-propyl-2-indanpropionic acid",CCCOC(=O)CCC1CC2=CC(=C(C=C2C1=O)OCC3=CC=CC=C3)OCC4=CC=CC=C4,,,,,,
2843,152844,"3,8-Diamino-5-(3-((3-((3-((6-chloro-2-methoxyacridin-9-yl)amino)propyl)amino)propyl)amino)propyl)-6-phenylphenanthridinium chloride pentahydrochloride",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCNCCC[N+]4=C5C=C(C=CC5=C6C=CC(=CC6=C4C7=CC=CC=C7)N)N.Cl.Cl.Cl.Cl.Cl.[Cl-],,,,,,
2844,152845,"3,8-Diamino-5-[3-[[3-[[3-[(6-chloro-2-methoxy-9-acridinyl)amino]propyl]amino]propyl]amino]propyl]-6-phenylphenanthridin-5-ium",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCNCCC[N+]4=C5C=C(C=CC5=C6C=CC(=CC6=C4C7=CC=CC=C7)N)N,,,,,,
2845,152846,"Androstan-17-one, 3-(acetyloxy)-5,6-epoxy-, (5alpha,6alpha)-",CC(=O)OC1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C[C@@H]5[C@@]2(C1)O5)CCC4=O)C)C,,,,,,
2846,152847,"4-Oxo-5-[(2-oxo-1,3-oxazolidin-3-YL)imino]pentanenitrile",C1COC(=O)N1N=CC(=O)CCC#N,,,,,,
2847,152848,"Benzo(a)pyrene, 12b,12c-dihydro-12b,12c-dimethyl-, trans-",C[C@]12C3=CC=C4[C@@]1(C(=CC5=CC=CC=C54)C=CC2=CC=C3)C,,,,,,
2848,152849,Sulfadiazine zinc,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Zn+2],,,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)', 'Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)']",,,
2849,152850,"2-[[7,8,11,12,13,22,23-Heptahydroxy-3,16-dioxo-21-(3,4,5-trihydroxybenzoyl)oxy-2,17,20-trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-hexaen-6-yl]oxy]-3,4,5-trihydroxybenzoic acid",C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)OC6=C(C(=C(C=C6C(=O)O)O)O)O)O,,,,,,
2850,152851,"3,3'-Di(isopropylthio)-4,4'-diaminodiphenylmethane",CC(C)SC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)SC(C)C)N,,,,,,
2851,152852,"Dichlorobis(1,2-ethanediamine-N,N')chromium(I) chloride",C(CN)N.C(CN)N.[Cl-].[Cl-].[Cl-].[Cr+3],,,,,,
2852,152853,Actinocylbis(threonyl-D-valylproline meethyl ester),CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)N3CCCC3C(=O)OC)N=C4C(=C(C(=O)C(=C4O2)C)N)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)N5CCCC5C(=O)OC,,,,,,
2853,152854,Actinocylbis(threonyl-d-valyl-4'-oxoproline Methyl Ester,CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)N3CC(=O)CC3C(=O)OC)N=C4C(=C(C(=O)C(=C4O2)C)N)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)N5CCC(=O)C5C(=O)OC,,,,,,
2854,152855,"methyl 2-[[2-[[8-amino-9-[[(2S,3R)-3-hydroxy-1-[[(2R)-1-methoxy-3-methyl-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]carbamoyl]-4,6-dimethyl-7-oxophenoxazine-1-carbonyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoate",CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)OC)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)OC,,,,,,
2855,152856,"Methanesulfonanilide, 3,3'-tetramethylenedioxybis(4-(9-acridinylamino)-, dihydrochloride",CS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OCCCCOC5=C(C=CC(=C5)NS(=O)(=O)C)NC6=C7C=CC=CC7=NC8=CC=CC=C86.Cl.Cl,,,,,,
2856,152857,N-[4-(acridin-9-ylamino)-3-[4-[2-(acridin-9-ylamino)-5-(methanesulfonamido)phenoxy]butoxy]phenyl]methanesulfonamide,CS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OCCCCOC5=C(C=CC(=C5)NS(=O)(=O)C)NC6=C7C=CC=CC7=NC8=CC=CC=C86,,,,,,
2857,152858,"Pentanesulfonanilide, 4'-(9-acridinylamino)-5-(4-quinolinylamino)-, dihydrochloride, hemihydrate",C1=CC=C2C(=C1)C(=CC=N2)NCCCCCS(=O)(=O)NC3=CC=C(C=C3)NC4=C5C=CC=CC5=NC6=CC=CC=C64.Cl.Cl,,,,,,
2858,152859,N-[4-(acridin-9-ylamino)phenyl]-5-(quinolin-4-ylamino)pentane-1-sulfonamide,C1=CC=C2C(=C1)C(=CC=N2)NCCCCCS(=O)(=O)NC3=CC=C(C=C3)NC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
2859,152860,"Ethanesulfonanilide, 4'-(9-acridinylamino)-2-(4-quinazolinylamino)-, dihydrochloride, hemihydrate",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NS(=O)(=O)CCNC5=NC=NC6=CC=CC=C65.Cl.Cl,,,,,,
2860,152861,N-[4-(acridin-9-ylamino)phenyl]-2-(quinazolin-4-ylamino)ethanesulfonamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NS(=O)(=O)CCNC5=NC=NC6=CC=CC=C65,,,,,,
2861,152862,"1,3-Propanedisulfonanilide, 4',4''-bis(9-acridinylamino)-, dihydrochloride, hemihydrate",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NS(=O)(=O)CCCS(=O)(=O)NC5=CC=C(C=C5)NC6=C7C=CC=CC7=NC8=CC=CC=C86.Cl.Cl,,,,,,
2862,152863,"N,N'-bis[4-(acridin-9-ylamino)phenyl]propane-1,3-disulfonamide",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NS(=O)(=O)CCCS(=O)(=O)NC5=CC=C(C=C5)NC6=C7C=CC=CC7=NC8=CC=CC=C86,,,,,,
2863,152864,Aclacinomycin Y,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7C=CC(=O)C(O7)C)O)N(C)C)O,,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
2864,152865,"3,5-Dimethylpyridine;ethene;platinum(2+);dichloride",CC1=CC(=CN=C1)C.C=C.[Cl-].[Cl-].[Pt+2],,,,,,
2865,152866,"1,2-Diaminocyclohexane platinum bis(glucuronate)",C1CCC(C(C1)N)N.C(=O)C(C(C(C(C(=O)[O-])O)O)O)O.C(=O)C(C(C(C(C(=O)[O-])O)O)O)O.[Pt+2],,,,,,
2866,152867,"Galacturonic acid, D-",C(=O)C(C(C(C(C(=O)O)O)O)O)O,,,,,,
2867,152868,"1,2-Cyclohexanediamine dinitratoplatinum",C1CCC(C(C1)N)N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pt+2],,,,,,
2868,152869,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-butoxybenzamide;hydrochloride",CCCCOC1=CC=C(C=C1)C(=O)NN=C(C)C2(CC(C3=C(C2)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5OC)O)OC6CC(C(C(O6)C)O)N)O.Cl,,,,,,
2869,152870,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-butoxybenzamide",CCCCOC1=CC=C(C=C1)C(=O)NN=C(C)C2(CC(C3=C(C2)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5OC)O)OC6CC(C(C(O6)C)O)N)O,,,,,,
2870,152871,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-methoxybenzamide;hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)OC)C)O)N)O.Cl,,,,,,
2871,152872,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-methoxybenzamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)OC)C)O)N)O,,,,,,
2872,152873,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-phenylbenzamide;hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)C7=CC=CC=C7)C)O)N)O.Cl,,,,,,
2873,152874,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-phenylbenzamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)C7=CC=CC=C7)C)O)N)O,,,,,,
2874,152875,CID 152875,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=CC=C6)CO)O)N)O.Cl,,,,,,
2875,152876,"N-[[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]benzamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=CC=C6)CO)O)N)O,,,,,,
2876,152877,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-hydroxybenzamide;hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)O)C)O)N)O.Cl,,,,,,
2877,152878,"N-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]-4-hydroxybenzamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=C(C=C6)O)C)O)N)O,,,,,,
2878,152879,"N,N-Dimethyladriamycin hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N(C)C)O.Cl,,,,,,
2879,152880,"Nickelate(Ni4O5)(1-), lithium",[Li-].[O-2].[O-2].[O-2].[O-2].[O-2].[Ni].[Ni].[Ni].[Ni],,,,,,
2880,152881,"7-((3,4-Dichlorobenzyl)amino)-actinomycin D",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)NCC8=CC(=C(C=C8)Cl)Cl,,,,,,
2881,152882,7-((2-Furanylmethyl)amino)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)NCC8=CC=CO8,,,,,,
2882,152883,7-(((2-Pyrrolyl)methyl)amino)-actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)NCC8=CC=CN8,,,,,,
2883,152884,"Actinomycin D, 7-(octylamino)-",CCCCCCCCNC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
2884,152885,"Platinum (II), (cyclohexane-1,2-diammine)dipyruvato-",CC(=O)C(=O)[O-].CC(=O)C(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],,,,,,
2885,152886,"18,19-Dioxa-3-thia-10,13-diazatricyclo(13.2.1.1(sup 5,8))nonadeca-5,7,15,17-tetraene-9,14-dione",C1CNC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)N1,,,,,,
2886,152887,"19,20-Dioxa-3-thia-10,14-diazatricyclo(14.2.1.1(sup 5,8))eicosa-5,7,16,18-tetraene-9,15-dione",C1CNC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)NC1,,,,,,
2887,152888,"22,23-Dioxa-3-thia-10,17-diazatricyclo(17.2.1.1(sup 5,8))tricosa-5,7,19,21-tetraene-9,18-dione",C1CCCNC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)NCC1,,,,,,
2888,152889,"3,6:10,13-Diepoxy-8,1,15-benzothiadiazacycloheptadecine-2,14(7H,9H)-dione, 1,15-dihydro-",C1C2=CC=C(O2)C(=O)NC3=CC=CC=C3NC(=O)C4=CC=C(O4)CS1,,,,,,
2889,152890,"22,23-Dioxa-9-thia-2,16-diazatetracyclo(15.3.1.1(sup 4,7).1(sup 11,14))tricosa-1(21),4,6,11,13,17,19-heptaene-3,15-dione",C1C2=CC=C(O2)C(=O)NC3=CC(=CC=C3)NC(=O)C4=CC=C(O4)CS1,,,,,,
2890,152891,"22,23-Dioxa-9-thia-2,16-diazatetracyclo(15.2.2.1(sup 4,7).1(sup 11,14))tricosa-1(21),4,6,11,13,17,19,20-heptaene-3,15-dione",C1C2=CC=C(O2)C(=O)NC3=CC=C(C=C3)NC(=O)C4=CC=C(O4)CS1,,,,,,
2891,152892,"21,22-Dioxa-3,13-dithia-10,16-diazatricyclo(16.2.1.1(sup 5,8))docosa-5,7,18,20-tetraene-9,17-dione",C1CSCCNC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)N1,,,,,,
2892,152893,"15,16-Dioxa-3-thia-10-azatricyclo(10.2.1.1(sup 5,8))hexadeca-5,7,12,14-tetraene-9,11-dione, 10-phenyl-",C1C2=CC=C(O2)C(=O)N(C(=O)C3=CC=C(O3)CS1)C4=CC=CC=C4,,,,,,
2893,152894,"N-methyl-1-(2,7,12,17-tetraethyl-3,8,13,18-tetramethyl-23,24-dihydroporphyrin-5-yl)methanamine",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)CC)CNC)C)CC)C)CC)C,,,,,,
2894,152895,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-xylo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-",C[C@H]1[C@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl,,,,,,
2895,152896,N-Didemethylaclacinomycin A,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N)O,,,,,,
2896,152897,"4-Quinolinecarboxylic acid, 6-hydroxy-5-(1-piperidinylmethyl)-, methyl ester, dihydrochlordie",COC(=O)C1=C2C(=NC=C1)C=CC(=C2CN3CCCCC3)O.Cl.Cl,,,,,,
2897,152898,Methyl 6-hydroxy-5-(piperidin-1-ylmethyl)quinoline-4-carboxylate,COC(=O)C1=C2C(=NC=C1)C=CC(=C2CN3CCCCC3)O,,,,,,
2898,152899,"Phenanthridinium, 6,6'-(1,5-pentanediylbis(iminocarbonyl-3,1-phenylene))bis(3,8-diamino-5-methyl-, dichloride",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)C(=O)NCCCCCNC(=O)C5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N.[Cl-].[Cl-],,,,,,
2899,152900,"3-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)-N-[5-[[3-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)benzoyl]amino]pentyl]benzamide",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)C(=O)NCCCCCNC(=O)C5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
2900,152901,4'-O-Methyldaunorubicin hydrochloride,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC.Cl,,,,,,
2901,152902,CID 152902,C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC,,,,,,
2902,152903,"7-(4-amino-5-methoxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC.Cl,,,,,,
2903,152904,"7-(4-amino-5-methoxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC,,,,,,
2904,152905,CID 152905,C1=CC(=C(C=C1C=NO)OC=NO)O,,,,,,
2905,152906,"But-2-enedioic acid--N-(propan-2-yl)-2-{4-[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazin-1-yl}ethanimidic acid (1/1)",CC(C)NC(=O)CN1CCN(CC1)C(=O)C=CC2=CC(=C(C(=C2)OC)OC)OC.C(=CC(=O)O)C(=O)O,,,,,,
2906,152907,"(2R,3R,4R,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanoic phosphoric anhydride",C([C@H]([C@@H]([C@@H]([C@H](C(=O)OP(=O)(O)O)N)O)O)O)O,,,,,,
2907,152908,"(8S,9S,10R,13S,14S,17S)-17-(N-methoxy-C-methylcarbonimidoyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=NOC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2908,152909,Tetracosaenoic acid,CCCCCCCCCCCCCCCCCCCCCC=CC(=O)O,,,,,,
2909,152910,3-Mercapto-2-methylpropionic acid,CC(CS)C(=O)O,,,,,,
2910,152911,Trinonadecanoylglycerol,CCCCCCCCCCCCCCCCCCC(=O)C(CO)(C(C(=O)CCCCCCCCCCCCCCCCCC)(C(=O)CCCCCCCCCCCCCCCCCC)O)O,,,,,,
2911,152912,Triamminetrichlororhodium,N.N.N.Cl[Rh](Cl)Cl,,,,,,
2912,152913,Xylenediamine,CC1=CC=C(C=C1)C(N)N,,,,,,
2913,152914,Leucylarginine,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N,,,,,,
2914,152915,2-Hydroxytricosanoic acid,CCCCCCCCCCCCCCCCCCCCCC(C(=O)O)O,,,,,,
2915,152916,"2-Phenyl 4,4,5,5-tetramethylimidazoline-1-oxyl",CC1(C(N(C(=N1)C2=CC=CC=C2)[O])(C)C)C,,,,,,
2916,152917,1H-Imidazole-4-carboxamide,C1=C(NC=N1)C(=O)N,,,,,,
2917,152918,S-2-((2-Thiazolylcarbamoyl)ethyl)aminoethyl hydrogen thiosulfate,C1=CSC(=N1)NC(=O)CCNCCSS(=O)(=O)O,,,,,,
2918,152919,5'-D-Riboflavin-D-glucopyranoside,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC[C@H]([C@H](C(O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
2919,152920,N-Bromoacetylglucosamine,C([C@H]([C@H]([C@@H]([C@H](C=O)NC(=O)CBr)O)O)O)O,,,,,,
2920,152921,21-Chloroprogesterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CCl)CCC4=CC(=O)CC[C@]34C,,,,,,
2921,152922,Mannonic amide,C([C@H]([C@H]([C@@H]([C@@H](C(=O)N)O)O)O)O)O,,,,,,
2922,152923,1-Benzylcyclopropylamine,C1CC1(CC2=CC=CC=C2)N,,,,,,
2923,152924,"1-Methyl-2,9-dihydropyrido[3,4-b]indol-7-one;sulfuric acid",CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1.OS(=O)(=O)O,,,,,,
2924,152925,Dibromopropane,CCC(Br)Br,,,,,,
2925,152926,Tropylium tetrafluoroborate,[B-](F)(F)(F)F.C1=CC=C[CH+]C=C1,,,,,,
2926,152927,3-Methylbut-1-en-1-ol,CC(C)C=CO,,,,,,
2927,152928,"[(8R,9S,10R,13S,14S)-17-acetyl-6-chloro-13-methyl-16-methylidene-3-oxo-2,8,9,10,11,12,14,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)C1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@H]34)Cl)C)OC(=O)C,,,,,,
2928,152929,CID 152929,C([C@@H]([C@@H]([C@@H](CO)O)O)O)NC1=C(C(=O)N=C(N1)N)N,,,,,,
2929,152930,"phosphono (2S,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate",C([C@H]([C@H]([C@@H]([C@@H](C(=O)OP(=O)(O)O)O)O)O)O)O,,,,,,
2930,152931,Chromone-2-carbohydroxamic acid,C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)NO,,,,,,
2931,152932,1-[Bis(4-fluorophenyl)methyl]piperazine,C1CN(CCN1)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,,,,,['1-[bis(4-fluorophenyl)methyl]piperazine is a known human metabolite of flunarizine.'],
2932,152933,N-Formyltryptophan,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC=O,,,,,,
2933,152934,"7-Hydroxypregn-4-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(CC4=CC(=O)CC[C@]34C)O)C,,,,,,
2934,152935,Methyltetrahydrophthalic acid,CC1(C=CCCC1C(=O)O)C(=O)O,,,,,,
2935,152936,Naphthyl glucuronide,C1=CC=C2C(=C1)C=CC=C2OC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
2936,152937,"N-(3,4,5-Trichlorophenyl)succinimide",C1CC(=O)N(C1=O)C2=CC(=C(C(=C2)Cl)Cl)Cl,,,,,,
2937,152938,4-(3-tert-Butylamino-2-hydroxypropoxy)-2-carboxyindole,CC(C)(C)NCC(COC1=CC=CC2=C1C=C(N2)C(=O)O)O,,,,,,
2938,152939,"4,5-Dimethoxybenzene-1,2-diamine",COC1=C(C=C(C(=C1)N)N)OC,,,,,,
2939,152940,21-Acryloxyprogesterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COC(=O)C=C)CCC4=CC(=O)CC[C@]34C,,,,,,
2940,152941,"3,4-Dichloro-N,N-di-sec-butylbenzamide",CCC(C)N(C(C)CC)C(=O)C1=CC(=C(C=C1)Cl)Cl,,,,,,
2941,152942,N-Carbethoxyhistidine,CCOC(=O)N[C@@H](CC1=CN=CN1)C(=O)O,,,,,,
2942,152943,Frovatriptan succinate,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O,,,['Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)'],,,
2943,152944,Frovatriptan succinate anhydrous,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O,,,,,,
2944,152945,CID 152945,C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,,,,,,
2945,152946,Moxifloxacin,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,"['For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).']","['Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: <i>Corynebacterium</i> species, <i>Micrococcus luteus</i>, <i>Staphylococcus aureus</i>, <i>Staphylococcus epidermidis</i>, <i>Staphylococcus haemolyticus</i>, <i>Staphylococcus hominis</i>, <i>Staphylococcus warneri</i>, <i>Streptococcus pneumoniae</i>, and <i>Streptococcus viridans</i> group. Aerobic Gram-negative microorganisms: <i>Acinetobacter lwoffii</i>, <i>Haemophilus influenzae</i>, and <i>Haemophilus parainfluenzae</i>. Other microorganisms: <i>Chlamydia trachomatis</i>.<br/>Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.']","['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)', 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)']","['Well absorbed from the gastrointestinal tract. Absolute oral bioavailability is approximately 90%. Food has little effect on absorption.', 'Approximately 45% of an oral or intravenous dose of moxifloxacin is excreted as unchanged drug (~20% in urine and ~25% in feces).', '1.7 to 2.7 L/kg', '12 +/- 2 L/hr', 'Moxifloxacin is approximately 30-50% bound to serum proteins, independent of drug concentration. The volume of distribution of moxifloxacin ranges from 1.7 to 2.7 L/kg. Moxifloxacin is widely distributed throughout the body, with tissue concentrations often exceeding plasma concentrations. Moxifloxacin has been detected in the saliva, nasal and bronchial secretions, mucosa of the sinuses, skin blister fluid, subcutaneous tissue, skeletal muscle, and abdominal tissues and fluids following oral or intravenous administration of 400 mg.', 'Approximately 45% of an oral or intravenous dose of moxifloxacin is excreted as unchanged drug (~20% in urine and ~25% in feces). A total of 96% + or - 4% of an oral dose is excreted as either unchanged drug or known metabolites. The mean (+ or - SD) apparent total body clearance and renal clearance are 12 + or - 2 L/hr and 2.6 + or - 0.5 L/hr, respectively.', 'Moxifloxacin, given as an oral tablet, is well absorbed from the gastrointestinal tract. The absolute bioavailability of moxifloxacin is approximately 90 percent. Co-administration with a high fat meal (that is, 500 calories from fat) does not affect the absorption of moxifloxacin.', 'The ocular penetration and pharmacokinetics of moxifloxacin in comparison to other fluoroquinolones (ofloxacin, ciprofloxacin, gatifloxacin, norfloxacin, levofloxacin, and lomefloxacin) have been determined by in vitro and ex vivo techniques, as well as in animal and human studies. ... The results consistently demonstrate higher maximum concentrations for moxifloxacin relative to the other fluoroquinolones in ocular tissues with levels well above its minimum inhibitory concentrations for relevant ocular pathogens. This superior performance is due to the unique structure of moxifloxacin that combines high lipophilicity for enhanced corneal penetration with high aqueous solubility at physiological pH. The latter property creates a high concentration gradient at the tear film/corneal epithelial interface providing a driving force for better ocular penetration for moxifloxacin. In addition, the higher concentration of moxifloxacin in VIGAMOX (i.e., 0.5% vs. 0.3%) allows more antibiotic to be available to ocular tissues. It is clear from the array of studies summarized in this report that moxifloxacin penetrates ocular tissues better (two- to three-fold) than gatifloxacin, ciprofloxacin, ofloxacin, or levofloxacin. This consistent, enhanced penetration of topical moxifloxacin offers powerful advantages for ophthalmic therapy.', 'For more Absorption, Distribution and Excretion (Complete) data for Moxifloxacin (6 total), please visit the HSDB record page.']","['Approximately 52% or oral or intravenous dose is metabolized via glucuronide and sulphate conjugation. The cytochrome P450 system is not involved in metabolism. The sulphate conjugate accounts for 38% of the dose, and the glucuronide conjugate accounts for 14% of the dose.', 'Approximately 52% of an oral or intravenous dose of moxifloxacin is metabolized via glucuronide and sulfate conjugation. The cytochrome P450 system is not involved in moxifloxacin metabolism, and is not affected by moxifloxacin. The sulfate conjugate (M1) accounts for approximately 38% of the dose, and is eliminated primarily in the feces. Approximately 14% of an oral or intravenous dose is converted to a glucuronide conjugate (M2), which is excreted exclusively in the urine. Peak plasma concentrations of M2 are approximately 40% those of the parent drug, while plasma concentrations of M1 are generally less than 10% those of moxifloxacin.']","['11.5-15.6 hours (single dose, oral)', 'The mean (+ or - SD) elimination half-life from plasma is 12 + or - 1.3 hours']"
2946,152947,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-methyl-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC,,,,,,
2947,152948,"(S)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-9,10-dihydro-6,11-dihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)C)N)O.Cl,,,,,,
2948,152949,"(10S)-8-acetyl-10-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,11-dihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)C)N)O,,,,,,
2949,152950,Pterosin B acetate,C[C@@H]1CC2=C(C1=O)C(=C(C(=C2)C)CCOC(=O)C)C,,,,,,
2950,152951,21R-Argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C,,,"['Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,,
2951,152952,"15,18-Tetracosadienoic acid",CCCCCC=CCC=CCCCCCCCCCCCCCC(=O)O,,,,,,
2952,152953,3-(3-Pyridyl)-L-alanine,C1=CC(=CN=C1)C[C@@H](C(=O)O)N,,,,,,
2953,152954,"5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC(C(C=C3)O)O,,,,,"['5-(3,4-dihydroxycyclohexa-1,5-dien-1-yl)-5-phenylimidazolidine-2,4-dione is a known human metabolite of phenytoin.']",
2954,152955,Lyxonic acid,C([C@H]([C@@H]([C@@H](C(=O)O)O)O)O)O,,,,,,
2955,152956,1-Phenylprop-2-en-1-amine,C=CC(C1=CC=CC=C1)N,,,,,,
2956,152957,N-Cyclohexanoyl-2-phenylglycine,C1CCC(CC1)C(=O)N[C@@H](C2=CC=CC=C2)C(=O)O,,,,,,
2957,152958,16-Heptadecenoic acid,C=CCCCCCCCCCCCCCCC(=O)O,,,,,,
2958,152959,5-Nitro-3-carboxybenzisoxazole,C1=CC2=C(C=C1[N+](=O)[O-])C(=NO2)C(=O)O,,,,,,
2959,152960,S-Sulfohomocysteine,C(CSS(=O)(=O)O)[C@@H](C(=O)O)N,,,,,,
2960,152961,2-Chloro-1-(1H-indol-3-yl)ethanone,C1=CC=C2C(=C1)C(=CN2)C(=O)CCl,,,,,,
2961,152962,Azulene Sn,CC1=C2C=CC(=C2C=C(C=C1)C(C)C)S(=O)(=O)OC,,,,,,
2962,152963,Estriol glucuronide,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)OC5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
2963,152964,"(8R,9S,10R,13S,14S)-17-hydroxy-10,13,17-trimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C)O)C=CC4=CC(=O)C=C[C@]34C,,,,,,
2964,152965,"3-Acetylamino-2,6-dimethylphenol",CC1=C(C(=C(C=C1)NC(=O)C)C)O,,,,,,
2965,152966,Chlorohexadienedioic acid,C(=CC(=O)O)C=C(C(=O)O)Cl,,,,,,
2966,152967,13(S)-HpOTrE,CCC=CCC(C=CC=CCCCCCCCC(=O)O)OO,,,,,,
2967,152968,3-Hydroxy-2-methylvaleric acid,CCC(C(C)C(=O)O)O,,,,,,
2968,152969,"2,10,11,11a-Tetrahydro-11a-methyl-1H-naphth(1,2-g)indol-7-ol",CC12CCC3=C(C1=NCC2)C=CC4=C3C=CC(=C4)O,,,,,,
2969,152970,Methoxyimine,CC12CCC3C4=C(C=CC3=C1N=CC2)C=C(C=C4)OC,,,,,,
2970,152971,17-Hydroxypregnenolone sulfate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(C4)OS(=O)(=O)O)C)C)O,,,,,,
2971,152972,"Tetracosa-2,4,6,8-tetraenoic acid",CCCCCCCCCCCCCCCC=CC=CC=CC=CC(=O)O,,,,,,
2972,152973,Ethyl dotriacontanoate,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC,,,,,,
2973,152974,Hydroxycarbamimidoyl-piperidine,C1CCN(CC1)C(=NO)N,,,,,,
2974,152975,Phenyl-N-methyl-N-benzylcarbamate,CN(CC1=CC=CC=C1)C(=O)OC2=CC=CC=C2,,,,,,
2975,152976,13-Hydroxy-10-oxooctadec-11-enoic acid,CCCCCC(C=CC(=O)CCCCCCCCC(=O)O)O,,,,,,
2976,152977,17alpha-Hydroperoxyprogesterone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OO,,,,,,
2977,152978,"Ethanamine, trifluoro-",CC(N(F)F)F,,,,,,
2978,152979,CID 152979,C1=CC=C2C(=C1)C(=CC(=C2O)O)N=NC(=N)S,,,,,,
2979,152980,2-(Difluoromethoxy)acetic acid,C(C(=O)O)OC(F)F,,,,,,
2980,152981,Pyroglutamylglycine,C1CC(=O)N[C@@H]1C(=O)NCC(=O)O,,,,,,
2981,152982,"6-Nitro-1,2,3-benzothiadiazole",C1=CC2=C(C=C1[N+](=O)[O-])SN=N2,,,,,,
2982,152983,8-((beta-D-Glucopyranosyl)oxy)quinoline,C1=CC2=C(C(=C1)OC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)N=CC=C2,,,,,,
2983,152984,"3-Hydroxy-2,2-dimethylbutanoic acid",CC(C(C)(C)C(=O)O)O,,,,,,
2984,152985,Diethyl-N-dodecylphosphoramidate,CCCCCCCCCCCCNP(=O)(OCC)OCC,,,,,,
2985,152986,(4-Azido-2-nitrophenyl)methyl-trimethylazanium,C[N+](C)(C)CC1=C(C=C(C=C1)N=[N+]=[N-])[N+](=O)[O-],,,,,,
2986,152987,"Succinic acid, thio-",C(CC(=O)S)C(=O)S,,,,,,
2987,152988,Methylphenylpropylhydrazine,CC(C)CN(C1=CC=CC=C1)N,,,,,,
2988,152989,2-[[(4-Hydroxyphenyl)azo]phenyl]benzoic acid,C1=CC=C(C(=C1)C2=CC=CC=C2N=NC3=CC=C(C=C3)O)C(=O)O,,,,,,
2989,152990,3-Deoxy-D-arabino-hexonic acid,C([C@@H]([C@@H](CO)O)O)[C@@H](C(=O)O)O,,,,,,
2990,152991,1-Undecylpyridinium,CCCCCCCCCCC[N+]1=CC=CC=C1,,,,,,
2991,152992,Diazobenzenesulfonamide benzenesulfonate,C1=CC=C(C=C1)S(=O)(=O)O.C1=CC2=C([N+]2=[N-])C(=C1)S(=O)(=O)N,,,,,,
2992,152993,"(2-Sulfamoyl-7-azoniabicyclo[4.1.0]hepta-1(6),2,4-trien-7-ylidene)azanide",C1=CC2=C([N+]2=[N-])C(=C1)S(=O)(=O)N,,,,,,
2993,152994,CID 152994,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=CC3=O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O2)O)O)O,,,,,,
2994,152995,7-Hydroxy-6-methoxyphthalide,COC1=C(C2=C(COC2=O)C=C1)O,,,,,,
2995,152996,"2-Carboxyribitol 1,5-bisphosphate",C([C@H]([C@H]([C@@](COP(=O)(O)O)(C(=O)O)O)O)O)OP(=O)(O)O,,,,,,
2996,152997,"2-Methyl-1,4-dinitrobut-2-ene",CC(=CC[N+](=O)[O-])C[N+](=O)[O-],,,,,,
2997,152998,"1,2-Dipalmitoyl-3-glucosylglycerol",CCCCCCCCCCCCCCCC(=O)OCC(COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
2998,152999,N-Benzylputrescine,C1=CC=C(C=C1)CNCCCCN,,,,,,
2999,153000,"3-Methyl-1,2-oxazol-5-ol",CC1=CC(=O)ON1,,,,,,
3000,153001,"9,12,13-Trihydroxyoctadec-10-enoic acid",CCCCCC(C(C=CC(CCCCCCCC(=O)O)O)O)O,,,,,,
3001,153002,"1-(5-Dimethylaminonaphthalene-1-sulfonamide)-3-N,N-dimethylaminopropane",CCCN(C)CC1=CC2=C(C=CC=C2N(C)C)C(=C1)S(=O)(=O)N,,,,,,
3002,153003,"11-Octadecenoic acid, 9,10,13-trihydroxy-, (11E)-",CCCCCC(C=CC(C(CCCCCCCC(=O)O)O)O)O,,,,,,
3003,153004,methyl (2R)-2-amino-3-methyl-3-sulfanylbutanoate,CC(C)([C@@H](C(=O)OC)N)S,,,,,,
3004,153005,Tyramine O-sulfate,C1=CC(=CC=C1CCN)OS(=O)(=O)O,,,,,,
3005,153006,3-Hydroxy-1-methylguanine,CN1C(=O)C2=C(N=CN2)N(C1=N)O,,,,,,
3006,153007,"1-Cyano-2-hydroxy-3,4-epithiobutane",C1C(S1)C(CC#N)O,,,,,,
3007,153008,"Norleucine, 5-hydroxy-6-oxo-",C(CC=O)C[C@@H](C(=O)O)NO,,,,,,
3008,153009,mollicellin H,CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C=C(C(=C3C)CC=C(C)C)O)C=O)O,,,,,,
3009,153010,"5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(1-oxopropyl)-, hydrochloride, (8S-cis)-",CCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O.Cl,,,,,,
3010,153011,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-4-methoxy-9-propanoyl-8,10-dihydro-7H-tetracene-5,12-dione",CCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
3011,153012,"4-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenecarboxaldehyde hydrochloride, (2S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C=O)O)N)O.Cl,,,,,,
3012,153013,"4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carbaldehyde",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C=O)O)N)O,,,,,,
3013,153014,Quinacrine half mustard,CCN(CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCCl.Cl.Cl,,,,,,
3014,153015,"1-N-(2-chloroethyl)-4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N-ethylpentane-1,4-diamine",CCN(CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCCl,,,,,,
3015,153016,cis-Dichloro(alpha-methylbenzenemethanamine)(ethene)platinum,CC(C1=CC=CC=C1)N.C=C.[Cl-].[Cl-].[Pt+2],,,,,,
3016,153017,"Benzo(10,11)chryseno(1,2-b)oxirene, 6b,7a-dihydro-, (6bR-cis)-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@H]6[C@@H]5O6)C=C2,,,,,,
3017,153018,"Dibenzo(b,def)chrysene, 13b,13c-dihydro-13b,13c-dimethyl-, trans-",C[C@]12C3=CC4=CC=CC=C4C1=CC=C5[C@@]2(C(=C6C=CC=CC6=C5)C=C3)C,,,,,,
3018,153019,"5-Nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione",C1=CC2=CC(=CC3=C2C(=C1)C(=O)NC3=O)[N+](=O)[O-],,,,,,
3019,153020,"4-tert-Butyl-2,6-bis(1-phenylethyl)phenol",CC(C1=CC=CC=C1)C2=CC(=CC(=C2O)C(C)C3=CC=CC=C3)C(C)(C)C,,,,,,
3020,153021,"Pyrimidine, 2-((5-nitro-2-pyridinyl)thio)-",C1=CN=C(N=C1)SC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
3021,153022,CID 153022,CC(=NN=C(N)N)C1=CC=C(C=C1)CNC(=O)NCC2=CC=C(C=C2)C(=NN=C(N)N)C,,,,,,
3022,153023,"Benzo(b)-1,5-naphthyridin-10-amine, 7-chloro-2-methoxy-N-(4-(1-pyrrolidinyl)butyl)-, trihydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCN4CCCC4.Cl.Cl.Cl,,,,,,
3023,153024,"7-chloro-2-methoxy-N-(4-pyrrolidin-1-ylbutyl)benzo[b][1,5]naphthyridin-10-amine",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCN4CCCC4,,,,,,
3024,153025,"Methanesulfonamide, N-(4-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)phenyl)-, monohydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC=C(C=C4)NS(=O)(=O)C.Cl,,,,,,
3025,153026,"N-[4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]phenyl]methanesulfonamide",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC=C(C=C4)NS(=O)(=O)C,,,,,,
3026,153027,"Methanesulfonamide, N-(3-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)phenyl)-, monohydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=CC=C4)NS(=O)(=O)C.Cl,,,,,,
3027,153028,"N-[3-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]phenyl]methanesulfonamide",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=CC=C4)NS(=O)(=O)C,,,,,,
3028,153029,"Methanesulfonamide, N-(2-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)phenyl)-, monohydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC=CC=C4NS(=O)(=O)C.Cl,,,,,,
3029,153030,"N-[2-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]phenyl]methanesulfonamide",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC=CC=C4NS(=O)(=O)C,,,,,,
3030,153031,"Cyclohepta(cd)pyrene, 7,8-dihydro-",C1CC2=CC3=CC=CC4=C3C5=C(C=CC(=C25)C=C1)C=C4,,,,,,
3031,153032,"D-Valinamide, N-((2-amino-9-(((2-hydroxy-1-(((1-(((2-hydroxyethyl)amino)carbonyl)-2-methylpropyl)amino)carbonyl)propyl)amino)carbonyl)-4,6-dimethyl-3-oxo-3H-phenoxazin-1-yl)carbonyl)-L-threonyl-N-(2-hydroxyethyl)-, (1S-(1R*(S*),2S*))-",CC1=C2C(=C(C=C1)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCCO)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCCO,,,,,,
3032,153033,"Oxirane, (9,10-dimethyl-2-anthracenyl)-",CC1=C2C=CC(=CC2=C(C3=CC=CC=C13)C)C4CO4,,,,,,
3033,153034,"Oxirane, ((5-methyl-2-nitrophenoxy)methyl)-",CC1=CC(=C(C=C1)[N+](=O)[O-])OCC2CO2,,,,,,
3034,153035,"Dibenz(c,j)oxireno(a)acridine, 1a,13b-dihydro-",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5C(O5)C6=CC=CC=C64,,,,,,
3035,153036,"Dibenz(c,h)oxireno(a)acridine, 4b,5a-dihydro-",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=CC=CC=C5C6C4O6)N=C32,,,,,,
3036,153037,"2-Oxido-16-oxa-2-azoniahexacyclo[12.9.0.03,12.04,9.015,17.018,23]tricosa-1(14),2,4,6,8,10,12,18,20,22-decaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=CC=CC=C5C6C4O6)[N+](=C32)[O-],,,,,,
3037,153038,"Triphenyleno(1,2-b)oxirene-9,10-diol, 9,10,10a,11a-tetrahydro-, (9alpha,10beta,10aalpha,11aalpha)-",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C(C(C5C4O5)O)O,,,,,,
3038,153039,"12-O-Tetradecanoylphorbol 13-acetate 6beta,7beta-oxide",CCCCCCCCCCCCCC(=O)OC1CC2(C3C=C(C(=O)C3(CC4(C(C2C5C1(C5(C)C)OC(=O)C)O4)CO)O)C)O,,,,,,
3039,153040,"Phenol, 4-(3-pyridinyl)-",C1=CC(=CN=C1)C2=CC=C(C=C2)O,,,,,,
3040,153041,"Phenanthridinium, 3,8-diamino-5-(1-methylethyl)-6-phenyl-",CC(C)[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N,,,,,,
3041,153042,"Phenanthridinium, 3,8-diamino-5-pentyl-6-phenyl-",CCCCC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N,,,,,,
3042,153043,"Phenanthridinium, 3,8-diamino-6-phenyl-5-(2-propenyl)-",C=CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N,,,,,,
3043,153044,"Phenanthridinium, 3,8-diamino-5-(3-aminopropyl)-6-phenyl-",C1=CC=C(C=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=[N+]2CCCN)N)N,,,,,,
3044,153045,"Phenanthridinium, 3,8-diamino-5-(3-(diethylamino)propyl)-6-phenyl-",CCN(CC)CCC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N,,,,,,
3045,153046,"Phenanthridinium, 3,8-diamino-5-(3-((2-aminoethyl)amino)propyl)-6-phenyl-",C1=CC=C(C=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=[N+]2CCCNCCN)N)N,,,,,,
3046,153047,"Quinomycin A, 3-(N-methylcysteine)-7-(N-methyl-3-oxoalanine)-8,4,4",CC1C(=O)N(C(C(=O)N(C(C(=O)OCC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)OCC(C(=O)N1)NC(=O)C2=NC3=CC=CC=C3N=C2)C(C)C)C)C=O)C)C)NC(=O)C4=NC5=CC=CC=C5N=C4)C(C)C)C)CS)C,,,,,,
3047,153048,"Piperidine, 1-(2-chloroethyl)-2-(chloromethyl)-, hydrobromide",C1CCN(C(C1)CCl)CCCl.Br,,,,,,
3048,153049,(beta-Chloroethyl)-2-chloromethylpiperidine,C1CCN(C(C1)CCl)CCCl,,,,,,
3049,153050,"2-Acridinesulfonamide, 9-amino-7-ethoxy-N,N-diethyl-, monomethanesulfonate",CCN(CC)S(=O)(=O)C1=CC2=C(C3=C(C=CC(=C3)OCC)N=C2C=C1)N.CS(=O)(=O)O,,,,,,
3050,153051,"9-amino-7-ethoxy-N,N-diethylacridine-2-sulfonamide",CCN(CC)S(=O)(=O)C1=CC2=C(C3=C(C=CC(=C3)OCC)N=C2C=C1)N,,,,,,
3051,153052,"1,2-Ethanediamine, N,N'-dinitroso-N,N'-bis(phenylmethyl)-",C1=CC=C(C=C1)CN(CCN(CC2=CC=CC=C2)N=O)N=O,,,,,,
3052,153053,"(R)-2-(1,5-Dimethyl-4-hexenyl)-5-methyl-1,4-benzenediol",CC1=CC(=C(C=C1O)[C@H](C)CCC=C(C)C)O,,,,,,
3053,153054,3'-Deoxy-cytidine-5'-triphosphate,C1[C@H](O[C@H]([C@@H]1O)N2C=CC(=NC2=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
3054,153055,4-pyridyl-N-t-butyl nitrone,CC(C)(C)[N+](=CC1=CC=NC=C1)[O-],,,,,,
3055,153056,5-Methoxy-N-methyl-2-nitrobenzenamine,CNC1=C(C=CC(=C1)OC)[N+](=O)[O-],,,,,,
3056,153057,CID 153057,CCN1C=CC2=C(C3C(=C(C2=C1)C)C4=C([NH2+]3)C=CC(=C4)O)C,,,,,,
3057,153058,"2-Ethyl-5,11-dimethyl-5a,6-dihydropyrido[4,3-b]carbazol-9-ol",CCN1C=CC2=C(C3C(=C(C2=C1)C)C4=C(N3)C=CC(=C4)O)C,,,,,,
3058,153059,"1-(2,6-Dichlorophenyl)-4-[(dimethylamino)methyl]non-1-en-3-one;hydrochloride",CCCCCC(CN(C)C)C(=O)C=CC1=C(C=CC=C1Cl)Cl.Cl,,,,,,
3059,153060,"1-(2,6-Dichlorophenyl)-4-[(dimethylamino)methyl]non-1-en-3-one",CCCCCC(CN(C)C)C(=O)C=CC1=C(C=CC=C1Cl)Cl,,,,,,
3060,153061,"1,3-Propanediamine, N-methyl-N'-(1-nitro-8-acridinyl)-",CNCCCNC1=CC=CC2=NC3=C(C=C21)C(=CC=C3)[N+](=O)[O-],,,,,,
3061,153062,"9-Acridinamine, N-propyl-",CCCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
3062,153063,CID 153063,C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)[O-].[Na+],,,,,,
3063,153064,"Propanoic acid, 3,3'-((9,10-dihydro-9,10-dioxo-1,8-anthracenediyl)bis(thio))bis-",C1=CC2=C(C(=C1)SCCC(=O)O)C(=O)C3=C(C2=O)C=CC=C3SCCC(=O)O,,,,,,
3064,153065,"Benzeneacetamide, N-(4-bromo-9,10-dihydro-2-methyl-9,10-dioxo-1-anthracenyl)-2-nitro-",CC1=CC(=C2C(=C1NC(=O)CC3=CC=CC=C3[N+](=O)[O-])C(=O)C4=CC=CC=C4C2=O)Br,,,,,,
3065,153066,CID 153066,C1=CC2=C(C(=C1)N)C(=O)C3=C(C=C(C(=C3C2=O)N)S(=O)(=O)[O-])Br.[Na+],,,,,,
3066,153067,"1,5-Diamino-4-bromo-9,10-dioxoanthracene-2-sulfonic acid",C1=CC2=C(C(=C1)N)C(=O)C3=C(C=C(C(=C3C2=O)N)S(=O)(=O)O)Br,,,,,,
3067,153068,CID 153068,CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)Cl)C(=O)C4=C(C=CC(=C4C3=O)O)O)S(=O)(=O)[O-].[Na+],,,,,,
3068,153069,"2-[(4-Chloro-5,8-dihydroxy-9,10-dioxoanthracen-1-yl)amino]-5-methylbenzenesulfonic acid",CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)Cl)C(=O)C4=C(C=CC(=C4C3=O)O)O)S(=O)(=O)O,,,,,,
3069,153070,"1-Propanesulfonic acid, 3,3',3'',3'''-((9,10-dihydro-9,10-dioxo-1,4,5,8-anthracenetetrayl)tetramino)tetrakis-, sodium salt",C1=CC(=C2C(=C1NCCCS(=O)(=O)[O-])C(=O)C3=C(C=CC(=C3C2=O)NCCCS(=O)(=O)[O-])NCCCS(=O)(=O)[O-])NCCCS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3070,153071,"3-[[9,10-Dioxo-4,5,8-tris(3-sulfopropylamino)anthracen-1-yl]amino]propane-1-sulfonic acid",C1=CC(=C2C(=C1NCCCS(=O)(=O)O)C(=O)C3=C(C=CC(=C3C2=O)NCCCS(=O)(=O)O)NCCCS(=O)(=O)O)NCCCS(=O)(=O)O,,,,,,
3071,153072,"9,10-Anthracenedione, 4-bromo-1,5-bis(cyclohexylamino)-2-methyl-",CC1=CC(=C2C(=C1NC3CCCCC3)C(=O)C4=C(C2=O)C(=CC=C4)NC5CCCCC5)Br,,,,,,
3072,153073,"9,10-Anthracenedione, 1,5-bis(cyclohexylamino)-4-hydroxy-2-methyl-",CC1=CC(=C2C(=C1NC3CCCCC3)C(=O)C4=C(C2=O)C(=CC=C4)NC5CCCCC5)O,,,,,,
3073,153074,"Acetamide, N-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-N-phenyl-",CC(=O)N(C1=CC=CC=C1)C2=CC=CC3=C2C(=O)C4=CC=CC=C4C3=O,,,,,,
3074,153075,"1,8-Bis((4-(diethylamino)-1-methylbutyl)amino)-9,10-anthracenedione",CCN(CC)CCCC(C)NC1=CC=CC2=C1C(=O)C3=C(C2=O)C=CC=C3NC(C)CCCN(CC)CC,,,,,,
3075,153076,"1-((4-(Diethylamino)-1-methylbutyl)amino)-9,10-anthracenedione",CCN(CC)CCCC(C)NC1=CC=CC2=C1C(=O)C3=CC=CC=C3C2=O,,,,,,
3076,153077,"1-((4-(Diethylamino)-1-methylbutyl)amino)-4-hydroxy-9,10-anthracenedione",CCN(CC)CCCC(C)NC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
3077,153078,3-Bromo-7-oxo-7H-benz(de)anthracene-9-sulfonic acid,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)O)Br,,,,,,
3078,153079,CID 153079,C1=CC2=C3C(=C1)C4=C(C=C(C=C4)S(=O)(=O)[O-])C(=O)C3=CC=C2.[Na+],,,,,,
3079,153080,Benzanthrone-9-sulfonic acid,C1=CC2=C3C(=C1)C4=C(C=C(C=C4)S(=O)(=O)O)C(=O)C3=CC=C2,,,,,,
3080,153081,"7-Oxo-7H-benz(de)anthracene-3,9-disulfonic acid sodium salt",C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3081,153082,"Benzanthrone-3,9-disulfonic acid",C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3082,153083,CID 153083,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)OCCCS(=O)(=O)[O-])C=CC=C4C2=O.[Na+],,,,,,
3083,153084,3-(7-Oxobenzo[a]phenalen-3-yl)oxypropane-1-sulfonic acid,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)OCCCS(=O)(=O)O)C=CC=C4C2=O,,,,,,
3084,153085,CID 153085,COC1=C2C=CC=C3C2=C(C=C1)C4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-].[Na+],,,,,,
3085,153086,3-Methoxy-7-oxo-7h-benzo[de]anthracene-9-sulfonic acid,COC1=C2C=CC=C3C2=C(C=C1)C4=C(C3=O)C=C(C=C4)S(=O)(=O)O,,,,,,
3086,153087,CID 153087,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)[O-])O.[Na+],,,,,,
3087,153088,3-Hydroxy-7-oxobenzo[a]phenalene-9-sulfonic acid,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)O)O,,,,,,
3088,153089,CID 153089,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)[O-])CS.[Na+],,,,,,
3089,153090,7-Oxo-3-(sulfanylmethyl)benzo[a]phenalene-9-sulfonic acid,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)O)CS,,,,,,
3090,153091,CID 153091,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)[O-])Cl.[Na+],,,,,,
3091,153092,3-Chloro-7-oxobenzo[a]phenalene-9-sulfonic acid,C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)S(=O)(=O)O)Cl,,,,,,
3092,153093,CID 153093,C1=CC2=C3C(=C1)C4=C(C(=CC=C4)S(=O)(=O)[O-])C(=O)C3=CC=C2.[Na+],,,,,,
3093,153094,7-Oxobenzo[a]phenalene-8-sulfonic acid,C1=CC2=C3C(=C1)C4=C(C(=CC=C4)S(=O)(=O)O)C(=O)C3=CC=C2,,,,,,
3094,153095,"7H-Benz(de)anthracene-7-one, 3-(methylthio)-",CSC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C4C3=O,,,,,,
3095,153096,"7H-Benz(de)anthracene-7-one, 3-(2-chloroethoxy)-",C1=CC=C2C(=C1)C3=C4C(=C(C=C3)OCCCl)C=CC=C4C2=O,,,,,,
3096,153097,"7H-Benz(de)anthracene-7-one, 3-((1,1-dimethylethyl)thio)-",CC(C)(C)SC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C4C3=O,,,,,,
3097,153098,"N,N-Diethyl-2,2-dimethyl-1-aziridinamine",CCN(CC)N1CC1(C)C,,,,,,
3098,153099,Thiobenzyl benzyloxycarbonyl-L-lysinate,C1=CC=C(C=C1)COC(=O)N[C@@H](CCCCN)C(=O)SCC2=CC=CC=C2,,,,,,
3099,153100,CID 153100,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCC(CC(CO)O)S(=O)(=O)[O-])O)O.[K+],,,,,,
3100,153101,"1-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]-5,6-dihydroxyhexane-3-sulfonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCC(CC(CO)O)S(=O)(=O)O)O)O,,,,,,
3101,153102,"9,10-Anthracenedione, 1-((2-(dimethylamino)ethyl)amino)-4-hydroxy-",CN(C)CCNC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
3102,153103,1-(beta-D-Arabinofuranosyl)-5-ethyluracil,CCC1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)']",,,
3103,153104,1-(2-Tetrahydrofuranyl)-2-methyl-5-nitroimidazole,CC1=NC=C(N1C2CCCO2)[N+](=O)[O-],,,,,,
3104,153105,"6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one;methanesulfonic acid",CN1CCN(CC1)C=C2C(=O)N3C(=N2)CN=C(C4=C3C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C5Cl.CS(=O)(=O)O,,,,,,
3105,153106,"Acenaphtho(1,2-e)(1,2,4)triazin-9(8H)-one",C1=CC2=C3C(=C1)C4=NC(=O)NN=C4C3=CC=C2,,,,,,
3106,153107,"9-(Acetyloxy)-2,5,11-trimethyl-6H-pyrido(4,3-b)carbazolium",CC1=C2C=CN(C=C2C(=C3C1[NH2+]C4=C3C=C(C=C4)OC(=O)C)C)C,,,,,,
3107,153108,"(2,5,11-Trimethyl-5a,6-dihydropyrido[4,3-b]carbazol-9-yl) acetate",CC1=C2C=CN(C=C2C(=C3C1NC4=C3C=C(C=C4)OC(=O)C)C)C,,,,,,
3108,153109,Lanasol Red G,C=C(C(=O)NC1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C=CC(=C4)NC(=O)C(=C)Br)S(=O)(=O)[O-])S(=O)(=O)[O-])Br.[Na+].[Na+].[Na+],,,,,,
3109,153110,"5-((4-((2-Bromo-1-oxoallyl)amino)benzoyl)amino)-3-((5-((2-bromo-1-oxoallyl)amino)-2-sulphophenyl)azo)-4-hydroxynaphthalene-2,7-disulphonic acid",C=C(C(=O)NC1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C=CC(=C4)NC(=O)C(=C)Br)S(=O)(=O)O)S(=O)(=O)O)Br,,,,,,
3110,153111,"2-Naphthalenesulfonic acid, 5-((4-((2-bromo-1-oxo-2-propenyl)amino)-2-sulfophenyl)azo)-4-hydroxy-6-(methylamino)-, disodium salt",CNC1=C(C2=C(C=C(C=C2C=C1)S(=O)(=O)[O-])O)N=NC3=C(C=C(C=C3)NC(=O)C(=C)Br)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3111,153112,5-[[4-(2-Bromoprop-2-enoylamino)-2-sulfophenyl]diazenyl]-4-hydroxy-6-(methylamino)naphthalene-2-sulfonic acid,CNC1=C(C2=C(C=C(C=C2C=C1)S(=O)(=O)O)O)N=NC3=C(C=C(C=C3)NC(=O)C(=C)Br)S(=O)(=O)O,,,,,,
3112,153113,"2-Anthracenesulfonic acid, 1-amino-4-((3-((2,3-dibromo-1-oxopropyl)amino)-2,4,6-trimethyl-5-sulfophenyl)amino)-9,10-dihydro-9,10-dioxo-, disodium salt",CC1=C(C(=C(C(=C1NC(=O)C(CBr)Br)C)S(=O)(=O)[O-])C)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3113,153114,"1-Amino-4-[3-(2,3-dibromopropanamido)-2,4,6-trimethyl-5-sulfoanilino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",CC1=C(C(=C(C(=C1NC(=O)C(CBr)Br)C)S(=O)(=O)O)C)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
3114,153115,"Disodium 4-[4-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-YL]-2,5-dichlorobenzenesulphonate",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)NC(=O)C(=C)Br)S(=O)(=O)[O-])C3=CC(=C(C=C3Cl)S(=O)(=O)[O-])Cl.[Na+].[Na+],,,,,,
3115,153116,"4-[4-[[5-(2-bromoprop-2-enoylamino)-2-sulfophenyl]diazenyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)NC(=O)C(=C)Br)S(=O)(=O)O)C3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl,,,,,,
3116,153117,CID 153117,C1=NC2=C(N1)C(=O)N=C(N2)NC=C(C=O)O,,,,,,
3117,153118,3-Methyloxadiazolidin-2-ium,CN1CCO[NH2+]1,,,,,,
3118,153119,3-Methyloxadiazolidine,CN1CCON1,,,,,,
3119,153120,CID 153120,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=CC3=O)OCCCS(=O)(=O)[O-])O2)O)O.[K+],,,,,,
3120,153121,CID 153121,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=CC3=O)OCCCS(=O)(=O)O)O2)O)O,,,,,,
3121,153122,"(+-)-2,3-Dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one",COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=CC=C3O2)O)O,,,,,,
3122,153123,CID 153123,COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OCC(=O)[O-])O)O.[Na+],,,,,,
3123,153124,"2-[[5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-2,3-dihydrochromen-7-yl]oxy]acetic acid",COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OCC(=O)O)O)O,,,,,,
3124,153125,"1-Propanone, 1-(2,6-dihydroxy-4-(2-(2-methoxyethoxy)ethoxy)phenyl)-3-(3-hydroxy-4-methoxyphenyl)-",COCCOCCOC1=CC(=C(C(=C1)O)C(=O)CCC2=CC(=C(C=C2)OC)O)O,,,,,,
3125,153126,"1-Propanone, 1-(4-(3-aminopropoxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCN)O)O,,,,,,
3126,153127,"2-Amino-4-(3,5-dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)butanoic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCC(C(=O)O)N)O)O,,,,,,
3127,153128,"4-(3,5-Dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)-2-sulfobutanoic acid potassium salt",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCC(C(=O)[O-])S(=O)(=O)[O-])O)O.[K+].[K+],,,,,,
3128,153129,"4-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]-2-sulfobutanoic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCC(C(=O)O)S(=O)(=O)O)O)O,,,,,,
3129,153130,CID 153130,CCCOC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O)O.[Na+],,,,,,
3130,153131,"2-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-propoxyphenyl)propanoyl]phenoxy]acetic acid",CCCOC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O)O,,,,,,
3131,153132,CID 153132,COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O)N.[Na+],,,,,,
3132,153133,"2-[4-[3-(3-Amino-4-methoxyphenyl)propanoyl]-3,5-dihydroxyphenoxy]acetic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O)N,,,,,,
3133,153134,CID 153134,C1=CC=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O.[Na+],,,,,,
3134,153135,"2-[3,5-Dihydroxy-4-(3-phenylpropanoyl)phenoxy]acetic acid",C1=CC=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O,,,,,,
3135,153136,CID 153136,C1=CC(=C(C=C1CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O)O)Cl.[Na+],,,,,,
3136,153137,"2-[4-[3-(4-Chloro-3-hydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy]acetic acid",C1=CC(=C(C=C1CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O)O)Cl,,,,,,
3137,153138,CID 153138,C1OC2=C(O1)C=C(C=C2)CCC(=O)C3=C(C=C(C=C3O)OCC(=O)[O-])O.[Na+],,,,,,
3138,153139,"2-[4-[3-(1,3-Benzodioxol-5-yl)propanoyl]-3,5-dihydroxyphenoxy]acetic acid",C1OC2=C(O1)C=C(C=C2)CCC(=O)C3=C(C=C(C=C3O)OCC(=O)O)O,,,,,,
3139,153140,CID 153140,C1=CC(=CC(=C1)O)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O.[Na+],,,,,,
3140,153141,"2-[3,5-Dihydroxy-4-[3-(3-hydroxyphenyl)propanoyl]phenoxy]acetic acid",C1=CC(=CC(=C1)O)CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O,,,,,,
3141,153142,CID 153142,C1=CC(=C(C=C1CCC(=O)C2=C(C=C(C=C2O)OCC(=O)[O-])O)O)O.[Na+],,,,,,
3142,153143,"2-[4-[3-(3,4-Dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy]acetic acid",C1=CC(=C(C=C1CCC(=O)C2=C(C=C(C=C2O)OCC(=O)O)O)O)O,,,,,,
3143,153144,CID 153144,COC1=C(C=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
3144,153145,3-[3-Hydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]phenoxy]propane-1-sulfonic acid,COC1=C(C=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OCCCS(=O)(=O)O)O)O,,,,,,
3145,153146,CID 153146,COC1=C(C=C(C=C1)CCCC2=C(C=C(C=C2O)OCC(=O)[O-])O)O.[Na+],,,,,,
3146,153147,"2-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propyl]phenoxy]acetic acid",COC1=C(C=C(C=C1)CCCC2=C(C=C(C=C2O)OCC(=O)O)O)O,,,,,,
3147,153148,"1,3,5-Benzenetriol, 2-(3-(3-hydroxy-4-methoxyphenyl)propyl)-",COC1=C(C=C(C=C1)CCCC2=C(C=C(C=C2O)O)O)O,,,,,,
3148,153149,CID 153149,CC(=O)C1=C(C=C(C=C1O)OCC(=O)[O-])O.[Na+],,,,,,
3149,153150,"2-(4-Acetyl-3,5-dihydroxyphenoxy)acetic acid",CC(=O)C1=C(C=C(C=C1O)OCC(=O)O)O,,,,,,
3150,153151,CID 153151,COC1=C(C=C(C=C1)CCC(=NO)C2=C(C=C(C=C2O)OCC(=O)[O-])O)O.[Na+],,,,,,
3151,153152,CID 153152,COC1=C(C=C(C=C1)CCC(=NO)C2=C(C=C(C=C2O)OCC(=O)O)O)O,,,,,,
3152,153153,CID 153153,COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OCCCS(=O)(=O)[O-])O)O.[K+],,,,,,
3153,153154,3-((5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochroman-7-yl)oxy)propane-1-sulfonic acid,COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OCCCS(=O)(=O)O)O)O,,,,,,
3154,153155,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-(4-morpholinyl)ethyl)amino)-",C1COCCN1CCNC2=C3C(=C(C=C2)NCCN4CCOCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
3155,153156,"9,10-Anthracenedione, 1,4-bis((2-(diethylamino)ethyl)amino)-5,8-dihydroxy-",CCN(CC)CCNC1=C2C(=C(C=C1)NCCN(CC)CC)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
3156,153157,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((3-((2-hydroxyethyl)amino)propyl)amino)-, dihydrochloride",C1=CC(=C2C(=C1NCCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCCNCCO.Cl.Cl,,,,,,
3157,153158,"1,4-Dihydroxy-5,8-bis[3-(2-hydroxyethylamino)propylamino]anthracene-9,10-dione",C1=CC(=C2C(=C1NCCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCCNCCO,,,,,,
3158,153159,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((3-hydroxypropyl)amino)ethyl)amino)-, dihydrochloride",C1=CC(=C2C(=C1NCCNCCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCCO.Cl.Cl,,,,,,
3159,153160,"1,4-Bis[2-(3-hydroxypropylamino)ethylamino]-5,8-dihydroxyanthraquinone",C1=CC(=C2C(=C1NCCNCCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCCO,,,,,,
3160,153161,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-((2-hydroxyethyl)amino)ethyl)amino)ethyl)amino)-, tetrahydrochloride",C1=CC(=C2C(=C1NCCNCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCNCCO.Cl.Cl.Cl.Cl,,,,,,
3161,153162,"1,4-Dihydroxy-5,8-bis[2-[2-(2-hydroxyethylamino)ethylamino]ethylamino]anthracene-9,10-dione",C1=CC(=C2C(=C1NCCNCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCNCCO,,,,,,
3162,153163,"9,10-Anthracenedione, 1,4-bis((2-(1-aziridinyl)ethyl)amino)-5,8-dihydroxy-",C1CN1CCNC2=C3C(=C(C=C2)NCCN4CC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
3163,153164,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-(4-morpholinyl)ethyl)amino)ethyl)amino)-, tetrahydrochloride",C1COCCN1CCNCCNC2=C3C(=C(C=C2)NCCNCCN4CCOCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O.Cl.Cl.Cl.Cl,,,,,,
3164,153165,"1,4-Dihydroxy-5,8-bis[2-(2-morpholin-4-ylethylamino)ethylamino]anthracene-9,10-dione",C1COCCN1CCNCCNC2=C3C(=C(C=C2)NCCNCCN4CCOCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
3165,153166,"9,10-Anthracenedione, 1,4-bis((2-(diethylamino)ethyl)amino)-",CCN(CC)CCNC1=C2C(=C(C=C1)NCCN(CC)CC)C(=O)C3=CC=CC=C3C2=O,,,,,,
3166,153167,"Pyridine, 1,2,3,4-tetrahydro-1-nitroso-",C1CC=CN(C1)N=O,,,,,,
3167,153168,"7H-Furo(3,2-g)(1)benzopyran-6-carbonitrile, 7-oxo-",C1=COC2=CC3=C(C=C21)C=C(C(=O)O3)C#N,,,,,,
3168,153169,"7H-Furo(3,2-g)(1)benzopyran-6-carboxylic acid, 7-oxo-, methyl ester",COC(=O)C1=CC2=C(C=C3C(=C2)C=CO3)OC1=O,,,,,,
3169,153170,"7H-Furo(3,2-g)(1)benzopyran-6-carboxylic acid, 7-oxo-, 1,1-dimethylethyl ester",CC(C)(C)OC(=O)C1=CC2=C(C=C3C(=C2)C=CO3)OC1=O,,,,,,
3170,153171,"Bis(2,3-dibromopropyl)phosphoramidate",C(C(CBr)Br)OP(=O)(N)OCC(CBr)Br,,,,,,
3171,153172,"1-Piperidinyloxy, 4-(((bis(1-aziridinyl)phosphinothioyl)amino)methyl)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O])(C)C)CNP(=S)(N2CC2)N3CC3)C,,,,,,
3172,153173,"1-Propanamine, N-(methoxymethyl)-2-methyl-N-nitroso-",CC(C)CN(COC)N=O,,,,,,
3173,153174,"9,10-Anthracenedione, 1,4-bis((2-(bis(2-hydroxyethyl)amino)ethyl)amino)-, dihydrochloride",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCN(CCO)CCO)NCCN(CCO)CCO.Cl.Cl,,,,,,
3174,153175,"1,4-Bis[2-[bis(2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCN(CCO)CCO)NCCN(CCO)CCO,,,,,,
3175,153176,"9,10-Anthracenedione, 1,4-bis((2-(2-pyridinyl)ethyl)amino)-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCC4=CC=CC=N4)NCCC5=CC=CC=N5,,,,,,
3176,153177,"9,10-Anthracenedione, 6,7-dichloro-1,4-bis((2-(dimethylamino)ethyl)amino)-",CN(C)CCNC1=C2C(=C(C=C1)NCCN(C)C)C(=O)C3=CC(=C(C=C3C2=O)Cl)Cl,,,,,,
3177,153178,"9,10-Anthracenedione, 1,4-bis((2-(bis(1-methylethyl)amino)ethyl)amino)-5,8-dihydroxy-",CC(C)N(CCNC1=C2C(=C(C=C1)NCCN(C(C)C)C(C)C)C(=O)C3=C(C=CC(=C3C2=O)O)O)C(C)C,,,,,,
3178,153179,"9,10-Anthracenedione, 1,4-bis((2-(dibutylamino)ethyl)amino)-5,8-dihydroxy-",CCCCN(CCCC)CCNC1=C2C(=C(C=C1)NCCN(CCCC)CCCC)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
3179,153180,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-(methylphenylamino)ethyl)amino)-",CN(CCNC1=C2C(=C(C=C1)NCCN(C)C3=CC=CC=C3)C(=O)C4=C(C=CC(=C4C2=O)O)O)C5=CC=CC=C5,,,,,,
3180,153181,"1,4-Dihydroxy-5,8-bis((2-(1-piperidinyl)ethyl)amino)-9,10-anthracenedione",C1CCN(CC1)CCNC2=C3C(=C(C=C2)NCCN4CCCCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
3181,153182,"1,4-Bis((2-((2,3-dihydroxypropyl)amino)ethyl)amino)-5,8-dihydroxy-9,10-anthracenedione",C1=CC(=C2C(=C1NCCNCC(CO)O)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCC(CO)O,,,,,,
3182,153183,"9,10-Anthracenedione, 1,4-bis((5-(dimethylamino)pentyl)amino)-5,8-dihydroxy-",CN(C)CCCCCNC1=C2C(=C(C=C1)NCCCCCN(C)C)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
3183,153184,"1,4-Bis((4-(diethylamino)-1-methylbutyl)amino)-5,8-dihydroxy-9,10-anthracenedione",CCN(CC)CCCC(C)NC1=C2C(=C(C=C1)NC(C)CCCN(CC)CC)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
3184,153185,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((3-(4-morpholinyl)propyl)amino)-, dihydrochloride",C1COCCN1CCCNC2=C3C(=C(C=C2)NCCCN4CCOCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O.Cl.Cl,,,,,,
3185,153186,"1,4-Dihydroxy-5,8-bis(3-morpholin-4-ylpropylamino)anthracene-9,10-dione",C1COCCN1CCCNC2=C3C(=C(C=C2)NCCCN4CCOCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
3186,153187,"Acetamide, N-(4-(5-amino-2-thienyl)phenyl)-, monohydrochloride",CC(=O)NC1=CC=C(C=C1)C2=CC=C(S2)N.Cl,,,,,,
3187,153188,N-[4-(5-aminothiophen-2-yl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=C(S2)N,,,,,,
3188,153189,"Acetamide, N-(5-(4-(acetylamino)phenyl)-2-thienyl)-",CC(=O)NC1=CC=C(C=C1)C2=CC=C(S2)NC(=O)C,,,,,,
3189,153190,"2-Anthracenecarboxylic acid, 5,8-bis((2-(dimethylamino)ethyl)amino)-9,10-dihydro-9,10-dioxo-",CN(C)CCNC1=C2C(=C(C=C1)NCCN(C)C)C(=O)C3=C(C2=O)C=CC(=C3)C(=O)O,,,,,,
3190,153191,"2',4'b,7,8',8',10'a-Hexamethyl-3',4',4'a,4'b,5',6',7',8',8'a,9',10',10'a-dodecahydro-2'H,3H-spiro[1-benzofuran-2,1'-phenanthrene]-4,5,7'-triol",C[C@H]1CC[C@@H]2[C@]3(CC[C@@H](C([C@@H]3CCC2(C14CC5=C(O4)C(=CC(=C5O)O)C)C)(C)C)O)C,,,,,,
3191,153192,CID 153192,CC(=O)OCC=C(C1=CC=C(C=C1)OC(=O)C)C(=CCOC(=O)C)C2=CC=C(C=C2)OC(=O)C,,,,,,
3192,153193,"Benzo(4,5)cyclohept(1,2,3-bc)acenaphthylene",C1=CC=C2C(=C1)C=CC3=CC4=CC=CC5=C4C3=C2C=C5,,,,,,
3193,153194,"Benz(a)anthracene-7,12-dimethanol, 2-hydroxy-",C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=C2CO)C=C(C=C4)O)CO,,,,,,
3194,153195,"3-Oxopregna-1,4-diene-20-carboxylic acid",CC([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C)C(=O)O,,,,,,
3195,153196,"((2-(2,4-Dichlorophenyl)-2-hydroxyethyl)amino)oxoacetic acid",C1=CC(=C(C=C1Cl)Cl)C(CNC(=O)C(=O)O)O,,,,,,
3196,153197,CID 153197,CC(C)N(C(C)C)C(=O)S(=O)CC(=CCl)Cl,,,,,,
3197,153198,"2,4-Dichloro-alpha-(4-chlorophenoxy)benzeneacetic acid",C1=CC(=CC=C1OC(C2=C(C=C(C=C2)Cl)Cl)C(=O)O)Cl,,,,,,
3198,153199,"3-(2-(2,4-Dichlorophenyl)-2-hydroxyethyl)-3,4-imidazolidinedione",C1C(=O)[N+](CN1)(CC(C2=C(C=C(C=C2)Cl)Cl)O)[O-],,,,,,
3199,153200,CID 153200,CCCCC[C@@H]1[C@H](O1)C=CC(=O)CCCCCCCC(=O)OC,,,,,,
3200,153201,"Benz(a)anthracene, 3-fluoro-7,12-dimethyl-",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC(=C3)F,,,,,,
3201,153202,"18,19-Dioxa-3,10,13-trithiatricyclo(13.2.1.1(5,8))nonadeca-5,7,15,17-tetraene-9,14-dione",C1CSC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)S1,,,,,,
3202,153203,"2-Propenoic acid, (9k11-dihydro-7-(1-hydroxy-1-(((1-methylethyl)amino)carbonyl)propyl)-9-oxoindolizino(1,2-b)quinolin-8-yl)methyl ester, (S)-",CC[C@](C1=C(C(=O)N2CC3=CC4=CC=CC=C4N=C3C2=C1)COC(=O)C=C)(C(=O)NC(C)C)O,,,,,,
3203,153204,"N,N-Dibenzyldaunorubicin",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O,,,,,,
3204,153205,"2-Nitronaphtho(1,2-b)furan",C1=CC=C2C(=C1)C=CC3=C2OC(=C3)[N+](=O)[O-],,,,,,
3205,153206,4'-epi-4'-O-Methyldaunorubicin hydrochloride,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC.Cl,,,,,,
3206,153207,CID 153207,C[C@H]1[C@@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC,,,,,,
3207,153208,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-4,6,9,11-tetrahydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)CO)O)N)O,,,,,,
3208,153209,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9-dihydroxy-4,11-dimethoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3OC)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
3209,153210,"N-1,2-Benzisothiazol-3-yl-2-chloroacetamide",C1=CC=C2C(=C1)C(=NS2)NC(=O)CCl,,,,,,
3210,153211,"N-1,2-Benzisothiazol-3-yl-4-nitrobenzamide",C1=CC=C2C(=C1)C(=NS2)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
3211,153212,"Acetamide, N-(5-chloro-1,2-benzisothiazol-3-yl)-",CC(=O)NC1=NSC2=C1C=C(C=C2)Cl,,,,,,
3212,153213,"2-Chloro-N-(5-chloro-1,2-benzisothiazol-3-yl)acetamide",C1=CC2=C(C=C1Cl)C(=NS2)NC(=O)CCl,,,,,,
3213,153214,"Acetamide, 2-chloro-N-(6-chloro-1,2-benzisothiazol-3-yl)-",C1=CC2=C(C=C1Cl)SN=C2NC(=O)CCl,,,,,,
3214,153215,5-Chlorobenzo[d]isothiazol-3-amine,C1=CC2=C(C=C1Cl)C(=NS2)N,,,,,,
3215,153216,CID 153216,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)S,,,,,,
3216,153217,"Benzeneacetamide, N-(4-bromo-9,10-dihydro-2-methyl-9,10-dioxo-1-anthracentyl)-4-methoxy-",CC1=CC(=C2C(=C1NC(=O)CC3=CC=C(C=C3)OC)C(=O)C4=CC=CC=C4C2=O)Br,,,,,,
3217,153218,"(R)-8-Acetyl-8-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-1-methoxy-5,12-naphthacenedione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@]2(CCC3=C(C2)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5OC)O)C(=O)C)N)O,,,,,,
3218,153219,"(R)-8-(((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)acetyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",C[C@H]1[C@H]([C@H](C[C@@H](O1)OCC(=O)[C@]2(CCC3=C(C2)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5OC)O)O)N)O,,,,,,
3219,153220,"9,10-Anhydrodaunorubicin",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC(=CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)C)N)O,,,,,,
3220,153221,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-9-hydroxy-4,6,11-trimethoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3OC)C(=O)C5=C(C4=O)C(=CC=C5)OC)OC)(C(=O)C)O)N)O,,,,,,
3221,153222,CID 153222,CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(S2)CCCC3(C)C,,,,,,
3222,153223,"2-(1-Methyl-5-nitroimidazolyl)-4,4-bis(hydroxymethyl)oxazolidine",CN1C(=CN=C1C2NC(CO2)(CO)CO)[N+](=O)[O-],,,,,,
3223,153224,2-((2-Methylaminoethyl)(p-methoxybenzyl)amino)pyridine,CNCCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2,,,,,,
3224,153225,"p-Methoxybenzeneselenol, sodium salt",COC1=CC=C(C=C1)[Se-].[Na+],,,,,,
3225,153226,4-Methoxybenzeneselenolate,COC1=CC=C(C=C1)[Se-],,,,,,
3226,153227,"(+)-trans-5,6-Dihydroxy-5,6-dihydrodibenz(a,h)anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@@H]([C@H](C5=CC=CC=C54)O)O,,,,,,
3227,153228,"Benz(a)anthracene-7-methanol, hydrogen sulfate, sodium salt",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CO.C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CO.[O-]S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3228,153229,N-Hydroxy-N-(4-(4-chlorophenoxy)phenyl)formamide,C1=CC(=CC=C1N(C=O)O)OC2=CC=C(C=C2)Cl,,,,,,
3229,153230,"Imidazo(2,1-b)thiazole, 2-methyl-6-(p-nitrophenyl)-5-nitroso-",CC1=CN2C(=C(N=C2S1)C3=CC=C(C=C3)[N+](=O)[O-])N=O,,,,,,
3230,153231,"2,3-Dihydro-5-nitro-6-(4-nitrophenyl)imidazo(2,1-b)thiazole",C1CSC2=NC(=C(N21)[N+](=O)[O-])C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
3231,153232,"Imidazo(2,1-b)thiazole, 2,3-dihydro-6-(p-chlorophenyl)-5-nitro-",C1CSC2=NC(=C(N21)[N+](=O)[O-])C3=CC=C(C=C3)Cl,,,,,,
3232,153233,"2,3-Dihydro-6-(4-methylphenyl)-5-nitroimidazo(2,1-b)thiazole",CC1=CC=C(C=C1)C2=C(N3CCSC3=N2)[N+](=O)[O-],,,,,,
3233,153234,"Imidazo(2,1-b)thiazole, 6-(p-chlorophenyl)-5-nitro-",C1=CC(=CC=C1C2=C(N3C=CSC3=N2)[N+](=O)[O-])Cl,,,,,,
3234,153235,"2,3-Dimethoxyprop-1-enylbenzene",COCC(=CC1=CC=CC=C1)OC,,,,,,
3235,153236,"2,7,12,17-Tetraethyl-15-(methoxymethyl)-3,8,13,18-tetramethyl-21,22-dihydroporphyrin",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)CC)COC)C)CC)C)CC)C,,,,,,
3236,153237,"Methyl 3-[(2,7,12,17-tetraethyl-3,8,13,18-tetramethyl-23,24-dihydroporphyrin-5-yl)methylamino]propanoate",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)CC)CNCCC(=O)OC)C)CC)C)CC)C,,,,,,
3237,153238,"Ethyl 2-[(2,7,12,17-tetraethyl-3,8,13,18-tetramethyl-23,24-dihydroporphyrin-5-yl)methylamino]acetate",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)CC)CNCC(=O)OCC)C)CC)C)CC)C,,,,,,
3238,153239,Propyl coenzyme A,CC(C)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
3239,153240,Butyl coenzyme A,CC(C)(C)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
3240,153241,Merimepodib,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)O[C@H]3CCOC3)C4=CN=CO4,['For the treatment of hepatitis C virus (HCV) infection.'],"['Merimepodib, an oral drug, contains a novel inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme responsible for stimulating the production of lymphocytes. Merimepodib has the potential to exert direct antiviral activity, as well as affect the immune response by acting on lymphocyte migration and proliferation. Consequently, merimepodib may be an effective treatment for hepatitis C virus (HCV) infection, as the disease involves both viral proliferation and liver inflammation.']",,,,
3241,153242,"Oxytocin, 1-(1-mercaptocyclohexaneacetic acid)-4-L-threonine-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCCCC2)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,,,,,,
3242,153243,10-Descarbomethoxy marcellomycin,CCC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)O)O)N(C)C)O,,,,,,
3243,153244,"N,N-Dimethyldaunorubicin hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C=CC(=C5C4=O)O)OC)(C(=O)C)O)N(C)C)O.Cl,,,,,,
3244,153245,"9-acetyl-7-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-1,6,9-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C=CC(=C5C4=O)O)OC)(C(=O)C)O)N(C)C)O,,,,,,
3245,153246,Descarbomethoxyrudolfomycin,CCC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7C(=CC(=O)C(O7)C)N)O)N(C)C)O,,,,,,
3246,153247,"Pentanoic acid, 2-hydroxy-3-methyl-, (4aS,7aS,8aR,9R,9aR,10S,12aS,13aR,13bR,13cR)-10-(3-furanyl)hexadecahydro-12a-hydroxy-4a,9a,13b-trimethyl-13-methylene-2,6,12-trioxo-2H,6H-cyclopenta(f)pyrano(4',3':6,7)oxepino(4,5-b)benzofuran-9-yl ester, (2R,3R)-",CC[C@@H](C)C(C(=O)O[C@H]1[C@H]2[C@@H](C(=C)[C@@]3([C@@]1(C(CC3=O)C4=COC=C4)C)O)[C@@]5([C@H]6CC(=O)OC[C@]6(OC(=O)C[C@@H]5O2)C)C)O,,,,,,
3247,153248,N(6)-4-Aminophenylmitomycin C,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NC5=CC=C(C=C5)N,,,,,,
3248,153249,"1,2,3-Oxadiazolium, 4,5-dihydro-3-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=NOCC1,,,,,,
3249,153250,"1,2,3-Oxadiazolium, 4,5-dihydro-3-methyl-",C[N+]1=NOCC1,,,,,,
3250,153251,"1,2,10-Trimethoxydehydroaporphine",CN1CCC2=CC(=C(C3=C4C=C(C=CC4=CC1=C23)OC)OC)OC,,,,,,
3251,153252,CID 153252,COC1=C(C=C(C=C1)CCC2=C3C(=CC(=CC3=O)OCCCS(=O)(=O)O)ON2)O.[K+],,,,,,
3252,153253,CID 153253,COC1=C(C=C(C=C1)CCC2=C3C(=CC(=CC3=O)OCCCS(=O)(=O)O)ON2)O,,,,,,
3253,153254,Methylsulfonamido-bleomycin A2,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)NS(=O)(=O)C)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=C(N=CS6)C(=O)NCCC[S+](C)C)O,,,,,,
3254,153255,Benzylsulfonamido-bleomycin A2,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)NS(=O)(=O)CC2=CC=CC=C2)C(=O)NC(C(C3=CN=CN3)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC6=NC(=CS6)C7=C(N=CS7)C(=O)NCCC[S+](C)C)O,,,,,,
3255,153256,"cis-3a,4,5,6,7,7a-Hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole-6,7-diol",CN1C(=CN=C1C2=NOC3C2CCC(C3O)O)[N+](=O)[O-],,,,,,
3256,153257,"3a,4,5,6,7,7a-Hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole-5,6-diol",CN1C(=CN=C1C2=NOC3C2CC(C(C3)O)O)[N+](=O)[O-],,,,,,
3257,153258,"N-(4-Amino-6-((3-((4-aminobutyl)amino)propyl)amino)-6-oxohexyl)-2'-(2-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-2-((2-((4-amino-2,4,5-trideoxy-erythro-pentonoyl)amino)-3-hydroxy-1-oxobutyl)amino)-1-hydroxyethyl)-(2,4'-bithiazole)-4-carboxamide",CC1C(C(C(C(O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCCC(CC(=O)NCCCNCCCCN)N)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)N)O)O)O)N,,,,,,
3258,153259,"(2,4'-Bithiazole)-4-carboxamide, N-(3-((4-aminobutyl)amino)propyl)-2'-(2-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-2-((2-((4-amino-2,4,5-trideoxy-erythro-pentonoyl)amino)-3-hydroxy-1-oxobutyl)amino)-1-hydroxyethyl)-",CC1C(C(C(C(O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCCNCCCCN)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)N)O)O)O)N,,,,,,
3259,153260,Tris(3-bromopropyl)phosphate,C(COP(=O)(OCCCBr)OCCCBr)CBr,,,,,,
3260,153261,Roseorubicin A,CCC1(CCC2=C(C1OC3CC(C(C(O3)C)OC4CC(C(C(O4)C)OC5CC(C(C(O5)C)OC6CCC(C(O6)C)OC7CCC(C(O7)C)O)O)N(C)C)N(C)C)C(=C8C(=C2O)C(=O)C9=C(C8=O)C=CC=C9O)O)O,,,,,,
3261,153262,Roseorubicin B,CCC1(CCC2=C(C1OC3CC(C(C(O3)C)OC4CC(C(C(O4)C)O)N(C)C)N(C)C)C(=C5C(=C2O)C(=O)C6=C(C5=O)C=CC=C6O)O)O,,,,,,
3262,153263,Dansylsulfonamido-bleomycin A2,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)NS(=O)(=O)C2=CC=CC3=C2C=CC(=C3)N(C)C)C(=O)NC(C(C4=CN=CN4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC7=NC(=CS7)C8=C(N=CS8)C(=O)NCCC[S+](C)C)O,,,,,,
3263,153264,"2-Chloro-N-(5,7-dichloro-2,1-benzisothiazol-3-yl)acetamide",C1=C(C=C(C2=NSC(=C21)NC(=O)CCl)Cl)Cl,,,,,,
3264,153265,"N-(2,2,6,6-Tetramethyl-1-oxy-4-piperidinyl)actinomycin D",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCNC8CC(N(C(C8)(C)C)O)(C)C)C,,,,,,
3265,153266,N-Benzyldaunomycin HCl,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NCC6=CC=CC=C6)O.Cl,,,,,,
3266,153267,N-Benzyldaunomycin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NCC6=CC=CC=C6)O,,,,,,
3267,153268,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-(bis(phenylmethyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-, hydrochloride, hydrate, (8S-cis)-(2:2:3)",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O.Cl,,,,,,
3268,153269,"7-[4-(dibenzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(1-hydroxyethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O,,,,,,
3269,153270,Pralnacasan,CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54,['For the treatment of rheumatoid arthritis (RA).'],"['Pralnacasan is a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE). Pralnacasan is an oral, anti-cytokine drug candidate licensed for development by Aventis Pharma from Vertex Pharmaceuticals. In November 2003, Aventis and Vertex Pharmaceuticals announced that they had voluntarily suspended the phase II clinical trials of pralnacasan due to results from an animal toxicity study that demonstrated liver abnormalities after a nine-month exposure to pralnacasan at high doses. While no similar liver toxicity has been seen to date in human trials, the companies will evaluate the animal toxicity results before proceeding with the phase II clinical program.']",,['Orally bioavailable'],,
3270,153271,N-Isopropyldaunorubicin hydrochloride,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(C)C)O.Cl,,,,,,
3271,153272,"9-acetyl-6,9,11-trihydroxy-7-[5-hydroxy-6-methyl-4-(propan-2-ylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(C)C)O,,,,,,
3272,153273,"N,N-Diethyldaunorubicin hydrochloride",CCN(CC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O.Cl,,,,,,
3273,153274,"9-acetyl-7-[4-(diethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CCN(CC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
3274,153275,"N,N-Diethyladriamycin hydrochloride",CCN(CC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O.Cl,,,,,,
3275,153276,"7-[4-(diethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CCN(CC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O,,,,,,
3276,153277,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-, hydrochloride, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCCCC6)O.Cl,,,,,,
3277,153278,"(7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-piperidin-1-yloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCCCC6)O,,,,,,
3278,153279,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((3-(decylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-6,8,11-trihydroxy-, hydrochloride, (8S-cis)-",CCCCCCCCCCNC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O.Cl,,,,,,
3279,153280,"9-acetyl-7-[4-(decylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CCCCCCCCCCNC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
3280,153281,"N,N-Didecyldaunorubicin hydrochloride",CCCCCCCCCCN(CCCCCCCCCC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O.Cl,,,,,,
3281,153282,"9-acetyl-7-[4-(didecylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CCCCCCCCCCN(CCCCCCCCCC)C1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
3282,153283,N-Benzyladriamycin hydrochloride,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NCC6=CC=CC=C6)O.Cl,,,,,,
3283,153284,N-Benzyladriamycin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NCC6=CC=CC=C6)O,,,,,,
3284,153285,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((3-(bis(phenylmethyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-6,8,11-trihydroxy-, hydrochloride, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O.Cl,,,,,,
3285,153286,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(1,2-dihydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-((phenylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-, hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)NCC6=CC=CC=C6)O.Cl,,,,,,
3286,153287,"7-[4-(benzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-9-(1,2-dihydroxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)NCC6=CC=CC=C6)O,,,,,,
3287,153288,"N,N-Dibenzyladriamycin hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O.Cl,,,,,,
3288,153289,"N,N-Dibenzyladriamycin",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O,,,,,,
3289,153290,"5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N6CCCCC6)O,,,,,,
3290,153291,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-((phenylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-, hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)NCC6=CC=CC=C6)O.Cl,,,,,,
3291,153292,"7-[4-(benzylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(1-hydroxyethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)NCC6=CC=CC=C6)O,,,,,,
3292,153293,"(10alpha,11beta,11aalpha,12aalpha)-10,11,11a,12a-Tetrahydrodibenz(5,6:7,8)anthra(1,2-b)oxirene-10,11-diol",C1=CC=C2C(=C1)C3=CC=CC=C3C4=CC5=C(C=C24)[C@H]([C@@H]([C@H]6[C@@H]5O6)O)O,,,,,,
3293,153294,Ccris 6340,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3[C@@H]([C@H]([C@@H]5[C@H]4O5)O)O,,,,,,
3294,153295,"(9alpha,10beta,11beta,12alpha)Benzo(e)pyrene-9,10,11,12-tetrahydro-",C1=CC2=C3C(=C1)C4=C([C@@H]([C@H]([C@H]([C@@H]4O)O)O)O)C5=CC=CC(=C53)C=C2,,,,,,
3295,153296,(2S)-(+)-Glycidyl tosylate,CC1=CC=C(C=C1)S(=O)(=O)OC[C@@H]2CO2,,,,,,
3296,153297,"10,15,20-Tris(1-methylpyridin-1-ium-4-yl)-5-phenyl-21,22-dihydroporphyrin",C[N+]1=CC=C(C=C1)C2=C3C=CC(=C(C4=CC=C(N4)C(=C5C=CC(=N5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C9=CC=CC=C9)N3,,,,,,
3297,153298,"10,15-Bis(1-methylpyridin-1-ium-4-yl)-5,20-diphenyl-21,22-dihydroporphyrin",C[N+]1=CC=C(C=C1)C2=C3C=CC(=N3)C(=C4C=CC(=C(C5=CC=C(N5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=CC=C8)N4)C9=CC=CC=C9,,,,,,
3298,153299,"3b,4a-Dihydrobenzo(9,10)pyreno(4,5-b)oxirene",C1=CC=C2C3=C4C(=CC=C3)C5C(O5)C6=CC=CC(=C64)C2=C1,,,,,,
3299,153300,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-",C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl,,,,,,
3300,153301,"3',4'-Diepidaunorubicin",C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
3301,153302,"10,16,21,22-Tetraoxa-3,13-dithiatricyclo(16.2.1.1.(sup 5,8))docosa-5,7,18,20-tetraene-9,17-dione",C1CSCCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)O1,,,,,,
3302,153303,"10,13,16,19,24,25-Hexaoxa-3-thiatricyclo(19.2.1.1(sup 5,8))pentacosa-5,7,21,23-tetraene-9,20-dione",C1COCCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)OCCO1,,,,,,
3303,153304,"10,13,16,19,22,27,28-Heptaoxa-3-thiatricyclo(22.2.1.1(sup 5,8))octacosa-5,7,24,26-tetraene-9,23-dione",C1COCCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)OCCOCCO1,,,,,,
3304,153305,"10,13,16,19,22,25,30,31-Octaoxa-3-thiatricyclo(25.2.1.1(sup 5,8))hentriaconta-5,7,24,26-tetraene-9,26-dione",C1COCCOCCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)OCCOCCO1,,,,,,
3305,153306,"10,13,16,19,22,25,28,33,34-Nonaoxa-3-thiatricyclo(28.2.1.1(5,8))tetratriaconta-5,7,30,32-tetraene-9,29-dione",C1COCCOCCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)OCCOCCOCCO1,,,,,,
3306,153307,"3,6:10,13-Diepoxy-1,15,8-benzodioxathiacycloheptadecin-2,14(7H,9H)-dione",C1C2=CC=C(O2)C(=O)OC3=CC=CC=C3OC(=O)C4=CC=C(O4)CS1,,,,,,
3307,153308,"10,15,20,21-Tetraoxa-3-thiatricyclo[15.2.1.15,8]henicosa-1(19),5,7,12,17-pentaene-9,16-dione",C1C=CCOC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)O1,,,,,,
3308,153309,Bis-isopropylamine dinitrato platinum II,CC(C)N.CC(C)N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pt+2],,,,,,
3309,153310,CID 153310,CCOC1=C2C3=C(C[C@H]4[C@H]5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1.CC1([C@@H]2CC[C@]1(C(=O)C2)CS(=O)(=O)O)C.CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.[Na+].Cl.Br,,,,,,
3310,153311,Transderm scop (TN),CN1[C@@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4,,,"['Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)', 'Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)', 'Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)']","['Scopolamine hydrobromide is rapidly absorbed following IM or subcutaneous injection. The drug is well absorbed from the GI tract, principally from the upper small intestine. Scopolamine also is well absorbed percutaneously. Following topical application behind the ear of a transdermal system, scopolamine is detected in plasma within 4 hours, with peak concentrations occurring within an average of 24 hours. In one study in healthy individuals, mean free and total (free plus conjugated) plasma scopolamine concentrations of 87 and 354 pg/mL, respectively, have been reported within 24 hours following topical application of a single transdermal scopolamine system that delivered approximately 1 mg/72 hours. /Scopolamine hydrobromide/', 'Following oral administration of a 0.906-mg dose of scopolamine in one individual, a peak concentration of about 2 ng/mL was reached within 1 hour. Although the commercially available transdermal system contains 1.5 mg of scopolamine, the membrane-controlled diffusion system is designed to deliver approximately 1 mg of the drug to systemic circulation at an approximately constant rate over a 72-hour period. An initial priming dose of 0.14 mg of scopolamine is released from the adhesive layer of the system at a controlled, asymptotically declining rate over 6 hours; then, the remainder of the dose is released at an approximate rate of 5 ug/hour for the remaining 66-hour functional lifetime of the system. The manufacturer states that the initial priming dose saturates binding sites on the skin and rapidly brings the plasma concentration to steady-state. In a crossover study comparing urinary excretion rates of scopolamine during multiple 12-hour collection intervals in healthy individuals, there was no difference between the rates of excretion of drug during steady-state (24-72 hours) for constant-rate IV infusion (3.7-6 mcg/hour) and transdermal administration. The transdermal system appeared to deliver the drug to systemic circulation at the same rate as the constant-rate IV infusion; however, relatively long collection intervals (12 hours) make it difficult to interpret the data precisely. During the 12- to 24-hour period of administration and after 72 hours, the rate of excretion of scopolamine was higher with the transdermal system than with the constant-rate IV infusion.', 'The distribution of scopolamine has not been fully characterized. The drug appears to be reversibly bound to plasma proteins. Scopolamine apparently crosses the blood-brain barrier since the drug causes CNS effects. The drug also reportedly crosses the placenta and is distributed into milk..', 'Although the metabolic and excretory fate of scopolamine has not been fully determined, the drug is thought to be almost completely metabolized (principally by conjugation) in the liver and excreted in urine. Following oral administration of a single dose of scopolamine in one study, only small amounts of the dose (about 4-5%) were excreted unchanged in urine within 50 hours; urinary clearance of unchanged drug was about 120 mL/minute. In another study, 3.4% or less than 1% of a single dose was excreted unchanged in urine within 72 hours following subcutaneous injection or oral administration of the drug, respectively. Following application of a single transdermal scopolamine system that delivered approximately 1 mg/72 hours in healthy individuals, the urinary excretion rate of free and total (free plus conjugated) scopolamine was about 0.7 and 3.8 ug/hour, respectively. Following removal of the transdermal system of scopolamine, depletion of scopolamine bound to skin receptors at the site of the application of the transdermal system results in a log-linear decrease in plasma scopolamine concentrations. Less than 10% of the total dose is excreted in urine as unchanged drug and its metabolites over 108 hours.']","['Although the metabolic and excretory fate of scopolamine has not been fully determined, the drug is thought to be almost completely metabolized (principally by conjugation) in the liver and excreted in urine.']","['Following application of a single transdermal scopolamine system that delivered approximately 1 mg/72 hours, the average elimination half-life of the drug was 9.5 hours.']"
3311,153312,CID 153312,C[C@H]1CCC=C(C(=O)N=C2C(=CNN3CCN(CC3)C)C(=C4C(=C2O)C(=C(C5=C4C(=O)[C@](O5)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,,,,,,
3312,153313,"2,4-Dichloro-1-[2-chloro-1-[methoxy(methylsulfanyl)phosphoryl]oxyethenyl]benzene",COP(=O)(OC(=CCl)C1=C(C=C(C=C1)Cl)Cl)SC,,,,,,
3313,153314,"Phosphonium, tetrakis((methyl((methylamino)carbonyl)amino)methyl)-,chloride",CNC(=O)N(C)C[P+](CN(C)C(=O)NC)(CN(C)C(=O)NC)CN(C)C(=O)NC.[Cl-],,,,,,
3314,153315,Tetrakis[(methyl-(methylcarbamoyl)amino)methyl]phosphanium,CNC(=O)N(C)C[P+](CN(C)C(=O)NC)(CN(C)C(=O)NC)CN(C)C(=O)NC,,,,,,
3315,153316,Tert-butyl-[(1-methylpyridin-2-ylidene)methyl]-oxoazanium,CC(C)(C)[N+](=O)C=C1C=CC=CN1C,,,,,,
3316,153317,CID 153317,CC(C)(C)[N+](=CC1=C[N+](=CC=C1)C)[O-],,,,,,
3317,153318,CID 153318,CC(C)(C)[N+](=O)C=C1C=CN(C=C1)C,,,,,,
3318,153319,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-(3-(dimethylamino)propyl)-5-nitro-",CN(C)CCCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)[N+](=O)[O-],,,,,,
3319,153320,"Phenol, 4,4'-(2,3-diethyl-2,3-oxiranediyl)bis-, trans-",CC[C@@]1([C@](O1)(CC)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O,,,,,,
3320,153321,"Phenol, 4,4'-(2,3-diethyl-2,3-oxiranediyl)bis-, cis-",CC[C@]1([C@](O1)(CC)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O,,,,,,
3321,153322,"Hydrazine, 1,1-bis(2-bromoethyl)-",C(CBr)N(CCBr)N,,,,,,
3322,153323,"Piperidine, 1-(2,2-dimethyl-1-aziridinyl)-",CC1(CN1N2CCCCC2)C,,,,,,
3323,153324,4-(2-((2-(4-Morpholinyl)ethyl)dithio)ethyl)morpholine,C1COCCN1CCSSCCN2CCOCC2,,,,,,
3324,153325,meso-Dimethylaminomethyletioporphyrin-1-cobalt complex,CCC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C([N-]5)C(=C1[N-]2)CN(C)C)C)CC)C(=C4CC)C)C(=C3CC)C)C.[Co+2],,,,,,
3325,153326,"4-[6-Hydroxy-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol",CC=C(C1=CC=C(C=C1)O)C(=CCO)C2=CC=C(C=C2)O,,,,,,
3326,153327,"Glycine, N-(1-(acetyloxy)butyl)-N-nitroso-, methyl ester",CCCC(N(CC(=O)OC)N=O)OC(=O)C,,,,,,
3327,153328,"beta-Alanine, N-(1-(acetyloxy)butyl)-N-nitroso-, methyl ester",CCCC(N(CCC(=O)OC)N=O)OC(=O)C,,,,,,
3328,153329,"Guanidine, (((3,5-diamino-6-chloropyrazinyl)carbonyl)oxy)-",C1(=C(N=C(C(=N1)Cl)N)N)C(=O)ON=C(N)N,,,,,,
3329,153330,"Pyrimido(1,2-a)purin-10(1H)-one, 7-hydroxy-",C1=C(C=NC2=NC3=C(C(=O)N21)NC=N3)O,,,,,,
3330,153331,CID 153331,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=O)NC=C(C=O)O,,,,,,
3331,153332,"Phosphonic acid, (3-(3,5-dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)propyl)-, potassium salt",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCP(=O)(O)O)O)O.[K+],,,,,,
3332,153333,"3-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]propylphosphonic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCCP(=O)(O)O)O)O,,,,,,
3333,153334,"Sulfamic acid, (2-(3,5-dihydroxy-4-(3-(3-hydroxy-4-methoxyphenyl)-1-oxopropyl)phenoxy)ethyl)-, monopotassium salt",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCNS(=O)(=O)O)O)O.[K+],,,,,,
3334,153335,"2-[3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenoxy]ethylsulfamic acid",COC1=C(C=C(C=C1)CCC(=O)C2=C(C=C(C=C2O)OCCNS(=O)(=O)O)O)O,,,,,,
3335,153336,"Ethanone, 2-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)-",COC1=C(C=C(C=C1)CC(=O)C2=C(C=C(C=C2O)O)O)O,,,,,,
3336,153337,"Oxireno(g)-1,2-benzisoxazole, 3a,4,5,5a,6a,6b-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-",CN1C(=CN=C1C2=NOC3C2CCC4C3O4)[N+](=O)[O-],,,,,,
3337,153338,"3,10-Dihydroxyactinomycin D oxazinone",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CCC(=C4C3=NC5=C(O4)C(=C6C(=C5C(=O)NC7C(OC(=O)C(N(C(=O)CN(C(=O)C8CCCN8C(=O)C(NC7=O)C(C)C)C)C)C(C)C)C)N=CC(=O)O6)C)C,,,,,,
3338,153339,"Propanal, 3-(butylnitrosoamino)-",CCCCN(CCC=O)N=O,,,,,,
3339,153340,"3,10-dihydroactinomycin D3-ethyloxazinone",CCC1=NC2=C(C3=C(C(=C2OC1=O)C)OC4=C(C=CC(=C4N3)C(=O)NC5C(OC(=O)C(N(C(=O)CN(C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)C)C)C(C)C)C)C)C(=O)NC7C(OC(=O)C(N(C(=O)CN(C(=O)C8CCCN8C(=O)C(NC7=O)C(C)C)C)C)C(C)C)C,,,,,,
3340,153341,"3,10-Dihydroactinomycin D 3-(fluoromethyl)oxazinone",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(N4)C(=C6C(=C5C)OC(=O)C(=N6)CF)C(=O)NC7C(OC(=O)C(N(C(=O)CN(C(=O)C8CCCN8C(=O)C(NC7=O)C(C)C)C)C)C(C)C)C,,,,,,
3341,153342,"3,10-Dihydroactinomycin D 3-(2-carboxyethyl)oxazinone",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(N4)C(=C6C(=C5C)OC(=O)C(=N6)CCC(=O)O)C(=O)NC7C(OC(=O)C(N(C(=O)CN(C(=O)C8CCCN8C(=O)C(NC7=O)C(C)C)C)C)C(C)C)C,,,,,,
3342,153343,"3,10-Dihydroactinomycin D 3-carboxymethyloxazinone",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(N4)C(=C6C(=C5C)OC(=O)C(=N6)CC(=O)O)C(=O)NC7C(OC(=O)C(N(C(=O)CN(C(=O)C8CCCN8C(=O)C(NC7=O)C(C)C)C)C)C(C)C)C,,,,,,
3343,153344,"Ethanaminium, 2,2'-((9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino)bis(N,N,N-trimethyl-, diiodide",C[N+](C)(C)CCNC1=C2C(=C(C=C1)NCC[N+](C)(C)C)C(=O)C3=CC=CC=C3C2=O.[I-].[I-],,,,,,
3344,153345,"2-[[9,10-Dioxo-4-[2-(trimethylazaniumyl)ethylamino]anthracen-1-yl]amino]ethyl-trimethylazanium",C[N+](C)(C)CCNC1=C2C(=C(C=C1)NCC[N+](C)(C)C)C(=O)C3=CC=CC=C3C2=O,,,,,,
3345,153346,"L-Valine, L-threonyl-D-valyl-L-prolyl-N-methylglycyl-N-methyl-,xi-lactone, 1,1'-diamide with 4-methyl-1,9-phenazinedicarboxylic acid10,5,5",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=CC=C3)N=C5C(=CC=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
3346,153347,"3,4-Bis(4-acetyloxyphenyl)hexa-2,4-dienyl acetate",CC=C(C1=CC=C(C=C1)OC(=O)C)C(=CCOC(=O)C)C2=CC=C(C=C2)OC(=O)C,,,,,,
3347,153348,2-Amino-4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,CCC(=C(CC)C1=CC(=C(C=C1)O)N)C2=CC=C(C=C2)O,,,,,,
3348,153349,"Phenol, 5-(2-(3,5-dimethoxyphenyl)ethyl)-2-methoxy-",COC1=C(C=C(C=C1)CCC2=CC(=CC(=C2)OC)OC)O,,,,,,
3349,153350,"Formamide, N-(2-(2,4-dichlorophenyl)-2-hydroxyethyl)-",C1=CC(=C(C=C1Cl)Cl)C(CNC=O)O,,,,,,
3350,153351,"Urea, (2-(2,4-dichlorophenyl)-2-hydroxyethyl)-",C1=CC(=C(C=C1Cl)Cl)C(CNC(=O)N)O,,,,,,
3351,153352,"Formamide, 1-((2-chloro-2-propenyl)sulfinyl)-N,N-diethyl-",CCN(CC)C(=O)S(=O)CC(=C)Cl,,,,,,
3352,153353,"Androst-4-en-3-one, 9,11-epoxy-17-hydroxy-17-methyl-, (11alpha,17beta)-",C[C@]12CCC(=O)C=C1CC[C@@H]3C24[C@@H](O4)C[C@]5([C@H]3CC[C@@]5(C)O)C,,,,,,
3353,153354,"1,2,3,10,11,11a-Hexahydro-9,11-dihydroxy-8-methyl-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one",CC1=C(C2=C(C=C1)C(=O)N3CCCC3C(N2)O)O,,,,,,
3354,153355,"Azuleno(1,2,3-cd)phenalene, 4,5,11,12-tetrahydro-",C1CC2=C3C=CC4=CCCC5=C4C3=C(C2=CC=C1)C=C5,,,,,,
3355,153356,7-Dis-O-ethylnogarol,CCO[C@H]1C[C@@](CC2=CC3=C(C(=C12)O)C(=O)C4=C(C=C5C(=C4C3=O)O[C@H]6[C@H]([C@H]([C@H]([C@]5(O6)C)O)N(C)C)O)O)(C)O,,,,,,
3356,153357,7-Dis-O-propylnogarol,CCCO[C@H]1C[C@@](CC2=CC3=C(C(=C12)O)C(=O)C4=C(C=C5C(=C4C3=O)O[C@H]6[C@H]([C@H]([C@H]([C@]5(O6)C)O)N(C)C)O)O)(C)O,,,,,,
3357,153358,4-[Bis(2-chloroethyl)amino]benzonitrile,C1=CC(=CC=C1C#N)N(CCCl)CCCl,,,,,,
3358,153359,"1,3,5-Benzenetriamine, N,N-bis(2-chloroethyl)-",C1=C(C=C(C=C1N)N(CCCl)CCCl)N,,,,,,
3359,153360,"(1,1'-Biphenyl)-4,4'-diamine, N-hydroxy-",C1=CC(=CC=C1C2=CC=C(C=C2)NO)N,,,,,['N-hydroxy-benzidine has known human metabolites that include N-hydroxy-benzidine O-acetyl.'],
3360,153361,7-Con-O-methylnogalarol,C[C@]1(C[C@H](C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C5C(=CC(=C4C3=O)O)[C@]6([C@@H]([C@@H]([C@@H]([C@H](O5)O6)O)N(C)C)O)C)O)OC)O,,,,,,
3361,153362,7-Con-O-propylnogarol,CCCO[C@H]1CC(CC2=CC3=C(C(=C12)O)C(=O)C4=C(C=C5C(=C4C3=O)O[C@H]6[C@@H]([C@@H]([C@@H]([C@@]5(O6)C)O)N(C)C)O)O)(C)O,,,,,,
3362,153363,"1,8,10-Anthracenetriol, 3-methoxy-6-methyl-",CC1=CC2=C(C3=C(C=C2C(=C1)O)C(=CC(=C3)OC)O)O,,,,,,
3363,153364,N2-(N-Glycyl-L-histidyl)-L-ornithine,C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)CN,,,,,,
3364,153365,CID 153365,CC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)OS(=O)(=O)[O-].[K+],,,,,,
3365,153366,(2-Hydroxyethyl)trimethylarsonium bromide,C[As+](C)(C)CCO.[Br-],,,,,,
3366,153367,"Benzenamine, N-(acetyloxy)-",CC(=O)ONC1=CC=CC=C1,,,,,,
3367,153368,"1,2,3,4,15,16-Hexahydro-3,4-dihydroxy-11-methyl-1,2-epoxy-17H-cyclopenta(a)phenanthren-17-one (1alpha,2alpha,3beta,4alpha)-",CC1=CC2=C(CCC2=O)C3=C1C4=C(C=C3)[C@H]([C@@H]([C@H]5[C@@H]4O5)O)O,,,,,,
3368,153369,"9,10-Anthracenedione, 3-(bromomethyl)-1,8-dihydroxy-",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)CBr,,,,,,
3369,153370,CID 153370,C[C@]([C@@H]([C@@H](C(=O)O)O)O)([C@H](C(=O)C1=C(C=C(C=C1Cl)Cl)Cl)OCN=NN)O,,,,,,
3370,153371,"9H-Fluorene, 2,5-diazido-",C1C2=CC=CC(=N[N+]#N)C2=C3C1=CC(=NN=[N-])C=C3,,,,,,
3371,153372,"2,7-Diazido-9H-fluorene",C1C2=CC(=NN=[N-])C=CC2=C3C1=CC(=N[N+]#N)C=C3,,,,,,
3372,153373,"Benzo(2,3)phenanthro(4,5-bcd)thiophene",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2SC5=CC=C4,,,,,,
3373,153374,2-Hydroxymoxestrol,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=C(C=C34)O)O)OC,,,,,,
3374,153375,"1,3-Propanediamine, N,N-diethyl-N'-(5-methyl-9-(phenylmethoxy)-6H-pyrido(4,3-b)carbazol-1-yl)-",CCN(CC)CCCNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CC(=C4)OCC5=CC=CC=C5)C,,,,,,
3375,153376,"1,3-Propanediamine, N'-(5,11-dimethyl-9-(phenylmethoxy)-6H-pyrido(4,3-b)carbazol-1-yl)-N,N-diethyl-",CCN(CC)CCCNC1=NC=CC2=C(C3=C(C(=C21)C)C4=C(N3)C=CC(=C4)OCC5=CC=CC=C5)C,,,,,,
3376,153377,"1,3,5-Triazine-2,4-diamine, 1-(4-butoxyphenyl)-1,6-dihydro-6,6-dimethyl-, hydrochloride",CCCCOC1=CC=C(C=C1)N2C(=NC(=NC2(C)C)N)N.Cl,,,,,,
3377,153378,"1-(4-Butoxyphenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine",CCCCOC1=CC=C(C=C1)N2C(=NC(=NC2(C)C)N)N,,,,,,
3378,153379,"1,3,5-Triazin-2-amine, 4,6-bis(1-aziridinyl)-N-(1-methylethyl)-",CC(C)NC1=NC(=NC(=N1)N2CC2)N3CC3,,,,,,
3379,153380,"10-Methoxy-2-methyl-7H-pyrido(4,3-c)carbazolium acetate",CC(=O)[O-].CN1CC2=C(C=CC3C2C4C=C(C=CC4[NH2+]3)OC)C=C1,,,,,,
3380,153381,"10-Methoxy-2,7-dimethyl-7H-pyrido(4,3-c)carbazolium acetate",CC(=O)[O-].C[NH+]1C2C=CC(=CC2C3C1C=CC4=C3CN(C=C4)C)OC,,,,,,
3381,153382,"10-Methoxy-7-methyl-2-(2-(1-piperidinyl)ethyl)-7H-pyrido(4,3-c)carbazolium acetate",CC(=O)[O-].C[NH+]1C2C=CC(=CC2C3C1C=CC4=C3CN(C=C4)CCN5CCCCC5)OC,,,,,,
3382,153383,"10-methoxy-7-methyl-2-(2-piperidin-1-ylethyl)-6a,7a,11a,11b-tetrahydro-1H-pyrido[4,3-c]carbazole",CN1C2C=CC(=CC2C3C1C=CC4=C3CN(C=C4)CCN5CCCCC5)OC,,,,,,
3383,153384,"10-Hydroxy-2-methyl-7H-pyrido(4,3-c)carbazolium acetate (salt)",CC(=O)[O-].CN1CC2=C(C=CC3C2C4C=C(C=CC4[NH2+]3)O)C=C1,,,,,,
3384,153385,"1H-Imidazole-2-sulfenic acid, 4,5-dihydro-",C1CN=C(N1)SO,,,,,,
3385,153386,"5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 3-butoxy-1,2,3,10,11,11a-hexahydro-8-hydroxy-7-methoxy-, (3R-cis)-",CCCCO[C@@H]1CC[C@@H]2N1C(=O)C3=CC(=C(C=C3NC2)O)OC,,,,,,
3386,153387,"2-(2,4-Dimethoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",COC1=CC(=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC)OC)OC,,,,,,
3387,153388,"1,2,3-Propanetriol, mixt. with water",C(C(CO)O)O.O,,,,,,
3388,153389,4-Dibenzothiophenamine,C1=CC=C2C(=C1)C3=C(S2)C(=CC=C3)N,,,,,,
3389,153390,"1,2,3,10,11,11a-Hexahydro-2,9-dihydroxy-11-methoxy-8-methyl-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one",CC1=C(C2=C(C=C1)C(=O)N3CC(CC3C(N2)OC)O)O,,,,,,
3390,153391,"4(3H)-Quinolinone, 3,3-dimethyl-",CC1(C=NC2=CC=CC=C2C1=O)C,,,,,,
3391,153392,"2,3-Dihydro-2-methoxy-3,3-dimethyl-4(1H)-quinolinone",CC1(C(NC2=CC=CC=C2C1=O)OC)C,,,,,,
3392,153393,"(S)-1,2,3,11a-Tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one",C1C[C@H]2C=NC3=CC=CC=C3C(=O)N2C1,,,,,,
3393,153394,"2-Pyrrolidinecarboxaldehyde, 1-(2-nitrobenzoyl)-, (S)-",C1C[C@H](N(C1)C(=O)C2=CC=CC=C2[N+](=O)[O-])C=O,,,,,,
3394,153395,4-Hydroxyfenbendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=C(C=C3)O,,,,,,
3395,153396,"4,5,7-Trimethylbenzo(a)pyrene",CC1=C2C=C3C(=C(C4=CC=CC5=C4C3=C(C2=CC=C1)C=C5)C)C,,,,,,
3396,153397,"Acetamide, N-((methylamino)carbonyl)-N-phenyl-",CC(=O)N(C1=CC=CC=C1)C(=O)NC,,,,,,
3397,153398,Pipemidic acid trihydrate,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCNCC3)C(=O)O.O.O.O,,,"['Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)', 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)']",,,
3398,153399,"beta-D-Glucopyranuronic acid, 1-((1,1'-biphenyl)-4-ylhydroxyamino)-1-deoxy-",C1=CC=C(C=C1)C2=CC=C(C=C2)N([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)O,,,,,,
3399,153400,"4,5-Dehydroniridazole",C1=CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-],,,,,,
3400,153401,"Dichloro(4,5-dimethoxy-o-phenylenediammine)platinum (II)",COC1=C(C=C(C(=C1)N)N)OC.Cl[Pt]Cl,,,,,,
3401,153402,"Platinum (II), dichloro(4-ethoxy-o-phenylenediammine)-",CCOC1=CC(=C(C=C1)N)N.Cl[Pt]Cl,,,,,,
3402,153403,"Platinum (II), dichloro(4-methoxy-o-phenylenediammine)-",COC1=CC(=C(C=C1)N)N.Cl[Pt]Cl,,,,,,
3403,153404,"3,4-Diaminoanisole",COC1=CC(=C(C=C1)N)N,,,,,,
3404,153405,"Dichloro(4,5-dichloro-o-phenylenediammine)platinum (II)",C1=C(C(=CC(=C1Cl)Cl)N)N.Cl[Pt]Cl,,,,,,
3405,153406,S-(2-Phenyl-2-hydroxyethyl)glutathione,C1=CC=C(C=C1)C(CSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O,,,,,,
3406,153407,CID 153407,CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)C3([C@@H]([C@H]([C@@H]([C@H](O3)C(=O)[O-])O)O)O)O.[Na+],,,,,,
3407,153408,"(2S,3S,4S,5R)-3,4,5,6-tetrahydroxy-6-[4-[[4-(methylamino)phenyl]diazenyl]phenyl]oxane-2-carboxylic acid",CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)C3([C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)O,,,,,,
3408,153409,CID 153409,C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)OS(=O)(=O)[O-].[K+],,,,,,
3409,153410,[4-[(4-Aminophenyl)diazenyl]phenyl] hydrogen sulfate,C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)OS(=O)(=O)O,,,,,,
3410,153411,"1a,2,3,11b-Tetrahydro-4,11-dimethylbenz(7,8)anthra(1,2-b)oxirene-2,3-diol",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1C(C(C5C4O5)O)O)C,,,,,,
3411,153412,"7-(Bromomethyl)-1,3,4,7,8-pentachloro-3-methylocta-1,5-diene",CC(C=CCl)(C(C=CC(CCl)(CBr)Cl)Cl)Cl,,,,,,
3412,153413,"(3R,4S,7S)-1,8-dibromo-3,4,7-trichloro-3,7-dimethylocta-1,5-diene",C[C@@](CBr)(C=C[C@@H]([C@@](C)(C=CBr)Cl)Cl)Cl,,,,,,
3413,153414,CID 153414,CCOC1=CC=C(C=C1)N=NC2=CC=C(C3=CC=CC=C32)N=NC4=CC(=CC=C4)S(=O)(=O)[O-].[Na+],,,,,,
3414,153415,3-[[4-[(4-Ethoxyphenyl)azo]-1-naphthyl]azo]benzenesulfonic acid,CCOC1=CC=C(C=C1)N=NC2=CC=C(C3=CC=CC=C32)N=NC4=CC(=CC=C4)S(=O)(=O)O,,,,,,
3415,153416,"1-Bromo-7-(bromomethyl)-3,4,7,8-tetrachloro-3-methylocta-1,5-diene",CC(C=CBr)(C(C=CC(CCl)(CBr)Cl)Cl)Cl,,,,,,
3416,153417,"N-(3-Aminopropyl)-1,3-propanediamine trihydrochloride",C(CN)CNCCCN.Cl.Cl.Cl,,,,,,
3417,153418,(Z)-N-tert-Butylpyridine-2-methaneimine N-oxide,CC(C)(C)[N+](=CC1=CC=CC=N1)[O-],,,,,,
3418,153419,N-tert-Butylpyridine-3-methaneimine N-oxide,CC(C)(C)[N+](=CC1=CN=CC=C1)[O-],,,,,,
3419,153420,"Acetamide, N,N'-(4-methoxy-1,3-phenylene)bis-",CC(=O)NC1=CC(=C(C=C1)OC)NC(=O)C,,,,,,
3420,153421,N-Nitrosodiethanolamine monoacetate,CC(=O)OCCN(CCO)N=O,,,,,,
3421,153422,"1,5-Bis((2-(dimethylamino)ethyl)thio)-9,10-anthracenedione",CN(C)CCSC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=CC=C3)SCCN(C)C,,,,,,
3422,153423,"Tetrachloro(2,2-dimethyl-1,3-propanediamine-N,N')platinum",CC(C)(CN)CN.Cl[Pt-2](Cl)(Cl)Cl,,,,,,
3423,153424,"2,7-Dibromo-4,9-dihydro-pyrido(2,3,4,5-lmn)phenanthridine-5,10-dione",C1=C(C=C2C3=C1C(=O)NC4=CC(=CC(=C43)C(=O)N2)Br)Br,,,,,,
3424,153425,CID 153425,C1=C(C=C2C3=C4C(=CC(=O)C=C4NC(=C31)O)C(=O)N2)O,,,,,,
3425,153426,"2,7-Dichloro-4,9-dihydro-4,9-dihydroxy-pyrido(2,3,4,5-lmn)phenanthridine-5,10-dione",C1=C(C=C2C3=C1C(=O)N(C4=CC(=CC(=C43)C(=O)N2O)Cl)O)Cl,,,,,,
3426,153427,"4,9-Dihydro-4,9-dihydroxy-2,7-diiodo-pyrido(2,3,4,5-lmn)phenanthridine-5,10-dione",C1=C(C=C2C3=C1C(=O)N(C4=CC(=CC(=C43)C(=O)N2O)I)O)I,,,,,,
3427,153428,CID 153428,C1=C(C=C2C3=C4C(=CC(=O)C=C4N(C(=C31)O)O)C(=O)N2O)O,,,,,,
3428,153429,CID 153429,CCOC(=O)C(=C(C)C=CC=C(C)C=CC1=C(C=C(C(C1)C)OC)C)F,,,,,,
3429,153430,"Benz(a)anthracene-12-carboxaldehyde, 7-(hydroxymethyl)-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C(=C32)C=O)CO,,,,,,
3430,153431,"Benz(a)anthracene-7,12-dimethanol, 8,9-dihydro-8,9-dihydroxy-, trans-",C1=CC=C2C(=C1)C=CC3=C(C4=C(C=C[C@@H]([C@H]4O)O)C(=C32)CO)CO,,,,,,
3431,153432,"Benz(a)anthracene-7,12-dimethanol, 5,6-dihydro-5,6-dihydroxy-, trans-",C1=CC=C2C(=C1)[C@@H]([C@H](C3=C(C4=CC=CC=C4C(=C23)CO)CO)O)O,,,,,,
3432,153433,N-(4-Nitrophenyl)-9-acridinamine monohydrochloride,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)[N+](=O)[O-].Cl,,,,,,
3433,153434,"Benzoic acid, 4-(9-acridinylamino)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)C(=O)O.Cl,,,,,,
3434,153435,"7H-Furo(3,2-g)(1)benzopyran-2,6-dicarboxylic acid, 9-methyl-7-oxo-, diethyl ester",CCOC(=O)C1=CC2=CC3=C(C(=C2OC1=O)C)OC(=C3)C(=O)OCC,,,,,,
3435,153436,"7H-Furo(3,2-g)(1)benzopyran-2-carboxylic acid, 7-oxo-, methyl ester",COC(=O)C1=CC2=C(O1)C=C3C(=C2)C=CC(=O)O3,,,,,,
3436,153437,"7H-Furo(2,3-f)(1)benzopyran-2,8-dicarboxylic acid, 7-oxo-, 8-ethyl 2-methyl ester",CCOC(=O)C1=CC2=C(C=CC3=C2OC(=C3)C(=O)OC)OC1=O,,,,,,
3437,153438,"7-Oxo-7H-furo(3,2-g)(1)benzopyran-2-carboxylic acid",C1=CC(=O)OC2=CC3=C(C=C21)C=C(O3)C(=O)O,,,,,,
3438,153439,"7H-Furo(2,3-f)(1)benzopyran-2-carboxylic acid, 7-oxo-, methyl ester",COC(=O)C1=CC2=C(O1)C3=C(C=C2)OC(=O)C=C3,,,,,,
3439,153440,1-Chloro-2-(4-nitrosophenoxy)benzene,C1=CC=C(C(=C1)OC2=CC=C(C=C2)N=O)Cl,,,,,,
3440,153441,"5,8-Dihydroxy-6,7-dimethoxyflavone",COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)O)OC,,,,,,
3441,153442,Demethylvinylbutonate,CCCC(=O)OC(=C(Cl)Cl)P(=O)(O)OC,,,,,,
3442,153443,2-Amino-5-methyl-5-hexenoic acid,CC(=C)CC[C@@H](C(=O)O)N,,,,,,
3443,153444,2-Azido-7-bromo-9H-fluorene,C1C2=C(C=CC(=C2)N=[N+]=[N-])C3=C1C=C(C=C3)Br,,,,,,
3444,153445,2-Azido-7-iodo-9H-fluorene,C1C2=C(C=CC(=C2)N=[N+]=[N-])C3=C1C=C(C=C3)I,,,,,,
3445,153446,CID 153446,C1=CC2=C3C=CC(=N[N+]#N)C=C3C(=C2C=C1)N=NC4=C(C=C(C=C4)N(O)[O-])[N+](=O)[O-],,,,,,
3446,153447,CID 153447,C1=CC=C2C(=C1)C3=C(C2=N[O-])C=C(C=C3)N[N+]#N,,,,,,
3447,153448,CID 153448,CCC(C)[N+](=CC1=CC=CC=C1S(=O)(=O)[O-])[O-].[Na+],,,,,,
3448,153449,CID 153449,CCC(C)[N+](=CC1=CC=CC=C1S(=O)(=O)O)[O-],,,,,,
3449,153450,"1-(1-Pyrenyl)-1,2-ethanediol",C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)C(CO)O,,,,,,
3450,153451,9-Chloro-10-(fluoromethyl)anthracene,C1=CC=C2C(=C1)C(=C3C=CC=CC3=C2Cl)CF,,,,,,
3451,153452,"1,2-Naphthalenedione, 4-(pentyloxy)-",CCCCCOC1=CC(=O)C(=O)C2=CC=CC=C21,,,,,,
3452,153453,2-Acetamido-6-nitrobenzoic Acid,CC(=O)NC1=C(C(=CC=C1)[N+](=O)[O-])C(=O)O,,,,,,
3453,153454,"2,4-Di(acetylamino)benzoic acid",CC(=O)NC1=CC(=C(C=C1)C(=O)O)NC(=O)C,,,,,,
3454,153455,"1H-Indole-2,3-dione, 1-((bis(2-chloroethyl)amino)methyl)-5-chloro-",C1=CC2=C(C=C1Cl)C(=O)C(=O)N2CN(CCCl)CCCl,,,,,,
3455,153456,"4(1H)-Pyrimidinone, 2-((2,4-dinitrophenyl)thio)-5-methyl-",CC1=CN=C(NC1=O)SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3456,153457,"3-Pyridinecarboxylic acid, 5-nitro-2-(2-pyrimidinylthio)-",C1=CN=C(N=C1)SC2=C(C=C(C=N2)[N+](=O)[O-])C(=O)O,,,,,,
3457,153458,CID 153458,C1=CC(=C(N=C1)SC2=NN=C(S2)S)[N+](=O)[O-],,,,,,
3458,153459,"1H-1,2,4-Triazole, 3-((2,4-dinitrophenyl)thio)-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=NC=NN2,,,,,,
3459,153460,"1H-Benzimidazole, 2-((2,4-dinitrophenyl)thio)-1-(2-(4-pyridinyl)ethyl)-",C1=CC=C2C(=C1)N=C(N2CCC3=CC=NC=C3)SC4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3460,153461,"1H-Indole-2,3-dione, 1-((bis(2-hydroxyethyl)amino)methyl)-5-iodo-",C1=CC2=C(C=C1I)C(=O)C(=O)N2CN(CCO)CCO,,,,,,
3461,153462,"1H-Indole-2,3-dione, 5-iodo-, 3-hydrazone",C1=CC2=C(C=C1I)C(=C(N2)O)N=N,,,,,,
3462,153463,"Benz(a)anthracene, 7-(2-bromoethyl)-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CCBr,,,,,,
3463,153464,N-(Pivaloyl)glycinohydroxamic acid,CC(C)(C)C(=O)NCC(=O)NO,,,,,,
3464,153465,(+-)-N-(2-(Hydroxyamino)-2-oxoethyl)-2-methylbutanamide,CCC(C)C(=O)NCC(=O)NO,,,,,,
3465,153466,Entozon,CCN(CC)CC(CNC1=C2C=CC(=CC2=NC3=CC(=C(C=C31)OC)OC)[N+](=O)[O-])O.Cl.Cl,,,,,,
3466,153467,CID 153467,CC1C(=C([N+](C2C1(C=C(C=C2)OC)C)(C)S)C=C=O)S.[I-],,,,,,
3467,153468,CID 153468,CC1C(=C([N+](C2C1(C=C(C=C2)OC)C)(C)S)C=C=O)S,,,,,,
3468,153469,CID 153469,CCN1C2=C(C=C(C=C2)OC)OC1=CC=CC3=[N+](C4=C(O3)C=C(C=C4)OC)CC.[I-],,,,,,
3469,153470,CID 153470,CCN1C2=C(C=C(C=C2)OC)OC1=CC=CC3=[N+](C4=C(O3)C=C(C=C4)OC)CC,,,,,,
3470,153471,CID 153471,CN1C2=C(C=CC(=C2)C#N)OC1=CC=CC3=[N+](C4=C(O3)C=CC(=C4)C#N)C.[O-]S(=O)(=O)F,,,,,,
3471,153472,CID 153472,CN1C2=C(C=CC(=C2)C#N)OC1=CC=CC3=[N+](C4=C(O3)C=CC(=C4)C#N)C,,,,,,
3472,153473,CID 153473,C1N2CN3CN1CN(C2)C3.C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N.C([C@@H](C(=O)O)N)S.Cl,,,,,,
3473,153474,"Acetamide, N-(7-methyl-9-oxo-9H-thioxanthen-3-yl)-, S,S-dioxide",CC1=CC2=C(C=C1)S(=O)(=O)C3=C(C2=O)C=CC(=C3)NC(=O)C,,,,,,
3474,153475,"Acetamide, N-(7-ethyl-9-oxo-9H-thioxanthen-3-yl)-, S,S-dioxide",CCC1=CC2=C(C=C1)S(=O)(=O)C3=C(C2=O)C=CC(=C3)NC(=O)C,,,,,,
3475,153476,"Acetamide, N-(9-oxo-7-propyl-9H-thioxanthen-3-yl)-, S,S-dioxide",CCCC1=CC2=C(C=C1)S(=O)(=O)C3=C(C2=O)C=CC(=C3)NC(=O)C,,,,,,
3476,153477,2-Amino-5-[2-chloro-4-(trifluoromethyl)phenoxy]benzoic acid,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)N)C(=O)O,,,,,,
3477,153478,"Di-mu-chlorodichlorobis(1,2,4,5-tetrahydro-2,4-dimethylpyrrolo(3,2,1-hi)indole)diplatinum",CC1CC2=C3N1C(CC3=CC=C2)C.CC1CC2=C3N1C(CC3=CC=C2)C.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
3478,153479,"3,5-Dimethyl-4-azatricyclo[5.3.1.04,11]undeca-1(11),7,9-triene",CC1CC2=C3N1C(CC3=CC=C2)C,,,,,,
3479,153480,N-(10-Aminodecyl)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCCCCCCCCN)C,,,,,,
3480,153481,7-O-Ethylnogarol,CCOC1CC(CC2=CC3=C(C(=C12)O)C(=O)C4=C(C=C5C(=C4C3=O)OC6C(C(C(C5(O6)C)O)N(C)C)O)O)(C)O,,,,,,
3481,153482,"Benzo(9,10)pyreno(4,5-b)oxirene",C1=CC=C2C3=C4C(=CC=C3)C5=C(O5)C6=CC=CC(=C64)C2=C1,,,,,,
3482,153483,CID 153483,CC=C1CC(C(C(=O)OCC2=C3C(CC[N+]3(C=C2)C)OC1=O)(C)OC(=O)C)C.CC(=O)[O-],,,,,,
3483,153484,CID 153484,CC=C1CC(C(C(=O)OCC2=C3C(CC[N+]3(C=C2)C)OC1=O)(C)OC(=O)C)C,,,,,,
3484,153485,16alpha-(125I)Iodoestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)[125I])CCC4=C3C=CC(=C4)O,,,,,,
3485,153486,"3,12-Dihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)(C(=O)CO)O)N)O,,,,,,
3486,153487,11-Deoxydaunomycinol,CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)(C(C)O)O)N)O,,,,,,
3487,153488,"syn-Phenanthrene-1,2-diol-3,4-oxide",C1=CC=C2C(=C1)C=CC3=C2[C@H]([C@H]([C@H]4[C@H]3O4)O)O,,,,,,
3488,153489,"Platinate(2-), diamminedioxalato-, dipotassium (E)-",C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].N.N.[K+].[K+].[Pt+2],,,,,,
3489,153490,Rhodamine 640 perchlorate,C1CC2=CC3=C(C4=C2N(C1)CCC4)OC5=C6CCC[N+]7=C6C(=CC5=C3C8=CC=CC=C8C(=O)O)CCC7.[O-]Cl(=O)(=O)=O,,,,,,
3490,153491,Octadecyl rhodamine 101 ester,C1CC2=CC3=C(C4=C2N(C1)CCC4)OC5=C6CCC[N+]7=C6C(=CC5=C3C8=CC=CC=C8C(=O)O)CCC7,,,,,,
3491,153492,Antibiotic SF 1739 HP,CC1=C(C2=C(C(N3C4C2N5CCOC5C6C4N(C(C6)C3O)C)CO)C(=O)C1=O)O,,,,,,
3492,153493,"Platinum, dihydroxybis(2-propanamine)(propanedioato(2-)-O,O')-, (OC-6-33)-",CC(C)N.CC(C)N.C(C(=O)[O-])C(=O)[O-].[OH-].[OH-].[Pt+4],,,,,,
3493,153494,"2-(Acetyloxy)-1,2,3,10,11,11a-hexahydro-9-hydroxy-11-methoxy-8-methyl-5H-pyrrolo(2,1-c)(1,4)benzodiozepin-5-one",CC1=C(C2=C(C=C1)C(=O)N3CC(CC3C(N2)OC)OC(=O)C)O,,,,,,
3494,153495,"3-(2-Chloroethyl)-3,4-dihydro-4-imino-1-methyl-2(1H)-pyrimidine monohydrochloride",CN1C=CC(=N)N(C1=O)CCCl.Cl,,,,,,
3495,153496,3-(2-Chloroethyl)-4-imino-1-methylpyrimidin-2-one,CN1C=CC(=N)N(C1=O)CCCl,,,,,,
3496,153497,CID 153497,CC1=C(C2=C(C=C1)C(=O)N3C=C(C[C@H]3[C@H](N2)OC)C=CC#N)O,,,,,,
3497,153498,CID 153498,CC1=C(C2=C(C=C1)C(=O)N3C=C(C[C@H]3[C@H](N2C(=O)C)O)C=CC(=O)N)O,,,,,,
3498,153499,Senecivernin,CC1C(C(C(=O)OCC2=CCN3C2C(CC3)OC(=O)C1=C)(C)O)C,,,,,,
3499,153500,Tert-butyl-[(1-oxidopyridin-2-ylidene)methyl]-oxoazanium,CC(C)(C)[N+](=O)C=C1C=CC=CN1[O-],,,,,,
3500,153501,N-tert-butyl-1-(1-oxidopyridin-1-ium-3-yl)methanimine oxide,CC(C)(C)[N+](=CC1=C[N+](=CC=C1)[O-])[O-],,,,,,
3501,153502,Sarsasapogenin 3-O-beta-D-xylopyranosyl-(1-4)-beta-D-glucopyranoside,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CCC6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O)O)C)C)C)OC1,,,,,,
3502,153503,Mntmpyp,CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=C[N+](=CC=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=C[N+](=CC=C9)C)C=C3)C=C1.[Mn+2],,,,,,
3503,153504,"5,15-bis(1-methylpyridin-1-ium-3-yl)-20-(1-methylpyridin-1-ium-4-yl)-10-(1-methylpyridin-4-ylidene)-21H-porphyrin",CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=CC=C(N5)C(=C6C=CC2=N6)C7=C[N+](=CC=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=C[N+](=CC=C9)C)C=C3)C=C1,,,,,,
3504,153505,"(2,2-Dimethylpropane-1,3-diammine)malonatoplatinum(II)",CC(C)(CN)CN.C(C(=O)[O-])C(=O)[O-].[Pt+2],,,,,,
3505,153506,Adriamycin semiquinone free radical,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C5=C(C(=CC=C5)OC)C(=C4C(=C23)O)O)O)O)(C(=O)CO)O)N)O,,,,,,
3506,153507,"5-Naphthacenyloxy, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11,12-tetrahydroxy-1-methoxy-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C5=C(C(=CC=C5)OC)C(=C4C(=C23)O)O)O)O)(C(=O)C)O)N)O,,,,,,
3507,153508,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-1-methoxy-, hydrochloride, (8R-trans)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)C)N)O.Cl,,,,,,
3508,153509,"8-Acetyl-10-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,11-dihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)C)N)O,,,,,,
3509,153510,Antibiotic RP 20798,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N)O.Cl,,,,,,
3510,153511,Daunorubicineal,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N)O,,,,,,
3511,153512,"10-((3-(Acetylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C)O.Cl,,,,,,
3512,153513,"N-[3-hydroxy-2-methyl-6-[[3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]acetamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C)O,,,,,,
3513,153514,"5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8R-trans)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@H](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)CO)N)O.Cl,,,,,,
3514,153515,9-Deoxydoxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@H](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)C(=O)CO)N)O,,,,,,
3515,153516,"10-((3-Amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride, (8S-cis)-",C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,,,,,,
3516,153517,"3',4'-Diepidoxorubicin",C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,,,,,,
3517,153518,N(sup 4)-9-Acridinyl-N(sup 1)-methylsulfanilamide hydrochloride,CNS(=O)(=O)C1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
3518,153519,4-(acridin-9-ylamino)-N-methylbenzenesulfonamide,CNS(=O)(=O)C1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
3519,153520,2-Fluorobenzopentaphene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C6C=C(C=CC6=C5)F)C=C3,,,,,,
3520,153521,"(SP-4-2)-Dichloro(N,N,N',N'-tetra-2-propenyl-1,2-ethanediamine-N,N')palladium",C=CCN(CCN(CC=C)CC=C)CC=C.[Cl-].[Cl-].[Pd+2],,,,,,
3521,153522,"N,N,N',N'-Tetraallylethylenediamine",C=CCN(CCN(CC=C)CC=C)CC=C,,,,,,
3522,153523,"2(1H)-Pyrimidine, 4-((2,4-dinitrophenyl)thio)-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=CC=NC(=O)N2,,,,,,
3523,153524,"3,10,22,23,24-Pentaoxa-17-thiatetracyclo(17.2.1.1(sup 5,8).1(sup 12,15))tetracosa-5,7,12,14,19,21-hexaene-2,11-dione",C1C2=CC=C(O2)COC(=O)C3=CC=C(O3)CSCC4=CC=C(O4)C(=O)O1,,,,,,
3524,153525,"2,5,8,22,25,28,34,35-Octaoxa-15-thia-30,31-diazatetracyclo(27.2.2.1(sup 10,13).1(sup 17,20))pentatriaconta-10,12,17,19,29,31,32-heptaene-9,21-dione",C1COC2=NN=C(C=C2)OCCOCCOC(=O)C3=CC=C(O3)CSCC4=CC=C(O4)C(=O)OCCO1,,,,,,
3525,153526,"7,10:14,17-Diepoxy-5H,13H-dibenzo(k,b(sub 1))(1,4,7,10,20,13,27)tetraoxathiadiazacyclononacosine-6,18(11H,19H)-dione, 25,26,28,29,31,32-hexahydro-",C1COCCOC2=CC=CC=C2NC(=O)C3=CC=C(O3)CSCC4=CC=C(O4)C(=O)NC5=CC=CC=C5OCCO1,,,,,,
3526,153527,"10,13,18,19-Tetraoxa-3-thiatricyclo(13.2.1.1(sup 5,8))nonadeca-5,7,15,17-tetraene-9,14-dione",C1COC(=O)C2=CC=C(O2)CSCC3=CC=C(O3)C(=O)O1,,,,,,
3527,153528,Manganese lactate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Mn+2],,,,,,
3528,153529,Dichlorobis(1H-pyrazole-N2)platinum,C1=CNN=C1.C1=CNN=C1.[Cl-].[Cl-].[Pt+2],,,,,,
3529,153530,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-1,6,9,11-tetrahydroxy-9-(1-hydroxyethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C=CC(=C5C4=O)OC)O)O)(C(C)O)O)N)O,,,,,,
3530,153531,"Platinum, (N,N-bis((2,3-eta)-2-propenyl)benzenamine)dichloro-",C=CCN(CC=C)C1=CC=CC=C1.[Cl-].[Cl-].[Pt+2],,,,,,
3531,153532,"L-Histidine, N-(N2-(N-glycyl-L-histidyl)-L-lysyl)-4",C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)CN,,,,,,
3532,153533,"L-Lysine, N2,N6-bis(N-glycyl-L-histidyl)-",C1=C(NC=N1)C[C@@H](C(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)CN)NC(=O)CN,,,,,,
3533,153534,"Quinolinium, 2-(aminocarbonyl)-1-methyl-",C[N+]1=C(C=CC2=CC=CC=C21)C(=O)N,,,,,,
3534,153535,"Quinolinium, 2-(aminocarbonyl)-1,4-dimethyl-",CC1=CC(=[N+](C2=CC=CC=C12)C)C(=O)N,,,,,,
3535,153536,"Pyrido(2,3-d)pyrimidine-2,4-diamine, 5-methyl-6-sec-pentyl-",CCCC(C)C1=CN=C2C(=C1C)C(=NC(=N2)N)N,,,,,,
3536,153537,"Phenol, 2,2'-methylenebis(4-chloro-, monomethyl deriv.",COC1=C(C=C(C=C1)Cl)CC2=C(C=CC(=C2)Cl)O,,,,,,
3537,153538,"7H-Pyrido(4,3-c)carbazolium, 10-methoxy-2-(2-(1-piperidinyl)ethyl)-, acetate, dimer",CC(=O)[O-].CC(=O)[O-].COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCCCC5.COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCCCC5,,,,,,
3538,153539,"10-methoxy-2-(2-piperidin-1-ylethyl)-7H-pyrido[4,3-c]carbazol-2-ium",COC1=CC2=C(C=C1)NC3=C2C4=C(C=C3)C=C[N+](=C4)CCN5CCCCC5,,,,,,
3539,153540,"7H-Pyrido(4,3-c)carbazolium, 10-hydroxy-2-(2-(1-piperidinyl)ethyl)-, acetate (salt), dimer",CC(=O)[O-].CC(=O)[O-].C1CCN(CC1)CC[N+]2=CC3=C(C=CC4=C3C5=C(N4)C=CC(=C5)O)C=C2.C1CCN(CC1)CC[N+]2=CC3=C(C=CC4=C3C5=C(N4)C=CC(=C5)O)C=C2,,,,,,
3540,153541,"2-(2-piperidin-1-ylethyl)-7H-pyrido[4,3-c]carbazol-2-ium-10-ol",C1CCN(CC1)CC[N+]2=CC3=C(C=CC4=C3C5=C(N4)C=CC(=C5)O)C=C2,,,,,,
3541,153542,"Urea, N-(5-chloropentyl)-N-nitroso-",C(CCN(C(=O)N)N=O)CCCl,,,,,,
3542,153543,"Urea, N-(4-chlorobutyl)-N-nitroso-",C(CCCl)CN(C(=O)N)N=O,,,,,,
3543,153544,"Urea, N'-(1,1-dimethylethyl)-N-methyl-N-nitroso-",CC(C)(C)NC(=O)N(C)N=O,,,,,,
3544,153545,"Urea, N-methyl-N'-(1-methylpropyl)-N-nitroso-",CCC(C)NC(=O)N(C)N=O,,,,,,
3545,153546,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, sodium salt, (S)-",CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O.[Na+],,,,,,
3546,153547,N-Methyl-N'-(p-nitrophenyl)-N'-methyl-N-nitrosourea,CN(C1=CC=C(C=C1)[N+](=O)[O-])C(=O)N(C)N=O,,,,,,
3547,153548,"Thymidine, alpha-(methylsulfonyl)-",CS(=O)(=O)CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
3548,153549,"Methanesulfonamide, N-(4-((3-(dimethylamino)-9-acridinyl)amino)phenyl)-",CN(C)C1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=CC=C(C=C4)NS(=O)(=O)C,,,,,,
3549,153550,CID 153550,CCOC(=O)CNCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
3550,153551,"Phenanthridinium, 3,8-diamino-6-(4-carboxyphenyl)-5-ethyl-, inner salt",CCN1C2=CC(=N)C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)C(=O)O)N,,,,,,
3551,153552,"L-Cysteine, N-acetyl-S-(2-bromocyclohexyl)-, methyl ester, trans-",CC(=O)N[C@@H](CS[C@@H]1CCCC[C@H]1Br)C(=O)OC,,,,,,
3552,153553,"L-Cysteine, N-acetyl-S-(2-chlorocyclohexyl)-, methyl ester, trans-",CC(=O)N[C@@H](CS[C@@H]1CCCC[C@H]1Cl)C(=O)OC,,,,,,
3553,153554,"L-Cysteine, N-acetyl-S-(2-methoxycyclohexyl)-, methyl ester, trans-",CC(=O)N[C@@H](CS[C@@H]1CCCC[C@H]1OC)C(=O)OC,,,,,,
3554,153555,"Pyrrolidine, 1,1'-(dithiodi-2,1-ethanediyl)bis-",C1CCN(C1)CCSSCCN2CCCC2,,,,,,
3555,153556,"Ethanone, 1-(3,4,6-trihydroxy-2-methoxyphenyl)-",CC(=O)C1=C(C(=C(C=C1O)O)O)OC,,,,,,
3556,153557,"alpha-L-Mannopyranoside, 4-(isothiocyanatomethyl)phenyl 6-deoxy-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)CN=C=S)O)O)O,,,,,,
3557,153558,"Platinum, dichlorobis(2,3-dihydrobenzo(b)thiophene)-, (SP-4-1)-",C1CSC2=CC=CC=C21.C1CSC2=CC=CC=C21.[Cl-].[Cl-].[Pt+2],,,,,,
3558,153559,"Platinum, dichlorobis((2-propenylthio)benzene)-, (SP-4-2)-",C=CCSC1=CC=CC=C1.C=CCSC1=CC=CC=C1.[Cl-].[Cl-].[Pt+2],,,,,,
3559,153560,"Platinum, (2-(1,2-dibromoethyl)benzenethiolato)(2-(eta2-ethenyl)benzenethiolato-S)-",C=CC1=CC=CC=C1[S-].C1=CC(=CC(=C1)[S-])C(CBr)Br.[Pt+2],,,,,,
3560,153561,"3-(1,2-Dibromoethyl)benzenethiol",C1=CC(=CC(=C1)S)C(CBr)Br,,,,,,
3561,153562,"Phenanthridinium, 6,6'-(1,2-ethanediylbis(iminocarbonyl-4,1-phenylene))bis(3,8-diamino-5-methyl-, dichloride",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)C(=O)NCCNC(=O)C5=CC=C(C=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N.[Cl-].[Cl-],,,,,,
3562,153563,"4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)-N-[2-[[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)benzoyl]amino]ethyl]benzamide",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)C(=O)NCCNC(=O)C5=CC=C(C=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
3563,153564,CID 153564,C1CC=CCCC=C1.C1=CC=C2C(=C1)N=CS2.[Cl-].[Rh],,,,,,
3564,153565,"Phenanthridinium, 6,6'-(1,2-ethanediylbis(iminocarbonyl-3,1-phenylene))bis(3,8-diamino-5-methyl-, dichloride",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)C(=O)NCCNC(=O)C5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N.[Cl-].[Cl-],,,,,,
3565,153566,"3-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)-N-[2-[[3-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)benzoyl]amino]ethyl]benzamide",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)C(=O)NCCNC(=O)C5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
3566,153567,"Pyreno(1',10':3,4,5)cyclohept(1,2-b)oxirene, 7,8,8a,9a-tetrahydro-",C1CC2=CC3=CC=CC4=C3C5=C(C=C4)C=CC(=C25)C6C1O6,,,,,,
3567,153568,"Pyrimidine, 4-methyl-2-((3-nitro-2-pyridinyl)thio)-",CC1=NC(=NC=C1)SC2=C(C=CC=N2)[N+](=O)[O-],,,,,,
3568,153569,"Pyrimidine, 2-((3-nitro-4-pyridinyl)thio)-",C1=CN=C(N=C1)SC2=C(C=NC=C2)[N+](=O)[O-],,,,,,
3569,153570,"Pyrimidine, 2-((3,5-dinitro-4-pyridinyl)thio)-",C1=CN=C(N=C1)SC2=C(C=NC=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
3570,153571,"Pyrimidine, 4-((3-nitro-2-pyridinyl)thio)-",C1=CC(=C(N=C1)SC2=NC=NC=C2)[N+](=O)[O-],,,,,,
3571,153572,"Imidodicarbonimidic diamide, N-(2,3,5,6-tetramethylphenyl)-, monohydrochloride",CC1=CC(=C(C(=C1C)N(C(=N)N)C(=N)N)C)C.Cl,,,['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)'],,,
3572,153573,"1-Carbamimidoyl-1-(2,3,5,6-tetramethylphenyl)guanidine",CC1=CC(=C(C(=C1C)N(C(=N)N)C(=N)N)C)C,,,,,,
3573,153574,"Cinnoline, 4-azido-, 1-oxide",C1=CC=C2C(=C1)C(=CN=[N+]2[O-])N=[N+]=[N-],,,,,,
3574,153575,"Benzo(e)pyrene-9,10-diol, 9,10-dihydro-, trans-(+-)-",C1=CC2=C3C(=C1)C4=C([C@@H]([C@H](C=C4)O)O)C5=CC=CC(=C53)C=C2,,,,,,
3575,153576,"1,3-Dimethyl-3-(phenylmethyl)-1-triazene",CN=NN(C)CC1=CC=CC=C1,,,,,,
3576,153577,"3,3-Dimethyl-1-(phenylmethyl)-1-triazene",CN(C)N=NCC1=CC=CC=C1,,,,,,
3577,153578,1-Butyl-3-methyl-3-(phenylmethyl)-1-triazene,CCCCN=NN(C)CC1=CC=CC=C1,,,,,,
3578,153579,(S)-1-Azido-2-phenylpropane,C[C@H](CN=[N+]=[N-])C1=CC=CC=C1,,,,,,
3579,153580,"Azuleno(1,2,3-cd)phenalene, 8-methyl-",CC1=CC=CC=C2C1=C3C=CC4=CC=CC5=C4C3=C2C=C5,,,,,,
3580,153581,"Azuleno(1,2,3-cd)phenalene, 7-methyl-",CC1=CC2=CC=CC3=C2C4=C(C=C3)C5=CC=CC=CC5=C14,,,,,,
3581,153582,"1H-Indole-2,3-dione, 5-iodo-, 3-(phenylhydrazone)",C1=CC=C(C=C1)N=NC2=C(NC3=C2C=C(C=C3)I)O,,,,,,
3582,153583,"Acenaphtho(1,2-d)pyrimidin-10-amine",C1=CC2=C3C(=C1)C4=C(C3=CC=C2)N=CN=C4N,,,,,,
3583,153584,"Acenaphtho(1,2-d)pyrimidin-8,10-diamine",C1=CC2=C3C(=C1)C4=C(C3=CC=C2)N=C(N=C4N)N,,,,,,
3584,153585,"Acenaphtho(1,2-b)pyrazin-8-amine",C1=CC2=C3C(=C1)C4=NC=C(N=C4C3=CC=C2)N,,,,,,
3585,153586,"Acenaphtho(1,2-d)pyrimidin-8-amine",C1=CC2=C3C(=C1)C4=CN=C(N=C4C3=CC=C2)N,,,,,,
3586,153587,"1,4-Butanediamine, N-(9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCCN,,,,,,
3587,153588,"N-(9-Methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-1,3-pentanediamine",CCC(CCNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CC(=C4)OC)C)N,,,,,,
3588,153589,"1,6-Hexanediamine, N-(9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCCCCN,,,,,,
3589,153590,"1,2-Ethanediamine, N,N-dimethyl-N'-(5-methyl-9-(phenylmethoxy)-6H-pyrido(4,3-b)carbazol-1-yl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OCC5=CC=CC=C5)NCCN(C)C,,,,,,
3590,153591,"1,3-Propanediamine, N'-(9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-N,N-dimethyl-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCN(C)C,,,,,,
3591,153592,"6H-Pyrido(4,3-b)carbazole, 9-methoxy-5-methyl-1-(1-piperidinyl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)N5CCCCC5,,,,,,
3592,153593,"1,3-Propanediamine, N-(5-methyl-9-(phenylmethoxy)-6H-pyrido(4,3-b)carbazol-1-yl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OCC5=CC=CC=C5)NCCCN,,,,,,
3593,153594,"6H-Pyrido(4,3-b)carbazol-1-amine, N-(3-(1H-imidazol-1-yl)propyl)-9-methoxy-5-methyl-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCN5C=CN=C5,,,,,,
3594,153595,1-(Oxazolidin-2-ylideneamino)-1H-indole,C1COC(=N1)NN2C=CC3=CC=CC=C32,,,,,,
3595,153596,"(1,1'-Biphenyl)-4,4'-diamine, N-(benzoyloxy)-",C1=CC=C(C=C1)C(=O)ONC2=CC=C(C=C2)C3=CC=C(C=C3)N,,,,,,
3596,153597,8-Deaminoethidium chloride,CC[N+]1=C(C2=CC=CC=C2C3=C1C=C(C=C3)N)C4=CC=CC=C4.[Cl-],,,,,,
3597,153598,3-Azido-5-ethyl-6-phenylphenanthridinium chloride,CCN1C2=CC(=N[N+]#N)C=CC2=C3C=CC=CC3=C1C4=CC=CC=C4.[Cl-],,,,,,
3598,153599,5-(Acetyloxy)-5-methyl-2(5H)-furanone,CC(=O)OC1(C=CC(=O)O1)C,,,,,,
3599,153600,S-(Pentachlorophenyl)-L-cysteine,C([C@@H](C(=O)O)N)SC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
3600,153601,CID 153601,C1=CC(=CC(=C1)N(O)O)C2=NC3=NC(=N)C=CC3=N2,,,,,,
3601,153602,CID 153602,C1=CC(=CC=C1C2=NC3=NC(=N)C=CC3=N2)N(O)O,,,,,,
3602,153603,"2-(2-Nitrophenyl)-1H-imidazo(4,5-c)pyridine",C1=CC=C(C(=C1)C2=NC3=C(N2)C=NC=C3)[N+](=O)[O-],,,,,,
3603,153604,"2-(4-Nitrophenyl)-1H-imidazo(4,5-c)pyridine",C1=CC(=CC=C1C2=NC3=C(N2)C=NC=C3)[N+](=O)[O-],,,,,,
3604,153605,CID 153605,C1=CC(=CC(=C1)[N+](=O)[O-])C2=NC3=C(NC=CC3=N2)Cl,,,,,,
3605,153606,CID 153606,C1=CNC(=C2C1=NC(=N2)C3=CC(=CC(=C3)[N+](=O)[O-])[N+](=O)[O-])Cl,,,,,,
3606,153607,"1H-Purine, 8-(4-nitrophenyl)-",C1=CC(=CC=C1C2=NC3=NC=NC=C3N2)[N+](=O)[O-],,,,,,
3607,153608,"2-(3-Bromophenyl)-1H-imidazo(4,5-b)pyridine",C1=CC(=CC(=C1)Br)C2=NC3=C(N2)C=CC=N3,,,,,,
3608,153609,"2-(4-Bromophenyl)-1H-imidazo(4,5-b)pyridine",C1=CC2=C(N=C1)N=C(N2)C3=CC=C(C=C3)Br,,,,,,
3609,153610,"1H-Imidazo(4,5-b)pyridin-5-amine, 2-phenyl-",C1=CC=C(C=C1)C2=NC3=C(N2)C=CC(=N3)N,,,,,,
3610,153611,"1H-Imidazo(4,5-b)pyridin-5-amine, 2-(2-methylphenyl)-",CC1=CC=CC=C1C2=NC3=C(N2)C=CC(=N3)N,,,,,,
3611,153612,"2-(3-Chlorophenyl)-1H-imidazo(4,5-b)pyridin-5-amine",C1=CC(=CC(=C1)Cl)C2=NC3=C(N2)C=CC(=N3)N,,,,,,
3612,153613,"1H-Imidazo(4,5-b)pyridin-5-amine, 2-(3-bromophenyl)-",C1=CC(=CC(=C1)Br)C2=NC3=C(N2)C=CC(=N3)N,,,,,,
3613,153614,"1H-Imidazo(4,5-b)pyridin-5-amine, 2-(4-bromophenyl)-",C1=CC(=CC=C1C2=NC3=C(N2)C=CC(=N3)N)Br,,,,,,
3614,153615,"2-Phenyl-3H-imidazo[4,5-c]pyridine",C1=CC=C(C=C1)C2=NC3=C(N2)C=NC=C3,,,,,,
3615,153616,"2-(3-Chlorophenyl)-1H-imidazo(4,5-c)pyridine",C1=CC(=CC(=C1)Cl)C2=NC3=C(N2)C=NC=C3,,,,,,
3616,153617,"2-(4-Chlorophenyl)-1H-imidazo(4,5-c)pyridine",C1=CC(=CC=C1C2=NC3=C(N2)C=NC=C3)Cl,,,,,,
3617,153618,"Benzenamine, 4-(1H-imidazo(4,5-c)pyridin-2-yl)-",C1=CC(=CC=C1C2=NC3=C(N2)C=NC=C3)N,,,,,,
3618,153619,CID 153619,C1=CC=C(C=C1)C2=NC3=C(NC=CC3=N2)Cl,,,,,,
3619,153620,CID 153620,CC1=CC=CC=C1C2=NC3=C(NC=CC3=N2)Cl,,,,,,
3620,153621,CID 153621,C1=CC(=CC(=C1)Cl)C2=NC3=C(NC=CC3=N2)Cl,,,,,,
3621,153622,CID 153622,C1=CC(=CC=C1C2=NC3=C(NC=CC3=N2)Cl)Cl,,,,,,
3622,153623,CID 153623,C1=CC(=CC=C1C2=NC3=C(NC=CC3=N2)Cl)Br,,,,,,
3623,153624,CID 153624,CC1=CC=C(C=C1)C2=NC3=C(NC=CC3=N2)Cl,,,,,,
3624,153625,"8-dichloroacetoxy-9-hydroxy-8,9-dihydroaflatoxin B1",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@H]([C@@H](O[C@@H]5OC4=C1)OC(=O)C(Cl)Cl)O,,,,,,
3625,153626,CID 153626,CCC1CCN(C1)N=NC2=CC=CC=C2,,,,,,
3626,153627,"1,8-Bis(2-diethylaminoethylamino)anthracene-9,10-dione",CCN(CC)CCNC1=CC=CC2=C1C(=O)C3=C(C2=O)C=CC=C3NCCN(CC)CC,,,,,,
3627,153628,"Naphthaceno(2,3-b)oxirene-2-carboxylic acid, 1a-ethyl-1a,2,4,9,11,11a-hexahydro-3,8,10-trihydroxy-4,9-dioxo-, methyl ester, (1aS-(1aalpha,2alpha,11aalpha))-",CC[C@]12[C@H](O1)CC3=C([C@H]2C(=O)OC)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5O)O,,,,,,
3628,153629,"1-(3,4-Dimethoxyphenyl)-3-phenyl-1,3-propanedione",COC1=C(C=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2)OC,,,,,,
3629,153630,"N-9-Acridinyl-N'-(3-(9-acridinylamino)propyl)-1,3-propanediamine trihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64.Cl.Cl.Cl,,,,,,
3630,153631,"N-9-Acridinyl-N'-(3-(9-acridinylamino)propyl)-1,3-propanediamine",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
3631,153632,"1,4-Butanediamine, N,N'-bis(3-(9-acridinylamino)propyl)-, tetrahydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNCCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64.Cl.Cl.Cl.Cl,,,,,,
3632,153633,"9-Acridinamine, N,N'-(oxydi-2,1-ethanediyl)bis-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCOCCNC4=C5C=CC=CC5=NC6=CC=CC=C64.Cl.Cl,,,,,,
3633,153634,N-[2-[2-(acridin-9-ylamino)ethoxy]ethyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCOCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
3634,153635,"1,6-Hexanediamine, N,N'-bis(6-chloro-2-methoxy-9-acridinyl)-, dihydrochloride",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)OC.Cl.Cl,,,,,,
3635,153636,"N,N'-Bis(2-methoxy-6-chloroacridine-9-yl)-1,6-hexanediamine",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)Cl)OC,,,,,,
3636,153637,"N,N'-Bis(3,6-dichloro-9-acridinyl)-1,6-hexanediamine",C1=CC2=C(C=C1Cl)N=C3C=C(C=CC3=C2NCCCCCCNC4=C5C=CC(=CC5=NC6=C4C=CC(=C6)Cl)Cl)Cl,,,,,,
3637,153638,"1,8-Octanediamine, N,N'-bis(3,6-dichloro-9-acridinyl)-, dihydrochloride",C1=CC2=C(C=C1Cl)N=C3C=C(C=CC3=C2NCCCCCCCCNC4=C5C=CC(=CC5=NC6=C4C=CC(=C6)Cl)Cl)Cl.Cl.Cl,,,,,,
3638,153639,"N,N'-bis(3,6-dichloroacridin-9-yl)octane-1,8-diamine",C1=CC2=C(C=C1Cl)N=C3C=C(C=CC3=C2NCCCCCCCCNC4=C5C=CC(=CC5=NC6=C4C=CC(=C6)Cl)Cl)Cl,,,,,,
3639,153640,"1,6-Hexanediamine, N,N'-bis(4-ethyl-9-acridinyl)-, dihydrochloride",CCC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)CC.Cl.Cl,,,,,,
3640,153641,"9-Acridinamine, 4,4'-(5,8-dioxa-2,11-dithiadodecane-1,12-diyl)bis-,dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCOCCOCCSCC4=CC=CC5=C(C6=CC=CC=C6N=C54)N)N.Cl.Cl,,,,,,
3641,153642,4-[2-[2-[2-[(9-Aminoacridin-4-yl)methylsulfanyl]ethoxy]ethoxy]ethylsulfanylmethyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCOCCOCCSCC4=CC=CC5=C(C6=CC=CC=C6N=C54)N)N,,,,,,
3642,153643,"9-Acridinamine, N-(2-(((9-amino-4-acridinyl)methyl)thio)ethyl)-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N.Cl.Cl,,,,,,
3643,153644,4-[2-(Acridin-9-ylamino)ethylsulfanylmethyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N,,,,,,
3644,153645,"9-Acridinamine, N-(6-(((9-amino-4-acridinyl)methyl)thio)hexyl)-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N.Cl.Cl,,,,,,
3645,153646,4-[6-(Acridin-9-ylamino)hexylsulfanylmethyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N,,,,,,
3646,153647,"9-Acridinamine, N-(8-(((9-amino-4-acridinyl)methyl)thio)octyl)-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N.Cl.Cl,,,,,,
3647,153648,4-[8-(Acridin-9-ylamino)octylsulfanylmethyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=C(C3=N2)CSCCCCCCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)N,,,,,,
3648,153649,"9(10H)-Acridinone, 10,10'-(oxydi-2,1-ethanediyl)bis-",C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CCOCCN4C5=CC=CC=C5C(=O)C6=CC=CC=C64,,,,,,
3649,153650,"9(10H)-Acridinone, 4,5-bis(((2-(dimethylamino)ethyl)thio)methyl)-, dihydrochloride",CN(C)CCSCC1=C2C(=CC=C1)C(=O)C3=CC=CC(=C3N2)CSCCN(C)C.Cl.Cl,,,,,,
3650,153651,"4,5-bis[2-(dimethylamino)ethylsulfanylmethyl]-10H-acridin-9-one",CN(C)CCSCC1=C2C(=CC=C1)C(=O)C3=CC=CC(=C3N2)CSCCN(C)C,,,,,,
3651,153652,"trans-1,2,3,4-Tetrahydrobenzo(c)phenanthrene-3,4-diol",C1CC2=C(C=CC3=C2C4=CC=CC=C4C=C3)[C@@H]([C@H]1O)O,,,,,,
3652,153653,"7H-Pyrido(3,2-c)carbazole, 10-methoxy-",COC1=CC2=C(C=C1)NC3=C2C4=C(C=CC=N4)C=C3,,,,,,
3653,153654,"7H-Pyrido(3,2-c)carbazol-10-ol",C1=CC2=C(C3=C(C=C2)NC4=C3C=C(C=C4)O)N=C1,,,,,,
3654,153655,"7H-Pyrido(3,2-c)carbazole, 10-methoxy-7-methyl-",CN1C2=C(C=C(C=C2)OC)C3=C1C=CC4=C3N=CC=C4,,,,,,
3655,153656,"2-(2-Hydroxyethyl)-10-methoxy-7H-pyrido(4,3-c)carbazolium iodide",COC1=CC2C(C=C1)[NH2+]C3C2C4=C(C=C3)C=CN(C4)CCO.[I-],,,,,,
3656,153657,"2-(10-Methoxy-1,6a,7,7a,11a,11b-hexahydropyrido[4,3-c]carbazol-2-yl)ethanol",COC1=CC2C(C=C1)NC3C2C4=C(C=C3)C=CN(C4)CCO,,,,,,
3657,153658,"7H-Pyrido(4,3-c)carbazolium, 10-methoxy-2-(2-(1-piperidinyl)ethyl)-, chloride",COC1=CC2C(C=C1)[NH2+]C3C2C4=C(C=C3)C=CN(C4)CCN5CCCCC5.[Cl-],,,,,,
3658,153659,"10-Methoxy-2-(2-piperidin-1-ylethyl)-1,6a,7,7a,11a,11b-hexahydropyrido[4,3-c]carbazole",COC1=CC2C(C=C1)NC3C2C4=C(C=C3)C=CN(C4)CCN5CCCCC5,,,,,,
3659,153660,"10-Hydroxy-3-methyl-7H-pyrido(3,4-c)carbazolium iodide",CN1C=CC2=C3C(C=CC2=C1)[NH2+]C4=C3C=C(C=C4)O.[I-],,,,,,
3660,153661,"3-Methyl-6a,7-dihydropyrido[3,4-c]carbazol-10-ol",CN1C=CC2=C3C(C=CC2=C1)NC4=C3C=C(C=C4)O,,,,,,
3661,153662,"10-Methoxy-7-methyl-2-(2-(1-piperidinyl)ethyl)-7H-pyrido(4,3-c)carbazolium chloride",C[NH+]1C2C=CC(=CC2C3C1C=CC4=C3CN(C=C4)CCN5CCCCC5)OC.[Cl-],,,,,,
3662,153663,"4-Methyl-7H-pyrido(2,3-c)carbazolium iodide",CN1C=CCC2=C1C=CC3C2C4C=CC=CC4[NH2+]3.[I-],,,,,,
3663,153664,"4-Methyl-1,6a,7,7a,11a,11b-hexahydropyrido[2,3-c]carbazole",CN1C=CCC2=C1C=CC3C2C4C=CC=CC4N3,,,,,,
3664,153665,CID 153665,C1[C@@H](O[C@@]([C@@]1(N)O)(C(N)(N)ON)N)N2C=NC3=C2NC(=NC3=O)N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
3665,153666,CID 153666,C1[C@@H](O[C@@]([C@@]1(N)O)(C(N)(N)ON)N)N2C=NC3=C2NC(=NC3=O)N,,,,,,
3666,153667,"1H-Purine, 2-((2,4-dinitrophenyl)thio)-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=NC=C3C(=N2)N=CN3,,,,,,
3667,153668,"Tris(2,2'-bipyrazyl)ruthenium(II)",C1=CN=C(C=N1)C2=NC=CN=C2.C1=CN=C(C=N1)C2=NC=CN=C2.C1=CN=C(C=N1)C2=NC=CN=C2.[Ru+2],,,,,,
3668,153669,"2,2'-Bipyrazine",C1=CN=C(C=N1)C2=NC=CN=C2,,,,,,
3669,153670,"1(6H)-Pyridazinebutanoic acid, 3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-",C1=CC(=CC=C1C2=C(C(=O)N(N=C2C3=CC=C(C=C3)Cl)CCCC(=O)O)C#N)Cl,,,,,,
3670,153671,[3-Chloro-2-(3-nitrobenzoyl)oxypropyl] 3-nitrobenzoate,C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)OCC(CCl)OC(=O)C2=CC(=CC=C2)[N+](=O)[O-],,,,,,
3671,153672,"5'-Thymidylic acid, disodium salt",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])[O-])O.[Na+].[Na+],,,,,,
3672,153673,"9-Acridinamine, N-(2-bromophenyl)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4Br.Cl,,,,,,
3673,153674,"N9-(4-Bromophenyl)-3,9-acridinediamine",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)N)NC4=CC=C(C=C4)Br,,,,,,
3674,153675,"N-(4-Nitrophenyl)-3,9-acridinediamine",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)NC4=CC=C(C=C4)[N+](=O)[O-])N,,,,,,
3675,153676,"N9-Phenyl-3,6,9-acridinetriamine",C1=CC=C(C=C1)NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)N)N,,,,,,
3676,153677,"Phenol, 4-((3,6-diamino-9-acridinyl)amino)-",C1=CC(=CC=C1NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)N)N)O,,,,,,
3677,153678,"N9-(4-Aminophenyl)-3,6,9-acridinetriamine",C1=CC(=CC=C1N)NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)N)N,,,,,,
3678,153679,"4-((3,6-Diamino-9-acridinyl)amino)benzenesulfonamide",C1=CC(=CC=C1NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)N)N)S(=O)(=O)N,,,,,,
3679,153680,CID 153680,C1=CC(=NC=C1C(F)(F)F)S,,,,,,
3680,153681,"Benzo(6,7)phenanthro(1,2-b)oxirene-10,11-diol, 1a,10,11,11a-tetrahydro-, (1aalpha,10beta,11alpha,11aalpha)-",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]([C@@H]([C@@H]5[C@H]4O5)O)O,,,,,,
3681,153682,"(3-(((2'-(2-(Acetylamino)ethyl)(2,4'-bithiazol)-4-yl)carbonyl)amino)propyl)dimethylsulfonium chloride",CC(=O)NCCC1=NC(=CS1)C2=NC(=CS2)C(=O)NCCC[S+](C)C.[Cl-],,,,,,
3682,153683,"7,7-Bis(2-((methoxycarbonyl)amino)ethyl)-3,11-dioxo-2,12-dioxa-4,10-diaza-7-phosphoniatridecane chloride",COC(=O)NCC[P+](CCNC(=O)OC)(CCNC(=O)OC)CCNC(=O)OC.[Cl-],,,,,,
3683,153684,Tetrakis[2-(methoxycarbonylamino)ethyl]phosphanium,COC(=O)NCC[P+](CCNC(=O)OC)(CCNC(=O)OC)CCNC(=O)OC,,,,,,
3684,153685,CID 153685,CCCCN1C=NC(=C2C1=NC=N2)N,,,,,,
3685,153686,"Benzamide, N-(acetyloxy)-N-methyl-",CC(=O)ON(C)C(=O)C1=CC=CC=C1,,,,,,
3686,153687,"Propylamine, N-(2-methylallyl)-N-nitroso-",CCCN(CC(=C)C)N=O,,,,,,
3687,153688,"1-Piperidinyloxy, 4-((1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)amino)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O])(C)C)NC2=CN(C(=O)NC2=O)[C@@H]3C[C@@H]([C@H](O3)CO)O)C,,,,,,
3688,153689,"trans-8,9-Dihydrobenzo(k)fluoranthene-8,9-diol",C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C5[C@@H]([C@H](C=CC5=C4)O)O,,,,,,
3689,153690,"2,4-Diaminoisopropoxybenzene dihydrochloride",CC(C)OC1=C(C=C(C=C1)N)N.Cl.Cl,,,,,,
3690,153691,"4-Propan-2-yloxybenzene-1,3-diamine",CC(C)OC1=C(C=C(C=C1)N)N,,,,,,
3691,153692,"4-Propoxy-1,3-benzenediamine dihydrochloride",CCCOC1=C(C=C(C=C1)N)N.Cl.Cl,,,,,,
3692,153693,"2,4-Diaminopropoxybenzene",CCCOC1=C(C=C(C=C1)N)N,,,,,,
3693,153694,"4-Butoxy-1,3-benzenediamine dihydrochloride",CCCCOC1=C(C=C(C=C1)N)N.Cl.Cl,,,,,,
3694,153695,"1,3-Benzenediamine, 4-butoxy-",CCCCOC1=C(C=C(C=C1)N)N,,,,,,
3695,153696,"5,6-Epoxy-7-methylbenz[c]acridine",CC1=C2C3=C(O3)C4=CC=CC=C4C2=NC5=CC=CC=C15,,,,,,
3696,153697,"Benz(c)acridine-5,6-diol, 5,6-dihydro-7-methyl-, trans-",CC1=C2[C@H]([C@@H](C3=CC=CC=C3C2=NC4=CC=CC=C14)O)O,,,,,,
3697,153698,"Benz(c)acridin-5-ol, 7-methyl-",CC1=C2C=C(C3=CC=CC=C3C2=NC4=CC=CC=C14)O,,,,,,
3698,153699,"Methyl 5-(2,4-dichlorophenoxy)-2-(hydroxyamino)benzoate",COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)Cl)Cl)NO,,,,,,
3699,153700,"1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-pyridin-3-ylprop-2-en-1-one",COC1=CC(=C(C(=C1)OC)C(=O)C=CC2=CN=CC=C2)O,,,,,,
3700,153701,"1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-(4-methylsulfanylphenyl)prop-2-en-1-one",COC1=CC(=C(C(=C1)OC)C(=O)C=CC2=CC=C(C=C2)SC)O,,,,,,
3701,153702,21-Chloropregnenolone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CCl)CC=C4[C@@]3(CCC(C4)O)C,,,,,,
3702,153703,CID 153703,C1=CC(=C(C(=C1)Cl)O)CCOC2=C(C(=NC=C2C#N)N)C#N,,,,,,
3703,153704,(4'-Hydroxyphenyl)-3-amino-6-methylbenzoquinoneimine,CC1=CC(=O)C(=C(C1=N)C2=CC=C(C=C2)O)N,,,,,,
3704,153705,3-Hexylsalicylic acid,CCCCCCC1=C(C(=CC=C1)C(=O)O)O,,,,,,
3705,153706,CID 153706,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](C)NC(=O)C,,,,,,
3706,153707,"1,2-Dihydro-2-imino-4-(1-naphthylvinyl)-1-pyridineethanol",C=C(C1=CC(=N)N(C=C1)CCO)C2=CC=CC3=CC=CC=C32,,,,,,
3707,153708,Boc-Glu-OBzl,CC(C)(C)OC(=O)N[C@@H](CCC(=O)O)C(=O)OCC1=CC=CC=C1,,,,,,
3708,153709,Improsulfan p-toluenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)[O-].CS(=O)(=O)OCCC[NH2+]CCCOS(=O)(=O)C,,,,,,
3709,153710,"Gold(1+), (mu-(1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S:S))bis(triethylphosphine)di-, chloride",CCP(CC)CC.CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Cl-].[Au+].[Au+],,,,,,
3710,153711,"(3,4,5-Triacetyloxy-6-sulfanyloxan-2-yl)methyl acetate",CC(=O)OCC1C(C(C(C(O1)S)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
3711,153712,"2-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]guanidine",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NN=C(N)N)C)O)N)O,,,,,,
3712,153713,L-Valyldaunorubicin HCl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C(C)C)N)O.Cl,,,,,,
3713,153714,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-amino-3-methylbutanamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C(C)C)N)O,,,,,,
3714,153715,L-Isoleucyldaunorubin HCl,CCC(C)C(C(=O)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N.Cl,,,,,,
3715,153716,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-amino-3-methylpentanamide",CCC(C)C(C(=O)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N,,,,,,
3716,153717,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-L-leucyl-L-leucyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, monohydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)N)O.Cl,,,,,,
3717,153718,"N-[1-[[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-amino-4-methylpentanamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)N)O,,,,,,
3718,153719,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-L-leucyl-L-alanyl)amino)-alpha-L-xylo-hexopyranosyl)oxy)-, monohydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C)NC(=O)C(CC(C)C)N)O.Cl,,,,,,
3719,153720,"N-[1-[[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]amino]-1-oxopropan-2-yl]-2-amino-4-methylpentanamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(C)NC(=O)C(CC(C)C)N)O,,,,,,
3720,153721,"8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-glycyl-L-leucyl)amino)-alpha-L-xylo-hexopyranosyl)oxy)-5,12-naphthacenedione monohydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(CC(C)C)NC(=O)CN)O.Cl,,,,,,
3721,153722,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-[(2-aminoacetyl)amino]-4-methylpentanamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(CC(C)C)NC(=O)CN)O,,,,,,
3722,153723,Alanylleucyl-daunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)O.Cl,,,,,,
3723,153724,CID 153724,C[C@H]1[C@H](C(C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(CC(C)C)NC(=O)[C@H](C)N)O,,,,,,
3724,153725,"6H-Pyrido(4,3-b)carbazole, 1-((2-aminoethyl)amino)-9-methoxy-5-methyl-, hemihydrate",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCN,,,,,,
3725,153726,"1-((3-(Dimethylamino)propyl)amino)-5,11-dimethyl-9-methoxy-6H-pyrido(4,3-b)carbazole ethanol",CC1=C2C=CN=C(C2=C(C3=C1NC4=C3C=C(C=C4)OC)C)NCCCN(C)C,,,,,,
3726,153727,"1-((2-(Dimethylamino)ethyl)amino)-5-methyl-6H-pyrido(4,3-b)carbazol-9-ol ethanol",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)O)NCCN(C)C,,,,,,
3727,153728,"2,2-Dimethyl-1-propanol hydrogen phosphorodithioate",CC(C)(C)COP(=S)(OCC(C)(C)C)S,,,,,,
3728,153729,8-Azido-5-ethyl-6-phenylphenethridinium chloride,CC[N+]1=C(C2=C(C=CC(=C2)N=[N+]=[N-])C3=CC=CC=C31)C4=CC=CC=C4.[Cl-],,,,,,
3729,153730,CID 153730,C[C@@H]1[C@H](O1)C=CC(=O)O,,,,,,
3730,153731,"8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCCCC6)O.Cl,,,,,,
3731,153732,"9-acetyl-6,9,11-trihydroxy-7-(5-hydroxy-6-methyl-4-piperidin-1-yloxan-2-yl)oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCCCC6)O,,,,,,
3732,153733,"7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCCCC6)O.Cl,,,,,,
3733,153734,"6,9,11-trihydroxy-9-(1-hydroxyethyl)-7-(5-hydroxy-6-methyl-4-piperidin-1-yloxan-2-yl)oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCCCC6)O,,,,,,
3734,153735,CID 153735,CC=C1CC(=C)[C@@](C(=O)OCC2=CC[N+]3([C@H]2[C@@H](CC3)OC1=O)[O-])(CO)O,,,,,,
3735,153736,"8-trichloroacetoxy-9-hydroxy-8,9-dihydroaflatoxin B1",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@H]([C@@H](O[C@@H]5OC4=C1)OC(=O)C(Cl)(Cl)Cl)O,,,,,,
3736,153737,CID 153737,CCCCCCCCCCCCCCCCCCOC=O.CCC1=CC(=C(C(=C1)C)O)C(C)C2=CC=CC=C2,,,,,,
3737,153738,Octadecyl formate,CCCCCCCCCCCCCCCCCCOC=O,,,,,,
3738,153739,CID 153739,CCC1=CC(=C(C(=C1)C)O)C(C)C2=CC=CC=C2,,,,,,
3739,153740,CID 153740,CCCCCCCCOC=O.CCC1=CC(=C(C(=C1)C)O)C(C)(C)C,,,,,,
3740,153741,6-t-Butyl-4-ethyl-o-cresol,CCC1=CC(=C(C(=C1)C)O)C(C)(C)C,,,,,,
3741,153742,CID 153742,CCCCCCCCCCCCCCCCCCOC=O.CCC1=CC(=C(C(=C1)C)O)C(C)(C)C,,,,,,
3742,153743,CID 153743,CCCCC(CC)COC=O.CCC1=CC(=C(C(=C1)C)O)C(C)(C)C,,,,,,
3743,153744,CID 153744,CCCCC(CC)COC=O.CCC1=CC(=C(C(=C1)C)O)C,,,,,,
3744,153745,"4-Ethyl-2,6-dimethylphenol",CCC1=CC(=C(C(=C1)C)O)C,,,,,,
3745,153746,"Platinum, (dicarbonato(2-)-O,O')dihydroxybis(2-(propanamine)-, (OC-6-33)-",CC(C)N.CC(C)N.C(=O)([O-])OC(=O)[O-].[OH-].[OH-].[Pt+4],,,,,,
3746,153747,Dicarbonic acid,C(=O)(O)OC(=O)O,,,,,,
3747,153748,"Platinate(1-), dichloro(2,4-diaminobutanoato-N,N')-, hydrogen, (SP-4-3-(S))-",[H+].C(CN)C(C(=O)[O-])N.[Cl-].[Cl-].[Pt+2],,,,,,
3748,153749,"Platinum, dichloro(ethyl 2,4-diaminobutaoate-N,N')-, (SP-4-3-(S))-",CCOC(=O)C(CCN)N.[Cl-].[Cl-].[Pt+2],,,,,,
3749,153750,"Ethyl 2,4-diaminobutanoate",CCOC(=O)C(CCN)N,,,,,,
3750,153751,Aclarubicin hydrochloride,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O.Cl,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)']",,,
3751,153752,CID 153752,CC[C@]1(CC(C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
3752,153753,4'-Epidaunomycin,C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
3753,153754,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-D-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",C[C@@H]1[C@H]([C@@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
3754,153755,CID 153755,C1=CC(=C(N=C1)SC2=NC(=N)C3=NC=NC3=N2)N(O)O,,,,,,
3755,153756,"2H-Furo(2,3-h)-1-benzopyran-2-one, 4,8-dimethyl-7-(hydroxymethyl)-",CC1=CC(=O)OC2=C1C=CC3=C2C(=C(O3)C)CO,,,,,,
3756,153757,"Benzenesulfonamide, o-(9-acridinylamino)-, hydrochloride, hemihydrate",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4S(=O)(=O)N.Cl,,,,,,
3757,153758,2-(9-Acridinylamino)benzenesulfonamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4S(=O)(=O)N,,,,,,
3758,153759,"9-Acridinamine, N-(2-chlorophenyl)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4Cl.Cl,,,,,,
3759,153760,CID 153760,COC1=C2C(=C3C(=O)C=CC=C3OC2=C4C5C6C(O6)OC5OC4=C1)O,,,,,,
3760,153761,"2,3-Dihydro-7-chloro-5-(2-chlorophenyl)-1-(4,5-dihydro-2-oxazolyl)-1H-1,4-benzodiazepine",C1CN(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3Cl)C4=NCCO4,,,,,,
3761,153762,"Bleomycinamide, N(sup 1)-(4-aminobutyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxy-",CC1C(C(C(C(O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCCCN)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)NC(=O)C(C(C4=CN=CN4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)OC(=O)N)O)NC(=O)C7=C(C(=NC(=N7)C(CC(=O)N)NCC(C(=O)N)N)N)C)O)O)O)N,,,,,,
3762,153763,"Acetic acid, hydroxy-, 2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester, (2S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CO)O)N)O,,,,,,
3763,153764,Talisomycin S(sub 2b),CC1C(C(C(C(O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCC[S+](C)C)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)NC(=O)C(C(C4=CN=CN4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)OC(=O)N)O)NC(=O)C7=C(C(=NC(=N7)C(CC(=O)N)NCC(C(=O)N)N)N)C)O)O)O)N,,,,,,
3764,153765,"Dipyrido(1,2-alpha:3',2'-d)imidazol-2-amine, N-(acetyloxy)-6-methyl-",CC1=CC=CN2C1=NC3=C2N=C(C=C3)NOC(=O)C,,,,,,
3765,153766,"5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,8,11-trihydroxy-10-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CCC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,,,,,
3766,153767,6-O-Methylaclacinomycin,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)OC)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,,,,,
3767,153768,Epelmycin E,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
3768,153769,epsilon-ISORMN-A,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
3769,153770,4''-Dehydrorhodomycin-Y,CC[C@]1(CCC2=C([C@H]1O[C@H]3C[C@@H]([C@@H]([C@@H](O3)C)O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O[C@H]5CCC(=O)[C@@H](O5)C)O)N(C)C)C(=C6C(=C2O)C(=O)C7=C(C6=O)C=CC=C7O)O)O,,,,,,
3770,153771,4-O-Methylaclacinomycin,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,,,,,
3771,153772,4'''-(R)-Aminoaclacinomycin A,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(C(O7)C)N)O)N(C)C)O,,,,,,
3772,153773,"2,2'-Anhydro-1-(beta-arabinofuranosyl)orotic acid hydrazide",C1=C(N2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)OC2=NC1=O)C(=O)NN,,,,,,
3773,153774,"Naphth(2,1-a)azulene, 5,6-dihydro-",C1CC2=C3C=CC=CC=C3C=C2C4=CC=CC=C41,,,,,,
3774,153775,"Carbamic acid, benzoyl(benzoyloxy)-, ethyl ester",CCOC(=O)N(C(=O)C1=CC=CC=C1)OC(=O)C2=CC=CC=C2,,,,,,
3775,153776,"Carbamic acid, acetyl(benzoyloxy)-, ethyl ester",CCOC(=O)N(C(=O)C)OC(=O)C1=CC=CC=C1,,,,,,
3776,153777,"Carbamic acid, (acetyloxy)benzoyl-, ethyl ester",CCOC(=O)NC(=O)C1=CC=CC=C1OC(=O)C,,,,,,
3777,153778,"1,2-Ethanediamine, N'-(9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)-N,N-dimethyl-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCN(C)C,,,,,,
3778,153779,"Methanesulfonamide, N-(4-((9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazol-1-yl)amino)phenyl)-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NC5=CC=C(C=C5)NS(=O)(=O)C,,,,,,
3779,153780,"Hydroperoxide, ((1,1-dimethylethyl)nitrosoamino)methyl",CC(C)(C)N(COO)N=O,,,,,,
3780,153781,"Sulfamic acid, (1-methylethyl)-, ethyl ester",CCOS(=O)(=O)NC(C)C,,,,,,
3781,153782,"Ethyl-N,N-dimethylaminosulfonate",CCOS(=O)(=O)N(C)C,,,,,,
3782,153783,"L-Alanine, N-(1-nitro-9-acridinyl)-, ethyl ester, monohydrochloride",CCOC(=O)[C@H](C)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl,,,,,,
3783,153784,ethyl (2S)-2-[(1-nitroacridin-9-yl)amino]propanoate,CCOC(=O)[C@H](C)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
3784,153785,"L-Methionine, N-(1-nitro-9-acridinyl)-, ethyl ester, monohydrochloride",CCOC(=O)C(CCSC)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl,,,,,,
3785,153786,Ethyl 4-methylsulfanyl-2-[(1-nitroacridin-9-yl)amino]butanoate,CCOC(=O)C(CCSC)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
3786,153787,"L-Methionine, N-(1-nitro-9-acridinyl)-, monohydrochloride",CSCC[C@@H](C(=O)O)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl,,,,,,
3787,153788,(2S)-4-methylsulfanyl-2-[(1-nitroacridin-9-yl)amino]butanoic acid,CSCC[C@@H](C(=O)O)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
3788,153789,"beta-Alanine, N-(1-nitro-9-acridinyl)-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])NCCC(=O)O.Cl,,,,,,
3789,153790,"L-Phenylalanine, N-(1-nitro-9-acridinyl)-, ethyl ester, monohydrochloride",CCOC(=O)C(CC1=CC=CC=C1)NC2=C3C(=NC4=CC=CC=C42)C=CC=C3[N+](=O)[O-].Cl,,,,,,
3790,153791,Ethyl 2-[(1-nitroacridin-9-yl)amino]-3-phenylpropanoate,CCOC(=O)C(CC1=CC=CC=C1)NC2=C3C(=NC4=CC=CC=C42)C=CC=C3[N+](=O)[O-],,,,,,
3791,153792,"Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, 1-oxide, (S)-",C1C[C@H](N(C1)N=O)C2=C[N+](=CC=C2)[O-],,,,,,
3792,153793,"Ethanol, 2-((2,7-bis(1,1-dimethylethyl)-9-acridinyl)amino)-, monohydrochloride",CC(C)(C)C1=CC2=C(C=C1)N=C3C=CC(=CC3=C2NCCO)C(C)(C)C.Cl,,,,,,
3793,153794,"2-[(2,7-Ditert-butylacridin-9-yl)amino]ethanol",CC(C)(C)C1=CC2=C(C=C1)N=C3C=CC(=CC3=C2NCCO)C(C)(C)C,,,,,,
3794,153795,"Platinum, dibromodichloro(1,2-ethanediamine-N,N')-, (OC-6-13)-",C(CN)N.[Cl-].[Cl-].[Br-].[Br-].[Pt+4],,,,,,
3795,153796,"Pyrimidine, 2-((6-methyl-5-nitro-2-pyridinyl)thio)-",CC1=C(C=CC(=N1)SC2=NC=CC=N2)[N+](=O)[O-],,,,,,
3796,153797,"Pyrimidine, 5-nitro-2-(2-pyrimidinylthio)-",C1=CN=C(N=C1)SC2=NC=C(C=N2)[N+](=O)[O-],,,,,,
3797,153798,"Pyrimidine, 5-nitro-2-(4-pyrimidinylthio)-",C1=CN=CN=C1SC2=NC=C(C=N2)[N+](=O)[O-],,,,,,
3798,153799,"Platinum, dichloro(diethyl 2,3-diaminobutanedioate-N,N')-, (SP-4-3-(R*,S*))-",CCOC(=O)C(C(C(=O)OCC)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
3799,153800,"Diethyl 2,3-diaminobutanedioate",CCOC(=O)C(C(C(=O)OCC)N)N,,,,,,
3800,153801,"L-Cysteine, N-acetyl-S-(2-chloro-1,1-difluoroethyl)-",CC(=O)N[C@@H](CSC(CCl)(F)F)C(=O)O,,,,,,
3801,153802,"L-Cysteine, N-acetyl-S-(2-bromo-1,1-difluoroethyl)-",CC(=O)N[C@@H](CSC(CBr)(F)F)C(=O)O,,,,,,
3802,153803,(2R)-2-acetamido-3-(2-chloro-1-fluoroethenyl)sulfanylpropanoic acid,CC(=O)N[C@@H](CSC(=CCl)F)C(=O)O,,,,,,
3803,153804,(2R)-2-acetamido-3-(2-bromo-1-fluoroethenyl)sulfanylpropanoic acid,CC(=O)N[C@@H](CSC(=CBr)F)C(=O)O,,,,,,
3804,153805,"Pyridinium, 2-(((4-(dimethylamino)phenyl)imino)methyl)-1-ethyl-, iodide",CC[N+]1=CC=CC=C1C=NC2=CC=C(C=C2)N(C)C.[I-],,,,,,
3805,153806,"4-[(1-ethylpyridin-1-ium-2-yl)methylideneamino]-N,N-dimethylaniline",CC[N+]1=CC=CC=C1C=NC2=CC=C(C=C2)N(C)C,,,,,,
3806,153807,"1H-Pyrazole, 3-(ethylthio)-5-methyl-4-nitro-",CCSC1=NNC(=C1[N+](=O)[O-])C,,,,,,
3807,153808,CID 153808,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45C2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C=C(C)C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)C=C(C)C(C)C,,,,,,
3808,153809,CID 153809,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45C2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)O)(OC5)C(=O)OC)O)O)C)OC(=O)C=C(C)C(C)C,,,,,,
3809,153810,"4-Acridinecarboxamide, 9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-N,N-dimethyl-",CN(C)C(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC,,,,,,
3810,153811,"4-Acridinecarboxamide, N-(2-hydroxyethyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCCO.Cl,,,,,,
3811,153812,"Methanesulfonanilide, 4'-((4-(N-(2-hydroxyethyl)carbamoyl)-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCCO,,,,,,
3812,153813,"4-Acridinecarboxamide, N-(3-hydroxypropyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCCCO.Cl,,,,,,
3813,153814,"Methanesulfonanilide, 4'-((4-(N-(3-hydroxypropyl)carbamoyl)-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)NCCCO,,,,,,
3814,153815,N-(2-Hydroxypropyl)-9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-4-acridinecarboxamide monohydrochloride,CC(CNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC)O.Cl,,,,,,
3815,153816,4'-((4-(N-(2-Hydroxypropyl)carbamoyl)-9-acridinyl)amino)-3'-methoxymethanesulfonanilide,CC(CNC(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC)O,,,,,,
3816,153817,"Benzoic acid, 4-((dihydroxypropyl)amino)-, ethyl ester",CCOC(=O)C1=CC=C(C=C1)NCCC(O)O,,,,,,
3817,153818,"3(2H)-Furanone, 5-ethenyl-2,2-dimethyl-",CC1(C(=O)C=C(O1)C=C)C,,,,,,
3818,153819,3-Methyl-3-(1-methylpropyl)-1-phenyl-1-triazene,CCC(C)N(C)N=NC1=CC=CC=C1,,,,,,
3819,153820,7-Bromomethylfluoranthene,C1=CC2=C3C(=C1)C4=CC=CC(=C4C3=CC=C2)CBr,,,,,,
3820,153821,"1H-Imidazo(4,5-f)quinolin-2-amine, 5-methyl-",CC1=CC2=C(C3=C1N=CC=C3)N=C(N2)N,,,,,,
3821,153822,"1H-Imidazo(4,5-f)quinolin-2-amine, 4-methyl-",CC1=C2C(=NC(=N2)N)C3=CC=CNC3=C1,,,,,,
3822,153823,"1H-Imidazo(4,5-f)quinolin-2-amine, 1,4-dimethyl-",CC1=CC2=C(C=CC=N2)C3=C1N=C(N3C)N,,,,,,
3823,153824,"6H-Pyrido(4,3-b)carbazole, 7,9-dichloro-5,11-dimethyl-",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4Cl)Cl)C,,,,,,
3824,153825,"3H-Imidazo(4,5-f)quinolin-2-amine, 3-methyl-, hydrobromide",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N.Br,,,,,,
3825,153826,"Butanamide, 4-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCC(=O)N,,,,,,
3826,153827,"1,5-Pentanediamine, N-(6-chloro-2-methoxy-9-acridinyl)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCN,,,,,,
3827,153828,"9-Acridinamine, 6-chloro-N-hexyl-2-methoxy-",CCCCCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,,,,,
3828,153829,"3(5H)-Phenanthridinone, 8-amino-5-ethyl-6-phenyl-",CCN1C2=CC(=O)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N,,,,,,
3829,153830,CID 153830,C=C[N+]1(C=CC(=N1)[N+](=O)[O-])C(=O)O,,,,,,
3830,153831,"7H-Dibenzo(c,g)carbazole, 7-hydroxy-",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3O)C=CC5=CC=CC=C54,,,,,,
3831,153832,"Benz[a]anthracen-12-ol, 7,12-dihydro-12-methyl-7-methylene-",CC1(C2=CC=CC=C2C(=C)C3=C1C4=CC=CC=C4C=C3)O,,,,,,
3832,153833,"3,5-Cyclohexadiene-1,2-dione, 3,4-dichloro-",C1=CC(=O)C(=O)C(=C1Cl)Cl,,,,,,
3833,153834,"3,5-Cyclohexadiene-1,2-dione, 3,6-dichloro-",C1=C(C(=O)C(=O)C(=C1)Cl)Cl,,,,,,
3834,153835,N-(2-Hydroxy-6-methylphenyl)acetamide,CC1=C(C(=CC=C1)O)NC(=O)C,,,,,,
3835,153836,Thiabendazole mixed with diphenyl,C1=CC=C(C=C1)C2=CC=CC=C2O.C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,,,,,,
3836,153837,"1H-Benzimidazole, 2,2'-(1,2-ethanediyl)bis(5-(4,5-dihydro-1H-imidazol-2-yl)-",C1CN=C(N1)C2=CC3=C(C=C2)N=C(N3)CCC4=NC5=C(N4)C=C(C=C5)C6=NCCN6,,,,,,
3837,153838,1-Methyl-1H-indazol-4-amine,CN1C2=CC=CC(=C2C=N1)N,,,,,,
3838,153839,"Benzo(e)(1)benzopyrano(4,3-b)indol-6(13H)-one",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C5=CC=CC=C5OC4=O,,,,,,
3839,153840,"13H-Benzo(h)pyrido(2,3-a)carbazole",C1=CC=C2C=C3C(=CC2=C1)C4=C(N3)C5=C(C=CC=N5)C=C4,,,,,,
3840,153841,"3-Acridinamine, 2-methyl-7-nitro-",CC1=CC2=CC3=C(C=CC(=C3)[N+](=O)[O-])N=C2C=C1N,,,,,,
3841,153842,"4-{5-[4-(Dimethylamino)phenyl]-1,5-diphenylpenta-2,4-dien-1-ylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium trifluoromethanesulfonate",CN(C)C1=CC=C(C=C1)C(=CC=CC(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3)C4=CC=CC=C4.C(F)(F)(F)S(=O)(=O)[O-],,,,,,
3842,153843,"[4-[5-[4-(Dimethylamino)phenyl]-1,5-diphenylpenta-2,4-dienylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",CN(C)C1=CC=C(C=C1)C(=CC=CC(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3843,153844,"6H-Quino(2,3,4-kl)acridine, 7,8-dihydro-7,7-dimethyl-",CC1(CC2=NC3=CC=CC=C3C4=C2C(=NC5=CC=CC=C54)C1)C,,,,,,
3844,153845,"Bicyclo(4.1.0)heptan-3-one, 1-methyl-4-(1-methylethylidene)-7-(3-oxobutyl)-, (1S,6R,7R)-",CC(=C1C[C@@H]2[C@H]([C@@]2(CC1=O)C)CCC(=O)C)C,,,,,,
3845,153846,"[17-Acetyl-8,14,17-trihydroxy-3-[5-[5-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] 3-phenylprop-2-enoate",CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4C(OC(CC4OC)OC5CCC6(C7CC(C8(C(CCC8(C7(CC=C6C5)O)O)(C(=O)C)O)C)OC(=O)C=CC9=CC=CC=C9)C)C)C)C)OC)O,,,,,,
3846,153847,Carpropamid,CCC1(C(C1(Cl)Cl)C)C(=O)NC(C)C2=CC=C(C=C2)Cl,,,,,,
3847,153848,4-(3-Hydroxyprop-1-enyl)-2-(3-methylbut-2-enyl)phenol,CC(=CCC1=C(C=CC(=C1)C=CCO)O)C,,,,,,
3848,153849,"Thymidine, 3'-azido-3'-deoxy-, 5'-hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C)N=[N+]=[N-],,,,,,
3849,153850,"5,12-Naphthacenedione, 8-acetyl-10-((3-(((4S)-4-amino-4-carboxy-1-oxobutyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)CCC(C(=O)O)N)O,,,,,,
3850,153851,"Dibenzofuran, hexabromodichloro-",C12=C(C(=C(C(=C1Cl)Cl)Br)Br)OC3=C2C(=C(C(=C3Br)Br)Br)Br,,,,,,
3851,153852,"Dibenzofuran, heptabromochloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Br-].[Br-].[Br-].[Br-].[Br-].[Br-].[Br-],,,,,,
3852,153853,"Dibenzofuran, tetrabromotrichloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Cl-].[Br-].[Br-].[Br-].[Br-],,,,,,
3853,153854,"Dibenzofuran, tribromotetrachloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Cl-].[Cl-].[Br-].[Br-].[Br-],,,,,,
3854,153855,Tetrabromodichlorodibenzofuran,C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Br-].[Br-].[Br-].[Br-],,,,,,
3855,153856,"Dibenzofuran, dibromopentachloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Br-].[Br-],,,,,,
3856,153857,"Dibenzofuran, tribromotrichloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Cl-].[Br-].[Br-].[Br-],,,,,,
3857,153858,Pentabromochlorodibenzofuran,C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Br-].[Br-].[Br-].[Br-].[Br-],,,,,,
3858,153859,"Dibenzofuran, tetrabromochloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Br-].[Br-].[Br-].[Br-],,,,,,
3859,153860,"Dibenzofuran, tribromodichloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Cl-].[Br-].[Br-].[Br-],,,,,,
3860,153861,"Dibenzofuran, tribromochloro-",C1=CC=C2C(=C1)C3=CC=CC=C3O2.[Cl-].[Br-].[Br-].[Br-],,,,,,
3861,153862,"Dibenzo(b,e)(1,4)dioxin, bromodichloro-",C1=CC=C2C(=C1)OC3=CC=CC=C3O2.[Cl-].[Cl-].[Br-],,,,,,
3862,153863,"Dibenzofuran, bromodichloro-",C1=CC=C2C(=C1)C3=C(C(=C(C=C3O2)Br)Cl)Cl,,,,,,
3863,153864,"2,2'-(2,5-Thiophenediylbis(4,2-pyrimidinediylthio))bis(N,N-dimethylethanamine) dihydrobromide",CN(C)CCSC1=NC=CC(=N1)C2=CC=C(S2)C3=NC(=NC=C3)SCCN(C)C.Br.Br,,,,,,
3864,153865,"2,5-Bis(2'-((2''-(dimethylamino)ethyl)thio)pyrimidin-4'-yl)thiophene",CN(C)CCSC1=NC=CC(=N1)C2=CC=C(S2)C3=NC(=NC=C3)SCCN(C)C,,,,,,
3865,153866,"Dibenzo(b,e)(1,4)dioxin, tetrabromochloro-",C1=CC2=C(C(=C1)Br)OC3=C(O2)C(=C(C(=C3Br)Br)Br)Cl,,,,,,
3866,153867,"Tribromodichlorodibenzo(b,e)(1,4)dioxin",C1=CC2C(C=C1)OC3C=CC=CC3O2.[Cl-].[Cl-].[Br-].[Br-].[Br-],,,,,,
3867,153868,"4a,5a,9a,10a-Tetrahydrodibenzo-p-dioxin",C1=CC2C(C=C1)OC3C=CC=CC3O2,,,,,,
3868,153869,"Dibromotrichlorodibenzo(b,e)(1,4)dioxin",C1=CC2C(C=C1)OC3C=CC=CC3O2.[Cl-].[Cl-].[Cl-].[Br-].[Br-],,,,,,
3869,153870,"2-Propenoic acid, polymer with ethene, compd. with N,N'-diethyl-1,3-propanediamine",CCNCCCNCC.C=C.C=CC(=O)O,,,,,,
3870,153871,"Dibromopentachlorodibenzo(b,e)(1,4)dioxin",C1=CC2C(C=C1)OC3C=CC=CC3O2.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Br-].[Br-],,,,,,
3871,153872,"Dibromohexachlorodibenzo(b,e)(1,4)dioxin",C1=CC2C(C=C1)OC3C=CC=CC3O2.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Br-].[Br-],,,,,,
3872,153873,"Dibenzofuran, dibromohexachloro-",C1=CC2C3C=CC=CC3OC2C=C1.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Br-].[Br-],,,,,,
3873,153874,"4a,5a,9a,9b-Tetrahydrodibenzofuran",C1=CC2C3C=CC=CC3OC2C=C1,,,,,,
3874,153875,"Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-(benzoyloxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)OC(=O)C6=CC=CC=C6,,,,,,
3875,153876,"Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-(1,6-hexanediylbis(oxy))bis(3-bromobenzenecarboximidamide) (2:1)",C1=CC(=C(C=C1C(=N)N)Br)OCCCCCCOC2=C(C=C(C=C2)C(=N)N)Br.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,,,,,,
3876,153877,3-Bromo-4-(6-(2-bromo-4-carbamimidoylphenoxy)hexoxy)benzenecarboximidamide,C1=CC(=C(C=C1C(=N)N)Br)OCCCCCCOC2=C(C=C(C=C2)C(=N)N)Br,,,,,,
3877,153878,"2,3-Dibromobiphenyl",C1=CC=C(C=C1)C2=C(C(=CC=C2)Br)Br,,,,,,
3878,153879,"2,3,4,6-Tetrabromobiphenyl",C1=CC=C(C=C1)C2=C(C(=C(C=C2Br)Br)Br)Br,,,,,,
3879,153880,"4-Bromo-2,3,7,8-tetrachlorodibenzofuran",C1=C2C3=CC(=C(C(=C3OC2=CC(=C1Cl)Cl)Br)Cl)Cl,,,,,,
3880,153881,"N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide;[cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C.C1CN(C(=N1)N[N+](=O)[O-])CC2=CN=C(C=C2)Cl,,,,,,
3881,153882,"Benzamide, 4-acetyl-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",CC(=O)C1=CC=C(C=C1)C(=O)N[C@H]2[C@H]3COC(=O)[C@@H]3[C@@H](C4=CC5=C(C=C24)OCO5)C6=CC(=C(C(=C6)OC)O)OC,,,,,,
3882,153883,"Benzamide, N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-3-nitro-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC(=CC=C6)[N+](=O)[O-],,,,,,
3883,153884,"Benzamide, 4-cyano-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=C(C=C6)C#N,,,,,,
3884,153885,"Benzamide, 4-amino-N-(5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-, (5S-(5alpha,5abeta,8abeta,9alpha))-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=C(C=C6)N,,,,,,
3885,153886,"2,2',3,3',4,6'-Hexabromobiphenyl",C1=CC(=C(C(=C1C2=C(C=CC(=C2Br)Br)Br)Br)Br)Br,,,,,,
3886,153887,"2,2',3,3',5,6'-Hexabromobiphenyl",C1=CC(=C(C(=C1Br)C2=C(C(=CC(=C2)Br)Br)Br)Br)Br,,,,,,
3887,153888,"1,1'-Biphenyl, 2,2',3,4,5',6-hexabromo-",C1=CC(=C(C=C1Br)C2=C(C(=C(C=C2Br)Br)Br)Br)Br,,,,,,
3888,153889,"1,1'-Biphenyl, 2,2',3,5,5',6-hexabromo-",C1=CC(=C(C=C1Br)C2=C(C(=CC(=C2Br)Br)Br)Br)Br,,,,,,
3889,153890,"1,1'-Biphenyl, 2,2',3,4,4',5,6'-heptabromo-",C1=C(C=C(C(=C1Br)C2=CC(=C(C(=C2Br)Br)Br)Br)Br)Br,,,,,,
3890,153891,"1,1'-Biphenyl, 2,2',3,4,4',6,6'-heptabromo-",C1=C(C=C(C(=C1Br)C2=C(C(=C(C=C2Br)Br)Br)Br)Br)Br,,,,,,
3891,153892,"1,1'-Biphenyl, 2,2',3,4,5,6,6'-heptabromo-",C1=CC(=C(C(=C1)Br)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br,,,,,,
3892,153893,"2,2',3,4',5,6,6'-Heptabromobiphenyl",C1=C(C=C(C(=C1Br)C2=C(C(=CC(=C2Br)Br)Br)Br)Br)Br,,,,,,
3893,153894,"2,2',3,3',4,4',6,6'-Octabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)Br)C2=C(C(=C(C=C2Br)Br)Br)Br)Br,,,,,,
3894,153895,"2,2',3,3',4,5',6,6'-Octabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)Br)C2=C(C(=CC(=C2Br)Br)Br)Br)Br,,,,,,
3895,153896,"2,2',3,4,4',5,6,6'-Octabromobiphenyl",C1=C(C=C(C(=C1Br)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br)Br,,,,,,
3896,153897,"2,2',3,3',4,5,5',6,6'-Nonabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br)Br,,,,,,
3897,153898,"1,3-Propanediol, 2-methyl-2-(((7-methyl-7H-benzo(c)carbazol-10-yl)methyl)amino)-",CC(CO)(CO)NCC1=CC2=C(C=C1)N(C3=C2C4=CC=CC=C4C=C3)C,,,,,,
3898,153899,"2,3,3',4,5,5'-Hexabromobiphenyl",C1=C(C=C(C=C1Br)Br)C2=CC(=C(C(=C2Br)Br)Br)Br,,,,,,
3899,153900,CID 153900,CN(CCOC1=CC2=C(C=C1)N=C[C@@H]3CCCN3C2=O)CCOC4=CC5=C(C=C4)N=C[C@@H]6CCCN6C5=O,,,,,,
3900,153901,"(2R,5R,6R)-6-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@@H](C(S4)(C)C)C(=O)O.C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,,,,,,
3901,153902,Piperacillin(base and/or unspecified salts),CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@@H](C(S4)(C)C)C(=O)O,,,,,,
3902,153903,3-Methylfuran-2-carbaldehyde,CC1=C(OC=C1)C=O,,,,,,
3903,153904,Folicur Top,CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl.CC(C)(C)C(CCC1=CC=C(C=C1)Cl)(CN2C=NC=N2)O,,,,,,
3904,153905,"2,3,4,6,7-Pentabromodibenzofuran",C1=CC(=C(C2=C1C3=CC(=C(C(=C3O2)Br)Br)Br)Br)Br,,,,,,
3905,153906,"1,2,3,4,6,7-Hexabromodibenzofuran",C1=CC(=C(C2=C1C3=C(O2)C(=C(C(=C3Br)Br)Br)Br)Br)Br,,,,,,
3906,153907,"Dibenzo(b,e)(1,4)dioxin, 1,2,3,4-tetrabromo-6,7,8,9-tetrachloro-",C12=C(C(=C(C(=C1Cl)Cl)Cl)Cl)OC3=C(O2)C(=C(C(=C3Br)Br)Br)Br,,,,,,
3907,153908,Ratio,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(SC=C2)C(=O)OC.CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,,,,,,
3908,153909,Tribenuron-methyl,CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,,,,"['The major route of excretion in rats is the urine. Urine samples contained 2-4 times of the administered radioactivity than the feces. Tissue levels of tribenuron methyl and its metabolites increased with dose, but there was no concentration of radioactivity in any particular organ or tissue.']","['Tribenuron-methyl is rapidly and extensively metabolized in animals by N-demethylation, de-esterification, hydrolysis of the sulfonylurea bridge, hydroxylation of the phenyl ring and/or O-demethylation of the triazine ring.', 'Major metabolites in the urine and feces included metsulfuron methyl, saccharin, and O-dimethyl triazine amine. the two major metabolic routes are the demethylation of the carbamoyl methyl group and the hydrolysis of the carbamate moiety.']",
3909,153910,Virolongin B,CC(CC1=CC(=C(C(=C1)OC)OC)OC)OC2=C(C=C(C=C2OC)CC=C)OC,,,,,,
3910,153911,2-(4-Ethenoxybutoxy)ethanol,C=COCCCCOCCO,,,,,,
3911,153912,"1,3-Propanediol, 2-(2-iodoethyl)-, diacetate",CC(=O)OCC(CCI)COC(=O)C,,,,,,
3912,153913,"Methanone, (2-butyl-3-benzofuranyl)(5-(2-(diethylamino)ethoxy)-2-thienyl)-, hydrochloride",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(S3)OCCN(CC)CC.Cl,,,,,,
3913,153914,"Methanone, (2-butyl-3-benzofuranyl)[5-[2-(diethylamino)ethoxy]-2-thienyl]-",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(S3)OCCN(CC)CC,,,,,,
3914,153915,"1,3-Propanediol, 2-methyl-2-(((7-methyl-7H-benzo(c)carbazol-3-yl)methyl)amino)-",CC(CO)(CO)NCC1=CC2=C(C=C1)C3=C(C=C2)N(C4=CC=CC=C43)C,,,,,,
3915,153916,"1,3-Propanediol, 2-methyl-2-(((7-methyl-7H-benzo(c)carbazol-5-yl)methyl)amino)-",CC(CO)(CO)NCC1=CC2=C(C3=CC=CC=C31)C4=CC=CC=C4N2C,,,,,,
3916,153917,"2-Methyl-2-(((7-methyl-7H-benzo(c)carbazol-8-yl)methyl)amino)-1,3-propanediol",CC(CO)(CO)NCC1=C2C(=CC=C1)C3=C(N2C)C=CC4=CC=CC=C43,,,,,,
3917,153918,"1,3-Propanediol, 2-(((7-ethyl-7H-benzo(c)carbazol-9-yl)methyl)amino)-2-methyl-",CCN1C2=C(C3=C1C=C(C=C3)CNC(C)(CO)CO)C4=CC=CC=C4C=C2,,,,,,
3918,153919,"2-Methyl-2-(((7-methyl-7H-benzo(c)carbazol-11-yl)methyl)amino)-1,3-propanediol",CCN1C2=C(C3=CC=CC=C3C=C2)C4=C(C=CC=C41)CNC(C)(CO)CO,,,,,,
3919,153920,Amicarbazone,CC(C)C1=NN(C(=O)N1N)C(=O)NC(C)(C)C,,,,"['A plant metabolism study was conducted on corn with soil application of (triazolinone-3-(14)C)amicarbazone at 1.6X the max seasonal rate; application to the soil was made pre-emergence, 4 hr after planting corn seed into containers in a greenhouse. The total radioactive residues (TRRs) were 0.988, 2.369, and 0.054 ppm in corn forage, fodder, and grain, respectively, with preharvest intervals (PHIs) of 104 to 126 days. Total extractable residues were 91 to 100% TRR. Residues were characterized/identified primarily by HPLC analysis with confirmatory analysis by TLC and LC/MS. Total identified residues were 74 to 79%TRR in corn commodities. Parent amicarbazone was the major residue identified in forage and fodder, and was found in smaller amt in grain. The major residue identified in grain was the metabolite iPr-2-OH DA MKH 3586, which was also found in forage and fodder. Other identified residues were DA MKH 3586, 4-N-glu-DA MKH 3586 and iPr-2-O-glu-DA MKH 3586 in grain, forage and fodder; and tBu-iPr-2-diOH DA MKH 3586 in forage only. Four additional glucose/glucoside conjugates were identified in small amt (< or = 5% TRR) in fodder.', '... A 23 field corn field trials each consisted or 3 application scenarios - a single broadcast application made preemergence, a single preplant incorporated application (both at 0.45 lb ai/acre) and an early postemergence application (0.25 lb ai/acre). All applications were made using ground application equipment. Even though the early postemergence application rate was the lowest of the 3 applications, it resulted in the highest combined residues of amicarbazone and its metabolites DA MKH 3586 and iPr-2-OH DA MKH 3586; residues following preplant incorporated application were slightly higher than those following preemergence application. Combined residues were at most 0.56 ppm in forage, 0.43 ppm in stover, and approx 0.05 ppm in field corn grain.', '... (Triazolinone-3-(14)C)amicarbazone ... was admin orally to 2 lactating goats at an avg of 101 ppm in the diet (42x the max theoretical dietary burden to dairy cattle). The goats were dosed once per day for 3 consecutive days. Milk was collected twice daily throughout the study, and tissues (muscle, fat, liver, and kidney) were collected at sacrifice. Radioactive residues were highest in the meat by-products liver and kidney, followed by muscle, fat, and milk ... Total residues amounting to 91 to 99% TRR were identified in goat matrices. Both parent amicarbazone and metabolite DA amicarbazone were major residues; amicarbazone was a major residue in all matrices with the exception of kidney. Metabolite iPr-2-OH DA amicarbazone was a major residue in kidney but was a minor residue in all other matrices. Metabolite t-Bu-OH MKH 3586 was also identified as a major residue in milk, muscle, and kidney, but was a minor residue in fat and liver. Metabolite iPr-Ene DA MKH 3586 was a major residue in liver but was a minor residue in all other matrices. Other identified metabolites were found at < or = 9% TRR; these included triazolinone MKH 3586, triazolinone DA MKH 3586, tBu-Acid MKH 3586, tBu-iPr-2-diOH DA MKH 3586 (kidney and liver only), iPr-1,2-diOH DA MKH 3586, and tBu-OH DA MKH 3586.', '... Encapsulated amicarbazone was admin orally to lactating cows for 30 days. Cows were dosed at 0.374, 1.238, or 4.538 ppm in the diet. Milk was sampled twice daily ... Samples of muscle, liver, kidney and fat were collected at sacrifice. Amicarbazone-related residues were below the method limit of quantitation (LOQ; <0.010 ppm) in whole milk samples collected over the course of the dosing period from the high-dose group ... Amicarbazone-related residues were highest in liver and kidney, and lower in muscle and fat. In the high dose group, residues were 1.165 to 1.193 ppm in liver, 0.080 to 0.127 ppm in kidney, 0.014 to 0.021 ppm in muscle, and < 0.010 to 0.012 ppm in fat ... Residues from the mid- and low-dose groups were 0.305 to 0.440 ppm and 0.191 to 0.235 ppm in liver, and 0.033 to 0.039 ppm and 0.017 to 0.018 ppm in kidney, respectively. Residues were below the method LOQ ... in muscle and fat samples from the mid-dose group ... The relationship between dosing level and amicarbazone-related residues appears to be linear in liver and kidney.', 'For more Absorption, Distribution and Excretion (Complete) data for AMICARBAZONE (7 total), please visit the HSDB record page.']","['In a rat metabolism study ... (triazolinone-3 (14)C) MKH 3586 (amicarbazone ... radiochemical purity > 99%) in water was admin to 4 male Fischer rats as a single gavage dose at 5.25 to 5.99 mg/kg ... Overall recovery of the radioactive dose was 95% by 72 hr following admin. The majority of the dose was recovered in the urine within 24 hr (64% dose), indicating substantial absorption. Fecal excretion accounted for 27% dose within 24 hr post-dose. Only 2% dose was recovered in the excreta after 24 hr ... Concn of radioactivity in the selected tissues at 72 hr post-dose were low (0.004 to 0.073 ug/g). HPLC and LC-MS/MS analysis were used to identify parent and 9 metabolites in excreta from male rats ... Identified cmpd in excreta accounted for 74% of the dose ... Minor amt of parent were detected in both urine (approximately 2% dose) and feces (< 1% dose). The major metabolite in excreta was a hydroxylated, deaminated derivative of the parent, iPr-2-OH DA (34% dose), mainly found in the urine (32% dose). Other hydroxylated deaminated derivatives were also identified: tBu-OH DA (11% dose in urine and 4% dose in feces), and iPr-1,2-di-OH DA (6% dose in urine and < 1% dose in feces). The glucuronic acid conjugate of the parent, MKH 3586 GA, accounted for 11% dose, mainly in the feces (10% dose). Other metabolites (each < or = 3% dose) identified in excreta included: tBu-1,2-di-iPr-tri-OH DA; tBu-iPr-di-OH DA; iPr-1,3-diOH DA; tBu-OH-iPr-ene and DA. Based on the metabolic profile, the metabolism of MKH 3586 in male rats primarily involves deamination followed by hydroxylation with elimination in the urine. Parent also undergoes glucuronic acid conjugation and elimination in the feces.', 'In a rat metabolism study ... (triazolinone-3-(14)C) 4-methyl MKH 3586 (soil metabolite of amicarbazone ... radiochemical purity > 99%) in water was admin to 4 male Fischer rats as a single gavage dose at 4.86 to 5.22 mg/kg ... Overall recovery of the radioactive dose was 91% by 96 hr following admin. The majority of the dose was recovered in the urine within 12 hr (70% dose), with total urinary excretion accounted for 80% dose, indicating substantial absorption. Fecal excretion (0 to 24 hr post-dose) accounted for 8% dose. Approx 3% dose was recovered in the excreta after 24 hr ... At 96 hr post-dose, the concn of radioactivity in the tissues were low (0.002 to 0.028 ug/g), with < 0.1% dose in each tissue. HPLC, (1)H-NMR, and LC-MS/MS analysis identified 12 components in excreta ... 4 of these cmpd were present as chiral pairs. Identified cmpd accounted for 75% of the dose ... The overall accountability of the admin dose was ~ 82% ... The tested substance was not detected in the urine or feces. Hydroxylation of the soil metabolite at the isopropyl moiety formed the major metabolite, 4-Me-i-Pr-2-OH DA MKH 3586 (29% dose), which was found primarily in urine (28% dose). Further hydroxylation at the tertiary butyl group resulted in the formation of 4-Me-t-Bu-iPr-2-di-OH DA MKH 3586, which accounted for 12% dose. Alternatively, additional hydroxylation of isopropyl moiety formed 4-Me-iPr-1,2-di-OH DA MKH 3586, which constituted 9% dose in urine. Desmethylation of the parent formed DA MKH 3586 (<1% dose), which was then hydroxylated at the isopropyl moiety to form iPr-2-OH DA MKH 3586 (8% dose). The parent was also be hydroxylated at the tertiary butyl moiety to form 4-Me-tBu-OH DA MKH 3586 (9% dose), which was only detected in urine. The other minor identified metabolites occurred resulted from further oxidation, usually hydroxylation. The pathway for the metabolism of 4-methyl DA MKH 3586 in rats primarily involves a series of hydroxylation reaction. No conjugates were detected. /4-Methyl MKH 3586 (soil metabolite of amicarbazone)/', '... The residues of concern in plants and livestock for tolerances and risk assessment consist of /amicarbazone ( 4-Amino-N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-methylethyl)-5-oxo-1H-1,2,4-triazole-1-carboxamide)/, a desamino metabolite /(DA amicarbazone: N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-methylethyl)-5-oxo-1H-1,2,4-triazone-1-carboxamide), and a hydroxylated derivative of the latter /(iPr-2-OH DA amicarbazone: N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-hydroxyl-1-methylethyl)-5-oxo-1H-1,2,4-triazone-1-carboxamide). The desamino metabolite is also included in the drinking water assessment along with its N-methyl derivative ...', '/It was/ proposed that the major metabolic pathway in corn involves the deamination of the triazole amino group to form the desamino metabolite (DA MKH 3586) followed by hydroxylation at the tertiary carbon of the isopropyl group to form iPr-2-OH DA MKH 3586. Additional pathways involve hydroxylation of the isopropyl methyl to form iPr-1-OH DA MKH 3586, followed by glucosidation; hydroxylation of the t-butyl and isopropyl groups to form tBu-iPr-2-diOH DA MKH 3586. In addition, DA MKH 3586 formed an N-glucoside; and glucosidation of hydroxylated DA MKH 3586 formed several minor O-glucosides.', 'For more Metabolism/Metabolites (Complete) data for AMICARBAZONE (10 total), please visit the HSDB record page.']",
3920,153921,Gadodiamide hydrate,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],"['The objective of this study was to determine the gadolinium (Gd) concentration remaining in human bone tissue after administration of standard clinical doses of 2 Gd-based contrast agents: ProHance and Omniscan. After administration of 0.1 mmol/kg of Gd chelate to patients undergoing hip replacement surgery, bone specimens were collected and analyzed, and compared with an age-matched control population without a history of Gd chelate administration. Bone specimens were collected fresh, refrigerated, and subsequently frozen. After grinding and freeze-drying, tissue digestion was performed using Teflon bombs and concentrated nitric acid. A method for analysis of Gd in bone specimens was developed and validated using inductively coupled plasma mass spectroscopy (ICP-MS). Results were compared with a previous study using a different technique for analysis of the same tissue specimens. Tissue retention was 1.77+/-0.704 microg Gd/g bone (n=9) for Omniscan and 0.477+/-0.271 microg Gd/g bone (n=10) for ProHance measured by ICP-MS. These findings confirmed results from the previous ICP-AES study. Omniscan (Gd[DTPA-BMA]) left approximately 4 times (previous study 2.5 times) more Gd behind in bone than did ProHance (Gd[HP-DO3A]).', 'Twenty-seven patients--nine with severely reduced renal function (glomerular filtration rate, 2-10 mL/min), nine undergoing hemodialysis, and nine undergoing continuous ambulatory peritoneal dialysis--were followed up for 5, 8, and 22 days, respectively, after receiving gadodiamide injection (0.1 mmol per kilogram body weight). Gadodiamide injection caused no changes in renal function. In patients with severely reduced renal function, the elimination half-life of gadodiamide injection was prolonged (34.3 hours +/- 22.9) compared with data in healthy volunteers (1.3 hours +/- 0.25). An average of 65% of the gadodiamide injected was eliminated during a hemodialysis session. After 22 days of continuous ambulatory peritoneal dialysis, 69% of the total amount of gadodiamide was excreted; this reflects the low peritoneal clearance. In all patients, no metabolism or transmetallation of gadodiamide was found. ...', 'The pharmacokinetic behavior of gadodiamide was consistent with its extracellular distribution. ... Gadodiamide was shown to be excreted rapidly, primarily through the kidneys. In rats, 94% of the administered dose was excreted in the urine within the first 24 hours after administration. Approximately 1% to 4% appeared in the feces during the same period.', '... /In rats/ following iv dosing of gadodiamide (NaCa DTPA-BMA) (0.015 mmol/kg) in a (14)C-labeled form, plasma concentrations of the drug declined rapidly with an elimination half-live of 0.31 hr, a distribution volume of 244 mL/kg and a plasma clearance of 9.2 mL/min/kg. These results demonstrate that NaCa DTPA-BMA distributes into the extracellular fluid compartment and is renally excreted via glomerular filtration. Of the dose of radioactivity given, 86.6% was excreted in urine by 4 hr after injection, and 95.3% in urine and 3.3% in feces by 120 hr. ...', 'For more Absorption, Distribution and Excretion (Complete) data for GADODIAMIDE (10 total), please visit the HSDB record page.']","['In addition, experiments were done /in rats/ to clarify the in vivo metabolism of gadodiamide (NaCa DTPA-BMA). Results show small quantities of transchelated forms of NaCa DTPA-BMA in urine. HPLC analysis demonstrated these metabolites were the Zn and Cu forms of the drug, resulting from displacement of the Ca ion in the NaCa DTPA-BMA molecule by endogeneous Zn or Cu. Further analyses by HPLC and ICP-AES demonstrate that the unchanged parent drug, the Zn and the Cu forms occur in relative quantities of approximately 92%, 7%, and 1%, respectively. This demonstrates that the Ca ion in caldiamide sodium can be replaced by Zn or Cu ions in vivo, but only to a small extent.']","['... /In rats/ following iv dosing of gadodiamide (NaCa DTPA-BMA) (0.015 mmol/kg) in a (14)C-labeled form, plasma concentrations of the drug declined rapidly with an elimination half-live of 0.31 hr ...', 'The pharmacokinetic behavior of gadodiamide was consistent with its extracellular distribution. Its half-life in rats, rabbits, and monkeys was short, 18, 38, and 75 minutes, respectively.', 'The pharmacokinetics of intravenously administered gadodiamide in normal subjects conforms to an open, two-compartment model with mean distribution and elimination half-lives (reported as mean + or -  SD) of 3.7 + or - 2.7 minutes and 77.8 + or -  16 minutes, respectively.', '... The average half-time of gadodiamide was 1.93 hr (SD 0.55) /in thirteen hemodialysis patients with abdominal disease receiving iv gadodiamide (0.1 mmol/kg body weight)/.', 'Twenty-seven patients--nine with severely reduced renal function (glomerular filtration rate, 2-10 mL/min), nine undergoing hemodialysis, and nine undergoing continuous ambulatory peritoneal dialysis--were followed up for 5, 8, and 22 days, respectively, after receiving gadodiamide injection (0.1 mmol per kilogram body weight). Gadodiamide injection caused no changes in renal function. In patients with severely reduced renal function, the elimination half-life of gadodiamide injection was prolonged (34.3 hours +/- 22.9) compared with data in healthy volunteers (1.3 hours +/- 0.25). ...']"
3921,153922,Kadsulactone A,CC1=CC[C@H](OC1=O)[C@@H](C)[C@H]2CC[C@@]3([C@@]2(CC[C@]45[C@H]3C[C@H]([C@@H]6[C@]4(C5)C=CC(=O)OC6(C)C)O)C)C,,,,,,
3922,153923,"Dibenzo(c,f)(2,7)naphthyridine, 6-ethyl-7-methyl-",CCC1=NC2=CC=CC=C2C3=C1C(=NC4=CC=CC=C43)C,,,,,,
3923,153924,"3,10-Dichlorodibenzo(c,f)(2,7)naphthyridine",C1=CC2=C(C=C1Cl)N=CC3=CN=C4C=C(C=CC4=C23)Cl,,,,,,
3924,153925,"6H-Quino(2,3,4-kl)acridine, 3,11-dichloro-7,8-dihydro-7,7-dimethyl-",CC1(CC2=NC3=C(C=CC(=C3)Cl)C4=C2C(=NC5=C4C=CC(=C5)Cl)C1)C,,,,,,
3925,153926,"6H-Quino(2,3,4-kl)acridine, 7,8-dihydro-2,3,11,12-tetramethoxy-7,7-dimethyl-",CC1(CC2=NC3=CC(=C(C=C3C4=C2C(=NC5=CC(=C(C=C54)OC)OC)C1)OC)OC)C,,,,,,
3926,153927,"Dibenzo(c,f)(2,7)naphthyridine, 6-ethyl-2,3,10,11-tetramethoxy-7-methyl-",CCC1=NC2=CC(=C(C=C2C3=C1C(=NC4=CC(=C(C=C43)OC)OC)C)OC)OC,,,,,,
3927,153928,"Dibenzo(c,f)cyclopenta(ij)(2,7)naphthyridine, 6,7-dihydro-2,3,10,11-tetramethoxy-",COC1=C(C=C2C(=C1)C3=C4C(=N2)CCC4=NC5=CC(=C(C=C53)OC)OC)OC,,,,,,
3928,153929,"Phenol, butylmethoxy-",CCCCC1=C(C(=CC=C1)O)OC,,,,,,
3929,153930,CID 153930,CC1(C=CC2=C3C(=C(C4=CC=CC=C4N3)O)C(=O)C=C2O1)C,,,,,,
3930,153931,"Palladium(2+), tetraammine-, (SP-4-1)-, carbonate (1:2)",C(=O)(O)[O-].C(=O)(O)[O-].N.N.N.N.[Pd+2],,,,,,
3931,153932,"1,2,3,4-Tetrabromo-7,8-dichlorodibenzo-p-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=C(O2)C(=C(C(=C3Br)Br)Br)Br,,,,,,
3932,153933,"L-Glutamic acid, 5-(2-phenylhydrazide)",C1=CC=C(C=C1)NNC(=O)CC[C@@H](C(=O)O)N,,,,,,
3933,153934,"Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-, (14bS)-",C1CN2[C@H](CN1)C3=CC=CC=C3CC4=CC=CC=C42,,,,,"['(S)-mianserin, N-Desmethyl is a known human metabolite of (S)-mianserin.']",
3934,153935,"Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-, (14bR)-",C1CN2[C@@H](CN1)C3=CC=CC=C3CC4=CC=CC=C42,,,,,"['N-Desmethylmianserin has known human metabolites that include (R)-mianserin, 8-hydroxy-N-desmethyl.']",
3935,153936,"5,12-Naphthacenedione, 8-acetyl-10-((2-deoxy-2-iodo-5-C-phenyl-beta-D-ribopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-(8alpha,10alpha(R*)))-",CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5[C@@H]([C@@H]([C@@H]([C@@H](O5)C6=CC=CC=C6)O)O)I)O,,,,,,
3936,153937,"(1R,2R,4aS,6aR,6aS,6bR,10S,12aR,14bR)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid",C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@H]2[C@]1(C)O)C)C(=O)O,,,,,,
3937,153938,"2-[(3S,4R,5S,6R,10S)-4,10-dihydroxy-3-(1-hydroxy-10-methyl-6-methylideneundeca-2,4,9-trien-2-yl)-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal",CC(=CCCC(=C)C=CC=C(CO)[C@@H]1CC[C@@]2([C@@H]1O)[C@@H](C(=C(C)C=O)CC[C@]2(C)O)CCCO)C,,,,,,
3938,153939,"N-((3S)-2,3-Dihydro-6-(phenylmethoxy)-3-benzofuranyl)-N-hydroxyurea",C1[C@H](C2=C(O1)C=C(C=C2)OCC3=CC=CC=C3)N(C(=O)N)O,,,,,,
3939,153940,Buddlejasaponin IV,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@H]([C@]2(C)CO)CC[C@@]4([C@@H]3C=C[C@@]56[C@]4(C[C@@H]([C@@]7([C@H]5CC(CC7)(C)C)CO6)O)C)C)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O,,,,,,
3940,153941,CID 153941,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N,,,,,,
3941,153942,"Bicyclo(4.1.0)heptan-3-one, 7-((3S)-3-hydroxybutyl)-1-methyl-4-(1-methylethylidene)-, (1S,6R,7R)-",C[C@@H](CC[C@@H]1[C@@H]2[C@]1(CC(=O)C(=C(C)C)C2)C)O,,,,,,
3942,153943,"4H-1,3-Benzoxazin-4-one, 2,3-dihydro-6-methyl-3-(2-(nitrooxy)ethyl)-",CC1=CC2=C(C=C1)OCN(C2=O)CCO[N+](=O)[O-],,,,,,
3943,153944,"2-[3-[2-[3-[2-(dimethylamino)ethylsulfanyl]phenyl]pyrimidin-4-yl]phenyl]sulfanyl-N,N-dimethylethanamine;trihydrobromide",CN(C)CCSC1=CC=CC(=C1)C2=NC(=NC=C2)C3=CC(=CC=C3)SCCN(C)C.Br.Br.Br,,,,,,
3944,153945,"10-Methyl-9,10-dihydro-3,6-acridinediamine",CN1C2=C(CC3=C1C=C(C=C3)N)C=CC(=C2)N,,,,,,
3945,153946,"(1S,3R,4R,5R)-3,4-Bis[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,5-dihydroxycyclohexane-1-carboxylic acid",C1[C@H]([C@H]([C@@H](C[C@@]1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O,,,,,,
3946,153947,"Oleanane, beta-D-galactopyranoside deriv.",C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2CC[C@]3([C@H]([C@]2(C)CO)CC[C@@]4([C@@H]3[C@@H](C=C5[C@]4(C[C@H]([C@@]6([C@H]5CC(CC6)(C)C)CO)O)C)OC)C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O,,,,,,
3947,153948,Ranirestat,C1C(=O)NC(=O)[C@@]12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F,['Investigated for use/treatment in neuropathy (diabetic).'],,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
3948,153949,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with N-(1-methylethyl)-2-propenamide and 2-propenoic acid",CCCCOC(=O)C(=C)C.CC(C)NC(=O)C=C.C=CC(=O)O,,,,,,
3949,153950,O-Ethyl ((4-((6-deoxy-alpha-L-mannopyranosyl)oxy)phenyl)methyl)carbamothioate,CCC1=C(C=CC(=C1)O[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)CNC(=O)S,,,,,,
3950,153951,"Benzamide, N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-2-hydroxy-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=CC=C6O,,,,,,
3951,153952,"Benzamide, 2-fluoro-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=CC=C6F,,,,,,
3952,153953,"Benzamide, 3-fluoro-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC(=CC=C6)F,,,,,,
3953,153954,"Benzamide, 4-fluoro-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=C(C=C6)F,,,,,,
3954,153955,"Benzamide, 4-(acetyloxy)-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",CC(=O)OC1=CC=C(C=C1)C(=O)N[C@H]2[C@H]3COC(=O)[C@@H]3[C@@H](C4=CC5=C(C=C24)OCO5)C6=CC(=C(C(=C6)OC)O)OC,,,,,,
3955,153956,"Benzamide, 3-cyano-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=CC(=C6)C#N,,,,,,
3956,153957,"Benzamide, N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-4-nitro-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC=C(C=C6)[N+](=O)[O-],,,,,,
3957,153958,"Benzamide, 3-amino-N-((5S,5aS,8aR,9R)-5,5a,6,8,8a,9-hexahydro-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC(=O)C6=CC(=CC=C6)N,,,,,,
3958,153959,CID 153959,CC(=C)C(=O)O[C@H]1CC(=CCC[C@@]2([C@H](O2)[C@@H]3[C@@H]1C(=C)C(=O)O3)C)CO,,,,,,
3959,153960,Mercury(1+);nitric acid;dihydrate,[N+](=O)(O)[O-].O.O.[Hg+],,,,,,
3960,153961,"1H-Cyclohepta(ghi)perylene-5,12-dione, 3-acetyl-6,11-bis(butylamino)-4,8,9,13-tetramethoxy-2-methyl-",CCCCNC1=C(C(=C2CC(=C3C4=C(C5=C6C(=C24)C1=CC(=C6C(=CC5=NCCCC)OC)OC)C(=O)C(=C3C(=O)C)OC)C)OC)O,,,,,,
3961,153962,"1,1'-Biphenyl, 2,2',3,4',5',6-hexachloro-5-(methylsulfonyl)-",CS(=O)(=O)C1=CC(=C(C(=C1Cl)C2=CC(=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
3962,153963,"4-Hydroxy-2,2',4',6'-tetrachlorobiphenyl",C1=CC(=C(C=C1O)Cl)C2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
3963,153964,"Nitric acid, mercury(2+)-203Hg salt",[N+](=O)(O)[O-].[203Hg+2].[203Hg+2],,,,,,
3964,153965,"Methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethyl-1-oxopentyl)-4-hydroxy-6,7,8-trimethoxy-2-naphthalenecarboxylate",CCC(CC)CC(=O)C1=C(C2=CC(=C(C(=C2C(=C1C(=O)OC)C3=CC(=C(C=C3)OC)OC)OC)OC)OC)O,,,,,,
3965,153966,"1H-1,2,4-Triazole-1-acetamide, 5-methyl-3-nitro-",CC1=NC(=NN1CC(=O)N)[N+](=O)[O-],,,,,,
3966,153967,"(3S,10S,13R,14R,15S,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,15-diol",C[C@H](CCC(=C)C(C)C)[C@H]1C[C@@H]([C@@]2([C@@]1(CC=C3C2=CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C)O,,,,,,
3967,153968,CID 153968,C1COCC2=C1NC=C3C2=NC(=N3)C4=NOC=C4.OP(=O)(O)O,,,,,,
3968,153969,CID 153969,C1COCC2=C1NC=C3C2=NC(=N3)C4=NOC=C4,,,,,,
3969,153970,Sapacitabine,CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N,"['Investigated for use/treatment in solid tumors, cutaneous t-cell lymphoma, myelodysplastic syndrome, and leukemia (lymphoid).']",,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
3970,153971,"1H-Imidazole, 4-(3-(3-(4-chlorophenyl)propoxy)propyl)-",C1=CC(=CC=C1CCCOCCCC2=CN=CN2)Cl,,,,,,
3971,153972,5-Fluoro-8-nitroquinoline,C1=CC2=C(C=CC(=C2N=C1)[N+](=O)[O-])F,,,,,,
3972,153973,"5,12-Naphthacenedione, 8-acetyl-10-((2,6-dideoxy-2-iodo-alpha-L-talopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)I)O)O,,,,,,
3973,153974,Etoxazole,CCOC1=C(C=CC(=C1)C(C)(C)C)C2COC(=N2)C3=C(C=CC=C3F)F,,,"['A pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators. (See all compounds classified as Acaricides.)']",,,
3974,153975,2'-Bromo-4'-epidaunorubicin,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)Br)N)O,,,,,,
3975,153976,Rostafuroxin,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(C5=COC=C5)O)O)C)O,,,,,,
3976,153977,Xenon-123,[123Xe],,,,,,
3977,153978,"Benzenebutanesulfonic acid, 3-phenoxy-alpha-phosphono-, (alphaS)-",C1=CC=C(C=C1)OC2=CC=CC(=C2)CCC[C@@H](P(=O)(O)O)S(=O)(=O)O,,,,,,
3978,153979,"Acetic acid, (4-(2-((2-hydroxy-3-phenoxypropyl)amino)ethoxy)phenoxy)-, (R)-",CC(=O)OOC1=CC=C(C=C1)OCCNC[C@H](COC2=CC=CC=C2)O,,,,,,
3979,153980,"Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1H-1,2,4-triazol-1-ylmethyl)-3-quinolinecarboxylate",CCOC(=O)C1=C(C2=CC(=C(C=C2N=C1CN3C=NC=N3)OC)OC)C4=CC(=C(C=C4)OC)OC,,,,,,
3980,153981,"2-[4-(1,2-diphenylprop-1-enyl)phenoxy]-N,N-dimethylethanamine",CC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,,,,,,
3981,153982,"(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(furo[2,3-b]pyridin-5-ylmethyl)piperazine-2-carboxamide",CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=C6C(=C5)C=CO6,,,,,,
3982,153983,"3-(3,4-Dimethoxyphenyl)prop-2-enyl 2-(2-methylbut-2-enoyloxymethyl)but-2-enoate",CC=C(C)C(=O)OCC(=CC)C(=O)OCC=CC1=CC(=C(C=C1)OC)OC,,,,,,
3983,153984,Propionylshikonin,CCC(=O)O[C@H](CC=C(C)C)C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O,,,,,,
3984,153985,Diflovidazin,C1=CC=C(C(=C1)C2=NN=C(N=N2)C3=C(C=CC=C3F)F)Cl,,,,,,
3985,153986,"(2S)-2-[(4-methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid",CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CNC(=O)C2=NN3CCCN(C(=O)C3=C2)CCC4CCNCC4)C(=O)O,,,,,,
3986,153987,"3,3'-Dibromo-1,1'-biphenyl",C1=CC(=CC(=C1)Br)C2=CC(=CC=C2)Br,,,,,,
3987,153988,"3-Cyclobutene-1,2-dione, 3-((3-(3-(4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl)propyl)-1H-indol-5-yl)amino)-4-methyl-",CC1=C(C(=O)C1=O)NC2=CC3=C(C=C2)NC=C3CCCN4CCN(CC4)C5=NC=NC=C5OC,,,,,,
3988,153989,"1,3-Propanediamine, N'-(3-methoxy-8-methylbenzo(f)pyrido(4,3-b)quinoxalin-11-yl)-N,N-dimethyl-",CC1=CN=C(C2=NC3=C(C=CC4=C3C=CC(=C4)OC)N=C12)NCCCN(C)C,,,,,,
3989,153990,Adentri,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)[C@@H]3C[C@H]4C[C@@H]3[C@H]5[C@@H]4O5,,,['Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)'],,,
3990,153991,2-[benzyl-[2-[butyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-2-oxoethyl]amino]acetic acid,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(=O)CN(CC4=CC=CC=C4)CC(=O)O,,,['Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)'],,,
3991,153992,CID 153992,C1CN(C(=O)C1=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)[O-])C4=CC=CC=C4.[Na+],,,,,,
3992,153993,"(E)-4,6-Dichloro-3-((2-oxo-1-phenylpyrrolidin-3-ylidene)methyl)-1H-indole-2-carboxylic acid",C1CN(C(=O)C1=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)O)C4=CC=CC=C4,,,,,,
3993,153994,Clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,['For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.'],"['Clevidipine belongs to a well-known class of drugs called dihydropyridine calcium channel antagonists. Clevidpine is the first third generation intravenous dihydropyridine calcium channel blocker. In vitro studies demonstrated that clevidipine acts by selectively relaxing the smooth muscle cells that line small arteries, resulting in arterial dilation, widening of the artery opening, and without reducing central venous pressure or reducing cardiac output.']",['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)'],"['urine 63-74%, feces 7-22%']",['Clevidipine is rapidly hydrolyzed to inactive metabolites by esterases in arterial blood.'],['1 minute']
3994,153995,"(R)-1-(2-(3-(3,4-Dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl)ethyl)-4-phenylpiperidine-4-carboxamide hydrochloride",COC1=CC(=CC(=C1OC)OC)C(=O)N2CC[C@](C2)(CCN3CCC(CC3)(C4=CC=CC=C4)C(=O)N)C5=CC(=C(C=C5)Cl)Cl.Cl,,,['Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)'],,,
3995,153996,"3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acid",COC1=CC(=CC(=C1OC)OC)C(=O)N2CC[C@](C2)(CCN3CCC(CC3)(C4=CC=CC=C4)C(=O)N)C5=CC(=C(C=C5)Cl)Cl,,,,,,
3996,153997,Zosuquidar Trihydrochloride,C1CN(CCN1C[C@H](COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5[C@H]6[C@H](C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl,,,,,,
3997,153998,"(2R)-1-[4-(3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl)piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol",C1CN(CCN1C[C@H](COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5C6C(C6(F)F)C7=CC=CC=C47,,,,,,
3998,153999,Ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,['Ruboxistaurin has known human metabolites that include N-desmethyl LY333531.'],
3999,154000,Reglitazar,CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC4C(=O)NOC4=O,['For the treatment of diabetes mellitus type 1 and 2.'],"['Reglixane shows a hypoglycemic effect and also a stronger triglyceride-lowering effect than the thiazolidine-2,4-diones. In preclinical studies, reglixane has been shown to prevent several diabetic complications, such as cataract, nephropathy, and neuropathy.']",,,,
4000,154001,"1,3,4-Oxadiazol-2(3H)-one, 5-(1-methylethyl)-",CC(C)C1=NNC(=O)O1,,,,,,
4001,154002,CID 154002,C1=CC=C2C(=C1)C=CC3=C2C=C4C(=CC=C5C4=C6C(=C(C5=O)O)O6)N3,,,,,,
4002,154003,"6,8,10-Triazaspiro(4.5)deca-6,8-diene-7,9-diamine, 10,10'-(1,6-hexanediylbis(oxy))bis-, dihydrochloride",C1CCC2(C1)N=C(N=C(N2OCCCCCCON3C(=NC(=NC34CCCC4)N)N)N)N.Cl.Cl,,,,,,
4003,154004,"10-[6-[(7,9-Diamino-6,8,10-triazaspiro[4.5]deca-6,8-dien-10-yl)oxy]hexoxy]-6,8,10-triazaspiro[4.5]deca-6,8-diene-7,9-diamine",C1CCC2(C1)N=C(N=C(N2OCCCCCCON3C(=NC(=NC34CCCC4)N)N)N)N,,,,,,
4004,154005,"5-((4-(2-(1H-Indol-1-yl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione",C1=CC=C2C(=C1)C=CN2CCOC3=CC=C(C=C3)CC4C(=O)NC(=O)S4,,,,,,
4005,154006,N-(4-Bromophenyl)-2-nitrobenzo(b)thiophen-3-amine,C1=CC=C2C(=C1)C(=C(S2)[N+](=O)[O-])NC3=CC=C(C=C3)Br,,,,,,
4006,154007,"Dibenz(a,j)acridine, 3,4-dihydro-",C1CC2=C(C=C1)C3=C(C=C2)N=C4C=CC5=CC=CC=C5C4=C3,,,,,,
4007,154008,"Benzo(b)thiophen-3-amine, N-(4-methylphenyl)-2-nitro-",CC1=CC=C(C=C1)NC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
4008,154009,N-(2-(Dimethylamino)ethyl)-3-phenyl-5-quinoxalinecarboxamide,CN(C)CCNC(=O)C1=C2C(=CC=C1)N=CC(=N2)C3=CC=CC=C3,,,,,,
4009,154010,N-(3-Bromophenyl)-2-nitrobenzo(b)thiophen-3-amine,C1=CC=C2C(=C1)C(=C(S2)[N+](=O)[O-])NC3=CC(=CC=C3)Br,,,,,,
4010,154011,"8-Quinolinecarboxylic acid, butyl ester",CCCCOC(=O)C1=CC=CC2=C1N=CC=C2,,,,,,
4011,154012,N-(3-Fluorophenyl)-2-nitrobenzo(b)thiophen-3-amine,C1=CC=C2C(=C1)C(=C(S2)[N+](=O)[O-])NC3=CC(=CC=C3)F,,,,,,
4012,154013,5-Nitrobenz(l)acephenanthrylene,C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC5=C4C(=C3)C(=C5)[N+](=O)[O-],,,,,,
4013,154014,N-(3-Methylphenyl)-2-nitrobenzo(b)thiophen-3-amine,CC1=CC(=CC=C1)NC2=C(SC3=CC=CC=C32)[N+](=O)[O-],,,,,,
4014,154015,"(S)-3-Azido-2-methylpropanoic acid, methyl ester",C[C@@H](CN=[N+]=[N-])C(=O)OC,,,,,,
4015,154016,"Phenol, 3-((2-nitrobenzo(b)thien-3-yl)amino)-",C1=CC=C2C(=C1)C(=C(S2)[N+](=O)[O-])NC3=CC(=CC=C3)O,,,,,,
4016,154017,(2R)-2-amino-3-(3-chloroprop-1-enylsulfanyl)propanoic acid,C(C=CSC[C@@H](C(=O)O)N)Cl,,,,,,
4017,154018,"Benzoic acid, 4-((1R)-1-(1,3-benzodioxol-5-yl)-2-(((4-(1-methylethyl)phenyl)sulfonyl)amino)-2-oxoethoxy)-3-propyl-",CCCC1=C(C=CC(=C1)C(=O)O)O[C@H](C2=CC3=C(C=C2)OCO3)C(=O)NS(=O)(=O)C4=CC=C(C=C4)C(C)C,,,,,,
4018,154019,N-(4-Hydroxybutyl)-N-nitrosourea,C(CCO)CN(C(=O)N)N=O,,,,,,
4019,154020,N-(2-Carboxyethyl)-N-nitrosourea,C(CN(C(=O)N)N=O)C(=O)O,,,,,,
4020,154021,N-(3-Carboxypropyl)-N-nitrosourea,C(CC(=O)O)CN(C(=O)N)N=O,,,,,,
4021,154022,methyl 6-chloro-2-hydroxy-3-(phenylmethoxycarbonylhydrazinylidene)-1H-indene-2-carboxylate,COC(=O)C1(CC2=C(C1=NNC(=O)OCC3=CC=CC=C3)C=CC(=C2)Cl)O,,,,,,
4022,154023,CID 154023,C[C@@H](C(=O)OC(C)(C)C)N(C([O-])OC(C)(C)C)N[N+]#N,,,,,,
4023,154024,CID 154024,C[C@@H](C(=O)OC(C)(C)C)N(C(O)OC(C)(C)C)N[N+]#N,,,,,,
4024,154025,CID 154025,C[C@@H](C(=O)O)N(C([O-])OC(C)(C)C)N[N+]#N,,,,,,
4025,154026,CID 154026,C[C@@H](C(=O)O)N(C(O)OC(C)(C)C)N[N+]#N,,,,,,
4026,154027,CID 154027,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O,,,,,,
4027,154028,3-[2-(4-Aminophenyl)ethenyl]benzonitrile,C1=CC(=CC(=C1)C#N)C=CC2=CC=C(C=C2)N,,,,,,
4028,154029,CID 154029,C1=CC(=CC=C1C=CC2=CC=C(C=C2)N)C#N,,,,,,
4029,154030,"(+/-)-3-(1,3,5,7-Decatetraenyloxy)-1,2-propanediol",CCC=CC=CC=CC=COCC(CO)O,,,,,,
4030,154031,"Undeca-2,4,6,8-tetraenal",CCC=CC=CC=CC=CC=O,,,,,,
4031,154032,"8-Azabicyclo(3.2.1)octane, 6-(6-chloro-3-pyridinyl)-, (1R,5S,6S)-rel-",C1C[C@@H]2C[C@H]([C@H](C1)N2)C3=CN=C(C=C3)Cl,,,,,,
4032,154033,Monomagnesium di-L-glutamate,C(CC(=O)[O-])[C@@H](C(=O)[O-])N.C(CC(=O)[O-])[C@@H](C(=O)[O-])N.[Mg+2],,,,,,
4033,154034,"anti-trans-1,2,3,4-Tetrahydro-6-methylchrysene-1,2-diol-3,4-epoxide",CC1=CC2=C(C=CC3=C2[C@H]4[C@@H](O4)C(C3O)O)C5=CC=CC=C15,,,,,,
4034,154035,p-Cresol glucuronide,CC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
4035,154036,"Ethane-1,2-diamine;3-(3,4,5-trimethoxyphenyl)prop-2-enoic acid",COC1=CC(=CC(=C1OC)OC)C=CC(=O)O.COC1=CC(=CC(=C1OC)OC)C=CC(=O)O.C(CN)N,,,,,,
4036,154037,"2,3-Dihydro-1H-cyclopenta(c)phenanthren-1-one",C1CC(=O)C2=C1C=CC3=C2C4=CC=CC=C4C=C3,,,,,,
4037,154038,"1,1-Dibutylhydrazine oxalate",CCCCN(CCCC)N.C(=O)(C(=O)O)O,,,,,,
4038,154039,4-(2'-Pyridyl)-1-methylpyridinium iodide,C[N+]1=CC=C(C=C1)C2=CC=CC=N2.[I-],,,,,,
4039,154040,1-Methyl-4-(2-pyridyl)pyridinium,C[N+]1=CC=C(C=C1)C2=CC=CC=N2,,,,,,
4040,154041,N-Ethyl-N'-(2-oxopropyl)-N-nitrosourea,CCN(C(=O)NCC(=O)C)N=O,,,,,,
4041,154042,"4-Amino-2,6-dimethoxyaniline",COC1=CC(=CC(=C1N)OC)N,,,,,,
4042,154043,CID 154043,CS(=O)(=O)O.C1=CC=C(C=C1)C[C@@H]2[C@@H]([C@H]([C@H](N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O,,,,,,
4043,154044,Mozenavir,C1=CC=C(C=C1)C[C@@H]2[C@@H]([C@H]([C@H](N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O,,,,,,
4044,154045,"12-Methylbenz(a)anthracene-3,4-dione",CC1=C2C(=CC3=CC=CC=C13)C=CC4=C2C=CC(=O)C4=O,,,,,,
4045,154046,"Pyridine, 4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-(4-(1H-1,2,4-triazol-1-yl)butyl)-",C1CN(CC=C1C2=CC=C(C=C2)F)CCCCN3C=NC=N3,,,,,,
4046,154047,"1,4-Dimethyl-3-aminocarbazole",CC1=CC(=C(C2=C1NC3=CC=CC=C32)C)N,,,,,,
4047,154048,Opaviraline,CC[C@H]1C(=O)NC2=C(N1C(=O)OC(C)C)C=C(C=C2)F,,,,,,
4048,154049,"6-Methylchrysene-1S,2R-diol-3R,4S-epoxide",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@H]5[C@H](O5)[C@@H]([C@H]4O)O,,,,,,
4049,154050,CID 154050,CC1=C(C=CO1)C(=NC2=CC(=C(C=C2)Cl)OCC=C(C)C)S,,,,,,
4050,154051,N-Nitroso-N-p-nitrophenyl-D-ribosylamine,C1[C@H]([C@H]([C@H](C(O1)N(C2=CC=C(C=C2)[N+](=O)[O-])N=O)O)O)O,,,,,,
4051,154052,N-Nitroso-N-p-nitrophenyl-L-arabinosylamine,C1[C@@H]([C@@H]([C@H](C(O1)N(C2=CC=C(C=C2)[N+](=O)[O-])N=O)O)O)O,,,,,,
4052,154053,N-p-Methylphenyl-D-arabinosylamine,CC1=CC=C(C=C1)NC2[C@H]([C@@H]([C@@H](CO2)O)O)O,,,,,,
4053,154054,N-Nitroso-N-p-nitrophenyl-D-xylosylamine,C1[C@H]([C@@H]([C@H](C(O1)N(C2=CC=C(C=C2)[N+](=O)[O-])N=O)O)O)O,,,,,,
4054,154055,N-Nitroso-N-p-nitrophenyl-D-lyxosylamine,C1[C@H]([C@@H]([C@@H](C(O1)N(C2=CC=C(C=C2)[N+](=O)[O-])N=O)O)O)O,,,,,,
4055,154056,CID 154056,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@@H]([C@H]3[C@](CC[C@@](S3)(CC(=O)N1)[C@](C)(C(=O)O)O)(C)O)O,,,,,,
4056,154057,CID 154057,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@H]3[C@@H](O3)[C@@]4(CC[C@@](S4)(CC(=O)N1)[C@](C)(C(=O)O)O)C,,,,,,
4057,154058,Solifenacin hydrochloride,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.Cl,,,,,,
4058,154059,Solifenacin,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5,"['Solifenacin tablets are indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.']",['Solifenacin antagonizes the M2 and M3 muscarinic receptors in the bladder to treat an overactive bladder. It has a long duration of action as it is usually taken once daily. Patients taking solifenacin should be aware of the risks of angioedema and anaphylaxis.'],"['Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)', 'Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)']","['Solifenacin is well absorbed in the duodenum, jejunum, and ileum but not the stomach. Absorption occurs via passive diffusion and so no transporters are involved. The mean oral bioavailability of solifenacin is 88%. The T<sub>max</sub> of solifenacin is 3-8 hours with a C<sub>ss</sub> of 32.3ng/mL for a 5mg oral dose and 62.9ng/mL for a 10mg oral dose.', '69.2±7.8% of a radiolabelled dose is recovered in the urine, 22.5±3.3% was recovered in feces, and 0.4±7.8% was recovered in exhaled air. 18% of solifenacin is eliminated as the N-oxide metabolite, 9% is eliminated as the 4R-hydroxy N-oxide metabolite, and 8% is eliminated as the 4R-hydroxy metabolite.', 'The volume of distribution of solifenacin is 600L.', 'The clearance of solifenacin is 7-14L/h and a renal clearance of 0.67-1.51L/h.']","['Solifenacin undergoes N-oxidation at the quinuclidin ring by cytochrome P450, though the exact enzymes are not revealed in the literature. The tetrahydroisoquinolone ring is 4R-hydroxylated by CYP3A4, CYP1A1, and CYP2D6. A 4R-hydroxy N-oxide metabolite is also formed by CYP3A4. Finally, solifenacin can undergo direct glucuronidation. Only solifenacin and the 4R-hydroxy metabolite are pharmacologically active.']",['The elimination half life of solifenacin ranges from 33-85 hours.']
4059,154060,"4-Quinolinecarboxamide, N-(aminoiminomethyl)-8-(2-methoxyethoxy)-2-phenyl-, monomethanesulfonate",COCCOC1=CC=CC2=C1N=C(C=C2C(=O)N=C(N)N)C3=CC=CC=C3.CS(=O)(=O)O,,,,,,
4060,154061,2-[[2-Phenyl-8-(2-methoxyethoxy)quinoline-4-yl]carbonyl]guanidine,COCCOC1=CC=CC2=C1N=C(C=C2C(=O)N=C(N)N)C3=CC=CC=C3,,,,,,
4061,154062,N-3-Ethylindole-D-xylosylamine,C1[C@H]([C@@H]([C@H](C(O1)NCCC2=CNC3=CC=CC=C32)O)O)O,,,,,,
4062,154063,"1-Anthracenecarboxamide, N-(2-(dimethylamino)ethyl-",CN(C)CCNC(=O)C1=CC=CC2=CC3=CC=CC=C3C=C21,,,,,,
4063,154064,"Dibenzo(b,e)(1,4)dioxin-1-carboxamide, N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=C2C(=CC=C1)OC3=CC=CC=C3O2,,,,,,
4064,154065,N-Acetoxy-N-acetyl-o-toluidine,CC1=CC=CC=C1N(C(=O)C)OC(=O)C,,,,,,
4065,154066,"1H-Indole-4-carboxylic acid, 1-(2-ethoxyethyl)-3-((4-(2-methyl-1H-imidazo(4,5-c)pyridin-1-yl)-1-piperidinyl)acetyl)-, methyl ester",CCOCCN1C=C(C2=C(C=CC=C21)C(=O)OC)C(=O)CN3CCC(CC3)N4C(=NC5=C4C=CN=C5)C,,,,,,
4066,154067,"Lanost-8-en-3-one, 2-(4-carboxy-3-hydroxy-3-methyl-1-oxobutoxy)-24,25-dihydroxy-, (2alpha)-",C[C@H](CCC(C(C)(C)O)O)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(C[C@H](C(=O)C4(C)C)OC(=O)CC(C)(CC(=O)O)O)C)C)C,,,,,,
4067,154068,Ziprasidone mesylate,CS(=O)(=O)O.C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,,,,,,
4068,154069,"3(2H)-Pyridazinone, 2-(3-((((2R)-2,3-dihydro-1,4-benzodioxin-2-yl)methyl)amino)propyl)-",C1[C@H](OC2=CC=CC=C2O1)CNCCCN3C(=O)C=CC=N3,,,,,,
4069,154070,"2,7-Anthracenedisulfonamide, N,N,N',N'-tetrakis(3-aminopropyl)-9,10-dihydro-9,10-dioxo-, tetrahydrochloride",C1=CC2=C(C=C1S(=O)(=O)N(CCCN)CCCN)C(=O)C3=C(C2=O)C=CC(=C3)S(=O)(=O)N(CCCN)CCCN.Cl.Cl.Cl.Cl,,,,,,
4070,154071,"N,N,N',N'-Tetrakis(3-aminopropyl)-9,10-dihydro-9,10-dioxoanthracene-2,7-disulfonamide",C1=CC2=C(C=C1S(=O)(=O)N(CCCN)CCCN)C(=O)C3=C(C2=O)C=CC(=C3)S(=O)(=O)N(CCCN)CCCN,,,,,,
4071,154072,"4-Thiazolidinecarboxamide, N-(1,1-dimethylethyl)-3-((2S,3S)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-1-oxo-4-phenylbutyl)-5,5-dimethyl-,(4R)-",CC1=C(C=CC=C1O)C(=O)N[C@@H](CC2=CC=CC=C2)[C@@H](C(=O)N3CSC([C@H]3C(=O)NC(C)(C)C)(C)C)O,,,,,,
4072,154073,"Propanoic acid, 2-hydroxy-, 2-ethylhexyl ester, (2S)-",CCCCC(CC)COC(=O)[C@H](C)O,,,,,,
4073,154074,"Platinate(2-), tetrachloro-, (SP-4-1)-, dihydrogen, compd. with N,N'-bis(3-aminopropyl)-1,4-butanediamine (2:1)",[H+].[H+].[H+].[H+].C(CCNCCCN)CNCCCN.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
4074,154075,"Platinum, (mu-(N,N'-bis(3-(amino-kappaN)propyl)-1,4-butanediamine-kappaN:kappaN'))tetrachlorodi-",C(CCNCCCN)CNCCCN.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
4075,154076,"Platinum, (mu-(N,N'-bis(3-(amino-kappaN)propyl)-1,4-butanediamine-kappaN:kappaN'))octachlorodi-",C(CCNCCCN)CNCCCN.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
4076,154077,Cobalt mesoporphyrin glycinate,CCC1=C(C2=NC1=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=NC(=C2)C(=C5C)CC)[N-]4)C)CCC(=O)[O-])CCC(=O)[O-])C)C.C(C(=O)[O-])N.C(C(=O)[O-])N.[Na+].[Na+].[Na+].[Co+3],,,,,,
4077,154078,"3H-Benz(e)indole-3-acetamide, 1-(chloromethyl)-1,2-dihydro-5-hydroxy-N-(2-(4-(((3-(methylthio)propyl)amino)carbonyl)(2,4'-bithiazol)-2'-yl)ethyl)-alpha-oxo-, (S)-",CSCCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)CCNC(=O)C(=O)N3CC(C4=C3C=C(C5=CC=CC=C54)O)CCl,,,,,,
4078,154079,"3H-Benz(e)indole-3-acetamide, 1-(chloromethyl)-1,2-dihydro-5-hydroxy-N-(2-(4-(((3-(methylsulfinyl)propyl)amino)carbonyl)(2,4'-bithiazol)-2'-yl)ethyl)-alpha-oxo-, (1S)-",CS(=O)CCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)CCNC(=O)C(=O)N3C[C@H](C4=C3C=C(C5=CC=CC=C54)O)CCl,,,,,,
4079,154080,"Sulfonium, (3-(((2'-(2-(((1-(chloromethyl)-1,2-dihydro-5-hydroxy-3H-benz(e)indol-3-yl)oxoacetyl)amino)ethyl)(2,4'-bithiazol)-4-yl)carbonyl)amino)propyl)dimethyl-, iodide, (S)-",C[S+](C)CCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)CCNC(=O)C(=O)N3CC(C4=C3C=C(C5=CC=CC=C54)O)CCl.[I-],,,,,,
4080,154081,"3-[[2-[2-[2-[[2-[1-(Chloromethyl)-5-hydroxy-1,2-dihydrobenzo[e]indol-3-yl]-2-oxoacetyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium",C[S+](C)CCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)CCNC(=O)C(=O)N3CC(C4=C3C=C(C5=CC=CC=C54)O)CCl,,,,,,
4081,154082,"3H-Benz(e)indole-3-butanamide, 1-(chloromethyl)-1,2-dihydro-5-hydroxy-N-(2-(4-(((3-(methylthio)propyl)amino)carbonyl)(2,4'-bithiazol)-2'-yl)ethyl)-gamma-oxo-, (S)-",CSCCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)CCNC(=O)CCC(=O)N3CC(C4=C3C=C(C5=CC=CC=C54)O)CCl,,,,,,
4082,154083,"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2Br)Br)Br,,,,,,
4083,154084,Potassium diazoacetate,C(=[N+]=[N-])C(=O)[O-].[K+],,,,,,
4084,154085,"2,2-Dihydroxyethenediazonium",C(=C(O)O)[N+]#N,,,,,,
4085,154086,ABT-491 hydrochloride,CC1=NC2=C(N1CC3=C(C=C(C=C3)C(=O)C4=CN(C5=CC=CC(=C54)C#C)C(=O)N(C)C)F)C=CN=C2.Cl,,,,,,
4086,154087,ABT-491 free base,CC1=NC2=C(N1CC3=C(C=C(C=C3)C(=O)C4=CN(C5=CC=CC(=C54)C#C)C(=O)N(C)C)F)C=CN=C2,,,,,,
4087,154088,2-hydroxy-N'-[(1H-pyrrol-2-yl)methylidene]benzohydrazide,C1=CC=C(C(=C1)C(=O)NN=CC2=CC=CN2)O,,,,,,
4088,154089,CID 154089,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@H]3[C@@H](O3)[C@@]4(CC[C@@](S4)(CC(=O)N1)[C@](C)(C(=O)OC)O)C,,,,,,
4089,154090,CID 154090,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@H]3[C@@H](O3)[C@@]4(CC[C@@](S4)(CC(=O)N1)[C@](C)(C(=O)OC(C)C)O)C,,,,,,
4090,154091,CID 154091,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@H]3[C@@H](O3)[C@@]4(CC[C@@](S4(=O)=O)(CC(=O)N1)[C@](C)(C(=O)OC)O)C,,,,,,
4091,154092,CID 154092,C[C@@H]1C2=NC(=CS2)C=CC=CC(=O)[C@@H]([C@H]3[C@](CC[C@@](S3)(CC(=O)N1)[C@](C)(C(=O)OC)O)(C)O)O,,,,,,
4092,154093,"[(1R,2R)-2-hydroxy-2-[(2R,3S)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-1-phenylethyl] 3-phenylprop-2-enoate",C1=CC=C(C=C1)C=CC(=O)O[C@H](C2=CC=CC=C2)[C@H]([C@H]3[C@H](C=CC(=O)O3)O)O,,,,,,
4093,154094,"2-[4-(2-bromo-1,2-diphenylethenyl)phenoxy]-N,N-dimethylethanamine",CN(C)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Br)C3=CC=CC=C3,,,,,,
4094,154095,Bamet-R2,CC(CCC(=O)NCC(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C.N.N.[Cl-].[Pt+2],,,,,,
4095,154096,2-Phenyl-2H-benzotriazole,C1=CC=C(C=C1)N2N=C3C=CC=CC3=N2,,,,,,
4096,154097,3-Fluoro-5-nitroquinoline,C1=CC2=C(C=C(C=N2)F)C(=C1)[N+](=O)[O-],,,,,,
4097,154098,"Propanoic acid, 2,2-dimethyl-, ((4-(3-phenoxyphenyl)-1-sulfobutyl)phosphinylidene)bis(oxymethylene) ester",CC(C)(C)C(=O)OCOP(=O)(C(CCCC1=CC(=CC=C1)OC2=CC=CC=C2)S(=O)(=O)O)OCOC(=O)C(C)(C)C,,,,,,
4098,154099,"4H-1,2,3,5-Benzotetrazepin-4-one, 3,5-dihydro-3,5-dimethyl-7-nitro-",CN1C2=C(C=CC(=C2)[N+](=O)[O-])N=NN(C1=O)C,,,,,,
4099,154100,Dexmethylphenidate hydrochloride,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2.Cl,,,"['Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)', 'A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
4100,154101,Dexmethylphenidate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,"['Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.']",['Dexmethylphenidate is the d-enantiomer of methylphenidate. This enantiomer is more pharmacologically active than the racemic mixture and may block norepinephrine and dopamine reuptake in synapses.'],"['Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)', 'A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']","['Taking dexmethylphenidate with or without food does not affect patients in a clinically relevant way. 90% of an oral dose is absorbed but as a result of hepatic first pass metabolism, oral bioavailability of dexmethylphenidate is 23% compared to l-methylphenidate with an oral bioavailability of 5%. Maximum concentration is generally reached in 1-1.5 hours.', 'Dexmethylphenidate is mainly eliminated renally. After 48 hours, 90% of the dose is collected in the urine and 3.3% is collected from feces.', '2.65L/kg when administered intravenously.', '0.40L/hr/kg following an intravenous dose and a renal clearance of 0.005L/hr/kg.']",['Dexmethylphenidate is metabolised to the inactive metabolite ritalinic acid by carboxylesterase 1A1 in the liver. Other minor pathways metabolise dexmethylphenidate to the inactive metabolites 6-oxo-methylphenidate and p-hydroxy-methylphenidate which are de-esterified and conjugated into other unknown metabolites.'],"['The mean terminal half life is approximately 2.2 hours. However other studies have shown 3.8-3.9 hours, or 5.96 hours after intravenous administration and 5.69 hours following an oral dose.']"
4101,154102,"1-(2,4-Dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one",COC1=CC(=CC(=C1C(=O)C=CC2=CC=CC=C2)O)O,,,,,,
4102,154103,Pumosetrag hydrochloride,C1CN2CCC1[C@H](C2)NC(=O)C3=CNC4=C(C3=O)SC=C4.Cl,,,,,,
4103,154104,Pumosetrag,C1CN2CCC1[C@H](C2)NC(=O)C3=CNC4=C(C3=O)SC=C4,"['Investigated for use/treatment in constipation, gastroesophageal reflux disease (GERD), gastrointestinal diseases and disorders (miscellaneous), and irritable bowel syndrome (IBS).']",,,,,
4104,154105,Isosaponarin,C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
4105,154106,4-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-3-hydroxy-2-phenylbut-1-enyl]phenol,CC(C(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3)O,,,,,,
4106,154107,"Acetamide, N-(2-(5-amino-7-bromo-4-chloro-2H-benzotriazol-2-yl)-5-(bis(2-methoxyethyl)amino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N2N=C3C(=CC(=C(C3=N2)Cl)N)Br)OC)N(CCOC)CCOC,,,,,,
4107,154108,"Dibenzo(c,f)(2,7)naphthyridine",C1=CC=C2C(=C1)C3=C(C=N2)C=NC4=CC=CC=C43,,,,,,
4108,154109,"[(1R,3S,5R,7S,9R,11S,13R,14S,16R,18S,20R,22S,25R,27S,30S,31R,33S,34R,35R,37S,40S,42R,44S,46R,48S)-34-hydroxy-40-[(2R)-2-hydroxy-5-methylideneocta-3,7-dien-2-yl]-13,25,27,30,35-pentamethyl-39-methylidene-13-(3-sulfooxypropyl)-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.03,25.05,22.07,20.09,18.011,16.031,48.033,46.035,44.037,42]nonatetracontan-14-yl] hydrogen sulfate",C[C@H]1CC[C@]2([C@@H](C[C@H]3[C@](O2)(CC[C@H]4[C@H](O3)C[C@H]5[C@H](O4)C[C@H]6[C@H](O5)C[C@H]7[C@H](O6)C[C@@H]([C@@](O7)(C)CCCOS(=O)(=O)O)OS(=O)(=O)O)C)O[C@@H]8[C@@H]1O[C@@H]9[C@@H](C8)O[C@H]1C[C@@H]2[C@H](CC(=C)[C@H](O2)[C@@](C)(C=CC(=C)CC=C)O)O[C@@]1([C@@H]9O)C)C,,,,,,
4109,154110,CID 154110,CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCCC[N+](C)(C)CCC[N+](C)(C)CCCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C.[I-].[I-].[I-].[I-],,,,,,
4110,154111,"N,N,N',N'-Tetramethyl-N,N'-bis[4-[4-[(3-methylbenzothiazole-2(3H)-ylidene)methyl]quinolinium-1-yl]butyl]-1,3-propanediaminium",CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCCC[N+](C)(C)CCC[N+](C)(C)CCCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C,,,,,,
4111,154112,CID 154112,CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCCCC[N+](C)(C)CCC[N+](C)(C)CCCCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C.[I-].[I-].[I-].[I-],,,,,,
4112,154113,CID 154113,CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCCCC[N+](C)(C)CCC[N+](C)(C)CCCCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C,,,,,,
4113,154114,"N-[[4-[(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-1-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine",C1CN=C(N1)NN=CC2=CC=C(C3=CC4=CC=CC=C4C=C23)C=NNC5=NCCN5,,,,,,
4114,154115,CID 154115,CN1CC[C@]23[C@@H]4[C@@H]1CC5=CC(=C(C(=C52)O[C@H]3[C@H](C=C4)O)O)CO,,,,,,
4115,154116,"Carbonic acid, diethyl ester, polymer with 2,2'-(1,2-ethanediylbis(oxy))bis(ethanol) and 1,6-hexanediol",CCOC(=O)OCC.C(CCCO)CCO.C(COCCOCCO)O,,,,,,
4116,154117,"1(2H)-Pyrazineacetamide, N-((6-amino-2-methyl-3-pyridinyl)methyl)-6-methyl-2-oxo-3-((2-phenylethyl)amino)-, dihydrochloride",CC1=CN=C(C(=O)N1CC(=O)NCC2=C(N=C(C=C2)N)C)NCCC3=CC=CC=C3.Cl.Cl,,,,,,
4117,154118,N-[(6-amino-2-methyl-3-pyridinyl)methyl]-2-[6-methyl-2-oxo-3-(2-phenylethylamino)-1-pyrazinyl]acetamide,CC1=CN=C(C(=O)N1CC(=O)NCC2=C(N=C(C=C2)N)C)NCCC3=CC=CC=C3,,,,,,
4118,154119,CID 154119,CCOC(=O)CN(CCN(CC1=CC=CC=C1O)CC(=O)[O-])CC2=CC=CC=C2O.[Na+],,,,,,
4119,154120,CGP-75254A free acid,CCOC(=O)CN(CCN(CC1=CC=CC=C1O)CC(=O)O)CC2=CC=CC=C2O,,,,,,
4120,154121,"1H-Indole-1-carboxamide, 4-ethynyl-3-(3-fluoro-4-((2-methyl-1H-imidazo(4,5-c)pyridin-1-yl)methyl)benzoyl)-N-methyl-",CC1=NC2=C(N1CC3=C(C=C(C=C3)C(=O)C4=CN(C5=CC=CC(=C54)C#C)C(=O)NC)F)C=CN=C2,,,,,,
4121,154122,"1H-Indole-1-carboxamide, 4-ethynyl-3-((3-fluoro-4-((2-methyl-1H-imidazo(4,5-c)pyridin-1-yl)methyl)phenyl)hydroxymethyl)-N,N-dimethyl-",CC1=NC2=C(N1CC3=C(C=C(C=C3)C(C4=CN(C5=CC=CC(=C54)C#C)C(=O)N(C)C)O)F)C=CN=C2,,,,,,
4122,154123,"1H-Imidazole-2-carboxamide, 4-(((4-((4-(bis(2-chloroethyl)amino)benzoyl)amino)-1-methyl-1H-imidazol-2-yl)carbonyl)amino)-N-(2-(((2-(2-methoxy-1-aziridinyl)ethyl)amino)carbonyl)-1-methyl-1H-imidazol-4-yl)-1-methyl-4",CN1C=C(N=C1C(=O)NC2=CN(C(=N2)C(=O)NC3=CN(C(=N3)C(=O)NCCN4CC4OC)C)C)NC(=O)C5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
4123,154124,"1H-Imidazole-2-carboxamide, 4-(((4-((4-(bis(2-chloroethyl)amino)benzoyl)amino)-1-methyl-1H-imidazol-2-yl)carbonyl)amino)-N-(2-(((4-(2-methoxy-1-aziridinyl)butyl)amino)carbonyl)-1-methyl-1H-imidazol-4-yl)-1-methyl-",CN1C=C(N=C1C(=O)NC2=CN(C(=N2)C(=O)NC3=CN(C(=N3)C(=O)NCCCCN4CC4OC)C)C)NC(=O)C5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
4124,154125,CID 154125,C[CH2-].C[CH2-].C1=CC=C(C(=C1)C(=O)NN=CC2=CC=CN2)O.[Cl-].[Cl-].[Sn+4],,,,,,
4125,154126,CID 154126,CCC[CH2-].CCC[CH2-].C1=CC=C(C(=C1)C(=O)NN=CC2=CC=CN2)O.[Cl-].[Cl-].[Sn+4],,,,,,
4126,154127,CID 154127,C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C1=CC=C(C(=C1)C(=O)NN=CC2=CC=CN2)O.[Cl-].[Cl-].[Sn+4],,,,,,
4127,154128,CID 154128,C[CH2-].C[CH2-].C1=CC=NC(=C1)C(=NN=CC2=CC=CN2)[O-].[Cl-].[Sn+4],,,,,,
4128,154129,N-(1H-pyrrol-2-ylmethylideneamino)pyridine-2-carboxamide,C1=CC=NC(=C1)C(=O)NN=CC2=CC=CN2,,,,,,
4129,154130,CID 154130,CCC[CH2-].CCC[CH2-].C1=CC=NC(=C1)C(=NN=CC2=CC=CN2)[O-].[Cl-].[Sn+4],,,,,,
4130,154131,CID 154131,C#CC=CCCCCCCCCCCCCCCC=CCCCCC=CCCCCC#C[C@@H](C#CCCCCCCC=C[C@H](C#C)O)O,,,,,,
4131,154132,"3-Cyclobutene-1,2-dione, 3-(((2,4-dichloro-6-methylphenyl)methyl)amino)-4-((1,1-dimethylpropyl)amino)-",CCC(C)(C)NC1=C(C(=O)C1=O)NCC2=C(C=C(C=C2C)Cl)Cl,,,,,,
4132,154133,CID 154133,C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H](C[C@H](C[C@H](CC(=O)C[C@H](CC(=O)O[C@@H]1[C@@H](C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)O)C(=O)NCCN(C)C)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)NC(=O)CN(C)C)O.C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O.C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
4133,154134,CID 154134,C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H](C[C@H](C[C@H](CC(=O)C[C@H](CC(=O)O[C@@H]1[C@@H](C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)O)C(=O)NCCN(C)C)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)NC(=O)CN(C)C)O,,,,,,
4134,154135,"2-Imidazolidinecarboxamide, N-hydroxy-1,3-bis((4-methoxyphenyl)sulfonyl)-",COC1=CC=C(C=C1)S(=O)(=O)N2CCN(C2C(=O)NO)S(=O)(=O)C3=CC=C(C=C3)OC,,,,,,
4135,154136,"2-Pyrimidinecarboxamide, hexahydro-N-hydroxy-1,3-bis((4-methoxyphenyl)sulfonyl)-",COC1=CC=C(C=C1)S(=O)(=O)N2CCCN(C2C(=O)NO)S(=O)(=O)C3=CC=C(C=C3)OC,,,,,,
4136,154137,"2-Pyrimidinecarboxamide, hexahydro-N,5-dihydroxy-1,3-bis((4-methoxyphenyl)sulfonyl)-",COC1=CC=C(C=C1)S(=O)(=O)N2CC(CN(C2C(=O)NO)S(=O)(=O)C3=CC=C(C=C3)OC)O,,,,,,
4137,154138,"N-(anthracen-9-ylmethylideneamino)-4,5-dihydro-1H-imidazol-2-amine",C1CN=C(N1)NN=CC2=C3C=CC=CC3=CC4=CC=CC=C42,,,,,,
4138,154139,"N-(acridin-9-ylmethylideneamino)-4,5-dihydro-1H-imidazol-2-amine",C1CN=C(N1)NN=CC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
4139,154140,"N-(anthracen-1-ylmethylideneamino)-4,5-dihydro-1H-imidazol-2-amine",C1CN=C(N1)NN=CC2=CC=CC3=CC4=CC=CC=C4C=C32,,,,,,
4140,154141,"Acetamide, N-(2-(6-amino-4-bromo-2H-benzotriazol-2-yl)-5-(bis(2-methoxyethyl)amino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N2N=C3C=C(C=C(C3=N2)Br)N)OC)N(CCOC)CCOC,,,,,,
4141,154142,"[4-[4-[2-(Dimethylamino)ethoxy]phenyl]-3,4-diphenylbut-3-en-2-yl] acetate",CC(C(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3)OC(=O)C,,,,,,
4142,154143,CID 154143,COC1=C2C=CC(=O)C=C2NC3=C1C=CO3,,,,,,
4143,154144,"Pyrimido(4,5-b)quinoline-3(2H)-acetamide, 10-butyl-N-(5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-4,10-dihydro-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)CN2C(=O)C3=CC4=C(C=CC=C4[N+](=O)[O-])N(C3=NC2=O)CCCC,,,,,,
4144,154145,"Pyrimido(4,5-b)quinoline-3(2H)-acetamide, 10-butyl-N-(5-(((5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-4,10-dihydro-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)C2=CC(=CN2C)NC(=O)CN3C(=O)C4=CC5=C(C=CC=C5[N+](=O)[O-])N(C4=NC3=O)CCCC,,,,,,
4145,154146,"Pyrimido(4,5-b)quinoline-3(2H)-acetamide, 10-butyl-N-(5-(((5-(((5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-4,10-dihydro-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)C2=CC(=CN2C)NC(=O)C3=CC(=CN3C)NC(=O)CN4C(=O)C5=CC6=C(C=CC=C6[N+](=O)[O-])N(C5=NC4=O)CCCC,,,,,,
4146,154147,"Pyrimido(4,5-b)quinoline-10(2H)-acetamide, N-(5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-3,4-dihydro-3-methyl-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)CN2C3=C(C=C4C2=NC(=O)N(C4=O)C)C(=CC=C3)[N+](=O)[O-],,,,,,
4147,154148,"Pyrimido(4,5-b)quinoline-10(2H)-acetamide, N-(5-(((5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-3,4-dihydro-3-methyl-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)C2=CC(=CN2C)NC(=O)CN3C4=C(C=C5C3=NC(=O)N(C5=O)C)C(=CC=C4)[N+](=O)[O-],,,,,,
4148,154149,"Pyrimido(4,5-b)quinoline-10(2H)-acetamide, N-(5-(((5-(((5-((butylamino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-3,4-dihydro-3-methyl-6-nitro-2,4-dioxo-",CCCCNC(=O)C1=CC(=CN1C)NC(=O)C2=CC(=CN2C)NC(=O)C3=CC(=CN3C)NC(=O)CN4C5=C(C=C6C4=NC(=O)N(C6=O)C)C(=CC=C5)[N+](=O)[O-],,,,,,
4149,154150,2-amino-N-butylacetamide hydrochloride,CCCCNC(=O)CN.Cl,,,,,,
4150,154151,2-amino-N-butylacetamide,CCCCNC(=O)CN,,,,,,
4151,154152,CID 154152,C1=CC=[N+](C(=C1)C=NO)CC=CC[N+]2=CC=C(C=C2)C(=O)N.[Br-].[Br-],,,,,,
4152,154153,CID 154153,C1=CC=[N+](C(=C1)C=NO)CC=CC[N+]2=CC=C(C=C2)C(=O)N,,,,,,
4153,154154,"1-Butoxy-6-(hydroxymethyl)-2-oxabicyclo(4.1.0)heptane-4,5,7-triol",CCCCOC12C(C1(C(C(CO2)O)O)CO)O,,,,,,
4154,154155,"6H-Pyrido(1,2,3-ef)-1,2,3,5-benzotetrazepin-4(3H)-one,3-(2-chloroethyl)-7,8-dihydro-",C1CC2=C3C(=CC=C2)N=NN(C(=O)N3C1)CCCl,,,,,,
4155,154156,"4H-Pyrido(2,3-f)-1,2,3,5-tetrazepin-4-one, 3-(2-chloroethyl)-3,5-dihydro-5-methyl-",CN1C2=C(C=CC=N2)N=NN(C1=O)CCCl,,,,,,
4156,154157,"Dibenzo(c,f)(2,7)naphthyridine, 2,3,10,11-tetramethoxy-6,7-dimethyl-",CC1=NC2=CC(=C(C=C2C3=C1C(=NC4=CC(=C(C=C43)OC)OC)C)OC)OC,,,,,,
4157,154158,CID 154158,CC1=C2C(=C3C=C(C(=CC3=NC2=O)OC)OC)C4=CC(=C(C=C4N1)OC)OC,,,,,,
4158,154159,"3-Hexyl-3,7-dihydroxy-1(3H)-isobenzofuranone",CCCCCCC1(C2=C(C(=CC=C2)O)C(=O)O1)O,,,,,,
4159,154160,"(2S,3S)-2-(dimethylamino)-N-[(2S)-2-[[(3R,5S)-3-methoxy-1-[(2S)-2-[(2R)-1-methoxy-2-methyl-3-oxo-3-[[(1R)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methylbutanoyl]-3-methylpentanamide",CC[C@H](C)[C@@H](C(=O)NC(=O)[C@H](C(C)C)N(C)C([C@@H](C)CC)[C@@H](CC(=O)N1CCC[C@H]1C([C@@H](C)C(=O)N[C@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C,,,,,,
4160,154161,"Benzo(a)pyrene-7,8,9-triol, 10-chloro-7,8,9,10-tetrahydro-, (7R,8S,9S,10S)-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@H]([C@@H]5O)O)O)Cl)C=C2,,,,,,
4161,154162,Glochidiolide,C1[C@@H](C=C[C@@]2([C@H]1OC(=O)C2)[C@@]34C[C@@H](C=CC3=CC(=O)O4)O)O,,,,,,
4162,154163,"2-Butan-2-yl-28-ethyl-17-[(4-methoxyphenyl)methyl]-7,13,16,20,22,22,24,25,29-nonamethyl-8-(2-methylpropyl)-14-propan-2-yl-1-oxa-4,7,10,13,16,19,24,27-octazacyclotriacontane-3,6,9,12,15,18,21,23,26,30-decone",CCC1C(C(=O)OC(C(=O)NCC(=O)N(C(C(=O)NCC(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)C(C(=O)N(C(C(=O)N1)C)C)(C)C)C)CC2=CC=C(C=C2)OC)C)C(C)C)C)CC(C)C)C)C(C)CC)C,,,,,,
4163,154164,Taxoline,CCC(C)C(=O)N[C@@H](C1=CC=CC=C1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)[C@@H](C(=C2C)C3(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)O)O,,,,,,
4164,154165,Tolyporphin J,CC1=CC2=CC3=NC(=CC4=CC(=C(N4)C=C5C(=O)C(C(=N5)C=C1N2)(C)O)C)C(C3=O)(C)O,,,,,,
4165,154166,Tolyporphine K,C[C@@H]1[C@@H](C[C@H]([C@@H](O1)C2(C3=CC4=NC(=CC5=NC(=CC6=NC(=CC(=C2O)N3)C=C6C)C(=C5)C)C(=C4)C)C)O)O,,,,,,
4166,154167,"Bicyclo(4.1.0)heptan-3-one, 4-(1-hydroxy-1-methylethyl)-1-methyl-7-(3-oxobutyl)-, (1S,4S,6R,7R)-",CC(=O)CC[C@@H]1[C@@H]2[C@]1(CC(=O)[C@@H](C2)C(C)(C)O)C,,,,,,
4167,154168,Curcarabranol B,CC(=O)CC[C@@H]1[C@@H]2[C@]1(CC(=O)[C@H](C2)C(C)(C)O)C,,,,,,
4168,154169,Aculeoside B,C[C@@H]1C[C@@H]([C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)COC(=O)C)OC(=O)C)OC(=O)C)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)C)C)C)OC1)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
4169,154170,"butyl (1S,3R,4R,5R)-1,3,4-trihydroxy-5-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyloxy]cyclohexane-1-carboxylate",CCCCOC(=O)[C@@]1(C[C@H]([C@H]([C@@H](C1)OC(=O)C=CC2=CC(=C(C=C2)O)OC)O)O)O,,,,,,
4170,154171,"butyl (3R,5R)-1,3,5-trihydroxy-4-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyloxy]cyclohexane-1-carboxylate",CCCCOC(=O)C1(C[C@H](C([C@@H](C1)O)OC(=O)C=CC2=CC(=C(C=C2)O)OC)O)O,,,,,,
4171,154172,"3H-Pyrazol-3-one, 1,2-dihydro-1-(2-hydroxy-3-(propylamino)propyl)-5-methyl-4-(1-oxo-3-phenylpropyl)-2-phenyl-",CCCNCC(CN1C(=C(C(=O)N1C2=CC=CC=C2)C(=O)CCC3=CC=CC=C3)C)O,,,,,,
4172,154173,10-(Methylsulfonyl)decanamide,CS(=O)(=O)CCCCCCCCCC(=O)N,,,,,,
4173,154174,2-Chloro-1-methylethyl(2-chloropropyl)ether,CC(COC(C)CCl)Cl,,,,,,
4174,154175,CID 154175,C1=C(C=C(C(=C1Cl)Cl)Cl)NC(=O)CCC(=O)N,,,,,,
4175,154176,"N-(2,3,4-Trichlorophenyl)-succinimide",C1CC(=O)N(C1=O)C2=C(C(=C(C=C2)Cl)Cl)Cl,,,,,,
4176,154177,CID 154177,CCN(C(=CO)N=O)N=O,,,,,,
4177,154178,CID 154178,CCCCN(C(=CO)N=O)N=O,,,,,,
4178,154179,"2,3-Dihydro-2,3-dihydroxybenzo(k)fluoranthene",C1=CC=C2C=C3C4=CC(C(C5=CC=CC(=C54)C3=CC2=C1)O)O,,,,,,
4179,154180,Benzo(b)triphenylen-2-ol,C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC=C4C5=C3C=C(C=C5)O,,,,,,
4180,154181,Benzo(b)triphenylen-4-ol,C1=CC=C2C=C3C4=CC=CC=C4C5=C(C3=CC2=C1)C=CC=C5O,,,,,,
4181,154182,"N-(2,3,4-Trichlorophenyl)-succinamide",C1=CC(=C(C(=C1NC(=O)CCC(=O)N)Cl)Cl)Cl,,,,,,
4182,154183,"3-Hydroxy[1]benzoxireno[3,2-h]quinolin-2(9H)-one",C1=CNC2=C3C(=C(C(=O)C4=C3O4)O)C=CC2=C1,,,,,,
4183,154184,"7,8-Epoxy-7,8,9,10-tetrahydrobenzo(h)quinoline",C1CC2=C(C=CC3=C2N=CC=C3)C4C1O4,,,,,,
4184,154185,"1a,2,3,9c-Tetrahydro[1]benzoxireno[3,2-h]quinoline",C1CC2=C(C3C1O3)C4=C(C=CC=N4)C=C2,,,,,,
4185,154186,Deterrol,CC1=C2C=CC(=C2C=C(C=C1)C(=C)C)CO,,,,,,
4186,154187,(R)-Glycidyl tosylate,CC1=CC=C(C=C1)S(=O)(=O)OC[C@H]2CO2,,,,,,
4187,154188,"6,7-Dihydro-8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole",COC1=CC=CC2=C1CC(C3=C2C4=C(C=C3)OCO4)[N+](=O)[O-],,,,,,
4188,154189,CID 154189,CN=NNC1=CC=C(C=C1)C(=O)[O-].[K+],,,,,,
4189,154190,1-4-(3-Methyltriazeno)benzoic acid,CN=NNC1=CC=C(C=C1)C(=O)O,,,,,,
4190,154191,"1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole",CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(C)CC,,,,,,
4191,154192,"Benzenamine, 4-((4-amino-3-chlorophenyl)methyl)-2-chloro-N-hydroxy-",C1=CC(=C(C=C1CC2=CC(=C(C=C2)NO)Cl)Cl)N,,,,,,
4192,154193,"1-Hydroxydibenz(a,c)anthracene",C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC=C4C5=C3C(=CC=C5)O,,,,,,
4193,154194,"4-[(Cyclopent-1-en-1-yl)amino]-1,2-dihydropyrimidin-2-one",C1CC=C(C1)NC2=CC=NC(=O)N2,,,,,,
4194,154195,"1,2-Diethylhydrazine oxalate",CCNNCC.C(=O)(C(=O)O)O,,,,,,
4195,154196,"p-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-7-yl)propenyl]benzoic acid",CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(C=C2)C(CCS3)(C)C,,,,,,
4196,154197,"2-Cyclohexen-1-one, 6-(1-hydroxy-1,5-dimethyl-4-hexenyl)-, (R*,R*)-(+-)-",CC(=CCC[C@](C)([C@H]1CCC=CC1=O)O)C,,,,,,
4197,154198,3-Diazo-N-nitrosobamethan,CCCCN(CC(C1=CC(=C(C=C1)[O-])[N+]#N)O)N=O,,,,,,
4198,154199,5-[2-[Butyl(nitroso)amino]-1-hydroxyethyl]-2-hydroxybenzenediazonium,CCCCN(CC(C1=CC(=C(C=C1)O)[N+]#N)O)N=O,,,,,,
4199,154200,N-Nitrosoindole-3-lactic acid,C1=CC=C2C(=C1)C(=CN2N=O)CC(C(=O)O)O,,,,,,
4200,154201,"11-(Hexyloxy)-15,16-dihydro-17H-cyclopenta(a)phenanthren-17-one",CCCCCCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,,,,,,
4201,154202,"16,17-Dihydro-15H-cyclopenta(a)phenanthren-11-ol",C1CC2=CC(=C3C(=C2C1)C=CC4=CC=CC=C43)O,,,,,,
4202,154203,"16,17-Dihydro-11-methoxy-15H-cyclopenta(a)phenanthrene",COC1=C2C(=C3CCCC3=C1)C=CC4=CC=CC=C42,,,,,,
4203,154204,"Olean-12-ene-3,23,28-triol",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)CO)C)C)(C)CO)O,,,,,,
4204,154205,"1,2-Dimethylhydrazine oxalate",CNNC.C(=O)(C(=O)O)O,,,,,,
4205,154206,Pendolmycin,CC(C)[C@H]1C(=O)N[C@@H](CC2=CNC3=C(C=CC(=C23)N1C)C(C)(C)C=C)CO,,,,,,
4206,154207,o-Nitrobenzyl butyrate,CCCC(=O)OCC1=CC=CC=C1[N+](=O)[O-],,,,,,
4207,154208,"4-[1-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-en-2-yl]benzoic acid",CC(=CC1=CC2=C(C=C1)C(CCC2(C)C)(C)C)C3=CC=C(C=C3)C(=O)O,,,,,,
4208,154209,p-Benzylphenylpropylene oxide,C1C(O1)CC2=CC=C(C=C2)CC3=CC=CC=C3,,,,,,
4209,154210,6-Azido-6-deoxy-alpha-D-mannopyranose,C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
4210,154211,"(+-)-1-(2-(1-Cyclopenten-1-yl)phenoxy)-3-((1,1-dimethylethyl)amino)-2-propanol",CC(C)(C)NCC(COC1=CC=CC=C1C2=CCCC2)O,,,,,,
4211,154212,"Octadecadienoic acid, (Z,Z)-",CCCCCCCCCCCCCC=CC=CC(=O)O,,,,,,
4212,154213,Ferric chloride heptahydrate,O.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Fe+3],,,,,,
4213,154214,"(R,R)-3-Azido-3-phenyl-1,2-propanediol",C1=CC=C(C=C1)[C@H]([C@H](CO)O)N=[N+]=[N-],,,,,,
4214,154215,"1-[(2R)-2-[(1S,2S)-8-[(3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,2-dihydroxyoctyl]piperidin-1-yl]ethanone",CC(=O)N1CCCC[C@@H]1[C@@H]([C@H](CCCCCCC2[C@H]([C@@H]([C@H](N2)CO)O)O)O)O,,,,,,
4215,154216,"2-Piperidineethanol, 1-acetyl-alpha-(6-((2R,3R,4R,5R)-1-acetyl-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)hexyl)-beta-hydroxy-, (alphaS,betaS,2R)-",CC(=O)N1CCCC[C@@H]1[C@@H]([C@H](CCCCCCC2[C@H]([C@@H]([C@H](N2C(=O)C)CO)O)O)O)O,,,,,,
4216,154217,2-(2-(Acetylamino)-4-(N-(2-cyanoethyl)ethylamino)-5-methoxyphenyl)-5-amino-7-bromo-4-chloro-2H-benzotriazole,CCN(CCC#N)C1=C(C=C(C(=C1)NC(=O)C)N2N=C3C(=CC(=C(C3=N2)Cl)N)Br)OC,,,,,,
4217,154218,Acetoxytetramethylbutylphenyl tetramethylbutylbenzofuranone,CC(=O)OC1=C(C=C(C=C1)C(C)(C)CC(C)(C)C)C2C3=C(C=CC(=C3)C(C)(C)CC(C)(C)C)OC2=O,,,,,,
4218,154219,CID 154219,C1=CC=NC(=C1)C=NN=C(N)S.C1=CC=NC(=C1)C=NN=C(N)S.[Cl-].[Cl-].[Pt+2],,,,,,
4219,154220,CID 154220,C1=CC=NC(=C1)C=NN=C(N)[S-].[Cl-].[Pd+2],,,,,,
4220,154221,CID 154221,C1=CC=NC(=C1)C=NN=C(N)S.C1=CC=NC(=C1)C=NN=C(N)S.[Cl-].[Cl-].[Pd+2],,,,,,
4221,154222,CID 154222,C1=CC=NC(=C1)C=NN=C(N)[S-].C1=CC=NC(=C1)C=NN=C(N)[S-].[Pd+2],,,,,,
4222,154223,Methyl 4-hydroxy-3-(3-methyl-2-butenyl)benzenepropanoate,CC(=CCC1=C(C=CC(=C1)CCC(=O)OC)O)C,,,,,,
4223,154224,"9-(4'-Aminophenyl)-9H-pyrido[3,4-b]indole",C1=CC=C2C(=C1)C3=C(N2C4=CC=C(C=C4)N)C=NC=C3,,,,,,
4224,154225,"Benzenamine, N-hydroxy-4-(9H-pyrido(3,4-b)indol-9-yl)-",C1=CC=C2C(=C1)C3=C(N2C4=CC=C(C=C4)NO)C=NC=C3,,,,,['N-hydroxy-aminophenylnorharman has known human metabolites that include 1-{[4-(9H-beta-Carbolin-9-yl)anilino]oxy}ethan-1-one.'],
4225,154226,CID 154226,CCOC(=O)C=C[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC2=CC=C(C=C2)F)CC(=O)[C@H](C(C)C)NC(=O)C3=NOC(=C3)C,,,,,,
4226,154227,"7,3',4'-Trimethoxyflavone",COC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC(=C(C=C3)OC)OC,,,,,,
4227,154228,"2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-methyl-3,7-bis((2-propenyloxy)methyl)-",C[Si]12OCCN(CC(O1)COCC=C)CC(O2)COCC=C,,,,,,
4228,154229,Dictamnine N-oxide,COC1=C2C=COC2=[N+](C3=CC=CC=C31)[O-],,,,,,
4229,154230,"Guanidine 2,4-dichlorphenoxyacetate",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O.C(=N)(N)N,,,,,,
4230,154231,N-Phenyl-N-(p-carboxyphenyl)urea,C1=CC=C(C=C1)N(C2=CC=C(C=C2)C(=O)O)C(=O)N,,,,,,
4231,154232,"1-Butanone, 4-isothiocyanato-1-(3-pyridinyl)-",C1=CC(=CN=C1)C(=O)CCCN=C=S,,,,,,
4232,154233,N-[2-(Dimethylamino)ethyl]-2-phenyl-1H-benzimidazole-4-carboxamide,CN(C)CCNC(=O)C1=C2C(=CC=C1)NC(=N2)C3=CC=CC=C3,,,,,,
4233,154234,Peramivir,CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C,['Indicated for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.'],,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
4234,154235,"Benzamide, N-(acetyloxy)-N-ethoxy-",CCON(C(=O)C1=CC=CC=C1)OC(=O)C,,,,,,
4235,154236,4-Benzamidooxybutyl acetate,CC(=O)OCCCCONC(=O)C1=CC=CC=C1,,,,,,
4236,154237,8-Benzamidooxyoctyl acetate,CC(=O)OCCCCCCCCONC(=O)C1=CC=CC=C1,,,,,,
4237,154238,N-Acetoxy-N-benzyloxybenzamide,CC(=O)ON(C(=O)C1=CC=CC=C1)OCC2=CC=CC=C2,,,,,,
4238,154239,6-Fluoro-5-nitroquinoline,C1=CC2=C(C=CC(=C2[N+](=O)[O-])F)N=C1,,,,,,
4239,154240,"2-(4-Methylphenyl)-5-(2-nitrophenyl)penta-2,4-dienenitrile",CC1=CC=C(C=C1)C(=CC=CC2=CC=CC=C2[N+](=O)[O-])C#N,,,,,,
4240,154241,"2-(4-Bromophenyl)-5-(2-methoxyphenyl)penta-2,4-dienenitrile",COC1=CC=CC=C1C=CC=C(C#N)C2=CC=C(C=C2)Br,,,,,,
4241,154242,"Quinoline, 3-fluoro-5-nitro-, 1-oxide",C1=CC2=C(C=C(C=[N+]2[O-])F)C(=C1)[N+](=O)[O-],,,,,,
4242,154243,CID 154243,C1=CC=C(C=C1)C=CC=C(C#N)C2=CC=CC=C2Cl,,,,,,
4243,154244,"2-(4-Fluorophenyl)-5-phenylpenta-2,4-dienenitrile",C1=CC=C(C=C1)C=CC=C(C#N)C2=CC=C(C=C2)F,,,,,,
4244,154245,"Quinoline, 6-fluoro-5-nitro-, 1-oxide",C1=CC2=C(C=CC(=C2[N+](=O)[O-])F)[N+](=C1)[O-],,,,,,
4245,154246,"2-(4-Bromophenyl)-5-(2-nitrophenyl)penta-2,4-dienenitrile",C1=CC=C(C(=C1)C=CC=C(C#N)C2=CC=C(C=C2)Br)[N+](=O)[O-],,,,,,
4246,154247,"Quinolinium, 1-methyl-5-nitro-, methanesulfonate",C[N+]1=CC=CC2=C1C=CC=C2[N+](=O)[O-].CS(=O)(=O)[O-],,,,,,
4247,154248,1-Methyl-5-nitroquinolinium,C[N+]1=CC=CC2=C1C=CC=C2[N+](=O)[O-],,,,,,
4248,154249,8-Bromomethylfluoranthene,C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C(C=C4)CBr,,,,,,
4249,154250,3-Fluoro-8-nitroquinoline,C1=CC2=CC(=CN=C2C(=C1)[N+](=O)[O-])F,,,,,,
4250,154251,CID 154251,CCC=CC=CC=CC=CC=CC=COCC(CO)O,,,,,,
4251,154252,7-Fluoro-8-nitroquinoline,C1=CC2=C(C(=C(C=C2)F)[N+](=O)[O-])N=C1,,,,,,
4252,154253,CID 154253,CCC(C=CC=CC=CC=CC=O)O,,,,,,
4253,154254,CID 154254,CCOC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N(CCO)CCO)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4254,154255,CID 154255,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4255,154256,Bazedoxifene acetate,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O,['Conbriza is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established.'],,"['A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)', 'Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)']",,,
4256,154257,Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,['Indicated for following conditions alone or in combination with conjugated estrogens in women with a uterus:  - Treatment of moderate to severe vasomotor symptoms associated with menopause  - Prevention of postmenopausal osteoporosis'],,"['A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)', 'Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)']","['Bazedoxifene is rapidly absorbed with a tmax of approximately 2 hours and exhibits a linear increase in plasma concentrations for single doses from 0.5 mg up to 120 mg and multiple daily doses from 1 mg to 80 mg. The absolute bioavailability of bazedoxifene is approximately 6%.', 'The major route of elimination of radio-labelled bazedoxifene is the faeces, and less than 1% of the dose is eliminated in urine.', 'Following intravenous administration of a 3 mg dose of bazedoxifene, the volume of distribution is 14.7 ± 3.9 l/kg.', 'The apparent oral clearance of bazedoxifene is approximately 4 to 5 l/h/kg.']","[""Glucuronidation is the major metabolic pathway.  After peroral application, bazedoxifene is metabolized by UDP-glucuronosyltransferases (UGTs) to bazedoxifene-4'-glucuronide (M4) and bazedoxifene-5-glucuronide (M5).Little or no cytochrome P450-mediated metabolism is evident. The concentrations of this glucuronide are approximately 10-fold higher than those of unchanged active substance in plasma.""]",['~30 hours.']
4257,154258,8-Fluoro-5-nitroquinoline 1-oxide,C1=CC2=C(C=CC(=C2[N+](=C1)[O-])F)[N+](=O)[O-],,,,,,
4258,154259,CID 154259,CC(=O)NC1=CC(=C(C=C1N2N=C3C=C(C=C(C3=[N+]2[O-])Br)N(O)O)OC)N(CCOC)CCOC,,,,,,
4259,154260,"Acetamide, N-(2-(5-amino-2H-benzotriazol-2-yl)-5-(bis(2-methoxyethyl)amino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N2N=C3C=CC(=CC3=N2)N)OC)N(CCOC)CCOC,,,,,,
4260,154261,"Acetamide, N-(2-(5-amino-4-chloro-2H-benzotriazol-2-yl)-5-(bis(2-methoxyethyl)amino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N2N=C3C=CC(=C(C3=N2)Cl)N)OC)N(CCOC)CCOC,,,,,,
4261,154262,"1,4,5-Trichloronaphthalene",C1=CC2=C(C=CC(=C2C(=C1)Cl)Cl)Cl,,,,,,
4262,154263,2-Ethyl-4-pentynoic acid,CCC(CC#C)C(=O)O,,,,,,
4263,154264,"1,2-Ethanediamine, N,N-dimethyl-N'-((4-(6-(4-methylphenyl)-2-pyridinyl)phenyl)methyl)-, dihydrobromide, monohydrate",CC1=CC=C(C=C1)C2=NC(=CC=C2)C3=CC=C(C=C3)CNCCN(C)C.O.Br.Br,,,,,,
4264,154265,"1,2-Ethanediamine, N,N-dimethyl-N'-((4-(6-(4-methylphenyl)-2-pyridinyl)phenyl)methyl)-",CC1=CC=C(C=C1)C2=NC(=CC=C2)C3=CC=C(C=C3)CNCCN(C)C,,,,,,
4265,154266,"4-Piperidinecarbonitrile, 3-methyl-1-((4-methylphenyl)sulfonyl)-4-phenyl-, (3R,4S)-rel-",C[C@H]1CN(CC[C@@]1(C#N)C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)C,,,,,,
4266,154267,Laureth-7 carboxylic acid,CCCCCCCCCCCCOCCOCC(=O)O,,,,,,
4267,154268,"2-(2,4-Di-tert-butylphenoxy)ethanol",CC(C)(C)C1=CC(=C(C=C1)OCCO)C(C)(C)C,,,,,,
4268,154269,Terephthalate,C1=CC(=CC=C1C(=O)[O-])C(=O)[O-],,,"['Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)']",,,
4269,154270,"Bis((1,2,4,5-eta)-1,5-diphenyl-1,4-pentadien-3-one)palladium",C1=CC=C(C=C1)C=CC(=O)C=CC2=CC=CC=C2.C1=CC=C(C=C1)C=CC(=O)C=CC2=CC=CC=C2.[Pd],,,,,,
4270,154271,7-Phenylheptan-1-ol,C1=CC=C(C=C1)CCCCCCCO,,,,,,
4271,154272,10-Deacetylbaccatin III,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O,,,,,,
4272,154273,6-Fluoro-8-nitroquinoline,C1=CC2=CC(=CC(=C2N=C1)[N+](=O)[O-])F,,,,,,
4273,154274,Estradiol hemihydrate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O.O,,,"['Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)']",,,
4274,154275,CID 154275,CCOC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4275,154276,CID 154276,CCCOC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4276,154277,CID 154277,CCCCOC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4277,154278,CID 154278,C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])OCCO.[Na+],,,,,,
4278,154279,Alpinetin,COC1=CC(=CC2=C1C(=O)C[C@H](O2)C3=CC=CC=C3)O,,,,,,
4279,154280,CID 154280,CCN(CC)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])OC.[Na+],,,,,,
4280,154281,CID 154281,CCN(CC)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])OCC.[Na+],,,,,,
4281,154282,"2,2',4,4',5,6'-Hexabromobiphenyl",C1=C(C=C(C(=C1Br)C2=CC(=C(C=C2Br)Br)Br)Br)Br,,,,,,
4282,154283,CID 154283,CCCOC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N(CC)CC)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4283,154284,CID 154284,CCCCOC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N(CC)CC)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4284,154285,CID 154285,CCN(CC)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])OCCO.[Na+],,,,,,
4285,154286,CID 154286,COC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N(CCO)CCO)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4286,154287,CID 154287,CCCOC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N(CCO)CCO)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-].[Na+],,,,,,
4287,154288,"Bis(2-bromoethyl) 2,3-dihydroxybutanedioate",C(CBr)OC(=O)C(C(C(=O)OCCBr)O)O,,,,,,
4288,154289,"Malic acid, bis(2-bromoethyl) ester",C(CBr)OC(=O)CC(C(=O)OCCBr)O,,,,,,
4289,154290,"Citric acid, tris(2-bromoethyl) ester",C(CBr)OC(=O)CC(CC(=O)OCCBr)(C(=O)OCCBr)O,,,,,,
4290,154291,"2,6-Bis(4-bromophenyl)-4-methyl-5-phenylhept-2-enedinitrile",CC(C=C(C#N)C1=CC=C(C=C1)Br)C(C2=CC=CC=C2)C(C#N)C3=CC=C(C=C3)Br,,,,,,
4291,154292,"2,6-Bis(3,4-dichlorophenyl)-4-methyl-5-phenyl-2-heptenedinitrile",CC(C=C(C#N)C1=CC(=C(C=C1)Cl)Cl)C(C2=CC=CC=C2)C(C#N)C3=CC(=C(C=C3)Cl)Cl,,,,,,
4292,154293,"2,6-Bis(4-fluorophenyl)-4-methyl-5-phenylhept-2-enedinitrile",CC(C=C(C#N)C1=CC=C(C=C1)F)C(C2=CC=CC=C2)C(C#N)C3=CC=C(C=C3)F,,,,,,
4293,154294,CID 154294,C[N+]1=C(N(C=C1)CCOCC#C)C=NO.[Cl-],,,,,,
4294,154295,CID 154295,C[N+]1=C(N(C=C1)CCOCC#C)C=NO,,,,,,
4295,154296,"Thiazolium, 2,4-dimethyl-3-(2-methyl-6-benzothiazolyl)-, perchlorate",CC1=CSC(=[N+]1C2=CC3=C(C=C2)N=C(S3)C)C.[O-]Cl(=O)(=O)=O,,,,,,
4296,154297,"6-(2,4-Dimethyl-1,3-thiazol-3-ium-3-yl)-2-methyl-1,3-benzothiazole",CC1=CSC(=[N+]1C2=CC3=C(C=C2)N=C(S3)C)C,,,,,,
4297,154298,"1,1'-Biphenyl, 2,3,4,5,6-pentabromo-",C1=CC=C(C=C1)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br,,,,,,
4298,154299,Oxolan-2-yl 2-methylprop-2-enoate,CC(=C)C(=O)OC1CCCO1,,,,,,
4299,154300,"Dibenzo(c,f)(2,7)naphthyridine, 2,3,10,11-tetramethoxy-",COC1=C(C=C2C(=C1)C3=C(C=N2)C=NC4=CC(=C(C=C43)OC)OC)OC,,,,,,
4300,154301,CID 154301,CC1=C2C(=C3C=CC=CC3=NC2=O)C4=CC=CC=C4N1,,,,,,
4301,154302,"2,3'-Dibromobiphenyl",C1=CC=C(C(=C1)C2=CC(=CC=C2)Br)Br,,,,,,
4302,154303,"2,4'-Dibromobiphenyl",C1=CC=C(C(=C1)C2=CC=C(C=C2)Br)Br,,,,,,
4303,154304,CID 154304,C([C@@H](C(=O)O)N)SCC(=O)[O-].[Na+],,,,,,
4304,154305,Diethyl malonyldicarbamate,CCOC(=O)NC(=O)CC(=O)NC(=O)OCC,,,,,,
4305,154306,"6H-Quino(2,3,4-kl)acridine, 7,8-dihydro-",C1CC2=NC3=CC=CC=C3C4=C2C(=NC5=CC=CC=C54)C1,,,,,,
4306,154307,CID 154307,CC(=O)[C@H]1CCC2[C@@]1(CCC3C2CCC4=CC(=NOCC(=O)O)CC[C@]34C)C,,,,,,
4307,154308,"2a,7b-Dihydro-7b-methoxy-2a-methyl-1,2-dioxeto (3,4-b)benzofuran",CC12C(C3=CC=CC=C3O1)(OO2)OC,,,,,,
4308,154309,"2a,7b-Dihydro-7b-methyl-1,2-dioxeto(3,4-b)benzofuran",CC12C(OC3=CC=CC=C31)OO2,,,,,,
4309,154310,"4-Acetyl-2a,7b-dihydro-2a,7b-dimethyl-1,2-dioxeto(3,4-b)benzofuran",CC(=O)C1=C2C(=CC=C1)C3(C(O2)(OO3)C)C,,,,,,
4310,154311,"2a,7b-Dihydro-7-methoxy-2a,7b-dimethyl-1,2-dioxeto(3,4-b)benzofuran",CC12C3=C(C=CC=C3OC)OC1(OO2)C,,,,,,
4311,154312,Anitop,CC1=C(C=CC(=C1)Cl)OCC(=O)O.CC(C(=O)O)OC1=C(C=C(C=C1)Cl)Cl.C1=C(C=C(C(=C1Br)O)Br)C#N.C1=C(C=C(C(=C1I)O)I)C#N,,,,,,
4312,154313,"2a,7b-Dihydro-4-methoxy-2a,7b-dimethyl-1,2-dioxeto(3,4-b)benzofuran",CC12C3=C(C(=CC=C3)OC)OC1(OO2)C,,,,,,
4313,154314,"5-(Acetyloxy)-2a,7b-dihydro-2a,7b-dimethyl-1,2-dioxeto(3,4-b)benzofuran",CC(=O)OC1=CC2=C(C=C1)C3(C(O2)(OO3)C)C,,,,,,
4314,154315,"Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bS)-",CN1CCN2[C@H](C1)C3=CC=CC=C3CC4=CC=CC=C42,,,,,"['(S)-mianserin has known human metabolites that include (S)-mianserin, 8-hydroxy, (S)-mianserin, N-Desmethyl, and (S)-mianserin, N-oxide.']",
4315,154316,"6-(Acetyloxy)-2a,7b-dihydro-2a,7b-dimethyl-1,2-dioxeto(3,4-b)benzofuran",CC(=O)OC1=CC2=C(C=C1)OC3(C2(OO3)C)C,,,,,,
4316,154317,"2a,7b-Dihydro-2a-(hydroxymethyl)-7b-methyl-1,2-dioxeto(3,4-b)benzofuran",CC12C3=CC=CC=C3OC1(OO2)CO,,,,,,
4317,154318,"2a,7b-Dihydro-2a,7b-bis(hydroxymethyl)-1,2-dioxeto(3,4-b)benzofuran",C1=CC=C2C(=C1)C3(C(O2)(OO3)CO)CO,,,,,,
4318,154319,"2a,7b-Dihydro-2a-(methoxymethyl)-7b-methyl-1,2-dioxeto(3,4-b)benzofuran",CC12C3=CC=CC=C3OC1(OO2)COC,,,,,,
4319,154320,"2a-(Acetyloxymethyl)-2a,7b-dihydro-7b-methyl-1,2-dioxeto(3,4-b)benzofuran",CC(=O)OCC12C(C3=CC=CC=C3O1)(OO2)C,,,,,,
4320,154321,"2a-(4-Chlorophenylcarbamoyloxymethyl)-2a,7b-dihydro-7b-methyl-1,2-dioxeto(3,4-b)benzofuran",CC12C3=CC=CC=C3OC1(OO2)COC(=O)NC4=CC=C(C=C4)Cl,,,,,,
4321,154322,CID 154322,C[N+]1=C(N(C=C1)CCN(C)C)C=NO.Cl.[Cl-],,,,,,
4322,154323,CID 154323,C[N+]1=C(N(C=C1)CCN(C)C)C=NO,,,,,,
4323,154324,Ccris 3554,CCN(C)C(=O)OC1=CC2=C(C=C1)N(C3C2(CCN3C)C)C.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
4324,154325,"(3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl) N-ethyl-N-methylcarbamate",CCN(C)C(=O)OC1=CC2=C(C=C1)N(C3C2(CCN3C)C)C,,,,,,
4325,154326,1-[3-[2-(Hydroxyiminomethyl)-3-methylimidazol-3-ium-1-yl]propyl]pyridin-1-ium-4-carboxamide;dichloride,C[N+]1=C(N(C=C1)CCC[N+]2=CC=C(C=C2)C(=O)N)C=NO.[Cl-].[Cl-],,,,,,
4326,154327,1-[3-[2-(Hydroxyiminomethyl)-3-methylimidazol-3-ium-1-yl]propyl]pyridin-1-ium-4-carboxamide,C[N+]1=C(N(C=C1)CCC[N+]2=CC=C(C=C2)C(=O)N)C=NO,,,,,,
4327,154328,CID 154328,CCC(CCOCN1C=C[N+](=C1C=NO)C)[N+](=O)[O-].[Cl-],,,,,,
4328,154329,CID 154329,CCC(CCOCN1C=C[N+](=C1C=NO)C)[N+](=O)[O-],,,,,,
4329,154330,6-Azabenzo(a)pyrene N-oxide,C1=CC=C2C(=C1)C3=C4C(=[N+]2[O-])C=CC5=CC=CC(=C54)C=C3,,,,,,
4330,154331,"2a,9b-Dihydro-2a,8,9b-trimethyl-6H-(1,2)dioxeto(3',4':4,5)furo(3,2-g)(1)benzopyran-6-one",CC1=CC(=O)OC2=CC3=C(C=C12)C4(C(O3)(OO4)C)C,,,,,,
4331,154332,Ccris 4165,CC1=CC(=O)OC2=C1C3=C(C=C2)OC4(C3(OO4)C)C,,,,,,
4332,154333,"7a,9a-Dihydro-7a,9a-dimethyl(1,2)dioxeto(3,4-b)naphtho(1,2-d)furan",CC12C3=C(C=CC4=CC=CC=C43)OC1(OO2)C,,,,,,
4333,154334,"6b,8a-Dihydro-6b,8a-dimethyl(1,2)dioxeto(3',4':4,5)furo(3,2-h)quinoline",CC12C3=C(C4=C(C=CC=N4)C=C3)OC1(OO2)C,,,,,,
4334,154335,Dimethyl-alpha-cyclodextrin,COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)OC)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)OC)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)OC)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)OC)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)OC)COC)COC)COC)COC)COC)OC)O,,,,,,
4335,154336,"6b,8a-Dihydro-4,6b,8a-trimethyl-2H-(1,2)dioxeto(3',4':4,5)furo(3,2-h)-1-benzopyran-2-one",CC1=CC(=O)OC2=C1C=CC3=C2OC4(C3(OO4)C)C,,,,,,
4336,154337,"cis-(+)-3'-Acetyl-3'-methylspiro(naphthalene-2(1H),2'-oxiran)-1-one",CC(=O)[C@]1([C@@]2(O1)C=CC3=CC=CC=C3C2=O)C,,,,,,
4337,154338,"cis-(+)-3'-Acetyl-3'-methylspiro(naphthalene-1(2H),2'-oxiran)-2-one",CC(=O)[C@@]1([C@]2(O1)C(=O)C=CC3=CC=CC=C23)C,,,,,,
4338,154339,"Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(ethylamino)-1,1-dimethyl-2-butynyl ester, hydrochloride",CCNCC#CC(C)(C)OC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,,,,,,
4339,154340,RCC-36 free base,CCNCC#CC(C)(C)OC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,,,,,['N-deethylated  ac1mip3e is a known human metabolite of ac1mip3e.'],
4340,154341,"Adenosine, N-(2-hydroxy-3-(1-naphthalenyloxy)propyl)-, (S)-",C1=CC=C2C(=C1)C=CC=C2OC[C@H](CNC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
4341,154342,p-Toluate,CC1=CC=C(C=C1)C(=O)[O-],,,,,,
4342,154343,9-Sulfooxymethyl-10-methylanthracene,CC1=C2C=CC=CC2=C(C3=CC=CC=C13)COS(=O)(=O)O,,,,,,
4343,154344,"1,2,6-Trichloronaphthalene",C1=CC2=C(C=CC(=C2Cl)Cl)C=C1Cl,,,,,,
4344,154345,CID 154345,C[N+]1=C(N(C=C1)CCCN(C)C)C=NO.[Cl-].[Cl-],,,,,,
4345,154346,CID 154346,C[N+]1=C(N(C=C1)CCCN(C)C)C=NO,,,,,,
4346,154347,CID 154347,C[N+]1=C(N(C=C1)CCS(=O)(=O)C)C=NO.[Cl-],,,,,,
4347,154348,CID 154348,C[N+]1=C(N(C=C1)CCS(=O)(=O)C)C=NO,,,,,,
4348,154349,(R)-2-Bromo-N-benzylpropanamide,C[C@H](C(=O)NCC1=CC=CC=C1)Br,,,,,,
4349,154350,"4-((2-Hydroxyethyl)dimethylammonio)-2,2,6,6-tetramethyl-1-piperidinyloxy iodide",CC1(CC(CC(N1O)(C)C)[N+](C)(C)CCO)C.[I-],,,,,,
4350,154351,TEMPO choline,CC1(CC(CC(N1O)(C)C)[N+](C)(C)CCO)C,,,,,,
4351,154352,(S)-2-Bromo-N-benzylpropanamide,C[C@@H](C(=O)NCC1=CC=CC=C1)Br,,,,,,
4352,154353,N-[[1-(2-prop-2-ynoxyethyl)pyridin-1-ium-2-yl]methylidene]hydroxylamine;chloride,C#CCOCC[N+]1=CC=CC=C1C=NO.[Cl-],,,,,,
4353,154354,N-[[1-(2-prop-2-ynoxyethyl)pyridin-1-ium-2-yl]methylidene]hydroxylamine,C#CCOCC[N+]1=CC=CC=C1C=NO,,,,,,
4354,154355,"4-Phenanthridinecarboxamide, N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC=CC2=C1N=CC3=CC=CC=C23,,,,,,
4355,154356,Dictamnic acid,COC1=C(C(=O)NC2=CC=CC=C21)C(=O)O,,,,,,
4356,154357,N-(2-(Dimethylamino)ethyl)benzo(f)quinoline-5-carboxamide,CN(C)CCNC(=O)C1=CC2=CC=CC=C2C3=C1N=CC=C3,,,,,,
4357,154358,"N-(2-(Dimethylamino)ethyl)-1,10-phenanthroline-2-carboxamide",CN(C)CCNC(=O)C1=NC2=C(C=CC3=C2N=CC=C3)C=C1,,,,,,
4358,154359,CID 154359,CC(=CCOC(=O)C)CC[C@H]1C(=C)CC[C@H]2[C@]1(CCC[C@@H]2C(=O)OC)C,,,,,,
4359,154360,N-(2-(Dimethylamino)ethyl)-2-phenyl-7-benzoxazolecarboxamide,CN(C)CCNC(=O)C1=C2C(=CC=C1)N=C(O2)C3=CC=CC=C3,,,,,,
4360,154361,N-(2-(Dimethylamino)ethyl)-2-phenyl-4-benzoxazolecarboxamide,CN(C)CCNC(=O)C1=C2C(=CC=C1)OC(=N2)C3=CC=CC=C3,,,,,,
4361,154362,"N-(2-(Dimethylamino)ethyl)-2-phenylimidazo(1,2-a)pyridine-8-carboxamide",CN(C)CCNC(=O)C1=CC=CN2C1=NC(=C2)C3=CC=CC=C3,,,,,,
4362,154363,N-(2-(Dimethylamino)ethyl)-2-phenyl-7-benzofurancarboxamide,CN(C)CCNC(=O)C1=CC=CC2=C1OC(=C2)C3=CC=CC=C3,,,,,,
4363,154364,"furo[2,3-b]quinolin-4(9H)-one",C1=CC=C2C(=C1)C(=O)C3=C(N2)OC=C3,,,,,,
4364,154365,3-[4-Hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid,CC(=CCC1=C(C=CC(=C1)C=CC(=O)O)O)C,,,,,,
4365,154366,"Benzoic acid, 2-(acetyloxy)-, mixt. with aluminum hydroxide (Al(OH)3), 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, N-(4-hydroxyphenyl)acetamide and magnesium hydroxide (Mg(OH)2)",CC(=O)NC1=CC=C(C=C1)O.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C.[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3],,,,,,
4366,154367,"1,1'-Biphenyl, 2,2',3,3',5,5'-hexabromo-",C1=C(C=C(C(=C1C2=C(C(=CC(=C2)Br)Br)Br)Br)Br)Br,,,,,,
4367,154368,"1-(2,6-Dimethylphenoxy)-N-hydroxy-2-propanamine",CC1=C(C(=CC=C1)C)OCC(C)NO,,,,,"['N-hydroxy-mexiletine has known human metabolites that include (2S,3S,4S,5R)-6-[1-(2,6-dimethylphenoxy)propan-2-ylamino]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.']",
4368,154369,"1,2,5-Trichloronaphthalene",C1=CC2=C(C=CC(=C2Cl)Cl)C(=C1)Cl,,,,,,
4369,154370,"1,2,7-Trichloronaphthalene",C1=CC(=CC2=C1C=CC(=C2Cl)Cl)Cl,,,,,,
4370,154371,"1,2,8-Trichloronaphthalene",C1=CC2=C(C(=C1)Cl)C(=C(C=C2)Cl)Cl,,,,,,
4371,154372,"1,6,7-Trichloronaphthalene",C1=CC2=CC(=C(C=C2C(=C1)Cl)Cl)Cl,,,,,,
4372,154373,Eucommiol,C1[C@H]([C@@H](C(=C1CO)CO)CCO)O,,,,,,
4373,154374,"Gallium-68(3+);2-hydroxypropane-1,2,3-tricarboxylic acid",C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[68Ga+3],,,,,,
4374,154375,3-Cyclopropylprop-2-enoic acid,C1CC1C=CC(=O)O,,,,,,
4375,154376,"3,4'-Dibromobiphenyl",C1=CC(=CC(=C1)Br)C2=CC=C(C=C2)Br,,,,,,
4376,154377,"2-Methyl-3-oxo-2-phenyl-2,3-dihydro-1H-indol-1-yloxy",CC1(C(=O)C2=CC=CC=C2N1[O])C3=CC=CC=C3,,,,,,
4377,154378,"1H-Indol-1-yloxy, 2-ethyl-2,3-dihydro-3-oxo-2-phenyl-",CCC1(C(=O)C2=CC=CC=C2N1[O])C3=CC=CC=C3,,,,,,
4378,154379,"4-(1-Cyanoethyl)-1,2,3,4-tetrahydronaphthalene-1-carbonitrile",CC(C#N)C1CCC(C2=CC=CC=C12)C#N,,,,,,
4379,154380,"4-Cyano-1,2,3,4-tetrahydro-1-naphthaleneacetonitrile",C1CC(C2=CC=CC=C2C1CCC#N)C#N,,,,,,
4380,154381,"3-Pentenoic acid, 2-methyl-, hexyl ester",CCCCCCOC(=O)C(C)C=CC,,,,,,
4381,154382,"2,3,5,6,2',3',5',6'-Octabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)C2=C(C(=CC(=C2Br)Br)Br)Br)Br)Br,,,,,,
4382,154383,"1,1'-Biphenyl, 3,4,4',5-tetrabromo-",C1=CC(=CC=C1C2=CC(=C(C(=C2)Br)Br)Br)Br,,,,,,
4383,154384,"1,1':2',1''-Terphenyl, 2,5-dichloro-",C1=CC=C(C=C1)C2=CC=CC=C2C3=C(C=CC(=C3)Cl)Cl,,,,,,
4384,154385,Telluric acid (H2(127Te)O3),O[127Te](=O)O,,,,,,
4385,154386,"4-(2-Bromo-1,2-diphenylethenyl)phenol",C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Br)C3=CC=C(C=C3)O,,,,,,
4386,154387,Procaine dihydrate,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.O.O,,,,,,
4387,154388,"2,4,4',6-Tetrabromobiphenyl",C1=CC(=CC=C1C2=C(C=C(C=C2Br)Br)Br)Br,,,,,,
4388,154389,"2,4',6-Tribromobiphenyl",C1=CC(=C(C(=C1)Br)C2=CC=C(C=C2)Br)Br,,,,,,
4389,154390,"1,1'-Biphenyl, 2,4,4'-tribromo-",C1=CC(=CC=C1C2=C(C=C(C=C2)Br)Br)Br,,,,,,
4390,154391,"2,3-Di(docosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
4391,154392,"1,2-Didocosanoyl-sn-glycero-3-phosphocholine, >=99% (TLC)",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
4392,154393,CID 154393,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,,,,,,
4393,154394,Acetyltetragastrin,CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,,,,,,
4394,154395,"o,o'-DDT",C1=CC=C(C(=C1)C(C2=CC=CC=C2Cl)C(Cl)(Cl)Cl)Cl,,,,,,
4395,154396,"1,1-Dimethylpropyl 3,5,5-trimethylperoxyhexanoate",CCC(C)(C)OOC(=O)CC(C)CC(C)(C)C,,,,,,
4396,154397,"2,2',3,3',4,4',5,5',6-Nonabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)Br)Br)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br,,,,,,
4397,154398,"2,6,11,15-Tetraazahexadecanediimidamide",C(CCNCCCN=C(N)N)CNCCCN=C(N)N,,,,,,
4398,154399,"Erythromycin, 4-O-alpha-D-glucopyranosyl-D-gluconate (salt)",CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@](C([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)O)O)O)O)O)O)O,,,,,,
4399,154400,CID 154400,C(C1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)O)O)O)O)O)O)O,,,,,,
4400,154401,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@](C([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,,,,,,
4401,154402,"2,2',3,3',4,5,5',6'-Octabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)Br)Br)C2=C(C(=CC(=C2Br)Br)Br)Br,,,,,,
4402,154403,4-Fluoro-N-isopropylaniline,CC(C)NC1=CC=C(C=C1)F,,,,,,
4403,154404,"1-Naphthalenepentanoic acid, decahydro-3-hydroxy-beta,5,5,8a-tetramethyl-2-methylene-, (betaR,1S,3S,4aR,8aR)-",C[C@H](CC[C@@H]1C(=C)[C@H](C[C@H]2[C@]1(CCCC2(C)C)C)O)CC(=O)O,,,,,,
4404,154405,"2,3',4,4',5'-Pentabromobiphenyl",C1=CC(=C(C=C1Br)Br)C2=CC(=C(C(=C2)Br)Br)Br,,,,,,
4405,154406,1-(4-Aminophenyl)-4-(4-methoxyphenyl)piperazine,COC1=CC=C(C=C1)N2CCN(CC2)C3=CC=C(C=C3)N,,,,,,
4406,154407,"Phenol, 2-methoxy-6-(2-methoxy-4-(2-propenyl)phenoxy)-4-(2-propenyl)-",COC1=C(C=CC(=C1)CC=C)OC2=CC(=CC(=C2O)OC)CC=C,,,,,,
4407,154408,4-(Dichloroacetyl)-1-piperazinecarboxaldehyde,C1CN(CCN1C=O)C(=O)C(Cl)Cl,,,,,,
4408,154409,"1,1'-Biphenyl, 2,2',3,4,6-pentabromo-",C1=CC=C(C(=C1)C2=C(C(=C(C=C2Br)Br)Br)Br)Br,,,,,,
4409,154410,"Phosphoric acid, mono(2,4-dichlorophenyl) monoethyl ester",CCOP(=O)(O)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
4410,154411,3-(Methoxymethyl)-1H-indole,COCC1=CNC2=CC=CC=C21,,,,,,
4411,154412,"Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)-",CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C42,,,,,"['(R)-mianserin has known human metabolites that include (R)-mianserin, 8-hydroxy, (R)-mianserin, N-oxide, and N-Desmethylmianserin.']",
4412,154413,Centchroman,CC1([C@@H]([C@H](C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C,,,"['Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)', 'Postcoital contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Postcoital, Synthetic.)']",,,
4413,154414,3-Chloro-4-(bromochloromethyl)-5-hydroxy-2(5H)-furanone,C1(C(=C(C(=O)O1)Cl)C(Cl)Br)O,,,,,,
4414,154415,3-Chloro-4-(dibromomethyl)-5-hydroxy-2(5H)-furanone,C1(C(=C(C(=O)O1)Cl)C(Br)Br)O,,,,,,
4415,154416,"5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione;[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate;(9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate;sulfuric acid;hydrobromide",CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2.CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3.CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3.CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.OS(=O)(=O)O.OS(=O)(=O)O.Br,,,,,,
4416,154417,L-Hyoscyamine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3,"['As a drug that is not FDA approved, hyscyamine has no official indications. Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic. Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation. Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.']","['Hyoscyamine is not FDA approved, and so it has not official indications. However, it is used as an antimuscarinic agent in a number of treatments and therapies. Hyoscyamine has a short duration of action as it may need to be given multiple times per day. Patients should be counselled regarding the risks and signs of anticholinergic toxicity.']","['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)', 'Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)', 'Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)', 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)', 'Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)']","['Hyoscyamine is completely absorbed by sublingual and oral routes, though exact data regarding the C<sub>max</sub>, T<sub>max</sub>, and AUC are not readily available.', 'The majority of hyoscyamine is eliminated in the urine as the unmetabolized parent compound.']","['Hyoscyamine is largely unmetabolized, however a small amount is hydrolyzed into tropine and tropic acid.', 'LIVER HOMOGENATES OF RABBITS CONTAINING (-)-HYOSCYAMINE ACYLHYDROLASE HYDROLYZED (-)-HYOSCYAMINE TO TROPINE AND(-)-TROPIC ACID BUT DID NOT CLEAVE (+)-HYOSCYAMINE.']",['The half life of hyoscyamine is 3.5 hours.']
4417,154418,3-Bromo-4-(dibromomethyl)-5-hydroxy-2(5H)-furanone,C1(C(=C(C(=O)O1)Br)C(Br)Br)O,,,,,,
4418,154419,"Benz(3,4)anthra(2,1-b)oxepin",C1=CC=C2C=C3C4=CC=CC=C4C5=C(C3=CC2=C1)C=CC=CO5,,,,,,
4419,154420,"Dibenz(a,c)anthracene-1,2-diol",C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC=C4C5=C3C(=C(C=C5)O)O,,,,,,
4420,154421,"Dibenz(a,c)anthracene-3,4-diol",C1=CC=C2C=C3C4=CC=CC=C4C5=C(C3=CC2=C1)C=CC(=C5O)O,,,,,,
4421,154422,o-Nitrobenzyl propionate,CCC(=O)OCC1=CC=CC=C1[N+](=O)[O-],,,,,,
4422,154423,"3-Nitro-9,10-dihydrobenzo(a)pyrene",C1CC2=C(C=C1)C=C3C=CC4=C(C=CC5=C4C3=C2C=C5)[N+](=O)[O-],,,,,,
4423,154424,"6-Nitro-9,10-dihydrobenzo(a)pyrene",C1CC2=C3C=CC4=C5C3=C(C=CC5=CC=C4)C(=C2C=C1)[N+](=O)[O-],,,,,,
4424,154425,"1-Nitro-7,8-dihydrobenzo(a)pyrene",C1CC2=C(C=C1)C3=C4C(=C2)C=CC5=C4C(=C(C=C5)[N+](=O)[O-])C=C3,,,,,,
4425,154426,"3-Nitro-7,8-dihydrobenzo(a)pyrene",C1CC2=C(C=C1)C3=C4C(=C2)C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],,,,,,
4426,154427,"6-Nitro-7,8-dihydrobenzo(a)pyrene",C1CC2=C(C3=C4C(=C2C=C1)C=CC5=C4C(=CC=C5)C=C3)[N+](=O)[O-],,,,,,
4427,154428,"5-Chrysenemethanol, 3-fluoro-",C1=CC=C2C3=C(C(=CC2=C1)CO)C4=C(C=CC(=C4)F)C=C3,,,,,,
4428,154429,"anti-Benzo(c)chrysene-9,10-diol-11,12-epoxide",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C5=C(C=C4)C(=C(C6=C5O6)O)O,,,,,,
4429,154430,"anti-Benzo(a)chrysene-11,12-diol-13,14-epoxide",C1=CC=C2C(=C1)C=CC3=C4C=CC5=C(C4=C6C(=C32)O6)C(=C(C=C5)O)O,,,,,,
4430,154431,"1-Nitro-9,10-dihydrobenzo(a)pyrene",C1CC2=C(C=C1)C=C3C=CC4=C5C3=C2C=CC5=C(C=C4)[N+](=O)[O-],,,,,,
4431,154432,"3beta-Bromo-6,6-(ethylenedisulfonyl)-5alpha-cholestane",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC4([C@@H]5[C@@]3(CC[C@@H](C5)Br)C)S(=O)(=O)CCS4(=O)=O)C,,,,,,
4432,154433,1-Hydroxymethylfluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=C(C=C4)CO,,,,,,
4433,154434,"9H-Carbazole, 1,4-dimethyl-3-nitro-",CC1=CC(=C(C2=C1NC3=CC=CC=C32)C)[N+](=O)[O-],,,,,,
4434,154435,"9H-Carbazole, 1,4-dimethyl-3,6-dinitro-",CC1=CC(=C(C2=C1NC3=C2C=C(C=C3)[N+](=O)[O-])C)[N+](=O)[O-],,,,,,
4435,154436,"1,4-Dimethyl-6-nitro-9H-carbazole",CC1=C2C3=C(C=CC(=C3)[N+](=O)[O-])NC2=C(C=C1)C,,,,,,
4436,154437,Watanidipine dihydrochloride,CC1=C(C(C(=C(N1)C)C(=O)OCCC2=CC=C(C=C2)N3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C6=CC(=CC=C6)[N+](=O)[O-])C(=O)OC.Cl.Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)']",,,
4437,154438,"1,2,2-Trichlorovinyl 2-nitrophenyl disulfide",C1=CC=C(C(=C1)[N+](=O)[O-])SSC(=C(Cl)Cl)Cl,,,,,,
4438,154439,"1-Fluoro-2,2-dichlorovinyl 2-nitrophenyl disulfide",C1=CC=C(C(=C1)[N+](=O)[O-])SSC(=C(Cl)Cl)F,,,,,,
4439,154440,CID 154440,C1=CC=C(C(=C1)[N+](=O)[O-])SSC(=C(C(F)(F)F)Cl)Cl,,,,,,
4440,154441,"Methyl 3,4-diphenyl-5-acetoxyamino-2-furoate",CC(=O)ONC1=C(C(=C(O1)C(=O)OC)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4441,154442,"Methyl 3,4-diphenyl-N-hydroxy-5-acetylamino-2-furoate",CC(=O)N(C1=C(C(=C(O1)C(=O)OC)C2=CC=CC=C2)C3=CC=CC=C3)O,,,,,,
4442,154443,"trans-3,4-Dihydroxy-3,4-dihydro-7-chlorobenz(a)anthracene",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2Cl)[C@@H]([C@H](C=C4)O)O,,,,,,
4443,154444,"Methyl 3,4-diphenyl-N-acetoxy-5-acetylamino-2-furoate",CC(=O)N(C1=C(C(=C(O1)C(=O)OC)C2=CC=CC=C2)C3=CC=CC=C3)OC(=O)C,,,,,,
4444,154445,CID 154445,C1=C(C(=N)C=C(C1=N)F)N(O)O,,,,,,
4445,154446,(R)-2-Azido-1-phenylethanol,C1=CC=C(C=C1)[C@H](CN=[N+]=[N-])O,,,,,,
4446,154447,2-Ethylhexyl 4-(dimethylamino)-3-nitrobenzoate,CCCCC(CC)COC(=O)C1=CC(=C(C=C1)N(C)C)[N+](=O)[O-],,,,,,
4447,154448,N-Nitrosoatenolol,CC(C)N(CC(COC1=CC=C(C=C1)CC(=O)N)O)N=O,,,,,,
4448,154449,N-Nitrosometoprolol,CC(C)N(CC(COC1=CC=C(C=C1)CCOC)O)N=O,,,,,,
4449,154450,N-Nitrosonadolol,CC(C)(C)N(CC(COC1=CC=CC2=C1CC(C(C2)O)O)O)N=O,,,,,,
4450,154451,N-Nitrososotalol,CC(C)N(CC(C1=CC=C(C=C1)NS(=O)(=O)C)O)N=O,,,,,,
4451,154452,"1,3-Dinitrobenzo(e)pyrene",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=C4)C(=CC(=C25)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4452,154453,"8-Quinolinecarboxylic acid, phenylmethyl ester",C1=CC=C(C=C1)COC(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
4453,154454,"8-Quinolinecarboxylic acid, (4-chlorophenyl)methyl ester",C1=CC2=C(C(=C1)C(=O)OCC3=CC=C(C=C3)Cl)N=CC=C2,,,,,,
4454,154455,6-(2-Ethyl-5-hydroxy-hexoxy)-6-oxo-hexanoic acid,CCC(CCC(C)O)COC(=O)CCCCC(=O)O,,,,,,
4455,154456,4-Nitrobenzo(e)pyrene,C1=CC=C2C(=C1)C3=C4C(=CC=C3)C(=CC5=C4C2=CC=C5)[N+](=O)[O-],,,,,,
4456,154457,"4-Nitro-9,10,11,12-tetrahydrobenzo(e)pyrene",C1CCC2=C(C1)C3=CC=CC4=CC(=C5C=CC=C2C5=C43)[N+](=O)[O-],,,,,,
4457,154458,"cis-3a,8a-Dihydro-4,6-dimethoxyfuro(2,3-b)benzofuran",COC1=CC2=C([C@H]3C=CO[C@H]3O2)C(=C1)OC,,,,,,
4458,154459,"Fluoranthene, 3-(bromomethyl)-",C1=CC=C2C(=C1)C3=C4C2=CC=CC4=C(C=C3)CBr,,,,,,
4459,154460,7-Hydroxymethylfluoranthene,C1=CC2=C3C(=C1)C4=CC=CC(=C4C3=CC=C2)CO,,,,,,
4460,154461,8-Fluoranthenemethanol,C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C(C=C4)CO,,,,,,
4461,154462,"5-Chrysenemethanol, 7-fluoro-",C1=CC=C2C(=C1)C=CC3=C2C(=CC4=C3C=CC=C4F)CO,,,,,,
4462,154463,1-Bromomethylfluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=C(C=C4)CBr,,,,,,
4463,154464,CID 154464,CC1=CC(=NN1C2=NNC(=C3C2=NC4=CC=CC=C43)NN)C.Cl,,,,,,
4464,154465,"1,1'-Biphenyl, 2,2',4,5,6'-pentabromo-",C1=CC(=C(C(=C1)Br)C2=CC(=C(C=C2Br)Br)Br)Br,,,,,,
4465,154466,"2-Azido-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N=[N+]=[N-],,,,,,
4466,154467,"(2R,11S,14S,15S,16S)-14-methylpentacyclo[13.2.2.01,14.02,11.05,10]nonadeca-5(10),6,8-triene-7,15,16-triol",C[C@]12CC[C@H]3[C@H](C14CC[C@]2([C@H](C4)O)O)CCC5=C3C=CC(=C5)O,,,,,,
4467,154468,CID 154468,C1=CC(=CC=C1N=C2C3=NC=NC3=NC=N2)N(O)O,,,,,,
4468,154469,"9H-Purin-6-amine, 2,9-bis(4-nitrophenyl)-",C1=CC(=CC=C1C2=NC(=C3C(=N2)N(C=N3)C4=CC=C(C=C4)[N+](=O)[O-])N)[N+](=O)[O-],,,,,,
4469,154470,"9H-Purin-6-amine, 8,9-bis(4-nitrophenyl)-",C1=CC(=CC=C1C2=NC3=C(N=CN=C3N2C4=CC=C(C=C4)[N+](=O)[O-])N)[N+](=O)[O-],,,,,,
4470,154471,"N,9-Bis(p-nitrophenyl)adenine",C1=CC(=CC=C1NC2=C3C(=NC=N2)N(C=N3)C4=CC=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4471,154472,Desbutal,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC.CC(CC1=CC=CC=C1)NC.Cl,,,,,,
4472,154473,"2,4-Diamino-6-nitrobiphenyl",C1=CC=C(C=C1)C2=C(C=C(C=C2[N+](=O)[O-])N)N,,,,,,
4473,154474,12beta-Hydroxy-3-oxo-5beta-cholan-24-oic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)O)C,,,,,,
4474,154475,"1,1'-Biphenyl, 2,3',4,5,5'-pentabromo-",C1=C(C=C(C=C1Br)Br)C2=CC(=C(C=C2Br)Br)Br,,,,,,
4475,154476,1-Methyltriazoline,CN1CCN=N1,,,,,,
4476,154477,"1,4-Dimethyl-6-acetyl-3-nitrocarbazole",CC1=CC(=C(C2=C1NC3=C2C=C(C=C3)C(=O)C)C)[N+](=O)[O-],,,,,,
4477,154478,"2,2',3,4,4',5-Hexabromobiphenyl",C1=CC(=C(C=C1Br)Br)C2=CC(=C(C(=C2Br)Br)Br)Br,,,,,,
4478,154479,"5-((2-(Dimethylamino)ethyl)amino)-8-hydroxy-1-methyl-6H-imidazo(4,5,1-de)acridin-6-one",CC1=NC2=C3N1C4=C(C=C(C=C4)O)C(=O)C3=C(C=C2)NCCN(C)C,,,,,,
4479,154480,"5-((3-Diethylamino)propyl)amino-8-hydroxy-6H-imidazo(4,5,1-de)acridin-6-one",CCN(CC)CCCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)O,,,,,,
4480,154481,1-(3-Methoxy-4-hydroxyphenyl)-7-phenylhept-1-en-3-one,COC1=C(C=CC(=C1)C=CC(=O)CCCCC2=CC=CC=C2)O,,,,,,
4481,154482,"2,2',3,3',4,4'-Hexabromo-1,1'-biphenyl",C1=CC(=C(C(=C1C2=C(C(=C(C=C2)Br)Br)Br)Br)Br)Br,,,,,,
4482,154483,"1,1'-Biphenyl, 2,2',3,3',4,5'-hexabromo-",C1=CC(=C(C(=C1C2=C(C(=CC(=C2)Br)Br)Br)Br)Br)Br,,,,,,
4483,154484,"1,1'-Biphenyl, 2,3,3',4',5',6-hexabromo-",C1=CC(=C(C(=C1Br)C2=CC(=C(C(=C2)Br)Br)Br)Br)Br,,,,,,
4484,154485,"2,3',4,4',6-Pentabromobiphenyl",C1=CC(=C(C=C1C2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
4485,154486,"2-Propenamide, N,N-didodecyl-",CCCCCCCCCCCCN(CCCCCCCCCCCC)C(=O)C=C,,,,,,
4486,154487,"N-(3,3-diphenyl-2(3H)-furanylidene)-N-methylmethanaminium bromide",C[N+](=C1C(C=CO1)(C2=CC=CC=C2)C3=CC=CC=C3)C.[Br-],,,,,,
4487,154488,"(3,3-Diphenylfuran-2-ylidene)-dimethylazanium",C[N+](=C1C(C=CO1)(C2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
4488,154489,"Formamide, N-(4-(1H-imidazol-4-yl)phenyl)-",C1=CC(=CC=C1C2=CN=CN2)NC=O,,,,,,
4489,154490,"Dibenzo(c,f)(2,7)naphthyridine, 6,7-dimethyl-",CC1=NC2=CC=CC=C2C3=C1C(=NC4=CC=CC=C43)C,,,,,,
4490,154491,"(1S,4aR,5S,8aR)-5-[5-(3-carboxypropanoyloxy)-3-methylpent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid",CC(=CCOC(=O)CCC(=O)O)CC[C@H]1C(=C)CC[C@@H]2[C@@]1(CCC[C@]2(C)C(=O)O)C,,,,,,
4491,154492,Diethyl-[2-(3-hydroxypropoxy)ethyl]-methylazanium;methane;chloride,C.CC[N+](C)(CC)CCOCCCO.[Cl-],,,,,,
4492,154493,"N,N-Diethyl-2-(3-hydroxypropoxy)-N-methylethan-1-aminium",CC[N+](C)(CC)CCOCCCO,,,,,,
4493,154494,Idazoxan hydrochloride,C1CN=C(N1)C2COC3=CC=CC=C3O2.Cl,,,['Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)'],,,
4494,154495,"Methyl 3-amino-2,2,3-trimethylbutyrate",CC(C)(C(=O)OC)C(C)(C)N,,,,,,
4495,154496,"2,2',3,4',6,6'-Hexabromobiphenyl",C1=CC(=C(C(=C1Br)C2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
4496,154497,CID 154497,C1=CC(=C(C(=C1)O)C(=O)[O-])O,,,,,,
4497,154498,8-Fluoro-5-nitroquinoline,C1=CC2=C(C=CC(=C2N=C1)F)[N+](=O)[O-],,,,,,
4498,154499,"2,3,4,4',5-Pentabromobiphenyl",C1=CC(=CC=C1C2=CC(=C(C(=C2Br)Br)Br)Br)Br,,,,,,
4499,154500,"5-((3-(Diethylamino)propyl)amino)-8-hydroxy-1-methyl-6H-imidazo(4,5,1-de)acridin-6-one",CCN(CC)CCCNC1=C2C3=C(C=C1)N=C(N3C4=C(C2=O)C=C(C=C4)O)C,,,,,,
4500,154501,"(2R,3S,4S,5R)-6-azido-2,3,4,5-tetrahydroxyhexanoic acid",C([C@H]([C@@H]([C@@H]([C@H](C(=O)O)O)O)O)O)N=[N+]=[N-],,,,,,
4501,154502,6-Azido-6-deoxy-D-galactitol,C([C@H]([C@@H]([C@@H]([C@H](CO)O)O)O)O)N=[N+]=[N-],,,,,,
4502,154503,"alpha-D-Glucopyranose, 6-azido-6-deoxy-",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
4503,154504,6-Azido-6-deoxy-alpha-D-altropyranose,C([C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
4504,154505,6-Azido-6-deoxy-beta-L-idopyranose,C([C@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
4505,154506,6-Azido-6-deoxy-alpha-D-allopyranose,C([C@@H]1[C@H]([C@H]([C@H]([C@H](O1)O)O)O)O)N=[N+]=[N-],,,,,,
4506,154507,CID 154507,CCCCC=CC=CO[C@@H](CC)CCC(CCC)CCCCCCCC(=O)O[C@]1([C@]2([C@H]([C@H](O[C@@]1(O2)O)CO[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O)O,,,,,,
4507,154508,CID 154508,CCCC(=CC(=O)OC1CC2C3(CCC(CC3=CCC2(C4(C1(C(CC4)(C(=O)C)O)C)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)O)OC)OC)OC)OC)C)C,,,,,,
4508,154509,"2,2',4,6'-Tetrabromobiphenyl",C1=CC(=C(C(=C1)Br)C2=C(C=C(C=C2)Br)Br)Br,,,,,,
4509,154510,2-Nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC(=CC(=C54)C=C3)[N+](=O)[O-],,,,,,
4510,154511,"2,2',4,4',6-Pentabromobiphenyl",C1=CC(=C(C=C1Br)Br)C2=C(C=C(C=C2Br)Br)Br,,,,,,
4511,154512,CID 154512,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C=CC4=O,,,,,,
4512,154513,"1,1'-Biphenyl, 3,3',4,5'-tetrabromo-",C1=CC(=C(C=C1C2=CC(=CC(=C2)Br)Br)Br)Br,,,,,,
4513,154514,CID 154514,CC1=CC(=O)C2=C(C1=O)C3=NC4=CC=CC=C4C3=C(N2)C,,,,,,
4514,154515,CID 154515,CC1=C2C3=CC=CC=C3N=C2C4=C(N1)C(=O)C=C(C4=O)N5CCN(CC5)C,,,,,,
4515,154516,"1,1'-Biphenyl, 2,3,3',4-tetrabromo-",C1=CC(=CC(=C1)Br)C2=C(C(=C(C=C2)Br)Br)Br,,,,,,
4516,154517,"1,1'-Biphenyl, 2,2',4,6,6'-pentabromo-",C1=CC(=C(C(=C1)Br)C2=C(C=C(C=C2Br)Br)Br)Br,,,,,,
4517,154518,"5,5'-Diamino-2,2'-dimethylazobenzene",CC1=C(C=C(C=C1)N)N=NC2=C(C=CC(=C2)N)C,,,,,,
4518,154519,"5,5'-Diamino-2,2'-dimethylazoxybenzene",CC1=C(C=C(C=C1)N)N=[N+](C2=C(C=CC(=C2)N)C)[O-],,,,,,
4519,154520,"1,4,7,10-Tetraazacyclododecane, 1,4,7-tris((4-methylphenyl)sulfonyl)-10-(methylsulfonyl)-",CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CCN(CCN(CC2)S(=O)(=O)C3=CC=C(C=C3)C)S(=O)(=O)C4=CC=C(C=C4)C)S(=O)(=O)C,,,,,,
4520,154521,3-Nitro-6-azabenzo[a]pyrene,C1=CC=C2C(=C1)C3=C4C(=N2)C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],,,,,,
4521,154522,"10,11-Dimethyl-7,8,8a,9a-tetrahydrochryseno[3,4-b]oxirene-7,8-diol",CC1=C(C2=C(C=CC3=C2C4C(O4)C(C3O)O)C5=CC=CC=C15)C,,,,,,
4522,154523,Monoammonium L-glutamate monohydrate,C(CC(=O)[O-])[C@@H](C(=O)O)N.[NH4+].O,,,,,,
4523,154524,CID 154524,CCCOC=CC=CC=CC=CC=CCC,,,,,,
4524,154525,CID 154525,CCC=CC=CC=CC=CC=COCC(C)O,,,,,,
4525,154526,"Platinum, (mu-(N,N'-bis(3-(amino-kappaN)propyl)-1,4-butanediamine-kappaN:kappaN'))bis(propanedioato(2-)-kappaO1,kappaO3)di-",C(CCNCCCN)CNCCCN.C(C(=O)[O-])C(=O)[O-].C(C(=O)[O-])C(=O)[O-].[Pt+2].[Pt+2],,,,,,
4526,154527,CID 154527,CCC=CC=CC=CC=CC=COCC(C1=CC=CC=C1)O,,,,,,
4527,154528,CID 154528,C1CCC2=C(C1)C=CC3=CC4=C(C(=C(C56C4(O5)C=CC=C6)O)O)N=C23,,,,,,
4528,154529,"Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-",CCS(=O)(=O)NC1=C(C=C(C=N1)C(F)(F)F)NC(=O)C2CCCCC2,,,['Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme. (See all compounds classified as Phospholipase A2 Inhibitors.)'],,,
4529,154530,"2-Nitro-4,5,7,8,9,10,11,12-octahydrobenzo(a)pyrene",C1CCC2=C3CCC4=CC(=CC5=C4C3=C(CC5)C=C2C1)[N+](=O)[O-],,,,,,
4530,154531,"2-Nitro-7,8,9,10,11,12-hexahydrochrysene",C1CCC2=C(C1)C=CC3=C2CCC4=C3C=CC(=C4)[N+](=O)[O-],,,,,,
4531,154532,"Dibenz(a,h)anthracene, 5,6,12,13-tetrahydro-3-nitro-",C1CC2=C(C=C3CCC4=C(C3=C2)C=CC(=C4)[N+](=O)[O-])C5=CC=CC=C51,,,,,,
4532,154533,"Dibenz(a,h)anthracene, 3-nitro-",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=CC(=C5)[N+](=O)[O-],,,,,,
4533,154534,"1H-Benzimidazole-5-carbonitrile, 2-amino-1-methyl-",CN1C2=C(C=C(C=C2)C#N)N=C1N,,,,,,
4534,154535,"1H-Benzimidazole-6-carbonitrile, 2-amino-1-methyl-",CN1C2=C(C=CC(=C2)C#N)N=C1N,,,,,,
4535,154536,"cis-(+-)-1a,7b-Dihydro-4-methyloxireno(f)quinolinium",C[N+]1=CC=CC2=C1C=C[C@@H]3[C@H]2O3,,,,,,
4536,154537,"(+-)-cis-5,6-Epoxy-5,6-dihydroquinoline N-oxide",C1=CC2=C(C=C[C@@H]3[C@H]2O3)[N+](=C1)[O-],,,,,,
4537,154538,"(+-)-cis-7,8-Epoxy-7,8-dihydroquinoline N-oxide",C1=CC2=C([C@@H]3[C@@H](O3)C=C2)[N+](=C1)[O-],,,,,,
4538,154539,"anti-5,6-Dihydroxy-7,8-epoxy-5,6,7,8-tetrahydroquinoline",C1=CC2=C(C3C(O3)C(C2O)O)N=C1,,,,,,
4539,154540,"7,8-Dihydroquinolin-8-ol",C1C=CC2=C(C1O)N=CC=C2,,,,,,
4540,154541,"trans-Quinoline-5,6,7,8-dioxide",C1=CC2=C(C3C(O3)[C@H]4[C@H]2O4)N=C1,,,,,,
4541,154542,"cis-Quinoline-5,6,7,8-dioxide",C1=CC2=C(C3C(O3)[C@@H]4[C@H]2O4)N=C1,,,,,,
4542,154543,4-(5-Cyano-3-oxopent-1-enyl)benzoic acid,C1=CC(=CC=C1C=CC(=O)CCC#N)C(=O)O,,,,,,
4543,154544,1-(p-Carboxyphenyl)-5-cyano-3-pentanone,C1=CC(=CC=C1CCC(=O)CCC#N)C(=O)O,,,,,,
4544,154545,"4,5-Dimethyl-5-hydroxy-3-(methoxycarbonyl)-3,4-epoxy-gamma-butyrolactone",CC12C(OC(=O)C1(O2)C(=O)OC)(C)O,,,,,,
4545,154546,"Methyl 5-ethyl-4-methyl-2-oxo-3,6-dioxabicyclo(3.1.0)hexane-1-carboxylate",CCC12C(OC(=O)C1(O2)C(=O)OC)C,,,,,,
4546,154547,"3,4-Epoxy-5-isopropyl-3-(methoxycarbonyl)-4-methyl-gamma-butyrolactone",CC(C)C1C2(C(O2)(C(=O)O1)C(=O)OC)C,,,,,,
4547,154548,"Methyl 2,4-dihydroxy-4,5-dimethyl-6-oxa-3-azabicyclo[3.1.0]hex-2-ene-1-carboxylate",CC12C(NC(=O)C1(O2)C(=O)OC)(C)O,,,,,,
4548,154549,"6-Oxa-3-azabicyclo(3.1.0)hexane-1-carboxylic acid, 5-ethyl-4-hydroxy-4-methyl-2-oxo-, methyl ester",CCC12C(NC(=O)C1(O2)C(=O)OC)(C)O,,,,,,
4549,154550,"1,1-Dicarbamoyl-1,2-epoxy-3-phenylpropan-3-one",C1=CC=C(C=C1)C(=O)C2C(O2)(C(=O)N)C(=O)N,,,,,,
4550,154551,"1,1-Dicarbamoyl-1,2-epoxy-2-ethyl-3-hydroxybutane",CCC1(C(O1)(C(=O)N)C(=O)N)C(C)O,,,,,,
4551,154552,"1-Carbamoyl-2,4-dimethyl-1,2-epoxy-3-hydroxy-1-(methoxycarbonyl)pentane",CC(C)C(C1(C(O1)(C(=O)N)C(=O)OC)C)O,,,,,,
4552,154553,"Methyl 2,4-dihydroxy-5-methyl-4-(propan-2-yl)-6-oxa-3-azabicyclo[3.1.0]hex-2-ene-1-carboxylate",CC(C)C1(C2(C(O2)(C(=O)N1)C(=O)OC)C)O,,,,,,
4553,154554,"(R,S)-2-Bromo-N-(4-methoxybenzyl)propanamide",CC(C(=O)NCC1=CC=C(C=C1)OC)Br,,,,,,
4554,154555,"(R,S)-2-Bromo-N-(4-hydroxy-3-methoxybenzyl)propanamide",CC(C(=O)NCC1=CC(=C(C=C1)O)OC)Br,,,,,,
4555,154556,"(R,S)-2-Bromo-N-(3,4-dimethoxybenzyl)propanamide",CC(C(=O)NCC1=CC(=C(C=C1)OC)OC)Br,,,,,,
4556,154557,2-Bromo-N-(tert-butyl)propanamide,CC(C(=O)NC(C)(C)C)Br,,,,,,
4557,154558,N-Benzyl-2-benzylaminopropanamide,CC(C(=O)NCC1=CC=CC=C1)NCC2=CC=CC=C2,,,,,,
4558,154559,"3,6,8-Trinitronorharman",C1=C(C=C(C2=C1C3=CC(=NC=C3N2)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4559,154560,"(3R-trans)-6,7-Dichloro-2,3,5,7a-tetrahydro-5-oxopyrrolo(2,1-b)thiazole-3-carboxylic acid, methyl ester",COC(=O)[C@@H]1CS[C@H]2N1C(=O)C(=C2Cl)Cl,,,,,,
4560,154561,7-Hydroxy-1-phenyl-1-octanone,CC(CCCCCC(=O)C1=CC=CC=C1)O,,,,,,
4561,154562,4-Hydroxy-1-(2-thienyl)-1-pentanone,CC(CCC(=O)C1=CC=CS1)O,,,,,,
4562,154563,4-Hydroxy-1-(3-pyridyl)-1-pentanone,CC(CCC(=O)C1=CN=CC=C1)O,,,,,,
4563,154564,"6-Methylbicyclo(4.1.0)hept-2-ene-1,2-dicarbaldehyde",CC12CCC=C(C1(C2)C=O)C=O,,,,,,
4564,154565,"3-(((4-Nitrophenyl)methylene)amino)-1H-indole-2-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C2=CC=CC=C2N1)N=CC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
4565,154566,"3-(((3,4,5-Trimethoxyphenyl)methylene)amino)-1H-indole-2-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C2=CC=CC=C2N1)N=CC3=CC(=C(C(=C3)OC)OC)OC,,,,,,
4566,154567,"3-(((4-(Acetylamino)phenyl)methylene)amino)-1H-indole-2-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C2=CC=CC=C2N1)N=CC3=CC=C(C=C3)NC(=O)C,,,,,,
4567,154568,"3-(((4-Hydroxyphenyl)methylene)amino)-1H-indole-2-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C2=CC=CC=C2N1)N=CC3=CC=C(C=C3)O,,,,,,
4568,154569,"3-(((4-Methylphenyl)methylene)amino)-1H-indole-2-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C2=CC=CC=C2N1)N=CC3=CC=C(C=C3)C,,,,,,
4569,154570,2-Nitroso-6-nitrotoluene,CC1=C(C=CC=C1[N+](=O)[O-])N=O,,,,,,
4570,154571,"3,3'-Diamino-2,2'-dimethylazoxybenzene",CC1=C(C=CC=C1N=[N+](C2=CC=CC(=C2C)N)[O-])N,,,,,,
4571,154572,"3,3'-Diamino-2,2'-dimethylazobenzene",CC1=C(C=CC=C1N=NC2=CC=CC(=C2C)N)N,,,,,,
4572,154573,"3,3'-Diacetylamino-2,2'-dimethylazoxybenzene",CC1=C(C=CC=C1N=[N+](C2=C(C(=C(C=C2)N)C(=O)C)C)[O-])C(=O)C,,,,,,
4573,154574,"3,3'-Diacetylamino-2,2'-dimethylazobenzene",CC1=C(C=CC=C1N=NC2=C(C(=C(C=C2)N)C(=O)C)C)C(=O)C,,,,,,
4574,154575,Piclamilast,COC1=C(C=C(C=C1)C(=O)NC2=C(C=NC=C2Cl)Cl)OC3CCCC3,,,['Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)'],,"['RP73401 has known human metabolites that include N-(3,5-Dichloropyridin-4-yl)-3-(3-hydroxycyclopentyl)oxy-4-methoxybenzamide.']",
4575,154576,"2,8-Dinitrodibenzofuran",C1=CC2=C(C=C1[N+](=O)[O-])C3=C(O2)C=CC(=C3)[N+](=O)[O-],,,,,,
4576,154577,"Benz(a)anthracene, 5,6,8,9,10,11-hexahydro-3-nitro-",C1CCC2=CC3=C(CCC4=C3C=CC(=C4)[N+](=O)[O-])C=C2C1,,,,,,
4577,154578,"2,3,4,9-Tetrahydro-1-methyl-6-nitro-2-nitroso-1H-pyrido(3,4-b)indole-3-carboxylic acid, methyl ester",CC1C2=C(CC(N1N=O)C(=O)OC)C3=C(N2)C=CC(=C3)[N+](=O)[O-],,,,,,
4578,154579,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11-(trifluoromethyl)-",C1CC(=O)C2=CC(=C3C(=C21)C=CC4=CC=CC=C43)C(F)(F)F,,,,,,
4579,154580,"1H-Imidazole-5-carboxamide, N,1-dimethyl-4-(methylamino)-N-nitroso-",CNC1=C(N(C=N1)C)C(=O)N(C)N=O,,,,,,
4580,154581,"N-[4-[(2,6-Diazidoacridin-9-yl)amino]phenyl]-3-aminopropane-1-sulfonamide",C1=CC(=NS(=O)(=O)CCCN)C=CC1=NC2=C3C=C(C=CC3=NC4=C2C=CC(=C4)N[N+]#N)NN=[N-],,,,,,
4581,154582,CID 154582,C1=CC(=CC=C1NC2=C3C=C(C=CC3=NC4=C2C=CC(=C4)N[N+]#N)N[N+]#N)NS(=O)(=O)CCCN,,,,,,
4582,154583,CID 154583,C1=CC(=CC=C1[N-]S(=O)(=O)CCCN)N=C2C3=C(C=C(C=C3)N[N+]#N)[N-]C4=C2C=CC(=C4)N[N+]#N,,,,,,
4583,154584,CID 154584,C1=CC(=CC=C1NC2=C3C=CC(=CC3=NC4=C2C=CC(=C4)N[N+]#N)N[N+]#N)NS(=O)(=O)CCCN,,,,,,
4584,154585,CID 154585,COC1=C(C=CC(=C1)NS(=O)(=O)C)[N-]C2=C3C=C(C=CC3=NC4=CC=CC=C42)N[N+]#N,,,,,,
4585,154586,CID 154586,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=C(C=CC3=NC4=CC=CC=C42)N[N+]#N,,,,,,
4586,154587,CID 154587,CC(=CC(=CC(=CCO)C(=O)OC)C)C=CC=C(C)C(=O)[C@@]12[C@H](O1)C(NC2=O)(CCO)O,,,,,,
4587,154588,"trans-4,15,16,17,-Tetrahydro-3H-cyclopenta(a)phenanthrene-3,4-diol",C1CC2=C(C1)C3=C(C=C2)C4=C(C=C3)[C@@H]([C@H](C=C4)O)O,,,,,,
4588,154589,"(R)-1,2-Dibromo-3-chloropropane",C([C@H](CBr)Br)Cl,,,,,,
4589,154590,"(S)-1,2-Dibromo-3-chloropropane",C([C@@H](CBr)Br)Cl,,,,,,
4590,154591,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,5-dimethyl-",CC1=CC2=C(C3=NC=CN=C13)N=C(N2C)N,,,,,,
4591,154592,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,5,7,8-tetramethyl-",CC1=CC2=C(C3=NC(=C(N=C13)C)C)N=C(N2C)N,,,,,,
4592,154593,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,4,5-trimethyl-",CC1=C(C2=NC=CN=C2C3=C1N(C(=N3)N)C)C,,,,,,
4593,154594,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,4,5,8-tetramethyl-",CC1=CN=C2C(=C(C3=C(C2=N1)N=C(N3C)N)C)C,,,,,,
4594,154595,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,4,5,7-tetramethyl-",CC1=CN=C2C3=C(C(=C(C2=N1)C)C)N(C(=N3)N)C,,,,,,
4595,154596,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,4,5,7,8-pentamethyl-",CC1=C(C2=NC(=C(N=C2C3=C1N(C(=N3)N)C)C)C)C,,,,,,
4596,154597,"2-Amino-3-methyl-7,8-diphenylimidazo(4,5-f)quinoxaline",CN1C2=C(C3=C(C=C2)N=C(C(=N3)C4=CC=CC=C4)C5=CC=CC=C5)N=C1N,,,,,,
4597,154598,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,5-dimethyl-8-phenyl-",CC1=CC2=C(C3=NC(=CN=C13)C4=CC=CC=C4)N=C(N2C)N,,,,,,
4598,154599,"3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,5-dimethyl-7-phenyl-",CC1=CC2=C(C3=NC=C(N=C13)C4=CC=CC=C4)N=C(N2C)N,,,,,,
4599,154600,CID 154600,CC(=O)C[C@H](CCC(=O)C=CC(=O)O)OC(=O)C=CC(=O)CCC=CC(=O)C,,,,,,
4600,154601,"1-Methylbenz(a)anthracene 5,6-oxide",CC1=C2C(=CC=C1)C3=C(O3)C4=CC5=CC=CC=C5C=C42,,,,,,
4601,154602,"2-Carbomethoxy-1H-pyrrolo(3,2-h)-N-methylquinolinium iodide",C[N+]1=CC=CC2=C1C3=C(C=C2)C=C(N3)C(=O)OC.[I-],,,,,,
4602,154603,"2-Methoxycarbonyl-9-methyl-1H-pyrrolo[3,2-h]quinolin-9-ium",C[N+]1=CC=CC2=C1C3=C(C=C2)C=C(N3)C(=O)OC,,,,,,
4603,154604,"2-Hydroxymethyl-1H-pyrrolo(3,2-h)quinoline",C1=CC2=C(C3=C(C=C2)C=C(N3)CO)N=C1,,,,,,
4604,154605,"methyl 1H-pyrrolo[3,2-h]quinoline-2-carboxylate",COC(=O)C1=CC2=C(N1)C3=C(C=CC=N3)C=C2,,,,,,
4605,154606,N-(4-Methoxyphenyl)-5-nitro-3-thiophenecarboxamide,COC1=CC=C(C=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4606,154607,N-(3-Methoxyphenyl)-5-nitro-3-thiophenecarboxamide,COC1=CC=CC(=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4607,154608,N-(2-Methoxyphenyl)-5-nitro-3-thiophenecarboxamide,COC1=CC=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4608,154609,N-(4-Methylphenyl)-5-nitro-3-thiophenecarboxamide,CC1=CC=C(C=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4609,154610,N-(3-Methylphenyl)-5-nitro-3-thiophenecarboxamide,CC1=CC(=CC=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4610,154611,N-(2-Methylphenyl)-5-nitro-3-thiophenecarboxamide,CC1=CC=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4611,154612,N-(3-Ethylphenyl)-5-nitro-3-thiophenecarboxamide,CCC1=CC(=CC=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4612,154613,N-(2-Ethylphenyl)-5-nitro-3-thiophenecarboxamide,CCC1=CC=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4613,154614,"3-Thiophenecarboxamide, 5-nitro-N-phenyl-",C1=CC=C(C=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4614,154615,N-(4-Fluorophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-])F,,,,,,
4615,154616,N-(3-Fluorophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC(=C1)F)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4616,154617,N-(2-Fluorophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC=C(C(=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-])F,,,,,,
4617,154618,N-(4-Chlorophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-])Cl,,,,,,
4618,154619,N-(3-Chlorophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC(=C1)Cl)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4619,154620,"3-Thiophenecarboxamide, N-(2-chlorophenyl)-5-nitro-",C1=CC=C(C(=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-])Cl,,,,,,
4620,154621,N-(4-Bromophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-])Br,,,,,,
4621,154622,N-(3-Bromophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC(=CC(=C1)Br)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4622,154623,N-(2-Bromophenyl)-5-nitro-3-thiophenecarboxamide,C1=CC=C(C(=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-])Br,,,,,,
4623,154624,"3-Thiophenecarboxamide, 5-nitro-N-(4-nitrophenyl)-",C1=CC(=CC=C1NC(=O)C2=CSC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4624,154625,"3-Thiophenecarboxamide, 5-nitro-N-(3-nitrophenyl)-",C1=CC(=CC(=C1)[N+](=O)[O-])NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4625,154626,"3-Thiophenecarboxamide, 5-nitro-N-(2-nitrophenyl)-",C1=CC=C(C(=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4626,154627,"3-Thiophenecarboxamide, N-methyl-5-nitro-N-phenyl-",CN(C1=CC=CC=C1)C(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4627,154628,N-(4-Ethylphenyl)-5-nitro-3-thiophenecarboxamide,CCC1=CC=C(C=C1)NC(=O)C2=CSC(=C2)[N+](=O)[O-],,,,,,
4628,154629,Dichloro-(S)-3-aminohexahydropyridine platinum(II),C1CCN[C@@H](C1)N.Cl[Pt]Cl,,,,,,
4629,154630,(2S)-piperidin-2-amine,C1CCN[C@@H](C1)N,,,,,,
4630,154631,"2-Amino-3-methyl-3H-imidazo[4,5-H]quinoline",CN1C2=C(C3=C(C=CC=N3)C=C2)N=C1N,,,,,,
4631,154632,"2-Amino-3-methyl-3H-imidazo[4,5-h]isoquinoline",CN1C2=C(C3=C(C=C2)C=CN=C3)N=C1N,,,,,,
4632,154633,"2-Amino-3-methyl-3h-imidazo[4,5-f]isoquinoline",CN1C2=C(C3=C(C=C2)C=NC=C3)N=C1N,,,,,,
4633,154634,Ccris 6655,C1CC2=C(C1)C3=C(C=C2)C4=C(C=C3)C(C(CC4=O)O)O,,,,,,
4634,154635,2-Methylazo-2-propyl hydroperoxide,CC(C)(N=NC)OO,,,,,,
4635,154636,2-Ethylazo-2-propyl hydroperoxide,CCN=NC(C)(C)OO,,,,,,
4636,154637,2-Propylazo-2-propyl hydroperoxide,CCCN=NC(C)(C)OO,,,,,,
4637,154638,"3,4-Dibromofuran-2(5H)-one",C1C(=C(C(=O)O1)Br)Br,,,,,,
4638,154639,(1-Nitroso-1H-imidazol-4-yl)acetohydroxamic acid,C1=C(N=CN1N=O)CC(=O)NO,,,,,,
4639,154640,4-Chloro-4H-cyclopenta(def)chrysene,C1=CC2=C3C(=C1)C=C4C3=C(C=C2)C5=CC(C=CC5=C4)Cl,,,,,,
4640,154641,"Formamide, N-ethyl-N-nitroso-",CCN(C=O)N=O,,,,,,
4641,154642,5-Nitro-1-(phenylmethyl)-1H-benzimidazole-2-carboxaldehyde O-((2-nitrophenyl)methyl)oxime,C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)[N+](=O)[O-])N=C2C=NOCC4=CC=CC=C4[N+](=O)[O-],,,,,,
4642,154643,1-((4-Chlorophenyl)methyl)-5-nitro-1H-benzimidazole-2-carboxaldehyde O-((3-nitrophenyl)methyl)oxime,C1=CC(=CC(=C1)[N+](=O)[O-])CON=CC2=NC3=C(N2CC4=CC=C(C=C4)Cl)C=CC(=C3)[N+](=O)[O-],,,,,,
4643,154644,"1-((2,4-Dichlorophenyl)methyl)-5-nitro-1H-benzimidazole-2-carboxaldehyde O-((2-nitrophenyl)methyl)oxime",C1=CC=C(C(=C1)CON=CC2=NC3=C(N2CC4=C(C=C(C=C4)Cl)Cl)C=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4644,154645,1-((4-Fluorophenyl)methyl)-5-nitro-1H-benzimidazole-2-carboxaldehyde O-((3-nitrophenyl)methyl)oxime,C1=CC(=CC(=C1)[N+](=O)[O-])CON=CC2=NC3=C(N2CC4=CC=C(C=C4)F)C=CC(=C3)[N+](=O)[O-],,,,,,
4645,154646,2-Methyl-5-nitro-1-(phenylmethyl)-1H-indole-3-carboxaldehyde O-((3-nitrophenyl)methyl)oxime,CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)[N+](=O)[O-])C=NOCC4=CC(=CC=C4)[N+](=O)[O-],,,,,,
4646,154647,CID 154647,CC1=C(C2=C(N1CC3=CC=C(C=C3)Cl)C=CC(=C2)[N+](=O)[O-])C=NOCC4=C(C=C(C=C4)Cl)Cl,,,,,,
4647,154648,CID 154648,CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)[N+](=O)[O-])C=NOCC4=CC=C(C=C4)Cl,,,,,,
4648,154649,CID 154649,CC1=C(C2=C(N1CC3=CC(=CC=C3)[N+](=O)[O-])C=CC(=C2)[N+](=O)[O-])C=NOCC4=CC=CC=C4,,,,,,
4649,154650,3-(1H-Imidazol-1-ylmethyl)-2-methyl-5-nitro-1-(phenylmethyl)-1H-indole,CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)[N+](=O)[O-])CN4C=CN=C4,,,,,,
4650,154651,"17H-Cyclopenta(a)phenanthren-17-one, 3,4,15,16-tetrahydro-3,4-dihydroxy-11-(trifluoromethyl)-,trans-",C1CC(=O)C2=CC(=C3C4=C(C=CC3=C21)[C@@H]([C@H](C=C4)O)O)C(F)(F)F,,,,,,
4651,154652,Potassium tetranitroplatinate(II) dihydrate,N(=O)[O-].N(=O)[O-].N(=O)[O-].N(=O)[O-].O.O.[K+].[K+].[Pt],,,,,,
4652,154653,"3,4-Dihydroxy-11-methyl-15,16-dihydrocyclopenta(a)phenanthren-17-one",CC1=CC2=C(CCC2=O)C3=C1C4=C(C=C3)C(=C(C=C4)O)O,,,,,,
4653,154654,3-(N-carbethoxy-N-nitrosamino)propionaldehyde,CCOC(=O)N(CCC=O)N=O,,,,,,
4654,154655,"Dibenz(a,h)anthracene, 3,4:10,11-tetrahydroxy-3,4,10,11-tetrahydro-, trans,trans-",C1=CC2=C(C=CC3=CC4=C(C=CC5=C4C=C[C@@H]([C@H]5O)O)C=C32)[C@@H]([C@H]1O)O,,,,,,
4655,154656,Amediplase,C1=CC=C2C(=C1)[C@@H]([C@H](C3=C2C=C4C=CC5=C(C4=C3)C=C[C@@H]([C@H]5O)O)O)O,['Investigated for use/treatment in myocardial infarction and thrombosis.'],,,,,
4656,154657,"6,7-Dichloro-2,3,5,7a-tetrahydro-5-oxopyrrolo(2,1-b)thiazole-3-carboxylic acid, methyl ester",COC(=O)C1CSC2N1C(=O)C(=C2Cl)Cl,,,,,,
4657,154658,"(3S-trans)-6,7-Dichloro-2,3,5,7a-tetrahydro-5-oxopyrrolo(2,1-b)thiazole-3-carboxylic acid, methyl ester",COC(=O)[C@H]1CS[C@@H]2N1C(=O)C(=C2Cl)Cl,,,,,,
4658,154659,6-Isothiocyanatobenzo[a]pyrene,C1=CC=C2C(=C1)C3=C4C(=C2N=C=S)C=CC5=CC=CC(=C54)C=C3,,,,,,
4659,154660,(R)-N-Nitroso-N-(2-benzyl-3-hydroxypropyl)butylamine,CCCCN(C[C@@H](CC1=CC=CC=C1)CO)N=O,,,,,,
4660,154661,(S)-N-Nitroso-N-(2-benzyl-3-hydroxypropyl)butylamine,CCCCN(C[C@H](CC1=CC=CC=C1)CO)N=O,,,,,,
4661,154662,(S)-N-Nitroso-N-(2-benzyloxy-3-hydroxypropyl)butylamine,CCCCN(C[C@@H](CO)OCC1=CC=CC=C1)N=O,,,,,,
4662,154663,"trans-4,5,5a,6,7,8,9,9a-Octahydrothiazolo(4,5-f)quinolin-2-amine",C1C[C@@H]2[C@H](CCC3=C2N=C(S3)N)NC1,,,,,,
4663,154664,"N-(4,5,5a,6,7,8-Hexahydro-6-(2-propenyl)thiazolo(4,5-f)quinolin-2-yl)acetamide",CC(=O)NC1=NC2=C(S1)CCC3C2=CCCN3CC=C,,,,,,
4664,154665,"4,5-Dihydrothiazolo(4,5-f)quinoline",C1CC2=C(C3=C1N=CC=C3)N=CS2,,,,,,
4665,154666,"4,5-Dihydro-4,4-dimethylthiazolo(4,5-f)quinolin-2-amine",CC1(CC2=C(C=CC=N2)C3=C1SC(=N3)N)C,,,,,,
4666,154667,"S-(2-Bromo-1,1,2-trifluoroethyl)-L-cysteine",C([C@@H](C(=O)O)N)SC(C(F)Br)(F)F,,,,,,
4667,154668,CID 154668,C1=CC2=NC3=C(C(=O)C(=CC3=C2C=C1N(O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4668,154669,CID 154669,C1=CC2=C3C=C(C(=O)C=C3N=C2C=C1)N(O)O,,,,,,
4669,154670,CID 154670,C1=CC2=C3C=C(C(=O)C(=C3N=C2C=C1)[N+](=O)[O-])N(O)O,,,,,,
4670,154671,CID 154671,C1=CC2=C3C=CC(=O)C(=C3N=C2C=C1)N(O)O,,,,,,
4671,154672,(R)-N-Nitroso-N-(2-benzyloxy-3-hydroxypropyl)butylamine,CCCCN(C[C@H](CO)OCC1=CC=CC=C1)N=O,,,,,,
4672,154673,3'-Methyl-3-hydroxy-chalcone,CC1=CC(=CC=C1)C(=O)C=CC2=CC(=CC=C2)O,,,,,,
4673,154674,CID 154674,COC1=CC=CC(=C1)C=CC2=CC=C(C=C2)N,,,,,,
4674,154675,Ccris 6972,CC(=O)C[C@@H]1CCC(=O)CCC(=O)O[C@@H](CCC(=O)CCC(=O)O1)CC(=O)C,,,,,,
4675,154676,"(8S-(8R*,16R*))-8,16-Bis(2-oxopropyl)-1,9-dioxacyclohexadecane-2,5,10-trione",CC(=O)C[C@@H]1CCCCCC(=O)O[C@@H](CCC(=O)CCC(=O)O1)CC(=O)C,,,,,,
4676,154677,3-Fluoroquinolin-5-amine,C1=CC(=C2C=C(C=NC2=C1)F)N,,,,,,
4677,154678,3-Fluoro-8-acetylaminoquinoline,CC(=O)NC1=CC=CC2=CC(=CN=C21)F,,,,,,
4678,154679,CID 154679,CC(C)C1=CC(=N)C=C(C1=N)N(O)O,,,,,,
4679,154680,CID 154680,CC1=CC(=N)C=C(C1=N)N(O)O,,,,,,
4680,154681,CID 154681,CC1=CC(=N)C(=C(C1=N)N(O)O)C,,,,,,
4681,154682,"1,4-Dioxaspiro(4.4)non-2-ylmethyl ethyl 4-(3-chlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate",CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)Cl)C(=O)OCC3COC4(O3)CCCC4)C)C,,,,,,
4682,154683,Mono(2-ethylhexyl) terephthalate,CCCCC(CC)COC(=O)C1=CC=C(C=C1)C(=O)O,,,,,,
4683,154684,"9-Acridinamine, N-(5-(4-((2-chloroethyl)ethylamino)phenoxy)pentyl)-",CCN(CCCl)C1=CC=C(C=C1)OCCCCCNC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
4684,154685,"1H-Imidazo(4,5-b)quinolin-2-amine, 1-methyl-",CN1C2=CC3=CC=CC=C3N=C2N=C1N,,,,,,
4685,154686,"2-Amino-1,7,9-trimethylimidazo[4,5-g]quinoxaline",CC1=NC2=C(C3=C(C=C2N=C1)N=C(N3C)N)C,,,,,,
4686,154687,"N,3,5-trimethylquinoxalin-6-amine",CC1=CN=C2C=CC(=C(C2=N1)C)NC,,,,,,
4687,154688,"13-Hydroxy-8,16-bis(2-oxopropyl)-1,9-dioxacyclohexadecane-2,5,10-trione",CC(=O)CC1CCC(CCC(=O)OC(CCC(=O)CCC(=O)O1)CC(=O)C)O,,,,,,
4688,154689,"6,7-Dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo(2,3-d)pyrimidine",CC1=CC2=C(N1C)N=C(N=C2N3CCCC3)N4CCCC4,,,,,,
4689,154690,8-Phenyloctyl isothiocyanate,C1=CC=C(C=C1)CCCCCCCCN=C=S,,,,,,
4690,154691,10-Phenyldecyl isothiocyanate,C1=CC=C(C=C1)CCCCCCCCCCN=C=S,,,,,,
4691,154692,"1-Methyl-1H-imidazo(4,5-b)(1,7)naphthyridin-2-amine",CN1C2=C(N=C3C=NC=CC3=C2)N=C1N,,,,,,
4692,154693,"1-Methylimidazo[4,5-b][1,6]naphthyridin-2-amine",CN1C2=C(N=C3C=CN=CC3=C2)N=C1N,,,,,,
4693,154694,"1-Methylimidazo[4,5-b][1,5]naphthyridin-2-amine",CN1C2=C(N=C3C=CC=NC3=C2)N=C1N,,,,,,
4694,154695,9-Amino-2-bromoacridine,C1=CC=C2C(=C1)C(=C3C=C(C=CC3=N2)Br)N,,,,,,
4695,154696,"9-Amino-2,7-dinitroacridine",C1=CC2=C(C=C1[N+](=O)[O-])C(=C3C=C(C=CC3=N2)[N+](=O)[O-])N,,,,,,
4696,154697,CID 154697,C1=CC2=C3C=CC(=N)C(=C3N=C2C=C1)N(O)O,,,,,,
4697,154698,1-Nitro-2-acetylpyrrole,CC(=O)C1=CC=CN1[N+](=O)[O-],,,,,,
4698,154699,"1,3,5-Trinitro-2-acetylpyrrole",CC(=O)C1=C(C=C(N1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4699,154700,"8-Quinolinesulfonic acid, 2-nitrophenyl ester",C1=CC=C(C(=C1)[N+](=O)[O-])OS(=O)(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
4700,154701,"8-Quinolinesulfonic acid, 3-nitrophenyl ester",C1=CC2=C(C(=C1)S(=O)(=O)OC3=CC=CC(=C3)[N+](=O)[O-])N=CC=C2,,,,,,
4701,154702,"8-Quinolinesulfonic acid, 4-methyl-2-nitrophenyl ester",CC1=CC(=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2N=CC=C3)[N+](=O)[O-],,,,,,
4702,154703,"8-Quinolinesulfonic acid, 2,4-dichlorophenyl ester",C1=CC2=C(C(=C1)S(=O)(=O)OC3=C(C=C(C=C3)Cl)Cl)N=CC=C2,,,,,,
4703,154704,"8-Quinolinesulfonic acid, 3,4-dichlorophenyl ester",C1=CC2=C(C(=C1)S(=O)(=O)OC3=CC(=C(C=C3)Cl)Cl)N=CC=C2,,,,,,
4704,154705,N-(2-Methylphenyl)-8-quinolinesulfonamide,CC1=CC=CC=C1NS(=O)(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
4705,154706,N-(3-Methylphenyl)-8-quinolinesulfonamide,CC1=CC(=CC=C1)NS(=O)(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
4706,154707,N-(2-Chlorophenyl)-8-quinolinesulfonamide,C1=CC=C(C(=C1)NS(=O)(=O)C2=CC=CC3=C2N=CC=C3)Cl,,,,,,
4707,154708,N-(3-Chlorophenyl)-8-quinolinesulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC(=CC=C3)Cl)N=CC=C2,,,,,,
4708,154709,N-(4-Chlorophenyl)-8-quinolinesulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC=C(C=C3)Cl)N=CC=C2,,,,,,
4709,154710,N-(3-Nitrophenyl)-8-quinolinesulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC(=CC=C3)[N+](=O)[O-])N=CC=C2,,,,,,
4710,154711,N-(4-(Dimethylamino)phenyl)-8-quinolinesulfonamide,CN(C)C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC3=C2N=CC=C3,,,,,,
4711,154712,"N-(2,4-Dichlorophenyl)-8-quinolinesulfonamide",C1=CC2=C(C(=C1)S(=O)(=O)NC3=C(C=C(C=C3)Cl)Cl)N=CC=C2,,,,,,
4712,154713,"N-(3,4-Dichlorophenyl)-8-quinolinesulfonamide",C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC(=C(C=C3)Cl)Cl)N=CC=C2,,,,,,
4713,154714,"N-(3,5-Dichlorophenyl)-8-quinolinesulfonamide",C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC(=CC(=C3)Cl)Cl)N=CC=C2,,,,,,
4714,154715,N-(4-Chloro-3-nitrophenyl)-8-quinolinesulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)NC3=CC(=C(C=C3)Cl)[N+](=O)[O-])N=CC=C2,,,,,,
4715,154716,N-(2-(Dimethylamino)ethyl)-8-quinolinesulfonamide,CN(C)CCNS(=O)(=O)C1=CC=CC2=C1N=CC=C2,,,,,,
4716,154717,N-hydroxyquinoline-8-sulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)NO)N=CC=C2,,,,,,
4717,154718,5-Sulfooxymethylfurfural,C1=C(OC(=C1)C=O)COS(=O)(=O)O,,,,,['5-Sulfooxymethylfurfural is a known human metabolite of 5-hydroxymethylfurfural.'],
4718,154719,"1,5-Dinitrophenanthrene",C1=CC2=C(C3=C(C=C2)C(=CC=C3)[N+](=O)[O-])C(=C1)[N+](=O)[O-],,,,,,
4719,154720,"1,6-Dinitrophenanthrene",C1=CC2=C(C=CC3=C2C=C(C=C3)[N+](=O)[O-])C(=C1)[N+](=O)[O-],,,,,,
4720,154721,"1,10-Dinitrophenanthrene",C1=CC=C2C3=C(C(=CC=C3)[N+](=O)[O-])C(=CC2=C1)[N+](=O)[O-],,,,,,
4721,154722,"2,6-Dinitrophenanthrene",C1=CC(=CC2=C1C=CC3=C2C=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4722,154723,"2,9-Dinitrophenanthrene",C1=CC=C2C(=C1)C3=C(C=C(C=C3)[N+](=O)[O-])C=C2[N+](=O)[O-],,,,,,
4723,154724,"2,10-Dinitrophenanthrene",C1=CC=C2C3=C(C=C(C=C3)[N+](=O)[O-])C(=CC2=C1)[N+](=O)[O-],,,,,,
4724,154725,"3,5-Dinitrophenanthrene",C1=CC2=C(C(=C1)[N+](=O)[O-])C3=C(C=C2)C=CC(=C3)[N+](=O)[O-],,,,,,
4725,154726,"3,10-Dinitrophenanthrene",C1=CC=C2C(=C1)C=C(C3=C2C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4726,154727,"4,9-Dinitrophenanthrene",C1=CC=C2C(=C1)C(=CC3=C2C(=CC=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4727,154728,"4,10-Dinitrophenanthrene",C1=CC=C2C(=C1)C=C(C3=C2C(=CC=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4728,154729,"1,5,9-Trinitrophenanthrene",C1=CC2=C3C(=C(C=C2C(=C1)[N+](=O)[O-])[N+](=O)[O-])C=CC=C3[N+](=O)[O-],,,,,,
4729,154730,"1,5,10-Trinitrophenanthrene",C1=CC2=CC(=C3C(=C2C(=C1)[N+](=O)[O-])C=CC=C3[N+](=O)[O-])[N+](=O)[O-],,,,,,
4730,154731,"1,6,9-Trinitrophenanthrene",C1=CC2=C3C=C(C=CC3=C(C=C2C(=C1)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4731,154732,"1,7,9-Trinitrophenanthrene",C1=CC2=C3C=CC(=CC3=C(C=C2C(=C1)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4732,154733,"2,5,10-Trinitrophenanthrene",C1=CC2=CC(=C3C=C(C=CC3=C2C(=C1)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4733,154734,"2,6,9-Trinitrophenanthrene",C1=CC2=C3C=C(C=CC3=C(C=C2C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4734,154735,"3,6,9-Trinitrophenanthrene",C1=CC(=CC2=C3C=C(C=CC3=C(C=C21)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4735,154736,"3,5,10-Trinitrophenanthrene",C1=CC2=CC(=C3C=CC(=CC3=C2C(=C1)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4736,154737,3-[2-(4-Nitrophenyl)ethenyl]benzonitrile,C1=CC(=CC(=C1)C#N)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4737,154738,4-[2-(4-Nitrophenyl)ethenyl]benzonitrile,C1=CC(=CC=C1C=CC2=CC=C(C=C2)[N+](=O)[O-])C#N,,,,,,
4738,154739,"1',5-Dimethoxy-3',7-dimethyl-(2,2'-binaphthalene)-1,4,5',8'-tetrol",CC1=CC2=C(C(=CC(=C2C(=C1)OC)O)C3=C(C4=C(C=CC(=C4C=C3C)O)O)OC)O,,,,,,
4739,154740,"1-Methylbenz(a)anthracene 5,6-imine",CC1=C2C(=CC=C1)C3=C(N3)C4=CC5=CC=CC=C5C=C42,,,,,,
4740,154741,"7-Ethylbenz(a)anthracene 5,6-oxide",CCC1=C2C(=CC3=CC=CC=C31)C4=CC=CC=C4C5=C2O5,,,,,,
4741,154742,"7-Ethylbenz(a)anthracene 5,6-imine",CCC1=C2C(=CC3=CC=CC=C31)C4=CC=CC=C4C5=C2N5,,,,,,
4742,154743,"4-((2-Chloro-4,6-dinitrophenyl)azo)-N,N-diethylbenzenamine",CCN(CC)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4743,154744,7-Hydroxymethyl-9-methylbenz(c)acridine,CC1=CC2=C(C=C1)N=C3C(=C2CO)C=CC4=CC=CC=C43,,,,,,
4744,154745,9-Hydroxymethyl-7-methylbenz(c)acridine,CC1=C2C=CC3=CC=CC=C3C2=NC4=C1C=C(C=C4)CO,,,,,,
4745,154746,"7,9-Bis(hydroxymethyl)benz(c)acridine",C1=CC=C2C(=C1)C=CC3=C(C4=C(C=CC(=C4)CO)N=C32)CO,,,,,,
4746,154747,7-Hydroxymethyl-10-methylbenz(c)acridine,CC1=CC2=C(C=C1)C(=C3C=CC4=CC=CC=C4C3=N2)CO,,,,,,
4747,154748,10-Hydroxymethyl-7-methylbenz(c)acridine,CC1=C2C=CC(=CC2=NC3=C1C=CC4=CC=CC=C43)CO,,,,,,
4748,154749,"7,10-Bis(hydroxymethyl)benz(c)acridine",C1=CC=C2C(=C1)C=CC3=C(C4=C(C=C(C=C4)CO)N=C32)CO,,,,,,
4749,154750,"7,9-Dimethylbenz(c)acridine-5,6-oxide",CC1=CC2=C(C3=C(C4=CC=CC=C4C5=C3O5)N=C2C=C1)C,,,,,,
4750,154751,"trans-5,6-Dihydro-5,6-dihydroxy-7,9-dimethylbenz(c)acridine",CC1=CC2=C(C3=C(C4=CC=CC=C4[C@H]([C@@H]3O)O)N=C2C=C1)C,,,,,,
4751,154752,"9-Hydroxymethyl-7-methylbenz(c)acridine-5,6-oxide",CC1=C2C=C(C=CC2=NC3=C1C4=C(O4)C5=CC=CC=C53)CO,,,,,,
4752,154753,"trans-5,6-Dihydro-5,6-dihydroxy-7,10-dimethylbenz(c)acridine",CC1=CC2=NC3=C([C@H]([C@@H](C4=CC=CC=C43)O)O)C(=C2C=C1)C,,,,,,
4753,154754,"trans-3,4-Dihydro-3,4-dihydroxy-7,9-dimethylbenz[C]acridine",CC1=CC2=C(C=C1)N=C3C4=C(C=CC3=C2C)[C@@H]([C@H](C=C4)O)O,,,,,,
4754,154755,"trans-8,9-Dihydro-8,9-dihydroxy-7,10-dimethylbenz[C]acridine",CC1=CC2=C([C@@H]([C@H]1O)O)C(=C3C=CC4=CC=CC=C4C3=N2)C,,,,,,
4755,154756,"trans-3,4-Dihydro-3,4-dihydroxy-7,10-dimethylbenz[C]acridine",CC1=CC2=NC3=C(C=CC4=C3C=C[C@@H]([C@H]4O)O)C(=C2C=C1)C,,,,,,
4756,154757,"1,1-Diethylhydrazine oxalate",CCN(CC)N.C(=O)(C(=O)O)O,,,,,,
4757,154758,"trans-3,4-Dihydro-9-(hydroxymethyl)-7-methyl-benz(c)acridine-3,4-diol",CC1=C2C=CC3=C(C2=NC4=C1C=C(C=C4)CO)C=C[C@@H]([C@H]3O)O,,,,,,
4758,154759,"7-Hydroxymethyl-9-methylbenz(c)acridine-3,4-dihydrodiol",CC1=CC2=C(C=C1)N=C3C4=C(C=CC3=C2CO)[C@@H]([C@H](C=C4)O)O,,,,,,
4759,154760,"1,1-Dipropylhydrazine oxalate",CCCN(CCC)N.C(=O)(C(=O)O)O,,,,,,
4760,154761,"1,2-Dipropylhydrazine oxalate",CCCNNCCC.C(=O)(C(=O)O)O,,,,,,
4761,154762,"6-Quinoxalinamine, N,5-dimethyl-",CC1=C(C=CC2=NC=CN=C12)NC,,,,,,
4762,154763,"6-Quinoxalinamine, N,2,5-trimethyl-",CC1=CN=C2C(=C(C=CC2=N1)NC)C,,,,,,
4763,154764,"6-Quinoxalinamine, N,2,3,5-tetramethyl-",CC1=C(C=CC2=NC(=C(N=C12)C)C)NC,,,,,,
4764,154765,"2,3-Diethyl-N,5-dimethyl-6-quinoxalinamine",CCC1=NC2=C(C(=C(C=C2)NC)C)N=C1CC,,,,,,
4765,154766,"6-Quinoxalinamine, N,5-dimethyl-3-phenyl-",CC1=C(C=CC2=NC=C(N=C12)C3=CC=CC=C3)NC,,,,,,
4766,154767,"6-Quinoxalinamine, 2,3,5-trimethyl-",CC1=C(C=CC2=NC(=C(N=C12)C)C)N,,,,,,
4767,154768,"6-Quinoxalinamine, N,N,2,3,5-pentamethyl-",CC1=C(C=CC2=NC(=C(N=C12)C)C)N(C)C,,,,,,
4768,154769,2-Chloro-3-methylbut-2-enedioic acid,CC(=C(C(=O)O)Cl)C(=O)O,,,,,,
4769,154770,"Pyrido(3,4-d)pyridazine 2-oxide",C1=CN=CC2=CN=[N+](C=C21)[O-],,,,,,
4770,154771,"Pyrido(3,4-d)pyridazine 3-oxide",C1=CN=CC2=C[N+](=NC=C21)[O-],,,,,,
4771,154772,"Pyrido(3,4-d)pyridazine 6-oxide",C1=C[N+](=CC2=CN=NC=C21)[O-],,,,,,
4772,154773,"Pyrido(3,4-d)pyridazin-1(2H)-one hydrazone",C1=CN=CC2=CN=NC(=C21)NN,,,,,,
4773,154774,"Pyrido(3,4-d)pyridazin-4(3H)-one hydrazone",C1=CN=CC2=C(N=NC=C21)NN,,,,,,
4774,154775,"1-Methoxypyrido[3,4-d]pyridazine",COC1=C2C=CN=CC2=CN=N1,,,,,,
4775,154776,"4-Methoxypyrido[3,4-d]pyridazine",COC1=C2C=NC=CC2=CN=N1,,,,,,
4776,154777,"1-Chloropyrido[3,4-d]pyridazine",C1=CN=CC2=CN=NC(=C21)Cl,,,,,,
4777,154778,"4-Chloropyrido[3,4-d]pyridazine",C1=CN=CC2=C(N=NC=C21)Cl,,,,,,
4778,154779,"Ethanone, 2-bromo-1-(3,4-dichloro-5-nitro-2-furanyl)-",C(C(=O)C1=C(C(=C(O1)[N+](=O)[O-])Cl)Cl)Br,,,,,,
4779,154780,3-Fluorobenzo[h]quinoline,C1=CC=C2C(=C1)C=CC3=CC(=CN=C32)F,,,,,,
4780,154781,5-Fluorobenzo[h]quinoline,C1=CC=C2C(=C1)C=C(C3=C2N=CC=C3)F,,,,,,
4781,154782,6-Fluorobenzo[h]quinoline,C1=CC=C2C(=C1)C(=CC3=C2N=CC=C3)F,,,,,,
4782,154783,7-Fluorobenzo[h]quinoline,C1=CC2=C(C=CC3=C2N=CC=C3)C(=C1)F,,,,,,
4783,154784,9-Fluorobenzo[h]quinoline,C1=CC2=C(C3=C(C=C2)C=CC(=C3)F)N=C1,,,,,,
4784,154785,"3,6-Difluorobenzo(h)quinoline",C1=CC=C2C(=C1)C(=CC3=CC(=CN=C23)F)F,,,,,,
4785,154786,"7,10-Difluorobenzo(h)quinoline",C1=CC2=C(C3=C(C=CC(=C3C=C2)F)F)N=C1,,,,,,
4786,154787,2-Fluorobenzo[f]quinoline,C1=CC=C2C(=C1)C=CC3=C2C=C(C=N3)F,,,,,,
4787,154788,7-Fluorobenzo[f]quinoline,C1=CC2=C(C=CC3=C2C=CC=N3)C(=C1)F,,,,,,
4788,154789,10-Fluorobenzo[f]quinoline,C1=CC2=C(C3=C(C=C2)N=CC=C3)C(=C1)F,,,,,,
4789,154790,"7,10-Difluorobenzo(f)quinoline",C1=CC2=C(C=CC3=C(C=CC(=C23)F)F)N=C1,,,,,,
4790,154791,Pentyl selenocyanate,CCCCC[Se]C#N,,,,,,
4791,154792,2-Chloro-4-methylthiobutanoic acid,CCCC(C(=O)S)Cl,,,,,,
4792,154793,"(1S,6S)-6-Methylbicyclo(4.1.0)hept-2-ene-1,2-dicarbaldehyde",C[C@@]12CCC=C([C@@]1(C2)C=O)C=O,,,,,,
4793,154794,"(1R,6R)-6-Methylbicyclo(4.1.0)hept-2-ene-1,2-dicarbaldehyde",C[C@]12CCC=C([C@]1(C2)C=O)C=O,,,,,,
4794,154795,"Bicyclo(4.1.0)hept-2-ene-1,2-dicarbaldehyde",C1CC2CC2(C(=C1)C=O)C=O,,,,,,
4795,154796,N-(4-Phenoxyphenyl)formamide,C1=CC=C(C=C1)OC2=CC=C(C=C2)NC=O,,,,,,
4796,154797,N-Hydroxy-N-(4-phenoxyphenyl)formamide,C1=CC=C(C=C1)OC2=CC=C(C=C2)N(C=O)O,,,,,,
4797,154798,"N-Hydroxy-N-(4-(2,4-dichlorophenoxy)phenyl)formamide",C1=CC(=CC=C1N(C=O)O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
4798,154799,"N-Hydroxy-N-(4-(2,4,6-trichlorophenoxy)phenyl)formamide",C1=CC(=CC=C1N(C=O)O)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
4799,154800,"3,3-Dichloro-4-(dichloromethylene)-2,5-pyrrolidinedione",C1(=C(Cl)Cl)C(=O)NC(=O)C1(Cl)Cl,,,,,,
4800,154801,"N-(2-Chloroethyl) N-ethyl-4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)benzenamine",CCN(CCCl)C1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C,,,,,,
4801,154802,"N,N-Bis(2-chloroethyl)-4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)benzenamine",CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)N(CCCl)CCCl,,,,,,
4802,154803,"Benzenamine, N,N-bis(2-chloroethyl)-4-(5-((5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl)methyl)-1H-benzimidazol-2-yl)-",CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)CC4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)N(CCCl)CCCl,,,,,,
4803,154804,"N,N-Bis(2-chloroethyl)-4-(5-(2-(5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl)ethyl)-1H-benzimidazol-2-yl)-benzenamine",CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)CCC4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)N(CCCl)CCCl,,,,,,
4804,154805,"N,N-Bis(2-chloroethyl)-4-(5-(3-(5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl)propyl)-1H-benzimidazol-2-yl)benzenamine",CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)CCCC4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)N(CCCl)CCCl,,,,,,
4805,154806,"N,N-Bis(2-chloroethyl)-4-(5-(6-(5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl)hexyl)-1H-benzimidazol-2-yl)benzenamine",CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)CCCCCCC4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)N(CCCl)CCCl,,,,,,
4806,154807,"1-Methyl-1H-imidazo(4,5-b)(1,8)naphthyridin-2-amine",CN1C2=C(N=C3C(=C2)C=CC=N3)N=C1N,,,,,,
4807,154808,p-Hydroxymethylbenzene diazonium hydrogen sulfate,C1=CC(=CC=C1CO)[N+]#N.OS(=O)(=O)[O-],,,,,,
4808,154809,p-Methoxymethylbenzene diazonium hydrogen sulfate,COCC1=CC=C(C=C1)[N+]#N.OS(=O)(=O)[O-],,,,,,
4809,154810,4-(Methoxymethyl)benzenediazonium,COCC1=CC=C(C=C1)[N+]#N,,,,,,
4810,154811,"3-(Dichloromethylene)-2,5-pyrrolidinedione",C1C(=C(Cl)Cl)C(=O)NC1=O,,,,,,
4811,154812,"3-Chloro-4-(dichloromethylene)-2,5-pyrrolidinedione",C1(C(=C(Cl)Cl)C(=O)NC1=O)Cl,,,,,,
4812,154813,4-Acetamido-4'-hydroxylaminodiphenyl ether,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)NO,,,,,,
4813,154814,N-(4-(4-(Acetylamino)phenoxy)phenyl)-N-hydroxyacetamide,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)N(C(=O)C)O,,,,,,
4814,154815,N-(4-(4-(Formylhydroxyamino)phenoxy)phenyl)acetamide,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)N(C=O)O,,,,,,
4815,154816,N-(4-(4-(Acetylamino)phenoxy)phenyl)-N-(acetyloxy)acetamide,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)N(C(=O)C)OC(=O)C,,,,,,
4816,154817,(R)-1-Azido-2-phenylpropane,C[C@@H](CN=[N+]=[N-])C1=CC=CC=C1,,,,,,
4817,154818,"(R,S)-1-Azido-3-phenylbutane",C[C@H](CCN=[N+]=[N-])C1=CC=CC=C1,,,,,,
4818,154819,"1-Azido-3,3-diphenylpropane",C1=CC=C(C=C1)C(CCN=[N+]=[N-])C2=CC=CC=C2,,,,,,
4819,154820,(R)-3-Azido-2-benzylpropanol,C1=CC=C(C=C1)C[C@H](CN=[N+]=[N-])CO,,,,,,
4820,154821,(S)-3-Azido-2-benzylpropanol,C1=CC=C(C=C1)C[C@@H](CN=[N+]=[N-])CO,,,,,,
4821,154822,m-Nitrobenzyl propionate,CCC(=O)OCC1=CC(=CC=C1)[N+](=O)[O-],,,,,,
4822,154823,1-Sulfooxy-3-methylcholanthrene,CC1=C2CC(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)OS(=O)(=O)O,,,,,,
4823,154824,10-(3-(Phthalimido)propyl)-2-chloro-10H-phenothiazine,C1=CC=C2C(=C1)C(=O)N(C2=O)CCCN3C4=CC=CC=C4SC5=C3C=C(C=C5)Cl,,,,,,
4824,154825,"1-Acetamidopyrene-4,5-quinone",CC(=O)NC1=C2C=CC3=C4C2=C(C=C1)C(=O)C(=O)C4=CC=C3,,,,,,
4825,154826,"7-Methyl-6-(trifluoromethyl)-2,4-dipyrrolidinyl-7H-pyrrolo(2,3-d)pyrimidine",CN1C(=CC2=C1N=C(N=C2N3CCCC3)N4CCCC4)C(F)(F)F,,,,,,
4826,154827,4-(1-Methylethylidene)-2-cyclohexen-1-ol,CC(=C1CCC(C=C1)O)C,,,,,,
4827,154828,1-Methyl-1H-cyclopenta(c)phenanthrene,CC1C=CC2=C1C3=C(C=C2)C=CC4=CC=CC=C43,,,,,,
4828,154829,"9,10,11,12-Tetrahydro-8H-dicyclopenta(a,c)phenanthren-7-one",C1CCC2=C(C1)CC(=O)C3=C2C4=CC=CC4=C5C3=CC=C5,,,,,,
4829,154830,1-(Methylnitrosoamino)-2-pentanone,CCCC(=O)CN(C)N=O,,,,,,
4830,154831,R(+)-1-Acetamino-3-(1-naphthyloxy)-2-propanol,CC(=O)NC[C@H](COC1=CC=CC2=CC=CC=C21)O,,,,,,
4831,154832,Ccris 7866,CC(=O)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O,,,,,,
4832,154833,"5-Nitro-7H-dibenzo(c,g)carbazole",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=C(C5=CC=CC=C54)[N+](=O)[O-],,,,,,
4833,154834,CID 154834,C1=CC=C2C(=C1)C=CC3=C2C4=C5C=CC(=O)C=C5C(=CC4=N3)N(O)O,,,,,,
4834,154835,CID 154835,C1=CC=C2C(=C1)C=CC3=NC4=CC(=C5C(=O)C=CC=C5C4=C32)N(O)O,,,,,,
4835,154836,CID 154836,C1=CC=C2C(=C1)C(=CC3=NC4=CC=C5C(=O)C=CC=C5C4=C23)N(O)O,,,,,,
4836,154837,CID 154837,C1=CC=C2C(=C1)C=CC3=NC4=CC(=C5C=CC(=O)C=C5C4=C32)N(O)O,,,,,,
4837,154838,CID 154838,C1=CC=C2C(=C1)C(=CC3=NC4=CC=C5C=CC(=O)C=C5C4=C23)N(O)O,,,,,,
4838,154839,"3,5-Difluoroquinoline",C1=CC2=C(C=C(C=N2)F)C(=C1)F,,,,,,
4839,154840,"6-Fluoro-1,7-phenanthroline",C1=CC2=CC(=C3C(=C2N=C1)C=CC=N3)F,,,,,,
4840,154841,"9-Fluoro-1,7-phenanthroline",C1=CC2=C(C3=C(C=C2)N=CC(=C3)F)N=C1,,,,,,
4841,154842,"3,9-Difluoro-1,7-phenanthroline",C1=CC2=C(C=C(C=N2)F)C3=NC=C(C=C31)F,,,,,,
4842,154843,"5-Fluoro-1,10-phenanthroline",C1=CC2=CC(=C3C=CC=NC3=C2N=C1)F,,,,,,
4843,154844,3-Acetamidofluoranthen-2-ol,CC(=O)NC1=C(C=C2C3=CC=CC=C3C4=CC=CC1=C42)O,,,,,,
4844,154845,3-Acetamidofluoranthen-8-ol,CC(=O)NC1=C2C=CC=C3C2=C(C=C1)C4=C3C=C(C=C4)O,,,,,,
4845,154846,3-Acetamidofluoranthen-9-ol,CC(=O)NC1=C2C=CC=C3C2=C(C=C1)C4=C3C=CC(=C4)O,,,,,,
4846,154847,3-Bromo-4-(bromomethyl)-2(5H)-furanone,C1C(=C(C(=O)O1)Br)CBr,,,,,,
4847,154848,3-Bromo-4-(bromomethyl)-5-hydroxy-2(5H)-furanone,C(C1=C(C(=O)OC1O)Br)Br,,,,,,
4848,154849,3-Chloro-4-(bromomethyl)-2(5H)-furanone,C1C(=C(C(=O)O1)Cl)CBr,,,,,,
4849,154850,"3,3'-Diamino-4'-methoxyflavone",COC1=C(C=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)N)N,,,,,,
4850,154851,"3,3'-Dinitro-4'-methoxyflavone",COC1=C(C=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4851,154852,9-Methyl-2-nitrocarbazole,CN1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],,,,,,
4852,154853,"1,4,9-Trimethyl-3-nitrocarbazole",CC1=CC(=C(C2=C1N(C3=CC=CC=C32)C)C)[N+](=O)[O-],,,,,,
4853,154854,"1,4,6-Trimethyl-3-nitrocarbazole",CC1=CC2=C(C=C1)NC3=C2C(=C(C=C3C)[N+](=O)[O-])C,,,,,,
4854,154855,"5,9-Dinitro-7H-dibenzo(c,g)carbazole",C1=CC=C2C(=C1)C(=CC3=C2C4=C(N3)C=C(C5=CC=CC=C54)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4855,154856,3-Bromo-4-(dibromomethyl)-2(5H)-furanone,C1C(=C(C(=O)O1)Br)C(Br)Br,,,,,,
4856,154857,"2(5H)-Furanone, 3-bromo-4-(chloromethyl)-",C1C(=C(C(=O)O1)Br)CCl,,,,,,
4857,154858,3-Chloro-4-(dibromomethyl)-2(5H)-furanone,C1C(=C(C(=O)O1)Cl)C(Br)Br,,,,,,
4858,154859,"N2-Hydroxy-2-amino-3-methyl-9H-pyrido(2,3-b)indole",CC1=CC2=C(NC3=CC=CC=C32)N=C1NO,,,,,"['2-hydroxylamino-3-methyl-9H-pyrido[2,3-b]indole has known human metabolites that include [(3-methyl-9H-pyrido[2,3-b]indol-2-yl)amino] hydrogen sulfate.']",
4859,154860,CID 154860,C(C(=C(C(=O)O)Cl)C=O)Cl,,,,,,
4860,154861,2-Chloro-3-methyl-4-oxobut-2-enoic acid,CC(=C(C(=O)O)Cl)C=O,,,,,,
4861,154862,CID 154862,C(C(=CC(=O)O)C(Cl)Cl)Cl,,,,,,
4862,154863,CID 154863,C(C(=C(C(=O)O)Cl)C(Cl)Cl)Cl,,,,,,
4863,154864,2-Chloro-3-(chloromethyl)but-2-enedioic acid,C(C(=C(C(=O)O)Cl)C(=O)O)Cl,,,,,,
4864,154865,Heptyl selenocyanate,CCCCCCC[Se]C#N,,,,,,
4865,154866,"5-Chloropyrido[2,3-d]pyridazine",C1=CC2=C(N=NC=C2N=C1)Cl,,,,,,
4866,154867,"8-Chloropyrido[2,3-d]pyridazine",C1=CC2=CN=NC(=C2N=C1)Cl,,,,,,
4867,154868,"Pyrido(2,3-d)pyridazin-8(7H)-one hydrazone",C1=CC2=CN=NC(=C2N=C1)NN,,,,,,
4868,154869,Hexa(p-hydroxyphenoxy)cyclotriphosphazene,C1=CC(=CC=C1O)ON2P(N=P(N(P2OC3=CC=C(C=C3)O)OC4=CC=C(C=C4)O)(OC5=CC=C(C=C5)O)OC6=CC=C(C=C6)O)OC7=CC=C(C=C7)O,,,,,,
4869,154870,"9-(2-Carboxyphenyl)-3,6-bis(diethylamino)xanthylium perchlorate",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=CC=CC=C4C(=O)O.[O-]Cl(=O)(=O)=O,,,,,,
4870,154871,"Ethanone, 1-[4-(acetyloxy)-3-[(acetyloxy)methyl]phenyl]-",CC(=O)C1=CC(=C(C=C1)OC(=O)C)COC(=O)C,,,,,,
4871,154872,"Ethanone, 2-((1,1-dimethylethyl)(phenymethyl)amino)-1-(4-hydroxy-3-(hydroxymethyl)phenyl)-, hydrochloride",CC(C)(C)N(CC1=CC=CC=C1)CC(=O)C2=CC(=C(C=C2)O)CO.Cl,,,,,,
4872,154873,4-Hydroxydibenzothiophene,C1=CC=C2C(=C1)C3=C(S2)C(=CC=C3)O,,,,,,
4873,154874,"Tritriacontane-16,18-dione",CCCCCCCCCCCCCCCC(=O)CC(=O)CCCCCCCCCCCCCCC,,,,,,
4874,154875,Ethanenitronate,[CH2-]C[N+](=O)[O-],,,,,,
4875,154876,Ethyl 8-quinolinecarboxylate,CCOC(=O)C1=CC=CC2=C1N=CC=C2,,,,,,
4876,154877,"15H-Cyclopenta(a)phenanthrene, 16,17-dihydro-11-methyl-",CC1=CC2=C(CCC2)C3=C1C4=CC=CC=C4C=C3,,,,,,
4877,154878,N-Benzyl-2-chloropropanamide,CC(C(=O)NCC1=CC=CC=C1)Cl,,,,,,
4878,154879,p-Carboxybenzene diazonium hydrogen sulfate,C1=CC(=CC=C1C(=O)O)[N+]#N.OS(=O)(=O)[O-],,,,,,
4879,154880,"Benzenediazonium, 4-carboxy-",C1=CC(=CC=C1C(=O)O)[N+]#N,,,,,,
4880,154881,6-Azabenzo(a)pyrene,C1=CC=C2C(=C1)C3=C4C(=N2)C=CC5=CC=CC(=C54)C=C3,,,,,,
4881,154882,1-Methoxyphthalazine,COC1=NN=CC2=CC=CC=C21,,,,,,
4882,154883,"N,N,O-Tri(methylcarbamoyl)hydroxylamine",CNC(=O)NOC(=O)N(C)C(=O)NC,,,,,,
4883,154884,"N,N-Di(methylcarbamoyl)hydroxylamine",CNC(=O)N(C)C(=O)NO,,,,,,
4884,154885,CID 154885,C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC=C(C(=C1)C(=O)[O-])O.[Cr+3],,,,,,
4885,154886,4-Methoxynitracrine,CN(C)CCCNC1=C2C(=CC=C(C2=NC3=CC=CC=C31)OC)[N+](=O)[O-],,,,,,
4886,154887,3-(4-Bromosylphenyl)-1-phenylprop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC=C(C=C2)Br=O,,,,,,
4887,154888,"N,N-Di(p-tolyl)hydrazine",CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)N,,,,,,
4888,154889,4-Hydroxy-1-phenyl-1-pentanone,CC(CCC(=O)C1=CC=CC=C1)O,,,,,,
4889,154890,"6-Allyl-5,6-dihydro-5-hydroxypyran-2-one",C=CCC1C(C=CC(=O)O1)O,,,,,,
4890,154891,"beta,beta,2,3,4,5,6-Heptachlorostyrene",C(=C(Cl)Cl)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
4891,154892,"Propan-2-yl 2,3-dichloro-4-oxobut-2-enoate",CC(C)OC(=O)C(=C(C=O)Cl)Cl,,,,,,
4892,154893,4-(Pyridin-3-yl)thiazol-2-amine,C1=CC(=CN=C1)C2=CSC(=N2)N,,,,,,
4893,154894,"1-Methylnaphth(2,3-d)imidazol-2-amine",CN1C2=CC3=CC=CC=C3C=C2N=C1N,,,,,,
4894,154895,"1-(2,3-Xylylazo)-2-naphthol",CC1=C(C(=CC=C1)N=NC2=C(C=CC3=CC=CC=C32)O)C,,,,,,
4895,154896,CID 154896,C1=CC(=CC=C1S)S(=O)(=O)[O-].[Na+],,,,,,
4896,154897,Diethyl (5-phenylisoxazol-3-yl) phosphate,CCOP(=O)(OCC)OC1=NOC(=C1)C2=CC=CC=C2,,,,,,
4897,154898,"N,N-Dimethyl-2,3-dihydrophenalen-2-amine hydrochloride",CN(C)C1CC2=CC=CC3=C2C(=CC=C3)C1.Cl,,,,,,
4898,154899,2-(2-Methylphenyl)benzoxazole,CC1=CC=CC=C1C2=NC3=CC=CC=C3O2,,,,,,
4899,154900,"3,7-dimethyl-N-phenyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=CC=C2)C)C,,,,,,
4900,154901,"9,10-Dinitroanthracene",C1=CC=C2C(=C1)C(=C3C=CC=CC3=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
4901,154902,"4,4'-Bis(methylamino)azobenzene",CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)NC,,,,,,
4902,154903,"5,7-Dibromoquinoline",C1=CC2=C(C=C(C=C2Br)Br)N=C1,,,,,,
4903,154904,"2,2-Diphenylethyl isothiocyanate",C1=CC=C(C=C1)C(CN=C=S)C2=CC=CC=C2,,,,,,
4904,154905,1-Ethynylpyrene,C#CC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
4905,154906,2-Amino-6-N-hydroxylaminopurine riboside,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)NO,,,,,,
4906,154907,N-Hydroxy-9-methyladenine,CN1C=NC2=C(N=CN=C21)NO,,,,,,
4907,154908,1-Chloro-3-[2-(4-nitrophenyl)ethenyl]benzene,C1=CC(=CC(=C1)Cl)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4908,154909,"3,4-Epoxy-2-methyl-1-butene",CC(=C)C1CO1,,,,,,
4909,154910,4-[2-(4-Methoxyphenyl)ethenyl]benzenamine,COC1=CC=C(C=C1)C=CC2=CC=C(C=C2)N,,,,,,
4910,154911,Calcium saccharate,[C@H]([C@@H]([C@@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O.[Ca+2],,,,,,
4911,154912,Cadmium sulfate hydrate,O.[O-]S(=O)(=O)[O-].[Cd+2],,,,,,
4912,154913,9-Methyl-1-oxido-purin-1-ium-6-amine,CN1C=NC2=C1N=CN(C2=N)O,,,,,,
4913,154914,Sodium aristolochate,COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)[O-].[Na+],,,"['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)', 'Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
4914,154915,(2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane,CCO[Si](CCC1CCC2C(C1)O2)(OCC)OCC,,,,,,
4915,154916,1-(2-Thiazolyl)-2-imidazolidinone,C1CN(C(=O)N1)C2=NC=CS2,,,,,,
4916,154917,N-Benzylpropanamide,CCC(=O)NCC1=CC=CC=C1,,,,,,
4917,154918,"Acenaphthylene, 3-nitro-",C1=CC2=C3C(=C1)C=CC3=C(C=C2)[N+](=O)[O-],,,,,,
4918,154919,5-Nitroacenaphthylene,C1=CC2=C3C(=CC=C(C3=C1)[N+](=O)[O-])C=C2,,,,,,
4919,154920,4-Bromophenylhydroxylamine,C1=CC(=CC=C1NO)Br,,,,,,
4920,154921,"2-Nitro-4,5,9,10-tetrahydropyrene",C1CC2=C3C(=CC(=C2)[N+](=O)[O-])CCC4=CC=CC1=C43,,,,,,
4921,154922,"Methyl 18-hydroxyoctadeca-2,4-dienoate",COC(=O)C=CC=CCCCCCCCCCCCCCO,,,,,,
4922,154923,Tamoxifen-d5,[2H]C([2H])([2H])C([2H])([2H])C(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,,,,,,
4923,154924,"Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, compd. with 1-pyrrolidineethanol (1:1), dihydrate",C1CCN(C1)CCO.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl.O.O,,,,,,
4924,154925,(R)-N-(Methyl-d-t)-N-nitrosourea,[3H]CN(C(=O)N)N=O,,,,,,
4925,154926,Benzophenone-9,COC1=C(C=C(C(=C1)O)C(=O)C2=CC(=C(C=C2O)OC)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4926,154927,"2,2'-Dihydroxy-4,4'-dimethoxybenzophenone-5,5'-disulfonic acid",COC1=C(C=C(C(=C1)O)C(=O)C2=CC(=C(C=C2O)OC)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4927,154928,D-Serine diazoacetate,C([C@H](C(=O)O)N)OC(=O)C=[N+]=[N-],,,,,,
4928,154929,2-[(2R)-2-amino-2-carboxyethoxy]-2-hydroxyethenediazonium,C([C@H](C(=O)O)N)OC(=C[N+]#N)O,,,,,,
4929,154930,"3H,5H-Pyreno(1,10-cd)pyran-3,5-dione",C1=CC2=C3C(=C1)C=C4C5=C(C=CC(=C35)C=C2)C(=O)OC4=O,,,,,,
4930,154931,"Bis(2,2'-bipyridine-N,N')oxalatochromium iodide",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C(=O)(C(=O)[O-])[O-].[Cr+3].[I-],,,,,,
4931,154932,Gossypol-polyvinylpyrrolidone,CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O.C=CN1CCCC1=O,,,,,,
4932,154933,Epoxyparthenolide,CC12CCC3C(C4C(O4)(CCC1O2)C)OC(=O)C3=C,,,,,,
4933,154934,CID 154934,CCC(C)C(=O)OC(C)OCC12C(CC(C(C1O)OC(=O)C)OC(=O)C)CC(C3(C2C(=O)C(C4(C35C(O5)CC4C6=COC=C6)C)O)C)O,,,,,,
4934,154935,"syn-Chrysene-3,4-diol 1,2-oxide",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3[C@H]([C@@H]([C@@H]5[C@H]4O5)O)O,,,,,,
4935,154936,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-((phenylseleno)acetyl)-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C[Se]C6=CC=CC=C6)O)NC(=O)C(F)(F)F)O,,,,,,
4936,154937,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-((phenylthio)acetyl)-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSC6=CC=CC=C6)O)NC(=O)C(F)(F)F)O,,,,,,
4937,154938,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)(C(=O)C)O)N)O,,,,,,
4938,154939,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9-dihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=CC4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)(C(=O)CO)O)N)O,,,,,,
4939,154940,"N-[13-butan-2-yl-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propyl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-2-[2-hydroxypropanoyl(methyl)amino]-4-methylpentanamide",CCCC1C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)NC(C(CC(=O)O1)O)C(C)CC)NC(=O)C(CC(C)C)N(C)C(=O)C(C)O)C)CC3=CC=C(C=C3)OC)C)CC(C)C)C,,,,,,
4940,154941,"meso-(2,3-Butanediamine)dichloroplatinum",CC(C(C)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
4941,154942,"1a,9b-Dihydro-4-phenyl-2H-oxireno(3,4)naphtho(1,2-b)pyran-2-one",C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C5C3O5,,,,,,
4942,154943,10-epi-Aclacinomycin A,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
4943,154944,"Nonaamminechloro-mu-hydroxydichromium(4+) tetrachloride, stereoisomer",N.N.N.N.N.N.N.N.N.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
4944,154945,"2,3-Dihydroxypropyl 5-deoxy-5-(dimethylarsinyl)-beta-D-Ribofuranoside",C[As](=O)(C)C[C@@H]1[C@H]([C@H]([C@@H](O1)OCC(CO)O)O)O,,,,,,
4945,154946,6-Methoxydaunomycin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)OC)(C(=O)C)O)N)O,,,,,,
4946,154947,"Methanesulfonamide, N-(3-methoxy-4-((3-methoxy-9-acridinyl)amino)phenyl)-, monohydrochloride",COC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC.Cl,,,,,,
4947,154948,"Methanesulfonamide, N-(4-((3-fluoro-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)F.Cl,,,,,,
4948,154949,"Methanesulfonanilide, 4'-((3-fluoro-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)F,,,,,,
4949,154950,"Carbamic acid, (9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-3-acridinyl)-, methyl ester, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)NC(=O)OC.Cl,,,,,,
4950,154951,"Methanesulfonamide, N-(4-((3-cyano-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)C#N.Cl,,,,,,
4951,154952,"Methanesulfonamide, N-(3-methoxy-4-((2-methyl-9-acridinyl)amino)phenyl)-, monohydrochloride",CC1=CC2=C(C3=CC=CC=C3N=C2C=C1)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC.Cl,,,,,,
4952,154953,"Methanesulfonanilide, 3'-methoxy-4'-((2-methyl-9-acridinyl)amino)-",CC1=CC2=C(C3=CC=CC=C3N=C2C=C1)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC,,,,,,
4953,154954,"Methanesulfonamide, N-(3-methoxy-4-((2-(1-methylethyl)-9-acridinyl)amino)phenyl)-, monohydrochloride",CC(C)C1=CC2=C(C3=CC=CC=C3N=C2C=C1)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC.Cl,,,,,,
4954,154955,"Methanesulfonanilide, 4'-((2-isopropyl-9-acridinyl)amino)-3'-methoxy-",CC(C)C1=CC2=C(C3=CC=CC=C3N=C2C=C1)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC,,,,,,
4955,154956,"Methanesulfonamide, N-(4-((2-fluoro-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=C(C=CC3=NC4=CC=CC=C42)F.Cl,,,,,,
4956,154957,"Methanesulfonanilide, 4'-((2-fluoro-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=C(C=CC3=NC4=CC=CC=C42)F,,,,,,
4957,154958,"Methanesulfonamide, N-(4-((2-iodo-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=C(C=CC3=NC4=CC=CC=C42)I.Cl,,,,,,
4958,154959,"Methanesulfonanilide, 4'-((2-iodo-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=C(C=CC3=NC4=CC=CC=C42)I,,,,,,
4959,154960,"Morpholine, 4-((9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-4-acridinyl)carbonyl)-, monohydrobromide",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N5CCOCC5.Br,,,,,,
4960,154961,"Methanesulfonanilide, 3'-methoxy-4'-((4-(morpholinocarbonyl)-9-acridinyl)amino)-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N5CCOCC5,,,,,,
4961,154962,"Methanesulfonamide, N-(4-((4-fluoro-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)F.Cl,,,,,,
4962,154963,"Methanesulfonanilide, 4'-((4-fluoro-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)F,,,,,,
4963,154964,"Methanesulfonamide, N-(4-((4-chloro-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)Cl.Cl,,,,,,
4964,154965,"Methanesulfonanilide, 4'-((4-chloro-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)Cl,,,,,,
4965,154966,"Methanesulfonamide, N-(4-((4-bromo-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)Br.Cl,,,,,,
4966,154967,"Methanesulfonanilide, 4'-((4-bromo-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)Br,,,,,,
4967,154968,"Methanesulfonamide, N-(4-((4-cyano-9-acridinyl)amino)-3-methoxyphenyl)-, monohydrochloride",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C#N.Cl,,,,,,
4968,154969,"Methanesulfonanilide, 4'-((4-cyano-9-acridinyl)amino)-3'-methoxy-",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C#N,,,,,,
4969,154970,"Rhodium, tris(pyridine)tris(thiocyanato-S)-, (OC-6-21)-",C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.C(#N)[S-].C(#N)[S-].C(#N)[S-].[Rh+3],,,,,,
4970,154971,"Propanoic acid, 3-(3-(1-piperidinylmethyl)phenoxy)-",C1CCN(CC1)CC2=CC(=CC=C2)OCCC(=O)O,,,,,,
4971,154972,CID 154972,CC(C)OP(=O)([O-])SCC1=CC=CC=C1.[Na+],,,,,,
4972,154973,S-Benzyl O-isopropyl hydrogen phosphorothioate,CC(C)OP(=O)(O)SCC1=CC=CC=C1,,,,,,
4973,154974,"Hexanamide, 6-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCC(=O)N,,,,,,
4974,154975,"Glycine, N-(6-chloro-2-methoxy-9-acridinyl)-, methyl ester",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCC(=O)OC,,,,,,
4975,154976,"beta-Alanine, N-(6-chloro-2-methoxy-9-acridinyl)-, methyl ester",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCC(=O)OC,,,,,,
4976,154977,"Hexanoic acid, 6-((6-chloro-2-methoxy-9-acridinyl)amino)-, methyl ester",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCC(=O)OC,,,,,,
4977,154978,"Propanamide, 3-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCC(=O)N,,,,,,
4978,154979,"Pentanamide, 5-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCC(=O)N,,,,,,
4979,154980,"Heptanamide, 7-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCCC(=O)N,,,,,,
4980,154981,"Octanamide, 8-((6-chloro-2-methoxy-9-acridinyl)amino)-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCCCCCC(=O)N,,,,,,
4981,154982,"Hexanamide, 6-((6-chloro-2-methoxy-9-acridinyl)amino)-N,N-dimethyl-",CN(C)C(=O)CCCCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,,,,,
4982,154983,Phenelzine hydrochloride,C1=CC=C(C=C1)CCNN.Cl,,,,,,
4983,154984,"Hexanamide, 6-((6-chloro-2-methoxy-9-acridinyl)amino)-N-methyl-",CNC(=O)CCCCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,,,,,
4984,154985,Oxido-[4-(2-phenylethenyl)phenyl]-[4-(2-phenylethenyl)phenyl]iminoazanium,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)N=[N+](C3=CC=C(C=C3)C=CC4=CC=CC=C4)[O-],,,,,,
4985,154986,CID 154986,C1=CC2=C(C=C1O)OC3=C(C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)C=CC(=C3)[O-].[Na+],,,,,,
4986,154987,Oxido-(2-phenylethyl)-(2-phenylethylimino)azanium,C1=CC=C(C=C1)CCN=[N+](CCC2=CC=CC=C2)[O-],,,,,,
4987,154988,"Sulfamic acid, 1,2-cyclohexanediyl ester",C1CCC(C(C1)OS(=O)(=O)N)OS(=O)(=O)N,,,,,,
4988,154989,"2,3-Disulfamoyloxybutane",CC(C(C)OS(=O)(=O)N)OS(=O)(=O)N,,,,,,
4989,154990,Tetrahydrobrusatol,CC1C2CC3C45COC(C4C(C(=O)O3)OC(=O)CC(C)C)(C(C(C5C2(CC(=O)C1O)C)O)O)C(=O)OC,,,,,,
4990,154991,CID 154991,COC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC=CC=O,,,,,,
4991,154992,Tigliane,C[C@@H]1C[C@H]2C[C@@H](C[C@@H]3[C@@H]([C@@H]2C1)[C@@H](C[C@@H]4[C@H]3C4(C)C)C)C,,,,,,
4992,154993,"4-Thiazolidinecarboxylic acid, 3-(2-mercapto-1-oxopropyl)-, (S-(R*,S*))-",C[C@@H](C(=O)N1CSC[C@H]1C(=O)O)S,,,,,,
4993,154994,Ethanol-14C,C[14CH2]O,,,,,,
4994,154995,CID 154995,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CN3C=C(C(=O)C(=C3)Cl)Cl)SC1)C(=O)[O-].[Na+],,,,,,
4995,154996,"(6R,7R)-3-(acetyloxymethyl)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CN3C=C(C(=O)C(=C3)Cl)Cl)SC1)C(=O)O,,,,,,
4996,154997,CID 154997,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)[O-].[Na+],,,,,,
4997,154998,"(6R,7R)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)O,,,,,,
4998,154999,"(1,1'-Biphenyl)-4-amine, 4'-fluoro-N-hydroxy-",C1=CC(=CC=C1C2=CC=C(C=C2)F)NO,,,,,,
4999,155000,"2-(2-Heptadec-1-enyl-4,5-dihydroimidazol-1-yl)ethanol;hydrochloride",CCCCCCCCCCCCCCCC=CC1=NCCN1CCO.Cl,,,,,,
5000,155001,"Oxalic acid, compd. with melamine (1:1)",C1(=NC(=NC(=N1)N)N)N.C(=O)(C(=O)[O-])[O-],,,,,,
5001,155002,Norverapamil hydrochloride,CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl,,,,,,
5002,155003,"Formamide, N-(2-(4-hydroxyphenyl)-1-methylethyl)-N-methyl-",CC(CC1=CC=C(C=C1)O)N(C)C=O,,,,,,
5003,155004,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(3-methyl-1-oxo-2-butenyl)-",CC(=CC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl)C,,,,,,
5004,155005,CID 155005,C1=CC(=C(C=C1C=CC(=O)[C@@H]([C@H](C(=O)O)O)C(=O)O)O)O,,,,,,
5005,155006,"2-Hydroxy-1,6-hexanediyl diacrylate",C=CC(=O)OCCCCC(COC(=O)C=C)O,,,,,,
5006,155007,Lilac aldehyde,CC(C=O)C1CCC(O1)(C)C=C,,,,,,
5007,155008,Aurasperone D,CC1=CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)OC)C4=C5C(=C(C6=C4C=C(C=C6O)OC)O)C(=O)C=C(O5)C)OC,,,,,,
5008,155009,"Acetamide, N-(2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-furanyl)-",CC1=C(C(=CC=C1)C)N(C2CCOC2=O)C(=O)COC,,,,,,
5009,155010,"3-Cyclopentene-1,2-dione, 3,5,5-trichloro-",C1=C(C(=O)C(=O)C1(Cl)Cl)Cl,,,,,,
5010,155011,Aurantio-obtusin,CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C(=C(C=C3C2=O)O)OC)O,,,,,,
5011,155012,"15,19,23-Trimethylheptatriacontane",CCCCCCCCCCCCCCC(C)CCCC(C)CCCC(C)CCCCCCCCCCCCCC,,,,,,
5012,155013,"Oxiranemethanol, polymer with nonylphenol",CCCCCCCCCC1=CC=CC=C1O.C1C(O1)CO,,,,,,
5013,155014,"2-Pyridinecarboxylic acid, 3,6-dichloro-, mixt. with 3-((methoxycarbonyl)amino)phenyl(3-methylphenyl)carbamate",CC1(CC=CC(=C1)N(C2=CC=CC=C2)C(=O)[O-])NC(=O)OC.C1=CC(=NC(=C1Cl)C(=O)O)Cl,,,,,,
5014,155015,"[3-(Methoxycarbonylamino)-3-methylcyclohexa-1,5-dien-1-yl]-phenylcarbamic acid",CC1(CC=CC(=C1)N(C2=CC=CC=C2)C(=O)O)NC(=O)OC,,,,,,
5015,155016,"(1R,2R)-2-(2-methoxy-4-prop-1-enylphenoxy)-1-(3,4,5-trimethoxyphenyl)propan-1-ol",CC=CC1=CC(=C(C=C1)O[C@H](C)[C@@H](C2=CC(=C(C(=C2)OC)OC)OC)O)OC,,,,,,
5016,155017,"1,2,3,6,7,8,11,12-Octahydrobenzo[e]pyren-9(10H)-one",C1CC2=C3C(=C4CCCC(=O)C4=C5C3=C(CCC5)C=C2)C1,,,,,,
5017,155018,Diphenyl[(phenylthio)phenyl]sulfonium hexafluorophosphate,C1=CC=C(C=C1)SC2=CC=CC=C2[S+](C3=CC=CC=C3)C4=CC=CC=C4.F[P-](F)(F)(F)(F)F,,,,,,
5018,155019,Diphenyl[2-(phenylsulfanyl)phenyl]sulfanium,C1=CC=C(C=C1)SC2=CC=CC=C2[S+](C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
5019,155020,"2-Isocyano-N,N-dimethylacetamide",CN(C)C(=O)C[N+]#[C-],,,,,,
5020,155021,17alpha-Ethylestran-17beta-ol,CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@H]3CCCC4)C)O,,,,,,
5021,155022,2-Hydroxy-7-methoxycadalene,CC1=CC2=C(C=C1OC)C(=C(C=C2C(C)C)O)C,,,,,,
5022,155023,"(4R,4aR,7S,7aR,12bS)-7,9-dihydroxy-3-methyl-1,2,4,4a,7,7a-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-13-one",CN1CC[C@]23[C@@H]4[C@@H]1C(=O)C5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,,,,,,
5023,155024,"1,3,5-Triazine-2,4,6-triamine, N,N-bis[3-[[4,6-bis[butyl(2,2,6,6-tetramethyl-4-piperidinyl)amino]-1,3,5-triazin-2-yl]amino]propyl]-N',N''-dibutyl-N',N''-bis(2,2,6,6-tetramethyl-4-piperidinyl)-",CCCCN(C1CC(NC(C1)(C)C)(C)C)C2=NC(=NC(=N2)NCCCN(CCCNC3=NC(=NC(=N3)N(CCCC)C4CC(NC(C4)(C)C)(C)C)N(CCCC)C5CC(NC(C5)(C)C)(C)C)C6=NC(=NC(=N6)N(CCCC)C7CC(NC(C7)(C)C)(C)C)N(CCCC)C8CC(NC(C8)(C)C)(C)C)N(CCCC)C9CC(NC(C9)(C)C)(C)C,,,,,,
5024,155025,"trans-(-)-2-(acetyloxy)-N,N,N-trimethylcyclopentanaminium iodide",CC(=O)O[C@@H]1CCC[C@H]1[N+](C)(C)C.[I-],,,,,,
5025,155026,CID 155026,CC(=O)OC1CCC[C@H]1[N+](C)(C)C,,,,,,
5026,155027,CID 155027,CCNC(=O)NC(=O)C(=NOC)C#N.O.[O-2].[O-2].[Cl-].[Cl-].[Cu+2].[Cu+2].[Cu+2],,,,,,
5027,155028,Cymoxanil-folpel mixt.,CCNC(=O)NC(=O)C(=NOC)C#N.C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,,,,,,
5028,155029,"beta-D-Glucopyranoside, (3beta,5alpha,25R)-spirostan-3-yl 4-O-alpha-D-glucopyranosyl-",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CCC6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@@H](O7)CO)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)C)C)C)OC1,,,,,,
5029,155030,(R)-pindolol,CC(C)NC[C@H](COC1=CC=CC2=C1C=CN2)O,,,,,,
5030,155031,"5-[(1S,2S,3S,5R)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]-4-oxopentanoic acid",CCCCCC(=O)CC[C@@H]1[C@H](C[C@H]([C@H]1CC(=O)CCC(=O)O)O)O,,,,,,
5031,155032,Arotinolol hydrochloride,CC(C)(C)NCC(CSC1=NC(=CS1)C2=CC=C(S2)C(=O)N)O.Cl,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)']",,,
5032,155033,CID 155033,CC(=CCC[C@](C)([C@@H]1CC[C@@]2([C@H]1[C@@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)C)O)C)O[C@@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)CO[C@@H]8[C@@H]([C@@H]([C@@H](CO8)O)O)O)O)O)O)C,,,,,,
5033,155034,"2-(38-Ethylidene-8,14,24,30-tetrazaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene)ethanol",CC=C1CN2CCC34C2CC1C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CCN1CC9=CCO)C1=CC=CC=C16,,,,,,
5034,155035,Prophalloin,CC1C(=O)NC2CC3=C(NC4=CC=CC=C34)SCC(C(=O)N5CCCC5C(=O)N1)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC(C)(C)O)C)C(C)O,,,,,,
5035,155036,"Phosphonic acid, (1,4-phenylenebis(methylene))bis-, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol",C1=CC(=CC=C1CP(=O)(O)O)CP(=O)(O)O.C(C(CO)(CO)CO)O,,,,,,
5036,155037,[4-(phosphonomethyl)phenyl]methylphosphonic Acid,C1=CC(=CC=C1CP(=O)(O)O)CP(=O)(O)O,,,,,,
5037,155038,"1H-Benzimidazole, 2-(4-thiazolyl)-, mixt. with iodine compd. with alpha-(nonylphenyl)-omega-hydroxypoly(oxy-1,2-ethanediyl)",CCCCCCCCCOCCO.C1=CC=CC=C1.C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3.II,,,,,,
5038,155039,Butyl methacrylate eicosyl methacrylate N-vinylpyrrolidone cetyl methacrylate isodecyl methacrylate stearyl methacrylate polymer,CCCCCCCCCCCCCCCCCCCCOC(=O)C(=C)C.CCCCCCCCCCCCCCCCCCOC(=O)C(=C)C.CCCCCCCCCCCCCCCCOC(=O)C(=C)C.CCCCOC(=O)C(=C)C.CC(C)CCCCCCCOC(=O)C(=C)C.C=CN1CCCC1=O,,,,,,
5039,155040,Icosyl methacrylate,CCCCCCCCCCCCCCCCCCCCOC(=O)C(=C)C,,,,,,
5040,155041,"Decyl alcohol, ethoxylated, phosphated, potassium salt",CCCCCCCCCCOCCO.OP(=O)(O)O.[K+],,,,,,
5041,155042,"Glycyrrhizin, ammoniated",C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O.N.N.N,,,,,,
5042,155043,"2-Propenamide, homopolymer, reaction products with dimethylamine and formaldehyde",CNC.C=CC(=O)N.C=O,,,,,,
5043,155044,"2,4-Imidazolidinedione, 5,5-dimethyl-, polymer with (chloromethyl)oxirane and methyloxirane",CC1CO1.CC1(C(=O)NC(=O)N1)C.C1C(O1)CCl,,,,,,
5044,155045,Triethanolamine glutamate,C(CC(=O)O)[C@@H](C(=O)O)N.C(CO)N(CCO)CCO,,,,,,
5045,155046,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 2-methyloxirane, 4-nonylphenol and oxirane",CCCCCCCCCC1=CC=C(C=C1)O.CC1CO1.CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1,,,,,,
5046,155047,"N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-N-[2-(2-hydroxyethoxy)ethyl]butane-1-sulfonamide",CCN(CCOCCO)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5047,155048,"N-ethyl-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-[2-(2-hydroxyethoxy)ethyl]pentane-1-sulfonamide",CCN(CCOCCO)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5048,155049,"N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[2-(2-hydroxyethoxy)ethyl]heptane-1-sulfonamide",CCN(CCOCCO)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5049,155050,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)-1,2-benzenediol",CC(C)(C)C1=CC(=C(C=C1)O)O.C=O,,,,,,
5050,155051,Staudine,COC1=C(C2=C(C=C1)[C@H]3C[C@@H]([C@@H]2N4C3=C5C=C(C(=O)C=C5CC4)OC)C6=CC(=C(C=C6OC)OC)OC)OC,,,,,,
5051,155052,CID 155052,CC(=O)N(C1=CC=C(C=C1)C2=CC=C(C=C2)F)C3=NC4=C(N3[C@H]5C[C@@H]([C@H](O5)CO)O)NC(=NC4=O)N,,,,,,
5052,155053,Menisdaurine,C1[C@@H](C=CC(=CC#N)[C@@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
5053,155054,"2(6H)-Benzofuranone, 7,7a-dihydro-6-hydroxy-, (6S,7aR)-",C1[C@@H](C=CC2=CC(=O)O[C@@H]21)O,,,,,,
5054,155055,"7-Oxabicyclo(4.1.0)hept-3-en-2-one, 5-hydroxy-3-methyl-, (1R,5S,6R)-",CC1=C[C@@H]([C@@H]2[C@H](C1=O)O2)O,,,,,,
5055,155056,"Formamide, N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methyl-, (R*,S*)-",C[C@@H]([C@@H](C1=CC=CC=C1)O)N(C)C=O,,,,,,
5056,155057,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(1-oxo-2-propenyl)-",C=CC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5057,155058,Methyl 3-(hydroxymethyl)benzoate,COC(=O)C1=CC=CC(=C1)CO,,,,,,
5058,155059,Glycosolone,CC(=CCC1=C(C2=C(C(=CC=C2)O)N(C1=O)C)OC)C,,,,,,
5059,155060,"3-Cyclohexene-1-carbonitrile, 4-(2-(2,2-dimethylcyclopropyl)ethyl)-",CC1(CC1CCC2=CCC(CC2)C#N)C,,,,,,
5060,155061,"Ethyl 4-[2-(2,2-dimethylcyclopropyl)ethyl]cyclohex-3-ene-1-carboxylate",CCOC(=O)C1CCC(=CC1)CCC2CC2(C)C,,,,,,
5061,155062,Salviarin,C[C@@]12CC(OC(=O)[C@@H]1CC[C@@]34[C@H]2CC=C[C@@H]3C(=O)OC4)C5=COC=C5,,,,,,
5062,155063,"Oxirane, 2,2'-(cyclohexanediylbis(methyleneoxymethylene))bis-",C1CCC(CC1)(COCC2CO2)COCC3CO3,,,,,,
5063,155064,"Quinolinium, 2-((dithiocarboxy)methyl)-1,6-dimethyl-, inner salt",CC1=CC2=C(C=C1)[N+](=C(C=C2)CC(=S)[S-])C,,,,,,
5064,155065,"2-(1,6-Dimethylquinolin-1-ium-2-yl)ethanedithioic acid",CC1=CC2=C(C=C1)[N+](=C(C=C2)CC(=S)S)C,,,,,,
5065,155066,"N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-3-phenylprop-2-en-1-imine",CC1=CC=C(C=C1)C2=CSC(=N2)N=CC=CC3=CC=CC=C3,,,,,,
5066,155067,2-[2-(4-Methoxyphenoxy)ethylideneamino]guanidine;sulfuric acid,COC1=CC=C(C=C1)OCC=NN=C(N)N.OS(=O)(=O)O,,,,,,
5067,155068,2-[2-(4-Methoxyphenoxy)ethylideneamino]guanidine,COC1=CC=C(C=C1)OCC=NN=C(N)N,,,,,,
5068,155069,"2(1H)-Pyridinone, 1-methyl-4-phenyl-",CN1C=CC(=CC1=O)C2=CC=CC=C2,,,,,,
5069,155070,"Dispiro(furan-3(2H),1'(5'H)-naphthalene-5',2''-oxiran)-2-one,4'-(acetyloxy)-4'a-((acetyloxy)methyl)-5-(3-furanyl)decahydro-2'-methyl-, (1'R,2'R,2''R,4'S,4'aR,5R,8'aS)-",C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]13C[C@@H](OC3=O)C4=COC=C4)CCC[C@]25CO5)OC(=O)C)OC(=O)C,,,,,,
5070,155071,"Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride, tetrahydrate",COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.O.O.O.[Cl-],,,,,,
5071,155072,4-Chloro-2-methylbut-1-ene,CC(=C)CCCl,,,,,,
5072,155073,"1H-(1,2,4)Triazolo(1,2-a)pyridazin-1-one, 2-(4-chloro-2-fluorophenyl)hexahydro-3-thioxo-",C1CCN2C(=S)N(C(=O)N2C1)C3=C(C=C(C=C3)Cl)F,,,,,,
5073,155074,Berberine chloride hydrate,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.[Cl-],,,,,,
5074,155075,CID 155075,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C.C1=CC=C(C=C1)C=CN,,,,,,
5075,155076,"Ethenamine, 2-phenyl-",C1=CC=C(C=C1)C=CN,,,,,,
5076,155077,"1,6-Octadiene-3,4-diol, 3,7-dimethyl-",CC(=CCC(C(C)(C=C)O)O)C,,,,,,
5077,155078,"3H-1,2,4-Triazolo(4,3-a)azepin-3-one, 2-(2,4-dichloro-5-(1-methylethoxy)phenyl)-2,5,6,7,8,9-hexahydro-",CC(C)OC1=C(C=C(C(=C1)N2C(=O)N3CCCCCC3=N2)Cl)Cl,,,,,,
5078,155079,"Phosphonic acid, (3-methyl-2-oxobutyl)-",CC(C)C(=O)CP(=O)(O)O,,,,,,
5079,155080,"1,4-Benzenediamine, 2-methoxy-N1,N1,5-trimethyl-, sulfate (1:1)",CC1=CC(=C(C=C1N)OC)N(C)C.OS(=O)(=O)O,,,,,,
5080,155081,"2-methoxy-N,N,5-trimethylbenzene-1,4-diamine",CC1=CC(=C(C=C1N)OC)N(C)C,,,,,,
5081,155082,(R)-Acebutolol,CCCC(=O)NC1=CC(=C(C=C1)OC[C@@H](CNC(C)C)O)C(=O)C,,,,,,
5082,155083,"Acebutolol, (S)-",CCCC(=O)NC1=CC(=C(C=C1)OC[C@H](CNC(C)C)O)C(=O)C,,,,,,
5083,155084,(S)-4-Hydroxy-2-pyrrolidinone,C1[C@@H](CNC1=O)O,,,,,,
5084,155085,"(5S,7S)-7-Methyl-1,6-dioxaspiro[4.5]decane",C[C@H]1CCC[C@]2(O1)CCCO2,,,,,,
5085,155086,n-Isobutyldodecatetraenamide,CCCC=CC=CC=CC=CC(=O)NCC(C)C,,,,,,
5086,155087,Aluminum;dihydroxy(oxo)silane,O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.[Al+3],,,,,,
5087,155088,"2,5-Cyclohexadien-1-one, 4-((4-chlorophenyl)imino)-",C1=CC(=O)C=CC1=NC2=CC=C(C=C2)Cl,,,,,,
5088,155089,"(1S,2S)-1-(3,4-dimethoxyphenyl)-2-(2-methoxy-4-prop-1-enylphenoxy)propan-1-ol",CC=CC1=CC(=C(C=C1)O[C@@H](C)[C@H](C2=CC(=C(C=C2)OC)OC)O)OC,,,,,,
5089,155090,"Benz(cd)indol-4-amine, 1,3,4,5-tetrahydro-N-methyl-5-(2-methyl-1-propenyl)-, (4R,5R)-",CC(=C[C@H]1[C@@H](CC2=CNC3=CC=CC1=C23)NC)C,,,,,,
5090,155091,"Phosphorothioic acid, O-(2-methoxyethyl) O,O-bis(4-nitrophenyl) ester",COCCOP(=S)(OC1=CC=C(C=C1)[N+](=O)[O-])OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5091,155092,"Trichothec-9-ene-3,4,8,15-tetrol, 12,13-epoxy-, 3,4,15-triacetate, (3alpha,4beta,8alpha)-",CC1=C[C@@H]2[C@](C[C@@H]1O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)OC(=O)C)OC(=O)C)C)COC(=O)C,,,,,,
5092,155093,"1,3(2H,4H)-Isoquinolinedione, 2-(3,5-dichlorophenyl)-",C1C2=CC=CC=C2C(=O)N(C1=O)C3=CC(=CC(=C3)Cl)Cl,,,,,,
5093,155094,6-Prenylnaringenin,CC(=CCC1=C(C2=C(C=C1O)O[C@@H](CC2=O)C3=CC=C(C=C3)O)O)C,,,,,,
5094,155095,Vincamine N4-mononitrate,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O.[N+](=O)(O)[O-],,,,,,
5095,155096,"Benzene, 1-(1-ethoxy-1-methylethyl)-4-methyl-",CCOC(C)(C)C1=CC=C(C=C1)C,,,,,,
5096,155097,"4-Pyridinecarboxamide, N-(2-benzoyl-4-chlorophenyl)-",C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Cl)NC(=O)C3=CC=NC=C3,,,,,,
5097,155098,"Sulfonium, 1,5-pentanediylbis(dimethyl-, diiodide",C[S+](C)CCCCC[S+](C)C.[I-].[I-],,,,,,
5098,155099,5-Dimethylsulfoniopentyl(dimethyl)sulfanium,C[S+](C)CCCCC[S+](C)C,,,,,,
5099,155100,CID 155100,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O2)O)O)O,,,,,,
5100,155101,"Ornithine, 2-(cyanomethyl)-",C(C[C@@](CC#N)(C(=O)O)N)CN,,,,,,
5101,155102,Aguerin B,CC(=C)C(=O)O[C@H]1CC(=C)[C@@H]2C[C@@H](C(=C)[C@@H]2[C@@H]3[C@@H]1C(=C)C(=O)O3)O,,,,,,
5102,155103,"Benzenemethanol, alpha-(1-(hydroxyamino)-1-methylethyl)-",CC(C)(C(C1=CC=CC=C1)O)NO,,,,,,
5103,155104,"Pentanoic acid, 2-hydroxy-2-(1-hydroxyethyl)-3-methyl-, (hexahydro-1H-pyrrolizin-1-yl)methyl ester",CCC(C)C(C(C)O)(C(=O)OCC1CCN2C1CCC2)O,,,,,,
5104,155105,"20-Ethyl-1,7-dihydroxy-6,8,16-trimethoxy-4-(2-methoxyethyl)aconitan-14-yl acetate",CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC(=O)C)OC)OC)O)OC)O)CCOC,,,,,,
5105,155106,"(2S)-2-[5-(3,7-dimethylocta-2,6-dienyl)-2,4-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one",CC(=CCCC(=CCC1=CC(=C(C=C1O)O)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)C)C,,,,,,
5106,155107,"1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid hydrochloride",C1CNCC=C1C(=O)O.Cl,,,"['Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). (See all compounds classified as GABA Agonists.)']",,,
5107,155108,"Methanamine, N-methyl-, reaction products with epichlorohydrin",CNC.C1C(O1)CCl,,,,,,
5108,155109,"Formaldehyde, polymer with nonylphenol, reaction products with diethanolamine and propylene oxide",CCCCCCCCCC1=CC=CC=C1O.CC1CO1.C=O.C(CO)NCCO,,,,,,
5109,155110,"Propane, 1,2,3-trichloro-, polymer with 1,1'-(methylenebis(oxy))bis(2-chloroethane) and sodium sulfide (Na2(Sx))",C(CCl)OCOCCCl.C(C(CCl)Cl)Cl.[Na+].[Na+].[S-2],,,,,,
5110,155111,"4,4-Bis(glycidyloxymethyl)-1-cyclohexene",C1CC(CC=C1)(COCC2CO2)COCC3CO3,,,,,,
5111,155112,"7-Oxabicyclo(4.1.0)heptane, 3,3-bis((oxiranylmethoxy)methyl)-, homopolymer",C1CC(CC2C1O2)(COCC3CO3)COCC4CO4,,,,,,
5112,155113,"2,3,4,5-Tetrachlorothioanisole",CSC1=CC(=C(C(=C1Cl)Cl)Cl)Cl,,,,,,
5113,155114,"N-Acetyl-S-(2,3,5,6-tetrachlorophenyl)-DL-cysteine",CC(=O)NC(CSC1=C(C(=CC(=C1Cl)Cl)Cl)Cl)C(=O)O,,,,,,
5114,155115,Benzofluor,CCSC1=CC(=C(C=C1)NS(=O)(=O)C)C(F)(F)F,,,,,,
5115,155116,"2-Propenenitrile, polymer with 1,3-butadiene, hydrogenated",C=CC=C.C=CC#N,,,,,,
5116,155117,CID 155117,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ba+2],,,,,,
5117,155118,CID 155118,CCCC[SnH](CCCC)CCCC.CCS(=O)(=O)O,,,,,,
5118,155119,Polhovolide,CC1=CCC2C1C3C(C(CC2(C)OC(=O)C)OC(=O)C(C)C)C(C(=O)O3)(C)OC(=O)C,,,,,,
5119,155120,"Butanedioic acid, mono(1-(((1-methylethyl)amino)methyl)-2-(1-naphthalenyloxy)ethyl) ester",CC(C)NCC(COC1=CC=CC2=CC=CC=C21)OC(=O)CCC(=O)O,,,,,,
5120,155121,"Isoquinoline, reaction products with benzyl chloride and quinoline",C1=CC=C(C=C1)CCl.C1=CC=C2C=NC=CC2=C1.C1=CC=C2C(=C1)C=CC=N2,,,,,,
5121,155122,"Thiazole, 2-phenyl-5-(triphenylmethyl)-",C1=CC=C(C=C1)C2=NC=C(S2)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
5122,155123,"Phenol, 4,4'-(1-methylethylidene)bis(2,6-dibromo-, polymer with 2,2'-((1-methylethylidene)bis((2,6-dibromo-4,1-phenylene)oxymethylene))bis(oxirane)",CC(C)(C1=CC(=C(C(=C1)Br)O)Br)C2=CC(=C(C(=C2)Br)O)Br.CC(C)(C1=CC(=C(C(=C1)Br)OCC2CO2)Br)C3=CC(=C(C(=C3)Br)OCC4CO4)Br,,,,,,
5123,155124,"2-Ethyl-3-methyl-4-(1-methyl-4-piperidyl)-2,4-dihydroindeno(1,2-c)pyrazol-4-ol",CCN1C(=C2C(=N1)C3=CC=CC=C3C2(C4CCN(CC4)C)O)C,,,,,,
5124,155125,"Acetic acid, mercapto-, isooctyl ester, reaction products with dichlorodimethylstannane, sodium sulfide (Na2S) and trichloromethylstannane",CC(C)CCCCCOC(=O)CS.C[Sn](C)(Cl)Cl.C[Sn](Cl)(Cl)Cl.[Na+].[Na+].[S-2],,,,,,
5125,155126,CID 155126,CCCCCCCCC=CCCCCCCCC(=O)OCCS.C[Sn](C)(Cl)Cl.C[Sn](Cl)(Cl)Cl.[Na+].[Na+].[S-2],,,,,,
5126,155127,CID 155127,C=CC(=O)O.OS(=O)[O-].[Na+],,,,,,
5127,155128,"Boric acid (H3BO3), compd. with 2,2',2''-nitrilotris(ethanol) (1:3)",B(O)(O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
5128,155129,Bis(2-methoxybenzylaminohex-6-ylaminoethyl)disulphane,COC1=CC=CC=C1CNCCCCCCNCCSSCCNCCCCCCNCC2=CC=CC=C2OC.Cl.Cl.Cl.Cl,,,,,,
5129,155130,"2-[1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctylsulfonyl(methyl)amino]ethyl 2-methylprop-2-enoate;2-[methyl(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyl)amino]ethyl 2-methylprop-2-enoate;2-[methyl(1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptylsulfonyl)amino]ethyl 2-methylprop-2-enoate;2-[methyl(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexylsulfonyl)amino]ethyl 2-methylprop-2-enoate;2-[methyl(1,1,2,2,3,3,4,4,5,5,5-undecafluoropentylsulfonyl)amino]ethyl 2-methylprop-2-enoate;octadecyl 2-methylprop-2-enoate",CCCCCCCCCCCCCCCCCCOC(=O)C(=C)C.CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5130,155131,"Cyclotetrasiloxane, octamethyl-, reaction products with silica",C[Si]1(O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)C.O=[Si]=O,,,,,,
5131,155132,"Acetic acid, chloro-, sodium salt, reaction products with 4,5-dihydro-1H-imidazole-1-ethanol 2-norcoco alkyl derivs. and sodium hydroxide",C1CN(C=N1)CCO.C(C(=O)[O-])Cl.[OH-].[Na+].[Na+],,,,,,
5132,155133,"1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-norcoco alkyl derivs.",C1CN(C=N1)CCO,,,,,,
5133,155134,"D-Glucitol, polymer with ethenylbenzene, methyloxirane, oxirane, 1,2,3-propanetriol and 2-propenenitrile",CC1CO1.C=CC#N.C=CC1=CC=CC=C1.C1CO1.C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O.C(C(CO)O)O,,,,,,
5134,155135,"1-[2,6-Bis[4-(trifluoromethyl)phenyl]-4-pyridyl]-2-(dibutylamino)ethanol",CCCCN(CCCC)CC(C1=CC(=NC(=C1)C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F)O,,,,,,
5135,155136,CID 155136,CC(=O)NC(=CC1=CC=CS1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
5136,155137,"Hexanedinitrile, polymer with 6-aminohexanenitrile, N-(6-aminohexyl)-1,6-hexanediamine, N,N'-bis(6-aminohexyl)-1,6-hexanediamine, 1,2-dichloroethane, 1,6-hexanediamine, 2-piperidinecarbonitrile and 2,4-pyridinediamine",C1CCNC(C1)C#N.C1=CN=C(C=C1N)N.C(CCCN)CCN.C(CCCNCCCCCCN)CCN.C(CCCNCCCCCCNCCCCCCN)CCN.C(CCC#N)CCN.C(CCC#N)CC#N.C(CCl)Cl,,,,,,
5137,155138,2-Cyanopiperidine,C1CCNC(C1)C#N,,,,,,
5138,155139,"N,N'-Bis(6-aminohexyl)-1,6-hexanediamine",C(CCCNCCCCCCNCCCCCCN)CCN,,,,,,
5139,155140,"Benzenesulfonamide, ar-methyl-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, butylated",CS(=O)(=O)N.C=O.C1=CC=CC=C1.C1(=NC(=NC(=N1)N)N)N,,,,,,
5140,155141,Hydroxychlornitrofen,C1=CC(=CC=C1O)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
5141,155142,Sustanon 250,CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.CC(C)CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C,,,,,,
5142,155143,Testosterone decanoate,CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
5143,155144,CID 155144,CC(C)CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2CCC4=CC(=O)CC[C@]34C)C,,,,,,
5144,155145,Methyl glucoside sesquistearate,CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O.COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
5145,155146,"(3S,4S,5R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol",COC1[C@@H]([C@H]([C@@H](C(O1)CO)O)O)O,,,,,,
5146,155147,"1-Octanol, 3,6-dimethyl-",CCC(C)CCC(C)CCO,,,,,,
5147,155148,Racemosin,CC1(C=CC2=C(C3=C(C(=C2O1)OC)OC(=O)C=C3)OC)C,,,,,,
5148,155149,"Urea, N-(methyl-d3)-N-nitroso-",[2H]C([2H])([2H])N(C(=O)N)N=O,,,,,,
5149,155150,"Propanoic acid, 2-methyl-2-((4-methyl-1-(phenylmethyl)-1H-pyrazol-3-yl)oxy)-",CC1=CN(N=C1OC(C)(C)C(=O)O)CC2=CC=CC=C2,,,,,,
5150,155151,"Silicic acid (H4SiO4), tetraethyl ester, hydrolysis products with chlorotrimethylsilane",CCO[Si](OCC)(OCC)OCC.C[Si](C)(C)Cl,,,,,,
5151,155152,"alpha-D-Glucopyranoside, 2-hydroxypropyl 4-O-beta-D-glucopyranosyl-",CC(CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O,,,,,,
5152,155153,"Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, ((1R,7aS)-hexahydro-1H-pyrrolizin-1-yl)methyl ester, (2R,3S)-",C[C@@H]([C@](C(C)C)(C(=O)OC[C@@H]1CCN2[C@H]1CCC2)O)O,,,,,,
5153,155154,Coromandaline,C[C@H]([C@](C(C)C)(C(=O)OC[C@@H]1CCN2[C@H]1CCC2)O)O,,,,,,
5154,155155,"2-Azetidinone, 4-(2-propenyl)-",C=CCC1CC(=O)N1,,,,,,
5155,155156,"1,3-Benzodithiole, 2-methyl-",CC1SC2=CC=CC=C2S1,,,,,,
5156,155157,CID 155157,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)OC5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O2)O)O)O,,,,,,
5157,155158,CID 155158,C1=CC=C(C=C1)C2=C(C(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O,,,,,,
5158,155159,CID 155159,C1=CC=C(C=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
5159,155160,4-O-Methylhonokiol,COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)O)CC=C,,,,,,
5160,155161,CID 155161,CCCCCCCCCCCC[N+](C)(C)CC1=CC(=C(C=C1)OC)C=C(C)[N+](=O)[O-].[Cl-],,,,,,
5161,155162,CID 155162,CCCCCCCCCCCC[N+](C)(C)CC1=CC(=C(C=C1)OC)C=C(C)[N+](=O)[O-],,,,,,
5162,155163,"Phosphonodithioic acid, phenyl-, S,S-dipentyl ester",CCCCCSP(=O)(C1=CC=CC=C1)SCCCCC,,,,,,
5163,155164,"[8-(Hydroxymethyl)-3-methylidene-4,13-dioxo-5,14-dioxatricyclo[10.2.1.02,6]pentadeca-7,12(15)-dien-11-yl] 2-methylbutanoate",CCC(C)C(=O)OC1CCC(=CC2C(C3C=C1C(=O)O3)C(=C)C(=O)O2)CO,,,,,,
5164,155165,(5R)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-phenylheptan-3-one,COC1=C(C=CC(=C1)CC[C@H](CC(=O)CCC2=CC=CC=C2)O)O,,,,,,
5165,155166,"2,2',4,4',5,5'-Hexabromodiphenyl ether",C1=C(C(=CC(=C1Br)Br)Br)OC2=CC(=C(C=C2Br)Br)Br,,,,,,
5166,155167,"Cysteine, N-acetyl-S-(2,3,4,5-tetrachlorophenyl)-",CC(=O)N[C@@H](CSC1=CC(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)O,,,,,,
5167,155168,"(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;but-2-enedioic acid",C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.C(=CC(=O)O)C(=O)O,,,,,,
5168,155169,Kolaflavanone,COC1=C(C=C(C=C1)[C@@H]2[C@H](C(=O)C3=C(C=C(C(=C3O2)[C@@H]4[C@H](OC5=CC(=CC(=C5C4=O)O)O)C6=CC=C(C=C6)O)O)O)O)O,,,,,,
5169,155170,S-(4-Bromophenyl)-L-cysteine,C1=CC(=CC=C1SC[C@@H](C(=O)O)N)Br,,,,,,
5170,155171,"3-Furanmethanaminium, tetrahydro-N,N,N,5-tetramethyl-, iodide, cis-",C[C@H]1C[C@H](CO1)C[N+](C)(C)C.[I-],,,,,,
5171,155172,CID 155172,C[C@H]1CC(CO1)C[N+](C)(C)C,,,,,,
5172,155173,Tomentosin,C[C@H]1C[C@@H]2[C@H](CC=C1CCC(=O)C)C(=C)C(=O)O2,,,,,,
5173,155174,"Spiro(1,3-dioxolo(4,5-g)isoquinoline-5(6H),7'-(7H)indeno(4,5-d)(1,3)dioxole)-6',8'-diol, 6',7,8,8'-tetrahydro-6-methyl-, (6'R,7'S,8'S)-",CN1CCC2=CC3=C(C=C2C14[C@@H](C5=C([C@@H]4O)C6=C(C=C5)OCO6)O)OCO3,,,,,,
5174,155175,"Octadecanoic acid, 2-phenoxy-",CCCCCCCCCCCCCCCCC(C(=O)O)OC1=CC=CC=C1,,,,,,
5175,155176,"Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, ethyl ester, (14alpha)-",CC[C@]12CCCN3[C@H]1C4=C(CC3)C5=CC=CC=C5N4[C@@](C2)(C(=O)OCC)O,,,,,,
5176,155177,"Benz(a)anthracene, 7-fluoro-12-methyl-",CC1=C2C(=C(C3=CC=CC=C13)F)C=CC4=CC=CC=C42,,,,,,
5177,155178,"L-Phenylalanine, N-(1-oxotetradecyl)-",CCCCCCCCCCCCCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O,,,,,,
5178,155179,CID 155179,C=CCC1CN=C(O1)S,,,,,,
5179,155180,"2-[5-(2-Octa-2,5-dienylidene-5-oxopyrrolidin-1-yl)pentyl]guanidine",CCC=CCC=CC=C1CCC(=O)N1CCCCCN=C(N)N,,,,,,
5180,155181,"Phosphonium, tetrakis(hydroxymethyl)-, chloride, polymer with ammonia and urea",C(O)[P+](CO)(CO)CO.C(=O)(N)N.N.[Cl-],,,,,,
5181,155182,"Azuleno(5,6-c)furan-1(3H)-one, 4a,5,6,7,7a,8-hexahydro-6,6,8-trimethyl-, (4aR,7aR,8R)-rel-",C[C@@H]1C=C2C(=C[C@@H]3[C@H]1CC(C3)(C)C)COC2=O,,,,,,
5182,155183,"[(3S,3aR,4S,6S,6aS,9aS,9bS)-6-hydroxy-3,6,9-trimethyl-3-(2-methylbut-2-enoyloxy)-2-oxo-4,5,6a,7,9a,9b-hexahydro-3aH-azuleno[4,5-b]furan-4-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1C[C@]([C@H]2CC=C([C@H]2[C@H]3[C@@H]1[C@](C(=O)O3)(C)OC(=O)C(=CC)C)C)(C)O,,,,,,
5183,155184,CID 155184,C[C@@H](CCC=C(C)CCC[C@@H](C)[C@H](CC=C(C)C)O)C[C@@H]([C@H](CO)N)O,,,,,,
5184,155185,Dihydroquinidine tartrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](C3CC4CCN3CC4C=C)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
5185,155186,"1H-Carbazol-3-amine, 2,3,4,9-tetrahydro-N-methyl-, monohydrochloride",CNC1CCC2=C(C1)C3=CC=CC=C3N2.Cl,,,,,,
5186,155187,CID 155187,CC1=CC(=O)C(=O)C=C1N(O)O,,,,,,
5187,155188,CID 155188,CCOC(=O)CC(C(=O)OCC)SP(=O)SO,,,,,,
5188,155189,"Dibenzo(a,g)quinolizinium, 5,6-dihydro-3-hydroxy-2,10,11-trimethoxy-",COC1=C(C=C2C=[N+]3CCC4=CC(=C(C=C4C3=CC2=C1)OC)O)OC,,,,,,
5189,155190,Aica phosphate,C1=CN(C(=N1)N)C(=O)N.OP(=O)(O)O,,,,,,
5190,155191,2-Aminoimidazole-1-carboxamide,C1=CN(C(=N1)N)C(=O)N,,,,,,
5191,155192,Leprolomin,CC1=C(C(=C(C=C1OC)OC2=C(C(=C(C(=C2O)C)OC)C(=O)C)O)C(=O)C)O,,,,,,
5192,155193,1-(beta-D-Glucopyranosyl)amobarbital,CCC1(C(=O)NC(=O)N(C1=O)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CCC(C)C,,,,,,
5193,155194,"2-Chloro-N-(((4-(2,2-dichloro-1,1-difluoroethoxy)phenyl)amino)carbonyl)benzamide",C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)OC(C(Cl)Cl)(F)F)Cl,,,,,,
5194,155195,2-[4-(Carbamoylamino)phenyl]acetic acid,C1=CC(=CC=C1CC(=O)O)NC(=O)N,,,,,,
5195,155196,CID 155196,CC(=O)P(=O)([O-])OC.[Na+],,,,,,
5196,155197,Methyl hydrogen (S)-acetylphosphonate,CC(=O)P(=O)(O)OC,,,,,,
5197,155198,N-Nitroso-N-methyloctadecylamine,CCCCCCCCCCCCCCCCCCN(C)N=O,,,,,,
5198,155199,"Urea, 1-(2-chloroethyl)-3,3-diethyl-1-nitroso-",CCN(CC)C(=O)N(CCCl)N=O,,,,,,
5199,155200,Antipyrinyl-4-peroxide,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)OO,,,,,,
5200,155201,"7H-Purin-6-amine, 8,9-dihydro-N-(phenylmethyl)-9-(tetrahydro-2H-pyran-2-yl)-",C1CCOC(C1)N2CNC3=C(N=CN=C32)NCC4=CC=CC=C4,,,,,,
5201,155202,Prednisolone caproate,CCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O,,,,,,
5202,155203,Prochloraz Mn,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.Cl[Mn]Cl,,,,,,
5203,155204,"9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-propionate",CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)O,,,,,,
5204,155205,"1-(2,3,4,9-Tetrahydro-1H-pyrido(3,4-b)indol-1-yl)-2-propanone",CC(=O)CC1C2=C(CCN1)C3=CC=CC=C3N2,,,,,,
5205,155206,(+)-Leucocyanidin,C1=CC(=C(C=C1[C@@H]2[C@H]([C@@H](C3=C(C=C(C=C3O2)O)O)O)O)O)O,,,,,,
5206,155207,1-Ethylsulfanyl-4-(methylamino)-3-[3-(trifluoromethyl)phenyl]but-3-en-2-one,CCSCC(=O)C(=CNC)C1=CC(=CC=C1)C(F)(F)F,,,,,,
5207,155208,"2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, hydrochloride, (S)-",CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O.Cl,,,,,,
5208,155209,1-(2-Bicyclo(2.2.1)hept-2-ylphenoxy)-3-((1-methylethyl)amino)-2-propanol hydrochloride,CC(C)NCC(COC1=CC=CC=C1C2CC3CCC2C3)O.Cl,,,,,,
5209,155210,"2,6-Diaminopurine hemisulfate salt",C1=NC2=NC(=NC(=C2N1)N)N.C1=NC2=NC(=NC(=C2N1)N)N.OS(=O)(=O)O,,,,,,
5210,155211,"Ethanaminium, N,N,N-trimethyl-2-((1-oxo-2-propenyl)oxy)-, chloride, polymer with 2-propenamide",C[N+](C)(C)CCOC(=O)C=C.C=CC(=O)N.[Cl-],,,,,,
5211,155212,N-2-(2-Heptyloxyphenylcarbamoyloxy)ethyl-N-benzylpiperidinium chloride,CCCCCCCOC1=CC=CC=C1NC(=O)OCC[N+]2(CCCCC2)CC3=CC=CC=C3.[Cl-],,,,,,
5212,155213,1-[2-[[2-(Heptyloxy)phenyl]carbamoyloxy]ethyl]-1-benzylpiperidinium,CCCCCCCOC1=CC=CC=C1NC(=O)OCC[N+]2(CCCCC2)CC3=CC=CC=C3,,,,,,
5213,155214,"Phosphonic acid, (p-acetamidophenyl)-",CC(=O)NC1=CC=C(C=C1)P(=O)(O)O,,,,,,
5214,155215,(2-Hydroxyethyl)-2-propenenitrile,C=C(CCO)C#N,,,,,,
5215,155216,N-Allylnorcocaine hydrochloride,COC(=O)C1[C@H]2CCC(N2CC=C)CC1OC(=O)C3=CC=CC=C3.Cl,,,,,,
5216,155217,Methyl 3-benzoyloxy-8-prop-2-enyl-8-azabicyclo[3.2.1]octane-2-carboxylate,COC(=O)C1C2CCC(N2CC=C)CC1OC(=O)C3=CC=CC=C3,,,,,,
5217,155218,4-[(4S)-4-amino-4-carboxybutanoyl]oxy-3-(hydrazinecarbonyl)benzoic acid,C1=CC(=C(C=C1C(=O)O)C(=O)NN)OC(=O)CC[C@@H](C(=O)O)N,,,,,,
5218,155219,N-Methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride,CN(CC#C)C1C=CC2=CC=CC=C12.Cl,,,,,,
5219,155220,N-methyl-N-prop-2-ynyl-1H-inden-1-amine,CN(CC#C)C1C=CC2=CC=CC=C12,,,,,,
5220,155221,N-Dimethylallylnorcocaine HCl,CC(=CCN1[C@@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC)C.Cl,,,,,,
5221,155222,"methyl (1R,2R,3S,5R)-3-benzoyloxy-8-(3-methylbut-2-enyl)-8-azabicyclo[3.2.1]octane-2-carboxylate",CC(=CCN1[C@@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC)C,,,,,,
5222,155223,N-(((5-(4-Bromophenyl)-6 methyl-pyrazinyl)amino)carbonyl)-2-chlorobenzamide,CC1=NC(=CN=C1C2=CC=C(C=C2)Br)NC(=O)NC(=O)C3=CC=CC=C3Cl,,,,,,
5223,155224,5-Methyl-2-(isopropyl)phenyl isovalerate,CC1=CC(=C(C=C1)C(C)C)OC(=O)CC(C)C,,,,,,
5224,155225,20-Hydroxyeicosatetraenic acid,C(CCCCCC=CC=CC=CC=CC(=O)O)CCCCCO,,,,,,
5225,155226,"Phosphorothioic acid, S-(2-(ethylsulfinyl)ethyl) O,O-dimethyl ester, mixt. with 4-chloro-alpha-(4-chlorophenyl)-alpha-(trichloromethyl)benzenemethanol and 1-naphthalenyl methylcarbamate",CCS(=O)CCSP(=O)(OC)OC.CNC(=O)OC1=CC=CC2=CC=CC=C21.C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(Cl)(Cl)Cl)O)Cl,,,,,,
5226,155227,(S)-S-Benzyl 6-amino-2-(((benzyloxy)carbonyl)amino)hexanethioate hydrochloride,C1=CC=C(C=C1)COC(=O)N[C@@H](CCCCN)C(=O)SCC2=CC=CC=C2.Cl,,,,,,
5227,155228,S-Benzyl 6-amino-2-{[(benzyloxy)carbonyl]amino}hexanethioate,C1=CC=C(C=C1)COC(=O)NC(CCCCN)C(=O)SCC2=CC=CC=C2,,,,,,
5228,155229,"Citric acid, sodium titanium salt",C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+].[Ti+4].[Ti+4].[Ti+4],,,,,,
5229,155230,"Cobaltate(1-), bis(2-((2-(amino-kappaN)-1-naphthalenyl)azo-kappaN1)-5-nitrophenolato(2-)-kappaO)-, sodium",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[NH-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[NH-].[Na+].[Co+3],,,,,,
5230,155231,Cobalt zirconium trioxide,[O-2].[O-2].[O-2].[Co].[Zr],,,,,,
5231,155232,Epicorazine A,C1C2C(C(C=CC2=O)O)N3C14C(=O)N5C6C(CC5(C3=O)SS4)C(=O)C=CC6O,,,,,,
5232,155233,"1,2,3,4,4a,5,6,6a,11b,13b-Decahydro-4,4,6a,9-tetramethyl-13H-benzo(a)furo(2,3,4-mn)xanthenol",CC1CCCC23C1(CCC4(C2C(C5=C(C=C(C=C5O4)C)O)OC3)C)C,,,,,,
5233,155234,"3'-Adenylic acid, N-benzoyl-2'-deoxy-, 2-chlorophenyl 2-cyanoethyl ester",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)OP(=O)(OCCC#N)OC5=CC=CC=C5Cl,,,,,,
5234,155235,"M-(5-Chloro-1,2-benzisothiazol-3-yl)-N'-phenylurea",C1=CC=C(C=C1)NC(=O)NC2=NSC3=C2C=C(C=C3)Cl,,,,,,
5235,155236,"4H,8H-Benzo(1,2-b:3,4-b')dipyran-4-one, 2,3-dihydro-5-methoxy-8,8-dimethyl-2-phenyl-, (S)-",CC1(C=CC2=C3C(=C(C=C2O1)OC)C(=O)C[C@H](O3)C4=CC=CC=C4)C,,,,,,
5236,155237,Barleriaquinone I,CC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C(=CC=C3)O,,,,,,
5237,155238,CID 155238,CC(=O)O[C@@H]1C[C@@H]([C@@]23COC(C1([C@@H]2C[C@H]([C@@]4([C@@H]3C(=O)C[C@@]5([C@]46[C@@H](O6)C[C@H]5C7=COC=C7)C)C)O)C)O)O,,,,,,
5238,155239,"Propanoic acid, 2-(4-methoxyphenoxy)-, methyl ester",CC(C(=O)OC)OC1=CC=C(C=C1)OC,,,,,,
5239,155240,Hydroxytyrosol Acetate,CC(=O)OCCC1=CC(=C(C=C1)O)O,,,,,,
5240,155241,4-{[5-(Trifluoromethyl)pyridin-2-yl]oxy}phenol,C1=CC(=CC=C1O)OC2=NC=C(C=C2)C(F)(F)F,,,,,,
5241,155242,"Pyridine, 2-(4-methoxyphenoxy)-5-(trifluoromethyl)-",COC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,,,,,,
5242,155243,"2,5-Cyclohexadiene-1,4-dione, 5-(1,1-dimethylethyl)-2,3-diiodo-",CC(C)(C)C1=CC(=O)C(=C(C1=O)I)I,,,,,,
5243,155244,"Cytidine, N-benzoyl-2'-deoxy-5'-O-(9-phenyl-9H-xanthen-9-yl)-",C1[C@@H](C(O[C@H]1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC4(C5=CC=CC=C5OC6=CC=CC=C64)C7=CC=CC=C7)O,,,,,,
5244,155245,"Butanoic acid, 3-(acetyloxy)-3-methyl-, 1-(1,4-dihydro-5,8-dihydroxy-1,4-dioxo-2-naphthalenyl)-4-methyl-3-pentenyl ester, (S)-",CC(=CC[C@@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)OC(=O)CC(C)(C)OC(=O)C)C,,,,,,
5245,155246,"1H-Imidazole-4-acetic acid, 2-amino-4,5-dihydro-",C1C(NC(=N1)N)CC(=O)O,,,,,,
5246,155247,"Phosphinic acid, (4-fluorophenyl)(hydroxy-3-pyridinylmethyl)-, ethyl ester",CCOP(=O)(C1=CC=C(C=C1)F)C(C2=CN=CC=C2)O,,,,,,
5247,155248,Moracin C,CC(=CCC1=C(C=C(C=C1O)C2=CC3=C(O2)C=C(C=C3)O)O)C,,,,,,
5248,155249,CID 155249,CCCCCCC[C@@H](CC=CCCC(=O)N(C)CC(=CCl)[C@@]12[C@@H](O1)C[C@H]([C@H](C2=O)C)OC(=O)C)OC,,,,,,
5249,155250,"1H-Benzimidazole, 7-nitro-1-propyl-5-(trifluoromethyl)-",CCCN1C=NC2=C1C(=CC(=C2)C(F)(F)F)[N+](=O)[O-],,,,,,
5250,155251,CID 155251,CCCNC1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)N(N=C2C=C(C=C(C2=NCCC)[N+](=O)[O-])C(F)(F)F)O,,,,,,
5251,155252,CID 155252,CCCN=C1C(=CC(=CC1=NN=C2C=C(C=C(C2=NCCC)[N+](=O)[O-])C(F)(F)F)C(F)(F)F)N(O)O,,,,,,
5252,155253,"Guanidine, N-cyano-N'-(2-(((5-ethyl-1H-imidazol-4-yl)methyl)thio)ethyl)-N''-methyl-",CCC1=C(NC=N1)CSCCNC(=NC)NC#N,,,,,,
5253,155254,"Acetic acid, chloronitro-, 1-methylethyl ester",CC(C)OC(=O)C([N+](=O)[O-])Cl,,,,,,
5254,155255,"Benzene, 1-(chloromethyl)-4-(3-chloropropyl)-",C1=CC(=CC=C1CCCCl)CCl,,,,,,
5255,155256,Schizandrin A,C[C@@H]1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3C[C@@H]1C)OC)OC)OC)OC)OC)OC,,,,,,
5256,155257,2-(2-Methylbut-2-enoyloxymethyl)but-2-enoic acid,CC=C(C)C(=O)OCC(=CC)C(=O)O,,,,,,
5257,155258,"Benzoic acid, 3-phenoxy-, hexyl ester",CCCCCCOC(=O)C1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
5258,155259,"2-Oxa-8,9-dithia-4,13-diazatetradecan-14-oic acid, 5,12-dicarboxy-3-oxo-1-phenyl-, 14-(phenylmethyl) ester, (5R,12R)-rel-",C1=CC=C(C=C1)COC(=O)N[C@@H](CCSSCC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)C(=O)O,,,,,,
5259,155260,"6H-Dibenzo(b,d)pyran-9-carboxylic acid, 1-hydroxy-6,6-dimethyl-3-(3-oxopentyl)-",CCC(=O)CCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C(=O)O)(C)C)O,,,,,,
5260,155261,"1,3-Benzodioxole, 4,5-dimethoxy-6-(2-methoxypropyl)-",CC(CC1=CC2=C(C(=C1OC)OC)OCO2)OC,,,,,,
5261,155262,CID 155262,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=C(C3=O)OC)OC)O2)O)OC)O,,,,,,
5262,155263,"Propanamide, N-(2,6-dinitro-4-(trifluoromethyl)phenyl)-N-propyl-",CCCN(C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])C(=O)CC,,,,,,
5263,155264,"4-(3,7-Dimethylocta-2,6-dienoxy)-9-methoxyfuro[3,2-g]chromen-7-one",CC(=CCCC(=CCOC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OC)C)C,,,,,,
5264,155265,"Ethanone, 1-(2-chloro-4-hydroxy-5-methoxyphenyl)-",CC(=O)C1=CC(=C(C=C1Cl)O)OC,,,,,,
5265,155266,1-Amino-3-(o-bromoanilino)-2-propanol dihydrochloride,C1=CC=C(C(=C1)NCC(CN)O)Br.Cl.Cl,,,,,,
5266,155267,1-Amino-3-(2-bromoanilino)propan-2-ol,C1=CC=C(C(=C1)NCC(CN)O)Br,,,,,,
5267,155268,"1,2,4-Triazolo(3,4-b)benzothiazole-5-methanol",C1=CC(=C2C(=C1)SC3=NN=CN23)CO,,,,,,
5268,155269,"4(1H)-Pyridinone, 3-(ethylthio)-1-methyl-5-(3-(trifluoromethyl)phenyl)-",CCSC1=CN(C=C(C1=O)C2=CC(=CC=C2)C(F)(F)F)C,,,,,,
5269,155270,"4(1H)-Pyridinone, 1-methyl-3-(propylthio)-5-(3-(trifluoromethyl)phenyl)-",CCCSC1=CN(C=C(C1=O)C2=CC(=CC=C2)C(F)(F)F)C,,,,,,
5270,155271,"[(1R,2S,3R,4R,5R,6R)-2,3,4,5-tetrahydroxy-6-phosphonooxycyclohexyl] dihydrogen phosphate",[C@H]1([C@H]([C@@H]([C@H]([C@@H]([C@@H]1O)OP(=O)(O)O)OP(=O)(O)O)O)O)O,,,,,,
5271,155272,"1,3-Dioxolo(4,5-g)isoquinolinium, 8-(acetyloxy)-5,6,7,8-tetrahydro-6,6-dimethyl-, iodide",CC(=O)OC1C[N+](CC2=CC3=C(C=C12)OCO3)(C)C.[I-],,,,,,
5272,155273,"(6,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-6-ium-8-yl) acetate",CC(=O)OC1C[N+](CC2=CC3=C(C=C12)OCO3)(C)C,,,,,,
5273,155274,"Oxirane, 2-(4-methoxyphenyl)-3-methyl-, (2R,3S)-rel-",C[C@@H]1[C@@H](O1)C2=CC=C(C=C2)OC,,,,,,
5274,155275,"4H-Pyran-4-one, 2,3,5-tribromo-6-(1,1-dibromopropyl)-",CCC(C1=C(C(=O)C(=C(O1)Br)Br)Br)(Br)Br,,,,,,
5275,155276,"Ethan-d5-amine, N-(methyl-d3)-N-nitroso-",[2H]C([2H])([2H])C([2H])([2H])N(C([2H])([2H])[2H])N=O,,,,,,
5276,155277,"2,2',3,4',5',6-Hexabromobiphenyl",C1=CC(=C(C(=C1Br)C2=CC(=C(C=C2Br)Br)Br)Br)Br,,,,,,
5277,155278,"2,2',3,3',4,4',5-Heptabromobiphenyl",C1=CC(=C(C(=C1C2=CC(=C(C(=C2Br)Br)Br)Br)Br)Br)Br,,,,,,
5278,155279,"2,2',3,3',4,4',5,6'-Octabromobiphenyl",C1=C(C(=C(C(=C1Br)Br)Br)Br)C2=C(C(=C(C=C2Br)Br)Br)Br,,,,,,
5279,155280,CID 155280,CCC=CCCCCCCCCCCCCOC(=O)C,,,,,,
5280,155281,"Oxayohimban-16-carboxylic acid, 20,21-didehydro-17-hydroxy-19-methyl-,methyl ester, (19beta)-",C[C@@H]1C2=CN3CCC4=C([C@@H]3C[C@@H]2C(C(O1)O)C(=O)OC)NC5=CC=CC=C45,,,,,,
5281,155282,"1,2,3,7,8,8a-Hexahydro-8-methylene-2-(1-methylethyl)-4H-1,4a-(epoxymethano)naphthalen-4-one",CC(C)C1CC(=O)C23COC1C2C(=C)CC=C3,,,,,,
5282,155283,"alpha-L-Mannopyranoside, (3beta)-cholest-5-en-3-yl 6-deoxy-",C[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2CC[C@@]3(C4CC[C@@]5([C@H](CCC5C4CC=C3C2)[C@H](C)CCCC(C)C)C)C)O)O)O,,,,,,
5283,155284,"beta-D-Galactopyranoside, (3beta,5alpha,25R)-spirostan-3-yl 6-deoxy-",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CCC6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@H]([C@@H](O7)C)O)O)O)C)C)C)OC1,,,,,,
5284,155285,"beta-D-Galactopyranoside, (3beta,5beta,25R)-spirostan-3-yl 6-deoxy-",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CCC5C4CCC6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)O)O)O)C)C)C)OC1,,,,,,
5285,155286,"Benzenemethanol, alpha-(1-methyl-1-(oxido(phenylmethylene)amino)ethyl)-",CC(C)(C(C1=CC=CC=C1)O)NC(=O)C2=CC=CC=C2,,,,,,
5286,155287,"4-[2-[2-(3,4-Dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2,3-dihydro-1-benzofuran-4-yl]ethenyl]benzene-1,2-diol",C1=CC(=C(C=C1C=CC2=C3C(C(OC3=CC(=C2)O)C4=CC(=C(C=C4)O)O)C5=CC(=CC(=C5)O)O)O)O,,,,,,
5287,155288,"4-[3-(3,5-Dihydroxyphenyl)-6-hydroxy-4-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol",C1=CC(=CC=C1C=CC2=C3C(C(OC3=CC(=C2)O)C4=CC(=C(C=C4)O)O)C5=CC(=CC(=C5)O)O)O,,,,,,
5288,155289,Paraquat dichloride mixt. with monolinuron,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.CN(C(=O)NC1=CC=C(C=C1)Cl)OC.[Cl-].[Cl-],,,,,,
5289,155290,Nefopam hydrochloride,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl,,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)']",,,
5290,155291,"Benzoic acid, 4-((3,4,5-trimethoxybenzoyl)amino)-, hydrazide",COC1=CC(=CC(=C1OC)OC)C(=O)NC2=CC=C(C=C2)C(=O)NN,,,,,,
5291,155292,"Benzo(f)quinoline-7,8-diol, 1,2,3,4,4a,5,6,10b-octahydro-4-methyl-, trans-",CN1CCC[C@@H]2[C@@H]1CCC3=C2C=CC(=C3O)O,,,,,,
5292,155293,2-((4-Methyl-2-oxo-2H-chromen-7-yl)oxy)acetohydrazide,CC1=CC(=O)OC2=C1C=CC(=C2)OCC(=O)NN,,,,,,
5293,155294,Fluazifop-methyl,CC(C(=O)OC)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,,,,,,
5294,155295,"Butanoic acid, 3,3-dimethyl-, 1,1-dimethylethyl ester",CC(C)(C)CC(=O)OC(C)(C)C,,,,,,
5295,155296,"Oxayohimban-16-carboxylic acid, 17-hydroxy-19-methyl-, methyl ester, (19beta)-",C[C@@H]1[C@H]2CN3CCC4=C([C@@H]3C[C@@H]2C(C(O1)O)C(=O)OC)NC5=CC=CC=C45,,,,,,
5296,155297,"Spiro(3H-indole-3,1'(5'H)-indolizin)-2(1H)-one, 6'-ethenyl-2',3',6',7',8',8'a-hexahydro-6-hydroxy-7'-(((1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido(3,4-b)indol-1-yl)methyl)-, (1'R,6'R,7'R,8'aS)-",CN1CCC2=C(C1CC3CC4C5(CCN4CC3C=C)C6=C(C=C(C=C6)O)NC5=O)NC7=CC=CC=C27,,,,,,
5297,155298,"(8S,10S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one;hydrochloride",CC1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3(C(C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C.Cl,,,,,,
5298,155299,"(8S,10S,13S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",CC1CC2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3(C(C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,,,,,,
5299,155300,CID 155300,CC1=CC[C@@H](C(=C[C@@H]2[C@@H]([C@@H](C1)OC(=O)C(=CCOC(=O)C)CO)C(=C)C(=O)O2)C)OC(=O)C,,,,,,
5300,155301,"Hexanoic acid, 2-(dibromomethylene)-",CCCCC(=C(Br)Br)C(=O)O,,,,,,
5301,155302,"1,3,4-Metheno-2H-cyclobuta(cd)pentalen-2-one, 1,1a,3,3a,4,5,5,5a-octachlorooctahydro-",C12C3(C(=O)C4(C1(C5(C4C3(C2(C5(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
5302,155303,"Benzamide, N-(((4-((2-chloro-1,1,2-trifluoroethyl)thio)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)SC(C(F)Cl)(F)F)F,,,,,,
5303,155304,Methyl 8-hydroxy-3-(1-hydroxy-3-oxobut-1-enyl)-7-methoxy-4-oxochromene-5-carboxylate,CC(=O)C=C(C1=COC2=C(C1=O)C(=CC(=C2O)OC)C(=O)OC)O,,,,,,
5304,155305,"2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-, monohydrate",COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.O,,,,,,
5305,155306,"2(3H)-Furanone, dihydro-3-((S)-hydroxyphenylmethyl)-4-((1-methyl-1H-imidazol-4-yl)methyl)-, (3S,4R)-",CN1C=C(N=C1)C[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC=CC=C3)O,,,,,,
5306,155307,"Acetamide, N-(4-hydroxy-2,5-dimethylphenyl)-",CC1=CC(=C(C=C1O)C)NC(=O)C,,,,,,
5307,155308,"1-Azulenecarboxaldehyde, 7-ethyl-4-methyl-",CCC1=CC2=C(C=CC2=C(C=C1)C)C=O,,,,,,
5308,155309,"Phosphoric acid, 3-methylphenyl diphenyl ester",CC1=CC(=CC=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
5309,155310,"Urea, N-1,2-benzisothiazol-3-yl-N'-phenyl-",C1=CC=C(C=C1)NC(=O)NC2=NSC3=CC=CC=C32,,,,,,
5310,155311,"Phosphoric acid, 3-(1-methylethyl)phenyl diphenyl ester",CC(C)C1=CC(=CC=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
5311,155312,"Dibenzo(b,e)(1,4)dioxin, 2,3-dichloro-7-methoxy-",COC1=CC2=C(C=C1)OC3=CC(=C(C=C3O2)Cl)Cl,,,,,,
5312,155313,N-Cyclopropylmethylnorcocaine HCl,COC(=O)C1[C@H]2CCC(N2CC3CC3)CC1OC(=O)C4=CC=CC=C4.Cl,,,,,,
5313,155314,methyl (1R)-3-benzoyloxy-8-(cyclopropylmethyl)-8-azabicyclo[3.2.1]octane-2-carboxylate,COC(=O)C1[C@H]2CCC(N2CC3CC3)CC1OC(=O)C4=CC=CC=C4,,,,,,
5314,155315,"1,2,3,4-Tetrahydroacridine",C1CCC2=NC3=CC=CC=C3C=C2C1,,,,,,
5315,155316,"beta-D-Glucopyranosiduronic acid, (1,1'-biphenyl)-3-yl",C1=CC=C(C=C1)C2=CC(=CC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
5316,155317,"(1,1'-Biphenyl)-3-ol, hydrogen sulfate",C1=CC=C(C=C1)C2=CC(=CC=C2)OS(=O)(=O)O,,,,,,
5317,155318,CID 155318,CC=C(C)C(=O)O[C@H]1CC[C@@]2(C[C@H]3C(=C(C(=O)O3)C)C[C@@]2([C@H]1C)C)O,,,,,,
5318,155319,Farformolide B,C[C@H]1CCC[C@]2([C@@]1([C@@H](C3=C(C(=O)O[C@]3(C2)OC)C)OC)C)O,,,,,,
5319,155320,Chamaejasmine,C1=CC(=CC=C1[C@H]2[C@@H](C(=O)C3=C(C=C(C=C3O2)O)O)[C@H]4[C@@H](OC5=CC(=CC(=C5C4=O)O)O)C6=CC=C(C=C6)O)O,,,,,,
5320,155321,"2,3,4-tribromo-1H-pyrrole",C1=C(C(=C(N1)Br)Br)Br,,,,,,
5321,155322,"1H-1,2,4-Triazole, 1-tricyclo(3.3.1.13,7)dec-1-yl-",C1C2CC3CC1CC(C2)(C3)N4C=NC=N4,,,,,,
5322,155323,"Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-(3-methylphenyl)-",CC1=CC(=CC=C1)C2=CCN(CC2)C,,,,,,
5323,155324,"Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-(4-methylphenyl)-",CC1=CC=C(C=C1)C2=CCN(CC2)C,,,,,,
5324,155325,"4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)C2=CC=C(C=C2)F,,,,,,
5325,155326,"D-Glucose, O-(9,10-dihydro-4-hydroxy-3-(hydroxymethyl)-9,10-dioxo-2-anthracenyl)-6-O-beta-D-xylopyranosyl-",C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)OC2=C(C(=C3C(=C2)C(=O)C4=CC=CC=C4C3=O)O)CO)O)O)O)O)O)O,,,,,,
5326,155327,Yomogiartemin,CC(=O)O[C@H]1C[C@@]([C@]23[C@@H]([C@@H]4[C@@H]1C(=C)C(=O)O4)[C@@]5([C@H]([C@H]2O3)O5)C)(C)O,,,,,,
5327,155328,"5-(6-Methoxy-1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one",COC1=CC2=C(C=C1C=CC=CC(=O)N3CCCCC3)OCO2,,,,,,
5328,155329,"(6R,7S)-7-[[2-[(4-carboxy-3-oxo-1,2-thiazol-5-yl)sulfanyl]acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSC4=C(C(=O)NS4)C(=O)O)OC)SC2)C(=O)O,,,,,,
5329,155330,Plaunolide,C=C1CCC23COC(=O)C2=CCCC3C14CC(OC4=O)C5=COC=C5,,,,,,
5330,155331,Stemonine,CCC1C2C3CCC(N3CCCC2OC14C=C(C(=O)O4)C)C5CC(C(=O)O5)C,,,,,,
5331,155332,CID 155332,CCCCCCC[C@@H](CC=CCCC(=O)N(C)CC(=CCl)CC(=CC(=O)N1CC(=CC1=O)OC)OC)OC,,,,,,
5332,155333,Septentriodine,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H](C6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CCC(=O)OC,,,,,,
5333,155334,Puberaconitine,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H](C6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CCC(=O)O,,,,,,
5334,155335,Sporidesmin J,C[C@@]12C(=O)N3[C@@H]4[C@]([C@H]([C@]3(C(=O)N1C)SS2)O)(C5=CC(=C(C(=C5N4)OC)OC)Cl)O,,,,,,
5335,155336,Octadec-13-en-1-ol,CCCCC=CCCCCCCCCCCCCO,,,,,,
5336,155337,"1H-1,2,4-Triazole-1-propanenitrile, alpha-butyl-alpha-phenyl-",CCCCC(CN1C=NC=N1)(C#N)C2=CC=CC=C2,,,,,,
5337,155338,(R)-3-Octyldihydrofuran-2(3H)-one,CCCCCCCC[C@@H]1CCOC1=O,,,,,,
5338,155339,"Butanoic acid, 2-methyl-, 5-methyl-2-(1-methylethyl)phenyl ester",CCC(C)C(=O)OC1=C(C=CC(=C1)C)C(C)C,,,,,,
5339,155340,"Naphtho(1,2-b)furan-2(3H)-one, 4-(acetyloxy)decahydro-6-hydroxy-5a-methyl-3,9-bis(methylene)-, (3aR,4R,5aR,6R,9aS,9bR)-",CC(=O)O[C@@H]1C[C@]2([C@@H](CCC(=C)[C@@H]2[C@@H]3[C@@H]1C(=C)C(=O)O3)O)C,,,,,,
5340,155341,"Benz(a)anthracene, 3-methoxy-",COC1=CC2=C(C=C1)C3=CC4=CC=CC=C4C=C3C=C2,,,,,,
5341,155342,Nicotinyl 6-aminonicotinate,C1=CC(=CN=C1)COC(=O)C2=CN=C(C=C2)N,,,,,,
5342,155343,CID 155343,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2O[C@@H]3CC4C(C[C@H]([C@@H]5[C@]4(CC[C@H]5[C@]6(CC[C@@H](O6)C(C)(C)O)C)C)O)[C@]7(C3C(C(CC7)O)(C)C)C)CO)O)O)O)O)O,,,,,,
5343,155344,"2H-1-Benzopyran, 3,4-dihydro-6,7-dimethoxy-2,2-dimethyl-",CC1(CCC2=CC(=C(C=C2O1)OC)OC)C,,,,,,
5344,155345,"1,4-Oxathiin-2-carboxamide, 5,6-dihydro-3-methyl-N-phenyl-",CC1=C(OCCS1)C(=O)NC2=CC=CC=C2,,,,,,
5345,155346,Cyanopindolol,CC(C)(C)NCC(COC1=CC=CC2=C1C=C(N2)C#N)O,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
5346,155347,CID 155347,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O.O.O.Cl,,,,,,
5347,155348,"L-Aspartic acid, N-(2-amino-2-carboxyethyl)-, (R)-",C([C@@H](C(=O)O)NC[C@H](C(=O)O)N)C(=O)O,,,,,,
5348,155349,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(2-methyl-1-oxopropyl)-",CC(C)C(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5349,155350,4-tert-butyl-N-ethyl-N-phenylbenzamide,CCN(C1=CC=CC=C1)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
5350,155351,"Benzamide, 4-(1,1-dimethylethyl)-N-(1-methylethyl)-N-phenyl-",CC(C)N(C1=CC=CC=C1)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
5351,155352,"4-(1,1-Dimethylethyl)-N-methyl-N-(4-methylphenyl)benzamide",CC1=CC=C(C=C1)N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
5352,155353,"Benzamide, 4-(1,1-dimethylethyl)-N-methyl-N-(2-propoxyphenyl)-",CCCOC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
5353,155354,epsilon-Acetamidocaproic acid zinc salt,CC(=O)NCCCCCC(=O)[O-].CC(=O)NCCCCCC(=O)[O-].[Zn+2],,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
5354,155355,"Benzo(b)thiophene, trimethyl-",CC1=C2C(=C(SC2=CC=C1)C)C,,,,,,
5355,155356,"Benzo(b)thiophene, tetramethyl-",CC1=C(C2=C(C=C1)SC(=C2C)C)C,,,,,,
5356,155357,"5-(4-Fluorophenyl)-5-phenyl-2,4-imidazolidinedione",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)F,,,,,,
5357,155358,"4'-Bromo-(1,1'-biphenyl)-3,4-diol",C1=CC(=CC=C1C2=CC(=C(C=C2)O)O)Br,,,,,,
5358,155359,3-(2-Hydroxy-3-(isopropylamino)propoxy)-2-phenyl-1-isoindolinone,CC(C)NC[C@H](CO[C@H]1C2=CC=CC=C2C(=O)N1C3=CC=CC=C3)O,,,,,,
5359,155360,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(methoxyacetyl)-",COCC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5360,155361,"3-Methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-ol",CC1=CCCC(C1C=C(C)C(C)O)(C)C,,,,,,
5361,155362,CID 155362,CC=C(CO)C(=O)O[C@@H]1CC(=C[C@H](CC(=C[C@@H]2[C@@H]1C(=C)C(=O)O2)C)O)C,,,,,,
5362,155363,4-[(6-Chloro-2-benzothiazolyl)oxy]phenol,C1=CC(=CC=C1O)OC2=NC3=C(S2)C=C(C=C3)Cl,,,,,,
5363,155364,"Benzofuran, dichloro-",C1=CC=C2C(=C1)C(=C(O2)Cl)Cl,,,,,,
5364,155365,Polystachin,CC(=O)O[C@H]([C@@H]1COC2=CC(=C3C(=O)C=C(OC3=C12)C4=CC=CC=C4)OC)C(C)(C)OC(=O)C,,,,,,
5365,155366,(R)-(-)-benoxaprofen,C[C@H](C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,,,,,,
5366,155367,Dihydroxylupanine,C1CCN2[C@@H](C1)[C@@H]3C[C@H](C2O)[C@]4(CCCC(=O)N4C3)O,,,,,,
5367,155368,"Guanidine, N-(4-aminobutyl)-N-(3-methyl-2-butyl)-, monobenzoate",CC(C)C(C)N(CCCCN)C(=N)N.C1=CC=C(C=C1)C(=O)O,,,,,,
5368,155369,1-(4-Aminobutyl)-1-(3-methylbutan-2-yl)guanidine,CC(C)C(C)N(CCCCN)C(=N)N,,,,,,
5369,155370,"Cyclopropanecarboxamide, 1-methyl-N-(4-(1-methylethoxy)-3-(trifluoromethyl)phenyl)-",CC(C)OC1=C(C=C(C=C1)NC(=O)C2(CC2)C)C(F)(F)F,,,,,,
5370,155371,2-Tetrahydropyranylbenzoate,C1CCOC(C1)C2=CC=CC=C2C(=O)[O-],,,,,,
5371,155372,2-(Oxan-2-yl)benzoic acid,C1CCOC(C1)C2=CC=CC=C2C(=O)O,,,,,,
5372,155373,"4H-Pyrido(1,2-a)pyrimidin-4-one, 2,6-dimethyl-3-ethyl-, monohydrochloride",CCC1=C(N=C2C=CC=C(N2C1=O)C)C.Cl,,,,,,
5373,155374,"1,2-Benzenedicarboxamide, N,N'-bis(3-(trifluoromethyl)phenyl)-",C1=CC=C(C(=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)C(=O)NC3=CC=CC(=C3)C(F)(F)F,,,,,,
5374,155375,"Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride, trihydrate",COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.O.O.[Cl-],,,,,,
5375,155376,methyl 2-(5-oxo-2H-furan-2-yl)acetate,COC(=O)CC1C=CC(=O)O1,,,,,,
5376,155377,"Thymidine, 3-propyl-",CCCN1C(=O)C(=CN(C1=O)[C@H]2C[C@@H]([C@H](O2)CO)O)C,,,,,,
5377,155378,Deglucopterocereine,CN1CCC2=C(C(=C(C=C2C1CO)OC)OC)O,,,,,,
5378,155379,"Peroxynitric acid, chlorodifluoromethyl ester",C(OO[N+](=O)[O-])(F)(F)Cl,,,,,,
5379,155380,Obtusin,CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C(=C(C=C3C2=O)OC)OC)O,,,,,,
5380,155381,Chrysoobtusin,CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C(=C(C=C3C2=O)OC)OC)OC,,,,,,
5381,155382,"alpha-(Phenylmethyl)-(1,1'-biphenyl)-4-methanamine",C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=CC=C3)N,,,,,,
5382,155383,"5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid",CCCCCC=CCC=CCC=CC=C[C@H](CCCC(=O)O)O,,,,,,
5383,155384,"Benzenemethanamine, N-(2,6-difluorophenyl)-4-((3-fluorophenyl)methoxy)-",C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CNC3=C(C=CC=C3F)F,,,,,,
5384,155385,N-Isopropyl-N-phenyloxamic acid,CC(C)N(C1=CC=CC=C1)C(=O)C(=O)O,,,,,,
5385,155386,"2,4-Dimercaptopentanedioic acid",C(C(C(=O)O)S)C(C(=O)O)S,,,,,,
5386,155387,"Orthoformic acid, cyclic ester with 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol",CC(C)(C)C12COC(OC1)OC2,,,,,,
5387,155388,"Orthoacetic acid, cyclic ester with 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol",CC12OCC(CO1)(CO2)C(C)(C)C,,,,,,
5388,155389,"4-(1,1-Dimethylethyl)-1-(1-methylethyl)-2,6,7-trioxabicyclo(2.2.2)octane",CC(C)C12OCC(CO1)(CO2)C(C)(C)C,,,,,,
5389,155390,"Orthobutyric acid, cyclic ester with 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol",CCCC12OCC(CO1)(CO2)C(C)(C)C,,,,,,
5390,155391,"Orthovaleric acid, cyclic ester with 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol",CCCCC12OCC(CO1)(CO2)C(C)(C)C,,,,,,
5391,155392,"4-Phenyl-1-propyl-3,5,8-trioxabicyclo[2.2.2]octane",CCCC12COC(OC1)(OC2)C3=CC=CC=C3,,,,,,
5392,155393,"Orthobenzoic acid, cyclic ester with 2-(hydroxymethyl)-2-isopropyl-1,3-propanediol",CC(C)C12COC(OC1)(OC2)C3=CC=CC=C3,,,,,,
5393,155394,"4-t-Butyl-1-phenyl-2,6,7-trioxabicyclo(2.2.2)octane",CC(C)(C)C12COC(OC1)(OC2)C3=CC=CC=C3,,,,,,
5394,155395,"Adenosine, 1,2-dihydro-1-methyl-2-oxo-",CN1C(=C2C(=NC1=O)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
5395,155396,"4,2':6',4''-Terpyridine",C1=CC(=NC(=C1)C2=CC=NC=C2)C3=CC=NC=C3,,,,,,
5396,155397,"4H-Pyrido(2,3-e)-1,2,4-thiadiazine, 4-methyl-, 1,1-dioxide",CN1C=NS(=O)(=O)C2=C1N=CC=C2,,,,,,
5397,155398,"Orthopropionic acid, cyclic ester with 2-(tert-butyl)-2-(hydroxymethyl)-1,3-propanediol",CCC12OCC(CO1)(CO2)C(C)(C)C,,,,,,
5398,155399,(+-)-2-Amino-N1-(2-hydroxyethyl)butanediamide,C(CO)NC(=O)CC(C(=O)N)N.C(CO)NC(=O)C(CC(=O)N)N,,,,,,
5399,155400,(N-2-hydroxyethyl)-dl-aspartamide,C(CO)NC(=O)C(CC(=O)N)N,,,,,,
5400,155401,2-amino-N'-(2-hydroxyethyl)butanediamide,C(CO)NC(=O)CC(C(=O)N)N,,,,,,
5401,155402,CID 155402,COC1=CC=C(C=C1)C2=C(C(=C3C(=O)C=C(C(=C3O2)O)OC)O)O,,,,,,
5402,155403,Imazalil-thiabendazole mixt.,C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl.C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,,,,,,
5403,155404,Reaction products of octanoic acid with aminoethylethanolamine,CCCCCCCC(=O)O.C(CNCCO)N,,,,,,
5404,155405,"2-Propenamide, homopolymer, reaction products with chloromethane, dimethylamine and formaldehyde",CNC.CCl.C=CC(=O)N.C=O,,,,,,
5405,155406,"2-Pyrrolidinone, 1-(5-nitro-2-thiazolyl)-",C1CC(=O)N(C1)C2=NC=C(S2)[N+](=O)[O-],,,,,,
5406,155407,1-Nitroacenaphthylene,C1=CC2=C3C(=C1)C=C(C3=CC=C2)[N+](=O)[O-],,,,,,
5407,155408,"2,6-Di-tert-butyl-4-methyl-4-tert-butylperoxy-2,5-cyclohexadienone",CC1(C=C(C(=O)C(=C1)C(C)(C)C)C(C)(C)C)OOC(C)(C)C,,,,,,
5408,155409,CID 155409,C[C@H](CCC(=O)[O-])[C@H]1CCC2[C@@]1(CCC3C2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C.[Na+],,,,,,
5409,155410,"(4R)-4-[(3R,5R,10S,13R,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@H]1CCC2[C@@]1(CCC3C2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
5410,155411,Barium tetracyanoplatinate(II) tetrahydrate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.O.O.O.O.[Ba+2].[Pt+2],,,,,,
5411,155412,Potassium hydroxylaminemonosulfonate,N([O-])S(=O)(=O)[O-].[K+].[K+],,,,,,
5412,155413,Oxidosulfamic acid,N([O-])S(=O)(=O)O,,,,,,
5413,155414,4-Chloro-N-(hydroxymethyl)benzamide,C1=CC(=CC=C1C(=O)NCO)Cl,,,,,,
5414,155415,4-[2-(4-Chloro-phenyl)-vinyl]-1-nitro-benzene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)Cl)[N+](=O)[O-],,,,,,
5415,155416,1-Methoxy-3-[2-(4-nitrophenyl)ethenyl]benzene,COC1=CC=CC(=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5416,155417,"4-Amino-2-methoxy-3,5-dimethylaniline",CC1=CC(=C(C(=C1N)C)OC)N,,,,,,
5417,155418,"Acrolein, 3,3-dichloro-2-(dichloromethyl)-",C(=O)C(=C(Cl)Cl)C(Cl)Cl,,,,,,
5418,155419,"N6-Methylquinoline-5,6-diamine",CNC1=C(C2=C(C=C1)N=CC=C2)N,,,,,,
5419,155420,Dichlorochromium;pyridine,C1=CC=NC=C1.C1=CC=NC=C1.Cl[Cr]Cl,,,,,,
5420,155421,N-(4-Chlorophenyl)-N-hydroxy-2-methylpropanamide,CC(C)C(=O)N(C1=CC=C(C=C1)Cl)O,,,,,,
5421,155422,4-Iodophenylhydroxylamine,C1=CC(=CC=C1NO)I,,,,,,
5422,155423,2-(3-Methylphenyl)benzoxazole,CC1=CC(=CC=C1)C2=NC3=CC=CC=C3O2,,,,,,
5423,155424,3-Amino-2-nitrophenol,C1=CC(=C(C(=C1)O)[N+](=O)[O-])N,,,,,,
5424,155425,CID 155425,C1=CC=C(C=C1)C2=C(N=CN2)[N+](=O)[O-],,,,,,
5425,155426,1-Methyl-4-phenyl-5-nitroimidazole,CN1C=NC(=C1[N+](=O)[O-])C2=CC=CC=C2,,,,,,
5426,155427,Pentachlorostyrene,C1=CC(=C(C(=C1)Cl)Cl)C(=C(Cl)Cl)Cl,,,,,,
5427,155428,Chromium (III) sulfate hydrate,O.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cr+3].[Cr+3],,,,,,
5428,155429,"2,4-Dimethylphenanthrene",CC1=CC(=C2C(=C1)C=CC3=CC=CC=C32)C,,,,,,
5429,155430,"1-(3,4-Dichlorophenyl)piperidine-2,5-dione",C1CC(=O)N(CC1=O)C2=CC(=C(C=C2)Cl)Cl,,,,,,
5430,155431,"1,2,10-Trimethoxy-7-oxoaporphine",CN1CCC2=CC(=C(C3=C2C1C(=O)C4=C3C=C(C=C4)OC)OC)OC,,,,,,
5431,155432,2-Nitro-5-aminophenol,C1=CC(=C(C=C1N)O)[N+](=O)[O-],,,,,,
5432,155433,"5,8-Difluoroquinoline",C1=CC2=C(C=CC(=C2N=C1)F)F,,,,,,
5433,155434,Acamprosate calcium,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],,,"['Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)']",,,
5434,155435,Acolbifene,CC1=C([C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O,,,,,,
5435,155436,Acolbifene Hydrochloride,CC1=C([C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O.Cl,,,,,,
5436,155437,"2-Azetidinone, 4-(2-propynyloxy)-",C#CCOC1CC(=O)N1,,,,,,
5437,155438,"Quinoline, 1-(1-azabicyclo(2.2.2)oct-2-ylcarbonyl)-1,2,3,4-tetrahydro-",C1CC2=CC=CC=C2N(C1)C(=O)C3CC4CCN3CC4,,,,,,
5438,155439,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(ethoxyacetyl)-",CCOCC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5439,155440,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-((1-methylethoxy)acetyl)-",CC(C)OCC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5440,155441,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(2-ethoxy-1-oxopropyl)-",CCOC(C)C(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5441,155442,"4H-Pyran-4-one, tetrahydro-3,5-dihydroxy-2-methyl-",CC1C(C(=O)C(CO1)O)O,,,,,,
5442,155443,(2S)-2-benzamido-3-(3-fluorophenyl)propanoic acid,C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC(=CC=C2)F)C(=O)O,,,,,,
5443,155444,"2-[(1R)-1-hydroxy-2-oxopropyl]hexa-2,4-dienal",CC=CC=C(C=O)[C@H](C(=O)C)O,,,,,,
5444,155445,"Hexadeca-10,12-dienal",CCCC=CC=CCCCCCCCCC=O,,,,,,
5445,155446,"1H-Pyrazole, 4-(6-(2-chloro-4-methoxyphenoxy)hexyl)-3,5-diethyl-, monomethanesulfonate",CCC1=C(C(=NN1)CC)CCCCCCOC2=C(C=C(C=C2)OC)Cl.CS(=O)(=O)O,,,,,,
5446,155447,"4-[6-(2-chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1H-pyrazole",CCC1=C(C(=NN1)CC)CCCCCCOC2=C(C=C(C=C2)OC)Cl,,,,,,
5447,155448,B-Nonylglucoside,CCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
5448,155449,CID 155449,C(CC1C(=O)NC(=O)NC1=O)C=CN,,,,,,
5449,155450,Isovaledione,CC(C)CC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5450,155451,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(2,2-dimethyl-1-oxopropyl)-",CC(C)(C)C(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5451,155452,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(3,3-dimethyl-1-oxobutyl)-",CC(C)(C)CC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5452,155453,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(2-methyl-1-oxobutyl)-",CCC(C)C(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5453,155454,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(3-methyl-1-oxopentyl)-",CCC(C)CC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5454,155455,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(2-ethyl-1-oxobutyl)-",CCC(CC)C(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5455,155456,"2,4-Imidazolidinedione, 3-(3,5-dichlorophenyl)-1-(4-methyl-1-oxopentyl)-",CC(C)CCC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
5456,155457,"2,4-Imidazolidinedione, 5-(3-fluorophenyl)-5-phenyl-",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC(=CC=C3)F,,,,,,
5457,155458,CID 155458,COC1=C(C=C2C(=C(C(=C(O2)C3=CC=C(C=C3)O)O)O)C1=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
5458,155459,"1,4-Naphthalenedione, 5-hydroxy-7-methoxy-",COC1=CC2=C(C(=O)C=CC2=O)C(=C1)O,,,,,,
5459,155460,"Benzamide, 4-(1,1-dimethylethyl)-N-phenyl-N-propyl-",CCCN(C1=CC=CC=C1)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
5460,155461,"5-Henicosylbenzene-1,3-diol",CCCCCCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
5461,155462,"5-Tricosyl-1,3-benzenediol",CCCCCCCCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
5462,155463,"5-Pentacosylbenzene-1,3-diol",CCCCCCCCCCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
5463,155464,"1,2-Anthracenediol",C1=CC=C2C=C3C(=CC2=C1)C=CC(=C3O)O,,,,,,
5464,155465,4-Hydroxy-4-methylcyclohex-2-en-1-one,CC1(CCC(=O)C=C1)O,,,,,,
5465,155466,"1,3-Cyclohexanedione, 5-(hydroxymethyl)-",C1C(CC(=O)CC1=O)CO,,,,,,
5466,155467,"Acetamide, N-(2-(acetyloxy)-3-(1-naphthalenyloxy)propyl)-N-(1-methylethyl)-",CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)OC(=O)C)C(=O)C,,,,,,
5467,155468,"Benzamide, 2-(acetylamino)-N-(2-methylphenyl)-",CC1=CC=CC=C1NC(=O)C2=CC=CC=C2NC(=O)C,,,,,,
5468,155469,Cotoprim,CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C.CCNC1=NC(=NC(=N1)SC)NC(C)(C)C,,,,,,
5469,155470,"1-(6-Hydroxy-2,3,4-trimethoxyphenyl)-3-phenylprop-2-en-1-one",COC1=C(C(=C(C(=C1)O)C(=O)C=CC2=CC=CC=C2)OC)OC,,,,,,
5470,155471,"[(4aR,7S,7aS)-7-methyl-1-[(2S,3R,4R,5S,6R)-3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] 3-phenylprop-2-enoate",C[C@@]1(CC[C@H]2[C@@H]1C(OC=C2)O[C@@H]3[C@@H]([C@H]([C@@H]([C@](O3)(CO)O)O)O)O)OC(=O)C=CC4=CC=CC=C4,,,,,,
5471,155472,"2-Butanone, 3-amino-1-diazo-",CC(C(=O)C=[N+]=[N-])N,,,,,,
5472,155473,CID 155473,CC(C(=C[N+]#N)O)N,,,,,,
5473,155474,2-(Hydroxymethyl)-1-phenylcyclopropane-1-carboxylic acid,C1C(C1(C2=CC=CC=C2)C(=O)O)CO,,,,,,
5474,155475,"4-[(6-Chloro-1,3-benzoxazol-2-yl)oxy]phenol",C1=CC(=CC=C1O)OC2=NC3=C(O2)C=C(C=C3)Cl,,,,,,
5475,155476,"2,5-Piperazinedione, 1-amino-4-phenyl-",C1C(=O)N(CC(=O)N1C2=CC=CC=C2)N,,,,,,
5476,155477,"6,6-Dimethylbicyclo[3.1.1]hept-3-en-2-one",CC1(C2CC1C(=O)C=C2)C,,,,,,
5477,155478,"Pentanoic acid, 2-hydroxy-3-methyl-, (1S,3S,3aR,4R,5R,6R,7aS)-1-(acetyloxy)-5-(formyloxy)-3-(3-furanyl)-6-((5R,5aR,9aR)-5,5a,6,7,9,9a-hexahydro-5,9a-dimethyl-2,7-dioxo-2H-pyrano(3,4-b)oxepin-5-yl)octahydro-7a-hydroxy-3a-methyl-7-methylene-1H-inden-4-yl ester, (2R,3R)-",CC[C@H](C)[C@H](C(=O)O[C@H]1[C@@H]([C@@H](C(=C)[C@@]2([C@@]1(C(C[C@@H]2OC(=O)C)C3=COC=C3)C)O)[C@]4(C=CC(=O)O[C@@]5([C@@H]4CC(=O)OC5)C)C)OC=O)O,,,,,,
5478,155479,2-Chloro-5-(chloromethyl)pyridine,C1=CC(=NC=C1CCl)Cl,,,,,,
5479,155480,"1-Azoniabicyclo(2.2.2)octane, 1-methyl-, chloride",C[N+]12CCC(CC1)CC2.[Cl-],,,,,,
5480,155481,1-Methyl-1-azoniabicyclo[2.2.2]octane,C[N+]12CCC(CC1)CC2,,,,,,
5481,155482,"Benzenamine, N,N-dichloro-",C1=CC=C(C=C1)N(Cl)Cl,,,,,,
5482,155483,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(dimethylamino)-, chloride",CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=CC=CC=C4C(=O)O.[Cl-],,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
5483,155484,Basagran DP,CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O.CC(C(=O)O)OC1=C(C=C(C=C1)Cl)Cl.CNC,,,,,,
5484,155485,CID 155485,COC1=C(C=C2C(=C(C(=C(O2)C3=CC(=C(C=C3)O)O)O)O)C1=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
5485,155486,"2,6-Piperidinedione, 3-ethyl-3-(3-hydroxy-4-methoxyphenyl)-",CCC1(CCC(=O)NC1=O)C2=CC(=C(C=C2)OC)O,,,,,,
5486,155487,"Benzamide, N-(((4-((4-chlorophenyl)methoxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OCC3=CC=C(C=C3)Cl)F,,,,,,
5487,155488,"Benzamide, N-(((4-((2,4-dichlorophenyl)methoxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OCC3=C(C=C(C=C3)Cl)Cl)F,,,,,,
5488,155489,"Benzamide, N-(((4-((3,4-dimethylphenyl)methoxy)phenyl)amino)carbonyl)-2,6-difluoro-",CC1=C(C=C(C=C1)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F)C,,,,,,
5489,155490,"Benzamide, N-(((4-((2-cyanophenyl)methoxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC=C(C(=C1)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F)C#N,,,,,,
5490,155491,"Benzamide, 2,6-difluoro-N-(((4-((3-(trifluoromethyl)phenyl)methoxy)phenyl)amino)carbonyl)-",C1=CC(=CC(=C1)C(F)(F)F)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
5491,155492,CID 155492,C1=CC(=CC(=C1)[N+](=O)[O-])COC2=CC=C(C=C2)NCNC(=O)C3=C(C=CC=C3F)F,,,,,,
5492,155493,Sideritoflavone,COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC(=C(C=C3)O)O)OC)OC,,,,,,
5493,155494,Epi-catalponol,CC(=CC[C@H]1C[C@@H](C2=CC=CC=C2C1=O)O)C,,,,,,
5494,155495,"[(1R,2R,7R,8aR)-1,8a-dimethyl-6-oxo-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydronaphthalen-2-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@@H]1CCC2=CC(=O)[C@H](C[C@@]2([C@H]1C)C)C(=C)C,,,,,,
5495,155496,CID 155496,CCOC(=O)C1=CC2=C(C(=C1)O)OC(=C3C2=CC=C(C3=O)O)O,,,,,,
5496,155497,Isopatulin,C1C2=CC(=O)OC2=CC(O1)O,,,,,,
5497,155498,Neopetasol,C[C@H]1[C@@H](CCC2=CC(=O)[C@H](C[C@]12C)C(=C)C)O,,,,,,
5498,155499,"2H-1-Benzopyran, 7-methoxy-2,2,5-trimethyl-",CC1=CC(=CC2=C1C=CC(O2)(C)C)OC,,,,,,
5499,155500,"2H-1-Benzopyran, 2,2-dimethyl-7-(2-propynyloxy)-",CC1(C=CC2=C(O1)C=C(C=C2)OCC#C)C,,,,,,
5500,155501,"1,18-Octadecenedioic acid",C(CCCCCCCC(=O)O)CCCCCCC=CC(=O)O,,,,,,
5501,155502,"Bicyclo(2.2.1)heptane, 2,3,5,5-tetrachloro-7,7-bis(chloromethyl)-1-(dichloromethyl)-, (exo,exo)-",C1C(C2C(C(C1(C2(CCl)CCl)C(Cl)Cl)Cl)Cl)(Cl)Cl,,,,,,
5502,155503,CID 155503,CC1=CC=C(C=C1)N=C(C)C2=C(OC(=C(C2=O)C(=O)C)O)O,,,,,,
5503,155504,CID 155504,CC=C(C)C(=O)O[C@H]1CN2CCC[C@H]2[C@H]1CO,,,,,,
5504,155505,CID 155505,CC=C(C)C(=O)O[C@H]1CN2CCC[C@H]2[C@H]1COC(=O)C=CC3=CC=C(C=C3)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O,,,,,,
5505,155506,"3,4,5-Triacetoxybenzoyl chloride",CC(=O)OC1=CC(=CC(=C1OC(=O)C)OC(=O)C)C(=O)Cl,,,,,,
5506,155507,Pterocereine,CN1CCC2=C(C(=C(C=C2C1CO)OC)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
5507,155508,"2-Propenoic acid, (octahydro-2H-quinolizin-1-yl)methyl ester, (1R-trans)-,homopolymer, hydrochloride",C=CC(=O)OC[C@@H]1CCCN2[C@@H]1CCCC2.Cl,,,,,,
5508,155509,"Lupinine, acrylate (ester)",C=CC(=O)OC[C@@H]1CCCN2[C@@H]1CCCC2,,,,,,
5509,155510,"2-Propenoic acid, 2-methyl-, (octahydro-2H-quinolizin-1-yl)methyl ester, (1R-trans)-, homopolymer, hydrochloride",CC(=C)C(=O)OC[C@@H]1CCCN2[C@@H]1CCCC2.Cl,,,,,,
5510,155511,"[(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl 2-methylprop-2-enoate",CC(=C)C(=O)OC[C@@H]1CCCN2[C@@H]1CCCC2,,,,,,
5511,155512,"Furo(2,3-b)quinolinium, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4,8-dimethoxy-9-methyl-, chloride, (S)-",CC(C)([C@@H]1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC)O.[Cl-],,,,,,
5512,155513,"2-[(2S)-4,8-dimethoxy-9-methyl-2,3-dihydrofuro[2,3-b]quinolin-9-ium-2-yl]propan-2-ol",CC(C)([C@@H]1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC)O,,,,,,
5513,155514,"4H-Dibenzo(de,g)quinoline-1,2-diol, 5,6,6a,7-tetrahydro-9,10-dimethoxy-6-methyl-, (6aS)-",CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)OC)O)O,,,,,,
5514,155515,"Benzenesulfonamide, N-(2,6-diethyl-4-nitrophenyl)-4-methyl-",CCC1=CC(=CC(=C1NS(=O)(=O)C2=CC=C(C=C2)C)CC)[N+](=O)[O-],,,,,,
5515,155516,"Naphtho(2,3-b)furan, 4,4a,7,8,8a,9-hexahydro-6,9,9-trimethyl-, (4aR,8aS)-",CC1=C[C@H]2CC3=C(C([C@H]2CC1)(C)C)OC=C3,,,,,,
5516,155517,"Naphtho(2,3-b)furan, 4,4a,5,6,8a,9-hexahydro-4,4,7-trimethyl-, (4aS,8aR)-",CC1=C[C@H]2CC3=C(C=CO3)C([C@H]2CC1)(C)C,,,,,,
5517,155518,"Phosphorothioic acid, S-cyclohexyl O,O-dimethyl ester",COP(=O)(OC)SC1CCCCC1,,,,,,
5518,155519,"(1R,9S)-6-methyl-9-[(2R)-6-methylhept-5-en-2-yl]cyclonona-2,5-diene-1,2-dicarbaldehyde",CC1=CCC=C([C@@H]([C@@H](CC1)[C@H](C)CCC=C(C)C)C=O)C=O,,,,,,
5519,155520,2-Hydroxy-2-(p-tolyl)propanoic acid,CC1=CC=C(C=C1)C(C)(C(=O)O)O,,,,,,
5520,155521,"1,2,3,4,4a,6,7,8,9,11a-Decahydro-11h-pyrido[2,1-b]quinazolin-11-one",C1CC[C@@H]2[C@H](C1)C(=O)N3CCCCC3=N2,,,,,,
5521,155522,"11H-Pyrido(2,1-b)quinazolin-11-one, 1,2,3,4,4a,6,7,8,9,11a-decahydro-,trans-",C1CC[C@H]2[C@H](C1)C(=O)N3CCCCC3=N2,,,,,,
5522,155523,"Benzene, 1-nitro-3-propoxy-",CCCOC1=CC=CC(=C1)[N+](=O)[O-],,,,,,
5523,155524,CID 155524,CC=CC(=O)[C@@H]1C[C@@H]2C[C@H]1C=C2,,,,,,
5524,155525,CID 155525,CC=CC(=O)[C@@H]1C[C@H]2CC[C@@H]1C2,,,,,,
5525,155526,"Dibenz(a,h)anthracene-3,4-dione",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=CC(=O)C5=O,,,,,,
5526,155527,"2,2':5',2''-Terthiophene, 3',4'-dimethyl-",CC1=C(SC(=C1C)C2=CC=CS2)C3=CC=CS3,,,,,,
5527,155528,"1,2-Propanediol, 3-propoxy-, (S)-",CCCOC[C@H](CO)O,,,,,,
5528,155529,"Thietane, 2-propyl-",CCCC1CCS1,,,,,,
5529,155530,"1,2-Dithiolane, 3-propyl-",CCCC1CCSS1,,,,,,
5530,155531,Methyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate,COC1=CC=C(C=C1)NN=C(C(=O)OC)Cl,,,,,,
5531,155532,"2,4(3H,5H)-Furandione, 5-phenyl-3-(1-phenylpropyl)-",CCC(C1C(=O)C(OC1=O)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
5532,155533,"Benzenamine, 3-chloro-2,6-dinitro-4-(trifluoromethyl)-N-(2-(trifluoromethyl)phenyl)-",C1=CC=C(C(=C1)C(F)(F)F)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
5533,155534,CID 155534,C1=C(C(=CC(C1C(F)(F)F)([N+](=O)[O-])Cl)NC2=C(C=C(C=C2Cl)Cl)Cl)[N+](=O)[O-],,,,,,
5534,155535,"Benzenamine, 3-chloro-N-(2,6-dichloro-4-nitrophenyl)-2,6-dinitro-4-(trifluoromethyl)-",C1=C(C=C(C(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
5535,155536,"Benzenamine, 3-chloro-N-(2,4-difluorophenyl)-2,6-dinitro-4-(trifluoromethyl)-",C1=CC(=C(C=C1F)F)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
5536,155537,"Benzenamine, 3-chloro-2,6-dinitro-4-(trifluoromethyl)-N-(4-(trifluoromethyl)phenyl)-",C1=CC(=CC=C1C(F)(F)F)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
5537,155538,"Benzenamine, 3-chloro-2,6-dinitro-4-(trifluoromethyl)-N-(3-(trifluoromethyl)phenyl)-",C1=CC(=CC(=C1)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
5538,155539,"Benzenamine, 3-chloro-N-(4-chloro-3-(trifluoromethyl)phenyl)-2,6-dinitro-4-(trifluoromethyl)-",C1=CC(=C(C=C1NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F)Cl,,,,,,
5539,155540,"Benzenamine, N-(3,5-bis(trifluoromethyl)phenyl)-3-chloro-2,6-dinitro-4-(trifluoromethyl)-",C1=C(C=C(C=C1C(F)(F)F)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
5540,155541,CID 155541,C[C@H]1[C@@H]([C@H]([C@H](C(O1)OC[C@@H]2[C@H]([C@@H]([C@H](C(O2)OC3=C([O+]=C4C=C(C=C(C4=C3)OC5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)C6=CC(=C(C(=C6)OC)O)O)O)O)O)O)O)OC(=O)C=CC7=CC=C(C=C7)O.[Cl-],,,,,,
5541,155542,CID 155542,C[C@H]1[C@@H]([C@H]([C@H](C(O1)OC[C@H]2[C@@H]([C@H]([C@H](C(O2)OC3=C(OC4=CC(=O)C=C(C4=C3)OC5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O)C6=CC(=C(C(=C6)OC)O)O)O)O)O)O)O)OC(=O)C=CC7=CC=C(C=C7)O,,,,,,
5542,155543,"Propane, 2,2'-oxybis(chloro-",CC(C)OC(C)C.ClCl,,,,,,
5543,155544,"Iron(2+), tetraaqua(N-hydroxy-5-oxo-2-pyrrolidinecarboxamidato)-, (OC-6-23)-",C1CC(=O)NC1C(=O)N[O-].O.O.O.O.[Fe+3],,,,,,
5544,155545,N-oxido-5-oxopyrrolidine-2-carboxamide,C1CC(=O)NC1C(=O)N[O-],,,,,,
5545,155546,Prolotestone,CCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C.CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C.C[C@@H]1C[C@]2([C@@H](CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)CC1=O)C.C[C@@H]1C[C@]2([C@@H](CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)C)C)CC1=O)C,,,,,,
5546,155547,Drostanolone acetate,C[C@@H]1C[C@]2([C@@H](CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)C)C)CC1=O)C,,,,,,
5547,155548,"[(2R,5S,8R,9S,10S,13S,14S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C,,,,,,
5548,155549,"5alpha-Androstan-3-one, 17beta-hydroxy-2alpha-methyl-, hexanoate",CCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C,,,,,,
5549,155550,Oxine-copper-captan mixt.,C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Cu+2],,,,,,
5550,155551,Physalin H,CC12CC3C4(C56C1C(=O)C(O5)(C7CC(C8(CC=CC(=O)C8(C7CCC6(C(=O)O4)O)C)Cl)O)OCC2C(=O)O3)C,,,,,,
5551,155552,"Benzamide, 2,6-difluoro-N-(((4-((2-fluorophenyl)methoxy)phenyl)amino)carbonyl)-",C1=CC=C(C(=C1)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F)F,,,,,,
5552,155553,"Benzamide, 2,6-difluoro-N-(((4-((3-fluorophenyl)methoxy)phenyl)amino)carbonyl)-",C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
5553,155554,"1-Deoxy-2beta,3beta-epoxynagilactone A",CC(C)C1=C2C(C3C4C(C2=CC(=O)O1)(CC5C(C4(C(=O)O3)C)O5)C)O,,,,,,
5554,155555,"3-Oxa-5,7-dithia-4-phosphanonan-9-oic acid, 4-methyl-, methyl ester, 4-sulfide",CCOP(=S)(C)SCSCC(=O)OC,,,,,,
5555,155556,"(1S,6S,8S)-3,8,12,16-tetramethyl-7,18-dioxatricyclo[13.3.0.06,8]octadeca-2,11,15-triene",CC1=CCC[C@]2([C@@H](O2)CCC(=C[C@H]3C(=C(CO3)C)CC1)C)C,,,,,,
5556,155557,4-tert-butyl-N-methyl-N-phenylbenzamide,CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2,,,,,,
5557,155558,11-Nortetrodotoxin,C12C3C(=O)C4C(C1(C(C(O3)(O4)O)O)NC(=NC2O)N)O,,,,,,
5558,155559,Ammonium tetraformate,C(=O)O.C(=O)O.C(=O)O.C(=O)O.N,,,,,,
5559,155560,"4,7-Epoxy-1H-isoindole-1,3(2H)-dione, hexahydro-2-ethyl-, (3aR-(3a-alpha,4-beta,7-beta,7a-alpha))-",CCN1C(=O)[C@@H]2[C@H]3CC[C@@H]([C@@H]2C1=O)O3,,,,,,
5560,155561,"Benzene;2-[2-(dimethylamino)ethoxy]ethanol;2,2,4-trimethylpentane",CC(C)CC(C)(C)C.CN(C)CCOCCO.C1=CC=CC=C1,,,,,,
5561,155562,"4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl decanoate",CCCCCCCCCC(=O)OC12CC(C3(C(C1C2(C)C)C=C(CC4(C3C=C(C4=O)C)O)CO)O)C,,,,,,
5562,155563,Disodium;2-[[hydroxy(oxido)phosphoryl]methylamino]acetate,C(C(=O)[O-])NCP(=O)(O)[O-].C(C(=O)[O-])NCP(=O)(O)[O-].C(C(=O)[O-])NCP(=O)(O)[O-].[Na+].[Na+],,,,,,
5563,155564,"3-Acetoxyscirpene-4,15-diol",CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)OC(=O)C)O)C)CO,,,,,,
5564,155565,"(6'-Ethyl-3',24-dihydroxy-21-methoxy-5',11,13,22-tetramethyl-2-oxospiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-4'-yl) 2-methylhexanoate",CCCCC(C)C(=O)OC1C(C(OC2(C1O)CC3CC(O2)CC=C(CC(C=CC=C4COC5C4(C(C=C(C5OC)C)C(=O)O3)O)C)C)CC)C,,,,,,
5565,155566,I131-Digitoxinyl benzoate,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC(=O)C9=CC(=C(C=C9)N)[131I])O)O,,,,,,
5566,155567,Duador,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC[N+]4(C)C)C)[N+]5(CCCC5)C.[Br-].[Br-],,,,,,
5567,155568,"(4aS,4bR,6aS,8R,10aS,10bS,12aS)-1,1,10a,12a-tetramethyl-8-(1-methylpyrrolidin-1-ium-1-yl)-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydro-2H-naphtho[2,1-f]quinolin-1-ium",C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC[N+]4(C)C)C)[N+]5(CCCC5)C,,,,,,
5568,155569,Yunaconitine,CCN1CC2(C(CC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)O)COC,,,,,,
5569,155570,"Tricyclo(3.3.1.1(3,7))decan-1-aminium, N,N'-bis((1,4-dioxo-1,4-butanediyl)bis(oxy-2,1-ethanediyl))bis(N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid, (1:2)",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+](C)(CCOC(=O)CCC(=O)OCC[N+](C)(C)C12CC3CC(C1)CC(C3)C2)C45CC6CC(C4)CC(C6)C5,,,,,,
5570,155571,"1,3,5-Triazine-2,4,6-triamine, compd. with 3,9-dihydroxy-2,4,8,10-tetraoxa-3,9-diphosphaspiro(5.5)undecane 3,9-dioxide (2:1)",C1C2(COP(=O)(O1)O)COP(=O)(OC2)O.C1(=NC(=NC(=N1)N)N)N.C1(=NC(=NC(=N1)N)N)N,,,,,,
5571,155572,Pentaerythrithol diphosphonate,C1C2(COP(=O)(O1)O)COP(=O)(OC2)O,,,,,,
5572,155573,Mepiquat-chloride and ethephon,C[N+]1(CCCCC1)C.C(CCl)P(=O)(O)O.[Cl-],,,,,,
5573,155574,"23-Hydroxy-3,6,9,12,15,18,21-heptaoxatricos-1-yl octadecanoate",CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCO,,,,,,
5574,155575,"1H-Azepine-1-carbothioic acid, hexahydro-4-oxo-, S-ethyl ester",CCSC(=O)N1CCCC(=O)CC1,,,,,,
5575,155576,Zinc o-acetylsalicylate,CC(=O)OC1=CC=CC=C1C(=O)[O-].CC(=O)OC1=CC=CC=C1C(=O)[O-].[Zn+2],,,,,,
5576,155577,"Azuleno(4,5-b)furan-2(3H)-one, decahydro-3,8-dihydroxy-3-(hydroxymethyl)-9-methyl-6-methylene-, (3R-(3alpha,3aalpha,6aalpha,8beta,9alpha,9aalpha,9bbeta))-",C[C@H]1[C@@H](C[C@H]2[C@@H]1[C@H]3[C@H](CCC2=C)[C@](C(=O)O3)(CO)O)O,,,,,,
5577,155578,D-Kyotorphin,C1=CC(=CC=C1C[C@@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)O)N)O,,,['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)'],,,
5578,155579,Triclopyr amine,C1=C(C(=NC(=C1Cl)Cl)OCC(=O)ON)Cl,,,,,,
5579,155580,Ethyl 3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate,CCOC(=O)[C@@H]1[C@H]2CC[C@@H](N2C)C[C@@H]1O,,,,,,
5580,155581,(2S)-2-(5-methoxynaphthalen-2-yl)propanoate;piperazin-1-ium,C[C@@H](C1=CC2=C(C=C1)C(=CC=C2)OC)C(=O)[O-].C1CNCC[NH2+]1,,,,,,
5581,155582,(2S)-2-(5-methoxynaphthalen-2-yl)propanoic acid,C[C@@H](C1=CC2=C(C=C1)C(=CC=C2)OC)C(=O)O,,,,,,
5582,155583,4-Methyl-N-ethylamino phenol sulfate,CCNC1=C(C=CC(=C1)O)C.OS(=O)(=O)O,,,,,,
5583,155584,Dibenzocarbazole,C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C5=CC=CC=C5N4,,,,,,
5584,155585,Isohelenol,C[C@@H]1C[C@@H]2C(=C(C(=O)O2)CO)[C@@H]([C@]3([C@H]1C=CC3=O)C)O,,,,,,
5585,155586,"Naphtho(2,3-b)furan-2(3H)-one, 3a,4,4a,8a,9,9a-hexahydro-3,5,8a-trimethyl-, (3S-(3alpha,3abeta,4abeta,8aalpha,9abeta))-",C[C@H]1[C@H]2C[C@H]3C(=CC=C[C@@]3(C[C@H]2OC1=O)C)C,,,,,,
5586,155587,5-O-Methylchamanetin,COC1=C2C(=O)CC(OC2=C(C(=C1)O)CC3=CC=CC=C3O)C4=CC=CC=C4,,,,,,
5587,155588,"Cyclopenta(c)pyran-7-carboxaldehyde, 4-(hydroxymethyl)-",C1=C(C2=COC=C(C2=C1)CO)C=O,,,,,,
5588,155589,Griselinoside,COC(=O)[C@@H]1CC(=O)[C@@H]2[C@H]1[C@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
5589,155590,"2-((3,4-Dihydro-1(2H)-quinolinyl)methyl)-1-azabicyclo(2.2.2)octane, (+/-)-",C1CC2=CC=CC=C2N(C1)CC3CC4CCN3CC4,,,,,,
5590,155591,Potassium hexakis(thiocyanato)platinate(IV),C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].[K+].[K+].[Pt+4],,,,,,
5591,155592,N-Benzyl-2-bromo-2-phenylacetamide,C1=CC=C(C=C1)CNC(=O)C(C2=CC=CC=C2)Br,,,,,,
5592,155593,Dicyclohexyl 21-crown-7,C1CCC(CC1)C2(COCCOCCOCCOCCOCCOCCO2)C3CCCCC3,,,,,,
5593,155594,"4-Amino-2,5-dimethoxyaniline",COC1=CC(=C(C=C1N)OC)N,,,,,,
5594,155595,9-Phenanthrylmethyl isothiocyanate,C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)CN=C=S,,,,,,
5595,155596,N-(4-Chlorophenyl)-succinamide,C1=CC(=CC=C1NC(=O)CCC(=O)N)Cl,,,,,,
5596,155597,"N-(3,4-Dichlorophenyl)-succinamide",C1=CC(=C(C=C1NC(=O)CCC(=O)N)Cl)Cl,,,,,,
5597,155598,1-Ethyltriazoline,CCN1CCN=N1,,,,,,
5598,155599,1-Benzyltriazoline,C1CN(N=N1)CC2=CC=CC=C2,,,,,,
5599,155600,CID 155600,C1=CC=C2C(=C1)N(C(=C[N+]2=O)C(=O)[O-])O,,,,,,
5600,155601,1-Hydroxy-4-oxoquinoxalin-4-ium-2-carboxylic acid,C1=CC=C2C(=C1)N(C(=C[N+]2=O)C(=O)O)O,,,,,,
5601,155602,"9H-Carbazole, 1,4,6-trimethyl-",CC1=CC2=C(C=C1)NC3=C(C=CC(=C23)C)C,,,,,,
5602,155603,p-Methylphenylpropylene oxide,CC1=CC=C(C=C1)CC2CO2,,,,,,
5603,155604,3-Azidopropanoic acid,C(CN=[N+]=[N-])C(=O)O,,,,,,
5604,155605,Azidoacetic acid,C(C(=O)O)N=[N+]=[N-],,,,,,
5605,155606,(4-Methoxyphenyl)(3-phenyloxiran-2-yl)methanone,COC1=CC=C(C=C1)C(=O)C2C(O2)C3=CC=CC=C3,,,,,,
5606,155607,CID 155607,CCN(CC)C(=S)S[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
5607,155608,Cyclopenta(fg)naphthacene,C1=CC=C2C3=C4C(=C5C=CC=CC5=CC4=CC2=C1)C=C3,,,,,,
5608,155609,"Pyrido(2,3-d)pyridazine 6-oxide",C1=CC2=C[N+](=NC=C2N=C1)[O-],,,,,,
5609,155610,"Pyrido(2,3-d)pyridazine 7-oxide",C1=CC2=CN=[N+](C=C2N=C1)[O-],,,,,,
5610,155611,"4,4'-Methylenebis(2-ethyl-6-methylaniline)",CCC1=C(C(=CC(=C1)CC2=CC(=C(C(=C2)C)N)CC)C)N,,,,,,
5611,155612,"trans-1,2,3,4,4a,9,10,10a-Octahydrophenanthrene",C1CC[C@@H]2[C@@H](C1)CCC3=CC=CC=C23,,,,,,
5612,155613,2-(3-Chlorophenyl)oxirane,C1C(O1)C2=CC(=CC=C2)Cl,,,,,,
5613,155614,6-Azido-6-deoxy-D-glucose,C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)N=[N+]=[N-],,,,,,
5614,155615,"1,1-Diphenyl-2-butynyl cyclohexylcarbamate",CC#CC(C1=CC=CC=C1)(C2=CC=CC=C2)OC(=O)NC3CCCCC3,,,,,,
5615,155616,"Pyrido(2,3-d)pyridazin-5(6H)-one hydrazone",C1=CC2=C(N=NC=C2N=C1)NN,,,,,,
5616,155617,N-(4-chlorophenyl)-4-nitroaniline,C1=CC(=CC=C1NC2=CC=C(C=C2)Cl)[N+](=O)[O-],,,,,,
5617,155618,Potassium hydroxylaminedisulfonate,N(O)(S(=O)(=O)[O-])S(=O)(=O)[O-].[K+].[K+],,,,,,
5618,155619,"Imidodisulfuric acid, hydroxy-",N(O)(S(=O)(=O)O)S(=O)(=O)O,,,,,,
5619,155620,m-Nitrobenzyl acetate,CC(=O)OCC1=CC(=CC=C1)[N+](=O)[O-],,,,,,
5620,155621,9-Trityladenine,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)N4C=NC5=C(N=CN=C54)N,,,,,,
5621,155622,Epoxy chloropropane,CC1C(O1)Cl,,,,,,
5622,155623,trans-1-Chloropropene oxide,C[C@@H]1[C@H](O1)Cl,,,,,,
5623,155624,Bis(p-methoxyphenyl)selenide,COC1=CC=C(C=C1)[Se]C2=CC=C(C=C2)OC,,,,,,
5624,155625,2-Hydroxydibenzothiophene,C1=CC=C2C(=C1)C3=C(S2)C=CC(=C3)O,,,,,,
5625,155626,"P-Mentha-2,8-dien-1-ol",CC(=C)C1CCC(C=C1)(C)O,,,,,,
5626,155627,2-(3-Chlorophenyl)benzoxazole,C1=CC=C2C(=C1)N=C(O2)C3=CC(=CC=C3)Cl,,,,,,
5627,155628,"3',4',7-Tri(hydroxyethyl)quercetin",C1C2=C(C(=CC1(CCO)O)O)C(=O)C(=C(O2)C3=CC(C(C=C3)(CCO)O)(CCO)O)O,,,,,,
5628,155629,"1,1'-Dimethyl-2,2'-bipyridinium diiodide",C[N+]1=CC=CC=C1C2=CC=CC=[N+]2C.[I-].[I-],,,,,,
5629,155630,"2,2'-Bipyridinium, 1,1'-dimethyl-",C[N+]1=CC=CC=C1C2=CC=CC=[N+]2C,,,,,,
5630,155631,Steporphine,CN1C[C@H](C2=CC3=C(C4=C2[C@H]1CC5=CC=CC=C54)OCO3)O,,,,,,
5631,155632,"Cyclohexane, bromochloro-",C1CCC(CC1)(Cl)Br,,,,,,
5632,155633,CID 155633,CCl.C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
5633,155634,H-DL-Phe-Pro-Arg-OH,C1C[C@H](N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
5634,155635,"1H-(1,2,4)Triazolo(1,2-a)pyridazin-1-one, hexahydro-2-phenyl-3-thioxo-",C1CCN2C(=S)N(C(=O)N2C1)C3=CC=CC=C3,,,,,,
5635,155636,"Naphthalenetriol, mono(hydrogen sulfate) mono(methylcarbamate)",CNC(=O)OC1=C(C2=CC=CC=C2C=C1O)OS(=O)(=O)O,,,,,,
5636,155637,"beta-Hydroxy-(1,1'-biphenyl)-4-propanoic acid",C1=CC=C(C=C1)C2=CC=C(C=C2)C(CC(=O)O)O,,,,,,
5637,155638,CID 155638,CCN1C=[N+](C2=C1C(=O)N=C(N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
5638,155639,"1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)pyrimidine-3-carboxamide",CC1CCCC2N1C(=O)C(=CN2C)C(=O)N,,,,,,
5639,155640,"Benzamide, 2,6-difluoro-N-(((4-((5-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)amino)carbonyl)-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OC3=NC=C(C=C3)C(F)(F)F)F,,,,,,
5640,155641,"Benzamide, N-(((4-((3-chloro-5-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OC3=C(C=C(C=N3)C(F)(F)F)Cl)F,,,,,,
5641,155642,"O-(2,3-Dichlorophenyl) O-methyl phenylphosphonothioate",COP(=S)(C1=CC=CC=C1)OC2=C(C(=CC=C2)Cl)Cl,,,,,,
5642,155643,"Phosphonothioic acid, phenyl-, O-(2-chlorophenyl) O-methyl ester",COP(=S)(C1=CC=CC=C1)OC2=CC=CC=C2Cl,,,,,,
5643,155644,O-(3-Chlorophenyl) O-methyl phenylphosphonothioate,COP(=S)(C1=CC=CC=C1)OC2=CC(=CC=C2)Cl,,,,,,
5644,155645,O-(4-Chlorophenyl) O-methyl phenylphosphonothioate,COP(=S)(C1=CC=CC=C1)OC2=CC=C(C=C2)Cl,,,,,,
5645,155646,"Phosphonothioic acid, phenyl-, O-(3,4-dichlorophenyl) O-methyl ester",COP(=S)(C1=CC=CC=C1)OC2=CC(=C(C=C2)Cl)Cl,,,,,,
5646,155647,"Phenylphosphonothioic acid O-(3,5-dichlorophenyl) O-methyl ester",COP(=S)(C1=CC=CC=C1)OC2=CC(=CC(=C2)Cl)Cl,,,,,,
5647,155648,"Phosphonothioic acid, phenyl-, O-(2,5-dichlorophenyl) O-ethyl ester",CCOP(=S)(C1=CC=CC=C1)OC2=C(C=CC(=C2)Cl)Cl,,,,,,
5648,155649,"O-(2,5-Dichlorophenyl) O-propyl phenylphosphonothioate",CCCOP(=S)(C1=CC=CC=C1)OC2=C(C=CC(=C2)Cl)Cl,,,,,,
5649,155650,Phenylphosphonothioic acid O-methyl O-(4-nitrophenyl) ester,COP(=S)(C1=CC=CC=C1)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5650,155651,"Butanedioic acid, 2-methylpropyl phenylmethyl ester",CC(C)COC(=O)CCC(=O)OCC1=CC=CC=C1,,,,,,
5651,155652,"Phenylphosphonothioic acid O-(2,6-dichlorophenyl) O-methyl ester",COP(=S)(C1=CC=CC=C1)OC2=C(C=CC=C2Cl)Cl,,,,,,
5652,155653,Methylthioacetylaminoethanol,CSCC(=O)NCCO,,,,,,
5653,155654,CID 155654,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3.CC(=NOC(=O)NC)SC,,,,,,
5654,155655,Malyngolide,CCCCCCCCC[C@]1(CC[C@H](C(=O)O1)C)CO,,,,,,
5655,155656,Tolmetin glucuronide,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,['Tolmetin glucuronide is a known human metabolite of Tolmetin.'],
5656,155657,"3H-Indolium, 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1,3,3-trimethyl-, acetate",CC(=O)[O-].CC1(C2=CC=CC=C2[N+](=C1C=CC3=CC=C(C=C3)N(C)C)C)C,,,,,,
5657,155658,"9-((3,7-Dimethylocta-2,6-dien-1-yl)-oxy)-7H-furo[3,2-g]chromen-7-one",CC(=CCCC(=CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)C)C,,,,,,
5658,155659,"Benzeneacetic acid, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)CC4=CC=CC=C4,,,,,,
5659,155660,"(2R-trans)-2-(3,4-Dihydroxyphenyl)-3-(heptyloxy)-3,4-dihydro-2H-1-benzopyran-5,7-diol",CCCCCCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
5660,155661,3-Palmitoylcatechin,CCCCCCCCCCCCCCCC(=O)O[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
5661,155662,"9,10-Anthracenedione, 1,5-bis[[1-(2-hydroxyethyl)-1H-1,2,4-triazol-3-yl]thio]-",C1=CC2=C(C(=C1)SC3=NN(C=N3)CCO)C(=O)C4=C(C2=O)C(=CC=C4)SC5=NN(C=N5)CCO,,,,,,
5662,155663,Sitophilure,CC[C@H]([C@H](C)C(=O)CC)O,,,,,,
5663,155664,Z-Phe-Ala-Diazomethylketone,C[C@@H](C(=O)C=[N+]=[N-])NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
5664,155665,2-Hydroxy-3-[[3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]but-1-ene-1-diazonium,CC(C(=C[N+]#N)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
5665,155666,"Propanoic acid, 3-[[bis(1-methylethoxy)phosphinothioyl]thio]-, ethyl ester",CCOC(=O)CCSP(=S)(OC(C)C)OC(C)C,,,,,,
5666,155667,Loflazepic acid,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O)F,,,,,,
5667,155668,"Phosphorothioic acid, O-(3-chloro-1-(1-methylethyl)-1H-pyrazol-5-yl) O,O-dimethyl ester",CC(C)N1C(=CC(=N1)Cl)OP(=S)(OC)OC,,,,,,
5668,155669,"Phosphorothioic acid, O-(3-chloro-1-methyl-1H-pyrazol-5-yl) O-ethyl O-methyl ester",CCOP(=S)(OC)OC1=CC(=NN1C)Cl,,,,,,
5669,155670,"1,5-Dichloro-3-(1,5-dichloropentan-3-ylsulfanyl)pentane",C(CCl)C(CCCl)SC(CCCl)CCCl,,,,,,
5670,155671,"N-Nitroso-3,4-epoxypiperidine",C1CN(CC2C1O2)N=O,,,,,,
5671,155672,Muscarone,C[C@H]1C(=O)C[C@H](O1)C[N+](C)(C)C,,,,,,
5672,155673,CID 155673,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3.C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O)O)O,,,,,,
5673,155674,"4(1H)-Pyridinone, 3-(4-hydroxyphenyl)-1-methyl-5-(3-(trifluoromethyl)phenyl)-",CN1C=C(C(=O)C(=C1)C2=CC(=CC=C2)C(F)(F)F)C3=CC=C(C=C3)O,,,,,,
5674,155675,"1,3-Dimethyl-2,4-dioxo-6-benzyl-1,2,3,4,5,6,7,8-octahydropyrimido(4,5-d)pyrimidine",CN1C2=C(CN(CN2)CC3=CC=CC=C3)C(=O)N(C1=O)C,,,,,,
5675,155676,CID 155676,CC(CCC=C(C)C)C[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)[O-])C2)O)O.[Na+],,,,,,
5676,155677,CID 155677,CC(CCC=C(C)C)C[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)C2)O)O,,,,,,
5677,155678,CID 155678,CC1C(=NOC(=O)NC)S(CO1)O,,,,,,
5678,155679,"Dibenzo(b,e)(1,4)dioxin-2-ol",C1=CC=C2C(=C1)OC3=C(O2)C=C(C=C3)O,,,,,,
5679,155680,"2,2,4-trimethyl-6-[1-(2,2,4-trimethyl-1H-quinolin-6-yl)ethyl]-1H-quinoline",CC1=CC(NC2=C1C=C(C=C2)C(C)C3=CC4=C(C=C3)NC(C=C4C)(C)C)(C)C,,,,,,
5680,155681,"Card-20(22)-enolide, 3,5,14-trihydroxy-, (3alpha,5beta)-",C[C@]12CC[C@H](C[C@]1(CC[C@@H]3[C@@H]2CC[C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O,,,,,,
5681,155682,"3,3,7-Trimethyl-4,9-dioxatricyclo(3.3.1.02,7)nonane",CC1(C2C3CC2(CC(O3)O1)C)C,,,,,,
5682,155683,"3-Hydroxymethylphenytoin N,N-dimethylglycine ester",CN(C)CC(=O)OCN1C(=O)C(NC1=O)(C2=CC=CC=C2)C3=CC=CC=C3.CS(=O)(=O)O,,,,,,
5683,155684,"3-(N,N-Dimethylglycyloxymethyl)diphenylhydantoin",CN(C)CC(=O)OCN1C(=O)C(NC1=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
5684,155685,Bromobenzene ether,C1=CC2=C(O2)C(=C1)Br,,,,,,
5685,155686,Thielavin B,CC1=CC(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)OC)C)O)C)O,,,,,,
5686,155687,"Benz(a)anthracen-3-ol, 7-methyl-",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC(=C3)O,,,,,,
5687,155688,Hexachlorocyclopentene,C1C(=C(C(C1(Cl)Cl)(Cl)Cl)Cl)Cl,,,,,,
5688,155689,Desethyl-N-acetylprocainamide,CCNCCNC(=O)C1=CC=C(C=C1)NC(=O)C,,,,,,
5689,155690,2-(4-Chlorophenyl)-4-hydroxy-3-methylbutanoic acid,CC(CO)C(C1=CC=C(C=C1)Cl)C(=O)O,,,,,,
5690,155691,"4-[(2S,3S)-3-tetradeca-1,3,5,8-tetraenyloxiran-2-yl]butanoic acid",CCCCCC=CCC=CC=CC=C[C@H]1[C@@H](O1)CCCC(=O)O,,,,,,
5691,155692,Spinosin,COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
5692,155693,Hydroxyazatridecenone,CCCCCCCCCC=CC(=O)NO,,,,,,
5693,155694,"Benzoic acid, 2-((7-chloro-4-quinolinyl)amino)-5-hydroxy-",C1=CC(=C(C=C1O)C(=O)O)NC2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
5694,155695,N-acetyl-S-(3-chloroprop-2-enyl) cysteine,CC(=O)N[C@@H](CSCC=CCl)C(=O)O,,,,,,
5695,155696,"(2S,3S,4S,5R,6S)-6-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CC(C)(C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)OC2=CC=C(C=C2)Cl,,,,,,
5696,155697,"2-Naphthalenesulfonic acid, 5-(acetylamino)-1-(acetyloxy)-, compd. with pyridine (1:1)",CC(=O)NC1=CC=CC2=C1C=CC(=C2OC(=O)C)S(=O)(=O)O.C1=CC=NC=C1,,,,,,
5697,155698,5-Acetamido-1-(acetyloxy)naphthalene-2-sulfonic acid,CC(=O)NC1=CC=CC2=C1C=CC(=C2OC(=O)C)S(=O)(=O)O,,,,,,
5698,155699,CID 155699,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.I.I,,,,,,
5699,155700,"Phosphonous acid, phenyl-, 2,6-bis(1,1-dimethylethyl)-4-methylphenyl 2,4-bis(1,1-dimethylethyl)phenyl ester",CC1=CC(=C(C(=C1)C(C)(C)C)OP(C2=CC=CC=C2)OC3=C(C=C(C=C3)C(C)(C)C)C(C)(C)C)C(C)(C)C,,,,,,
5700,155701,C.I. Reactive Yellow 25,CC1=C(C=CC(=C1)S(=O)(=O)[O-])N2C(=O)C(C(=N2)C(=O)[O-])N=NC3=C(C=CC(=C3)NC(=O)C4=CC5=C(C=C4)N=C(C(=N5)Cl)Cl)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
5701,155702,"4-({5-[(2,3-Dichloroquinoxaline-6-carbonyl)amino]-2-sulfophenyl}diazenyl)-1-(2-methyl-4-sulfophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid",CC1=C(C=CC(=C1)S(=O)(=O)O)N2C(=O)C(C(=N2)C(=O)O)N=NC3=C(C=CC(=C3)NC(=O)C4=CC5=C(C=C4)N=C(C(=N5)Cl)Cl)S(=O)(=O)O,,,,,,
5702,155703,Deacyl acebutolol,CC(C)NCC(COC1=C(C=C(C=C1)N)C(=O)C)O,,,,,,
5703,155704,4-Bis(2-hydroxyethyl)amino-L-phenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCO)CCO,,,,,,
5704,155705,"2,3,4,5,6,7-Hexahydro-1,4-dimethyl-1,6-methano-1H-4-benzazonin-10-ol hydrobromide",CC12CCN(CC(C1)CC3=C2C=C(C=C3)O)C.Br,,,,,,
5705,155706,Hydroxyzomepirac,CN1C(=CC(=C1C(=O)C2=CC=C(C=C2)Cl)CO)CC(=O)O,,,,,,
5706,155707,N-Hydroxynorcocaine,COC(=O)C1[C@H]2CCC(N2O)CC1OC(=O)C3=CC=CC=C3,,,,,,
5707,155708,2-Ethoxy-4-formylphenyl acetate,CCOC1=C(C=CC(=C1)C=O)OC(=O)C,,,,,,
5708,155709,[4-[[3-Chloro-4-[(2-cyanoethyl)amino]phenyl]azo]phenacyl]trimethylammonium chloride,C[N+](C)(C)CC(=O)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)NCCC#N)Cl.[Cl-],,,,,,
5709,155710,"4-[[3-Chloro-4-[(2-cyanoethyl)amino]phenyl]azo]-N,N,N-trimethyl-beta-oxobenzeneethanaminium",C[N+](C)(C)CC(=O)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)NCCC#N)Cl,,,,,,
5710,155711,CID 155711,C[C@@H]1[C@](O1)(C)C(=O)O[C@@H]2CC(=C[C@H](CC(=C[C@@H]3[C@@H]2C(=C)C(=O)O3)C)O)C,,,,,,
5711,155712,"N,N-diethyl-3-(hydroxymethyl)benzamide",CCN(CC)C(=O)C1=CC=CC(=C1)CO,,,,,"['N,N-diethyl-m-hydroxymethylbenzamide is a known human metabolite of DEET.']",
5712,155713,3-(Diethylcarbamoyl)benzoic acid,CCN(CC)C(=O)C1=CC(=CC=C1)C(=O)O,,,,,,
5713,155714,"(5R,7S,8S,13R,15S,16S)-3,5,7,11,13,15-hexamethyl-8,16-bis(1,3-oxazol-5-ylmethyl)-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione",C[C@@H]1C[C@@H]([C@@H](OC(=O)C(=C[C@@H](C[C@@H]([C@@H](OC(=O)C(=C1)C)CC2=CN=CO2)C)C)C)CC3=CN=CO3)C,,,,,,
5714,155715,Acetylhymenograndin,C[C@@H]1C[C@@H]2[C@H](C[C@]3([C@H]1[C@H]([C@H]([C@@H]3OC(=O)C)OC(=O)C)OC(=O)C)C)C(=C)C(=O)O2,,,,,,
5715,155716,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-methylphenyl)methyl ester",CC1=CC(=CC=C1)COC(=O)C2C(C2(C)C)C=C(C)C,,,,,,
5716,155717,"2-Propenoic acid, 2-(((3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl)sulfonyl)methylamino)ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)CCC(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5717,155718,"Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, monoacetate",CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC.CC(=O)O,,,,,,
5718,155719,N-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]benzamide,CC1=NC=C(C(=C1O)C=NNC(=O)C2=CC=CC=C2)CO,,,,,,
5719,155720,10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(C3=CC=CC=C31)O,,,,,,
5720,155721,N-(4-(4-Methyl-1-piperazinyl)phenyl)benzo(g)quinolin-4-amine,CN1CCN(CC1)C2=CC=C(C=C2)NC3=CC=NC4=CC5=CC=CC=C5C=C34,,,,,,
5721,155722,"3,4',5-Tribromobiphenyl",C1=CC(=CC=C1C2=CC(=CC(=C2)Br)Br)Br,,,,,,
5722,155723,4-[(4-Methoxybenzoyl)amino]butanoic acid,COC1=CC=C(C=C1)C(=O)NCCCC(=O)O,,,,,,
5723,155724,"4,8-Epithioazulene, decahydro-3a-methyl-7-methylene-1-(1-methylethyl)-, (1S-(1alpha,3aalpha,4alpha,8alpha,8aalpha))-",CC(C)[C@@H]1CC[C@@]2([C@H]1[C@@H]3C(=C)CC[C@@H]2S3)C,,,,,,
5724,155725,11-Hydroxytephrosin,CC1(C=CC2=C(O1)C=C(C3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@]4(C3=O)O)OC)OC)O)C,,,,,,
5725,155726,"trans-4-Acetyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-2(3H)-furanone",CC(=O)C1CC(=O)OC1C2=CC(=C(C=C2)OC)OC,,,,,,
5726,155727,Captan-binepacryl mixt.,CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)C=C(C)C.C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,,,,,,
5727,155728,1-[3-(Ethoxymethoxy)phenyl]non-1-en-3-one,CCCCCCC(=O)C=CC1=CC(=CC=C1)OCOCC,,,,,,
5728,155729,Picobenzide N-oxide,CC1=CC(=CC(=C1)C(=O)[NH+](CC2=CC=NC=C2)[O-])C,,,,,,
5729,155730,"3,5-dimethyl-N-oxido-N-(pyridin-4-ylmethyl)benzamide",CC1=CC(=CC(=C1)C(=O)N(CC2=CC=NC=C2)[O-])C,,,,,,
5730,155731,N-4-Phenylphenacylheliotridanium,CC1CC[N+]2(C1CCC2)CC(=O)C3=CC=C(C=C3)C4=CC=CC=C4.[Br-],,,,,,
5731,155732,"2-(1-methyl-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-4-ium-4-yl)-1-(4-phenylphenyl)ethanone",CC1CC[N+]2(C1CCC2)CC(=O)C3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
5732,155733,"3-benzo[b][1]benzazepin-11-yl-N,N-dimethylpropan-1-amine;but-2-enedioic acid",CN(C)CCCN1C2=CC=CC=C2C=CC3=CC=CC=C31.C(=CC(=O)O)C(=O)O,,,,,,
5733,155734,"2-Methyl-5-tridec-8-enylbenzene-1,3-diol",CCCCC=CCCCCCCCC1=CC(=C(C(=C1)O)C)O,,,,,,
5734,155735,Pyrenocin B,CC1=C(C(=CC(=O)O1)OC)C(=O)CC(C)O,,,,,,
5735,155736,"Morpholine, 2,6-dimethyl-4-((2-oxo-3(2H)-benzothiazolyl)acetyl)-",CC1CN(CC(O1)C)C(=O)CN2C3=CC=CC=C3SC2=O,,,,,,
5736,155737,CID 155737,CC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC=CCCC=CCCC(=CC(C)(C)O)C)C)C)C)C)C)C)C)C)C,,,,,,
5737,155738,(2S)-2-Hydroxy-2-methyl-N-[(2R)-1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]butanamide,CC[C@@](C)(C(=O)N[C@H]1CCCN1C(=O)C=CC2=CC=CC=C2)O,,,,,,
5738,155739,"1H-1,2,4-Triazole-1-ethanol, beta-(4-chlorophenoxy)-alpha-(1,1-dimethylethyl)-, mixt. with 2-(2-furanyl)-1H-benzimidazole",CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O.C1=CC=C2C(=C1)NC(=N2)C3=CC=CO3,,,,,,
5739,155740,"1-Cyclohexyl-5-(1-piperidinylmethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione",C=CCC1(C(=O)NC(=O)N(C1=O)C2CCCCC2)CN3CCCCC3,,,,,,
5740,155741,"Ethanamide, N-ethyl-N-hydroxy-, compd. with sulfur dioxide (1:1)",CCN(C(=O)C)O.O=S=O,,,,,,
5741,155742,N-ethyl-N-hydroxyacetamide,CCN(C(=O)C)O,,,,,,
5742,155743,Allyl-alpha-allyloxycarbonyloxyacrylate,C=CCOC(=O)C(=C)OC(=O)OCC=C,,,,,,
5743,155744,"Sulfamide, N,N-diethyl-N'-((8alpha)-6-methylergolin-8-yl)-, monohydrochloride",CCN(CC)S(=O)(=O)N[C@H]1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C.Cl,,,,,,
5744,155745,"(6aR,9S)-9-(diethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline",CCN(CC)S(=O)(=O)N[C@H]1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
5745,155746,Mesulergine hydrochloride,CN1C[C@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)NS(=O)(=O)N(C)C.Cl,,,"['Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)', 'Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)', 'Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)']",,,
5746,155747,"Pyrimidine, 4-ethoxy-6-methyl-2-(1-methylethyl)-",CCOC1=NC(=NC(=C1)C)C(C)C,,,,,,
5747,155748,Perfluoro-2-pentene,C(=C(C(F)(F)F)F)(C(C(F)(F)F)(F)F)F,,,,,,
5748,155749,Pergolide sulfoxide,CCCN1C[C@@H](CC2[C@H]1CC3=CNC4=CC=CC2=C34)CS(=O)C,,,,,,
5749,155750,Pergolide sulfone,CCCN1C[C@@H](CC2[C@H]1CC3=CNC4=CC=CC2=C34)CS(=O)(=O)C,,,,,,
5750,155751,"Dibenz(e,k)acephenanthrylene-9,14-dione",C1=CC=C2C(=C1)C=C3C4=CC=CC5=C6C(=O)C=CC=C6C(=C54)C=C3C2=O,,,,,,
5751,155752,Methyl 3-hydroxydodecanoate,CCCCCCCCCC(CC(=O)OC)O,,,,,,
5752,155753,Cotoran-Dual mixt,CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C.CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,,,,,,
5753,155754,"(8R,9S,10S,13R,14S,17S)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-2,3,3-triol",C[C@H](CCCC(C)C)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CC(C(C4)(O)O)O)C)C,,,,,,
5754,155755,CID 155755,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CN=[N+]=[N-])C(=O)[O-].[Na+],,,,,,
5755,155756,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(azidomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CN=[N+]=[N-])C(=O)O,,,,,,
5756,155757,"(2-(Ethyl(4-((3-phenyl-1,2,4-thiadiazol-5-yl)azo)phenyl)amino)ethyl)trimethylammonium methyl sulphate",CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=NC(=NS2)C3=CC=CC=C3.COS(=O)(=O)[O-],,,,,,
5757,155758,"2-[Ethyl[4-(3-phenyl-1,2,4-thiadiazol-5-ylazo)phenyl]amino]-N,N,N-trimethylethanaminium",CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=NC(=NS2)C3=CC=CC=C3,,,,,,
5758,155759,Kartox,CN(C)C(CSC(=O)N)CSC(=O)N.C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl.Cl,,,,,,
5759,155760,"(1-Methyl-1,2-ethanediyl)bis(oxy(2-hydroxy-3,1-propanediyl)) diacrylate",CC(COCC(COC(=O)C=C)O)OCC(COC(=O)C=C)O,,,,,,
5760,155761,Tricosanal,CCCCCCCCCCCCCCCCCCCCCCC=O,,,"['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)', 'Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
5761,155762,Heptacosanal,CCCCCCCCCCCCCCCCCCCCCCCCCCC=O,,,,,,
5762,155763,O-Desmethylcarvedilol,C1=CC=C2C(=C1)C3=C(N2)C=CC=C3OCC(CNCCOC4=CC=CC=C4O)O,,,,,,
5763,155764,Spruceanol,CC1=C(C=C2C(=C1C=C)CC[C@H]3[C@]2(CC[C@H](C3(C)C)O)C)O,,,,,,
5764,155765,"(2S,3S,4S,5R)-6-[4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)OC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)S(=O)(=O)N)Cl,,,,,,
5765,155766,"6,7-Diphenyl-2,3-dihydro-1H-pyrrolizine",C1CC2=C(C(=CN2C1)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
5766,155767,Methyl 3-(5-methylfuran-2-yl)-2-nitroprop-2-enoate,CC1=CC=C(O1)C=C(C(=O)OC)[N+](=O)[O-],,,,,,
5767,155768,Methyl 3-(5-iodofuran-2-yl)-2-nitroprop-2-enoate,COC(=O)C(=CC1=CC=C(O1)I)[N+](=O)[O-],,,,,,
5768,155769,"Butanamide, N-(aminocarbonyl)-N-butyl-",CCCCN(C(=O)CCC)C(=O)N,,,,,,
5769,155770,Tocainide cbg,CC1=C(C(=CC=C1)C)NC(=O)C(C)NC(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
5770,155771,"2-Octynoic acid, 2-propen-1-yl ester",CCCCCC#CC(=O)OCC=C,,,,,,
5771,155772,Bmhsi,COC1=CC=C(C=C1)C2=C(N=C(N2)S(=O)CCO)C3=CC=C(C=C3)OC,,,,,,
5772,155773,CID 155773,C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O.C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O.C(=CC(=O)O)C(=O)O,,,,,,
5773,155774,Xamoterol,C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O,,,['Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)'],,,
5774,155775,Vismin,CC1=CC2=CC3=C(C(=CC(=O)C3(CC=C(C)C)CC=C(C)C)O)C(=C2C(=C1)O)O,,,,,,
5775,155776,"3-bromo-2,6-dimethoxy-N-[(1S)-1-pyrrolidin-2-ylpropyl]benzamide;hydrochloride",CC[C@@H](C1CCCN1)NC(=O)C2=C(C=CC(=C2OC)Br)OC.Cl,,,,,,
5776,155777,"3-bromo-2,6-dimethoxy-N-[(1S)-1-pyrrolidin-2-ylpropyl]benzamide",CC[C@@H](C1CCCN1)NC(=O)C2=C(C=CC(=C2OC)Br)OC,,,,,,
5777,155778,"1-Methyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)C2=CC(=CC=C2)OC,,,,,,
5778,155779,CID 155779,CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C(=O)[O-].[Na+],,,,,,
5779,155780,2-(16-Methylheptadecanoyloxy)propanoic acid,CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C(=O)O,,,,,,
5780,155781,CID 155781,CC(=O)N(C[C@H](CP(=O)(O)[O-])O)O.[Na+],,,,,,
5781,155782,"Phosphonic acid, (3-(acetylhydroxyamino)-2-hydroxypropyl)-, (R)-",CC(=O)N(C[C@H](CP(=O)(O)O)O)O,,,,,,
5782,155783,"1-Cyclohexene-1-carboxylic acid,5-((3-(3,4-dihydroxyphenyl)-1-oxo-2-p ropenyl)oxy)-3,4-dihydroxy-,(3r-(3alpha,4alpha,5beta))-",C1[C@H]([C@@H]([C@@H](C=C1C(=O)O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O,,,,,,
5783,155784,"2,6,10,15,19-Pentamethyleicosane",CC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C,,,,,,
5784,155785,"2-Hydroxy-3-phosphonopentane-1,2,3-tricarboxylate",CCC(C(=O)[O-])(C(CC(=O)[O-])(C(=O)[O-])O)P(=O)(O)O,,,,,,
5785,155786,"2-Hydroxy-3-phosphonopentane-1,2,3-tricarboxylic acid",CCC(C(=O)O)(C(CC(=O)O)(C(=O)O)O)P(=O)(O)O,,,,,,
5786,155787,"Disodium 1,4-dihydroanthracene-9,10-diolate",C1C=CCC2=C(C3=CC=CC=C3C(=C21)[O-])[O-].[Na+].[Na+],,,,,,
5787,155788,"3-Pyridinecarboxylic acid, 5-cyclohexyl-",C1CCC(CC1)C2=CC(=CN=C2)C(=O)O,,,,,,
5788,155789,1-Butyl-2-methylhydrazine dihydrochloride,CCCCNNC.Cl.Cl,,,,,,
5789,155790,"4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-2,11-dihydroxy-1,10-dimethoxy-6,6-dimethyl-, (S)-",C[N+]1(CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC)O)C,,,,,,
5790,155791,14-Hydroxycaryophyllene oxide,CC12CCC3C(CC3(C)CO)C(=C)CCC1O2,,,,,,
5791,155792,"1-Pentanol, 5-(nitrosopentylamino)-",CCCCCN(CCCCCO)N=O,,,,,,
5792,155793,CID 155793,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC(=O)C3=C(C(=COC3=C2)C4=CC=C(C=C4)O)O)O)O)O,,,,,,
5793,155794,Ufiprazole,CC1=CN=C(C(=C1OC)C)CSC2=NC3=C(N2)C=C(C=C3)OC,,,,,,
5794,155795,"3-Acetyl-2,7-naphthyridine",CC(=O)C1=NC=C2C=NC=CC2=C1,,,,,,
5795,155796,"7-Nitro-2-(1,1,2,2-tetrafluoroethyl)-5-(trifluoromethyl)benzimidazole",C1=C(C=C(C2=C1NC(=N2)C(C(F)F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
5796,155797,Quinpirole dihydrochloride,CCCN1CCC[C@@H]2[C@@H]1CC3=C(C2)NN=C3.Cl.Cl,,,,,,
5797,155798,"2H-Pyrazolo(3,4-g)quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, (4aR,8aR)-rel-",CCCN1CCC[C@@H]2[C@@H]1CC3=C(C2)NN=C3,,,,,,
5798,155799,1-(1-Naphthyloxy)-3-(bis(2-chloroethyl)amino)-2-propanol,C1=CC=C2C(=C1)C=CC=C2OCC(CN(CCCl)CCCl)O,,,,,,
5799,155800,CID 155800,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=C2C(=O)CC(CC2=O)C3=CC=C(C=C3)OC)C)C,,,,,,
5800,155801,CID 155801,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=C2C(=O)CCCCCC2=O)C)C,,,,,,
5801,155802,"2-Propen-1-one, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-",C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2O)O)O)O,,,,,,
5802,155803,"Poly(N(alpha),N(epsilon)-L-lysinediylterephthaloyl)",C1=CC(=C(C=C1[C]=O)N[C@@H](CCCC[NH])C(=O)O)[C]=O,,,,,,
5803,155804,"Cyclopropanecarboxylic acid, 2,2-dichloro-1-(4-ethoxyphenyl)-, (3-phenoxyphenyl)methyl ester",CCOC1=CC=C(C=C1)C2(CC2(Cl)Cl)C(=O)OCC3=CC(=CC=C3)OC4=CC=CC=C4,,,,,,
5804,155805,Desmethylastemizole,C1CN(CCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)CCC5=CC=C(C=C5)O,,,,,['6-desmethylastermizole is a known human metabolite of astemizole.'],
5805,155806,8-Methoxymethyl-3-isobutyl-1-methylxanthine,CC(C)CN1C2=C(C(=O)N(C1=O)C)NC(=N2)COC,,,,,,
5806,155807,"2-Phenazinamine, 3-(cyclohexylimino)-3,5-dihydro-N,5-diphenyl-",C1CCC(CC1)N=C2C=C3C(=NC4=CC=CC=C4N3C5=CC=CC=C5)C=C2NC6=CC=CC=C6,,,,,,
5807,155808,N(4)-Hydroxydeoxycytidine triphosphate,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NO)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
5808,155809,N-(4-aminobutyl)-N-(3-aminopropyl)nitrous amide,C(CCN(CCCN)N=O)CN,,,,,,
5809,155810,"9-Acridinamine, 3-azido-",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)N=[N+]=[N-])N,,,,,,
5810,155811,9-Amino-3-azido-10-methylacridinium chloride,C[N+]1=C2C=C(C=CC2=C(C3=CC=CC=C31)N)N=[N+]=[N-].[Cl-],,,,,,
5811,155812,3-Azido-10-methylacridin-10-ium-9-amine,C[N+]1=C2C=C(C=CC2=C(C3=CC=CC=C31)N)N=[N+]=[N-],,,,,,
5812,155813,"9-Acridinamine, 6-azido-2-ethoxy-",CCOC1=CC2=C(C3=C(C=C(C=C3)N=[N+]=[N-])N=C2C=C1)N,,,,,,
5813,155814,9-Azido-10-methylacridinium chloride,CN1C2=CC=CC=C2C(=N[N+]#N)C3=CC=CC=C31.[Cl-],,,,,,
5814,155815,Varespladib,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,,,,,,
5815,155816,CID 155816,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)[O-])C(=O)C(=O)N.[Na+],,,,,,
5816,155817,9-Azido-1-nitroacridine,C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])N=[N+]=[N-],,,,,,
5817,155818,1-Azido-10-methylacridinium chloride,CN1C2=CC=CC=C2C=C3C1=CC=CC3=N[N+]#N.[Cl-],,,,,,
5818,155819,1-Diazonioimino-10-methylacridine,CN1C2=CC=CC=C2C=C3C1=CC=CC3=N[N+]#N,,,,,,
5819,155820,"Acridine, 2-azido-",C1=CC=C2C(=C1)C=C3C=C(C=CC3=N2)N=[N+]=[N-],,,,,,
5820,155821,2-Azido-10-methylacridinium chloride,C[N+]1=C2C=CC(=CC2=CC3=CC=CC=C31)N=[N+]=[N-].[Cl-],,,,,,
5821,155822,2-Azido-10-methylacridin-10-ium,C[N+]1=C2C=CC(=CC2=CC3=CC=CC=C31)N=[N+]=[N-],,,,,,
5822,155823,3-Azido-10-methylacridinium chloride,CN1C2=CC=CC=C2C=C3C1=CC(=N[N+]#N)C=C3.[Cl-],,,,,,
5823,155824,"3-Acridinamine, 6-azido-",C1=CC(=CC2=NC3=C(C=CC(=C3)N=[N+]=[N-])C=C21)N,,,,,,
5824,155825,3-Amino-6-azido-10-methylacridinium chloride,C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N=[N+]=[N-])N.[Cl-],,,,,,
5825,155826,6-Azido-10-methylacridin-10-ium-3-amine,C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N=[N+]=[N-])N,,,,,,
5826,155827,"9-Acridinamine, 2-azido-",C1=CC=C2C(=C1)C(=C3C=C(C=CC3=N2)N=[N+]=[N-])N,,,,,,
5827,155828,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-((1-oxopropoxy)methyl)-, (S)-",CCC(=O)OCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=CC=CC=C51,,,,,,
5828,155829,CID 155829,CN1C2=C(C=C(C=C2)N[N+]#N)C(=N)C3=CC=CC=C31.[Cl-],,,,,,
5829,155830,CID 155830,CN1C2=C(C=C(C=C2)N[N+]#N)C(=N)C3=CC=CC=C31,,,,,,
5830,155831,10-Deacetyltaxol,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O,,,,,,
5831,155832,4-Methyl-4-((tetradecyloxy)methyl)morpholinium chloride,CCCCCCCCCCCCCCOC[N+]1(CCOCC1)C.[Cl-],,,,,,
5832,155833,4-Methyl-4-(tetradecoxymethyl)morpholin-4-ium,CCCCCCCCCCCCCCOC[N+]1(CCOCC1)C,,,,,,
5833,155834,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,11-dihydroxy-4,9-dimethoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)OC)N)O,,,,,,
5834,155835,N(6)-3-Hydroxypropylmitomycin C,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NCCCO,,,,,,
5835,155836,Sulfurmycin A,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@]([C@@H](C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5O)C(=O)OC)(CC(=O)C)O)N(C)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O,,,,,,
5836,155837,Auramycin B,C[C@H]1[C@@H]2[C@H](C[C@@H](O1)O[C@@H]3[C@@H](O[C@H](C[C@@H]3N(C)C)O[C@H]4C[C@@]([C@@H](C5=CC6=C(C(=C45)O)C(=O)C7=C(C6=O)C=CC=C7O)C(=O)OC)(C)O)C)O[C@H]8CC(=O)[C@@H](O[C@H]8O2)C,,,,,,
5837,155838,Auramycin A,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@]([C@@H](C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5O)C(=O)OC)(C)O)N(C)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O,,,,,,
5838,155839,Sulfurmycin B,C[C@H]1[C@@H]2[C@H](C[C@@H](O1)O[C@@H]3[C@@H](O[C@H](C[C@@H]3N(C)C)O[C@H]4C[C@@]([C@@H](C5=CC6=C(C(=C45)O)C(=O)C7=C(C6=O)C=CC=C7O)C(=O)OC)(CC(=O)C)O)C)O[C@H]8CC(=O)[C@@H](O[C@H]8O2)C,,,,,,
5839,155840,"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-hydroxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;chloride",CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCC[S+](C)C)O.[Cl-],,,,,,
5840,155841,CID 155841,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NCC(C(=O)N)N)C(=O)NC([C@H](C2=CN=CN2)O)C(=O)N[C@H](C)[C@H](C(C)C(=O)NC([C@@H](C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCC[S+](C)C)O,,,,,,
5841,155842,7-Methoxyactinomycin D dihydrate,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)OC,,,,,,
5842,155843,7-Ethoxyactinomycin D dihydrate,CCOC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
5843,155844,"2-amino-4,6-dimethyl-3-oxo-7-propoxy-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",CCCOC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
5844,155845,7-Butoxyactinomycin D trihydrate,CCCCOC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
5845,155846,7-(Hexyloxy)actinomycin D,CCCCCCOC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
5846,155847,7-(Heptyloxy)actinomycin D,CCCCCCCOC1=C(C2=C(C(=C1)C(=O)NC3C(OC(=O)C(N(C(=O)CN(C(=O)C4CCCN4C(=O)C(NC3=O)C(C)C)C)C)C(C)C)C)N=C5C(=C(C(=O)C(=C5O2)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
5847,155848,7-((4-Chlorophenyl)methoxy)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)OCC8=CC=C(C=C8)Cl,,,,,,
5848,155849,"7-((3,4-Dichlorophenyl)methoxy)actinomycin D",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)OCC8=CC(=C(C=C8)Cl)Cl,,,,,,
5849,155850,N-Propylactinomycin D dihydrate,CCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5850,155851,N-Butylactinomycin D,CCCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5851,155852,N-Pentylactinomycin D,CCCCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5852,155853,N-Hexylactinomycin D,CCCCCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5853,155854,N-Nonylactinomycin D,CCCCCCCCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5854,155855,N-Undecylactinomycin D,CCCCCCCCCCCNC1=C(C2=NC3=C(C=CC(=C3OC2=C(C1=O)C)C)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCN5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C,,,,,,
5855,155856,N-(4-Aminobutyl)actinomycin D dihydrate,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCCN)C,,,,,,
5856,155857,CID 155857,CC1=C(N=C2C=CC=CC23C1=NC=N3)N,,,,,,
5857,155858,"1,3-Dioxane, 2-methoxy-5,5-dimethyl-",CC1(COC(OC1)OC)C,,,,,,
5858,155859,"Butanoic acid, 2-methyl-, (1R,2S,4R,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-8a-((acetyloxy)methyl)-5-((2S,3aR,6aS)-hexahydrofuro(2,3-b)furan-2-yl)octahydro-2-hydroxy-5,6-dimethylspiro(naphthalene-1(2H),2'-oxiran)-4-yl ester, (2S)-",CC[C@H](C)C(=O)O[C@@H]1CC([C@]2(CO2)[C@]3([C@H]1[C@@]([C@@H](C[C@@H]3OC(=O)C)C)(C)C4C[C@H]5CCO[C@H]5O4)COC(=O)C)O,,,,,,
5859,155860,(25S)-6alpha-hydroxy-5alpha-spirostan-3-one,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CCC(=O)C6)C)O)C)C)OC1,,,,,,
5860,155861,"2-(3,7-Dimethylocta-2,6-dienyl)-5-(2-phenylethenyl)benzene-1,3-diol",CC(=CCCC(=CCC1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O)C)C,,,,,,
5861,155862,"(2S)-4-(2,3-dimethoxy-7,9,10,11,11a,12-hexahydronaphtho[2,1-f]indolizin-6-yl)but-3-en-2-ol",C[C@@H](C=CC1=C2CN3CCCC3CC2=C4C=C(C(=CC4=C1)OC)OC)O,,,,,,
5862,155863,"Hydrazinecarboximidamide, N-phenyl-, mononitrate",C1=CC=C(C=C1)N=C(N)NN.[N+](=O)(O)[O-],,,,,,
5863,155864,N-phenylhydrazinecarboximidamide,C1=CC=C(C=C1)N=C(N)NN,,,,,,
5864,155865,"6H-Pyrido(4,3-b)carbazol-8-ol, 5,11-dimethyl-",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=CC(=C4)O)C,,,,,,
5865,155866,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-methylphenyl)methyl ester",CC1=CC=C(C=C1)COC(=O)C2C(C2(C)C)C=C(C)C,,,,,,
5866,155867,CID 155867,C[C@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O.C1=CC(=C(C=C1N)O)C(=O)O,,,,,,
5867,155868,CID 155868,C[C@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,,,,,,
5868,155869,"Phosphorodithioic acid, S,S-dibutyl ester",CCCCSP(=O)(O)SCCCC,,,,,,
5869,155870,"2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-pentynyl)-",CC(C#CCN1CCCC1=O)N2CCCC2,,,,,,
5870,155871,CID 155871,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC.C(=CC(=O)O)C(=O)O,,,,,,
5871,155872,"Butanedioic acid, compd. with 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide",CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC.C(CC(=O)O)C(=O)O,,,,,,
5872,155873,CID 155873,CC(=O)O.CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,,,,,,
5873,155874,"Propanoic acid, 3-((4-methylphenyl)amino)-3-oxo-, ethyl ester",CCOC(=O)CC(=O)NC1=CC=C(C=C1)C,,,,,,
5874,155875,2-(5-Methylfuran-2-yl)acetic acid,CC1=CC=C(O1)CC(=O)O,,,,,,
5875,155876,3-(hydroxymethyl)-5-[2-(3-methoxy-5-oxo-2H-pyrrol-1-yl)-2-oxoethylidene]-1-methylpyrrol-2-one,CN1C(=CC(=O)N2CC(=CC2=O)OC)C=C(C1=O)CO,,,,,,
5876,155877,CID 155877,C[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@@H](C=C(CC[C@@H](C(=O)C=CC3=O)O)C)C=C1C)CC(C)C,,,,,,
5877,155878,CID 155878,C[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@@H](C=C(CCC(=O)C(=O)CCC3=O)C)C=C1C)CC(C)C,,,,,,
5878,155879,"Benzenepropanoic acid, beta-((methylamino)carbonyl)-",CNC(=O)C(CC(=O)O)C1=CC=CC=C1,,,,,,
5879,155880,"Benzeneacetic acid, alpha-(2-(methylamino)-2-oxoethyl)-",CNC(=O)CC(C1=CC=CC=C1)C(=O)O,,,,,,
5880,155881,CID 155881,CC1=CC(=O)C2=C3C1=C4C(=CC(=O)C5=C4C6=C7C(=C(C(=C(C7=C5O)O)C8CCCCN8)O)C9=C(C(=C(C(=C2O)C9=C36)O)C1CCCCN1)O)C,,,,,,
5881,155882,Plantarenaloside,C[C@@H]1CC[C@]2([C@@H]1[C@@H](OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
5882,155883,CID 155883,C[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@@H](C=C(CC[C@@H]([C@H](C=CC3=O)O)O)C)C=C1C)CC(C)C,,,,,,
5883,155884,"Octanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-",CCCCCCCC(=O)O[C@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4C1(C4(C)C)OC(=O)C)O)C,,,,,,
5884,155885,"Octanoic acid, 9-(acetyloxy)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-9aH-cyclopropa(3,4)benz(1,2-e)azulen-9a-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-",CCCCCCCC(=O)OC12[C@@H](C1(C)C)[C@@H]3C=C(C[C@]4([C@H]([C@]3([C@@H]([C@@H]2OC(=O)C)C)O)C=C(C4=O)C)O)CO,,,,,,
5885,155886,"Benzoic acid, 2-((4-chlorophenyl)phenylmethoxy)-",C1=CC=C(C=C1)C(C2=CC=C(C=C2)Cl)OC3=CC=CC=C3C(=O)O,,,,,,
5886,155887,"Benzoic acid, 2-((4-methylphenyl)phenylmethoxy)-",CC1=CC=C(C=C1)C(C2=CC=CC=C2)OC3=CC=CC=C3C(=O)O,,,,,,
5887,155888,"Benzoic acid, 2-((4-methoxyphenyl)phenylmethoxy)-",COC1=CC=C(C=C1)C(C2=CC=CC=C2)OC3=CC=CC=C3C(=O)O,,,,,,
5888,155889,2-{[(4-Chlorophenyl)(phenyl)methyl]amino}benzoic acid,C1=CC=C(C=C1)C(C2=CC=C(C=C2)Cl)NC3=CC=CC=C3C(=O)O,,,,,,
5889,155890,"Benzoic acid, 2-(((4-methoxyphenyl)phenylmethyl)amino)-",COC1=CC=C(C=C1)C(C2=CC=CC=C2)NC3=CC=CC=C3C(=O)O,,,,,,
5890,155891,"Benzoic acid, 4-(((4-methylphenyl)phenylmethyl)amino)-",CC1=CC=C(C=C1)C(C2=CC=CC=C2)NC3=CC=C(C=C3)C(=O)O,,,,,,
5891,155892,"Phenol, 3-tridecyl-",CCCCCCCCCCCCCC1=CC(=CC=C1)O,,,,,,
5892,155893,"1H-Benzotriazole, 1-benzoyl-5,6-dichloro-",C1=CC=C(C=C1)C(=O)N2C3=CC(=C(C=C3N=N2)Cl)Cl,,,,,,
5893,155894,"Tetrasulfide, ethyl methyl",CCSSSSC,,,,,,
5894,155895,"Benzenepropanamine, 2-amino-, dihydrochloride",C1=CC=C(C(=C1)CCCN)N.Cl.Cl,,,,,,
5895,155896,2-(3-Aminopropyl)aniline,C1=CC=C(C(=C1)CCCN)N,,,,,,
5896,155897,"Formamide, N-(6-(6-hydroxy-1,3-benzodioxol-5-yl)naphtho(2,3-d)-1,3-dioxol-5-yl)-N-methyl-",CN(C=O)C1=C(C=CC2=CC3=C(C=C21)OCO3)C4=CC5=C(C=C4O)OCO5,,,,,,
5897,155898,"Butanoic acid, 4-((2,6-dimethylphenyl)thio)-",CC1=C(C(=CC=C1)C)SCCCC(=O)O,,,,,,
5898,155899,CID 155899,CC1=C[C@@H]2[C@@H]([C@@H](C[C@@]3(CC[C@]1(O3)O)C)OC(=O)C(C)C)C(=C)C(=O)O2,,,,,,
5899,155900,CID 155900,C1=CC(=CC#N)[C@@H]([C@H]([C@H]1O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
5900,155901,"(3R,4aS,8aR)-3-hydroxy-5,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde",C[C@]12CCCC([C@@H]1C[C@H](C(=C2)C=O)O)(C)C,,,,,,
5901,155902,2-Methyl-2-bornene,CC1=CC2CCC1(C2(C)C)C,,,,,,
5902,155903,CID 155903,CC1=CC=CN2C1=NC3=C2N=C(C=C3)NC4=NC5=C(N4)C(=O)N=C(N5)N,,,,,,
5903,155904,"Glycine, N-((3alpha,5beta,7beta)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl)-, sodium salt",C[C@H](CCC(=O)NCC(=O)[O-])[C@H]1CCC2[C@@]1(CCC3C2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)OS(=O)(=O)[O-])C)O)C.[Na+].[Na+],,,,,,
5904,155905,"2-[[(4R)-4-[(3R,5R,7S,10S,13R,17R)-7-hydroxy-10,13-dimethyl-3-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid",C[C@H](CCC(=O)NCC(=O)O)[C@H]1CCC2[C@@]1(CCC3C2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)OS(=O)(=O)O)C)O)C,,,,,,
5905,155906,"1,3,5-Triazine-2,4(1H,3H)-dione, 6-(dimethylamino)-3-(4-hydroxycyclohexyl)-1-methyl-",CN1C(=NC(=O)N(C1=O)C2CCC(CC2)O)N(C)C,,,,,,
5906,155907,"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1-(4-hydroxycyclohexyl)-3-methyl-",CN1C(=O)NC(=O)N(C1=O)C2CCC(CC2)O,,,,,,
5907,155908,CID 155908,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4[C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
5908,155909,"1,3,5-Triazine-2,4(1H,3H)-dione, 3-(4-hydroxycyclohexyl)-1-methyl-6-(methylamino)-",CNC1=NC(=O)N(C(=O)N1C)C2CCC(CC2)O,,,,,,
5909,155910,"Cyclopropanecarboxylic acid, 3-(3,3-dimethyloxiranyl)-2,2-dimethyl-,2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester, (1R-(1alpha(S*),3beta(R*)))-",CC1=C(C(=O)C[C@H]1OC(=O)[C@@H]2[C@@H](C2(C)C)[C@H]3C(O3)(C)C)CC=C,,,,,,
5910,155911,Furanether A,C[C@@]12CC3=COC=C3[C@@H](O1)[C@H]4[C@@H]2CC(C4)(C)C,,,,,,
5911,155912,"Azuleno(5,6-c)furan-3(1H)-one, 5,6,7,7a,8,9-hexahydro-8-hydroxy-6,6,8-trimethyl-, (7aS,8S)-",C[C@@]1(CC2=C(C=C3[C@@H]1CC(C3)(C)C)C(=O)OC2)O,,,,,,
5912,155913,CID 155913,C(C(=O)O)P(=O)CO,,,,,,
5913,155914,"Acetic acid, trifluoro-, rhodium(2+) salt",C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].[Rh+2],,,,,,
5914,155915,"Ethanesulfonic acid, 2-((2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-1-oxopropyl)amino)-",CC(C)(C(=O)NCCS(=O)(=O)O)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,,,,,,
5915,155916,"1-Isobenzofuranol, 1,3-dihydro-6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-",CN1CCC2=CC3=C(C=C2C1C4C5=C(C(O4)O)C(=C(C=C5)OC)OC)OCO3,,,,,,
5916,155917,CID 155917,CC(=O)OCC1=C2[C@@H](C[C@]([C@@]3(CC[C@@](O3)(C=C2OC1=O)C)O)(C)O)OC(=O)C,,,,,,
5917,155918,"1H-Pyrrolo(2,1-a)isoindole-6,9-dione, 2,3-dihydro-7-methyl-5-phenyl-",CC1=CC(=O)C2=C3CCCN3C(=C2C1=O)C4=CC=CC=C4,,,,,,
5918,155919,"1,3-Benzodioxole, 4,5,6-trichloro-",C1OC2=CC(=C(C(=C2O1)Cl)Cl)Cl,,,,,,
5919,155920,"(3R,8R)-7-ethylidene-5-methyl-5,12-diazatetracyclo[9.7.0.03,8.013,18]octadeca-1(11),13,15,17-tetraen-10-one",CC=C1CN(C[C@H]2[C@H]1CC(=O)C3=C(C2)C4=CC=CC=C4N3)C,,,,,,
5920,155921,"Cis-3-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropanecarboxylicacid",CC1([C@H]([C@H]1C(=O)O)C=C(C(F)(F)F)Cl)C,,,,,,
5921,155922,(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCP(=O)(O)O)CC(=O)N,,,,,,
5922,155923,"(1R,3S)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropane-1-carboxylic acid",CC1([C@@H]([C@H]1C(=O)O)C=C(C(F)(F)F)Cl)C,,,,,,
5923,155924,"4,5,6,7-Tetrahydro-1H-benzo[d]imidazol-5-amine",C1CC2=C(CC1N)NC=N2,,,,,,
5924,155925,"4-Pyrimidinepropanoic acid, alpha,2-diamino-1,4,5,6-tetrahydro-",C1CN=C(NC1CC(C(=O)O)N)N,,,,,,
5925,155926,CID 155926,CC[C@@H](C)C(=O)NC1CCCN1C(=O)C=CC2=CC=CC=C2,,,,,,
5926,155927,"Hexanedioic acid, 2-hydroxy-2,3,4-trimethyl-5-methylene-",CC(C(C)C(C)(C(=O)O)O)C(=C)C(=O)O,,,,,,
5927,155928,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-cyclohexyl-3-(4-morpholinylmethyl)-5,5-di-2-propenyl-",C=CCC1(C(=O)N(C(=O)N(C1=O)C2CCCCC2)CN3CCOCC3)CC=C,,,,,,
5928,155929,"5,6-Quinolinedione, 8-methoxy-2,4-dimethyl-",CC1=CC(=NC2=C1C(=O)C(=O)C=C2OC)C,,,,,,
5929,155930,"1-Oxa-4-aza-2,6-disilacyclohexane, 4-((3-methoxyphenyl)methyl)-2,2,6,6-tetramethyl-, hydrochloride",COC1=CC=CC(=C1)CN2C[Si](O[Si](C2)(C)C)(C)C.Cl,,,,,,
5930,155931,"4-((3-Methoxyphenyl)methyl)-2,2,6,6-tetramethyl-1-oxa-4-aza-2,6-disilacyclohexane",COC1=CC=CC(=C1)CN2C[Si](O[Si](C2)(C)C)(C)C,,,,,,
5931,155932,"Acetic acid, ((7-hydroxy-2-naphthalenyl)oxy)-",C1=CC(=CC2=C1C=CC(=C2)OCC(=O)O)O,,,,,,
5932,155933,"Benzenesulfonamide, N-(((4,6-dimethyl-2-pyrimidinyl)amino)carbonyl)-2-nitro-",CC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2[N+](=O)[O-])C,,,,,,
5933,155934,"Urs-12-en-28-oic acid, 2,3-dihydroxy-, (3beta)-",C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC([C@@H](C5(C)C)O)O)C)C)[C@H]2[C@H]1C)C)C(=O)O,,,,,,
5934,155935,"Acetamide, N,N'-(4-hydroxy-6-methoxy-1,3-phenylene)bis-",CC(=O)NC1=CC(=C(C=C1O)OC)NC(=O)C,,,,,,
5935,155936,"1,4:5,8-Dimethanonaphthalene, 2-ethyl-1,2,3,4,4a,5,8,8a-octahydro-",CCC1CC2CC1C3C2C4CC3C=C4,,,,,,
5936,155937,"2H-1-Benzopyran-2-one, 6,7-dimethoxy-8-(3-methyl-2-butenyl)-",CC(=CCC1=C2C(=CC(=C1OC)OC)C=CC(=O)O2)C,,,,,,
5937,155938,"1-Ethyl-1-methyl-1a,3a-dihydrocyclopropa[c][2]benzofuran-3-one",CCC1(C2C13C=CC=CC3C(=O)O2)C,,,,,,
5938,155939,"Hexanenitrile, 6-(methylthio)-",CSCCCCCC#N,,,,,,
5939,155940,CID 155940,C(=C(C=C(C(=O)O)Cl)Cl)C(=O)O,,,,,,
5940,155941,"6,7-Dihydroneridienone A",CC(=O)C1=CC[C@@H]2[C@@]1([C@@H](C[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,,,,,,
5941,155942,8-Epiiridotrial glucoside,C[C@@H]1CC[C@H]2[C@@H]1[C@@H](OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
5942,155943,"Azuleno(6,5-b)furan-2(3H)-one, 3a,4,4a,7,7a,8,9,9a-octahydro-5-methyl-3,8-bis(methylene)-, (3aR,4aR,7aR,9aS)-",CC1=CC[C@@H]2[C@H]1C[C@H]3[C@H](CC2=C)OC(=O)C3=C,,,,,,
5943,155944,"1H-Imidazole, 1-(1-chloro-9-phenyl-9H-xanthen-9-yl)-",C1=CC=C(C=C1)C2(C3=CC=CC=C3OC4=C2C(=CC=C4)Cl)N5C=CN=C5,,,,,,
5944,155945,"1H-Imidazole, 2-(1-chloro-9-phenyl-9H-xanthen-9-yl)-",C1=CC=C(C=C1)C2(C3=CC=CC=C3OC4=C2C(=CC=C4)Cl)C5=NC=CN5,,,,,,
5945,155946,"2,3-Quinoxalinedione, 1,4-dihydro-, dihydrazone, methanesulfonate",CS(=O)(=O)O.C1=CC=C2C(=C1)N=C(C(=N2)NN)NN,,,,,,
5946,155947,"2,3-Dihydrazinylquinoxaline",C1=CC=C2C(=C1)N=C(C(=N2)NN)NN,,,,,,
5947,155948,Atractylenolide III,CC1=C2C[C@H]3C(=C)CCC[C@@]3(C[C@@]2(OC1=O)O)C,,,,,,
5948,155949,"2-Propenoic acid, polymer with 1,5-hexadiene-3,4-diol",C=CC(C(C=C)O)O.C=CC(=O)O,,,,,,
5949,155950,"4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5-(beta-D-glucopyranosyloxy)-2-(4-hydroxyphenyl)-7-methoxy-",COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
5950,155951,"4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5-(beta-D-glucopyranosyloxy)-2-(4-hydroxyphenyl)-7-methoxy-",COC1=C(C2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C=C(O2)C4=CC=C(C=C4)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
5951,155952,"D-Glutamic acid, N-(N-(N-acetylmuramoyl)-L-alanyl)-, 5-decyl 1-methyl ester",CCCCCC(CCCC)OC(=O)[C@@H](CCC(=O)OC)NC(=O)[C@H](C)NC(=O)C(C)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)O)NC(=O)C,,,,,,
5952,155953,"L-Cysteine, N-acetyl-S-(1,2-dihydro-2-hydroxy-1-naphthalenyl)-",CC(=O)N[C@@H](CSC1C(C=CC2=CC=CC=C12)O)C(=O)O,,,,,,
5953,155954,4-(4-Isobutylphenyl)-4-oxobutanoic acid,CC(C)CC1=CC=C(C=C1)C(=O)CCC(=O)O,,,,,,
5954,155955,"Cyclohexanone, 2-(9-phenanthrenyl)-",C1CCC(=O)C(C1)C2=CC3=CC=CC=C3C4=CC=CC=C42,,,,,,
5955,155956,"Pyridinium, 1-methyl-3-(1-methyl-5-oxo-2-pyrrolidinyl)-, (S)-",CN1[C@@H](CCC1=O)C2=C[N+](=CC=C2)C,,,,,,
5956,155957,"(1R,2S)-Naphthalene 1,2-oxide",C1=CC=C2[C@@H]3[C@@H](O3)C=CC2=C1,,,,,,
5957,155958,"1,4-Benzenedicarboxylic acid, 2,3,5,6-tetrachloro-, mixt. with 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione",CN1C(=O)N(OC1=O)C2=CC(=C(C=C2)Cl)Cl.C1(=C(C(=C(C(=C1Cl)Cl)C(=O)O)Cl)Cl)C(=O)O,,,,,,
5958,155959,"2H-1,4-Oxazine, 3,4-dihydro-4,6-diphenyl-",C1COC(=CN1C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
5959,155960,"Pyrazine, 1,2,3,4-tetrahydro-1,4,5-triphenyl-",C1CN(C(=CN1C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
5960,155961,"Naphtho(2,3-b)furan-2(4H)-one, 4a,5,6,7,8,8a,9,9a-octahydro-9a-hydroxy-3,4a,5-trimethyl-, (4aR,5S,8aR,9aR)-",C[C@H]1CCC[C@H]2[C@@]1(CC3=C(C(=O)O[C@@]3(C2)O)C)C,,,,,,
5961,155962,CID 155962,CC=C(C)C(=O)O[C@@H]1CC[C@@H]2C[C@@H]3C(=C(C(=O)O3)C)[C@H]([C@@]2([C@H]1C)C)O,,,,,,
5962,155963,"11-Hydroxyicosa-2,4,6,8-tetraenoic acid",CCCCCCCCCC(CC=CC=CC=CC=CC(=O)O)O,,,,,,
5963,155964,CID 155964,CCCCCCCCCCCC(=O)C=CC=CC=CC=C(O)O,,,,,,
5964,155965,"Ethanone, 1-(5-(2-aminoethyl)-2-hydroxyphenyl)-",CC(=O)C1=C(C=CC(=C1)CCN)O,,,,,,
5965,155966,3-Phenylpyrazin-2-ol,C1=CC=C(C=C1)C2=NC=CNC2=O,,,,,,
5966,155967,N-Octyldecylamine,CCCCCCCCCCNCCCCCCCC,,,,,,
5967,155968,CID 155968,CC(C)C=CC1=C(C2=C(C3=C(CC(CC3=O)O)C=C2C=C1OC)O)O,,,,,,
5968,155969,"1-(1-Ethylpropyl)-5,6-dimethyl-7-nitro-1H-benzimidazole",CCC(CC)N1C=NC2=C1C(=C(C(=C2)C)C)[N+](=O)[O-],,,,,,
5969,155970,"2(1H)-Pyrazinone, 3-(4-hydroxyphenyl)-6-methyl-",CC1=CN=C(C(=O)N1)C2=CC=C(C=C2)O,,,,,,
5970,155971,"Tyrosine, 3-acetyl-",CC(=O)C1=C(C=CC(=C1)C[C@@H](C(=O)O)N)O,,,,,,
5971,155972,"beta-D-Glucopyranoside, (1S,4aS,5R,7aR)-7-((benzoyloxy)methyl)-1,4a,5,7a-tetrahydro-4a,5-dihydroxycyclopenta(c)pyran-1-yl",C1C=C([C@H]2[C@@H]1C=COC2O[C@@H]3[C@@H]([C@H](C([C@](O3)(CO)O)(O)O)O)O)COC(=O)C4=CC=CC=C4,,,,,,
5972,155973,"2,3-Dihydroxypropyl 4-chlorobenzoate",C1=CC(=CC=C1C(=O)OCC(CO)O)Cl,,,,,,
5973,155974,"Benzenesulfonamide, 4-(dipropylamino)-3,5-dinitro-, mixt. with 2-chloro-1-(3-ethoxy-4-nitrophenoxy)-4-(trifluoromethyl)benzene",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)N)[N+](=O)[O-].CCOC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
5974,155975,"Propanamide, N,N-diethyl-2-(1-naphthalenyloxy)-, mixt. with 4-(methylsulfonyl)-2,6-dinitro-N,N-dipropylbenzenamine",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)C)[N+](=O)[O-].CCN(CC)C(=O)C(C)OC1=CC=CC2=CC=CC=C21,,,,,,
5975,155976,moracin I,CC(=CCC1=C(C=C(C=C1OC)O)C2=CC3=C(O2)C=C(C=C3)O)C,,,,,,
5976,155977,"3-Furanmethanol, 2-(3,4-dimethoxyphenyl)tetrahydro-4-((4-hydroxy-3-methoxyphenyl)methyl)-, (2S,3R,4R)-",COC1=C(C=C(C=C1)[C@@H]2[C@H]([C@H](CO2)CC3=CC(=C(C=C3)O)OC)CO)OC,,,,,,
5977,155978,"2,6,10,14,24,28,32-Hentetracontaneheptone, 8,16,18,26,34,36-hexahydroxy-",CCCCCC(CC(CC(=O)CCCC(=O)CC(CC(=O)CCCCCC(CC(CC(=O)CCCC(=O)CC(CC(=O)CCCC(=O)C)O)O)O)O)O)O,,,,,,
5978,155979,10-Hydroxyepi-21-O-methylkribine,C[C@@H]1C2=CN3C4=C(C=C(C=C4)O)C5=C3[C@H](C[C@@H]2C[C@@H](O1)OC)N(CC5)C,,,,,,
5979,155980,10-Hydroxy-21-O-methylkribine,C[C@@H]1C2=CN3C4=C(C=C(C=C4)O)C5=C3[C@H](C[C@@H]2C[C@H](O1)OC)N(CC5)C,,,,,,
5980,155981,CID 155981,CCCC[C@@H](C)C=C1C[C@]([C@@H]2CCCN2C1)(C)O,,,,,,
5981,155982,"(7R,8R,8aS)-8-methyl-6-[(2R)-2-methylhexylidene]-1,2,3,5,7,8a-hexahydroindolizine-7,8-diol",CCCC[C@@H](C)C=C1CN2CCC[C@H]2[C@@]([C@@H]1O)(C)O,,,,,,
5982,155983,"1,4-Naphthalenedione, 2-(2-methylpropyl)-",CC(C)CC1=CC(=O)C2=CC=CC=C2C1=O,,,,,,
5983,155984,CID 155984,C[C@H](C1CC[C@](O1)(C)C=C)C(=O)C=CC(C)(C)O,,,,,,
5984,155985,"2,4-Imidazolidinedione, 3-ethyl-1-(methoxymethyl)-5-phenyl-",CCN1C(=O)C(N(C1=O)COC)C2=CC=CC=C2,,,,,,
5985,155986,CID 155986,C[C@@H]1[C@H]2[C@H](O2)C=CC(=O)C=CC(=O)O1,,,,,,
5986,155987,"2H-1,5-Benzodiazepin-2-one, 5-(chloroacetyl)-1,3,4,5-tetrahydro-4-methyl-",CC1CC(=O)NC2=CC=CC=C2N1C(=O)CCl,,,,,,
5987,155988,"1-Dodecanaminium, N,N-dimethyl-N-(2-(2,3,5,6-tetramethylphenoxy)ethyl)-,bromide",CCCCCCCCCCCC[N+](C)(C)CCOC1=C(C(=CC(=C1C)C)C)C.[Br-],,,,,,
5988,155989,"N-[2-(2,3,5,6-Tetramethylphenoxy)ethyl]-N,N-dimethyl-1-dodecanaminium",CCCCCCCCCCCC[N+](C)(C)CCOC1=C(C(=CC(=C1C)C)C)C,,,,,,
5989,155990,"1-Dodecanaminium, N,N-dimethyl-N-(2-((2,3,5,6-tetramethylphenyl)thio)ethyl)-, bromide",CCCCCCCCCCCC[N+](C)(C)CCSC1=C(C(=CC(=C1C)C)C)C.[Br-],,,,,,
5990,155991,"N-[2-[(2,3,5,6-Tetramethylphenyl)thio]ethyl]-N,N-dimethyl-1-dodecanaminium",CCCCCCCCCCCC[N+](C)(C)CCSC1=C(C(=CC(=C1C)C)C)C,,,,,,
5991,155992,CID 155992,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=O)C4=C(C(=C(OC4=C3)C5=CC(=C(C=C5)O)O)O)O)CO)O)O)O)O)O,,,,,,
5992,155993,"Benzoic acid, 3,6-dichloro-2-methoxy-, mixt. with (2,4-dichlorophenoxy)acetic acid and 2-(2,4-dichlorophenoxy)propanoic acid",CC(C(=O)O)OC1=C(C=C(C=C1)Cl)Cl.COC1=C(C=CC(=C1C(=O)O)Cl)Cl.C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,,,,,,
5993,155994,"Morpholinium, 4-((dodecyloxy)methyl)-4-methyl-, chloride",CCCCCCCCCCCCOC[N+]1(CCOCC1)C.[Cl-],,,,,,
5994,155995,4-(Dodecoxymethyl)-4-methylmorpholin-4-ium,CCCCCCCCCCCCOC[N+]1(CCOCC1)C,,,,,,
5995,155996,"Glycine, N,N'-(1,2-diphenyl-1,2-ethanediyl)bis(N-(carboxymethyl)-, (R*,S*)-",C1=CC=C(C=C1)[C@H]([C@H](C2=CC=CC=C2)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
5996,155997,CID 155997,C1[C@H](N=C(C=C1C=CN2[C@@H](CC3=CC(=C(C=C32)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C(=O)O)C(=O)O)C(=O)O.Cl,,,,,,
5997,155998,"2,5,8,11-Tetraoxatridecan-13-ol, tetramethyl-",CC(COCCOCCOCCO)OC(C)(C)C,,,,,,
5998,155999,9-methoxy-9H-fluorene,COC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
5999,156000,"Spiro(5.5)undecan-3-ol, 2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylene-, (2S,3R,6S,8S,9S)-",C[C@@]1(CC[C@]2(C[C@@H]1Cl)C(=C)C[C@H]([C@H](C2(C)C)Br)O)Br,,,,,,
6000,156001,"2-Bromo-1,1,1-trichloropropane",CC(C(Cl)(Cl)Cl)Br,,,,,,
6001,156002,"Benzoic acid, trichloromethoxy-",C1=CC=C(C(=C1)C(=O)O)OC(Cl)(Cl)Cl,,,,,,
6002,156003,Fenthiaprop,CC(C(=O)O)OC1=CC=C(C=C1)OC2=NC3=C(S2)C=C(C=C3)Cl,,,,,,
6003,156004,"Methyldioxy, methoxy-",COCO[O],,,,,,
6004,156005,"Propanoic acid, 2-(4-chloro-2-methylphenoxy)-, potassium salt, mixt. with disodium methylarsonate",CC1=C(C=CC(=C1)Cl)OC(C)C(=O)[O-].C[As](=O)([O-])[O-].[Na+].[Na+].[K+],,,,,,
6005,156006,7-Acetyllycopsamine,C[C@@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)OC(=O)C)O)O,,,,,,
6006,156007,CID 156007,CC(C)(C(=O)[O-])ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].[Na+],,,,,,
6007,156008,2-Azabicyclo[2.1.1]hexane-1-carboxylic acid,C1C2CC1(NC2)C(=O)O,,,,,,
6008,156009,Methyl 4-methylpentadecanoate,CCCCCCCCCCCC(C)CCC(=O)OC,,,,,,
6009,156010,"Oxiranemethanol, alpha-1,3-heptadiynyl-3-(6-heptenyl)-",CCCC#CC#CC(C1C(O1)CCCCCC=C)O,,,,,,
6010,156011,Silvaticamide,CC1=CC(=C2C(C3=C(C=CC(=C3NC(=O)C2=C1OCC=C(C)C)CC=C(C)C)O)O)O,,,,,,
6011,156012,"Methanone, 1,3-dioxolo(4,5-g)isoquinolin-5-yl(2-hydroxy-3,4-dimethoxyphenyl)-",COC1=C(C=C(C(=C1OC)O)C=O)C2=NC=CC3=CC4=C(C=C32)OCO4,,,,,,
6012,156013,3-[Nitroso(propyl)amino]propyl acetate,CCCN(CCCOC(=O)C)N=O,,,,,,
6013,156014,CID 156014,C1=C(C=NC(=C1[N+](=O)[O-])C=NO)[N+](=O)[O-],,,,,,
6014,156015,"Benzenetriol, methyl-",CC1=C(C(=C(C=C1)O)O)O,,,,,,
6015,156016,"2H-1-Benzopyran, 3,4-dichloro-7-methoxy-2,2-dimethyl-",CC1(C(=C(C2=C(O1)C=C(C=C2)OC)Cl)Cl)C,,,,,,
6016,156017,"2H-1-Benzopyran, 3,4-dichloro-6,7-dimethoxy-2,2-dimethyl-",CC1(C(=C(C2=CC(=C(C=C2O1)OC)OC)Cl)Cl)C,,,,,,
6017,156018,(-)-Thalrugosinone,CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C=O)OC)OC)OC)OC)OC,,,,,,
6018,156019,(3H)-Lysine-tetrodotoxin,C(CCN)CC(C(=O)O)NCC1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O,,,,,,
6019,156020,"Tetrodotoxin, 11-((carboxymethyl)amino)-11-deoxy-, labeled with tritium",C(C(=O)O)NCC1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O,,,,,,
6020,156021,"Tetrodotoxin, 11-deoxy-11-oxo-",C(=O)C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O,,,,,,
6021,156022,CID 156022,CC=C(C)C(=O)O[C@@H]1C[C@@]2([C@H](O2)CC(C(=C[C@@H]3[C@@H]1C(=C)C(=O)O3)C)OC(=O)C)C,,,,,,
6022,156023,"(2R,8S,11R,12R,14R,17S)-16-(furan-3-yl)-9-hydroxy-2,7,7,11,17-pentamethyl-6,13-dioxapentacyclo[9.8.0.02,8.012,14.012,17]nonadec-3-ene-5,10-dione",C[C@@]12CCC3[C@]4(C=CC(=O)OC([C@@H]4C(C(=O)[C@]3([C@@]15[C@H](O5)CC2C6=COC=C6)C)O)(C)C)C,,,,,,
6023,156024,CID 156024,CC(=O)OC1[C@@H]2[C@](C=CC(=O)OC2(C)C)(C3CC[C@]4(C(C[C@H]5[C@@]4([C@@]3(C1OC(=O)C)C)O5)C6=COC=C6)C)C,,,,,,
6024,156025,"2H-Oxireno(c)(1)benzopyran, 1a,7b-dihydro-5-methoxy-2,2-dimethyl-",CC1(C2C(O2)C3=C(O1)C=C(C=C3)OC)C,,,,,,
6025,156026,"4H-Furo(2,3-b)pyran-2(3H)-one, 3a,7a-dihydro-4-hydroxy-, (3aR,4S,7aR)-rel-",C1[C@@H]2[C@H](C=CO[C@@H]2OC1=O)O,,,,,,
6026,156027,"3,6-Dihydroxy-2-undeca-1,3,5-trienylbenzaldehyde",CCCCCC=CC=CC=CC1=C(C=CC(=C1C=O)O)O,,,,,,
6027,156028,"Dispiro(furan-3(2H),1'(5'H)-naphthalene-5',2''-oxiran)-2-one,4'-(acetyloxy)-4'a-((acetyloxy)methyl)-5-(3-furanyl)decahydro-2'-methyl-, (1'R-(1'alpha(S*),2'alpha,4'beta,4'aalpha,5'alpha,8'abeta))-",C[C@@H]1C[C@H]([C@@]2([C@@H]([C@@]13C[C@H](OC3=O)C4=COC=C4)CCC[C@]25CO5)COC(=O)C)OC(=O)C,,,,,,
6028,156029,"18,19-Dinorcholestane, 5,14-dimethyl-, (5beta,10alpha,14beta,17alpha)-",C[C@H](CCCC(C)C)[C@@H]1CC[C@]2([C@@H]1CC[C@H]3[C@H]2CC[C@]4([C@H]3CCCC4)C)C,,,,,,
6029,156030,Teupolin I,C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]13C[C@H](OC3=O)C4=COC=C4)CCC[C@]25CO5)COC(=O)C)O,,,,,,
6030,156031,CID 156031,[C-4].[Tl+],,,,,,
6031,156032,"17-[5-(2-Hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,9,13,14-pentamethyl-3-[5-[6-(trioxidanylperoxy)hexoxy]pentylperoxyperoxymethoxy]-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one",CC1(C(CCC2C1=CCC3C2(C(=O)CC4(C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)C)C)OCOOOOCCCCCOCCCCCCOOOOO)C,,,,,,
6032,156033,"(1,3)Oxazino(5,4-d)(1,3)oxazine-4,8-dione, 2,6-diphenyl-",C1=CC=C(C=C1)C2=NC3=C(C(=O)O2)N=C(OC3=O)C4=CC=CC=C4,,,,,,
6033,156034,"5-Hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadecane-3,7-dione",CC1C(=O)OCC2CCN3C2C(CC3)OC(=O)C(C1(C)O)C,,,,,,
6034,156035,CID 156035,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@@H](CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O,,,,,,
6035,156036,"[[(R)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propionyl]amino]acetic acid",C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,,,,,,
6036,156037,Cocaine N-Oxide,C[N+]1([C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC)[O-],,,,,,
6037,156038,"4,9-Dihydroxy-8-methyl-4,9-di(propan-2-yl)-2,7,11-trioxa-16-azatricyclo[11.5.1.016,19]nonadec-13-ene-3,6,10-trione",CC1C(C(=O)OCC2=CCN3C2C(CC3)OC(=O)C(CC(=O)O1)(C(C)C)O)(C(C)C)O,,,,,,
6038,156039,"26-Norolean-7-ene, 13-methyl-, (13alpha,14beta)-",C[C@@]12CC[C@@]3(C4=CC[C@@H]5[C@@]([C@H]4CC[C@]3([C@@H]1CC(CC2)(C)C)C)(CCCC5(C)C)C)C,,,,,,
6039,156040,CID 156040,CC=C(C)C(=O)O[C@H]1[C@@H]([C@H](O[C@H]2[C@]1(O[C@H]3[C@@H](C2)O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)O)C(=O)O)O,,,,,,
6040,156041,"1H-Imidazolium, 4,5-dihydro-2-phenyl-1,3-bis(phenylmethyl)-, (triiodide)",C1CN(C(N1CC2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC=C4.I[I-]I,,,,,,
6041,156042,"2,3-Dihydrodarlingine",CC1C(OC2=C(C1=O)C3CCC(C2)N3C)C,,,,,,
6042,156043,"9H-(1,3)Thiazino(3,2-a)perimidine, 10,11-dihydro-",C1CN2C3=CC=CC4=C3C(=CC=C4)N=C2SC1,,,,,,
6043,156044,CID 156044,CC(=O)O[C@@H]1[C@H]([C@@]23C[C@@](C(C2O)CC[C@H]3[C@@]([C@H]4[C@]1(C([C@@H]5[C@H]4O5)(C)C)O)(C)O)(C)O)O,,,,,,
6044,156045,CID 156045,C1=COC([C@H]2[C@@H]1[C@@H]([C@H]3[C@@]2(O3)CO)OC(=O)C=CC4=CC=C(C=C4)O)OC5[C@@H](C([C@@H]([C@H](O5)CO)O)O)O,,,,,,
6045,156046,2-Adamantylhydrazine,C1C2CC3CC1CC(C2)C3NN,,,,,,
6046,156047,CID 156047,CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C,,,,,,
6047,156048,"9H-Xanthen-9-one, 2-hydroxy-5-methoxy-",COC1=CC=CC2=C1OC3=C(C2=O)C=C(C=C3)O,,,,,,
6048,156049,CID 156049,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(O1)(O)S,,,,,,
6049,156050,"1,3-Isobenzofurandione, polymer with 1,2-ethanediol, (tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenyl)methyl ester",CC(C)C1CC[C@H]2C(C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)CO)C.C1=CC=C2C(=C1)C(=O)OC2=O.C(CO)O,,,,,,
6050,156051,(+)-Silymonin,COC1=C(C=CC(=C1)[C@@H]2[C@H]3CO[C@@]4([C@H]3C(=C[C@H]2C4=O)[C@@H]5CC(=O)C6=C(C=C(C=C6O5)O)O)O)O,,,,,,
6051,156052,Furapiole,CC1CC2=CC3=C(C(=C2O1)OC)OCO3,,,,,,
6052,156053,"Chromate(1-), (3-hydroxy-4-(2-(1-hydroxy-8-sulfo-2-naphthalenyl)diazenyl)-1-naphthalenesulfonato(4-))-, sodium (1:1)",C1=CC=C2C(=C1)C(=CC(=C2N=NC3=C(C4=C(C=CC=C4S(=O)(=O)[O-])C=C3)[O-])[O-])S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
6053,156054,Almasilato,O.O[Si](=O)O.O[Si](=O)O.[Mg+2].[Al+3].[Al+3],,,,,,
6054,156055,Ephedradine B,COC1=C(C=CC(=C1)[C@H]2[C@H]3C4=C(O2)C=CC(=C4)[C@@H]5CC(=O)NCCCN(C3=O)CCCCNCCCN5)O,,,,,,
6055,156056,"Carbonic dichloride, polymer with 4,4'-(1-methylethylidene)bis(2,6-dibromophenol), bis(2,4,6-tribromophenyl) ester",CC(C)(C1=CC(=C(C(=C1)Br)O)Br)C2=CC(=C(C(=C2)Br)O)Br.C1=C(C=C(C(=C1Br)O)Br)Br.C(=O)(Cl)Cl,,,,,,
6056,156057,Tetraamminedichlororhodium chloride,N.N.N.N.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
6057,156058,"5,6-Dihydro-6-(3-tris(1-methylethyl)phosphoranylidene)-1-triazenyl)benzo(c)phenanthren-5-ol trans-",CC(C)P(=NN=N[C@@H]1[C@H](C2=CC=CC=C2C3=C1C=CC4=CC=CC=C43)O)(C(C)C)C(C)C,,,,,,
6058,156059,Lucidine B,C[C@@H]1C[C@H]2CC3=N[C@@H](CC[C@@H]3[C@@H]4C[C@H]2[C@H](C1)N(C4)C)C[C@H]5C[C@@H](C[C@@H]6[C@H]5CCCN6C(=O)C)C,,,,,,
6059,156060,"Quinoline, 1-acetyl-5-((2,3,4,4a,6,6a,7,8,9,10,10a,11-dodecahydro-4a-hydroxy-9,12-dimethyl-7,5-(iminomethano)-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-2-yl)methyl)decahydro-7-methyl-, (2S-(2alpha(4aR*,5S*,7R*,8aS*),4abeta,5beta,6aalpha,7beta,9alpha,10aalpha))-",C[C@@H]1C[C@H]2CC3=N[C@H](CC[C@@]3([C@@H]4C[C@H]2[C@H](C1)N(C4)C)O)C[C@H]5C[C@@H](C[C@@H]6[C@H]5CCCN6C(=O)C)C,,,,,,
6060,156061,"Pyrrolo(2,1-b)oxazole, 7a-(2,5-dimethylphenyl)hexahydro-",CC1=CC(=C(C=C1)C)C23CCCN2CCO3,,,,,,
6061,156062,CID 156062,CC(=O)C(=C([N-]C1=CC=CC=C1)[O-])[N-]N=C2C=C(C=CC2=O)[N+](=O)O.CC(=O)C(=NN=C1C=C(C=CC1=O)N([O-])[O-])C(=O)NC2=CC=CC=C2.[Na+].[Co+3],,,,,,
6062,156063,"24-Norchola-20,22-diene-4-carboxaldehyde, 3-(acetyloxy)-21,23-epoxy-1,7,19-trihydroxy-4,8-dimethyl-11,15-dioxo-, cyclic 4,19-hemiacetal",CC(=O)OC1CC(C23COC(C1(C2CC(C4(C3C(=O)CC5(C4C(=O)CC5C6=COC=C6)C)C)O)C)O)O,,,,,,
6063,156064,Marinobufagin 3-sulfate,C[C@]12CC[C@@H](C[C@]1(CC[C@@H]3[C@@H]2CC[C@]4([C@]35[C@H](O5)C[C@@H]4C6=COC(=O)C=C6)C)O)OS(=O)(=O)O,,,,,,
6064,156065,CID 156065,C1CCC(CC1)C(=O)C2=CC=[N+](C=C2)COC[N+]3=CC=CC=C3C=NO.[I-].[I-],,,,,,
6065,156066,1-[[[4-(Cyclohexylcarbonyl)pyridinio]methoxy]methyl]-2-[(hydroxyimino)methyl]pyridinium,C1CCC(CC1)C(=O)C2=CC=[N+](C=C2)COC[N+]3=CC=CC=C3C=NO,,,,,,
6066,156067,Propylbutyldopamine,CCCCN(CCC)CCC1=CC(=C(C=C1)O)O,,,,,,
6067,156068,"11-hydroxy-14-(1H-imidazol-5-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7-triene-12,15-dione",CC(C)(C=C)C12CC(C(=O)N3C1(NC(=O)C3=CC4=CN=CN4)N(C5=CC=CC=C25)OC)O,,,,,,
6068,156069,"(1R,4S,5'S,6R,6'R,8R,13S,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H](C([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)C,,,,,,
6069,156070,"Cobaltate(1-), bis(2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))-, sodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N([O-])[O-])C3=CC=CC=C3.[Na+].[Co+3],,,,,,
6070,156071,CID 156071,CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N(O)O)C3=CC=CC=C3,,,,,,
6071,156072,"4-[[3-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]-5-methyl-2-phenylpyrazol-3-one",CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N([O-])[O-])C3=CC=CC=C3,,,,,,
6072,156073,Leiocarposide,COC1=C(C=CC(=C1C(=O)OCC2=CC=CC=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
6073,156074,CID 156074,CC(=O)C1=CC=CC=C1.[Cl-].[Cl-].[Cl-].[Cl-],,,,,,
6074,156075,Vephylline-malate (1:1),CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCN(CCO)CCO.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
6075,156076,Vephylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCN(CCO)CCO,,,,,,
6076,156077,Telocinobufatoxin,C[C@]12CC[C@@H](C[C@]1(CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)OC(=O)CCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
6077,156078,CID 156078,CC[C@@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NC([C@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N)N,,,,,,
6078,156079,Tuftsin Diacetate,C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O.CC(=O)O.CC(=O)O,,,,,,
6079,156080,Tuftsin,C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O,,,['Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)'],,,
6080,156081,CID 156081,CC(C(=O)ON=CC(=O)C)OC1=CC=C(C=C1)OC2=CC=C(C=C2)C(F)(F)F,,,,,,
6081,156082,5-Trifluoropentoxypicolinic acid,C1=CC(=NC=C1OCCCCC(F)(F)F)C(=O)O,,,,,,
6082,156083,Thelenotoside B,CC(C)CC(CC1(C2CCC3(C2(CCC4C3=CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)OC7C(C(C(C(O7)CO)OC8C(C(C(CO8)O)OC9C(C(C(C(O9)CO)O)OC)O)O)O)O)C)C(=O)O1)C)C)OC(=O)C,,,,,,
6083,156084,CID 156084,CC=C(C)C(=O)O[C@H]1[C@@H]([C@H](O[C@H]2[C@]1(O[C@H]3[C@@H](C2)O[C@H]([C@@H]3OC)N4C=NC5=C(N=CN=C54)N)O)C(=O)OC)O,,,,,,
6084,156085,CID 156085,CC(=O)C(=C([N-]C1=CC=CC=C1)O)[N-]N=C2C=C(C=CC2=O)S(=O)(=O)N.CC(=O)C(=NNC1=C(C=CC(=C1)S(=O)(=O)N)[O-])C(=NC2=CC=CC=C2)[O-].[Na+].[Co+3],,,,,,
6085,156086,Sannamycin A,CNC[C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@@H]([C@H]([C@H]2O)N(C)C(=O)CN)OC)N)N,,,,,,
6086,156087,CID 156087,CC[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@@H](C=CC[C@@H](C=C([C@H](C(=O)C=CC3=O)O)C)C)[C@H]4[C@@]1(O4)C)[C@@H](C)C5=CNC6=CC=CC=C65,,,,,,
6087,156088,Istamycin B,CNC[C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@@H](C[C@@H]([C@H]([C@H]2O)N(C)C(=O)CN)OC)N)N,,,,,,
6088,156089,Dehydrocrotonin,C[C@@H]1CCC2[C@@H]([C@@]13C[C@@H](OC3=O)C4=COC=C4)CC(=O)C=C2C,,,,,,
6089,156090,"7-({[2-Hydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-4-oxo-1,2,3,4,5,7a-hexahydro-4lambda~5~-pyrrolizin-1-yl 2-methylbut-2-enoate",CC=C(C)C(=O)OC1CC[N+]2(C1C(=CC2)COC(=O)C(C(C)C)(C(C)O)O)[O-],,,,,,
6090,156091,CID 156091,CC(C(=O)N[C@H]1[C@H]2[C@@H]([C@H](CC(=O)C2=C(O[C@]1(C)C(Cl)Cl)O)O)O)NC(=O)C,,,,,,
6091,156092,Securinegine,C1CCN2C3CC4C2(C1)OC(=O)C=C4C=C3,,,,,,
6092,156093,Cryptolepine hydrochloride,CN1C2=CC=CC=C2C=C3C1=C4C=CC=CC4=N3.Cl,,,,,,
6093,156094,Deoxyartemsinin,C[C@@H]1C=C[C@@H]2[C@H](C(=O)O[C@@H]3C2[C@H]1CC[C@@](O3)(C)O)C,,,,,,
6094,156095,2-(5-Nitro-2-furyl)vinyl azide,C1=C(OC(=C1)[N+](=O)[O-])C=CN=[N+]=[N-],,,,,,
6095,156096,CID 156096,C1=C(OC(=C1)[N+](=O)[O-])C=CN[N+]#N,,,,,,
6096,156097,CID 156097,CC(=O)O[C@H]1C=C[C@H]2[C@@H]3CC4=C5[C@]2(C1OC5=C(C=C4)OC)CCN3C.OP(=O)(O)O,,,,,,
6097,156098,CID 156098,CC(=O)O[C@H]1C=C[C@H]2[C@@H]3CC4=C5[C@]2(C1OC5=C(C=C4)OC)CCN3C,,,,,,
6098,156099,Chrysanthellin A,CC1C(C(C(C(O1)OC2C(COC(C2O)OC3C(OC(C(C3O)O)OC4C(C(COC4OC(=O)C56CCC(CC5C7=CCC8C9(CCC(C(C9CCC8(C7(CC6O)C)C)(C)C)OC1C(C(C(C(O1)CO)O)O)O)C)(C)C)O)O)C)O)O)O)O,,,,,,
6099,156100,"(1S,6R,7R,8S,9R,12R,13R,15S,17R,21S,23S)-6,8,11,11,17,22,22-heptamethyl-10,14,26-trioxaheptacyclo[21.2.1.01,21.03,18.06,17.07,15.09,13]hexacos-3(18)-ene-12,13-diol",C[C@H]1[C@H]2[C@H](C[C@@]3([C@@]2(CCC4=C3CC[C@@H]5[C@@]6(C4)CC[C@@H](C5(C)C)O6)C)C)O[C@]7([C@@H]1OC([C@H]7O)(C)C)O,,,,,,
6100,156101,"N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]prop-2-enamide;(1-oxidopyridin-1-ium-3-yl) 3-[3-(prop-2-enoylamino)propanoylamino]propanoate;N-[(prop-2-enoylamino)methyl]prop-2-enamide",C=CC(=O)NCCC(=O)NCCC(=O)OC1=C[N+](=CC=C1)[O-].C=CC(=O)NCNC(=O)C=C.C=CC(=O)NC(CO)(CO)CO,,,,,,
6101,156102,(1-Oxidopyridin-1-ium-3-yl) 3-[3-(prop-2-enoylamino)propanoylamino]propanoate,C=CC(=O)NCCC(=O)NCCC(=O)OC1=C[N+](=CC=C1)[O-],,,,,,
6102,156103,Hainanolidol,C[C@@H]1[C@H]([C@@H]2[C@H]3CC4=C5[C@H]3C1(CCC5=CC(=O)C=C4C)C(=O)O2)O,,,,,,
6103,156104,"2-[(5S,7R,9S)-14-hydroxy-9-methoxy-4-methyl-4,10-diazatetracyclo[8.6.1.05,17.011,16]heptadeca-1(17),11(16),12,14-tetraen-7-yl]but-2-enal",CC=C(C=O)[C@@H]1C[C@H]2C3=C(CCN2C)C4=C(N3[C@H](C1)OC)C=CC(=C4)O,,,,,,
6104,156105,Janthitrem B,CC(=C)[C@@H]1[C@@H](C=C2[C@@H](O1)CC[C@]3([C@]2(CC[C@@H]4[C@@]3(C5=C(C4)C6=CC7=C(C=C6N5)C8=CC(OC([C@H]8[C@@H]7O)(C)C)(C)C)C)O)C)O,,,,,,
6105,156106,Janthitrem C,CC(=C)[C@@H]1[C@@H](C=C2[C@@H](O1)CC[C@]3([C@]2(CC[C@@H]4[C@@]3(C5=C(C4)C6=C(N5)C=C7C(=C6)C[C@H]8C7=CC(OC8(C)C)(C)C)C)O)C)O,,,,,,
6106,156107,CID 156107,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@H](C)C(=O)NC(C(C)C)C(=O)NCC(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)C6CCC(=O)N6)O,,,,,,
6107,156108,CID 156108,C[C@H](CC(=C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C)[C@H](C)C(C)C,,,,,,
6108,156109,"28-Norolean-12-ene-3,17-diol, (3beta)-",CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)O)C,,,,,,
6109,156110,"Olean-12-en-28-oic acid, 3,23-(ethylidenebis(oxy))-, (3beta,4alpha)-",CC1OC[C@]2([C@H](O1)CC[C@]3(C2CC[C@@]4([C@@H]3CC=C5[C@]4(CC[C@@]6([C@@H]5CC(CC6)(C)C)C(=O)O)C)C)C)C,,,,,,
6110,156111,"(1,1'-Biphenyl)-3-ol, 2,4,6-trichloro-",C1=CC=C(C=C1)C2=C(C(=C(C=C2Cl)Cl)O)Cl,,,,,,
6111,156112,Rhein 8-beta-D-Glucuronide,C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C(=O)C4=C(C2=O)C=C(C=C4O)C(=O)O,,,,,,
6112,156113,CID 156113,CC1=C2C3=CC=CC=C3N=C2C=C(N1)NC4=NC5=C(N4)C(=O)N=C(N5)N,,,,,,
6113,156114,CID 156114,C[C@H]1CC=C[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2(C(=O)CCC(=O)C1)C(=O)N[C@H]4CC5=CNC6=CC=CC=C65)C)C,,,,,,
6114,156115,"2(1H)-Quinazolinone, 6-chloro-1-cyclopropyl-4-phenyl-",C1CC1N2C3=C(C=C(C=C3)Cl)C(=NC2=O)C4=CC=CC=C4,,,,,,
6115,156116,"Urea, N,N-dimethyl-N'-(3-(2-phenylethoxy)phenyl)-",CN(C)C(=O)NC1=CC(=CC=C1)OCCC2=CC=CC=C2,,,,,,
6116,156117,"3H-Naphtho(1,8-bc)furan-3,8(4H)-dione, 5,5a,6,7-tetrahydro-7-methyl-5-(1-methylethyl)-, (5R,5aR,7S)-",C[C@H]1C[C@@H]2[C@H](CC(=O)C3=COC(=C23)C1=O)C(C)C,,,,,,
6117,156118,"Phenol, 2-((1S)-1,5-dimethyl-4-hexenyl)-5-methyl-",CC1=CC(=C(C=C1)[C@@H](C)CCC=C(C)C)O,,,,,,
6118,156119,"Phosphorothioic acid, O,O-dimethyl S-(2-((1-methyl-2-(methylamino)-2-oxoethyl)sulfonyl)ethyl) ester",C[C@@H](C(=O)NC)S(=O)(=O)CCOP(=S)(OC)OC,,,,,,
6119,156120,"2-Cyclopenten-1-one, 5-hydroxy-",C1C=CC(=O)C1O,,,,,,
6120,156121,"Propanoic acid, 2-methyl-2-(((methylamino)carbonyl)oxy)-, methyl ester",CC(C)(C(=O)OC)OC(=O)NC,,,,,,
6121,156122,CID 156122,C1=CC=C(C(=C1)C2=COC3=CC(=O)C=C(C3=C2O)O)O,,,,,,
6122,156123,"6H-Furo(3,2-h)(1)benzopyran-5,7-diol, 3-chloro-7,8-dihydro-2,8,8-trimethyl-, (-)-",CC1=C(C2=CC(=C3CC(C(OC3=C2O1)(C)C)O)O)Cl,,,,,,
6123,156124,"1H-2-Benzopyran, 3,4-dihydro-3-phenyl-, (R)-",C1[C@@H](OCC2=CC=CC=C21)C3=CC=CC=C3,,,,,,
6124,156125,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(decylamino)-3-methoxy-6-methyl-",CCCCCCCCCCNC1=C(C(=O)C(=C(C1=O)OC)NCCCCCCCCCC)C,,,,,,
6125,156126,L-Vinylglycine,C=C[C@@H](C(=O)O)N,,,,,,
6126,156127,Selmid,CCNCC.CCN(CC)CN1C(=O)[C@@H]2[C@@H]3C[C@@H]4[C@@]5(CCC[C@H]([C@H]5CC[C@]4([C@@H]2C1=O)C(=C3)C(C)C)C(=O)OC)C,,,,,,
6127,156128,"methyl (1S,4R,5R,9R,10R,12R,13R,17R)-15-(diethylaminomethyl)-9-methyl-14,16-dioxo-18-propan-2-yl-15-azapentacyclo[10.5.2.01,10.04,9.013,17]nonadec-18-ene-5-carboxylate",CCN(CC)CN1C(=O)[C@@H]2[C@@H]3C[C@@H]4[C@@]5(CCC[C@H]([C@H]5CC[C@]4([C@@H]2C1=O)C(=C3)C(C)C)C(=O)OC)C,,,,,,
6128,156129,CID 156129,COC1=CC2=C(C=C1)NC3=CC=CC(=O)C3=C2O,,,,,,
6129,156130,"4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-6,8-bis((2-hydroxyphenyl)methyl)-5-methoxy-2-phenyl-",COC1=C(C(=C(C2=C1C(=O)CC(O2)C3=CC=CC=C3)CC4=CC=CC=C4O)O)CC5=CC=CC=C5O,,,,,,
6130,156131,"Phenol, 4-chloro-3-methyl-, phosphite (3:1)",CC1=C(C=CC(=C1)OP(OC2=CC(=C(C=C2)Cl)C)OC3=CC(=C(C=C3)Cl)C)Cl,,,,,,
6131,156132,"Oxazole, 2-(4-fluorophenyl)-4,5-dihydro-4,4-dimethyl-",CC1(COC(=N1)C2=CC=C(C=C2)F)C,,,,,,
6132,156133,"Benz(a)anthracene, 9-fluoro-12-methyl-",CC1=C2C(=CC3=C1C=CC(=C3)F)C=CC4=CC=CC=C42,,,,,,
6133,156134,"Guanidine, (3,5-bis(trifluoromethyl)phenyl)-, mononitrate",C1=C(C=C(C=C1C(F)(F)F)N=C(N)N)C(F)(F)F.[N+](=O)(O)[O-],,,,,,
6134,156135,"2-[3,5-Bis(trifluoromethyl)phenyl]guanidine",C1=C(C=C(C=C1C(F)(F)F)N=C(N)N)C(F)(F)F,,,,,,
6135,156136,"1,4-Naphthalenedione, 2-bromo-3-(1-methylethyl)-",CC(C)C1=C(C(=O)C2=CC=CC=C2C1=O)Br,,,,,,
6136,156137,"2,4-Imidazolidinedione, 5-acetyl-5-hydroxy-3-(1-methylpropyl)-",CCC(C)N1C(=O)C(NC1=O)(C(=O)C)O,,,,,,
6137,156138,"D-Mannitol, 3,4-di-O-methyl-, 1,6-dimethanesulfonate",CO[C@H]([C@@H](COS(=O)(=O)C)O)[C@@H]([C@@H](COS(=O)(=O)C)O)OC,,,,,,
6138,156139,"Benzo[a]pyrene-7,10-dione",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C(=O)C=CC5=O)C=C2,,,,,,
6139,156140,"L-Arginine, mono-2-thiazolidinecarboxylate",C1CSC(N1)C(=O)O.C(C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
6140,156141,"Furan, 2-ethenyl-5-nitro-",C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
6141,156142,"Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 8-chloro-5,6-dihydro-9,10-dimethoxy-",COC1=C(C2=C([N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)Cl)OC,,,,,,
6142,156143,"Dibenzofuran, 2,7-difluoro-",C1=CC2=C(C=C1F)OC3=C2C=C(C=C3)F,,,,,,
6143,156144,"methyl (2R)-2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate",C[C@H](C(=O)OC)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
6144,156145,"Azuleno(5,6-c)furan-1(3H)-one, 4,4a,5,6,7,7a,8,9-octahydro-3,4,8-trihydroxy-6,6,8-trimethyl-",CC1(CC2C(C1)C(CC3=C(C2O)C(OC3=O)O)(C)O)C,,,,,,
6145,156146,Diamino cobalt,[NH2-].[NH2-].[Co+2],,,,,,
6146,156147,"(R)-6',7'-Dihydroxybergamottin",CC(=CCOC1=C2C=CC(=O)OC2=CC3=C1C=CO3)CCC(C(C)(C)O)O,,,['Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)'],,,
6147,156148,CID 156148,COC(=O)C(C1=C(OC2=CC=CC(=O)C2=C1O)C=C)C(=O)OC,,,,,,
6148,156149,Kuwanon F,CC(=CCCC1(C=CC2=CC(=C(C=C2O1)O)C3CC(=O)C4=C(C=C(C=C4O3)O)O)C)C,,,,,,
6149,156150,1-Tritriacontanol,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO,,,,,,
6150,156151,"Benzenepentanoic acid, 3-chloro-4-methoxy-delta-oxo-",COC1=C(C=C(C=C1)C(=O)CCCC(=O)O)Cl,,,,,,
6151,156152,"9,10-Anthracenedipropanoic acid",C1=CC=C2C(=C1)C(=C3C=CC=CC3=C2CCC(=O)O)CCC(=O)O,,,,,,
6152,156153,"Urea, N-cyclohexyl-N'-(4-((2S)-3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-",CC(C)(C)NC[C@@H](COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,,,,,
6153,156154,"Urea, N-cyclohexyl-N'-(4-((2R)-3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-",CC(C)(C)NC[C@H](COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,,,,,,
6154,156155,6''-O-Acetyldaidzin,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC3=C(C=C2)C(=O)C(=CO3)C4=CC=C(C=C4)O)O)O)O,,,,,,
6155,156156,"9H-Purin-6-amine, 9-(2-propenyl)-, 1-oxide",C=CCN1C=NC2=C1N=CN(C2=N)O,,,,,,
6156,156157,Phytic acid dodecapotassium salt,C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O.[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+],,,,,,
6157,156158,"Ergoline-8-carbothioic acid, 6-methyl-, S-ester with coenzyme A, (8beta)-",CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O,,,,,,
6158,156159,"Zinc, (N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alaninato(2-))-, (T-4)-",CC(C)(CO)C(C(=NCCC(=O)[O-])[O-])O.[Zn+2],,,,,,
6159,156160,"1-(2,6-dimethylphenyl)-N-phenylmethanimine oxide",CC1=C(C(=CC=C1)C)C=[N+](C2=CC=CC=C2)[O-],,,,,,
6160,156161,13-Hydroxyballonigrinolide,CC1=C([C@]2(CCC[C@]3([C@@H]2[C@@H](C1=O)OC3=O)C)C)CCC4(CC(=O)OC4)O,,,,,,
6161,156162,"alpha-D-Ribopyranoside, phenylmethyl 2,3-anhydro-,trifluoromethanesulfonate",C1[C@H]([C@@H]2[C@@H](O2)[C@H](O1)OCC3=CC=CC=C3)OS(=O)(=O)C(F)(F)F,,,,,,
6162,156163,"beta-L-Ribopyranoside, phenylmethyl 2,3-anhydro-,trifluoromethanesulfonate",C1[C@@H]([C@H]2[C@H](O2)[C@H](O1)OCC3=CC=CC=C3)OS(=O)(=O)C(F)(F)F,,,,,,
6163,156164,"alpha-D-Lyxopyranoside, phenylmethyl 2,3-anhydro-,trifluoromethanesulfonate",C1[C@H]([C@H]2[C@H](O2)[C@H](O1)OCC3=CC=CC=C3)OS(=O)(=O)C(F)(F)F,,,,,,
6164,156165,"1,1,1-Trifluoro-3-iodopropane",C(CI)C(F)(F)F,,,,,,
6165,156166,14-O-Acetyl-talatisamine,CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6OC(=O)C)OC)O)OC)COC,,,,,,
6166,156167,"Aconitane-1,7,8,14-tetrol, 20-ethyl-4-(hydroxymethyl)-6,16-dimethoxy-, (1alpha,6beta,14alpha,16beta)-",CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6O)OC)O)O)OC)O)CO,,,,,,
6167,156168,"[6,7-Dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadecan-17-yl] deca-2,4,6-trienoate",CCCC=CC=CC=CC(=O)OC1C(C23C4CC(C(=O)C4(C(C5(C(C2C6C1(OC(O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C,,,,,,
6168,156169,Crotananine,CC1C(C(C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC(=O)C1C)O)C,,,,,,
6169,156170,Cronaburmine,CC1C(C(=O)OC2CCN3C2C(=CC3)COC(=O)C1C(C)O)C,,,,,,
6170,156171,Decabassianolide,CC(C)CC1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)CC(C)C)C)C(C)C)CC(C)C)C)C(C)C)CC(C)C)C)C(C)C)CC(C)C)C)C(C)C,,,,,,
6171,156172,"Pyrimidine, 4-ethyl-2-((phenylmethyl)thio)-6-(trifluoromethyl)-",CCC1=CC(=NC(=N1)SCC2=CC=CC=C2)C(F)(F)F,,,,,,
6172,156173,"Phosphonic acid, (1-((2-amino-1-oxopentyl)amino)ethyl)-, (R-(R*,S*))-",CCC[C@@H](C(=O)N[C@@H](C)P(=O)(O)O)N,,,,,,
6173,156174,"1H-Benz(e)inden-1-one, 2-amino-2,3-dihydro-5-methyl-, hydrochloride",CC1=CC2=C(C3=CC=CC=C13)C(=O)C(C2)N.Cl,,,,,,
6174,156175,"2-Amino-5-methyl-2,3-dihydrocyclopenta[a]naphthalen-1-one",CC1=CC2=C(C3=CC=CC=C13)C(=O)C(C2)N,,,,,,
6175,156176,"3H-Benz(e)inden-3-one, 2-amino-1,2-dihydro-7-methyl-, hydrochloride",CC1=CC2=C(C=C1)C3=C(C=C2)C(=O)C(C3)N.Cl,,,,,,
6176,156177,"2-Amino-7-methyl-1,2-dihydrocyclopenta[a]naphthalen-3-one",CC1=CC2=C(C=C1)C3=C(C=C2)C(=O)C(C3)N,,,,,,
6177,156178,"Urea, N-(2-chloroethyl)-N'-(2-hydroxyethyl)-",C(CO)NC(=O)NCCCl,,,,,,
6178,156179,"1,2-Propanediol, 3-methoxy-, (S)-",COC[C@H](CO)O,,,,,,
6179,156180,5-[5-(3-Butyl-3-methyloxiran-2-yl)-3-methylpent-2-enoxy]-2-ethylpyridine,CCCCC1(C(O1)CCC(=CCOC2=CN=C(C=C2)CC)C)C,,,,,,
6180,156181,CID 156181,CC(=NN=C(N1CCOCC1)S)C2=CC=CC=N2,,,,,,
6181,156182,"5,6,7,8-Tetrahydroquinolin-5-amine",C1CC(C2=C(C1)N=CC=C2)N,,,,,,
6182,156183,"2H-1-Benzopyran, 6-methoxy-2,2-dimethyl-7-(2-propynyloxy)-",CC1(C=CC2=CC(=C(C=C2O1)OCC#C)OC)C,,,,,,
6183,156184,"Methyldioxy, dichlorofluoro-",C(O[O])(F)(Cl)Cl,,,,,,
6184,156185,"4H-Dibenzo(de,g)quinoline-1,4-diol, 5,6,6a,7-tetrahydro-2,10,11-trimethoxy-6-methyl-, (4R,6aS)-",CN1C[C@@H](C2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)OC)O)OC)O,,,,,,
6185,156186,"2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-(3-phenylpropoxy)-, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OCCCC4=CC=CC=C4,,,,,,
6186,156187,"2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-propoxy-, (2R-trans)-",CCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6187,156188,"2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3-(dodecyloxy)-3,4-dihydro-, (2R-trans)-",CCCCCCCCCCCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6188,156189,"2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3-(hexadecyloxy)-3,4-dihydro-, (2R-trans)-",CCCCCCCCCCCCCCCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6189,156190,"2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-(octadecyloxy)-, (2R-trans)-",CCCCCCCCCCCCCCCCCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6190,156191,"2H-1-Benzopyran-5,7-diol, 3-butoxy-2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-",CCCCO[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6191,156192,"Butanoic acid, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-trans)-",CCCC(=O)O[C@H]1CC2=C(C=C(C=C2O[C@@H]1C3=CC(=C(C=C3)O)O)O)O,,,,,,
6192,156193,"Butanedioic acid, mono(2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl) ester, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)CCC(=O)O,,,,,,
6193,156194,"2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,3-benzoate, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC=CC=C4,,,,,,
6194,156195,"Benzoic acid, 4-fluoro-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC=C(C=C4)F,,,,,,
6195,156196,"Benzoic acid, 3,4-dihydroxy-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C=C4)O)O,,,,,,
6196,156197,"1,2-Benzenedicarboxylic acid, mono(2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl) ester, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC=CC=C4C(=O)O,,,,,,
6197,156198,"2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,3-(phenylcarbamate), (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)NC4=CC=CC=C4,,,,,,
6198,156199,"Propanenitrile, 3-((2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl)oxy)-, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OCCC#N,,,,,,
6199,156200,"2H-1-Benzopyran-5,7-diol, 3-(3-aminopropoxy)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OCCCN,,,,,,
6200,156201,"Naphtho(2,3-c)furan-1(3H)-one, 9-(1,3-benzodioxol-5-yl)-3a,4,9,9a-tetrahydro-7,8-dimethoxy-, (3aR,9R,9aR)-",COC1=C(C2=C(C[C@H]3COC(=O)[C@@H]3[C@@H]2C4=CC5=C(C=C4)OCO5)C=C1)OC,,,,,,
6201,156202,Polygamain,C1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C31)OCO4)C5=CC6=C(C=C5)OCO6,,,,,,
6202,156203,"3,6-Dimethyl-7a-hydroxy-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one",CC1CCC2=C(C(=O)OC2(C1)O)C,,,,,,
6203,156204,"Pentanoic acid, 2,2,4-trimethyl-, methyl ester",CC(C)CC(C)(C)C(=O)OC,,,,,,
6204,156205,"Butanamide, 4-(diethylamino)-N-(2-methoxy-4,6-dimethylphenyl)-, monohydrochloride",CCN(CC)CCCC(=O)NC1=C(C=C(C=C1OC)C)C.Cl,,,,,,
6205,156206,"4-(diethylamino)-N-(2-methoxy-4,6-dimethylphenyl)butanamide",CCN(CC)CCCC(=O)NC1=C(C=C(C=C1OC)C)C,,,,,,
6206,156207,CID 156207,CS(=O)C(=CC1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
6207,156208,"Dibenzo(b,e)(1,4)dioxin-2-amine, 7,8-dichloro-",C1=CC2=C(C=C1N)OC3=CC(=C(C=C3O2)Cl)Cl,,,,,,
6208,156209,"Dibenzo(b,e)(1,4)dioxin, 2,3-dichloro-7-fluoro-",C1=CC2=C(C=C1F)OC3=CC(=C(C=C3O2)Cl)Cl,,,,,,
6209,156210,"Dibenzo(b,e)(1,4)dioxin-2-carbonitrile, 7,8-dichloro-",C1=CC2=C(C=C1C#N)OC3=CC(=C(C=C3O2)Cl)Cl,,,,,,
6210,156211,"Dibenzo(b,e)(1,4)dioxin-2-amine, 3,7,8-trichloro-",C1=C(C(=CC2=C1OC3=CC(=C(C=C3O2)Cl)Cl)Cl)N,,,,,,
6211,156212,"Dibenzo(b,e)(1,4)dioxin-2-carbonitrile, 3,7,8-trichloro-",C1=C(C(=CC2=C1OC3=CC(=C(C=C3O2)Cl)Cl)Cl)C#N,,,,,,
6212,156213,"Benzoic acid, 5-(acetylamino)-2-hydroxy-, phenyl ester",CC(=O)NC1=CC(=C(C=C1)O)C(=O)OC2=CC=CC=C2,,,,,,
6213,156214,"Benzoic acid, 3-(acetylamino)-2-hydroxy-, phenyl ester",CC(=O)NC1=CC=CC(=C1O)C(=O)OC2=CC=CC=C2,,,,,,
6214,156215,CID 156215,CCC[C@H]1O[C@@H](C(=NO[Si](C)(C)C)S1)C,,,,,,
6215,156216,"(1,3-oxathiolan-4-ylideneamino) N-(2-chloroethyl)carbamate",C1C(=NOC(=O)NCCCl)SCO1,,,,,,
6216,156217,CID 156217,CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C)C(C)C,,,,,,
6217,156218,CID 156218,CCNC(=O)ON=C1[C@H](O[C@@H](S1)C)C,,,,,,
6218,156219,"2H-1-Benzopyran-2-one, 7-butoxy-",CCCCOC1=CC2=C(C=C1)C=CC(=O)O2,,,,,"['7-butoxy-2h-chromen-2-one has known human metabolites that include 7-(1-hydroxybutoxy)-3,4,4a,5,6,7,8,8a-octahydro-2H-chromen-2-ol, 7-(3-hydroxybutoxy)-3,4,4a,5,6,7,8,8a-octahydro-2H-chromen-2-ol, and 7-(4-hydroxybutoxy)-3,4,4a,5,6,7,8,8a-octahydro-2H-chromen-2-ol.']",
6219,156220,"4(1H)-Pyridinone, 3-(ethylsulfinyl)-1-methyl-5-(3-(trifluoromethyl)phenyl)-",CCS(=O)C1=CN(C=C(C1=O)C2=CC(=CC=C2)C(F)(F)F)C,,,,,,
6220,156221,"6-(1-Hydroxyethyl)-2,2-dimethyl-2H-1-benzopyran",CC(C1=CC2=C(C=C1)OC(C=C2)(C)C)O,,,,,,
6221,156222,CID 156222,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)OCC2=CC=CC=C2)O)O)O,,,,,,
6222,156223,"2,3-dihydroxypropyl [1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate",CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(CO)O,,,,,,
6223,156224,Indanestrol,CCC1C(C(C2=C1C=CC(=C2)O)C)C3=CC=C(C=C3)O,,,,,,
6224,156225,"Dibenzo(b,e)(1,4)dioxin-1,2-diol",C1=CC=C2C(=C1)OC3=C(O2)C(=C(C=C3)O)O,,,,,,
6225,156226,C.I. Reactive Blue 160,C1=CC=C(C=C1)C(N=NC2=C(C=C(C=C2)S(=O)(=O)[O-])C(=O)[O-])N=NC3=CC(=CC(=C3O)NC4=NC(=NC(=N4)Cl)NC5=C(C=C(C(=C5)S(=O)(=O)[O-])NC6=NC(=NC(=N6)NC7=CC(=CC=C7)S(=O)(=O)O)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
6226,156227,"2-[[[[3-[[4-Chloro-6-[4-[[4-chloro-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2,5-disulfoanilino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]diazenyl]-phenylmethyl]diazenyl]-5-sulfobenzoic acid",C1=CC=C(C=C1)C(N=NC2=C(C=C(C=C2)S(=O)(=O)O)C(=O)O)N=NC3=CC(=CC(=C3O)NC4=NC(=NC(=N4)Cl)NC5=C(C=C(C(=C5)S(=O)(=O)O)NC6=NC(=NC(=N6)NC7=CC(=CC=C7)S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6227,156228,"2-(3,5-Dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid",CC1(CC1(C)C(=O)O)C(=O)NC2=CC(=CC(=C2)Cl)Cl,,,,,,
6228,156229,CID 156229,COC1=C2C(=CC=C(O2)O)C=C(C1=O)CC(=O)O,,,,,,
6229,156230,CID 156230,COC1=C2C(=CC=C(O2)O)C=C(C1=O)C(C(=O)O)O,,,,,,
6230,156231,CID 156231,CC1=C(O[C@@H](C1=O)CC(=CCC[C@H](C)C=CC=C(C)CCCC2=COC=C2)C)O,,,,,,
6231,156232,(R)-3-Phenoxy-mandelonitrile,C1=CC=C(C=C1)OC2=CC=CC(=C2)[C@H](C#N)O,,,,,,
6232,156233,"Benzoic acid, 2-((6-methoxy-2-naphthalenyl)carbonyl)-",COC1=CC2=C(C=C1)C=C(C=C2)C(=O)C3=CC=CC=C3C(=O)O,,,,,,
6233,156234,"1(3H)-Isobenzofuranone, 3-(6-methoxy-2-naphthalenyl)-3-methyl-",CC1(C2=CC=CC=C2C(=O)O1)C3=CC4=C(C=C3)C=C(C=C4)OC,,,,,,
6234,156235,CID 156235,C[C@H]1[C@H]2[C@@H](NC(=O)[C@@]23[C@@H](C=C(CC[C@H]([C@H](C=CC3=O)O)O)C)C=C1C)CC(C)C,,,,,,
6235,156236,"Methanone, (4-aminophenyl)(4-(1,1-dimethylethyl)phenyl)-",CC(C)(C)C1=CC(=C(C=C1)C=O)C2=CC=C(C=C2)N,,,,,,
6236,156237,"9,10-Anthracenedione, 1-((6-deoxy-alpha-L-mannopyranosyl)oxy)-3,8-dihydroxy-6-methyl-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC(=CC3=C2C(=O)C4=C(C3=O)C=C(C=C4O)C)O)O)O)O,,,,,,
6237,156238,"Benzene, 2-chloro-1-(3,4-dinitrophenoxy)-4-(trifluoromethyl)-",C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6238,156239,"1,3,5-Triazine-2,4,6-triamine, N,N',N''-tributyl-N,N',N''-tris(2,2,6,6-tetramethyl-4-piperidinyl)-",CCCCN(C1CC(NC(C1)(C)C)(C)C)C2=NC(=NC(=N2)N(CCCC)C3CC(NC(C3)(C)C)(C)C)N(CCCC)C4CC(NC(C4)(C)C)(C)C,,,,,,
6239,156240,"Benz(a)anthracen-12-ol, 3-methoxy-7-methyl-, acetate",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)OC(=O)C)C=CC(=C3)OC,,,,,,
6240,156241,"Benz(a)anthracene, 3-methoxy-7-methyl-",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC(=C3)OC,,,,,,
6241,156242,"Benzoic acid, 2-bromo-, 3-iodo-2-propynyl ester",C1=CC=C(C(=C1)C(=O)OCC#CI)Br,,,,,,
6242,156243,"2-Cyclopenten-1-one, 2-(phenylseleno)-",C1CC(=O)C(=C1)[Se]C2=CC=CC=C2,,,,,,
6243,156244,"4H-Benzo(de)(1,3)benzodioxolo(5,6-g)quinoline-4,5(6H)-dione,1,2-dimethoxy-6-methyl-",CN1C2=C3C(=CC(=C(C3=C4C=C5C(=CC4=C2)OCO5)OC)OC)C(=O)C1=O,,,,,,
6244,156245,Orelline,C1=CNC(=C(C1=O)O)C2=C(C(=O)C=CN2)O,,,,,,
6245,156246,CID 156246,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=COC3=CC(=O)C=C(C3=C2O)O)O)O)O,,,,,,
6246,156247,"Spiro(5.5)undec-3-en-1-one, 4,8-dibromo-9-chloro-2,5,5,9-tetramethyl-, (2R,6S,8R,9R)-rel-(+)-",C[C@@H]1C=C(C([C@]2(C1=O)CC[C@@]([C@@H](C2)Br)(C)Cl)(C)C)Br,,,,,,
6247,156248,2-Methoxyethyl 2-{5-[2-chloro-4-(trifluoromethyl)-phenoxy]-2-nitrophenoxy}propanoate,CC(C(=O)OCCOC)OC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
6248,156249,"2,3-Pyrazinedicarbonitrile, 5-(3-chlorophenyl)-6-(propylamino)-",CCCNC1=NC(=C(N=C1C2=CC(=CC=C2)Cl)C#N)C#N,,,,,,
6249,156250,2-[2-(5-Carbamimidoyl-1-benzofuran-2-yl)ethenyl]-1-benzofuran-5-carboximidamide;dihydrochloride,C1=CC2=C(C=C1C(=N)N)C=C(O2)C=CC3=CC4=C(O3)C=CC(=C4)C(=N)N.Cl.Cl,,,,,,
6250,156251,"L-Leucinamide, L-tyrosylglycylglycyl-L-phenylalanyl-N-tricyclo(3.3.1.13,7)dec-1-yl-5",CC(C)C[C@@H](C(=O)NC12CC3CC(C1)CC(C3)C2)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)CNC(=O)[C@H](CC5=CC=C(C=C5)O)N,,,,,,
6251,156252,CID 156252,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC(=O)CCC(=O)O)C,['Treatment of severe malaria caused by Plasmodium falciparum'],,,"['Following administration to humans, artesunate is rapidly hydrolyzed to its principal active metabolite, dihydroartemisinin.  The pharmacokinetics of artesunate are characterized by marked inter-subject variability, differing significantly between healthy volunteers and infected patients, and among patients with different disease severity.', ""The pharmacokinetic of artesunate and dihydroartemisin are characterized by marked inter-subject variability. The pharmacokinetic parameters of artesunate and dihydroartemisinin differ significantly between healthy volunteers and infected patients, and among patients with different disease severity. Pharmacokinetic data from unbound plasma concentrations of artesunate or dihydroartemisinin should be interpreted with caution because the drug accumulates selectively in parasitized RBC's In in vitro experiments, accumulation of dihydroartemisinin in infected RBC's is in concentrations approximately 300-fold higher than those in plasma ."", 'The pharmacokinetics of oral dihydroartemisinin (DHA) following the dose of 2 and 4 mg/ kg body weight dihydroartemisinin and 4 mg/kg body weight oral artesunate (AS) were investigated in 20 healthy Thai volunteers (10 males, 10 females). All formulations were generally well tolerated. Oral DHA was rapidly absorbed from gastrointestinal tract with marked inter-individual variation. The pharmacokinetics of DHA following the two dose levels were similar and linearity in its kinetics was observed. Based on the model-independent pharmacokinetic analysis, median (95% CI) values for Cmax of 181 (120-306) and 360 (181-658) ng/ml were achieved at 1.5 hours following 2 and 4 mg/kg body weight dose, respectively. The corresponding values for AUC0-infinity, t1/2z, CL/f and Vz/f were 377 (199-1,128) vs 907 (324-2,289) ng.hr/mL, 0.96 (0.70-1.81) vs 1.2 (0.75-1.44) hours, 7.7 (4.3-12.3) vs 6.6 (3.1-10.1) L/kg, and 90.5 (28.6-178.2) vs 6.6 (3.1-10.1) mL/min/kg, respectively (2 vs 4 mg/kg dose). Oral AS was rapidly biotransformed to DHA, which was detectable in plasma as early as 15 minutes of AS dosing. Following 4 mg/kg dose, median (95% CI) value for Cmax of 519 (236-284) ng/mL was achieved at 0.7 (0.25-1.5) hours. AUC0-infinity, and t1/2z were 657 (362-2,079) ng.hr/mL, 0.74 (0.34-1.42) hours, respectively. Cmax of DHA following oral AS were significantly higher, but total systemic exposure was greater following oral DHA at the same dose level (4 mg/kg body weight). There was no significant sex difference in pharmacokinetics of DHA', 'The aims of this study were to determine the pharmacokinetic parameters of a single dose of 200 mg oral and rectal artesunate in healthy volunteers, and to suggest a rational dosage regimen for rectal administration. The study design was a randomized open cross-over study of 12 healthy volunteers... Pharmacokinetic parameters were derived from the main metabolite alpha-dihydroartemisinin data due to the rapid disappearance of artesunate from the plasma. Dihydroartemisinin following oral administration of artesunate had a significantly higher AUC(0-infinity) (P<0.05 95% confidence interval (CI) -1168.73, -667.61 ng x hr/mL(-1)) and Cmax (P<0.05; 95% CI -419.73, -171.44 ng/mL(-1)), and had shorter tmax (P<0.05; 95% CI -0.97, -0.10 hr) than that following rectal artesunate. There was no statistically significant difference in the elimination half-life between both routes of administration (P>0.05; 95% CI -0.14, 0.53 hr). The relative bioavailability of rectal artesunate was [mean (coefficient of variation %) 54.9 (24.8%) %].', 'For more Absorption, Distribution and Excretion (Complete) data for ARTESUNIC ACID (8 total), please visit the HSDB record page.']","['Following administration to humans, artesunate is rapidly hydrolyzed to its principle active metabolite, dihydroartemisinin. Data from in vitro studies with human liver microsomes and from clinical studies suggest that DHA-glucoronide (10-position) is the principal Phase II metabolite of DHA and that uridine diphosphate glucuronyl transferase isoforms 1A1, 1A8-9, or 2B7 may be the main conjugating enzyme.', 'Artemisinin is completely and rapidly absorbed after oral administration in rats.  However, a very low plasma level was obtained even after a dose of 300 mg/kg.  Liver was found to be the chief site of inactivation.  When artemisinin was given i.m., significant and more persistent plasma levels were detected.  Artemisinin was shown to pass the blood-brain and blood-placenta barriers after i.v. injection.  Very little unchanged artemisinin was found in the urine or feces in 48 hours regardless of the route of administration.  Metabolites identified after administration to humans include deoxyartemisinin, deoxydihydroartemisinin, and 9,10-dihydroxydeoxyartemisinin.']","['In volunteer studies, artsunate was cleared very rapidly (within minutes) by biotransformation to dihydroartemisinin, which was eliminated by with a half-life of approximately 45 minutes.']"
6252,156253,"Aconitane-1,7,8,14-tetrol, 20-ethyl-16-methoxy-4-(methoxymethyl)-, (1alpha,14alpha,16beta)-",CCN1CC2(CCC(C34C2CC(C31)(C5(CC(C6CC4C5C6O)OC)O)O)O)COC,,,,,,
6253,156254,"Eburnamenine-14-carboxylic acid, 11-bromo-, methyl ester, (3alpha,16alpha)-",CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=C(N4C(=C2)C(=O)OC)C=C(C=C5)Br,,,,,,
6254,156255,"18,27-Dinordammara-8,12-dien-3-ol, 20,24-epoxy-24-methyl-, (3beta,20xi)-",CCC1(CCC(O1)(C)C2CCC3(C2=CCC4=C3CCC5C4(CCC(C5(C)C)O)C)C)C,,,,,,
6255,156256,"Pyrrolidine, 2-butyl-5-heptyl-, (2R,5R)-rel-",CCCCCCC[C@@H]1CC[C@H](N1)CCCC,,,,,,
6256,156257,"Dispiro(furan-3(2H),1'(5'H)-naphthalene-5',2''-oxiran)-4'(4'aH)-one,2-(acetyloxy)-4'a-((acetyloxy)methyl)-5-(3-furanyl)octahydro-3'-hydroxy-2'-methyl-, (1'S,2S,2'S,2''R,3'R,4'aR,5S,8'aR)-",C[C@@H]1[C@@H](C(=O)[C@@]2([C@@H](C13CC(O[C@H]3OC(=O)C)C4=COC=C4)CCC[C@]25CO5)COC(=O)C)O,,,,,,
6257,156258,Ohchinolid A,CC1=C2[C@H](CC1C3=COC=C3)OC(=O)C[C@H]4[C@]2([C@@H]([C@H]5[C@@H]6[C@@]4([C@H](C[C@H]([C@]6(CO5)C)OC(=O)C)OC(=O)C)C)OC(=O)C7=CC=CC=C7)C,,,,,,
6258,156259,CID 156259,CC=C(C)C(=O)O[C@@H]1[C@H]2[C@H]3[C@](CO2)([C@@H](C[C@@H]([C@@]3([C@@H]4[C@@]1(C5=C(C(C[C@@H]5OC(=O)C4)C6=COC=C6)C)C)C)OC(=O)C)OC(=O)C)C,,,,,,
6259,156260,"Methyl 6,10b-dihydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4,5,8-tetraoxo-1,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-phenanthro[1,2-c]pyran-2-carboxylate",C[C@]12CCC(=O)C(C1=C(C(=O)[C@@]3(C2(CC(=C)[C@]4([C@H]3C(=O)O[C@@](C4=O)(C)C(=O)OC)C)O)C)O)(C)C,,,,,,
6260,156261,"D-arabino-alpha-L-ido-7-Undeculo-7,3-pyranose-1,4-furanuronic acid,1-(6-amino-9H-purin-9-yl)-6,10-anhydro-1,5-dideoxy-2-O-methyl-, methyl ester, 8-(2-methylpropanoate), (7R)-",CC(C)C(=O)O[C@H]1[C@@H]([C@H](O[C@@H]2[C@]1(O[C@H]3[C@@H](C2)O[C@H]([C@@H]3OC)N4C=NC5=C(N=CN=C54)N)O)C(=O)OC)O,,,,,,
6261,156262,4-Chloropyrene,C1=CC2=C3C(=C1)C=C(C4=CC=CC(=C43)C=C2)Cl,,,,,,
6262,156263,CID 156263,CCCCCCCC(=O)NCCC(N(C)[O-])N(C)[O-],,,,,,
6263,156264,CID 156264,CCCCCCCCCC(=O)NCCC(N(C)[O-])N(C)[O-],,,,,,
6264,156265,"3,5-Bis(trifluoromethyl)phenylboronic acid",B(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)(O)O,,,,,,
6265,156266,2-Ethylhexyl decanoate,CCCCCCCCCC(=O)OCC(CC)CCCC,,,,,,
6266,156267,alpha-(p-Isopentylthiophenyl)-1-imidazoleethanol,CC(C)CCSC1=CC=C(C=C1)C(CN2C=CN=C2)O,,,,,,
6267,156268,"7-(4-Acetylpiperazin-1-yl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C(=O)C)F)C(=O)O,,,,,,
6268,156269,Loquatoside,C1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2C(C3=C(C=C(C=C3OC2C4=CC(=C(C=C4)O)O)O)O)O)O)O)O,,,,,,
6269,156270,"5-(1-Hydroxy-2-(4-phenyl-1-piperidinyl)ethyl)-1,3-benzenediol",C1CN(CCC1C2=CC=CC=C2)CC(C3=CC(=CC(=C3)O)O)O,,,,,,
6270,156271,Ketoace,C1C[C@H](N(C1)C(=O)CCC(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3)C(=O)O,,,,,,
6271,156272,"2H-1-Benzopyran-6-ol, 7-methoxy-2,2-dimethyl-",CC1(C=CC2=CC(=C(C=C2O1)OC)O)C,,,,,,
6272,156273,"2-Butyl-4-methyl-1,3-dioxolane",CCCCC1OCC(O1)C,,,,,,
6273,156274,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-phenoxyphenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)OC3=CC=CC=C3)C,,,,,,
6274,156275,"(3-phenoxyphenyl)methyl (1R,3S)-2,2-dimethyl-3-(2-methylpropoxyiminomethyl)cyclopropane-1-carboxylate",CC(C)CON=C[C@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3,,,,,,
6275,156276,"O,S,S-Tripropyl dithiophosphate",CCCOP(=O)(SCCC)SCCC,,,,,,
6276,156277,"N-Cyclopropyl-5,6-dimethoxytryptamine",COC1=C(C=C2C(=C1)C(=CN2)CCNC3CC3)OC,,,,,,
6277,156278,"N-Cyclopropyl-6,7-dimethoxytryptamine",COC1=C(C2=C(C=C1)C(=CN2)CCNC3CC3)OC,,,,,,
6278,156279,CID 156279,C[C@@H](C(=O)C[C@@H](C(=O)N)N[C@H]1C2[C@@H]([C@H](CC(=O)C2=C(O[C@]1(C)C(Cl)Cl)O)O)O)N,,,,,,
6279,156280,Acamelin,CC1=CC2=C(O1)C(=O)C(=CC2=O)OC,,,,,,
6280,156281,"Benzoic acid, 2-(isocyanatosulfonyl)-, methyl ester",COC(=O)C1=CC=CC=C1S(=O)(=O)N=C=O,,,,,,
6281,156282,Bao gong teng A,CC(=O)O[C@H]1C[C@@H]2[C@H](CC[C@H]1N2)O,,,,,,
6282,156283,CID 156283,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)[O-].O.O.O.[Na+],,,,,,
6283,156284,Desacetyl-alacepril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O,,,,,,
6284,156285,2-[2-[[(5-Bromo-2-hydroxyphenyl)-carboxymethyl]amino]ethylamino]-2-(2-hydroxyphenyl)acetic acid,C1=CC=C(C(=C1)C(C(=O)O)NCCNC(C2=C(C=CC(=C2)Br)O)C(=O)O)O,,,,,,
6285,156286,Triptophenolide methyl ether,CC(C)C1=C(C2=C(C=C1)[C@]3(CCC4=C([C@@H]3CC2)COC4=O)C)OC,,,,,,
6286,156287,"2-Imidazolidinone, 1-(3-chlorophenyl)-3-(2-(3,3-dimethyl-1-azetidinyl)ethyl)-, monohydrochloride",CC1(CN(C1)CCN2CCN(C2=O)C3=CC(=CC=C3)Cl)C.Cl,,,,,,
6287,156288,4-Oxononanal,CCCCCC(=O)CCC=O,,,,,,
6288,156289,8-Mercaptooctanoic acid,C(CCCC(=O)O)CCCS,,,,,,
6289,156290,"(1R,3R)-3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid (pentafluorophenyl)methyl ester",CC1([C@H]([C@H]1C(=O)OCC2=C(C(=C(C(=C2F)F)F)F)F)C=C(Cl)Cl)C,,,,,,
6290,156291,CID 156291,CCCCCCCCCCCCCCCCCCC(=O)C[C@H](CC(=O)P(=O)(C(=O)CC[N+](C)(C)C)[O-])OC(=O)C,,,,,,
6291,156292,CID 156292,CCCCCCCCCCCCCCCCCCC(=O)C[C@H](CC(=O)P(=O)(C(=O)CC[N+](C)(C)C)O)OC(=O)C,,,,,,
6292,156293,4-Hydroxyaloin,C1=CC2=C(C(=C1)O)C(=O)C3=C(C=C(C(=C3C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)CO)O,,,,,,
6293,156294,"2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, (R)-",CC(C)N(CC[C@@](C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,,,,,,
6294,156295,Disopiramide,CC(C)N(CC[C@](C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,,,,,['Disopiramide has known human metabolites that include N-Desisopropyldisopyramide.'],
6295,156296,"4-Methoxy-5-methyl-6-(7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaenyl)pyran-2-one",CC=C(C)C=C(C)C=C(C)C=CC=CC=CC1=C(C(=CC(=O)O1)OC)C,,,,,,
6296,156297,"1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol",COC1=C(C=C(C=C1)CCNCC(COC2=CC(=C(C=C2)O)O)O)OC,,,['Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)'],,,
6297,156298,"Phenol, 3,3'-((propylimino)di-2,1-ethanediyl)bis-, hydrochloride",CCCN(CCC1=CC(=CC=C1)O)CCC2=CC(=CC=C2)O.Cl,,,,,,
6298,156299,8alpha-Hydroxyverrucarol,CC1=C[C@@H]2[C@](C[C@@H]1O)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)O)C)CO,,,,,,
6299,156300,CID 156300,C[C@@H](C(=O)[O-])Cl.[Na+],,,,,,
6300,156301,"O-Methyl O-(2,4,5-trichlorophenyl) phenylphosphonothioate",COP(=S)(C1=CC=CC=C1)OC2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
6301,156302,14-Deoxylactucin,CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)O)C(=C)C(=O)O3)C(=CC2=O)C,,,,,,
6302,156303,"cis-(+-)-4-(2,2-Dimethyl-5-(4-methoxyphenyl)-3-pyrrolidinyl)pyridine dihydrochloride",CC1([C@@H](C[C@@H](N1)C2=CC=C(C=C2)OC)C3=CC=NC=C3)C.Cl.Cl,,,,,,
6303,156304,CID 156304,CC1([C@@H](CC(N1)C2=CC=C(C=C2)OC)C3=CC=NC=C3)C,,,,,,
6304,156305,Decahydrohistrionicotoxin,CCCCC1[C@@H](CCC[C@]12CCCC(N2)CCCC=C)O,,,,,,
6305,156306,Baytan Universal,CC1=CC(=NN1C2=NC3=CC=CC=C3N2)C.CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O.C1=CC=C2C(=C1)NC(=N2)C3=CC=CO3,,,,,,
6306,156307,Canadine methohyroxide,C[N+]12CCC3=CC4=C(C=C3C1CC5=C(C2)C(=C(C=C5)OC)OC)OCO4.[OH-],,,,,,
6307,156308,alpha-Canadine methochloride,C[N+]12CCC3=CC4=C(C=C3C1CC5=C(C2)C(=C(C=C5)OC)OC)OCO4,,,,,,
6308,156309,Recainam hydrochloride,CC1=C(C(=CC=C1)C)NC(=O)NCCCNC(C)C.Cl,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
6309,156310,(2-(2-(Phenylmethyl)-1H-benzimidazol-1-yl)ethyl)phosphonic acid bis(2-chloroethyl) ester,C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCP(=O)(OCCCl)OCCCl,,,,,,
6310,156311,"Acetyl-2,6-dimethyl-4-benzoquinone imine",CC1=CC(=O)C=C(C1=NC(=O)C)C,,,,,,
6311,156312,4-Deacetylneosolaniol,CC1=C[C@@H]2[C@](C[C@@H]1O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)O)C)COC(=O)C,,,,,,
6312,156313,"(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C,,,,,,
6313,156314,"N,N-Dipropylcarboxamidotryptamine",CCCN(CCC)CCC1=CNC2=C1C=C(C=C2)C(=O)N,,,,,,
6314,156315,"Benz(j)aceanthrylene, 8-fluoro-1,2-dihydro-3-methyl-",CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4C=C(C=C5)F)C=C1,,,,,,
6315,156316,10-Fluoro-3-methylcholanthrene,CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4C=CC=C5F)C=C1,,,,,,
6316,156317,"trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C[C@@H]([C@H]3O)O,,,,,,
6317,156318,"3'-Hydroxy-2-(N-methyl-N-(1,1-dimethyl-2-phenylethyl)amino)acetophenone",CC(C)(CC1=CC=CC=C1)N(C)CC(=O)C2=CC(=CC=C2)O,,,,,,
6318,156319,2-Ethylamino-1-(3-stearoylphenyl)ethanol,CCCCCCCCCCCCCCCCCC(=O)OC1=CC=CC(=C1)C(CNCC)O,,,,,,
6319,156320,Ibopamine hydrochloride,CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C.Cl,,,"['Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)', 'Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)', 'Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)']",,,
6320,156321,Bromperidol decanoate,CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Br,,,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)']",,,
6321,156322,Acrylamidopropyltrimonium chloride/acrylamide copolymer (400 MPA.S),C[N+](C)(C)CCCNC(=O)C=C.C=CC(=O)N.[Cl-],,,,,,
6322,156323,Trimethyl-[3-(prop-2-enoylamino)propyl]azanium,C[N+](C)(C)CCCNC(=O)C=C,,,,,,
6323,156324,"3-(5-Nitro-2-furyl)-imidazo(1,2-a)pyridine",C1=CC2=NC=C(N2C=C1)C3=CC=C(O3)[N+](=O)[O-],,,,,,
6324,156325,CID 156325,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
6325,156326,"(6R)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene",CN1C[C@@H]2C(C1)C3=CC=CC=C3OC4=C2C=C(C=C4)Cl,,,,,,
6326,156327,"(8S,11R,13S,14S,17S)-11-[4-(hydroxyiminomethyl)phenyl]-17-methoxy-17-(methoxymethyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(COC)OC)C5=CC=C(C=C5)C=NO,,,,,,
6327,156328,Besonprodil,C1CN(CCC1CC2=CC=C(C=C2)F)CCS(=O)C3=CC4=C(C=C3)NC(=O)O4,,,,,,
6328,156329,Stocal Super,CCN(CC)C1=NC(=CC(=N1)OP(=S)(OC)OC)C.CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
6329,156330,Carbendazim mixture with prochloraz,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.COC(=O)NC1=NC2=CC=CC=C2N1,,,,,,
6330,156331,"1,2-Ethanediaminium, N,N,N',N'-tetramethyl-N,N'-bis(2-(octyloxy)-2-oxoethyl)-, dichloride",CCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCC.[Cl-].[Cl-],,,,,,
6331,156332,Ethylenebis[(octyloxycarbonylmethyl)dimethylaminium],CCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCC,,,,,,
6332,156333,Nemonapride,C[C@@H]1[C@@H](CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl,,,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
6333,156334,"1-Dodecanamine, N-(nitrosomethyl)-",CCCCCCCCCCCCNCN=O,,,,,,
6334,156335,5-Methylsulfonylamino-6-phenoxy-1-indanone,CS(=O)(=O)NC1=C(C=C2C(=C1)CCC2=O)OC3=CC=CC=C3,,,,,,
6335,156336,Decussine,C[C@@H]1C2=C(C=CN=C2)C=C3C4=C(CCN3C)C5=CC=CC=C5N14,,,,,,
6336,156337,"2H-1-Benzopyran, 6-methoxy-2,2-dimethyl-7-(2,2,2-trifluoroethoxy)-",CC1(C=CC2=CC(=C(C=C2O1)OCC(F)(F)F)OC)C,,,,,,
6337,156338,"4H-1-Benzopyran-4-one, 8-(2,5-dihydro-5,5-dimethyl-2-oxo-3-furanyl)-7-methoxy-2-phenyl-",CC1(C=C(C(=O)O1)C2=C(C=CC3=C2OC(=CC3=O)C4=CC=CC=C4)OC)C,,,,,,
6338,156339,"6-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-4-methoxy-2-methyl-1H-pyrimidin-2-amine hydrochloride",CC1(NC(=CC(=N1)OC)Cl)NC2=NCCN2.Cl,,,,,,
6339,156340,"6-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-4-methoxy-2-methyl-1H-pyrimidin-2-amine",CC1(NC(=CC(=N1)OC)Cl)NC2=NCCN2,,,,,,
6340,156341,Pseudosemiglabrin,CC(=O)O[C@@H]1[C@H]2[C@H](OC3=C2C4=C(C=C3)C(=O)C=C(O4)C5=CC=CC=C5)OC1(C)C,,,,,,
6341,156342,Carbendazim/triadimefon,CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl.COC(=O)NC1=NC2=CC=CC=C2N1,,,,,,
6342,156343,CID 156343,CC1=C(C=CC(=C1)Cl)OCC(=O)[O-].CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O.[Na+],,,,,,
6343,156344,CID 156344,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC(C(=O)O)N)OC)SC2)C(=O)[O-].[Na+],,,,,,
6344,156345,"(6R,7S)-7-[[2-(2-amino-2-carboxyethyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC(C(=O)O)N)OC)SC2)C(=O)O,,,,,,
6345,156346,"Hypophosphoric acid, calcium salt",[O-]P([O-])[O-].[O-]P([O-])[O-].[Ca+2].[Ca+2].[Ca+2],,,,,,
6346,156347,"1H-Benzimidazole-5-methanol, 2-amino-alpha-phenyl-",C1=CC=C(C=C1)C(C2=CC3=C(C=C2)N=C(N3)N)O,,,,,,
6347,156348,CID 156348,CC1=CN=C(C=C1)C(=O)OC2=C3C4=C(C[C@H]5[C@H]6[C@]4(CCN5C)[C@@H](O3)[C@H](C=C6)O)C=C2,,,,,,
6348,156349,Silatiemonium iodide,C[N+]1(CCOCC1)CC[Si](C2=CC=CC=C2)(C3=CC=CS3)O.[I-],,,,,,
6349,156350,Hydroxy-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]-phenyl-thiophen-2-ylsilane,C[N+]1(CCOCC1)CC[Si](C2=CC=CC=C2)(C3=CC=CS3)O,,,,,,
6350,156351,3-Ethoxycarbonylmethylbenzothiazolium bromide,CCOC(=O)C[N+]1=CSC2=CC=CC=C21.[Br-],,,,,,
6351,156352,"Ethyl 2-(1,3-benzothiazol-3-ium-3-yl)acetate",CCOC(=O)C[N+]1=CSC2=CC=CC=C21,,,,,,
6352,156353,"2H-Benzopyran, 2,2-dimethyl-7-(1-methylethoxy)-",CC(C)OC1=CC2=C(C=C1)C=CC(O2)(C)C,,,,,,
6353,156354,"1,2-Dihydro-6-neopentyl-2-oxonicotinic acid",CC(C)(C)CC1=CC=C(C(=O)N1)C(=O)O,,,,,,
6354,156355,"L-Cysteine, S-(7-methyl-5-oxo-5H-1,3,4-thiadiazolo(3,2-a)pyrimidin-2-yl)-",CC1=CC(=O)N2C(=N1)SC(=N2)SC[C@@H](C(=O)O)N,,,,,,
6355,156356,2-(4-Dimethylvinylphenyl)propionic acid,CC(C1=CC=C(C=C1)C=C(C)C)C(=O)O,,,,,,
6356,156357,"Benzamide, 2,6-difluoro-N-(((4-propylphenyl)amino)carbonyl)-",CCCC1=CC=C(C=C1)NC(=O)NC(=O)C2=C(C=CC=C2F)F,,,,,,
6357,156358,"1H-Benzimidazole-1-propanoic acid, 2,3-dihydro-2-oxo-",C1=CC=C2C(=C1)NC(=O)N2CCC(=O)O,,,,,,
6358,156359,"Benzamide, 2-chloro-N-(((4-(trifluoromethyl)phenyl)amino)carbonyl)-",C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)C(F)(F)F)Cl,,,,,,
6359,156360,"4-Methylthio-1,2-dithiolane",CSC1CSSC1,,,,,,
6360,156361,CID 156361,CC=C(C)C(=O)O[C@@H]1C[C@@]2([C@H](C[C@@](O2)(C(=C[C@@H]3[C@@H]1C(=C)C(=O)O3)C)O)O)C,,,,,,
6361,156362,"1H-Pyrazino(1,2-a)quinoxalin-5(6H)-one, 2,3,4,4a-tetrahydro-",C1CN2C(CN1)C(=O)NC3=CC=CC=C32,,,,,,
6362,156363,Adimolol hydrochloride hydrate,CC(C)(CCN1C2=CC=CC=C2NC1=O)NCC(COC3=CC=CC4=CC=CC=C43)O.O.Cl,,,,,,
6363,156364,"Butanedioic acid, mono(2-((dichloroacetyl)amino)-3-hydroxy-1-(4-nitrophenyl)propyl) ester, (R-(R*,R*))-",C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)OC(=O)CCC(=O)O)[N+](=O)[O-],,,,,,
6364,156365,CID 156365,CCCCCC(C)(C)[C@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)C)O,,,,,,
6365,156366,"4-Thiazolidinone, 3-(2-fluorophenyl)-5-methyl-2-(3-pyridinyl)-",CC1C(=O)N(C(S1)C2=CN=CC=C2)C3=CC=CC=C3F,,,,,,
6366,156367,"4-Thiazolidinone, 3-(4-fluorophenyl)-5-methyl-2-(3-pyridinyl)-",CC1C(=O)N(C(S1)C2=CN=CC=C2)C3=CC=C(C=C3)F,,,,,,
6367,156368,"Phosphorodithioic acid, O,S-dimethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) ester",COP(=O)(SC)SCN1C(=O)C2=CC=CC=C2N=N1,,,,,,
6368,156369,Calcium;2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid,C1=CC=C(C=C1)N2C=C(C(=N2)C3=CC=C(C=C3)Cl)CC(=O)O.C1=CC=C(C=C1)N2C=C(C(=N2)C3=CC=C(C=C3)Cl)CC(=O)O.[Ca+2],,,,,,
6369,156370,"Phosphorothioic acid, O,O-diethyl O-2-quinoxalinyl ester, mixt. with S-(2-(ethylthio)ethyl) O,O-dimethyl phosphorodithioate",CCOP(=S)(OCC)OC1=NC2=CC=CC=C2N=C1.CCSCCSP(=S)(OC)OC,,,,,,
6370,156371,"21-Methyl-3,13-diaza-21-azoniapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one;chloride",C[N+]1=C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3.[Cl-],,,,,,
6371,156372,Dehydroevidiamine,C[N+]1=C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3,,,,,,
6372,156373,2-[(2-Oxo-3-piperidinyl)sulfamoyl]benzoic acid,C1CC(C(=O)NC1)NS(=O)(=O)C2=CC=CC=C2C(=O)O,,,,,,
6373,156374,"7,8-Dimethoxy-3,4-dihydroisoquinoline",COC1=C(C2=C(CCN=C2)C=C1)OC,,,,,,
6374,156375,Iofetamine (123I),CC(C)NC(C)CC1=CC=C(C=C1)[123I],,,"['Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)']",,,
6375,156376,Chloroethylnorapomorphine,C1CN([C@@H]2CC3=C(C4=CC=CC1=C24)C(=C(C=C3)O)O)CCCl,,,,,,
6376,156377,"4,8-Dimethyldecanal",CCC(C)CCCC(C)CCC=O,,,,,,
6377,156378,CID 156378,CC(=CC1=CC=C(C=C1)CC2=CN=CC=C2)C(=O)[O-].[Na+],,,,,,
6378,156379,"Cyclohexanecarbonitrile, 1-piperidino-, hydrobromide",C1CCC(CC1)(C#N)N2CCCCC2.Br,,,,,,
6379,156380,"4H-Pyran-4-one, 3-hydroxy-2-isobutyl-",CC(C)CC1=C(C(=O)C=CO1)O,,,,,,
6380,156381,"Benzene, chloro(dichlorofluoromethyl)-",C1=CC=C(C(=C1)C(F)(Cl)Cl)Cl,,,,,,
6381,156382,N-Hydroxycantharidinimide,CC12C3CCC(C1(C(=O)N(C2=O)O)C)O3,,,,,,
6382,156383,Calcium;magnesium;tetraacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Mg+2].[Ca+2],,,,,,
6383,156384,CID 156384,C1=CC(=CC=C1C2=CC(=C3C(=CC(=O)C(=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
6384,156385,Glucosylorientin,C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
6385,156386,4-Bromospiperone,C1CN(CCC12C(=O)NCN2C3=CC=C(C=C3)Br)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
6386,156387,Antibiotic WS5995A,CC1=CC2=C(C(=C1)OC)C3=C(C(=O)C4=C(C3=O)C=CC=C4O)OC2=O,,,,,,
6387,156388,"2-(1,4-Dihydro-5-hydroxy-1,4-dioxo-2-naphthalenyl)-3-methoxy-5-methylbenzoic acid",CC1=CC(=C(C(=C1)OC)C2=CC(=O)C3=C(C2=O)C=CC=C3O)C(=O)O,,,,,,
6388,156389,1-Methyl-1-azoniabicyclo[2.2.2]octan-3-ol,C[N+]12CCC(CC1)C(C2)O,,,,,,
6389,156390,Naproxen lysine,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
6390,156391,Naproxen,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,"['Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain. Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.']","['Naproxen is an established non-selective NSAID and is useful as an analgesic, anti-inflammatory and antipyretic. Similar to other NSAIDs, the pharmacological activity of naproxen can be attributed to the inhibition of cyclo-oxygenase, which in turn reduces prostaglandin synthesis in various tissues and fluids including the synovial fluid, gastric mucosa, and the blood.   Although naproxen is an effective analgesic, it can have unintended deleterious effects in the patient. For instance, naproxen can adversely affect blood pressure control. A study found that use of naproxen induced an increase in blood pressure, although the increase was not as significant as that found with ibuprofen use.  Further, studies have found that the risk of upper gastrointestinal bleeding is on average four-fold higher for individuals taking NSAIDs. Other factors that increase the risk of upper gastrointestinal bleeding include concurrent use of corticosteroids or anticoagulants, and a history of gastrointestinal ulcers.']","['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)', 'Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)']","['Naproxen is available as a free acid and sodium salt. At comparable doses, (naproxen 500 mg = naproxen sodium 550 mg) they differ slightly in their rates of absorption, but otherwise they are therapeutically and pharmacologically equivalent. Naproxen sodium achieves a peak plasma concentration after 1 hour, while peak plasma concentration is observed after 2 hours with naproxen (free acid). There are no differences between the 2 forms in the post-absorption phase pharmacokinetics. The difference in initial absorption should be considered when treating acute pain, since naproxen sodium may offer a quicker onset of action.  The mean Cmax for the various formulations (immediate release, enteric coated, controlled release etc.) of naproxen are comparable and range from 94 mcg/mL to 97.4 mcg/mL. In one pharmacokinetic study, the mean Tmax of naproxen 500 mg (immediate release) given every 12 hours over 5 days was 3 hours,  compared to a mean Tmax of 5 hours for Naprelan 1000 mg (controlled release) given every 24 hours over 5 days. In this same study, the AUC<sub>0-24hr</sub> was 1446mcgxhr/mL for naproxen immediate release and 1448 mcgxhr/mL for the controlled release formulation. A separate study comparing the pharmacokinetics of Naprosyn tablets and EC-Naprosyn observed the following values: Tmax and AUC<sub>0-12hrs</sub> of EC-Naprosyn were 4 hours and 845 mcgxhr/mL respectively, and Tmax and AUC<sub>0-12hrs</sub> values of Naprosyn were 1.9 hours and 767 mcgxhr/mL respectively.   When given in combination with sumatriptan the Cmax of naproxen is roughly 36% lower compared to naproxen sodium 550 mg tablets, and the median Tmax is 5 hours.  Based on the AUC and Cmax of naproxen, Vimovo (naproxen/esomeprazole combination product) and enteric-coated naproxen may be considered bioequivalent.  Overall, naproxen is rapidly and completely absorbed when administered orally and rectally. Food may contribute to a delay in the absorption of orally administered naproxen, but will not affect the extent of absorption.', ""After oral administration, about 95% of naproxen and it's metabolites can be recovered in the urine with 66-92% recovered as conjugated metabolite and less than 1% recovered as naproxen or desmethylnaproxen. Less than 5% of naproxen is excreted in the feces."", 'Naproxen has a volume of distribution of 0.16 L/kg.', 'Naproxen is cleared at a rate of 0.13 mL/min/kg.', 'Oral absorption of naproxen in dogs is rapid, with peak plasma concentration reached in 0.5-3 hr. The reported elimination half-life in dogs is 34-72 hr. Naproxen is highly protein bound (>99.0%). In dogs, naproxen is primarily eliminated through the bile, whereas in other species, the primary route of elimination is through the kidneys. The long half-life of naproxen in dogs appears to be due to its extensive enterohepatic recirculation.', 'After therapeutic doses, naproxen is more than 99% bound to plasma proteins. When naproxen binding sites become saturated (at twice daily doses of 500 mg or more), plasma free drug concentrations increase and may result in increased urinary clearance rates. Therefore, plasma naproxen concentrations tend to plateau when dosage exceeds 500 mg twice daily. In a study in patients with severe renal failure, binding of naproxen to serum proteins was decreased compared to healthy adults; the decreased binding may have accounted for an increase in metabolism and apparent volume of distribution of the drug observed in these patients. In patients with chronic alcoholic liver disease, total plasma concentrations of naproxen are decreased while concentrations of the unbound drug are increased.', 'The pharmacokinetics of naproxen, its metabolite 6-hydroxy-alpha-methyl-2-naphthaleneacetic acid (O-desmethylnaproxen), and their acyl glucuronides were studied in 10 subjects (ages 20-50 yr) who received an oral dose of 500 mg naproxen. Mean half-life of naproxen in 9 subjects was 24.7 hr. A half-life of 7.4 hr in the 10th subject was considered an extraordinary case. Naproxen acyl glucuronide accounted for 50.8% of the dose, its isomerized conjugate isoglucuronide for 6.5%, O-desmethylnaproxen acyl glucuronide for 14.3%, and its isoglucuronide for 5.5%. Excretion of naproxen and O-desmethylnaproxen was negligible. Plasma protein binding was 98% for naproxen, 100% for O-desmethylnaproxen, 92% for naproxen acyl glucuronide, 66% for naproxen isoglucuronide, 72% for O-desmethylnaproxen acyl glucuronide, and 42% for O-desmethylnaproxen isoglucuronide. It was concluded that naproxen is O-desmethylated and parent drug and metabolite are conjugated into acyl glucuronides.', 'The effects of rheumatoid arthritis disease activity on the pharmacokinetics of the highly albumin-bound nonsteroidal anti-inflammatory drug naproxen were studied in six patients during chronic therapy. In the same patients, kinetics during active disease were compared with those in improvement. Active disease is commonly associated with hypoalbuminemia: 30 +/- 4 gm/L vs. 41 +/- 2 gm/L (mean +/- SD) at the time of improvement. Total naproxen concentrations were significantly lower in active disease, together with a larger apparent volume of distribution (10.6 +/- 1.8 L vs. 8.4 +/- 1.3 L; P less than 0.05) and total body clearance (0.79 +/- 1.8 L/hr vs. 0.59 +/- 0.14 L/hr; P less than 0.001). Peak unbound naproxen concentrations were 29% +/- 19% (P less than 0.05) lower at the time of improvement. The unbound clearance was found diminished during active disease (390 +/- 277 L/hr) in comparison with improvement (488 +/- 343 L/hr; P less than 0.05). Clinical implications of the alterations in naproxen kinetics induced by polyarticular inflammation in patients with rheumatoid arthritis are discussed.', 'For more Absorption, Distribution and Excretion (Complete) data for NAPROXEN (15 total), please visit the HSDB record page.']","['Naproxen is heavily metabolized in the liver and undergoes both Phase I and Phase II metabolism. The first step involves demethylation of naproxen via CYP 1A2, 2C8, and 2C9. Both naproxen and desmethylnaproxen proceed to Phase II metabolism; however, desmethylnaproxen can form both acyl and phenolic glucoronide products, while naproxen only produces the acyl glucuronide. The acyl glucuronidation process involves UGT 1A1, 1A3, 1A6, 1A7, 1A9, 1A10 and 2B7, while phenolic glucuronidation is catalyzed by UGT 1A1, 1A7,1A9, and 1A10. Desmethylnaproxen also undergoes sulphation which is mediated by SULT 1A1, 1B1 and 1E1.', 'Naproxen is extensively metabolized in the liver to 6-desmethylnaproxen. Approximately 95% of the drug is excreted in urine as unchanged naproxen (less than 1%) and 6-desmethylnaproxen (less than 1%) and their glucuronide or other conjugates (66-92%). Some data suggest that renal excretion of unchanged naproxen may be negligible or absent; previously reported concentrations of unchanged drug may reflect rapid hydrolysis of conjugates during collection, storage, and handling of urine samples. The half-life of naproxen metabolites and conjugates is shorter than 12 hours.  Naproxen metabolites may accumulate in patients with renal impairment. Elimination of naproxen is reduced in patients with severe renal impairment. A small amount (less than 5%) of the drug is excreted in feces.', 'The pharmacokinetics of naproxen, its metabolite 6-hydroxy-alpha-methyl-2-naphthaleneacetic acid (O-desmethylnaproxen), and their acyl glucuronides were studied in 10 subjects (ages 20-50 yr) who received an oral dose of 500 mg naproxen. Mean half-life of naproxen in 9 subjects was 24.7 h. A half-life of 7.4 h in the 10th subject was considered an extraordinary case. Naproxen acyl glucuronide accounted for 50.8% of the dose, its isomerized conjugate isoglucuronide for 6.5%, O-desmethylnaproxen acyl glucuronide for 14.3%, and its isoglucuronide for 5.5%. Excretion of naproxen and O-desmethylnaproxen was negligible. Plasma protein binding was 98% for naproxen, 100% for O-desmethylnaproxen, 92% for naproxen acyl glucuronide, 66% for naproxen isoglucuronide, 72% for O-desmethylnaproxen acyl glucuronide, and 42% for O-desmethylnaproxen isoglucuronide. It was concluded that naproxen is O-desmethylated and parent drug and metabolite are conjugated into acyl glucuronides.', 'Naproxen has known human metabolites that include (2S,3S,4S,5R)-3,4,5-Trihydroxy-6-[(2S)-2-(6-methoxynaphthalen-2-yl)propanoyl]oxyoxane-2-carboxylic acid and O-Desmethylnaproxen.']","['The elimination half-life of naproxen is reported to be 12-17 hours.', 'The reported elimination half-life in dogs is 34-72 hr.', 'In healthy adults, the plasma half-life of naproxen reportedly ranges from 10-20 hr. The manufacturer state that the plasma half-life of naproxen is about 13 hr. The plasma half-life and elimination of the drug appear to be similar in children and adults.', 'The pharmacokinetics of naproxen, its metabolite 6-hydroxy-alpha-methyl-2-naphthaleneacetic acid (O-desmethylnaproxen), and their acyl glucuronides were studied in 10 subjects (ages 20-50 yr) who received an oral dose of 500 mg naproxen. Mean half-life of naproxen in 9 subjects was 24.7 hr. A half-life of 7.4 hr in the 10th subject was considered an extraordinary case. ...']"
6391,156392,CID 156392,C(=CC(=O)C(=O)O)C(=C(O)O)Cl,,,,,,
6392,156393,"1,1,3-Trimethyl-5-phenylbiuret",CC1=CC=CC=C1N(C(=O)N)C(=O)N(C)C,,,,,,
6393,156394,Ketanserinol,C1CN(CCC1C(C2=CC=C(C=C2)F)O)CCN3C(=O)C4=CC=CC=C4NC3=O,,,,,,
6394,156395,(R)-(+)-Cathinone hydrochloride,C[C@H](C(=O)C1=CC=CC=C1)N.Cl,,,,,,
6395,156396,"3,8,15-Trihydroxy-12,13-epoxytrichothec-9-en-4-yl acetate",CC1=C[C@@H]2[C@](C[C@@H]1O)([C@]3([C@@H]([C@H]([C@H](C34CO4)O2)O)OC(=O)C)C)CO,,,,,,
6396,156397,Edta calcium sodium,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Ca+2].[Ca+2].[Ca+2].[Ca+2],,,,,,
6397,156398,"3,4-Dihydro-3-(4-methoxyphenyl)-2H-1-benzopyran-6,7-diol",COC1=CC=C(C=C1)C2CC3=CC(=C(C=C3OC2)O)O,,,,,,
6398,156399,"1H-Pyrazol-5-ol, 3-methyl-1-phenyl-, hydrogen sulfate (ester)",CC1=NN(C(=C1)OS(=O)(=O)O)C2=CC=CC=C2,,,,,,
6399,156400,"Butanoic acid, 3-oxo-, 2-hydroxy-1,3-propanediyl ester",CC(=O)CC(=O)OCC(COC(=O)CC(=O)C)O,,,,,,
6400,156401,"2-(2-Naphthyl)-1,2-propanediol",CC(CO)(C1=CC2=CC=CC=C2C=C1)O,,,,,,
6401,156402,2-(2-Naphthyl)-2-hydroxypropanoic acid,CC(C1=CC2=CC=CC=C2C=C1)(C(=O)O)O,,,,,,
6402,156403,"Benzeneethanethioamide, 4-methoxy-N,N-dimethyl-",CN(C)C(=S)CC1=CC=C(C=C1)OC,,,,,,
6403,156404,"Butanoic acid, 4-oxo-4-((4-((2-pyrimidinylamino)sulfonyl)phenyl)amino)-, disilver(1+) salt",C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)CCC(=O)[O-].C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)CCC(=O)[O-].[Ag+].[Ag+],,,,,,
6404,156405,4-Oxo-4-{4-[(pyrimidin-2-yl)sulfamoyl]anilino}butanoic acid,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)CCC(=O)O,,,,,,
6405,156406,Florfenicol amine,CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CF)N)O,,,,,,
6406,156407,"Cyclobutanecarboxylic acid, 1-(4-ethoxyphenyl)-2,2,3,3-tetrafluoro-, 1-(3-phenoxyphenyl)-2-propynyl ester",CCOC1=CC=C(C=C1)C2(CC(C2(F)F)(F)F)C(=O)OC(C#C)C3=CC(=CC=C3)OC4=CC=CC=C4,,,,,,
6407,156408,Ndeae-mxd,CCN(CC)CCN(C1=C(C=CC=C1C)C)C(=O)C(C2=CC=CC=C2)O,,,,,,
6408,156409,"9,10-Ethanoanthracene-9(10H)-ethanol, alpha-((methylamino)methyl)-, hydrochloride, (S)-",CNC[C@H](CC12CCC(C3=CC=CC=C31)C4=CC=CC=C24)O.Cl,,,,,,
6409,156410,(+)-Oxaprotiline,CNC[C@H](CC12CCC(C3=CC=CC=C31)C4=CC=CC=C24)O,,,,,,
6410,156411,Paramax,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl.CC(=O)NC1=CC=C(C=C1)O.Cl,,,,,,
6411,156412,CID 156412,CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)C(=C(N)O)C1=O)O)O)O)Cl)O.C1=CC(=C(C=C1S(=O)(=O)O)C(=O)O)O,,,,,,
6412,156413,Canertinib dihydrochloride,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl.Cl,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)', 'Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)']",,,
6413,156414,Canertinib,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,['Investigated for use/treatment in breast cancer and lung cancer.'],,,,,
6414,156415,CID 156415,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)[C@@H]4CCCO4)C(=O)[O-].[Na+],,,,,,
6415,156416,CID 156416,CON=C(C1=CSC(=N1)N)C(=O)NC2[C@@H]3N(C2=O)C(=C(CS3)[C@@H]4CCCO4)C(=O)O,,,,,,
6416,156417,Abbott-195773,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OCC=CC4=CC5=CC=CC=C5N=C4)C)C)NC(=O)O2)C,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
6417,156418,Cinacalcet hydrochloride,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,['* Secondary hyperparathyroidism :'],,"['Small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR) in the PARATHYROID GLANDS and other tissues. They lower the threshold for CaSR activation by extracellular calcium ions and diminish PARATHYROID HORMONE (PTH) release from parathyroid cells. (See all compounds classified as Calcimimetic Agents.)', 'Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)']",,,
6418,156419,Cinacalcet,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,['For the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma.'],"['Cinacalcet is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues). Secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) is a progressive disease, associated with increases in parathyroid hormone (PTH) levels and derangements in calcium and phosphorus metabolism. Increased PTH stimulates osteoclastic activity resulting in cortical bone resorption and marrow fibrosis. The goals of treatment of secondary hyperparathyroidism are to lower levels of PTH, calcium, and phosphorus in the blood, in order to prevent progressive bone disease and the systemic consequences of disordered mineral metabolism. In CKD patients on dialysis with uncontrolled secondary HPT, reductions in PTH are associated with a favorable impact on bone-specific alkaline phosphatase (BALP), bone turnover and bone fibrosis. Cinacalcet reduces calcium levels by increasing the sensitivity of the calcium sensing receptor to extracellular calcium.']","['Small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR) in the PARATHYROID GLANDS and other tissues. They lower the threshold for CaSR activation by extracellular calcium ions and diminish PARATHYROID HORMONE (PTH) release from parathyroid cells. (See all compounds classified as Calcimimetic Agents.)', 'Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)']","['Rapidly absorbed following oral administration.', 'Cinacalcet is metabolized by multiple enzymes, primarily CYP3A4, CYP2D6 and CYP1A2. Renal excretion of metabolites was the primary route of elimination of radioactivity.', '1000 L', 'The metabolism and disposition of calcimimetic agent cinacalcet HCl was examined after a single oral administration to mice, rats, monkeys, and human volunteers. In all species examined, cinacalcet was well absorbed, with greater than 74% oral bioavailability of cinacalcet-derived radioactivity in monkeys and humans. In rats, cinacalcet-derived radioactivity was widely distributed into most tissues, with no marked gender-related differences. In all animal models examined, radioactivity was excreted rapidly via both hepatobiliary and urinary routes. In humans, radioactivity was cleared primarily via the urinary route (80%), with 17% excreted in the feces. Cinacalcet was not detected in the urine in humans. ...', 'After absorption, cinacalcet concentrations decline in a biphasic fashion with a terminal half life of 30 to 40 hours. Renal excretion of metabolites was the primary route of elimination of radioactivity. Approximately 80% of the dose was recovered in the urine and 15% in the feces.', 'Steady-state drug levels are achieved within 7 days. The mean accumulation ratio is approximately 2 with once-daily oral administration. The median accumulation ratio is approximately 2 to 5 with twice-daily oral administration. The AUC and Cmax of cinacalcet increase proportionally over the dose range of 30 to 180 mg once daily. The pharmacokinetic profile of cinacalcet does not change over time with once-daily dosing of 30 to 180 mg. The volume of distribution is high (approximately 1000 L), indicating extensive distribution. Cinacalcet is approximately 93% to 97% bound to plasma proteins. The ratio of blood cinacalcet concentration to plasma cinacalcet concentration is 0.8 at a blood cinacalcet concentration of 10 ng/mL.', 'After oral administration of cinacalcet, Cmax is achieved in approximately 2 to 6 hours. A food-effect study in healthy volunteers indicated that the Cmax and AUC were increased 82% and 68%, respectively, when cinacalcet was administered with a high-fat meal compared with fasting, Cmax and AUC of cinacalcet were increased 65% and 50%, respectively, when cinacalcet was administered with a low-fat meal compared with fasting.', 'For more Absorption, Distribution and Excretion (Complete) data for CINACALCET (6 total), please visit the HSDB record page.']","['Metabolism is hepatic by multiple enzymes, primarily CYP3A4, CYP2D6, and CYP1A2. After administration of a 75 mg radiolabeled dose to healthy volunteers, cinacalcet was rapidly and extensively metabolized via: 1) oxidative N-dealkylation to hydrocinnamic acid and hydroxy-hydrocinnamic acid, which are further metabolized via &szlig;-oxidation and glycine conjugation; the oxidative N-dealkylation process also generates metabolites that contain the naphthalene ring; and 2) oxidation of the naphthalene ring on the parent drug to form dihydrodiols, which are further conjugated with glucuronic acid.', 'The metabolism and disposition of calcimimetic agent cinacalcet HCl was examined after a single oral administration to mice, rats, monkeys, and human volunteers. ... The primary routes of metabolism of cinacalcet were N-dealkylation leading to carboxylic acid derivatives (excreted in urine as glycine conjugates) and oxidation of naphthalene ring to form dihydrodiols (excreted in urine and bile as glucuronide conjugates). The plasma radioactivity in both animals and humans was primarily composed of carboxylic acid metabolites and dihydrodiol glucuronides, with <1% circulating radioactivity accounting for the unchanged cinacalcet. Overall, the circulating and excreted metabolite profile of cinacalcet in humans was qualitatively similar to that observed in preclinical animal models.', 'Cinacalcet is metabolized by multiple cytochrome P-450 (CYP) isoenzymes, mainly CYP3A4, CYP2D6, and CYP1A2, and is a potent inhibitor of CYP2D6 in vitro.', 'Rapidly and extensively metabolized hepatically by multiple enzymes, primarily CYP3A4, CYP2D6, and CYP1A2 via oxidative N-dealkylation to hydrocinnamic acid and hydroxy-hydrocinnamic acid which are further metabolized via beta-oxidation and glycine conjugations; the oxidative N-dealkylation process also generates metabolites that contains the naphthalene ring; and oxidation of the naphthalene ring on the parent drug to form dihydrodiols which are further conjugated with glucuronic aicd. The hydrocinnamic acid metabolite was shown to be inactive at concentrations up to 10 uM in a cell-based assay measuring calcium-receptor activation. The glucuronide conjugates formed after oxidation were shown to have a potency approximately 0.003 times that of cinacalcet in a cell-based assay measuring a calcimimetic response.']","['Terminal half-life is 30 to 40 hours. The mean half-life of cinacalcet is prolonged by 33% and 70% in patients with moderate and severe hepatic impairment, respectively.', 'The mean half life of cinacalcet is prolonged by 33% and 70% in patients with moderate and severe hepatic impairment, respectively.', 'terminal half-life: 30 to 40 hours']"
6419,156420,Delucemine hydrochloride,CNCCC(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F.Cl,,,,,,
6420,156421,Delucemine,CNCCC(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F,,,,,,
6421,156422,Doramapimod,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,,,,,,
6422,156423,Lormetazepam glucuronide,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=CC=CC=C4Cl,,,,,,
6423,156424,"Dipotassium O,O'-(4,4'-diaminobiphenyl-3,3'-ylene)diglycollate",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)OCC(=O)[O-])OCC(=O)[O-])N.[K+].[K+],,,,,,
6424,156425,"Methyldioxy, dichloro-",C(O[O])(Cl)Cl,,,,,,
6425,156426,"Methyldioxy, chloro-",C(O[O])Cl,,,,,,
6426,156427,"4H-1-Benzopyran-4-one, 2-(4-((4-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)phenyl)-2,3-dihydro-5,7-dimethoxy-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC3=CC=C(C=C3)C4CC(=O)C5=C(O4)C=C(C=C5OC)OC)CO)O)O)O,,,,,,
6427,156428,"[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-phenylprop-2-enoyloxy)oxan-2-yl]methyl 4-hydroxy-2-methylidenebutanoate",C=C(CCO)C(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)C=CC2=CC=CC=C2)O)O)O,,,,,,
6428,156429,"2-Butanone, 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-, (1R)-",CC(C)(C)C(=O)[C@H](N1C=NC=N1)OC2=CC=C(C=C2)Cl,,,,,,
6429,156430,CID 156430,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O)O,,,,,,
6430,156431,Celerin,CC(C)(C=C)C1=CC(=C(C2=C1C=CC(=O)O2)O)OC,,,,,,
6431,156432,CID 156432,CC(=O)C1=C2C(=C3C=CC=CC3=N2)C=C(N1)C(=O)O,,,,,,
6432,156433,"Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (9S)-, (2R,3R)-2,3-dihydroxybutanedioate (salt)",COC1=CC2=C(C=CN=C2C=C1)[C@@H](C3CC4CCN3CC4C=C)O.[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O,,,,,,
6433,156434,"2H-(1)Benzopyrano(3,4-c)pyridine-2,4(3H)-dione, 1,5-dihydro-5-imino-",C1C2=C(C(=N)OC3=CC=CC=C23)C(=O)NC1=O,,,,,,
6434,156435,"3(2H)-Pyridazinone, 6-chloro-2-(3-methoxyphenyl)-4-(4-morpholinyl)-",COC1=CC=CC(=C1)N2C(=O)C(=CC(=N2)Cl)N3CCOCC3,,,,,,
6435,156436,CID 156436,CCC(CC)(C(=O)N=C(N)S)C(=O)OC,,,,,,
6436,156437,"4H-Furo(2,3-h)-1-benzopyran-4-one, 2-(2-methoxyphenyl)-",COC1=CC=CC=C1C2=CC(=O)C3=C(O2)C4=C(C=C3)OC=C4,,,,,,
6437,156438,"Ethanamine, 2-(1H-benzotriazol-1-yloxy)-N,N-dimethyl-",CN(C)CCON1C2=CC=CC=C2N=N1,,,,,,
6438,156439,"1-Propanamine, 3-(1H-benzotriazol-1-yloxy)-N,N-dimethyl-",CN(C)CCCON1C2=CC=CC=C2N=N1,,,,,,
6439,156440,"1H-Benzotriazole-1-ethanamine, N,N-dimethyl-, 3-oxide",CN(C)CCN1C2=CC=CC=C2[N+](=N1)[O-],,,,,,
6440,156441,"1H-Benzotriazole-1-propanamine, N,N-dimethyl-, 3-oxide",CN(C)CCCN1C2=CC=CC=C2[N+](=N1)[O-],,,,,,
6441,156442,"Olean-12-ene-3,16-diol, 28,29-epoxy-29-methoxy-, (3beta,16alpha,20beta)-",C[C@]12CC[C@@]3(COC1OC)[C@H](C2)C4=CC[C@@H]5[C@]6(CC[C@@H](C(C6CC[C@]5([C@@]4(C[C@H]3O)C)C)(C)C)O)C,,,,,,
6442,156443,"Glycine, L-gamma-glutamyl-S-(4-nitrophenyl)-L-cysteinyl-",C1=CC(=CC=C1[N+](=O)[O-])SC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N,,,,,,
6443,156444,"Benzamide, 2,6-difluoro-N-(((4-(3-phenylpropoxy)phenyl)amino)carbonyl)-",C1=CC=C(C=C1)CCCOC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
6444,156445,"Pyrazinecarboxylic acid, 3-(ethylthio)-, hydrazide",CCSC1=NC=CN=C1C(=O)NN,,,,,,
6445,156446,"Cyclopropanecarboxamide, N-(5-(1,1-dimethylethyl)-3-isoxazolyl)-",CC(C)(C)C1=CC(=NO1)NC(=O)C2CC2,,,,,,
6446,156447,"1H-Cycloprop(e)azulene, decahydro-3,3,7b-trimethyl-5-methylene-, (1aS,4aS,7aR,7bR)-",C[C@@]12C[C@@H]1CC(C[C@H]3[C@H]2CCC3=C)(C)C,,,,,,
6447,156448,"Isoquinoline, 1,2,3,4-tetrahydro-5,6,7,8-tetramethoxy-2-methyl-",CN1CCC2=C(C1)C(=C(C(=C2OC)OC)OC)OC,,,,,,
6448,156449,"Ethanol, 1,2-dichloro-",C(C(O)Cl)Cl,,,,,,
6449,156450,"(1R,3S)-rel-(3-Phenoxyphenyl)methyl 3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylate",CC1([C@H]([C@@H]1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6450,156451,CID 156451,CC1([C@@H]([C@@H]1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6451,156452,"2H-Indol-2-one, 3-(2-(4-chlorophenyl)-2-hydroxyethyl)-1,3-dihydro-1,3-dimethyl-",CC1(C2=CC=CC=C2N(C1=O)C)CC(C3=CC=C(C=C3)Cl)O,,,,,,
6452,156453,"2H-Indol-2-one, 1,3-dihydro-3-(2-hydroxy-2-(4-methoxyphenyl)ethyl)-1,3-dimethyl-",CC1(C2=CC=CC=C2N(C1=O)C)CC(C3=CC=C(C=C3)OC)O,,,,,,
6453,156454,"Cyano(3-phenoxyphenyl)methyl 3-[[(cyclopropylmethoxy)imino]methyl]-2,2-dimethylcyclopropanecarboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=NOCC4CC4)C,,,,,,
6454,156455,"Phosphoramidic acid, (1-methylethyl)-, dimethyl ester",CC(C)NP(=O)(OC)OC,,,,,,
6455,156456,"[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(4H-imidazol-4-yl)propanoyl] (2S,3R)-3-hydroxy-2-[[(2S)-pyrrolidine-2-carbonyl]amino]butanoate",C[C@H]([C@@H](C(=O)OC(=O)[C@H](CC1C=NC=N1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)NC(=O)[C@@H]3CCCN3)O,,,,,,
6456,156457,"Hexanoic acid, 2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide",CCCCC(C(=O)NC1=CC=CC=C1)C(=O)N(C2=CC=CC=C2)NC3=CC=CC=C3,,,,,,
6457,156458,"3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-4-(1-piperidinylmethyl)-",CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)CN4CCCCC4,,,,,,
6458,156459,"1H-Pyrrolizin-1-ol, hexahydro-7-methylene-, (1R-trans)-",C=C1CCN2[C@H]1[C@@H](CC2)O,,,,,,
6459,156460,"6H-Dibenzo(b,d)pyran-1,9,10-triol, 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-",CCCCCC1=CC(=C2C(=C1)OC(C3=C2[C@@H]([C@@](CC3)(C)O)O)(C)C)O,,,,,,
6460,156461,"(1R,2S,6S,9S,10S,11S,14S,15S,17S,18S,20R,23R,24S)-6,10,23-Trimethyl-4-azahexacyclo[12.11.0.02,11.04,9.015,24.018,23]pentacosane-10,17,20-triol",C[C@H]1CC[C@H]2[C@@]([C@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@H](C6)O)C)O)(C)O,,,,,,
6461,156462,"Chrysene, 1,2,3,4,4a,11,12,12a-octahydro-3,4,7,12a-tetramethyl-",CC1CCC2(CCC3=C(C2C1C)C=CC4=C(C=CC=C34)C)C,,,,,,
6462,156463,"Pregn-4-ene-3,20-dione, 21-(4-(diethylamino)-1,4-dioxobutoxy)-11,17-dihydroxy-, (11beta)-",CCN(CC)C(=O)CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
6463,156464,"1H-Pyrazole-1-carboximidamide, N-(aminoiminomethyl)-4,5-dihydro-3,5,5-trimethyl-",CC1=NN(C(C1)(C)C)C(=N)N=C(N)N,,,,,,
6464,156465,"Anthra(2,3-b)furan-5,10-dione, 2,3-dihydro-4,6,8-trihydroxy-3-(2-hydroxyethyl)-",C1C(C2=C(O1)C=C3C(=C2O)C(=O)C4=C(C3=O)C=C(C=C4O)O)CCO,,,,,,
6465,156466,"1,3-Benzoxathiole, 5-(1-(2-(2-ethoxyethoxy)ethoxy)ethoxy)-",CCOCCOCCOC(C)OC1=CC2=C(C=C1)OCS2,,,,,,
6466,156467,"L-Asparagine, N,N-bis(phenylmethyl)-",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)[C@@H](CC(=O)N)C(=O)O,,,,,,
6467,156468,N-[1-[4-(2-methylpropyl)phenyl]ethylidene]hydroxylamine,CC(C)CC1=CC=C(C=C1)C(=NO)C,,,,,,
6468,156469,1-(4-Isobutylphenyl)ethanamine,CC(C)CC1=CC=C(C=C1)C(C)N,,,,,,
6469,156470,"Phosphoric acid, 2,6-bis(1-methylethyl)phenyl diphenyl ester",CC(C)C1=C(C(=CC=C1)C(C)C)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
6470,156471,"Nitric acid, iron salt, hydrate",[N+](=O)(O)[O-].O.[Fe+3],,,,,,
6471,156472,"2,5-Piperazinedione, 3-(hydroxymethyl)-6-((4-((3-methyl-2-butenyl)oxy)phenyl)methyl)-, (3S,6S)-",CC(=CCOC1=CC=C(C=C1)C[C@H]2C(=O)N[C@H](C(=O)N2)CO)C,,,,,,
6472,156473,"1-Piperazineethanol, 4-(7-chloro-4-quinolinyl)-alpha-((4-(7-chloro-4-quinolinyl)-1-piperazinyl)methyl)-",C1CN(CCN1CC(CN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)O)C5=C6C=CC(=CC6=NC=C5)Cl,,,,,,
6473,156474,"Benzenebutanoic acid, 3-chloro-4-(1-methylethoxy)-gamma-oxo-",CC(C)OC1=C(C=C(C=C1)C(=O)CCC(=O)O)Cl,,,,,,
6474,156475,CID 156475,CC1C(=CC(=O)O)CCC2=C1C=CC(=C2)C3CCCCC3,,,,,,
6475,156476,CID 156476,CC1(C(=CC(=O)O)CCC2=C1C=CC(=C2)C3CCCCC3)C,,,,,,
6476,156477,"(1-Hydroxy-2,4,4-trimethylpentan-3-yl) 2-methylpropanoate",CC(C)C(=O)OC(C(C)CO)C(C)(C)C,,,,,,
6477,156478,"1,4-Naphthalenedione, 3-(3,4-dihydro-9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-1H-naphtho(2,3-c)pyran-8-yl)-5-hydroxy-2-methoxy-",CC1CC2=C(C(=C3C(=C2)C=C(C(=C3O)C4=C(C(=O)C5=C(C4=O)C(=CC=C5)O)OC)OC)O)C(=O)O1,,,,,,
6478,156479,Xanthoviridicatin G,CC1CC2=C(C(=C3C(=C2)C=C(C4=C3OC5=C4C(=O)C6=C(C5=O)C=CC=C6O)OC)O)C(=O)O1,,,,,,
6479,156480,"Propanethioic acid, 3-amino-3-imino-",C(C(=N)N)C(=O)S,,,,,,
6480,156481,CID 156481,[Li+].C1=CC2=C3C(=C1)C=CC4=CC=CC(=C43)C=C2,,,,,,
6481,156482,"1-Butanol, 2-ethyl-, nitrate",CCC(CC)CO[N+](=O)[O-],,,,,,
6482,156483,"1,4-Naphthalenedione, 2-(chloromethyl)-3-ethyl-",CCC1=C(C(=O)C2=CC=CC=C2C1=O)CCl,,,,,,
6483,156484,"7,8-Dichloro-2-dibenzofuranol",C1=CC2=C(C=C1O)C3=CC(=C(C=C3O2)Cl)Cl,,,,,,
6484,156485,"Urea, 9H-xanthen-9-yl-",C1=CC=C2C(=C1)C(C3=CC=CC=C3O2)NC(=O)N,,,,,,
6485,156486,"Benzamide, 3-((diethylamino)methyl)-N-(2,6-dimethylphenyl)-",CCN(CC)CC1=CC(=CC=C1)C(=O)NC2=C(C=CC=C2C)C,,,,,,
6486,156487,"2,2',3,3',6,6'-Hexachloro-4-biphenylol",C1=CC(=C(C(=C1Cl)C2=C(C=C(C(=C2Cl)Cl)O)Cl)Cl)Cl,,,,,,
6487,156488,"Pyridinium, 3-(methoxycarbonyl)-1-methyl-2-(methylthio)-, iodide",C[N+]1=CC=CC(=C1SC)C(=O)OC.[I-],,,,,,
6488,156489,3-(Methoxycarbonyl)-1-methyl-2-(methylsulfanyl)pyridinium,C[N+]1=CC=CC(=C1SC)C(=O)OC,,,,,,
6489,156490,"3-Pyridinecarboxylic acid, 1,2-dihydro-1-methyl-2-thioxo-",CN1C=CC=C(C1=S)C(=O)O,,,,,,
6490,156491,"Pyridinium, 3-carboxy-1-methyl-2-(methylthio)-, iodide",C[N+]1=CC=CC(=C1SC)C(=O)O.[I-],,,,,,
6491,156492,3-Carboxy-1-methyl-2-(methylsulfanyl)pyridinium,C[N+]1=CC=CC(=C1SC)C(=O)O,,,,,,
6492,156493,"Pyrrolo(2,1-d)(1,5)benzothiazepine, 2-chloro-6-(4-nitrophenyl)-,5,5-dioxide",C1=CN2C(=C1)C=C(S(=O)(=O)C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
6493,156494,"Pyrrolo(2,1-d)(1,5)benzothiazepine, 2-chloro-6-(3-pyridinyl)-, 5,5-dioxide",C1=CC(=CN=C1)C2=CC3=CC=CN3C4=C(S2(=O)=O)C=CC(=C4)Cl,,,,,,
6494,156495,"8-(3,4-Dihydroxy-3-methylbut-1-enyl)-7-methoxychromen-2-one",CC(CO)(C=CC1=C(C=CC2=C1OC(=O)C=C2)OC)O,,,,,,
6495,156496,"Butanoic acid, 4-(((3alpha,5alpha)-cholestan-3-yl)amino)mercapto-4-oxo-",C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(CC[C@H](C4)NSC(=O)CCC(=O)O)C)C,,,,,,
6496,156497,"Lup-12-en-3-ol, (3beta,18beta,19beta)-",CC(C)[C@H]1CC[C@]2([C@@H]1C3=CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C,,,,,,
6497,156498,"1H-Benzotriazole, 6-chloro-1-(4-methylbenzoyl)-",CC1=CC=C(C=C1)C(=O)N2C3=C(C=CC(=C3)Cl)N=N2,,,,,,
6498,156499,"Urea, (4,6-dimethyl-2-pyrimidinyl)-",CC1=CC(=NC(=N1)NC(=O)N)C,,,,,,
6499,156500,"Urea, (4-ethyl-6-methyl-2-pyrimidinyl)-",CCC1=NC(=NC(=C1)C)NC(=O)N,,,,,,
6500,156501,"4H-1-Benzopyran-4-one, 3,5-bis((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-, (2R-trans)-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC3=C(C2=O)C(=CC(=C3)O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)C5=CC(=C(C=C5)O)O)O)O)O,,,,,,
6501,156502,"Stigmast-5-ene-3-thiol, (3beta)-",CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)S)C)C)C(C)C,,,,,,
6502,156503,CID 156503,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)C4=CNC5=C(C4=O)N=CC=C5)C(=O)[O-])C.[Na+],,,,,,
6503,156504,CID 156504,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)C4=CNC5=C(C4=O)N=CC=C5)C(=O)O)C,,,,,,
6504,156505,"Acetic acid, ((4-(3-methoxyphenyl)-2-thiazolyl)amino)oxo-, ethyl ester",CCOC(=O)C(=O)NC1=NC(=CS1)C2=CC(=CC=C2)OC,,,,,,
6505,156506,CID 156506,CC(C)(C1CC2=C(O1)C=C3C(=CC=C(O3)O)C2=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
6506,156507,"Z-(1R,S)-cis-2,2-dimethyl-3-(2,2-chloro-3,3,3-trifluoro-1-propenyl)cyclopropanecarboxylic acid",CC1(C(C1C(=O)O)C=C(C(F)(F)F)Cl)C,,,,,,
6507,156508,CID 156508,[Li+].C(C(F)(F)F)N(CC(F)(F)F)C(=S)[S-],,,,,,
6508,156509,Tyrindoxyl sulfate,CSC1=C(C2=C(N1)C=C(C=C2)Br)OS(=O)(=O)O,,,,,,
6509,156510,deoxyuvidin B,CC1=CC(=O)[C@@H]2[C@@]([C@H]1CO)(CC[C@@H](C2(C)C)O)C,,,,,,
6510,156511,"7,8-Dihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1,2-dione",CC1=CC2=C(C(=C1O)O)C(=O)C(=O)C=C2C(C)C,,,,,,
6511,156512,"Cyclopentanemethanaminium, 2-hydroxy-N,N,N,3-tetramethyl-, iodide, (1alpha,2beta,3alpha)-",C[C@@H]1CC[C@@H]([C@H]1O)C[N+](C)(C)C.[I-],,,,,,
6512,156513,CID 156513,CC1CCC([C@H]1O)C[N+](C)(C)C,,,,,,
6513,156514,"4-(3,7,11-Trimethyldodeca-1,6,10-trien-3-yl)benzene-1,2-diol",CC(=CCCC(=CCCC(C)(C=C)C1=CC(=C(C=C1)O)O)C)C,,,,,,
6514,156515,6beta-Acetoxyisodrimenin,CC(=O)O[C@@H]1CC2=C(C(=O)OC2)[C@@]3([C@@H]1C(CCC3)(C)C)C,,,,,,
6515,156516,"Phenol, 4-((2R,3R,4S,5S)-5-(3,4-dimethoxyphenyl)tetrahydro-3,4-dimethyl-2-furanyl)-2-methoxy-, rel-(+)-",C[C@@H]1[C@@H]([C@H](O[C@H]1C2=CC(=C(C=C2)O)OC)C3=CC(=C(C=C3)OC)OC)C,,,,,,
6516,156517,nectandrin-B,C[C@@H]1[C@@H]([C@H](O[C@H]1C2=CC(=C(C=C2)O)OC)C3=CC(=C(C=C3)O)OC)C,,,,,,
6517,156518,"Benzene, 1-((5-chloro-4-pentynyl)oxy)-4-phenoxy-",C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCCC#CCl,,,,,,
6518,156519,5-Phenyl-2-(4-pyridyl)oxazole,C1=CC=C(C=C1)C2=CN=C(O2)C3=CC=NC=C3,,,,,,
6519,156520,"Phenol, 4-(1-ethyl-1H-imidazol-5-yl)-",CCN1C=NC=C1C2=CC=C(C=C2)O,,,,,,
6520,156521,"2-[(5S,7R,9S)-9,14-dihydroxy-4-methyl-4,10-diazatetracyclo[8.6.1.05,17.011,16]heptadeca-1(17),11(16),12,14-tetraen-7-yl]but-2-enal",CC=C(C=O)[C@@H]1C[C@H]2C3=C(CCN2C)C4=C(N3[C@H](C1)O)C=CC(=C4)O,,,,,,
6521,156522,3-Methyl-4-(methylamino)phenol,CC1=C(C=CC(=C1)O)NC,,,,,,
6522,156523,"7H-Furo(3,2-h)(2)benzopyran-3(2H)-one, 6,9-dihydro-7-hydroxy-7-methyl-2-(1-methylethylidene)-, (7R)-",CC(=C1C(=O)C2=C(O1)C3=C(C[C@](OC3)(C)O)C=C2)C,,,,,,
6523,156524,"1H-Benzimidazole, 2-(((5-phenyl-1,3,4-oxadiazol-2-yl)thio)methyl)-",C1=CC=C(C=C1)C2=NN=C(O2)SCC3=NC4=CC=CC=C4N3,,,,,,
6524,156525,"1H-Benzimidazole, 2-(((5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl)thio)methyl)-",C1=CC=C2C(=C1)NC(=N2)CSC3=NN=C(O3)C4=CC=NC=C4,,,,,,
6525,156526,"1H-Benzimidazole, 2-(((5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)thio)methyl)-",C1=CC=C2C(=C1)NC(=N2)CSC3=NN=C(O3)C4=CC=C(C=C4)Cl,,,,,,
6526,156527,"Benzoic acid, 4-(7-amino-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-",C1=CC(=CC=C1C(=O)O)N2C3=NC=NC(=C3N=N2)N,,,,,,
6527,156528,"Ethane, 1,1'-thiobis(2-(ethylsulfinyl)-",CCS(=O)CCSCCS(=O)CC,,,,,,
6528,156529,"(+/-)-Cis-14,15-epoxy-5(Z),8(Z),11(Z)-eicosatrienoic acid",CCCCC[C@@H]1[C@@H](O1)CC=CCC=CCC=CCCCC(=O)O,,,,,,
6529,156530,"1,2-Dimethylpyrene",CC1=CC2=C3C(=C1C)C=CC4=CC=CC(=C43)C=C2,,,,,,
6530,156531,"Pyrene, 4-(1-methylethyl)-",CC(C)C1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3,,,,,,
6531,156532,"Methanone, (7,8-dihydro-1,3-dioxolo(4,5-g)isoquinolin-5-yl)(2-hydroxy-3,4-dimethoxyphenyl)-",COC1=C(C(=C(C=C1)C(=O)C2=NCCC3=CC4=C(C=C32)OCO4)O)OC,,,,,,
6532,156533,"1-Propanone, 1-(10-(2-(methylamino)propyl)-10H-phenothiazin-2-yl)-",CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)NC,,,,,,
6533,156534,"Indeno(1,2-b)pyran-2-carboxylic acid, 4,5-dihydro-4-oxo-",C1C2=CC=CC=C2C3=C1C(=O)C=C(O3)C(=O)O,,,,,,
6534,156535,"Germylene, dimethyl-",C[Ge]C,,,,,,
6535,156536,"L-Valine, N-[2-chloro-4-(trifluoromethyl)phenyl]-",CC(C)[C@@H](C(=O)O)NC1=C(C=C(C=C1)C(F)(F)F)Cl,,,,,,
6536,156537,"3H-Indolo(3,2,1-de)(1,5)naphthyridine-2,6-dione, 3-methoxy-",CON1C2=C3C(=CC1=O)C4=CC=CC=C4N3C(=O)C=C2,,,,,,
6537,156538,"Ergost-2-en-1-one, 6,7:16,26:22,26:24,25-tetraepoxy-5-hydroxy-, (5alpha,6alpha,7alpha,16alpha,22R,24S,25S,26R)-",C[C@@H]1[C@H]2C[C@]3([C@](O3)([C@H](O2)O[C@@H]4[C@H]1[C@]5(CC[C@H]6[C@H]([C@@H]5C4)[C@@H]7[C@@H](O7)[C@@]8([C@@]6(C(=O)C=CC8)C)O)C)C)C,,,,,,
6538,156539,"Ergost-2-en-1-one, 6,7:22,26:24,25-triepoxy-5,16,26-trihydroxy-, (5alpha,6alpha,7alpha,16alpha,22R,24S,25S,26R)-",C[C@H]([C@H]1C[C@]2([C@](O2)([C@@H](O1)O)C)C)[C@H]3[C@@H](C[C@@H]4[C@@]3(CC[C@H]5[C@H]4[C@@H]6[C@@H](O6)[C@@]7([C@@]5(C(=O)C=CC7)C)O)C)O,,,,,,
6539,156540,1-[3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]piperazine,C1CN(CCN1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
6540,156541,Propranolol hemisuccinate hydrochloride,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)OC(=O)CCC(=O)O.Cl,,,,,,
6541,156542,"methyl (2S)-2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate",C[C@@H](C(=O)OC)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
6542,156543,"1,5-Cyclodecadiene, 1,5-dimethyl-8-(1-methylethenyl)-, (1E,5Z,8S)-",CC1=CCCC(=CC[C@H](CC1)C(=C)C)C,,,,,,
6543,156544,Amdinocillin methylacetate,CC(=O)COC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2N=CN3CCCCCC3)(C)C,,,,,,
6544,156545,"3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione,11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-8-methylene-, (1S-(1alpha,6balpha,9beta,9abeta,11alpha,11bbeta))-",CC(=O)O[C@@H]1C[C@]2([C@@H](CC(=C)[C@@H]2O)C3=C1[C@]4([C@H](OC(=O)C5=COC(=C54)C3=O)COC)C)C,,,,,,
6545,156546,"Carbamothioic acid, diethyl-, S-((4-chlorophenyl)methyl) ester, mixt. with N'-(3,4-dichlorophenyl)-N-methoxy-N-methylurea",CCN(CC)C(=O)SCC1=CC=C(C=C1)Cl.CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,,,,,,
6546,156547,"6-Quinolinol, 1,1'-dioxybis(1,2,3,4-tetrahydro-2,2,4-trimethyl-",CC1CC(N(C2=C1C=C(C=C2)O)OON3C4=C(C=C(C=C4)O)C(CC3(C)C)C)(C)C,,,,,,
6547,156548,"6-Quinolinol, 1,1'-dioxybis(1,2-dihydro-2,2,4-trimethyl-",CC1=CC(N(C2=C1C=C(C=C2)O)OON3C4=C(C=C(C=C4)O)C(=CC3(C)C)C)(C)C,,,,,,
6548,156549,"Pentadeca-1,3-diene",CCCCCCCCCCCC=CC=C,,,,,,
6549,156550,"xylo-2-Hexulosonic acid, methyl ester",COC(=O)C(=O)[C@@H]([C@H]([C@@H](CO)O)O)O,,,,,,
6550,156551,"Benzonitrile, 3,5-dibromo-4-hydroxy-, mixt. with 6-chloro-N-ethyl-N'-(1-methylethyl)-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC(C)C.C1=C(C=C(C(=C1Br)O)Br)C#N,,,,,,
6551,156552,Bentazon/atrazine,CCNC1=NC(=NC(=N1)Cl)NC(C)C.CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,,,,,,
6552,156553,N-(2-ethenoxyethoxy)naphthalene-1-carboximidoyl cyanide,C=COCCON=C(C#N)C1=CC=CC2=CC=CC=C21,,,,,,
6553,156554,"1,2-Nonadiene, 3-bromo-",CCCCCCC(=C=C)Br,,,,,,
6554,156555,S-Benzoylcaptopril,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)O,,,,,,
6555,156556,4-Nitrophenoxyacetic acid hydrazide,C1=CC(=CC=C1[N+](=O)[O-])OCC(=O)NN,,,,,,
6556,156557,CID 156557,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)N(O)O)N=NC=O,,,,,,
6557,156558,CID 156558,CC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6558,156559,CID 156559,CCC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6559,156560,CID 156560,CC(C)C(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6560,156561,CID 156561,CC(C)(C)C(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6561,156562,CID 156562,C1=CC=C(C=C1)C(=O)N=NC2=C(C=CC(=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)N(O)O,,,,,,
6562,156563,CID 156563,C1=CC=C(C=C1)CC(=O)N=NC2=C(C=CC(=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)N(O)O,,,,,,
6563,156564,CID 156564,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)N(O)O)N=NC(=O)CCl,,,,,,
6564,156565,CID 156565,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)N(N=N)O)C(=CC(=O)O)C(=O)O,,,,,,
6565,156566,CID 156566,CC(=O)C(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6566,156567,CID 156567,COC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6567,156568,CID 156568,CCOC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6568,156569,CID 156569,CCCCOC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6569,156570,CID 156570,C1=CC=C(C=C1)OC(=O)N=NC2=C(C=CC(=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)N(O)O,,,,,,
6570,156571,CID 156571,COCC(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6571,156572,CID 156572,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)NN)C(CC(=O)[O-])C(=O)O,,,,,,
6572,156573,CID 156573,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)NN)C(CC(=O)O)C(=O)O,,,,,,
6573,156574,CID 156574,CCOC(=O)C(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6574,156575,CID 156575,COC(=O)C(=O)N=NC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)N(O)O,,,,,,
6575,156576,"Acetamide, 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl)-, mixt. with 5-amino-4-chloro-2-phenyl-3(2H)-pyridazinone",CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C.C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)N)Cl,,,,,,
6576,156577,"Spirostan-3-ol, (3alpha,5alpha,25S)-",C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@H](C6)O)C)C)C)OC1,,,,,,
6577,156578,"2-Pyrrolidinone, 1-(4-(1-azetidinyl)-2-butynyl)-",C1CC(=O)N(C1)CC#CCN2CCC2,,,,,,
6578,156579,"3,5-Cyclohexadiene-1,2-diol, 3,6-dichloro-4-(2,5-dichlorophenyl)-",C1=CC(=C(C=C1Cl)C2=C(C(C(C(=C2)Cl)O)O)Cl)Cl,,,,,,
6579,156580,Pokeberrygenin,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(C[C@@H]([C@@H](C5(C)C)O)O)C)C)[C@H]2C1)C)C(=O)O)C(=O)OC,,,,,,
6580,156581,"16,18-Dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,12-dione",CC1CC=CCCCCC(=O)CC2=C(C(=CC(=C2)O)O)C(=O)O1,,,,,,
6581,156582,CID 156582,CC(C)(C)C1=CC=C(C=C1)P(=O)Cl,,,,,,
6582,156583,"3-Quinolinol, 4-amino-6,7-dimethoxy-, monohydrochloride",COC1=C(C=C2C(=C1)C(=C(C=N2)O)N)OC.Cl,,,,,,
6583,156584,"4-Amino-6,7-dimethoxyquinolin-3-ol",COC1=C(C=C2C(=C1)C(=C(C=N2)O)N)OC,,,,,,
6584,156585,"7-Oxabicyclo(4.1.0)heptane-3-methanol, acetate",CC(=O)OCC1CCC2C(C1)O2,,,,,,
6585,156586,CID 156586,C1=CC(=C(C(=C1)Cl)NC(=NCCN)S)Cl.C(=CC(=O)[O-])C(=O)[O-],,,,,,
6586,156587,CID 156587,C1=CC(=C(C(=C1)Cl)NC(=NCCN)S)Cl,,,,,,
6587,156588,4-Hydroxy-N-(2-hydroxyethyl)benzamide,C1=CC(=CC=C1C(=O)NCCO)O,,,,,,
6588,156589,Tephrinone,CC(=CCC1=C(C=C(C2=C1OC(CC2=O)C3=CC=CC=C3)O)OC)C,,,,,,
6589,156590,"Glycine, N-(carboxymethyl)-N-(2-((3-cyano-4,5-dimethyl-1H-pyrrol-2-yl)amino)-2-oxoethyl)-",CC1=C(NC(=C1C#N)NC(=O)CN(CC(=O)O)CC(=O)O)C,,,,,,
6590,156591,Dicalcium Etidronate,CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-].[Ca+2].[Ca+2],,,['Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)'],,,
6591,156592,"Furo(3',4':6,7)naphtho(1,2-d)-1,3-dioxol-7(9H)-one, 10-(7-hydroxy-1,3-benzodioxol-5-yl)-",C1C2=C(C=C3C=CC4=C(C3=C2C5=CC(=C6C(=C5)OCO6)O)OCO4)C(=O)O1,,,,,,
6592,156593,"9(10H)-Acridinone, 1,2,3,4-tetramethoxy-",COC1=C(C(=C(C2=C1C(=O)C3=CC=CC=C3N2)OC)OC)OC,,,,,,
6593,156594,"N-Methyl-3,5,6-trichloro-2-pyridone",CN1C(=C(C=C(C1=O)Cl)Cl)Cl,,,,,,
6594,156595,"[(3aR,4R,9S,11aR)-9-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] 2-(acetyloxymethyl)-4-hydroxybut-2-enoate",CC1=CC[C@@H](C(=C[C@@H]2[C@@H]([C@@H](C1)OC(=O)C(=CCO)COC(=O)C)C(=C)C(=O)O2)C)OC(=O)C,,,,,,
6595,156596,Thalistine,CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=CC(=C(C(=C7CCN6C)O)OC)OC)OC)OC)OCO3,,,,,,
6596,156597,"4H-Pyrazolo(1,5-a)benzimidazole, 2-ethyl-4-methyl-, monohydrochloride",CCC1=NN2C3=CC=CC=C3N(C2=C1)C.Cl,,,,,,
6597,156598,"2-Ethyl-4-methylpyrazolo[1,5-a]benzimidazole",CCC1=NN2C3=CC=CC=C3N(C2=C1)C,,,,,,
6598,156599,"Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-2-(iodo-131I)-",C1=CC(=C(C=C1N(CCCl)CCCl)[131I])CCCC(=O)O,,,,,,
6599,156600,"1,1'-Biphenyl, 3,3',4',5-tetrachloro-4-methoxy-",COC1=C(C=C(C=C1Cl)C2=CC(=C(C=C2)Cl)Cl)Cl,,,,,,
6600,156601,"Naphtho(1,2-b)furan-2(3H)-one, decahydro-4,6-dihydroxy-5a-methyl-3,9-bis(methylene)-, (3aR,4S,5aR,6R,9aS,9bR)-",C[C@@]12C[C@@H]([C@@H]3[C@@H]([C@H]1C(=C)CC[C@H]2O)OC(=O)C3=C)O,,,,,,
6601,156602,"1,5-Cyclohexadiene-1-carboxylic acid, 3,4-dioxo-",C1=CC(=O)C(=O)C=C1C(=O)O,,,,,,
6602,156603,"1-Octanesulfonamide, N-dodecyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-",CCCCCCCCCCCCNS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6603,156604,"Pentanedioic acid, 2-methylpropyl phenylmethyl ester",CC(C)COC(=O)CCCC(=O)OCC1=CC=CC=C1,,,,,,
6604,156605,"2,2-Dimethyl-4-phenylpentanenitrile",CC(CC(C)(C)C#N)C1=CC=CC=C1,,,,,,
6605,156606,"Benzo(a)(1,3)benzodioxolo(5,6-g)quinolizinium, 5,6-dihydro-3-hydroxy-2-methoxy-",COC1=C(C=C2CC[N+]3=CC4=CC5=C(C=C4C=C3C2=C1)OCO5)O,,,,,,
6606,156607,"2-Butanol, 3-((2-(3,4-dimethoxyphenyl)ethyl)amino)-1-phenoxy-, (R*,R*)-",C[C@H]([C@H](COC1=CC=CC=C1)O)NCCC2=CC(=C(C=C2)OC)OC,,,,,,
6607,156608,"1-O-(1-Hydroxy-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-9-carbonyl)hexopyranose",CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C(=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
6608,156609,"1,4-Benzenediol, 2-methoxy-, diacetate",CC(=O)OC1=CC(=C(C=C1)OC(=O)C)OC,,,,,,
6609,156610,"Naphth(2,1-a)aceanthrylene",C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC5=CC6=CC=CC=C6C3=C54,,,,,,
6610,156611,"Pyridine, 4-(3-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl-",CN1CCC(=CC1)C2=CC(=CC=C2)F,,,,,,
6611,156612,"3-[1-(4-Methoxyphenyl)-6-methylocta-1,5,7-trien-4-yl]-2,2-dimethyloxirane",CC(=CC(CC=CC1=CC=C(C=C1)OC)C2C(O2)(C)C)C=C,,,,,,
6612,156613,"(4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4-dimethoxyphenyl)methylidene]oxolan-2-one",COC1=C(C=C(C=C1)C=C2[C@H](COC2=O)CC3=CC4=C(C=C3)OCO4)OC,,,,,,
6613,156614,"2-Propynoic acid, 3-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C#CC(=O)O,,,,,,
6614,156615,(R)-alpha-Methylhistamine,C[C@H](CC1=CN=CN1)N,,,,,,
6615,156616,"3-Chloro-5-phenyl-5,11-dihydroisoindolo[2,1-a]quinazoline",C1C2=CC=CC=C2C3=NC(C4=C(N31)C=CC(=C4)Cl)C5=CC=CC=C5,,,,,,
6616,156617,1-(5-Nitrobenzotriazol-1-yl)-3-phenylprop-2-en-1-one,C1=CC=C(C=C1)C=CC(=O)N2C3=C(C=C(C=C3)[N+](=O)[O-])N=N2,,,,,,
6617,156618,"1-Piperidineacetamide, N-(4,8-dimethyl-2-oxo-2H-furo(2,3-h)-1-benzopyran-9-yl)-",CC1=CC(=O)OC2=C1C=CC3=C2C(=C(O3)C)NC(=O)CN4CCCCC4,,,,,,
6618,156619,"[(3aS,4S,5R,6R,10R,11aR)-6-hydroxy-6,10-dimethyl-3-methylidene-5-(2-methylprop-2-enoyloxy)-2,7-dioxo-3a,4,5,10,11,11a-hexahydrocyclodeca[b]furan-4-yl] 2-methylprop-2-enoate",C[C@@H]1C[C@@H]2[C@@H]([C@@H]([C@H]([C@@](C(=O)C=C1)(C)O)OC(=O)C(=C)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
6619,156620,"2-Naphthalenesulfonic acid, 3-hydroxy-4-(phenylazo)-",C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)S(=O)(=O)O)O,,,,,,
6620,156621,"2-Furancarboxaldehyde, tetrahydro-5-oxo-, (2S)-",C1CC(=O)O[C@@H]1C=O,,,,,,
6621,156622,CID 156622,CN1[C@@H]2CCC1CC(=O)C2=C(C=CC3=CC=CC=C3)O,,,,,,
6622,156623,"Pyridine, 4-(2-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl-",CN1CCC(=CC1)C2=CC=CC=C2F,,,,,,
6623,156624,"2-Dodecanone, 12-(5-hydroxy-1,6-dimethyl-2-piperidinyl)-, (2S-(2alpha,5alpha,6alpha))-",C[C@H]1[C@H](CC[C@@H](N1C)CCCCCCCCCCC(=O)C)O,,,,,,
6624,156625,Akagerinelactone,CN1CCC2=C3[C@@H]1C[C@H](C[C@@H](N3C4=CC=CC=C24)O)C5=CCOC5=O,,,,,,
6625,156626,Hexyl 2-ethylhexyl phthalate,CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,,,,,,
6626,156627,"Carbamic acid, (1-((ethylamino)carbonyl)-1H-benzimidazol-2-yl)-, methyl ester",CCNC(=O)N1C2=CC=CC=C2N=C1NC(=O)OC,,,,,,
6627,156628,"N,N-dimethyl-3-phenylprop-2-en-1-amine",CN(C)CC=CC1=CC=CC=C1,,,,,,
6628,156629,"Acetamide, N-(4-(beta-D-glucopyranosyloxy)phenyl)-",CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
6629,156630,"Sulfuric acid, monododecyl ester, compd. with (R)-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-benzenediol (1:1)",CCCCCCCCCCCCOS(=O)(=O)O.CNC[C@@H](C1=CC(=C(C=C1)O)O)O,,,,,,
6630,156631,"Hydrazine, (4-((4-chlorophenyl)thio)phenyl)-",C1=CC(=CC=C1NN)SC2=CC=C(C=C2)Cl,,,,,,
6631,156632,"2H-1,4-Diazepin-2-one, 1,1'-(1,2-ethanediyl)bis(hexahydro-3,3,5,5,7-pentamethyl-, (R*,R*)-",C[C@@H]1CC(NC(C(=O)N1CCN2[C@@H](CC(NC(C2=O)(C)C)(C)C)C)(C)C)(C)C,,,,,,
6632,156633,Latifonin,CC1(C2C(C(COC2=O)C(=O)OC)C(C1O)O)O,,,,,,
6633,156634,Posoquenin,CC1(C2C(C(C1O)O)C(=COC2=O)C(=O)OC)O,,,,,,
6634,156635,"beta-D-Glucopyranose, 1-(1,4a,5,6,7,7a-hexahydro-1-hydroxy-7-methylcyclopenta(c)pyran-4-carboxylate)",CC1CCC2C1C(OC=C2C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
6635,156636,CID 156636,C[C@H]1C[C@@H]2[C@H]([C@H](C(=O)O2)C)[C@H](CC(=CCC1=O)C)OC(=O)C,,,,,,
6636,156637,"9(10H)-Anthracenone, 1,8-dihydroxy-3-(hydroxymethyl)-10-((4,6-O-(1-methylethylidene)-beta-D-glucopyranosyl)oxy)-, (R)-",CC1(OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3C4=C(C(=CC=C4)O)C(=O)C5=C3C=C(C=C5O)CO)O)O)C,,,,,,
6637,156638,"N-(2-Methylpropyl)dodeca-2,4,8,10-tetraenamide",CC=CC=CCCC=CC=CC(=O)NCC(C)C,,,,,,
6638,156639,"4-[2,2-Dichloro-1-(4-methoxyphenyl)ethenyl]phenol",COC1=CC=C(C=C1)C(=C(Cl)Cl)C2=CC=C(C=C2)O,,,,,,
6639,156640,"Acetamide, 2-chloro-N-(1-methylethyl)-N-(3,5,5-trimethyl-1-cyclohexen-1-yl)-",CC1CC(CC(=C1)N(C(C)C)C(=O)CCl)(C)C,,,,,,
6640,156641,"Imidodicarbonimidic diamide, N-phenyl-, monoacetate",CC(=O)O.C1=CC=C(C=C1)N(C(=N)N)C(=N)N,,,,,,
6641,156642,"n,n-Diamidinoaniline",C1=CC=C(C=C1)N(C(=N)N)C(=N)N,,,,,,
6642,156643,CID 156643,CC[C@@H](C)[C@H](C(=O)O[C@H]1[C@@H]([C@@H](C(=C)[C@@]2([C@@]1([C@H](C[C@@H]2OC(=O)C(=CC)C)C3=COC=C3)C)O)[C@@]4([C@H]([C@]5(CO[C@](O5)(CC4OC(=O)C)O)C)CC(=O)OC)C)OC=O)O,,,,,,
6643,156644,CID 156644,CC[C@H](C)[C@H](C(=O)O[C@H]1[C@@H]([C@@H](C(=C)[C@@]2([C@@]1([C@@H](C[C@@H]2OC(=O)C(=CC)C)C3=COC=C3)C)O)[C@]4(C=CC(=O)O[C@]5([C@@H]4CC(=O)OC5)C)C)OC=O)O,,,,,,
6644,156645,"Benz(a)anthracene, 1,2-dimethyl-",CC1=C(C2=C(C=C1)C=CC3=CC4=CC=CC=C4C=C32)C,,,,,,
6645,156646,"1H-Indole-4,6-dicarboximidamide, 2-phenyl-",C1=CC=C(C=C1)C2=CC3=C(C=C(C=C3N2)C(=N)N)C(=N)N,,,"['Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)', 'Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. (See all compounds classified as Intercalating Agents.)', 'Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
6646,156647,"5H-1,3,4-Thiadiazolo(3,2-a)(1,3,5)triazin-5-one",C1=NC(=O)N2C(=N1)SC=N2,,,,,,
6647,156648,CID 156648,COC(=O)C(=NNC1=CC(=CC=C1)Cl)Cl,,,,,,
6648,156649,CID 156649,COC(=O)C(=NNC1=CC(=C(C=C1)Cl)Cl)Cl,,,,,,
6649,156650,"Benzamide, 3-((2-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-oxoethyl)amino)-, monohydrochloride",COC1=C(C=C(C=C1)CCNC(=O)CNC2=CC=CC(=C2)C(=O)N)OC.Cl,,,,,,
6650,156651,"3-[[2-[2-(3,4-Dimethoxyphenyl)ethylamino]-2-oxoethyl]amino]benzamide",COC1=C(C=C(C=C1)CCNC(=O)CNC2=CC=CC(=C2)C(=O)N)OC,,,,,,
6651,156652,4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone,CN(CCCC(=O)C1=C[N+](=CC=C1)[O-])N=O,,,,,['NNK-N-Oxide is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK).'],
6652,156653,"1-(3-Pyridinyl)-1,4-butanediol",C1=CC(=CN=C1)C(CCCO)O,,,,,"['1-(3-Pyridinyl)-1,4-butanediol (1,4-Diol) is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK).']",
6653,156654,"Methanamine, N-bromo-N-chloro-",CN(Cl)Br,,,,,,
6654,156655,CID 156655,CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)F)C)C(C)C,,,,,,
6655,156656,Neosolaspigenin,C[C@H]1C[C@H]([C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C)C)OC1)O,,,,,,
6656,156657,CID 156657,CC1=C2C(=C(C=C(C2=NC=C1)NC(C)CCCN)OC)C.C(=CC(=O)O)C(=O)O,,,,,,
6657,156658,"4-N-(6-methoxy-4,5-dimethylquinolin-8-yl)pentane-1,4-diamine",CC1=C2C(=C(C=C(C2=NC=C1)NC(C)CCCN)OC)C,,,,,,
6658,156659,Efletirizine dihydrochloride,C1CN(CCN1CCOCC(=O)O)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F.Cl.Cl,,,,,,
6659,156660,"beta-Fenchyl acetate, exo-",CC(=O)O[C@@H]1[C@]2(CC[C@H](C2)C1(C)C)C,,,,,,
6660,156661,CID 156661,CC1=C(C(=CC=C1)C)N(C2CCOC2=O)C(=O)CCl.C(CN=C(S)[S-])NC([S-])[S-].[Mn+2],,,,,,
6661,156662,CID 156662,C(CN=C(S)S)NC(S)S,,,,,,
6662,156663,"Phosphonic acid, (4-aminophenyl)-, potassium salt",C1=CC(=CC=C1N)P(=O)([O-])[O-].[K+].[K+],,,,,,
6663,156664,"4-[2-(3-Hydroxybutyl)-1,3-dioxolan-2-yl]but-2-enoic acid",CC(CCC1(OCCO1)CC=CC(=O)O)O,,,,,,
6664,156665,Eglumetad,C1C[C@]([C@H]2[C@@H]1[C@@H]2C(=O)O)(C(=O)O)N.O,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)', 'Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)']",,,
6665,156666,"(1S,2S,5R)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid",C1C[C@]([C@H]2[C@@H]1C2C(=O)O)(C(=O)O)N,,,,,,
6666,156667,"Octadecanoic acid, compd. with N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxybutanediamide",CCCCCCCCCCCCCCCCCC(=O)O.CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,,,,,,
6667,156668,"Hydrazine, (4-(phenylthio)phenyl)-",C1=CC=C(C=C1)SC2=CC=C(C=C2)NN,,,,,,
6668,156669,"Benzamide, N-(3,5-dichloro-2-pyridinyl)-",C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=N2)Cl)Cl,,,,,,
6669,156670,"1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-2-methyl-1-(2-methyl-2-propenyl)-",CC(=C)CC1C2=C(CCN1C)C3=CC=CC=C3N2,,,,,,
6670,156671,CID 156671,CC1=C2C(=C(C=C(C2=NC=C1)NC(C)CCCN)OC)F.C(=CC(=O)O)C(=O)O,,,,,,
6671,156672,"N4-(5-Fluoro-6-methoxy-4-methylquinolin-8-yl)pentane-1,4-diamine",CC1=C2C(=C(C=C(C2=NC=C1)NC(C)CCCN)OC)F,,,,,,
6672,156673,"D:A-Friedoolean-6-en-3-one, 1-hydroxy-, (1beta)-",C[C@H]1C(=O)C[C@H]([C@@H]2[C@@]1(C=C[C@H]3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C)C)C)C)C)O,,,,,,
6673,156674,"2,5-Cyclohexadiene-1,4-dione, 2-hydroxy-6-methoxy-3,5-dimethyl-",CC1=C(C(=C(C(=O)C1=O)OC)C)O,,,,,,
6674,156675,"Ibogamine-18-carboxylic acid, 13-hydroxy-, methyl ester",CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=CC(=C5)O)C(=O)OC,,,,,,
6675,156676,"(1R,9R)-4-hydroxy-3,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10,13-pentaen-12-one",CN1CC[C@@]23C=C(C(=O)C=C2[C@H]1CC4=C3C(=C(C=C4)O)OC)OC,,,,,,
6676,156677,"Dibenz(a,j)anthracene-7,14-dione, 3-methoxy-",COC1=CC2=C(C=C1)C3=C(C=C2)C(=O)C4=C(C3=O)C5=CC=CC=C5C=C4,,,,,,
6677,156678,"2H,5H-Pyrano(3,2-c)(1)benzopyran-5-one, 4-ethenyl-3,4-dihydro-2-hydroxy-2-(1-hydroxy-2-methyl-2-propenyl)-4,10-dimethyl-, (2S,4R)-",CC1=C2C(=CC=C1)OC(=O)C3=C2O[C@@](C[C@]3(C)C=C)(C(C(=C)C)O)O,,,,,,
6678,156679,Wentilactone A,C[C@@]12[C@@H]3[C@@H](C=C4COC(=O)C=C4[C@]3([C@H]5[C@@H]([C@@H]1O)O5)C)OC2=O,,,,,,
6679,156680,Gambiriin C,C1[C@@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC=C(C=C5)O)O)O)O)C6=CC(=C(C=C6)O)O)O,,,,,,
6680,156681,CID 156681,C1=CC=C(C=C1)C=CC(=O)OC[C@@]23[C@@H]4[C@@H](C=COC4O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[C@@H]([C@@H]2O3)O,,,,,,
6681,156682,CID 156682,COC1=C(C=C(C=C1O)C2=COC3=CC(=O)C=C(C3=C2O)O)O,,,,,,
6682,156683,"Benzamide, 4-(1,1-dimethylethyl)-N-methyl-N-(3-methylphenyl)-",CC1=CC(=CC=C1)N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
6683,156684,"Benzamide, 4-(1,1-dimethylethyl)-N-(2-methoxyphenyl)-N-methyl-",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2OC,,,,,,
6684,156685,"Benzamide, 4-(1,1-dimethylethyl)-N-(2-ethoxyphenyl)-N-methyl-",CCOC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
6685,156686,"Benzamide, N-(2-chlorophenyl)-4-(1,1-dimethylethyl)-N-methyl-",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2Cl,,,,,,
6686,156687,2-(4-Bromobenzyl)benzo[d]oxazole,C1=CC=C2C(=C1)N=C(O2)CC3=CC=C(C=C3)Br,,,,,,
6687,156688,"3-((1-Ethylpropyl)amino)-6-methyl-2,4-dinitrobenzyl alcohol",CCC(CC)NC1=C(C=C(C(=C1[N+](=O)[O-])CO)C)[N+](=O)[O-],,,,,,
6688,156689,Edonentan monohydrate,CC1=C(ON=C1NS(=O)(=O)C2=CC=CC=C2C3=C(C=C(C=C3)C4=NC=CO4)CN(C)C(=O)CC(C)(C)C)C.O,,,,,,
6689,156690,Edonentan,CC1=C(ON=C1NS(=O)(=O)C2=CC=CC=C2C3=C(C=C(C=C3)C4=NC=CO4)CN(C)C(=O)CC(C)(C)C)C,,,['Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)'],,,
6690,156691,"Valine, N-(2-chloro-4-(trifluoromethyl)phenyl)-, methyl ester",CC(C)[C@@H](C(=O)OC)NC1=C(C=C(C=C1)C(F)(F)F)Cl,,,,,,
6691,156692,(2S)-2-amino-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide,C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CC=C(C=C6)O)N,,,,,,
6692,156693,"Benzoic acid, 2-chloro-4-hydroxy-3,5-dimethoxy-",COC1=C(C(=C(C(=C1)C(=O)O)Cl)OC)O,,,,,,
6693,156694,CID 156694,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)O,,,,,,
6694,156695,"(2-methyl-3-phenylphenyl)methyl (3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1=C(C=CC=C1C2=CC=CC=C2)COC(=O)C3[C@@H](C3(C)C)C=C(Cl)Cl,,,,,,
6695,156696,"(1R,3R)-7-[2-(hydroxymethyl)-4,5-dimethoxynaphthalen-1-yl]-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol",C[C@@H]1CC2=C([C@H](N1)C)C(=C(C=C2)C3=C4C=CC=C(C4=C(C=C3CO)OC)OC)O,,,,,,
6696,156697,"4H-Dibenzo(de,g)quinoline-1,10-diol, 5,6,6a,7-tetrahydro-2-methoxy-6-methyl-11-(4-(((1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-, (6aR)-",CN1CCC2=CC(=C(C3=C2[C@H]1CC4=C3C(=C(C=C4)O)OC5=CC=C(C=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)OC)OC)O)OC,,,,,,
6697,156698,Asperlactone,C[C@H]1[C@@H](O1)C2=C[C@@H](OC2=O)[C@H](C)O,,,,,,
6698,156699,"4-[1-Hydroxy-2-(4-hydroxy-7,12-dimethyl-14-oxo-1-oxacyclotetradeca-8,12-dien-2-yl)ethyl]-1,3-thiazolidin-2-one",CC1CCC(CC(OC(=O)C=C(CCC=C1)C)CC(C2CSC(=O)N2)O)O,,,,,,
6699,156700,"Phosphinothioic acid, (1,1-dimethylethyl)phenyl-, S-methyl ester",CC(C)(C)P(=O)(C1=CC=CC=C1)SC,,,,,,
6700,156701,3-(4-Cyclohexylphenyl)-5-methyloxolan-2-one,CC1CC(C(=O)O1)C2=CC=C(C=C2)C3CCCCC3,,,,,,
6701,156702,"Decanoic acid, (1aR,1bS,4aR,7aS,7bR,8R,9R,9aS)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b,9a-trihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester",CCCCCCCCCC(=O)O[C@@H]1[C@H]([C@@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)O)O)C,,,,,,
6702,156703,3-(2-Phenylethenyl)phenol,C1=CC=C(C=C1)C=CC2=CC(=CC=C2)O,,,,,,
6703,156704,CID 156704,CC=C(C)C(=O)N[C@@H](C1=CC=CC=C1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)[C@@H](C(=C2C)C3(C)C)O)C)OC(=O)C6=CC=CC=C6)O)O,,,,,,
6704,156705,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-3-(2-propynyloxy)phenyl)-4,5,6,7-tetrahydro-",C#CCOC1=C(C=CC(=C1)N2C(=O)C3=C(C2=O)CCCC3)Cl,,,,,,
6705,156706,"3,3-Pyrrolidinedicarboxylic acid, 2-oxo-, diethyl ester",CCOC(=O)C1(CCNC1=O)C(=O)OCC,,,,,,
6706,156707,sanggenon A,CC(=CC[C@@]12C3=C(C=C(C=C3)O)O[C@@]1(C(=O)C4=C(O2)C=C5C(=C4O)C=CC(O5)(C)C)O)C,,,,,,
6707,156708,"2,4(1H,3H)-Pyrimidinedione, 1-((3,4-dichlorophenyl)methyl)-",C1=CC(=C(C=C1CN2C=CC(=O)NC2=O)Cl)Cl,,,,,,
6708,156709,Ligustrazine hydrochloride,CC1=C(N=C(C(=N1)C)C)C.Cl,,,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,
6709,156710,"Azacycloundecane, 1-nitroso-",C1CCCCCN(CCCC1)N=O,,,,,,
6710,156711,"7H-Furo(3,2-g)(1)benzopyran-7-one, 3,9-dimethoxy-2-(1-methylethyl)-",CC(C)C1=C(C2=C(O1)C(=C3C(=C2)C=CC(=O)O3)OC)OC,,,,,,
6711,156712,"Dibenzo(b,e)(1,4)dioxin-13C12, 2,3,7,8-tetrachloro-",[13CH]1=[13C]2[13C](=[13CH][13C](=[13C]1Cl)Cl)O[13C]3=[13CH][13C](=[13C]([13CH]=[13C]3O2)Cl)Cl,,,,,,
6712,156713,"alpha-L-Mannopyranoside, 3,4-dihydro-4,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 6-deoxy-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2C(C3=C(C=C(C=C3OC2C4=CC(=C(C(=C4)O)O)O)O)O)O)O)O)O,,,,,,
6713,156714,"Benzene, 2,4-dichloro-1-(3-methoxy-4-nitrosophenoxy)-",COC1=C(C=CC(=C1)OC2=C(C=C(C=C2)Cl)Cl)N=O,,,,,,
6714,156715,"Phosphonic acid, (1,1-dichloroethyl)-, diphenyl ester",CC(P(=O)(OC1=CC=CC=C1)OC2=CC=CC=C2)(Cl)Cl,,,,,,
6715,156716,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-chlorophenyl) ester",CC(P(=O)(OC1=CC=C(C=C1)Cl)OC2=CC=C(C=C2)Cl)(Cl)Cl,,,,,,
6716,156717,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2-chlorophenyl) ester",CC(P(=O)(OC1=CC=CC=C1Cl)OC2=CC=CC=C2Cl)(Cl)Cl,,,,,,
6717,156718,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-nitrophenyl) ester",CC(P(=O)(OC1=CC=C(C=C1)[N+](=O)[O-])OC2=CC=C(C=C2)[N+](=O)[O-])(Cl)Cl,,,,,,
6718,156719,"Phosphonic acid, (1,1-dichloroethyl)-, bis(3-nitrophenyl) ester",CC(P(=O)(OC1=CC=CC(=C1)[N+](=O)[O-])OC2=CC=CC(=C2)[N+](=O)[O-])(Cl)Cl,,,,,,
6719,156720,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2-nitrophenyl) ester",CC(P(=O)(OC1=CC=CC=C1[N+](=O)[O-])OC2=CC=CC=C2[N+](=O)[O-])(Cl)Cl,,,,,,
6720,156721,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-methylphenyl) ester",CC1=CC=C(C=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC=C(C=C2)C,,,,,,
6721,156722,"Phosphonic acid, (1,1-dichloroethyl)-, bis(3-methylphenyl) ester",CC1=CC(=CC=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC=CC(=C2)C,,,,,,
6722,156723,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2-methylphenyl) ester",CC1=CC=CC=C1OP(=O)(C(C)(Cl)Cl)OC2=CC=CC=C2C,,,,,,
6723,156724,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-methoxyphenyl) ester",CC(P(=O)(OC1=CC=C(C=C1)OC)OC2=CC=C(C=C2)OC)(Cl)Cl,,,,,,
6724,156725,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2-methoxyphenyl) ester",CC(P(=O)(OC1=CC=CC=C1OC)OC2=CC=CC=C2OC)(Cl)Cl,,,,,,
6725,156726,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-(1,1-dimethylethyl)phenyl)ester",CC(C)(C)C1=CC=C(C=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC=C(C=C2)C(C)(C)C,,,,,,
6726,156727,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-(methylthio)phenyl) ester",CC(P(=O)(OC1=CC=C(C=C1)SC)OC2=CC=C(C=C2)SC)(Cl)Cl,,,,,,
6727,156728,"Phosphonic acid, (1,1-dichloroethyl)-, bis(5-methyl-2-nitrophenyl) ester",CC1=CC(=C(C=C1)[N+](=O)[O-])OP(=O)(C(C)(Cl)Cl)OC2=C(C=CC(=C2)C)[N+](=O)[O-],,,,,,
6728,156729,"Phosphonic acid, (1,1-dichloroethyl)-, bis(4-chloro-3-methylphenyl) ester",CC1=C(C=CC(=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC(=C(C=C2)Cl)C)Cl,,,,,,
6729,156730,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2-chloro-4-nitrophenyl) ester",CC(P(=O)(OC1=C(C=C(C=C1)[N+](=O)[O-])Cl)OC2=C(C=C(C=C2)[N+](=O)[O-])Cl)(Cl)Cl,,,,,,
6730,156731,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2,4-dichlorophenyl) ester",CC(P(=O)(OC1=C(C=C(C=C1)Cl)Cl)OC2=C(C=C(C=C2)Cl)Cl)(Cl)Cl,,,,,,
6731,156732,"Phosphonic acid, (1,1-dichloroethyl)-, bis(3-methyl-4-(methylthio)phenyl)ester",CC1=C(C=CC(=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC(=C(C=C2)SC)C)SC,,,,,,
6732,156733,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2,4,5-trichlorophenyl) ester",CC(P(=O)(OC1=CC(=C(C=C1Cl)Cl)Cl)OC2=CC(=C(C=C2Cl)Cl)Cl)(Cl)Cl,,,,,,
6733,156734,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2,6-dimethylphenyl) ester",CC1=C(C(=CC=C1)C)OP(=O)(C(C)(Cl)Cl)OC2=C(C=CC=C2C)C,,,,,,
6734,156735,"Phosphonic acid, (1,1-dichloroethyl)-, bis(3,4-dimethylphenyl) ester",CC1=C(C=C(C=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC(=C(C=C2)C)C)C,,,,,,
6735,156736,"Phosphonic acid, (1,1-dichloroethyl)-, bis(3,5-dimethylphenyl) ester",CC1=CC(=CC(=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC(=CC(=C2)C)C)C,,,,,,
6736,156737,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2,3-dimethylphenyl) ester",CC1=C(C(=CC=C1)OP(=O)(C(C)(Cl)Cl)OC2=CC=CC(=C2C)C)C,,,,,,
6737,156738,"Phosphonic acid, (1,1-dichloroethyl)-, bis(2,4-dimethylphenyl) ester",CC1=CC(=C(C=C1)OP(=O)(C(C)(Cl)Cl)OC2=C(C=C(C=C2)C)C)C,,,,,,
6738,156739,"4-Pyridinecarboxylic acid, 2-bromo-6-propyl-, hydrazide",CCCC1=NC(=CC(=C1)C(=O)NN)Br,,,,,,
6739,156740,"2,2',3,3',4,5'-Hexachlorodiphenyl ether",C1=CC(=C(C(=C1OC2=C(C(=CC(=C2)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
6740,156741,Raimondal,CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1OC)O,,,,,,
6741,156742,"[2-[(3S,8R,9S,10R,13S,14S)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
6742,156743,Isoferreirin,COC1=C(C=CC(=C1)O)C2COC3=CC(=CC(=C3C2=O)O)O,,,,,,
6743,156744,2-[3-(4-Hydroxyphenyl)prop-2-enoyloxy]ethyl-trimethylazanium;chloride,C[N+](C)(C)CCOC(=O)C=CC1=CC=C(C=C1)O.[Cl-],,,,,,
6744,156745,2-[3-(4-Hydroxyphenyl)prop-2-enoyloxy]ethyl-trimethylazanium,C[N+](C)(C)CCOC(=O)C=CC1=CC=C(C=C1)O,,,,,,
6745,156746,"Phosphoramidic acid, (1-methylethyl)-, ethyl 5-methyl-2-nitrophenyl ester",CCOP(=O)(NC(C)C)OC1=C(C=CC(=C1)C)[N+](=O)[O-],,,,,,
6746,156747,"Butanoic acid, 2-(((aminocarbonyl)amino)carbonyl)-2-ethyl-,2-(dimethylamino)ethyl ester, monohydrochloride",CCC(CC)(C(=O)NC(=O)N)C(=O)OCCN(C)C.Cl,,,,,,
6747,156748,2-(Dimethylamino)ethyl 2-(carbamoylcarbamoyl)-2-ethylbutanoate,CCC(CC)(C(=O)NC(=O)N)C(=O)OCCN(C)C,,,,,,
6748,156749,"1H-1,2,4-Triazole-1-ethanol, alpha,alpha-diphenyl-",C1=CC=C(C=C1)C(CN2C=NC=N2)(C3=CC=CC=C3)O,,,,,,
6749,156750,CID 156750,CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)OC(=O)C=CC=C[C@@H]([C@@H](C)O)O)C)COC(=O)C=C(C)CCO,,,,,,
6750,156751,CID 156751,CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)OC(=O)C=CC=C[C@@H]([C@@H](C)O)O)C)CO,,,,,,
6751,156752,CID 156752,CC=C(C)C(=O)O[C@H]1[C@H]2C3[C@](CO2)([C@@H](C[C@@H]([C@@]3([C@H]([C@]1(C)C4=C([C@@H](C[C@@H]4OC(=O)C)C5=COC=C5)C)CC(=O)OC)C)OC(=O)C)OC(=O)C)C,,,,,,
6752,156753,"2H-Naphtho(1,8-bc)furan-6-acetic acid, 3,5-bis(acetyloxy)-7-((3R,5S)-5-(acetyloxy)-3-(3-furanyl)-2-methyl-1-cyclopenten-1-yl)-8-(benzoyloxy)decahydro-2a,5a,7-trimethyl-, methyl ester, (2aR,3R,5S,5aR,6R,7R,8S,8aR,8bR)-",CC1=C([C@H](C[C@H]1C2=COC=C2)OC(=O)C)[C@]3([C@@H]([C@]4([C@H](C[C@H]([C@@]5(C4[C@H]([C@@H]3OC(=O)C6=CC=CC=C6)OC5)C)OC(=O)C)OC(=O)C)C)CC(=O)OC)C,,,,,,
6753,156754,"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6754,156755,"[(R)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6755,156756,"[(S)-cyano-(3-phenoxyphenyl)methyl] (1S,3S)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@@H]([C@@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6756,156757,"[(R)-cyano-(3-phenoxyphenyl)methyl] (1S,3S)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@@H]([C@@H]1C(=O)O[C@@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,,,,,,
6757,156758,"Tin, bis(N-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinyl)methylene)-L-isoleucinato-N,O1)-, (T-4)-",CCC(C)C(C(=O)[O-])N=CC1=C(C(=NC=C1CO)C)O.CCC(C)C(C(=O)[O-])N=CC1=C(C(=NC=C1CO)C)O.[Sn+2],,,,,,
6758,156759,2-[[3-Hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]-3-methylpentanoic acid,CCC(C)C(C(=O)O)N=CC1=C(C(=NC=C1CO)C)O,,,,,,
6759,156760,N-Desmethylthalrugosidine,CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6)OC)O)OC)OC)OC,,,,,,
6760,156761,Thalpindione,CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C=O)OC)O)OC)OC)OC,,,,,,
6761,156762,"L-Arabinosylamine, N-(4-nitrophenyl)-",C1=CC(=CC=C1NC2[C@@H]([C@H]([C@@H](O2)CO)O)O)[N+](=O)[O-],,,,,,
6762,156763,Meridianone,C[C@@]12CC[C@H]([C@]3([C@@]1(O2)C[C@@H]4[C@@H](C3)OC(=O)C4=C)C)O,,,,,,
6763,156764,CID 156764,CC=C(C)C(=O)O[C@H]1CCC2=C[C@@H]3C(=C(C(=O)O3)C)C[C@@]2([C@H]1C)C,,,,,,
6764,156765,Uvidin A,C[C@]12CCCC([C@@H]1C(=O)[C@H]3[C@@]([C@@H]2CO)(O3)C)(C)C,,,,,,
6765,156766,Kihadanin B,C[C@@]12CC[C@@H]3[C@]4(C=CC(=O)OC([C@@H]4CC(=O)[C@]3([C@@]15[C@H](O5)C(=O)O[C@H]2C6=CC(OC6=O)O)C)(C)C)C,,,,,,
6766,156767,"4H-1-Benzopyran-4-one, 5-((6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranosyl)oxy)-2-(3,4-dimethoxyphenyl)-3,6,7-trimethoxy-",C[C@H]1C([C@H]([C@H](C(O1)OC2=C3C(=CC(=C2OC)OC)OC(=C(C3=O)OC)C4=CC(=C(C=C4)OC)OC)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
6767,156768,"Thiosulfuric acid (H2S2O3), S-((4-nitrophenyl)methyl) ester, potassiumsalt",C1=CC(=CC=C1CSS(=O)(=O)O)[N+](=O)[O-].[K+],,,,,,
6768,156769,4-Nitrobenzyl mercaptan S-sulfate,C1=CC(=CC=C1CSS(=O)(=O)O)[N+](=O)[O-],,,,,,
6769,156770,"7-Oxa-5-thia-2-aza-6-phosphanonanoic acid, 6-ethoxy-2-methyl-3-oxo-, ethyl ester, 6-oxide",CCOC(=O)N(C)C(=O)CSP(=O)(OCC)OCC,,,,,,
6770,156771,Magellaninone,CC1=CC(=O)[C@]23C[C@@H]4CN(CC[C@@H]4[C@H]2C(=O)C[C@@H]3C1)C,,,,,,
6771,156772,CID 156772,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CN(C)CCN(C)C.[Co+2],,,,,,
6772,156773,(+)-Piperitol beta-glucoside,COC1=C(C=CC(=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)OC6C(C(C(C(O6)CO)O)O)O,,,,,,
6773,156774,"Oleanan-16-one, 13,28-epoxy-3,29-dihydroxy-, (3beta,20beta)-",C[C@@]1(CC[C@@]23CO[C@]4([C@@H]2C1)CC[C@@H]5[C@]6(CC[C@@H](C([C@@H]6CC[C@]5([C@@]4(CC3=O)C)C)(C)C)O)C)CO,,,,,,
6774,156775,"Viroisin, 2-(2-(methylsulfinyl)-L-tryptophan)-3-(4,5-dihydroxy-L-leucine)-4-L-alanine-7",CC1C(=O)NC(C(=O)NC(C(=O)N2CC(C(C2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(C)(CO)O)CC3=C(NC4=CC=CC=C43)S(=O)C)C)O)O)CO)C(C)O,,,,,,
6775,156776,"Hexanoic acid, 2-hydroxy-2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide",CCCCC(C(=O)NC1=CC=CC=C1)(C(=O)N(C2=CC=CC=C2)NC3=CC=CC=C3)O,,,,,,
6776,156777,Cyclokievitone,CC1(C=CC2=C(O1)C=C(C3=C2OCC(C3=O)C4=C(C=C(C=C4)O)O)O)C,,,,,,
6777,156778,Uplandicine,C[C@@H]([C@](C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)OC(=O)C)(C(C)(C)O)O)O,,,,,,
6778,156779,"1,2-Chrysenediol, 1,2-dihydro-11-methyl-, (1R,2R)-rel-",CC1=CC2=C(C=C[C@@H]([C@H]2O)O)C3=C1C4=CC=CC=C4C=C3,,,,,,
6779,156780,"1,2-Chrysenediol, 1,2-dihydro-5-methyl-, (1R,2R)-rel-",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@@H]([C@H](C=C4)O)O,,,,,,
6780,156781,"(1R,7R,8R,18R)-8-hydroxy-5,7,8-trimethyl-2,10-dioxa-15-azatricyclo[10.5.1.015,18]octadeca-4,12-diene-3,9-dione",C[C@@H]1CC(=CC(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]1(C)O)C,,,,,,
6781,156782,"1H-Benzo(d)naphthalen-1-ol, 2,3,4,4a,5,6,7,7a,10,11-decahydro-8-(1H-indol-3-yl)-4,4a,7-trimethyl-9-(1-methylethyl)-, (1R,4S,4aR,7S,7aR,11aR)-rel-",C[C@@H]1CC[C@]2([C@@H](CC[C@@H](C23[C@@H]1C(=C(CC3)C(C)C)C4=CNC5=CC=CC=C54)O)C)C,,,,,,
6782,156783,Graecunin E,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)OC9C(C(C(C(O9)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O)O)C)C)C)OC1,,,,,,
6783,156784,Graecunin G,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)C)C)C)OC1,,,,,,
6784,156785,"Spiro(furan-2(5H),2'-tricyclo(3.3.1.13,7)decan)-5-one,dihydro-4-methylene-",C=C1CC2(C3CC4CC(C3)CC2C4)OC1=O,,,,,,
6785,156786,"Benz(a)anthracene-3,4-diol, 3,4-dihydro-7-methyl-, (3R,4R)-rel-",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=C[C@@H]([C@H]3O)O,,,,,,
6786,156787,"2-Oxa-spiro[4.5]dec-8-ene-1,7-dione, 4,6-dihydroxy-3,10-dimethyl-",CC1C=CC(=O)C(C12C(C(OC2=O)C)O)O,,,,,,
6787,156788,"(1S,2R)-2-(dimethylamino)-1-phenylpropan-1-ol;1,1-dioxo-1,2-benzothiazol-3-one",C[C@H]([C@H](C1=CC=CC=C1)O)N(C)C.C1=CC=C2C(=C1)C(=O)NS2(=O)=O,,,,,,
6788,156789,"[(1S,4R,5R,6R,7S,11S,12R,13S,16S,17S,18S,19R)-4,5,16,17-tetrahydroxy-6,14,18-trimethyl-9-oxo-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-en-12-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@@H]1[C@H]2C(=C[C@@H]([C@H]([C@@]2([C@@H]3[C@@]45[C@@H]1OC(=O)C[C@H]4[C@H]([C@H]([C@@]3(OC5)O)O)C)C)O)O)C,,,,,,
6789,156790,"(4R,6R,8R)-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.06,8]nonadeca-1(15),9,11,16,18-pentaene-2,13-dione",C[C@@H]1C[C@@H]2[C@H](O2)C=CC=CC(=O)CC3=C(C(=CC(=C3)O)O)C(=O)O1,,,,,,
6790,156791,CID 156791,C1=CC=C(C=C1)C=CC(=O)OCC2C(C(C(C(O2)OC3C4C(C=CO3)C(C=C4CO)O)O)O)O,,,,,,
6791,156792,"4,16,17,21,22-Pentamethoxy-10,27-dimethyl-2,19-dioxa-10,27-diazaheptacyclo[28.2.2.13,7.120,24.09,14.013,18.028,35]hexatriaconta-1(32),3,5,7(36),13(18),14,16,20,22,24(35),30,33-dodecaen-23-ol",CN1CCC2=C3C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=CC(=C(C(=C7CCN6C)OC3=C(C(=C2O)OC)OC)OC)OC)OC,,,,,,
6792,156793,Barbigerone,CC1(C=CC2=C(O1)C=CC3=C2OC=C(C3=O)C4=CC(=C(C=C4OC)OC)OC)C,,,,,,
6793,156794,"1H-Naphtho(1,8a-c)furan-3(5H)-one, 5-(acetyloxy)-7-(2-(2,5-dihydro-5-oxo-3-furanyl)ethyl)-6,6a,7,8,9,10-hexahydro-7,8-dimethyl-, (5S-(5alpha,6aalpha,7alpha,8beta,10aR*))-",CC1CCC23COC(=O)C2=CC(CC3C1(C)CCC4=CC(=O)OC4)OC(=O)C,,,,,,
6794,156795,CID 156795,CNC1=C(C=C(C=C1)N=NC2=CC=CC=C2)NC3=NC(=O)C4=C(N3)N(C=N4)C5C[C@@H]([C@H](O5)CO)O,,,,,,
6795,156796,"Erythrinanium, 1,6-didehydro-15-hydroxy-3-methoxy-9-methyl-, (3beta)-",C[N+]12CCC3=CC[C@@H](C[C@@]31C4=C(CC2)C=CC(=C4)O)OC,,,,,,
6796,156797,"6,8-Dioxabicyclo(3.2.1)octane, 7-ethyl-5-methyl-, (1R,5S,7R)-rel-",CC[C@H]1[C@@H]2CCC[C@@](O2)(O1)C,,,,,,
6797,156798,Cannogenol-3-O-beta-D-allomethyloside,C[C@@H]1[C@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)CO)O)O)O,,,,,,
6798,156799,Gallium Ga 68 alizarin,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)[O-].C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)[O-].C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)[O-].[68Ga+3],,,,,,
6799,156800,"Spiro(7H-indeno(4,5-d)-1,3-dioxole-7,1'(2'H)-isoquinolin)-8(6H)-one,7'-(beta-D-glucopyranosyloxy)-3',4'-dihydro-6'-methoxy-2'-methyl-, (2'S)-",CN1CCC2=CC(=C(C=C2[C@]13CC4=C(C3=O)C5=C(C=C4)OCO5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)OC,,,,,,
6800,156801,Gallium Ga 68 alizarin red S,C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)[O-])S(=O)(=O)[O-].C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)[O-])S(=O)(=O)[O-].C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[68Ga+3],,,,,,
6801,156802,Unii-8jti620gsi,C[C@]12C[C@H](C[C@]3([C@@H]1[C@@H](C=C4C2=CC(=O)OC4)OC3=O)C)O,,,,,,
6802,156803,CID 156803,CC=C(C)C(=O)O[C@@H]1[C@H]([C@@]2([C@@H]3C=C(C(=O)[C@H]3CC(=C[C@H]2C4C1(C4(C)C)O)COC(=O)C(C)C)C)O)C,,,,,,
6803,156804,"alpha-L-Mannopyranoside, 3,4-dihydro-4,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 6-deoxy-4-O-beta-D-glucopyranosyl-",CC1C(C(C(C(O1)OC2C(C3=C(C=C(C=C3OC2C4=CC(=C(C(=C4)O)O)O)O)O)O)O)O)OC5C(C(C(C(O5)CO)O)O)O,,,,,,
6804,156805,CID 156805,CC=C(C)C(=O)O[C@@H]1[C@H]2[C@H]3[C@](CO2)(C(CC([C@@]3(C4[C@@]1(C5=C([C@@H](CC5OC(C4)O)C6=CC=CO6)C)C)C)OC(=O)C)OC(=O)C)C,,,,,,
6805,156806,"D-Ribosylamine, N-(4-nitrophenyl)-",C1=CC(=CC=C1N=C[C@@H]([C@@H]([C@@H](CO)O)O)O)[N+](=O)[O-],,,,,,
6806,156807,"D-Lyxosylamine, N-(4-nitrophenyl)-",C1=CC(=CC=C1N=C[C@H]([C@H]([C@@H](CO)O)O)O)[N+](=O)[O-],,,,,,
6807,156808,CID 156808,CCCC1=C(N2C(=NC3=C(N2C1=O)C=C(C=C3)C)N(C)C)[O-].[Na+],,,,,,
6808,156809,"5-(Dimethylamino)-3-hydroxy-9-methyl-2-propylpyrazolo[1,2-a][1,2,4]benzotriazin-1-one",CCCC1=C(N2C(=NC3=C(N2C1=O)C=C(C=C3)C)N(C)C)O,,,,,,
6809,156810,Deoxoviroidin,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CC(C(C2C(=O)N1)O)O)CO)C(C)O)C(C)C)CC(C)(CO)O)CC3=C(NC4=CC=CC=C43)S(=O)C,,,,,,
6810,156811,LA-Viroidin,CC1C(=O)NC(C(=O)NC(C(=O)N2CC(C(C2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(C)(CO)O)CC3=C(NC4=CC=CC=C43)S(=O)(=O)C)C)O)O)CO)C(C)O,,,,,,
6811,156812,Deoxoviroisin,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CC(C(C2C(=O)N1)O)O)CO)C(C)O)C(C)C)CC(CO)(CO)O)CC3=C(NC4=CC=CC=C43)S(=O)C,,,,,,
6812,156813,"3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6-trien-8-ynoic acid",CC1=C(C(CCC1)(C)C)C#CC(=CC=CC(=CC(=O)O)C)C,,,,,,
6813,156814,"2-[[2-Amino-4-hydroxy-4-(4-hydroxyphenyl)-3-methylbutanoyl]amino]-2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid",CC(C(C1=CC=C(C=C1)O)O)C(C(=O)NC(C2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)C(=O)O)N,,,,,,
6814,156815,Hydroxypiperaquine,C1CN(CCN1CC(CN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)O)C5=C6C=CC(=CC6=NC=C5)Cl.[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-],,,,,,
6815,156816,"6,12-Dihydroxy-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2'-oxirane]-11,17,22-trione",CC1CCOC(=O)C=CC=CC(=O)OC2CC3C4(C2(C5(CC(C(=CC5O3)C)O)COC(=O)C1O)C)CO4,,,,,,
6816,156817,"12-Hydroxy-5-(hydroxymethyl)-13,25-dimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2'-oxirane]-11,17,22-trione",CC1CCOC(=O)C=CC=CC(=O)OC2CC3C4(C2(C5(CCC(=CC5O3)CO)COC(=O)C1O)C)CO4,,,,,,
6817,156818,Wedeloside,CC(C)CC(=O)NC1C(C(C(OC1OC2CC3(C4CCC5(CC4(CCC3C(C2)(C(=O)O)C(=O)O)C(C5=C)O)O)C)CO)O)OC(=O)CCC6=CC=CC=C6,,,,,,
6818,156819,CID 156819,COC1=CC=C(C=C1)N(CCCC(=O)[O-])C(=O)C2=CC=C(C=C2)Cl.[Na+],,,,,,
6819,156820,3-Tetradecoxypropyl propanoate,CCCCCCCCCCCCCCOCCCOC(=O)CC,,,,,,
6820,156821,"But-2-enedioic acid;2-[3-(methylamino)propylidene]tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol",CNCCC=C1C2=CC=CC=C2CC(C3=CC=CC=C31)O.C(=CC(=O)O)C(=O)O,,,,,,
6821,156822,Hydrel,C(CCl)P(=O)(O)O.C(CCl)P(=O)(O)O.NN,,,,,,
6822,156823,"(1S,4aS,7R,7aS)-7-hydroxy-7-[3-(4-hydroxyphenyl)prop-2-enoyloxymethyl]-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[c]pyran-4-carboxylic acid",C1=C[C@@]([C@@H]2[C@H]1C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)O)(COC(=O)C=CC4=CC=C(C=C4)O)O,,,,,,
6823,156824,"3,4,4-Trimethylpentanoic acid",CC(CC(=O)O)C(C)(C)C,,,,,,
6824,156825,"Lithium sodium 3-((4-amino-5-methoxy-2-methylphenyl)azo)-1,5-naphthalenedisulfonate",[Li+].CC1=CC(=C(C=C1N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O)OC)N.[Na+],,,,,,
6825,156826,CID 156826,CC1(CCCC23[C@@H]1[C@@H](C([C@]45[C@H]2CC[C@H](C4O)C(=C)C5=O)(OC3)O)O)C,,,,,,
6826,156827,Triadimefon and captafol mixture,CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl.C1C=CCC2C1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,,,,,,
6827,156828,"Acridinium, 10,10'-(1,6-hexanediyl)bis(9-(methylamino)-, dichloride, monohydrochloride",CNC1=C2C=CC=CC2=[N+](C3=CC=CC=C31)CCCCCC[N+]4=C5C=CC=CC5=C(C6=CC=CC=C64)NC.Cl.[Cl-].[Cl-],,,,,,
6828,156829,N-methyl-10-[6-[9-(methylamino)acridin-10-ium-10-yl]hexyl]acridin-10-ium-9-amine,CNC1=C2C=CC=CC2=[N+](C3=CC=CC=C31)CCCCCC[N+]4=C5C=CC=CC5=C(C6=CC=CC=C64)NC,,,,,,
6829,156830,CID 156830,C1CN2C(=N[C@H]([C@H]3[C@]2([C@H]1O)N=C(N3)N)COC(=O)N)N,,,,,,
6830,156831,Echinoside A,CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CC(C67C5(CCC6(C(OC7=O)(C)CCCC(C)C)O)C)O)C)OS(=O)(=O)O)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)OC)O)O.[Na+],,,,,,
6831,156832,"[5-[5-[4-[3,5-Dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-6-[[5,10-dihydroxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-11-en-16-yl]oxy]-4-hydroxyoxan-3-yl] hydrogen sulfate",CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CC(C67C5(CCC6(C(OC7=O)(C)CCCC(C)C)O)C)O)C)OS(=O)(=O)O)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)OC)O)O,,,,,,
6832,156833,Articulins,CC1CCC23COC(=O)C2=CC(CC3C1(C)CCC4=CC(=O)OC4)O,,,,,,
6833,156834,Epitaondiol,CC1=CC(=CC2=C1O[C@]3(CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@H]3C2)C)(C)C)O)C)C)O,,,,,,
6834,156835,Strobamine,CN1[C@@H]2CC[C@H]1C3=C(C2)O[C@@H](CC3=O)C4=CC=CC=C4,,,,,,
6835,156836,14-Acetyldictyocarpine,CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4(C6C7OC(=O)C)O)OC)OCO5)OC(=O)C)OC)C,,,,,,
6836,156837,17-n-Pentylsparteine dihydrogen tartrate,CCCCCC1C2CC(CN3C2CCCC3)C4N1CCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
6837,156838,17-Pentylsparteine,CCCCCC1C2CC(CN3C2CCCC3)C4N1CCCC4,,,,,,
6838,156839,CID 156839,CC1=C(C(=CC=C1)C)N([C@@H](C)C(=O)OC)C(=O)COC.C(CN=C(S)[S-])N=C(S)[S-].C(CN=C(S)[S-])N=C(S)[S-].[Mn+2].[Zn+2],,,,,,
6839,156840,(S)-Metalaxyl,CC1=C(C(=CC=C1)C)N([C@@H](C)C(=O)OC)C(=O)COC,,,,,,
6840,156841,"3,7-Dimethylocta-2,7-dienyl propanoate",CCC(=O)OCC=C(C)CCCC(=C)C,,,,,,
6841,156842,17-n-Butylsparteine dihydrogen tartrate,CCCCC1C2CC(CN3C2CCCC3)C4N1CCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
6842,156843,17-Butylsparteine,CCCCC1C2CC(CN3C2CCCC3)C4N1CCCC4,,,,,,
6843,156844,"7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride",CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.Cl,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
6844,156845,Technetium citrate,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[99Tc],,,,,,
6845,156846,CID 156846,CC1=C(SCCO1)C(=O)NC2=CC=CC=C2.COC(=O)NC1=NC2=CC=CC=C2N1.C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Cu+2],,,,,,
6846,156847,"2-Propenamide, homopolymer, reaction products with dimethylamine and formaldehyde, di-Me sulfate-quaternized",CNC.COS(=O)(=O)OC.C=CC(=O)N.C=O,,,,,,
6847,156848,CID 156848,CC1C2CC(C(C=CC=C(CC3=CC(=C(C=C3NC(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)C)Cl)OC)C)OC)(NC(=O)O2)O,,,,,,
6848,156849,5-[2-(benzenesulfonyl)ethyl]-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole;hydrobromide,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br,,,,,,
6849,156850,5-[2-(benzenesulfonyl)ethyl]-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,,,,,,
6850,156851,CID 156851,CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,,,,,,
6851,156852,10-Hydroxycoronaridine,CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)O)C(=O)OC,,,,,,
6852,156853,"(3R,3aS,9aS,9bS)-3a,6-dimethylspiro[1,2,8,9,9a,9b-hexahydrocyclopenta[a]naphthalene-3,5'-oxolane]-2',7-dione",CC1=C2C=C[C@]3([C@H]([C@@H]2CCC1=O)CC[C@@]34CCC(=O)O4)C,,,,,,
6853,156854,CID 156854,CCOC1=C2C3=C(C[C@H]4C5=CC=C([C@@H]([C@@]53CCN4C)O2)OC)C=C1,,,,,,
6854,156855,gamma-Chloronorvaline,C[C@@H](C[C@@H](C(=O)O)N)Cl,,,,,,
6855,156856,"[(1R,2R,6S,7S,8R,10S,11S,12R,14S,16S,17R,18R)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-nona-1,3-dienyl-5-oxo-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] acetate",CCCCCC=CC=C[C@]12O[C@@H]3[C@@H]4[C@H]5[C@](O5)([C@H]([C@]6([C@H]([C@@]4(O1)[C@@H]([C@H]([C@@]3(O2)C(=C)C)OC(=O)C)C)C=C(C6=O)C)O)O)CO,,,,,,
6856,156857,Dihydroxyaflavinine,C[C@@H]1CC[C@@H](C23[C@]1([C@@H](C[C@H]([C@H]2C(=C(CC3)[C@H](C)CO)C4=CNC5=CC=CC=C54)C)O)C)O,,,,,,
6857,156858,"Cyanamide (4,6-bis((1-methylethylamino)-1,3,5-triazin-2-yl)methyl-, sulfate (1:1)",CC(C)NC1=NC(=NC(=N1)N(C)C#N)NC(C)C.OS(=O)(=O)O,,,,,,
6858,156859,Thionium,CCCCCCCCCCOC(=O)C[N+](C)(C)CCSCC[N+](C)(C)CC(=O)OCCCCCCCCCC.[Cl-].[Cl-],,,,,,
6859,156860,"Ethanaminium, 2,2'-thiobis[N-[2-(decyloxy)-2-oxoethyl]-N,N-dimethyl-",CCCCCCCCCCOC(=O)C[N+](C)(C)CCSCC[N+](C)(C)CC(=O)OCCCCCCCCCC,,,,,,
6860,156861,"N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[[3-[1-(dimethylamino)propan-2-ylamino]-3-oxopropyl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-6-hydroxy-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-(4-methylhex-2-enoyl)pyrrolidine-2-carboxamide",CCC(C)C=CC(=O)N1CC(CC1C(=O)NC(CC(C)CC(CC(=O)CC)O)C(=O)NC(C(C(C)C)O)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCC(=O)NC(C)CN(C)C)C,,,,,,
6861,156862,"N-[6-hydroxy-1-[[3-hydroxy-4-methyl-1-[[2-methyl-1-[[4-methyl-1-[[4-methyl-1-[[2-methyl-1-[[2-methyl-1-[[3-[1-(methylamino)propan-2-ylamino]-3-oxopropyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-(4-methylhex-2-enoyl)pyrrolidine-2-carboxamide",CCC(C)C=CC(=O)N1CC(CC1C(=O)NC(CC(C)CC(CC(=O)CC)O)C(=O)NC(C(C(C)C)O)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NCCC(=O)NC(C)CNC)C,,,,,,
6862,156863,Propantheline iodide,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[I-],,,,,,
6863,156864,"2-(2',3'-Dichloro-4'-carboxymethyleneoxybenzoyl)chromone",C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)C3=C(C(=C(C=C3)OCC(=O)O)Cl)Cl,,,,,,
6864,156865,CID 156865,CC1=C[C@@H]2[C@@](CC1)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)OC(=O)C=CC=CC([C@H](C)O)O)C)CO,,,,,,
6865,156866,Aspirin phenylalanine ethyl ester,CCOC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=CC=C2OC(=O)C,,,,,,
6866,156867,Pyronaridine Tetraphosphate,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
6867,156868,Desethylprocainamide,CCNCCNC(=O)C1=CC=C(C=C1)N,,,,,,
6868,156869,1-Triphenylenol,C1=CC=C2C(=C1)C3=C(C4=CC=CC=C24)C(=CC=C3)O,,,,,,
6869,156870,Dehydrostephanine,CN1CCC2=CC3=C(C4=C5C=CC=C(C5=CC1=C24)OC)OCO3,,,,,,
6870,156871,2-Cyano-2-hydroxyiminoacetamide copper,C(=C(C(=O)N)N=O)=[N-].C(=C(C(=O)N)N=O)=[N-].[Cu+2],,,,,,
6871,156872,CID 156872,C(#N)C(=C(N)O)N=O,,,,,,
6872,156873,"Phosphorothioic acid, O,O-dimethyl S-propyl ester",CCCSP(=O)(OC)OC,,,,,,
6873,156874,Pivalopril,CC(CSC(=O)C(C)(C)C)C(=O)N(CC(=O)O)C1CCCC1,,,,,,
6874,156875,Cleomiscosin B,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(C=C4C=CC(=O)OC4=C3O2)OC)CO)O,,,,,,
6875,156876,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrahydro-2-(3-methoxyphenyl)-",COC1=CC=CC(=C1)N2C(=O)C3=C(C2=O)CCCC3,,,,,,
6876,156877,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrahydro-2-(4-(trifluoromethyl)phenyl)-",C1CCC2=C(C1)C(=O)N(C2=O)C3=CC=C(C=C3)C(F)(F)F,,,,,,
6877,156878,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrahydro-2-(4-methoxy-3-methylphenyl)-",CC1=C(C=CC(=C1)N2C(=O)C3=C(C2=O)CCCC3)OC,,,,,,
6878,156879,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-3-nitrophenyl)-4,5,6,7-tetrahydro-",C1CCC2=C(C1)C(=O)N(C2=O)C3=CC(=C(C=C3)Cl)[N+](=O)[O-],,,,,,
6879,156880,"Benzamide, 2,6-difluoro-N-(((6-(3-(trifluoromethyl)phenoxy)-3-pyridinyl)amino)carbonyl)-",C1=CC(=CC(=C1)OC2=NC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F)C(F)(F)F,,,,,,
6880,156881,"Benzamide, N-(((6-((2,4-dichlorophenyl)methoxy)-3-pyridinyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CN=C(C=C2)OCC3=C(C=C(C=C3)Cl)Cl)F,,,,,,
6881,156882,"Benzamide, 2-chloro-N-(((6-((2,4-dichlorophenyl)methoxy)-3-pyridinyl)amino)carbonyl)-6-fluoro-",C1=CC(=C(C(=C1)Cl)C(=O)NC(=O)NC2=CN=C(C=C2)OCC3=C(C=C(C=C3)Cl)Cl)F,,,,,,
6882,156883,"L-Prolinamide, N-((tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)",C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)C3CCC(=O)O3)C(=O)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)']",,,
6883,156884,"3,5-Pyrazolidinedione, 4-butyl-4-(4-morpholinylmethyl)-1,2-diphenyl-",CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)CN4CCOCC4,,,,,,
6884,156885,"8-Hydroxy-8-(3-hydroxybut-1-enyl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one",CC(C=CC1(C2(CC(=O)CC1(OC2)C)C)O)O,,,,,,
6885,156886,CID 156886,CC1=C(C2=C(C=C1)C(=O)N3C=C(C=C3C=N2)C=CC(=O)N)O,,,,,,
6886,156887,"O,S-Dimethyl phenylphosphonothioate",COP(=O)(C1=CC=CC=C1)SC,,,,,,
6887,156888,Ethyl acifluorfen,CCOC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
6888,156889,"(1R,9S,10R,11S)-17-(cyclobutylmethyl)-11-methyl-13-methylidene-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",C[C@H]1CC(=C)C[C@@]23[C@@H]1[C@H](CC4=C2C=C(C=C4)O)N(CC3)CC5CCC5,,,,,,
6889,156890,"1H-Imidazo(4,5-b)pyridine, 2-(2,4-dimethoxyphenyl)-",COC1=CC(=C(C=C1)C2=NC3=C(N2)C=CC=N3)OC,,,,,,
6890,156891,"1,5-Naphthalenedisulfonic acid, 2-[[8-[[4-chloro-6-[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]azo]-, pentasodium salt",C1=CC(=CC(=C1)S(=O)(=O)CCOS(=O)(=O)[O-])NC2=NC(=NC(=N2)Cl)NC3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C(=C4O)N=NC5=C(C6=C(C=C5)C(=CC=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
6891,156892,"5-[[4-Chloro-6-[3-(2-sulfooxyethylsulfonyl)anilino]-1,3,5-triazin-2-yl]amino]-3-[(1,5-disulfonaphthalen-2-yl)diazenyl]-4-hydroxynaphthalene-2,7-disulfonic acid",C1=CC(=CC(=C1)S(=O)(=O)CCOS(=O)(=O)O)NC2=NC(=NC(=N2)Cl)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=C(C6=C(C=C5)C(=CC=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6892,156893,Methyl acrylamidoglycolate methyl ether,COC(C(=O)OC)NC(=O)C=C,,,,,,
6893,156894,2-Phenyl-4-(2-(piperidin-3-yl)ethyl)quinoline,C1CC(CNC1)CCC2=CC(=NC3=CC=CC=C32)C4=CC=CC=C4,,,,,,
6894,156895,"4beta,15-Diacetoxy-3alpha-hydroxy-12,13-epoxytrichothec-9-en-8-one",CC1=C[C@@H]2[C@](CC1=O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,,,,,,
6895,156896,3-(3-Methylthiophen-2-yl)-propenoic acid,CC1=C(SC=C1)C=CC(=O)O,,,,,,
6896,156897,CID 156897,C1CN(CCN1)C2=NC3=C(C(=N2)N4CCS(CC4)[O-])N=CN=C3SCCC5=CC=CC=C5,,,,,,
6897,156898,CID 156898,C1CN(CCN1)C2=NC3=C(C(=N2)N4CCS(CC4)O)N=CN=C3SCCC5=CC=CC=C5,,,,,,
6898,156899,3-Hydroxybutyl lactate,CC(CCOC(=O)C(C)O)O,,,,,,
6899,156900,"Ethanol, 2,2',2''-nitrilotris-, nitrate (salt), mixt. with hydroxylamine nitrate (salt)",C(CO)N(CCO)CCO.NO.[N+](=O)(O)[O-].[N+](=O)(O)[O-],,,,,,
6900,156901,"1,3,5-Triazine-2,4(1H,3H)-dione, 1-amino-3-(2,2-dimethylpropyl)-6-(ethylthio)-",CCSC1=NC(=O)N(C(=O)N1N)CC(C)(C)C,,,,,,
6901,156902,"1-(2,3-Dihydroxypropyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",CCC1(C(=O)NC(=O)N(C1=O)CC(CO)O)C2=CC=CC=C2,,,,,,
6902,156903,"Acetamide, 2-chloro-N-(ethoxymethyl)-N-(2-methyl-6-(1-methylethoxy)phenyl)-",CCOCN(C1=C(C=CC=C1OC(C)C)C)C(=O)CCl,,,,,,
6903,156904,"Acetamide, 2-chloro-N-(ethoxymethyl)-N-(2-methyl-6-propoxyphenyl)-",CCCOC1=CC=CC(=C1N(COCC)C(=O)CCl)C,,,,,,
6904,156905,"Acetamide, 2-chloro-N-(2-methoxy-3,6-dimethylphenyl)-N-((1-methylethoxy)methyl)-",CC1=C(C(=C(C=C1)C)OC)N(COC(C)C)C(=O)CCl,,,,,,
6905,156906,"Acetamide, 2-chloro-N-methyl-N-(2-methyl-6-(3-methylbutoxy)phenyl)-",CC1=C(C(=CC=C1)OCCC(C)C)N(C)C(=O)CCl,,,,,,
6906,156907,"Acetamide, 2-chloro-N-methyl-N-(2-methyl-6-(1-methylethoxy)phenyl)-",CC1=C(C(=CC=C1)OC(C)C)N(C)C(=O)CCl,,,,,,
6907,156908,Ethyl 2-[2-(4-methylphenyl)-4-oxochromen-7-yl]oxyacetate,CCOC(=O)COC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=C(C=C3)C,,,,,,
6908,156909,3-(5-tert-Butyl-3-isoxazolyl)-4-hydroxy-1-methyl-2-imidazolidinone,CC(C)(C)C1=CC(=NO1)N2C(CN(C2=O)C)O,,,,,,
6909,156910,"2-Imidazolidinone, 3-(3-(1,1-dimethylethyl)-5-isoxazolyl)-4-hydroxy-1-methyl-",CC(C)(C)C1=NOC(=C1)N2C(CN(C2=O)C)O,,,,,,
6910,156911,CID 156911,CC1=C2C(=CC(=C2C=C(C=C1)C(C)C)C)S(=O)(=O)[O-].C(CC(=O)N)[C@@H](C(=O)O)N.[Na+],,,,,,
6911,156912,"[(1R,2S,3R,4S,7R,9S,10R,12R,15R)-4,12-diacetyloxy-1,9,15-trihydroxy-10-(hydroxymethyl)-14,17,17-trimethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate",CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@](C2(C)C)(C[C@H]1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)CO)OC(=O)C,,,,,,
6912,156913,2-(Pentachlorophenoxy)phenol,C1=CC=C(C(=C1)O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
6913,156914,"Phenol, 4-(pentachlorophenoxy)-",C1=CC(=CC=C1O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
6914,156915,"Propanamide, N-(2,4-dichlorophenyl)-2,2-dimethyl-N-(3-pyridinylmethyl)-",CC(C)(C)C(=O)N(CC1=CN=CC=C1)C2=C(C=C(C=C2)Cl)Cl,,,,,,
6915,156916,"5-(4-Amino-6-(phenylamino)-1,3,5-triazin-2-yl)-4-hydroxy-3-((sulfophenyl)azo)-2,7-naphthalenedisulfonic acid trisodium salt",C1=CC=C(C=C1)NC2=NC(=NC(=N2)N)C3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C(=C4O)N=NC5=CC=CC=C5S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6916,156917,"5-(4-Amino-6-anilino-1,3,5-triazin-2-yl)-4-hydroxy-3-[(2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid",C1=CC=C(C=C1)NC2=NC(=NC(=N2)N)C3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=CC=CC=C5S(=O)(=O)O)S(=O)(=O)O,,,,,,
6917,156918,"Benzoic acid, 2-hydroxy-5-((4-((((4-((4-hydroxy-3-sulfophenyl)azo)phenyl)amino)carbonyl)amino)phenyl)azo)-, disodium salt",C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)S(=O)(=O)[O-])N=NC4=CC(=C(C=C4)O)C(=O)[O-].[Na+].[Na+],,,,,,
6918,156919,2-Hydroxy-5-[[4-[[4-[(4-hydroxy-3-sulfophenyl)diazenyl]phenyl]carbamoylamino]phenyl]diazenyl]benzoic acid,C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)S(=O)(=O)O)N=NC4=CC(=C(C=C4)O)C(=O)O,,,,,,
6919,156920,"1,2-Dibutylhydrazine dihydrochloride",CCCCNNCCCC.Cl.Cl,,,,,,
6920,156921,Ethyl 4-[4-(4-trifluoromethylphenoxy)phenoxy]-2-pentenoate,CCOC(=O)C=CC(C)OC1=CC=C(C=C1)OC2=CC=C(C=C2)C(F)(F)F,,,,,,
6921,156922,3-(tert-Butylamino)propionylindole hydrochloride hydrate,CC(C(=O)C1=CNC2=CC=CC=C21)NC(C)(C)C.O.Cl,,,,,,
6922,156923,2-(tert-butylamino)-1-(1H-indol-3-yl)propan-1-one,CC(C(=O)C1=CNC2=CC=CC=C21)NC(C)(C)C,,,,,,
6923,156924,"Benzamide, 2,6-difluoro-N-(((4-phenoxyphenyl)amino)carbonyl)-",C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
6924,156925,CID 156925,C1CCC23C(=C4C(=CC5=C6C4=C(C2(C1)O3)C=CC6=CC7=CC=CC=C75)O)O,,,,,,
6925,156926,CID 156926,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C(=O)CO.[O-]P(=O)([O-])[O-].[O-]S(=O)(=O)[O-].[Na+],,,,,,
6926,156927,3-Hydroxy-1-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)oxy]-1-phenylpropan-2-one,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C(=O)CO,,,,,,
6927,156928,Dimethyl l-curine dimethochloride,C[N+]1(CCC2=CC(=C3C=C2[C@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[Cl-].[Cl-],,,,,,
6928,156929,Acnistin A,C[C@]12CCC3C(C1CC[C@@]2([C@H]4C[C@@]5(C[C@H]4OC(=O)[C@]5(C)O)C)O)C[C@H]6[C@]7([C@@]3(C(=O)C=CC7)C)O6,,,,,,
6929,156930,Theophylline magnesium salicylate,CN1C2=C(C(=O)N(C1=O)C)NC=N2.C1=CC=C(C(=C1)C(O)[O-])[O-].[Mg+2],,,,,,
6930,156931,Salicylyl alcohol,C1=CC=C(C(=C1)C(O)O)O,,,,,,
6931,156932,CID 156932,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=NNC(=O)CC(CC(=O)NN=C(C)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=CC=CC=C9C8=O)O)OC1CC(C(C(O1)C)O)N)O)N)C)O)N)O.Cl.Cl.Cl,,,,,,
6932,156933,CID 156933,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=NNC(=O)CC(CC(=O)NN=C(C)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=CC=CC=C9C8=O)O)OC1CC(C(C(O1)C)O)N)O)N)C)O)N)O,,,,,,
6933,156934,Paraherquamide,C[C@]1(CCN2[C@]13C[C@@H]4[C@](C2)(C[C@@]5(C4(C)C)C6=C(C7=C(C=C6)OC(C=CO7)(C)C)NC5=O)N(C3=O)C)O,,,,,,
6934,156935,Cosmomycin B,CC[C@]1(CCC2=C([C@H]1O[C@H]3C[C@@H]([C@@H]([C@@H](O3)C)O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O[C@H]5CC[C@@H]([C@@H](O5)C)O)O)N(C)C)C(=C6C(=C2O)C(=O)C7=C(C6=O)C=CC=C7O)O)O,,,,,,
6935,156936,CID 156936,C[C@@H]1CC[C@]2(CCCCO2)O[C@@H]1[C@@H](C)CC([C@@H]3C(=C)[C@H]([C@H]4[C@H](O3)CC[C@]5(O4)CC[C@@H](O5)C=C[C@@H](C)[C@@H]6C[C@@]7([C@@H](S7)[C@@]8(O6)[C@@H](CC[C@H](O8)C[C@](C)(C(=O)O)O)O)C)O)O,,,,,,
6936,156937,"(6R,25)-5-O-Demethyl-28-deoxy-6,28-epoxy-25-(1-methylethyl)milbemycin B",C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)C)O[C@@H]1C(C)C,,,,,,
6937,156938,"cis-(1)-2,3,4,5-Tetrahydro-3-(methylamino)-1-benzoxepin-5-ol hydrochloride",CN[C@H]1C[C@H](C2=CC=CC=C2OC1)O.Cl,,,,,,
6938,156939,"methyl (2R)-3-[(2S,6R,8S,11R)-2-[(2R)-4-[(2S,2'R,4R,4aS,6R,8aR)-4-hydroxy-2-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2-yl]-11-hydroxy-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-hydroxy-2-methylpropanoate",C[C@@H]1CC[C@]2(CCCCO2)O[C@@H]1[C@@H](C)C[C@@H]([C@@H]3C(=C)[C@H]([C@H]4[C@H](O3)CC[C@]5(O4)CC[C@@H](O5)C=C[C@@H](C)[C@@H]6CC(=C[C@@]7(O6)[C@@H](CC[C@H](O7)C[C@](C)(C(=O)OC)O)O)C)O)O,,,,,,
6939,156940,"[(9S,10S)-8,8-dimethyl-10-(3-methylbutanoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-9-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1[C@H](C2=C(C=CC3=C2OC(=O)C=C3)OC1(C)C)OC(=O)CC(C)C,,,,,,
6940,156941,N-(5-Aminopentyl)actinomycin D hydrate,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCCCN)C,,,,,,
6941,156942,N-(8-Aminooctyl)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCCCCCCN)C,,,,,,
6942,156943,N(sup 2)-3'-Aminopropylactinomycin D dihydrate,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCN)C,,,,,,
6943,156944,"2H-Furo(2,3-h)-1-benzopyran-2-one, 4,8-dimethyl-7-((2-(dimethylamino)ethoxy)methyl)-",CC1=CC(=O)OC2=C1C=CC3=C2C(=C(O3)C)COCCN(C)C,,,,,,
6944,156945,N-Benzoyl-2'-deoxy-5'-O-(9-phenyl-9H-xanthen-9-yl)adenosine,C1[C@@H](C(O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC5(C6=CC=CC=C6OC7=CC=CC=C75)C8=CC=CC=C8)O,,,,,,
6945,156946,"Propan-2-yl 2-[4-[(7-chloro-1-oxido-1,2,4-benzotriazin-1-ium-3-yl)-methylamino]phenoxy]propanoate",CC(C)OC(=O)C(C)OC1=CC=C(C=C1)N(C)C2=NC3=C(C=C(C=C3)Cl)[N+](=N2)[O-],,,,,,
6946,156947,13-Methylaclacinomycin A,CC1C(C(CC(O1)OC2CC(C(C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5O)C(=O)OC)(C(C)C)O)N(C)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O,,,,,,
6947,156948,13-Methylaclacinomycin M,CC1C(CCC(O1)OC2C(OC(CC2O)OC3C(OC(CC3N(C)C)OC4CC(C(C5=CC6=C(C(=C45)O)C(=O)C7=C(C6=O)C=CC=C7O)C(=O)OC)(C(C)C)O)C)C)O,,,,,,
6948,156949,13-Methylaclacinomycin S,CC1C(C(CC(O1)OC2C(OC(CC2N(C)C)OC3CC(C(C4=CC5=C(C(=C34)O)C(=O)C6=C(C5=O)C=CC=C6O)C(=O)OC)(C(C)C)O)C)O)O,,,,,,
6949,156950,13-Methylaclacinomycin T,CC1C(C(CC(O1)OC2CC(C(C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5O)C(=O)OC)(C(C)C)O)N(C)C)O,,,,,,
6950,156951,Catharanthamine,CCC12CC3CN(C1)CCC4=C(C(C3O2)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)NC1=CC=CC=C41,,,,,,
6951,156952,"Benzenemethanol, 3,3'-azobis-",C1=CC(=CC(=C1)N=NC2=CC=CC(=C2)CO)CO,,,,,,
6952,156953,"3,3'-Azobisbenzenemethanol diacetate (ester)",CC(=O)OCC1=CC(=CC=C1)N=NC2=CC=CC(=C2)COC(=O)C,,,,,,
6953,156954,Rubeomycin B,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(C)O)O)N)OC(CC(C)O)OC(C)CO,,,,,,
6954,156955,Carminomycin II,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)C)O)N)OC(CC(C)O)OC(C)CO,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)']",,,
6955,156956,"(11-Chloro-15,21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 3-[methyl(2-methylpropanoyl)amino]butanoate",CC1C2CC(C(C=CC=C(C(C3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)CC(C)N(C)C(=O)C(C)C)C)O)C)OC)(NC(=O)O2)O,,,,,,
6956,156957,"Bis(D-gluconato(2-)-O1,O2)oxotechnetate(1-)-99Tc",C(C(C(C(C(C(C(=O)[O-])[O-])O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])[O-])O)O)O)O)O.O=[99Tc+3],,,,,,
6957,156958,"Urea, (2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-, monohydrochloride",C1CN(CCN1CCNC(=O)N)C2=CC=CC(=C2)C(F)(F)F.Cl,,,,,,
6958,156959,"Furo(3,2-c)pyridine, 4,5-dihydro-5-methyl-4-(2-propenyl)-",CN1C=CC2=C(C1CC=C)C=CO2,,,,,,
6959,156960,"Benzene, 1-methoxy-2-(1,2,2,2-tetrachloroethyl)-",COC1=CC=CC=C1C(C(Cl)(Cl)Cl)Cl,,,,,,
6960,156961,CID 156961,COC1=CC=C(C=C1)C(=CCl)C2=CC=CC=C2OC,,,,,,
6961,156962,"Benzene, 1-(2,2-dichloro-1-(4-methoxyphenyl)ethenyl)-2-methoxy-",COC1=CC=C(C=C1)C(=C(Cl)Cl)C2=CC=CC=C2OC,,,,,,
6962,156963,"Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(2-methoxy-",COC1=CC=CC=C1C(C2=CC=CC=C2OC)C(Cl)(Cl)Cl,,,,,,
6963,156964,"Benzene, 1,1'-thiobis(3,4-dichloro-",C1=CC(=C(C=C1SC2=CC(=C(C=C2)Cl)Cl)Cl)Cl,,,,,,
6964,156965,"Pentanoic acid, 4-methyl-2-(1-methylethyl)-, (3-phenoxyphenyl)methyl ester",CC(C)CC(C(C)C)C(=O)OCC1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
6965,156966,"Butanoic acid, 2-(4-methoxyphenoxy)-3-methyl-, (3-phenoxyphenyl)methyl ester",CC(C)C(C(=O)OCC1=CC(=CC=C1)OC2=CC=CC=C2)OC3=CC=C(C=C3)OC,,,,,,
6966,156967,"Benzamide, N-(acetyloxy)-4-butoxy-",CCCCOC1=CC=C(C=C1)C(=O)NOC(=O)C,,,,,,
6967,156968,(R)-2-Bromo-3-methylbutyric acid,CC(C)[C@H](C(=O)O)Br,,,,,,
6968,156969,"Sulfamide, trimethyl((4-nitrophenyl)methyl)-",CN(C)S(=O)(=O)N(C)CC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
6969,156970,"(2,4-Dichloropyrido[3,2-d]pyrimidin-6-yl)methyl acetate",CC(=O)OCC1=NC2=C(C=C1)N=C(N=C2Cl)Cl,,,,,,
6970,156971,CID 156971,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)N=C(N)S)O)O)O)O,,,,,,
6971,156972,CID 156972,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)OCCOCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=C(C=C5)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
6972,156973,2-[2-[4-[(4-Chlorophenyl)benzyl]piperazin-1-YL]ethoxy]ethyl 2-(3-benzoylphenyl)propionate,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)OCCOCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=C(C=C5)Cl,,,,,,
6973,156974,"Piperazine, 1-(3-pyridinylmethyl)-, monoacetate",CC(=O)O.C1CN(CCN1)CC2=CN=CC=C2,,,,,,
6974,156975,1-(Pyridin-3-ylmethyl)piperazine,C1CN(CCN1)CC2=CN=CC=C2,,,,,,
6975,156976,CID 156976,COC1=CC(=CC(=C1OC)O)C2=CC(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
6976,156977,"L-Cysteine, N-acetyl-S-(chlorophenyl)-",CC(=O)N[C@@H](CSC1=CC=CC=C1Cl)C(=O)O,,,,,,
6977,156978,"2-Azetidinone, 4-((2-(hydroxymethyl)phenyl)thio)-",C1C(NC1=O)SC2=CC=CC=C2CO,,,,,,
6978,156979,"1,3-Benzodioxole-5-carboxylic acid, 6-(2-(dimethylamino)ethyl)-",CN(C)CCC1=CC2=C(C=C1C(=O)O)OCO2,,,,,,
6979,156980,"4H-Pyrrolo(2,1-b)(1,3)benzodiazepine",C1=CC=C2C(=C1)C=CN3C=CC=C3N2,,,,,,
6980,156981,"Benzenesulfonic acid, 4-pentadecyl-",CCCCCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
6981,156982,"4,7-Epoxy-1H-isoindole-1,3(2H)-dione, hexahydro-3a,7a-dimethyl-2-(2-propenyl)-, (3aalpha,4beta,7beta,7aalpha)-",C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)N(C2=O)CC=C)C)O3,,,,,,
6982,156983,CID 156983,CC1=C[C@H](OC1=O)OC=C2[C@H]3CC4=CC=CC=C4[C@H]3OC2=O,,,,,,
6983,156984,CID 156984,CC1=CC(OC1=O)OC=C2[C@H]3CC=C[C@H]3OC2=O,,,,,,
6984,156985,Hispor,CCCC1COC(O1)(CN2C=NC=N2)C3=C(C=C(C=C3)Cl)Cl.COC(=O)NC1=NC2=CC=CC=C2N1,,,,,,
6985,156986,Astraciceran,COC1=CC2=C(C=C1C3CC4=C(C=C(C=C4)O)OC3)OCO2,,,,,,
6986,156987,Lysine amidotrizoate,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.C(CCN)C[C@@H](C(=O)O)N,,,,,,
6987,156988,"(3aS,6aS)-3-[[(2S)-4-methyl-5-oxo-2H-furan-2-yl]oxymethylidene]-4,6a-dihydro-3aH-cyclopenta[b]furan-2-one",CC1=C[C@H](OC1=O)OC=C2[C@@H]3CC=C[C@@H]3OC2=O,,,,,,
6988,156989,1-Nonacosene,CCCCCCCCCCCCCCCCCCCCCCCCCCCC=C,,,,,,
6989,156990,"8-Azabicyclo(3.2.1)octane-2-methanol, 3-(acetyloxy)-8-methyl-alpha-phenyl-, (alphaR,1R,2R,3R,5S)-",CC(=O)O[C@@H]1C[C@@H]2CC[C@H]([C@@H]1[C@H](C3=CC=CC=C3)O)N2C,,,,,,
6990,156991,Knightinol acetate,CC(=O)O[C@H]1C[C@@H]2CC[C@H]([C@@H]1[C@H](C3=CC=CC=C3)OC(=O)C)N2C,,,,,,
6991,156992,"5,8,2'-Trihydroxy-7-methoxyflavone",COC1=C(C2=C(C(=C1)O)C(=O)C=C(O2)C3=CC=CC=C3O)O,,,,,,
6992,156993,"5,8,2'-Trihydroxy-6,7-dimethoxyflavone",COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3O)O)OC,,,,,,
6993,156994,"Benz(e)acephenanthrylene, 11,12-dihydro-",C1CC2=C3C=CC=C4C3=C(C=C2C=C1)C5=CC=CC=C54,,,,,,
6994,156995,"7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-bis((3,3-dimethyloxiranyl)methoxy)-",CC1(C(O1)COC2=C3C=COC3=C(C4=C2C=CC(=O)O4)OCC5C(O5)(C)C)C,,,,,,
6995,156996,Baptifoline acetate,CC(=O)OC1CCN2CC3CC(C2C1)CN4C3=CC=CC4=O,,,,,,
6996,156997,(4S)-4-Hydroxy-3-methyl-2-prop-2-ynyl-cyclopent-2-EN-1-one,CC1=C(C(=O)C[C@@H]1O)CC#C,,,,,,
6997,156998,"2,6-Methano-2H-1-benzoxocin-5-methanol, 3,4,5,6-tetrahydro-7-hydroxy-alpha,alpha,2-trimethyl-9-propyl-",CCCC1=CC(=C2C3CC(CCC3C(C)(C)O)(OC2=C1)C)O,,,,,,
6998,156999,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-2-hydroxy-1,4a-dimethyl-7-(1-methylethenyl)-, (1S,2S,4aS,10aR)-",CC(=C)C1=CC2=C(C=C1)[C@]3(CC[C@@H]([C@H]([C@H]3CC2)C(=O)OC)O)C,,,,,,
6999,157000,Yuankanin,COC1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)O)O)O)C(=O)C=C(O2)C5=CC=C(C=C5)O,,,,,,
7000,157001,"Carbamodithioic acid, cyclohexylmethyl-, sodium salt",CN(C1CCCCC1)C(=S)S.[Na+],,,,,,
7001,157002,Methylcyclohexyldithiocarbamic acid,CN(C1CCCCC1)C(=S)S,,,,,,
7002,157003,"Ethanamine, 2-(4-(1,2-dichloro-1,2-diphenylethyl)phenoxy)-N,N-diethyl-",CCN(CC)CCOC1=CC=C(C=C1)C(C2=CC=CC=C2)(C(C3=CC=CC=C3)Cl)Cl,,,,,,
7003,157004,3-Chloro-2-methoxyphenol,COC1=C(C=CC=C1Cl)O,,,,,,
7004,157005,"Phenol, 2,3-dichloro-6-methoxy-",COC1=C(C(=C(C=C1)Cl)Cl)O,,,,,,
7005,157006,"Benzene, 1-ethenyl-4,5-dimethoxy-2-(1-methylethoxy)-",CC(C)OC1=CC(=C(C=C1C=C)OC)OC,,,,,,
7006,157007,"Benzene, 1,2-dimethoxy-4-(1-methylethoxy)-",CC(C)OC1=CC(=C(C=C1)OC)OC,,,,,,
7007,157008,"azane;(6R,7R)-7-[[(2S)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@H](C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O.N.N,,,,,,
7008,157009,"(6R,7R)-7-[[(2S)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@H](C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,,,,,,
7009,157010,CID 157010,CC1(C2CC3C(C(=O)C(=C(NCNC4C(C(C(OC4O)CO)O)O)O)C(=O)C3(C(=O)C2=C(C5=C1C=CC=C5O)O)O)N(C)C)O.Cl.Cl,,,,,,
7010,157011,CID 157011,CC1(C2CC3C(C(=O)C(=C(NCNC4C(C(C(OC4O)CO)O)O)O)C(=O)C3(C(=O)C2=C(C5=C1C=CC=C5O)O)O)N(C)C)O,,,,,,
7011,157012,"(3R,4R)-3,4-dihydrophenanthrene-3,4-diol",C1=CC=C2C(=C1)C=CC3=C2[C@H]([C@@H](C=C3)O)O,,,,,,
7012,157013,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-((O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy)-5-hydroxy-7-methoxy-",COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O,,,,,,
7013,157014,Nkolbisine,CC(C)(C(COC1=C(C=C2C(=C1)C(=C3C=COC3=N2)OC)OC)O)O,,,,,,
7014,157015,CID 157015,C1=CC(=C(C=C1[C@]2([C@H]([C@@H]([C@](O[C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)(C(=O)OC4=COC5=CC(=O)C=CC5=C4O)O)O)O)O)O)O,,,,,,
7015,157016,"3-(Butan-2-yl)-3,4,8-trihydroxy-7-methyl-8-(propan-2-yl)-3,4,11,13,15,16,16a,16b-octahydro-7H-[1,5,10]trioxacyclotetradecino[7,8,9-gh]pyrrolizine-2,5,9(8H)-trione",CCC(C)C1(C(C(=O)OC(C(C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C(C)C)O)C)O)O,,,,,,
7016,157017,"(1R,19R)-4,5,9-Trihydroxy-4-(2-hydroxybutan-2-yl)-8-methyl-9-propan-2-yl-2,7,11-trioxa-16-azatricyclo[11.5.1.016,19]nonadec-13-ene-3,6,10-trione",CCC(C)(C1(C(C(=O)OC(C(C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C(C)C)O)C)O)O)O,,,,,,
7017,157018,(4R)-4-aminohex-5-enoic acid,C=C[C@@H](CCC(=O)O)N,,,,,,
7018,157019,CID 157019,CC(=CCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3)CO,,,,,,
7019,157020,"Phosphonic acid, (4-hydroxyphenyl)-, monoethyl ester",CCOP(=O)(C1=CC=C(C=C1)O)O,,,,,,
7020,157021,Trichilin C,CCC(C)C(=O)OC1C2(C3CC(C4(C(C3(CO1)C(C(C2OC(=O)C)OC(=O)C)O)C(C(=O)C5(C46C(O6)CC5C7=COC=C7)C)O)C)O)C,,,,,,
7021,157022,Meliatoxin A1,CCC(C)C(=O)OC1C2(C3CC(C4(C(C3(CO1)C(C(C2OC(=O)C)OC(=O)C)O)C(=O)CC5(C46C(O6)CC5C7=COC=C7)C)C)O)C,,,,,,
7022,157023,"2-[[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]iminomethyl]phenol",C1=CC=C(C(=C1)C=NC2=NC(=CS2)C3=CC=C(C=C3)Cl)O,,,,,,
7023,157024,Trichilin B,CCC(C)C(=O)OC1C2(C3CC(C4(C(C3(CO1)C(C(C2OC(=O)C)OC(=O)C)O)C(=O)C(C5(C46C(O6)CC5C7=COC=C7)C)O)C)O)C,,,,,,
7024,157025,Halosafen,CCS(=O)(=O)NC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Cl)C(F)(F)F)F)[N+](=O)[O-],,,,,,
7025,157026,"3,5-Dichloro-4-fluorobenzotrifluoride",C1=C(C=C(C(=C1Cl)F)Cl)C(F)(F)F,,,,,,
7026,157027,N-[4-[(6-methoxyquinolin-8-yl)amino]pentyl]acetamide,CC(CCCNC(=O)C)NC1=C2C(=CC(=C1)OC)C=CC=N2,,,,,,
7027,157028,"1-Bromo-5-(2,2-dimethyl-6-methylidenecyclohex-3-en-1-yl)-3-methylpent-3-en-2-ol",CC(=CCC1C(=C)CC=CC1(C)C)C(CBr)O,,,,,,
7028,157029,"Furo(3,4-b)(1)benzoxepin, 7-bromo-1,3,3a,4a,5,6,7,8,8a,9-decahydro-4a,8,8-trimethyl-, (3aR,4aS,7S,8aS)-",C[C@]12CC[C@@H](C([C@@H]1CC=C3COC[C@@H]3O2)(C)C)Br,,,,,,
7029,157030,"Barium, (3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione-N7,O6)(2-hydroxybenzoato(2-)-O1,O2)-, (T-4)-",CN1C2=C(C(=O)N(C1=O)C)NC=N2.C1=CC=C(C(=C1)C(=O)[O-])[O-].[Ba+2],,,,,,
7030,157031,"1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-3-methyl-4-(2-propenyl)-",CN1CC2CC(C1CC=C)CN3C2=CC=CC3=O,,,,,,
7031,157032,4-Fluoro-3-phenoxybenzoic acid,C1=CC=C(C=C1)OC2=C(C=CC(=C2)C(=O)O)F,,,,,,
7032,157033,"Benz(a)acridine-3,4-diol, 3,4-dihydro-, trans-",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=N2)[C@@H]([C@H](C=C4)O)O,,,,,,
7033,157034,"2-Pyrimidinamine, 1,6-dihydro-N,N,4,6,6-pentamethyl-",CC1=CC(N=C(N1)N(C)C)(C)C,,,,,,
7034,157035,CID 157035,CCCCCC=CC(CC=CCO)OC1CCCCO1,,,,,,
7035,157036,"Cobalt(1+), dimethyl(2,3,9,10-tetramethyl-1,4,8,11-tetraazacyclotetradeca-1,3,8,10-tetraene-N1,N4,N8,N11)-, (OC-6-11)-, perchlorate",[CH3-].[CH3-].CC1=NCCCN=C(C(=NCCCN=C1C)C)C.[O-]Cl(=O)(=O)=O.[Co+3],,,,,,
7036,157037,"N,N''-(Trimethylene)-N',N'''-(trimethylene)bis(2,3-butanediimine)",CC1=NCCCN=C(C(=NCCCN=C1C)C)C,,,,,,
7037,157038,"Technetium-99Tc, bis(N-(carboxymethyl)-N-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)glycinato(2-))-",CC1=C(C(=CC=C1)C)NC(=O)CN(CC(=O)[O-])CC(=O)[O-].CC1=C(C(=CC=C1)C)NC(=O)CN(CC(=O)[O-])CC(=O)[O-].[99Tc+4],,,,,,
7038,157039,p-O-Desmethyl Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)O)OC)(C#N)C2=CC(=C(C=C2)OC)OC,,,,,['D-702 is a known human metabolite of Verapamil.'],
7039,157040,"Ergosta-3,5-diene, (24xi)-",C[C@H](CCC(C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC=C4)C)C,,,,,,
7040,157041,CID 157041,COC1=CC2=C(C(=C1)OC)C3=C(OC4=CC(=O)C=CC4=C3O2)O,,,,,,
7041,157042,Bromochloroamine,N(Cl)Br,,,,,,
7042,157043,"Benzamide, N-(((3,5-dichloro-4-((2,2-dichlorocyclopropyl)methoxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1C(C1(Cl)Cl)COC2=C(C=C(C=C2Cl)NC(=O)NC(=O)C3=C(C=CC=C3F)F)Cl,,,,,,
7043,157044,"1-Butanol, 4-(nitrosoamino)-",C(CCO)CNN=O,,,,,,
7044,157045,6-Glucopyranosyl 3'-azido-3'-deoxy-5'-thymidinyl phosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@H](O3)O)O)O)O)N=[N+]=[N-],,,,,,
7045,157046,"4-(3,4-Dichlorophenyl)-2-[[2-(4-methylpiperazin-1-yl)phenyl]methylidene]thiomorpholin-3-one;2-hydroxypropane-1,2,3-tricarboxylic acid",CN1CCN(CC1)C2=CC=CC=C2C=C3C(=O)N(CCS3)C4=CC(=C(C=C4)Cl)Cl.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
7046,157047,"4-(3,4-Dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one",CN1CCN(CC1)C2=CC=CC=C2C=C3C(=O)N(CCS3)C4=CC(=C(C=C4)Cl)Cl,,,,,,
7047,157048,CID 157048,CN1CCN(CC1)C2=CC=CC=C2C=C3C(=O)N(CCS3)C4=CC(=C(C=C4)Cl)Cl.Cl,,,,,,
7048,157049,Ertiprotafib,CC1=CC(=CC(=C1O[C@H](CC2=CC=CC=C2)C(=O)O)C)C3=C4C(=C(SC4=C(C5=CC=CC=C53)Br)C)C,['Investigated for use/treatment in diabetes mellitus type 2.'],,,,,
7049,157050,"[(13S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate",CC(=O)OC1=CC2=C(C=C1)C3CC[C@@]4([C@H](CCC4C3CC2)O)C,,,,,,
7050,157051,"[(7S)-5-oxo-6,7-dihydropyrrolo[3,4-b]pyrazin-7-yl] 2-(5-chloropyridin-2-yl)-4-methylpiperazine-1-carboxylate",CN1CCN(C(C1)C2=NC=C(C=C2)Cl)C(=O)O[C@H]3C4=NC=CN=C4C(=O)N3,,,,,,
7051,157052,"ethyl (8S,9S,10R,11S,13S,14S)-17-(2,2-dichloroacetyl)oxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate",CCOC(=O)C1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)C(Cl)Cl,,,,,,
7052,157053,Bivittoside A,CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CC(C67C5(CCC6C(OC7=O)(C)CCCC(C)C)C)O)C)O)O)O)O)O,,,,,,
7053,157054,CID 157054,CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CC(C67C5(CCC6C(OC7=O)(C)CCCC(C)C)C)O)C)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)OC)O)O)O)O)O)O,,,,,,
7054,157055,"16-[5-[4-[3,5-Dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[5-[4-[3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-11-en-8-one",CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CCC67C5(CCC6C(OC7=O)(C)CCCC(C)C)C)C)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)OC)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)CO)O)OC)O)O,,,,,,
7055,157056,"16-[5-[4-[3,5-Dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[5-[4-[3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxyoxan-2-yl]oxy-10-hydroxy-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-11-en-8-one",CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)C)CCC5C4=CC(C67C5(CCC6C(OC7=O)(C)CCCC(C)C)C)O)C)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)OC)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)OC1C(C(C(C(O1)CO)O)OC)O)O,,,,,,
7056,157057,"2,7-Dihydroxycadalene",CC1=CC2=C(C=C1O)C(=C(C=C2C(C)C)O)C,,,,,,
7057,157058,"Acetic acid, hydroxy((1-oxo-2-propenyl)amino)-, methyl ester",COC(=O)C(NC(=O)C=C)O,,,,,,
7058,157059,"4H-Dibenzo(de,g)quinoline-2,7-diol, 5,6,6a,7-tetrahydro-1-methoxy-, (6aS,7R)-",COC1=C(C=C2CCN[C@H]3C2=C1C4=CC=CC=C4[C@H]3O)O,,,,,,
7059,157060,"Oxyacanthan-6-ol, 7,8'-epoxy-6',12'-dimethoxy-2'-methyl-, 2'-oxide",C[N+]1(CCC2=CC(=C3C4=C2C1CC5=C(C(=CC=C5)OC)OC6=CC=C(CC7C8=C(O3)C(=C(C=C8CCN7)O)O4)C=C6)OC)[O-],,,,,,
7060,157061,"Ibogamine-18-carboxylic acid, 21-hydroxy-, methyl ester",COC(=O)[C@@]12C[C@H]3C[C@@H]([C@@H]1N(C3)CCC4=C2NC5=CC=CC=C45)CCO,,,,,,
7061,157062,CID 157062,C1=CC(=CC=C1C2=CN(N=C2CC(=O)[O-])C3=CC=C(C=C3)F)Cl.[Na+],,,,,,
7062,157063,"Benz(a)anthracene, 12-fluoro-",C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C(=C32)F,,,,,,
7063,157064,"Benz(a)anthracene, 7,12-difluoro-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C(=C32)F)F,,,,,,
7064,157065,"1,2,4-Benzotriazine-3-acetic acid, hydrazide",C1=CC=C2C(=C1)N=C(N=N2)CC(=O)NN,,,,,,
7065,157066,Ergocornam,CC(C)C1C(=O)N2CCCC2C(=O)N1C(=O)C(C(C)C)NC(=O)C3CN(C4CC5=CNC6=CC=CC(=C56)C4=C3)C,,,,,,
7066,157067,CID 157067,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)[O-].[Na+],,,,,,
7067,157068,"Benzenesulfonamide, 4-amino-N-(3-ethyl-5-isoxazolyl)-",CCC1=NOC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
7068,157069,"4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-, bromide, (S)-",C[N+]1(CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)O)OC)C.[Br-],,,,,,
7069,157070,"1,2,4-Benzotriazine-3-acetic acid, methyl ester",COC(=O)CC1=NC2=CC=CC=C2N=N1,,,,,,
7070,157071,Benzo(e)pyren-3-ol,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)O)C=CC5=C4C2=CC=C5,,,,,,
7071,157072,"Benzoic acid, 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitro-, 2-methoxy-1-methyl-2-oxoethyl ester",CC(C(=O)OC)OC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7072,157073,"1H-Indene-1,3(2H)-dione, 2-(2,5-dimethyl-1H-indol-3-yl)-2-hydroxy-",CC1=CC2=C(C=C1)NC(=C2C3(C(=O)C4=CC=CC=C4C3=O)O)C,,,,,,
7073,157074,CID 157074,C1=CC=C(C=C1)CCN=C(NNC(=O)C2=CC=CC=C2)S,,,,,,
7074,157075,"3,7,8,14,17-Pentahydroxy-20-oxopregn-5-en-12-yl benzoate",CC(=O)C1(CC[C@]2([C@@]1([C@@H](C[C@H]3C2([C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)O)OC(=O)C5=CC=CC=C5)C)O)O,,,,,,
7075,157076,L-8-Oxotetrahydropalmatine,COC1=C(C2=C(C[C@H]3C4=CC(=C(C=C4CCN3C2=O)OC)OC)C=C1)OC,,,,,,
7076,157077,Decentapicrin C,C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COC(=O)C4=CC(=CC=C4)O)O)O)O,,,,,,
7077,157078,Decentapicrin B,C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)OC(=O)C4=CC(=CC=C4)O)O)O,,,,,,
7078,157079,Decentapicrin A,C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)OC(=O)C4=CC(=CC=C4)O)O,,,,,,
7079,157080,Quinamine,C=CC1CN2CCC1CC2C34C(CCO3)(C5=CC=CC=C5N4)O,,,,,,
7080,157081,"Ingenol-3,4:5,20-diacetonide",CC1CC2C(C2(C)C)C3C=C4COC(OC4C56C1(C3=O)C=C(C5OC(O6)(C)C)C)(C)C,,,,,,
7081,157082,"Urea, N-methyl-N'-(4-methylphenyl)-N-phenyl-",CC1=CC=C(C=C1)NC(=O)N(C)C2=CC=CC=C2,,,,,,
7082,157083,"Urea, N-methyl-N'-(3-methylphenyl)-N-phenyl-",CC1=CC(=CC=C1)NC(=O)N(C)C2=CC=CC=C2,,,,,,
7083,157084,"Urea, N'-(4-bromophenyl)-N-methyl-N-phenyl-",CN(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)Br,,,,,,
7084,157085,"Urea, N'-(3-chlorophenyl)-N-methyl-N-phenyl-",CN(C1=CC=CC=C1)C(=O)NC2=CC(=CC=C2)Cl,,,,,,
7085,157086,"D-Glucose, 3-octanoate",CCCCCCCC(=O)O[C@H]([C@H](C=O)O)[C@@H]([C@@H](CO)O)O,,,,,,
7086,157087,"Acetamide, N-(2-(2-benzofuranyl)-2-hydroxy-1-(hydroxymethyl)ethyl)-2,2-dichloro-",C1=CC=C2C(=C1)C=C(O2)C(C(CO)NC(=O)C(Cl)Cl)O,,,,,,
7087,157088,"Ethanaminium, 2-((2-(iodo-125I)benzoyl)oxy)-N,N,N-trimethyl-, chloride",C[N+](C)(C)CCOC(=O)C1=CC=CC=C1[125I].[Cl-],,,,,,
7088,157089,2-(2-(125I)iodanylbenzoyl)oxyethyl-trimethylazanium,C[N+](C)(C)CCOC(=O)C1=CC=CC=C1[125I],,,,,,
7089,157090,"Ethanaminium, 2-((2-(iodo-125I)benzoyl)amino)-N,N,N-trimethyl-, chloride",C[N+](C)(C)CCNC(=O)C1=CC=CC=C1[125I].[Cl-],,,,,,
7090,157091,2-[(2-(125I)iodanylbenzoyl)amino]ethyl-trimethylazanium,C[N+](C)(C)CCNC(=O)C1=CC=CC=C1[125I],,,,,,
7091,157092,"2-Pyridinecarboxylic acid, 3,6-dichloro-, mixt. with ((3,5,6-trichloro-2-pyridinyl)oxy)acetic acid",C1=CC(=NC(=C1Cl)C(=O)O)Cl.C1=C(C(=NC(=C1Cl)Cl)OCC(=O)O)Cl,,,,,,
7092,157093,CID 157093,C1C2=CC=CC=C2C(=O)C3=C(S1)C=C(C=C3)CC(=O)[O-].[Na+],,,,,,
7093,157094,"Furo(3,2-c)pyridine, 4,5-dihydro-5-methyl-4-(phenylmethyl)-",CN1C=CC2=C(C1CC3=CC=CC=C3)C=CO2,,,,,,
7094,157095,CID 157095,C1=CC=C(C(=C1)CN2C3=CC=CC=C3C(=C2Cl)C=C[N+](=O)[O-])Cl,,,,,,
7095,157096,"3-Phenylacetylamino-2,6-piperidinedione",C1CC(=O)NC(=O)C1NC(=O)CC2=CC=CC=C2,,,,,,
7096,157097,"(5R,6S,12R)-5,6-dihydroxy-12-methyl-1-oxacyclododec-3-en-2-one",C[C@@H]1CCCCC[C@@H]([C@@H](C=CC(=O)O1)O)O,,,,,,
7097,157098,"Benzene, 1,1'-(2-nitroethylidene)bis(4-ethoxy-",CCOC1=CC=C(C=C1)C(C[N+](=O)[O-])C2=CC=C(C=C2)OCC,,,,,,
7098,157099,"Benzoic acid, 2-(((2-amino-2-oxoethyl)amino)sulfonyl)-",C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)NCC(=O)N,,,,,,
7099,157100,"Benzamide, 2-(((2-amino-2-oxoethyl)amino)sulfonyl)-",C1=CC=C(C(=C1)C(=O)N)S(=O)(=O)NCC(=O)N,,,,,,
7100,157101,"2-[3-(ethylamino)-5-oxooxolan-2-yl]-2-hydroxy-N-[1-(8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl)-3-methylbutyl]acetamide",CCNC1CC(=O)OC1C(C(=O)NC(CC(C)C)C2CC3=C(C(=CC=C3)O)C(=O)O2)O,,,,,,
7101,157102,Candidone,CC(=CCC1=C2C(=C(C=C1OC)OC)C(=O)C[C@H](O2)C3=CC=CC=C3)C,,,,,,
7102,157103,"4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(2-hydroxyphenyl)-6,8-dimethyl-, (2S)-",CC1=C(C(=C2C(=C1O)C(=O)C[C@H](O2)C3=CC=CC=C3O)C)O,,,,,,
7103,157104,CID 157104,C1=C(NC(=NC1=O)NC(=O)N)C(F)(F)F,,,,,,
7104,157105,"4H-Dibenzo(de,g)quinoline-1,10-diol, 5,6,6a,7-tetrahydro-2-methoxy-6-methyl-9-(4-(((1S)-1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-, (6aR)-",CN1CCC2=CC(=C(C3=C2[C@H]1CC4=CC(=C(C=C43)O)OC5=CC=C(C=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)OC)O)O)OC,,,,,,
7105,157106,2-Chloro-beta-oxo-alpha-(4-phenyl-2(3H)-thiazolylidene)benzenepropanenitrile,C1=CC=C(C=C1)C2=CSC(=N2)C(=C(C3=CC=CC=C3Cl)O)C#N,,,,,,
7106,157107,"Methylium, trichloro-, radical ion(1+)",[C+](Cl)(Cl)Cl,,,,,,
7107,157108,CID 157108,C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)OC4=C(C(=C(C(=C4O)C(=O)C=CC5=CC=C(C=C5)O)O)[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O,,,,,,
7108,157109,CID 157109,CC1CC=CC2C(C(=C)C(C3C2(CC4(C(O4)C(C1=O)(C)O)O)C(=O)NC3CC5=CC=CC=C5)C)O,,,,,,
7109,157110,Stesakine,CN1CCC2=CC3=C(C4=C2[C@H]1CC5=C4C=CC(=C5OC)O)OCO3,,,,,,
7110,157111,"3,4,8-Triazatetracyclo(4.3.1.02,5.07,9)dec-3-ene, 8-(4-chlorophenyl)-, (1R,2R,5S,6S,7R,9S)-rel-",C1[C@@H]2[C@H]3[C@@H]([C@H]1C4C2N4C5=CC=C(C=C5)Cl)N=N3,,,,,,
7111,157112,"2H-1-Benzopyran-2-one, 8-((2S)-2-hydroxy-3-methyl-3-butenyl)-5,7-dimethoxy-",CC(=C)[C@H](CC1=C(C=C(C2=C1OC(=O)C=C2)OC)OC)O,,,,,,
7112,157113,CID 157113,CC[C@H]1CC2C[C@H]3[C@H]1N4C2O[C@@H](C4)C5=C3NC6=C5C=C(C=C6)OC,,,,,,
7113,157114,10-Hydroxyheyneanine,C[C@@H]([C@@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)O)C(=O)OC)O,,,,,,
7114,157115,"Cholan-24-amide, N-(bicyclo(2.2.1)hept-2-ylmethyl)-3-hydroxy-, (3alpha,5beta)-",C[C@H](CCC(=O)NCC1CC2CCC1C2)[C@H]3CC[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@H](C6)O)C)C,,,,,,
7115,157116,"Ibogamin-20-ol, 8,19-epoxy-12-methoxy-, (4alpha,8beta,19S,20S)-",CC(C1CC2CC3C1N4C2OC(C4)C5=C3NC6=C5C=C(C=C6)OC)O,,,,,,
7116,157117,CID 157117,CC1=C(C(=CC=O)[C@H](C1)O)C=O,,,,,,
7117,157118,Methyl 2-acetyltormentate,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(C[C@H]([C@@H](C5(C)C)O)OC(=O)C)C)C)[C@H]2[C@]1(C)O)C)C(=O)OC,,,,,,
7118,157119,"L-Proline, 1-(((1,1-dimethylethoxy)carbonyl)amino)-",CC(C)(C)OC(=O)NN1CCC[C@H]1C(=O)O,,,,,,
7119,157120,[2-Nitro-3-(4-nitrophenyl)prop-2-enyl] acetate,CC(=O)OCC(=CC1=CC=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7120,157121,"2-Propen-1-ol, 3-(4-methoxyphenyl)-2-nitro-, 1-acetate",CC(=O)OCC(=CC1=CC=C(C=C1)OC)[N+](=O)[O-],,,,,,
7121,157122,"[3-(3,4-Dimethoxyphenyl)-2-nitroprop-2-enyl] acetate",CC(=O)OCC(=CC1=CC(=C(C=C1)OC)OC)[N+](=O)[O-],,,,,,
7122,157123,[3-(4-Chlorophenyl)-2-nitroprop-2-enyl] acetate,CC(=O)OCC(=CC1=CC=C(C=C1)Cl)[N+](=O)[O-],,,,,,
7123,157124,[3-(3-Fluorophenyl)-2-nitroprop-2-enyl] acetate,CC(=O)OCC(=CC1=CC(=CC=C1)F)[N+](=O)[O-],,,,,,
7124,157125,[3-(3-Chlorophenyl)-2-nitroprop-2-enyl] acetate,CC(=O)OCC(=CC1=CC(=CC=C1)Cl)[N+](=O)[O-],,,,,,
7125,157126,[3-(2-Chlorophenyl)-2-nitroprop-2-enyl] acetate,CC(=O)OCC(=CC1=CC=CC=C1Cl)[N+](=O)[O-],,,,,,
7126,157127,"1,3-Benzodioxole, 5-(4-methoxyphenyl)-6-propoxy-",CCCOC1=CC2=C(C=C1C3=CC=C(C=C3)OC)OCO2,,,,,,
7127,157128,"Isoquinolinium, 1,2,3,4-tetrahydro-8-hydroxy-1-((4-hydroxyphenyl)methyl)-7-methoxy-2,2-dimethyl-, chloride",C[N+]1(CCC2=C(C1CC3=CC=C(C=C3)O)C(=C(C=C2)OC)O)C.[Cl-],,,,,,
7128,157129,Oblongine,C[N+]1(CCC2=C(C1CC3=CC=C(C=C3)O)C(=C(C=C2)OC)O)C,,,,,,
7129,157130,"1-Propanone, 1-(10-(2-(methylamino)propyl)-10H-phenothiazin-2-yl)-, monohydrochloride",CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)NC.Cl,,,,,,
7130,157131,"Phosphorodiamidic acid, N,N'-dimethyl-, methyl ester",CNP(=O)(NC)OC,,,,,,
7131,157132,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester, (4R)-",CC1=C([C@H](C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,,,,,,
7132,157133,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester, (4S)-",CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,,,,,,
7133,157134,"Pentanoic acid, 2-hydroxy-3-methyl-, (1S,3S,3aR,4R,5R,6R,7aS)-1-(acetyloxy)-5-(formyloxy)-3-(3-furanyl)-6-((5R,5aR,9aS)-5,5a,6,7,9,9a-hexahydro-5,9a-dimethyl-2,7-dioxo-2H-pyrano(3,4-b)oxepin-5-yl)octahydro-7a-hydroxy-3a-methyl-7-methylene-1H-inden-4-yl ester",CC[C@H](C)C(C(=O)O[C@H]1[C@@H]([C@@H](C(=C)[C@@]2([C@@]1(C(C[C@@H]2OC(=O)C)C3=COC=C3)C)O)[C@]4(C=CC(=O)O[C@]5([C@@H]4CC(=O)OC5)C)C)OC=O)O,,,,,,
7134,157135,"[(1S,2S,3R,5S,8S,10S,11R)-9,10-dihydroxy-12,12-dimethyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-3-yl] acetate",CC(=O)O[C@@H]1C[C@@H]2C[C@]3([C@@H]1[C@]45CCCC([C@H]4[C@@H](C3(OC5)O)O)(C)C)C(=O)C2=C,,,,,,
7135,157136,"Benzeneacetic acid, 4-(methoxycarbonyl)-alpha-methyl-, methyl ester",CC(C1=CC=C(C=C1)C(=O)OC)C(=O)OC,,,,,,
7136,157137,"1-Benzopyrylium, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-(beta-D-xylopyranosyloxy)-, chloride",C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC3=C(C=C(C=C3[O+]=C2C4=CC=C(C=C4)O)O)O)O)O)O.[Cl-],,,,,,
7137,157138,"5-hydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxychromen-7-one",C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=O)C=C(C3=C2)O)C4=CC=C(C=C4)O)O)O)O,,,,,,
7138,157139,"(1S,5R)-6,6-dimethylnorpinan-2-one",CC1([C@@H]2CCC(=O)[C@H]1C2)C,,,,,,
7139,157140,Secologanin dimethyl acetal,COC(C[C@H]1[C@H]([C@@H](OC=C1C(=O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C=C)OC,,,,,,
7140,157141,CID 157141,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)NC(=O)NC5=CN=C(NC5=O)NC6=CC=C(C=C6)S(=O)(=O)N)OC)SC2)C(=O)[O-].[Na+],,,,,,
7141,157142,"(6R,7S)-7-[[2-(4-hydroxyphenyl)-2-[[6-oxo-2-(4-sulfamoylanilino)-1H-pyrimidin-5-yl]carbamoylamino]acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)NC(=O)NC5=CN=C(NC5=O)NC6=CC=C(C=C6)S(=O)(=O)N)OC)SC2)C(=O)O,,,,,,
7142,157143,Mulberrofuran C,CC1=C[C@H]([C@H]([C@@H](C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C=C(C=C4O)C5=CC6=C(O5)C=C(C=C6)O)O,,,,,,
7143,157144,"2H,3H-Cyclopenta(d')naphtho(1,8-bc:2,3-b')difuran-6-acetic acid,8-(3-furanyl)-2a,4,5,5a,6,6a,8,9,9a,10a,10b,10c-dodecahydro-3-hydroxy-2a,5a,6a,7-tetramethyl-5-(3-methyl-1-oxobutoxy)-, methyl ester, (2aR,3R,5S,5aR,6R,6aR,8R,9aR,10aS,10bR,10cR)-",CC1=C2[C@@H](CC1C3=COC=C3)O[C@H]4[C@@]2([C@@H]([C@]5([C@H](C[C@H]([C@@]6([C@@H]5[C@H]4OC6)C)O)OC(=O)CC(C)C)C)CC(=O)OC)C,,,,,,
7144,157145,Glaucenine,CCC(C)C(=O)OC1C2CC3(C1C4(CC2OC)C5(C(C6C37C5N(CC6(CCC7OC)C)CC)OC(=O)C)OCO4)O,,,,,,
7145,157146,Glaucerine,CCN1CC2(CCC(C34C2C(C5(C31)C6(CC(C7CC4(C6C7OC(=O)C(C)C)O)OC)OCO5)OC(=O)C)OC)C,,,,,,
7146,157147,Glaucedine,CCC(C)C(=O)OC1C2CC3C1C(CC2OC)(C4(C(C5C36C4N(CC5(CCC6OC)COC)CC)OC)O)O,,,,,,
7147,157148,"beta-D-Glucopyranoside, 5-((6-deoxy-alpha-L-mannopyranosyl)oxy)-1,4a,5,7a-tetrahydro-7-(hydroxymethyl)cyclopenta(c)pyran-1-yl, (1S,4aR,5S,7aS)-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@]2([C@H]([C@@H]([C@H]([C@H](O2)OC3[C@H]4[C@H](CC=C4CO)C=CO3)O)O)O)CO)O)O)O,,,,,,
7148,157149,"Anthracene, 2-ethynyl-",C#CC1=CC2=CC3=CC=CC=C3C=C2C=C1,,,,,,
7149,157150,"Phosphonic acid, ((3,4-dimethoxyphenyl)methyl)-, diethyl ester",CCOP(=O)(CC1=CC(=C(C=C1)OC)OC)OCC,,,,,,
7150,157151,"4,5-Difluoro-2-nitroaniline",C1=C(C(=CC(=C1F)F)[N+](=O)[O-])N,,,,,,
7151,157152,"Piperazine, 1,4-bis(dichloroacetyl)-2,5-dimethyl-",CC1CN(C(CN1C(=O)C(Cl)Cl)C)C(=O)C(Cl)Cl,,,,,,
7152,157153,3-Chloro-4-fluorobenzotrifluoride,C1=CC(=C(C=C1C(F)(F)F)Cl)F,,,,,,
7153,157154,CID 157154,CC1([C@H]2CC[C@H](C2)C1C=C3C(=O)N=C(S3)S)C,,,,,,
7154,157155,"4H-1-Benzopyran-4-one-2-14C, 2-phenyl-",C1=CC=C(C=C1)[14C]2=CC(=O)C3=CC=CC=C3O2,,,,,,
7155,157156,"Propanoic acid, 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)-, methyl ester",CC(C(=O)OC)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl,,,,,,
7156,157157,"Benzamide, 4-(1,1-dimethylethyl)-N-methyl-N-(2-methylphenyl)-",CC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
7157,157158,"Dibenzo(a,g)quinolizinium, 5,6-dihydro-3,10-dihydroxy-2,9-dimethoxy-,chloride",COC1=C(C=C2CC[N+]3=C(C2=C1)C=C4C=CC(=C(C4=C3)OC)O)O.[Cl-],,,,,,
7158,157159,"2,9-Dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3,10-diol",COC1=C(C=C2CC[N+]3=C(C2=C1)C=C4C=CC(=C(C4=C3)OC)O)O,,,,,,
7159,157160,CID 157160,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O,,,,,,
7160,157161,"Pyrrolidine, 2,2,3,3,4,4,5,5-octafluoro-1-(pentafluoroethyl)-",C1(C(C(N(C1(F)F)C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7161,157162,"6-Hydroxy-2-[2-(4-hydroxyphenyl)ethenyl]-3,1-benzoxazin-4-one",C1=CC(=CC=C1C=CC2=NC3=C(C=C(C=C3)O)C(=O)O2)O,,,,,,
7162,157163,"Acetamide, 2-chloro-N-(2,6-dimethyl-1-cyclohexen-1-yl)-N-((2-oxo-3(2H)-benzothiazolyl)methyl)-",CC1CCCC(=C1N(CN2C3=CC=CC=C3SC2=O)C(=O)CCl)C,,,,,,
7163,157164,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1-(2-hydroxy-3-(3-hydroxybutoxy)propyl)-5-phenyl-",CCC1(C(=O)NC(=O)N(C1=O)CC(COCCC(C)O)O)C2=CC=CC=C2,,,,,,
7164,157165,"Acetamide, 2-chloro-N-(2-methoxy-6-methylphenyl)-N-((1-methylethoxy)methyl)-",CC1=C(C(=CC=C1)OC)N(COC(C)C)C(=O)CCl,,,,,,
7165,157166,CID 157166,CC1=C(NC(=NC1=O)NC)C,,,,,,
7166,157167,6-Hydroxy-2-benzoxazolinone,C1=CC2=C(C=C1O)OC(=O)N2,,,,,,
7167,157168,24-Acetylhydroshengmanol xyloside,C[C@@H]1C[C@H](O[C@]2([C@H]1[C@]3(CCC45C[C@@]46CC[C@@H](C(C6CC[C@H]5[C@@]3([C@H]2O)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)O)[C@@H](C(C)(C)O)OC(=O)C,,,,,,
7168,157169,"4H-3,1-Benzoxazin-4-one, 2-[2-(3-methoxyphenyl)ethenyl]-",COC1=CC=CC(=C1)C=CC2=NC3=CC=CC=C3C(=O)O2,,,,,,
7169,157170,"4H-3,1-Benzoxazin-4-one, 2-[4-(4-hydroxyphenyl)-1,3-butadienyl]-",C1=CC=C2C(=C1)C(=O)OC(=N2)C=CC=CC3=CC=C(C=C3)O,,,,,,
7170,157171,Epipodophyllotoxin ethyl ether,CCO[C@H]1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)OC)OC,,,,,,
7171,157172,Epipicropodophyllotoxin ethyl ether,CCO[C@H]1[C@H]2COC(=O)[C@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)OC)OC,,,,,,
7172,157173,"Thymidine, 5,6-dihydro-, (5R)-",C[C@@H]1CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
7173,157174,"2-Pyridinecarboxylic acid, 5-(3-phenylpropyl)-, methyl ester,hydrochloride",COC(=O)C1=NC=C(C=C1)CCCC2=CC=CC=C2.Cl,,,,,,
7174,157175,Methyl 5-(3-phenylpropyl)pyridine-2-carboxylate,COC(=O)C1=NC=C(C=C1)CCCC2=CC=CC=C2,,,,,,
7175,157176,Stichloroside C2,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4(C5CCC67C(CCC6(C5=CCC4C3(C)C)C)C(OC7=O)(C)CC(CC(=C)C)OC(=O)C)C)CO)O)OC8C(C(C(C(O8)CO)O)OC)O)O)O)OC9C(C(C(CO9)OC1C(C(C(CO1)O)OC1C(C(C(C(O1)CO)O)OC)O)O)O)O,,,,,,
7176,157177,Stichloroside B1,CC(C)CC(CC1(C2CCC3(C2(CCC4C3=CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)OC)O)O)O)OC9C(C(C(C(O9)CO)OC2C(C(C(CO2)O)OC2C(C(C(C(O2)CO)O)OC)O)O)O)O)C)C(=O)O1)C)C)OC(=O)C,,,,,,
7177,157178,Pfafforside B,CC(C)CC(CC1(C2CCC3(C2(CCC4C3=CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)OC)O)O)O)OC9C(C(C(CO9)OC2C(C(C(C(O2)CO)O)OC2C(C(C(C(O2)CO)O)OC)O)O)O)O)C)C(=O)O1)C)C)OC(=O)C,,,,,,
7178,157179,"beta-D-Glucopyranosiduronic acid, (2,4-dinitrophenyl)methyl",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
7179,157180,2-nitro-6(5H)-phenanthridinone,C1=CC=C2C(=C1)C3=C(C=CC(=C3)[N+](=O)[O-])NC2=O,,,,,,
7180,157181,"Butanedioic acid, mono(1,2,3,6a,9a,11-hexahydro-4-methoxy-1,11-dioxocyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-3-yl) ester, (3S-(3alpha,6aalpha,9aalpha))-",COC1=C2C3=C(C(=O)C[C@@H]3OC(=O)CCC(=O)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,,,,,
7181,157182,CID 157182,CC(=CC(=O)O)CC[C@@H]1CCC[C@H]2[C@]1(CCCC2(C)C)C,,,,,,
7182,157183,"2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1-methyl-, hydrochloride",CN1C(=C(C(=O)NC1=O)N)N.Cl,,,,,,
7183,157184,"5,6-Diamino-1-methyluracil",CN1C(=C(C(=O)NC1=O)N)N,,,,,,
7184,157185,CID 157185,CCCCN=C(NC1=CN=C(C=C1)C(=O)N)S,,,,,,
7185,157186,CID 157186,C1=CC=C(C=C1)N=C(NC2=CN=C(C=C2)C(=O)N)S,,,,,,
7186,157187,Droxicainide,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2CCO,,,,,,
7187,157188,"Benz(a)anthracene-1,2,3,4-tetrol, 1,2,3,4-tetrahydro-",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C(C(C(C4O)O)O)O,,,,,,
7188,157189,Millettin,CC(=CCC1=C2C(=C(C3=C1OC4=C(C3=O)C5=C(O4)C=C(C=C5)O)O)C=CC(O2)(C)C)C,,,,,,
7189,157190,"Benzamide, 4-(1,1-dimethylethyl)-N-(2-hydroxyphenyl)-N-methyl-",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2O,,,,,,
7190,157191,Delphinifoline,CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6O)OC)O)O)O)O)COC,,,,,,
7191,157192,CID 157192,CCOC(=O)C1=C(C2=CC=CC=C2N1C(=O)C3=CC(=CC=C3)Cl)C=NN=C(N)S,,,,,,
7192,157193,"Cyclopropanecarboxylic acid, 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-, 2,3-dihydro-4-phenyl-1H-inden-2-yl ester",CC1(C(C1C(=O)OC2CC3=C(C2)C(=CC=C3)C4=CC=CC=C4)C=C(C(F)(F)F)Cl)C,,,,,,
7193,157194,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-,2,3-dihydro-4-phenyl-1H-inden-2-yl ester",CC1(C(C1C(=O)OC2CC3=C(C2)C(=CC=C3)C4=CC=CC=C4)C=C(Cl)Cl)C,,,,,,
7194,157195,"2H-1,2,4,6-Thiatriazine, 3-chloro-5-methoxy-2-methyl-, 1,1-dioxide",CN1C(=NC(=NS1(=O)=O)OC)Cl,,,,,,
7195,157196,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-ethyl-5-methoxy-, 1,1-dioxide",CCN1C(=NC(=NS1(=O)=O)OC)Cl,,,,,,
7196,157197,"2H-1,2,4,6-Thiatriazine, 3-chloro-5-ethoxy-2-methyl-, 1,1-dioxide",CCOC1=NS(=O)(=O)N(C(=N1)Cl)C,,,,,,
7197,157198,"2H-1,2,4,6-Thiatriazine, 3-chloro-5-methoxy-2-(1-methylethyl)-,1,1-dioxide",CC(C)N1C(=NC(=NS1(=O)=O)OC)Cl,,,,,,
7198,157199,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-methyl-5-propoxy-, 1,1-dioxide",CCCOC1=NS(=O)(=O)N(C(=N1)Cl)C,,,,,,
7199,157200,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-methyl-5-(methylthio)-, 1,1-dioxide",CN1C(=NC(=NS1(=O)=O)SC)Cl,,,,,,
7200,157201,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 5-methoxy-2-methyl-, 1,1-dioxide",CN1C(=O)NC(=NS1(=O)=O)OC,,,,,,
7201,157202,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 2-ethyl-5-methoxy-, 1,1-dioxide",CCN1C(=O)NC(=NS1(=O)=O)OC,,,,,,
7202,157203,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 5-ethoxy-2-methyl-, 1,1-dioxide",CCOC1=NS(=O)(=O)N(C(=O)N1)C,,,,,,
7203,157204,"1H-Indole, 1-acetyl-2-phenyl-",CC(=O)N1C2=CC=CC=C2C=C1C3=CC=CC=C3,,,,,,
7204,157205,6'-O-bea-Glucosylaucubin,C1C=C([C@H]2[C@@H]1C=COC2O[C@@H]3[C@@H]([C@H]([C@@H]([C@@](O3)(CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O)CO,,,,,,
7205,157206,"Pentadeca-6,9-dien-2-on",CCCCCC=CCC=CCCCC(=O)C,,,,,,
7206,157207,"7H-Dibenzo(de,g)quinolin-7-one, 9-hydroxy-1,2-dimethoxy-",COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=C2C=CC(=C4)O)OC,,,,,,
7207,157208,"Indeno(1,2,3-ij)isoquinolin-9-ol, 5,6-dimethoxy-",COC1=C(C2=C3C(=C1)C=CN=C3C4=C2C=CC(=C4)O)OC,,,,,,
7208,157209,"6,7-Dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-5-ol",COC1=CC=C(C=C1)CC2C3=CC(=C(C(=C3CCN2)O)OC)OC,,,,,,
7209,157210,Etilefrine pivalate hydrochloride,CCNCC(C1=CC(=CC=C1)OC(=O)C(C)(C)C)O.Cl,,,"['Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)', 'Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)', 'Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)', 'Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)']",,,
7210,157211,Etilefrine pivalate,CCNCC(C1=CC(=CC=C1)OC(=O)C(C)(C)C)O,,,,,,
7211,157212,"1H-Dibenzo(de,g)quinolin-1-one, 7-amino-2-methoxy-",COC1=C(C2=C3C(=C1)C=CN=C3C(=N)C4=CC=CC=C42)O,,,,,,
7212,157213,"Methyl 4-(acetyloxymethyl)-10-(2,3-dimethyloxirane-2-carbonyl)oxy-9-hydroxy-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradeca-5,7-diene-8-carboxylate",CC1C(O1)(C)C(=O)OC2C3C(C4C(O4)(C=CC=C(C2O)C(=O)OC)COC(=O)C)OC(=O)C3=C,,,,,,
7213,157214,"Carbamic acid, (1-(1-naphthalenyl)ethyl)-, cyano(3-phenoxyphenyl)methyl ester",CC(C1=CC=CC2=CC=CC=C21)NC(=O)OC(C#N)C3=CC(=CC=C3)OC4=CC=CC=C4,,,,,,
7214,157215,"1,3,2-Oxazaphospholidine, 2-ethoxy-4-(2-methylpropyl)-, 2-oxide",CCOP1(=O)NC(CO1)CC(C)C,,,,,,
7215,157216,"Dipotassium 4,4'-dinitrostilbene-2,2'-disulphonate",C1=CC(=C(C=C1[N+](=O)[O-])S(=O)(=O)[O-])C=CC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)[O-].[K+].[K+],,,,,,
7216,157217,"(6,6'-Bi-7H-dibenzo(c,g)carbazole)-5,5'-diol",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C(=C(C5=CC=CC=C54)O)C6=C(C7=CC=CC=C7C8=C6NC9=C8C1=CC=CC=C1C=C9)O,,,,,,
7217,157218,"5,6,7-Trimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline",COC1=CC=C(C=C1)CC2C3=CC(=C(C(=C3CCN2)OC)OC)OC,,,,,,
7218,157219,CID 157219,CCOC(=O)[C@H]1[C@@H](C1(C)C)C=C(C2=CC=C(C=C2)Cl)Cl,,,,,,
7219,157220,"Acetamide, N-(3-(9,10-ethanoanthracen-9(10H)-yl)propyl)-N-methyl-",CC(=O)N(C)CCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,,,,,,
7220,157221,"Propane, 1-(1-(difluoro(pentafluoroethoxy)methyl)-1,2,2,2-tetrafluoroethoxy)-1,1,2,3,3,3-hexafluoro-2-(heptafluoropropoxy)-",C(C(OC(C(OC(C(F)(F)F)(F)F)(F)F)(C(F)(F)F)F)(F)F)(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F,,,,,,
7221,157222,"3,5-Pyridinedicarboxaldehyde, 1,4-dihydro-1,4-dimethyl-",CC1C(=CN(C=C1C=O)C)C=O,,,,,,
7222,157223,"Benzeneacetic acid, 4-chloro-alpha-(1-methylethyl)-, (3-(3-bromophenoxy)phenyl)cyanomethyl ester",CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC(=CC=C3)Br,,,,,,
7223,157224,"1,3,2-Oxazaphospholidine, 4-ethyl-2-methoxy-, 2-sulfide",CCC1COP(=S)(N1)OC,,,,,,
7224,157225,3-Hydroxyquinine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@]4(C=C)O)O,,,,,,
7225,157226,Foliaspongin,CCC(CC(=O)OC1CC2C3(CCC4C(CCCC4(C3CC(C2(C(C1C(=O)C)C=O)C)O)C)(C)CC)C)O,,,,,,
7226,157227,"Pyridine, 4-(methylthio)-2,6-diphenyl-",CSC1=CC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7227,157228,"Pyridine, 2,6-bis(4-methoxyphenyl)-4-(methylthio)-",COC1=CC=C(C=C1)C2=CC(=CC(=N2)C3=CC=C(C=C3)OC)SC,,,,,,
7228,157229,"Phenol, 3-(pentachlorophenoxy)-",C1=CC(=CC(=C1)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)O,,,,,,
7229,157230,"1,3,2-Oxazaphospholidine, 2-methoxy-4-(2-methylpropyl)-, 2-sulfide",CC(C)CC1COP(=S)(N1)OC,,,,,,
7230,157231,"1,2,4-Benzenetricarboxylic acid, tris(1-ethylhexyl) ester",CCCCCC(CC)OC(=O)C1=CC(=C(C=C1)C(=O)OC(CC)CCCCC)C(=O)OC(CC)CCCCC,,,,,,
7231,157232,"Acetic acid, (2,3-dichloro-6-(2-thienylcarbonyl)phenoxy)-",C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)Cl)Cl)OCC(=O)O,,,,,,
7232,157233,"Acetamide, 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxy-1-methylethyl)-",CC1=C(C(=CC=C1)C)N(C(C)COC)C(=O)CCl,,,,,,
7233,157234,"2-Oxazolidinemethanol, alpha,3-diphenyl-",C1COC(N1C2=CC=CC=C2)C(C3=CC=CC=C3)O,,,,,,
7234,157235,"1H-Pyrrolo(1,2-a)indole-5,8-dione, 2,7-diamino-9-(((aminocarbonyl)oxy)methyl)-2,3-dihydro-1-hydroxy-6-methyl-, (1R,2R)-rel-",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]([C@H](C3=C2COC(=O)N)O)N)N,,,,,,
7235,157236,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 5-methoxy-2-(1-methylethyl)-,1,1-dioxide",CC(C)N1C(=O)NC(=NS1(=O)=O)OC,,,,,,
7236,157237,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-,cyano(3-phenoxyphenyl)methyl ester, mixt. with O,O-diethylO-(3,5,6-trichloro-2-pyridinyl) phosphorothioate",CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl.CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
7237,157238,"Stannane, tributylpentyl-",CCCCC[Sn](CCCC)(CCCC)CCCC,,,,,,
7238,157239,Dibutyldipentyltin,CCCCC[Sn](CCCC)(CCCC)CCCCC,,,,,,
7239,157240,Butyltripentyltin,CCCCC[Sn](CCCC)(CCCCC)CCCCC,,,,,,
7240,157241,"(2S,3R,4S,5R,6R)-6-[[(6aR,6bS,8aR,9R,10S,12aR,14bR)-9-[(2S,3R,4S,5S)-3,5-dihydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid",C[C@@]12CC[C@@]3(C(=CCC4[C@]3(CCC5[C@@]4(CCC(C5(C)CO)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O)C)C)[C@H]1CC([C@@H]([C@@H]2O[C@H]8[C@@H]([C@H]([C@H](CO8)O)O[C@@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O)(C)C)C,,,,,,
7241,157242,"beta-D-Glucopyranosiduronic acid, (3beta,4beta,21beta,22beta)-22-((3-O-beta-D-glucopyranosyl-alpha-L-arabinopyranosyl)oxy)-21,23-dihydroxyolean-12-en-3-yl O-beta-D-glucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->2)-",CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1O)OC6C(C(C(CO6)O)OC7C(C(C(C(O7)CO)O)O)O)O)C)C)C)(C)CO)OC8C(C(C(C(O8)C(=O)O)O)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)C,,,,,,
7242,157243,"N-(3,6-dihydropyrrolo[2,3-c]carbazol-1-ylmethylidene)hydroxylamine",C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3C(=CN4)C=NO,,,,,,
7243,157244,"Pyrene, 1-(1-methylethyl)-",CC(C)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
7244,157245,2-Pyrenol,C1=CC2=C3C(=C1)C=CC4=C3C(=CC(=C4)O)C=C2,,,,,,
7245,157246,"Pyrene, 2-(1-methylethyl)-",CC(C)C1=CC2=C3C(=C1)C=CC4=C3C(=CC=C4)C=C2,,,,,,
7246,157247,"Pyrene, 1,3,5,7,9-pentakis(1-methylethyl)-",CC(C)C1=CC2=C(C=C3C(=CC(=C4C3=C2C(=C1)C(=C4)C(C)C)C(C)C)C(C)C)C(C)C,,,,,,
7247,157248,"1,4-Naphthalenedione, 2-(chloromethyl)-3-pentyl-",CCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)CCl,,,,,,
7248,157249,"1,4-Naphthalenedione, 2-(chloromethyl)-3-heptyl-",CCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)CCl,,,,,,
7249,157250,"1,4-Naphthalenedione, 2-bromo-3-heptyl-",CCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)Br,,,,,,
7250,157251,"1,2-Ethanediamine, N'-methyl-N-2-pyridinyl-N-(2-thienylmethyl)-",CNCCN(CC1=CC=CS1)C2=CC=CC=N2,,,,,,
7251,157252,"1,2-Ethanediamine, N,N-dimethyl-N'-2-pyridinyl-N'-(2-thienylmethyl)-,N-oxide",C[N+](C)(CCN(CC1=CC=CS1)C2=CC=CC=N2)[O-],,,,,,
7252,157253,"7H-2-Benzopyran-7-one, 4-methyl-2-phenyl-",CC1=C2C=CC(=O)C=C2OC(=C1)C3=CC=CC=C3,,,,,,
7253,157254,CID 157254,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@H]([C@@H]5O)O)O)NC6=NC(=O)C7=C(N6)N=CN7)C=C2,,,,,,
7254,157255,"3-[[(3R,5R,8R,9R,10R,12R,13R,14S,17R)-12-acetyloxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3-oxopropanoic acid",CC(=O)O[C@@H]1C[C@@H]2[C@]3(CC[C@H](C([C@@H]3CC[C@]2([C@@]4([C@H]1[C@@H](CC4)[C@@]5(CC[C@@H](O5)C(C)(C)O)C)C)C)(C)C)OC(=O)CC(=O)O)C,,,,,,
7255,157256,"1,6-Dimethyl-9H-carbazole",CC1=CC2=C(C=C1)NC3=C(C=CC=C23)C,,,,,,
7256,157257,"1,7-dimethyl-9H-carbazole",CC1=CC2=C(C=C1)C3=CC=CC(=C3N2)C,,,,,,
7257,157258,"2,5-Dimethyl-9H-carbazole",CC1=CC2=C(C=C1)C3=C(C=CC=C3N2)C,,,,,,
7258,157259,"2,6-Dimethyl-9H-carbazole",CC1=CC2=C(C=C1)NC3=C2C=CC(=C3)C,,,,,,
7259,157260,"[(1R,4R,4aR,5S,7R,8S,8aR)-5-acetyloxy-4a-(acetyloxymethyl)-8-[(2S)-2-hydroxy-2-(5-oxo-2H-furan-3-yl)ethyl]-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2'-oxirane]-1-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@@H]1CC[C@]2(CO2)[C@]3([C@H]1[C@@]([C@@H](C[C@@H]3OC(=O)C)C)(C)C[C@@H](C4=CC(=O)OC4)O)COC(=O)C,,,,,,
7260,157261,Decaptelaloside,C[C@]1([C@H](O[C@H]([C@@H]([C@H]1O)O)OC2[C@H]3[C@@H](CC[C@@H]3CO)C=CO2)CO)O,,,,,,
7261,157262,11-O-beta-Glucosyl decaloside,C1C=C[C@H]2[C@@H]1C=COC2O[C@@H]3[C@@H]([C@H]([C@]([C@@](O3)(CO)O)(CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
7262,157263,4-Methoxy-5-[methoxy(phenyl)methylidene]furan-2-one,COC1=CC(=O)OC1=C(C2=CC=CC=C2)OC,,,,,,
7263,157264,"(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",CC=C(CC[C@@H](C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C)C(C)C,,,,,,
7264,157265,CID 157265,C1=C(C=C(C(=C1Br)N=O)Br)S(=O)(=O)[O-].[Na+],,,,,,
7265,157266,"1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-6-(trifluoromethyl)-",C1CNCC2=C1C3=C(N2)C=CC(=C3)C(F)(F)F,,,,,,
7266,157267,CID 157267,COC1=CC(=NS(=O)(=O)C)C=CC1=NC2=C3C=CC(=CC3=NC4=C2C=CC=C4C(=O)N)N(O)O,,,,,,
7267,157268,"2-beta-D-Lyxopyranosyl-6,6-dimethyl-4,5,6,7-tetrahydroindol-4-one",CC1(CC2=C(C=C(N2)O[C@H]3[C@H]([C@H]([C@@H](CO3)O)O)O)C(=O)C1)C,,,,,,
7268,157269,Flufenican,C1=CC=C(C=C1)NC(=O)C2=C(N=CC=C2)OC3=CC=CC(=C3)C(F)(F)F,,,,,,
7269,157270,"1H-1,2,4-Triazole-1-ethanol, beta-((4-chlorophenyl)methyl)-alpha-(2-methylpropyl)-",CC(C)CC(C(CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,,,,,,
7270,157271,"1H-Imidazole-4-ethanaminium, 2-(((2S,3S)-3-amino-3-carboxy-2-hydroxypropyl)thio)-alpha-carboxy-N,N,N-trimethyl-, inner salt, (alphaS)-",C[N+](C)(C)[C@@H](CC1=CN=C(N1)SC[C@H]([C@@H](C(=O)O)N)O)C(=O)[O-],,,,,,
7271,157272,"[(1S)-2-[2-[(2S,3S)-3-amino-3-carboxy-2-hydroxypropyl]sulfanyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium",C[N+](C)(C)[C@@H](CC1=CN=C(N1)SC[C@H]([C@@H](C(=O)O)N)O)C(=O)O,,,,,,
7272,157273,"N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide",CC=CC=CC=CCCC=CC=CC(=O)NCC(C)C,,,,,,
7273,157274,3-Acetamidophenylboronic acid,B(C1=CC(=CC=C1)NC(=O)C)(O)O,,,,,,
7274,157275,"Antimony, dihydroxymethyloxo-",C[Sb](=O)(O)O,,,,,,
7275,157276,"1-Pyrrolidin-1-yldeca-2,4-dien-1-one",CCCCCC=CC=CC(=O)N1CCCC1,,,,,,
7276,157277,Nimbandiol,CC1=C2[C@H](C[C@H]1C3=COC=C3)O[C@H]4[C@@]2([C@@H]([C@]5([C@@H]([C@H]4O)[C@](C=CC5=O)(C)O)C)CC(=O)OC)C,,,,,,
7277,157278,"methyl 2-[(1S,2R,3S,4S,8S,9S,10R,13R,15S)-2-acetyloxy-13-(furan-3-yl)-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.03,8.011,15]hexadeca-5,11-dien-9-yl]acetate",C[C@H]1C=CC(=O)[C@@]2([C@H]1[C@H]([C@@H]3[C@]([C@@H]2CC(=O)OC)(C4=C([C@@H](C[C@@H]4O3)C5=COC=C5)C)C)OC(=O)C)C,,,,,,
7278,157279,"Ergosta-5,24-dien-26-oic acid, 1-(acetyloxy)-3,20,22-trihydroxy-,delta-lactone, (1alpha,3beta,22R)-",CC1=C(C(=O)O[C@H](C1)[C@@](C)([C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4([C@H](C[C@@H](C5)O)OC(=O)C)C)C)O)C,,,,,,
7279,157280,"Benzoic acid, 3-(aminocarbonyl)-, ethyl ester",CCOC(=O)C1=CC=CC(=C1)C(=O)N,,,,,,
7280,157281,"Urea, N-(2-(hydroxymethyl)-2-(2-propenyl)-4-pentenyl)-N'-methyl-",CNC(=O)NCC(CC=C)(CC=C)CO,,,,,,
7281,157282,"Imidazo(2,1-b)thiazole-35S, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride",C1C[35S]C2=NC(CN21)C3=CC=CC=C3.Cl,,,,,,
7282,157283,"6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b](135S)[1,3]thiazole",C1C[35S]C2=NC(CN21)C3=CC=CC=C3,,,,,,
7283,157284,"Benzo(g)quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis-",C1CN(CCN1CCCN2CCN(CC2)C3=CC=NC4=CC5=CC=CC=C5C=C34)C6=CC=NC7=CC8=CC=CC=C8C=C67,,,,,,
7284,157285,CID 157285,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[OH-].Cl.[Co+3],,,,,,
7285,157286,CID 157286,C1=CC=C(C=C1)C(C2=CC=CC=C2)[NH2+][NH3+],,,,,,
7286,157287,Benzhydryl-hydrazine,C1=CC=C(C=C1)C(C2=CC=CC=C2)NN,,,,,,
7287,157288,"1,3-Bis(p-hydroxyphenyl)pentane-1,4-diene",C=CC(C=CC1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,,,,,
7288,157289,"3-(3,4-Dichlorophenoxy)benzaldehyde",C1=CC(=CC(=C1)OC2=CC(=C(C=C2)Cl)Cl)C=O,,,,,,
7289,157290,"2-(4-Fluorophenyl)-1,3-thiazinane hydrochloride",C1CNC(SC1)C2=CC=C(C=C2)F.Cl,,,,,,
7290,157291,"2-(4-Fluorophenyl)-1,3-thiazinane",C1CNC(SC1)C2=CC=C(C=C2)F,,,,,,
7291,157292,"2-(m-Bromophenyl)tetrahydro-2H-1,3-thiazine hydrochloride",C1CNC(SC1)C2=CC(=CC=C2)Br.Cl,,,,,,
7292,157293,"2-(3-Bromophenyl)-1,3-thiazinane",C1CNC(SC1)C2=CC(=CC=C2)Br,,,,,,
7293,157294,6-Hydroxyindoramin,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=C3C=CC(=C4)O,,,,,,
7294,157295,"1-Piperazinecarboxamide, 4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-N-cyclopentyl-",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)NC4CCCC4)N)OC,,,,,,
7295,157296,"2-Thiophenecarboxylic acid, 3-(isocyanatosulfonyl)-, methyl ester",COC(=O)C1=C(C=CS1)S(=O)(=O)N=C=O,,,,,,
7296,157297,Einecs 279-164-2,C(CCN)CC(C(=O)O)N.C([C@@H](C(=O)O)N)SCC(=O)O,,,,,,
7297,157298,"3-(4-Isopropyl-m-tolyl)-1,1-dimethylurea",CC1=C(C=CC(=C1)NC(=O)N(C)C)C(C)C,,,,,,
7298,157299,"1,2-Benzenetriol, 5-(aminomethyl)-, hydriodide",C1=C(C=C(C(=C1O)O)O)CN.I,,,,,,
7299,157300,"1,2-Benzenediol, 3-(aminomethyl)-, hydriodide",C1=CC(=C(C(=C1)O)O)CN.I,,,,,,
7300,157301,Aethiopinone,CC1=C(C2=C(C=C1)C=C(C(=O)C2=O)C(C)C)CCCC(=C)C,,,,,,
7301,157302,"3,4-Dinitrobenzyl alcohol",C1=CC(=C(C=C1CO)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7302,157303,"Carbamic acid, dimethyl-, 3-(2-(dimethylamino)ethoxy)phenyl ester, monohydrochloride",CN(C)CCOC1=CC(=CC=C1)OC(=O)N(C)C.Cl,,,,,,
7303,157304,"Clopyralid mixture with 2,4-D",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O.C1=CC(=NC(=C1Cl)C(=O)O)Cl,,,,,,
7304,157305,"2-Propenoic acid, octahydro-4,7-methano-1H-indenyl ester",C=CC(=O)OC1CCC2C1C3CCC2C3,,,,,,
7305,157306,"9,10-Dihydroxy-7,8-epoxy-7,8,9,10-tetrahydro-3-methylcholanthrene",CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4C6C(O6)C(C5O)O)C=C1,,,,,,
7306,157307,"(8S-cis)-8-Acetyl-10-((3-amino-3,5-dideoxy-alpha-D-ribofuranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride",C[C@@H]1[C@H]([C@H]([C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)O)N.Cl,,,,,,
7307,157308,CID 157308,C[C@@H]1[C@H]([C@H]([C@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)O)N,,,,,,
7308,157309,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-3,5-dideoxy-beta-D-ribofuranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-",C[C@@H]1[C@H]([C@H]([C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)O)N.Cl,,,,,,
7309,157310,CID 157310,C[C@@H]1[C@H]([C@H]([C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)O)N,,,,,,
7310,157311,"Benzenamine, 2,4-dinitro-N-(4-(1,1,2,2-tetrafluoroethoxy)phenyl)-6-(trifluoromethyl)-",C1=CC(=CC=C1NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)OC(C(F)F)(F)F,,,,,,
7311,157312,"Ethylene-vinyl-N,N,-diethylglycinate copolymer",CCN(CC)[C@@]1(CCOC1=O)C=C,,,,,,
7312,157313,Epinastine hydrochloride,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N.Cl,,,"['Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)']",,,
7313,157314,"2-Imidazolidinone, 4-(acetyloxy)-3-(5-(1,1-dimethylethyl)-3-isoxazolyl)-1-methyl-",CC(=O)OC1CN(C(=O)N1C2=NOC(=C2)C(C)(C)C)C,,,,,,
7314,157315,"2,3-Dihydro-3-hydroxypyrrolo(2,1-b)quinazolin-9(1H)-one hydrochloride",C1CN2C(=NC3=CC=CC=C3C2=O)C1O.Cl,,,,,,
7315,157316,Copper-67(II) chloride,Cl[67Cu]Cl,,,,,,
7316,157317,C.I. Reactive Yellow 145,C1=CC(=CC(=C1)S(=O)(=O)CCOS(=O)(=O)[O-])NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)N=NC4=CC5=C(C=C(C=C5C=C4S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)N.[Na+].[Na+].[Na+].[Na+],,,,,,
7317,157318,Reactive Yellow MERL,C1=CC(=CC(=C1)S(=O)(=O)CCOS(=O)(=O)O)NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)N=NC4=CC5=C(C=C(C=C5C=C4S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)N,,,,,,
7318,157319,CID 157319,C[C@H]1[C@@H]2CC[C@H](C[C@H]2C3=C(N1)C=C(C=C3O)O[C@@H](C)CCCC4=CC=CC=C4)O,,,,,,
7319,157320,Bmdpc,CC(=C)C(=O)OCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCOC(=O)C(=C)C,,,,,,
7320,157321,"2-[[(2R)-2,3-bis[12-(2-methylprop-2-enoyloxy)dodecanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CC(=C)C(=O)OCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCOC(=O)C(=C)C,,,,,,
7321,157322,CID 157322,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)[O-].O.O.[Na+],,,,,,
7322,157323,CID 157323,C1CCC23C4=CC5=CC=CC=C5C=C4C=CC2(C1)O3,,,,,,
7323,157324,"(+)-trans-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]5[C@H](O5)[C@@H]([C@H]4O)O,,,,,,
7324,157325,"(+)-(1R,2S,3S,4R)-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@@H]5[C@@H](O5)[C@H]([C@@H]4O)O,,,,,,
7325,157326,"1-[(1S,5S,7R,8R)-6,6,8-trimethyl-2-tricyclo[5.3.1.01,5]undecanylidene]propan-2-one",C[C@@H]1CC[C@]23C[C@H]1C([C@@H]2CCC3=CC(=O)C)(C)C,,,,,,
7326,157327,"[(1S,2S,3aR,4S,5S,9R,11R,13aS)-4,9,11-triacetyloxy-3a-hydroxy-2,5,8,8,12-pentamethyl-2,3,4,5,9,10,11,13a-octahydro-1H-cyclopenta[12]annulen-1-yl] benzoate",C[C@H]1C[C@]2([C@H]([C@H]1OC(=O)C3=CC=CC=C3)C=C([C@@H](C[C@H](C(C=C[C@@H]([C@@H]2OC(=O)C)C)(C)C)OC(=O)C)OC(=O)C)C)O,,,,,,
7327,157328,"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-[[4-[[[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]amino]methyl]phenyl]methylamino]-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NCC6=CC=C(C=C6)CN[C@H]7C[C@@H](O[C@H]([C@H]7O)C)O[C@H]8C[C@@](CC9=C8C(=C1C(=C9O)C(=O)C2=C(C1=O)C(=CC=C2)OC)O)(C(=O)C)O)O,,,,,,
7328,157329,Unk-D-Phe-D-Cys(1)-Phe-Trp-D-Lys-xiThr-Cys(1)-DL-xiThr-ol,CC([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)C(C)F)C(=O)NC(CO)C(C)O)O,,,,,,
7329,157330,N-(4-Aminobutyl)-N-nitrosobenzamide monohydrochloride,C1=CC=C(C=C1)C(=O)N(CCCCN)N=O.Cl,,,,,,
7330,157331,N-(4-aminobutyl)-N-nitrosobenzamide,C1=CC=C(C=C1)C(=O)N(CCCCN)N=O,,,,,,
7331,157332,Goniothalamicinone,CCCCCCCCCCCCCC[C@H]([C@H]1CC[C@@H](O1)[C@@H](CC[C@@H](CCCCC[C@@H]2C[C@H](C(=O)O2)CC(=O)C)O)O)O,,,,,,
7332,157333,CID 157333,C[C@@H]1CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C=C(C)C(C)(C)OC(=O)C)(OC5)C(=O)OC)O)O)C)O,,,,,,
7333,157334,CID 157334,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)O,,,,,,
7334,157335,CID 157335,C1CCC(C(C1)[NH-])[NH-].C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.[N+](=O)([O-])[O-].[Pt+4],,,,,,
7335,157336,"Bis-(2,2-dinitropropyl)acetal Mixture With Formal",CC(OCC(C)([N+](=O)[O-])[N+](=O)[O-])OCC(C)([N+](=O)[O-])[N+](=O)[O-].CC(COCOCC(C)([N+](=O)[O-])[N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-],,,,,,
7336,157337,"N-(3-(Dimethylamino)propyl)-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonamide N-oxide",CN(C)CCC[NH+]([O-])S(=O)(=O)CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7337,157338,"N-[3-(dimethylamino)propyl]-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-N-oxidooctane-1-sulfonamide",CN(C)CCCN([O-])S(=O)(=O)CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7338,157339,"Benzoic acid, 2-(acetyloxy)-, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester, (2R-trans)-",CC(=O)OC1=CC=CC=C1C(=O)O[C@H]2CC3=C(C=C(C=C3O[C@@H]2C4=CC(=C(C=C4)O)O)O)O,,,,,,
7339,157340,Tetramethylammonium hydrogen sulfate,C[N+](C)(C)C.OS(=O)(=O)[O-],,,,,,
7340,157341,"Furo(3,2-b)furan, 6-bromo-2-((1S)-3-bromo-1,2-propadienyl)-2,3,3a,6a-tetrahydro-5-((1S,2R)-2-((2S,3R)-3-methyloxiranyl)cyclopropyl)-, (2S,3aR,6aS)-",C[C@@H]1[C@H](O1)C2C[C@@H]2C3=C([C@@H]4[C@H](O3)C[C@H](O4)C=C=CBr)Br,,,,,,
7341,157342,"Ethyl (1R,2R,6R,7S)-tricyclo[5.2.1.02,6]decane-2-carboxylate",CCOC(=O)[C@@]12CCC[C@@H]1[C@H]3CC[C@@H]2C3,,,,,,
7342,157343,"Ethyl hexahydro-4,7-methanoindane-3a-carboxylate",CCOC(=O)[C@@]12CCC[C@@H]1[C@@H]3CC[C@H]2C3,,,,,,
7343,157344,CID 157344,CCCN1C=NC(=C2C1=NC=N2)N,,,,,,
7344,157345,"Morpholine, 4-(1,2,4-benzotriazin-3-ylacetyl)-",C1COCCN1C(=O)CC2=NC3=CC=CC=C3N=N2,,,,,,
7345,157346,"Piperidine, 1-(1,2,4-benzotriazin-3-ylacetyl)-",C1CCN(CC1)C(=O)CC2=NC3=CC=CC=C3N=N2,,,,,,
7346,157347,"[Cyano-(3-phenoxyphenyl)methyl] 3-(furan-2-ylmethoxyiminomethyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=NOCC4=CC=CO4)C,,,,,,
7347,157348,Amsalog,CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C(=O)NC)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC.C(CS(=O)(=O)O)O,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)']",,,
7348,157349,CID 157349,CCCC[SnH](CCCC)CCCC.[OH],,,,,,
7349,157350,Hydroxyl radical,[OH],,,['Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)'],,,
7350,157351,"cis-Dichlorobis(2,2'-bipyrazyl)ruthenium(II)",C1=CN=C(C=N1)C2=NC=CN=C2.C1=CN=C(C=N1)C2=NC=CN=C2.Cl[Ru]Cl,,,,,,
7351,157352,4-(4-Methylpiperidyl)pyridine,CC1CCN(CC1)C2=CC=NC=C2,,,,,,
7352,157353,epsilon-dATP,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CN4C3(C=C4)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
7353,157354,Lactitol dihydrate,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O.O.O,,,,,,
7354,157355,Lactitol,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,['Lactitol is indicated for the treatment of chronic idiopathic constipation in adults.'],['Lactitol helps to facilitate bowel movements by drawing water into the gastrointestinal tract. The oral administration of lactitol may reduce the absorption of concomitant medications - other oral medications should be administered at least 2 hours before or 2 hours after lactitol.'],"['Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)', 'Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)']","['In healthy subjects under fed conditions, oral administration of 20 grams of lactitol resulted in a mean T<sub>max</sub> of 3.6 ± 1.2 hours, C<sub>max</sub> of 776 ± 253 ng/mL, and a mean AUC of 6,019 ± 1,771 ng*hr/mL.', 'Lactitol is not absorbed in the gastrointestinal tract to any significant extent. The vast majority of an ingested dose is likely degraded into organic acids in the colon and eliminated in the feces.', 'Data regarding the volume of distribution of lactitol are unavailable.', 'Data regarding the clearance of lactitol are unavailable.', 'Three male rats (150-200 g; six to eight weeks of age; one not pretreated and two habituated to a diet containing 7% lactitol) were orally intubated with about 2 mg D-(sorbitol-1-(14)C) lactitol. In the studies with the rats habituated to lactitol, 9-15% of the radioactivity was recovered from the air exhaled in the period 0-5 hours and 48% from the air exhaled in the period 0-24 hours. The urine and the feces contained a minor proportion of the administered radioactivity (urine, 2.3% after five hours and 6.8% after 24 hours; feces, 11.7% after 24 hours). The gastrointestinal tract contained 33% of the radioactivity after five hours and 5% after 24 hours; the remainder of the body contained 20% after five hours and 9% after 24 hours. It was concluded that lactitol is extensively degraded in the rat after oral administration presumably mainly by the intestinal microflora and that habituation of the rats to unlabelled lactitol did not essentially affect the rate and extent of degradation.', 'In studies designed to investigate the metabolism of erythritol in vivo in healthy volunteers and to compare the fermentation of erythritol by human fecal flora in vitro with that of glucose and lactitol, four male and two female volunteers aged 21-25 undertook an overnight fast and were then chosen at random to receive a single dose of 25 g (13)C-erythritol, (13)C-glucose, and (13)C-lactitol in 250 mL of water with at least three days between each treatment. Breath samples were taken for analysis of (13)C-carbon dioxide and hydrogen gas before treatment and at 30 min intervals up to 6 hr after treatment. The ratio of (13)C: (12)C-carbon dioxide was measured by isotope-ratio mass spectrometry. Urine samples were collected over 0-6 and 6-24 hr after treatment, and the erythritol and lactitol concentrations in urine were measured by HPLC. ... During the first 6 and 24 hr after dosing, 52 and 84%, respectively, of the administered erythritol was recovered in the urine. No increase in expired (13)C-carbon dioxide or hydrogen gas was observed, indicating that no fermentation had occurred in the gut. In contrast, there was a rapid increase in expired (13)C-carbon dioxide after consumption of glucose and a more gradual rise after ingestion of lactitol. Excretion of hydrogen gas in expired air was also increased after treatment with lactitol. Neither lactitol nor glucose was detected in significant amounts in the urine. ...', 'The gastrointestinal absorption of lactitol has been studied in 6 healthy volunteers and 8 patients with cirrhosis. Following administration of lactitol 0.5 g/kg, no lactitol was found in serum. The urinary excretion of lactitol over 24 hr ranged from 0.1 to 1.4% of the administered dose (0.46% in cirrhotics and 0.35% in healthy volunteers). Blood D- and L-lactate and plasma glucose did not increase following lactitol. The data indicate that lactitol was poorly absorbed from the gastrointestinal tract in healthy volunteers and patients with cirrhosis, and that the disaccharide did not disturb glucose or lactate homeostasis.', 'The fate of orally ingested lactitol, a non-absorbed sugar, was measured in six healthy human subjects by following the three routes of disposal of universally (14)C-labelled sugar. Lactitol was given as a 20 g daily dose to six healthy volunteers for 14 days and on the seventh day, 10 muCi of L-[U-(14)C]-lactitol was given with the unlabelled sugar and excretion of the (14)C in breath, urine and faeces was followed. The peak of (14)CO2 excretion occurred at six hours and total (14)CO2 accounted for 62.9 (5.0)% of isotope given, whilst 6.5 (3.6)% and 2.0 (0.3)% of the label were recovered from faeces and urine respectively. These data suggest that lactitol is extensively metabolised in the human colon and that a significant proportion of the bacterial metabolites are available for colonic absorption. Calculation revealed that 54.5% of the theoretical energy content of this compound was utilised by the subjects. ...']","['As it undergoes little-to-no systemic absorption, lactitol is unlikely to undergo any significant degree of metabolism.', 'In studies designed to investigate the metabolism of erythritol in vivo in healthy volunteers and to compare the fermentation of erythritol by human fecal flora in vitro with that of glucose and lactitol, four male and two female volunteers aged 21-25 undertook an overnight fast and were then chosen at random to receive a single dose of 25 g (13)C-erythritol, (13)C-glucose, and (13)C-lactitol in 250 mL of water with at least three days between each treatment. Breath samples were taken for analysis of (13)C-carbon dioxide and hydrogen gas before treatment and at 30 min intervals up to 6 hrs after treatment. The ratio of (13)C: (12)C-carbon dioxide was measured by isotope-ratio mass spectrometry. ... In order to maintain a constant metabolic rate, the subjects remained at rest during the study. For the assay of fermentation in vitro, fecal samples were collected from six healthy volunteers (sex and age not specified) who ate a normal western diet. None of the subjects complained of gastrointestinal symptomsand none had used antibiotics in the past six months. The samples were incubated under anaerobic conditions for 6 hr, and then the hydrogen gas concentration was measured in the head-space of the incubation vials. ... After a 6 hr incubation with erythritol, the amount of hydrogen gas formed by the fecal flora was comparable to that in control vials, but significantly (p < 0.001) more hydrogen gas was produced in the glucose and lactitol vials than in either control or erythritol.']",['The average half-life of orally administered lactitol is 2.4 hours.']
7355,157356,"2-Anthraceneacetamide, N-(2-(diethylamino)ethyl)-9,10-dihydro-1,4-dihydroxy-9,10-dioxo-, monohydrochloride",CCN(CC)CCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O.Cl,,,,,,
7356,157357,"N-[2-(diethylamino)ethyl]-2-(1,4-dihydroxy-9,10-dioxoanthracen-2-yl)acetamide",CCN(CC)CCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
7357,157358,"2-Anthraceneacetamide, N-(3-(dimethylamino)propyl)-9,10-dihydro-1,4-dihydroxy-9,10-dioxo-, monohydrochloride",CN(C)CCCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O.Cl,,,,,,
7358,157359,"2-(1,4-dihydroxy-9,10-dioxoanthracen-2-yl)-N-[3-(dimethylamino)propyl]acetamide",CN(C)CCCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
7359,157360,"2-Anthraceneacetamide, N-(3-(diethylamino)propyl)-9,10-dihydro-1,4-dihydroxy-9,10-dioxo-, monohydrochloride",CCN(CC)CCCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O.Cl,,,,,,
7360,157361,"N-[3-(diethylamino)propyl]-2-(1,4-dihydroxy-9,10-dioxoanthracen-2-yl)acetamide",CCN(CC)CCCNC(=O)CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
7361,157362,"2-Anthracenecarboxamide, N-(3-(diethylamino)propyl)-9,10-dihydro-9,10-dioxo-, monohydrochloride",CCN(CC)CCCNC(=O)C1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O.Cl,,,,,,
7362,157363,"N-[3-(diethylamino)propyl]-9,10-dioxoanthracene-2-carboxamide",CCN(CC)CCCNC(=O)C1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O,,,,,,
7363,157364,Vamin,CC1=C(C(=CC=C1)C)N(C2CCOC2=O)C(=O)CCl.C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,,,['Specialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS. (See all compounds classified as Parenteral Nutrition Solutions.)'],,,
7364,157365,2-(p-(2H-Indazol-2-yl)phenyl)propionic acid,CC(C1=CC=C(C=C1)N2C=C3C=CC=CC3=N2)C(=O)O,,,,,,
7365,157366,"Triphenylene, 1-nitro-",C1=CC=C2C(=C1)C3=C(C4=CC=CC=C24)C(=CC=C3)[N+](=O)[O-],,,,,,
7366,157367,Sapintoxin C,C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@H]4[C@@H](C(=C3)C)O)C)O)OC(=O)C)OC(=O)C5=CC=CC=C5NC,,,,,,
7367,157368,"1,7b,10-Triazabenzo(5,6)cyclohepta(1,2,3-jk)fluoren-5-ol,1,2,3,8,13,13a-hexahydro-1,8-dimethyl-",CC1C2=C(CC3C4=C(CCN3C)C5=C(N14)C=CC(=C5)O)C=CN=C2,,,,,,
7368,157369,CID 157369,C[C@H]1C=CC=C(C(=O)N=C2C(=CNN3CCN(CC3)C4CCCC4)C(=C5C(=C2O)C(=C(C6=C5C(=O)[C@](O6)(OC=C[C@@H]([C@@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)O)C)OC)C)C)O)O)C,,,,,,
7369,157370,"Phenanthridinium, 6,6'-(1,10-decanediylbis(oxy-3,1-phenylene))bis(3,8-diamino-5-methyl-, dichloride",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)OCCCCCCCCCCOC5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N.[Cl-].[Cl-],,,,,,
7370,157371,"6-[3-[10-[3-(3,8-Diamino-5-methylphenanthridin-5-ium-6-yl)phenoxy]decoxy]phenyl]-5-methylphenanthridin-5-ium-3,8-diamine",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)OCCCCCCCCCCOC5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
7371,157372,"Phenanthridinium, 6,6'-(1,7-heptanediylbis(oxy-3,1-phenylene))bis(3,8-diamino-5-methyl-, dibromide",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)OCCCCCCCOC5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N.[Br-].[Br-],,,,,,
7372,157373,"6-[3-[7-[3-(3,8-Diamino-5-methylphenanthridin-5-ium-6-yl)phenoxy]heptoxy]phenyl]-5-methylphenanthridin-5-ium-3,8-diamine",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC(=CC=C4)OCCCCCCCOC5=CC=CC(=C5)C6=C7C=C(C=CC7=C8C=CC(=CC8=[N+]6C)N)N)N)N,,,,,,
7373,157374,Cytarazid triphosphate,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)N=[N+]=[N-],,,,,,
7374,157375,CID 157375,C1CNC(=C(CC2=CC(=C(C(=C2)Br)O)OC3=C(C=C(CC(=C(NCCC4=CC(=C(C(=C4)Br)O)OC5=C(C=C1C=C5)Br)O)N=O)C=C3Br)Br)N=O)O,,,,,,
7375,157376,"Platinum(2+), triammineaqua-, (SP-4-2)-, dinitrate",N.N.N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.[Pt+2],,,,,,
7376,157377,4-O-Methylaclacinomycin N,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(C(O7)C)O)O)N(C)C)O,,,,,,
7377,157378,4-O-Methylaclacinomycin S,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)O)O)N(C)C)O,,,,,,
7378,157379,CID 157379,CCN1C=NC2=C1NC(=NC2=O)N.CN1C=CC(=NC1=O)N.N.N.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Pt+2],,,,,,
7379,157380,CID 157380,CCN1C=NC2=C1NC(=NC2=O)[NH-].CN1C=CC(=NC1=O)N.N.N.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Pt+2],,,,,,
7380,157381,4'''-Aclacinomycinamide,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(C(O7)C)NC(=O)C)O)N(C)C)O,,,,,,
7381,157382,"Destruxin A, 2-L-valine-",C[C@H]1C(=O)NCCC(=O)O[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)C(C)C)CC=C,,,,,,
7382,157383,Feudomycin B,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(CC(=O)C)O)N)O,,,,,,
7383,157384,Feudomycin A,CC[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O,,,,,,
7384,157385,Pirlimycin,CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,"['For the treatment of subclinical mastitis in lactating cows due to Gram-positive cocci susceptible to pirlimycin including staphylococcal organisms such as Staphylococcus aureus, both penicillinase-positive and penicillinase-negative, and coagulase-negative staphylococci; streptococcal organisms including Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis.']",,,,,
7385,157386,"2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-arabinofuranosyl)-5-methyl-",CC1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)F,,,,,,
7386,157387,1-(2'-Deoxy-2'-fluoro-beta-arabinofuranosyl)-5-methylcytosine triphosphate,CC1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)F,,,,,,
7387,157388,"2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-arabinofuranosyl)-5-iodo-",C1=C(C(=NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)F)N)I,,,,,,
7388,157389,"Sodium dihydrogen bis(2-hydroxy-5-sulphobenzoato(3-)-O1,O2)samarate(3-)",[H+].[H+].C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)[O-])[O-].C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)[O-])[O-].[Na+].[Sm+3],,,,,,
7389,157390,CID 157390,CC1C(C(C(C(O1)OC2C(C=C3C2=CC#CC4C(O4)(C#C3)C(CO)O)OC(=O)C5=C(C=CC6=C5C=C(C=C6C)OC)O)NC)O)O,,,,,,
7390,157391,Antibiotic MA 144U9,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)O)O)O)O,,,,,,
7391,157392,"2alpha,3beta,20beta-Urs-delta 12-ene-23beta,28-dioic acid 2,3-diacetate",C[C@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@]5(C)C(=O)O)OC(=O)C)OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C(=O)O,,,,,,
7392,157393,"N,N'-(((1R,2R,3S,4S)-3,4-bis(2-amino-1H-imidazol-5-yl)cyclobutane-1,2-diyl)bis(methylene))bis(4-bromo-1H-pyrrole-2-carboxamide) dihydrochloride",C1=C(NC=C1Br)C(=O)NC[C@@H]2[C@H]([C@@H]([C@H]2C3=CN=C(N3)N)C4=CN=C(N4)N)CNC(=O)C5=CC(=CN5)Br.Cl.Cl,,,,,,
7393,157394,Sceptrin,C1=C(NC=C1Br)C(=O)NC[C@@H]2[C@H]([C@@H]([C@H]2C3=CN=C(N3)N)C4=CN=C(N4)N)CNC(=O)C5=CC(=CN5)Br,,,,,,
7394,157395,Stachyurin,C1C(C(OC(=O)C2=CC(=C(C(=C2C3=C(C(=C(C=C3C(=O)O1)O)O)O)O)O)O)C4C5C(C6=C(C(=C(C(=C6C(=O)O5)C7=C(C(=C(C=C7C(=O)O4)O)O)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O,,,,,,
7395,157396,"Phenaleno(1,9-gh)quinoline, 9-methyl-",CC1=NC2=C(C=C1)C=C3C=CC4=C5C3=C2C=CC5=CC=C4,,,,,,
7396,157397,"[(3R,3As,4S,8aS)-3-hydroxy-6,8a-dimethyl-8-oxo-3-propan-2-yl-2,3a,4,5-tetrahydro-1H-azulen-4-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1CC(=CC(=O)[C@@]2([C@@H]1[C@@](CC2)(C(C)C)O)C)C,,,,,,
7397,157398,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrobromide, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCOCC6)O.Br,,,,,,
7398,157399,Morpholinodaunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCOCC6)O,,,,,,
7399,157400,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(4-methoxy-1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCC(CC6)OC)O.Cl,,,,,,
7400,157401,"(9S)-6,9,11-trihydroxy-9-(1-hydroxyethyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-(4-methoxypiperidin-1-yl)-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCC(CC6)OC)O,,,,,,
7401,157402,"5,12-Naphthacenedione, 8-acetyl-10-((3-(cyclohexylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC6CCCCC6)O.Cl,,,,,,
7402,157403,"9-acetyl-7-[4-(cyclohexylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC6CCCCC6)O,,,,,,
7403,157404,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((tetrahydro-2H-pyran-4-yl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC6CCOCC6)O.Cl,,,,,,
7404,157405,"9-acetyl-6,9,11-trihydroxy-7-[5-hydroxy-6-methyl-4-(oxan-4-ylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC6CCOCC6)O,,,,,,
7405,157406,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-methoxy-1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCC(CC6)OC)O.Cl,,,,,,
7406,157407,"9-acetyl-6,9,11-trihydroxy-7-[5-hydroxy-4-(4-methoxypiperidin-1-yl)-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCC(CC6)OC)O,,,,,,
7407,157408,Dynorphin (1-10) amide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
7408,157409,"Poly(difluoromethylene), alpha-fluoro-omega-[2-(sulfooxy)ethyl]-, ammonium salt",C(COS(=O)(=O)O)C(F)(F)F.N,,,,,,
7409,157410,"3,3,3-Trifluoropropyl hydrogen sulfate",C(COS(=O)(=O)O)C(F)(F)F,,,,,,
7410,157411,"Poly(difluoromethylene), alpha-fluoro-omega-(2-sulfoethyl)-",C(CS(=O)(=O)O)C(F)(F)F,,,,,,
7411,157412,"Poly(difluoromethylene), alpha-fluoro-omega-(2-sulfoethyl)-, ammonium salt",C(CS(=O)(=O)O)C(F)(F)F.N,,,,,,
7412,157413,"Neodecanoic acid, oxiranylmethyl ester, polymer with ethenylbenzene, 2-hydroxyethyl 2-propenoate, 1,3-isobenzofurandione and methyl 2-methyl-2-propenoate",CC(=C)C(=O)OC.CC(C)(C)CCCCCC(=O)OCC1CO1.C=CC1=CC=CC=C1.C=CC(=O)OCCO.C1=CC=C2C(=C1)C(=O)OC2=O,,,,,,
7413,157414,CID 157414,CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)CC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)C=C(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C,,,,,,
7414,157415,Bisbrusatolyl succinate,CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)CCC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)C=C(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C,,,,,,
7415,157416,Heyneaninehydroxyindolenine,C[C@@H]([C@@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CC[C@@]4(C3=NC5=CC=CC=C54)O)C(=O)OC)O,,,,,,
7416,157417,Capsicum fuscoviolaceum,CC1C(=O)OC2CC1(C3C(=O)C4(C5CC=C6CC=CC(=O)C6(C5CCC7(C3(C2(OC7=O)C)O4)O)C)O)C,,,,,,
7417,157418,Cyplatate,[H+].[H+].C1CCC(C(C1)N)N.C(C(C(=O)[O-])NC(=O)CP(=O)([O-])[O-])C(=O)[O-].[Pt+2],,,,,,
7418,157419,CID 157419,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C4=NC5=C(N4[C@H]6C[C@@H]([C@H](O6)COP(=O)(O)OC7C[C@@H](O[C@@H]7CO)N8C=CC(=NC8=O)N)O)NC(=NC5=O)N,,,,,,
7419,157420,"Gona-1,3,5,7,9,15-hexaen-12-one, (13xi,14xi)-",C1C=CC2C1C(=O)CC3=C2C=CC4=CC=CC=C34,,,,,,
7420,157421,3-(((2-(2-(Acetylamino)ethyl-4-thiazolyl)carbonyl)amino)propyl)dimethylsulfonium chloride,CC(=O)NCCC1=NC(=CS1)C(=O)NCCC[S+](C)C.[Cl-],,,,,,
7421,157422,"3-[[2-(2-Acetamidoethyl)-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium",CC(=O)NCCC1=NC(=CS1)C(=O)NCCC[S+](C)C,,,,,,
7422,157423,"Methyl 11-acetyloxy-12-ethyl-4-(17-ethyl-17-hydroxy-13-methoxycarbonyl-1-oxido-11-aza-1-azoniatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CCC1(CC2CC(C3=C(CC[N+](C2)(C1)[O-])C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,,,,,,
7423,157424,"Cobaltate(1-), bis(5,8-dichloro-2-((2-hydroxy-4-nitrophenyl)azo)-1-naphthalenolato(2-))-, hydrogen",[H+].C1=CC(=NN=C2C=CC3=C(C=CC(=C3C2=O)Cl)Cl)C(=O)C=C1N([O-])[O-].C1=CC(=C(C=C1[N+](=O)[O-])[O-])N=NC2=C(C3=C(C=CC(=C3C=C2)Cl)Cl)[O-].[Co+3],,,,,,
7424,157425,CID 157425,C1=CC(=NN=C2C=CC3=C(C=CC(=C3C2=O)Cl)Cl)C(=O)C=C1N(O)O,,,,,,
7425,157426,"5,8-Dichloro-2-[[4-(dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]naphthalen-1-one",C1=CC(=NN=C2C=CC3=C(C=CC(=C3C2=O)Cl)Cl)C(=O)C=C1N([O-])[O-],,,,,,
7426,157427,Trisarubicinol,C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2[C@@H](O[C@H](C[C@@H]2N(C)C)OC3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)O)O)(C(C)O)O)C)O)O[C@H]7CCC(=O)[C@@H](O7)C,,,,,,
7427,157428,"Benzo(2)pyrene, 1-(1,1-dimethylethyl)-",CC(C)(C)C1=C2C=CC3=C4C2=C(C=CC4=CC5=CC=CC=C35)C=C1,,,,,,
7428,157429,Gadopentetic acid [MI],[H+].[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],,,
7429,157430,Cofplaton,[H+].[H+].CN1C2=C(N=C1OCCCN(C)C)N(C(=O)N(C2=O)C)C.CN1C2=C(N=C1OCCCN(C)C)N(C(=O)N(C2=O)C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],,,,,,
7430,157431,"Purimido(4,5-b)quinoline-2,4(3H,10H)-dione, 10-ethyl-8-methoxy-",CCN1C2=C(C=CC(=C2)OC)C=C3C1=NC(=O)NC3=O,,,,,,
7431,157432,"(Z)-(Cyclohexane-1,2-diammine)isocitratoplatinum(II)",[H+].[H+].C1CCC(C(C1)N)N.C(C(C(C(=O)[O-])[O-])C(=O)[O-])C(=O)[O-].[Pt+2],,,,,,
7432,157433,"Platinum, aqua(1,2-diphenyl-1,2-ethanediamine-N,N')(sulfato(2-)-O)-, (SP-4-4-(R*,S*))-",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)N)N.O.[O-]S(=O)(=O)[O-].[Pt+2],,,,,,
7433,157434,"Platinum, (1,2-ethanediamine-N,N')(hydroxypropanedioato(2-)-O1,O3)-, (SP-4-2)-",C(CN)N.C(C(=O)[O-])(C(=O)[O-])O.[Pt+2],,,,,,
7434,157435,3-Keto-4-pentenoyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(=O)C=C)O,,,,,,
7435,157436,"2-Methylpropan-2-ol;propane-1,2-diol",CC(CO)O.CC(C)(C)O,,,,,,
7436,157437,"8-(1,2-Dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N6CCOCC6)O.Cl,,,,,,
7437,157438,"5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N6CCOCC6)O,,,,,,
7438,157439,2-Hydroxyaclacinomycin S,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)O)O)N(C)C)O,,,,,,
7439,157440,2-Hydroxyaclacinomycin T,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)OC5CC(C(C(O5)C)O)N(C)C)O,,,,,,
7440,157441,2-Hydroxyaclacinomycin N,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(C(O7)C)O)O)N(C)C)O,,,,,,
7441,157442,CID 157442,C1[C@@H]([C@H](OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(OP(=O)(O)OP(=O)(O)O)S)O,,,,,,
7442,157443,Tc-99m Mdp,C(P(=O)(O)O)P(=O)(O)O.[99Tc],,,"['Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)']",,,
7443,157444,beta-Isorhodomycinone,CC[C@]1(C[C@@H](C2=C([C@H]1O)C(=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
7444,157445,alpha2-Rmn-A,CCC1(CC(C2=CC3=C(C(=C2C1O)O)C(=O)C4=C(C=CC(=C4C3=O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,,,,,
7445,157446,Feudomycin D,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@]([C@@H](C3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)O)(C)O)N)O,,,,,,
7446,157447,Daunomycinone-A,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N(C)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O,,,,,,
7447,157448,Daunomycinone-S,CC1C(C(CC(O1)OC2C(OC(CC2N(C)C)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)OC)O)(C(=O)C)O)C)O)O,,,,,,
7448,157449,Daunomycinone-L,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O,,,,,,
7449,157450,Daunomycinone-K,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O,,,,,,
7450,157451,4-O-Methylaclacinomycin T,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)N(C)C)O,,,,,,
7451,157452,CID 157452,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=NO)C(O7)C)O)N(C)C)O,,,,,,
7452,157453,"Tris(1,2-ethanediamine-N,N')rhodium(2+) dichloride",C(CN)N.C(CN)N.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
7453,157454,Patellamide A,CC[C@H](C)[C@H]1C2=N[C@@H](CO2)C(=O)N[C@@H](C3=NC(=CS3)C(=O)N[C@H](C4=N[C@@H]([C@H](O4)C)C(=O)N[C@@H](C5=NC(=CS5)C(=O)N1)C(C)C)[C@@H](C)CC)C(C)C,,,,,,
7454,157455,"N,N,N',N'-Tetraethyl-1,3,6,8-tetraoxobenzo(lmn)(3,8)phenanthroline-2,7-dibutanaminium diiodide",CC[N+](C)(CC)CCCC(C)N1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)C(C)CCC[N+](C)(CC)CC)C1=O.[I-].[I-],,,,,,
7455,157456,"4-[13-[5-[Diethyl(methyl)azaniumyl]pentan-2-yl]-5,7,12,14-tetraoxo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]pentyl-diethyl-methylazanium",CC[N+](C)(CC)CCCC(C)N1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)C(C)CCC[N+](C)(CC)CC)C1=O,,,,,,
7456,157457,"alpha,alpha'-Bis(4-aminobutyl)-1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-N,N'-bis(tricyclo(3.3.1.1(3,7))dec-1-yl)benzo(lmn)(3,8)phenanthroline-2,7-diacetamide dihydrobromide",C1C2CC3CC1CC(C2)(C3)NC(=O)C(CCCCN)N4C(=O)C5=C6C(=CC=C7C6=C(C=C5)C(=O)N(C7=O)C(CCCCN)C(=O)NC89CC1CC(C8)CC(C1)C9)C4=O.Br.Br,,,,,,
7457,157458,"N-(1-adamantyl)-2-[13-[1-(1-adamantylamino)-6-amino-1-oxohexan-2-yl]-5,7,12,14-tetraoxo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]-6-aminohexanamide",C1C2CC3CC1CC(C2)(C3)NC(=O)C(CCCCN)N4C(=O)C5=C6C(=CC=C7C6=C(C=C5)C(=O)N(C7=O)C(CCCCN)C(=O)NC89CC1CC(C8)CC(C1)C9)C4=O,,,,,,
7458,157459,"alpha,alpha'-Bis(4-aminobutyl)-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo(lmn)(3,8)phenanthroline-2,7-diacetamide dihydrobromide",C1=CC2=C3C(=CC=C4C3=C1C(=O)N(C4=O)C(CCCCN)C(=O)N)C(=O)N(C2=O)C(CCCCN)C(=O)N.Br.Br,,,,,,
7459,157460,"6-Amino-2-[13-(1,6-diamino-1-oxohexan-2-yl)-5,7,12,14-tetraoxo-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]hexanamide",C1=CC2=C3C(=CC=C4C3=C1C(=O)N(C4=O)C(CCCCN)C(=O)N)C(=O)N(C2=O)C(CCCCN)C(=O)N,,,,,,
7460,157461,"Benzo(lmn)(3,8)phenanthroline-1,3,6,8(2H,7H)-tetrone, 2,7-bis(3-(dimethylamino)propyl)-, dihydrobromide",CN(C)CCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)CCCN(C)C)C1=O.Br.Br,,,,,,
7461,157462,"2,7-Bis(3-(dimethylamino)propyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone",CN(C)CCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)CCCN(C)C)C1=O,,,,,,
7462,157463,"Benzo(lmn)(3,8)phenanthroline-1,3,6,8(2H,7H)-tetrone, 2,7-bis(2-(dimethylamino)ethyl)-, dihydrobromide",CN(C)CCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)CCN(C)C)C1=O.Br.Br,,,,,,
7463,157464,Naphthalenediimide,CN(C)CCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C(=O)N(C4=O)CCN(C)C)C1=O,,,,,,
7464,157465,"7',8'-Didehydro-5,6-epoxy-6,7-dihydro-3,3'-dihydroxy-beta,beta-caroten-8(5H)-one",CC1=C(C(CC(C1)O)(C)C)C#CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C(=O)CC23C(CC(CC2(O3)C)O)(C)C)C)C,,,,,,
7465,157466,Triamcinolone acetonide-21-(beta-benzoylamino)isobutyrate,CC(CNC(=O)C1=CC=CC=C1)C(=O)OCC(=O)[C@@]23[C@H](C[C@@H]4[C@@]2(C[C@@H](C5([C@H]4CCC6=CC(=O)C=C[C@@]65C)F)O)C)OC(O3)C7=CC=C(C=C7)N(C)C,,,,,,
7466,157467,"Benz(a)anthracene-10,11-diol, 10,11-dihydro-7-methyl-",CC1=C2C=CC3=CC=CC=C3C2=CC4=C1C=CC(C4O)O,,,,,,
7467,157468,CID 157468,CN=C(N=C(C1=CC=CC=C1)S)S,,,,,,
7468,157469,"1,2-Benzenedicarboxylic acid, 4-hydroxybutyl propyl ester",CCCOC(=O)C1=CC=CC=C1C(=O)OCCCCO,,,,,,
7469,157470,"2-Propenoic acid, polymer with N-(1-methylethyl)-2-propenamide",CC(C)NC(=O)C=C.C=CC(=O)O,,,,,,
7470,157471,"Phenol, 3-(1-propyl-3-piperidinyl)-, hydrochloride",CCCN1CCCC(C1)C2=CC(=CC=C2)O.Cl,,,,,,
7471,157472,CID 157472,C1CNC(=C(CC2=CC(=C(C=C2)OC3=C(C(=CC(=C3)CC(=C(NC=CC4=CC(=C(C=C4)OC5=C(C(=CC1=C5)Br)O)Br)O)N=O)Br)O)Br)N=O)O,,,,,,
7472,157473,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-(2-(methylamino)ethyl)-5-nitro-",CNCCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)[N+](=O)[O-],,,,,,
7473,157474,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-(2-hydroxyethyl)-5-nitro-",C1=CC2=CC(=CC3=C2C(=C1)C(=O)N(C3=O)CCO)[N+](=O)[O-],,,,,,
7474,157475,CID 157475,COC1=CC=C(C=C1)C2=CC(=C3C(=CC(=CC3=O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)OC)O)O)O)O2)O,,,,,,
7475,157476,"1,7b,10-Triazabenzo(5,6)cyclohepta(1,2,3-jk)fluorene, 1,2,3,8,13,13a-hexahydro-1,8-dimethyl-, (8R,13aS)-",C[C@@H]1C2=C(C[C@H]3C4=C(CCN3C)C5=CC=CC=C5N14)C=CN=C2,,,,,,
7476,157477,"Dibenz(a,h)anthracene-1,2,3,4-tetrol, 1,2,3,4-tetrahydro-, (1alpha,2beta,3alpha,4beta)-",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)[C@H]([C@@H]([C@H]([C@@H]5O)O)O)O,,,,,,
7477,157478,(-)-Corlumine,CN1CCC2=CC(=C(C=C2[C@@H]1[C@@H]3C4=C(C5=C(C=C4)OCO5)C(=O)O3)OC)OC,,,,,,
7478,157479,4-Deoxyphorbol,C[C@@H]1[C@H](C2(C(C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@H]4CC(=C3)CO)C)O)O)O,,,,,,
7479,157480,Aucubigenin-1-O-beta-serotinoside,C1C=C([C@H]2[C@@H]1C=COC2O[C@@H]3[C@@H]([C@H]([C@@H]([C@@](O3)(CO[C@@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)O)O)O)O)CO,,,,,,
7480,157481,CID 157481,CC(=NN=C(N)S)C1=CC=C(S1)Cl,,,,,,
7481,157482,CID 157482,C[C@@H](CCC=C(C)C(=O)OC)[C@@H]1CC[C@]2([C@]1(CC[C@H]3C2=CCC4[C@@]3(CCC(=O)C4(C)C)C)C)C,,,,,,
7482,157483,1-Thiocyanatobut-3-en-2-ol,C=CC(CSC#N)O,,,,,,
7483,157484,CID 157484,C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)OC(=O)C=CC7=CC(=C(C=C7)O)OC)O)O,,,,,,
7484,157485,"3-Butenenitrile, 2-((6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy)-3-methyl-, (2S)-",CC(=C)[C@@H](C#N)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@H](CO2)O)O)O)O)O)O,,,,,,
7485,157486,"(3R,6S,11S,12S,15S,16R)-15-[(2S)-5-ethyl-6-methylhept-6-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol",CCC(CC[C@H](C)[C@@H]1CC[C@@]2([C@@]1(CCC34[C@H]2CCC5[C@]3(C4)CC[C@@H](C5(C)C)O)C)C)C(=C)C,,,,,,
7486,157487,4-But-2-enoyl-3-methoxy-5-methylbenzoic acid,CC=CC(=O)C1=C(C=C(C=C1C)C(=O)O)OC,,,,,,
7487,157488,5-Methoxy-2-(5-prop-1-enyl-1-benzofuran-2-yl)phenol,CC=CC1=CC2=C(C=C1)OC(=C2)C3=C(C=C(C=C3)OC)O,,,,,,
7488,157489,Diclofensine hydrochloride,CN1CC(C2=C(C1)C=C(C=C2)OC)C3=CC(=C(C=C3)Cl)Cl.Cl,,,,,,
7489,157490,"Ibogamine-18-carboxylic acid, 13,20-dihydroxy-, methyl ester, (4alpha,20S)-",C[C@@H]([C@@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=CC(=C5)O)C(=O)OC)O,,,,,,
7490,157491,Carolenalol,C[C@H]1[C@H]2C[C@@H]3C(=C([C@H]([C@H]2OC1=O)O)C)C[C@H]([C@@]3(C)O)O,,,,,,
7491,157492,CID 157492,CC=C(C)C(=O)O[C@@H]1CC2=C(C(=O)[C@@H]3[C@H](C[C@H]2[C@@]1(C)O)[C@@H](C(=O)O3)C)C,,,,,,
7492,157493,11-Carolenalin-4-O-beta-D-glucoside,C[C@H]1[C@H]2C[C@@H]3[C@@H](C[C@H]([C@]3(C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C(=C[C@H]2OC1=O)C,,,,,,
7493,157494,CID 157494,CC=C(C)C(=O)O[C@@H]1C[C@@H]2[C@H]([C@@]1(C)O)C[C@@H]3[C@@H](C(=O)O[C@@H]3C=C2C)C,,,,,,
7494,157495,(S)-fluazifop-butyl,CCCCOC(=O)[C@H](C)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,,,,,,
7495,157496,Octylphosphinic acid sodium salt,CCCCCCCCP(=O)[O-].[Na+],,,,,,
7496,157497,Octylphosphinic acid,CCCCCCCCP(=O)O,,,,,,
7497,157498,"Vincaleukoblastine, 4'-deoxy-3',4'-epoxy-12'-hydroxy-, (3'alpha,4'alpha)-",CCC12CN3CCC4=C(C(CC(C3)C1O2)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)N(C1=C4C=C(C=C1)O)C,,,,,,
7498,157499,"5-[7-(3,7-Dimethylocta-2,6-dienyl)-6-methoxy-1-benzofuran-2-yl]benzene-1,3-diol",CC(=CCCC(=CCC1=C(C=CC2=C1OC(=C2)C3=CC(=CC(=C3)O)O)OC)C)C,,,,,,
7499,157500,"(14S)-3,7,11-trimethyl-14-prop-1-en-2-ylcyclotetradeca-1,3,6,10-tetraene",CC1=CCCC(=CCC=C(C=C[C@H](CC1)C(=C)C)C)C,,,,,,
7500,157501,"22-Oxa-5,9,14-triazatetracyclo[16.9.2.01,23.021,28]nonacosa-2,16,18(29),19,21(28)-pentaene-4,15,25-trione",C1CCNC(=O)C=CC2=CC3=C(C=C2)OC4C3(CCC(=O)C4)C=CC(=O)NCCCNC1,,,,,,
7501,157502,"22-Oxa-5,10,14-triazatetracyclo[16.9.2.01,23.021,28]nonacosa-2,16,18(29),19,21(28)-pentaene-4,15,25-trione",C1CCNC(=O)C=CC23CCC(=O)CC2OC4=C3C=C(C=C4)C=CC(=O)NCCCNC1,,,,,,
7502,157503,Pentmethrin,CCC=C(C)C(C#N)OC(=O)C1C(C1(C)C)C=C(Cl)Cl,,,,,,
7503,157504,"Octadecanamide, N-cyano-",CCCCCCCCCCCCCCCCCC(=O)NC#N,,,,,,
7504,157505,CID 157505,CCC=CCCCC=CCC=CCC(C)C1=CC=CC=C1O,,,,,,
7505,157506,CID 157506,CC1=CCCC(=C[C@H](CC[C@H](C(=CCC1)C)C(=C)C)O)C,,,,,,
7506,157507,"Dibenz(a,h)anthracene-1,2,3,4-tetrol, 1,2,3,4-tetrahydro-",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C(C(C(C5O)O)O)O,,,,,,
7507,157508,"1,2,3,4-Chrysenetetrol, 1,2,3,4-tetrahydro-",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C(C(C(C4O)O)O)O,,,,,,
7508,157509,Anhydrofusarubin,CC1=CC2=C(CO1)C(=C3C(=O)C=C(C(=O)C3=C2O)OC)O,,,,,,
7509,157510,Destruxin E1 5,CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCCC2C(=O)N1)CC3CO3)C)C)C(C)C)C,,,,,,
7510,157511,Destruxin D2,CC1C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)N1C)C(C)C)C)C(C)C)CC(C)C(=O)O,,,,,,
7511,157512,Destruxin D1,CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCCC2C(=O)N1)CC(C)C(=O)O)C)C)C(C)C)C,,,,,,
7512,157513,Destruxin C2,CC1C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)N1C)C(C)C)C)C(C)C)CC(C)CO,,,,,,
7513,157514,Destruxin B2 6,CC1C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)N1C)C(C)C)C)C(C)C)CC(C)C,,,,,,
7514,157515,"5,6-Didehydro-alpha-isolupanine",C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4C3=CCCC4=O,,,,,,
7515,157516,"Dodecanoic acid, 2-(dimethylamino)-1-methylethyl ester",CCCCCCCCCCCC(=O)OC(C)CN(C)C,,,,,,
7516,157517,Evobioside,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
7517,157518,4-(4-Hydroxybutylamino)butan-1-ol,C(CCO)CNCCCCO,,,,,,
7518,157519,"2-Pentanone, 5-(nitrosopentylamino)-",CCCCCN(CCCC(=O)C)N=O,,,,,,
7519,157520,"4-Pyridinecarboxylic acid, 3-(acetyloxy)-",CC(=O)OC1=C(C=CN=C1)C(=O)O,,,,,,
7520,157521,"2-Pentanol, 5-(nitrosopentylamino)-",CCCCCN(CCCC(C)O)N=O,,,,,,
7521,157522,CID 157522,CCCCC=CCC=CCC=CCC(C)C1=C(C=CC=C1O)O,,,,,,
7522,157523,CID 157523,CCCCC=CCC=CCC(CCCC)C1=C(C=CC=C1O)O,,,,,,
7523,157524,"Methanone, (4-methyl-3-nitrophenyl)phenyl-",CC1=C(C=C(C=C1)C(=O)C2=CC=CC=C2)[N+](=O)[O-],,,,,,
7524,157525,CID 157525,COC1=CC(=CC(=C1OC)OC)C2=CC(=C3C=C(C(=O)C=C3O2)O)O,,,,,,
7525,157526,CID 157526,CCCCCCCCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N,,,,,,
7526,157527,"Caryoptinol, 14,15-dihydro-2-hydroxy-, 3-(2-methylbutanoate), (2beta,3beta)-",CC[C@H](C)C(=O)OC1[C@H](C[C@@H]2[C@@]([C@@H](C[C@@H]([C@]2([C@@]13CO3)COC(=O)C)OC(=O)C)C)(C)C4C[C@H]5CCO[C@H]5O4)O,,,,,,
7527,157528,Ivain Iii,CCOC1C[C@@H]2CC(O[C@@H]2O1)[C@]3([C@@H](C[C@@H]([C@@]4([C@@H]3C[C@@H]([C@@H]([C@]45CO5)OC(=O)C(C)C)O)COC(=O)C)OC(=O)C)C)C,,,,,,
7528,157529,"Caryoptinol, 14,15-dihydro-, 2-methylpropanoate, (3beta)-",C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]1(C)C3C[C@H]4CCO[C@H]4O3)CC[C@@H]([C@]25CO5)OC(=O)C(C)C)COC(=O)C)OC(=O)C,,,,,,
7529,157530,Ajugareptansone B,C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]1(C)CCC3=CC(=O)OC3)C(=O)C=C[C@]24CO4)COC(=O)C)OC(=O)C,,,,,,
7530,157531,"[(1R,4aR,5S,6R,8S,8aR)-8-acetyloxy-8a-(acetyloxymethyl)-5,6-dimethyl-4-oxo-5-[2-(5-oxo-2H-furan-3-yl)ethyl]spiro[2,3,4a,6,7,8-hexahydronaphthalene-1,2'-oxirane]-2-yl] (2S)-2-methylbutanoate",CC[C@H](C)C(=O)OC1CC(=O)[C@@H]2[C@@]([C@@H](C[C@@H]([C@]2([C@@]13CO3)COC(=O)C)OC(=O)C)C)(C)CCC4=CC(=O)OC4,,,,,,
7531,157532,CID 157532,C[C@@H]1[C@]2(C([C@@](O1)([C@H]([C@@](O2)(C)C=CC=CC=CC3=C(C(=CC(=O)O3)OC)C)O)C)O)C,,,,,,
7532,157533,"3'-Cytidylic acid, N-benzoyl-2'-deoxy-5'-O-(9-phenyl-9H-xanthen-9-yl)-, mono(2-chlorophenyl) ester",C1[C@@H](C(O[C@H]1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC4(C5=CC=CC=C5OC6=CC=CC=C64)C7=CC=CC=C7)OP(=O)(O)OC8=CC=CC=C8Cl,,,,,,
7533,157534,"Carbamic acid, 4-pyridinyl-, methyl ester",COC(=O)NC1=CC=NC=C1,,,,,,
7534,157535,"Propanoic acid, 2-methyl-, (1R,2S,3S,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-8a-((acetyloxy)methyl)-5-((2S,3aR,6aS)-hexahydrofuro(2,3-b)furan-2-yl)octahydro-3-hydroxy-5,6-dimethylspiro(naphthalene-1(2H),2'-oxiran)-2-yl ester",C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]1(C)C3C[C@H]4CCO[C@H]4O3)C[C@@H]([C@@H]([C@]25CO5)OC(=O)C(C)C)O)COC(=O)C)OC(=O)C,,,,,,
7535,157536,CID 157536,C1=C2C(=NC=NC2=O)N(N1)CO,,,,,,
7536,157537,"4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-1,5-bis(hydroxymethyl)-",C1=NN(C2=C1C(=O)N(C=N2)CO)CO,,,,,,
7537,157538,"L-Lysine, N2-(N2-(N-L-tyrosyl-L-histidyl)-L-lysyl)-4",C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O,,,,,,
7538,157539,"[8-Acetyloxy-11-ethyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] 4-methoxybenzoate",CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)COC,,,,,,
7539,157540,"2-Pyridinamine, 3,5-dichloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-6-methyl-",CC1=NC(=C(C=C1Cl)Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
7540,157541,"2-Pyridinamine, 3,5-dichloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-4,6-dimethyl-",CC1=C(C(=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C)Cl,,,,,,
7541,157542,"2-Pyridinamine, 3,5-dichloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-4-methyl-",CC1=C(C(=NC=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])Cl,,,,,,
7542,157543,"2-Pyridinamine, 3-bromo-5-chloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-",C1=C(C=NC(=C1Br)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])Cl,,,,,,
7543,157544,"2-Pyridinamine, N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",C1=CC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
7544,157545,"2-Pyridinamine, 5-bromo-3-chloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-",C1=C(C=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])Br,,,,,,
7545,157546,"2-Pyridinamine, 3-bromo-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",C1=C(C=NC(=C1Br)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
7546,157547,"2-Pyridinamine, 5-bromo-6-chloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-3-(trifluoromethyl)-",C1=C(C(=C(C(=C1[N+](=O)[O-])NC2=NC(=C(C=C2C(F)(F)F)Br)Cl)[N+](=O)[O-])Cl)C(F)(F)F,,,,,,
7547,157548,"2-Pyridinamine, 3-bromo-6-chloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",C1=C(C(=C(C(=C1[N+](=O)[O-])NC2=C(C=C(C(=N2)Cl)C(F)(F)F)Br)[N+](=O)[O-])Cl)C(F)(F)F,,,,,,
7548,157549,"2-Pyridinamine, 3,6-dichloro-N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",C1=C(C(=C(C(=C1[N+](=O)[O-])NC2=C(C=C(C(=N2)Cl)C(F)(F)F)Cl)[N+](=O)[O-])Cl)C(F)(F)F,,,,,,
7549,157550,"2-Pyridinamine, N-(3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl)-3-(trifluoromethyl)-",C1=CC(=C(N=C1)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
7550,157551,"2-Pyridinamine, 3-chloro-N-(3-methoxy-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",COC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7551,157552,"2-Pyridinamine, 3-chloro-N-(3-ethoxy-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",CCOC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7552,157553,"2-Pyridinamine, 3-chloro-N-(2,6-dinitro-3-propoxy-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",CCCOC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7553,157554,"2-Pyridinamine, N-(3-butoxy-2,6-dinitro-4-(trifluoromethyl)phenyl)-3-chloro-5-(trifluoromethyl)-",CCCCOC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7554,157555,"2-Pyridinamine, 3-chloro-N-(3-(2-methylpropoxy)-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",CC(C)COC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7555,157556,"2-Pyridinamine, 3-chloro-N-(3-(methylthio)-2,6-dinitro-4-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-",CSC1=C(C(=C(C=C1C(F)(F)F)[N+](=O)[O-])NC2=C(C=C(C=N2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7556,157557,"Cyclopenta(c)pyran-4-carboxaldehyde, 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a-hydroxy-7-methyl-, (1S,4aR,7S,7aR)-",C[C@H]1CC[C@]2([C@@H]1[C@@H](OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
7557,157558,"Hetisan-1,7,13-triol, 13-benzoate, (1beta,7alpha,13S)-",C[C@@]12CC[C@H](C34[C@@H]1[C@@H]5[C@H](C67[C@H]3C[C@H](C([C@@H]6C4N5C2)OC(=O)C8=CC=CC=C8)C(=C)C7)O)O,,,,,,
7558,157559,"Phenol, 2-(2-chloro-1-methylethoxy)-, methylcarbamate",CC(CCl)OC1=CC=CC=C1OC(=O)NC,,,,,,
7559,157560,"[(1R,6R,9S,13R,14S,16R,17S,18R,19S)-19-benzyl-7,9,16,17-tetramethyl-2,5,21-trioxo-15-oxa-20-azatetracyclo[11.8.0.01,18.014,16]henicosa-3,7,11-trien-6-yl] acetate",C[C@H]1CC=C[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2(C(=O)C=CC(=O)[C@@H](C(=C1)C)OC(=O)C)C(=O)N[C@H]4CC5=CC=CC=C5)C)C,,,,,,
7560,157561,Augustine,CO[C@@H]1C[C@@H]2[C@@]3(CCN2CC4=CC5=C(C=C43)OCO5)[C@@H]6[C@H]1O6,,,,,,
7561,157562,"2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride",C1CN=C(N1)CC(C2=CC=CC=C2)C3=CC=CC=N3.Cl.Cl,,,"['Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)', 'Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)']",,,
7562,157563,"2-Buten-1-one, 1-(2-hydroxy-5-(1-hydroxyethyl)phenyl)-3-methyl-",CC(C1=CC(=C(C=C1)O)C(=O)C=C(C)C)O,,,,,,
7563,157564,"4H-1-Benzopyran-4-one, 2,3-dihydro-6-(1-hydroxyethyl)-2,2-dimethyl-",CC(C1=CC2=C(C=C1)OC(CC2=O)(C)C)O,,,,,,
7564,157565,CID 157565,CCC=CCC=CCC=CC=CC=CC([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)N,,,,,,
7565,157566,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2,6-dimethyl-4-(2-propenyl)phenyl)methyl ester",CC1=CC(=CC(=C1COC(=O)C2C(C2(C)C)C=C(C)C)C)CC=C,,,,,,
7566,157567,Methyl (4-methoxyphenoxy)acetate,COC1=CC=C(C=C1)OCC(=O)OC,,,,,,
7567,157568,Tetrahydrofuran-3-carbaldehyde,C1COCC1C=O,,,,,,
7568,157569,"5,5-Dimethyl-2-(2-nitrophenyl)-1,3-dioxane",CC1(COC(OC1)C2=CC=CC=C2[N+](=O)[O-])C,,,,,,
7569,157570,"2,4(1H,3H)-Pyrimidinedione, 1,3-bis(hydroxymethyl)-",C1=CN(C(=O)N(C1=O)CO)CO,,,,,,
7570,157571,"2,4(1H,3H)-Pyrimidinedione, 1-(hydroxymethyl)-3-methyl-",CN1C(=O)C=CN(C1=O)CO,,,,,,
7571,157572,"2,4(1H,3H)-Pyrimidinedione, 3-(hydroxymethyl)-1-methyl-",CN1C=CC(=O)N(C1=O)CO,,,,,,
7572,157573,CID 157573,CCC1=C2C(=CC(=C1)C3=C(N(S(=O)(=O)C4=CC=CC=C43)C5=CC=CC=C5C(F)(F)F)C(=O)[O-])OCO2.[K+],,,,,,
7573,157574,Fandosentan,CCC1=C2C(=CC(=C1)C3=C(N(S(=O)(=O)C4=CC=CC=C43)C5=CC=CC=C5C(F)(F)F)C(=O)O)OCO2,,,,,,
7574,157575,"2,4-Cyclohexadien-1-one, 3,5,6-trihydroxy-4,6-dimethyl-2-(1-oxobutyl)-",CCCC(=O)C1=C(C(=C(C(C1=O)(C)O)O)C)O,,,,,,
7575,157576,3-[1-[4-[(6-Methoxyquinolin-8-yl)amino]pentylamino]ethylidene]oxolan-2-one,CC(CCCNC(=C1CCOC1=O)C)NC2=C3C(=CC(=C2)OC)C=CC=N3,,,,,,
7576,157577,"Methyl 13-oxo-9,11-octadecadienoate",CCCCCC(=O)C=CC=CCCCCCCCC(=O)OC,,,,,,
7577,157578,"1-Naphthalenol, 5-methoxy-2-methyl-",CC1=C(C2=C(C=C1)C(=CC=C2)OC)O,,,,,,
7578,157579,"Bicyclo(3.1.1)hept-2-en-6-one, 7,7-dimethyl-",CC1(C2CC=CC1C2=O)C,,,,,,
7579,157580,"Bicyclo(3.1.1)hept-2-en-6-ol, 7,7-dimethyl-, (1alpha,5alpha,6alpha)-",CC1([C@@H]2CC=C[C@H]1[C@@H]2O)C,,,,,,
7580,157581,"Bicyclo(3.1.1)heptan-6-ol, 7,7-dimethyl-, (1alpha,5alpha,6alpha)-",CC1([C@@H]2CCC[C@H]1C2O)C,,,,,,
7581,157582,"7,7-Dimethylbicyclo[3.1.1]heptan-6-one",CC1(C2CCCC1C2=O)C,,,,,,
7582,157583,"Furo(2,3-b)quinolin-4(9H)-one, 9-ethyl-7-methoxy-",CCN1C2=C(C=CC(=C2)OC)C(=O)C3=C1OC=C3,,,,,,
7583,157584,"4H-Benzo(5,6)cyclohepta(1,2-b)furan, 5,5a,6,10-tetrahydro-5a,6-dimethyl-, (5aR,6S)-rel-(-)-",C[C@H]1C=CC=C2[C@@]1(CCC3=C(C2)OC=C3)C,,,,,,
7584,157585,"Benzeneacetic acid, 4-chloro-alpha-(1-methylethyl)-,cyano(3-phenoxyphenyl)methyl ester, mixt. with O,O-dimethylO-(3-methyl-4-nitrophenyl) phosphorothioate",CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-].CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,,,,,,
7585,157586,"2,6-Dichloro-4'-biphenylol",C1=CC(=C(C(=C1)Cl)C2=CC=C(C=C2)O)Cl,,,,,,
7586,157587,"3-(3,5-Dichlorophenyl)phenol",C1=CC(=CC(=C1)O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
7587,157588,Euryfuran,C[C@@]12CCCC([C@H]1CCC3=COC=C23)(C)C,,,,,,
7588,157589,"Butanoic acid, 2-ethyl-2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester,(1S-(1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta))-",CCC(C)(CC)C(=O)O[C@H]1C[C@@H](C=C2[C@@H]1[C@@H]([C@@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,,,,,
7589,157590,"Butanoic acid, 2,2-diethyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta))-",CCC(CC)(CC)C(=O)O[C@H]1C[C@@H](C=C2[C@@H]1[C@@H]([C@@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,,,,,
7590,157591,"4-Thiazolecarboxylic acid, 2-(beta-D-glucopyranosylamino)-, ethyl ester, monohydrobromide",CCOC(=O)C1=CSC(=N1)N[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O.Br,,,,,,
7591,157592,"ethyl 2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-1,3-thiazole-4-carboxylate",CCOC(=O)C1=CSC(=N1)N[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
7592,157593,"4-Thiazolidinone, 2-thioxo-3-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-",CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C(=O)CSC2=S)OC(=O)C)OC(=O)C,,,,,,
7593,157594,"1-(2,4-Dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one",CC=CC=CC(=O)C1=C(C(=C(C(=C1)C)O)C)O,,,,,,
7594,157595,"9-Acridinamine, N-(3-(6-amino-9H-purin-9-yl)propyl)-6-chloro-2-methoxy-",COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCN4C=NC5=C(N=CN=C54)N,,,,,,
7595,157596,"2,4(1H,3H)-Pyrimidinedione, 1-(3-((6-chloro-2-methoxy-9-acridinyl)amino)propyl)-5-methyl-",CC1=CN(C(=O)NC1=O)CCCNC2=C3C=C(C=CC3=NC4=C2C=CC(=C4)Cl)OC,,,,,,
7596,157597,"9-Acridinamine, 6-chloro-2-methoxy-N-propyl-",CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,,,,,,
7597,157598,"Urs-12-ene-27,28-dioic acid, 3-((6-deoxy-alpha-L-galactopyranosyl)oxy)-, (3beta)-",C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H](C5(C)C)O[C@H]6[C@H]([C@@H]([C@@H]([C@@H](O6)C)O)O)O)C)C)[C@H]2[C@H]1C)C(=O)O)C(=O)O,,,,,,
7598,157599,"Phosphorothioic acid, O,O-bis(4-nitrophenyl) O-pentyl ester",CCCCCOP(=S)(OC1=CC=C(C=C1)[N+](=O)[O-])OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7599,157600,"(2R,3R)-3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one",COC1=C(C=C(C=C1)[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)OC)O)O)O,,,,,,
7600,157601,CID 157601,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=O)C(=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O2)O)O)O,,,,,,
7601,157602,Furyloxyfen,C1COCC1OC2=C(C=CC(=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
7602,157603,"Benzo(f)quinoline, 7,8,9,10-tetrahydro-",C1CCC2=C(C1)C=CC3=C2C=CC=N3,,,,,,
7603,157604,"Pentanedioic acid, 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-, dimethyl ester",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC(CCC(=O)OC)C(=O)OC,,,,,,
7604,157605,"1H-Azepino(5,4,3-cd)indole, 3,4,5,6-tetrahydro-6-(2-methyl-1-propenyl)-, (-)-",CC(=CC1C2=C3C(=CNC3=CC=C2)CCN1)C,,,,,,
7605,157606,"4H-1-Benzopyran-4-one, 2,3-dihydro-8-hydroxy-5,6,7-trimethoxy-2-phenyl-",COC1=C(C(=C(C2=C1C(=O)CC(O2)C3=CC=CC=C3)O)OC)OC,,,,,,
7606,157607,5-(4-Hydroxybenzylidene)hydantoin,C1=CC(=CC=C1C=C2C(=O)NC(=O)N2)O,,,,,,
7607,157608,"1-Heptanol, 4,4,5,5,6,6,7,7,7-nonafluoro-2-iodo-",C(C(CO)I)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
7608,157609,[5-(Hydroxymethyl)-2-[2-(3-phenylprop-2-enoyloxymethyl)oxiran-2-yl]phenyl] 2-methylpropanoate,CC(C)C(=O)OC1=C(C=CC(=C1)CO)C2(CO2)COC(=O)C=CC3=CC=CC=C3,,,,,,
7609,157610,"[2-[1,2-Dihydroxy-3-(3-phenylprop-2-enoyloxy)propan-2-yl]-5-(hydroxymethyl)phenyl] 2-methylpropanoate",CC(C)C(=O)OC1=C(C=CC(=C1)CO)C(CO)(COC(=O)C=CC2=CC=CC=C2)O,,,,,,
7610,157611,"Docosanoic acid, triacontyl ester",CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
7611,157612,"Methanesulfonamide, N-(4-(benz(b)acridin-12-ylamino)-3-methoxyphenyl)-, monomethanesulfonate",COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC5=CC=CC=C5C=C42.CS(=O)(=O)O,,,,,,
7612,157613,N-[3-Methoxy-4-[[benz[b]acridin-12-yl]amino]phenyl]methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC5=CC=CC=C5C=C42,,,,,,
7613,157614,"3-Hydroxy-4,6a,6b,8a,14a-pentamethyl-11-methylidene-7,8,9,10,12,12a,13,14-octahydropicen-2-one",CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(=C)CC5)C)C)C)C)O,,,,,,
7614,157615,"Hetisan-15-ol, (15beta)-",C[C@@]12CCCC34[C@@H]1[C@@H]5CC67[C@H]3C[C@H](C[C@@H]6C4N5C2)C(=C)[C@H]7O,,,,,,
7615,157616,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-",C[C@H]1[C@H]([C@H](CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCOCC6)O,,,,,,
7616,157617,CID 157617,CCCC=CC=CCCCCCCCCCOC(=O)C=CC1=CC=CC=C1,,,,,,
7617,157618,"Stigmasta-3,5-diene, (24xi)-",CCC(CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC=C4)C)C)C(C)C,,,,,,
7618,157619,"Glycine, N-(N-L-gamma-glutamyl-S-(2-hydroxy-2-phenylethyl)-L-cysteinyl)-, (R)-",C1=CC=C(C=C1)C(CSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O,,,,,,
7619,157620,CID 157620,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(=CC(=O)O)C(=O)O,,,,,,
7620,157621,"19-Hexyl-6-methyl-9-(2-methylpropyl)-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone",CCCCCCC1CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O1)C(C)C)C)CC(C)C)C(C)C,,,,,,
7621,157622,"19-Hexyl-3,6-dimethyl-9-(2-methylpropyl)-12-propan-2-yl-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone",CCCCCCC1CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O1)C)C)CC(C)C)C(C)C,,,,,,
7622,157623,"19-Butyl-3,6-dimethyl-9-(2-methylpropyl)-12-propan-2-yl-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone",CCCCC1CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O1)C)C)CC(C)C)C(C)C,,,,,,
7623,157624,dThd-P-m6Gua-dRibf-P-dCyd-P-dAdo,CC1=CN(C(=O)NC1=O)[C@H]2CC([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C4N=C(N=C5OC)N)OP(=O)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=CC(=NC7=O)N)OP(=O)(O)OC[C@@H]8[C@H](CC(O8)N9C=NC1=C(N=CN=C19)N)O,,,,,,
7624,157625,Indium-111 tropolone,C1=CC=C(C(=O)C=C1)[O-].C1=CC=C(C(=O)C=C1)[O-].C1=CC=C(C(=O)C=C1)[O-].[111In+3],,,,,,
7625,157626,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((2,2,3,3,3-pentafluoro-1-oxopropyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C(C(F)(F)F)(F)F)O,,,,,,
7626,157627,"methyl (2S)-2-[(2R,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate",CC=C1CN2CCC3=C([C@@H]2C[C@@H]1[C@@H](CO)C(=O)OC)NC4=CC=CC=C34,,,,,,
7627,157628,"2,5-Cyclohexadiene-1,4-dione, 2-(4-((1S)-1-(acetyloxy)-4-methyl-3-pentenyl)-2-furanyl)-",CC(=CC[C@@H](C1=COC(=C1)C2=CC(=O)C=CC2=O)OC(=O)C)C,,,,,,
7628,157629,Echinone,CC(=CC[C@@H](C1=CC(=C2C(=O)C=CC(=O)C2=C1OC)O)OC(=O)C)C,,,,,,
7629,157630,"Imidazo(2,1-b)benzothiazole-2-carboxylic acid, 5-chloro-",C1=CC2=C(C(=C1)Cl)N3C=C(N=C3S2)C(=O)O,,,,,,
7630,157631,Tinnevellin glucoside,CC1=CC2=CC(=CC(=C2C(=C1C(=O)C)O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
7631,157632,CID 157632,COC1=C2C(=C(C=C(O2)C3=CC=CC=C3)O)C(=CC1=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
7632,157633,"4H-1-Benzopyran-4-one, 2-(2,6-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-",C1=CC(=C(C(=C1)O)[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O,,,,,,
7633,157634,"[(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)C=CC3=CC(=C(C=C3)OC)O)CO)OCCC4=CC(=C(C=C4)OC)O)O)O)O)O,,,,,,
7634,157635,"18,19-Dinorcholesta-1,3,5,7,9,11,13-heptaene, 4,17-dimethyl-, (17alpha)-",CC1=C2C=CC3=C(C2=CC=C1)C=CC4=C3CC[C@]4(C)[C@H](C)CCCC(C)C,,,,,,
7635,157636,"(17R)-1,17-dimethyl-17-[(2R)-6-methylheptan-2-yl]-15,16-dihydrocyclopenta[a]phenanthrene",CC1=C2C(=CC=C1)C=CC3=C2C=CC4=C3CC[C@]4(C)[C@H](C)CCCC(C)C,,,,,,
7636,157637,CID 157637,CC[C@@H](CC[C@@H](C)[C@]1(CCC2=C1C=CC3=C2C=CC4=CC=CC(=C43)C)C)C(C)C,,,,,,
7637,157638,"2-[3-hydroxy-3-(2-hydroxy-5-oxo-2H-furan-3-yl)propylidene]-6-methyl-8-(2,6,6-trimethylcyclohexen-1-yl)oct-5-enal",CC1=C(C(CCC1)(C)C)CCC(=CCCC(=CCC(C2=CC(=O)OC2O)O)C=O)C,,,,,,
7638,157639,"[(7R,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-3-methyl-2-[(1S)-1-(2-methylbut-2-enoyloxy)ethyl]butanoate",CC=C(C)C(=O)O[C@@H](C)[C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)O)O,,,,,,
7639,157640,"Phenol, 3-amino-2-chloro-6-methyl-, hydrochloride",CC1=C(C(=C(C=C1)N)Cl)O.Cl,,,,,,
7640,157641,5-Amino-6-chloro-o-cresol,CC1=C(C(=C(C=C1)N)Cl)O,,,,,,
7641,157642,"1-Naphthalenecarboxaldehyde, 2,7-dihydroxy-8-methoxy-6-methyl-4-(1-methylethyl)-",CC1=CC2=C(C(=C(C=C2C(C)C)O)C=O)C(=C1O)OC,,,,,,
7642,157643,"4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2,3-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2R,3R)-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O)O)O,,,,,,
7643,157644,Silver lactate,CC(C(=O)[O-])O.[Ag+],,,,,,
7644,157645,"Gona-1,3,5,7,9,15-hexaen-12-ol, (13xi,14xi)-",C1C=CC2C1C(CC3=C2C=CC4=CC=CC=C34)O,,,,,,
7645,157646,"(6-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-4,5,7,8,11,12,15,15a-octahydro-3aH-cyclotetradeca[b]furan-5-yl) acetate",CC1=CCCC(C(CC2C(CC(=CCC1)C)OC(=O)C2=C)OC(=O)C)(C)O,,,,,,
7646,157647,CID 157647,CC=C(C)C(=O)OC(C)[C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)OC(=O)C)O,,,,,,
7647,157648,CID 157648,CC(C1=C[C@@]2(C=C[C@H]3[C@@H]2[C@@H](OC=C3C(=O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC1=O)OC(=O)C=CC5=CC=C(C=C5)O,,,,,,
7648,157649,"1,4-Benzodioxin-2(3H)-one, 6,8-dimethoxy-3-(1-methylethylidene)-",CC(=C1C(=O)OC2=C(O1)C=C(C=C2OC)OC)C,,,,,,
7649,157650,"Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetramethyl-, mixt. with 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione",CC1(C(=O)N(C(=O)O1)C2=CC(=CC(=C2)Cl)Cl)C=C.CN(C)C(=S)SSC(=S)N(C)C,,,,,,
7650,157651,Bis[2-(2-hydroxyethoxy)ethyl]-(2-hydroxyethyl)-octadecylazanium;chloride,CCCCCCCCCCCCCCCCCC[N+](CCO)(CCOCCO)CCOCCO.[Cl-],,,,,,
7651,157652,Bis[2-(2-hydroxyethoxy)ethyl]-(2-hydroxyethyl)-octadecylazanium,CCCCCCCCCCCCCCCCCC[N+](CCO)(CCOCCO)CCOCCO,,,,,,
7652,157653,"1-Naphthalenesulfonamide, N-(8-aminooctyl)-5-chloro-",C1=CC2=C(C=CC=C2Cl)C(=C1)S(=O)(=O)NCCCCCCCCN,,,,,,
7653,157654,"Carbonic acid, 2-((4-(1,1-dimethylethyl)benzoyl)methylamino)phenyl ethyl ester",CCOC(=O)OC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
7654,157655,"Carbonic acid, 2-((4-(1,1-dimethylethyl)benzoyl)methylamino)phenyl phenyl ester",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2OC(=O)OC3=CC=CC=C3,,,,,,
7655,157656,"Carbonic acid, 2-((4-(1,1-dimethylethyl)benzoyl)methylamino)phenyl methyl ester",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2OC(=O)OC,,,,,,
7656,157657,CID 157657,CC[C@@H]([C@@H]([C@H](C(C)[C@H]1C2C([C@@H]([C@@H](C3[C@@]2(CCC3)C)O)O)C4CC(=O)CC[C@@H]4[C@@H](O1)C)O)O)C(C)C,,,,,,
7657,157658,"Benzamide, N-(2-(acetyloxy)phenyl)-4-(1,1-dimethylethyl)-N-methyl-",CC(=O)OC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
7658,157659,"Benzamide, 4-(1,1-dimethylethyl)-N-methyl-N-(2-(1-oxopropoxy)phenyl)-",CCC(=O)OC1=CC=CC=C1N(C)C(=O)C2=CC=C(C=C2)C(C)(C)C,,,,,,
7659,157660,"Benzamide, N-(2-(benzoyloxy)phenyl)-4-(1,1-dimethylethyl)-N-methyl-",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C2=CC=CC=C2OC(=O)C3=CC=CC=C3,,,,,,
7660,157661,"1H-Naphtho(2,3-c)pyran-1-one, 3,4-dihydro-9,10-dihydroxy-7-methoxy-3-methylene-",COC1=CC(=C2C(=C1)C=C3CC(=C)OC(=O)C3=C2O)O,,,,,,
7661,157662,"(2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-5-[3-[2-(4-hydroxyphenyl)ethylamino]-3-oxoprop-1-enyl]-7-methoxy-2,3-dihydro-1-benzofuran-3-carboxamide",COC1=CC(=CC2=C1O[C@H]([C@@H]2C(=O)NCCC3=CC=C(C=C3)O)C4=CC(=C(C=C4)O)OC)C=CC(=O)NCCC5=CC=C(C=C5)O,,,,,,
7662,157663,"1,3,5-Triazine-2,4-diamine, N-ethyl-N'-(1-methylethyl)-6-(methylsulfinyl)-",CCNC1=NC(=NC(=N1)S(=O)C)NC(C)C,,,,,,
7663,157664,"1H-1,2,4-Triazole-1-ethanol, alpha-(1,1-dimethylethyl)-beta-(2-phenoxyethyl)-",CC(C)(C)C(C(CCOC1=CC=CC=C1)N2C=NC=N2)O,,,,,,
7664,157665,"2H-1,2,4,6-Thiatriazine, 5-methoxy-2-methyl-3-(2-propynyloxy)-,1,1-dioxide",CN1C(=NC(=NS1(=O)=O)OC)OCC#C,,,,,,
7665,157666,"1-Tridecanamine, N-methyl-N-nitroso-",CCCCCCCCCCCCCN(C)N=O,,,,,,
7666,157667,"Icosa-2,4,6-trienoic acid",CCCCCCCCCCCCCC=CC=CC=CC(=O)O,,,,,,
7667,157668,CID 157668,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)[O-])C2=CSC(=N2)N.[Na+],,,,,,
7668,157669,CID 157669,C[C@H]1[C@H](C(=O)N1S(=O)(=O)[O-])NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N.[K+].[K+],,,,,,
7669,157670,"2-[[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3R)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid",C[C@H]1[C@H](C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,,,,,,
7670,157671,"4H-1-Benzopyran-4-one, 2-(2,6-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2S)-",C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=C(C=CC=C3O)O,,,,,,
7671,157672,(+)-Nicotine,CN1CCC[C@@H]1C2=CN=CC=C2,,,,,,
7672,157673,"Benzenepropanamide, alpha-amino-N-(2-((6-amino-9H-purin-9-yl)methoxy)ethyl)-",C1=CC=C(C=C1)CC(C(=O)NCCOCN2C=NC3=C(N=CN=C32)N)N,,,,,,
7673,157674,"Benzenepropanamide, alpha-amino-N-(3-(6-amino-9H-purin-9-yl)propyl)-",C1=CC=C(C=C1)CC(C(=O)NCCCN2C=NC3=C(N=CN=C32)N)N,,,,,,
7674,157675,"L-Phenylalanine, N-((3,4-dihydro-4,8-dihydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl)-, (3R-trans)-",C[C@@H]1[C@H](C2=C(C(=C(C=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)O)C(=O)O1)O,,,,,,
7675,157676,"Cholest-7-en-6-one, 22,25-epoxy-2,3,5,14,20-pentahydroxy-, (2beta,3beta,5beta)-",C[C@]12CC[C@H]3C(=CC(=O)[C@]4([C@@]3(C[C@@H]([C@@H](C4)O)O)C)O)C1(CC[C@H]2[C@](C)(C5CCC(O5)(C)C)O)O,,,,,,
7676,157677,CID 157677,CCC(C)OC(=O)C(=CN(C)C1=CC=CC=C1)C#N,,,,,,
7677,157678,4'-Hydroxyflurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=C(C=C2)O)F)C(=O)O,,,,,,
7678,157679,"Benzenepropanamide, alpha-((2-(acetyloxy)benzoyl)amino)-, (S)-",CC(=O)OC1=CC=CC=C1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N,,,,,,
7679,157680,"Methanone, (5-(3,3-dimethyloxiranyl)-3-ethenyl-3,4-dihydro-3-methyl-2H-pyrrol-2-yl)-1H-indol-3-yl-",CC1(C(O1)C2=NC(C(C2)(C)C=C)C(=O)C3=CNC4=CC=CC=C43)C,,,,,,
7680,157681,"Spirost-25(27)-ene-1,3-diol, (1beta,3alpha,5alpha)-",C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@@H]5[C@@]4([C@@H](C[C@H](C5)O)O)C)C)O[C@]16CCC(=C)CO6,,,,,,
7681,157682,Annomuricin A,CCCCCCCCCCCCC(C1CCC(O1)C(CCCC(C(CCCCCC(CC2=CC(OC2=O)C)O)O)O)O)O,,,,,,
7682,157683,"(1S,2R,4aS,6aR,6aR,6bR,8aR,10S,12aR,14bS)-10-hydroxy-4a-[3-(4-hydroxyphenyl)prop-2-enoyloxymethyl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-6a-carboxylic acid",C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C(=O)O)COC(=O)C=CC6=CC=C(C=C6)O,,,,,,
7683,157684,Deacetoxyvinzolidine,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@](C[C@@]1([C@@H]8N6C)C(=O)N(C(=O)O1)CCCl)(C=CC9)CC)OC)C(=O)OC)O,,,,,,
7684,157685,Ophirapstanol trisulfate.3Na,C[C@H](CCC(C)C(C)(C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H](C4[C@@]3(C[C@@H]([C@H](C4)OS(=O)(=O)[O-])OS(=O)(=O)[O-])C)OS(=O)(=O)[O-])C.[Na+],,,,,,
7685,157686,"[(2S,3S,6S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3-disulfooxy-17-[(2R)-5,6,6,7-tetramethyloctan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl] hydrogen sulfate",C[C@H](CCC(C)C(C)(C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H](C4[C@@]3(C[C@@H]([C@H](C4)OS(=O)(=O)O)OS(=O)(=O)O)C)OS(=O)(=O)O)C,,,,,,
7686,157687,"N,N-dimethyl-1-[4-(4-propoxyphenyl)phenyl]methanamine oxide",CCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C[N+](C)(C)[O-],,,,,,
7687,157688,"Methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-4-[(12S,14S,16S)-16-(1,1-difluoroethyl)-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]12C=CCN3[C@@H]1[C@]4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)[C@]6(C[C@@H]7C[C@@H](CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,,,,,,
7688,157689,Maipgg,CCOC(=O)CNC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)N=C=S)NC(=O)CSC(=O)C,,,,,,
7689,157690,Garenoxacin mesylate,C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F.CS(=O)(=O)O.O,,,,,,
7690,157691,Gemcabene calcium,CC(C)(CCCCOCCCCC(C)(C)C(=O)[O-])C(=O)[O-].[Ca+2],,,,,,
7691,157692,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,"['Investigated for use/treatment in atherosclerosis, cardiovascular disorders, and hyperlipidemia.']",,,,,
7692,157693,"Estra-4,9,11-trien-3-one, 16,17-dihydroxy-, (16alpha,17beta)-",C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1C[C@H]([C@@H]2O)O,,,,,,
7693,157694,"16alpha-Hydroxyestra-4,9,11-trien-3,17-dione",C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1C[C@H](C2=O)O,,,,,,
7694,157695,CID 157695,COC1=CC2=C(N3C=CC4=C3C(=CC=C4)C2=CC1=O)O,,,,,,
7695,157696,"1-Naphthalenepropanoic acid, alpha-amino-beta-phenyl-",C1=CC=C(C=C1)C(C2=CC=CC3=CC=CC=C32)C(C(=O)O)N,,,,,,
7696,157697,"Cyclopropanecarboxylic acid, 3-(2,2-dibromoethenyl)-2,2-dimethyl-, (R)-cyano(3-phenoxyphenyl)methyl ester, (1S,3S)-rel-",CC1([C@@H]([C@@H]1C(=O)O[C@@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,,,,,,
7697,157698,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethyl)-2,2-dimethyl-,cyano(4-fluoro-3-phenoxyphenyl)methyl ester",CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)CC(Cl)Cl)C,,,,,,
7698,157699,"2-Naphthalenepropanoic acid, alpha-amino-beta-phenyl-",C1=CC=C(C=C1)C(C2=CC3=CC=CC=C3C=C2)C(C(=O)O)N,,,,,,
7699,157700,"Phenol, 4-(1,1-dimethyl-2-((3-phenoxyphenyl)methoxy)ethyl)-",CC(C)(COCC1=CC(=CC=C1)OC2=CC=CC=C2)C3=CC=C(C=C3)O,,,,,,
7700,157701,"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3S)-2,2-dimethyl-3-[3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]cyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=CC(=O)OC(C)(C)C)C,,,,,,
7701,157702,(S)-Nitrendipine,CCOC(=O)C1=C(NC(=C([C@@H]1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,,,,,,
7702,157703,"Dicyclopenta[cd,lm]perylene",C1=CC2=CC=C3C4=CC=C5C=CC6=C5C4=C(C=C6)C7=C3C2=C1C=C7,,,,,,
7703,157704,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (4R)-",CCOC(=O)C1=C(NC(=C([C@H]1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,,,,,"['3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (4r)- has known human metabolites that include Nitrendipine M (dehydro).']",
7704,157705,"2H-Pyran-2-one, 6,6'-(1,17-heptadecanediyl)bis(tetrahydro-4-(2-methylpropyl)-",CC(C)CC1CC(OC(=O)C1)CCCCCCCCCCCCCCCCCC2CC(CC(=O)O2)CC(C)C,,,,,,
7705,157706,"2(5H)-Furanone, 4-(hydroxymethyl)-",C1C(=CC(=O)O1)CO,,,,,,
7706,157707,"Selenonium, (2-ethoxy-2-oxoethyl)dimethyl-",CCOC(=O)C[Se+](C)C,,,,,,
7707,157708,"Spirostan-12-one, 3-((6-O-alpha-D-glucopyranosyl-alpha-D-glucopyranosyl)oxy)-, (3beta,5alpha,25R)-",C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(C(=O)C[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C)C)C)OC1,,,,,,
7708,157709,"Methanol, (nitrosoamino)-",C(NN=O)O,,,,,,
7709,157710,"(2R,3R,4S,5S,6R)-2-[[(6R,8R,10R,12S,14S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol",CC(=CCC[C@](C)(C1CC[C@]2(C1[C@H](CC3[C@]2(C[C@H](C4[C@@]3(CCC(C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O)C,,,,,,
7710,157711,20(R)Ginsenoside Rg2,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3C[C@@]4(C(C[C@@H](C5[C@@]4(CC[C@H]5[C@@](C)(CCC=C(C)C)O)C)O)[C@@]6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O,,,,,,
7711,157712,"1H-Indene-1,3(2H)-dione, 2,2-dihydroxy-4-nitro-",C1=CC2=C(C(=C1)[N+](=O)[O-])C(=O)C(C2=O)(O)O,,,,,,
7712,157713,"Benzenepropanoic acid, alpha-((2-(acetyloxy)benzoyl)oxy)-, ethyl ester, (S)-",CCOC(=O)[C@H](CC1=CC=CC=C1)OC(=O)C2=CC=CC=C2OC(=O)C,,,,,,
7713,157714,"Dec-2-en-4,6-diynoic acid",CCCC#CC#CC=CC(=O)O,,,,,,
7714,157715,6-O-Glucosyl-2'-O-benzoylaucubin,C1[C@@H]2[C@H](C=CO1)C(C=C2CO)O[C@@]3([C@@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)OC(=O)C5=CC=CC=C5,,,,,,
7715,157716,(S)-Metoprolol,CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOC)O,,,,,,
7716,157717,(R)-Metoprolol,CC(C)NC[C@H](COC1=CC=C(C=C1)CCOC)O,,,,,"['(r)-metoprolol has known human metabolites that include N_DEISOPROPYLATION, O-Demethylmetoprolol, and alpha-Hydroxymetoprolol.']",
7717,157718,"beta-D-Glucopyranoside, (1S,4aR,5S,6S,7S,7aS)-1,4a,5,6,7,7a-hexahydro-5,6,7-trihydroxy-7-(hydroxymethyl)cyclopenta(c)pyran-1-yl",C1C[C@]([C@@H]2[C@H]1C=COC2O[C@@H]3[C@@H]([C@H]([C@@H]([C@](O3)(C(O)O)O)O)O)O)(CO)O,,,,,,
7718,157719,"4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-1,10-dihydroxy-2,11-dimethoxy-6,6-dimethyl-, iodide",C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)O)OC)O)OC)C.[I-],,,,,,
7719,157720,"2,11-dimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-6-ium-1,10-diol",C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)O)OC)O)OC)C,,,,,,
7720,157721,CID 157721,CCN1C(=CC(=O)C(=C1C2=CC=C(C=C2)Cl)C(=O)[O-])C.[K+],,,,,,
7721,157722,Karetazan,CCN1C(=CC(=O)C(=C1C2=CC=C(C=C2)Cl)C(=O)O)C,,,,,,
7722,157723,"Benzenamine, N,N-dimethyl-2,4-bis(4-morpholinylmethyl)-",CN(C)C1=C(C=C(C=C1)CN2CCOCC2)CN3CCOCC3,,,,,,
7723,157724,"L-Alanine, N-acetyl-3-((pentachlorophenyl)sulfinyl)-",CC(=O)N[C@@H](CS(=O)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)C(=O)O,,,,,,
7724,157725,"Pregnane-3,20-dione, 17,21-dihydroxy-16-methyl-, (5alpha,16alpha)-",C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)CO)O)C)C,,,,,,
7725,157726,"Benzene, 1-(2-chloro-1-methoxyethyl)-4-nitro-",COC(CCl)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
7726,157727,"L-Cysteine, S,S'-(2,3,5,6-tetrachloro-1,4-phenylene)bis-",C([C@@H](C(=O)O)N)SC1=C(C(=C(C(=C1Cl)Cl)SC[C@@H](C(=O)O)N)Cl)Cl,,,,,,
7727,157728,"Benzenesulfonamide, 2-chloro-5-hydroxy-N-(((4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino)carbonyl)-",CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(C=CC(=C2)O)Cl,,,,,,
7728,157729,"2-Pentadecanone, 1,1,1-trifluoro-",CCCCCCCCCCCCCC(=O)C(F)(F)F,,,,,,
7729,157730,"2-Nonadecanone, 1,1,1-trifluoro-",CCCCCCCCCCCCCCCCCC(=O)C(F)(F)F,,,,,,
7730,157731,"1,5-Ethano-3H-2-benzazepin-3-one, 1,2,4,5-tetrahydro-5-phenyl-",C1CC2(CC(=O)NC1C3=CC=CC=C32)C4=CC=CC=C4,,,,,,
7731,157732,"1,5-Ethano-3H-2-benzazepin-3-one, 1,2,4,5-tetrahydro-2-methyl-5-phenyl-",CN1C2CCC(CC1=O)(C3=CC=CC=C23)C4=CC=CC=C4,,,,,,
7732,157733,"[6-Acetyloxy-3,3a-dihydroxy-3,6,9-trimethyl-7-(3-methylbutanoyloxy)-8-(2-methylbut-2-enoyloxy)-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-4-yl] 2-methylbutanoate",CCC(C)C(=O)OC1CC(C2C(C(C(=C2C3C1(C(C(=O)O3)(C)O)O)C)OC(=O)C(=CC)C)OC(=O)CC(C)C)(C)OC(=O)C,,,,,,
7733,157734,"1H-Imidazo(4,5-c)pyridine, 4,5,6,7-tetrahydro-4,4-di-2-pyridinyl-",C1CNC(C2=C1NC=N2)(C3=CC=CC=N3)C4=CC=CC=N4,,,,,,
7734,157735,2-Chloroethyl vinyl sulfide,C=CSCCCl,,,,,,
7735,157736,"Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-,ethyl ester",CCOC(=O)CCC1=CC=C(C=C1)OCC(CNC(C)C)O,,,,,,
7736,157737,"Benzenepropanoic acid, 3-fluoro-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, ethyl ester, hydrochloride",CCOC(=O)CCC1=CC(=C(C=C1)OCC(CNC(C)C)O)F.Cl,,,,,,
7737,157738,Propenyltrimethoxybenzol,CC=CC1=C(C(=C(C=C1)OC)OC)OC,,,,,,
7738,157739,"Indolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridinium, 5,7,8,13,13b,14-hexahydro-5,6-dimethyl-, (5S,6R,13bS)-",C[C@H]1C2=C(C[C@@H]3[N@@+]1(CCC4=C3NC5=CC=CC=C45)C)C=CN=C2,,,,,,
7739,157740,"Piperazinium, 1,1-dimethyl-4-nitroso-, iodide",C[N+]1(CCN(CC1)N=O)C.[I-],,,,,,
7740,157741,"1,1-Dimethyl-4-nitrosopiperazin-1-ium",C[N+]1(CCN(CC1)N=O)C,,,,,,
7741,157742,"Urea, N'-(3,4-dichlorophenyl)-N-methoxy-N-methyl-, mixt. with N-(1,1-dimethylethyl)-N'-ethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)SC)NC(C)(C)C.CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,,,,,,
7742,157743,"Urea, N'-(5-(2-hydroxy-1,1-dimethylethyl)-3-isoxazolyl)-N,N-dimethyl-",CC(C)(CO)C1=CC(=NO1)NC(=O)N(C)C,,,,,,
7743,157744,"Urea, N-(5-(2-hydroxy-1,1-dimethylethyl)-3-isoxazolyl)-N'-methyl-",CC(C)(CO)C1=CC(=NO1)NC(=O)NC,,,,,,
7744,157745,"4H-1-Benzopyran-4-one, 2-(4-(beta-D-glucopyranosyloxy)phenyl)-2,3-dihydro-5,7-dihydroxy-, (2S)-",C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
7745,157746,CID 157746,CC[C@@H](CO)[C@@H]1[C@]([C@H]2[C@@H](C[C@@](C[C@@H]2C(=O)[C@@]1(C)O)(C)O)C)(C)C(=O)C=CO,,,,,,
7746,157747,"1,3-Dioxane, 5-hexyl-2-(4-nitrophenyl)-, trans-",CCCCCCC1COC(OC1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7747,157748,"Lysine, mono(alpha-methyl-2H-indazole-2-acetate)",CC(C(=O)O)N1C=C2C=CC=CC2=N1.C(CCN)C[C@@H](C(=O)O)N,,,,,,
7748,157749,2-(2H-indazol-2-yl)propanoic acid,CC(C(=O)O)N1C=C2C=CC=CC2=N1,,,,,,
7749,157750,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-7-((4-O-beta-D-xylopyranosyl-beta-D-arabinopyranosyl)oxy)-, (S)-",C1[C@H](OC2=CC(=CC(=C2C1=O)O)O[C@H]3[C@H]([C@@H]([C@@H](CO3)O[C@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)O)O)C5=CC(=C(C=C5)O)O,,,,,,
7750,157751,"3,2':5',3''-Terthiophene",C1=CSC=C1C2=CC=C(S2)C3=CSC=C3,,,,,,
7751,157752,"1-(5-Methyl-1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-3-[4-(trifluoromethyl)phenyl]prop-2-en-1-ol",CC1(COCOC1)C(C(=CC2=CC=C(C=C2)C(F)(F)F)N3C=NC=N3)O,,,,,,
7752,157753,CID 157753,COC(=O)C1=CC=C(O1)C=C(C(=O)OC)[N+](=O)[O-],,,,,,
7753,157754,"1-Cyclopentene-1-methanol, 2-methyl-",CC1=C(CCC1)CO,,,,,,
7754,157755,"Pyrrolidine, 2,5-dimethyl-1-((4-methylphenyl)sulfonyl)-, cis-",C[C@@H]1CC[C@@H](N1S(=O)(=O)C2=CC=C(C=C2)C)C,,,,,,
7755,157756,"3-Pyridinecarboxylic acid, 5-butyl-2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-",CCCCC1=CC(=C(N=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)O,,,,,,
7756,157757,"3-Pyridinecarboxylic acid, 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-phenyl-",CC(C)C1(C(=O)NC(=N1)C2=C(C=C(C=N2)C3=CC=CC=C3)C(=O)O)C,,,,,,
7757,157758,"3-Pyridinecarboxylic acid, 5-bromo-2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-",CC(C)C1(C(=O)NC(=N1)C2=C(C=C(C=N2)Br)C(=O)O)C,,,,,,
7758,157759,5-(hydroxymethyl)-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)pyridine-3-carboxylic Acid,CC(C)C1(C(=O)NC(=N1)C2=C(C=C(C=N2)CO)C(=O)O)C,,,,,,
7759,157760,"3,7,11,15,19,23,27,31,35,39,43,47,51-Tridecamethyldopentaconta-2,6,10,14,18,22,26,30,34,38,42,46,50-tridecaen-1-ol",CC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCCC(=CCO)C)C)C)C)C)C)C)C)C)C)C)C)C,,,,,,
7760,157761,"1,3-Benzodioxole, 5-((2-(2-butoxyethoxy)ethoxy)methyl)-6-propyl-, mixt. with 1,1'-(2,2,2-trichloroethylidene)bis(4-chlorobenzene)",CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2.C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,,,,,,
7761,157762,"Benzoic acid, 2-(methylamino)-, (1aR,1bS,4S,4aR,7aR,7bR,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester",C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@H]4[C@@H](C(=C3)CO)O)C)O)OC(=O)C)OC(=O)C5=CC=CC=C5NC,,,,,,
7762,157763,"Phosphinic acid, methyl(4-nitrophenyl)-",CP(=O)(C1=CC=C(C=C1)[N+](=O)[O-])O,,,,,,
7763,157764,"Phenanthro(1,2-c)furan-8(4H)-one, 6-((acetyloxy)methyl)-7-hydroxy-3b,5,5a,6,7,9,9a,9b,10,11-decahydro-3b,6,9a-trimethyl-, (3bR,5aR,6S,7S,9aR,9bR)-",CC(=O)OC[C@@]1([C@@H]2CC[C@@]3([C@@H]([C@]2(CC(=O)[C@H]1O)C)CCC4=COC=C43)C)C,,,,,,
7764,157765,"1-[3-[(1S,5R,6S)-6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one",CC1=C[C@@H]([C@H]([C@@H](C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C(=C(C=C3)O)CC=C(C)C)O)C4=C(C=CC(=C4O)C(=O)C=CC5=C(C=C(C=C5)O)O)O,,,,,,
7765,157766,"Dibenzo(b,e)(1,4)dioxin, 2,3,7-trichloro-8-methoxy-",COC1=C(C=C2C(=C1)OC3=CC(=C(C=C3O2)Cl)Cl)Cl,,,,,,
7766,157767,"1,1'-Biphenyl, 2,2',4,4',5-pentabromo-",C1=CC(=C(C=C1Br)Br)C2=CC(=C(C=C2Br)Br)Br,,,,,,
7767,157768,"1-Pentadecanol, 4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,15-pentacosafluoro-2-iodo-",C(C(CO)I)C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7768,157769,Deacetylscilliroside,C[C@]12CC[C@@H]3[C@]4(CC[C@@H](C=C4[C@@H](C[C@]3([C@]1(CC[C@@H]2C5=COC(=O)C=C5)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C,,,,,,
7769,157770,"2H-1,2,4,6-Thiatriazine, 5-methoxy-2-methyl-3-(methylthio)-, 1,1-dioxide",CN1C(=NC(=NS1(=O)=O)OC)SC,,,,,,
7770,157771,CID 157771,C[C@H]1CC=C[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4C2([C@@H](C=C[C@](C1)(C)O)OC(=O)C)C(=O)N[C@H]4CC5=CC=CC=C5)C)C,,,,,,
7771,157772,CID 157772,CC(=C(C)N=NC(=O)C1=CC=NC=C1)NNC(=O)C2=CC=NC=C2,,,,,,
7772,157773,Fuziline,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@H](C(C31)[C@@]5([C@@H]6[C@H]4CC([C@@H]6O)[C@H]([C@@H]5O)OC)O)OC)O)COC,,,,,,
7773,157774,CID 157774,CC1=CN(C(=O)NC1=O)[C@H]2CC([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)OP(=O)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=CC(=NC7=O)N)OP(=O)(O)OC[C@@H]8C(CC(O8)N9C=NC1=C(N=CN=C19)N)O,,,,,,
7774,157775,"2H-1,3,5-Triazino(2,1-b)benzoxazol-2-imine",C1=CC=C2C(=C1)N3C=NC(=N)N=C3O2,,,,,,
7775,157776,"Tricyclo(3.3.1.13,7)decane, 1,3,6,6-tetrabromo-",C1C2CC3(CC(C2(Br)Br)CC1(C3)Br)Br,,,,,,
7776,157777,"1,10alpha-Epoxy-8alpha-hydroxyachillin",CC1C2C(CC3(C4(O3)C(C2OC1=O)C(=CC4=O)C)C)O,,,,,,
7777,157778,3-Butyladamantan-1-amine,CCCCC12CC3CC(C1)CC(C3)(C2)N,,,,,,
7778,157779,"Tin(2+), bis(phenylmethyl)-",[CH2-]C1=CC=CC=C1.[CH2-]C1=CC=CC=C1.[Sn+4],,,,,,
7779,157780,CID 157780,CC1=C(C(=O)[C@]23CCCN(CCC=C2[C@H](C[C@@H]3C1)O)C)OC,,,,,,
7780,157781,"Methyl 17-ethyl-6-(15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate",CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC(=C5)C6CC7C(C(CC8=C6NC9=CC=CC=C89)N(CC7=CC)C)C(=O)OC)C(=O)OC,,,,,,
7781,157782,"Methyl 17-ethyl-7-(15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate",CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)C6CC7C(C(CC8=C6NC9=CC=CC=C89)N(CC7=CC)C)C(=O)OC)C(=O)OC,,,,,,
7782,157783,"Methyl 17-ethyl-5-(15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate",CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=CC=C5C6CC7C(C(CC8=C6NC9=CC=CC=C89)N(CC7=CC)C)C(=O)OC)C(=O)OC,,,,,,
7783,157784,"Ibogamine-18-carboxylic acid, 19-hydroxy-12-methoxy-, methyl ester, (19R)-",CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2O)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC,,,,,,
7784,157785,Surenolactone,C[C@@]12CC[C@@H]3[C@]4(C=CC(=O)OC([C@@H]4CC(=O)O[C@]3([C@@]15[C@H](O5)C[C@H]2C6=COC=C6)C)(C)C)C,,,,,,
7785,157786,"Ulithiacyclamide, 1,15-de(dithiobis(methylene))-8,22-dide(2-methylpropyl)-8-methyl-1-(1-methylethyl)-15-(1-methylpropyl)-22-(phenylmethyl)-, (1S,8R,15S(S),22R)-",CCC(C)C1C2=NC(C(O2)C)C(=O)NC(C3=NC(=CS3)C(=O)NC(C4=NC(C(O4)C)C(=O)NC(C5=NC(=CS5)C(=O)N1)C)C(C)C)CC6=CC=CC=C6,,,,,,
7786,157787,3'alpha-Isopravastatin,CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@H]([C@@H]([C@@H]([C@@H]12)CC[C@H](C[C@H](CC(=O)O)O)O)C)O,,,,,,
7787,157788,CID 157788,CC(=O)O[C@@H]1C[C@@H]2[C@@]([C@]3(C(=O)C(O[C@]3([C@]2([C@]45[C@@]1([C@@H](OC(=O)[C@H]4O5)C6=COC=C6)C)C)O)(C)C)O)(C)C=CC(=O)OC,,,,,,
7788,157789,Cucumarioside G1,CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC67C(C(CC6(C5=CCC4C3(C)C)C)OC(=O)C)C(OC7=O)(C)CCC=C(C)C)C)OS(=O)(=O)O)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)OC)O)O.[Na+],,,,,,
7789,157790,"[16-[3-[5-[4-(3,5-Dihydroxy-4-methoxyoxan-2-yl)oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-5-sulfooxyoxan-2-yl]oxy-2,6,13,17,17-pentamethyl-6-(4-methylpent-3-enyl)-8-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-1(20)-en-4-yl] acetate",CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC67C(C(CC6(C5=CCC4C3(C)C)C)OC(=O)C)C(OC7=O)(C)CCC=C(C)C)C)OS(=O)(=O)O)O)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)OC)O)O,,,,,,
7790,157791,"11H-Benzofuro(3,2-b)(1)benzopyran-11-one, 2-(5,6-dihydro-9-hydroxy-2-methyl-2,6-methano-2H-1-benzoxocin-4-yl)-5a,10a-dihydro-1,3,5a,8-tetrahydroxy-10a-(3-methyl-2-butenyl)-",CC(=CCC12C(=O)C3=C(C=C(C(=C3O)C4=CC5(CC(C4)C6=C(O5)C=C(C=C6)O)C)O)OC1(C7=C(O2)C=C(C=C7)O)O)C,,,,,,
7791,157792,"5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-ethyl-7,8,9,10-tetrahydro-1,8,11-trihydroxy-, (8S-cis)-",CCC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
7792,157793,"Benzenediazonium, 4-((2,6-dichloro-4-nitrophenyl)azo)-2,5-dimethoxy-, (T-4)-tetrachlorozincate(2-) (2:1)",COC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl)OC)[N+]#N.COC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl)OC)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
7793,157794,4-[4-(4-Trifluoromethylphenoxy)phenoxy]-2-pentenoic acid,CC(C=CC(=O)O)OC1=CC=C(C=C1)OC2=CC=C(C=C2)C(F)(F)F,,,,,,
7794,157795,"1,3-Propanediamine, N,N-dimethyl-N'-(1,2,3,4-tetrahydro-9-acridinyl)-",CN(C)CCCNC1=C2CCCCC2=NC3=CC=CC=C31,,,,,,
7795,157796,Distel(2+),CC1=C2C=CN=C(C2=C(C3=C1NC4=C3C=C(C=C4)OC)C)NCCCNC(=O)C5=CC(=CN5C)NC(=O)C6=CC(=CN6C)NC(=O)C7=CC(=CN7C)NC(=O)CCN,,,,,,
7796,157797,CID 157797,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=CC(=O)C2=CC=C(C=C2)C(=O)O,,,,,,
7797,157798,Cylindol B,COC(=O)C1=C(C=CC(=C1)OC2=CC(=C(C=C2)O)C(=O)OC)O,,,,,,
7798,157799,4-Deacetyltaxol,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)O)O)C)OC(=O)C,,,,,,
7799,157800,CID 157800,C[C@@H]1[C@H]([C@@H](C[C@@H](O1)C2=C3C(=C(C=C2)O)C(=O)C4=C(C3=O)[C@@H]5[C@@H](CC(=O)O5)O[C@@H]4C)[N+](C)(C)[O-])O,,,,,,
7800,157801,Leptosine I,CC(C)C12C(=O)N3C4C5(C(C3(C(=O)N1C)SSSS2)OC67C(C58C(N6C(=O)C(N(C7=O)C)CO)NC9=CC=CC=C89)O)C1=CC=CC=C1N4,,,,,,
7801,157802,CID 157802,CC1C(C(CC(O1)OC2C(OC(CC2(C)N(C)C)C3=C(C4=C(C=C3)C(=O)C5=CC(=O)C6=C(C=C(OC6=C5C4=O)C7(C(O7)C)C)O)O)C)OC)O,,,,,,
7802,157803,"2-[7-(3,3-Dimethyl-1-pentyl-1,3-dihydro-2H-indol-2-ylidene)hepta-1,3,5-trien-1-yl]-3,3-dimethyl-1-pentyl-3H-indol-1-ium iodide",CCCCCN1C2=CC=CC=C2C(C1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCC)(C)C.[I-],,,,,,
7803,157804,"2-[7-(3,3-Dimethyl-1-pentylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]-3,3-dimethyl-1-pentylindole",CCCCCN1C2=CC=CC=C2C(C1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCC)(C)C,,,,,,
7804,157805,"1,2-Dihydro-1-(chloromethyl)-5-hydroxy-8-methyl-3H-furano(3,2-e)indole",CC1=COC2=C(C=C3C(=C12)[C@H](CN3)CCl)O,,,,,,
7805,157806,N-benzyl-N-hydroxy-5-phenylpentanamide,C1=CC=C(C=C1)CCCCC(=O)N(CC2=CC=CC=C2)O,,,,,,
7806,157807,Aspartyl-tyrosyl-phosphomethionyl-aspartyl-methionyl-lysine,CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
7807,157808,Succinimidyl 6-[3-(2-Pyridyldithio)propionamido]hexanoate,C1CC(=O)N(C1=O)OC(=O)CCCCCNC(=O)CCSSC2=CC=CC=N2,,,,,,
7808,157809,[1-Hydroxy-3-[methyl(3-phenoxypropyl)amino]-1-phosphonopropyl]phosphonic acid,CN(CCCOC1=CC=CC=C1)CCC(O)(P(=O)(O)O)P(=O)(O)O,,,,,,
7809,157810,"Benzoic acid, 2-hydroxy-4-((4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyl)oxy)-3,5,6-trimethyl-, 4-carboxy-3-methoxy-2,5,6-trimethylphenyl ester",CC1=C(C(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)O)C)OC)C)O)C,,,,,,
7810,157811,1-Hydroxy-2-[(2-hydroxy-5-methoxyphenyl)methylideneamino]guanidine;4-methylbenzenesulfonic acid,CC1=CC=C(C=C1)S(=O)(=O)O.COC1=CC(=C(C=C1)O)C=NN=C(N)NO,,,,,,
7811,157812,1-Hydroxy-2-[(2-hydroxy-5-methoxyphenyl)methylideneamino]guanidine,COC1=CC(=C(C=C1)O)C=NN=C(N)NO,,,,,,
7812,157813,2-(Methylimino)-5-(1H-indol-3-ylmethylene)-1-methylimidazolidin-4-one,CNC1=NC(=C(N1C)C=C2C=NC3=CC=CC=C32)O,,,,,,
7813,157814,5-(Difluorosulfomethyl)uracil,C1=C(C(=O)NC(=O)N1)C(F)(F)S(=O)(=O)O,,,,,,
7814,157815,"(R)-N-(1,3-Dimethyl-2-butenyl)-1H-purin-6-amine",C[C@H](C=C(C)C)NC1=NC=NC2=C1NC=N2,,,,,,
7815,157816,N-Dmb-adenosine,C[C@H](C=C(C)C)NC1=C2C(=NC=N1)N(C=N2)C3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7816,157817,CID 157817,CC1=NC=CN1.CC1=NC=CN1.CC(=CC(=NCCN=C(C)C=C(C)[O-])C)[O-].[Co+3].[Br-],,,,,,
7817,157818,"N,N'-Ethylenebis(2-hydroxy-2-pentene-4-imine)",CC(=CC(=O)C)NCCNC(=CC(=O)C)C,,,,,,
7818,157819,"5,7-Diamino-2-(4-aminophenyl)-6-hydroxy-4H-1-benzopyran-4-one trihydrochloride",C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3N)O)N)N.Cl.Cl.Cl,,,,,,
7819,157820,"4',5,7-Triamino-6-hydroxyflavone",C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3N)O)N)N,,,,,,
7820,157821,CID 157821,C1C(NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)O.Cl.Cl,,,,,,
7821,157822,CID 157822,C1C(NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)O,,,,,,
7822,157823,"Butanamide, N-(3-((2-((2,3-dihydro-6-hydroxy-2-oxo-1H-naphtho(2,1-b)(1,4)thiazin-5-yl)thio)ethyl)amino)-3-oxopropyl)-2,4-dihydroxy-3,3-dimethyl-, (R)-",CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCSC1=C(C2=CC=CC=C2C3=C1SCC(=O)N3)O)O,,,,,,
7823,157824,Bila 2157 BS,CC(C)C[C@@H]([C@@H]([C@H](CC1CCCCC1)NC(=O)[C@H](CC2=CSC(=N2)N)CC(=O)N(CC3CCCCC3)CC(=O)N(C)CCC4=CC=CC=N4)O)O,,,,,,
7824,157825,"4-(3-Hydroperoxy-3-methylbut-1-enyl)-9-methoxyfuro[3,2-g]chromen-7-one",CC(C)(C=CC1=C2C=CC(=O)OC2=C(C3=C1C=CO3)OC)OO,,,,,,
7825,157826,Cororubicin,CC1C(C(CC(O1)OC2C(OC(CC2(C)[N+](=O)[O-])OC3C(OC(CC3O)OC4C(C(C5OC6=C7C(=C(C=C6C4(O5)C)O)C(=O)C8=C(C7=O)C=C9C(C(CCC9=C8O)(C)O)C(=O)OC)O)N(C)C)C)C)O)O,,,,,,
7826,157827,CID 157827,C1=C2C(=NC(=N2)N)C=NN1,,,,,,
7827,157828,Thalifaberidine,CN1CCC2=C3[C@@H]1CC4=C(C(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)O)OC5=CC=C(C=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)O)OC,,,,,,
7828,157829,"methyl 2-[(1R,3R,4R)-6-[(4R,6R)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-4,9-dihydroxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetate",C[C@@H]1C([C@@H](CC(O1)C2=C3C(=C(C=C2)O)C(=O)C4=C(C3=O)[C@H]([C@H](O[C@@H]4C)CC(=O)OC)O)N(C)C)O,,,,,,
7829,157830,CID 157830,CC1C(C(CC(O1)OC2C(OC(CC2(C)NC)C3=C(C4=C(C=C3)C(=O)C5=CC(=O)C6=C(C=C(OC6=C5C4=O)C7(C(O7)C)C)O)O)C)OC)O,,,,,,
7830,157831,"N-[(3S,4R,5S,9R,10R,13R,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-(4-propan-2-ylidene-2,3-dihydropyrrol-5-yl)propan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide",C[C@H](CC1=NCCC1=C(C)C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4C3=CC[C@H]5[C@@]4(CC[C@@H]([C@@H]5O)NC(=O)C)C)C,,,,,,
7831,157832,Lokysterolamine A,C[C@H](CC1=NCCC1=C(C)C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4C3=CC[C@@H]5[C@@]4(CC[C@@H]([C@@H]5O)N(C)C)C)C,,,,,,
7832,157833,Gelliusine A,C1=CC2=C(C=C1Br)NC=C2C(CN)C3=C(C=C4C(=C3)NC(=C4CCN)C(CN)C5=CNC6=C5C=CC(=C6)Br)O,,,,,,
7833,157834,Aipp-EM,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)NCCNC(=O)CCC4=CC(=C(C=C4)N=[N+]=[N-])[125I])CCC5=C3C=CC(=C5)OC(=O)N(CCCl)CCCl,,,,,,
7834,157835,cyclo[Abu-Sar-N(Me)Val-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-N(Me)Val-N(Me)Bmt],CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)C)C,,,,,,
7835,157836,Levocarnitine propionate hydrochloride,CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-],,,,,,
7836,157837,Levocarnitine-propionate,CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C,,,,,,
7837,157838,"1H-Indole-1-acetic acid, 3-((4,5,7-trifluoro-2-benzothiazolyl)methyl)-, monohydrate",C1=CC=C2C(=C1)C(=CN2CC(=O)O)CC3=NC4=C(C(=CC(=C4S3)F)F)F.O,,,,,,
7838,157839,Lidorestat,C1=CC=C2C(=C1)C(=CN2CC(=O)O)CC3=NC4=C(C(=CC(=C4S3)F)F)F,,,,,,
7839,157840,Ustiloxin D,CC[C@@]1([C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](C2=CC(=C(C=C2)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C,,,,,,
7840,157841,Ustiloxin C,CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2S(=O)CCO)O)O1)O)NC)C)C(=O)NCC(=O)O)C,,,,,,
7841,157842,CID 157842,CCCC(=O)C1=C(C(=O)C2=C(OC3=C(C2=C1)C=CC=C3O)O)C,,,,,,
7842,157843,2-Phenylphenanthridinone,C1=CC=C(C=C1)C2=CC3=C(C=C2)NC(=O)C4=CC=CC=C43,,,,,,
7843,157844,CID 157844,C1=C(SC(=C1)NCCCC2=C(NC(=NC2=O)N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
7844,157845,CID 157845,C1=C(SC(=N1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCCCC2=C(NC(=NC2=O)N)N,,,,,,
7845,157846,Behentrimonium methosulfate,CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
7846,157847,Docosyltrimethylaminium,CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C,,,,,,
7847,157848,"2-[[2-[[2-[[3-[[2-[[2-[(2-Amino-3-methylbutanoyl)amino]-2-(3,5-dihydroxyphenyl)acetyl]amino]-4-methylpentanoyl]amino]-2-oxo-4-phenylbutanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]butanedioic acid",CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(C2=CC(=CC(=C2)O)O)NC(=O)C(C(C)C)N,,,,,,
7848,157849,N-Acetyl-S-(2-carbamoylethyl)-L-cysteine,CC(=O)N[C@@H](CSCCC(=O)N)C(=O)O,,,,,,
7849,157850,Hexakis(ethoxyisobutylisonitrile)technetium(I),CCOC(C)(C)C[N+]#[C-].CCOC(C)(C)C[N+]#[C-].CCOC(C)(C)C[N+]#[C-].CCOC(C)(C)C[N+]#[C-].CCOC(C)(C)C[N+]#[C-].CCOC(C)(C)C[N+]#[C-].[99Tc],,,,,,
7850,157851,"Propane, 2-ethoxy-1-isocyano-2-methyl-",CCOC(C)(C)C[N+]#[C-],,,,,,
7851,157852,"Pyridinium, 3-((4-((4-(((4-(aminomethyl)phenyl)amino)carbonyl)benzoyl)amino)benzoyl)amino)-1-methyl-, salt with 4-methylbenzensulfonic acid (1:1)",CC1=CC=C(C=C1)S(=O)(=O)O.C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)CN,,,,,,
7852,157853,"1-N-[4-(aminomethyl)phenyl]-4-N-[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)CN,,,,,,
7853,157854,"Quinolinium, 1-methyl-4-((4-((5-((4-((1-methylpyridinium-4-yl)amino)phenyl)amino)-1,5-dioxopentyl)amino)phenyl)amino)-, salt with 4-methylbenzenesulfonic acid (1:2)",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)CCCC(=O)NC3=CC=C(C=C3)NC4=CC=[N+](C5=CC=CC=C45)C,,,,,,
7854,157855,"1-(3,5-Dichlorophenyl)-3-(methoxymethyl)pyrrolidine-2,5-dione",COCC1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,,,,
7855,157856,"Benzenesulfonamide, N-[[(4,6-dimethoxy-1,3,5-triazin-2-yl)amino]carbonyl]-2-(pentafluoroethoxy)-",COC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2OC(C(F)(F)F)(F)F)OC,,,,,,
7856,157857,"1,1,1-Trifluoro-N-((trifluoromethyl)sulfonyl)methanesulfonamide",C(F)(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F,,,,,,
7857,157858,"4(1H)-Pyridinone, 1-methyl-3-(1-oxopropyl)-5-(3-(trifluoromethyl)phenyl)-",CCC(=O)C1=CN(C=C(C1=O)C2=CC(=CC=C2)C(F)(F)F)C,,,,,,
7858,157859,"4(1H)-Pyridinone, 1-methyl-3-(1-oxobutyl)-5-(3-(trifluoromethyl)phenyl)-",CCCC(=O)C1=CN(C=C(C1=O)C2=CC(=CC=C2)C(F)(F)F)C,,,,,,
7859,157860,CID 157860,CCC(=C)C(=O)[O-].CC(=C)C(=O)O.C(CO)N.[Na+],,,,,,
7860,157861,"Piperazine, 1-(4-chlorophenyl)-4-(2-(3,4,5-trimethoxyphenyl)ethyl)-",COC1=CC(=CC(=C1OC)OC)CCN2CCN(CC2)C3=CC=C(C=C3)Cl,,,,,,
7861,157862,2-[1-Hydroxy-4-(4-hydroxyphenyl)cyclohexyl]butanoic acid,CCC(C(=O)O)C1(CCC(CC1)C2=CC=C(C=C2)O)O,,,,,,
7862,157863,Methyl chloronitroacetate,COC(=O)C([N+](=O)[O-])Cl,,,,,,
7863,157864,CID 157864,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4=CN=NS4)C(=O)[O-].[Na+],,,,,,
7864,157865,"methyl (1R,4aR,5R,6R,8S,8aR)-8-acetyloxy-5,6,8a-trimethyl-5-[2-(5-oxo-2H-furan-3-yl)ethyl]-1,2,3,4,4a,6,7,8-octahydronaphthalene-1-carboxylate",C[C@@H]1C[C@@H]([C@]2([C@@H](CCC[C@@H]2[C@]1(C)CCC3=CC(=O)OC3)C(=O)OC)C)OC(=O)C,,,,,,
7865,157866,"1H-Naphtho(2',3':6,7)phenanthro(3,2-c)pyran-1,9,14-trione, 3,4,6,7-tetrahydro-7-(acetyloxy)-8-methoxy-3-methyl-10,15,16-trihydroxy-",CC1CC2=CC3=C(C4=C(C(C3)OC(=O)C)C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)O)OC)C(=C2C(=O)O1)O,,,,,,
7866,157867,Ajugarin-v,C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]1(C)CCC3=CC(=O)OC3)CCC[C@]24CO4)C)OC(=O)C,,,,,,
7867,157868,"Benzamide, 2,6-dichloro-N-[5-(4-chlorophenyl)-3-isoxazolyl]-",C1=CC(=C(C(=C1)Cl)C(=O)NC2=NOC(=C2)C3=CC=C(C=C3)Cl)Cl,,,,,,
7868,157869,"1,6-Hexanediamine, N1,N6-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymer with 2,4-dichloro-6-(4-morpholinyl)-1,3,5-triazine",CC1(CC(CC(N1)(C)C)NCCCCCCNC2CC(NC(C2)(C)C)(C)C)C.C1COCCN1C2=NC(=NC(=N2)Cl)Cl,,,,,,
7869,157870,Vinclozolin epoxide,CC1(C(=O)N(C(=O)O1)C2=CC(=CC(=C2)Cl)Cl)C3CO3,,,,,,
7870,157871,"Benzamide, 2,6-dimethoxy-N-[3-(2-methoxy-1,1-dimethylethyl)-5-isoxazolyl]-",CC(C)(COC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
7871,157872,"Benzamide, N-(5-(1-ethyl-1-methylpropyl)-1,3,4-thiadiazol-2-yl)-2,6-dimethoxy-",CCC(C)(CC)C1=NN=C(S1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
7872,157873,"Benzamide, N-[6-(1,1-dimethylethyl)-3-pyridazinyl]-2,6-dimethoxy-",CC(C)(C)C1=NN=C(C=C1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
7873,157874,"Benzamide, 2,6-dimethoxy-N-(3-methyl-5-isoxazolyl)-",CC1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
7874,157875,"2-methyl-3,4-dihydro-1H-isoquinoline-4,6,7-triol",CN1CC(C2=CC(=C(C=C2C1)O)O)O,,,,,,
7875,157876,CID 157876,CC(=O)O.C[SnH](C1=CC(=C(C=C1)Cl)Cl)C2=CC(=C(C=C2)Cl)Cl,,,,,,
7876,157877,CID 157877,C[SnH](C1=CC(=C(C=C1)Cl)Cl)C2=CC(=C(C=C2)Cl)Cl,,,,,,
7877,157878,"1(3H)-Isobenzofuranone, 6-methoxy-3-(trichloromethyl)-",COC1=CC2=C(C=C1)C(OC2=O)C(Cl)(Cl)Cl,,,,,,
7878,157879,"6-(Chloromethyl)pteridine-2,4-diamine monohydrochloride",C1=C(N=C2C(=NC(=NC2=N1)N)N)CCl.Cl,,,,,,
7879,157880,"2,4-Diamino-6-chloromethylpteridine",C1=C(N=C2C(=NC(=NC2=N1)N)N)CCl,,,,,,
7880,157881,"Methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate",CC1(CC(CC(N1C)(C)C)OC(=O)CCCCCCCCC(=O)OC)C,,,,,,
7881,157882,Bis(trimethoxysilylpropyl)amine,CO[Si](CCCNCCC[Si](OC)(OC)OC)(OC)OC,,,,,,
7882,157883,"11-Ethoxy-15,16-dihydrocyclopenta(a)phenanthren-17-one",CCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,,,,,,
7883,157884,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-11-hydroxy-",C1CC(=O)C2=CC(=C3C(=C21)C=CC4=CC=CC=C43)O,,,,,,
7884,157885,"2(1H)-Pyrimidinone, tetrahydro-1,3-di-2-propenyl-",C=CCN1CCCN(C1=O)CC=C,,,,,,
7885,157886,"2-Naphthalenesulfonic acid, 6-((2,3-dibromo-1-oxopropyl)amino)-3-(2-(5-((2,3-dibromo-1-oxopropyl)amino)-2-sulfophenyl)diazenyl)-4-hydroxy-, sodium salt (1:2)",C1=CC(=CC2=C(C(=C(C=C21)S(=O)(=O)[O-])N=NC3=C(C=CC(=C3)NC(=O)C(CBr)Br)S(=O)(=O)[O-])O)NC(=O)C(CBr)Br.[Na+].[Na+],,,,,,
7886,157887,CID 157887,B1[BH-]2BC(C1)(B3B2B4B5B4B53)CC(CN6C=CN=C6[N+](=O)[O-])O.[Cs+],,,,,,
7887,157888,CID 157888,B1[BH-]2BC(C1)(B3B2B4B5B4B53)CC(CN6C=CN=C6[N+](=O)[O-])O,,,,,,
7888,157889,"Cholestane-3,5,6,8,15-pentol, 24-((2-O-(2-O-methyl-beta-D-xylopyranosyl)-alpha-L-arabinofuranosyl)oxy)-, (3beta,5alpha,6beta,15alpha)-",C[C@H](CCC(C(C)C)O[C@H]1[C@@H]([C@H]([C@@H](O1)CO)O)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)OC)[C@@H]3C[C@@H]([C@@H]4[C@@]3(CC[C@H]5C4(C[C@H]([C@@]6([C@@]5(CC[C@@H](C6)O)C)O)O)O)C)O,,,,,,
7889,157890,CID 157890,B1B2B3B2B3B1B4B5B6C57B4C76C8=CN(C(=O)NC8=O)[C@H]9[C@H]([C@@H]([C@H](O9)CO)O)F,,,,,,
7890,157891,Isobutyl (S)-2-chloropropionate,C[C@@H](C(=O)OCC(C)C)Cl,,,,,,
7891,157892,"Ethyl 5-amino-1-(2,4-dichlorophenyl)-1H-pyrazole-4-carboxylate",CCOC(=O)C1=C(N(N=C1)C2=C(C=C(C=C2)Cl)Cl)N,,,,,,
7892,157893,"1-Azoniabicyclo(4.2.0)octane, 1-methyl-, chloride",C[N+]12CCCCC1CC2.[Cl-],,,,,,
7893,157894,1-Methyl-1-azoniabicyclo[4.2.0]octane,C[N+]12CCCCC1CC2,,,,,,
7894,157895,"syn-2,3-Dihydroxy-1,10b-epoxy-1,2,3-trihydrofluoranthene",C1=CC=C2C(=C1)C3=C4[C@@]25[C@@H](O5)C(C(C4=CC=C3)O)O,,,,,,
7895,157896,"6-Carboxy-6-methyl-2-chloro-6H-dibenzo(b,d)pyran",CC1(C2=CC=CC=C2C3=C(O1)C=CC(=C3)Cl)C(=O)O,,,,,,
7896,157897,Ataralgin,CC(=O)NC1=CC=C(C=C1)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C.COC1=CC=CC=C1OCC(CO)O,,,,,,
7897,157898,"Bis(2,4,4-trimethylpentyl)phosphinic acid",CC(CC(C)(C)C)CP(=O)(CC(C)CC(C)(C)C)O,,,,,,
7898,157899,CID 157899,CC1=C(N(C2=C(N1[O-])C=CC(=C2)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)O)[O-])C(=O)N(C)[C@H](C)[C@@H](C4=CC=CC=C4)O,,,,,,
7899,157900,CID 157900,CC=C[C@@H]1[C@H]([C@@H](C[C@@](O1)([C@@H](C)[C@@H]([C@H](C)[C@@H]2[C@H](C=CC=C(C[C@H]([C@@H]([C@@H]([C@@H]([C@@H](C=C(C=C(C(=O)O2)OC)C)C)O)C)O)C)C)OC)O)O)O[C@H]3C[C@H]([C@@H]([C@H](O3)C)OC(=O)N)O)C,,,,,,
7900,157901,"2-[[12-ethyl-4-(17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl)-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid",CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)O)O)CC)OC)C(=O)OC)O,,,,,,
7901,157902,V-Trp-E,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OCC)O)O)CC)OC)C(=O)OC)O,,,,,,
7902,157903,"Methyl 13,20-epoxy-2,3,11,12,16-pentahydroxy-15-(3-methyl-1-oxobutoxy)picrasan-21-oate",CC1[C@@H]2C[C@@H]3[C@@]45CO[C@@]([C@@H]4[C@H](C(O3)O)OC(=O)CC(C)C)([C@H]([C@@H]([C@@H]5[C@]2(CC(C1O)O)C)O)O)C(=O)OC,,,,,,
7903,157904,"2H,6H-Benzo(1,2-b:5,4-b')dipyran-2-one, 7-(beta-D-glucopyranosyloxy)-7,8-dihydro-10-hydroxy-8,8-dimethyl-",CC1(C(CC2=C(O1)C(=C3C(=C2)C=CC(=O)O3)O)OC4C(C(C(C(O4)CO)O)O)O)C,,,,,,
7904,157905,"Picras-3-en-21-oic acid, 13,20-epoxy-11,12-dihydroxy-3,15-bis(3-methyl-1-oxo-2-butenyl)oxy)-2,16-dioxo-, methyl ester, (11beta,12alpha,15beta)-",CC1=C(C(=O)C[C@]2(C1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)C=C(C)C,,,,,,
7905,157906,Bistetrahydrobrusatolyl succinate,CC1C2CC3C45COC(C4C(C(=O)O3)OC(=O)CC(C)C)(C(C(C5C2(CC(=O)C1OC(=O)CCC(=O)OC6C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)CC(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C)C)O)O)C(=O)OC,,,,,,
7906,157907,Bisdihydrobrusatolyl succinate,CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)CC(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)CCC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)CC(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C,,,,,,
7907,157908,Bisbrusatolyl adipate,CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)CCCCC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)C=C(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C,,,,,,
7908,157909,"Bis-12,12'-diacetylbrusatolyl succinate",CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)OC(=O)C)O)C)OC(=O)CCC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)C=C(C)C)(C(C(C1C7(CC6=O)C)O)OC(=O)C)C(=O)OC)C,,,,,,
7909,157910,"12-Acetyl-3,15-disenecioyl bruceolide",CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)OC(=O)C)O)C)OC(=O)C=C(C)C,,,,,,
7910,157911,Bisbrusatolyl glutarate,CC1=C(C(=O)CC2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)OC(=O)CCCC(=O)OC6=C(C7CC8C91COC(C9C(C(=O)O8)OC(=O)C=C(C)C)(C(C(C1C7(CC6=O)C)O)O)C(=O)OC)C,,,,,,
7911,157912,"L-Leucine, N,N-t2",[3H]N([3H])[C@@H](CC(C)C)C(=O)O,,,,,,
7912,157913,CID 157913,[3H]C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)C([3H])([3H])O)O)O)NC(=NC2=O)N,,,,,,
7913,157914,Ccris 1520,CC(=O)OC[C@]1(CC23CC[C@@H]4C5=C(C=C[C@]4([C@@H]2CC[C@@H]1C3)C)OC=C5)O,,,,,,
7914,157915,Ccris 1519,CC(=O)OC[C@]1(CC23CC[C@@H]4C5=C(CC[C@]4([C@@H]2CC[C@@H]1C3)C)OC=C5)O,,,,,,
7915,157916,Antibiotic DC 45B2,CC1C(C(CC(O1)OC23C4C(C5=C(O2)C6=C(C=C5C)C(=C7C(CC(C(=O)C7=C6O)O)OC8CC(C(OC8)(C)OC(=O)C)(C)O)OC)OC(C39CO9)(O4)C(OC)OC)O)(C(C)O)O,,,,,,
7916,157917,Lercanidipine hydrochloride,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
7917,157918,Lubazodone hydrochloride,C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3.Cl,,,,,,
7918,157919,Lubazodone,C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3,,,,,,
7919,157920,Lubiprostone,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F,['For the treatment of chronic idiopathic constipation in the adult population. Also used for the treatment of irritable bowel syndrome with constipation in women who are 18 years of age or older.'],"['Chronic idiopathic constipation is generally defined by infrequent or difficult passage of stool. The signs and symptoms associated with chronic idiopathic constipation (i.e., abdominal pain or discomfort, bloating, straining, and hard or lumpy stools) may be the result of abnormal colonic motility that can delay the transit of intestinal contents and impede the evacuation of rectal contents. One approach to the treatment of chronic idiopathic constipation is the secretion of fluid into the abdominal lumen through the activation of chloride channels in the apical membrane of the gastrointestinal epithelium. Lubiprostone is a locally acting chloride channel activator that increases intestinal chloride and fluid secretion without altering sodium and potassium concentrations in the serum.']",['A class of drugs that stimulate chloride ion influx through cell membrane channels. (See all compounds classified as Chloride Channel Agonists.)'],"['Lubiprostone has low systemic availability following oral administration and concentrations of lubiprostone in plasma are below the level of quantitation (10 pg/mL).', 'Peak plasma concentration was shown to be around 1.14 hours, with a majority of the drug excreted in the urine within 48 hours.  Lubiprostone and M3 are only detected in trace amounts in human feces.']","['The results of both human and animal studies indicate that lubiprostone is rapidly and extensively metabolized by 15-position reduction, &alpha;-chain &beta;-oxidation, and &omega;-chain &omega;-oxidation. These biotransformations are not mediated by the hepatic cytochrome P450 system but rather appear to be mediated by the ubiquitously expressed carbonyl reductase. M3, a metabolite of lubiprostone in both humans and animals is formed by the reduction of the carbonyl group at the 15-hydroxy moiety that consists of both &alpha;-hydroxy and &beta;-hydroxy epimers. M3 makes up less than 10% of the dose of radiolabeled lubiprostone.']",['0.9 to 1.4 hours']
7920,157921,Methyl aminolevulinate hydrochloride,COC(=O)CCC(=O)CN.Cl,['Treatment of acne vulgaris'],,,,,
7921,157922,Methyl aminolevulinate,COC(=O)CCC(=O)CN,"['For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).']","['After topical application of methyl aminolevulinate, porphyrins will accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PpIX) are photoactive, fluorescing compounds and, upon light activation in the presence of oxygen, singlet oxygen is formed which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells.']",['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)'],"['In vitro, after 24 hours the mean cumulative absorption through human skin was 0.26% of the administered dose.']",,
7922,157923,Apovincaminic acid phthalidyl ester hydrochloride,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OC6C7=CC=CC=C7C(=O)O6.Cl,,,,,,
7923,157924,CID 157924,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OC6C7=CC=CC=C7C(=O)O6,,,,,,
7924,157925,Strontium cation Sr-85,[85Sr+2],,,,,,
7925,157926,"[(2S)-3,3-dimethyl-4,4-dioxido-7-oxo-4lambda4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl]oxymethyl (2R,5R,6R)-6-[(2-amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;4-methylbenzenesulfonic acid",CC1=CC=C(C=C1)S(=O)(=O)O.CC1([C@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)OCOC(=O)[C@H]4C(S(C5N4C(=O)C5)([O-])[O-])(C)C)C,,,,,,
7926,157927,"[(2S)-4,4-dihydroxy-3,3-dimethyl-7-oxo-4lambda4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl]oxymethyl (2R,5R,6R)-6-[(2-amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1([C@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)OCOC(=O)[C@H]4C(S(C5N4C(=O)C5)(O)O)(C)C)C,,,,,,
7927,157928,"4(1H)-Pyrimidinone, 1-(2-deoxy-5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-erythro-pentofuranosyl)-2-methoxy-5-methyl-",CC1=CN(C(=NC1=O)OC)[C@@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
7928,157929,"[hydroxy-[[(2R,3S,5S)-3-hydroxy-5-(4-methoxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate",CC1=CN(C(=O)N=C1OC)[C@@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
7929,157930,"5-Hexenoic acid, 4-(acetyloxy)-",CC(=O)OC(CCC(=O)O)C=C,,,,,,
7930,157931,CID 157931,CC1=C(N=C(N1)C2=CC=CC=C2)CC#N.C(=CC(=O)[O-])C(=O)[O-],,,,,,
7931,157932,CID 157932,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(OP(=O)(O)OP(=O)(O)O)S)O,,,,,,
7932,157933,14-Butyl-14-thiaadriamycin,CCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
7933,157934,14-Pentyl-14-thiaadriamycin,CCCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
7934,157935,14-Dodecyl-14-thiaadriamycin,CCCCCCCCCCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
7935,157936,14-Phenyl-14-thiaadriamycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSC6=CC=CC=C6)O)N)O,,,,,,
7936,157937,14-(Carbethoxymethyl)-14-thiaadriamycin,CCOC(=O)CSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)N)O,,,,,,
7937,157938,N-(Trifluoroacetyl)-14-thiaadriamycin,CCCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,,,,,
7938,157939,N-(Trifluoroacetyl)-14-dodecyl-14-thiaadriamycin,CCCCCCCCCCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,,,,,
7939,157940,14-Phenyl-14-selenaadriamycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C[Se]C6=CC=CC=C6)O)N)O,,,,,,
7940,157941,"S,S-Bis(daunorubicin-14-yl)ethane-1,2-dithiol",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSCCSCC(=O)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=C(C8=O)C=CC=C9OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O,,,,,,
7941,157942,"S,S-Bis(daunorubicin-14-yl)propane-1,2-dithiol",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSCCCSCC(=O)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=C(C8=O)C=CC=C9OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O,,,,,,
7942,157943,"S,S-Bis(daunorubicin-14-yl)hexane-1,2-dithiol",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSCCCCCCSCC(=O)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=C(C8=O)C=CC=C9OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O,,,,,,
7943,157944,"S,S-Bis(daunorubicin-14-yl)nonane-1,2-dithiol",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CSCCCCCCCCCSCC(=O)C6(CC(C7=C(C6)C(=C8C(=C7O)C(=O)C9=C(C8=O)C=CC=C9OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O,,,,,,
7944,157945,CID 157945,C([C@@H]([C@H]1C(=O)C(=C(O1)O)O)O)O.[O-]S(=O)(=O)[O-].[Cu+2],,,,,,
7945,157946,CID 157946,C([C@@H]([C@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
7946,157947,"5,12-Naphthacenedione, 8-((butylthio)acetyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CCCCSCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,,,,,
7947,157948,"1,4-Naphthalenedione, 6-(hydroxymethyl)-",C1=CC2=C(C=C1CO)C(=O)C=CC2=O,,,,,,
7948,157949,"Piperidinium, 4-((diphenylacetyl)oxy)-1,1-dimethyl-, tosylate",CC1=CC=C(C=C1)S(=O)(=O)O.C[N+]1(CCC(CC1)OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
7949,157950,"[(2S,3S)-3-(acetyloxymethyl)-4-(1,3-benzodioxol-5-yl)-2-(1,3-benzodioxol-5-ylmethyl)butyl] acetate",CC(=O)OC[C@@H](CC1=CC2=C(C=C1)OCO2)[C@H](CC3=CC4=C(C=C3)OCO4)COC(=O)C,,,,,,
7950,157951,"Acetaldehyde, ((6-amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)amino)-",CN1C(=C(C(=O)N(C1=O)C)NCC=O)N,,,,,,
7951,157952,"Ethanamine, 2-((5-methyl-1H-imidazol-4-yl)methoxy)-",CC1=C(N=CN1)COCCN,,,,,,
7952,157953,Triphasiol,CC(C)C(=O)CC1=C(C=CC2=C1OC(=O)C=C2)OCC(C(C)(C)O)O,,,,,,
7953,157954,"1,3,4-Metheno-1H-cyclobuta(cd)pentalene, 1,1a,2,3,3a,4,5,5a,5b,6-decachlorooctahydro-, cis-",C1(C2(C3(C4(C2(C5(C1(C3(C5(C4Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
7954,157955,"Trichothec-9-en-8-one, 12,13-epoxy-3,15-dihydroxy-",CC1=C[C@@H]2[C@](CC1=O)([C@]3(CC([C@H]([C@@]34CO4)O2)O)C)CO,,,,,,
7955,157956,"Propanoic acid, 2,2-dimethyl-, methylenebis(2-oxo-2H-1-benzopyran-3,4-diyl) ester",CC(C)(C)C(=O)OC1=C(C2=CC=CC=C2OC1=O)CC3=C(C(=O)OC4=CC=CC=C43)OC(=O)C(C)(C)C,,,,,,
7956,157957,"3-Pyridinecarboxylic acid, methylenebis(2-oxo-2H-1-benzopyran-3,4-diyl)ester",C1=CC=C2C(=C1)C(=C(C(=O)O2)OC(=O)C3=CN=CC=C3)CC4=C(C(=O)OC5=CC=CC=C54)OC(=O)C6=CN=CC=C6,,,,,,
7957,157958,"Benzenemethanol, 2-((6,7-dimethoxy-1-isoquinolinyl)methyl)-4,5-dimethoxy-alpha-methylene-, acetate (ester)",CC(=O)OC(=C)C1=CC(=C(C=C1CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC)OC,,,,,,
7958,157959,"Propanoic acid, 2-methyl-, 1-(2-((6,7-dimethoxy-1-isoquinolinyl)methyl)-4,5-dimethoxyphenyl)ethenyl ester",CC(C)C(=O)OC(=C)C1=CC(=C(C=C1CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC)OC,,,,,,
7959,157960,"Propanoic acid, 2,2-dimethyl-, 1-(2-((6,7-dimethoxy-1-isoquinolinyl)methyl)-4,5-dimethoxyphenyl)ethenyl ester",CC(C)(C)C(=O)OC(=C)C1=CC(=C(C=C1CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC)OC,,,,,,
7960,157961,"2-Imidazolidinone, 4-(acetyloxy)-3-(3-(1,1-dimethylethyl)-5-isoxazolyl)-1-methyl-",CC(=O)OC1CN(C(=O)N1C2=CC(=NO2)C(C)(C)C)C,,,,,,
7961,157962,CID 157962,CCCNC1=NC(=O)N=C(N1)NCC,,,,,,
7962,157963,"2-Butanone, 4-(4-hydroxy-2,2-dioxido-1,2-benzoxathiin-3-yl)-4-phenyl-",CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OS2(=O)=O)O,,,,,,
7963,157964,CID 157964,C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)N)NC(=O)CCl,,,,,,
7964,157965,"L-Prolinamide, N-(3-(chloroacetyl)benzoyl)-L-phenylalanyl-",C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=CC(=C3)C(=O)CCl)C(=O)N,,,,,,
7965,157966,"L-Prolinamide, N-(4-(chloroacetyl)benzoyl)-L-phenylalanyl-",C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=C(C=C3)C(=O)CCl)C(=O)N,,,,,,
7966,157967,"Heptadeca-1,12-diene",CCCCC=CCCCCCCCCCC=C,,,,,,
7967,157968,"Benzo(h)quinoline, 2,4,6-trimethyl-",CC1=CC(=NC2=C1C=C(C3=CC=CC=C32)C)C,,,,,,
7968,157969,"Benzene, (dimethoxymethoxy)-",COC(OC)OC1=CC=CC=C1,,,,,,
7969,157970,4-(4-Methylphenyl)-2-(benzylideneamino)thiazole,CC1=CC=C(C=C1)C2=CSC(=N2)N=CC3=CC=CC=C3,,,,,,
7970,157971,CID 157971,CO[C@@]1(CN2[C@@H]1SCC(=C2C(=O)[O-])CO)NC(=O)CCCC(C(=O)O)N.[Na+],,,,,,
7971,157972,"(6R,7R)-7-[(5-amino-5-carboxypentanoyl)amino]-3-(hydroxymethyl)-7-methoxy-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CO[C@@]1(CN2[C@@H]1SCC(=C2C(=O)O)CO)NC(=O)CCCC(C(=O)O)N,,,,,,
7972,157973,"5,9:7,10a-Dimethano-10aH-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-2-imino-, (4R,4aR,5R,7S,9S,10S,10aR,11S,12R)-",[C@H]12[C@@H]3[C@@H]([C@@H]4[C@H]([C@]1([C@H]([C@](O3)(O4)O)O)NC(=N[C@@H]2O)N)O)O,,,,,,
7973,157974,"7H-Dibenzo(de,g)quinolin-9-ol, 1,2,3-trimethoxy-7,7-dimethyl-",CC1(C2=C(C=CC(=C2)O)C3=C(C(=C(C4=C3C1=NC=C4)OC)OC)OC)C,,,,,,
7974,157975,"24-Ethylcholesta-3,5,22-triene",CCC(C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC=C4)C)C)C(C)C,,,,,,
7975,157976,"[(1S,2R,3aR,4R,5R,11R,13aS)-3a,4-diacetyloxy-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1,2,3,4,5,10,11,13a-octahydrocyclopenta[12]annulen-1-yl] benzoate",C[C@@H]1C[C@]2([C@H]([C@H]1OC(=O)C3=CC=CC=C3)C=C([C@@H](CC(=O)C(C=C[C@H]([C@H]2OC(=O)C)C)(C)C)O)C)OC(=O)C,,,,,,
7976,157977,Austalide A,CC1=C2COC(=O)C2=C(C3=C1O[C@]4(C[C@H]([C@@]56[C@@]([C@H]4C3)(CC[C@@](O5)(OC6(C)C)OC)C)OC(=O)C)C)OC,,,,,,
7977,157978,Austalide B,CC1=C2COC(=O)C2=C(C3=C1O[C@]4(C[C@H]([C@@]56[C@@]([C@H]4C3)(CC[C@@](O5)(OC6(C)C)OC)C)O)C)OC,,,,,,
7978,157979,8RL82T4Cqt,CC1=C2COC(=O)C2=C(C3=C1O[C@]4(C[C@H]([C@@]56[C@@]([C@H]4C3)([C@@H](C[C@@](O5)(OC6(C)C)OC)OC(=O)C)C)O)C)OC,,,,,,
7979,157980,"Benzamide, N-(((4-((5-chloro-3-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OC3=C(C=C(C=N3)Cl)C(F)(F)F)F,,,,,,
7980,157981,"(2,3'-Bipiperidine)-5'-carboxylic acid, 1'-(3-butenyl)-, (2R,3'S,5'R)-",C=CCCN1C[C@H](C[C@H](C1)C(=O)O)[C@H]2CCCCN2,,,,,,
7981,157982,"10,10a-Dihydroxy-7-methoxy-2,2-dimethyl-5-(2-methylprop-1-en-1-yl)-11,15-dioxo-1,2,10,10a,11,13,14,14a,15,15b-decahydro-5H,12H-3,4-dioxa-5a,11a,15a-triazacycloocta[1,2,3-lm]indeno[5,6-b]fluoren-13-yl acetate",CC(=CC1N2C3=C(C=CC(=C3)OC)C4=C2C(CC(OO1)(C)C)N5C(=O)C6CC(CN6C(=O)C5(C4O)O)OC(=O)C)C,,,,,,
7982,157983,2-Pentenylfuran,CCCC=CC1=CC=CO1,,,,,,
7983,157984,"Acetic acid, (2-(4-(1,1-dimethylhexyl)phenoxy)ethoxy)-, methyl ester",CCCCCC(C)(C)C1=CC=C(C=C1)OCCOCC(=O)OC,,,,,,
7984,157985,"Benzene, 1,3-dichloro-5-methyl-2-(1-methylethyl)-",CC1=CC(=C(C(=C1)Cl)C(C)C)Cl,,,,,,
7985,157986,"Acetic acid, (2-(bromo-4-(1,1-dimethylhexyl)phenoxy)ethoxy)-, methyl ester",CCCCCC(C)(C)C1=CC(=C(C=C1)OCCOCC(=O)OC)Br,,,,,,
7986,157987,"Acetamide, N-((1S,2R)-2-hydroxy-1-methyl-2-phenylethyl)-",C[C@@H]([C@@H](C1=CC=CC=C1)O)NC(=O)C,,,,,,
7987,157988,"Acetamide, N-((1S,2R)-2-(acetyloxy)-1-methyl-2-phenylethyl)-",C[C@@H]([C@@H](C1=CC=CC=C1)OC(=O)C)NC(=O)C,,,,,,
7988,157989,"2H-1-Benzopyran-2-one, 7-(((1R,4aR,6R,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylene-1-naphthalenyl)methoxy)-6,8-dimethoxy-",C[C@]12CC[C@H](C([C@@H]1CCC(=C)[C@H]2COC3=C(C=C4C=CC(=O)OC4=C3OC)OC)(C)C)O,,,,,,
7989,157990,CID 157990,C1COP(=O)(N[C@@H]1ONC(=O)N)N(CCCl)CCCl,,,,,,
7990,157991,Snap,CC(=O)N[C@H](C(=O)O)C(C)(C)SN=O,,,"['A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
7991,157992,"Phenanthro(1,2-b)furan-1,7(2H,5H)-dione, 3a,5a,6,8,9,9a,9b,10,11,11a-decahydro-6,6,9a,11a-tetramethyl-, (3aR,5aR,9aR,9bR,11aS)-",C[C@]12CCC(=O)C([C@@H]1CC=C3[C@@H]2CC[C@]4([C@@H]3OCC4=O)C)(C)C,,,,,,
7992,157993,"Eburnamenin-14-ol, 17,18-didehydro-14,15-dihydro-, (3alpha,14alpha,16alpha)-",CC[C@]12C[C@@H](N3C4=CC=CC=C4C5=C3[C@H]1N(CC5)CC=C2)O,,,,,,
7993,157994,7-Chloroethyl-8-benzyltheophylline,CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)CC3=CC=CC=C3)CCCl,,,,,,
7994,157995,"(S)-4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one",C[C@]12CCCC(C1=CC(=O)O2)(C)C,,,,,,
7995,157996,Benz(e)acephenanthrylen-5-ol,C1=CC=C2C3=C4C(=CC=C3)C5=C(C4=CC2=C1)C=CC(=C5)O,,,,,,
7996,157997,Benz(e)acephenanthrylen-4-ol,C1=CC=C2C3=C4C(=CC=C3)C5=C(C4=CC2=C1)C=CC=C5O,,,,,,
7997,157998,"Benzoic acid, 4-(4-formyl-2-hydroxyphenoxy)-3-methoxy-",COC1=C(C=CC(=C1)C(=O)O)OC2=C(C=C(C=C2)C=O)O,,,,,,
7998,157999,CID 157999,CC=C1CN2CCC34C(C1CC2C3N(C5=C4C=C(C=C5)O)C)C(=O)OC,,,,,,
7999,158000,CID 158000,CCC(C)C=C(C)C=CC(=O)C1=C(N(C=C(C1=O)C2=CC=C(C=C2)O)O)O,,,,,,
8000,158001,"1-Acenaphthylenol, 1,2-dihydro-6-nitro-",C1C(C2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-])O,,,,,,
8001,158002,6-O-beta-Glucopyranosylaucubin,C1=CO[C@H]([C@H]2[C@@H]1[C@@H](C=C2CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
8002,158003,Acalyphin,CN1C(C(C(=CC1=O)OC)(C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
8003,158004,"Furandicarboxylic acid, dimethyl ester",COC(=O)C1=C(OC=C1)C(=O)OC,,,,,,
8004,158005,"3alpha,7beta-Dihydroxy-12-oxo-5beta-cholan-24-oic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
8005,158006,"Pyridine, 2-(4-methoxyphenyl)-4-(methylthio)-6-phenyl-",COC1=CC=C(C=C1)C2=CC(=CC(=N2)C3=CC=CC=C3)SC,,,,,,
8006,158007,"Acetic acid, ((dipropoxyphosphinothioyl)oxy)((dipropoxyphosphinyl)thio)-,ethyl ester",CCCOP(=O)(OCCC)SC(C(=O)OCC)OP(=S)(OCCC)OCCC,,,,,,
8007,158008,"Acetic acid, ((bis(2-methylpropoxy)phosphinothioyl)oxy)((bis(2-methylpropoxy)phosphinyl)thio)-, ethyl ester",CCOC(=O)C(OP(=S)(OCC(C)C)OCC(C)C)SP(=O)(OCC(C)C)OCC(C)C,,,,,,
8008,158009,"Glycine, L-gamma-glutamyl-S-(2-bromoethyl)-L-cysteinyl-",C(CC(=O)N(CC(=O)O)C(=O)[C@H](CSCCBr)N)[C@@H](C(=O)O)N,,,,,,
8009,158010,"Pregn-4-ene-3,11,20-trione, 17-hydroxy-21-((1-oxooctyl)oxy)-",CCCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
8010,158011,"Benzoic acid, 4-(2,2-dimethyl-1-oxopropoxy)-, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,3-phenylene ester",CC(C)(C)C(=O)OC1=CC=C(C=C1)C(=O)OC2=CC(=CC(=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)OC(=O)C(C)(C)C,,,,,,
8011,158012,"Acetic acid, ((bis(1-methylethoxy)phosphinothioyl)oxy)((bis(1-methylethoxy)phosphinyl)thio)-, ethyl ester",CCOC(=O)C(OP(=S)(OC(C)C)OC(C)C)SP(=O)(OC(C)C)OC(C)C,,,,,,
8012,158013,"Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, compd. with 2-methyl-2-propanamine (1:1)",CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.CC(C)(C)N,,,,,,
8013,158014,CID 158014,CCCC[SnH](CCCC)CCCC.C1=C(OC(=C1)[N+](=O)[O-])C(=O)O,,,,,,
8014,158015,"2(1H)-Quinolinone, 6-hydroxy-4-methoxy-1-methyl-",CN1C2=C(C=C(C=C2)O)C(=CC1=O)OC,,,,,,
8015,158016,"Pyrrolidine, 2-hexyl-5-nonyl-",CCCCCCCCCC1CCC(N1)CCCCCC,,,,,,
8016,158017,"2H-Pyrrole, 5-(5-hexenyl)-3,4-dihydro-2-(8-nonenyl)-",C=CCCCCCCCC1CCC(=N1)CCCCC=C,,,,,,
8017,158018,"1-Ethyl-1-methyl-1a,3a,6,7-tetrahydrocyclopropa[c][2]benzofuran-3-one",CCC1(C2C13CCC=CC3C(=O)O2)C,,,,,,
8018,158019,"9H-Xanthen-9-one, 7-hydroxy-2,3,4-trimethoxy-",COC1=C(C(=C2C(=C1)C(=O)C3=C(O2)C=CC(=C3)O)OC)OC,,,,,,
8019,158020,"Phenol, 3-((2-hydroxycyclohexyl)(methylamino)methyl)-, (1alpha(R*),2alpha)-",CN[C@@H]([C@@H]1CCCC[C@@H]1O)C2=CC(=CC=C2)O,,,,,,
8020,158021,CID 158021,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)OC3=C(OC4=CC(=CC(=O)C4=C3O)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O)C6=CC(=C(C=C6)O)O)O)O)O)O)O)O,,,,,,
8021,158022,"Naphtho(2,3-c)furan-1(3H)-one, 9-(1,3-benzodioxol-5-yl)-7,8-dihydroxy-4-methoxy-",COC1=C2COC(=O)C2=C(C3=C1C=CC(=C3O)O)C4=CC5=C(C=C4)OCO5,,,,,,
8022,158023,"Naphtho(1,8-bc)pyran-2(3H)-one, decahydro-9-hydroxy-6,9-dimethyl-3-methylene-, (3aR,6R,6aS,9R,9aR,9bS)-",C[C@@H]1CC[C@@H]2C3[C@H]1CC[C@@]([C@@H]3OC(=O)C2=C)(C)O,,,,,,
8023,158024,"Naphtho(2,3-c)furan-1(3H)-one, 9-(1,3-benzodioxol-5-yl)-7-hydroxy-4,8-dimethoxy-",COC1=C2COC(=O)C2=C(C3=C1C=CC(=C3OC)O)C4=CC5=C(C=C4)OCO5,,,,,,
8024,158025,"[4-Acetyloxy-5-hydroxy-2-[[2-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl]oxy]-6-methyloxan-3-yl] 3-(4-methoxyphenyl)prop-2-enoate",CC1C(C(C(C(O1)OC2C3C=COC(C3C4(C2O4)CO)OC5C(C(C(C(O5)CO)O)O)O)OC(=O)C=CC6=CC=C(C=C6)OC)OC(=O)C)O,,,,,,
8025,158026,"1-[1-Oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2-piperidinone",COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCCCC2=O,,,,,,
8026,158027,"Naphtho(1,2-b)furan-2,8(4H,9H)-dione, 5,5a,6,7,9a,9b-hexahydro-3-hydroxy-5a,9-dimethyl-, (5aS-(5aalpha,9beta,9abeta,9balpha))-",C[C@H]1[C@@H]2[C@@H]3C(=C(C(=O)O3)O)CC[C@]2(CCC1=O)C,,,,,,
8027,158028,CID 158028,C1=CC2=C3C(=CC=C4C3=C1C=CC4=O)C(=C5C2=CC(=O)C=C5)N(O)O,,,,,,
8028,158029,"3-Furanmethanol, tetrahydro-5-hydroxy-alpha-(4-hydroxy-3-methoxyphenyl)-4-((4-hydroxy-3-methoxyphenyl)methyl)-",COC1=C(C=CC(=C1)CC2C(COC2O)C(C3=CC(=C(C=C3)O)OC)O)O,,,,,,
8029,158030,CID 158030,CCC1=C2C=C3C(=C4C(=O)CC(=C5[C@H]([C@@H](C(=CC6=NC(=CC(=N2)C1=CO)C(=C6C)C=C)N5)C)CCC(=O)O)C4=N3)C,,,,,,
8030,158031,"4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-, (S)-",CC1=C(C(=C2C(=C1O)C(=O)C[C@H](O2)C3=C(C=CC(=C3)OC)O)C)O,,,,,,
8031,158032,4-Nitrophenanthrene,C1=CC=C2C(=C1)C=CC3=C2C(=CC=C3)[N+](=O)[O-],,,,,,
8032,158033,"3-Chlorolactic acid, (S)-",C([C@H](C(=O)O)O)Cl,,,,,,
8033,158034,"Benzeneacetonitrile, 3-hydroxy-alpha-((6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy)-, (alphaS)-",C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC(C#N)C3=CC(=CC=C3)O)O)O)O)O)O)O,,,,,,
8034,158035,N-[Amino-[(3E)-3-methoxyiminopropoxy]phosphoryl]-2-chloro-N-(2-chloroethyl)ethanamine,CON=CCCOP(=O)(N)N(CCCl)CCCl,,,,,,
8035,158036,"3-Cyclohexene-1-carboxaldehyde, 4-methyl-1-(1-methyl-2-methylenecyclopentyl)-, (R*,S*)-",CC1=CC[C@@](CC1)(C=O)[C@]2(CCCC2=C)C,,,,,,
8036,158037,methyl N-[6-(2-methylpropylsulfinyl)-1H-benzimidazol-2-yl]carbamate;hydrochloride,CC(C)CS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC.Cl,,,,,,
8037,158038,"Quinoline, 8-((2-nitrophenyl)methoxy)-",C1=CC=C(C(=C1)COC2=CC=CC3=C2N=CC=C3)[N+](=O)[O-],,,,,,
8038,158039,"Benzoic acid, 5-hydroxy-2-((3-(trifluoromethyl)phenyl)amino)-,2-hydroxyethyl ester",C1=CC(=CC(=C1)NC2=C(C=C(C=C2)O)C(=O)OCCO)C(F)(F)F,,,,,,
8039,158040,"Zinc, bis(D-gluconato-kappaO1,kappaO2)-, (T-4)-",C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Zn+2],,,,,,
8040,158041,Tanghinoside,CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C46C(O6)CC3C2)O)C7=CC(=O)OC7)C)C)OC(=O)C)OC)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O,,,,,,
8041,158042,Acetylthevetin B,CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC(=O)C)OC)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O,,,,,,
8042,158043,Deacetyltanghinoside,CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C46C(O6)CC3C2)O)C7=CC(=O)OC7)C)C)O)OC)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O,,,,,,
8043,158044,Corynetoxin HI7a,CCC(C)CCCCCCCCCCC(CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O)O,,,,,,
8044,158045,CID 158045,CCC(C)CCCCCCCCCCC=CC(=O)NC1C(C(C(OC1OC2C(C(C(C(O2)CO)O)O)NC(=O)C)CC(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O)O,,,,,,
8045,158046,"17-(4-ethyl-6-methyl-5-methylideneheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",CCC(CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(=C)C(C)C,,,,,,
8046,158047,"2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy-, compd. with 2-chloro-alpha-(((1-methylethyl)amino)methyl)benzenemethanol",CC(C)NCC(C1=CC=CC=C1Cl)O.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,,,,,,
8047,158048,Senbusine A,CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6O)OC)O)O)O)COC,,,,,,
8048,158049,"Aconitane-1,8,14,15-tetrol, 20-ethyl-16-methoxy-4-(methoxymethyl)-,(1alpha,14alpha,15alpha,16beta)-",CCN1CC2(CCC(C34C2CC(C31)C5(C6C4CC(C6O)C(C5O)OC)O)O)COC,,,,,,
8049,158050,Apron-captan mixt.,CC1=C(C(=CC=C1)C)N([C@@H](C)C(=O)OC)C(=O)COC.C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,,,,,,
8050,158051,"Alanine, N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-, methyl ester, mixt. with 2-((trichloromethyl)thio)-1H-isoindole-1,3(2H)-dione",CC1=C(C(=CC=C1)C)N([C@@H](C)C(=O)OC)C(=O)COC.C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,,,,,,
8051,158052,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-bis(trifluoromethyl)-, cyano(3-phenoxyphenyl)methyl ester",C1=CC=C(C=C1)OC2=CC=CC(=C2)C(C#N)OC(=O)C3C(C3(C(F)(F)F)C(F)(F)F)C=C(Cl)Cl,,,,,,
8052,158053,"Benzeneacetic acid, 4-chloro-alpha-(2,2,2-trifluoro-1-(trifluoromethyl)ethyl)-, cyano(3-phenoxyphenyl)methyl ester",C1=CC=C(C=C1)OC2=CC=CC(=C2)C(C#N)OC(=O)C(C3=CC=C(C=C3)Cl)C(C(F)(F)F)C(F)(F)F,,,,,,
8053,158054,Tafricanin B,C[C@@H]1C[C@@H]([C@@]2([C@@H]([C@@]13CC(OC3=O)C4=COC=C4)CCC(=O)[C@@]2(CCl)O)COC(=O)C)OC(=O)C,,,,,,
8054,158055,Tafricanin A,C[C@@H]1CC(=O)[C@@]2([C@@H]([C@@]13CC(OC3=O)C4=COC=C4)CCC(=O)[C@@]2(CCl)O)COC(=O)C,,,,,,
8055,158056,"6-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3-(hydroxymethyl)-5,7,9,11,13-pentamethyl-oxacyclotetradecane-2,10-dione",CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)CO)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,,,,,,
8056,158057,"Hydroxylamine, O-(3-chloro-2-propenyl)-, hydrochloride",C(C=CCl)ON.Cl,,,,,,
8057,158058,O-(3-Chloroallyl)hydroxylamine,C(/C=C/Cl)ON,,,,,,
8058,158059,"3-Oxazolidinyloxy, 2-(5-((9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl)oxy)-5-oxopentyl)-4,4-dimethyl-2-propyl-",CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)OC(=O)C)OC(=O)C(C)(C)CCCC(C)(C)C5N(CCO5)[O],,,,,,
8059,158060,"1,4-Oxathiin-3-carboxamide, 5,6-dihydro-2-methyl-N-phenyl-, mixt. with 1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)-1H-imidazole and2-(4-thiazolyl)-1H-benzimidazole",CC1=C(SCCO1)C(=O)NC2=CC=CC=C2.C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl.C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,,,,,,
8060,158061,"Benzo(b)phenanthro(3,4-d)thiophene",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C5=CC=CC=C5S4,,,,,,
8061,158062,"1H-Indene-1,3(2H)-dione, 2-(diphenylacetyl)-, sodium salt",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)C3C(=O)C4=CC=CC=C4C3=O.[Na+],,,,,,
8062,158063,"L-Cysteine, N-acetyl-S-((2-chlorophenyl)methyl)-, methyl ester",CC(=O)N[C@@H](CSCC1=CC=CC=C1Cl)C(=O)OC,,,,,,
8063,158064,"1,7-Dichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(O2)C=C(C=C3)Cl,,,,,,
8064,158065,"1,8-Dichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(O2)C=CC(=C3)Cl,,,,,,
8065,158066,"1,2,7-Trichlorodibenzo-p-dioxin",C1=CC2=C(C=C1Cl)OC3=C(O2)C(=C(C=C3)Cl)Cl,,,,,,
8066,158067,"1,2,8-Trichlorodibenzo-p-dioxin",C1=CC2=C(C=C1Cl)OC3=C(O2)C=CC(=C3Cl)Cl,,,,,,
8067,158068,"1,2,9-Trichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(O2)C=CC(=C3Cl)Cl,,,,,,
8068,158069,"2H-Benzimidazol-2-one, 5-chloro-1-(1-(3-(2,3-dihydro-5-hydroxy-2-oxo-1H-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-",C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=C(C=C(C=C5)O)NC4=O,,,,,['3-[3-[4-(5-Chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propyl]-6-hydroxy-1H-benzimidazol-2-one is a known human metabolite of domperidone.'],
8069,158070,"(1,3)Benzodioxolo(5,6-c)phenanthridine-13-methanol, 12,13-dihydro-1-hydroxy-2-methoxy-12-methyl-",CN1C(C2=C(C=CC(=C2O)OC)C3=C1C4=CC5=C(C=C4C=C3)OCO5)CO,,,,,,
8070,158071,"Benzenemethanol, 2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-5-methoxy-",CC(C)(C)NCC(C1=C(C(=CC(=C1)OC)O)Cl)O,,,,,,
8071,158072,"4-[2-(12-Fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethoxy]-4-oxobutanoic acid",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@H]4[C@]2(OC(O4)(C)C)C(=O)COC(=O)CCC(=O)O)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,,,,,,
8072,158073,"D-Gluconic acid, compd. with 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
8073,158074,"1,4,6-Trichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(C=CC(=C3O2)Cl)Cl,,,,,,
8074,158075,"1,4,7-Trichlorodibenzo-p-dioxin",C1=CC2=C(C=C1Cl)OC3=C(C=CC(=C3O2)Cl)Cl,,,,,,
8075,158076,"(2R,3R)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pentan-3-ol",CC(C)(C)[C@H]([C@@H](CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,,,,,,
8076,158077,"1(2H)-Anthracenone, 3,4-dihydro-2,3,8,9-tetrahydroxy-6-methoxy-3,7-dimethyl-",CC1=C(C2=C(C3=C(CC(C(C3=O)O)(C)O)C=C2C=C1OC)O)O,,,,,,
8077,158078,"Card-20(22)-enolide, 12,14-dihydroxy-11-oxo-2,3-(((2S,3S,4R,6R)-tetrahydro-3-hydroxy-4-methoxy-6-methyl-2H-pyran-3,2-diyl)bis(oxy))-, (2alpha,3beta,5beta,12alpha)-",C[C@@H]1C[C@H]([C@]2([C@@H](O1)O[C@H]3C[C@]4([C@H](CC[C@@H]5[C@@H]4C(=O)[C@@H]([C@]6(C5(CC[C@@H]6C7=CC(=O)OC7)O)C)O)C[C@@H]3O2)C)O)OC,,,,,,
8078,158079,"3,9,23-trihydroxy-22-methoxy-1,5,20-trimethyl-6-(5-oxo-2H-furan-3-yl)-11,17,19,24-tetraoxaheptacyclo[12.12.0.02,10.05,9.010,12.016,25.018,23]hexacos-14-en-4-one",CC1CC(C2(C(O1)OC3C=C4CC5C6(O5)C(C4(CC3O2)C)C(C(=O)C7(C6(CCC7C8=CC(=O)OC8)O)C)O)O)OC,,,,,,
8079,158080,Heliocoromandaline,C[C@H]([C@](C(C)C)(C(=O)OC[C@H]1CCN2[C@H]1CCC2)O)O,,,,,,
8080,158081,Heliocurassavicine,C[C@@H]([C@](C(C)C)(C(=O)OC[C@H]1CCN2[C@H]1CCC2)O)O,,,,,,
8081,158082,"Benzamide, 2,6-dichloro-N-[5-(4-fluorophenyl)-3-isoxazolyl]-",C1=CC(=C(C(=C1)Cl)C(=O)NC2=NOC(=C2)C3=CC=C(C=C3)F)Cl,,,,,,
8082,158083,CID 158083,C1=CC=C(C=C1)NC(=NC(=O)C2=CC=C(O2)[N+](=O)[O-])S,,,,,,
8083,158084,"(1S,2S,4S,5'S,7S,8R,9S,12S,13S,14R,16R,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-14,16-diol",C[C@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5([C@@H](C[C@@H](C6)O)O)C)C)C)OC1,,,,,,
8084,158085,Heliocurassavinine,C[C@@H]([C@](C(C)C)(C(=O)OC[C@H]1CCN2[C@@H]1CCC2)O)O,,,,,,
8085,158086,"Phenol, 4-(1-ethyl-2-(4-hydroxyphenyl)butyl)-2-methoxy-, (R*,S*)-",CC[C@H](C1=CC=C(C=C1)O)[C@@H](CC)C2=CC(=C(C=C2)O)OC,,,,,,
8086,158087,"Propanedioic acid, 1,3-dithiol-2-ylidene-, bis(1-methylpropyl) ester",CCC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)CC,,,,,,
8087,158088,"5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-ol, 6,7,7a,8-tetrahydro-9,10-dimethoxy-7-methyl-, (7aS,8R)-",CN1CCC2=CC3=C(C4=C2[C@H]1[C@@H](C5=C4C=CC(=C5OC)OC)O)OCO3,,,,,,
8088,158089,"5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-ol, 6,7,7a,8-tetrahydro-9-methoxy-7-methyl-, (7aS,8R)-",CN1CCC2=CC3=C(C4=C2[C@H]1[C@@H](C5=C4C=CC=C5OC)O)OCO3,,,,,,
8089,158090,CID 158090,COC(=O)C(=NNC1=CC=CC=C1Cl)Cl,,,,,,
8090,158091,Methyl 2-chloro-2-[(4-methylphenyl)hydrazinylidene]acetate,CC1=CC=C(C=C1)NN=C(C(=O)OC)Cl,,,,,,
8091,158092,CID 158092,CC1=CC[C@@H]2[C@H]1[C@@H]3[C@@H]([C@@H](CC2=C)OC(=O)C(=CCO)CO)C(=C)C(=O)O3,,,,,,
8092,158093,"Decanoic acid, 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-6-yl ester, (1aR-(1aalpha,2beta,5beta,5abeta,6beta,8aalpha,9alpha,10aalpha))-",CCCCCCCCCC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C,,,,,,
8093,158094,"3,4-Dihydroaucubin",C1COC(C2C1C(C=C2CO)O)OC3C(C(C(C(O3)CO)O)O)O,,,,,,
8094,158095,"4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)-",CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C=C(C=C4)OC)OC)OC,,,,,,
8095,158096,"9(10H)-Anthracenone, 10-beta-D-glucopyranosyl-1,2,8-trihydroxy-6-(hydroxymethyl)-, (10R)-",C1=CC(=C(C2=C1[C@H](C3=C(C2=O)C(=CC(=C3)CO)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
8096,158097,Phellinine,CO[C@H]1[C@@H](C[C@]23C4=CC5=C(C=C4CCCN2CC[C@@]36[C@@H]1O6)OCO5)O,,,,,,
8097,158098,"3-(But-3-en-1-yl)decahydro-6H-1,5-methanopyrido[1,2-a][1,5]diazocin-6-one",C=CCCN1CC2CC(C1)C(=O)N3C2CCCC3,,,,,,
8098,158099,3-(beta-Hydroxyethyl)coronaridine,CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2CCO)CCC4=C3NC5=CC=CC=C45)C(=O)OC,,,,,,
8099,158100,"3-Oxotirucalla-7,24-dien-21-oic acid",CC(=CCC[C@@H]([C@@H]1CC[C@]2([C@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)C)C)C(=O)O)C,,,,,,
8100,158101,7beta-Hydroxy-8-epiiridodial glucoside,C[C@H]1CC[C@@H]2[C@H]1C(OC=C2)O[C@@H]3[C@@H]([C@H]([C@]([C@H](O3)C(O)O)(C)O)O)O,,,,,,
8101,158102,Polytryn,CCCSP(=O)(OCC)OC1=C(C=C(C=C1)Br)Cl.CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
8102,158103,gomisin N,C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4C[C@H]1C)OC)OC)OC)OC)OCO3,,,"['Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
8103,158104,CID 158104,COC(=O)C1=CO[C@H]([C@@H]([C@@H]1C(=CCC2[C@H]([C@@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C=C)C=O)C=C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
8104,158105,6'-(m-Hydroxybenzoyl)loganin,C[C@@H]1[C@@H](C[C@@H]2[C@H]1[C@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COC(=O)C4=CC(=CC=C4)O)O)O)O)O,,,,,,
8105,158106,CID 158106,C1=CC(=C(C(=C1)O)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)O,,,,,,
8106,158107,O-Methylphellinine,CO[C@@H]1C[C@]23C4=CC5=C(C=C4CCCN2CC[C@@]36[C@@H]([C@H]1OC)O6)OCO5,,,,,,
8107,158108,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-fluorophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2F)C,,,,,,
8108,158109,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-bromophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2Br)C,,,,,,
8109,158110,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-iodophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2I)C,,,,,,
8110,158111,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-ethylphenyl)methyl ester, (1R-trans)-",CCC1=CC=CC=C1COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8111,158112,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-ethoxyphenyl)methyl ester, (1R-trans)-",CCOC1=CC=CC=C1COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8112,158113,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-(1-methylethoxy)phenyl)methyl ester, (1R-trans)-",CC(C)OC1=CC=CC=C1COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8113,158114,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-nitrophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2[N+](=O)[O-])C,,,,,,
8114,158115,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-cyanophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2C#N)C,,,,,,
8115,158116,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-(methylsulfonyl)phenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2S(=O)(=O)C)C,,,,,,
8116,158117,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-fluorophenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)F)C,,,,,,
8117,158118,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-bromophenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)Br)C,,,,,,
8118,158119,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-iodophenyl)methyl ester, trans-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)I)C,,,,,,
8119,158120,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-ethylphenyl)methyl ester, (1R,3R)-",CCC1=CC(=CC=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8120,158121,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-(1-methylethyl)phenyl)methyl ester, (1R,3R)-",CC(C)C1=CC=CC(=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8121,158122,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-methoxyphenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)OC)C,,,,,,
8122,158123,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-ethoxyphenyl)methyl ester, (1R,3R)-",CCOC1=CC=CC(=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8123,158124,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-(1-methylethoxy)phenyl)methyl ester, (1R,3R)-",CC(C)OC1=CC=CC(=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8124,158125,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-benzoylphenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)C(=O)C3=CC=CC=C3)C,,,,,,
8125,158126,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-nitrophenyl)methyl ester, trans-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)[N+](=O)[O-])C,,,,,,
8126,158127,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-cyanophenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)C#N)C,,,,,,
8127,158128,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-(methylsulfonyl)phenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)S(=O)(=O)C)C,,,,,,
8128,158129,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-bromophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)Br)C,,,,,,
8129,158130,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-iodophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)I)C,,,,,,
8130,158131,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-ethylphenyl)methyl ester, (1R-trans)-",CCC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8131,158132,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-propylphenyl)methyl ester, (1R-trans)-",CCCC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8132,158133,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-(1-methylethyl)phenyl)methyl ester, (1R-trans)-",CC(C)C1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8133,158134,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-(1,1-dimethylethyl)phenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)C(C)(C)C)C,,,,,,
8134,158135,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-ethoxyphenyl)methyl ester, (1R-trans)-",CCOC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8135,158136,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-(1-methylethoxy)phenyl)methyl ester, (1R-trans)-",CC(C)OC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8136,158137,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-(methylsulfonyl)phenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)S(=O)(=O)C)C,,,,,,
8137,158138,"Pyrimido(1,2-a)benzimidazole, 4-methyl-2-(trifluoromethyl)-",CC1=CC(=NC2=NC3=CC=CC=C3N12)C(F)(F)F,,,,,,
8138,158139,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-butylphenyl)methyl ester, (1R-trans)-",CCCCC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8139,158140,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-(cyanomethyl)phenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)CC#N)C,,,,,,
8140,158141,"5H-Pyrano(3,2-c)quinolin-5-one, 2,6-dihydro-2,2,6-trimethyl-7-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=CC=CC2=C1N(C(=O)C3=C2OC(C=C3)(C)C)C)C,,,,,,
8141,158142,"5H-Pyrano(3,2-c)quinolin-5-one, 2,6-dihydro-8-methoxy-2,2,6-trimethyl-7-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=C(C=CC2=C1N(C(=O)C3=C2OC(C=C3)(C)C)C)OC)C,,,,,,
8142,158143,"Lanosta-7,24-dien-21-oic acid, 3-hydroxy-, (3alpha,13alpha,14beta,17alpha,20S)-",CC(=CCC[C@@H]([C@@H]1CC[C@]2([C@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@H](C4(C)C)O)C)C)C)C(=O)O)C,,,,,,
8143,158144,8-Epiloganic acid,C[C@@H]1[C@H](C[C@H]2[C@@H]1[C@@H](OC=C2C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
8144,158145,"[(1R,3S,4R,5R,7S,8R,9R,12S,13S,14S)-4,13-diacetyloxy-8-hydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.01,12.05,7]hexadec-10-en-9-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1[C@@H]([C@H]2[C@H](C2(C)C)[C@H]([C@@H](C(=O)[C@@]34C[C@@H]([C@@H]([C@@]3(O4)C=C1C)OC(=O)C)C)C)OC(=O)C)O,,,,,,
8145,158146,"2-Propenoic acid, 2-methyl-, 5-(acetyloxy)-2,3,3a,4,5,6,7,10,11,11a-decahydro-6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca(b)furan-4-yl ester, (3aS-(3aR*,4R*,5S*,6S*,10S*,11aS*))-",C[C@@H]1C[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(C(=O)C=C1O3)C)OC(=O)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
8146,158147,"Dibenzo(b,e)(1,4)dioxin-1-ol, 2,3,7,8-tetrachloro-",C1=C2C(=CC(=C1Cl)Cl)OC3=C(C(=C(C=C3O2)Cl)Cl)O,,,,,,
8147,158148,Kopsoffine,CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(C2)C6=CC7=C(C=C6)NC89C71CCN2C1C(CCC2)(CC8)CC9C(=O)OC,,,,,,
8148,158149,2-[(4-Ethoxyphenyl)methylideneamino]guanidine,CCOC1=CC=C(C=C1)C=NN=C(N)N,,,,,,
8149,158150,alpha-Arteether,CCO[C@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,,,,,,
8150,158151,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-chlorophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2Cl)C,,,,,,
8151,158152,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-methoxyphenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2OC)C,,,,,,
8152,158153,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-phenoxyphenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2OC3=CC=CC=C3)C,,,,,,
8153,158154,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-chlorophenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)Cl)C,,,,,,
8154,158155,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-methylphenyl)methyl ester, (1R,3R)-",CC1=CC(=CC=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8155,158156,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3-(phenylmethyl)phenyl)methyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC(=C2)CC3=CC=CC=C3)C,,,,,,
8156,158157,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-fluorophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)F)C,,,,,,
8157,158158,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-chlorophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)Cl)C,,,,,,
8158,158159,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-methylphenyl)methyl ester, (1R-trans)-",CC1=CC=C(C=C1)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8159,158160,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-methoxyphenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)OC)C,,,,,,
8160,158161,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-nitrophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C,,,,,,
8161,158162,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (2-methylphenyl)methyl ester, (1R-trans)-",CC1=CC=CC=C1COC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C,,,,,,
8162,158163,"[(7R,8R)-7-(2-methylbut-2-enoyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoate",CC=C(C)C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@@H](C)O)(C(C)C)O,,,,,,
8163,158164,"Pyridinium, 1-methyl-3-phenyl-",C[N+]1=CC=CC(=C1)C2=CC=CC=C2,,,,,,
8164,158165,"Aluminum, (L-histidinato-kappaN,kappaO)dihydroxy-, (T-4)-, mixt. with magnesium hydroxide (Mg(OH)2)",C1=C(NN=C1)CC(C(=O)[O-])N.[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3],,,,,,
8165,158166,2-amino-3-(1H-pyrazol-5-yl)propanoic acid,C1=C(NN=C1)CC(C(=O)O)N,,,,,,
8166,158167,"Benzamide, N-(3-(1,1-dimethylbutyl)-5-isoxazolyl)-2,6-dimethoxy-",CCCC(C)(C)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
8167,158168,"Benzamide, N-(3-(1-ethylcycloheptyl)-5-isoxazolyl)-2,6-dimethoxy-",CCC1(CCCCCC1)C2=NOC(=C2)NC(=O)C3=C(C=CC=C3OC)OC,,,,,,
8168,158169,"Benzamide, N-(6-(1-ethyl-1-methylpropyl)-3-pyridazinyl)-2,6-dimethoxy-",CCC(C)(CC)C1=NN=C(C=C1)NC(=O)C2=C(C=CC=C2OC)OC,,,,,,
8169,158170,"Ethanol, 2-(dimethylarsinyl)-",C[As](=O)(C)CCO,,,,,,
8170,158171,CID 158171,C[C@H]1[C@H](C[C@]2([C@@H]1C(OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)OC(=O)C=CC4=CC=C(C=C4)O,,,,,,
8171,158172,7-O-(p-Hydroxy)benzoyltecomoside,C[C@H]1[C@H](C[C@]2([C@@H]1C(OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)OC(=O)C4=CC=C(C=C4)O,,,,,,
8172,158173,CID 158173,CC(=C(CO)CO)CCC=C(C)C(=O)O[C@]1([C@H]([C@@H]([C@H]([C@H](O1)OC2[C@H]3C=CC[C@H]3C=CO2)O)O)O)CO,,,,,,
8173,158174,Ergobutine,CC[C@@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(CC)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
8174,158175,Ergobutyrine,CC[C@@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
8175,158176,"Iron(2+), bis(ethyl L-phenylalaninate-N,O')-, sulfate (1:1)",CCOC(=O)C(CC1=CC=CC=C1)N.CCOC(=O)C(CC1=CC=CC=C1)N.[O-]S(=O)(=O)[O-].[Fe+2],,,,,,
8176,158177,"Iron(2+), bis(ethyl leucinate-N,O')-, sulfate (1:1)",CCOC(=O)C(CC(C)C)N.CCOC(=O)C(CC(C)C)N.[O-]S(=O)(=O)[O-].[Fe+2],,,,,,
8177,158178,Ethyl 2-amino-4-methylpentanoate,CCOC(=O)C(CC(C)C)N,,,,,,
8178,158179,"Emetan-6',10-diol, 7',11-dimethoxy-",CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@@H]4C5=CC(=C(C=C5CCN4)O)OC)OC)O,,,,,,
8179,158180,"beta-D-Glucopyranuronic acid, 1-(1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetate)",COC1=CC2=C(C=C1)N(C=C2CC(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C(=O)C4=CC=C(C=C4)Cl,,,,,,
8180,158181,CID 158181,C[C@@H]1[C@@H](C[C@@]2([C@H]1[C@@H](OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)OC(=O)C=CC4=CC=CC=C4,,,,,,
8181,158182,"Ergoline, 8,9-didehydro-6,8-dimethyl-, (10beta)-",CC1=C[C@@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
8182,158183,"3-benzyl-6-(1H-indol-3-ylmethyl)piperazine-2,5-dione",C1=CC=C(C=C1)CC2C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43,,,,,,
8183,158184,"1H-Isoindolo(2,1-c)(2,3)benzodiazepine",C1C=CC=C2C1CC3C4C=CC=CC4CN3NC2,,,,,,
8184,158185,"5-Pyrimidinemethanol, alpha-(2-chlorophenyl)-alpha-(4-fluorophenyl)-,mixt. with 1-(2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl)-1H-imidazole",C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl.C1=CC=C(C(=C1)C(C2=CC=C(C=C2)F)(C3=CN=CN=C3)O)Cl,,,,,,
8185,158186,"5-[(1R,7S,8R,9R)-7-hydroxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid",CC(=CC=C[C@@]1([C@@H]2CC[C@@]3([C@@]2(CCC(=CC3)C(=O)OC)O)C(=O)O1)C)C(=O)O,,,,,,
8186,158187,"Azuleno(6,5-b)furan-2,5-dione, 3,3a,4,4a,7a,8,9,9a-octahydro-7a-hydroxy-8-methyl-3-methylene-, (3aR,4aR,7aS,8R,9aR)-",C[C@@H]1C[C@@H]2[C@H](C[C@@H]3[C@]1(C=CC3=O)O)C(=C)C(=O)O2,,,,,,
8187,158188,"Benzenemethanamine, N-(5-(4-methylphenyl)-3H-1,2,4-dithiazol-3-ylidene)-",CC1=CC=C(C=C1)C2=NC(=NCC3=CC=CC=C3)SS2,,,,,,
8188,158189,"Pyridine, 2-(2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl)-,dihydrochloride, hydrate (2:3)",C1CN=C(N1)CC(C2=CC=CC=C2)C3=CC=CC=N3.C1CN=C(N1)CC(C2=CC=CC=C2)C3=CC=CC=N3.O.O.O.Cl.Cl.Cl.Cl,,,,,,
8189,158190,"2-Methyl-4,5-trimethylene-4-isothiazolin-3-one",CN1C(=O)C2=C(S1)CCC2,,,,,,
8190,158191,Gyne-Sulf,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N.C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N.C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,,,,,,
8191,158192,Senecicannabine,C[C@H]1C2(O1)C[C@]3(CO3)[C@@](C(=O)OCC4=CCN5[C@H]4[C@@H](CC5)OC2=O)(C)O,,,,,,
8192,158193,"beta-D-Glucopyranose, cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate) cyclic 2-9:4-1-(3,4,4a,9b-tetrahydro-4,4,4a,6,7-pentahydroxy-3-oxo-1,9-dibenzofurandicarboxylate) 1-(3,4,5-trihydroxybenzoate), stereoisomer",C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7C(=CC(=O)C(C7(O6)O)(O)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O,,,,,,
8193,158194,"17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-palmitate",CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
8194,158195,"Benzoic acid, 3,3'-methylenebis(6-amino-, dipentyl ester",CCCCCOC(=O)C1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C(=O)OCCCCC)N,,,,,,
8195,158196,CID 158196,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)[O-].CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)C(=O)NC4=C[N+](=CC=C4)C,,,,,,
8196,158197,CID 158197,CC1C(C(C(C(O1)OC2C(C(OC(C2O)OC3=CC(=O)C4=C(C(=C(OC4=C3)C5=CC=C(C=C5)O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)C)O)O)O)O,,,,,,
8197,158198,Nupharin A,C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O3)O)O)O)O)O)O,,,,,,
8198,158199,"Oxireno(5,6)benz(1,2-a)acridine-2,3-diol, 1a,2,3,11c-tetrahydro-, (1aalpha,2beta,3alpha,11calpha)-",C1=CC=C2C(=C1)C=C3C(=N2)C=CC4=C3C5C(O5)C(C4O)O,,,,,,
8199,158200,"1,2-Epoxy-3,6-anhydrodulcitol",C1[C@@H]([C@H]([C@@H](O1)[C@H]2CO2)O)O,,,,,,
8200,158201,"1,4-Anhydro-6-bromo-6-deoxygalactitol",C1[C@H]([C@@H]([C@H](O1)[C@H](CBr)O)O)O,,,,,,
8201,158202,2'-Guanidyl-2'-deaminogentamicin C1,CC([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)OC3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N=C(N)N)NC,,,,,,
8202,158203,Ancistrocline,CC1CC2=C(C(=CC(=C2C(N1C)C)OC)O)C3=C4C=CC=C(C4=C(C=C3C)OC)OC,,,,,,
8203,158204,"10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,9,10,12-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-12-imino-1-methoxy-5(8H)-naphthacenone",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=N)C(=CC=C5)OC)O)(C(C)O)O)N)O,,,,,,
8204,158205,"5(8H)-Naphthacenone, 8-acetyl-7,9,10,12-tetrahydro-6,8,11-trihydroxy-12-imino-1-methoxy-10-((2,3,6-trideoxy-3-(bis(phenylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=N)C(=CC=C5)OC)O)(C(=O)C)O)N(CC6=CC=CC=C6)CC7=CC=CC=C7)O,,,,,,
8205,158206,"5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-7-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride, (7R-trans)-",CC[C@]1(CCC2=C([C@H]1O[C@H]3C[C@@H]([C@@H]([C@@H](O3)C)O)N)C(=C4C(=C2O)C(=O)C5=C(C4=O)C=CC=C5O)O)O.Cl,,,,,,
8206,158207,"(7R)-8-Ethyl-7,8,9,10-tetrahydro-1,6,8alpha,11-tetrahydroxy-7beta-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5,12-naphthacenedione",CC[C@]1(CCC2=C([C@H]1O[C@H]3C[C@@H]([C@@H]([C@@H](O3)C)O)N)C(=C4C(=C2O)C(=O)C5=C(C4=O)C=CC=C5O)O)O,,,,,,
8207,158208,"Glycine, N-(S-(7-(acetylamino)-9H-fluoren-2-yl)-N-L-gamma-glutamyl-L-cysteinyl)-",CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
8208,158209,N-(S-(2-(Acetylamino)-9H-fluoren-1-yl)-N-L-gamma-glutamyl-L-cysteinyl)glycine,CC(=O)NC1=C(C2=C(C=C1)C3=CC=CC=C3C2)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
8209,158210,"Glycine, N-(S-(2-(acetylamino)-9H-fluoren-3-yl)-N-L-gamma-glutamyl-L-cysteinyl)-",CC(=O)NC1=C(C=C2C(=C1)CC3=CC=CC=C32)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
8210,158211,"Glycine, N-(S-(2-(acetylamino)-9H-fluoren-4-yl)-N-L-gamma-glutamyl-L-cysteinyl)-",CC(=O)NC1=CC2=C(C3=CC=CC=C3C2)C(=C1)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
8211,158212,Humantenmine,CCC1=N[C@H]2C[C@@]3([C@H]4CC1[C@@H]2CO4)C5=CC=CC=C5N(C3=O)OC,,,,,,
8212,158213,Rabdosin C,CC(=O)OCC12C(CCC(C1CO)(C)C)OC(=O)C34C2C(CC(C3)C(=C)C4=O)O,,,,,,
8213,158214,"Desoxy-14,15-epoxyprieurianin",CCC(C)C(C(=O)OC1C(C(C(=C)C23C1(C(CC2O3)C4=COC=C4)C)C5(C(CC(=O)OC(C5CC(=O)OC)(C)COC(=O)C)OC(=O)C)C)OC=O)O,,,,,,
8214,158215,"Carbamic acid, (5-amino-3-(((4-chlorophenyl)methylamino)methyl)-1,2-dihydropyrido(3,4-b)pyrazn-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)CN(C)C3=CC=C(C=C3)Cl)N,,,,,,
8215,158216,CID 158216,CCCOP(=S)(NNC(=C(C)N=O)C)OCCC,,,,,,
8216,158217,"Zinc(2+), tris(1,10-phenanthroline-N1,N10)-, (OC-6-11-delta)-",C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.[Zn+2],,,,,,
8217,158218,"3-Nitrobenzothiazolo(3,2-a)quinolinium perchlorate",C1=CC=C2C(=C1)[N+]3=C(S2)C=CC4=C3C=CC(=C4)[N+](=O)[O-].[O-]Cl(=O)(=O)=O,,,,,,
8218,158219,Benzocantharidin,C[C@@]12[C@H]3C4=CC=CC=C4[C@@H]([C@@]1(C(=O)OC2=O)C)O3,,,,,,
8219,158220,"2-amino-4,6-dimethyl-7-(oxiran-2-ylmethoxy)-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=C(C4=C3N=C5C(=C(C(=O)C(=C5O4)C)N)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C)OCC8CO8,,,,,,
8220,158221,Dolaconine,CCN1CC2CCC(C34C2CC(C31)C5(CC(C6CC4C5C6OC(=O)C)OC)O)OC,,,,,,
8221,158222,"5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC,,,,,,
8222,158223,"4H-Dibenzo(de,g)quinolin-3-ol, 5,6,6a,7-tetrahydro-1,2-dimethoxy-, (R)-",COC1=C2C3=CC=CC=C3C[C@@H]4C2=C(CCN4)C(=C1OC)O,,,,,,
8223,158224,"1-Heptanone, 1-(6,7-dimethoxy-5-propyl-1,3-benzodioxol-4-yl)-",CCCCCCC(=O)C1=C(C(=C(C2=C1OCO2)OC)OC)CCC,,,,,,
8224,158225,"1-Nonanone, 1-(6,7-dimethoxy-5-propyl-1,3-benzodioxol-4-yl)-",CCCCCCCCC(=O)C1=C(C(=C(C2=C1OCO2)OC)OC)CCC,,,,,,
8225,158226,"beta-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-4-oxo-4H-1-benzopyran-7-yl, methyl ester",COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC(=C(C=C3)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)OC)O)O)O,,,,,,
8226,158227,"beta-D-Glucopyranosiduronic acid, 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-4-oxo-4H-1-benzopyran-7-yl",COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC(=C(C=C3)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
8227,158228,"2-[6-[6-[4,5-Dihydroxy-6-(hydroxymethyl)-2-(8-hydroxy-5',7,10,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-6-methyloxane-3,4,5-triol",CC1CCC2(C(C3(C(O2)CC4C3C(CC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)C)OC9C(C(C(C(O9)C)OC2C(C(C(C(O2)C)O)O)O)O)O)O)O)C)C)O)C)OC1,,,,,,
8228,158229,CID 158229,CC1=CCCC(C12CC3=C4C2=C(C=C(C4=C(C5=C3C(C6C(C(=O)C(=C(N)O)C(=O)C6(C5=O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC)(C)C,,,,,,
8229,158230,CID 158230,CC1(C=CC2=CC3=C(C(=C2O1)O)OC4=CC=CC(=O)C4=C3O)C,,,,,,
8230,158231,CID 158231,CC(=O)N1C2=CC=CC=C2C(=O)C1=C(C3=CC=C(C=C3)[N+](=O)[O-])OC(=O)C,,,,,,
8231,158232,Chlorpromazine propionate,CCC(=O)O.CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,,,,,
8232,158233,"Octanoic acid, compd. with 2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine",CCCCCCCC(=O)O.CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,,,,,
8233,158234,"Hexadecanoic acid, compd. with 2-chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine",CCCCCCCCCCCCCCCC(=O)O.CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,,,,,
8234,158235,CID 158235,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
8235,158236,CID 158236,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)NC3=NC4=C(N3[C@H]5C[C@@H]([C@H](O5)CO)O)NC(=NC4=O)N,,,,,,
8236,158237,CID 158237,CC(=O)N(C1=CC=C(C=C1)C2=CC=C(C=C2)N)C3=NC4=C(N3[C@H]5C[C@@H]([C@H](O5)CO)O)NC(=NC4=O)N,,,,,,
8237,158238,CID 158238,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)N(C3=NC4=C(N3[C@@H]5C[C@@H]([C@H](O5)CO)O)NC(=NC4=O)N)C(=O)C,,,,,,
8238,158239,"Bromobenzene-3,4-dihydrodiol",C1=CC(=CC(C1O)O)Br,,,,,,
8239,158240,"Ethanimidamide, N-(2-(3-chlorophenoxy)propyl)-N-phenyl-",CC(CN(C1=CC=CC=C1)C(=N)C)OC2=CC(=CC=C2)Cl,,,,,,
8240,158241,CID 158241,CC[C@H]1[C@]([C@@H]([C@@H](C(=O)[C@@](C[C@@]([C@@H]([C@@H]([C@@H]([C@@H](C(=O)O1)C)O[C@@H]2C[C@@]([C@@H]([C@@H](O2)C)O)(CC)OC)C)O[C@@H]3[C@@H]([C@@H](C[C@@H](O3)C)N(C)C)O)(C)O)(C)F)C)O)(C)O.CCOC(=O)CCC(=O)O,,,,,,
8241,158242,CID 158242,CC[C@H]1[C@]([C@@H]([C@@H](C(=O)[C@@](C[C@@]([C@@H]([C@@H]([C@@H]([C@@H](C(=O)O1)C)O[C@@H]2C[C@@]([C@@H]([C@@H](O2)C)O)(CC)OC)C)O[C@@H]3[C@@H]([C@@H](C[C@@H](O3)C)N(C)C)O)(C)O)(C)F)C)O)(C)O,,,,,,
8242,158243,"1,2-Naphthalenediol, 6-(dipropylamino)-5,6,7,8-tetrahydro-, (R)-",CCCN(CCC)[C@@H]1CCC2=C(C1)C=CC(=C2O)O,,,,,,
8243,158244,"2-Naphthalenepentanoic acid, 5,6,7,8-tetrahydro-beta-hydroxy-beta,3,4,8,8-pentamethyl-, (betaS)-",CC1=C(C(=CC2=C1CCCC2(C)C)CC[C@@](C)(CC(=O)O)O)C,,,,,,
8244,158245,"Benz(a)anthracene-5,6-diol, 5,6-dihydro-11-methyl-, (5R-trans)-",CC1=C2C=C3C4=CC=CC=C4[C@H]([C@@H](C3=CC2=CC=C1)O)O,,,,,,
8245,158246,"2,4,6(1H,3H,5H)-Pyrimidinetrione-2-13C-1,3-15N2, 5-ethyl-1,3-dimethyl-5-phenyl-",CCC1(C(=O)[15N]([13C](=O)[15N](C1=O)C)C)C2=CC=CC=C2,,,,,,
8246,158247,"8,14-Methano-2H,14H-1-benzopyrano(7,8-d)(1,3)benzodioxocin-3,5,11,13,15-pentol, 3,4-dihydro-2,8-bis(4-hydroxyphenyl)-, (2R,3R,8R,14S,15S)-",C1[C@H]([C@H](OC2=C1C(=CC3=C2[C@H]4C([C@@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC=C(C=C6)O)O)O)C7=CC=C(C=C7)O)O,,,,,,
8247,158248,"3-Amino-4,5-dihydroxy-6-[[1-(8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl)-3-methylbutyl]amino]-6-oxohexanoic acid",CC(C)CC(C1CC2=C(C(=CC=C2)O)C(=O)O1)NC(=O)C(C(C(CC(=O)O)N)O)O,,,,,,
8248,158249,"9,10-Anthracenedione, 1-(alpha-L-arabinopyranosyloxy)-3,8-dihydroxy-6-methyl-",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O[C@H]4[C@@H]([C@H]([C@H](CO4)O)O)O)O,,,,,,
8249,158250,"beta-Alanine, N-(4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl)-",CCNC1=NC(=NC(=N1)Cl)NCCC(=O)O,,,,,,
8250,158251,"1-(4-Bromo-2,6-dimethoxyphenyl)propan-2-amine",CC(CC1=C(C=C(C=C1OC)Br)OC)N,,,,,,
8251,158252,Abyssinin,CC(=O)O[C@]12CC[C@@H]3[C@@H]([C@]1(CC[C@@H]4[C@H]2O4)C=O)CC[C@]5(C3=C(C(=O)[C@@H]5C6=COC(=O)C=C6)OC)C,,,,,,
8252,158253,"beta-D-Glucopyranosiduronic acid, (3beta,22beta)-22-hydroxyolean-12-en-3-yl 2-O-beta-D-glucopyranosyl-",C[C@@]12CC[C@@]3(C(=CCC4[C@]3(CCC5[C@@]4(CCC(C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)[C@H]1CC(C[C@@H]2O)(C)C)C,,,,,,
8253,158254,"beta-D-Glucopyranosiduronic acid, (3beta,4beta,22beta)-22,23-dihydroxyolean-12-en-3-yl 2-O-beta-D-glucopyranosyl-",C[C@@]12CC[C@@]3(C(=CCC4[C@]3(CCC5[C@@]4(CCC(C5(C)CO)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)[C@H]1CC(C[C@@H]2O)(C)C)C,,,,,,
8254,158255,"8,14-Methano-2H,14H-1-benzopyrano(7,8-d)(1,3)benzodioxocin-3,5,11,13,15-pentol, 3,4-dihydro-2,8-bis(4-hydroxyphenyl)-, (2R,3R,8S,14R,15R)-",C1[C@H]([C@H](OC2=C1C(=CC3=C2[C@@H]4C([C@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC=C(C=C6)O)O)O)C7=CC=C(C=C7)O)O,,,,,,
8255,158256,"Phosphonothioic acid, phenyl-, O-ethyl S-(4-(ethylthio)butyl) ester",CCOP(=O)(C1=CC=CC=C1)SCCCCSCC,,,,,,
8256,158257,"Phosphonic acid, (1-((2-amino-4-methyl-1-oxopentyl)amino)ethyl)-",CC(C)CC(C(=O)NC(C)P(=O)(O)O)N,,,,,,
8257,158258,"2'-Hydroxy-7,4'-dimethoxyisoflavanone",COC1=CC(=C(C=C1)C2COC3=C(C2=O)C=CC(=C3)OC)O,,,,,,
8258,158259,Pingpeimine A,C[C@H]1CC[C@H]2[C@@]([C@H]3[C@H](C[C@@]4([C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)O)O)(C)O,,,,,,
8259,158260,"(1S,4S,10S,13R,15R)-4-Hydroxy-15-methyl-6-azatetracyclo[8.6.0.01,6.02,13]hexadec-2-en-11-one",C[C@@H]1C[C@@H]2CC(=O)[C@H]3CCCN4[C@]3(C1)C2=C[C@@H](C4)O,,,,,,
8260,158261,8-Deoxyserratinidine,CC1CC2CC(C3C24CCCN(C4=C1)CCC3)NC(=O)C,,,,,,
8261,158262,"1,1'-Biphenyl, 2,3,4,5-tetrachloro-4'-iodo-",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)I,,,,,,
8262,158263,"1,1'-Biphenyl, 2,3,4,5-tetrachloro-4'-fluoro-",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)F,,,,,,
8263,158264,"1,1'-Biphenyl, 4'-bromo-2,3,4,5-tetrachloro-",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)Br,,,,,,
8264,158265,"Acetamide, N-(5-chloro-2,4-dihydroxyphenyl)-",CC(=O)NC1=CC(=C(C=C1O)O)Cl,,,,,,
8265,158266,"10-Hydroxy-8,12-octadecadienoic acid",CCCCCC=CCC(C=CCCCCCCC(=O)O)O,,,,,,
8266,158267,CID 158267,CC1=CC2=CC3=C(C(=O)C2=C(O1)O)C(=O)C4=C(C=C(C=C4O3)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C(=O)O,,,,,,
8267,158268,"Sulfamic acid, (2-methylcyclohexyl)-",CC1CCCCC1OS(=O)(=O)N,,,,,,
8268,158269,"Sulfamic acid, (3-methylcyclohexyl)-",CC1CCCC(C1)NS(=O)(=O)O,,,,,,
8269,158270,Octyl 2-[4-(2-methylpropyl)phenyl]propanoate,CCCCCCCCOC(=O)C(C)C1=CC=C(C=C1)CC(C)C,,,,,,
8270,158271,CID 158271,CCCCCC=CCC=CC[C@H]1[C@H](O1)CC=CCCCC(=O)O,,,,,,
8271,158272,"1,1'-Biphenyl, 2,2',3,3',4,5,5'-heptabromo-",C1=C(C=C(C(=C1C2=CC(=C(C(=C2Br)Br)Br)Br)Br)Br)Br,,,,,,
8272,158273,"17-(4,6-dimethyl-5-methylideneoctan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",CCC(C)C(=C)C(C)CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,,,,,,
8273,158274,Arsenenite,O=[As]=O,,,,,,
8274,158275,Shengmanol xyloside,C[C@@H]1C[C@@H](O[C@]2([C@H]1[C@]3(CCC45C[C@@]46CCC(C(C6CCC5[C@@]3([C@H]2O)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)O)[C@H]8C(O8)(C)C,,,,,,
8275,158276,Melleolide,CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@H]4[C@@H]3CC(C4)(C)C)C=O)O)C)O)O,,,,,,
8276,158277,Yuanhuafin,C[C@@H]1[C@H]([C@]2([C@H]3[C@H]4[C@]1(C5C=C(C(=O)[C@]5([C@@H]([C@@]6([C@H]4O6)CO)O)O)C)O[C@](O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C,,,,,,
8277,158278,"Propanenitrile, 3-(1,3-benzodioxol-5-yloxy)-",C1OC2=C(O1)C=C(C=C2)OCCC#N,,,,,,
8278,158279,Epidihydrofawcettidine,CC1CC2CC(C3C24CCCN(C4=C1)CCC3)O,,,,,,
8279,158280,"7,4'-Dihydroxyflavan",C1CC2=C(C=C(C=C2)O)O[C@@H]1C3=CC=C(C=C3)O,,,,,,
8280,158281,"11H-Benzo(a)carbazole, 5,5'-(phenylmethylene)bis(11-ethyl-",CCN1C2=CC=CC=C2C3=C1C4=CC=CC=C4C(=C3)C(C5=CC=CC=C5)C6=CC7=C(C8=CC=CC=C86)N(C9=CC=CC=C97)CC,,,,,,
8281,158282,Butoxyethoxy acetate,CCCCOCCOOC(=O)C,,,,,,
8282,158283,"1-Hexanaminium, N-hexyl-N,N-dimethyl-, chloride",CCCCCC[N+](C)(C)CCCCCC.[Cl-],,,,,,
8283,158284,Dihexyldimethylaminium,CCCCCC[N+](C)(C)CCCCCC,,,,,,
8284,158285,CID 158285,CC1=CC(=C(C(=C1NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])C)S(=O)(=O)O)C.[Na+],,,,,,
8285,158286,"1-Amino-9,10-dioxo-4-(2,4,6-trimethyl-3-sulfoanilino)anthracene-2-sulfonic acid",CC1=CC(=C(C(=C1NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)C)S(=O)(=O)O)C,,,,,,
8286,158287,"Phosphorodiamidic acid, N,N'-diethyl-, methyl ester",CCNP(=O)(NCC)OC,,,,,,
8287,158288,"Phosphorodiamidic acid, N,N'-dipropyl-, methyl ester",CCCNP(=O)(NCCC)OC,,,,,,
8288,158289,"1,3,6,9-Nonadecatetraen",CCCCCCCCCC=CCC=CCC=CC=C,,,,,,
8289,158290,"1H-Imidazole-4-ethanamine, alpha,5-dimethyl-",CC1=C(N=CN1)CC(C)N,,,,,,
8290,158291,"2-Butanol, 3-nitro-, (R*,S*)-",C[C@@H]([C@@H](C)O)[N+](=O)[O-],,,,,,
8291,158292,"2-Butanol, 3-nitro-, (R*,R*)-",C[C@H]([C@@H](C)O)[N+](=O)[O-],,,,,,
8292,158293,"Cyclopropane, 1-chloro-1-(trichloroethenyl)-",C1CC1(C(=C(Cl)Cl)Cl)Cl,,,,,,
8293,158294,CID 158294,CCC(=O)O[C@@H]1CC(=O)O[C@@H](CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C)C,,,,,,
8294,158295,"14-(3-Chloro-2-oxopropyl)-12-hydroxy-1,3,11,24,31,41,44-heptamethyl-2,6,10,15,19,25,29,34,38,43,47-undecaoxaundecacyclo[26.22.0.03,26.05,24.07,20.09,18.011,16.030,48.033,46.035,44.037,42]pentaconta-21,40-dien-39-one",CC1CC2C(CC3(C(O2)CC4C(O3)C(=CC(=O)O4)C)C)OC5C1OC6CC7C(CC8C(O7)(CC=CC9C(O8)CC1C(O9)CC2C(O1)(C(CC(O2)CC(=O)CCl)O)C)C)(OC6(CC5)C)C,,,,,,
8295,158296,"methyl 2,2,2-trifluoro-N-(methylcarbamoyloxy)ethanimidothioate",CNC(=O)ON=C(C(F)(F)F)SC,,,,,,
8296,158297,CID 158297,COC1=CC(=O)C2=C(C3=C(C(=C(C(=C3OC2=C1)OC)O)OC)O)O,,,,,,
8297,158298,"Tetradecanoic acid, 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-6-yl ester, (1aR-(1aalpha,2beta,5beta,5abeta,6beta,8aalpha,9alpha,10aalpha))-",CCCCCCCCCCCCCC(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(C[C@H](C2=O)[C@H]4C(C4(C)C)C[C@H]3C)CO)O)O)C,,,,,,
8298,158299,"N,N'-Bis(2,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide",CC(C)(C)C1=CC(=C(C=C1)C(C)(C)C)N2C(=O)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C(=O)N(C8=O)C9=C(C=CC(=C9)C(C)(C)C)C(C)(C)C)C2=O,,,,,,
8299,158300,"Benzoic acid, 2-[(isocyanatosulfonyl)methyl]-, methyl ester",COC(=O)C1=CC=CC=C1CS(=O)(=O)N=C=O,,,,,,
8300,158301,CID 158301,CC[C@@H]([C@@H]1CC=CC[C@@H]([C@@H](O1)CC=CC#C)Cl)Br,,,,,,
8301,158302,"Benzenemethanamine, N,4-dinitro-N-propyl-",CCCN(CC1=CC=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
8302,158303,"4,4'-Bipyridinium, 1,1'-dimethyl-, mixt. with 2-((4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl)amino)-2-methylpropanenitrile",CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C#N.C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C,,,,,,
8303,158304,"Silane, decylmethyldioctyl-",CCCCCCCCCC[Si](C)(CCCCCCCC)CCCCCCCC,,,,,,
8304,158305,CID 158305,CC(=CC1=CC(=CC=C1)OC2=CC=CC=C2)C(C#N)OC(=O)C3C(C3(C)C)C=C(Cl)Cl,,,,,,
8305,158306,CID 158306,CC(=CC1=CC(=CC=C1)OC2=CC=CC=C2)C(C#C)OC(=O)C3C(C3(C)C)C=C(Cl)Cl,,,,,,
8306,158307,"beta-D-arabino-Hexopyranoside, (3beta,14beta)-3,14-dihydroxypregn-5-en-20-yl 2,6-dideoxy-",C[C@@H]1[C@H]([C@@H](C[C@H](O1)OC(C)[C@H]2CC[C@]3([C@@]2(CCC4C3CC=C5[C@@]4(CCC(C5)O)C)C)O)O)O,,,,,,
8307,158308,"1-Propanone, 1-(2,4-dihydroxy-3-((2-hydroxyphenyl)methyl)-6-methoxy-5-methylphenyl)-3-phenyl-",CC1=C(C(=C(C(=C1OC)C(=O)CCC2=CC=CC=C2)O)CC3=CC=CC=C3O)O,,,,,,
8308,158309,"Berbaman-6',7,12-triol, 6-methoxy-2,2'-dimethyl-, (1beta)-",CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)O)O)O,,,,,,
8309,158310,"2H-1-Benzopyran-2-one, 8-hydroxy-4-methoxy-5-methyl-",CC1=C2C(=CC(=O)OC2=C(C=C1)O)OC,,,,,,
8310,158311,Arcapillin,COC1=C(C=C(C(=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)O)O,,,,,,
8311,158312,"2-Naphthaleneacetic acid, 6-(1-hydroxy-1-methylethyl)-alpha-methyl-",CC(C1=CC2=C(C=C1)C=C(C=C2)C(C)(C)O)C(=O)O,,,,,,
8312,158313,"2,6-Naphthalenediacetic acid, alpha,alpha'-dimethyl-",CC(C1=CC2=C(C=C1)C=C(C=C2)C(C)C(=O)O)C(=O)O,,,,,,
8313,158314,"2-Naphthaleneacetic acid, alpha-hydroxy-6-(1-hydroxy-1-methylethyl)-alpha-methyl-",CC(C)(C1=CC2=C(C=C1)C=C(C=C2)C(C)(C(=O)O)O)O,,,,,,
8314,158315,"2,6-Naphthalenedimethanol, alpha-(hydroxymethyl)-alpha,alpha',alpha'-trimethyl-",CC(C)(C1=CC2=C(C=C1)C=C(C=C2)C(C)(CO)O)O,,,,,,
8315,158316,"3-Pyridinecarboxamide, N-(4-fluorophenyl)-2-(3-(trifluoromethyl)phenoxy)-",C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F)C(F)(F)F,,,,,,
8316,158317,"3-Pyridinecarboxamide, 2-(3-fluorophenoxy)-N-(4-fluorophenyl)-",C1=CC(=CC(=C1)F)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F,,,,,,
8317,158318,"3-Pyridinecarboxamide, 2-(3-chlorophenoxy)-N-(4-fluorophenyl)-",C1=CC(=CC(=C1)Cl)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F,,,,,,
8318,158319,"3-Pyridinecarboxamide, 2-(3-cyanophenoxy)-N-(4-fluorophenyl)-",C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F)C#N,,,,,,
8319,158320,"3-Pyridinecarboxamide, N-(4-fluorophenyl)-2-(3-(methylsulfonyl)phenoxy)-",CS(=O)(=O)C1=CC=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F,,,,,,
8320,158321,"5-Heptadeca-8,11,14-trienylbenzene-1,3-diol",CCC=CCC=CCC=CCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
8321,158322,CID 158322,CCCC(CC=CCC=CCCCCC=CC)OC(=O)C1=CC=CC=C1O,,,,,,
8322,158323,"3-Pyridinecarboxamide, N-(4-fluorophenyl)-2-(3-methoxyphenoxy)-",COC1=CC(=CC=C1)OC2=C(C=CC=N2)C(=O)NC3=CC=C(C=C3)F,,,,,,
8323,158324,"(21,24-dihydroxy-5',11,13-trimethyl-2-oxo-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-22-yl)methyl 1H-pyrrole-2-carboxylate",CC1CCC2(CC3CC(O2)CC=C(CC(C=CC=C4COC5C4(C(C=C(C5O)COC(=O)C6=CC=CN6)C(=O)O3)O)C)C)OC1C(C)C,,,,,,
8324,158325,"Phenol, 4,4'-((2R,3S,4S,5S)-tetrahydro-3,4-dimethyl-2,5-furandiyl)bis(2-methoxy-",C[C@H]1[C@@H](C(OC1C2=CC(=C(C=C2)O)OC)C3=CC(=C(C=C3)O)OC)C,,,,,,
8325,158326,"6H-Pyrido(4,3-b)carbazol-10-ol, 5,11-dimethyl-",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C(=CC=C4)O)C,,,,,,
8326,158327,CID 158327,C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C([C@@]4(C[C@@H](C(=C[C@H]4C(=O)O3)C)OC)O)CO)C)C)O[C@@H]1C(C)C,,,,,,
8327,158328,"1H-Indene-1-propanoic acid, 4-carboxy-5-(((1S,4S)-3,3-dimethyl-2-oxo-7-oxabicyclo(2.2.1)hept-1-yl)methyl)-2,6,7,7a-tetrahydro-7-hydroxy-beta,1,7a-trimethyl-, (betaR,1S,7R,7aS)-",C[C@H](CC(=O)OC)[C@H]1CC=C2[C@]1([C@@H](CC(=C2C(=O)O)C[C@]34CC[C@H](O3)C(C4=O)(C)C)O)C,,,,,,
8328,158329,"Benzo(a)-1,3-benzodioxolo(4,5-g)quinolizinium, 8,9-dimethoxy-6-methyl-",CC1=C2C=CC3=C(C2=C[N+]4=C1C5=CC(=C(C=C5C=C4)OC)OC)OCO3,,,,,,
8329,158330,CID 158330,C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C,,,,,,
8330,158331,"1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-beta-methoxy-alpha-methyl-",CC(C1=C(C=C(C=C1)Cl)Cl)(C(N2C=NC=N2)OC)O,,,,,,
8331,158332,"L-Alanine, N-(2,6-dimethylphenyl)-",CC1=C(C(=CC=C1)C)N[C@@H](C)C(=O)O,,,,,,
8332,158333,tert-Butylphenyl diphenyl phosphate,CC(C)(C)C1=CC=CC=C1OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,"[""The fungal metabolism of tert-butylphenyl diphenyl phosphate (BPDP) was studied. Cunninghamella elegans was incubated with BPDP for 7 days, and the metabolites formed were separated by thin-layer, gas-liquid, or high-pressure liquid chromatography and identified by (1)H nuclear magnetic resonance and mass spectral techniques. C. elegans metabolized BPDP predominantly at the tert-butyl moiety to form the carboxylic acid 4-(2-carboxy-2-propyl)triphenyl phosphate. In addition, 4-hydroxy-4'-(2-carboxy-2-propyl)triphenyl phosphate, triphenyl phosphate, diphenyl phosphate, 4-(2-carboxy-2-propyl)diphenyl phosphate, 2-(4-hydroxyphenyl)-2-methyl propionic acid, and phenol were detected. Similar metabolites were found in the 28 fungal cultures which were examined for their ability to metabolize BPDP. Experiments with [(14)C]BPDP indicated that C. elegans metabolized 70% of the BPDP after 7 days and that the ratio of organic-soluble metabolites to water-soluble metabolites was 8:2. The results indicate that fungi preferentially oxidize BPDP at the alkyl side chain and at the aromatic rings to form hydroxylated derivatives. The trace levels of mono- and diaryl metabolites and the low level of phosphotriesterase activity measured in C. elegans indicate that phosphatase cleavage is a minor pathway for fungal metabolism of BPDP.""]",
8333,158334,Spiramycini,C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C,,,,,,
8334,158335,"N,N-Diisobutyl-2-(octyl(phenyl)phosphoryl)acetamide",CCCCCCCCP(=O)(CC(=O)N(CC(C)C)CC(C)C)C1=CC=CC=C1,,,,,,
8335,158336,CID 158336,COC1C(CCN=C1S)SC,,,,,,
8336,158337,"4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-5-methoxy-6,8-dimethyl-2-phenyl-, (R)-",CC1=C(C(=C(C2=C1O[C@H](CC2=O)C3=CC=CC=C3)OC)C)O,,,,,,
8337,158338,"Azuleno(6,5-b)furan-2,5-dione, 3,3a,4,4a,7a,8,9,9a-octahydro-4a-hydroxy-8-methyl-3-methylene-, (3aR,4aS,7aR,8R,9aR)-",C[C@@H]1C[C@@H]2[C@H](C[C@@]3([C@H]1C=CC3=O)O)C(=C)C(=O)O2,,,,,,
8338,158339,CID 158339,CC(CCC=C(C)[C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)CO,,,,,,
8339,158340,"1-Azoniabicyclo(4.2.0)octane, 1-methyl-, iodide",C[N+]12CCCCC1CC2.[I-],,,,,,
8340,158341,Daphneticin,COC1=CC(=CC(=C1O)OC)[C@@H]2[C@H](OC3=C(O2)C=CC4=C3OC(=O)C=C4)CO,,,,,,
8341,158342,"4H-1-Benzopyran-4-one, 8-(acetyloxy)-2,3-dihydro-5-hydroxy-7-methoxy-2-phenyl-, (S)-",CC(=O)OC1=C(C=C(C2=C1O[C@@H](CC2=O)C3=CC=CC=C3)O)OC,,,,,,
8342,158343,"1-Benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5-bis(beta-D-galactopyranosyloxy)-7-hydroxy-, chloride",C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O.[Cl-],,,,,,
8343,158344,"2-(3,4-dihydroxyphenyl)-3,5-bis[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]chromen-7-one",C1=CC(=C(C=C1C2=C(C=C3C(=CC(=O)C=C3O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O2)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
8344,158345,"6H-Pyrido(4,3-b)carbazole-5-carboxaldehyde, 11-methyl-, 2-oxide",CC1=C2C3=CC=CC=C3N=C2C(=C4C1=CN(C=C4)O)C=O,,,,,,
8345,158346,"6H-Pyrido(4,3-b)carbazole-11-methanol, 5-methyl-",CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)CO,,,,,,
8346,158347,CID 158347,C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)C)(C)OC(=O)C)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C,,,,,,
8347,158348,Satavaptan,CCOC1=CC2=C(C=C1)N(C(=O)C23CCC(CC3)OCCN4CCOCC4)S(=O)(=O)C5=C(C=C(C=C5)C(=O)NC(C)(C)C)OC,"['Investigated for use/treatment in cardiovascular disorders, in the treatment of syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) and in hyponatremia.']",['Increases urine volume through selective antagonism of V1b/V2 receptors.'],['Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)'],,,
8348,158349,7-Diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C(=O)NCCN3C(=O)C=CC3=O,,,,,,
8349,158350,"1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione;2-phenyl-3H-benzimidazole-5-sulfonic acid;1,7,7-trimethyl-3-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-2-one",CC1=CC=C(C=C1)C=C2C3CCC(C2=O)(C3(C)C)C.CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC.C1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)S(=O)(=O)O,,,,,,
8350,158351,"N-(4-(N-((2,4-Diaminofuro(2,3-d)pyrimidin-5-yl)methyl)amino)benzoyl)glutamic acid",C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=COC3=NC(=NC(=C23)N)N,,,,,,
8351,158352,CID 158352,COC1CC(OC2C1C3C(C(C2OC)O)C4(C(=C(C(=O)C5=CCC(OC54O3)C6=CC=CC=C6)OC)OC)OC)C7=CC=CC=C7,,,,,,
8352,158353,Hunterioside,C=CC1C(C(=COC1OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O)C(=O)O)CC4C5=C(CCN4)C6=CC=CC=C6N5,,,,,,
8353,158354,Benzoyltaxol,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=C(C=C6)C(=O)C7=CC=CC=C7)O)O)OC(=O)C8=CC=CC=C8)(CO4)OC(=O)C)O)C)OC(=O)C,,,,,,
8354,158355,3-Nitrofluoranthene-8-sulfate,C1=CC2=C(C=CC3=C2C(=C1)C4=C3C=CC(=C4)OS(=O)(=O)O)[N+](=O)[O-],,,,,,
8355,158356,3-Nitrofluoranthene-9-sulfate,C1=CC2=C(C=CC3=C2C(=C1)C4=C3C=C(C=C4)OS(=O)(=O)O)[N+](=O)[O-],,,,,,
8356,158357,"methyl (2S)-2-[[(2S)-2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate",CC[C@H](C)[C@@H](CO[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC)NC[C@H](CS)N,,,,,,
8357,158358,"3-Pentyl-2-[7-(3-pentyl-1,3-benzothiazol-2(3H)-ylidene)hepta-1,3,5-trien-1-yl]-1,3-benzothiazol-3-ium iodide",CCCCCN1C2=CC=CC=C2SC1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4S3)CCCCC.[I-],,,,,,
8358,158359,"3-Pentyl-2-[7-(3-pentyl-1,3-benzothiazol-3-ium-2-yl)hepta-2,4,6-trienylidene]-1,3-benzothiazole",CCCCCN1C2=CC=CC=C2SC1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4S3)CCCCC,,,,,,
8359,158360,Methylglyoxal-deoxyguanosine adduct,CC1(C(N2C(=O)C3=C(N=C2N1)N(C=N3)[C@H]4C[C@@H]([C@H](O4)CO)O)O)O,,,,,,
8360,158361,Mer NF5003B,CC1CCC2C(C(C(CC2(C13CC4=C(C=C(C(=C4O3)C=O)CO)O)C)O)O)(C)C,,,,,,
8361,158362,Mer NF5003E,CC1CCC2C(C(CCC2(C13CC4=C(C=C(C(=C4O3)C=O)CO)O)C)O)(C)C,,,,,,
8362,158363,Faranoxi,C1=CC(=CC=C1CC(=O)O)[N+](CCCl)(CCCl)[O-].OP(=O)(O)O,,,,,,
8363,158364,"4-(carboxymethyl)-N,N-bis(2-chloroethyl)benzeneamine oxide",C1=CC(=CC=C1CC(=O)O)[N+](CCCl)(CCCl)[O-],,,,,,
8364,158365,CID 158365,C1[C@H]2C(=O)N[C@H](C(=O)N2[C@@H]3[C@]1(C4=CC=CC=C4N3)[C@]56C[C@H]7C(=O)N[C@H](C(=O)N7[C@H]5NC8=CC=CC=C68)CC9=CC=CC=C9)CC1=CC=CC=C1,,,,,,
8365,158366,CID 158366,CC1=C(C(CCC1)(C)C)C=CC(=CC=C[C@](C)([C@@H](CO)O)O)C,,,,,,
8366,158367,Dnsgu,C12C(N(C(=O)N1)N=O)N(C(=O)N2)N=O.C12C(NC(=O)N1N=O)N(C(=O)N2)N=O,,,,,,
8367,158368,"2,6-Dinitroso-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione",C12C(NC(=O)N1N=O)N(C(=O)N2)N=O,,,,,,
8368,158369,"3,4-Dinitroso-1,3a,6,6a-tetrahydroimidazo[4,5-d]imidazole-2,5-dione",C12C(N(C(=O)N1)N=O)N(C(=O)N2)N=O,,,,,,
8369,158370,Sesaminone,C1[C@H]([C@@H]([C@H](O1)C2=CC3=C(C=C2)OCO3)CO)C(=O)C4=CC5=C(C=C4)OCO5,,,,,,
8370,158371,"6,3'-p-Dihydroxypaclitaxel",CC1=C2[C@H](C(=O)[C@]3([C@H]([C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C4=CC=C(C=C4)O)NC(=O)C5=CC=CC=C5)O)O)OC(=O)C6=CC=CC=C6)[C@@]7(CO[C@@H]7[C@H]([C@@H]3O)O)OC(=O)C)C)OC(=O)C,,,,,,
8371,158372,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-N-(4,4,4-trifluoro-2-methyl-3-oxobutan-2-yl)-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C(=O)C(F)(F)F)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,,,,,,
8372,158373,"(1R-(1alpha,4alpha,13R*(S*)))-1',9'a-Dihydro-1-methylspiro(1,4-ethano-2H-pyrazino(2,1-b)quinazoline-13,9'-(9H)imidazo(1,2-a)indole)-3,3',6(1H,2'H,4H)-trione",CC12C3=NC4=CC=CC=C4C(=O)N3C(CC15C6NCC(=O)N6C7=CC=CC=C57)C(=O)N2,,,,,,
8373,158374,CID 158374,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)OC9C(C3C(CC4C(O3)CC3(O4)CC4C(O3)C(CC3(O4)CC(C4C(O3)CC(C(O4)CC(=O)CCO)O)C)C)OC9CC(C1=C)O2)C,,,,,,
8374,158375,CID 158375,CC1CC2=CC3=C(C4=C(C(C3)O)C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)O)OC)C(=C2C(=O)O1)O,,,,,,
8375,158376,"Furo[2,3d]pyrimidine antifolate",CN(CC1=COC2=NC(=NC(=C12)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
8376,158377,CID 158377,CC1CCCC=C[C@H]2CC(C[C@@H]2[C@H](C=CC(=O)O1)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O,,,,,,
8377,158378,Benzamide adenine nucleotide,C1=CC(=CC(=C1)C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O,,,,,,
8378,158379,"4-Amino-1-ribofuranosylpyrrolo(2,3-d)pyridazin-7(6H)-one",C1=CN(C2=C1C(=NNC2=O)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
8379,158380,4-[2-[2-[bis(4-methoxyphenyl)-phenylmethoxy]ethyl-[3-(9H-fluoren-9-ylmethoxycarbonylamino)propyl]amino]ethoxy]-4-oxobutanoic acid,COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCCN(CCCNC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46)CCOC(=O)CCC(=O)O,,,,,,
8380,158381,CID 158381,CC(C)C1=C(C(=C(N1C=C[C@@H](C[C@@H](CC(=O)OC)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)Br,,,,,,
8381,158382,"Glycine, N-(S-(chloromethyl)-N-L-gamma-glutamyl-L-cysteinyl)-",C(CC(=O)O)[C@@H](C(=O)N[C@@H](CSCCl)C(=O)NCC(=O)O)N,,,,,,
8382,158383,"3',11-Dibutyrylankinomycin",CCCC(=O)OC1C(OC(CC1(C)N(C)C)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C5=C(C(=C4)C)C(=O)C=C(O5)C6(C(O6)C7C(O7)C)C)OC(=O)CCC)C,,,,,,
8383,158384,Ritetronium,CC[N+]1(CCCCC1)C2=CC=C(C=C2)N3C(=O)C4=C5C(=CC=C6C5=C(C=C4)C(=O)N(C6=O)C7=CC=C(C=C7)[N+]8(CCCCC8)CC)C3=O,,,,,,
8384,158385,Xcytrin,CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)[O-].CC(=O)[O-].[Gd+3],"[""Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's).""]",,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)', 'Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)']",,,
8385,158386,"5'-(Furan-3-yl)-8-methyl-6,6a-dihydro-1H,8H-spiro[naphtho[1,8a-c]furan-7,3'-oxolane]-2',3,10(5H,9H)-trione",C[C@@H]1CC(=O)C23COC(=O)C2=CCC[C@@H]3[C@@]14C[C@H](OC4=O)C5=COC=C5,,,,,,
8386,158387,CID 158387,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O)O)O)O.C1=CC(=C(C=C1C=CC(=O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)O,,,,,,
8387,158388,"(3R,4R,6S)-6-methyloxane-2,3,4,5-tetrol",C[C@H]1C([C@H]([C@H](C(O1)O)O)O)O,,,,,,
8388,158389,"Copper alloy, Cu,Zn (U.S. Bronze B-124)",[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Zn].[Zn].[Zn],,,,,,
8389,158390,CID 158390,CC(=O)O.C1=CC(=CC=C1C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O,,,,,,
8390,158391,CID 158391,C1=CC(=CC=C1C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O,,,,,,
8391,158392,Morphine 3-nicotinate,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC(=O)C6=CN=CC=C6)O[C@H]3[C@H](C=C4)O,,,,,,
8392,158393,5-Fluoro-(2'-nitrofuryl)-2-benzimidazole,C1=CC2=C(C=C1F)NC(=N2)C3=CC=C(O3)[N+](=O)[O-],,,,,,
8393,158394,"Ethanol, 2,2'-((2-((1-nitro-9-acridinyl)amino)ethyl)imino)bis-, dihydrochloride",C1=CC=C2C(=C1)C(=C3C(=N2)C=CC=C3[N+](=O)[O-])NCCN(CCO)CCO.Cl.Cl,,,,,,
8394,158395,"4-(2,3-Dimethylmaleimido)hippuric acid",CC1=C(C(=O)N(C1=O)C2=CC=C(C=C2)C(=O)NCC(=O)O)C,,,,,,
8395,158396,4-Maleimidohippuric acid,C1=CC(=CC=C1C(=O)NCC(=O)O)N2C(=O)C=CC2=O,,,,,,
8396,158397,(S)-Ampa,CC1=C(C(=O)NO1)C[C@@H](C(=O)O)N,,,,,,
8397,158398,3-(m-Isopropoxyphenyl)succinimide,CC(C)OC1=CC=CC(=C1)C2CC(=O)NC2=O,,,,,,
8398,158399,"(3R)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol",CC(C)(C)[C@H](C(=CC1=C(C=C(C=C1)Cl)Cl)N2C=NC=N2)O,,,,,,
8399,158400,"(3S)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol",CC(C)(C)[C@@H](C(=CC1=C(C=C(C=C1)Cl)Cl)N2C=NC=N2)O,,,,,,
8400,158401,CID 158401,CC(=O)NC(CCS(C=C)C(=O)C)C(=O)OC,,,,,,
8401,158402,"1-(2,6-Dimethylphenylamino)-2-dimethylaminopropane dihydrochloride",CC1=C(C(=CC=C1)C)NCC(C)N(C)C.Cl.Cl,,,,,,
8402,158403,4-Isopropylthioxanthone,CC(C)C1=CC=CC2=C1SC3=CC=CC=C3C2=O,,,,,,
8403,158404,Nickel-63(II) chloride,[Cl-].[Cl-].[Ni+2],,,,,,
8404,158405,"3,6-Acridinediamine, 2,7-diethyl-",CCC1=CC2=CC3=CC(=C(C=C3N=C2C=C1N)N)CC,,,,,,
8405,158406,"3,6-Acridinediamine, 2,7-bis(1-methylethyl)-",CC(C)C1=CC2=CC3=CC(=C(C=C3N=C2C=C1N)N)C(C)C,,,,,,
8406,158407,"5-(Diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium methyl sulphate",CC(C)N(C1=N[N+](=C(S1)N=NC2=CC=C(C=C2)N(C)C)C)C(C)C.COS(=O)(=O)[O-],,,,,,
8407,158408,"5-(Diisopropylamino)-2-[4-(dimethylamino)phenylazo]-3-methyl-1,3,4-thiadiazole-3-ium",CC(C)N(C1=N[N+](=C(S1)N=NC2=CC=C(C=C2)N(C)C)C)C(C)C,,,,,,
8408,158409,"1,4,6-Octatrien-3-ol, 3,7-dimethyl-",CC(=CC=CC(C)(C=C)O)C,,,,,,
8409,158410,Cyclopentenyl propionate musk,CCC(=O)OCC(C)(C)CC1=C(CCC1C(=C)C)C,,,,,,
8410,158411,"Benzene, 1-(1-ethoxyethoxy)-2-methoxy-4-(1-propen-1-yl)-",CCOC(C)OC1=C(C=C(C=C1)C=CC)OC,,,,,,
8411,158412,CID 158412,CCCCCCCCCCCC[Sn]CCCCCCCCCCCC.CC(C)CCCCCOC(=O)C[S-].CC(C)CCCCCOC(=O)C[S-],,,,,,
8412,158413,Didodecylstannane,CCCCCCCCCCCC[Sn]CCCCCCCCCCCC,,,,,,
8413,158414,"Naphth(2,3-a)aceanthrylene",C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC5=CC6=CC=CC=C6C3=C54,,,,,,
8414,158415,CID 158415,C1=CC(=NCCO)C(=CC1=NCCO)N(O)O,,,,,,
8415,158416,"1H-Benzimidazol-5-ol, 2-phenyl-, hydrogen sulfate (ester)",C1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)OS(=O)(=O)O,,,,,,
8416,158417,"Methanone, (2-hydroxy-4-methoxy-5-(sulfooxy)phenyl)phenyl-",COC1=C(C=C(C(=C1)O)C(=O)C2=CC=CC=C2)OS(=O)(=O)O,,,,,,
8417,158418,CID 158418,COC1=CC=CC=C1P(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8418,158419,"Phosphinic acid, (4-(dichloromethyl)phenyl)(4-nitrophenyl)-, 4-nitrophenyl ester",C1=CC(=CC=C1C(Cl)Cl)P(=O)(C2=CC=C(C=C2)[N+](=O)[O-])OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
8419,158420,Dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (II),CC1=NC=C(N1CCO)[N+](=O)[O-].CC1=NC=C(N1CCO)[N+](=O)[O-].Cl[Pt]Cl,,,,,,
8420,158421,"1-Propanaminium, N,N-diethyl-N-methyl-3-((2,3,3,3-tetrafluoro-2-(1,1,2,3,3,3-hexafluoro-2-(heptafluoropropoxy)propoxy)-1-oxopropyl)amino)-, iodide",CC[N+](C)(CC)CCCNC(=O)C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F.[I-],,,,,,
8421,158422,"Diethyl-methyl-[3-[[2,3,3,3-tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propoxy]propanoyl]amino]propyl]azanium",CC[N+](C)(CC)CCCNC(=O)C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F,,,,,,
8422,158423,"Palladium, dichlorobispyridoxal-",CC1=NC=C(C(=C1O)C=O)CO.CC1=NC=C(C(=C1O)C=O)CO.[Cl-].[Cl-].[Pd+2],,,,,,
8423,158424,"Benzo(b)naphtho(1,2-d)thiophene, 2-methyl-",CC1=CC2=C(C=C1)C=CC3=C2C4=CC=CC=C4S3,,,,,,
8424,158425,"Benzo(b)naphtho(1,2-d)thiophene, 5-methyl-",CC1=CC2=C(C3=CC=CC=C13)C4=CC=CC=C4S2,,,,,,
8425,158426,"Benzo(b)naphtho(1,2-d)thiophene, 6-methyl-",CC1=CC2=CC=CC=C2C3=C1SC4=CC=CC=C43,,,,,,
8426,158427,"Benzo(b)naphtho(1,2-d)thiophene, 8-methyl-",CC1=C2C(=CC=C1)C3=C(S2)C=CC4=CC=CC=C43,,,,,,
8427,158428,CID 158428,C([C@@H]([C@@H]1C(=O)C(=C(O1)O)OP(=O)([O-])[O-])O)O.[Mg+2],,,,,,
8428,158429,Zinc isodecanoate,CC(C)CCCCCCC(=O)[O-].CC(C)CCCCCCC(=O)[O-].[Zn+2],,,,,,
8429,158430,"N-(3-Aminopropyl)-N'-(3-(dipyrido(1,2-a:3',2'-d)imidazol-2-ylamino)propyl)-1,4-butanediamine hydrobromide (2:9)",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)NCCCNCCCCNCCCN.C1=CC2=NC3=C(N2C=C1)N=C(C=C3)NCCCNCCCCNCCCN.Br.Br.Br.Br.Br.Br.Br.Br.Br,,,,,,
8430,158431,"N-(3-aminopropyl)-N'-[3-(1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-ylamino)propyl]butane-1,4-diamine",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)NCCCNCCCCNCCCN,,,,,,
8431,158432,"9H-Fluorene-4-carboxamide, 2,7-dinitro-9-oxo-",C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C3=C2C(=CC(=C3)[N+](=O)[O-])C(=O)N,,,,,,
8432,158433,1-(Hydroxy(1-methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol ethanedioate (2:1)(salt),CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)O)O.CC(C)N(CC(COC1=CC=CC2=CC=CC=C21)O)O.C(=O)(C(=O)[O-])[O-],,,,,,
8433,158434,Flumipropyn,CC(C#C)OC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Cl,,,,,,
8434,158435,CID 158435,C1[C@H]([C@@H]1C=CC2=CC3=CC=CC=C3C=C2)CCCC(=O)NC4=CC=CC=C4C(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
8435,158436,CID 158436,C1[C@H]([C@@H]1C=CC2=CC3=CC=CC=C3C=C2)CCCC(=O)NC4=CC=CC=C4C(=O)O,,,,,,
8436,158437,Cyclopeptolide 1,CC[C@H](C)[C@H]1C(=O)NCC(=O)N([C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N2CCCC[C@H]2C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)[C@@H](C)CC)C)CC(=O)O)C)C(C)C)C(C)C)C)C)CC3=CC=C(C=C3)OC)C(C)C)C,,,,,,
8437,158438,Naminidil,C[C@H](C(C)(C)C)N=C(NC#N)NC1=CC=C(C=C1)C#N,,,,,,
8438,158439,CID 158439,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC[C@@H]3CC[C@@H](O3)N4C=NC5=C4NC=NC5=O)N=[N+]=[N-],,,,,,
8439,158440,Ablavar,C1CC(CCC1OP(=O)([O-])OC[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3],,,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],,,
8440,158441,Fosveset,C1CC(CCC1OP(=O)(O)OC[C@@H](CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8441,158442,"N-(2-Bromo-4-fluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1)F)Br)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8442,158443,"2,3,4,5,6-pentachloro-N-[2,4-dinitro-6-(trifluoromethyl)phenyl]-N-methylaniline",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
8443,158444,"N-(4-Bromophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=CC=C(C=C1)Br)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8444,158445,"2,6-Dibromo-N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-4-fluoro-N-methylbenzenamine",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2Br)F)Br,,,,,,
8445,158446,"N-(2-Bromo-4-chlorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1)Cl)Br)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8446,158447,"ethyl (2R,3R)-3-[[4-methyl-1-oxo-1-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]pentan-2-yl]carbamoyl]oxirane-2-carboxylate;sulfuric acid",CCOC(=O)[C@H]1[C@@H](O1)C(=O)NC(CC(C)C)C(=O)N2CCN(CC2)CC3=C(C(=C(C=C3)OC)OC)OC.CCOC(=O)[C@H]1[C@@H](O1)C(=O)NC(CC(C)C)C(=O)N2CCN(CC2)CC3=C(C(=C(C=C3)OC)OC)OC.OS(=O)(=O)O,,,,,,
8447,158448,"ethyl (2R,3R)-3-[[4-methyl-1-oxo-1-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]pentan-2-yl]carbamoyl]oxirane-2-carboxylate",CCOC(=O)[C@H]1[C@@H](O1)C(=O)NC(CC(C)C)C(=O)N2CCN(CC2)CC3=C(C(=C(C=C3)OC)OC)OC,,,,,,
8448,158449,"2-Pyridinamine, 5-(4-chlorophenyl)-4,6-dimethyl-",CC1=CC(=NC(=C1C2=CC=C(C=C2)Cl)C)N,,,,,,
8449,158450,"Benzamide, N-(((5-(4-chlorophenyl)-4,6-dimethyl-2-pyridinyl)amino)carbonyl)-2,6-difluoro-",CC1=CC(=NC(=C1C2=CC=C(C=C2)Cl)C)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
8450,158451,Ethyldimethylpropylammonium bromide,CCC[N+](C)(C)CC.[Br-],,,,,,
8451,158452,"1-Propanaminium, N-ethyl-N,N-dimethyl-",CCC[N+](C)(C)CC,,,,,,
8452,158453,"6-Chloro-N-cyclohexyl-N'-ethyl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC2CCCCC2,,,,,,
8453,158454,"2',3,7,7,13-Pentamethylspiro[12-oxa-11lambda6-thiatetracyclo[8.4.0.02,5.06,9]tetradeca-1(10),2(5),6(9)-triene-8,1'-cyclopropane] 11,11-dioxide",CC1CC2=C1C3=C(C4=C2C(C45CC5C)(C)C)S(=O)(=O)OC(C3)C,,,,,,
8454,158455,1-(2-Acryloyloxyethyl) trimellitate,C=CC(=O)OCCOC(=O)C1=C(C=C(C=C1)C(=O)O)C(=O)O,,,,,,
8455,158456,"2-Propenoic acid, 2-[[[[3-[[(hexahydro-2-oxo-1H-azepin-1-yl)carbonyl]amino]-4-methylphenyl]amino]carbonyl]oxy]ethyl ester",CC1=C(C=C(C=C1)NC(=O)OCCOC(=O)C=C)NC(=O)N2CCCCCC2=O,,,,,,
8456,158457,"1,3-Dioctylcyclohexane",CCCCCCCCC1CCCC(C1)CCCCCCCC,,,,,,
8457,158458,"16-Oxahexacyclo[12.9.0.02,7.08,13.015,17.018,23]tricosa-1(14),2,4,6,8,10,12,15(17),18,20,22-undecaene",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C5=CC=CC=C5C6=C4O6,,,,,,
8458,158459,"12,13-Dihydroxy-10,11-epoxy-10,11,12,13-tetrahydrodibenz(a,e)fluoranthenene",C1=CC=C2C(=C1)C=C3C4=C(C=C5C3=C2C6=CC=CC=C65)C7C(O7)C(C4O)O,,,,,,
8459,158460,"Acetic acid, mercapto-, C10-16-alkyl esters, reaction products with dichlorodioctylstannane and trichlorooctylstannane",CCCCCCCC[Sn](CCCCCCCC)(Cl)Cl.CCCCCCCC[Sn](Cl)(Cl)Cl.C(C(=O)O)S,,,,,,
8460,158461,"Zinc, bis(dimethylcarbamodithioato-S,S')-, (T-4)-, mixt. with tetramethylthioperoxydicarbonic diamide (((Me2N)C(S))2S2)",CN(C)C(=S)[S-].CN(C)C(=S)[S-].CN(C)C(=S)SSC(=S)N(C)C.[Zn+2],,,,,,
8461,158462,Ccris 2343,CSCCC(=O)N1[C@@H](CS[C@@H]1C2=CC=CC=C2O)C(=O)O,,,,,,
8462,158463,CID 158463,[H+].[H+].[CH-]1C=CC=C1.[CH-]1C=CC=C1.C(=CC(=O)[O-])C(=O)[O-].C(=CC(=O)[O-])C(=O)[O-].[Ti+4],,,,,,
8463,158464,"Gold(1+);3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane;nitrate",CCP(CC)CC.CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[N+](=O)([O-])[O-].[Au+].[Au+],,,,,,
8464,158465,5-(5-(Trimethylammonio)-L-norvaline)-10-(5-(trimethylammonio)-L-norvaline)gramicidin S dichloride,CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC[N+](C)(C)C)C(C)C)CC4=CC=CC=C4)CC(C)C)CCC[N+](C)(C)C)C(C)C)CC5=CC=CC=C5.[Cl-].[Cl-],,,,,,
8465,158466,"3-[(3R,6S,9S,12S,15S,21R,24S,27S,30S,33S)-3,21-dibenzyl-6,24-bis(2-methylpropyl)-2,5,8,11,14,20,23,26,29,32-decaoxo-12,30-di(propan-2-yl)-27-[3-(trimethylazaniumyl)propyl]-1,4,7,10,13,19,22,25,28,31-decazatricyclo[31.3.0.015,19]hexatriacontan-9-yl]propyl-trimethylazanium",CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC[N+](C)(C)C)C(C)C)CC4=CC=CC=C4)CC(C)C)CCC[N+](C)(C)C)C(C)C)CC5=CC=CC=C5,,,,,,
8466,158467,"Gold, (ethyl diethylphosphinite-P)(1-thio-beta-D-glucopyranose 2,3,4,6-tetraaceto-S)-",CCOP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],,,,,,
8467,158468,Diethylphosphinous acid ethyl ester,CCOP(CC)CC,,,,,,
8468,158469,D-Homo-S,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H]5C[C@H]5[C@]4(C)O)C,,,,,,
8469,158470,Episcopalidine,CC(=O)OC1CC23C4CC5C(=C)CC46CC(=O)C2C(C1OC(=O)C7=CC=CC=C7)(CN(C3C6C5=O)C)C,,,,,,
8470,158471,alpha-Glycyrrhizin,C[C@]12CC[C@](C[C@@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O,,,,,,
8471,158472,"4,13-Dihydroxy-9-(3-hydroxy-4,5-dimethoxyphenyl)-4,4a,8,9-tetrahydro-1aH,7H,12H-8,11a-(azenometheno)[1,2,4]dithiazepino[4,3-b]oxireno[e][1,2]benzoxazin-7-one",COC1=CC(=CC(=C1OC)O)C2C3C(=O)N4C(CC56C(O5)C=CC(C6O4)O)(C(=O)N3)SS2,,,,,,
8472,158473,"2-Propanol, 1-(diethylamino)-3-((6-methyl-5H-pyrido(3',4':4,5)pyrrolo(2,3-g)isoquinolin-10-yl)amino)-, trimaleate",CCN(CC)CC(CNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CN=C4)C)O,,,,,,
8473,158474,Enoximone sulfoxide,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)S(=O)C,,,,,,
8474,158475,Holacanthone,C[C@@H]1[C@@H]2[C@H](C(=O)O[C@H]3[C@@]24CO[C@@]([C@@H]1O)([C@@H]4[C@@]5([C@@H](C3)C(=CC(=O)[C@H]5O)C)C)O)OC(=O)C,,,,,,
8475,158476,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-9,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C=C23)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,,,,,,
8476,158477,Wilforlide A,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4C[C@]6(C[C@@H]5OC6=O)C)C)C)C)(C)C)O,,,,,,
8477,158478,Dichlorobis(tranylcypromine)platinum(II),C1C(C1N)C2=CC=CC=C2.C1C(C1N)C2=CC=CC=C2.[Cl-].[Cl-].[Pt+2],,,,,,
8478,158479,CID 158479,CCN(CC)C1=CC=CC=C1.CN(C)C1=CC=CC=C1.C1=CC=C(C=C1)C=O.C1=CC=C(C(=C1)C(=O)[O-])O,,,,,,
8479,158480,Isodonoic acid,CC(=O)O[C@H]1CCC([C@H]([C@@]12COC(=O)[C@]34[C@H]2[C@H](C[C@H](C3)C(=C)C4=O)O)C(=O)O)(C)C,,,,,,
8480,158481,"Adenosine 5'-(tetrahydrogen triphosphate), N,6-didehydro-2'-deoxy-1,6-dihydro-1-methyl-",CN1C=NC2=C(C1=N)N=CN2C3C[C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
8481,158482,"Adenosine 5'-(tetrahydrogen triphosphate), N,6-didehydro-2'-deoxy-3,6-dihydro-3-methyl-",CN1C=NC(=N)C2=C1N(C=N2)C3C[C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
8482,158483,"9-acetyl-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-9,11-dihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C=C23)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,,,,,,
8483,158484,N6-4-Methyl-2-thiazolylmitomycin C,CC1=CSC(=N1)NC2=C(C(=O)C3=C(C2=O)[C@H]([C@@]4(N3C[C@H]5[C@@H]4N5)OC)COC(=O)N)C,,,,,,
8484,158485,CID 158485,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NC5=NN=CC5,,,,,,
8485,158486,Quinocarcin,CN1[C@H]2C[C@H]([C@@H]1[C@@H]3CC4=C([C@H]5N3[C@@H]2OC5)C(=CC=C4)OC)C(=O)O,,,,,,
8486,158487,"(1R)-16-ethylidene-2-methylidene-4,14-diazatetracyclo[12.2.2.03,11.05,10]octadeca-3(11),5,7,9-tetraene",CC=C1CN2CC[C@H]1C(=C)C3=C(CC2)C4=CC=CC=C4N3,,,,,,
8487,158488,Cr-Protoporphyrin,[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)[O-])CCC(=O)[O-].[Cr+3],,,,,,
8488,158489,Nymania 1,CC[C@@H](C)[C@H](C(=O)O[C@H]1[C@@H]([C@@H](C(=C)[C@@]2([C@@]1([C@@H](CC2=O)C3=COC=C3)C)O)[C@]4([C@H](C[C@@]5(OC[C@]([C@@H]4CC(=O)OC)(O5)C)O)OC(=O)C)C)OC=O)O,,,,,,
8489,158490,Isocopalendial,C[C@]12CCCC([C@@H]1CC[C@@]3([C@@H]2CC=C([C@H]3C=O)C=O)C)(C)C,,,,,,
8490,158491,Vanadocene citrate,[H+].[H+].[CH-]1C=CC=C1.[CH-]1C=CC=C1.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[V],,,,,,
8491,158492,CID 158492,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NN6CCN(CC6)C)C)O)N)O,,,,,,
8492,158493,CID 158493,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=NN6CCN(CC6)C)C)O)N)O,,,,,,
8493,158494,CID 158494,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=C(N4[C@](C2)(C(=O)OC)O)C=C(C=C5)Br.C(=CC(=O)O)C(=O)O,,,,,,
8494,158495,Hexaglucosylcyclotriphosphazene,C(C1C(C(C(C(O1)O)O)OP2(=NP(=NP(=N2)(OC3C(C(OC(C3O)O)CO)O)OC4C(C(OC(C4O)O)CO)O)(OC5C(C(OC(C5O)O)CO)O)OC6C(C(OC(C6O)O)CO)O)OC7C(C(OC(C7O)O)CO)O)O)O,,,,,,
8495,158496,Elubiol,CCOC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,,,,,,
8496,158497,"1-Propene, 1,1,2-tribromo-3-chloro-",C(C(=C(Br)Br)Br)Cl,,,,,,
8497,158498,CID 158498,COC(=O)C1=CO[C@@H]([C@@H]2[C@H]1[C@@H](C=C2COC(=O)C=CC3=CC(=C(C=C3)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
8498,158499,"Cyclopenta(c)pyran-4-carboxylic acid, 5,6-bis(acetyloxy)-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-7-methyl-, methyl ester, (1S,4aS,5S,6R,7S,7aR)-",C[C@H]1[C@@H]2[C@H]([C@@H]([C@@H]1OC(=O)C)OC(=O)C)C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)OC,,,,,,
8499,158500,"4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,3,10-tetramethoxy-6-methyl-, (S-(R*,R*))-",CN1CCC2=C3[C@@H]1CC4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC5=CC(=C(C=C5C[C@H]6C7=CC(=C(C=C7CCN6)OC)OC)OC)OC,,,,,,
8500,158501,25(R)-Hydroxyprotopanaxadiol,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2C[C@H]([C@H]4[C@]3(CC[C@@H]4[C@@](C)(CCCC(C)(C)O)O)C)O)C)(C)C)O,,,,,,
8501,158502,"Acetamide, N-(4-chloro-6-((1-methylethyl)amino)-1,3,5-triazin-2-yl)-",CC(C)NC1=NC(=NC(=N1)Cl)NC(=O)C,,,,,,
8502,158503,"7H-Dibenzo(de,g)quinolin-7-one, 3-hydroxy-1,2-dimethoxy-",COC1=C2C3=CC=CC=C3C(=O)C4=NC=CC(=C24)C(=C1OC)O,,,,,,
8503,158504,"Furan, 2,5-bis(3,4-dimethoxyphenyl)tetrahydro-3,4-dimethyl-, (2R,3S,4S,5R)-rel-(+)-",C[C@@H]1[C@H]([C@H](O[C@@H]1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C,,,,,,
8504,158505,CID 158505,C[C@H](C(=O)N(CC(=O)O)C1CC2=CC=CC=C2C1)N[C@@H](CCC3=CC=CC=C3)C(=O)O,,,,,,
8505,158506,"Ethanaminium, N-ethyl-N-(5-((4-methylphenyl)thio)-9H-benzo(a)phenoxazin-9-ylidene)-, nitrate",CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=C(C=C5)C)OC2=C1)CC.[N+](=O)([O-])[O-],,,,,,
8506,158507,Diethyl-[5-(4-methylphenyl)sulfanylbenzo[a]phenoxazin-9-ylidene]azanium,CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=C(C=C5)C)OC2=C1)CC,,,,,,
8507,158508,"Ethanaminium, N-ethyl-N-(5-((3-methylphenyl)thio)-9H-benzo(a)phenoxazin-9-ylidene)-, nitrate",CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=CC(=C5)C)OC2=C1)CC.[N+](=O)([O-])[O-],,,,,,
8508,158509,Diethyl-[5-(3-methylphenyl)sulfanylbenzo[a]phenoxazin-9-ylidene]azanium,CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=CC(=C5)C)OC2=C1)CC,,,,,,
8509,158510,"Ethanaminium, N-ethyl-N-(5-((2-methylphenyl)thio)-9H-benzo(a)phenoxazin-9-ylidene)-, nitrate",CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=CC=C5C)OC2=C1)CC.[N+](=O)([O-])[O-],,,,,,
8510,158511,Diethyl-[5-(2-methylphenyl)sulfanylbenzo[a]phenoxazin-9-ylidene]azanium,CC[N+](=C1C=CC2=NC3=C(C=C(C4=CC=CC=C43)SC5=CC=CC=C5C)OC2=C1)CC,,,,,,
8511,158512,"3-Pyridinecarboxylic acid, 2-chloroethyl ester",C1=CC(=CN=C1)C(=O)OCCCl,,,,,,
8512,158513,CID 158513,C[C@H](C(=O)[O-])N(C=O)O.[Na+],,,,,,
8513,158514,2-(N-Hydroxyformamido)Propanoic Acid,CC(C(=O)O)N(C=O)O,,,,,,
8514,158515,"[(1S,4aR,6S,7R,7aS)-4-formyl-4a,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-6-yl] 3-phenylprop-2-enoate",C[C@@]1([C@H](C[C@]2([C@@H]1[C@@H](OC=C2C=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)OC(=O)C=CC4=CC=CC=C4)O,,,,,,
8515,158516,"7H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline-7-carboxaldehyde,5,6,7a,8-tetrahydro-, (7aR)-",C1CN([C@@H]2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5)C=O,,,,,,
8516,158517,CID 158517,C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5OC)C)C(=O)O3)O)C)C)O[C@@H]1C(C)C,,,,,,
8517,158518,"2,4(1H,3H)-Pyrimidinedione, 5-fluorodihydro-1,3-dimethyl-",CN1CC(C(=O)N(C1=O)C)F,,,,,,
8518,158519,"4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxy-3-(3-methyl-2-butenyl)phenyl)-6,8-bis(3-methyl-2-butenyl)-, (2S)-",CC(=CCC1=C(C=CC(=C1)[C@@H]2CC(=O)C3=C(C(=C(C(=C3O2)CC=C(C)C)O)CC=C(C)C)O)O)C,,,,,,
8519,158520,"4-[7-(3,7-Dimethylocta-2,6-dienyl)-6-hydroxy-1-benzofuran-2-yl]-5-(3-methylbut-2-enyl)benzene-1,2-diol",CC(=CCCC(=CCC1=C(C=CC2=C1OC(=C2)C3=CC(=C(C=C3CC=C(C)C)O)O)O)C)C,,,,,,
8520,158521,CID 158521,CC(C1=CC=CC=N1)NN=C(N(C)C)S,,,,,,
8521,158522,CID 158522,CC(C1=CC=CC=N1)NN=C(N2CCCC2)S,,,,,,
8522,158523,"2H,4H-Cycloprop(4,5)oxireno(6,7)indeno(5,6-c)furan-4-ol,octahydro-5a,7,7-trimethyl-, (1aS,4S,4aS,5aR,5bS,8aR,8bS)-",C[C@]12C[C@]13[C@H](OC[C@]34[C@@H](O4)[C@H]5[C@@H]2CC(C5)(C)C)O,,,,,,
8523,158524,"6,11-Hexadecadienyl acetate",CCCCC=CCCCC=CCCCCCOC(=O)C,,,,,,
8524,158525,2-(4-Ethoxyphenyl)-2-methylpropan-1-ol,CCOC1=CC=C(C=C1)C(C)(C)CO,,,,,,
8525,158526,"2,5-Cyclohexadien-1-one, 4-((2,6-diethylphenyl)imino)-2,6-dimethoxy-",CCC1=C(C(=CC=C1)CC)N=C2C=C(C(=O)C(=C2)OC)OC,,,,,,
8526,158527,"Silane, didecylmethyloctyl-",CCCCCCCCCC[Si](C)(CCCCCCCC)CCCCCCCCCC,,,,,,
8527,158528,"Cinchonan, 9-chloro-6'-methoxy-, (8alpha,9S)-",COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)Cl,,,,,,
8528,158529,"2,4-Octadienoic acid",CCCC=CC=CC(=O)O,,,,,,
8529,158530,"Phosphoramidothioic acid, phenylpropyl-, S-phenyl O-propyl ester",CCCOP(=O)(NCCCC1=CC=CC=C1)SC2=CC=CC=C2,,,,,,
8530,158531,"Phosphoramidothioic acid, (2-chlorophenyl)-, O-ethyl S-phenyl ester",CCOP(=N)(OC1=CC=CC=C1Cl)SC2=CC=CC=C2,,,,,,
8531,158532,"L-Norvaline, 5-(phosphonooxy)-",C(C[C@@H](C(=O)O)N)COP(=O)(O)O,,,,,,
8532,158533,"Estra-1,3,5(10)-trien-17-one, 3-(acetyloxy)-2-methoxy-",CC(=O)OC1=C(C=C2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CCC4=O)C)OC,,,,,,
8533,158534,CID 158534,CC(=O)OC1=C(C=C(C=C1)C=CCC#CC2=CC(=C(C=C2)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
8534,158535,"2-Pyridinamine, N-(3-bromo-2,6-dinitro-4-(trifluoromethyl)phenyl)-3-chloro-5-(trifluoromethyl)-",C1=C(C=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Br)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,,,
8535,158536,Gadoteric acid,C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],"['Gadoteric acid is indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.']","['Gadoterate affects proton relaxation times and consequently the MR signal, and the contrast obtained is characterized by the relaxivity of the gadoterate molecule. The relaxivity values for gadoterate are similar across the spectrum of magnetic field strengths used in clinical MRI (0.2 - 1.5 T). Gadoterate does not cross the intact blood-brain barrier and, therefore, does not enhance normal brain or lesions that have a normal blood-brain barrier, e.g. cysts, mature post-operative scars. However, disruption of the blood-brain barrier or abnormal vascularity allows distribution of gadoterate in lesions such as neoplasms, abscesses, and infarcts.']","['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)', 'Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)']","['Gadoteric acid is excreted primarily in urine.', 'The volume of distribution at steady state of total gadolinium in normal subjects is 179 and 211 mL/kg in female and male subjects respectively, roughly equivalent to that of extracellular water.', 'In healthy subjects, the renal and total clearance rates of total gadolinium are comparable (1.27 and 1.74 mL/min/kg in females; and 1.40 and 1.64 mL/min/kg in males, respectively).']",['Gadoterate is not known to be metabolized.'],"['Gadoteric acid demonstrates a mean elimination half-life of about 1.4 hr and 2.0 hr in female and male subjects, respectively.']"
8536,158537,"Aconitane-4,7,8,9-tetrol, 20-ethyl-1,14,16-trimethoxy-, 4-(2-(acetylamino)benzoate), (1beta,14alpha,16beta)-",CCN1C[C@@]2(CC[C@H](C34[C@@H]2CC(C31)([C@]5(C[C@@H](C6CC4[C@@]5([C@H]6OC)O)OC)O)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C,,,,,,
8537,158538,Puberaconitidine,CCN1C[C@@]2(CC[C@H](C34[C@@H]2C(C(C31)([C@]5(C[C@@H](C6CC4C5[C@H]6OC)OC)OC)O)OC)OC)COC(=O)C7=CC=CC=C7NC(=O)CCC(=O)O,,,,,,
8538,158539,"1-Phenanthrenemethanol, 7-ethenyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a,7-trimethyl-, (1S,4aR,4bS,7S,10aR)-",C[C@@]1(CC[C@H]2C(=CC[C@@H]3[C@@]2(CCC[C@]3(C)CO)C)C1)C=C,,,,,,
8539,158540,"1,3-Dipropyl-8-[(1S,3S,4S)-5beta,6beta-epoxybicyclo[2.2.1]heptane-3alpha-yl]-7H-purine-2,6(1H,3H)-dione",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)[C@H]3C[C@H]4C[C@@H]3[C@@H]5[C@H]4O5,,,,,,
8540,158541,CID 158541,C1[C@H](CN[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NC(=O)[C@H](CC4=CC=C(C=C4)F)N)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O,,,,,,
8541,158542,CID 158542,C1[C@H](CN[C@@H]1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NC(=O)[C@H](CC4=CC=C(C=C4)F)N)O,,,,,,
8542,158543,"5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2-methyl-6-[2-[2-(pyridin-4-ylmethylamino)ethoxy]ethoxymethyl]-1,4-dihydropyridine-3,5-dicarboxylate",CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)COCCOCCNCC3=CC=NC=C3,,,,,,
8543,158544,Brisbagenin fucoside-4-(hydrogen sulfate),C[C@H]1CCC2([C@H]([C@H]3C(O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5([C@@H](C[C@@H](C6)O)O[C@@H]7[C@H]([C@@H]([C@@H]([C@@H](O7)C)OS(=O)(=O)O)O)O)C)C)C)OC1,,,,,,
8544,158545,1-O-2AcFS-Ssoa,C[C@H]1CCC2([C@H]([C@H]3C(O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5([C@@H](C[C@@H](C6)OC(=O)C)O[C@@H]7[C@H](C([C@@H]([C@@H](O7)C)OS(=O)(=O)O)OC(=O)C)OC(=O)C)C)C)C)OC1,,,,,,
8545,158546,Asimilobine-2-O-glucoside,COC1=C(C=C2CCN[C@H]3C2=C1C4=CC=CC=C4C3)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
8546,158547,Angelmicin B,CCCC1(C(C(C(C2C1(C(=O)C3=C(C4=C(C=C3C2)C(=C(C(=C4O)C5=C(C(=O)C6=C(C7=C(C(=C6C5=O)O)C(=O)C8(C9C7OC8(C(C(C9OC1CC(C(C(O1)C)O)O)O)OC1CCC(C(O1)C)OC1CCC(C(O1)C)(C(=O)C)O)CCC)O)O)OC)OC)OC)O)O)OC1CC(C(C(O1)C)O)O)O)OC1CCC(C(O1)C)OC1CCC(C(O1)C)(C(=O)C)O)O,,,,,,
8547,158548,CID 158548,C1CC2CCCC3C2C(C1)OC4(O3)C5C(O5)C(=O)C67C4(O6)C(CCC7O)O,,,,,,
8548,158549,tert-Butyloxycarbonyl-4-(tri-n-butylstannyl)-phenylalanine tetrafluorophenyl ester,CCCC[Sn](CCCC)(CCCC)C1=CC=C(C=C1)C[C@@H](C(=O)OC2=C(C(=CC(=C2F)F)F)F)NC(=O)OC(C)(C)C,,,,,,
8549,158550,Atazanavir sulfate,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,"['Reyataz capsules, co-administered with low dose ritonavir, are indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products (see section 4. 2).']",,"['Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)']",,,
8550,158551,beta-Methylene sad,C1=C(N=C([Se]1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(CP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)O)C(=O)N,,,,,,
8551,158552,CID 158552,C[C@@H](C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N,,,,,,
8552,158553,Fmoc-eey(P)AA,C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24,,,,,,
8553,158554,Echinocystic acid 3-O-sodium sulfate,C[C@]12CCC(C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)O)C)C)(C)C)OS(=O)(=O)O.[Na+],,,,,,
8554,158555,"(4aR,5R,6aR,6aS,6bR,8aR,12aR,14bS)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-sulfooxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid",C[C@]12CCC(C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)O)C)C)(C)C)OS(=O)(=O)O,,,,,,
8555,158556,CID 158556,CC1=C(C(=O)C2=C(C1=O)C3C4C5[C@@H](C[C@@H](N5)C(N4C2CO)C#N)C6N3CCO6)OC,,,,,,
8556,158557,CID 158557,CC1=C(C2=C(C(N3C([C@H]4C[C@@H]5C(C3C2N6C5OCC6)N4C)C#N)CO)C(=C1OC)O)O,,,,,,
8557,158558,CID 158558,CC1=C(C(=O)C2=C(C1=O)C3C4C5[C@@H](C[C@@H](N5C)C(N4C2CO)C#N)C(N3CCO)C#N)OC,,,,,,
8558,158559,"Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)-, (1alpha,6alpha,14alpha,15beta,16beta)-",CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@H](C(C31)[C@@]5([C@@H]6[C@H]4C[C@@H]([C@@H]6O)[C@H]([C@H]5O)OC)O)OC)O)COC,,,,,,
8559,158560,"4H-Dibenzo(de,g)quinolin-2-ol, 5,6,6a,7-tetrahydro-1,3-dimethoxy-, (R)-",COC1=C(C(=C2C3=CC=CC=C3C[C@@H]4C2=C1CCN4)OC)O,,,,,,
8560,158561,"Phosphoramidothioic acid, phenylpropyl-, O-methyl S-phenyl ester",COP(=O)(NCCCC1=CC=CC=C1)SC2=CC=CC=C2,,,,,,
8561,158562,Crassicaulidine,CCN1C[C@@]2([C@@H](C[C@@H](C34[C@@H]2[C@H](C(C31)[C@@]5([C@@H]6[C@H]4C[C@@H]([C@@H]6O)[C@H]([C@H]5O)OC)O)OC)O)O)COC,,,,,,
8562,158563,"Olean-12-ene-3,21,22-triol, (3beta,21beta,22beta)-",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC([C@H]([C@H]5O)O)(C)C)C)C)C)(C)C)O,,,,,,
8563,158564,Talaromycin A,CC[C@@H]1CC[C@@]2(C[C@@H]([C@@H](CO2)CO)O)OC1,,,,,,
8564,158565,"Ethanamine, N,N-dimethyl-2-((4-(2-thienyl)-2-pyrimidinyl)thio)-, monohydrobromide",CN(C)CCSC1=NC=CC(=N1)C2=CC=CS2.Br,,,,,,
8565,158566,"5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-ol, 6,7,7a,8-tetrahydro-, (7aS-cis)-",C1CN[C@@H]2[C@H](C3=CC=CC=C3C4=C2C1=CC5=C4OCO5)O,,,,,,
8566,158567,N-Desmethylcycleanine,CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC=C(O3)C=C7)NCCC6=CC(=C5OC)OC)OC)OC,,,,,,
8567,158568,"Ethanone, 1-(3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl)-",CC(=O)C1=CC(=C(C=C1)O)N2N=C3C=CC=CC3=N2,,,,,,
8568,158569,Talaromycin B,CC[C@@H]1CC[C@@]2(C[C@@H]([C@H](CO2)CO)O)OC1,,,,,,
8569,158570,Iturin D,CCCCCCCCCCCC1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)CO)CC(=O)N)CCC(=O)N)CC(=O)N)CC3=CC=C(C=C3)O)CC(=O)N,,,,,,
8570,158571,"1,2-Benzisothiazole-3-propanamine, N,N-dimethyl-gamma-phenyl-, monohydrochloride",CN(C)CCC(C1=CC=CC=C1)C2=NSC3=CC=CC=C32.Cl,,,,,,
8571,158572,"N,N-Dimethylamino-3-phenyl-3-(1,2-benzisothiazol-3-yl)propylamine",CN(C)CCC(C1=CC=CC=C1)C2=NSC3=CC=CC=C32,,,,,,
8572,158573,Avocadene,C=CCCCCCCCCCCCC(CC(CO)O)O,,,,,,
8573,158574,"Benzonitrile, 2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-4-hydroxy-",CC(C)(C)NCC(COC1=C(C=CC(=C1)O)C#N)O,,,,,,
8574,158575,"L-Ornithine, N2-acetyl-N5-(3-phenoxybenzoyl)-",CC(=O)N[C@@H](CCCNC(=O)C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,,,,,,
8575,158576,"beta-D-Glucopyranosiduronic acid, (2,6-dinitrophenyl)methyl",C1=CC(=C(C(=C1)[N+](=O)[O-])CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)[N+](=O)[O-],,,,,,
8576,158577,"Benzoic acid, 2-(1-methyl-2-pyrrolidinyl)-, (S)-",CN1CCC[C@H]1C2=CC=CC=C2C(=O)O,,,,,,
8577,158578,Vinhaticyl acetate,C[C@@H]1[C@@H]2CC[C@H]3[C@](CCC[C@@]3([C@H]2CC4=C1C=CO4)C)(C)COC(=O)C,,,,,,
8578,158579,"Carbamic acid, (5-phenyl-1H-benzimidazol-2-yl)-, ethyl ester",CCOC(=O)NC1=NC2=C(N1)C=C(C=C2)C3=CC=CC=C3,,,,,,
8579,158580,CID 158580,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O)O)O,,,,,,
8580,158581,CID 158581,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=O)C=CC4=C3O)C5=C(C(=C(C=C5)O)O)O)CO)O)O)O)O)O,,,,,,
8581,158582,"1H-Cyclopropa(3,4)cycloocta(1,2-c)furan-1-one, 4-((1R)-1,5-dimethyl-4-hexenyl)-3,4,5,6,7,7a,8,8a-octahydro-5-hydroxy-7-methyl-, (4S,5R,7R,7aS,8aS)-",C[C@@H]1C[C@H]([C@H](C2=C([C@@H]3[C@H]1C3)C(=O)OC2)[C@H](C)CCC=C(C)C)O,,,,,,
8582,158583,"1H-Indole-3-ethanol, 2-(5-ethenyl-1-azabicyclo(2.2.2)oct-2-yl)-5-methoxy-, (1S-(1alpha,2alpha,4alpha,5beta))-",COC1=CC2=C(C=C1)NC(=C2CCO)C3CC4CCN3CC4C=C,,,,,,
8583,158584,"4H-1-Benzopyran-4-one, 8-arabinosyl-6-beta-D-galactopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-",CC(C(C(C(=O)C1=C2C(=C(C(=C1O)C3C(C(C(C(O3)CO)O)O)O)O)C(=O)C=C(O2)C4=CC=C(C=C4)O)O)O)O,,,,,,
8584,158585,"2,5-Octadien-1-ol",CCC=CCC=CCO,,,,,,
8585,158586,"beta-D-Glucopyranoside, (1S,4aS,5S,6R,7R,7aS)-6-chloro-1,4a,5,6,7,7a-hexahydro-5,7-dihydroxy-4-methylcyclopenta(c)pyran-1-yl",C[C@@]1([C@@H]([C@H]([C@H](O[C@@]1([C@H](O)Cl)O)OC2[C@H]3[C@@H](CC[C@H]3O)C=CO2)O)O)O,,,,,,
8586,158587,"(2R,3S,4R,5R,6S)-6-[[(4aS,7aR)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-2-(hydroxymethyl)-3-methyloxane-2,3,4,5-tetrol",C[C@@]1([C@@H]([C@H]([C@H](O[C@@]1(CO)O)OC2[C@@H]3C=CC[C@H]3C=CO2)O)O)O,,,,,,
8587,158588,"beta-D-Glucopyranoside, 1,4a,5,6,7,7a-hexahydro-7-hydroxy-4-methylcyclopenta(c)pyran-1-yl",CC1=COC(C2C1CCC2O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8588,158589,CID 158589,CCCCCCCCCCCCC1=CC=C(C=C1)OCC(=O)[O-].[Na+],,,,,,
8589,158590,(4-Dodecylphenoxy)acetic acid,CCCCCCCCCCCCC1=CC=C(C=C1)OCC(=O)O,,,,,,
8590,158591,"Pyridine, 1-acetyl-1,2,3,4-tetrahydro-5-(1-(1H-indol-3-ylmethyl)-2-piperidinyl)-",CC(=O)N1CCCC(=C1)C2CCCCN2CC3=CNC4=CC=CC=C43,,,,,,
8591,158592,"1,3(2H,4H)-Isoquinolinedione, 2-(4-chlorophenyl)-",C1C2=CC=CC=C2C(=O)N(C1=O)C3=CC=C(C=C3)Cl,,,,,,
8592,158593,"Cholesta-7,9(11)-dien-6-one, 2,3,14,20,22-pentahydroxy-, (2beta,3beta,5beta,22R)-",CC(C)CC[C@H]([C@@](C)([C@@H]1CC[C@@]2([C@@]1(CC=C3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C)O)O)O,,,,,,
8593,158594,Flavidin,C1CC2=C3C(=CC(=C2)O)OCC4=CC(=CC1=C43)O,,,,,,
8594,158595,Asparanin D,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)O)OC9C(C(C(CO9)O)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)C)C)C)OC1,,,,,,
8595,158596,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-ethoxy-",CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,,,,,
8596,158597,Asparoside D,CC1C2C(CC3C2(CCC4C3CCC5C4(CCC(C5)OC6C(C(C(C(O6)COC7C(C(C(C(O7)C)O)O)O)OC8C(C(C(CO8)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)O,,,,,,
8597,158598,Asparoside C,CC1C2C(CC3C2(CCC4C3CCC5C4(CCC(C5)OC6C(C(C(C(O6)COC7C(C(C(C(O7)C)O)O)O)OC8C(C(C(CO8)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)OC,,,,,,
8598,158599,"beta-D-Glucopyranoside, (1S,4aS,7R,7aR)-1,4a,5,6,7,7a-hexahydro-4,7-dimethylcyclopenta(c)pyran-1-yl",C[C@@H]1CC[C@@H]2[C@@H]1C(OC=C2)O[C@H]3[C@@H]([C@H]([C@]([C@H](O3)CO)(C)O)O)O,,,,,,
8599,158600,CID 158600,CCCC1(C(=O)N=C(N(C1=O)C)S)C2=CC=CC=C2,,,,,,
8600,158601,"2,2',3,3',4,5,5',6'-Octachlorodiphenyl ether",C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)OC2=C(C(=CC(=C2Cl)Cl)Cl)Cl,,,,,,
8601,158602,"2,5-Cyclohexadiene-1,4-dione, 2-(methylamino)-5-(((1R,2S,4aS,8aS)-1,2,3,4,4a,7,8,8a-octahydro-1,2,4a,5-tetramethyl-1-naphthalenyl)methyl)-",C[C@H]1CC[C@]2([C@H]([C@]1(C)CC3=CC(=O)C(=CC3=O)NC)CCC=C2C)C,,,,,,
8602,158603,"2,5-Cyclohexadiene-1,4-dione, 2-(methylamino)-6-(((1R,2S,4aS,8aS)-1,2,3,4,4a,7,8,8a-octahydro-1,2,4a,5-tetramethyl-1-naphthalenyl)methyl)-",C[C@H]1CC[C@]2([C@H]([C@]1(C)CC3=CC(=O)C=C(C3=O)NC)CCC=C2C)C,,,,,,
8603,158604,Asparanin C,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)O)OC9C(C(C(CO9)O)O)O)O)O)C)C)C)OC1,,,,,,
8604,158605,Gallium oxide,[O-2].[O-2].[O-2].[Ga+3].[Ga+3],,,,,,
8605,158606,Ethanediazonium,CC[N+]#N,,,,,,
8606,158607,"Methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl)propionate",COC1=CC=C(C=C1)[C@H]2[C@@H](O2)C(=O)OC,,,,,,
8607,158608,Versicolorone,CC(=O)CCC1COC2=C1C(=C3C(=C2)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O,,,,,,
8608,158609,"(11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,16-trimethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 2-[(2,3-dimethylcyclopropanecarbonyl)-methylamino]propanoate",CC1C(C1C(=O)N(C)C(C)C(=O)OC2CC(=O)NC3=C(C(=CC(=C3)CC(=CC=CC(C4(CC(C(C5C2(O5)C)C)OC(=O)N4)O)OC)C)OC)Cl)C,,,,,,
8609,158610,"Olean-12-ene-23,28-dioic acid, 2,3,16-trihydroxy-, (2beta,3beta,4alpha,16alpha)-",C[C@@]12CCC3[C@@]([C@H]1CC=C4[C@]2(C[C@H]([C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)O)C)(C[C@@H]([C@@H]([C@@]3(C)C(=O)O)O)O)C,,,,,,
8610,158611,"4H-1-Benzopyran-3-sulfinic acid, 4-oxo-",C1=CC=C2C(=C1)C(=O)C(=CO2)S(=O)O,,,,,,
8611,158612,CID 158612,C1CSCN1C(=O)C2=CC=CC=C2C(=O)[O-].[Na+],,,,,,
8612,158613,Nesosteine,C1CSCN1C(=O)C2=CC=CC=C2C(=O)O,,,,,,
8613,158614,"2,3-Piperidinedicarboxylic acid, (2R,3R)-rel-",C1C[C@H]([C@@H](NC1)C(=O)O)C(=O)O,,,,,,
8614,158615,"Ethanol, 2-(2-(5,6-dichloro-1H-benzimidazol-1-yl)ethoxy)-",C1=C2C(=CC(=C1Cl)Cl)N(C=N2)CCOCCO,,,,,,
8615,158616,"Benzeneethanamine, 4-(dimethylamino)-alpha,2-dimethyl-, (alphaS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)",CC1=C(C=CC(=C1)N(C)C)C[C@H](C)N.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
8616,158617,"O5-methyl O3-propan-2-yl (4S)-4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,,,,,,
8617,158618,"Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-5-((2-nitrophenyl)azo)-",CC(C)(C)C1=C(C(=CC(=C1)CCC(=O)O)N=NC2=CC=CC=C2[N+](=O)[O-])O,,,,,,
8618,158619,"Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-",CC(C)(C)C1=C(C(=CC(=C1)CCC(=O)O)N2N=C3C=CC=CC3=N2)O,,,,,,
8619,158620,"2-Oxazolidinone, 3-(4-((3-chlorophenyl)methoxy)phenyl)-5-((methylamino)methyl)-, monomethanesulfonate",CNCC1CN(C(=O)O1)C2=CC=C(C=C2)OCC3=CC(=CC=C3)Cl.CS(=O)(=O)O,,,,,,
8620,158621,3-[4-[(3-Chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]oxazolidin-2-one,CNCC1CN(C(=O)O1)C2=CC=C(C=C2)OCC3=CC(=CC=C3)Cl,,,,,,
8621,158622,"Hexanoic acid, 1,2,3,9-tetrahydropyrrolo(2,1-b)quinazolin-3-yl ester, (R)-",CCCCCC(=O)O[C@@H]1CCN2C1=NC3=CC=CC=C3C2,,,,,,
8622,158623,"Nonanoic acid, 1,2,3,9-tetrahydropyrrolo(2,1-b)quinazolin-3-yl ester, (R)-",CCCCCCCCC(=O)O[C@@H]1CCN2C1=NC3=CC=CC=C3C2,,,,,,
8623,158624,"Decanoic acid, 1,2,3,9-tetrahydropyrrolo(2,1-b)quinazolin-3-yl ester, (R)-",CCCCCCCCCC(=O)O[C@@H]1CCN2C1=NC3=CC=CC=C3C2,,,,,,
8624,158625,"Pyrrolo(2,1-b)quinazolin-3-ol, 1,2,3,9-tetrahydro-, propanoate (ester), (R)-",CCC(=O)O[C@@H]1CCN2C1=NC3=CC=CC=C3C2,,,,,,
8625,158626,"Adenosine, 8-((1,1'-biphenyl)-4-ylamino)-2'-deoxy-",C1[C@@H]([C@H](O[C@H]1N2C3=NC=NC(=C3N=C2NC4=CC=C(C=C4)C5=CC=CC=C5)N)CO)O,,,,,,
8626,158627,"2,3',4,4'-Tetrabromobiphenyl",C1=CC(=C(C=C1C2=C(C=C(C=C2)Br)Br)Br)Br,,,,,,
8627,158628,"3,3',4,4',5-Pentabromobiphenyl",C1=CC(=C(C=C1C2=CC(=C(C(=C2)Br)Br)Br)Br)Br,,,,,,
8628,158629,"2,3,3',4,4',5'-Hexabromobiphenyl",C1=CC(=C(C(=C1C2=CC(=C(C(=C2)Br)Br)Br)Br)Br)Br,,,,,,
8629,158630,"1,1'-Biphenyl, 2,3',4,4',5',6-hexabromo-",C1=C(C=C(C(=C1Br)Br)Br)C2=C(C=C(C=C2Br)Br)Br,,,,,,
8630,158631,"2,2',3,4',5,5',6-Heptabromobiphenyl",C1=C(C(=CC(=C1Br)Br)Br)C2=C(C(=CC(=C2Br)Br)Br)Br,,,,,,
8631,158632,3-Phenanthreneacetic acid,C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)CC(=O)O,,,,,,
8632,158633,"Pentanoic acid, 2-hydroxy-2-(1-hydroxyethyl)-3-methyl-, (2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl ester",CCC(C)C(C(C)O)(C(=O)OCC1=CCN2C1CCC2)O,,,,,,
8633,158634,"4-(3,7-Dimethylocta-2,6-dienyl)-5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol",CC(=CCCC(=CCC1=C(C=C(C=C1O)O)C2=CC3=C(O2)C=C(C=C3)O)C)C,,,,,,
8634,158635,"Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-5-oxo-2-pyrrolidinyl)methyl)-2-methoxy-, (R)-",CCN1[C@H](CCC1=O)CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,,,,,,
8635,158636,"Benzenemethanamine, N-nitroso-",C1=CC=C(C=C1)CNN=O,,,,,,
8636,158637,alpha-Arbutin,C1=CC(=CC=C1O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
8637,158638,5-Nitrobenzo[d]isothiazol-3-amine,C1=CC2=C(C=C1[N+](=O)[O-])C(=NS2)N,,,,,,
8638,158639,"Benzenepropanamine, N-hydroxy-gamma-phenyl-N-(1-phenylethyl)-,hydrochloride",CC(C1=CC=CC=C1)N(CCC(C2=CC=CC=C2)C3=CC=CC=C3)O.Cl,,,,,,
8639,158640,"N-(3,3-diphenylpropyl)-N-(1-phenylethyl)hydroxylamine",CC(C1=CC=CC=C1)N(CCC(C2=CC=CC=C2)C3=CC=CC=C3)O,,,,,,
8640,158641,6beta-Hydroxyloganin,C[C@@H]1[C@@H]2[C@H]([C@@H]([C@@H]1O)O)C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)OC,,,,,,
8641,158642,CID 158642,CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)O)C)COC(=O)C=C(C)CCO,,,,,,
8642,158643,O7'-Demethyl-O1-methylpakistanine,CN1CCC2=CC(=C(C3=C2[C@H]1CC4=CC(=C(C=C43)O)OC5=CC=C(C=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)OC)O)OC)OC,,,,,,
8643,158644,"Platinum, dichlorobis(alpha-(methoxymethyl)-2-nitro-1H-imidazole-1-ethanol-N3)-, (SP-4-2)-",COCC(CN1C=CN=C1[N+](=O)[O-])O.COCC(CN1C=CN=C1[N+](=O)[O-])O.[Cl-].[Cl-].[Pt+2],,,,,,
8644,158645,"3-Octanone, 2-hydroxy-, (2S)-",CCCCCC(=O)[C@H](C)O,,,,,,
8645,158646,"Phosphoramidothioic dichloride, cyclohexyl-",C1CCC(CC1)NP(=S)(Cl)Cl,,,,,,
8646,158647,9-Methyl-10-nitroanthracene,CC1=C2C=CC=CC2=C(C3=CC=CC=C13)[N+](=O)[O-],,,,,,
8647,158648,Homoerythratine,CO[C@@H]1C[C@@]23C(=C[C@H]1O)CCN2CCCC4=CC5=C(C=C34)OCO5,,,,,,
8648,158649,"Benzenamine, 4-chloro-2-fluoro-5-(1-methylethoxy)-",CC(C)OC1=C(C=C(C(=C1)N)F)Cl,,,,,,
8649,158650,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-2-fluoro-5-(1-methylethoxy)phenyl)-4,5,6,7-tetrahydro-",CC(C)OC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Cl,,,,,,
8650,158651,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-2-fluoro-5-hydroxyphenyl)-4,5,6,7-tetrahydro-",C1CCC2=C(C1)C(=O)N(C2=O)C3=CC(=C(C=C3F)Cl)O,,,,,,
8651,158652,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-2-fluoro-5-methoxyphenyl)-4,5,6,7-tetrahydro-",COC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Cl,,,,,,
8652,158653,"1H-Isoindole-1,3(2H)-dione, 2-(4-bromo-2-fluoro-5-methoxyphenyl)-4,5,6,7-tetrahydro-",COC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Br,,,,,,
8653,158654,5-Amino-2-chloro-4-fluorophenol,C1=C(C(=CC(=C1O)Cl)F)N,,,,,,
8654,158655,2-Chloro-4-fluoro-5-nitrophenol,C1=C(C(=CC(=C1O)Cl)F)[N+](=O)[O-],,,,,,
8655,158656,"1,2-Benzenedicarboxylic acid, mono(1-ethylbutyl) ester",CCCC(CC)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
8656,158657,"9-Hydroxy-5',6,10,14,16-pentamethyl-6'-propan-2-ylspiro[2,20-dioxatricyclo[17.3.1.04,9]tricosa-5,10,12,16-tetraene-21,2'-oxane]-3,7-dione",CC1CCC2(CC3CC(O2)CC=C(CC(C=CC=C(C4(CC(=O)C(=CC4C(=O)O3)C)O)C)C)C)OC1C(C)C,,,,,,
8657,158658,"1,2,3-Chrysenetriol, 1,2,3,4-tetrahydro-",C1C(C(C(C2=C1C3=C(C=C2)C4=CC=CC=C4C=C3)O)O)O,,,,,,
8658,158659,4-chloro-N-(2-cyanoethoxymethyl)benzamide,C1=CC(=CC=C1C(=O)NCOCCC#N)Cl,,,,,,
8659,158660,"Benzenamine, N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-2,4,6-trifluoro-N-methyl-",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2F)F)F,,,,,,
8660,158661,"N-(3,4-Difluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=CC(=C(C=C1)F)F)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8661,158662,"N-[2,4-dinitro-6-(trifluoromethyl)phenyl]-2,3,4,5,6-pentafluoro-N-methylaniline",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C(=C(C(=C2F)F)F)F)F,,,,,,
8662,158663,"Benzenamine, 2,6-dichloro-N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-4-fluoro-N-methyl-",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2Cl)F)Cl,,,,,,
8663,158664,"N-(2,4-Dichlorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1)Cl)Cl)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8664,158665,"N-(3,4-Dibromophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=CC(=C(C=C1)Br)Br)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8665,158666,"Benzenamine, 2-bromo-6-chloro-N-(2,4-dinitro-6-(trifluoromethyl)phenyl)-4-fluoro-N-methyl-",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2Br)F)Cl,,,,,,
8666,158667,"N-(2-Bromo-4,6-difluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2Br)F)F,,,,,,
8667,158668,"N-(2-Chloro-4-fluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1)F)Cl)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8668,158669,"N-(2-Chloro-4,6-difluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F)C2=C(C=C(C=C2Cl)F)F,,,,,,
8669,158670,4-Hydroxycephalotaxine,COC1=CC23CCCN2CCC4=CC5=C(C=C4C3(C1O)O)OCO5,,,,,,
8670,158671,"2H-Benzo(a)quinolizine-2-ethanol, 3-ethyl-1,3,4,6,7,11b-hexahydro-9-hydroxy-10-methoxy-, (2R,3R,11bS)-",CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1CCO)OC)O,,,,,,
8671,158672,(+)-Indolactam V,CC(C)[C@@H]1C(=O)N[C@H](CC2=CNC3=C2C(=CC=C3)N1C)CO,,,,,,
8672,158673,"Benzenesulfonamide, 2-(5-amino-1,3,4-thiadiazol-2-yl)-N-methyl-",CNS(=O)(=O)C1=CC=CC=C1C2=NN=C(S2)N,,,,,,
8673,158674,"1,3-Benzodioxole, 5-ethoxy-6-(1-phenylethyl)-",CCOC1=CC2=C(C=C1C(C)C3=CC=CC=C3)OCO2,,,,,,
8674,158675,"L-Cysteine, N-acetyl-S-(1,2-dihydro-1-hydroxy-2-naphthalenyl)-",CC(=O)N[C@@H](CSC1C=CC2=CC=CC=C2C1O)C(=O)O,,,,,,
8675,158676,"Kaur-16-ene-3,7-dione, 18-(acetyloxy)-, (4beta)-",CC(=O)OC[C@@]1([C@H]2CC(=O)[C@@]34C[C@H](CC[C@H]3[C@@]2(CCC1=O)C)C(=C)C4)C,,,,,,
8676,158677,"10,10-Difluoroallethrin",CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C)CC=C(F)F,,,,,,
8677,158678,"Cyclohexane, 1,2,3,4,5,6-hexachloro-1-methyl-, (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-",CC1([C@@H]([C@H](C([C@@H]([C@H]1Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8678,158679,"2-Thiazolamine, 4-(5-(hydroxyamino)-2-furanyl)-",C1=C(OC(=C1)NO)C2=CSC(=N2)N,,,,,,
8679,158680,"2-[4-Hydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl)oxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)C)C)C)OC1,,,,,,
8680,158681,"9,10-Anthracenedione, 2-ethenyl-1,3,6,8-tetrahydroxy-7-methyl-",CC1=C(C=C2C(=C1O)C(=O)C3=C(C(=C(C=C3C2=O)O)C=C)O)O,,,,,,
8681,158682,"methyl (4S,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-(2-hydroxyethylidene)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate",COC(=O)C1=CO[C@H](C(=CCO)[C@@H]1CC(=O)OCCC2=CC(=C(C=C2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8682,158683,ZK-90055 (hydrochloride),CC(C)(C)NCC(C1=C2C=C(NC2=C(C=C1)O)C(=O)OC)O.Cl,,,,,,
8683,158684,methyl 4-[2-(tert-butylamino)-1-hydroxyethyl]-7-hydroxy-1H-indole-2-carboxylate,CC(C)(C)NCC(C1=C2C=C(NC2=C(C=C1)O)C(=O)OC)O,,,,,,
8684,158685,"6,8-Dimethoxy-7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)chromen-2-one",CC(=CCCC(=CCCC(=CCOC1=C(C=C2C=CC(=O)OC2=C1OC)OC)C)C)C,,,,,,
8685,158686,"1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-4-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=C2C(=CC3=C1OCO3)C(=C4C=COC4=N2)OC)C,,,,,,
8686,158687,"3-[5,7-dihydroxy-2,2-dimethyl-8-(2-methylbut-3-en-2-yl)-4-oxo-3H-chromen-6-yl]prop-2-enoic acid",CC1(CC(=O)C2=C(O1)C(=C(C(=C2O)C=CC(=O)O)O)C(C)(C)C=C)C,,,,,,
8687,158688,"Benzeneacetic acid, alpha-hydroxy-, 3-carboxy-3,5-dimethylcyclohexyl ester",CC1CC(CC(C1)(C)C(=O)O)OC(=O)C(C2=CC=CC=C2)O,,,,,,
8688,158689,"Benzeneacetic acid, alpha-hydroxy-, 3-(hydroxymethyl)-3,5-dimethylcyclohexyl ester",CC1CC(CC(C1)(C)CO)OC(=O)C(C2=CC=CC=C2)O,,,,,,
8689,158690,"Bicyclo(4.3.1)dec-7-ene-7-carboxaldehyde, 4,10-bis(acetyloxy)-5-((1R)-1,5-dimethyl-4-hexenyl)-2-methylene-, (1S,4R,5S,6S,10R)-",CC(CCC=C(C)C)[C@@H]1[C@@H](CC(=C)[C@H]2CC=C([C@H]1[C@@H]2OC(=O)C)C=O)OC(=O)C,,,,,,
8690,158691,"10,11-Dimethoxy-17-epi-alpha-yohimbine",COC1=C(C=C2C(=C1)C3=C(N2)[C@@H]4C[C@H]5[C@H](CC[C@H]([C@H]5C(=O)OC)O)CN4CC3)OC,,,,,,
8691,158692,"[(2S,3R,4S,5R)-4,5-Dihydroxy-2-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-[[(3R,9S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl] acetate",CC(=O)O[C@@H]1[C@H]([C@@H](CO[C@H]1O[C@@]2([C@@H]([C@H](O[C@H]([C@@H]2O)O[C@H]3CC4[C@@]5(C[C@@H]([C@@H]([C@]5(CCC46C[C@]67C3C(CCC7)(C)C)C)[C@]8(CC[C@H](O8)C(C)(C)O)C)O)C)CO)O)O)O)O,,,,,,
8692,158693,"4-(2-Hydroxypropyl)benzene-1,2-diol",CC(CC1=CC(=C(C=C1)O)O)O,,,,,,
8693,158694,"(2R,3R,4S,5S,6R)-2-[[(3R,9R,12S,14R,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol",C[C@]12CCC34C[C@@]35CCC(C(C5[C@@H](CC4[C@@]1(C[C@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O,,,,,,
8694,158695,"L-Arabinitol, 5-(6-amino-9H-purin-9-yl)-5-deoxy-",C1=NC(=C2C(=N1)N(C=N2)C[C@@H]([C@@H]([C@H](CO)O)O)O)N,,,,,,
8695,158696,"1H-1,2,4-Triazole-1-ethanol, beta-((2,4-dichlorophenyl)methyl)-alpha-(1,1-dimethylethyl)-, (alphaS,betaS)-",CC(C)(C)[C@@H]([C@H](CC1=C(C=C(C=C1)Cl)Cl)N2C=NC=N2)O,,,,,,
8696,158697,Dichlobutrazol,CC(C)(C)[C@H]([C@@H](CC1=C(C=C(C=C1)Cl)Cl)N2C=NC=N2)O,,,,,,
8697,158698,"2H-1-Benzopyran-2-one, 6,8-dimethoxy-7-(((1R,4aR,6S,8aS)-1,4,4a,5,6,7,8,8a-octahydro-6-hydroxy-2,5,5,8a-tetramethyl-1-naphthalenyl)methoxy)-",CC1=CC[C@@H]2[C@@]([C@@H]1COC3=C(C=C4C=CC(=O)OC4=C3OC)OC)(CC[C@@H](C2(C)C)O)C,,,,,,
8698,158699,"A'-Neogammaceran-3-ol, acetate, (3beta)-",CC(C)[C@H]1CC[C@]2([C@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OC(=O)C)C)C)C)C,,,,,,
8699,158700,11-Methoxy-alpha-yohimbine,COC1=CC2=C(C=C1)C3=C(N2)[C@@H]4C[C@H]5[C@H](CC[C@@H]([C@H]5C(=O)OC)O)CN4CC3,,,,,,
8700,158701,11-Methoxy-17-epi-alpha-yohimbine,COC1=CC2=C(C=C1)C3=C(N2)[C@@H]4C[C@H]5[C@H](CC[C@H]([C@H]5C(=O)OC)O)CN4CC3,,,,,,
8701,158702,"Phenol, 2-iodo-6-(2-methylpropyl)-4-nitro-",CC(C)CC1=C(C(=CC(=C1)[N+](=O)[O-])I)O,,,,,,
8702,158703,"Methanone, (4-methoxyphenyl)(5,6,7-trimethoxy-1-isoquinolinyl)-",COC1=CC=C(C=C1)C(=O)C2=NC=CC3=C(C(=C(C=C32)OC)OC)OC,,,,,,
8703,158704,Ervafolidene,CCC12CC3C4C(CC56N4CCC7(C5O)C8=CC=CC=C8NC7=C(C6)C(=O)OC)(OC39C3(C1N(CC3)CC=C2)C1=CC=CC=C1N9)CC,,,,,,
8704,158705,CID 158705,CC(C)CNC(=O)C=CC=CCCCCCC1=CC2=C(C=C1)OCO2,,,,,,
8705,158706,Atisenol,CC12CCCC3(C1CCC45C3CC(CC4)C(=C)C5O)COC2=O,,,,,,
8706,158707,"Naphtho(1,2-b)furan-2,8(3H,4H)-dione, 4-(acetyloxy)-3a,5,5a,9,9a,9b-hexahydro-5a-methyl-3,9-bis(methylene)-, (3aR,4S,5aS,9aR,9bR)-",CC(=O)O[C@H]1C[C@]2(C=CC(=O)C(=C)[C@@H]2[C@@H]3[C@@H]1C(=C)C(=O)O3)C,,,,,,
8707,158708,"(3R,8S)-3-methoxyheptadeca-1,9-dien-4,6-diyn-8-ol",CCCCCCCC=C[C@@H](C#CC#C[C@@H](C=C)OC)O,,,,,,
8708,158709,CID 158709,CC1=C[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(C(=O)C=C1O3)C)O)OC(=O)CC(C)C)C(=C)C(=O)O2,,,,,,
8709,158710,"[(3aS,4S,5R,6R,11aR)-5,6-dihydroxy-6,10-dimethyl-3-methylidene-2,7-dioxo-3a,4,5,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] 3-methylbutanoate",CC1=CCC(=O)[C@]([C@@H]([C@H]([C@@H]2[C@@H](C1)OC(=O)C2=C)OC(=O)CC(C)C)O)(C)O,,,,,,
8710,158711,"1H-Indole-1-acetic acid, 3-((4-chlorophenyl)hydroxymethyl)-6-hydroxy-2-methyl-",CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)O)C(C3=CC=C(C=C3)Cl)O,,,,,,
8711,158712,"Phosphorothioic acid, O,O-diethyl S-1-hexynyl ester",CCCCC#CSP(=O)(OCC)OCC,,,,,,
8712,158713,"Phosphorothioic acid, O,O-diethyl S-(3-(ethylthio)-1-propynyl) ester",CCOP(=O)(OCC)SC#CCSCC,,,,,,
8713,158714,"(1R,3R,8R,12S,13R,17R,24R,25S,26S)-12-hydroxy-17-[(1S)-1-hydroxyethyl]-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2'-oxirane]-11,22-dione",C[C@@H]1CCO[C@H](C=CC=CC(=O)O[C@@H]2C[C@@H]3[C@]4([C@]2([C@]5(CCC(=C[C@H]5O3)C)COC(=O)[C@H]1O)C)CO4)[C@H](C)O,,,,,,
8714,158715,"1H-Cycloprop(e)azulene, decahydro-4-isocyano-1,1,4,7-tetramethyl-",CC1CCC2C1C3C(C3(C)C)CCC2(C)[N+]#[C-],,,,,,
8715,158716,"Pyrene, hexadecahydro-1,8-diisocyano-1,2,5,8-tetramethyl-",CC1CC2CC(C(C3C2C4C1CCC(C4CC3)(C)[N+]#[C-])(C)[N+]#[C-])C,,,,,,
8716,158717,"Galactitol, 5,6-anhydro-1-bromo-1-deoxy-",C1[C@H](O1)[C@H]([C@H]([C@@H](CBr)O)O)O,,,,,,
8717,158718,Acanthaglycoside A,CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(OC(C3O)OC4CC5C6CCC(C6(CC=C5C7(C4CC(CC7)OS(=O)(=O)O)C)C)C(C)(CC(=O)C=C(C)C)O)C)O)OC8C(C(C(C(O8)C)O)O)OC9C(C(C(C(O9)C)O)O)O)O)O)O)O.[Na+],,,,,,
8718,158719,"[6-[4-[5-[4,5-dihydroxy-6-methyl-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-4-hydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-(2-hydroxy-6-methyl-4-oxohept-5-en-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate",CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(OC(C3O)OC4CC5C6CCC(C6(CC=C5C7(C4CC(CC7)OS(=O)(=O)O)C)C)C(C)(CC(=O)C=C(C)C)O)C)O)OC8C(C(C(C(O8)C)O)O)OC9C(C(C(C(O9)C)O)O)O)O)O)O)O,,,,,,
8719,158720,"Pyrrolo(2,1-b)quinazolin-9(1H)-one, 2,3-dihydro-3,7-dihydroxy-, (3S)-",C1CN2C(=NC3=C(C2=O)C=C(C=C3)O)[C@H]1O,,,,,,
8720,158721,"Triphenyleno(1,2-b)oxirene, 10a,11a-dihydro-",C1=CC=C2C(=C1)C3=C(C4C(O4)C=C3)C5=CC=CC=C25,,,,,,
8721,158722,"1H-Indene-1,3(2H)-dione, 5-chloro-2,2-dihydroxy-6-methoxy-",COC1=C(C=C2C(=C1)C(=O)C(C2=O)(O)O)Cl,,,,,,
8722,158723,CID 158723,CC(O)P(=O)O,,,,,,
8723,158724,"Phosphonothioic acid, phenyl-, O-ethyl O-(2,4,5-trichlorophenyl) ester",CCOP(=S)(C1=CC=CC=C1)OC2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
8724,158725,"2,4(1H,3H)-Pyrimidinedione, 1-(5-((6-chloro-2-methoxy-9-acridinyl)amino)pentyl)-5-methyl-",CC1=CN(C(=O)NC1=O)CCCCCNC2=C3C=C(C=CC3=NC4=C2C=CC(=C4)Cl)OC,,,,,,
8725,158726,Thflfootoside A,CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC67C(CCC6(C5=CCC4C3(C)C)C)C(OC7=O)(C)CC(CC(C)C)OC(=O)C)C)O)O)O)O)OC8C(C(C(CO8)O)OC9C(C(C(C(O9)CO)O)OC)O)O,,,,,,
8726,158727,"Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-1-piperidinyl)-N-nitroso-",C1CC(=O)N(C(=O)C1)NC(=O)N(CCCl)N=O,,,,,,
8727,158728,CID 158728,CCC(=O)NC=C(C)CC1=CC(=C(C=C1)Cl)Cl,,,,,,
8728,158729,"(2S,3R,4S,5S,6R)-2-(3-phenylprop-2-enoxy)-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol",C1[C@@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OCC=CC3=CC=CC=C3)O)O)O)O)O)O,,,,,,
8729,158730,"Eburnamenine-14-carboxylic acid, 11-bromo-14,15-dihydro-14-hydroxy-, (3alpha,14beta,16alpha)-",CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=C(N4[C@](C2)(C(=O)O)O)C=C(C=C5)Br,,,,,,
8730,158731,"10H-Phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)-, hydrochloride",C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53.Cl,,,,,,
8731,158732,"Benzamide, 2,6-difluoro-N-(((4-(phenylazo)phenyl)amino)carbonyl)-",C1=CC=C(C=C1)N=NC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
8732,158733,"Ethyl 3,4-difluoro-2,2-dimethylbut-3-enoate",CCOC(=O)C(C)(C)C(=CF)F,,,,,,
8733,158734,"Benzene, 1,1'-(2-methyl-2-nitropropylidene)bis(4-methoxy-",CC(C)(C(C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC)[N+](=O)[O-],,,,,,
8734,158735,"1,3-Dimethyl-2-imino-5-(6-bromo-1H-indole-3-ylmethylene)imidazolidine-4-one",CN1C(=C(N(C1=N)C)O)C=C2C=NC3=C2C=CC(=C3)Br,,,,,,
8735,158736,2-Chloroethenylarsonous acid,C(=C[As](O)O)Cl,,,,,,
8736,158737,"24-Norcholan-23-oic acid, 3,7,12-trihydroxy-, monosodium salt, (3alpha,5beta,7alpha,12alpha)-",C[C@H](CC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C.[Na+],,,,,,
8737,158738,Norcholic acid,C[C@H](CC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
8738,158739,2-Methoxystypandrone,CC1=CC2=C(C(=O)C=C(C2=O)OC)C(=C1C(=O)C)O,,,,,,
8739,158740,CID 158740,C[C@H]([C@@H]1CCC2[C@@]1(CC[C@H]3C2C=CC4=CC(=O)CC[C@]34C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
8740,158741,"8-(2-Acetamido-3-phenylbutanoyl)oxy-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid",CC(C1=CC=CC=C1)C(C(=O)OC(C=CC=CC=CC(=O)O)C2(CO2)C)NC(=O)C,,,,,,
8741,158742,"7-Isoquinolinol, 1,2,3,4-tetrahydro-1-((3-hydroxy-4-methoxyphenyl)methyl)-6-methoxy-2-(2-propenyl)-, (S)-",COC1=C(C=C(C=C1)C[C@H]2C3=CC(=C(C=C3CCN2CC=C)OC)O)O,,,,,,
8742,158743,"Benzonitrile, 2,2'-(3-methyl-1-triazene-1,3-diyl)bis(4-(trifluoromethyl)-",CN(C1=C(C=CC(=C1)C(F)(F)F)C#N)N=NC2=C(C=CC(=C2)C(F)(F)F)C#N,,,,,,
8743,158744,"Benzonitrile, 2,2'-(3-benzoyl-1-triazene-1,3-diyl)bis(4-(trifluoromethyl)-",C1=CC=C(C=C1)C(=O)N(C2=C(C=CC(=C2)C(F)(F)F)C#N)N=NC3=C(C=CC(=C3)C(F)(F)F)C#N,,,,,,
8744,158745,CID 158745,C(CP(=O)O)[C@@H](C(=O)O)N,,,,,,
8745,158746,"L-Glutamic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)[O-].C(CC(=O)O)[C@@H](C(=O)O)N,,,,,,
8746,158747,"2-[2-(4-Methoxyphenyl)ethenyl]-1,8-naphthyridine",COC1=CC=C(C=C1)C=CC2=NC3=C(C=CC=N3)C=C2,,,,,,
8747,158748,"Carbamic acid, (3,4-dichlorophenyl)-, 4-acetylphenyl ester",CC(=O)C1=CC=C(C=C1)OC(=O)NC2=CC(=C(C=C2)Cl)Cl,,,,,,
8748,158749,"Thieno(3,2-c)pyridine, 4,5-dihydro-5-methyl-4-(2-propenyl)-",CN1C=CC2=C(C1CC=C)C=CS2,,,,,,
8749,158750,Betaenone B,CC[C@@H](C)[C@@H]1[C@]([C@H]2[C@@H](C[C@@](C[C@@H]2C(=O)[C@@]1(C)O)(C)O)C)(C)C(=O)CCO,,,,,,
8750,158751,"1,3-Propanediol, 1,2-bis(4-methoxyphenyl)-",COC1=CC=C(C=C1)C(CO)C(C2=CC=C(C=C2)OC)O,,,,,,
8751,158752,CID 158752,COC1=C(C=C(C=C1)C(=CF)CN)OC.Cl,,,,,,
8752,158753,"L-Proline, 1-(N-(2-(benzoylamino)-3-phenylpropyl)glycyl)-, (S)-",C1C[C@H](N(C1)C(=O)CNC[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3)C(=O)O,,,,,,
8753,158754,"3-Decyn-2-one, 1,1,1-trifluoro-",CCCCCCC#CC(=O)C(F)(F)F,,,,,,
8754,158755,Oryzalexin A,C[C@]1(CC[C@@H]2C(=C1)C(=O)C[C@H]3[C@]2(CC[C@H](C3(C)C)O)C)C=C,,,,,,
8755,158756,"Glycine, N-(S-(2-chloro-1,1,2-trifluoroethyl)-N-L-gamma-glutamyl-L-cysteinyl)-",C(CC(=O)N[C@@H](CSC(C(F)Cl)(F)F)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
8756,158757,"Pyrimido(1,2-a)purin-10(3H)-one, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-4,6,7,8-tetrahydro-8-hydroxy-6-methyl-, (6S,8S)-",C[C@H]1C[C@@H](N2C(=O)C3=C(N=C2N1)N(C=N3)[C@@H]4C[C@@H]([C@H](O4)CO)O)O,,,,,,
8757,158758,(S)-(+)-rolipram,COC1=C(C=C(C=C1)[C@@H]2CC(=O)NC2)OC3CCCC3,,,,,,
8758,158759,"Phosphonic acid, (1,4-phenylenebis(aminomethylene))bis-",C1=CC(=CC=C1C(N)P(=O)(O)O)C(N)P(=O)(O)O,,,,,,
8759,158760,"Phenol, 3,4,5-trichloro-2-methoxy-, acetate",CC(=O)OC1=CC(=C(C(=C1OC)Cl)Cl)Cl,,,,,,
8760,158761,"Phenol, 2,3,4,5-tetrachloro-6-methoxy-, acetate",CC(=O)OC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)OC,,,,,,
8761,158762,"Phosphonamidic acid, P-(dichloromethyl)-, methyl ester",COP(=O)(C(Cl)Cl)N,,,,,,
8762,158763,"Phosphonamidic acid, P-(dichloromethyl)-N-methyl-, methyl ester",CNP(=O)(C(Cl)Cl)OC,,,,,,
8763,158764,"Phosphonamidic acid, P-(dichloromethyl)-N-propyl-, methyl ester",CCCNP(=O)(C(Cl)Cl)OC,,,,,,
8764,158765,"Phosphonamidic acid, N-butyl-P-(dichloromethyl)-, methyl ester",CCCCNP(=O)(C(Cl)Cl)OC,,,,,,
8765,158766,"Phosphonamidic acid, P-(dichloromethyl)-N-(1-methylethyl)-, methyl ester",CC(C)NP(=O)(C(Cl)Cl)OC,,,,,,
8766,158767,"Phosphonamidic acid, P-(dichloromethyl)-N-phenyl-, methyl ester",COP(=O)(C1=CC=C(C=C1)C(Cl)Cl)N,,,,,,
8767,158768,"Phosphonamidic acid, P-(dichloromethyl)-N-(4-methoxyphenyl)-, methyl ester",COC1=CC=C(C=C1)NP(=O)(C(Cl)Cl)OC,,,,,,
8768,158769,"Phosphonamidic acid, P-(dichloromethyl)-N-(4-methylphenyl)-, methyl ester",CC1=CC=C(C=C1)NP(=O)(C(Cl)Cl)OC,,,,,,
8769,158770,"Phosphonamidic acid, P-(dichloromethyl)-N,N-dimethyl-, methyl ester",CN(C)P(=O)(C(Cl)Cl)OC,,,,,,
8770,158771,"Phosphonamidic acid, P-(dichloromethyl)-N,N-diethyl-, methyl ester",CCN(CC)P(=O)(C(Cl)Cl)OC,,,,,,
8771,158772,"Phosphonic diamide, P-(dichloromethyl)-",C(P(=O)(N)N)(Cl)Cl,,,,,,
8772,158773,"Phosphonic diamide, P-(dichloromethyl)-N,N'-dimethyl-",CNP(=O)(C(Cl)Cl)NC,,,,,,
8773,158774,"Phosphonic diamide, P-(dichloromethyl)-N,N'-dipropyl-",CCCNP(=O)(C(Cl)Cl)NCCC,,,,,,
8774,158775,"Phosphonic diamide, N,N'-dibutyl-P-(dichloromethyl)-",CCCCNP(=O)(C(Cl)Cl)NCCCC,,,,,,
8775,158776,"Phosphonic diamide, P-(dichloromethyl)-N,N'-bis(1-methylethyl)-",CC(C)NP(=O)(C(Cl)Cl)NC(C)C,,,,,,
8776,158777,"Phosphonic diamide, P-(dichloromethyl)-N,N'-bis(4-methoxyphenyl)-",COC1=CC=C(C=C1)NP(=O)(C(Cl)Cl)NC2=CC=C(C=C2)OC,,,,,,
8777,158778,"Phosphonic diamide, P-(dichloromethyl)-N,N'-bis(4-methylphenyl)-",CC1=CC=C(C=C1)NP(=O)(C(Cl)Cl)NC2=CC=C(C=C2)C,,,,,,
8778,158779,"Phosphonic diamide, P-(dichloromethyl)-N,N,N',N'-tetraethyl-",CCN(CC)P(=O)(C(Cl)Cl)N(CC)CC,,,,,,
8779,158780,Glufanide disodium,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)[O-])NC(=O)[C@H](CCC(=O)[O-])N.[Na+].[Na+],,,,,,
8780,158781,Olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,"['Olmesartan is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents.   Olmesartan is also used off-label for the management Type 2 Diabetes-associated nephropathy, heart failure, and post-myocardial infarction, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization. Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.']","[""Overall, olmesartan's physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium.    **Hypotension in Volume- or Salt-Depleted Patients**  In patients with an activated renin-angiotensin aldosterone system, such as volume-and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with olmesartan. Initiate treatment under close medical supervision. If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline. A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized.  Valvular Stenosis: there is concern on theoretical grounds that patients with aortic stenosis might be at a particular risk of decreased coronary perfusion, because they do not develop as much afterload reduction.   **Impaired Renal Function**  As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan. In patients whose renal function may depend upon the activity of the renin-angiotensin- aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan.  In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported. There has been no long-term use of olmesartan medoxomil in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected.   **Sprue-like Enteropathy**  Severe, chronic diarrhea with substantial weight loss has been reported in patients taking olmesartan months to years after drug initiation. Intestinal biopsies of patients often demonstrated villous atrophy. If a patient develops these symptoms during treatment with olmesartan, exclude other etiologies. Consider discontinuation of olmesartan medoxomil in cases where no other etiology is identified.   **Electrolyte Imbalances**  Olmesartan medoxomil contains olmesartan, a drug that inhibits the renin-angiotensin system (RAS). Drugs that inhibit the RAS can cause hyperkalemia. Monitor serum electrolytes periodically.""]","['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)']","['When taken orally, the prodrug olmesartan medoxomil is rapidly absorbed in the gastrointestinal tract and metabolized to olmesartan. The esterification with medoxomil was created with the intention of increasing olmesartan bioavailability from 4.5% to 28.6%.  Oral administration of 10-160 mg of olmesartan has been shown to reach peak plasma concentration of 0.22-2.1 mg/L after 1-3 hours with an AUC of 1.6-19.9mgh/L. The pharmacokinetic profile of olmesartan has been observed to be nearly linear and dose-dependent under the therapeutic range. The steady-state level of olmesartan is achieved after once a day dosing during 3 to 5 days.', 'The main elimination route of olmesartan is in the unchanged form through the feces. From the systemically bioavailable dose, about 10-16% is eliminated in the urine.', '17 L', 'Total plasma clearance is 1.3 L/h and the renal clearance is 0.6 L/h.', 'In rats, olmesartan crossed the blood-brain barrier poorly, if at all. Olmesartan passed across the placental barrier in rats and was distributed to the fetus.', 'The volume of distribution of olmesartan is approximately 17 L. Olmesartan is highly bound to plasma proteins (99%) and does not penetrate red blood cells. The protein binding is constant at plasma olmesartan concentrations well above the range achieved with recommended doses.', 'Olmesartan medoxomil is rapidly and completely bioactivated by ester hydrolysis to olmesartan during absorption from the gastrointestinal tract. Benicar tablets and the suspension formulation prepared from Benicar tablets are bioequivalent. The absolute bioavailability of olmesartan is approximately 26%. After oral administration, the peak plasma concentration (Cmax ) of olmesartan is reached after 1 to 2 hours. Food does not affect the bioavailability of olmesartan.', 'Total plasma clearance of olmesartan is 1.3 L/hr, with a renal clearance of 0.6 L/hr. Approximately 35% to 50% of the absorbed dose is recovered in urine while the remainder is eliminated in feces via the bile. ... Olmesartan shows linear pharmacokinetics following single oral doses of up to 320 mg and multiple oral doses of up to 80 mg. Steady-state levels of olmesartan are achieved within 3 to 5 days and no accumulation in plasma occurs with once-daily dosing.', 'Olmesartan is distributed into milk in rats; it is not known whether the drug is distributed into milk in humans.']","['Olmesartan medoxomil is rapidly and completely bioactivated by ester hydrolysis to olmesartan during absorption from the gastrointestinal tract. This rapid first-pass metabolism was confirmed by the lack of measurable amounts of olmesartan medoxomil in plasma or excreta. This first-pass metabolism is not driven by cytochrome enzymes and hence it is not expected to interact with other drugs via this mechanism.  The pharmacologically active moiety does not appear to undergo further metabolism.', 'Following the rapid and complete conversion of olmesartan medoxomil to olmesartan during absorption, there is virtually no further metabolism of olmesartan.']","['The mean plasma olmesartan half-life is reported to be from 10-15 hours after multiple oral administration.', 'Olmesartan appears to be eliminated in a biphasic manner with a terminal elimination half-life of approximately 13 hours.']"
8781,158782,Edotreotide,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@H](CO)[C@@H](C)O)O,['This medicinal product is for diagnostic use only.'],,"['Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)']",,,
8782,158783,"(2S)-2-[(benzylamino)methyl]-2,3,7,9-tetrahydro-[1,4]dioxino[2,3-e]indol-8-one;but-2-enedioic acid",C1[C@@H](OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
8783,158784,Aplindore,C1[C@@H](OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4,"[""Investigated for use/treatment in parkinson's disease and neurologic disorders.""]",,,,,
8784,158785,CID 158785,COCCOC(=O)NCCCC[C@@H](C(=O)NCCCCCOP(=O)(C)O)NC(=O)OCCOC.[NaH],,,,,,
8785,158786,"5-[[(2S)-2,6-bis(2-methoxyethoxycarbonylamino)hexanoyl]amino]pentoxy-methylphosphinic acid",COCCOC(=O)NCCCC[C@@H](C(=O)NCCCCCOP(=O)(C)O)NC(=O)OCCOC,,,,,,
8786,158787,"N-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide",C1CC1CON(C2=C(C=NC=C2Cl)Cl)C(=O)C3=CC=C(C=C3)OC(F)F,,,,,,
8787,158788,CID 158788,C1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)[O-])O.[Na+],,,,,,
8788,158789,Salcaprozic acid,C1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)O)O,,,,,,
8789,158790,"Piperidine, 3-((4-methoxyphenoxy)methyl)-4-phenyl-, (3R,4S)-",COC1=CC=C(C=C1)OC[C@H]2CNCC[C@@H]2C3=CC=CC=C3,,,,,,
8790,158791,"4H-1,3,2-Benzodioxaphosphorin, 4-methyl-2-phenyl-, 2-oxide",CC1C2=CC=CC=C2OP(=O)(O1)C3=CC=CC=C3,,,,,,
8791,158792,CID 158792,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+],,,,,,
8792,158793,Talibegron hydrochloride,C1=CC=C(C=C1)[C@H](CNCCOC2=CC=C(C=C2)CC(=O)O)O.Cl,,,,,,
8793,158794,Talibegron,C1=CC=C(C=C1)[C@H](CNCCOC2=CC=C(C=C2)CC(=O)O)O,,,,,,
8794,158795,Tecadenoson,C1COC[C@@H]1NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,['Investigated for use/treatment in arrhythmia and atrial fibrillation.'],"['Tecadenoson is a novel A1 adenosine receptor stimulator. Adenosine is a naturally occurring compound that stimulates all adenosine receptor subtypes in the body, including the A2 adenosine receptor which lowers blood pressure. In non-clinical trials, tecadenoson selectively stimulated the A1 adenosine receptor in the AV node and slowed the speed of electrical conduction across the AV node, reducing the number of electrical impulses that reached the ventricle, without affecting blood pressure. Clinical studies to date with intravenous tecadenoson suggest that it may slow the speed of AV nodal conduction by selectively stimulating the A1 adenosine receptor, and may avoid blood pressure lowering by not stimulating the A2 adenosine receptor. Thus, it may be possible to use intravenous tecadenoson to convert patients from PSVT to normal sinus rhythm without lowering blood pressure or causing adverse events related to vasodilitation such as flushing, palpitations or headache.']",['Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)'],,,
8795,158796,Tecalcet hydrochloride,C[C@H](C1=CC(=CC=C1)OC)NCCCC2=CC=CC=C2Cl.Cl,,,,,,
8796,158797,Tecalcet,C[C@H](C1=CC(=CC=C1)OC)NCCCC2=CC=CC=C2Cl,,,,,['Tecalcet has known human metabolites that include 3-[1-[3-(2-Chlorophenyl)propylamino]ethyl]phenol.'],
8797,158798,Antazoline phosphate,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.OP(=O)(O)O,,,"['Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)', 'Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)']",,,
8798,158799,CID 158799,C[C@H](C(=O)OC)NP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C=CBr)O)OC3=CC=CC=C3,,,,,,
8799,158800,"[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate",C[C@@H]1CC=CC=C[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,,,,,,
8800,158801,CID 158801,CC[C@@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N,,,,,,
8801,158802,Mupinensisone,C[C@]12CC[C@@](C[C@H]1C3=CC[C@@H]4[C@]5(CCC(=O)C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)C)(C)CO,,,,,,
8802,158803,Teuquadrin B,CC1CC2[C@@]3(C(CCCC3C14CC(OC4=O)C5=COC=C5)C(=O)O2)COC(=O)C,,,,,,
8803,158804,CID 158804,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O,,,,,,
8804,158805,CID 158805,CC1=CN=C2C=CC3=C(C2=N1)NC(N3C)NC4NC5=C(N4C6CC(C(O6)COP(=O)(O)O)OP(=O)(O)O)NC(=NC5=O)N,,,,,,
8805,158806,"Methyl 9alpha-fluoro-11beta,21-dihydroxy-3,20-dioxo-1,4-pregnadiene-16alpha-carboxylate",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@H]2C(=O)CO)C(=O)OC)CCC4=CC(=O)C=C[C@@]43C)F)O,,,,,,
8806,158807,CID 158807,CC[C@H]1CCC2[C@@H]([C@H](C(C3(O2)CCC(C(O3)CC(CC)O)C)C)OC(=O)C=C[C@@H]([C@H]([C@@H](C(=O)[C@@H]([C@@H]([C@@H](C(=O)[C@]([C@@H]([C@@H](CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C,,,,,,
8807,158808,Oxopropaline A,CC1C(C(C(C(O1)OC(CO)C(=O)C2=NC=C(C3=C2NC4=CC=CC=C43)C)O)O)O,,,,,,
8808,158809,"2-hydroxy-1-(4-methyl-9H-pyrido[3,4-b]indol-1-yl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxypropan-1-one",CC1C(C(C(C(O1)OCC(C(=O)C2=NC=C(C3=C2NC4=CC=CC=C43)C)O)O)O)O,,,,,,
8809,158810,Oxopropaline D,CC1=CN=C(C2=C1C3=CC=CC=C3N2)C(=O)[C@H](CO)O,,,,,,
8810,158811,Oxopropaline E,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OCCC(=O)C2=NC=C(C3=C2NC4=CC=CC=C43)C)O)O)O,,,,,,
8811,158812,Oxopropaline G,CC1=CN=C(C2=C1C3=CC=CC=C3N2)C(=O)CCO,,,,,,
8812,158813,"Phosphonic diamide, P-(dichloromethyl)-N,N'-diethyl-",CCNP(=O)(C(Cl)Cl)NCC,,,,,,
8813,158814,but-2-enedioic acid;N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43.C(=CC(=O)O)C(=O)O,,,,,,
8814,158815,P-Hydroxymethamphetamine,C[C@@H](CC1=CC=C(C=C1)O)NC,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)']",,['4-Hydroxymethamphetamine is a known human metabolite of Metamphetamine.'],
8815,158816,"Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetra(chloro-37Cl)-",C1=C2C(=CC(=C1[37Cl])[37Cl])OC3=CC(=C(C=C3O2)[37Cl])[37Cl],,,,,,
8816,158817,"(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-oxobutanoate",CC(=O)CC(=O)OCC1COC(O1)(C)C,,,,,,
8817,158818,"alpha-D-Glucopyranose, 1-(3,3',5-trihydroxy(1,1'-biphenyl)-2-carboxylate)",C1=CC(=CC(=C1)O)C2=C(C(=CC(=C2)O)O)C(=O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8818,158819,"beta-D-Glucopyranose, 1-(3,3',5-trihydroxy(1,1'-biphenyl)-2-carboxylate)",C1=CC(=CC(=C1)O)C2=C(C(=CC(=C2)O)O)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8819,158820,"3-Chlorohexa-2,4-dienoic acid",CC=CC(=CC(=O)O)Cl,,,,,,
8820,158821,"Phosphoramidodithioic acid, formylmethyl-, O-ethyl S-(1-methylpropyl) ester",CCC(C)SP(=S)(N(C)C=O)OCC,,,,,,
8821,158822,"Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-, (OC-6-11)-diamminetetrakis(thiocyanato-N)chromate(1-)",COC1=C(C=C2C=[N+]3CCC4=CC5=C(C=C4C3=CC2=C1)OCO5)OC.C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].N.N.[Cr+3],,,,,,
8822,158823,"Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-10,11-dimethoxy-",COC1=C(C=C2C=[N+]3CCC4=CC5=C(C=C4C3=CC2=C1)OCO5)OC,,,,,,
8823,158824,"Phosphoramidodithioic acid, ethyl(thioxomethyl)-, O-ethyl S-(1-methylpropyl) ester",CCC(C)SP(=S)(N(CC)C=S)OCC,,,,,,
8824,158825,"Disulfide, bis((methylthio)methyl)",CSCSSCSC,,,,,,
8825,158826,Dysazecine,CN1CCCC2=CC3=C(C=C2C4=CC(=C(C=C4CC1)OC)OC)OCO3,,,,,,
8826,158827,Neotomatine,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)C)C)NC1,,,,,,
8827,158828,"9,10-Dichlorooctadec-12-enoic acid",CCCCCC=CCC(C(CCCCCCCC(=O)O)Cl)Cl,,,,,,
8828,158829,CID 158829,CCCCCC(C(CC=CCCCCCCCC(=O)O)Cl)Cl,,,,,,
8829,158830,(pentan-2-ylideneamino) N-methylcarbamate,CCCC(=NOC(=O)NC)C,,,,,,
8830,158831,Ethyl 2-methyl-3-(methylcarbamoyloxyimino)butanoate,CCOC(=O)C(C)C(=NOC(=O)NC)C,,,,,,
8831,158832,"3-Pentanone, O-((methylamino)carbonyl)oxime",CCC(=NOC(=O)NC)CC,,,,,,
8832,158833,"1,3,5-Triazin-2-amine, 4-chloro-N,N-diethyl-6-(3-fluorophenoxy)-",CCN(CC)C1=NC(=NC(=N1)Cl)OC2=CC(=CC=C2)F,,,,,,
8833,158834,"1,2,3,4-Tetrahydrobenzo[f]quinoxaline-5,6-dione",C1CN=C2C(=C(C3=CC=CC=C3C2=N1)O)O,,,,,,
8834,158835,"Benzeneethanol, 4-ethoxy-beta-(4-ethoxyphenyl)-alpha,alpha-dimethyl-",CCOC1=CC=C(C=C1)C(C2=CC=C(C=C2)OCC)C(C)(C)O,,,,,,
8835,158836,"Benzenepropanamine, N-((1R)-1-methyl-2-phenylethyl)-gamma-phenyl-",C[C@H](CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8836,158837,"Oxayohimbanium, 3,4,16,17-tetradehydro-16-(methoxycarbonyl)-19-methyl-, (19alpha)-",C[C@H]1[C@H]2C[N+]3=C(C[C@@H]2C(=CO1)C(=O)OC)C4=C(CC3)C5=CC=CC=C5N4,,,,,,
8837,158838,(S)-Homolaudanosine,CN1CCC2=CC(=C(C=C2[C@@H]1CCC3=CC(=C(C=C3)OC)OC)OC)OC,,,,,,
8838,158839,"17H-Cyclopenta(a)phenanthren-17-one, 15,16-dihydro-1-methyl-",CC1=C2C(=CC=C1)C=CC3=C2C=CC4=C3CCC4=O,,,,,,
8839,158840,"9H-Fluorene, 9,9'-(bicyclo(4.4.1)undeca-1,3,5,7,9-pentaene-2,7-diyldimethylidyne)bis-",C1C2=CC=CC=C1C(=CC=C2C=C3C4=CC=CC=C4C5=CC=CC=C53)C=C6C7=CC=CC=C7C8=CC=CC=C86,,,,,,
8840,158841,"Bicyclo(4.4.1)undeca-1,3,5,7,9-pentaene-2-carboxaldehyde,7-(9H-fluoren-9-ylidenemethyl)-",C1C2=C(C=CC=C1C(=CC=C2)C=C3C4=CC=CC=C4C5=CC=CC=C53)C=O,,,,,,
8841,158842,"4(1H)-Pyrimidinone, 5-(1,3-benzodioxol-5-ylmethyl)-2-((2-(((5-methyl-1H-imidazol-4-yl)methyl)sulfinyl)ethyl)amino)-",CC1=C(N=CN1)CS(=O)CCNC2=NC=C(C(=O)N2)CC3=CC4=C(C=C3)OCO4,,,,,,
8842,158843,CID 158843,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COS(=O)(=O)[O-])C3=CC=CC=C3.[K+],,,,,,
8843,158844,"(2,5-Dioxo-4,4-diphenylimidazolidin-1-yl)methyl hydrogen sulfate",C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COS(=O)(=O)O)C3=CC=CC=C3,,,,,,
8844,158845,Curculigoside,COC1=C(C(=CC=C1)OC)C(=O)OCC2=C(C=CC(=C2)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8845,158846,"8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one, 9-methoxy-5-(9-methoxy-7-methyl-7H-benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-yl)-",CN1C=CC2=CC3=C(C4=C2C1=C(C5=C4C=CC=C5OC)C6=CN=C7C8=C(C9=C(C7=O)C(=CC=C9)OC)C1=C(C=C68)OCO1)OCO3,,,,,,
8846,158847,"[(3S,3aR,5aS,6R,9aR,9bS)-6-acetyloxy-3,5a,9-trimethyl-2-oxo-4,5,6,7,9a,9b-hexahydro-3aH-benzo[g][1]benzofuran-3-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@]1([C@@H]2CC[C@@]3([C@@H](CC=C([C@H]3[C@@H]2OC1=O)C)OC(=O)C)C)C,,,,,,
8847,158848,"4H,6H,8H-Pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-4,13(1H)-dione, 9-(3-furanyl)-2a,3,6b,7,8a,9,11,12b,14,14a-decahydro-1,1,8a,12b-tetramethyl-, (2aS,6aR,6bR,8aS,9R,12bR,14aR)-",CC1(C2CC(=O)C3(C(C24COC(=O)CC4O1)CCC5(C3=CCOC5C6=COC=C6)C)C)C,,,,,,
8848,158849,C.I. Reactive Red 220,C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C=CC(=C4)NC5=NC(=NC(=N5)F)NC6=C(C7=CC=CC=C7C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
8849,158850,"5-Benzamido-3-((5-((4-fluoro-6-((1-sulfo-2-naphthalenyl)amino)-1,3,5-triazin-2-yl)amino)-2-sulfophenyl)diazenyl)-4-hydroxy-2,7-naphthalenedisulfonic acid",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C=CC(=C4)NC5=NC(=NC(=N5)F)NC6=C(C7=CC=CC=C7C=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
8850,158851,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranosyloxy)-2,3-dihydro-5-methoxy-6-methyl-, (S)-",CC1=C(C=C2C(=C1OC)C(=O)C[C@H](O2)C3=CC(=C(C=C3)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
8851,158852,"Benzeneacetamide, N-(aminocarbonyl)-4-iodo-",C1=CC(=CC=C1CC(=O)NC(=O)N)I,,,,,,
8852,158853,"3-Quinolinecarboxylic acid, 4-hydroxy-6-(1H-pyrrol-1-yl)-",C1=CN(C=C1)C2=CC3=C(C=C2)NC=C(C3=O)C(=O)O,,,,,,
8853,158854,Macrophorin A,C[C@]12CCCC([C@@H]1CCC(=C)[C@@H]2C[C@]34[C@H](O3)[C@@H](C(=CC4=O)CO)O)(C)C,,,,,,
8854,158855,"Guanosine, 2'-deoxy-6-O-(1-methylethyl)-",CC(C)OC1=NC(=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)CO)O)N,,,,,,
8855,158856,Carbamazepine dihydrate,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N.O.O,,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)', 'Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inducers.)', 'Agents that are used to treat bipolar disorders or mania associated with other affective disorders. (See all compounds classified as Antimanic Agents.)', 'Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)', 'A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. (See all compounds classified as Sodium Channel Blockers.)']",,,
8856,158857,"1-Decanol, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heneicosafluoro-",C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(C(C(O)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
8857,158858,4-Methylidenetetradec-2-enal,CCCCCCCCCCC(=C)C=CC=O,,,,,,
8858,158859,Pentadecadienal,CCCCCCCCCCC=CC=CC=O,,,,,,
8859,158860,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 2-methyl-5-phenyl-, 1,1-dioxide",CN1C(=O)NC(=NS1(=O)=O)C2=CC=CC=C2,,,,,,
8860,158861,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 2-methyl-5-(1-methylethyl)-, 1,1-dioxide",CC(C)C1=NS(=O)(=O)N(C(=O)N1)C,,,,,,
8861,158862,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 2-ethyl-5-methyl-, 1,1-dioxide",CCN1C(=O)NC(=NS1(=O)=O)C,,,,,,
8862,158863,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 5-methyl-2-propyl-, 1,1-dioxide",CCCN1C(=O)NC(=NS1(=O)=O)C,,,,,,
8863,158864,"2H-1,2,4,6-Thiatriazin-3(4H)-one, 5-ethyl-2-methyl-, 1,1-dioxide",CCC1=NS(=O)(=O)N(C(=O)N1)C,,,,,,
8864,158865,"2H-1,2,4,6-Thiatriazine, 3-chloro-2,5-dimethyl-, 1,1-dioxide",CC1=NS(=O)(=O)N(C(=N1)Cl)C,,,,,,
8865,158866,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-ethyl-5-methyl-, 1,1-dioxide",CCN1C(=NC(=NS1(=O)=O)C)Cl,,,,,,
8866,158867,"2H-1,2,4,6-Thiatriazine, 3-chloro-5-ethyl-2-methyl-, 1,1-dioxide",CCC1=NS(=O)(=O)N(C(=N1)Cl)C,,,,,,
8867,158868,"1-Oxaspiro(4.5)dec-9-ene-7,8-dione, 6,6,10-trichloro-",C1CC2(C(=CC(=O)C(=O)C2(Cl)Cl)Cl)OC1,,,,,,
8868,158869,"1-Oxaspiro(4.5)dec-9-ene-7,8-dione, 6,6,9,10-tetrachloro-",C1CC2(C(=C(C(=O)C(=O)C2(Cl)Cl)Cl)Cl)OC1,,,,,,
8869,158870,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-(2-chloroethyl)-5-ethyl-, 1,1-dioxide",CCC1=NS(=O)(=O)N(C(=N1)Cl)CCCl,,,,,,
8870,158871,"2H-1,2,4,6-Thiatriazine, 3-chloro-2-methyl-5-(1-methylethyl)-, 1,1-dioxide",CC(C)C1=NS(=O)(=O)N(C(=N1)Cl)C,,,,,,
8871,158872,Eproxindine hydrochloride,CCN(CC)CC(CNC(=O)C1=C(C2=CC=CC=C2N1C3=CC=CC=C3)OC)O.Cl,,,,,,
8872,158873,"1,2,3-Oxadiazolium, 4-((diethylamino)sulfonyl)-5-hydroxy-3-(2-methylphenyl)-, inner salt",CCN(CC)S(=O)(=O)C1=C(ON=[N+]1C2=CC=CC=C2C)[O-],,,,,,
8873,158874,"N,N-diethyl-3-(2-methylphenyl)-5-oxo-2H-oxadiazol-3-ium-4-sulfonamide",CCN(CC)S(=O)(=O)C1=[N+](NOC1=O)C2=CC=CC=C2C,,,,,,
8874,158875,"1,2,3-Oxadiazolium, 4-((ethylamino)sulfonyl)-5-hydroxy-3-(3-methylphenyl)-, inner salt",CCNS(=O)(=O)C1=C(ON=[N+]1C2=CC=CC=C2C)[O-],,,,,,
8875,158876,N-ethyl-3-(2-methylphenyl)-5-oxo-2H-oxadiazol-3-ium-4-sulfonamide,CCNS(=O)(=O)C1=[N+](NOC1=O)C2=CC=CC=C2C,,,,,,
8876,158877,"Furo(2,3-b)quinoline, 4-methoxy-7-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=CC2=C(C=C1)C(=C3C=COC3=N2)OC)C,,,,,,
8877,158878,CID 158878,C1C=C([C@@H]2[C@H]1C=COC2O[C@@H]3[C@@H]([C@H]([C@@H]([C@@](O3)(CO)O)O)O)O)COC(=O)C=CC4=CC=C(C=C4)O,,,,,,
8878,158879,CID 158879,CC(=CCO)CCC=C(C)C(=O)O[C@@H]1C[C@]([C@@H]2[C@H]1C=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)(C)O,,,,,,
8879,158880,CID 158880,CC(=CCO)CCC=C(C)C(=O)O[C@H]1[C@@H]2C=CO[C@H]([C@@H]2[C@@]3([C@H]1O3)CO)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
8880,158881,"Benzenemethanol, 2-((2-hydroxypropyl)methylamino)-alpha,alpha-diphenyl-",CC(CN(C)C1=CC=CC=C1C(C2=CC=CC=C2)(C3=CC=CC=C3)O)O,,,,,,
8881,158882,Cycleanine N-oxide,CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC=C(O3)C=C7)[N+](CCC6=CC(=C5OC)OC)(C)[O-])OC)OC,,,,,,
8882,158883,"Benzo(f)-1,3-benzodioxolo(6,5,4-cd)indol-5(6H)-one, 8-hydroxy-",C1OC2=C(O1)C3=C4C=CC=C(C4=CC5=C3C(=C2)C(=O)N5)O,,,,,,
8883,158884,"1,6-Dioxa-2-azaspiro(4.6)undeca-2,7,9-triene-3-carboxamide,N-(3-(4-(2-aminoethyl)-2,6-dibromophenoxy)propyl)-8,10-dibromo-4-hydroxy-9-methoxy-, (4R,5R)-rel-(-)-",COC1=C(O[C@]2(CC=C1Br)[C@H](C(=NO2)C(=O)NCCCOC3=C(C=C(C=C3Br)CCN)Br)O)Br,,,,,,
8884,158885,"1,6-Dioxa-2-azaspiro(4.6)undeca-2,7,9-triene-3-carboxamide,N-(3-(4-(2-amino-1-hydroxyethyl)-2,6-dibromophenoxy)propyl)-8,10-dibromo-4-hydroxy-9-methoxy-",COC1=C(CC2(C(C(=NO2)C(=O)NCCCOC3=C(C=C(C=C3Br)C(CN)O)Br)O)OC=C1Br)Br,,,,,,
8885,158886,"D-Leucine, N2-(3,7-dimethyl-1-oxooctyl)-L-lysyl-L-lysyl-L-threonyl-L-lysyl-, cyclic (5->2)-peptide, dihydrochloride 5",C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCC[C@@H](C(=O)N1)NC(=O)[C@H](CCCCN)NC(=O)CC(C)CCCC(C)C)CC(C)C)CCCCN)O.Cl.Cl,,,,,,
8886,158887,CID 158887,C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCCC(C(=O)N1)NC(=O)[C@H](CCCCN)NC(=O)CC(C)CCCC(C)C)CC(C)C)CCCCN)O,,,,,,
8887,158888,CID 158888,CC1=C[C@H]([C@H]2[C@H](CC(=C)[C@H](CC1)O)OC(=O)C2=C)OC(=O)C,,,,,,
8888,158889,"Methanamine, 1-(5-(5-bromo-1H-pyrrol-2-yl)-3-methoxy-2H-pyrrol-2-ylidene)-, (1Z)-",COC1=C(NC(=C1)C2=CC=C(N2)Br)C=N,,,,,,
8889,158890,"Estra-1,3,5(10)-triene-3,17-diol, 16-(iodo-123I)-, (16alpha,17beta)-",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)[123I])CCC4=C3C=CC(=C4)O,,,,,,
8890,158891,"beta-D-Glucopyranosiduronic acid, (3beta,4alpha)-17-carboxy-23-hydroxy-28-norolean-12-en-3-yl",C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,,,,,,
8891,158892,"3-Butenoic acid, 3-methyl-2-(1-methylethyl)-, cyano(3-phenoxyphenyl)methyl ester",CC(C)C(C(=C)C)C(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
8892,158893,"Butanoic acid, 3,3-dimethyl-, cyano(3-phenoxyphenyl)methyl ester",CC(C)(C)CC(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
8893,158894,"1H-Imidazole, 1-(3,7-dimethyl-6-octenyl)-5-phenyl-",CC(CCC=C(C)C)CCN1C=NC=C1C2=CC=CC=C2,,,,,,
8894,158895,"2,4-Imidazolidinedione, 3-((1-oxopropoxy)methyl)-5,5-diphenyl-",CCC(=O)OCN1C(=O)C(NC1=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8895,158896,"Pentanoic acid, (2,5-dioxo-4,4-diphenyl-1-imidazolidinyl)methyl ester",CCCCC(=O)OCN1C(=O)C(NC1=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8896,158897,"2,4-Dichloro-1-(methylsulfonyl)benzene",CS(=O)(=O)C1=C(C=C(C=C1)Cl)Cl,,,,,,
8897,158898,CID 158898,C1=CC=C(C=C1)C2=NC3=CC(=O)C=CC3=C(O2)O,,,,,,
8898,158899,N-benzoyl-4-hydroxyanthranilic acid,C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)O)C(=O)O,,,,,,
8899,158900,"2,6,7-Trioxabicyclo(2.2.2)octane, 1,4-diphenyl-",C1C2(COC(O1)(OC2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
8900,158901,"Carbamothioic acid, hexyl-, S-phenyl ester",CCCCCCNC(=O)SC1=CC=CC=C1,,,,,,
8901,158902,"Carbamic acid, hexyl-, phenyl ester",CCCCCCNC(=O)OC1=CC=CC=C1,,,,,,
8902,158903,"Carbamic acid, ethyl-, 2-(4-(3-fluorophenoxy)phenoxy)ethyl ester",CCNC(=O)OCCOC1=CC=C(C=C1)OC2=CC(=CC=C2)F,,,,,,
8903,158904,"Carbamic acid, ethyl-, 2-(4-(3-chlorophenoxy)phenoxy)ethyl ester",CCNC(=O)OCCOC1=CC=C(C=C1)OC2=CC(=CC=C2)Cl,,,,,,
8904,158905,"Butanedioic acid, compd. with 1-(1-(2-(3,4-dimethoxyphenyl)-2-hydroxy-1-methylethyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one",CC(C(C1=CC(=C(C=C1)OC)OC)O)N2CCC(CC2)N3C4=CC=CC=C4NC3=O.C(CC(=O)O)C(=O)O,,,,,,
8905,158906,"1-(1-(2-Hydroxy-2-(3,4-dimethoxyphenyl)-1-methylethyl)-4-piperidyl)-2-benzimidazolinone succinate",CC(C(C1=CC(=C(C=C1)OC)OC)O)N2CCC(CC2)N3C4=CC=CC=C4NC3=O,,,,,,
8906,158907,CID 158907,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5CC(OC5OC4=C1)S(=O)(=O)[O-].[Na+],,,,,,
8907,158908,"11-Methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraene-5-sulfonic acid",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5CC(OC5OC4=C1)S(=O)(=O)O,,,,,,
8908,158909,"4-Pyridinecarbonitrile, 2-(1-(12,13-dihydro-1,2-dimethoxy-12-methyl(1,3)benzodioxolo(5,6-c)phenanthridin-13-yl)ethyl)-, (R*,S*)-",C[C@@H]([C@@H]1C2=C(C=CC(=C2OC)OC)C3=C(N1C)C4=CC5=C(C=C4C=C3)OCO5)C6=NC=CC(=C6)C#N,,,,,,
8909,158910,"Spirostan-11-one, 3,12-dihydroxy-, (3beta,5alpha,12beta,25R)-",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3([C@@H](C(=O)[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C)C)OC1,,,,,,
8910,158911,"(2S,3S,4S,5S,6R)-6-[(tert-butylamino)methyl]-5-(2-cyclopentylphenoxy)-6-ethoxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CCO[C@]1([C@@]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)(O)OC2=CC=CC=C2C3CCCC3)CNC(C)(C)C,,,,,,
8911,158912,"Phosphorodithioic acid, O-ethyl S-(1-methylpropyl) S-propyl ester",CCCSP(=O)(OCC)SC(C)CC,,,,,,
8912,158913,CID 158913,CCNC(=O)NC(=O)C(=NOC)C#N.C(CN=C(S)[S-])NC(S)[S-].[Mn+2],,,,,,
8913,158914,"5-Hydroxy-6-(1-hydroxyethyl)-2,7-dimethoxy-1,4-naphthoquinone",CC(C1=C(C=C2C(=C1O)C(=O)C=C(C2=O)OC)OC)O,,,,,,
8914,158915,"Phosphoramidic acid, cyclooctyl-, diphenyl ester",C1CCCC(CCC1)NP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
8915,158916,"Propanediamide, 2-(3,4-dichlorophenyl)-2-hydroxy-",C1=CC(=C(C=C1C(C(=O)N)(C(=O)N)O)Cl)Cl,,,,,,
8916,158917,"Naphtho(2,3-c)furan-1(3H)-one, 9-(acetyloxy)-6-methoxy-8-((2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy)-",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=C3C(=CC(=C2)OC)C=C4COC(=O)C4=C3OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
8917,158918,"Naphtho(2,3-c)furan-1(3H)-one, 9-(acetyloxy)-8-((2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-beta-D-xylopyranosyl)-beta-D-glucopyranosyl)oxy)-",CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC=CC4=CC5=C(C(=C43)OC(=O)C)C(=O)OC5)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
8918,158919,"Naphtho(2,3-c)furan-1(3H)-one, 9-(acetyloxy)-6-methoxy-8-((2,3,4-tri-O-acetyl-6-O-(2,3,4-tri-O-acetyl-beta-D-xylopyranosyl)-beta-D-glucopyranosyl)oxy)-",CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C4C(=CC(=C3)OC)C=C5COC(=O)C5=C4OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
8919,158920,"L-Methionine, N-((2'-(2-aminoethyl)(2,4'-bithiazol)-4-yl)carbonyl)-, ethyl ester",CCOC(=O)[C@H](CCSC)NC(=O)C1=CSC(=N1)C2=CSC(=N2)CCN,,,,,,
8920,158921,"Uridine, 2'-deoxy-5-ethyl-, 3',3'''-sulfite",CCC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)OS(=O)O[C@H]3C[C@@H](O[C@@H]3CO)N4C=C(C(=O)NC4=O)CC,,,,,,
8921,158922,CID 158922,C1CCC(CC1)NCCC(COC2=CC=CC3=CC=CC=C32)O.C(=CC(=O)O)C(=O)O,,,,,,
8922,158923,"beta-D-Glucopyranoside, 7-(acetyloxy)-1,4a,5,6,7,7a-hexahydro-4a-hydroxy-4,7-dimethylcyclopenta(c)pyran-1-yl, (1S-(1alpha,4aalpha,7alpha,7aalpha))-",CC1=COC(C2C1(CCC2(C)OC(=O)C)O)OC3C(C(C(C(O3)CO)O)O)O,,,,,,
8923,158924,"2,13-Octadecadien-1-ol, 1-acetate, (2Z,13Z)-",CCCCC=CCCCCCCCCCC=CCOC(=O)C,,,,,,
8924,158925,CID 158925,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)NC)O,,,,,,
8925,158926,"2-amino-N-[4-amino-3-[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]-N-methylacetamide;disulfate",CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN)O)O)N)N)N.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-],,,,,,
8926,158927,3-O-Demethylfortimicin A,CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN)O)O)N)N)N,,,,,,
8927,158928,"6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one, 10-methoxy-",COC1=CC2=C(C=C1)N3C(=O)C=CC4=NC=CC2=C43,,,,,,
8928,158929,10-Hydroxycanthin-6-one,C1=CC2=C(C=C1O)C3=C4N2C(=O)C=CC4=NC=C3,,,,,,
8929,158930,"3H-Indolo(3,2,1-de)(1,5)naphthyridine-2,6-dione, 10-hydroxy-3-methoxy-",CON1C2=C3C(=CC1=O)C4=C(N3C(=O)C=C2)C=CC(=C4)O,,,,,,
8930,158931,"1,3,5-Triazine-2,4(1H,3H)-dione, 1,5-diacetyldihydro-",CC(=O)N1CN(C(=O)NC1=O)C(=O)C,,,,,,
8931,158932,3-(3-Methoxy-4-sulfooxyphenyl)prop-2-enoic acid,COC1=C(C=CC(=C1)C=CC(=O)O)OS(=O)(=O)O,,,,,,
8932,158933,"Dodecanamide, N-(2-(dimethyloxidoamino)ethyl)-",CCCCCCCCCCCC(=O)NCC[N+](C)(C)[O-],,,,,,
8933,158934,"Dodecanamide, N-(4-(dimethyloxidoamino)butyl)-",CCCCCCCCCCCC(=O)NCCCC[N+](C)(C)[O-],,,,,,
8934,158935,"Dodecanamide, N-(6-(dimethyloxidoamino)hexyl)-",CCCCCCCCCCCC(=O)NCCCCCC[N+](C)(C)[O-],,,,,,
8935,158936,"Dodecanamide, N-(8-(dimethyloxidoamino)octyl)-",CCCCCCCCCCCC(=O)NCCCCCCCC[N+](C)(C)[O-],,,,,,
8936,158937,"Dodecanoic acid, 2-(dimethyloxidoamino)ethyl ester",CCCCCCCCCCCC(=O)OCC[N+](C)(C)[O-],,,,,,
8937,158938,"Dodecanoic acid, 3-(dimethyloxidoamino)propyl ester",CCCCCCCCCCCC(=O)OCCC[N+](C)(C)[O-],,,,,,
8938,158939,CID 158939,CCC(=O)OCC(COC(=O)CC)OCN1C=NC2=C1NC(=NC2=O)N,,,,,,
8939,158940,5-Epideoxyloganic acid,C[C@H]1CC[C@@H]2[C@H]1[C@H](OC=C2C(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8940,158941,Cleistanthoside A,CO[C@@H]1CO[C@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC3=C4COC(=O)C4=C(C5=CC(=C(C=C53)OC)OC)C6=CC7=C(C=C6)OCO7,,,,,,
8941,158942,"Ethanone, 1-(4-(beta-D-glucopyranosyloxy)-3,5-dimethoxyphenyl)-",CC(=O)C1=CC(=C(C(=C1)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC,,,,,,
8942,158943,"O-((-)-Menthyl)-N,N'-diisopropylisourea",C[C@H]1CC[C@@H]([C@@H](C1)OC(=NC(C)C)NC(C)C)C(C)C,,,,,,
8943,158944,Iwaconitin,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@H](C(C31)C5(C[C@@H]([C@]6(C[C@@H]4[C@@H]5[C@H]6OC(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C8=CC=C(C=C8)OC)OC)OC)COC,,,,,,
8944,158945,"1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-5-(2-(methylamino)ethyl)-, (2S,3S)-",CNCCN1C2=CC=CC=C2S[C@H]([C@H](C1=O)O)C3=CC=C(C=C3)OC,,,,,,
8945,158946,"Olean-12-en-29-oic acid, 3,23-dihydroxy-, (3beta,4beta,20alpha)-",C[C@@]12CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H]([C@]5(C)CO)O)C)C)[C@H]1CC(CC2)(C)C(=O)O)C,,,,,,
8946,158947,Anchusoside-3,C[C@@]12CCC3[C@@]([C@@H]1CC=C4[C@]2(CC[C@@]5([C@@H]4CC([C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)(C)C)C(=O)O)C)(C[C@@H]([C@H]([C@]3(C)CO)O)O)C,,,,,,
8947,158948,"Butanoic acid, 2-(1,1-dimethylethyl)-3-hydroxy-3-methyl-, methyl ester",CC(C)(C)C(C(=O)OC)C(C)(C)O,,,,,,
8948,158949,Benzyloxycarbonylmitomycin C,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4C(=O)OCC5=CC=CC=C5)N,,,,,,
8949,158950,"Benzene, 1-(3-ethoxybutoxy)-4-phenoxy-",CCOC(C)CCOC1=CC=C(C=C1)OC2=CC=CC=C2,,,,,,
8950,158951,"Aconitane-1,8,14-triol, 16-methoxy-4-methyl-, 14-acetate, (1alpha,14alpha,16beta)-",CC(=O)OC1C2CC3C1C(CC2OC)(C4CC5C36C4NCC5(CCC6O)C)O,,,,,,
8951,158952,"Urea, N-methyl-N'-(2-methylphenyl)-N-phenyl-",CC1=CC=CC=C1NC(=O)N(C)C2=CC=CC=C2,,,,,,
8952,158953,"Phosphonic acid, (5-methoxy-2-methyl-1,1-dioxido-2H-1,2,4,6-thiatriazin-3-yl)-, dimethyl ester",CN1C(=NC(=NS1(=O)=O)OC)P(=O)(OC)OC,,,,,,
8953,158954,"(1S,12S,15S)-16-ethyl-15-methyl-11-methylidene-15-oxido-9-aza-15-azoniatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraene",CCC1[C@@H]2CC[N@+]([C@@H]1C3=C(C2=C)NC4=CC=CC=C43)(C)[O-],,,,,,
8954,158955,6alpha-Acetyloxy-10betaH-furanoeremophil-1-one,C[C@H]1CCC(=O)[C@H]2[C@@]1([C@H](C3=C(C2)OC=C3C)OC(=O)C)C,,,,,,
8955,158956,"[(4R,4aR,5S,8aR)-3,4a,5-trimethyl-8-oxo-4,5,6,7,8a,9-hexahydrobenzo[f][1]benzofuran-4-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1C2=C(C[C@@H]3[C@]1([C@H](CCC3=O)C)C)OC=C2C,,,,,,
8956,158957,"Acetic acid, bis((diethoxyphosphinyl)thio)-, ethyl ester",CCOC(=O)C(SP(=O)(OCC)OCC)SP(=O)(OCC)OCC,,,,,,
8957,158958,"Acetic acid, bis((dipropoxyphosphinyl)thio)-, ethyl ester",CCCOP(=O)(OCCC)SC(C(=O)OCC)SP(=O)(OCCC)OCCC,,,,,,
8958,158959,"Acetic acid, bis((dibutoxyphosphinyl)thio)-, ethyl ester",CCCCOP(=O)(OCCCC)SC(C(=O)OCC)SP(=O)(OCCCC)OCCCC,,,,,,
8959,158960,"Acetic acid, bis((bis(2-methylpropoxy)phosphinyl)thio)-, ethyl ester",CCOC(=O)C(SP(=O)(OCC(C)C)OCC(C)C)SP(=O)(OCC(C)C)OCC(C)C,,,,,,
8960,158961,"1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxypropyl)-1,3-dimethyl-, (S)-",C[C@@H](CN1C=NC2=C1C(=O)N(C(=O)N2C)C)O,,,,,,
8961,158962,"1H-Purine-2,6-dione, 3,7-dihydro-7-(2-hydroxypropyl)-1,3-dimethyl-, (R)-",C[C@H](CN1C=NC2=C1C(=O)N(C(=O)N2C)C)O,,,,,,
8962,158963,Phorbol 12-p-azidobenzoate 13-benzoate,C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)OC(=O)C5=CC=CC=C5)OC(=O)C6=CC=C(C=C6)N7N=N7,,,,,,
8963,158964,"1-Dodecanaminium, N-(2-ethoxy-2-oxoethyl)-N,N-dimethyl-, bromide, mixt. with 14-(2,4-dichloro-5-methylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol",CCCCCCCCCCCC[N+](C)(C)CC(=O)OCC.CC1=CC(=C(C=C1Cl)Cl)OCCOCCOCCOCCOCCO.[Br-],,,,,,
8964,158965,"14-(2,4-Dichloro-5-methylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol",CC1=CC(=C(C=C1Cl)Cl)OCCOCCOCCOCCOCCO,,,,,,
8965,158966,"24-Norchola-1,14,20,22-tetraene-3,7-dione, 21,23-epoxy-4,4,8-trimethyl-, (5alpha,13alpha,17alpha)-",C[C@@]12CC[C@@H]3[C@]4(C=CC(=O)C([C@@H]4CC(=O)C3(C1=CC[C@H]2C5=COC=C5)C)(C)C)C,,,,,,
8966,158967,"Benzamide, N-(((3,5-dichloro-4-((6-chloro-4-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C(=C2)Cl)OC3=NC(=CC(=C3)C(F)(F)F)Cl)Cl)F,,,,,,
8967,158968,"5,9-Dimethyl-1-oxacycloundeca-5,9-dien-2-one",CC1=CCCC(=CCOC(=O)CC1)C,,,,,,
8968,158969,CID 158969,C[C@H]1CCCCCCC=CCC(=O)O1,,,,,,
8969,158970,"1,3-Dioxane, 5-((2-methoxyphenoxy)methyl)-2-phenyl-",COC1=CC=CC=C1OCC2COC(OC2)C3=CC=CC=C3,,,,,,
8970,158971,"Morpholine, 4-dodecyl-2,6-dimethyl-, (2R,6R)-rel-",CCCCCCCCCCCCN1C[C@H](O[C@@H](C1)C)C,,,,,,
8971,158972,"Acetic acid, (4-((2R)-2-(((2R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-, methyl ester, hydrobromide, rel-",CC(CC1=CC=C(C=C1)OCC(=O)OC)NC[C@@H](C2=CC(=CC=C2)Cl)O.Br,,,,,,
8972,158973,"Acetic acid, (4-((2R)-2-(((2R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)-, methyl ester, rel-",CC(CC1=CC=C(C=C1)OCC(=O)OC)NC[C@@H](C2=CC(=CC=C2)Cl)O,,,,,,
8973,158974,Acromelic acid B,C1[C@@H]([C@@H]([C@H](N1)C(=O)O)CC(=O)O)C2=C(NC(=O)C=C2)C(=O)O,,,,,,
8974,158975,"2,7-Phenanthrenediol, 3,4-dimethoxy-",COC1=C(C=C2C=CC3=C(C2=C1OC)C=CC(=C3)O)O,,,,,,
8975,158976,"1,5-Dimethoxyphenanthrene-2,7-diol",COC1=C2C(=CC(=C1)O)C=CC3=C2C=CC(=C3OC)O,,,,,,
8976,158977,"3-[[4-[(2-Chloro-4,6-dinitrophenyl)azo]naphthyl]amino]propane-1,2-diol",C1=CC=C2C(=C1)C(=CC=C2N=NC3=C(C=C(C=C3Cl)[N+](=O)[O-])[N+](=O)[O-])NCC(CO)O,,,,,,
8977,158978,"3-((4-(4-Morpholinyl)-6-propyl-1,3,5-triazin-2-yl)amino)-1,2-propanediol",CCCC1=NC(=NC(=N1)N2CCOCC2)NCC(CO)O,,,,,,
8978,158979,"Propanedinitrile, ((2,6-dibromo-4-nitrophenyl)hydrazono)-",C1=C(C=C(C(=C1Br)NN=C(C#N)C#N)Br)[N+](=O)[O-],,,,,,
8979,158980,L-methionine sulfoxide,CS(=O)CC[C@@H](C(=O)O)N,,,,,,
8980,158981,"(3R,5R)-3,4,5-tris[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1-hydroxycyclohexane-1-carboxylic acid",C1[C@H](C([C@@H](CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)O,,,,,,
8981,158982,"Benzene, 2,4-dimethoxy-1-(1-methylethoxy)-",CC(C)OC1=C(C=C(C=C1)OC)OC,,,,,,
8982,158983,Clivonidine,CN1CC[C@H]2[C@@H]1[C@H]3[C@H](C=C2)OC(=O)C4=CC5=C(C=C34)OCO5,,,,,,
8983,158984,"7H-Pyrimido(1,2-b)(1,2,4)triazolo(3,4-f)pyridazine, 8,9-dihydro-",C1CN=C2C=CC3=NN=CN3N2C1,,,,,,
8984,158985,"L-Cysteine, N-acetyl-S-(3,5-dichlorophenyl)-",CC(=O)N[C@@H](CSC1=CC(=CC(=C1)Cl)Cl)C(=O)O,,,,,,
8985,158986,"18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-((1-oxopentyl)oxy)-, (17alpha)-",CCCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)CC)C#C,,,,,,
8986,158987,"2H-Quinolizine, 2-(3,4-dimethoxyphenyl)octahydro-3-(4-methoxyphenyl)-, (2S,3S,9aR)-",COC1=CC=C(C=C1)[C@H]2CN3CCCCC3C[C@@H]2C4=CC(=C(C=C4)OC)OC,,,,,,
8987,158988,"L-Sorbofuranose, 2,3:4,6-bis-O-(1-methylethylidene)-",CC1(OC[C@H]2[C@@H](O1)[C@H]3C(O2)(OC(O3)(C)C)CO)C,,,,,,
8988,158989,"Anthracene, 1-methyl-10-nitro-",CC1=CC=CC2=C(C3=CC=CC=C3C=C12)[N+](=O)[O-],,,,,,
8989,158990,CID 158990,CC[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C(C5=O)C)C(=O)O3)O)C)C)C,,,,,,
8990,158991,CID 158991,C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C(C5=O)C)C(=O)O3)O)C)C)O[C@@H]1C,,,,,,
8991,158992,"(1,1'-Biphenyl)-3,4-diol, 2,2',5,5'-tetrachloro-",C1=CC(=C(C=C1Cl)C2=CC(=C(C(=C2Cl)O)O)Cl)Cl,,,,,,
8992,158993,"(1,1'-Biphenyl)-3,3'-diol, 2,2',5,5'-tetrachloro-",C1=C(C=C(C(=C1C2=C(C(=CC(=C2)Cl)O)Cl)Cl)O)Cl,,,,,,
8993,158994,"1H-Pyrrole-2-acetic acid, 5-(4-methylbenzoyl)-, 4-(acetylamino)phenyl ester",CC1=CC=C(C=C1)C(=O)C2=CC=C(N2)CC(=O)OC3=CC=C(C=C3)NC(=O)C,,,,,,
8994,158995,"Anthracene, 1-methyl-9-nitro-",CC1=CC=CC2=CC3=CC=CC=C3C(=C12)[N+](=O)[O-],,,,,,
8995,158996,"3-{2-[2-Ethoxy-1-propen-1-yl]-1,3-benzoxazol-3-ium-3-yl}-1-propanesulfonate",CCOC(=CC1=[N+](C2=CC=CC=C2O1)CCCS(=O)(=O)[O-])C,,,,,,
8996,158997,"3-[2-(2-Ethoxyprop-1-enyl)-1,3-benzoxazol-3-ium-3-yl]propane-1-sulfonic acid",CCOC(=CC1=[N+](C2=CC=CC=C2O1)CCCS(=O)(=O)O)C,,,,,,
8997,158998,CID 158998,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C=CC3=CC(=C(C=C3)O)OC,,,,,,
8998,158999,((+)-Thujane)-3-spiro-2'-thiazolidine-4'-oic acid,C[C@H]1[C@H]2C[C@]2(C[C@]13NC(CS3)C(=O)O)C(C)C,,,,,,
8999,159000,"(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-5-propan-2-ylhept-5-en-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene",CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC=C4)C)C)C(C)C,,,,,,
9000,159001,"2-Furanpropanoic acid, alpha-phenyl-beta-(phenylamino)-",C1=CC=C(C=C1)C(C(C2=CC=CO2)NC3=CC=CC=C3)C(=O)O,,,,,,
9001,159002,"2,6-Dimethyl-1-phenylpiperazine",CC1CNCC(N1C2=CC=CC=C2)C,,,,,,
9002,159003,"Benz(a)anthracene, 7,12-dimethyl-9-(trifluoromethyl)-",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1C=C(C=C4)C(F)(F)F)C,,,,,,
9003,159004,"Benz(a)anthracene, 7,12-dimethyl-10-(trifluoromethyl)-",CC1=C2C=CC(=CC2=C(C3=C1C=CC4=CC=CC=C43)C)C(F)(F)F,,,,,,
9004,159005,"2-Naphthalenemethanol, 1,2,3,5,6,7,8,8a-octahydro-alpha,alpha,8,8a-tetramethyl-, (2R,8R,8aS)-",C[C@@H]1CCCC2=CC[C@H](C[C@@]12C)C(C)(C)O,,,,,,
9005,159006,"4H-Pyran-4-one, 2-ethyl-2,3-dihydro-3,5-dimethyl-6-(1-methyl-2-oxobutyl)-, (2S,3R)-",CC[C@H]1[C@H](C(=O)C(=C(O1)C(C)C(=O)CC)C)C,,,,,,
9006,159007,"4H-Pyran-4-one, 2-ethyl-2,3-dihydro-6-((1S,2S)-2-hydroxy-1-methylbutyl)-3,5-dimethyl-, (2S,3R)-",CC[C@H]1[C@H](C(=O)C(=C(O1)[C@@H](C)C(CC)O)C)C,,,,,,
9007,159008,"1H-(1,2,4)Triazolo(1,2-a)pyridazin-1-one, 2-(4-chloro-2-fluoro-5-(1-methylethoxy)phenyl)hexahydro-3-thioxo-",CC(C)OC1=C(C=C(C(=C1)N2C(=O)N3CCCCN3C2=S)F)Cl,,,,,,
9008,159009,"2H-Furo(2,3-h)-1-benzopyran-2-one, 3-chloro-5,6-dihydro-4-(methylphenylamino)-",CN(C1=CC=CC=C1)C2=C(C(=O)OC3=C2CCC4=C3C=CO4)Cl,,,,,,
9009,159010,"5-Chloro-3-[7-(5,5-dimethyl-4-oxooxolan-2-yl)-3-methylocta-2,6-dienyl]-2,4-dihydroxy-6-methylbenzaldehyde",CC1=C(C(=C(C(=C1Cl)O)CC=C(C)CCC=C(C)C2CC(=O)C(O2)(C)C)O)C=O,,,,,,
9010,159011,"beta-D-Galactopyranoside, (3beta,22alpha,25S)-22,25-epoxy-26-(beta-D-glucopyranosyloxy)furost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-",C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O[C@H]6C([C@H]([C@H]([C@H](O6)CO)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O[C@]19CC[C@@](O9)(C)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
9011,159012,Aculeatiside A,C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O[C@]19CC[C@@](O9)(C)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
9012,159013,CID 159013,COC1=C(C=C(C=C1)C2=COC3=CC(=O)C(=C(C3=C2O)O)OC)O,,,,,,
9013,159014,"beta-D-Glucopyranoside, 4-ethenylphenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC=C(C=C3)C=C)O)O)O)O)O)O,,,,,,
9014,159015,"2H-Furo(2,3-h)-1-benzopyran-2-one, 8,9-dihydro-9-hydroxy-8-(1-hydroxy-1-methylethyl)-",CC(C)(C1C(C2=C(O1)C=CC3=C2OC(=O)C=C3)O)O,,,,,,
9015,159016,"Phosphorane, diethoxytriphenyl-, (TB-5-11)-",CCOP(C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)OCC,,,,,,
9016,159017,"1,2-Dibromoethane-d2(1,2)",[2H]C(C([2H])Br)Br,,,,,,
9017,159018,"Urea, (5-(2-hydroxy-1,1-dimethylethyl)-3-isoxazolyl)-",CC(C)(CO)C1=CC(=NO1)NC(=O)N,,,,,,
9018,159019,"Dibenz(c,e)azocine, 5,6,7,8-tetrahydro-1,2,11-trimethoxy-6-methyl-",CN1CCC2=C(C=C(C=C2)OC)C3=C(C1)C=CC(=C3OC)OC,,,,,,
9019,159020,"Card-20(22)-enolide, 3,11,14,19-tetrahydroxy-, (3beta,5beta,11alpha)-",C[C@]12C[C@H]([C@H]3[C@H](C1(CC[C@@H]2C4=CC(=O)OC4)O)CC[C@H]5[C@@]3(CC[C@@H](C5)O)CO)O,,,,,,
9020,159021,"1,5-Pentanediaminium, 1-carboxy-N,N,N,N',N',N'-hexamethyl-, (S)-,ethanedioate (1:2)",C[N+](C)(C)CCCC[C@@H](C(=O)O)[N+](C)(C)C.C(=O)(C(=O)[O-])O.C(=O)(C(=O)[O-])O,,,,,,
9021,159022,[(1S)-1-carboxy-5-(trimethylazaniumyl)pentyl]-trimethylazanium,C[N+](C)(C)CCCC[C@@H](C(=O)O)[N+](C)(C)C,,,,,,
9022,159023,"Carbamic acid, (3-((hexyloxy)methyl)phenyl)-",CCCCCCOCC1=CC(=CC=C1)OC(=O)N,,,,,,
9023,159024,"Phosphonothioic acid, phenyl-, O-methyl O-(2,3,5,6-tetrachlorophenyl)ester",COP(=S)(C1=CC=CC=C1)OC2=C(C(=CC(=C2Cl)Cl)Cl)Cl,,,,,,
9024,159025,"Phosphonothioic acid, phenyl-, O-methyl O-(pentachlorophenyl) ester",COP(=S)(C1=CC=CC=C1)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
9025,159026,"4H-1-Benzopyran-4-one, 2,3-dihydro-2-(3-hydroxy-4-methoxyphenyl)-5,7-dimethoxy-8-methyl-, (S)-",CC1=C2C(=C(C=C1OC)OC)C(=O)C[C@H](O2)C3=CC(=C(C=C3)OC)O,,,,,,
9026,159027,"1,5-Dimethyl-2-piperidone",CC1CCC(=O)N(C1)C,,,,,,
9027,159028,CID 159028,CC1=CC(=O)C2=C3C1=C(OC4=CC(=C(C(=C43)C(=O)C2=O)O)OC)O,,,,,,
9028,159029,Tenaxin I,COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3O)OC)OC,,,,,,
9029,159030,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (1,1'-biphenyl)-3-ylmethyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)C3=CC=CC=C3)C,,,,,,
9030,159031,Acifluorfen-Bentazone,CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O.C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)O,,,,,,
9031,159032,"Naphtho(2,3-b)furan-2-methanol, alpha-(((1-methylethyl)amino)methyl)-",CC(C)NCC(C1=CC2=CC3=CC=CC=C3C=C2O1)O,,,,,,
9032,159033,"3-Methyl-1,2-dihydronaphthalene-1,2-diol",CC1=CC2=CC=CC=C2C(C1O)O,,,,,,
9033,159034,Claviculine,CN1CCC2=C3[C@@H]1CC4=C(C(=C(C=C4)OC)O)OC3=C(C=C2)O,,,,,,
9034,159035,"beta-D-Glucopyranosiduronic acid, (2-chlorophenyl)methyl",C1=CC=C(C(=C1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)Cl,,,,,,
9035,159036,"1H,3H-Pyrano(3,4-c)pyran-5-carboxaldehyde, 4,6-dihydro-6-methyl-1-oxo-",CC1C(=C2CCOC(=O)C2=CO1)C=O,,,,,,
9036,159037,"4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-2-methyl-, dihydrochloride",CC1=C(C(=O)N2C=CC=CC2=N1)CCN3CCC(=C(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F)CC3.Cl.Cl,,,,,,
9037,159038,Aerophobin 2,COC1=C([C@@H]([C@]2(CC(=NO2)C(=O)NCCCC3=CN=C(N3)N)C=C1Br)O)Br,,,,,,
9038,159039,"methyl (3S,4S)-6-(4-chloro-3-methoxyphenyl)-4-methoxy-2-(methoxymethylidene)-3-methylhex-5-enoate",C[C@H]([C@H](C=CC1=CC(=C(C=C1)Cl)OC)OC)C(=COC)C(=O)OC,,,,,,
9039,159040,"Benzamide, 4-hydroxy-N-(2-(2-(2-piperidinyl)ethyl)phenyl)-",C1CCNC(C1)CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)O,,,,,"['N,O-didemethylencainide is a known human metabolite of N-demethylencainide and O-demethylencainide.']",
9040,159041,Fistularin 3,COC1=C([C@@H]([C@]2(CC(=NO2)C(=O)NCC(COC3=C(C=C(C=C3Br)C(CNC(=O)C4=NO[C@@]5(C4)C=C(C(=C([C@@H]5O)Br)OC)Br)O)Br)O)C=C1Br)O)Br,,,,,,
9041,159042,"Phosphoramidothioic acid, (1-methylethyl)-, O-(2-chloro-6-nitrophenyl)O-ethyl ester",CCOP(=S)(NC(C)C)OC1=C(C=CC=C1Cl)[N+](=O)[O-],,,,,,
9042,159043,"3-Cyclohexen-1-ol, 1-(1-chloro-1-methylethyl)-4-methyl-",CC1=CCC(CC1)(C(C)(C)Cl)O,,,,,,
9043,159044,"7-Oxabicyclo(2.2.1)heptane-1-methanol, 3-hydroxy-alpha,alpha,4-trimethyl-, exo-",CC12CCC(O1)(CC2O)C(C)(C)O,,,,,,
9044,159045,CID 159045,CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)Cl.C(=CC(=O)O)C(=O)O,,,,,,
9045,159046,"1,6-Bis(trimethoxysilyl)hexane",CO[Si](CCCCCC[Si](OC)(OC)OC)(OC)OC,,,,,,
9046,159047,"(2,2':5',2''-Terthiophene)-5-carboxylic acid",C1=CSC(=C1)C2=CC=C(S2)C3=CC=C(S3)C(=O)O,,,,,,
9047,159048,"2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)-3-fluorotetrahydro-, 2-oxide",C1CN(P(=O)(OC1)N(CCCl)CCCl)F,,,,,,
9048,159049,"2H-1,3,2-Oxazaphosphorin-2-amine, 3-chloro-N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide",C1CN(P(=O)(OC1)N(CCCl)CCCl)Cl,,,,,,
9049,159050,"2H-1,3,2-Oxazaphosphorin-2-amine, 3-bromo-N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide",C1CN(P(=O)(OC1)N(CCCl)CCCl)Br,,,,,,
9050,159051,"2-Exo-hydroxy-1,4-cineole",CC(C)[C@@]12CC[C@@](O1)([C@H](C2)O)C,,,,,,
9051,159052,"10-[(2R,3S)-3-oct-2-enyloxiran-2-yl]deca-5,8-dienoic acid",CCCCCC=CC[C@H]1[C@H](O1)CC=CCC=CCCCC(=O)O,,,,,,
9052,159053,"1-Propanone, 1-(2-aminophenyl)-3-(1-piperidinyl)-, monohydrochloride",C1CCN(CC1)CCC(=O)C2=CC=CC=C2N.Cl,,,,,,
9053,159054,Ingacamph,CC1CCC(C(C1)O)C(C)C.C[C@@]12CC[C@@H](C1(C)C)CC2=O.COC(=O)C1=CC=CC=C1O,,,,,,
9054,159055,D-Camphor,C[C@@]12CC[C@@H](C1(C)C)CC2=O,,,,,['(+)-Camphor has known human metabolites that include 5-exo-hydroxycamphor and 8-hydroxycamphor.'],
9055,159056,CID 159056,C[N+](C)(C)CCOC(=O)C=CC1=CC(=C(C=C1)O)O,,,,,,
9056,159057,3-(3-hydroxy-4-methoxyphenyl)-N-[2-(1H-imidazol-5-yl)ethyl]prop-2-enamide,COC1=C(C=C(C=C1)C=CC(=O)NCCC2=CN=CN2)O,,,,,,
9057,159058,"Sulfamic acid, (5-methyl-3-isoxazolyl)-",CC1=CC(=NO1)NS(=O)(=O)O,,,,,,
9058,159059,"Hexanamide, N-(3-(2-(2-(2-hydroxy-6-methylphenyl)-2-oxoethyl)-1-pyrrolidinyl)propyl)-",CCCCCC(=O)NCCCN1CCCC1CC(=O)C2=C(C=CC=C2O)C,,,,,,
9059,159060,"3H-Oxireno(7,8)naphtho(8a,1-b)furan-3-one, decahydro-4,7,9a-trimethyl-, (1aR,1bR,4R,4aS,7R,7aS,9aR)-",C[C@@H]1CC[C@H]2[C@H](C(=O)OC23[C@H]1CC[C@@]4([C@H]3O4)C)C,,,,,,
9060,159061,"Benzoic acid, 3,6-dichloro-2-methoxy-, 2-ethoxy-1-methyl-2-oxoethyl ester",CCOC(=O)C(C)OC(=O)C1=C(C=CC(=C1OC)Cl)Cl,,,,,,
9061,159062,CID 159062,CN1CC[C@]23C[C@@H](C(=O)C=C2[C@@H]1CC4=CC5=C(C=C34)OCO5)OC,,,,,,
9062,159063,"(1R,12S,16R)-16-methoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.5.3.01,13.02,10.04,8]icosa-2,4(8),9,13-tetraen-15-one",CN1CC[C@]23C[C@H](C(=O)C=C2[C@@H]1CC4=CC5=C(C=C34)OCO5)OC,,,,,,
9063,159064,"1-Dodecanol, 3,7,11-trimethyl-, (R*,R*)-",C[C@@H](CCC[C@@H](C)CCO)CCCC(C)C,,,,,,
9064,159065,"1(2H)-Naphthalenone, octahydro-4-hydroxy-7,7-dimethoxy-4a-methyl-, (4alpha,4aalpha,8abeta)-",C[C@]12CCC(C[C@@H]1C(=O)CC[C@@H]2O)(OC)OC,,,,,,
9065,159066,"2-Pyrrolidinimine, 1,5-dimethyl-3,3-diphenyl-, monohydrochloride",CC1CC(C(=N)N1C)(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
9066,159067,"2-Imino-1,5-dimethyl-3,3-diphenylpyrrolidine",CC1CC(C(=N)N1C)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
9067,159068,CID 159068,C1=CC=C2C(=C1)C(=C(S2)C=O)NN=C(N)S,,,,,,
9068,159069,CID 159069,C(CP(=O)CO)C(C(=O)O)N.[Na+],,,,,,
9069,159070,CID 159070,C(CP(=O)CO)C(C(=O)O)N,,,,,,
9070,159071,"1H-1,2,4-Triazole-1-ethanol, beta-butoxy-alpha-(2,4-dichlorophenyl)-alpha-methyl-",CCC(C)ON1C=NCN1CC(C)(C2=C(C=C(C=C2)Cl)Cl)O,,,,,,
9071,159072,"Isoquinolinium, 1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-2,2-dimethyl-",C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)O)C,,,,,,
9072,159073,"1-Oxa-5-azaspiro(2.5)oct-6-ene-4,8-dione, 6-methyl-2-(2-methyl-1-oxobutyl)-, (2S-(2alpha(R*),3alpha))-",CCC(C)C(=O)[C@@H]1C2(O1)C(=O)C=C(NC2=O)C,,,,,,
9073,159074,CID 159074,COC1=C2C(=C(C3=C(O2)C=CC(=C3)O)O)C(=O)C=C1,,,,,,
9074,159075,CID 159075,CC=C(C)C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)COC(=O)C(=CC)CO,,,,,,
9075,159076,"Phosphonamidodithioic acid, P-ethyl-N-(1-methylethyl)-, 1,1-dimethylethyl ester",CCP(=S)(NC(C)C)SC(C)(C)C,,,,,,
9076,159077,"1-Pyrrolidinecarboxylic acid, 2,4-dichloro-5-(2-propynyloxy)phenyl ester",C#CCOC1=CC(=C(C=C1Cl)Cl)OC(=O)N2CCCC2,,,,,,
9077,159078,"Glycine, N-(N-L-gamma-glutamyl-3-thiiranio-L-alanyl)-, bromide",C1C[S+]1C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N.[Br-],,,,,,
9078,159079,Glutathione episulfonium ion,C1C[S+]1C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
9079,159080,"1-Piperidinecarboxylic acid, 2,4-dichloro-5-(2-propynyloxy)phenyl ester",C#CCOC1=CC(=C(C=C1Cl)Cl)OC(=O)N2CCCCC2,,,,,,
9080,159081,Teuscordonin,CC1CC2C3(C(C14CC(OC4=O)C5=COC=C5)CCC=C3C(=O)O2)CO,,,,,,
9081,159082,19-Hydroxyvenalstonine,COC(=O)C1CC23C=CCN4C2C5(C1(CC3O)NC6=CC=CC=C65)CC4,,,,,,
9082,159083,19-Hydroxyvenalstonidine,COC(=O)C1CC23C(CC14C5(C2N(CC5)CC6C3O6)C7=CC=CC=C7N4)O,,,,,,
9083,159084,3-Oxovenalstonidine,COC(=O)C1CC23CCC14C5(C2N(CC5)C(=O)C6C3O6)C7=CC=CC=C7N4,,,,,,
9084,159085,"beta-D-Glucopyranoside, (3beta,7beta,9beta,10alpha,16beta)-7-methoxy-9-methyl-3-(beta-D-xylopyranosyloxy)-19-norlanosta-5,24-dien-16-yl, 6-acetate",C[C@H](CCC=C(C)C)[C@H]1[C@@H](C[C@@]2([C@@]1(CC[C@]3(C2[C@@H](C=C4[C@@H]3CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H](CO5)O)O)O)OC)C)C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C)O)O)O,,,,,,
9085,159086,"1,2-Benzenediol, 6-bromo-3-((3-bromo-4-hydroxyphenyl)methyl)-4-(hydroxymethyl)-",C1=CC(=C(C=C1CC2=C(C(=C(C=C2CO)Br)O)O)Br)O,,,,,,
9086,159087,Dess-Martin periodinane,CC(=O)OI1(C2=CC=CC=C2C(=O)O1)(OC(=O)C)OC(=O)C,,,,,,
9087,159088,Mukaadial,C[C@]12CCCC([C@@H]1[C@H](C=C([C@@]2(C=O)O)C=O)O)(C)C,,,,,,
9088,159089,"2H-Tetrazole, 2-(3-iodo-2-propynyl)-",C1=NN(N=N1)CC#CI,,,,,,
9089,159090,"Butanoic acid, 2-methyl-, (1R,2S,3R,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-8a-((acetyloxy)methyl)octahydro-3-hydroxy-5,6-dimethyl-5-((2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro(2,3-b)furan-2-yl)spiro(naphthalene-1(2H),2'-oxiran)-2-yl ester",CC[C@H](C)C(=O)OC1[C@@H](C[C@@H]2[C@@]([C@@H](C[C@@H]([C@]2([C@@]13CO3)COC(=O)C)OC(=O)C)C)(C)C4C[C@H]5C=CO[C@H]5O4)O,,,,,,
9090,159091,"Butanediperoxoic acid, dodecyl-",CCCCCCCCCCCCC(CC(=O)OO)C(=O)OO,,,,,,
9091,159092,"Butanediperoxoic acid, decyl-",CCCCCCCCCCC(CC(=O)OO)C(=O)OO,,,,,,
9092,159093,"Benzoic acid, 2-(((((4-(difluoromethoxy)-6-methyl-2-pyrimidinyl)amino)carbonyl)amino)sulfonyl)-, methyl ester",CC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)OC(F)F,,,,,,
9093,159094,"Benzenesulfonamide, N-(((4-(difluoromethoxy)-6-methyl-2-pyrimidinyl)amino)carbonyl)-2-nitro-",CC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2[N+](=O)[O-])OC(F)F,,,,,,
9094,159095,1-Methyl-9-nitrophenanthrene,CC1=C2C=C(C3=CC=CC=C3C2=CC=C1)[N+](=O)[O-],,,,,,
9095,159096,"Hexanenitrile, 4-ethyl-4-methyl-3-oxo-",CCC(C)(CC)C(=O)CC#N,,,,,,
9096,159097,"[9-chloro-8-hydroxy-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl] hydrogen sulfate",C1CNCC(C2=CC(=C(C(=C21)Cl)O)OS(=O)(=O)O)C3=CC=C(C=C3)O,,,,,,
9097,159098,"1,4-Benzenediamine, N4-ethyl-N4-(2-methoxyethyl)-2-methyl-, 4-methylbenzenesulfonate",CCN(CCOC)C1=CC(=C(C=C1)N)C.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
9098,159099,"Naphtho(1,2-b)furan-2,8(3H,4H)-dione, 3a,5,5a,6,7,9b-hexahydro-6-hydroxy-5a,9-dimethyl-3-methylene-, (3aS,5aR,6R,9bS)-",CC1=C2[C@@H]3[C@@H](CC[C@]2([C@@H](CC1=O)O)C)C(=C)C(=O)O3,,,,,,
9099,159100,"Cyclopenta(c)pyran-4-carboxylic acid, 1,4a,7,7a-tetrahydro-1,7-dihydroxy-7-(hydroxymethyl)-, methyl ester, (1R-(1alpha,4aalpha,7beta,7aalpha))-",COC(=O)C1=CO[C@H]([C@H]2[C@@H]1C=C[C@]2(CO)O)O,,,,,,
9100,159101,"2-Phenanthrenol, 1,2,3,4,4a,4b,5,6,7,8,8a,9-dodecahydro-2,4b,8,8-tetramethyl-, (2R,4aS,4bS,8aS)-",C[C@]1(CC[C@H]2C(=CC[C@@H]3[C@@]2(CCCC3(C)C)C)C1)O,,,,,,
9101,159102,"1,3,5-Triazino(1,2-a)benzimidazole-10(2H)-carboxamide,3,4-dihydro-N,2,2,3-tetramethyl-4-oxo-",CC1(N=C2N(C3=CC=CC=C3N2C(=O)NC)C(=O)N1C)C,,,,,,
9102,159103,"1,3,5-Triazino(1,2-a)benzimidazol-4(1H)-one, 3-ethyl-2,3-dihydro-2,2-dimethyl-",CCN1C(=O)N2C3=CC=CC=C3N=C2NC1(C)C,,,,,,
9103,159104,"1,3,5-Triazino(1,2-a)benzimidazol-4(1H)-one, 2,3-dihydro-2,2-dimethyl-3-propyl-",CCCN1C(=O)N2C3=CC=CC=C3N=C2NC1(C)C,,,,,,
9104,159105,"1,3,5-Triazino(1,2-a)benzimidazol-4(1H)-one, 3-butyl-2,3-dihydro-2,2-dimethyl-",CCCCN1C(=O)N2C3=CC=CC=C3N=C2NC1(C)C,,,,,,
9105,159106,"1,3,5-Triazino(1,2-a)benzimidazol-4(1H)-one, 2-ethyl-2,3-dihydro-2,3-dimethyl-",CCC1(NC2=NC3=CC=CC=C3N2C(=O)N1C)C,,,,,,
9106,159107,"1,3,5-Triazino(1,2-a)benzimidazole-10(2H)-carboxamide,N-ethyl-3,4-dihydro-2,2,3-trimethyl-4-oxo-",CCNC(=O)N1C2=CC=CC=C2N3C1=NC(N(C3=O)C)(C)C,,,,,,
9107,159108,"1,3,5-Triazino(1,2-a)benzimidazole-10(2H)-carboxamide,3,4-dihydro-2,2,3-trimethyl-4-oxo-N-propyl-",CCCNC(=O)N1C2=CC=CC=C2N3C1=NC(N(C3=O)C)(C)C,,,,,,
9108,159109,"1,3,5-Triazino(1,2-a)benzimidazole-10(2H)-carboxamide,3,4-dihydro-2,2,3-trimethyl-N-(1-methylethyl)-4-oxo-",CC(C)NC(=O)N1C2=CC=CC=C2N3C1=NC(N(C3=O)C)(C)C,,,,,,
9109,159110,"1,3,5-Triazino(1,2-a)benzimidazol-4(3H)-one, 10-acetyl-2,10-dihydro-2,2,3-trimethyl-",CC(=O)N1C2=CC=CC=C2N3C1=NC(N(C3=O)C)(C)C,,,,,,
9110,159111,"1,3,5-Triazino(1,2-a)benzimidazol-4(3H)-one, 2,10-dihydro-2,2,3,10-tetramethyl-",CC1(N=C2N(C3=CC=CC=C3N2C(=O)N1C)C)C,,,,,,
9111,159112,"1,3,5-Triazino(1,2-a)benzimidazol-4(1H)-one, 2,2-diethyl-2,3-dihydro-3-methyl-",CCC1(NC2=NC3=CC=CC=C3N2C(=O)N1C)CC,,,,,,
9112,159113,"Spiro(cyclopentane-1,2'(1'H)-(1,3,5)triazino(1,2-a)benzimidazol)-4'(3'H)-one, 3'-methyl-",CN1C(=O)N2C3=CC=CC=C3N=C2NC14CCCC4,,,,,,
9113,159114,"1,3,5-Triazino(1,2-a)benzimidazol-4(3H)-one, 2,10-dihydro-2,2,3-trimethyl-10-(methylsulfonyl)-",CC1(N=C2N(C3=CC=CC=C3N2S(=O)(=O)C)C(=O)N1C)C,,,,,,
9114,159115,"1,3,5-Triazino(1,2-a)benzimidazole-4(1H)-thione, 2,3-dihydro-2,2,3-trimethyl-",CC1(NC2=NC3=CC=CC=C3N2C(=S)N1C)C,,,,,,
9115,159116,"3-Oxa-5,7-dithia-4-phosphanonan-9-oic acid, 4-methyl-, methyl ester,7-oxide 4-sulfide",CCOP(=S)(C)SCS(=O)CC(=O)OC,,,,,,
9116,159117,"3-Oxa-5,7-dithia-4-phosphanonan-9-oic acid, 4-methyl-, methyl ester,4,7-dioxide",CCOP(=O)(C)SCS(=O)CC(=O)OC,,,,,,
9117,159118,"3-Oxa-5,7-dithia-4-phosphanonan-9-oic acid, 4-methyl-, 4-sulfide",CCOP(=S)(C)SCSCC(=O)O,,,,,,
9118,159119,"beta-D-Glucopyranoside, ((1S,2R,3R)-1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2-naphthalenyl)methyl",COC1=CC(=CC(=C1O)OC)[C@@H]2C([C@@H](CC3=CC(=C(C(=C23)OC)O)OC)CO)[C@@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC,,,,,,
9119,159120,"1,2-dihydro-2,2,3-trimethyl-1,3,5-triazino[1,2-a]benzimidazol-4(3H)-one",CC1(NC2=NC3=CC=CC=C3N2C(=O)N1C)C,,,,,,
9120,159121,"1,3-Benzodioxole, 5-ethoxy-",CCOC1=CC2=C(C=C1)OCO2,,,,,,
9121,159122,"1,3-Benzodioxole, 5-propoxy-",CCCOC1=CC2=C(C=C1)OCO2,,,,,,
9122,159123,"1,3-Benzodioxole, 5-butoxy-",CCCCOC1=CC2=C(C=C1)OCO2,,,,,,
9123,159124,"1,3-Benzodioxole, 5-(pentyloxy)-",CCCCCOC1=CC2=C(C=C1)OCO2,,,,,,
9124,159125,"1,3-Benzodioxole, 5-(hexyloxy)-",CCCCCCOC1=CC2=C(C=C1)OCO2,,,,,,
9125,159126,"Tetradeca-2,4,6,8,10,12-hexaenedial",C(=CC=CC=CC=O)C=CC=CC=CC=O,,,,,,
9126,159127,Benzeneethan-d4-amine,[2H]C([2H])(C1=CC=CC=C1)C([2H])([2H])N,,,,,,
9127,159128,"1,4-Naphthalenedione, 5-methoxy-2-(3-methylbutyl)-",CC(C)CCC1=CC(=O)C2=C(C1=O)C=CC=C2OC,,,,,,
9128,159129,"Benzoic acid, 2-(((((4-(hydroxymethyl)-6-methoxy-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)-, methyl ester",COC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)CO,,,,,,
9129,159130,"Thieno(2,3-c)pyridine, 6,7-dihydro-6-methyl-7-(2-propenyl)-",CN1C=CC2=C(C1CC=C)SC=C2,,,,,,
9130,159131,Octadecyl tetracos-9-enoate,CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCCCCCCCC,,,,,,
9131,159132,CID 159132,CC(=CCC(=O)O)C=C,,,,,,
9132,159133,"6,14-Methano-10H,14H-(1)benzopyrano(7,6-d)(1,3)benzodioxocin-1,3,11,13,15-pentol, 11,12-dihydro-6,10-bis(4-hydroxyphenyl)-, (6S,10S,11S,14S,15R)-",C1[C@@H]([C@@H](OC2=CC3=C([C@H]4[C@H]([C@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC=C(C=C6)O)O)C(=C21)O)C7=CC=C(C=C7)O)O,,,,,,
9133,159134,Scabraside,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@@H]3CCOC(=O)C3=CO2)C=C)OC(=O)C4=CC=CC=C4)OC(=O)C)OC(=O)C5=C(C(=CC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O,,,,,,
9134,159135,"7-[9-(3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dienoxy]-6,8-dimethoxychromen-2-one",CC(=CCCC(=CCOC1=C(C=C2C=CC(=O)OC2=C1OC)OC)C)CCC3C(O3)(C)C,,,,,,
9135,159136,CID 159136,CC(C)C(=O)CCC(=CCCC(=CCOC1=C(C=C2C=CC(=O)OC2=C1OC)OC)C)C,,,,,,
9136,159137,"Phenol, 4-(2-propenyl)-2-(4-(2-propenyl)phenoxy)-",C=CCC1=CC=C(C=C1)OC2=C(C=CC(=C2)CC=C)O,,,,,,
9137,159138,Isodrimartol A,CC1=CC[C@H]2[C@]([C@@H]1COC3=C(C=C4C=CC(=O)OC4=C3OC)OC)(CC[C@@H](C2(C)C)O)C,,,,,,
9138,159139,"Benzo(f)quinoline-7,8-diol, 7,8-dihydro-",C1=CC2=C(C=CC3=C2C=CC(C3O)O)N=C1,,,,,,
9139,159140,"Benzo(f)quinoline-5,6-diol, 5,6-dihydro-",C1=CC=C2C3=C(C(C(C2=C1)O)O)N=CC=C3,,,,,,
9140,159141,Benzo(f)quinolin-8-ol,C1=CC2=C(C=CC3=C2C=CC(=C3)O)N=C1,,,,,,
9141,159142,"Benzo(h)quinoline-7,8-diol, 7,8-dihydro-",C1=CC2=C(C3=C(C=C2)C(C(C=C3)O)O)N=C1,,,,,,
9142,159143,"Phosphorothioic acid, S-(3-(butylthio)-1-propynyl) O,O-diethyl ester",CCCCSCC#CSP(=O)(OCC)OCC,,,,,,
9143,159144,"Phosphorothioic acid, S-(3-(acetyloxy)-1-propynyl) O,O-diethyl ester",CCOP(=O)(OCC)SC#CCOC(=O)C,,,,,,
9144,159145,"Phosphorothioic acid, O,O-diethyl S-(phenylethynyl) ester",CCOP(=O)(OCC)SC#CC1=CC=CC=C1,,,,,,
9145,159146,"Phosphorothioic acid, S-(3-(ethylthio)-1-propynyl) O,O-dimethyl ester",CCSCC#CSP(=O)(OC)OC,,,,,,
9146,159147,"Phosphorothioic acid, S-1-hexynyl O,O-dimethyl ester",CCCCC#CSP(=O)(OC)OC,,,,,,
9147,159148,"Pentanoic-5,5,5-d3 acid, 2-(propyl-3,3,3-d3)-",[2H]C([2H])([2H])CCC(CCC([2H])([2H])[2H])C(=O)O,,,,,,
9148,159149,"Ethanone, 1-(5,6,7,8-tetrahydro-3,8,8-trimethyl-2-naphthalenyl)-",CC1=CC2=C(C=C1C(=O)C)C(CCC2)(C)C,,,,,,
9149,159150,Acetylisodrimartol A,CC1=CC[C@H]2[C@]([C@@H]1COC3=C(C=C4C=CC(=O)OC4=C3OC)OC)(CC[C@@H](C2(C)C)OC(=O)C)C,,,,,,
9150,159151,"Alanine, N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-",CC1=C(C(=CC=C1)C)N([C@@H](C)C(=O)O)C(=O)COC,,,,,,
9151,159152,(2S)-2-[(4-ethoxy-4-oxobut-2-en-2-yl)amino]-3-phenylpropanoic acid,CCOC(=O)C=C(C)N[C@@H](CC1=CC=CC=C1)C(=O)O,,,,,,
9152,159153,"Phosphorodithioic acid, S-(3-(ethylthio)-1-propynyl) O,O-dimethyl ester",CCSCC#CSP(=S)(OC)OC,,,,,,
9153,159154,"Phosphorodithioic acid, O,O-diethyl S-(3-(ethylthio)-1-propynyl) ester",CCOP(=S)(OCC)SC#CCSCC,,,,,,
9154,159155,"Phosphorodithioic acid, S-(3-(butylthio)-1-propynyl) O,O-diethyl ester",CCCCSCC#CSP(=S)(OCC)OCC,,,,,,
9155,159156,Methyl methacrylate-potassium 3-sulfopropyl methacrylate copolymer,CC(=C)C(=O)OC.CC(=C)C(=O)OCCCS(=O)(=O)O.[K+],,,,,,
9156,159157,3-Sulfopropyl methacrylate,CC(=C)C(=O)OCCCS(=O)(=O)O,,,,,,
9157,159158,2-(1-Methyl-1H-imidazol-2-yl)ethanamine,CN1C=CN=C1CCN,,,,,,
9158,159159,Benzo(f)quinoxalin-6-amine,C1=CC=C2C(=C1)C(=CC3=NC=CN=C23)N,,,,,,
9159,159160,"3,5-Cyclohexadiene-1,2-diol, 4-ethenyl-",C=CC1=CC(C(C=C1)O)O,,,,,,
9160,159161,"1,3-Propanediol, 2-nitro-1-phenyl-, diacetate (ester), (1R,2R)-rel-",CC(=O)OC[C@H]([C@@H](C1=CC=CC=C1)OC(=O)C)[N+](=O)[O-],,,,,,
9161,159162,"Benzonitrile, 2-(((1-methyl-4-(1-methylethyl)-7-oxabicyclo(2.2.1)hept-2-yl)oxy)methyl)-, exo-",CC(C)C12CCC(O1)(C(C2)OCC3=CC=CC=C3C#N)C,,,,,,
9162,159163,"Benzamide, 2-(((1-methyl-4-(1-methylethyl)-7-oxabicyclo(2.2.1)hept-2-yl)oxy)methyl)-, exo-",CC(C)C12CCC(O1)(C(C2)OCC3=CC=CC=C3C(=O)N)C,,,,,,
9163,159164,"Benzoic acid, 2-(((1-methyl-4-(1-methylethyl)-7-oxabicyclo(2.2.1)hept-2-yl)oxy)methyl)-, exo-",CC(C)C12CCC(O1)(C(C2)OCC3=CC=CC=C3C(=O)O)C,,,,,,
9164,159165,Austalide J,CC1=C2COC(=O)C2=C(C3=C1O[C@]4(CC[C@@]5([C@@]([C@H]4C3)(CCC(=O)OC5(C)C)C)O)C)OC,,,,,,
9165,159166,Austalide K,CC1=C2COC(=O)C2=C(C3=C1O[C@]4(CC[C@@H]5[C@@]([C@H]4C3)(CCC(=O)C5(C)C)C)C)OC,,,,,,
9166,159167,"Acetamide, N-(3-acetyl-4-((2R)-2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-",CC(C)NC[C@H](COC1=C(C=C(C=C1)NC(=O)C)C(=O)C)O,,,,,,
9167,159168,"alpha-L-Arabinopyranoside, (3beta,16beta,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl O-beta-D-xylopyranosyl-(1->2)-O-beta-D-glucopyranosyl-(1->3)-, 2-acetate",CC(=C[C@H]1C[C@]([C@@H]2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@]36C[C@@]2(O1)OC6)C)(C)C)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O[C@H]8[C@@H]([C@H](C([C@H](O8)CO)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)OC(=O)C)C)(C)O)C,,,,,,
9168,159169,"2H-Pyrano(2,3,4-kl)xanthen-2-one, 5,9,10-trihydroxy-",C1=C2C(=CC(=C1O)O)OC3=CC(=O)C=C4C3=C2C=C(O4)O,,,,,,
9169,159170,"8,16,24-Pentatriacontanetrione, 6,14,22,30,32,34-hexahydroxy-, (6R,14R,22R,30R,32S,34S)-",CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](C[C@H](C[C@H](C)O)O)O)O)O)O,,,,,,
9170,159171,PM-toxin B,CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](C[C@H](C)O)O)O)O)O,,,,,,
9171,159172,"Benzothiazolium, 3-butyl-, bromide",CCCC[N+]1=CSC2=CC=CC=C21.[Br-],,,,,,
9172,159173,3-Butylbenzothiazolium,CCCC[N+]1=CSC2=CC=CC=C21,,,,,,
9173,159174,"Benzothiazolium, 3-(2-propenyl)-, iodide",C=CC[N+]1=CSC2=CC=CC=C21.[I-],,,,,,
9174,159175,"Benzothiazolium, 3-(2-propenyl)-",C=CC[N+]1=CSC2=CC=CC=C21,,,,,,
9175,159176,"Benzothiazolium, 4-chloro-3-methyl-, iodide",C[N+]1=CSC2=C1C(=CC=C2)Cl.[I-],,,,,,
9176,159177,"4-Chloro-3-methyl-1,3-benzothiazol-3-ium",C[N+]1=CSC2=C1C(=CC=C2)Cl,,,,,,
9177,159178,"Benzothiazolium, 4-chloro-3-methyl-, bromide",C[N+]1=CSC2=C1C(=CC=C2)Cl.[Br-],,,,,,
9178,159179,"Benzothiazolium, 6-chloro-3-methyl-, bromide",C[N+]1=CSC2=C1C=CC(=C2)Cl.[Br-],,,,,,
9179,159180,"6-Chloro-3-methyl-1,3-benzothiazol-3-ium",C[N+]1=CSC2=C1C=CC(=C2)Cl,,,,,,
9180,159181,"Benzothiazolium, 3-(2-methoxy-2-oxoethyl)-, bromide",COC(=O)C[N+]1=CSC2=CC=CC=C21.[Br-],,,,,,
9181,159182,"Methyl 2-(1,3-benzothiazol-3-ium-3-yl)acetate",COC(=O)C[N+]1=CSC2=CC=CC=C21,,,,,,
9182,159183,"Benzothiazolium, 3-(2-oxo-2-propoxyethyl)-, bromide",CCCOC(=O)C[N+]1=CSC2=CC=CC=C21.[Br-],,,,,,
9183,159184,"Propyl 2-(1,3-benzothiazol-3-ium-3-yl)acetate",CCCOC(=O)C[N+]1=CSC2=CC=CC=C21,,,,,,
9184,159185,"Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, mono(hydrogensulfate) (ester), (R)-",CNC[C@@H](C1=CC(=CC=C1)O)OS(=O)(=O)O,,,,,,
9185,159186,"Benzenemethanol, 2-hydroxy-alpha-((methylamino)methyl)-, benzoate (salt)",CNCC(C1=CC=CC=C1O)O.C1=CC=C(C=C1)C(=O)[O-],,,,,,
9186,159187,2-[1-Hydroxy-2-(methylamino)ethyl]phenol,CNCC(C1=CC=CC=C1O)O,,,,,,
9187,159188,Revenast hydrochloride,C1CN(CCN1CCCN2C(=O)C=C(N2C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=N5.Cl,,,,,,
9188,159189,2-(2-Hydroxy-5-prop-1-enylphenyl)-4-prop-1-enylphenol,CC=CC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)C=CC)O,,,,,,
9189,159190,"Ethyl 4-(2',5'-dioxospiro[8-azabicyclo[3.2.1]octane-3,4'-imidazolidine]-8-yl)butanoate;hydrochloride",CCOC(=O)CCCN1C2CCC1CC3(C2)C(=O)NC(=O)N3.Cl,,,,,,
9190,159191,"Ethyl 4-(2',5'-dioxospiro[8-azabicyclo[3.2.1]octane-3,4'-imidazolidine]-8-yl)butanoate",CCOC(=O)CCCN1C2CCC1CC3(C2)C(=O)NC(=O)N3,,,,,,
9191,159192,"1H-Imidazole, 1-((heptadecafluorooctyl)sulfonyl)-",C1=CN(C=N1)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9192,159193,"N,N-diethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide",CCN(CC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9193,159194,"1-Octanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-2-propynyl-",CCN(CC#C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9194,159195,"1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(1-methylethyl)-",CC(C)NS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9195,159196,"1-Octanesulfonamide, N-ethenyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-methyl-",CN(C=C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9196,159197,"1-Octanesulfonamide, N-(2-chloroethyl)-N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-",CCN(CCCl)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9197,159198,"8,14-Methano-2H,14H-1-benzopyrano(7,8-d)(1,3)benzodioxocin-3,5,11,13-tetrol, 3,4-dihydro-2,8-bis(4-hydroxyphenyl)-, (2R,3R,8S,14R)-",C1C(C(OC2=C1C(=CC3=C2C4CC(O3)(OC5=CC(=CC(=C45)O)O)C6=CC=C(C=C6)O)O)C7=CC=C(C=C7)O)O,,,,,,
9198,159199,"2-Amino-3-methyl-4,5-dihydropyrimidin-6-one",CN1CCC(=O)N=C1N,,,,,,
9199,159200,CID 159200,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC(=O)C3=C(C=C(OC3=C2)C4=CC=C(C=C4)O)O)O)O)O,,,,,,
9200,159201,Ethylhexyl triazone,CCCCC(CC)COC(=O)C1=CC=C(C=C1)NC2=NC(=NC(=N2)NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)NC4=CC=C(C=C4)C(=O)OCC(CC)CCCC,,,,,,
9201,159202,CID 159202,C[C@@H](C1CC[C@](O1)(C)C=C)C(=O)C=CC(C)(C)OO,,,,,,
9202,159203,CID 159203,CCC1=C(C(=O)C(=C(O1)C(C)C=C(C)[C@@H]([C@H](C)[C@H]([C@@H](C)C2=C(C(=O)C(=C(O2)[C@H](C)[C@H](CC)O)C)C)O)O)C)C,,,,,,
9203,159204,Robustadial A,CC(C)C[C@H]1C[C@@]2(CC[C@H]3C[C@@H]2C3(C)C)OC4=C(C(=C(C(=C14)O)C=O)O)C=O,,,,,,
9204,159205,"Urea, N'-(3-butylphenyl)-N,N-dimethyl-",CCCCC1=CC(=CC=C1)NC(=O)N(C)C,,,,,,
9205,159206,"Urea, N'-(3-((2,4-dichlorophenyl)methoxy)phenyl)-N,N-dimethyl-",CN(C)C(=O)NC1=CC(=CC=C1)OCC2=C(C=C(C=C2)Cl)Cl,,,,,,
9206,159207,"Urea, N'-(4-(dodecyloxy)phenyl)-N,N-dimethyl-",CCCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)N(C)C,,,,,,
9207,159208,N-(3-phenylcyclohex-2-en-1-ylidene)hydroxylamine,C1CC(=CC(=NO)C1)C2=CC=CC=C2,,,,,,
9208,159209,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-(2-(dimethylamino)ethyl)-6-nitro-",CN(C)CCN1C(=O)C2=C3C(=C(C=C2)[N+](=O)[O-])C=CC=C3C1=O,,,,,,
9209,159210,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 6-nitro-2-(2-(1-pyrrolidinyl)ethyl)-",C1CCN(C1)CCN2C(=O)C3=C4C(=C(C=C3)[N+](=O)[O-])C=CC=C4C2=O,,,,,,
9210,159211,"1H-Benz(de)isoquinoline-1,3(2H)-dione, 2-(2-(diethylamino)ethyl)-6-nitro-",CCN(CC)CCN1C(=O)C2=C3C(=C(C=C2)[N+](=O)[O-])C=CC=C3C1=O,,,,,,
9211,159212,"(11-Chloro-21-hydroxy-12,15,20-trimethoxy-2,5,16-trimethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 2-[methyl(2-methylpropanoyl)amino]propanoate",CC1C2CC(C(C=CC=C(C(C3=CC(=C(C(=C3)OC)Cl)NC(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)C(C)C)OC)C)OC)(NC(=O)O2)O,,,,,,
9212,159213,CID 159213,COC1=C(C(=C(C=C1)CC(=O)NOS(=O)(=O)O)[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)S)OC,,,,,,
9213,159214,"Propyldioxy, 2-oxo-",CC(=O)CO[O],,,,,,
9214,159215,"Peroxide, 2-methyl-1-oxo-2-propenyl nitro",CC(=C)C(=O)OO[N+](=O)[O-],,,,,,
9215,159216,"1,2,3,4-Chrysenetetrol, 1,2,3,4-tetrahydro-5-methyl-",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)C(C(C(C4O)O)O)O,,,,,,
9216,159217,"Cholestane-3,6,8,15-tetrol, 24-(alpha-L-arabinofuranosyloxy)-, (3beta,5alpha,6alpha,15beta)-",C[C@H](CCC(C(C)C)O[C@H]1[C@@H]([C@H]([C@@H](O1)CO)O)O)[C@H]2C[C@@H]([C@H]3[C@@]2(CC[C@@H]4C3(C[C@H]([C@H]5[C@@]4(CC[C@@H](C5)O)C)O)O)C)O,,,,,,
9217,159218,"2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,tetrahydrate, (2R-trans)-",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O.O.O.O.O,,,,,,
9218,159219,Robustadial B,CC(C)C[C@@H]1C[C@@]2(CC[C@H]3C[C@@H]2C3(C)C)OC4=C(C(=C(C(=C14)O)C=O)O)C=O,,,,,,
9219,159220,"Benzeneethanaminium, beta-methoxy-N,N,N-trimethyl-, chloride",C[N+](C)(C)CC(C1=CC=CC=C1)OC.[Cl-],,,,,,
9220,159221,(2-Methoxy-2-phenylethyl)-trimethylazanium,C[N+](C)(C)CC(C1=CC=CC=C1)OC,,,,,,
9221,159222,"(11-Chloro-21-hydroxy-12,15,20-trimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 2-[methyl(2-methylpropanoyl)amino]propanoate",CC1C2CC(C(C=CC=C(C(C3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)C(C)C)C)OC)C)OC)(NC(=O)O2)O,,,,,,
9222,159223,PM-Toxin A,CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)C)O)O)O)O,,,,,,
9223,159224,"2,10,18-Tritriacontanetrione, 4,12,20,24,26,28-hexahydroxy-, (4R,12R,20R,24S,26R,28R)-",CCCCC[C@H](C[C@H](C[C@H](CCC[C@H](CC(=O)CCCCC[C@H](CC(=O)CCCCC[C@H](CC(=O)C)O)O)O)O)O)O,,,,,,
9224,159225,"beta-D-Ribofuranoside, (2S)-2-hydroxy-3-(sulfooxy)propyl5-deoxy-5-(dimethylarsinyl)-",C[As](=O)(C)C[C@@H]1[C@H]([C@H]([C@@H](O1)OC[C@@H](COS(=O)(=O)O)O)O)O,,,,,,
9225,159226,"Azuleno(4,5-b)furan-2(3H)-one, decahydro-5,8-dihydroxy-3,9-dimethyl-6-methylene-",CC1C(CC2C1C3C(CC(C2=C)O)C(C(=O)O3)C)O,,,,,,
9226,159227,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (pentamethylphenyl)methyl ester, trans-",CC1=C(C(=C(C(=C1C)C)COC(=O)[C@@H]2[C@H](C2(C)C)C=C(Cl)Cl)C)C,,,,,,
9227,159228,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-iodophenyl)methyl ester, trans-",CC1([C@@H]([C@H]1C(=O)OCC2=CC(=CC=C2)I)C=C(Cl)Cl)C,,,,,,
9228,159229,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (3,5-dinitrophenyl)methyl ester, trans-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])C,,,,,,
9229,159230,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3,5-dinitrophenyl)methyl ester, trans-",CC1([C@@H]([C@H]1C(=O)OCC2=CC(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])C=C(Cl)Cl)C,,,,,,
9230,159231,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-nitrophenyl)methyl ester, trans-",CC1([C@@H]([C@H]1C(=O)OCC2=CC(=CC=C2)[N+](=O)[O-])C=C(Cl)Cl)C,,,,,,
9231,159232,"4H-Dibenzo(de,g)quinoline-1,4-diol, 5,6,6a,7-tetrahydro-2,10,11-trimethoxy-6-methyl-, (4S-cis)-",CN1C[C@H](C2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)OC)O)OC)O,,,,,,
9232,159233,alpha-Solanine-alpha-chaconine mixt.,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C.C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C,,,,,,
9233,159234,CID 159234,C[C@@H]1CC[C@@H]2[C@@H]([C@@H]3[C@H](N2C1)C[C@H]4[C@@]3(CC[C@@H]5[C@H]4CC=C6[C@]5(CC[C@@H](C6)O[C@@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)CO)O[C@@H]8[C@@H](C([C@H]([C@@H](O8)C)O)O)O)O)O[C@@H]9[C@@H](C([C@H]([C@@H](O9)C)O)O)O)C)C)C,,,,,,
9234,159235,CID 159235,C[C@@H]1CC[C@@H]2[C@@H]([C@@H]3[C@H](N2C1)C[C@H]4[C@@]3(CC[C@@H]5[C@H]4CC=C6[C@]5(CC[C@@H](C6)O[C@@H]7[C@@H](C([C@H]([C@@H](O7)CO)O)O[C@@H]8[C@@H](C(C([C@@H](O8)CO)O)O)O)O[C@@H]9[C@@H](C(C([C@@H](O9)C)O)O)O)C)C)C,,,,,,
9235,159236,Gizzerosine,C1=C(NC=N1)CCNCCCC[C@@H](C(=O)O)N,,,,,,
9236,159237,"Thieno(2,3-c)pyridine, 7-((3,4-dimethoxyphenyl)methyl)-6,7-dihydro-6-methyl-",CN1C=CC2=C(C1CC3=CC(=C(C=C3)OC)OC)SC=C2,,,,,,
9237,159238,beta-Pyrufuran,COC1=C(C(=C(C2=C1C3=CC=CC=C3O2)OC)O)OC,,,,,,
9238,159239,alpha-Pyrufuran,COC1=C(C(=C(C2=C1C3=CC=CC=C3O2)OC)OC)O,,,,,,
9239,159240,"Benz(j)aceanthrylene-9,10-diol, 1,2,9,10-tetrahydro-, trans-",C1CC2=C3C1=CC=CC3=CC4=C2C=CC5=C4C=C[C@@H]([C@H]5O)O,,,,,,
9240,159241,"1,2-Anthracenediol, 1,2-dihydro-9-(hydroxymethyl)-10-methyl-",CC1=C2C=CC(C(C2=C(C3=CC=CC=C13)CO)O)O,,,,,,
9241,159242,"1,2-Anthracenediol, 1,2-dihydro-10-(hydroxymethyl)-9-methyl-",CC1=C2C(C(C=CC2=C(C3=CC=CC=C13)CO)O)O,,,,,,
9242,159243,"1,2-Anthracenediol, 1,2-dihydro-10-(hydroxymethyl)-",C1=CC=C2C(=C1)C=C3C(C(C=CC3=C2CO)O)O,,,,,,
9243,159244,"Azuleno(4,5-b)furan-2,8(3H,4H)-dione, octahydro-5-hydroxy-3,9-dimethyl-6-methylene-",CC1C2CC(C(=C)C3CC(=O)C(C3C2OC1=O)C)O,,,,,,
9244,159245,"Phosphoramidothioic acid, (1-methylpropyl)-, O-ethyl O-(5-methoxy-2-nitrophenyl) ester",CCC(C)NP(=S)(OCC)OC1=C(C=CC(=C1)OC)[N+](=O)[O-],,,,,,
9245,159246,Thalifaberine,CN1CCC2=C3[C@@H]1CC4=C(C(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC)OC5=CC=C(C=C5)C[C@H]6C7=CC(=C(C=C7CCN6C)OC)OC,,,,,,
9246,159247,Sevelamer hydrochloride,C=CCN.C1C(O1)CCl.Cl,"['Tasermity is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.']",,['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)'],,,
9247,159248,CID 159248,CCCCCCCCCCCCCCCC=CC(C(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)N)O[C@@]5(C[C@@H]([C@H]([C@@H](O5)C(C(CO)O)O)N)O)C(=O)O)O)O)O)N)O,,,,,,
9248,159249,CID 159249,C(CN=C(N)S)N=C(N)S,,,,,,
9249,159250,Strontium dichloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2],,,,,,
9250,159251,"Platinate(2-), tetrachloro-, disodium, (SP-4-1)-",[Na+].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
9251,159252,Butanedioic acid;iron(2+),C(CC(=O)O)C(=O)O.[Fe+2],,,,,,
9252,159253,"Oxalic acid, potassium salt",C(=O)(C(=O)[O-])[O-].[K+],,,,,,
9253,159254,Neodymium trinitrate,[N+](=O)(O)[O-].[N+](=O)(O)[O-].[N+](=O)(O)[O-].[Nd+3],,,,,,
9254,159255,Hydroxylammonium hydrogensulphate,NO.OS(=O)(=O)O,,,,,,
9255,159256,(2S)-2-[[2-[4-[bis(2-chloroethyl)amino]phenyl]acetyl]amino]-3-phenylpropanoic acid,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
9256,159257,Methylcyanocarbamate dimer,COC(=O)NC#N.COC(=O)NC#N,,,,,,
9257,159258,Versicolorins,C1=CC2=C(C(=C1CO)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,,,,,,
9258,159259,Lanthanum sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[La+3].[La+3],,,,,,
9259,159260,Disodium;telluric acid,O[Te](=O)(=O)O.[Na+].[Na+],,,,,,
9260,159261,"Tetrathionic acid, disodium salt",OS(=O)(=O)SSS(=O)(=O)O.[Na+].[Na+],,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
9261,159262,"Phosphoric acid, manganese salt",[O-]P(=O)([O-])[O-].[Mn+2],,,,,,
9262,159263,"Acridine, 3-bromo-9-((4-(dimethylamino)butyl)amino)-5-methoxy-, dihydrochloride",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C.Cl.[Cl-].[Cl-].[Zn+2],,,,,,
9263,159264,CID 159264,COC1=C2C(=C(C3=C(C=C4C(=C3O2)C5CCOC5O4)OC)O)C(=O)C=C1,,,,,,
9264,159265,Erbium trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Er+3],,,,,,
9265,159266,Gadolinium trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Gd+3],,,,,,
9266,159267,Chromomycinone,CC1=C(C2=C(C3=C(C[C@H]([C@@H](C3=O)O)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)C=C2C=C1O)O)O,,,,,,
9267,159268,Diboron trizinc hexaoxide,B(O)(O)O.B(O)(O)O.B(O)(O)O.[Zn].[Zn],,,,,,
9268,159269,Telbivudine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,['For the treatment of chronic hepatitis B in adult and adolescent patients ≥16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.'],"[""Telbivudine is a synthetic thymidine nucleoside analogue with activity against hepatitis B virus (HBV). Telbivudine is the unmodified β–L enantiomer of the naturally occurring nucleoside, thymidine. It undergoes phosphorylation via interaction with cellular kinases to form the active metabolite, telbivudine 5'-triphosphate.""]","['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)']","['Absorbed following oral administration. Telbivudine absorption and exposure were unaffected when a single 600–mg dose was administered with a high–fat (~55 g), high–calorie (~950 kcal) meal.', 'Telbivudine is eliminated primarily by urinary excretion of unchanged drug.', '7.6 +/- 2.9 L/h [Normal renal function (Clcr>80 mL/min)]']","['No metabolites of telbivudine were detected following administration of [14C]–telbivudine in humans. Telbivudine is not a substrate, or inhibitor of the cytochrome P450 (CYP450) enzyme system.']",['Approximately 15 hours.']
9269,159270,CID 159270,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C(N)O)C(=O)[C@]4(C(=O)C3=C(C2=C1O)O)O)N(C)C)N(C)C,,,,,,
9270,159271,Tilmacoxib,CC1=NC(=C(O1)C2=CC(=C(C=C2)S(=O)(=O)N)F)C3CCCCC3,,,,,,
9271,159272,"Diphosphoric acid, iron sodium salt",OP(=O)(O)OP(=O)(O)O.[Na+].[Fe+2],,,,,,
9272,159273,Corticosterone-21-hemisuccinate,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)COC(=O)CCC(=O)O)C)O,,,,,,
9273,159274,Calcium;sulfurous acid,OS(=O)O.[Ca+2],,,,,,
9274,159275,Disilver;sulfuric acid,OS(=O)(=O)O.[Ag+].[Ag+],,,,,,
9275,159276,Malouetine,C[C@@H](C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)[N+](C)(C)C)C)C)[N+](C)(C)C.[I-].[I-],,,,,,
9276,159277,CID 159277,C[C@@H](C1CCC2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)[N+](C)(C)C)C)C)[N+](C)(C)C,,,,,,
9277,159278,Salidroside,C1=CC(=CC=C1CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
9278,159279,Bacteriochlorin a,CC[C@@H]1[C@H](C2=NC1=CC3=C(C(=C(N3)C(=C4[C@H]([C@@H](C(=N4)C=C5C(=C(C(=C2)N5)C(=O)C)C)C)CCC(=O)O)CC(=O)O)C(=O)O)C)C,,,,,,
9279,159280,"(1R,9S,10R)-16-methyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,16-trien-5-one",CC1=C[C@@H]2CC3=C(C=CC(=O)N3)[C@@]4(C1)[C@@H]2CCCN4,,,,,,
9280,159281,CID 159281,C[C@H]1C[C@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@@]45C[C@@H]6[C@@H](O4)[C@H]7[C@@H](O6)C(O5)[C@H]8[C@H](O7)CC[C@H](O8)CC(=O)O[C@@H]9[C@H]([C@@H]3[C@@H](C[C@@H]4[C@H](O3)C[C@]3(O4)C[C@@H]4[C@H](O3)[C@@H](C[C@]3(O4)C[C@H]([C@@H]4[C@H](O3)C[C@@H](O4)[C@H](C[C@H](CO)O)O)C)C)O[C@@H]9C[C@@H](C1=C)O2)C,,,,,,
9281,159282,"Phosphoric acid, ammonium salt (1:3)",[NH4+].[NH4+].[NH4+].[O-]P(=O)([O-])[O-],,,"['Substances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity. (See all compounds classified as Fertilizers.)', 'Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. (See all compounds classified as Food Additives.)']",,,
9282,159283,Yttrium nitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Y+3],,,,,,
9283,159284,Triostin C,CC1C(=O)N(C2CSSCC(C(=O)N(C(C(=O)OCC(C(=O)N1)NC(=O)C3=NC4=CC=CC=C4N=C3)C(C)C(C)C)C)N(C(=O)C(NC(=O)C(COC(=O)C(N(C2=O)C)C(C)C(C)C)NC(=O)C5=NC6=CC=CC=C6N=C5)C)C)C,,,,,,
9284,159285,"Adenosine, 3'-deoxy-, 1-oxide",C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C2N=CN(C3=N)O)CO,,,,,,
9285,159286,Tetrachloroplatinate dianion-rhodamine-123 complex,COC(=O)C1=CC=CC=C1C2=C3C=CC(=[NH2+])C=C3OC4=C2C=CC(=C4)N.COC(=O)C1=CC=CC=C1C2=C3C=CC(=[NH2+])C=C3OC4=C2C=CC(=C4)N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
9286,159287,Malvidin,COC1=CC(=CC(=C1O)OC)C2=[O+]C3=CC(=CC(=C3C=C2O)O)O,,,,,,
9287,159288,CID 159288,C[C@H]1[C@@H](C[C@@H](C2(CO2)[C@H](C[C@@H]3CC=C[C@H](O3)C[C@H](CC=C(C=CC(=O)OC1[C@@H](C)[C@H]([C@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)OC)OC)OC,,,,,,
9288,159289,CI-959 free acid,CC(C)OC1=C(SC2=C1C=C(C=C2)OC)C(=O)NC3=NNN=N3,,,,,,
9289,159290,Rhodium(III) sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Rh+3].[Rh+3],,,,,,
9290,159291,Morpholinoanthracycline MX,CCC1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)OC5CC(C(C(O5)C)O)N6CCOCC6)O,,,,,,
9291,159292,Rhodium(II) formamidinate,CC1=CC=C(C=C1)[N-]C=NC2=CC=C(C=C2)C.CC1=CC=C(C=C1)[N-]C=NC2=CC=C(C=C2)C.C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].O.O.[Rh+2].[Rh+2],,,,,,
9292,159293,"N,N'-Di-p-tolyl-formamidine",CC1=CC=C(C=C1)NC=NC2=CC=C(C=C2)C,,,,,,
9293,159294,CID 159294,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)OS(=O)(=O)O)C,,,,,,
9294,159295,Hexaamminecobalt(III) chloride,N.N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Co+3],,,,,,
9295,159296,Adenosine-3'-5'-diphosphate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)OP(=O)(O)O)O)N,,,,,,
9296,159297,Bis(anhydro)aklavinone,CCC1=C(C2=CC3=C(C(=C2C=C1)O)C(=O)C4=C(C3=O)C=CC=C4O)C(=O)OC,,,,,,
9297,159298,4'-Methylniridazole,CC1=C(SC(=N1)N2CCNC2=O)[N+](=O)[O-],,,,,,
9298,159299,CID 159299,C[C@]12C[C@H]([C@H]3[C@H]([C@]1(CC[C@@H]2C4=COC(=O)C=C4)O)CC[C@@]56[C@@]3([C@H]7C[C@H](C5)O[C@](O7)(O6)C)C=O)O,,,,,,
9299,159300,Oxaunomycin,CC[C@]1(C[C@@H](C2=C([C@H]1O)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O,,,,,,
9300,159301,CID 159301,C[C@H]1[C@@H](C[C@@H]([C@@H]([C@H](C[C@@H]2CC=C[C@H](O2)C[C@H](CC=C(C=CC(=O)O[C@@H]1[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)OC)CO)OC)OC,,,,,,
9301,159302,CID 159302,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)N(C)C)O.Cl,,,,,,
9302,159303,"(5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2-deoxy-2-(dimethylamino)-4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside",CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)N(C)C)O,,,,,,
9303,159304,"3-(4-Chlorophenyl)propane-1,2-diamine;platinum(2+);dichloride",C1=CC(=CC=C1CC(CN)N)Cl.[Cl-].[Cl-].[Pt+2],,,,,,
9304,159305,"1-(4-Chlorobenzyl)-1,2-ethanediamine",C1=CC(=CC=C1CC(CN)N)Cl,,,,,,
9305,159306,"Tetralithium 7-amino-1-hydroxy-2-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-3,6-disulfonate",[Li+].[Li+].[Li+].[Li+].C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C(C5=CC(=C(C=C5C=C4S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)S(=O)(=O)[O-])S(=O)(=O)[O-],,,,,,
9306,159307,Black 7984,C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C(C5=CC(=C(C=C5C=C4S(=O)(=O)O)S(=O)(=O)O)N)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9307,159308,"Oxytocin, pen(1)-(4-mephe)(2)-thr(4)-orn(8)-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC([C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)C)N)(C)C)C(=O)N3CCCC3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,,,,,,
9308,159309,"(7S,9S)-7-[(2R,4S,5S,6S)-5-amino-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)O)N,,,,,,
9309,159310,CID 159310,C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2C#CC=CC#CC3([C@@H](C(=O)C(=C2C3=CCSSSC)NC(=O)OC)O)O)O[C@H]4C[C@@H]([C@H](CO4)NC(C)C)OC)O)NO[C@H]5C[C@@H]([C@@H]([C@H](O5)C)SC)O,,,,,,
9310,159311,Bulleyaconitine A,CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6(CC4C5C6C(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)COC,,,,,,
9311,159312,CID 159312,CC=C(C)[C@@]1([C@]([C@H]([C@]([C@H](O1)CO)(C)O)O)(C)O)OCCC=CC=CCC(=CCC2=C(C(=O)C(=C(N2)OC)OC)C)C,,,,,,
9312,159313,Barminomycin I,CC1C=NC2CC(OC(C2OC(O1)CC(C)O)C)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)O)O)(C(=O)C)O,,,,,,
9313,159314,CID 159314,C1CCC(C1)[C@@H](C=C[C@H]2[C@@H](C[C@H]3[C@@H]2CC(=CCCCC(=O)O)C3)O)O.C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)O)O,,,,,,
9314,159315,CID 159315,C1CCC(C1)[C@@H](C=C[C@@H]2[C@H]3CC(=CCCCC(=O)O)C[C@H]3CC2O)O,,,,,,
9315,159316,"Benzene, reaction products with chlorine and sulfur chloride (S2Cl2), chlorides",C1=CC=CC=C1.S(SCl)Cl.ClCl,,,,,,
9316,159317,Oxophoebine,COC1=C(C(=C2C3=CC4=C(C=C3C(=O)C5=NC=CC1=C25)OCO4)OC)OC,,,,,,
9317,159318,1-(2-Allyloxyethoxy)octadecane; ethyl prop-2-enoate; 2-methylprop-2-enoic acid,CCCCCCCCCCCCCCCCCCOCCOCC=C.CCOC(=O)C=C.CC(=C)C(=O)O,,,,,,
9318,159319,2-(Octadecyloxy)ethylallyl ether,CCCCCCCCCCCCCCCCCCOCCOCC=C,,,,,,
9319,159320,7-Octylindolactam V,CCCCCCCCC1=C2C3=C(C=C1)N([C@H](C(=O)N[C@@H](CC3=CN2)CO)C(C)C)C,,,,,,
9320,159321,Sulfonoglycolipid,CCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CS(=O)(=O)O)O)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
9321,159322,2-Methoxyethyl nonanoate,CCCCCCCCC(=O)OCCOC,,,,,,
9322,159323,6-Methylenetestosterone acetate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C)C4=CC(=O)CC[C@]34C)C,,,,,,
9323,159324,Tipifarnib,CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,"['Investigated for use/treatment in colorectal cancer, leukemia (myeloid), pancreatic cancer, and solid tumors.']","['R115777, a nonpeptidomimetic farnesyl transferase inhibitor, suppresses the growth of human pancreatic adenocarcinoma cell lines. This growth inhibition is associated with modulation in the phosphorylation levels of signal transducers and activators of transcription 3 (STAT3) and extracellular signal-regulated kinases (ERK).']",['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
9324,159325,Torcetrapib,CC[C@@H]1C[C@@H](C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,['Investigated for use/treatment in peripheral vascular disease and hyperlipidemia.'],,['Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)'],,,
9325,159326,Abafungin,CC1=CC(=C(C=C1)OC2=CC=CC=C2C3=CSC(=N3)NC4=NCCCN4)C,"['Investigated for use/treatment in fungal infections, bacterial infection, skin infections/disorders, and onychomycosis.']",,,,,
9326,159327,Antibiotic 1063Z; (-)-Pulvomycin,CC1C(C(C(C(O1)OC(C)C(C=CC=CC=CC(=O)C(C)C(C(C)C2CC=CC=CC=CC(C(=O)C(=CC=CC(=CC(C(=CCC(=O)O2)C)O)C)C)O)O)O)OC)O)OC,,,,,,
9327,159328,Capozide,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O.C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA. (See all compounds classified as Sodium Chloride Symporter Inhibitors.)', 'A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)']",,,
9328,159329,Dioxooctadecadienoic acid,CCCCCCC(=O)C=CC=CC(=O)CCCCCC(=O)O,,,,,,
9329,159330,Triptonoterpenol,CC(C)C1=CC(=C2C(=C1OC)CC[C@H]3[C@]2(CCC(=O)[C@@]3(C)CO)C)O,,,,,,
9330,159331,Thevetin,C[C@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CCC5C6=CC(=O)OC6)O)C)C)O)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O,,,,,,
9331,159332,CID 159332,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C(=C(C=C4O)OC)Cl)O)O)N(C)C)O,,,,,,
9332,159333,"[2-[2-[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[5-[[1-[2-[4-[4-[4-(diaminomethylideneamino)butylcarbamoyl]-1,3-thiazol-2-yl]-4,5-dihydro-1,3-thiazol-2-yl]ethylamino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-4-methyl-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(CS5)C6=NC(=CS6)C(=O)NCCCCN=C(N)N)O,,,,,,
9333,159334,Phleomycin E,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(CS5)C6=NC(=CS6)C(=O)NCCCCNC(=NCCCCN=C(N)N)N)O,,,,,,
9334,159335,N-Deacetyllappaconitine,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2CC(C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7N,,,,,,
9335,159336,"3-[(6-Deoxy-2,3-di-o-methylhexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide",CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)OC)OC)O,,,,,,
9336,159337,CID 159337,C1=CC(=CC=C1C(C2=CC=C(C=C2)O)C(C3=COC4=CC(=O)C=CC4=C3O)C(=O)C5=C(C=C(C=C5)O)O)O,,,,,,
9337,159338,1-Methyl-5-(2-deoxy-2-fluoroarabinofuranosyl)uracil,CN1C=C(C(=O)NC1=O)C2[C@H]([C@@H]([C@H](O2)CO)O)F,,,,,,
9338,159339,CID 159339,CC[C@@H]1C(C=C(C=CC(=O)[C@@H](C[C@@H](C([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)O)OC,,,,,,
9339,159340,CID 159340,C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](CO[C@H]2O[C@H]3CC[C@]4(C(C3(C)C)CCC5C4=C[C@@H](C67C5(CC[C@@]6([C@@](OC7=O)(C)[C@@H]8CCC(O8)(C)C)O)C)O)C)OS(=O)(=O)[O-])O)O)O)O.[Na+],,,,,,
9340,159341,CID 159341,C[C@H]1C([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@@H](CO[C@@H]2O[C@@H]3CC[C@]4(C(C3(C)C)CCC5C4=C[C@H](C67C5(CC[C@@]6([C@@](OC7=O)(C)[C@H]8CCC(O8)(C)C)O)C)O)C)OS(=O)(=O)O)O)O)O)O,,,,,,
9341,159342,Floccosin,CC1CC2=CC3=C(C(C4(C(C3=O)(O4)OC)C56C(C7=C(C=C8CC(OC(=O)C8=C7O)C)C(=O)C5(O6)OC)O)O)C(=C2C(=O)O1)O,,,,,,
9342,159343,Triazolium-bis(triazole)tetrachlororuthenate(III),C1=NC=NN1.C1=NC=NN1.C1=NC=NN1.[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
9343,159344,Bistriazolium-triazolepentachlororuthenate(III),[H+].[H+].C1=NC=NN1.C1=NC=NN1.C1=NC=NN1.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
9344,159345,"3-[[5,7,9,19,21,23,27,29,30,31-decahydroxy-8,12,18,22,26-pentamethyl-13-[4-methyl-12-[(N'-methylcarbamimidoyl)amino]dodec-8-en-2-yl]-15-oxo-14,33-dioxabicyclo[27.3.1]tritriaconta-10,16-dien-3-yl]oxy]-3-oxopropanoic acid",CC1CCC(C(C(CC(C(C=CC(=O)OC(C(C=CC(C(C(CC(CC(CC2CC(C(C(O2)(CC1O)O)O)O)OC(=O)CC(=O)O)O)O)C)O)C)C(C)CC(C)CCCC=CCCCNC(=NC)N)C)O)O)C)O,,,,,,
9345,159346,3-Amino-1h-indole-2-carbohydrazide,C1=CC=C2C(=C1)C(=C(N2)C(=O)NN)N,,,,,,
9346,159347,Aluminum magnesium hydroxide carbonate,C(=O)([O-])[O-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3],,,,,,
9347,159348,(S)-N-(4-((Aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-L-prolinamide,C1C[C@H](N(C1)[C@@H](CCCN=C(N)N)C#N)C(=O)NC(=O)[C@@H](CC2=CC=CC=C2)N,,,,,,
9348,159349,Chromium copper oxide,[O-2].[Cr].[Cu],,,,,,
9349,159350,Molybdenum hydroxide oxide phosphate,[OH-].[O-2].[P-3].[Mo],,,,,,
9350,159351,Gold chloride (VAN),[Cl-].[Au],,,,,,
9351,159352,"Methyl 3,4-diphenyl-5-hydroxylamino-2-furoate",COC(=O)C1=C(C(=C(O1)NO)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
9352,159353,"Isothiazolo(5,4-b)quinoline-3,4(2H,9H)-dione, 9-cyclopropyl-6,8-difluoro-7-(1-piperazinyl)-",C1CC1N2C3=C(C(=C(C=C3C(=O)C4=C2SNC4=O)F)N5CCNCC5)F,,,,,,
9353,159354,Torcitabine,C1[C@H]([C@@H](O[C@@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
9354,159355,Tosagestin,C[C@]12CC(=C)[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,
9355,159356,Hydrabamine dihydrochloride hydrate,CC(C)C1=CC2=C(C=C1)[C@]3(CCC[C@@]([C@@H]3CC2)(C)CNCCNC[C@@]4(CCC[C@]5([C@H]4CCC6=C5C=CC(=C6)C(C)C)C)C)C.O.Cl.Cl,,,,,,
9356,159357,Hydrabamine,CC(C)C1=CC2=C(C=C1)[C@]3(CCC[C@@]([C@@H]3CC2)(C)CNCCNC[C@@]4(CCC[C@]5([C@H]4CCC6=C5C=CC(=C6)C(C)C)C)C)C,,,,,,
9357,159358,17-Ethynylandrost-2-ene-17-ol-17-acetate,CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC=CC4)C)C)C#C,,,,,,
9358,159359,5-Iodocytidine,C1=C(C(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)I,,,,,,
9359,159360,Apigeninidin,C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2)O)O)O.[Cl-],,,,,,
9360,159361,5-Hydroxy-2-(4-hydroxyphenyl)chromen-7-one,C1=CC(=CC=C1C2=CC=C3C(=CC(=O)C=C3O2)O)O,,,,,,
9361,159362,CID 159362,CCCCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCCCCCC(=O)O.[CaH2].[BaH2],,,,,,
9362,159363,3-Amino-6-chloro-n-(diaminomethylidene)pyrazine-2-carboxamide,C1=C(N=C(C(=N1)N)C(=O)N=C(N)N)Cl,,,,,,
9363,159364,"6-(3,7-Dimethyl-2,4,6,8-nonatetraen-1-ylidene)-1,5,5-trimethylcyclohexene",CC1=CCCC(C1=CC=C(C)C=CC=C(C)C=C)(C)C,,,,,,
9364,159365,"Spiro(estr-4-ene-17,2'(3'H)-furan)-3-one, 4',5'-dihydro-, (17R)-",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]24CCCO4)CCC5=CC(=O)CC[C@H]35,,,,,,
9365,159366,CID 159366,[LiH].O[Si](O)(O)O.[AlH3],,,,,,
9366,159367,Spinel,O=[Al-]=O.O=[Al-]=O.[Mg+2],,,,,,
9367,159368,CID 159368,O.O[Si](O)(O)O.[AlH3].[AlH3],,,,,,
9368,159369,Aluminum sulfide (Al2S3),[Al+3].[Al+3].[S-2].[S-2].[S-2],,,,,,
9369,159370,Dysprosium oxide,[O-2].[O-2].[O-2].[Dy+3].[Dy+3],,,,,,
9370,159371,Europium oxide,[O-2].[O-2].[O-2].[Eu+3].[Eu+3],,,,,,
9371,159372,Ferric subsulfate,[OH-].[OH-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3],,,['Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)'],,,
9372,159373,Neodymium oxide,[O-2].[O-2].[O-2].[Nd+3].[Nd+3],,,,,,
9373,159374,Yttrium oxide,[O-2].[O-2].[O-2].[Y+3].[Y+3],,,,,,
9374,159375,Ytterbium oxide (Yb2O3),[O-2].[O-2].[O-2].[Yb+3].[Yb+3],,,,,,
9375,159376,Thallium sulfide (Tl2S3),[S-2].[Tl+].[Tl+],,,,,,
9376,159377,CID 159377,O.[OH-].[MgH2].[AlH3],,,,,,
9377,159378,CID 159378,C1=CC=C(C(=C1)OCO)S(=O)(=O)[O-].[K+],,,,,,
9378,159379,Hydroxymethoxybenzenesulphonic acid,C1=CC=C(C(=C1)OCO)S(=O)(=O)O,,,,,,
9379,159380,Sodium fluoroaluminate,[F-].[F-].[F-].[F-].[Na+].[Al+3],,,,,,
9380,159381,Aluminum hydroxide sulfate (Al(OH)(SO4)),[OH-].[O-]S(=O)(=O)[O-].[Al+3],,,,,,
9381,159382,Tricopper;dihydroxide;disulfate,[OH-].[OH-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cu+2].[Cu+2].[Cu+2],,,,,,
9382,159383,"Boric acid, sodium salt",B([O-])([O-])[O-].[Na+].[Na+].[Na+],,,,,,
9383,159384,Cobalt aluminate,[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Co+2].[Co+2],,,,,,
9384,159385,"Lead oxide (PbO), lead-contg.",[O-2].[Pb+2],,,,,,
9385,159386,CID 159386,[O-][O-].[Mg+2],,,,,,
9386,159387,Vanadium carbide (VC),C.[V],,,,,,
9387,159388,CID 159388,O.[MgH2].[AlH3],,,,,,
9388,159389,Alumane;zirconium,[AlH3].[AlH3].[AlH3].[Zr],,,,,,
9389,159390,"Iron, diarsoranylidyne-",[Fe](#[As])#[As],,,,,,
9390,159391,CID 159391,[LiH].[LiH].B.B.B.B.O.O.O.O.O.O.O,,,,,,
9391,159392,CID 159392,O.O.O.O.[CaH2].[Fe].[Fe],,,,,,
9392,159393,Cadmium phosphide (Cd3P2),[P-3].[P-3].[Cd+2].[Cd+2].[Cd+2],,,,,,
9393,159394,Cerium sulfide,[S-2].[S-2].[S-2].[Ce+3].[Ce+3],,,,,,
9394,159395,Cobalt titanium oxide (Co2TiO4),[O-2].[O-2].[O-2].[Ti+4].[Co+2],,,,,,
9395,159396,"Cobalt, compd. with samarium (5:1)",[Co].[Co].[Co].[Co].[Co].[Sm],,,,,,
9396,159397,Chromium sulfide (Cr2S3),[S-2].[S-2].[S-2].[Cr+3].[Cr+3],,,,,,
9397,159398,CID 159398,[SiH4].[Cr].[Cr].[Cr],,,,,,
9398,159399,Tricopper phosphide,[P-3].[P-3].[Cu+2].[Cu+2].[Cu+2],,,,,,
9399,159400,CID 159400,[O-2].[O-2].[O-2].[Na+].[Na+].[GeH4],,,,,,
9400,159401,CID 159401,[GeH4].[TeH2],,,,,,
9401,159402,Iodine pentoxide,O=I(=O)OI(=O)=O,,,,,,
9402,159403,Potassium titanium oxide,[O-2].[O-2].[O-2].[K+].[K+].[Ti+4],,,,,,
9403,159404,Lithium niobium trioxide,[Li+].[O-2].[O-2].[O-2].[Nb+5],,,,,,
9404,159405,Lithium tantalum oxide (LiTaO3),[Li+].[O-2].[O-2].[O-2].[Ta+5],,,,,,
9405,159406,Lutetium oxide (Lu2O3),[O-2].[O-2].[O-2].[Lu+3].[Lu+3],,,,,,
9406,159407,Magnesium titanium trioxide,[O-2].[O-2].[O-2].[Mg+2].[Ti+4],,,,,,
9407,159408,Azane;titanium,N.[Ti],,,,,,
9408,159409,Rhodium(III) oxide,[O-2].[O-2].[O-2].[Rh+3].[Rh+3],,,,,,
9409,159410,Terbium oxide (Tb2O3),[O-2].[O-2].[O-2].[Tb+3].[Tb+3],,,,,,
9410,159411,Thulium oxide,[O-2].[O-2].[O-2].[Tm+3].[Tm+3],,,,,,
9411,159412,CID 159412,O.OS(=O)(=O)O.[PbH2],,,,,,
9412,159413,Praseodymium oxide (Pr6O11),[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Pr+3].[Pr+3].[Pr+3].[Pr+3].[Pr+3].[Pr+3],,,,,,
9413,159414,Rhenium heptasulfide,[S-2].[S-2].[S-2].[S-2].[S-2].[S-2].[S-2].[Re].[Re],,,,,,
9414,159415,Calcium aluminate,[O-][Al]=O.[O-][Al]=O.[Ca+2],,,,,,
9415,159416,Dodecaaluminium calcium nonadecaoxide,[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Ca+2].[Ca+2],,,,,,
9416,159417,CID 159417,[AsH3].[AsH3].[TeH2].[TeH2].[TeH2],,,,,,
9417,159418,Ferroxdure,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Ba+2],,,,,,
9418,159419,Barium titanium oxide,[O-2].[O-2].[O-2].[Ti+4].[Ba+2],,,,,,
9419,159420,CID 159420,[PbH2].[BiH3],,,,,,
9420,159421,Cobalt diiron tetraoxide,[O-2].[O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Co+2].[Co+2],,,,,,
9421,159422,Nbtxr3,[O-2].[O-2].[Hf+4],,,,,,
9422,159423,Holmium oxide,[O-2].[O-2].[O-2].[Ho+3].[Ho+3],,,,,,
9423,159424,Dirhenium trioxide,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Re].[Re],,,,,,
9424,159425,Samarium oxide,[O-2].[O-2].[O-2].[Sm+3].[Sm+3],,,,,,
9425,159426,Erbium oxide (Er2O3),[O-2].[O-2].[O-2].[Er+3].[Er+3],,,,,,
9426,159427,Gadolinium oxide,[O-2].[O-2].[O-2].[Gd+3].[Gd+3],,,,,,
9427,159428,CID 159428,[SiH4].[SiH4].[SiH4].[Ti].[Ti].[Ti].[Ti].[Ti],,,,,,
9428,159429,Hexaaluminium pentaoxide disilicate,[O-2].[O-2].[O-2].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Al+3].[Al+3].[Al+3].[Al+3],,,,,,
9429,159430,Molybdenum carbide (Mo2C),C.[Mo].[Mo],,,,,,
9430,159431,Niobium carbide (NbC),C.[Nb],,,,,,
9431,159432,Tantalum carbide (TaC),C.[Ta],,,,,,
9432,159433,Titanium carbide (TiC),C.[Ti],,,,,,
9433,159434,Einecs 235-125-1,C.[Zr],,,,,,
9434,159435,Chromium carbide (Cr7C3),C.C.C.[Cr].[Cr].[Cr].[Cr].[Cr].[Cr].[Cr],,,,,,
9435,159436,Ilmenite,O.O.O.[Ti].[Fe],,,,,,
9436,159437,CID 159437,O.O.O.[NaH].[AlH3].[SiH4].[KH].[CaH2],,,,,,
9437,159438,CID 159438,O.O.O.O.O.O.O.O.O.O.O.O.O.[O-][Si](=O)O[Si](=O)[O-].[NaH].[AlH3].[KH].[CaH2],,,,,,
9438,159439,CID 159439,O.[O-][Si](=O)O[Si](=O)[O-].[AlH3].[AlH3],,,,,,
9439,159440,Ammonium cyanide,[C-]#N.[NH4+],,,,,,
9440,159441,"N-benzyl-4-[(1,4-dimethyl-1,5-dihydro-1,2,4-triazol-1-ium-5-yl)diazenyl]-N-methylaniline;bromide",C[NH+]1C(N(C=N1)C)N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3.[Br-],,,,,,
9441,159442,CID 159442,O.O.O.O.O.O.O.O.O.O.O.O.[GeH4].[GeH4].[GeH4].[BiH3].[BiH3].[BiH3].[BiH3],,,,,,
9442,159443,CID 159443,O.O.O.O.O[Si](O)(O)O[Si](O)(O)O.[AlH3].[AlH3],,,,,,
9443,159444,Gadolinium sulfur oxide,[O-2].[O-2].[O-2].[S-2].[S-2].[S-2].[Gd+3].[Gd+3].[Gd+3].[Gd+3],,,,,,
9444,159445,Yttrium oxysulfide,[O-2].[O-2].[O-2].[S-2].[S-2].[S-2].[Y+3].[Y+3].[Y+3].[Y+3],,,,,,
9445,159446,Dodecabismuthino silicon icosaoxide,[O-2].[O-2].[O-2].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Bi+3].[Bi+3].[Bi+3].[Bi+3],,,,,,
9446,159447,Potassium zinc chromate oxide (K2Zn4(CrO4)4O),[O-2].[O-][Cr](=O)(=O)[O-].[K+].[Zn+2],,,,,,
9447,159448,"Phosphino, selenoxo-",[P]=[Se],,,,,,
9448,159449,"Antimony(3+);2,3-dioxidobutanedioate",C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].[Sb+3].[Sb+3],,,,,,
9449,159450,"(1S,3R,4R,7R,11R,15S,16R,17R,18S,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,11,17,37-heptahydroxy-15,16,18-trimethyl-9,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid",C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](CC(=O)C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,,,,,,
9450,159451,Cadmium selenide sulfide,[S-2].[Se-2].[Cd+2].[Cd+2],,,,,,
9451,159452,Lead titanium zirconium oxide,[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2],,,,,,
9452,159453,Cobaltsulfide,[S-2].[Co+2],,,,,,
9453,159454,Potassium titanium oxide phosphate (KTiO(PO4)),[O-2].[O-]P(=O)([O-])[O-].[K+].[Ti+4],,,,,,
9454,159455,Oxygen(2-);terbium,[O-2].[Tb],,,,,,
9455,159456,Ferric phosphorus(-3) anion,[P-3].[Fe+3],,,,,,
9456,159457,Hafnium dihydride,[H-].[H-].[Hf],,,,,,
9457,159458,Sodium ammonium phosphate,[NH4+].OP(=O)([O-])[O-].[Na+],,,,,,
9458,159459,Acetamido thiadiazole butyl sulfonamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)NC(C)(C)C,,,,,,
9459,159460,Cirsimarin,COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)OC,,,,,,
9460,159461,Yakkasterone,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@]4([C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
9461,159462,Zinc decanoate,CCCCCCCCCC(=O)[O-].CCCCCCCCCC(=O)[O-].[Zn+2],,,,,,
9462,159463,CID 159463,C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C2NC=NC3=O)CO,,,,,,
9463,159464,"1-(5-nitrofuran-2-yl)-N-(1,2,4-triazol-4-yl)methanimine",C1=C(OC(=C1)[N+](=O)[O-])C=NN2C=NN=C2,,,,,,
9464,159465,CID 159465,COC1=CC2=C(C=C1)OC3=CC(=CC(=O)C3=C2O)OC,,,,,,
9465,159466,6-(1-Pyrrolidinyl)-N-(1H-5-tetrazolyl)pyrazine-2-carboxamide,C1CCN(C1)C2=NC(=CN=C2)C(=O)NC3=NNN=N3,,,,,,
9466,159467,2'-Deoxy-O(6)-(2-hydroxyethyl)guanosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3OCCO)N)CO)O,,,,,,
9467,159468,"2-Propenoic acid, 2-(((2-methoxyphenyl)acetyl)amino)-",COC1=CC=CC=C1CC(=O)NC(=C)C(=O)O,,,,,,
9468,159469,"Tris(2,3-dibromobutyl) phosphate",CC(C(COP(=O)(OCC(C(C)Br)Br)OCC(C(C)Br)Br)Br)Br,,,,,,
9469,159470,"Methanimidamide, N'-(1,6-dihydro-6-oxo-2-pyridinyl)-N,N-dipropyl-",CCCN(CCC)C=NC1=CC=CC(=O)N1,,,,,,
9470,159471,"[[2-[3-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-sulfanyloxan-2-yl]phenyl]acetyl]amino] hydrogen sulfate",CC1=C(C(=CC=C1)CC(=O)NOS(=O)(=O)O)[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)S,,,,,,
9471,159472,"anti-1,2,3,4-Tetrahydro-5-methylchrysene-1,2-diol-3,4-epoxide",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@H]([C@@H]([C@H]5[C@@H]4O5)O)O,,,,,,
9472,159473,"6-Methylchrysene-1R,2S-diol-3S,4R-epoxide",CC1=CC2=C(C=CC3=C2[C@@H]4[C@@H](O4)[C@H]([C@@H]3O)O)C5=CC=CC=C15,,,,,,
9473,159474,"Benzylpentachlorobuta-1,3-dienyl sulfide",C1=CC=C(C=C1)CSC(=C(C(=C(Cl)Cl)Cl)Cl)Cl,,,,,,
9474,159475,6-Fluorometaraminol,C[C@@H]([C@@H](C1=C(C=CC(=C1)O)[18F])O)N,,,,,,
9475,159476,Flobufen,CC(CC(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)F)F)C(=O)O,,,['Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)'],,,
9476,159477,"1,4-Dihydro-1-ethyl-7-phenylpyrrol(1,2-a)-pyrimidine-4-one",CCN1C=CC(=O)N2C1=CC(=C2)C3=CC=CC=C3,,,,,,
9477,159478,CID 159478,C[C@H]1CC[C@]2([C@@H](C[C@H]3[C@](O2)(CC[C@H]4[C@H](O3)C[C@H]5[C@H](O4)C[C@H]6[C@H](O5)C[C@H]7[C@H](O6)C[C@@H]([C@@](O7)(C)CCOS(=O)(=O)O)OS(=O)(=O)O)C)O[C@@H]8[C@@H]1O[C@@H]9[C@@H](C8)O[C@H]1C[C@@H]2[C@H](CC(=C)[C@H](O2)[C@@](C)(C=CC(=C)CC=C)O)O[C@@]1([C@@H]9O)C)C,,,,,,
9478,159479,"6,7-Epoxycanrenone",C[C@]12CCC(=O)C=C1[C@@H]3[C@@H](O3)[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@]56CCC(=O)O6)C,,,,,,
9479,159480,2'-Deoxy-5'-o-thiophosphonocytidine,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=S)(O)O)O,,,,,,
9480,159481,n-[4-(4-Ethylpiperazin-1-yl)phenyl]benzo[g]quinolin-4-amine,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC=NC4=CC5=CC=CC=C5C=C34,,,,,,
9481,159482,"[(2R)-3-[[(2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
9482,159483,"L-Threonine, N-(1-L-lysyl-D-prolyl)-",C[C@H]([C@@H](C(=O)O)NC(=O)[C@H]1CCCN1C(=O)[C@H](CCCCN)N)O,,,,,,
9483,159484,2-Nitroimidazole-1-acetohydroxamic acid,C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NO,,,,,,
9484,159485,"7-Iodo-2,3-dibromodibenzo-p-dioxin",C1=CC2=C(C=C1I)OC3=CC(=C(C=C3O2)Br)Br,,,,,,
9485,159486,"[(2S,3S,5R)-3-azido-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COP(=O)(O)O)N=[N+]=[N-],,,,,,
9486,159487,CID 159487,CCCC=CC=CC=CC1C2C1C3C(C2C=CC=C)C=CCC(=O)O[C@@]45C[C@H]([C@]6([C@H]([C@@H]4[C@@]5(COC3=O)C)C=C(C[C@]7(C6C=C(C7=O)C)O)CO)O)C,,,,,,
9487,159488,"Diacetamide, 2,2'-diiodo-",C(C(=O)NC(=O)CI)I,,,,,,
9488,159489,"2-Amino-5-phosphonomethyl(1,1'-biphenyl)-3-propanoic acid",C1=CC=C(C=C1)C2=CC(=CC(=C2)CP(=O)(O)O)C[C@@H](C(=O)O)N,,,,,,
9489,159490,Karounidiol,C[C@]12CC[C@@](C[C@H]1[C@@]3(CC=C4C(=CC[C@@H]5[C@@]4(CC[C@H](C5(C)C)O)C)[C@]3(CC2)C)C)(C)CO,,,,,,
9490,159491,"6-(2-Cyclohexylethyl)-(1,3,4)thiadiazolo(3,2-a)-1,2,3-triazolo(4,5-d)pyrimidin-9(1H)-one",C1CCC(CC1)CCC2=NN3C(=O)C4=NNN=C4N=C3S2,,,,,,
9491,159492,"3-(3,5-Di-t-butyl-4-hydroxyphenyl)-7H-thiazolo(3,2-b)(1,2,4)triazin-7-one",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C2=CSC3=NC(=O)C=NN23,,,,,,
9492,159493,"N-[4-(4-methylphenyl)sulfinyl-1-phenylhexa-1,5-dien-3-yl]aniline",CC1=CC=C(C=C1)S(=O)C(C=C)C(C=CC2=CC=CC=C2)NC3=CC=CC=C3,,,,,,
9493,159494,"3,14,15,17,19,20-Hexahydroxy-6'-(2-hydroxybutyl)-5',6,14,18,20,29-hexamethylspiro[4,24,28-trioxatricyclo[23.3.1.03,8]nonacosa-9,21-diene-27,2'-oxane]-23-one",CCC(CC1C(CCC2(O1)CC3C(C(O2)CC4(C(CC(CO4)C)C=CCCCC(C(CC(C(C(C(C=CC(=O)O3)(C)O)O)C)O)O)(C)O)O)C)C)O,,,,,,
9494,159495,"Phosphorous trichloride, reaction products with 1,1'-biphenyl and 2,4-bis(1,1-dimethylethyl)phenol",CC(C)(C)C1=CC(=C(C=C1)O)C(C)(C)C.C1=CC=C(C=C1)C2=CC=CC=C2.P(Cl)(Cl)Cl,,,,,,
9495,159496,"(2r,3r,5s,6r)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol",C([C@@H]1[C@H](C([C@H]([C@H](N1)CO)O)O)O)O,,,,,,
9496,159497,"[(3R,4R,5S,6R,9S,10S)-4-acetyloxy-1-[formyl(methyl)amino]-11-[(10S,11R,16S,20S,21R,22S)-16-hydroxy-10,22-dimethoxy-11,21-dimethyl-12,18-dioxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-1(28),2(31),4,6(30),8,13,24,26(29)-octaen-20-yl]-10-methoxy-3,5,9-trimethylundec-1-en-6-yl] (2R)-2,3-dimethoxypropanoate",C[C@@H]1[C@H](CC=CC2=NC(=CO2)C3=NC(=CO3)C4=NC(=CO4)[C@H]([C@H](C(=O)C=CC[C@@H](CC(=O)O[C@H]1C[C@@H]([C@@H](C)CC[C@H]([C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC(=O)C)OC(=O)[C@@H](COC)OC)OC)O)C)OC)OC,,,,,,
9497,159498,2'-Deoxy-2'-fluorothymidine,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)F,,,,,,
9498,159499,"15-[(4-Hydroxyphenyl)methyl]-18-(6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl)-1,5,12,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid",CC1C(NC(=O)C(NC(=O)C(C(NC(=O)C(NC(=O)C(NC(=O)C(=C)N(C(=O)CCC(NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)CC2=CC=C(C=C2)O)C=CC(=CC(C)C(CC3=CC=CC=C3)OC)C,,,,,,
9499,159500,"11-Methyl-20,21-dinoreburnamenine",CC1=CC2=C(C=C1)C3=C4N2C=C[C@@H]5[C@@H]4N(CCC5)CC3,,,,,,
9500,159501,"Spiro(9H-fluorene-9,4'-imidazolidine)-2',5'-dione, 2,7-difluoro-4-methoxy-",COC1=CC(=CC2=C1C3=C(C24C(=O)NC(=O)N4)C=C(C=C3)F)F,,,,,,
9501,159502,Hydrodolasetron,C1C2CC3CC(CC1N3CC2O)OC(=O)C4=CNC5=CC=CC=C54,,,,,,
9502,159503,CID 159503,C[C@H]1[C@@H](C[C@@H]([C@]2(CO2)[C@H](C[C@@H]3CC=C[C@H](O3)C[C@H]([C@H](C=C(C=CC(=O)O[C@@H]1[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)OC)OC)OC)OC,,,,,,
9503,159504,CID 159504,C[C@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)O)NC(=O)[C@@H]7CCCN7C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC8=CC=C(C=C8)O)N,,,,,,
9504,159505,Ethyl 3-[(diethoxyphosphorothioyl)oxy]but-2-enoate,CCOC(=O)C=C(C)OP(=S)(OCC)OCC,,,,,,
9505,159506,CID 159506,CC1C(C(=O)OC2C(C(C3(C(C(C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C)OC(=O)C)OC(=O)C6=CC=CC=C6)COC(=O)C)OC(=O)C)OC(=O)C7=CN(C(=O)C=C7)C)C,,,,,,
9506,159507,Perfragilin A,CN1C=C2C(=CC1=O)C(=O)C(=C(C2=O)N)SC,,,,,,
9507,159508,1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine,C1CCN(CC1)CCOC2=CC=C(C=C2)C3C(=CC4=CC=CC=C4O3)C5=CC=CC=C5,,,,,,
9508,159509,"N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane",CCC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N(CC3CO3)CC4CO4)CC)N(CC5CO5)CC6CO6,,,,,,
9509,159510,"2-(2,4-Dimethylpentan-3-yloxy)ethanol",CC(C)C(C(C)C)OCCO,,,,,,
9510,159511,"3,13,15,25,35,37-Hexahydroxy-11,33-bis[3-hydroxy-6-(4-methoxy-6-methyloxan-2-yl)-4-methylhexan-2-yl]-17,39-dimethoxy-6,12,16,28,34-pentamethyl-10,32,45,46-tetraoxatricyclo[39.3.1.119,23]hexatetraconta-5,7,21,27,29,43-hexaene-9,31-dione",CC1CC(CC(O1)CCC(C)C(C(C)C2C(C(CC(CC(CC3CC=CC(O3)CC(CC=C(C=CC(=O)OC(C(C(CC(C(C(CC4CC=CC(O4)CC(CC=C(C=CC(=O)O2)C)O)OC)C)O)O)C)C(C)C(C(C)CCC5CC(CC(O5)C)OC)O)C)O)OC)O)O)C)O)OC,,,,,,
9511,159512,"5-alpha,6-alpha-(Oxycarbonothioylthio)cholestan-3-beta-ol acetate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]4C5([C@@]3(CC[C@@H](C5)OC(=O)C)C)OC(=S)S4)C,,,,,,
9512,159513,"(2S,3S,4S,5R,6R)-6-[[(2S,3S,5R)-3-amino-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)N,,,,,,
9513,159514,"3,5-Bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium chloride",COC1=C(C=CC(=C1)C2=C(C=C3C(=CC(=CC3=[O+]2)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O.[Cl-],,,,,,
9514,159515,"2-(4-hydroxy-3-methoxyphenyl)-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]chromen-7-one",COC1=C(C=CC(=C1)C2=C(C=C3C(=CC(=O)C=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O,,,,,,
9515,159516,Pristimerin,CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)OC)C)C)C)C)O,,,,,,
9516,159517,CID 159517,C1=CC=C(C=C1)NC2=NC(=O)N=C(N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=O)N=C(N5)NC6=CC=CC=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9517,159518,"2,2'-(Ethene-1,2-diyl)bis{5-[(6-anilino-4-oxo-1,4-dihydro-1,3,5-triazin-2-yl)amino]benzene-1-sulfonic acid}",C1=CC=C(C=C1)NC2=NC(=O)N=C(N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=O)N=C(N5)NC6=CC=CC=C6)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9518,159519,C.I. Direct Orange 72,CC1=CC(=C(C=C1N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=CC6=C(C=C(C=C6C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])OC.[Na+].[Na+].[Na+].[Na+],,,,,,
9519,159520,"7,7'-{Carbonylbis[azanediyl(5-methoxy-2-methyl-4,1-phenylene)diazene-2,1-diyl]}di(naphthalene-1,3-disulfonic acid)",CC1=CC(=C(C=C1N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=CC6=C(C=C(C=C6C=C5)S(=O)(=O)O)S(=O)(=O)O)OC,,,,,,
9520,159521,"2-Naphthalenesulfonic acid, 7-[[4-chloro-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]methylamino]-4-hydroxy-3-[(4-methoxy-2-sulfophenyl)azo]-, trisodium salt",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C=C(C=C3)OC)S(=O)(=O)[O-])S(=O)(=O)[O-])C4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)[O-])Cl.[Na+].[Na+].[Na+],,,,,,
9521,159522,"7-[[4-Chloro-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl](methyl)amino]-4-hydroxy-3-[(4-methoxy-2-sulfophenyl)azo]-2-naphthalenesulfonic acid",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C=C(C=C3)OC)S(=O)(=O)O)S(=O)(=O)O)C4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)O)Cl,,,,,,
9522,159523,ZINC;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Zn+2],,,,,,
9523,159524,CID 159524,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3[O-])O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.OS(=O)(=O)O.[Na+],,,,,,
9524,159525,"trisodium 2-chloro-5-[[4,5-dihydro-3-methyl-5-oxo-1-[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]-1H-pyrazol-4-yl]azo]-4-sulphonatobenzoate",CC1=NN(C(=O)C1N=NC2=C(C=C(C(=C2)C(=O)[O-])Cl)S(=O)(=O)[O-])C3=CC=C(C=C3)S(=O)(=O)CCOS(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
9525,159526,2-chloro-5-[[3-methyl-5-oxo-1-[4-(2-sulfooxyethylsulfonyl)phenyl]-4H-pyrazol-4-yl]diazenyl]-4-sulfobenzoic acid,CC1=NN(C(=O)C1N=NC2=C(C=C(C(=C2)C(=O)O)Cl)S(=O)(=O)O)C3=CC=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
9526,159527,CID 159527,CC1=C(C(=CC=C1)Cl)N2C(=O)C(C(=N2)C)N=NC3=C(C=CC(=C3)NC(=O)C4=CC5=C(C=C4)N=C(NN5[O-])Cl)S(=O)(=O)O.[Na+],,,,,,
9527,159528,CID 159528,CC1=C(C(=CC=C1)Cl)N2C(=O)C(C(=N2)C)N=NC3=C(C=CC(=C3)NC(=O)C4=CC5=C(C=C4)N=C(NN5[O-])Cl)S(=O)(=O)O,,,,,,
9528,159529,Teucrin A,C[C@@H]1[C@@H]([C@H]2C3=C(CCC[C@@H]3[C@@]14C[C@H](OC4=O)C5=COC=C5)C(=O)O2)O,,,,,,
9529,159530,CID 159530,C1=CC(=C(C=C1NN=C2C(=O)C=CC(=NN=C3C=C(C=CC3=O)S(=O)(=O)[O-])C2=O)N)N([O-])[O-].[Na+].[Cu+2],,,,,,
9530,159531,CID 159531,C1=CC(=C(C=C1NN=C2C(=O)C=CC(=NN=C3C=C(C=CC3=O)S(=O)(=O)O)C2=O)N)N([O-])[O-],,,,,,
9531,159532,CID 159532,C1=NC2=C(NN=C2C(=N1)N)C3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
9532,159533,"Maleic acid, vinyl acetate, vinyl alcohol, ethyl acrylate, acrylic acid polymer, sodium salt",CCOC(=O)C=C.CC(=O)OC=C.C1=CC(=O)OC1=O.[Na+],,,,,,
9533,159534,"Ferrate(1-), ((N,N'-1,3-propanediylbis(N-((carboxy-kappaO)methyl)glycinato-kappaN,kappaO))(4-))-, ammonium, (OC-6-21)-",C(CN(CC(=O)[O-])CC(=O)[O-])CN(CC(=O)[O-])CC(=O)[O-].[NH4+].[Fe+3],,,,,,
9534,159535,"5-Methylchrysene-7S,8R-diol-9R,10S-epoxide",CC1=CC2=C([C@@H]3[C@@H](O3)[C@H]([C@@H]2O)O)C4=C1C5=CC=CC=C5C=C4,,,,,,
9535,159536,"(2S,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-naphthalen-1-yloxyacetyl)amino]propanoyl]amino]-N-[(2S,3S)-3-methyl-1-oxo-1-(pyridin-2-ylmethylamino)pentan-2-yl]-2-propan-2-ylhexanamide",CC[C@H](C)[C@@H](C(=O)NCC1=CC=CC=N1)NC(=O)[C@H]([C@H]([C@@H]([C@H](CC2CCCCC2)NC(=O)[C@H](CC3=CN=CN3)NC(=O)COC4=CC=CC5=CC=CC=C54)O)O)C(C)C,,,,,,
9536,159537,"16,17,27-Trihydroxy-21-(2-hydroxy-3,4-dimethyloxan-2-yl)-31-methyl-2,15,25,30-tetramethylidene-22,33,34,35,36,37-hexaoxahexacyclo[27.3.1.11,5.16,10.111,14.124,28]heptatriaconta-8,19-dien-23-one",CC1CCOC(C1C)(C2C=CCC(C(C(=C)C3CCC(O3)C4C=CCC(O4)C5CCC(=C)C6(O5)CC(C(=C)C(O6)C7C(CC(=C)C(O7)C(=O)O2)O)C)O)O)O,,,,,,
9537,159538,Saframycin Mx-1,CC1=C(C2=C([C@@H]3[C@@H]4CC5=C([C@@H](N4[C@H]([C@H]([C@H]2OC)N3C)O)CNC(=O)[C@H](C)N)C(=O)C(=C(C5=O)C)OC)C(=C1OC)O)O,,,,,,
9538,159539,CID 159539,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C(=CC(=O)C3=C2O)O)CC=C(C)C)C4=CC=C(C=C4)OC)O)O)O,,,,,,
9539,159540,"(2S)-2-methyl-4-[(2R,8R,11R)-2,8,11-trihydroxy-11-[(5R)-5-[(1R)-1-hydroxypentadecyl]oxolan-2-yl]undecyl]-2H-furan-5-one",CCCCCCCCCCCCCC[C@H]([C@H]1CCC(O1)[C@@H](CC[C@@H](CCCCC[C@H](CC2=C[C@@H](OC2=O)C)O)O)O)O,,,,,,
9540,159541,(+)-Cpi-cdpi2,CC1=CNC2=C1[C@@]34C[C@@H]3CN(C4=CC2=O)C(=O)C5=CC6=C(N5)C=CC7=C6CCN7C(=O)C8=CC9=C(N8)C=CC1=C9CCN1C(=O)N,,,,,,
9541,159542,Tunichlorin,[H+].CCC1=C(C2=NC1=CC3=C(C4=C(CC(=C4[N-]3)C5=NC(=CC6=NC(=C2)C(=C6C)CO)C(C5CCC(=O)[O-])C)[O-])C)C.[Ni+2],,,,,,
9542,159543,"3-[11-Ethyl-4-hydroxy-16-(hydroxymethyl)-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid",CCC1=C(C2=NC1=CC3=C(C4=C(CC(=C5C(C(C(=CC6=NC(=C2)C(=C6C)CO)N5)C)CCC(=O)O)C4=N3)O)C)C,,,,,,
9543,159544,CID 159544,CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3C45[C@@H]2[C@H]([C@@H]([C@@]([C@@H]4[C@H](C(=O)O3)C(=O)C(=O)C=C(C)C(C)(C)OC(=O)C)(OC5)C(=O)OC)O)O)C)O,,,,,,
9544,159545,"Methyl 5-(benzoyloxy)-9,11b-dimethyl-8-oxotetradecahydro-9,11a-methanocyclohepta[a]naphthalene-4-carboxylate",CC12CCC3(C1)C(CC(C4C3(CCCC4C(=O)OC)C)OC(=O)C5=CC=CC=C5)CC2=O,,,,,,
9545,159546,"Imidazo(2,1-a)isoquinoline, 2,3-dihydro-5-(4-(2-(3,4,5-trimethoxyphenyl)ethyl)phenyl)-, monohydrochloride",COC1=CC(=CC(=C1OC)OC)CCC2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35.Cl,,,,,,
9546,159547,"5-[4-[2-(3,4,5-Trimethoxyphenyl)ethyl]phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline",COC1=CC(=CC(=C1OC)OC)CCC2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35,,,,,,
9547,159548,Philanthotoxin 343,CCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCCCNCCCCNCCCN,,,,,,
9548,159549,"1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-hydroxy-4-(2-hydroxyethyl)-, (S)-",C1C2=CC3=CC=CC=C3N=C2C4=CC5=C(COC(=O)[C@@]5(CCO)O)C(=O)N41,,,,,,
9549,159550,CID 159550,CC1(CCC(C2=C1C=C(C(=C2)O)C(=O)C=C(C3=CC=C(C=C3)C(=O)O)O)(C)C)C,,,,,,
9550,159551,"Bisoxireno(1,10a:3,4)phenanthro(3,2-b)furan-9-ol, 1,2,3,4,4a,5,6,7a,9,11a,11b,11c-dodecahydro-4,4,8,11c-tetramethyl-",CC1=C2C3C4(O3)CCC5C(CCCC5(C4C6C2(O6)OC1O)C)(C)C,,,,,,
9551,159552,Cycleaneonine,CN1CCC2=CC(=C3C(=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC=C(CO3)C=C7)N(CCC6=CC(=C5OC)OC)C)O)OC,,,,,,
9552,159553,14-Salicyloyldaunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)C6=CC=CC=C6O)O)N)O,,,,,,
9553,159554,14-Salicyloylcarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)COC(=O)C6=CC=CC=C6O)O)N)O,,,,,,
9554,159555,Mepamil,CC1=CC=CC=C1C(CCCN(C)CCC2=CC(=C(C=C2)OC)OC)(C#N)C(C)C,,,,,,
9555,159556,Cerebrocrast,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2OC(F)F)C(=O)OCCOCCC)C)C,,,,,,
9556,159557,Histidyl-aspartyl-methionyl-asparaginyl-lysyl-valyl-leucyl-aspartyl-leucine,CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)OC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)NC(=O)[C@H](C(C)C)N,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
9557,159558,Desacetylnudicauline,CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6O)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)C[C@@H](C8=O)C,,,,,,
9558,159559,"Card-20(22)-enolide, 12,14,19-trihydroxy-2,3-((tetrahydro-3,4-dihydroxy-6-(hydroxymethyl)-2H-pyran-3,2-diyl)bis(oxy))-, (3beta(2S,3S,4S,6S),5alpha,12beta)-",C[C@@]12[C@H](CCC1([C@@H]3CC[C@H]4C[C@H]5C(C[C@@]4([C@H]3C[C@H]2O)CO)O[C@H]6[C@@](O5)([C@H](C[C@H](O6)CO)O)O)O)C7=CC(=O)OC7,,,,,,
9559,159560,CID 159560,CCCC=CC(=O)O[C@H]1[C@]2(C=C(C34CC3([C@H]2CC1(C)C)C(=O)O[C@@H]4O)C=O)O,,,,,,
9560,159561,14-Chlorodaunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CCl)O)N)O,,,,,,
9561,159562,"L-Arginine, compd. with 5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H-indole-2-carboxamide (1:1)",CC(C)OC1=C(N(C2=C1C=C(C=C2)OC)C3=CC=CC=C3)C(=O)NC4=NNN=N4.C(C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
9562,159563,5-Methoxy-3-(1-methylethoxy)-1-phenyl-N-2H-tetrazol-5-yl-1H-indole-2-carboxamide,CC(C)OC1=C(N(C2=C1C=C(C=C2)OC)C3=CC=CC=C3)C(=O)NC4=NNN=N4,,,,,,
9563,159564,"Enkephalin, pen(2,5)-4-chloro-phe(4)-",CC1([C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(SS1)(C)C)C(=O)O)CC2=CC=C(C=C2)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C,,,,,,
9564,159565,CID 159565,C[C@H]1[C@@H]2CC=C([C@H]3C[C@]4(CC[C@H]([C@@H]4C[C@@H]3C(=C2C[C@@H]1O[C@H]5[C@@H]([C@H]([C@@H](CO5)O)O)O)C)C(C)C)C)C=O,,,,,,
9565,159566,"2,4-cis-Asimicinone",CCCCCCCCCC[C@@H]([C@H]1CC[C@@H](O1)[C@H]2CCC(O2)[C@@H](CCCCCCCCCC[C@@H]3C[C@H](C(=O)O3)CC(=O)C)O)O,,,,,,
9566,159567,2-Deoxyguanosine-5-monophosphateammoniumsalt,CC(C)[C@@H](C(=O)[C@]1(CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC)C(=O)O[C@@H](C(C)C)C(=O)N3[C@H](C(=CC3=O)OC)CC4=CC=CC=C4)NC(=O)[C@H](C(C)C)N(C)C,,,,,,
9567,159568,CID 159568,C[C@@H]1C(=CCC[C@]1(C)CCC(=CCC2=C(C(=O)C=C(C2=O)OC)O)C)C,,,,,,
9568,159569,"3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium, 4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, polymer with butyl 2-methyl-2-propenoate",CCCCOC(=O)C(=C)C.CC(=C)C(=O)OCCOP(=O)([O-])OCC[N+](C)(C)C,,,,,,
9569,159570,Reaction products of acrylamide with formaldehyde-melamine polymer butyl methyl ether and hydrogen peroxide,C=CC(=O)N.C=O.C1(=NC(=NC(=N1)N)N)N.OO,,,,,,
9570,159571,"Bufa-20,22-dienolide, 1-(acetyloxy)-11,19-epoxy-3,5,14,19-tetrahydroxy-, (1beta,3beta,5beta,11alpha,19R)-",CC(=O)O[C@@H]1C[C@@H](C[C@@]2(C13[C@@H](O[C@H]4C3C(CC2)[C@]5(CC[C@@H]([C@]5(C4)C)C6=COC(=O)C=C6)O)O)O)O,,,,,,
9571,159572,"[(2-sulfamoylacetyl)amino] (4aR,6S,7R,7aS)-4-carbamoyl-6-hydroxy-2-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyridine-7-carboxylate",CN1C[C@H]2[C@@H](C[C@@H]([C@@H]2C(=O)ONC(=O)CS(=O)(=O)N)O)C(=C1)C(=O)N,,,,,,
9572,159573,"Nimbolide, 28-deoxo-",CC1=C2[C@@H](CC1C3=COC=C3)O[C@H]4[C@@]2([C@@H]([C@@]5([C@H]6[C@H]4OC[C@@]6(C=CC5=O)C)C)CC(=O)OC)C,,,,,,
9573,159574,Isomallotochromanol,CC1=C(C(=C(C(=C1OC)CC2=C3C(=C(C(=C2O)C(=O)C)O)CC(C(O3)(C)C)O)O)C(=O)C)O,,,,,,
9574,159575,Desacetylnavelbine,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)O)CC)OC)C(=O)OC,,,,,,
9575,159576,CID 159576,CC(=C[C@@H]1OC(C2(O1)COC3=C(O2)C=C(C=C3)C=CC=C(C)C(=COC)C(=O)OC)(C)C)C,,,,,,
9576,159577,CID 159577,C1CNC(=C(CC2=CC(=C(C(=C2)Br)OC3=C(C(=CC(=C3)CC(=C(NC[C@H](C4=CC(=C(C=C4)OC5=C(C(=CC1=C5)Br)O)Br)O)O)N=O)Br)O)Br)N=O)O,,,,,,
9577,159578,2-Oxo-6-dehydroxyneoanisatin,C[C@H]1[C@@H]2CC3([C@H](C(=O)C[C@]3(C14COC4=O)O)C)[C@H](C(=O)O2)O,,,,,,
9578,159579,18-Crown-6-tetracarboxybisdiammineplatinum(II),C1COC(C(OCCOCCOC(C(OCCO1)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].N.N.N.N.[Pt+2].[Pt+2],,,,,,
9579,159580,"1,4,7,10,13,16-Hexaoxacyclooctadecane-2,3,11,12-tetracarboxylic acid",C1COC(C(OCCOCCOC(C(OCCO1)C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
9580,159581,Incanumine,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)OC9C(C(C(CO9)O)O)O)O)O)OC2C(C(C(CO2)O)O)O)O)C)C)C)NC1,,,,,,
9581,159582,"Methyl 6-[3-hydroxy-4-(3-methylbut-2-enoxy)phenyl]-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate",CC(=CCOC1=C(C=C(C=C1)C=CC=C(C)C(=COC)C(=O)OC)O)C,,,,,,
9582,159583,Kijimicin,CCC(C1(CC(C(O1)(C2CC(C(O2)C3(CCC(O3)C4CCC5(O4)C(C(C(C(O5)C(C)C(C(C)C(=O)O)OC)C)OC)C)C)C)O)C)C)O,,,,,,
9583,159584,CID 159584,C[C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)OC2CC3C(C(CC(O3)(CC(CC(C(CCC(=O)OC(CCCC=CC=CC=CC=C2)C(C)C)O)O)O)O)O)C(=O)O)O)N)O,,,,,,
9584,159585,CID 159585,C[C@H]1C(=C[C@@]2(C=C([C@H]3[C@]1(C=C([C@@H]3[C@H]2C=CC(=O)C4=C(N5CCCC5C4=O)O)C)C)C)C)C,,,,,,
9585,159586,CID 159586,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2[C@H](C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)N[C@H](CO)C(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)N(C)C,,,,,,
9586,159587,Westiellamide,C[C@@H]1[C@H]2C(=O)N[C@H](C3=N[C@@H]([C@H](O3)C)C(=O)N[C@H](C4=N[C@@H]([C@H](O4)C)C(=O)N[C@H](C(=N2)O1)C(C)C)C(C)C)C(C)C,,,,,,
9587,159588,Tripchlorolide,CC(C)[C@@]1([C@@H]([C@H]2[C@@]3(O2)[C@]4(CCC5=C([C@@H]4C[C@H]6[C@]3([C@@H]1O)O6)COC5=O)C)Cl)O,,,,,,
9588,159589,"10-(Acetyloxy)-2,2,5a,9-tetramethyloctahydro-2H-3,9a-methano-1-benzoxepine-4,5,6,7-tetrayl tetrabenzoate",C[C@@H]1C[C@@H]([C@@H]([C@@]2(C13[C@@H]([C@@H]([C@H]([C@H]2OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)C(O3)(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)OC(=O)C7=CC=CC=C7,,,,,,
9589,159590,"(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-Dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone",C[C@@H]1C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O1)CC(C)C)C)CC2=CC=CC=C2)CC(C)C)C)C)CC(C)C)C)CC3=CC=CC=C3)CC(C)C)C,,,,,,
9590,159591,CID 159591,C1C[C@@H]2CC(=O)N3C4=C(C5=C3[C@@H]2[C@@H](C1)[C@@H](C5)N)C(=CC=C4)O.Cl,,,,,,
9591,159592,CID 159592,C1C[C@@H]2CC(=O)N3C4=C(C5=C3C2C(C1)[C@@H](C5)N)C(=CC=C4)O,,,,,,
9592,159593,CID 159593,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)CCC(=O)OCCOC)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
9593,159594,Atrasentan,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4,['Investigated for use/treatment in prostate cancer and cancer/tumors (unspecified).'],,"['Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
9594,159595,Atrasentan hydrochloride,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl,['Treatment of nephropathy'],,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)']",,,
9595,159596,"2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (1-dimethylcarbamoyl-2,2-dimethyl-propyl)-amide",CCCC[C@H](CN(C=O)O)C(=O)N[C@H](C(=O)N(C)C)C(C)(C)C,,,,,,
9596,159597,3-(Diethylamino)-N-phenylbutyramide monohydrochloride,CC[NH+](CC)C(C)CC(=O)NC1=CC=CC=C1.[Cl-],,,,,,
9597,159598,Amotosalen hydrochloride,CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)COCCN)C.Cl,,,"['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)', 'Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)']",,,
9598,159599,Amotosalen,CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)COCCN)C,,,"['Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)', 'Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)']",,,
9599,159600,Fentanyl citrate and droperidol,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3.C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,"['The use of two or more chemicals simultaneously or sequentially to induce anesthesia. The drugs need not be in the same dosage form. (See all compounds classified as Anesthetics, Combined.)', 'Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)']",,,
9600,159601,"Pentapotassium 3-((9,10-bis(sulphonatooxy)-1-anthryl)amino)anthra(2,1,9-mna)naphth(2,3-h)acridine-5,10,15-triyl tris(sulphate)",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=C2OS(=O)(=O)[O-])NC4=CC5=C(C6=C7C(=C5C=C4)C=CC8=C7C(=C9C=CC1=C(C2=CC=CC=C2C(=C1C9=N8)OS(=O)(=O)[O-])OS(=O)(=O)[O-])C=C6)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+],,,,,,
9601,159602,"[24-[(9,10-Disulfooxyanthracen-1-yl)amino]-6,13-disulfooxy-16-azaoctacyclo[18.10.2.02,15.05,14.07,12.017,31.021,26.028,32]dotriaconta-1,3,5,7,9,11,13,15,17(31),18,20,22,24,26,28(32),29-hexadecaen-27-yl] hydrogen sulfate",C1=CC=C2C(=C1)C(=C3C=CC=C(C3=C2OS(=O)(=O)O)NC4=CC5=C(C6=C7C(=C5C=C4)C=CC8=C7C(=C9C=CC1=C(C2=CC=CC=C2C(=C1C9=N8)OS(=O)(=O)O)OS(=O)(=O)O)C=C6)OS(=O)(=O)O)OS(=O)(=O)O,,,,,,
9602,159603,Resiquimod,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,['Investigated for use/treatment in genital herpes.'],,,,,
9603,159604,Hexadecyl(trimethyl)azanium;4-methylbenzenesulfonic acid,CCCCCCCCCCCCCCCC[N+](C)(C)C.CC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
9604,159605,Calcium succinate,C(CC(=O)[O-])C(=O)[O-].[Ca+2],,,,,,
9605,159606,Tricycloquinazoline,C1=CC=C2C(=C1)C3=NC4=CC=CC=C4C5=NC6=CC=CC=C6C(=N2)N35,,,,,,
9606,159607,Benz[k]acephenanthrylene,C1=CC=C2C=C3C4=CC=CC5=C4C(=CC3=CC2=C1)C=C5,,,,,,
9607,159608,Cyclopenta[hi]chrysene,C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C4C3=CC=C5,,,,,,
9608,159609,"1H-Imidazo[1,2-b]pyrazole",C1=CNN2C1=NC=C2,,,,,,
9609,159610,Einecs 215-689-5,[Cl-].[Cl-].[Cl-].[Cl-].[Sn+4],,,,,,
9610,159611,Copper silicate,[O-][Si](=O)[O-].[Cu+2],,,,,,
9611,159612,Cobalt tin oxide (CoSnO3),[O-2].[O-2].[O-2].[Co+2].[Sn+4],,,,,,
9612,159613,Kopsinine F,COC(=O)N1C2=C(C=CC3=C2OCO3)C45C16CCC7(C4N(CCC7)CC5)CC6C(=O)OOC,,,,,,
9613,159614,Vindolicine,CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=C4C=C(C(=C5)OC)CC6=CC7=C(C=C6OC)N(C8C79CCN1C9C(C=CC1)(C(C8(C(=O)OC)O)OC(=O)C)CC)C)C,,,,,,
9614,159615,"(1R,3S,9R,10S,13R,23R,25S,26R,27S)-23-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-10-ethyl-1,3,9,27-tetrahydroxy-7,11-dioxo-13-propyl-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid",CCC[C@@H]1CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](CCCC(=O)C[C@H]([C@@H](C(=O)O1)CC)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,,,,,,
9615,159616,CID 159616,CC[C@@H]1[C@H](C=C(C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC.OP(=O)(O)O,,,,,,
9616,159617,CID 159617,CC[C@H]1[C@@H](C=C(C=CC(=O)[C@H](CC([C@H]([C@@H]([C@@H](CC(=O)O1)O)C)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O[C@@H]3C[C@@]([C@@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)C)CO[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)OC)OC,,,,,,
9617,159618,Deoxycorticosterone sulfate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COS(=O)(=O)O)CCC4=CC(=O)CC[C@]34C,,,,,,
9618,159619,"1,2-Dihydrobenzo[k]tetraphene-1,2-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C(C(C=C5)O)O,,,,,,
9619,159620,"3,4-Dihydrodibenz(a,h)anthracene-3,4-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=CC(C5O)O,,,,,,
9620,159621,"Chol-4-en-24-oic acid, 3-oxo-",C[C@H](CCC(=O)O)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
9621,159622,Trifluoperazine sulfoxide,CN1CCN(CC1)CCCN2C3=CC=CC=C3S(=O)C4=C2C=C(C=C4)C(F)(F)F,,,,,,
9622,159623,3-Oxo-5-beta-cholan-24-oic acid,C[C@H](CCC(=O)O)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
9623,159624,4-(2-(5-Nitro-2-furanyl)ethenyl)benzamide,C1=CC(=CC=C1C=CC2=CC=C(O2)[N+](=O)[O-])C(=O)N,,,,,,
9624,159625,Glutathione sulfonate,C(CC(=O)N(CC(=O)O)C(=O)[C@H](CSS(=O)(=O)O)N)[C@@H](C(=O)O)N,,,,,,
9625,159626,Acranil,CCN(CC)CC(CNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)O.Cl.Cl,,,,,,
9626,159627,1-Bromopyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)Br,,,,,,
9627,159628,Butyltriphenylphosphonium bromide,CCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
9628,159629,Butyl(triphenyl)phosphonium,CCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
9629,159630,D-Arabino-hexos-2-ulose,C([C@H]([C@H]([C@@H](C(=O)C=O)O)O)O)O,,,,,,
9630,159631,"2-(3,4-Dimethylphenyl)oxirane",CC1=C(C=C(C=C1)C2CO2)C,,,,,,
9631,159632,Stannous dioctanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Sn+2],,,,,,
9632,159633,"(1S,9S)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10,13-pentaen-12-one",CN1CC[C@]23C=C(C(=O)C=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC,,,,,,
9633,159634,"C.I. Direct Red 79, tetrasodium salt",CC1=CC(=C(C=C1N=NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C=C3O)S(=O)(=O)[O-])OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=C6C(=CC(=C5)S(=O)(=O)[O-])C=C(C=C6O)S(=O)(=O)[O-])OC.[Na+].[Na+].[Na+].[Na+],,,,,,
9634,159635,"4-Hydroxy-5-[4-[[4-[(8-hydroxy-3,6-disulfo-1-naphthyl)azo]-2-methoxy-5-methyl-phenyl]carbamoylamino]-5-methoxy-2-methyl-phenyl]azo-naphthalene-2,7-disulfonic acid",CC1=CC(=C(C=C1N=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O)OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=C6C(=CC(=C5)S(=O)(=O)O)C=C(C=C6O)S(=O)(=O)O)OC,,,,,,
9635,159636,Hydroxyglutamin,C(CC(=O)N)[C@@H](C(=O)O)NO,,,,,,
9636,159637,Maackiain acetate,CC(=O)OC1=CC2=C(C=C1)[C@H]3[C@@H](CO2)C4=CC5=C(C=C4O3)OCO5,,,,,,
9637,159638,CID 159638,C1=C(C=C(C(=C1O)O)O)C(=O)[O-].[Na+],,,,,,
9638,159639,Oxalic acid-d2,[2H]OC(=O)C(=O)O[2H],,,,,,
9639,159640,Griseolutein B,COC1=CC=C(C2=NC3=CC=CC(=C3N=C12)C(=O)O)COC(CO)O,,,,,,
9640,159641,Calcium thiocyanate,C(#N)[S-].C(#N)[S-].[Ca+2],,,,,,
9641,159642,Didesipramine,C1CC2=CC=CC=C2N(C3=CC=CC=C31)CCCN,,,,,,
9642,159643,Asteromycin,CNCC(=O)NC(CO)C(=O)NC1C(C(C(OC1C(=O)N)N2C=CC(=NC2=O)N)O)O,,,,,,
9643,159644,"4-(4-Methoxyphenyl)-1,3-thiazol-2-amine",COC1=CC=C(C=C1)C2=CSC(=N2)N,,,,,,
9644,159645,Triphenyltin-bis(diethyl)dithiophosphate,CCOP(=S)(OCC)S[Sn](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
9645,159646,Ungeremine,C1C[N+]2=CC3=CC4=C(C=C3C5=CC(=CC1=C52)O)OCO4,,,,,,
9646,159647,3-(6-Chloro-3-methyl-1H-inden-2-yl)pyridine,CC1=C(CC2=C1C=CC(=C2)Cl)C3=CN=CC=C3,,,,,,
9647,159648,Ethyl acetoxy(acetyl)carbamate,CCOC(=O)N(C(=O)C)OC(=O)C,,,,,,
9648,159649,"1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one",CN1C(=N)C=CN(C1=O)[C@@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
9649,159650,Pteleine,COC1=CC2=C(C=C1)N=C3C(=C2OC)C=CO3,,,,,,
9650,159651,Carboxytolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C(=O)O,,,,,,
9651,159652,2'-Deoxy-n-hydroxycytidine 5'-(dihydrogen phosphate),C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NO)COP(=O)(O)O)O,,,,,,
9652,159653,CID 159653,C1(C(=O)[N-]C(=O)N1)NC(=O)N.O.[AlH+]Cl,,,,,,
9653,159654,Neferine,CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC,,,,,,
9654,159655,3-Dehydrocholic acid,C[C@H](CCC(=O)O)[C@@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CCC(=O)C4)C)O)O)C,,,,,,
9655,159656,"Docosa-4,7,10,13,16-pentaenoic acid",CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)O,,,,,,
9656,159657,3-Methyl-l-tyrosine,CC1=C(C=CC(=C1)C[C@@H](C(=O)O)N)O,,,,,,
9657,159658,Silver methanesulfonate,CS(=O)(=O)[O-].[Ag+],,,,,,
9658,159659,Laminine,C[N+](C)(C)CCCCC(C(=O)[O-])N,,,,,,
9659,159660,"n,n,n-Trimethyllysine",C[N+](C)(C)CCCCC(C(=O)O)N,,,,,,
9660,159661,Ammonium laurate,CCCCCCCCCCCC(=O)[O-].[NH4+],,,,,,
9661,159662,Hirudonine,C(CCN=C(N)N)CNCCCN=C(N)N,,,,,,
9662,159663,Androsterone sulfate,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)OS(=O)(=O)O,,,,,,
9663,159664,2-Oxohexanoic acid,CCCCC(=O)C(=O)O,,,,,,
9664,159665,5-Hydroxyindomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)O)CC(=O)O,,,,,['O-Desmethylindomethacin is a known human metabolite of indomethacin.'],
9665,159666,"2-(Aziridin-1-yl)-4,6-dimethoxy-1,3,5-triazine",COC1=NC(=NC(=N1)N2CC2)OC,,,,,,
9666,159667,Nicotinoylprocaine,CCN(CC)CCOC(=O)C1=CC=C(C=C1)NC(=O)C2=CN=CC=C2,,,,,,
9667,159668,2-methyl-7-nitro-2H-indazole,CN1C=C2C=CC=C(C2=N1)[N+](=O)[O-],,,,,,
9668,159669,"Quinoline, 4-((3-((2-chloroethyl)ethylamino)propyl)amino)-6-methoxy-, dihydrochloride",CCN(CCCNC1=C2C=C(C=CC2=NC=C1)OC)CCCl.Cl.Cl,,,,,,
9669,159670,"N'-(2-chloroethyl)-N'-ethyl-N-(6-methoxyquinolin-4-yl)propane-1,3-diamine",CCN(CCCNC1=C2C=C(C=CC2=NC=C1)OC)CCCl,,,,,,
9670,159671,3-(Ethyl-2-chloroethyl)aminopropylamine dihydrochloride,CCN(CCCN)CCCl.Cl.Cl,,,,,,
9671,159672,"N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine",CCN(CCCN)CCCl,,,,,,
9672,159673,Cerium phosphate,[O-]P(=O)([O-])[O-].[Ce+3],,,,,,
9673,159674,Cerium sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Ce+3].[Ce+3],,,,,,
9674,159675,indium(III)chloride,[Cl-].[Cl-].[Cl-].[In+3],,,,,,
9675,159676,Dipotassium;phosphorous acid,OP(O)O.[K+].[K+],,,,,,
9676,159677,Sodium vanadium oxide (Na4V2O7),[O-2].[O-2].[O-2].[Na+].[V],,,,,,
9677,159678,Zirconyl chloride octahydrate,O.O.O.O.O.O.O.O.O=[Zr].Cl.Cl,,,,,,
9678,159679,Iron triperchlorate,[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Fe+3],,,,,,
9679,159680,Dibismuth molybdenum hexaoxide,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Mo].[Mo].[Bi+3].[Bi+3],,,,,,
9680,159681,"Rhodium chloride, trihydrate",O.O.O.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
9681,159682,"Chromate(1-), diamminetetrakis(thiocyanato-kappaN)-, ammonium (1:1), (OC-6-11)-",C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].[NH4+].N.N.[Cr+3],,,,,,
9682,159683,CID 159683,CC=C(C[C@@H](C)[C@](C)(C(=O)O)O)C(=O)O,,,,,,
9683,159684,Cerium(IV) sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Ce+4],,,,,,
9684,159685,Zinc sulfite,[O-]S(=O)[O-].[Zn+2],,,,,,
9685,159686,Zinc selenite,[O-][Se](=O)[O-].[Zn+2],,,,,,
9686,159687,"Silicic acid (H4SiO4), zinc salt (1:2)",O[Si](O)(O)O.[Zn].[Zn],,,,,,
9687,159688,Zinc dihydrogen phosphate dihydrate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Zn+2],,,,,,
9688,159689,Hexacyanochromate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[Cr+3],,,,,,
9689,159690,Thallium trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Tl+3],,,,,,
9690,159691,Magnesium;disulfite,[O-]S(=O)[O-].[O-]S(=O)[O-].[Mg+2],,,,,,
9691,159692,Trisodium hexafluoroaluminate,[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Al+3],,,,,,
9692,159693,"Hydrazine, monohydrobromide",NN.Br,,,,,,
9693,159694,Lanthanum phosphate,[O-]P(=O)([O-])[O-].[La+3],,,,,,
9694,159695,Calcium nitrite,N(=O)[O-].N(=O)[O-].[Ca+2],,,,,,
9695,159696,Calcium selenite,[O-][Se](=O)[O-].[Ca+2],,,,,,
9696,159697,Diammonium zinc disulphate,[NH4+].[NH4+].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Zn+2].[Zn+2],,,,,,
9697,159698,Tin(II) tetrafluoroborate,[B-](F)(F)(F)F.[B-](F)(F)(F)F.[Sn+2],,,,,,
9698,159699,Chloropentaamminerhodium(III),N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
9699,159700,Dipotassium tetrabromoplatinate,[K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2],,,,,,
9700,159701,"3,3'-Diindolyl-2,2'-tetrasulfide",C1=CC=C2C(=C1)C3=C(N2)SSSSC4=C3C5=CC=CC=C5N4,,,,,,
9701,159702,Chloropentaamminecobalt(III) dichloride,N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Co+3],,,,,,
9702,159703,Disodium disulphate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9703,159704,Zinc bis(piperidine-1-carbodithioate),C1CCN(CC1)C(=S)[S-].C1CCN(CC1)C(=S)[S-].[Zn+2],,,,,,
9704,159705,"Pyrimidine, 2,4,6-tris(1-aziridinyl)-",C1CN1C2=CC(=NC(=N2)N3CC3)N4CC4,,,,,,
9705,159706,"Pyrimidine, 2,4,6-tris(1-aziridinyl)-5-chloro-",C1CN1C2=C(C(=NC(=N2)N3CC3)N4CC4)Cl,,,,,,
9706,159707,CID 159707,O[IH](O)(O)(O)(O)O.[Na+].[Na+].[Na+],,,,,,
9707,159708,CID 159708,O[IH](O)(O)(O)(O)O,,,,,,
9708,159709,Potassium cobalticyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[Co+3],,,,,,
9709,159710,"Aurate(1-), bis(cyano-c)-, potassium",[C-]#N.[C-]#N.[K+].[Au+],,,,,,
9710,159711,Cadmium molybdenum tetroxide,[O-2].[O-2].[O-2].[O-2].[Mo].[Cd+2],,,,,,
9711,159712,Potassium;phosphorous acid,OP(O)O.[K+],,,,,,
9712,159713,Fiton,C1CCC(=O)NCC1.C1CCC(=O)NCC1.C1CCC(=O)NCC1.[Cl-].[Cl-].[Cu+2],,,,,,
9713,159714,CID 159714,C[C@H]1C=CC=C(C(=O)N=C2C(=CNN3CCN(CC3)C)C(=O)C4=C(C2=O)C(=C(C5=C4C(=O)[C@](O5)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,,,,,,
9714,159715,Hexaaminecobalt triacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].N.N.N.N.N.N.[Co+3],,,,,,
9715,159716,"Iridate(3-), hexachloro-, tripotassium, (OC-6-11)-",[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[K+].[Ir+3],,,,,,
9716,159717,CID 159717,CCCCCCCCC(=O)[O-].[Na+],,,,,,
9717,159718,Desmethylcyproheptadine,C1CNCCC1=C2C3=CC=CC=C3C=CC4=CC=CC=C42,,,,,,
9718,159719,Bismuth orthovanadate,[O-2].[O-2].[O-2].[O-2].[V].[Bi+3],,,,,,
9719,159720,"Ethanol, 2-ethoxy-, magnesium salt",CCOCC[O-].CCOCC[O-].[Mg+2],,,,,,
9720,159721,"Rhodium(1+), dichlorotetrakis(pyridine)-, chloride",C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
9721,159722,Silver tetrafluoroborate,[B-](F)(F)(F)F.[Ag+],,,,,,
9722,159723,"2,3-Dihydroxy-4-methylcyclopent-2-en-1-one",CC1CC(=O)C(=C1O)O,,,,,,
9723,159724,"6,6'-(p-Phenylenebis(carbonylimino))bis(1-butylquinolinium) ditosylate",CCCC[N+]1=CC=CC2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC5=C(C=C4)[N+](=CC=C5)CCCC.CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
9724,159725,"Quinolinium, 6,6'-(1,4-phenylenebis(carbonylimino))bis(1-butyl-",CCCC[N+]1=CC=CC2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC5=C(C=C4)[N+](=CC=C5)CCCC,,,,,,
9725,159726,Hydroxymethyldeoxyuridine triphosphate,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CO)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
9726,159727,"(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(10R,12S,13R,14R,17R)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-4,6-bis(hydroxymethyl)oxane-3,5-diol",CC(=CCC[C@@](C)([C@@H]1CC[C@]2([C@@H]1[C@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)CO)O)C)O)C)O)C,,,,,,
9727,159728,Sodium ferricyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Na+].[Na+].[Na+].[Fe+3],,,,,,
9728,159729,Dihydro-alpha-ergocryptine mesylate,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O.CS(=O)(=O)O,,,"['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)']",,,
9729,159730,"9,10-Dihydroergocryptine",CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4CC5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O,,,,,,
9730,159731,Hexaammineruthenium trichloride,N.N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
9731,159732,Rutheniumacetylacetonate,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ru+3],,,,,,
9732,159733,"Cobaltate(4-), (29H,31H-phthalocyanine-2,9,16,23-tetrasulfonato(6-)-kappaN29,kappaN30,kappaN31,kappaN32)-, tetrahydrogen, (SP-4-1)-",[H+].[H+].[H+].[H+].C1=CC2=C(C=C1S(=O)(=O)[O-])C3=NC4=NC(=NC5=NC(=NC6=C7C=CC(=CC7=C([N-]6)N=C2[N-]3)S(=O)(=O)[O-])C8=C5C=CC(=C8)S(=O)(=O)[O-])C9=C4C=CC(=C9)S(=O)(=O)[O-].[Co+2],,,,,,
9733,159734,CID 159734,C1=CC2=C(C=C1S(=O)(=O)O)C3=NC2=NC4=NC(=NC5=NC(=NC6=C7C=C(C=CC7=C(N6)N3)S(=O)(=O)O)C8=C5C=C(C=C8)S(=O)(=O)O)C9=C4C=C(C=C9)S(=O)(=O)O,,,,,,
9734,159735,alpha-Allyl-alpha-allophanyl-gamma-butyrolactone,CC1CC(C(=O)O1)(CC=C)C(=O)NC(=O)NC2=CC=CC=C2,,,,,,
9735,159736,Biligram,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=C(C(=C(C(=C1I)NC(=O)COCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I,,,,,,
9736,159737,Strontium phosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Sr+2].[Sr+2].[Sr+2],,,,,,
9737,159738,1-Deaza-adenosine,C1=CN=C2C(=C1N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
9738,159739,Trilead dicitrate,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Pb+2].[Pb+2].[Pb+2],,,,,,
9739,159740,Aluminum perchlorate,[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Al+3],,,,,,
9740,159741,Potassium bis(oxalato)oxotitanate(IV) dihydrate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].O=[Ti+2].[K+].[K+],,,,,,
9741,159742,CID 159742,[Li+].[B-](C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
9742,159743,"Silicic acid, aluminum salt",[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Al+3].[Al+3],,,,,,
9743,159744,But-2-enedioic acid--ammonia (1/2),C(=CC(=O)O)C(=O)O.N.N,,,,,,
9744,159745,"Ruthenium, trihydroxynitrosyl-",[N-]=O.O.O.O.[Ru+],,,,,,
9745,159746,(r)-Benzyloxymethyl-oxirane,C1[C@@H](O1)COCC2=CC=CC=C2,,,,,,
9746,159747,Zinc acrylate,C=CC(=O)[O-].C=CC(=O)[O-].[Zn+2],,,"['Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses. (See all compounds classified as Tissue Adhesives.)']",,,
9747,159748,"Cobaltate(3-), hexakis(nitrito-O)-, trisodium, (OC-6-11)-",N(=O)[O-].N(=O)[O-].N(=O)[O-].N(=O)[O-].N(=O)[O-].N(=O)[O-].[Na+].[Na+].[Na+].[Co+3],,,,,,
9748,159749,CID 159749,CC(=CC=CC=C(C)C=CC=C(C)C=C=C1[C@](C[C@H](CC1(C)C)O)(C)O)C=CC=C(C)C=C[C@]23[C@](O2)(C[C@H](CC3(C)C)O)C,,,,,,
9749,159750,CID 159750,CCCCCCCCC=CCCCCCCCC(=O)O.[Co+2],,,,,,
9750,159751,Pranferol,CC(C)[C@H](COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)O,,,,,,
9751,159752,Triethanolamine acetate,CC(=O)O.C(CO)N(CCO)CCO,,,,,,
9752,159753,Dipotassium pentachloronitrosylruthenate,N#[O+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Ru+2],,,,,,
9753,159754,"Lauric acid, barium cadmium salt",CCCCCCCCCCCC(=O)O.[Cd+2].[Ba+2],,,,,,
9754,159755,1-(2-Methoxyphenyl)propan-2-amine,CC(CC1=CC=CC=C1OC)N,,,,,,
9755,159756,Terephthalamidine,C1=CC(=CC=C1C(=N)N)C(=N)N,,,,,,
9756,159757,C.I. Direct Red 83,C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)[O-])N=NC5=C(C=CC(=C5)S(=O)(=O)[O-])[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC6=C(C=CC(=C6)S(=O)(=O)[O-])[O-])[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
9757,159758,4-Hydroxy-7-[[5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-hydroxy-5-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)O)N=NC5=C(C=CC(=C5)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O)N=NC6=C(C=CC(=C6)S(=O)(=O)O)O)O,,,,,,
9758,159759,"Phosphonic acid, sodium salt",OP(O)O.[Na+],,,,,,
9759,159760,Dipotassium;telluric acid,O[Te](=O)(=O)O.[K+].[K+],,,,,,
9760,159761,"Phosphoric acid, titanium(4+) salt (4:3)",[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ti+4].[Ti+4].[Ti+4],,,,,,
9761,159762,Sodium percarbonate,C(=O)([O-])[O-].C(=O)([O-])[O-].OO.OO.OO.[Na+].[Na+].[Na+].[Na+],,,,"['Dermal absorption is assumed to be low due to the hydrophilic character and the ionic structure of the substance. When sodium percarbonate comes into contact with body fluids it will dissociate into hydrogen peroxide, carbonate ions and sodium ions. All three substances are naturally present in the human body.']",,
9762,159763,"Copper;16-ethenyl-11-ethyl-3-methoxycarbonyl-12,17,21,26-tetramethyl-22-[3-oxo-3-(3,7,11,15-tetramethylhexadec-2-enoxy)propyl]-23,24,25-triaza-7-azanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2(6),4,8(26),9,11,13(25),14,16,18(24),19-undecaen-4-olate",CCC1=C(C2=NC1=CC3=C(C4=C(C(C(=C4[N-]3)C5=NC(=CC6=NC(=C2)C(=C6C)C=C)C(C5CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C)C(=O)OC)[O-])C)C.[Cu+2],,,,,,
9763,159764,"Methyl 16-ethenyl-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-22-[3-oxo-3-(3,7,11,15-tetramethylhexadec-2-enoxy)propyl]-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaene-3-carboxylate",CCC1=C(C2=NC1=CC3=C(C4=C(C(C(=C5C(C(C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C4=N3)C(=O)OC)O)C)C,,,,,,
9764,159765,CID 159765,C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC=C(C(=C1)C(=O)[O-])O.[Pb+2],,,,,,
9765,159766,"5,9-Dimethyl-furo[3,2-g]chromen-7-one",CC1=CC(=O)OC2=C1C=C3C=COC3=C2C,,,,,,
9766,159767,cis-Dibromodiammineplatinum(II),N.N.[Br-].[Br-].[Pt+2],,,,,,
9767,159768,2-Amino-3-(2-oxoindolin-3-yl)propanoic acid,C1=CC=C2C(=C1)C(C(=O)N2)CC(C(=O)O)N,,,,,,
9768,159769,Cadmium lactate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Cd+2],,,,,,
9769,159770,CID 159770,C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC=C(C(=C1)C(=O)[O-])O.[Cu+2],,,,,,
9770,159771,Gadolinium(3+) acetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Gd+3],,,,,,
9771,159772,4-Guanidinobenzoic acid,C1=CC(=CC=C1C(=O)O)N=C(N)N,,,,,,
9772,159773,Azanylidyneoxidanium;iron;methanethiolate,C[S-].C[S-].N#[O+].N#[O+].N#[O+].N#[O+].[Fe].[Fe],,,,,,
9773,159774,CID 159774,C1=CC=C(C=C1)C=CC(=O)[O-].[K+],,,,,,
9774,159775,CID 159775,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)O)OP(=O)(O)O,,,,,,
9775,159776,Aklavinone,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O)O,,,,,,
9776,159777,"Hexamethylenetetramine, compd. with methyl((alpha,4-dichloro-o-tolyl)oxy)acetate (1:1)",COC(=O)COC1=C(C=C(C=C1)Cl)CCl.C1N2CN3CN1CN(C2)C3,,,,,,
9777,159778,Methyl 2-[4-chloro-2-(chloromethyl)phenoxy]acetate,COC(=O)COC1=C(C=C(C=C1)Cl)CCl,,,,,,
9778,159779,"Hexamethylenetetramine, compd. with ethyl((alpha,4-dichloro-o-tolyl)oxy)acetate (1:1)",CCOC(=O)COC1=C(C=C(C=C1)Cl)CCl.C1N2CN3CN1CN(C2)C3,,,,,,
9779,159780,Ethyl[4-chloro-2-(chloromethyl)phenoxy]acetate,CCOC(=O)COC1=C(C=C(C=C1)Cl)CCl,,,,,,
9780,159781,"Hexamethylenetetramine, compd. with ethyl((4-bromo-alpha-chloro-o-tolyl)oxy)acetate (1:1)",CCOC(=O)COC1=C(C=C(C=C1)Br)CCl.C1N2CN3CN1CN(C2)C3,,,,,,
9781,159782,Ethyl [4-bromo-2-(chloromethyl)phenoxy]acetate,CCOC(=O)COC1=C(C=C(C=C1)Br)CCl,,,,,,
9782,159783,"Hexamethylenetetramine, compd. with methyl((4-bromo-alpha-chloro-o-tolyl)oxy)acetate (1:1)",COC(=O)COC1=C(C=C(C=C1)Br)CCl.C1N2CN3CN1CN(C2)C3,,,,,,
9783,159784,Methyl 2-[4-bromo-2-(chloromethyl)phenoxy]acetate,COC(=O)COC1=C(C=C(C=C1)Br)CCl,,,,,,
9784,159785,Zinc myristate,CCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCC(=O)[O-].[Zn+2],,,,,,
9785,159786,"4,4'-Methylenebis(2-isopropyl-6-methylaniline)",CC1=CC(=CC(=C1N)C(C)C)CC2=CC(=C(C(=C2)C)N)C(C)C,,,,,,
9786,159787,CID 159787,C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)O)NCCO)S(=O)(=O)O)S(=O)(=O)O.[Na+].[Na+].[Na+].[Na+],,,,,,
9787,159788,"5-[[4-(2-Hydroxyethylamino)-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-(2-hydroxyethylamino)-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)O)NCCO)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9788,159789,CID 159789,CC(=O)C=C(C1=CC=CC=C1)[O-].CC(=O)C=C(C1=CC=CC=C1)[O-].CC(=O)C=C(C1=CC=CC=C1)[O-].[Cr+3],,,,,,
9789,159790,Tetraamine platinum,N.N.N.N.[Pt+2],,,,,,
9790,159791,"3-(1,1,3-Trioxo-1,2-benzothiazol-2-yl)piperidine-2,6-dione",C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3S2(=O)=O,,,,,,
9791,159792,"Octanoic acid, compd. with 2,2'-iminobis[ethanol] (1:1)",CCCCCCCC(=O)O.C(CO)NCCO,,,,,,
9792,159793,"(3R,4S,5R)-3,4,5,6-tetrahydroxy-2-oxohexanoic acid",C([C@H]([C@@H]([C@H](C(=O)C(=O)O)O)O)O)O,,,,,,
9793,159794,"1,3,3-Trimethyl-2-[7-(1,3,3-trimethylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]indole;perchlorate",CC1(C2=CC=CC=C2[N+](=C1C=CC=CC=CC=C3C(C4=CC=CC=C4N3C)(C)C)C)C.[O-]Cl(=O)(=O)=O,,,,,,
9794,159795,Thalidasine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C4)OC)OC5=CC=C(C[C@H]6C7=CC(=C(C(=C7CCN6C)O3)OC)OC)C=C5)OC)OC,,,,,,
9795,159796,Bisdequalinium,CC1=[N+]2CCCCCCCCCC[N+]3=C(C=C(C4=CC=CC=C43)NCCCCCCCCCCNC(=C1)C5=CC=CC=C52)C,,,,,,
9796,159797,Diallyl sulfone,C=CCS(=O)(=O)CC=C,,,,,,
9797,159798,CID 159798,CC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CC5=CC=CC=C5)CC6=CC=CC=C6)C(C)C)CC7=CC=CC=C7)CC8=CC=CC=C8,,,,,,
9798,159799,Dipotassium hexaiodoplatinate,[K+].[K+].[I-].[I-].[I-].[I-].[I-].[I-].[Pt+4],,,,,,
9799,159800,Dipotassium titanium hexafluoride,[F-].[F-].[F-].[F-].[F-].[F-].[K+].[K+].[Ti+4],,,,,,
9800,159801,Disodium hexafluorostannate(2-),[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Sn+4],,,,,,
9801,159802,CID 159802,[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[SbH3],,,,,,
9802,159803,Hexafluorosilicate(2-) calcium (1:1),[F-].[F-].[F-].[F-].[F-].[F-].[Si+4].[Ca+2],,,,,,
9803,159804,Diazanium;iridium;hexachloride,[NH4+].[NH4+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ir],,,,,,
9804,159805,"Iridate(2-), hexachloro-, disodium, (OC-6-11)-",[Na+].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ir],,,,,,
9805,159806,Ammonium titanium fluoride,[NH4+].[NH4+].[F-].[F-].[F-].[F-].[F-].[F-].[Ti+4],,,,,,
9806,159807,CID 159807,[H+].[B+3].CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N.C1=CC=C(C(=C1)[O-])[O-].C1=CC=C(C(=C1)[O-])[O-],,,,,,
9807,159808,"Phosphoric acid, titanium(4+) salt",[O-]P(=O)([O-])[O-].[Ti+4],,,,,,
9808,159809,Tetrahydroharmine,CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)OC,,,,,,
9809,159810,Potassium hexafluoroarsenate,F[As-](F)(F)(F)(F)F.[K+],,,,,,
9810,159811,Gold(3+);hydron;tetrabromide,[H+].[Br-].[Br-].[Br-].[Br-].[Au+3],,,,,,
9811,159812,Diuronium sulphate,C(=O)(N)N.C(=O)(N)N.[O-]S(=O)(=O)[O-],,,,,,
9812,159813,"(4aS,6aR,6aS,6bR,10S,12aR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid",C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@H](CO6)O)O)O,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)'],,,
9813,159814,Viridifloric acid,C[C@H]([C@](C(C)C)(C(=O)O)O)O,,,,,,
9814,159815,Disodium azelate,C(CCCC(=O)[O-])CCCC(=O)[O-].[Na+].[Na+],,,"['Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
9815,159816,CID 159816,CC(=O)OC(C)(C)C=CC(=O)[C@@](C)([C@@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3CC(=O)[C@H](C4(C)C)O)C)C)C)O)O,,,,,,
9816,159817,"(2R)-2-(2-phenylethenyl)-2,3-dihydropyran-6-one",C1C=CC(=O)O[C@H]1C=CC2=CC=CC=C2,,,,,,
9817,159818,Bismuth;phosphoric acid,OP(=O)(O)O.[Bi+3],,,,,,
9818,159819,Aristololactam-glucoside,COC1=CC=CC2=C3C4=C(C=C21)N(C(=O)C4=CC5=C3OCO5)[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
9819,159820,4-Phenanthrenamine,C1=CC=C2C(=C1)C=CC3=C2C(=CC=C3)N,,,,,,
9820,159821,"Magnesium;methyl 16-acetyl-11-ethyl-12,17,21,26-tetramethyl-4-oxo-22-[3-oxo-3-(3,7,11,15-tetramethylhexadec-2-enoxy)propyl]-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2(6),5(26),8,10(25),13,15,17,19-nonaene-3-carboxylate",CCC1C(C2=CC3=C(C(=C([N-]3)C=C4C(C(C(=N4)C5=C6C(=C(C(=CC1=N2)[N-]6)C)C(=O)C5C(=O)OC)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C)C)C(=O)C)C.[Mg+2],,,,,,
9821,159822,"Methyl 16-acetyl-11-ethyl-12,17,21,26-tetramethyl-4-oxo-22-[3-oxo-3-(3,7,11,15-tetramethylhexadec-2-enoxy)propyl]-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2(6),5(26),8,10(25),13,15,17,19-nonaene-3-carboxylate",CCC1C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C5=C6C(=C(C(=CC1=N2)N6)C)C(=O)C5C(=O)OC)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C)C)C(=O)C)C,,,,,,
9822,159823,"7,8,9,10-Tetrahydrobenzo[a]pyren-10-ol",C1CC(C2=C(C1)C=C3C=CC4=C5C3=C2C=CC5=CC=C4)O,,,,,"['10-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene has known human metabolites that include 7,8,9,10-tetrahydrobenzo[a]pyren-10-yl hydrogen sulfate.']",
9823,159824,"Europium(3+);6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-5-oxooct-3-en-3-olate",CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)[O-].[Eu+3],,,,,,
9824,159825,"1,1,1,2,2,3,3-Heptafluoro-6-hydroxy-7,7-dimethyloct-5-en-4-one",CC(C)(C)C(=CC(=O)C(C(C(F)(F)F)(F)F)(F)F)O,,,,,,
9825,159826,CID 159826,C1=NC2=C(N1[C@@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(N=C2S)N,,,,,,
9826,159827,"N-[3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]hydroxylamine",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=NO)C)C,,,,,,
9827,159828,(+)-LSD tartrate,CCN(CC)C(=O)C1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C.CCN(CC)C(=O)C1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C.C(C(C(=O)[O-])O)(C(=O)[O-])O,,,,,,
9828,159829,"(6aR)-N,N-diethyl-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CCN(CC)C(=O)C1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
9829,159830,Hematoporphyrin dihydrochloride,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)O)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O.Cl.Cl,,,,,,
9830,159831,CID 159831,C1(=NC(=NC(=N1)[S-])S)S.[Na+].[Na+].[Na+],,,,,,
9831,159832,Atomic oxygen,[O],,,['Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)'],,,
9832,159833,"4-N-[4-(diaminomethylideneamino)phenyl]-1-N-[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide;iodide;hydroiodide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=C(N)N.I.[I-],,,,,,
9833,159834,"4-N-[4-(diaminomethylideneamino)phenyl]-1-N-[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=C(N)N,,,,,,
9834,159835,CID 159835,CC1(C=CC2=C(O1)C3=CC=C(OC3=C(C2=O)C(C)(C)C=C)O)C,,,,,,
9835,159836,Potassium magnesium sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Mg+2].[Mg+2].[K+].[K+],,,,,,
9836,159837,Bis(cyclohexylammonium)sulfate,C1CCC(CC1)N.C1CCC(CC1)N.OS(=O)(=O)O,,,,,,
9837,159838,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt",C1=CC=C(C=C1)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)NCCO)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9838,159839,"4,4'-Bis[4-(beta-hydroxyethylamino)-6-phenylamino-1,3,5-triazin-2-ylamino]stilbene-2,2'-disulfonic acid",C1=CC=C(C=C1)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)NCCO)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9839,159840,CID 159840,CN1C=CC2C3=CC=CC=C3[NH2+]C2=C1,,,,,,
9840,159841,"2-Methyl-4a,9-dihydropyrido[3,4-b]indole",CN1C=CC2C3=CC=CC=C3NC2=C1,,,,,,
9841,159842,D-6-Methyl-8-cyanomethylergoline,CN1C[C@@H](CC2[C@H]1CC3=CNC4=CC=CC2=C34)CC#N,,,,,,
9842,159843,Methanenitronate,[CH2-][N+](=O)[O-],,,,,,
9843,159844,Nitromethanide,C=[N+](O)[O-],,,,,,
9844,159845,Mitomycin F,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4C)OC,,,,,,
9845,159846,Baldrinal,CC(=O)OCC1=COC=C2C1=CC=C2C=O,,,,,,
9846,159847,Lombricine,C(COP(=O)(O)OC[C@@H](C(=O)O)N)N=C(N)N,,,,,,
9847,159848,"Uranate(1-), dioxo(phosphato(3-)-kappaO,kappaO')-, hydrogen, (T-4)-",[H+].[O-]P(=O)([O-])[O-].O=[U+2]=O,,,,,,
9848,159849,"7H-Pyrrolo(2,3-d)pyrimidine-5-carboxylic acid, 4-amino-7-beta-D-ribofuranosyl-, methyl ester",COC(=O)C1=CN(C2=NC=NC(=C12)N)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
9849,159850,Stampyrine,CCCCCCCCCCCCCCCCCC(=O)NC1=C(N(N(C1=O)C2=CC=CC=C2)C)C,,,,,,
9850,159851,Pentaamminechlororuthenium dichloride,N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
9851,159852,CID 159852,CC(=CCC1=CC2=C3C(=C(OC2=CC1=O)O)C4=C(O3)C=C(C=C4)O)C,,,,,,
9852,159853,"Phosphonic diamide, P-4-piperidyl-N,N,N',N'-tetramethyl-",CNP(=O)(C1CCN(CC1)C)N(C)C,,,,,,
9853,159854,"2,5-Dimethyl-3,6-diaziridinyl-1,4-benzoquinone",CC1=C(C(=O)C(=C(C1=O)N2CC2)C)N3CC3,,,,,,
9854,159855,Actinomycin X2,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CC(=O)CN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,,,,,
9855,159856,Dimethyl aziridinium,C[N+]1(CC1)C.Cl.[Cl-],,,,,,
9856,159857,"1,1-Dimethylaziridinium",C[N+]1(CC1)C,,,,,,
9857,159858,"Ruthenium, trichloronitrosyl-",[N-]=O.Cl[Ru](Cl)Cl,,,,,,
9858,159859,Streptozotocin tetraacetate,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)OC(=O)C)NC(=O)N(C)N=O)OC(=O)C)OC(=O)C,,,,,,
9859,159860,"(2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[(1S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)CC4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1,,,,,,
9860,159861,Gracillin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1,,,,,,
9861,159862,Trihydrogen bis(3-hydroxy-4-((2-hydroxy-1-naphthyl)azo)naphthalene-1-sulphonato(3-))chromate(3-),[H+].[H+].[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)[O-])[O-])[O-].[Cr+3],,,,,,
9862,159863,Zinc dithiophosphate,[O-]P(=S)([O-])[S-].[O-]P(=S)([O-])[S-].[Zn+2].[Zn+2].[Zn+2],,,,,,
9863,159864,Acetyltaurine,CC(=O)NCCS(=O)(=O)O,,,,,,
9864,159865,Silver sulfate,[O-]S(=O)(=O)[O-].[Ag+].[Ag+],,,,,,
9865,159866,"3,6,9,12,15-Pentaoxatricosan-1-ol",CCCCCCCCOCCOCCOCCOCCOCCO,,,,,,
9866,159867,5-Deazariboflavin,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=C2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
9867,159868,Calcium;4-oxopent-2-en-2-olate,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ca+2],,,,,,
9868,159869,Lysyl-lysyl-lysyl-lysyl-lysyl,C(CCN)C[C@@H](C(=O)C(CC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)CN)N,,,,,,
9869,159870,Carcinolipin,CCC(C)CCCCCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C,,,,,,
9870,159871,Chlorcyclamide,C1CC=CC(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl,,,,,,
9871,159872,CID 159872,CCNC1=NC(=O)C2=C(N1)N=CN2,,,,,,
9872,159873,"2,5-Dihydroxy-3-methyl-6-nonadec-14-enylcyclohexa-2,5-diene-1,4-dione",CCCCC=CCCCCCCCCCCCCCC1=C(C(=O)C(=C(C1=O)O)C)O,,,,,,
9873,159874,"[(3aR,4S,11aR)-10-(hydroxymethyl)-6-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] 2-(hydroxymethyl)prop-2-enoate",CC1=CCCC(=C[C@@H]2[C@@H]([C@H](C1)OC(=O)C(=C)CO)C(=C)C(=O)O2)CO,,,,,,
9874,159875,CID 159875,C1=CC(=CC=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O,,,,,,
9875,159876,Diplacin,C1C[N+]2(CCC(C2C1CO)O)CCOC3=CC(=CC=C3)OCC[N+]45CCC(C4C(CC5)O)CO.[Cl-].[Cl-],,,,,,
9876,159877,"4-[2-[3-[2-[1-hydroxy-7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-4-ium-4-yl]ethoxy]phenoxy]ethyl]-7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-4-ium-1-ol",C1C[N+]2(CCC(C2C1CO)O)CCOC3=CC(=CC=C3)OCC[N+]45CCC(C4C(CC5)O)CO,,,,,,
9877,159878,CID 159878,CCOC(C)C(=NN=C(N)[S-])C=NN=C(N)[S-].[Cu+2],,,,,,
9878,159879,Hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine,C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](=O)(=O)O,,,,,,
9879,159880,Caffeidine,CNC1=C(N(C=N1)C)C(=O)NC,,,,,,
9880,159881,Bandrowski's base,C1=CC(=CC=C1N)N=C2C=C(C(=NC3=CC=C(C=C3)N)C=C2N)N,,,,,,
9881,159882,"Acridine, 9-((3-(dimethylamino)propyl)amino)-1-nitro-, N-oxide",CN(C)CCC[NH+](C1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])[O-],,,,,,
9882,159883,"N,N-dimethyl-N'-(1-nitroacridin-9-yl)-N'-oxidopropane-1,3-diamine",CN(C)CCCN(C1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-])[O-],,,,,,
9883,159884,Diamminediaqua platinum(II),N.N.O.O.[Pt+2],,,,,,
9884,159885,CID 159885,CCC1=C2C=C3C(=C4C(=O)[C@@H](C(=C5[C@H]([C@@H](C(=CC6=NC(=CC(=N2)C1=CO)C(=C6C)C=C)N5)C)CCC(=O)O)C4=N3)C(=O)OC)C,,,,,,
9885,159886,"[6-[4-(Dimethylamino)-5-hydroxy-6-[[4-hydroxy-5-methoxy-9,16-dimethyl-2,10-dioxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate",CC1CC=CC=CC(=O)C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C,,,,,,
9886,159887,Isocunabic acid,C[C@@]12CCC[C@]([C@H]1CC[C@]34[C@H]2CCC(C3)C(=C)C4)(C)C(=O)O,,,,,,
9887,159888,Fumariline,CN1CCC2=CC3=C(C=C2[C@]14CC5=C(C4=O)C6=C(C=C5)OCO6)OCO3,,,,,,
9888,159889,Iprindole hydrochloride,CN(C)CCCN1C2=C(CCCCCC2)C3=CC=CC=C31.Cl,,,,,,
9889,159890,Triethanolamine lactate,CC(C(=O)O)O.C(CO)N(CCO)CCO,,,,,,
9890,159891,Talatisamine,CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC,,,,,,
9891,159892,N(4)-Hydroxycytosine,C1=C(NC(=O)N=C1)NO,,,,,,
9892,159893,Perazine sulfoxide,CN1CCN(CC1)CCCN2C3=CC=CC=C3S(=O)C4=CC=CC=C42,,,,,['Perazine sulfoxide is a known human metabolite of perazine.'],
9893,159894,"Methyl 4-hydroxy-3,5-dimethoxycinnamate; Sinapic acid methyl ester",COC1=CC(=CC(=C1O)OC)C=CC(=O)OC,,,,,,
9894,159895,"Ethanol, 2-amino-, nitrate (salt)",C(CO)N.[N+](=O)(O)[O-],,,,,,
9895,159896,CID 159896,B(O)(O)O.[KH],,,,,,
9896,159897,CID 159897,CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=NO)CC[C@H]34)C)C#C,,,,,,
9897,159898,3-[(2-O-Hexopyranosylpentopyranosyl)oxy]-23-hydroxyolean-12-en-28-oic acid,C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)CO)O[C@H]6[C@@H]([C@H]([C@H](CO6)O)O)O[C@@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
9898,159899,N-Desisopropylpropranolol,C1=CC=C2C(=C1)C=CC=C2OCC(CN)O,,,,,['N-Desisopropylpropranolol is a known human metabolite of dexpropranolol (propranolol).'],
9899,159900,6-Oxybenzo(a)pyrene,C1=CC=C2C(=C1)C3=C4C(=C2[O])C=CC5=CC=CC(=C54)C=C3,,,,,,
9900,159901,Acluracil,CCC1=C(N(C(=O)N(C1=O)CC)CC=C)Cl,,,,,,
9901,159902,CID 159902,CC1=COC(=[N+]1C)C=CNC2=CC=CC=C2.[I-],,,,,,
9902,159903,"2-(2-Anilinovinyl)-3,4-dimethyloxazol-3-ium",CC1=COC(=[N+]1C)C=CNC2=CC=CC=C2,,,,,,
9903,159904,"[(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-yl] dihydrogen phosphate",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)OP(=O)(O)O)O)O,,,,,,
9904,159905,Sodium D-tartrate,[C@H]([C@@H](C(=O)[O-])O)(C(=O)[O-])O.[Na+].[Na+],,,,,,
9905,159906,"Methanamine, N-methyl-, sulfate",CNC.OS(=O)(=O)O,,,,,,
9906,159907,L-Pyroglutamyl-L-alanine,C[C@@H](C(=O)O)NC(=O)[C@@H]1CCC(=O)N1,,,,,,
9907,159908,Epsilon-pyrromycinone,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O)O,,,,,,
9908,159909,Urea sulfate,C(=O)(N)N.OS(=O)(=O)O,,,,,,
9909,159910,Manganese protoporphyrin IX,[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)[O-])CCC(=O)[O-].[Mn+2],,,,,,
9910,159911,Guattegaumerine,CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)O)O)O)OC,,,,,,
9911,159912,N3-Ethylthymidine,CCN1C(=O)C(=CN(C1=O)[C@H]2C[C@@H]([C@H](O2)CO)O)C,,,,,,
9912,159913,Silver phosphate,[O-]P(=O)([O-])[O-].[Ag+].[Ag+].[Ag+],,,,,,
9913,159914,(6-(Hydroxymethyl)-2-pyridyl)methyl 2-(4-chlorophenoxy)-2-methylpropionate hydrochloride,CC(C)(C(=O)OCC1=CC=CC(=N1)CO)OC2=CC=C(C=C2)Cl.Cl,,,,,,
9914,159915,"2,3,5,6-Tetrachloro-4-(pentachlorophenoxy)phenol",C1(=C(C(=C(C(=C1Cl)Cl)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl)O,,,,,,
9915,159916,"8-Chloro-10-[3-(dimethylamino)propyl]phenothiazine-2,3-diol",CN(C)CCCN1C2=CC(=C(C=C2SC3=C1C=C(C=C3)Cl)O)O,,,,,,
9916,159917,Caerulomycin,COC1=CC(=NC(=C1)C2=CC=CC=N2)C=NO,,,,,,
9917,159918,2-Bis(2-methylthio)vinyl-1-methylquinolinium,C[N+]1=C(C=CC2=CC=CC=C21)C=C(SC)SC.[I-],,,,,,
9918,159919,"2-[2,2-Bis(methylsulfanyl)ethenyl]-1-methylquinolin-1-ium",C[N+]1=C(C=CC2=CC=CC=C21)C=C(SC)SC,,,,,,
9919,159920,"1-[(5-Aminofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1N=CC2=CC=C(O2)N,,,,,,
9920,159921,"(2S,3R,5R,9R,10R,13R,17R)-2,3,14-trihydroxy-17-[(2S,3R)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one",C[C@@H]([C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C)O)[C@@H](CCC(C)C)O,,,,,,
9921,159922,Peroxymonosulfate,[O-]OS(=O)(=O)[O-],,,,,,
9922,159923,"5,5-Dimethylcyclophosphamide",CC1(CNP(=O)(OC1)N(CCCl)CCCl)C,,,,,,
9923,159924,Methylammonium nitrate,CN.[N+](=O)(O)[O-],,,,,,
9924,159925,CID 159925,C[C@H]1CC=C[C@H]2[C@@H](C(=C([C@@H]3[C@@]2([C@@H](C=C[C@@](C1=O)(C)O)OC(=O)C)C(=O)NC3CC4=CC=CC=C4)C)C)O,,,,,,
9925,159926,Macrosporin,CC1=CC2=C(C=C1O)C(=O)C3=C(C2=O)C=C(C=C3O)OC,,,,,,
9926,159927,"3,22,23-Trihydroxy-27,29-epoxystigmasta-5,24(28)-diene-7,29-dione",CC1COC(=O)C=C1[C@H]([C@H]([C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C(=O)C=C5[C@@]4(CC[C@@H](C5)O)C)C)O)O,,,,,,
9927,159928,Disodium mercaptosuccinate,C(C(C(=O)[O-])S)C(=O)[O-].[Na+].[Na+],,,,,,
9928,159929,Nitroquine,C1=CC(=C(C=C1CN(C2=CC3=C(C=C2)N=C(N=C3N)N)N=O)Cl)Cl,,,,,,
9929,159930,"(1R,4S,5R,9S,10S,13R,15S)-15-Hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid",C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@H](C3)C(=C)[C@@H]4O)(C)C(=O)O,,,,,,
9930,159931,Zeorin,C[C@]12CC[C@@H]([C@@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(C[C@@H]([C@@H]5[C@@]4(CCCC5(C)C)C)O)C)C)C(C)(C)O,,,,,,
9931,159932,CID 159932,C1=CC=[N+](C(=C1)C=NO)COC[N+]2=CC=CC(=C2)C(=O)N.[Cl-].[Cl-],,,,,,
9932,159933,CID 159933,C1=CC=[N+](C(=C1)C=NO)COC[N+]2=CC=CC(=C2)C(=O)N,,,,,,
9933,159934,CID 159934,CCCCCCCC(CC=CCCCC)C1=C(C=CC=C1O)O,,,,,,
9934,159935,CID 159935,CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@@H](CC4)N=[N+]=[N-],,,,,,
9935,159936,(Cyclic(glycyl-N(5)-acetyl-N(5)-hydroxy-L-ornithyl-N(5)-hydroxy-L-ornithyl-N(5)-acetyl-N(5)-hydroxy-L-ornithylgylcyl-L-seryl)ato(3-))iron,CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CO)CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])[O-].[Fe+3],,,,,,
9936,159937,"N-[3-[5,8-bis[3-[acetyl(oxido)amino]propyl]-14-(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl]-N-oxidoacetamide",CC(=O)N(CCCC1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CO)CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])[O-],,,,,,
9937,159938,CID 159938,CC=C1C[C@H]([C@@](C(=O)OCC2=C3[C@@H](CCN3C=C2)OC1=O)(CO)O)C,,,,,,
9938,159939,CID 159939,C[C@]12C[C@@H]3[C@@]4(C56[C@@H]1C(=O)[C@@](O5)([C@@H]7CC=C8CC=CC(=O)[C@]8([C@@H]7CC[C@@]6(C(=O)O4)O)C)OC[C@H]2C(=O)O3)C,,,,,,
9939,159940,Metabisulfite,[O-]S(=O)S(=O)(=O)[O-],,,,,,
9940,159941,"Thiosulfuric acid (H2S2O3), disilver(1+) salt",OS(=O)(=S)O.[Ag+].[Ag+],,,,,,
9941,159942,"4,4-Dimethylmorpholinium chloride",C[N+]1(CCOCC1)C.[Cl-],,,,,,
9942,159943,CID 159943,OP(O)O.[NaH].[CaH2],,,,,,
9943,159944,"1,3-Propanediaminium, N-(2-((2,4-dinitrophenyl)amino)ethyl)-N,N,N',N',N'-pentamethyl-",C[N+](C)(C)CCC[N+](C)(C)CCNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-].[Br-].[Br-],,,,,,
9944,159945,"2-(2,4-Dinitroanilino)ethyl-dimethyl-[3-(trimethylazaniumyl)propyl]azanium",C[N+](C)(C)CCC[N+](C)(C)CCNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9945,159946,Diethanolamine acetate,CC(=O)O.C(CO)NCCO,,,,,,
9946,159947,"1-Hexanol, aluminum salt",CCCCCC[O-].CCCCCC[O-].CCCCCC[O-].[Al+3],,,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)', 'Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)']",,,
9947,159948,CID 159948,CCCCCCCCC(=O)[O-].[K+],,,,,,
9948,159949,Lignan P,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
9949,159950,alpha-Methyl-4-phenyl-1-piperidinepropionohydroxamic acid monohydrochloride,CC(CN1CCC(CC1)C2=CC=CC=C2)C(=O)NO.Cl,,,,,,
9950,159951,2-Methyl-3-(4-phenylpiperidino)propionohydroxamic acid,CC(CN1CCC(CC1)C2=CC=CC=C2)C(=O)NO,,,,,,
9951,159952,Benzyltributylammonium chloride,CCCC[N+](CCCC)(CCCC)CC1=CC=CC=C1.[Cl-],,,,,,
9952,159953,"Pyridinium, 3,3'-((2,5-dimethylterephthaloyl)bis(imino-p-phenylenecarbonylimino))bis(1-methyl-, di-p-toluenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC(=C(C=C1C(=O)NC2=CC=C(C=C2)C(=O)NC3=C[N+](=CC=C3)C)C)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
9953,159954,"2,5-dimethyl-1-N,4-N-bis[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide",CC1=CC(=C(C=C1C(=O)NC2=CC=C(C=C2)C(=O)NC3=C[N+](=CC=C3)C)C)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
9954,159955,CID 159955,C[C@@H]1[C@H]2C[C@@H](C=CC(=CC[C@@H](C=CC(=C[C@H]([C@@](C1=O)(C(=O)O2)C)NC(=O)C(=O)C)C)O)C)O,,,,,,
9955,159956,"Pyridinium, 3,3'-(1,4-phenylenebis(carbonylimino-4,1-phenylenecarbonylimino))bis(1-ethyl-",CC[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)CC,,,,,,
9956,159957,"5h-Phenanthro[4,5-bcd]pyran-5-one",C1=CC2=C3C(=C1)C(=O)OC4=CC=CC(=C43)C=C2,,,,,,
9957,159958,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)-, disodium salt",C1=CC=C(C=C1)C2=NN(N=C2)C3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N5N=CC(=N5)C6=CC=CC=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9958,159959,5-Hydroxytryptoline,C1CNCC2=C1C3=C(N2)C=CC(=C3)O,,,,,"['1H,2H,3H,4H,9H-pyrido[3,4]indol-6-ol is a known human metabolite of pinoline.']",
9959,159960,Chromocarb diethylamine,CCNCC.C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O,,,,,,
9960,159961,Eritadenine,C1=NC(=C2C(=N1)N(C=N2)C[C@H]([C@H](C(=O)O)O)O)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
9961,159962,beta-Peltatin A methyl ether,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@@H](CC4=C(C5=C(C=C24)OCO5)OC)COC3=O,,,,,,
9962,159963,"8-chloro-3-cyclohexylimino-N,5-diphenylphenazin-2-amine",C1CCC(CC1)N=C2C=C3C(=NC4=C(N3C5=CC=CC=C5)C=CC(=C4)Cl)C=C2NC6=CC=CC=C6,,,,,,
9963,159964,CID 159964,CN=C(NNC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)S,,,,,,
9964,159965,"Copper(2+) [9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-3-{3-oxo-3-[(3,7,11,15-tetramethylhexadec-2-en-1-yl)oxy]propyl}-23,25-didehydro-3,4,20,21-tetrahydro-13H-phorbin-25-id-13-ylidene]methanolate",CCC1=C2C=C3C(=C4C(=O)C(C(=C4[N-]3)C5=NC(=CC6=NC(=CC(=N2)C1=C[O-])C(=C6C)C=C)C(C5CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C)C(=O)OC)C.[Cu+2],,,,,,
9965,159966,Aknadinine,CN1CC[C@@]23[C@@]1(CCC4=C2C(=C(C=C4)OC)O)C(=C(C(=O)C3)OC)OC,,,,,,
9966,159967,"28,38-Di(ethylidene)-8,14,24,30-tetrazaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaene",CC=C1CN2CCC34C2CC1C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CCN1CC9=CC)C1=CC=CC=C16,,,,,,
9967,159968,Isoconazole nitrate,C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],,,"['Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,,
9968,159969,Acrovestone,CC(C)CC(C1=C(C(=C(C(=C1O)CC=C(C)C)O)C(=O)C)O)C2=C(C(=C(C(=C2O)CC=C(C)C)OC)C(=O)C)O,,,,,,
9969,159970,"(2s,4As,6as,8ar,10s,12as,14as,14br)-10-hydroxy-2,4a,6a,9,9,12a,14a-heptamethyl-1,2,3,4,4a,5,6,6a,7,8,8a,9,10,11,12,12a,13,14,14a,14b-icosahydropicene-2-carboxylic acid",C[C@]12CC[C@](C[C@H]1[C@@]3(CCC4=C([C@]3(CC2)C)CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)(C)C(=O)O,,,,,,
9970,159971,Colartin,C[C@H]1[C@@H]2CC[C@]3(CCC[C@@]([C@@H]3[C@H]2OC1=O)(C)O)C,,,,,,
9971,159972,6alpha-Bromo-17beta-hydroxy-17alpha-methyl-4-oxa-5alpha-androstan-3-one,C[C@]12CCC(=O)O[C@@H]1[C@H](C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)Br,,,,,,
9972,159973,CID 159973,[Cl-].[Cl-].[Cl-].[Cl-].[GaH3].[Ga+3],,,,,,
9973,159974,"(6|A,9xi,11|A,16|A)-9-fluoro-6,11,17,21-tetrahydroxy-16-methylpregna-1,4-diene-3,20-dione",C[C@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C=C[C@@]4(C3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)O,,,,,,
9974,159975,"1,1'-(Pentamethylenedioxy)bis(3-chloro-2-propanol)",C(CCOCC(CCl)O)CCOCC(CCl)O,,,,,,
9975,159976,Azaphen,CN1CCN(CC1)C2=NN=C3C(=C2)N(C4=CC=CC=C4O3)C.Cl.Cl,,,,,,
9976,159977,Pipofezine,CN1CCN(CC1)C2=NN=C3C(=C2)N(C4=CC=CC=C4O3)C,,,,,,
9977,159978,Zinc formaldehyde sulfoxylate,C(O)S(=O)[O-].C(O)S(=O)[O-].[Zn+2],,,,,,
9978,159979,"Hexanedioic acid, polymer with 1,3-butanediol",CC(CCO)O.C(CCC(=O)O)CC(=O)O,,,,,,
9979,159980,"Formaldehyde, polymer with 1,3-benzenediol",C=O.C1=CC(=CC(=C1)O)O,,,,,,
9980,159981,1-(5-Nitro-2-furyl)-2-(6-amino-3-pyridazyl)-ethylene hydrochloride,C1=CC(=NN=C1C=CC2=CC=C(O2)[N+](=O)[O-])N.Cl,,,,,,
9981,159982,Justicidin A,COC1=C(C=C2C(=C1)C(=C3C(=C2OC)COC3=O)C4=CC5=C(C=C4)OCO5)OC,,,,,,
9982,159983,"D-Fructose, 1-((1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-1-deoxy-, (S)-",C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NCC(=O)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
9983,159984,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene",CC(=C)C(=O)OC.C=CC1=CC=CC=C1,,,,,,
9984,159985,"Benzenesulfonamide, 4-methyl-, polymer with formaldehyde",CC1=CC=C(C=C1)S(=O)(=O)N.C=O,,,,,,
9985,159986,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate",CCCCOC(=O)C=C.CC(=C)C(=O)O,,,,,,
9986,159987,"Carbonic acid, polymer with 4,4'-(1-methylethylidene)bis(phenol)",CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C(=O)(O)O,,,,,,
9987,159988,"1,3-Isobenzofurandione, polymer with 2,5-furandione and 1,2-propanediol",CC(CO)O.C1=CC=C2C(=C1)C(=O)OC2=O.C1=CC(=O)OC1=O,,,,,,
9988,159989,"Benzene, ethenyl-, polymer with 2-methyl-1,3-butadiene, hydrogenated",CC(=C)C=C.C=CC1=CC=CC=C1,,,,,,
9989,159990,Tefzel,C=C.C(=C(F)F)(F)F,,,,,,
9990,159991,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with 1,3-butadiene and ethenylbenzene",CC(=C)C(=O)OC.C=CC=C.C=CC1=CC=CC=C1,,,,,,
9991,159992,"2-Propenoic acid, polymer with 1,3-butadiene and ethenylbenzene",C=CC=C.C=CC1=CC=CC=C1.C=CC(=O)O,,,,,,
9992,159993,Formaldehyde; 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C=O,,,,,,
9993,159994,Poly(methyl vinyl ether-alt-maleic acid monoethyl ester),CCOC(=O)C=CC(=O)O.COC=C,,,,,,
9994,159995,"Hexanedioic acid, polymer with 1,2-propanediol",CC(CO)O.C(CCC(=O)O)CC(=O)O,,,,,,
9995,159996,"Ethene, chlorotrifluoro-, polymer with ethene",C=C.C(=C(F)Cl)(F)F,,,,,,
9996,159997,"Urea, polymer with formaldehyde and phenol",C=O.C1=CC=CC=C1.C(=O)(N)N,,,,,,
9997,159998,"2-Butenedioic acid (2Z)-, polymer with methoxyethene, butyl ester",CCCCOC(=O)C=CC(=O)O.COC=C,,,,,,
9998,159999,Crebanine,CN1CCC2=CC3=C(C4=C2C1CC5=C4C=CC(=C5OC)OC)OCO3,,,,,,
9999,160000,Centperazine,CCN1CCC2CN(CCN2C1=O)C,,,,,,
